,index,Gene_name,MIM_id,MIM_phenotype_id,MIM_disease,Orphanet_disorder,Orphanet_association_type,Trait_association(GWAS),Interactions(ConsensusPathDB)_rankscore,gnomAD_pLI_rankscore,GDI_rankscore,LoFtool_score_rankscore
0,5,A2ML1,610627,,,Noonan syndrome,Disease-causing germline mutation(s) in,"Total cholesterol levels[28334899];Small cell lung carcinoma[28604730];Cholesterol, total[24097068];",0.6628220858895706,0.5097988653945332,0.021404333072304882,0.03806015960712093
1,12,AAAS,605378,231550;,,Triple A syndrome,Disease-causing germline mutation(s) in,,0.923680981595092,0.0817431665807117,0.6436961628817541,0.677255985267035
2,22,AAGAB,614888,148600;,,Punctate palmoplantar keratoderma type 1,Disease-causing germline mutation(s) (loss of function) in,Allergic rhinitis[30013184];Asthma[29273806;29273806];,0.752760736196319,0.16039195461578132,0.08248499086400418,0.18615715162676488
3,29,AARS,601065,613287;616339;,"[MIM:613287]Charcot-Marie-Tooth disease 2N;[MIM:616339]Epileptic encephalopathy, early infantile, 29;",Autosomal dominant Charcot-Marie-Tooth disease type 2N;Undetermined early-onset epileptic encephalopathy,Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) (loss of function) in,,0.752760736196319,0.40587931923671994,0.23701383450796137,0.2523020257826888
4,30,AARS2,612035,614096;615889;,"[MIM:614096]Combined oxidative phosphorylation deficiency 8;[MIM:615889]Leukoencephalopathy, progressive, with ovarian failure [recessive?];",Combined oxidative phosphorylation defect type 8;Hereditary diffuse leukoencephalopathy with axonal spheroids and pigmented glia;Ovarioleukodystrophy,Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) (loss of function) in;Disease-causing germline mutation(s) (loss of function) in,,0.9030674846625767,0.04100051572975761,0.3466457843904986,0.14379987722529158
5,35,AASS,605113,238700;616034;,"[MIM:238700]Hyperlysinemia, 1 [recessive?];[MIM:616034]2,4-dienoyl-CoA reductase deficiency [recessive?];",Saccharopinuria;Hyperlysinemia,Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in,,0.8685889570552148,0.0814853017019082,0.5664317410597756,0.4854205033763045
6,41,ABAT,137150,613163;,,Gamma-aminobutyric acid transaminase deficiency,Disease-causing germline mutation(s) in,Anger[24489884];Menopause (age at onset)[26414677];Bronchopulmonary dysplasia in preterm infants[30113228];,0.38061349693251534,0.2114492006188757,0.7214826416079353,0.7826887661141805
7,42,ABCA1,600046,205400;604091;,[MIM:205400]High density lipoprotein deficiency 1;[MIM:604091]High density lipoprotein deficiency 2 [dominant?];,Apolipoprotein A-I deficiency;Tangier disease,Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in,"Response to fenofibrate (total cholesterol levels)[27002377];Glaucoma[30054594;30054594];Advanced age-related macular degeneration[26691988];Waist-to-hip ratio adjusted for BMI in active individuals[28448500;28448500;28448500;28448500];Gout[22179738];Pelvic organ prolapse[26545240;26545240];Metabolic syndrome[22399527];Glaucoma (primary open-angle)[25173105;29452408;29891935;29891935;29891935];Total cholesterol levels[29403010;28334899;28334899;28334899];Itch intensity from mosquito bite adjusted by bite size[28199695];Allergic rhinitis[25085501];Cardiometabolic and hematological traits[27668658];Cholesterol, total[20686565;24097068;25961943;26582766];Waist-to-hip ratio adjusted for body mass index[28448500;28448500;28448500;25673412;25673412;25673412;25673412;28448500];Waist-to-hip ratio adjusted for BMI (adjusted for smoking behaviour)[28443625;28443625];Whole-brain volume (Alzheimer's disease interaction)[21116278];Lung cancer in ever smokers[28604730];Waist-to-hip ratio adjusted for BMI (joint analysis for main effect and physical activity interaction)[28448500;28448500;28448500;28448500];Metabolite levels (lipoprotein measures)[27005778];Coronary artery disease[29212778;29212778];HDL cholesterol[21909109;20686565;20864672;18193044;19060911;23505323;21347282;19060906;24097068;26780889;25961943;26582766;28270201;18193043];Response to bronchodilator in chronic obstructive pulmonary disease (change in FEV1)[26503814;26503814;26503814];HDL cholesterol levels[28334899;28334899;28334899];Lipid metabolism phenotypes[22286219];Aluminium levels[26025379];Glaucoma (high intraocular pressure)[25173107];Myopia (pathological)[23049088];Metabolite levels[22916037];High density lipoprotein cholesterol levels[29615537;29403010];Periodontitis (Mean PAL)[24024966];Intraocular pressure[28073927;28073927;25173106;29617998;29617998;29235454;30054594;29785010];Low high density lipoprotein cholesterol levels[26879886];",0.5128834355828221,0.5500257864878804,0.07413208039676325,0.9027010435850215
8,44,ABCA3,601615,610921;,[MIM:610921]Pulmonary surfactant metabolism dysfunction 3;,Idiopathic pulmonary fibrosis;Interstitial lung disease due to ABCA3 deficiency;Infant acute respiratory distress syndrome,Candidate gene tested in;Disease-causing germline mutation(s) (loss of function) in;Candidate gene tested in,RR interval (tricyclic/tetracyclic antidepressant use interaction)[28039329];,0.3492024539877301,0.6766374419804023,0.5324980422866092,0.929097605893186
9,45,ABCA4,601691,153800;248200;601718;604116;,"[MIM:248200]Fundus flavimaculatus;[MIM:153800]Macular degeneration, age-related, 2;[MIM:604116]Cone-rod dystrophy 3;[MIM:601718]Retinitis pigmentosa 19;",Stargardt disease;Retinitis pigmentosa;Cone rod dystrophy,Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in,D-dimer levels[21502573];Dialysis-related mortality[21546767];Palmitoleic acid (16:1n-7) levels[23362303];Nonsyndromic cleft lip with cleft palate[28232668];,0.038773006134969326,0.09179989685404848,0.07387105194466197,0.9677716390423573
10,46,ABCA5,612503,,,Gingival fibromatosis-hypertrichosis syndrome,Disease-causing germline mutation(s) (loss of function) in,Blood protein levels[29875488;29875488];,0.08736196319018405,0.09902011346054668,0.10206212477160011,0.8934929404542664
11,48,ABCA7,605414,608907;,[MIM:608907]Alzheimer disease 9;,Early-onset autosomal dominant Alzheimer disease,Candidate gene tested in,Mean corpuscular hemoglobin concentration[27863252;29403010];Alzheimer's disease (late onset)[21460841;24162737;23571587];Mean corpuscular volume[27863252];Lymphocyte percentage of white cells[27863252];Neutrophil percentage of white cells[27863252];Myeloid white cell count[27863252];Sum basophil neutrophil counts[27863252];Sum neutrophil eosinophil counts[27863252];Neutrophil count[27863252];Alzheimer's disease[21460840];Eosinophil percentage of white cells[27863252];,0.7139877300613497,0.6825683341928829,0.04254763769250848,0.9149785144260283
12,54,ABCA12,607800,242500;601277;,"[MIM:601277]Ichthyosis, congenital, autosomal recessive 4A [recessive?];[MIM:242500]Ichthyosis, congenital, autosomal recessive 4B [recessive?];",Lamellar ichthyosis;Harlequin ichthyosis;Congenital non-bullous ichthyosiform erythroderma,Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in,,0.10711656441717791,0.7955131511088189,0.10545549464891674,0.9579496623695519
13,58,ABCB4,171060,600803;602347;614972;,"[MIM:602347]Cholestasis, progressive familial intrahepatic, 3;[MIM:614972]Cholestasis of pregnancy, intrahepatic 3;[MIM:600803]Gallbladder disease 1;",Low phospholipid-associated cholelithiasis;Intrahepatic cholestasis of pregnancy;Progressive familial intrahepatic cholestasis type 3,Disease-causing germline mutation(s) (loss of function) in;Major susceptibility factor in;Disease-causing germline mutation(s) (loss of function) in,Epithelial ovarian cancer[25134534];Alanine transaminase levels[29403010];Gallbladder cancer[28274756];,0.10711656441717791,0.20732336255801959,0.07047768206734534,0.9522713321055862
14,60,ABCB6,605452,111600;609153;614497;615402;,"[MIM:614497]Microphthalmia, isolated, with coloboma, 7;[MIM:615402]Dyschromatosis universalis hereditaria 3 [dominant?];[MIM:609153]Pseudohyperkalemia, familial, 2, due to red cell leak;",Dyschromatosis universalis hereditaria;Familial pseudohyperkalemia;Coloboma of choroid and retina;Colobomatous microphthalmia;Coloboma of optic disc;Coloboma of macula;Coloboma of eyelid;Coloboma of eye lens;Coloboma of iris,Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) (gain of function) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in,Reticulocyte fraction of red cells[27863252];Reticulocyte count[27863252];,0.403680981595092,0.03893759669932955,0.406943356825894,0.6932166973603437
15,61,ABCB7,300135,301310;,"[MIM:301310]Anemia, sideroblastic, spinocerebellar ataxia;",X-linked sideroblastic anemia and spinocerebellar ataxia,Disease-causing germline mutation(s) (loss of function) in,,0.7921472392638037,0.8731304796286746,0.34821195510310626,0.8724677716390423
16,68,ABCB11,603201,601847;605479;,"[MIM:601847]Cholestasis, progressive familial intrahepatic, 2;[MIM:605479]Cholestasis, benign recurrent intrahepatic, 2;",Intrahepatic cholestasis of pregnancy;Progressive familial intrahepatic cholestasis type 2;Benign recurrent intrahepatic cholestasis type 2,Major susceptibility factor in;Disease-causing germline mutation(s) (loss of function) in;Disease-causing germline mutation(s) in,"Systolic blood pressure in sickle cell anemia[24058526];Fasting blood glucose[29621232];Glycated hemoglobin levels[20858683;24647736;29170429];Alanine transaminase levels[29403010];Liver enzyme levels (alkaline phosphatase)[22001757];Egg allergy[25710614];Gamma glutamyl transferase levels[29403010];Total cholesterol levels[28334899];Fasting plasma glucose[18521185];Metabolite levels[21909109];Aspartate aminotransferase levels[29403010];Metabolic syndrome (bivariate traits)[21386085];Cholesterol, total[24097068];Metabolic traits[19060910];",0.12711656441717792,0.08483754512635379,0.36439571913338553,0.0
17,70,ABCC2,601107,237500;,,Dubin-Johnson syndrome,Disease-causing germline mutation(s) in,Colorectal cancer[24737748;26151821;26151821];Carboplatin disposition in epthelial ovarian cancer[29367611];,0.4331288343558282,0.0038679731820526046,0.2330984077264422,0.793585021485574
18,75,ABCC6,603234,264800;614473;,"[MIM:264800]Pseudoxanthoma elasticum;[MIM:614473]Arterial calcification of infancy, generalized, 2 [recessive?];",Pseudoxanthoma elasticum;Generalized arterial calcification of infancy,Disease-causing germline mutation(s) (loss of function) in;Disease-causing germline mutation(s) in,Multiple myeloma (survival)[26198393];,0.16220858895705523,0.5902527075812274,0.12477160010441138,0.9464395334561081
19,78,ABCC8,600509,240800;256450;602485;606176;610374;,"[MIM:240800]Leucine-induced hypoglycemia;[MIM:256450]Familial hyperinsulinemic hypoglycemia 1;[MIM:606176]Diabetes mellitus, permanent neonatal;[MIM:610374]Transient neonatal diabetes mellitus 2;",Autosomal dominant hyperinsulinism due to SUR1 deficiency;Diazoxide-resistant focal hyperinsulinism due to SUR1 deficiency;MODY;DEND syndrome;Autosomal recessive hyperinsulinism due to SUR1 deficiency;Permanent neonatal diabetes mellitus;Transient neonatal diabetes mellitus,Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in,Body mass index[26426971;26426971];Gout[22179738;22179738];Alcohol dependence symptom count[29460428];Mean arterial pressure[27618448];,0.19190184049079756,0.3548220732336256,0.4030279300443748,0.8959484346224678
20,79,ABCC9,601439,239850;608569;614050;,"[MIM:608569]Cardiomyopathy, dilated 1O;[MIM:614050]Atrial fibrillation, familial, 12;[MIM:239850]Hypertrichotic osteochondrodysplasia;","Familial isolated dilated cardiomyopathy;Acromegaloid facial appearance syndrome;Hypertrichosis-acromegaloid facial appearance syndrome;Hypertrichotic osteochondrodysplasia, Cantu type;Brugada syndrome;Familial atrial fibrillation",Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) (gain of function) in;Candidate gene tested in,Itch intensity from mosquito bite adjusted by bite size[28199695];Gout[22179738];Hippocampal sclerosis of aging[24770881];Birth weight[27680694];Obesity-related traits[23251661];,0.27361963190184047,0.2150593089221248,0.6175933176716262,0.887354205033763
21,84,ABCD1,300371,300100;,[MIM:300100]Adrenoleukodystrophy;,X-linked cerebral adrenoleukodystrophy;Adrenomyeloneuropathy;CADDS,Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Role in the phenotype of,Body mass index[26426971];,0.629079754601227,0.867199587416194,0.8580005220569042,0.9481276856967464
22,92,ABCD4,603214,614857;,,"Methylmalonic acidemia with homocystinuria, type cblJ",Disease-causing germline mutation(s) (loss of function) in,,0.2585276073619632,0.1554925219185147,0.03811015400678674,0.7102516881522406
23,103,ABCG5,605459,210250;,[MIM:210250]Sitosterolemia [recessive?];,Sitosterolemia;Homozygous familial hypercholesterolemia,Disease-causing germline mutation(s) in;Candidate gene tested in,"Lipid metabolism phenotypes[19936222];C-reactive protein levels or total cholesterol levels (pleiotropy)[27286809];Cholesterol, total[20686565;19060911;24097068];Metabolite levels (lipoprotein measures)[27005778];LDL cholesterol[20686565;19060911;24097068];Coronary artery disease[29212778;29212778;29212778];Coronary artery disease (myocardial infarction, percutaneous transluminal coronary angioplasty, coronary artery bypass grafting, angina or chromic ischemic heart disease)[28714975];",0.12711656441717792,0.09051057246003094,0.17619420516836334,0.48066298342541436
24,104,ABCG8,605460,210250;611465;,[MIM:611465]Gallbladder disease 4;[MIM:210250]Sitosterolemia [recessive?];,Sitosterolemia;Homozygous familial hypercholesterolemia,Disease-causing germline mutation(s) in;Candidate gene tested in,"Lipid metabolism phenotypes[19936222];Phytosterol levels[20529992;20529992];Cholesterol, total[20686565;24097068;25961943;28270201];LDL cholesterol[20686565;23726366;19060906;25961943];Gallstone disease[17632509;27094239;27094239];C-reactive protein levels or LDL-cholesterol levels (pleiotropy)[27286809];Coronary artery disease[29212778;29212778;29212778];Coronary artery disease (myocardial infarction, percutaneous transluminal coronary angioplasty, coronary artery bypass grafting, angina or chromic ischemic heart disease)[28714975];",0.2498159509202454,0.027591542031975246,0.025841816758026624,0.5639963167587477
25,109,ABHD5,604780,275630;,[MIM:275630]Chanarin-Dorfman syndrome [recessive?];,Neutral lipid storage disease with ichthyosis,Disease-causing germline mutation(s) in,Inflammatory skin disease[25574825];,0.2585276073619632,0.18282619907168643,0.6776298616549203,0.38551258440761205
26,115,ABHD12,613599,612674;,"[MIM:612674]Polyneuropathy, hearing loss, ataxia, retinitis pigmentosa, and cataract;",Polyneuropathy-hearing loss-ataxia-retinitis pigmentosa-cataract syndrome,Disease-causing germline mutation(s) in,Liver enzyme levels (alkaline phosphatase)[22001757];,0.861840490797546,0.5077359463641052,0.5157922213521274,0.09008594229588705
27,142,ABL1,189980,608232;617602;,"[MIM:608232]Leukemia, chronic myeloid;[MIM:617602]Congenital heart defects and skeletal malformations syndrome [dominant?];",Chronic myeloid leukemia;Precursor B-cell acute lymphoblastic leukemia;Precursor T-cell acute lymphoblastic leukemia,Part of a fusion gene in;Part of a fusion gene in;Part of a fusion gene in,Coronary artery calcified atherosclerotic plaque score in type 2 diabetes[29221444];Response to amphetamines[22952603];,0.7175460122699386,0.7240845796802475,0.5533803184547116,0.9883364027010436
28,161,ACAD8,604773,611283;,,Isobutyryl-CoA dehydrogenase deficiency,Disease-causing germline mutation(s) (loss of function) in,Obesity-related traits[23251661;23251661];,0.5631901840490797,0.17457452294997422,0.6447402766901592,0.552793124616329
29,162,ACAD9,611103,611126;,,Acyl-CoA dehydrogenase 9 deficiency,Disease-causing germline mutation(s) in,Dental caries[23064961];,0.9038036809815951,0.26585869004641566,0.5484207778647873,0.6904542664211173
30,165,ACADL,609576,,,Long chain acyl-CoA dehydrogenase deficiency,Disease-causing germline mutation(s) in,Serum metabolite levels[23093944];Acylcarnitine levels[26068415];Blood metabolite levels[24816252];Metabolite levels[20037589;23281178];Serum metabolite concentrations in chronic kidney disease[29545352];Amino acid levels[26068415;26068415];Urinary metabolites (H-NMR features)[24586186];,0.14576687116564419,0.0812274368231047,0.16392586791960323,0.4958563535911602
31,166,ACADM,607008,201450;,[MIM:201450]Acyl-CoA dehydrogenase medium-chain deficiency;,Medium chain acyl-CoA dehydrogenase deficiency,Disease-causing germline mutation(s) in,Blood metabolite ratios[24816252];Serum metabolite levels[23093944;23093944;23093944;23093944];Acylcarnitine levels[26068415;26068415;26068415];Serum metabolite ratios in chronic kidney disease[29545352;29545352];Blood metabolite levels[24816252;24816252;24816252;24816252];Metabolite levels[20037589];Serum metabolite concentrations in chronic kidney disease[29545352];Daytime sleep phenotypes[27126917];Metabolic traits[21886157];,0.9315337423312884,0.12893243940175347,0.7791699295223179,0.7067219152854513
32,167,ACADS,606885,201470;,[MIM:201470]Acyl-CoA dehydrogenase short-chain deficiency;,Short chain acyl-CoA dehydrogenase deficiency,Disease-causing germline mutation(s) in,Serum metabolite levels[23093944];Mean corpuscular volume[29403010];Serum metabolite ratios in chronic kidney disease[29545352;29545352;29545352];Allergic rhinitis[30013184];Blood metabolite levels[24816252];Metabolite levels[20037589];Serum metabolite concentrations in chronic kidney disease[29545352];Red blood cell count[27863252];Urinary metabolites (H-NMR features)[24586186];Red cell distribution width[27863252];Metabolic traits[21886157];,0.5658895705521473,0.1523981433728726,0.1942051683633516,0.655463474524248
33,168,ACADSB,600301,610006;,,2-methylbutyryl-CoA dehydrogenase deficiency,Disease-causing germline mutation(s) (loss of function) in,Lower body strength[27325353];,0.9246625766871166,0.21660649819494585,0.2652049073348995,0.5457335788827502
34,169,ACADVL,609575,201475;,[MIM:201475]Acyl-CoA dehydrogenase very long-chain deficiency;,Very long chain acyl-CoA dehydrogenase deficiency,Disease-causing germline mutation(s) in,,0.8503067484662576,0.26095925734914904,0.3852779953014879,0.8620319214241866
35,170,ACAN,155760,165800;608361;612813;,"[MIM:608361]Spondyloepiphyseal dysplasia type Kimberley [dominant?];[MIM:612813]Spondyloepimetaphyseal dysplasia, aggrecan type;[MIM:165800]Short stature and advanced bone age, with or without early-onset osteoarthritis and/or osteochondritis dissecans [dominant?];","Spondyloepimetaphyseal dysplasia, aggrecan type;Familial osteochondritis dissecans;Short stature-advanced bone age-early-onset osteoarthritis syndrome;Spondyloepiphyseal dysplasia, Kimberley type",Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) (loss of function) in;Disease-causing germline mutation(s) in,Waist circumference adjusted for BMI (joint analysis main effects and physical activity interaction)[28448500;28448500;28448500];Dupuytren's disease[28886342];Waist circumference adjusted for BMI in non-smokers[28443625;28443625];Hip circumference adjusted for BMI[25673412];Waist circumference adjusted for BMI (joint analysis main effects and smoking interaction)[28443625;28443625];Age-related hearing impairment[27764096;27764096];Waist circumference adjusted for BMI (adjusted for smoking behaviour)[28443625;28443625];Height[21998595;25133637;23563607;20881960;20881960;18391952;28270201;25429064;25282103];Infant length[25281659];Waist circumference adjusted for body mass index[28448500;28448500;28448500;25673412;25673412];Waist circumference adjusted for BMI in active individuals[28448500;28448500;28448500];,0.14576687116564419,1.0,0.004698512137823023,0.9057704112952731
36,175,ACAT1,607809,203750;,[MIM:203750]3-ketothiolase deficiency [recessive?];,Beta-ketothiolase deficiency,Disease-causing germline mutation(s) in,,0.9467484662576687,0.5033522434244456,0.18350300182719917,0.5391344383057091
37,185,ACD,609377,616553;,"[MIM:616553]Dyskeratosis congenita, autosomal dominant, 6 [dominant?];[MIM:616553]Dyskeratosis congenita, autosomal recessive, 7 [recessive?];",Hoyeraal-Hreidarsson syndrome;Familial melanoma;Hereditary isolated aplastic anemia,Disease-causing germline mutation(s) in;Major susceptibility factor in;Disease-causing germline mutation(s) in,Schizophrenia[25056061];,0.58,0.16322846828261992,0.7666405638214565,0.10205647636586863
38,186,ACE,106180,267430;601367;612624;614519;,[MIM:601367]Ischemic stroke;[MIM:267430]Renal tubular dysgenesis;[MIM:612624]Microvascular complications of diabetes 3;[MIM:614519]Intracerebral hemorrhage;,Renal tubular dysgenesis of genetic origin,Disease-causing germline mutation(s) in,Serum metabolite levels[24625756;24625756;24625756;23093944;23093944;23093944;23093944;23093944];Alzheimer's disease (late onset)[24162737];Diastolic blood pressure[28739976;28739976;28135244];Blood metabolite levels[24816252;24816252;24816252;24816252;24816252];Diastolic blood pressure x alcohol consumption interaction (2df test)[29912962];Diastolic blood pressure x smoking status (ever vs never) interaction (2df test)[29455858;29455858];Blood protein levels[30072576];Systolic blood pressure x smoking status (current vs non-current) interaction (2df test)[29455858;29455858];Blood metabolite ratios[24816252];Angiotensin-converting enzyme activity[20066004];Cerebrospinal fluid levels of Alzheimer's disease-related proteins[25340798];Diastolic blood pressure x smoking status (current vs non-current) interaction (2df test)[29455858;29455858];Metabolite levels[23281178];Systolic blood pressure x smoking status (ever vs never) interaction (2df test)[29455858;29455858];Systolic blood pressure x alcohol consumption interaction (2df test)[29912962];Metabolic traits[21886157];,0.4117791411042945,0.13047962867457452,0.2662490211433046,0.13720073664825047
39,191,ACER3,617036,,,Alkaline ceramidase 3 deficiency,Disease-causing germline mutation(s) in,,0.49570552147239266,0.6962351727694688,0.9796397807361003,0.3612645794966237
40,203,ACO2,100850,614559;616289;,[MIM:614559]Infantile cerebellar-retinal degeneration [recessive?];[MIM:616289]Optic atrophy 9;,Infantile cerebellar-retinal degeneration;Autosomal recessive isolated optic atrophy,Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in,Neuroticism[29255261];,0.859877300613497,0.5257864878803507,0.737144348734012,0.4189686924493554
41,204,ACOD1,615275,,,CAD-CDG,Disease-causing germline mutation(s) in,Hearing function[25060954];Tourette's syndrome or obsessive-compulsive disorder[25158072];,0.038773006134969326,0.7902269210933471,0.0,0.0
42,215,ACOX1,609751,264470;,,Peroxisomal acyl-CoA oxidase deficiency,Disease-causing germline mutation(s) in,Systolic blood pressure[28135244];White matter hyperintensity burden[25663218;25663218];,0.7979141104294478,0.41284167096441465,0.5288436439571913,0.6658993247391037
43,222,ACP4,606362,617297;,[MIM:617297]Amelogenesis imperfecta 1J [recessive?];,Hypoplastic amelogenesis imperfecta,Disease-causing germline mutation(s) (loss of function) in,Diverticular disease[30177863];,0.038773006134969326,0.08303249097472924,0.0,0.0
44,223,ACP5,171640,607944;,[MIM:607944]Spondyloenchondrodysplasia with immune dysregulation;,Spondyloenchondrodysplasia,Disease-causing germline mutation(s) in,Multiple sclerosis (severity)[19010793];Blood protein levels[29875488;30072576];,0.36171779141104293,0.5384218669417226,0.2811276429130775,0.7306629834254144
45,233,ACSF3,614245,614265;,[MIM:614265]Combined malonic and methylmalonic aciduria;,Combined malonic and methylmalonic acidemia,Disease-causing germline mutation(s) in,,0.8369325153374233,0.10804538421866942,0.4815974941268598,0.06368937998772253
46,236,ACSL4,300157,300194;300387;,"[MIM:300387]Mental retardation, X-linked 63;[MIM:300194]Alport syndrome with mental retardation, midface hypoplasia and elliptocytosis;",X-linked non-syndromic intellectual disability;Alport syndrome-intellectual disability-midface hypoplasia-elliptocytosis syndrome,Disease-causing germline mutation(s) in;Role in the phenotype of,,0.6825766871165644,0.5985043837029397,0.9028974158183242,0.0
47,250,ACTA1,102610,161800;255310;616852;,"[MIM:161800]Nemaline myopathy 3;[MIM:161800]Myopathy, actin, congenital, with excess of thin myofilaments;[MIM:255310]Myopathy, congenital, with fiber-type disproportion;[MIM:616852]Myopathy, scapulohumeroperoneal [dominant?];",Severe congenital nemaline myopathy;Intermediate nemaline myopathy;Typical nemaline myopathy;Childhood-onset nemaline myopathy;Congenital fiber-type disproportion myopathy;Progressive scapulohumeroperoneal distal myopathy;Rigid spine syndrome;Zebra body myopathy;Congenital myopathy with excess of thin filaments,Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in,Chronic lymphocytic leukemia[24292274;28165464];,0.7608588957055215,0.19159360495100566,0.9561472200469852,0.5988336402701043
48,251,ACTA2,102620,611788;613834;614042;,"[MIM:611788]Aortic aneurysm, familial thoracic 6;[MIM:614042]Moyamoya disease 5;[MIM:613834]Multisystemic smooth muscle dysfunction syndrome;",Moyamoya disease;Multisystemic smooth muscle dysfunction syndrome;Familial thoracic aortic aneurysm and aortic dissection,Major susceptibility factor in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in,"Chronic lymphocytic leukemia[23770605;26956414];Chronic inflammatory diseases (ankylosing spondylitis, Crohn's disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy)[26974007];Selective IgA deficiency[27723758];Immunoglobulin A[20694011];",0.9116564417177914,0.8785456420835482,0.982250065257113,0.7441682013505218
49,253,ACTB,102630,243310;607371;,"[MIM:607371]Dystonia, juvenile-onset;[MIM:243310]Baraitser-Winter syndrome 1;",Baraitser-Winter cerebrofrontofacial syndrome;Becker nevus syndrome;Developmental malformations-deafness-dystonia syndrome,Disease-causing germline mutation(s) (gain of function) in;Disease-causing somatic mutation(s) in;Disease-causing germline mutation(s) in,Relative hand skill in reading disability[24068947];Global electrical heterogeneity phenotypes[29622589];,0.9862576687116564,0.7439401753481176,0.9932132602453667,0.9892572130141191
50,268,ACTC1,102540,612098;612794;613424;,"[MIM:613424]Cardiomyopathy, dilated 1R;[MIM:612098]Cardiomyopathy, familial hypertrophic 11;[MIM:612794]Atrial septal defect 5;","Familial isolated dilated cardiomyopathy;Left ventricular noncompaction;Atrial septal defect, ostium secundum type",Disease-causing germline mutation(s) in;Major susceptibility factor in;Disease-causing germline mutation(s) in,Refractive error[20835239];Axial length[24144296];,0.8723926380368098,0.812790097988654,0.988775776559645,0.7826887661141805
51,269,ACTG1,102560,604717;614583;,"[MIM:604717]Deafness, autosomal dominant, 20 [dominant?];[MIM:614583]Baraitser-Winter syndrome 2;",Baraitser-Winter cerebrofrontofacial syndrome;Autosomal dominant non-syndromic sensorineural deafness type DFNA;Coloboma of choroid and retina;Coloboma of iris,Disease-causing germline mutation(s) (gain of function) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in,Hand grip strength[29313844];,0.9626993865030675,0.6222279525528623,0.916731923779692,0.9183548189073051
52,293,ACTG2,102545,155310;,[MIM:155310]Visceral myopathy;,Familial visceral myopathy;Megacystis-microcolon-intestinal hypoperistalsis syndrome;Myopathic intestinal pseudoobstruction,Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in,,0.7512883435582822,0.7016503352243424,0.9595405899243018,0.5391344383057091
53,294,ACTL6A,604958,,,Non-specific syndromic intellectual disability,Disease-causing germline mutation(s) (loss of function) in,,0.878282208588957,0.6812790097988654,0.7071260767423649,0.9441375076734193
54,301,ACTN1,102575,615193;,"[MIM:615193]Bleeding disorder, platelet-type 15 [dominant?];",Autosomal dominant macrothrombocytopenia,Disease-causing germline mutation(s) in,Mean platelet volume[27863252;27863252];Rheumatoid arthritis (ACPA-positive)[23143596];Mosquito bite size[28199695];Urinary albumin excretion[30220432];Smoking behavior[19247474];Cognitive decline rate in late mild cognitive impairment[26252872;26252872];Fibrinogen[23969696];Platelet distribution width[27863252];Fibrinogen levels[28107422;28107422];Prostate cancer[23535732];Platelet count[26805783;29403010];Periodontitis (Mean PAL)[24024966];,0.9633128834355829,0.7916451779267664,0.5489428347689899,0.4429097605893186
55,303,ACTN2,102573,612158;,"[MIM:612158]Cardiomyopathy, familial hypertrophic 23, with or without left ventricular non-compaction;[MIM:612158]Cardiomyopathy, dilated 1AA, with or without left ventricular non-compaction;",Familial isolated dilated cardiomyopathy,Disease-causing germline mutation(s) in,Periodontitis (CDC/AAP)[24024966];,0.6384049079754601,0.889633831872099,0.38945445053510835,0.8219766728054021
56,305,ACTN4,604638,603278;,[MIM:603278]Focal segmental glomerulosclerosis 1;,Familial idiopathic steroid-resistant nephrotic syndrome with focal segmental hyalinosis,Disease-causing germline mutation(s) in,Heart rate[23583979];,0.9337423312883436,0.8001547189272821,0.6141999477943095,0.9355432780847146
57,333,ACVR1,102576,135100;,,Fibrodysplasia ossificans progressiva,Disease-causing germline mutation(s) (gain of function) in,Severe gingival inflammation[28459102];,0.5326380368098159,0.7472924187725631,0.734273035760898,0.7306629834254144
58,337,ACVR2B,602730,613751;,"[MIM:613751]Heterotaxy, visceral, 4, autosomal;",Situs ambiguus,Major susceptibility factor in,P wave duration[24850809];,0.47337423312883437,0.8251676121712223,0.7676846776298617,0.9591774094536526
59,339,ACVRL1,601284,600376;,"[MIM:600376]Telangiectasia, hereditary hemorrhagic, 2;",Hereditary hemorrhagic telangiectasia;Heritable pulmonary arterial hypertension,Disease-causing germline mutation(s) in;Candidate gene tested in,Urate levels[23263486];White blood cell count[27863252];Myeloid white cell count[27863252];Hematocrit[29403010];Plateletcrit[27863252];Hemoglobin[29403010];Monocyte count[27863252];,0.4917791411042945,0.573749355337803,0.5852257896110676,0.8288827501534684
60,340,ACY1,104620,609924;,,Neurological conditions associated with aminoacylase 1 deficiency,Disease-causing germline mutation(s) (loss of function) in,,0.3925153374233129,0.19030428055698814,0.3536935525972331,0.0
61,345,ADA,608958,102700;,[MIM:102700]Severe combined immunodeficiency autosomal recessive T- cell-negative/B-cell-negative/NK-cell-negative due to adenosine deaminase deficiency [recessive?];,Severe combined immunodeficiency due to adenosine deaminase deficiency;Omenn syndrome,Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in,Inflammatory bowel disease[28067908];Ulcerative colitis[23128233;28067908];,0.7568098159509202,0.09515214027849407,0.29705037849125554,0.6855432780847146
62,346,ADA2,607575,182410;615688;,[MIM:615688]Polyarteritis nodosa;[MIM:182410]Sneddon syndrome;,Sneddon syndrome;Vasculitis due to ADA2 deficiency,Disease-causing germline mutation(s) (loss of function) in;Disease-causing germline mutation(s) (loss of function) in,Verbal declarative memory[25648963];Blood protein levels[29875488;30072576;30072576];,0.038773006134969326,0.7475502836513667,0.0,0.0
63,361,ADAM9,602713,612775;,[MIM:612775]Cone-rod dystrophy 9;,Cone rod dystrophy,Disease-causing germline mutation(s) in,,0.5874846625766871,0.499484270242393,0.40146175933176714,0.3970227133210559
64,362,ADAM10,602192,615537;615590;,[MIM:615537]Reticulate acropigmentation of Kitamura;[MIM:615590]Alzheimer disease 18;,Reticulate acropigmentation of Kitamura,Disease-causing germline mutation(s) (loss of function) in,,0.5170552147239263,0.5719443011861784,0.7927434090315845,0.6445672191528545
65,366,ADAM17,603639,614328;,"[MIM:614328]Inflammatory skin and bowel disease, neonatal, 1;",Neonatal inflammatory skin and bowel disease,Disease-causing germline mutation(s) (loss of function) in,,0.403680981595092,0.8996905621454357,0.3925867919603237,0.552793124616329
66,385,ADAMTS2,604539,225410;,"[MIM:225410]Ehlers-Danlos syndrome, dermatosparaxis type [recessive?];","Ehlers-Danlos syndrome, dermatosparaxis type",Disease-causing germline mutation(s) in,Depression in response to interferon-based therapy in chronic hepatitis C[27723809];Central corneal thickness[29760442];Visceral adipose tissue adjusted for BMI[22589738];Height[25282103];Attention deficit hyperactivity disorder (time to onset)[18937294];Stroke (pediatric)[22990015];Intraocular pressure[29617998;29617998];,0.2947239263803681,0.5680763280041259,0.04620203602192639,0.7360343769183548
67,386,ADAMTS3,605011,,,Hennekam syndrome,Disease-causing germline mutation(s) (loss of function) in,"Waist circumference adjusted for BMI (joint analysis main effects and physical activity interaction)[28448500];Dialysis-related mortality[21546767];Waist circumference adjusted for BMI in non-smokers[28443625];Waist circumference adjusted for BMI (adjusted for smoking behaviour)[28443625];Cholesterol ester levels in large LDL[29084231];Waist circumference adjusted for body mass index[26785701;28448500;28448500];Total cholesterol levels in LDL[29084231];Total cholesterol levels in small LDL[29084231;29084231;29084231;29084231];Total cholesterol levels in large LDL[29084231];Small LDL particle concentration[29084231;29084231;29084231;29084231];Large LDL particle concentration[29084231];Dental caries[23259602;23259602];Serum total cholesterol levels[29084231];Hip circumference adjusted for BMI[25673412;25673412];Cholesterol ester levels in medium LDL[29084231;29084231;29084231];Waist circumference adjusted for BMI (joint analysis main effects and smoking interaction)[28443625];Total cholesterol levels in medium LDL[29084231;29084231;29084231];Metabolite levels[22916037];Medium LDL particle concentration[29084231;29084231;29084231];Height[20881960;25429064;25282103];Cholesterol, total[25961943];Waist circumference adjusted for BMI in active individuals[28448500];",0.038773006134969326,0.11552346570397112,0.44557556773688334,0.4011663597298956
68,398,ADAMTS10,608990,277600;,[MIM:277600]Weill-Marchesani syndrome 1;,Weill-Marchesani syndrome,Disease-causing germline mutation(s) in,Resting metabolic rate[28476931];Itch intensity from mosquito bite adjusted by bite size[28199695;28199695;28199695];Tonsillectomy[27182965;28928442];Atopic dermatitis[26482879];Waist circumference adjusted for BMI in non-smokers[28443625];Waist circumference adjusted for BMI (joint analysis main effects and smoking interaction)[28443625;28443625];Waist circumference adjusted for BMI (adjusted for smoking behaviour)[28443625;28443625];Height[20881960;18391951;25282103];Waist circumference adjusted for body mass index[25673412;25673412];Itch intensity from mosquito bite[28199695];,0.17791411042944785,0.8349664775657556,0.2837379274340903,0.37952731737262124
69,400,ADAMTS13,604134,274150;,[MIM:274150]Thrombotic thrombocytopenic purpura congenital;,Congenital thrombotic thrombocytopenic purpura,Disease-causing germline mutation(s) (loss of function) in,Activated partial thromboplastin time[22703881];ADAMTS13 levels[29296746;29296746;29296746];vWF levels in ischaemic stroke and hyperhomocysteinaemia[28495826];Pancreatic cancer[25086665];Liver enzyme levels[18940312];Gut microbiota (functional units)[27694959];Coagulation factor levels[23267103;23267103];ADAMTS13 activity[25934476;25934476];Blood protein levels[28240269;29875488;30072576;30072576];Cobalt levels[26025379];Circulating fibroblast growth factor 23 levels[30217807];,0.08736196319018405,0.31794739556472407,0.15270164447924825,0.3396255371393493
70,404,ADAMTS17,607511,613195;,[MIM:613195]Weill-Marchesani syndrome 4 [recessive?];,Ichthyosis-short stature-brachydactyly-microspherophakia syndrome,Disease-causing germline mutation(s) (loss of function) in,Response to fenofibrate (triglyceride levels)[27002377];Urate levels in lean individuals[25811787];Osteosarcoma[23727862];Hip circumference adjusted for BMI[25673412;25673412];Gastroesophageal reflux disease[27485664];Waist circumference adjusted for BMI (adjusted for smoking behaviour)[28443625];Height[23563607;20881960;18391951;25429064;25282103];Waist circumference adjusted for body mass index[25673412;25673412];Coronary artery calcified atherosclerotic plaque (130 HU threshold) in type 2 diabetes[29221444];Intraocular pressure[29617998;29235454];,0.038773006134969326,0.4902011346054667,0.07622030801357348,0.34714548802946593
71,405,ADAMTS18,607512,615458;,"[MIM:615458]Microcornea, myopic chorioretinal atrophy, and telecanthus;",Microcornea-myopic chorioretinal atrophy-telecanthus syndrome,Disease-causing germline mutation(s) in,Type 2 diabetes (age of onset)[28060188];Adverse response to chemotherapy (neutropenia/leucopenia) (all antimicrotubule drugs)[23648065];Amyotrophic lateral sclerosis (sporadic)[24529757];Bone mineral density (Ward's triangle area)[27397699];Bone mineral density[19249006];White matter integrity[22425255];Intraocular pressure[29617998;29617998;29235454;30054594];Asparaginase-induced acute pancreatitis in acute lymphoblastic leukemia (onset time)[27114598];Upper eyelid sagging severity[29654602];,0.12711656441717792,0.5043837029396596,0.007047768206734534,0.13459177409453651
72,409,ADAMTSL1,609198,,,Microcephaly-facial dysmorphism-ocular anomalies-multiple congenital anomalies syndrome,Disease-causing germline mutation(s) in,QT interval (drug interaction)[23459443];Midgestational circulating levels of PBDEs[28235828];Spherical equivalent or myopia (age of diagnosis)[29808027];Fat distribution (HIV)[21897333];Small cell lung carcinoma[28604730];Cerebral cortical growth[29682794];Amyotrophic lateral sclerosis (sporadic)[24529757];Myopia[27182965];Diastolic blood pressure x smoking status (ever vs never) interaction (2df test)[29455858];Perceived unattractiveness to mosquitoes[28199695];Hip circumference (psychosocial stress interaction)[25271088];Systolic blood pressure x smoking status (ever vs never) interaction (2df test)[29455858];Obesity-related traits[23251661;23251661];Depression in smokers[30219690];Nicotine dependence[28440896];,0.19190184049079756,0.6609076843733883,0.1007569825110937,0.23603437691835483
73,410,ADAMTSL2,612277,231050;,[MIM:231050]Geleophysic dysplasia 1 [recessive?];,Geleophysic dysplasia,Disease-causing germline mutation(s) in,,0.08736196319018405,0.2264053635894791,0.7003393369877317,0.0
74,412,ADAMTSL4,610113,225100;225200;,"[MIM:225100]Ectopia lentis 2, isolated, autosomal recessive [recessive?];[MIM:225200]Ectopia lentis et pupillae;",Isolated ectopia lentis,Disease-causing germline mutation(s) in,Migraine[27322543];Rhegmatogenous retinal detachment[23585552];Coronary artery disease[29212778];,0.6174233128834355,0.033522434244455904,0.2529365700861394,0.011203192142418661
75,417,ADAR,146920,127400;615010;,[MIM:127400]Dyschromatosis symmetrica hereditaria [dominant?];[MIM:615010]Aicardi-Goutieres syndrome 6;,Aicardi-Gouti�res syndrome;Familial infantile bilateral striatal necrosis;Dyschromatosis symmetrica hereditaria,Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) (loss of function) in;Disease-causing germline mutation(s) in,C-reactive protein levels or triglyceride levels (pleiotropy)[27286809];Lung cancer[28604730];Squamous cell lung carcinoma[28604730];Cerebrospinal fluid levels of Alzheimer's disease-related proteins[25340798];Prostate cancer[23535732];,0.9465030674846626,0.5611139762764311,0.6891151135473766,0.7539901780233272
76,423,ADAT3,615302,615286;,"[MIM:615286]Mental retardation, autosomal recessive 36 [recessive?];",Intellectual disability-strabismus syndrome,Disease-causing germline mutation(s) in,,0.17791411042944785,0.5861268695203713,0.6100234925606891,0.0
77,428,ADCY1,103072,610154;,"[MIM:610154]Deafness, autosomal recessive, 44 [recessive?];",Autosomal recessive non-syndromic sensorineural deafness type DFNB,Disease-causing germline mutation(s) (loss of function) in,Subjective response to lithium treatment in bipolar disorder[26503763];Bipolar disorder lithium response (continuous) or schizophrenia[29121268];Night sleep phenotypes[27126917];,0.17791411042944785,0.5466735430634347,0.5763508222396241,0.7372621240024555
78,432,ADCY5,600293,606703;,"[MIM:606703]Dyskinesia, familial, with facial myokymia;",Benign hereditary chorea;Familial dyskinesia and facial myokymia,Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in,Type 2 diabetes[22693455;24509480;26818947;28254843;22885922;22885922;22885922;29358691;28869590;28869590];Fasting blood glucose[20081858;22581228;22581228];Homeostasis model assessment of beta-cell function[20081858];Gestational age at birth (maternal effect)[28877031];Glycated hemoglobin levels[28898252];Lymphocyte counts[27863252];Chronic kidney disease[26420894];Disease progression in age-related macular degeneration[29346644];Body mass index[25673413;25673413];Two-hour glucose challenge[20081857];Birth weight[20372150;23202124;27680694];Monocyte count[27863252];Obesity-related traits[23251661];Fasting blood glucose (BMI interaction)[22581228;22581228];,0.22687116564417178,0.975373904074265,0.6055860088749674,0.6519337016574586
79,433,ADCY6,600294,616287;,[MIM:616287]Lethal congenital contracture syndrome 8 [recessive?];,Hypomyelination neuropathy-arthrogryposis syndrome,Disease-causing germline mutation(s) in,Clozapine-induced agranulocytosis[25187353];,0.3168098159509202,0.36848891181021143,0.3988514748107544,0.6720380601596071
80,437,ADCY10,605205,143870;,[MIM:143870]Hypercalciuria absorptive 2;,Idiopathic hypercalciuria,Disease-causing germline mutation(s) in,,0.08736196319018405,0.008767405879319236,0.3098407726442182,0.0187231430325353
81,443,ADD3,601568,617008;,"[MIM:617008]Cerebral palsy, spastic quadriplegic 3 [recessive?];",Inherited congenital spastic tetraplegia,Disease-causing germline mutation(s) (loss of function) in,Biliary atresia[20460270];White blood cell count[29403010];Bipolar disorder[28072414];Neutrophil count[29403010];,0.9771779141104294,0.9716348633316142,0.4158183241973375,0.6398096992019644
82,458,ADGRE2,606100,125630;,[MIM:125630]Vibratory urticaria [dominant?];,Vibratory urticaria,Disease-causing germline mutation(s) (gain of function) in,Blood protein levels[30072576];Plasma androstenedione levels in resected early stage-receptor positive breast cancer[28429243];,0.10711656441717791,0.01263537906137184,0.0,0.0
83,469,ADGRG1,604110,606854;615752;,"[MIM:606854]Polymicrogyria, bilateral frontoparietal;[MIM:615752]Polymicrogyria, bilateral perisylvian, autosomal recessive [recessive?];",Bilateral perisylvian polymicrogyria;Bilateral frontoparietal polymicrogyria,Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in,Prostate cancer[29892016];Prostate cancer (advanced)[29892016];,0.16220858895705523,0.6462093862815884,0.0,0.0
84,470,ADGRG2,300572,300985;,"[MIM:300985]Congenital bilateral aplasia of the vas deferens, X- linked;",Congenital bilateral absence of vas deferens,Disease-causing germline mutation(s) in,,0.038773006134969326,0.8764827230531201,0.0,0.0
85,481,ADGRV1,602851,604352;605472;,"[MIM:605472]Usher syndrome 2C;[MIM:604352]Febrile seizures, familial, 4;",Usher syndrome type 2;Generalized epilepsy with febrile seizures-plus,Disease-causing germline mutation(s) in;Candidate gene tested in,Small cell lung carcinoma[28604730];Initial pursuit acceleration[29064472];Schizophrenia[28991256];Atopy[28927820];,0.038773006134969326,0.12274368231046931,0.0,0.0
86,506,ADK,102750,614300;,,Hypermethioninemia encephalopathy due to adenosine kinase deficiency,Disease-causing germline mutation(s) (loss of function) in,Diverticular disease[30177863];Soluble interleukin-2 receptor subunit alpha[26293465];Permanent tooth development[21931568];Hypospadias[25108383];Primary tooth development (time to first tooth eruption)[23704328];Primary tooth development (number of teeth)[23704328];,0.27975460122699386,0.29061371841155237,0.9321326024536675,0.42004297114794353
87,510,ADNP,611386,615873;,,ADNP syndrome,Disease-causing germline mutation(s) in,Prostate cancer[25217961;25217961];,0.9214723926380368,0.8383187209902011,0.6463064474027669,0.9769797421731123
88,515,ADORA2A,102776,,,Acute encephalopathy with biphasic seizures and late reduced diffusion,Major susceptibility factor in,"Acne (severe)[24927181];Severity of nausea and vomiting of pregnancy[29563502];Coronary artery disease[26343387];Coronary artery disease (myocardial infarction, percutaneous transluminal coronary angioplasty, coronary artery bypass grafting, angina or chromic ischemic heart disease)[28714975];",0.27975460122699386,0.7037132542547705,0.5740015661707126,0.2569060773480663
89,530,ADRA2B,104260,607876;,"[MIM:607876]Epilepsy, familial adult myoclonic, 2;",Benign adult familial myoclonic epilepsy,Disease-causing germline mutation(s) (gain of function) in,,0.19190184049079756,0.2070654976792161,0.7248760114852519,0.17971147943523635
90,536,ADSL,608222,103050;,,Adenylosuccinate lyase deficiency,Disease-causing germline mutation(s) in,Body mass index[26426971];Height[19570815];,0.9663803680981595,0.7101598762248582,0.5267554163403811,0.6708103130755064
91,538,ADSSL1,612498,617030;,,Adenylosuccinate synthetase-like 1-related distal myopathy,Disease-causing germline mutation(s) in,Breast cancer[29059683];,0.12711656441717792,0.5139247034553894,0.5126598799269121,0.09898710865561694
92,553,AFF1,159557,,,Precursor B-cell acute lymphoblastic leukemia,Part of a fusion gene in,Mean corpuscular volume[27863252;29403010];Mean corpuscular hemoglobin[27863252;29403010];White blood cell count (basophil)[29403010;27863252];Total bilirubin levels[29403010];Hematocrit[27863252;29403010];Heel bone mineral density[28869591;28869591];Basophil percentage of white cells[27863252;27863252];Triglycerides[20686565;20864672;25961943];Red blood cell count[27863252];Basophil percentage of granulocytes[27863252];Hemoglobin concentration[27863252];Alzheimer's disease (cognitive decline)[23535033];Mean platelet volume[27863252];Systemic lupus erythematosus[22291604];Hemoglobin[29403010];Eyebrow thickness[26926045];Bulimia nervosa[23568457];,0.7190184049079754,0.9308922124806601,0.5317149569303053,0.2452424800491099
93,555,AFF2,300806,309548;,,FRAXE intellectual disability,Disease-causing germline mutation(s) in,,0.14576687116564419,0.9620938628158845,0.7551553119290002,0.6457949662369552
94,558,AFF4,604417,616368;,[MIM:616368]CHOPS syndrome;,Cognitive impairment-coarse facies-heart defects-obesity-pulmonary involvement-short stature-skeletal dysplasia syndrome,Disease-causing germline mutation(s) (gain of function) in,Itch intensity from mosquito bite adjusted by bite size[28199695;28199695];Itch intensity from mosquito bite[28199695];,0.7834355828220859,0.9159360495100567,0.5794831636648394,0.580877839165132
95,561,AFG3L2,604581,610246;614487;,"[MIM:610246]Spinocerebellar ataxia 28 [dominant?];[MIM:614487]Spastic ataxia 5, autosomal recessive [recessive?];",Early-onset spastic ataxia-myoclonic epilepsy-neuropathy syndrome;Spinocerebellar ataxia type 28,Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in,,0.9896932515337423,0.5105724600309438,0.8078830592534586,0.6513198281154082
96,565,AFP,104150,615969;615970;,"[MIM:615969]Alpha-fetoprotein deficiency;[MIM:615970]Alpha-fetoprotein, hereditary persistence [dominant?];",Hereditary persistence of alpha-fetoprotein;Congenital deficiency in alpha-fetoprotein,Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in,Blood protein levels[30072576];Prostate cancer[23535732];Tumor biomarkers[23300138];,0.32380368098159507,0.08767405879319237,0.39989558861915947,0.1111111111111111
97,567,AGA,613228,208400;,[MIM:208400]Aspartylglucosaminuria;,Aspartylglucosaminuria,Disease-causing germline mutation(s) in,Colorectal cancer (calcium intake interaction)[25192705];Serum selenium levels[23698163];Motion sickness[25628336];Familial hepatitis B virus-related hepatocellular carcinoma[28662289];Response to mTOR inhibitor (everolimus)[24009623];,0.5645398773006135,0.1931407942238267,0.590185330200992,0.5308471454880295
98,583,AGBL1,615496,615523;,,Fuchs endothelial corneal dystrophy,Disease-causing germline mutation(s) in,Neuroticism[29255261];Loneliness (linear analysis)[27629369];Response to anti-depressant treatment in major depressive disorder[22041458];Migraine[21448238];Psychosis (methamphetamine induced)[23594818];Cytomegalovirus antibody response[21993531];Schizophrenia[18347602];Coronary artery calcification[23870195];Ischemic stroke[26089329];Thrombin-activatable fibrinolysis inhibitor activation peptide[29378355];Activated partial thromboplastin time[22703881];Modified Stumvoll Insulin Sensitivity Index (BMI interaction)[27416945];Loneliness[27629369];Fasting insulin (dietary factor interaction)[24204828];Thiazide-induced adverse metabolic effects in hypertensive patients[23400010];Homeostasis model assessment of insulin resistance (dietary factor interaction)[24204828];,0.038773006134969326,0.011603919546157814,0.28582615505090053,0.0
99,589,AGBL5,615900,617023;,,Retinitis pigmentosa,Disease-causing germline mutation(s) in,,0.14576687116564419,0.7632800412583806,0.4842077786478726,0.19429097605893186
100,595,AGGF1,608464,149000;,,Klippel-Tr�naunay syndrome,Major susceptibility factor in,,0.7120245398773006,0.6077875193398659,0.240407204385278,0.40423572744014735
101,606,AGK,610345,212350;614691;,[MIM:212350]Mitochondrial DNA depletion syndrome 10 [recessive?];[MIM:614691]Cataract 38;,Congenital cataract-hypertrophic cardiomyopathy-mitochondrial myopathy syndrome;Total early-onset cataract,Disease-causing germline mutation(s) (loss of function) in;Disease-causing germline mutation(s) in,Mood disorder and prion disease[25897833];,0.8337423312883435,0.17663744198040227,0.6408248499086401,0.08578882750153469
102,608,AGL,610860,232400;,[MIM:232400]Glycogen storage disease 3;,Glycogen storage disease due to glycogen debranching enzyme deficiency,Disease-causing germline mutation(s) in,White matter integrity (bipolar disorder risk interaction)[23218918];Carotid intima media thickness[26343869];,0.6058895705521472,0.01701908200103146,0.09866875489428348,0.9116022099447514
103,617,AGPAT2,603100,608594;,[MIM:608594]Congenital generalized lipodystrophy 1 [recessive?];,Berardinelli-Seip congenital lipodystrophy,Disease-causing germline mutation(s) in,,0.26588957055214724,0.16400206291903044,0.3941529626729314,0.7797728667894414
104,623,AGPS,603051,600121;,[MIM:600121]Rhizomelic chondrodysplasia punctata 3;,Rhizomelic chondrodysplasia punctata type 3,Disease-causing germline mutation(s) in,,0.8647852760736197,0.8818978855079939,0.9083790133124511,0.7539901780233272
105,626,AGRN,103320,615120;,"[MIM:615120]Myasthenic syndrome, congenital, 8 [recessive?];",Presynaptic congenital myasthenic syndromes;Postsynaptic congenital myasthenic syndromes,Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in,,0.5614723926380368,0.5660134089736978,0.2255285826155051,0.42464702271332105
106,628,AGT,106150,145500;267430;,[MIM:145500]Essential hypertension;[MIM:267430]Renal tubular dysgenesis;,Renal tubular dysgenesis of genetic origin,Disease-causing germline mutation(s) in,Systolic blood pressure[27618452];Diastolic blood pressure (cigarette smoking interaction)[29455858];Diastolic blood pressure[27618452;28739976];Systolic blood pressure x alcohol consumption interaction (2df test)[29912962];Diastolic blood pressure x alcohol consumption interaction (2df test)[29912962;29912962];Blood protein levels[30072576];Mean arterial pressure[27618448];Coronary artery disease[29212778];Systolic blood pressure (cigarette smoking interaction)[29455858];,0.4154601226993865,0.1521402784940691,0.3489950404594101,0.8442295887047269
107,630,AGTR1,106165,267430;,[MIM:267430]Renal tubular dysgenesis;,Renal tubular dysgenesis of genetic origin,Disease-causing germline mutation(s) in,Monobrow[27182965];Chin dimples[27182965];Lead levels in blood[25820613];,0.4431901840490797,0.3249097472924188,0.761419994779431,0.13812154696132597
108,631,AGTR2,300034,,,X-linked non-syndromic intellectual disability,Disease-causing germline mutation(s) in,Type 2 diabetes[29358691;30130595];Gestational age at birth (maternal effect)[28877031];Cystic fibrosis severity[21602797];Preterm birth (maternal effect)[28877031];Lung disease severity in cystic fibrosis[26417704;26417704;26417704;26417704;26417704;26417704];,0.3492024539877301,0.42753996905621455,0.6906812842599843,0.2438612645794966
109,633,AGXT,604285,259900;,[MIM:259900]Hyperoxaluria primary 1;,Primary hyperoxaluria type 1,Disease-causing germline mutation(s) in,Urinary metabolites[26352407];Blood metabolite levels[24816252];Height[25282103];,0.36171779141104293,0.16941722537390408,0.3659618898459932,0.8735420503376304
110,637,AHCY,180960,613752;,[MIM:613752]Hypermethioninemia with S-adenosylhomocysteine hydrolase deficiency;,Psychomotor retardation due to S-adenosylhomocysteine hydrolase deficiency,Disease-causing germline mutation(s) in,Vitiligo[27723757];,0.9644171779141104,0.4724084579680248,0.6233359436178544,0.5972989564149785
111,648,AHDC1,615790,615829;,"[MIM:615829]Mental retardation, autosomal dominant 25 [dominant?];",AHDC1-related intellectual disability-obstructive sleep apnea-mild dysmorphism syndrome,Disease-causing germline mutation(s) in,Coronary artery disease[29212778];,0.6761963190184049,1.0,0.36048029235186635,0.9674647022713321
112,649,AHI1,608894,608629;,[MIM:608629]Joubert syndrome 3;,Retinitis pigmentosa;Joubert syndrome;Joubert syndrome with ocular defect,Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in,Multiple sclerosis[21833088;24076602];Systemic lupus erythematosus[27399966;26502338;28714469];White blood cell count[27863252];Nodular sclerosis Hodgkin lymphoma[29196614];Myeloid white cell count[27863252];Sum basophil neutrophil counts[27863252];Sum neutrophil eosinophil counts[27863252];Monocyte count[27863252];Selective IgA deficiency[27723758];Granulocyte count[27863252];Neutrophil count[27863252];Hodgkin's lymphoma[29196614];,0.6596319018404908,0.6941722537390408,0.34586269903419475,0.003376304481276857
113,652,AHR,600253,,,Retinitis pigmentosa,Disease-causing germline mutation(s) in,"Alanine aminotransferase (ALT) levels after remission induction therapy in actute lymphoblastic leukemia (ALL)[28090653];Lung cancer in ever smokers[28604730];Urinary albumin excretion[30220432];Severe influenza A (H1N1) infection[26379185];Urinary albumin excretion (no hypertensive medication)[30220432];Blood metabolite levels[24816252];Coffee consumption (cups per day)[25288136];Inflammatory bowel disease[26192919];Rosacea symptom severity[29771307];Caffeine metabolism (plasma 1,7-dimethylxanthine (paraxanthine) to 1,3,7-trimethylxanthine (caffeine) ratio)[27702941;27702941;27702941;27702941;27702941;27702941;27702941;27702941];Cutaneous squamous cell carcinoma[27424798];Plasma kynurenine levels in major depressive disorder[29317604];Caffeine consumption[21490707];Caffeine metabolism (plasma 1,3,7-trimethylxanthine (caffeine) level)[27702941;27702941;27702941;27702941;27702941;27702941];Metabolic traits[21886157];Coffee consumption[25288136;21357676;29367735];Ulcerative colitis[26192919];",0.4936196319018405,0.9834966477565755,0.2826938136256852,0.4478207489257213
114,656,AHSG,138680,203650;,[MIM:203650]Alopecia-mental retardation syndrome 1 [recessive?];,Alopecia-intellectual disability syndrome,Disease-causing germline mutation(s) in,Activated partial thromboplastin time[22703881];Blood protein levels[28240269;29875488;29875488;29875488;30072576;30072576;30072576;30072576;30072576];,0.7707975460122699,0.10881897885507993,0.6389976507439311,0.11955187231430325
115,659,AICDA,605257,605258;,[MIM:605258]Immunodeficiency with hyper-IgM 2;,Hyper-IgM syndrome type 2,Disease-causing germline mutation(s) in,Takayasu arteritis[25604533];,0.5170552147239263,0.2558019597730789,0.7888279822500652,0.3670963781461019
116,663,AIFM1,300169,300614;300816;310490;,"[MIM:300816]Combined oxidative phosphorylation deficiency 6;[MIM:310490]Cowchock syndrome;[MIM:300614]Deafness, X-linked, 5;","Spondyloepimetaphyseal dysplasia, Bieganski type;X-linked hereditary sensory and autonomic neuropathy with deafness;Severe X-linked mitochondrial encephalomyopathy;X-linked Charcot-Marie-Tooth disease type 4",Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in,,0.9852760736196319,0.8976276431150078,0.8055338031845471,0.8204419889502762
117,671,AIMP1,603605,260600;,"[MIM:260600]Leukodystrophy, hypomyelinating, 3 [recessive?];",Pelizaeus-Merzbacher-like disease due to AIMP1 mutation;Autosomal recessive non-syndromic intellectual disability,Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) (loss of function) in,,0.9306748466257668,0.5317173800928313,0.2492821717567215,0.025475751995089013
118,675,AIP,605555,102200;600634;,[MIM:600634]Prolactin-secreting pituitary adenoma;,Acromegaly;Prolactinoma;Familial isolated pituitary adenoma;Silent pituitary adenoma;Null pituitary adenoma,Major susceptibility factor in;Major susceptibility factor in;Disease-causing germline mutation(s) in;Major susceptibility factor in;Major susceptibility factor in,,0.7279754601226994,0.8883445074780815,0.7950926651004959,0.6869244935543278
119,676,AIPL1,604392,604393;,,Cone rod dystrophy;Leber congenital amaurosis,Candidate gene tested in;Disease-causing germline mutation(s) in,Manganese levels[26025379];C-reactive protein levels[29403010];Cognitive decline rate in late mild cognitive impairment[26252872;26252872];Paclitaxel-induced cytotoxicity[26015512];,0.3925153374233129,0.25348117586384733,0.1446097624641086,0.8465316144874155
120,677,AIRE,607358,109100;240300;,"[MIM:240300]Autoimmune polyendocrine syndrome 1, with or without reversible metaphyseal dysplasia;",Familial isolated hypoparathyroidism due to impaired PTH secretion;Autoimmune polyendocrinopathy type 1,Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) (loss of function) in,Rheumatoid arthritis[21505073];,0.5505521472392638,0.3483754512635379,0.5074393108848865,0.7539901780233272
121,685,AK1,103000,612631;,[MIM:612631]Hemolytic anemia due to adenylate kinase deficiency;,Hemolytic anemia due to adenylate kinase deficiency,Disease-causing germline mutation(s) in,Body mass index[26426971];Hematocrit[27863252];Red blood cell count[27863252];Blood protein levels[30072576];Hemoglobin concentration[27863252];,0.40773006134969325,0.7501289324394017,0.4306969459671104,0.462707182320442
122,686,AK2,103020,267500;,[MIM:267500]Reticular dysgenesis [recessive?];,Reticular dysgenesis,Disease-causing germline mutation(s) (loss of function) in,Gut microbiota (beta diversity)[27723756];,0.9251533742331288,0.3500515729757607,0.6797180892717306,0.31675874769797424
123,706,AK7,615364,617965;,,Non-syndromic male infertility due to sperm motility disorder,Disease-causing germline mutation(s) in,,0.19190184049079756,0.7044868488911811,0.17019055077003392,0.34714548802946593
124,708,AK9,615358,,,Postsynaptic congenital myasthenic syndromes,Disease-causing germline mutation(s) in,Lung cancer in ever smokers[28604730];,0.22687116564417178,0.25734914904589995,0.011485251892456277,0.0
125,720,AKAP9,604001,611820;,[MIM:611820]Long QT syndrome 11;,Brugada syndrome;Romano-Ward syndrome,Candidate gene tested in;Disease-causing germline mutation(s) (loss of function) in,Disrupted circadian rhythm (low relative amplitude of rest-activity cycles)[30120083];Acute urticaria and angioedema (non-steroidal anti-inflammatory drug-induced)[24236485];Breast cancer[29059683];,0.8939877300613497,0.5252707581227437,0.033150613416862436,0.059085328422345
126,737,AKR1B1,103880,,,Kennedy disease;Familial hypospadias;Partial androgen insensitivity syndrome;Complete androgen insensitivity syndrome,Disease-causing germline mutation(s) in;Candidate gene tested in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in,White matter growth[29682794];Blood protein levels[29875488;30072576];,0.4403680981595092,0.2851985559566787,0.6747585486818063,0.17756292203806015
127,751,AKR1C2,600450,614279;,,"46,XY disorder of sex development due to testicular 17,20-desmolase deficiency",Disease-causing germline mutation(s) (loss of function) in,Longevity[26912274];,0.2498159509202454,0.10314595152140278,0.5063951970764813,0.06952117863720074
128,753,AKR1C4,600451,614279;,"[MIM:614279]46,XY sex reversal 8;","46,XY disorder of sex development due to testicular 17,20-desmolase deficiency",Modifying germline mutation in,Blood metabolite ratios[24816252];Triglyceride levels[28334899];Triglycerides[24097068];,0.12711656441717792,0.039711191335740074,0.36700600365439834,0.07826887661141804
129,758,AKR1D1,604741,235555;,,Congenital bile acid synthesis defect type 2,Disease-causing germline mutation(s) in,Blood metabolite ratios[24816252];C-reactive protein levels in ischemic stroke[26718567];Blood metabolite levels[24816252];Bipolar disorder with mood-incongruent psychosis[23092984];,0.19190184049079756,0.6304796286745745,0.8705298877577656,0.05555555555555555
130,765,AKT1,164730,114480;114500;176920;615109;,[MIM:114480]Breast cancer;[MIM:114500]Colorectal cancer;[MIM:176920]Proteus syndrome;[MIM:615109]Cowden syndrome 6;,Cowden syndrome;Proteus syndrome,Disease-causing germline mutation(s) (gain of function) in;Disease-causing somatic mutation(s) in,HDL cholesterol levels[28334899];Endometrial cancer[27135401];Endometrial endometrioid carcinoma[27135401];HDL cholesterol[24097068;25961943];,0.7319018404907975,0.5206291903042806,0.9198642652049074,0.48281154082259053
131,767,AKT2,164731,125853;240900;,"[MIM:125853]Diabetes mellitus, non-insulin-dependent;[MIM:240900]Hypoinsulinemic hypoglycemia with hemihypertrophy;",Hypoinsulinemic hypoglycemia and body hemihypertrophy;AKT2-related familial partial lipodystrophy,Disease-causing germline mutation(s) (gain of function) in;Disease-causing germline mutation(s) in,Diastolic blood pressure[28739976;28739976];Cerebrospinal T-tau levels[26252872];Cerebrospinal fluid t-tau:AB1-42 ratio[26252872];,0.7182822085889571,0.8806085611139762,0.8888018794048551,0.5161141804788214
132,768,AKT3,611223,615937;,[MIM:615937]Megalencephaly-polymicrogyria-polydactyly-hydrocephalus syndrome 2;,Megalencephaly-polymicrogyria-postaxial polydactyly-hydrocephalus syndrome;Hemimegalencephaly,Disease-causing germline mutation(s) in;Disease-causing somatic mutation(s) in,Diabetic retinopathy[21441570;21441570];Self-reported risk-taking behaviour[30181555];RR interval (heart rate)[20031603];Schizophrenia[23974872;25056061;28991256];Diastolic blood pressure x smoking status (current vs non-current) interaction (2df test)[29455858;29455858];Diastolic blood pressure x smoking status (ever vs never) interaction (2df test)[29455858;29455858];Menarche (age at onset)[23599027;23599027];Post-traumatic stress disorder (asjusted for relatedness)[23726511];Non-glioblastoma glioma[28346443];Educational attainment[25201988];,0.3925153374233129,0.8641052088705519,0.9556251631427826,0.5007673419275629
133,771,ALAD,125270,612740;,[MIM:612740]Acute hepatic porphyria;,Porphyria due to ALA dehydratase deficiency,Disease-causing germline mutation(s) in,Lead levels in blood[25820613;25820613];,0.33226993865030674,0.5239814337287262,0.38240668232837377,0.7383364027010436
134,773,ALAS2,301300,300751;300752;,"[MIM:300752]Erythropoietic protoporphyria, X-linked dominant;",X-linked erythropoietic protoporphyria;X-linked sideroblastic anemia,Disease-causing germline mutation(s) (gain of function) in;Disease-causing germline mutation(s) in,,0.17791411042944785,0.873388344507478,0.8180631688854085,0.0
135,774,ALB,103600,615999;616000;,"[MIM:615999]Hyperthyroxinemia, familial dysalbuminemic;[MIM:616000]Analbuminemia [recessive?];",Congenital analbuminemia,Disease-causing germline mutation(s) in,Cholesterol ester levels in large LDL[29084231];Total cholesterol levels in LDL[29084231;29084231];Total cholesterol levels in small LDL[29084231];Total cholesterol levels in large LDL[29084231];Small LDL particle concentration[29084231;29084231];Large LDL particle concentration[29084231];Free cholesterol levels in large LDL[29084231];Lipid metabolism phenotypes[22286219];Free cholesterol levels[29084231];Serum total cholesterol levels[29084231;29084231];Metabolite levels (small molecules and protein measures)[27005778];Cholesterol ester levels in medium LDL[29084231];Total cholesterol levels in medium LDL[29084231];Medium LDL particle concentration[29084231];Esterified cholesterol levels[29084231];Prostate cancer[23535732];,0.8292024539877301,0.7325941206807632,0.815713912816497,0.24984653161448742
136,778,ALDH1A3,600463,615113;,,Isolated microphthalmia-anophthalmia-coloboma,Disease-causing germline mutation(s) in,Chin dimples[27182965];,0.17791411042944785,0.3661681279009799,0.27564604541895066,0.2776243093922652
137,786,ALDH3A2,609523,270200;,,Sj�gren-Larsson syndrome,Disease-causing germline mutation(s) in,,0.9904294478527608,0.721763795771016,0.674497520229705,0.5914671577655003
138,789,ALDH4A1,606811,239510;,,Hyperprolinemia type 2,Disease-causing germline mutation(s) in,Anorexia nervosa[23568457];Alzheimer's disease (survival time)[25649651];,0.7879754601226994,0.28623001547189275,0.25163142782563297,0.07028852056476366
139,790,ALDH5A1,610045,271980;,,Succinic semialdehyde dehydrogenase deficiency,Disease-causing germline mutation(s) in,Liver enzyme levels (alkaline phosphatase)[22001757];,0.8071165644171779,0.1707065497679216,0.18794048551292092,0.5089011663597299
140,791,ALDH6A1,603178,614105;,[MIM:614105]Methylmalonate semialdehyde dehydrogenase deficiency;,Developmental delay due to methylmalonate semialdehyde dehydrogenase deficiency,Disease-causing germline mutation(s) in,Blood protein levels[28240269;28240269];Red cell distribution width[27863252];,0.43754601226993867,0.18772563176895307,0.7828243278517358,0.3632596685082873
141,792,ALDH7A1,107323,266100;,,Pyridoxine-dependent epilepsy,Disease-causing germline mutation(s) in,Osteoporosis[20072603];Coronary artery calcified atherosclerotic plaque (90 or 130 HU threshold) in type 2 diabetes[29221444];,0.8674846625766871,0.02862300154718927,0.2920908379013312,0.4444444444444444
142,800,ALDH18A1,138250,219150;601162;616586;616603;,"[MIM:219150]Cutis laxa, autosomal recessive, 3A [recessive?];[MIM:616603]Cutis laxa, autosomal dominant, 3 [dominant?];[MIM:601162]Spastic paraplegia 9A, autosomal dominant [dominant?];[MIM:616586]Spastic paraplegia 9B, autosomal recessive [recessive?];",Autosomal dominant spastic paraplegia type 9B;Autosomal dominant spastic paraplegia type 9A;Autosomal recessive spastic paraplegia type 9B;ALDH18A1-related De Barsy syndrome;Autosomal dominant cutis laxa,Disease-causing germline mutation(s) (loss of function) in;Disease-causing germline mutation(s) (loss of function) in;Disease-causing germline mutation(s) (loss of function) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in,Blood metabolite levels[24816252];Staphylococcus aureus nasal carriage (persistent)[26569114];,0.9360736196319018,0.3574007220216607,0.2829548420777865,0.32535297728667895
143,801,ALDOA,103850,611881;,[MIM:611881]Glycogen storage disease 12;,Glycogen storage disease due to aldolase A deficiency,Disease-causing germline mutation(s) in,Autism spectrum disorder or schizophrenia[28540026];Schizophrenia[25056061];,0.9717791411042945,0.48272305312016506,0.7619420516836335,0.9045426642111725
144,804,ALDOB,612724,229600;,[MIM:229600]Hereditary fructose intolerance;,Hereditary fructose intolerance,Disease-causing germline mutation(s) in,Serum alkaline phosphatase levels[29403010];Liver enzyme levels (alkaline phosphatase)[22001757];Age-related cataracts[25352737];,0.3669938650306748,0.1923671995874162,0.5747846515270164,0.7383364027010436
145,806,ALG1,605907,608540;,[MIM:608540]Congenital disorder of glycosylation 1K;,ALG1-CDG,Disease-causing germline mutation(s) (loss of function) in,Phospholipid levels (plasma)[22359512];,0.8458895705521472,0.3300670448684889,0.26833724876011483,0.4547268262737876
146,821,ALG2,607905,607906;616228;,"[MIM:607906]Congenital disorder of glycosylation 1I;[MIM:616228]Myasthenic syndrome, congenital, 14 [recessive?];",Congenital myasthenic syndromes with glycosylation defect;ALG2-CDG,Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) (loss of function) in,Callous-unemotional behaviour[23874384];Gestational age at birth (maternal effect)[28877031];,0.33975460122699386,0.2717895822588963,0.4380057426259462,0.45058317986494784
147,822,ALG3,608750,601110;,[MIM:601110]Congenital disorder of glycosylation 1D;,ALG3-CDG,Disease-causing germline mutation(s) (loss of function) in,Major depressive disorder[22472876];,0.8711656441717791,0.0745229499742135,0.6230749151657531,0.677255985267035
148,825,ALG6,604566,603147;,[MIM:603147]Congenital disorder of glycosylation 1C;,ALG6-CDG,Disease-causing germline mutation(s) (loss of function) in,,0.7262576687116564,0.4071686436307375,0.46750195771339076,0.5488029465930019
149,826,ALG8,608103,608104;617874;,[MIM:608104]Congenital disorder of glycosylation 1H;[MIM:617874]Polycystic liver disease 3 with or without kidney cysts [dominant?];,ALG8-CDG,Disease-causing germline mutation(s) (loss of function) in,Depression in smokers[30219690];,0.36171779141104293,0.22846828261990718,0.3114069433568259,0.700890116635973
150,827,ALG9,606941,263210;608776;,[MIM:608776]Congenital disorder of glycosylation 1L;[MIM:263210]Gillessen-Kaesbach-Nishimura syndrome [recessive?];,ALG9-CDG,Disease-causing germline mutation(s) (loss of function) in,,0.885398773006135,0.32336255801959773,0.139389193422083,0.09422958870472682
151,831,ALG11,613666,613661;,[MIM:613661]Congenital disorder of glycosylation 1P;,ALG11-CDG,Disease-causing germline mutation(s) in,,0.20368098159509201,0.3893759669932955,0.6183764030279301,0.09484346224677716
152,832,ALG12,607144,607143;,,ALG12-CDG,Disease-causing germline mutation(s) (loss of function) in,Acne (severe)[24927181];,0.19190184049079756,0.7065497679216091,0.28608718350300183,0.42602823818293434
153,833,ALG13,300776,300884;,"[MIM:300884]Epileptic encephalopathy, early infantile, 36;",X-linked non-syndromic intellectual disability;ALG13-CDG,Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in,Rosacea symptom severity[29771307];,0.6186503067484662,0.9130995358432181,0.7650743931088488,0.5664518109269491
154,835,ALG14,612866,616227;,"[MIM:616227]Myasthenic syndrome, congenital, 15;",Congenital myasthenic syndromes with glycosylation defect,Disease-causing germline mutation(s) in,Phospholipid levels (plasma)[22359512];Stearic acid (18:0) levels[23362303];Palmitic acid (16:0) levels[23362303];,0.08736196319018405,0.34734399174832387,0.8637431480031323,0.4349294045426642
155,836,ALK,105590,613014;,[MIM:613014]Neuroblastoma 3;,Neuroblastoma;Neuroblastoma;Inflammatory myofibroblastic tumor;Differentiated thyroid carcinoma;ALK-positive large B-cell lymphoma;Selection of therapeutic option in non-small cell lung carcinoma;ALK-positive anaplastic large cell lymphoma,Disease-causing somatic mutation(s) in;Major susceptibility factor in;Part of a fusion gene in;Part of a fusion gene in;Part of a fusion gene in;Biomarker tested in;Disease-causing somatic mutation(s) in,Systolic blood pressure[26969751];Glucose homeostasis traits[25524916];Body mass index[25673413];Adiponectin levels (BMI-adjusted)[26299439];,0.554601226993865,0.6575554409489428,0.08379013312451057,0.6497851442602823
156,849,ALMS1,606844,203800;,[MIM:203800]Alstrom syndrome [recessive?];,Alstr�m syndrome,Disease-causing germline mutation(s) in,Urinary metabolite concentrations in chronic kidney disease[29545352];Serum metabolite levels[23093944;23093944;23093944;23093944;23093944;23093944;23093944;23093944;23093944;23093944;23093944];Age at voice drop[27182965];Creatinine levels[20383145];Chronic kidney disease[20383146];Menarche (age at onset)[27182965];Urinary metabolites (H-NMR features)[24586186;24586186;24586186];Glomerular filtration rate[27588450;27588450];Intelligence (MTAG)[29326435];Glomerular filtration rate in non diabetics (creatinine)[26831199];Urinary metabolite ratios in chronic kidney disease[29545352;29545352;29545352];Metabolite levels[21931564];Metabolite levels  (X-11787)[23934736];Glomerular filtration rate (creatinine)[26831199];,0.9393865030674846,0.0023207839092315627,0.005742625946228139,0.044812768569674644
157,856,ALOX12B,603741,242100;,,Lamellar ichthyosis;Self-improving collodion baby;Congenital non-bullous ichthyosiform erythroderma,Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in,,0.6030674846625766,0.3406395048994327,0.5841816758026624,0.5833333333333334
158,863,ALOXE3,607206,606545;,,Lamellar ichthyosis;Self-improving collodion baby;Congenital non-bullous ichthyosiform erythroderma,Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in,,0.33226993865030674,0.0332645693656524,0.26859827721221613,0.7183855125844076
159,869,ALPK3,617608,618052;,"[MIM:618052]Cardiomyopathy, familial hypertrophic 27;",Retinitis pigmentosa,Disease-causing germline mutation(s) in,Adverse response to chemotherapy (neutropenia/leucopenia) (gemcitabine)[23648065];Autism spectrum disorder or schizophrenia[28540026];P wave terminal force[28794112;28794112];Alzheimer's disease (age of onset)[22005931;22005931];,0.038773006134969326,0.017534811758638472,0.10101801096319499,0.1505524861878453
160,870,ALPL,171760,146300;241500;241510;,[MIM:146300]Hypophosphatasia;[MIM:241510]Hypophosphatasia childhood type;[MIM:241500]Hypophosphatasia infantile type;,Odontohypophosphatasia;Perinatal lethal hypophosphatasia;Prenatal benign hypophosphatasia;Infantile hypophosphatasia;Childhood-onset hypophosphatasia;Adult hypophosphatasia,Disease-causing germline mutation(s) (loss of function) in;Disease-causing germline mutation(s) (loss of function) in;Disease-causing germline mutation(s) (loss of function) in;Disease-causing germline mutation(s) (loss of function) in;Disease-causing germline mutation(s) (loss of function) in;Disease-causing germline mutation(s) (loss of function) in,Blood metabolite ratios[24816252;24816252];Adverse response to chemotherapy (neutropenia/leucopenia) (all platinum-based drugs)[23648065];Vitamin B levels in ischemic stroke[25147783];Phosphorus levels[20558539;29403010];Response to TNF-alpha inhibitors in rheumatoid arthritis[22569225];Serum alkaline phosphatase levels[29403010];Liver enzyme levels (alkaline phosphatase)[22001757];Liver enzyme levels[18940312];Hematological and biochemical traits[20139978];Folate pathway vitamin levels[19744961;19303062];Metabolic traits[21886157];Kidney stones[26272126];,0.23865030674846627,0.3194945848375451,0.18637431480031325,0.8919582565991406
161,873,ALS2,606352,205100;606353;607225;,[MIM:205100]Amyotrophic lateral sclerosis 2;[MIM:606353]Juvenile primary lateral sclerosis;[MIM:607225]Infantile-onset ascending spastic paralysis;,Juvenile primary lateral sclerosis;Infantile-onset ascending hereditary spastic paralysis;Juvenile amyotrophic lateral sclerosis,Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in,,0.6312883435582822,0.6882413615265601,0.3813625685199687,0.5228667894413751
162,879,ALX1,601527,613456;,[MIM:613456]Frontonasal dysplasia 3;,Frontonasal dysplasia-severe microphthalmia-severe facial clefting syndrome,Disease-causing germline mutation(s) (loss of function) in,Nose size[27182965];Bone mineral density (Ward's triangle area)[27397699];Lung function (FEV1)[30061609];Lung function (FVC)[30061609;30061609;30061609];,0.27975460122699386,0.612429087158329,0.565909684155573,0.6981276856967464
163,880,ALX3,606014,136760;,[MIM:136760]Frontonasal dysplasia 1;,Frontorhiny,Disease-causing germline mutation(s) (loss of function) in,Blood metabolite levels[24816252];Visceral adipose tissue/subcutaneous adipose tissue ratio[22589738];,0.27361963190184047,0.43785456420835484,0.7851735839206474,0.7140883977900553
164,881,ALX4,605420,601224;609597;613451;615529;,[MIM:613451]Frontonasal dysplasia 2;[MIM:601224]Potocki-Shaffer syndrome;[MIM:615529]Craniosynostosis 5;,Frontonasal dysplasia-alopecia-genital anomalies syndrome;Enlarged parietal foramina;Isolated scaphocephaly;Potocki-Shaffer syndrome,Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) (loss of function) in;Major susceptibility factor in;Role in the phenotype of,Cadmium levels[26025379];Blood pressure measurement (high sodium intervention)[24165912;24165912];Male-pattern baldness[27182965;29146897];Monobrow[27182965];Gout[22179738];Excessive hairiness[29895819];Thrombin-activatable fibrinolysis inhibitor activation peptide[29378355];,0.6030674846625766,0.6433728726147498,0.02714695901853302,0.7067219152854513
165,883,AMACR,604489,214950;614307;,[MIM:614307]Alpha-methylacyl-CoA racemase deficiency [recessive?];[MIM:214950]Congenital bile acid synthesis defect 4;,Congenital bile acid synthesis defect type 4,Disease-causing germline mutation(s) in,,0.14576687116564419,0.5590510572460031,0.06917253980683895,0.24232658072437077
166,884,AMBN,601259,616270;,,Hypoplastic amelogenesis imperfecta,Disease-causing germline mutation(s) in,,0.16220858895705523,0.1333161423414131,0.05794831636648395,0.16789441375076733
167,895,AMELX,300391,301200;,[MIM:301200]Amelogenesis imperfecta 1E;,Hypomaturation amelogenesis imperfecta,Disease-causing germline mutation(s) in,,0.038773006134969326,0.5348117586384734,0.5632993996345602,0.7251381215469613
168,897,AMER1,300647,300373;,,Osteopathia striata-cranial sclerosis syndrome,Disease-causing germline mutation(s) in,,0.7088343558282209,0.8981433728726147,0.6669276951187679,0.0
169,901,AMH,600957,261550;,[MIM:261550]Persistent Muellerian duct syndrome 1;,Persistent M�llerian duct syndrome,Disease-causing germline mutation(s) in,Pulse pressure[26390057;27618447];,0.21484662576687116,0.4473955647240846,0.6572696423910206,0.0
170,902,AMHR2,600956,261550;,[MIM:261550]Persistent Muellerian duct syndrome 2;,Persistent M�llerian duct syndrome,Disease-causing germline mutation(s) in,,0.20368098159509201,0.3506962351727695,0.7809971286870269,0.6445672191528545
171,907,AMMECR1,300195,300194;300990;,"[MIM:300990]Midface hypoplasia, hearing impairment, elliptocytosis, and nephrocalcinosis;[MIM:300194]Alport syndrome with mental retardation, midface hypoplasia and elliptocytosis;",Alport syndrome-intellectual disability-midface hypoplasia-elliptocytosis syndrome;Alport syndrome-intellectual disability-midface hypoplasia-elliptocytosis syndrome,Disease-causing germline mutation(s) in;Role in the phenotype of,,0.32380368098159507,0.7870036101083032,0.9015922735578178,0.8173726212400245
172,911,AMN,605799,261100;,[MIM:261100]Recessive hereditary megaloblastic anemia 1;,Imerslund-Gr�sbeck syndrome,Disease-causing germline mutation(s) in,Body mass index[26426971];,0.12711656441717792,0.6031459515214028,0.4904724614983033,0.0
173,916,AMPD1,102770,615511;,[MIM:615511]Myopathy due to myoadenylate deaminase deficiency;,Adenosine monophosphate deaminase deficiency,Disease-causing germline mutation(s) in,Autism[24189344;24189344;24189344];,0.17791411042944785,0.026044352759154205,0.2594622813886714,0.7498465316144874
174,917,AMPD2,102771,615686;615809;,"[MIM:615809]Pontocerebellar hypoplasia 9;[MIM:615686]Spastic paraplegia 63, autosomal recessive [recessive?];",Pontocerebellar hypoplasia type 9;Autosomal recessive spastic paraplegia type 63,Disease-causing germline mutation(s) (loss of function) in;Disease-causing germline mutation(s) in,Major depressive disorder[20125088];,0.6019631901840491,0.5087674058793192,0.184286087183503,0.866329036218539
175,918,AMPD3,102772,612874;,[MIM:612874]Adenosine monophosphate deaminase deficiency erythrocyte type;,Adenosine monophosphate deaminase deficiency,Disease-causing germline mutation(s) in,HDL cholesterol levels[28334899];HDL cholesterol[20686565;24097068];,0.5614723926380368,0.5404847859721505,0.3657008613938919,0.9436771025168815
176,920,AMT,238310,605899;,[MIM:605899]Non-ketotic hyperglycinemia;,Atypical glycine encephalopathy;Neonatal glycine encephalopathy;Infantile glycine encephalopathy,Disease-causing germline mutation(s) (loss of function) in;Disease-causing germline mutation(s) (loss of function) in;Disease-causing germline mutation(s) (loss of function) in,Inflammatory bowel disease[28067908];Gut microbiota (functional units)[27694959];Crohn's disease[28067908];Blood protein levels[28240269];Cognitive function[25644384];Coronary artery disease[29212778];Ulcerative colitis[28067908];,0.33975460122699386,0.37596699329551314,0.6157661185069172,0.7918968692449355
177,921,AMTN,610912,617607;,[MIM:617607]Amelogenesis imperfecta 3B [dominant?];,Hypocalcified amelogenesis imperfecta,Disease-causing germline mutation(s) in,,0.23865030674846627,0.12867457452294997,0.1829809449229966,0.17756292203806015
178,934,ANAPC2,606946,,,Sotos syndrome,Disease-causing germline mutation(s) (loss of function) in,,0.7647852760736197,0.9773078906652913,0.7032106499608457,0.7038060159607121
179,945,ANG,105850,611895;,[MIM:611895]Amyotrophic lateral sclerosis 9;,Amyotrophic lateral sclerosis,Disease-causing germline mutation(s) in,Blood protein levels[28240269;28240269;28240269;30072576];,0.5760736196319018,0.6425992779783394,0.9702427564604542,0.0
180,956,ANGPTL6,609336,,,Familial cerebral saccular aneurysm,Disease-causing germline mutation(s) (loss of function) in,Thiazide-induced adverse metabolic effects in hypertensive patients[23400010];Protein quantitative trait loci[18464913];,0.038773006134969326,0.16477565755544094,0.6635343252414513,0.0
181,964,ANK1,612641,182900;,[MIM:182900]Spherocytosis 1 [dominant?] [recessive?];,8p11.2 deletion syndrome;Hereditary spherocytosis,Role in the phenotype of;Disease-causing germline mutation(s) in,Type 2 diabetes[22456796;24509480;26818947;22885922;22885922;29358691;28869590;28869590];Mean corpuscular hemoglobin concentration[28017375;28017375;27863252;27863252;27863252];Granulocyte percentage of myeloid white cells[27863252];High light scatter reticulocyte percentage of red cells[27863252;27863252;27863252;27863252];Mean corpuscular volume[27863252];Lymphocyte percentage of white cells[27863252];Reticulocyte count[27863252;27863252;27863252;27863252;27863252];Glycated hemoglobin levels[20858683;20858683;24647736;28898252;28898252;28898252];Lymphocyte counts[27863252;27863252];High light scatter reticulocyte count[27863252;27863252;27863252;27863252];Red cell distribution width[27863252];Corrected insulin response adjusted for insulin sensitivity index[24699409];Immature fraction of reticulocytes[27863252];Pulmonary function decline[22424883];Reticulocyte fraction of red cells[27863252;27863252;27863252;27863252;27863252];Corrected insulin response[24699409];Neutrophil percentage of white cells[27863252];Birth weight[27680694];Insulin levels adjusted for BMI[24699409];,0.3856441717791411,0.3592057761732852,0.267554163403811,0.7783916513198281
182,965,ANK2,106410,600919;,[MIM:600919]Long QT syndrome 4;,Romano-Ward syndrome,Disease-causing germline mutation(s) (loss of function) in,Body mass index[26426971];Stroke[29531354;29531354];Parkinson's disease[28892059];Ischemic stroke[29531354;29531354];Fractional exhaled nitric oxide (childhood)[24315451;24315451];Blood trace element (Cu levels)[23720494];,0.6803680981595092,0.6046931407942239,0.06577916992952232,0.4766728054020872
183,966,ANK3,600465,615493;,"[MIM:615493]Mental retardation, autosomal recessive 37 [recessive?];",ANK3-related intellectual disability-sleep disturbance syndrome,Disease-causing germline mutation(s) in,"Plasma amyloid beta peptide concentrations (ABx-42)[24535457];Bipolar disorder or major depressive disorder[20351715];Autism spectrum disorder, attention deficit-hyperactivity disorder, bipolar disorder, major depressive disorder, and schizophrenia (combined)[23453885;23453885];Amyotrophic lateral sclerosis (sporadic)[24529757];Schizophrenia[20185149];Bipolar disorder[21926972;18711365;22182935;24618891;28072414];Behavioral disturbance or psychiatric symptoms and prion disease[25897833];Coronary artery calcified atherosclerotic plaque (130 HU threshold) in type 2 diabetes[29221444];Venous thromboembolism adjusted for sickle cell variant rs77121243-T[28203683];",0.7617177914110429,0.6335740072202166,0.11067606369094231,0.6497851442602823
184,972,ANKFY1,607927,,,Familial idiopathic steroid-resistant nephrotic syndrome with diffuse mesangial proliferation,Disease-causing germline mutation(s) in,"Functional impairment in major depressive disorder, bipolar disorder and schizophrenia[24039173];",0.6723926380368098,0.644404332129964,0.6376925084834247,0.3670963781461019
185,973,ANKH,605145,118600;123000;,"[MIM:123000]Craniometaphyseal dysplasia, autosomal dominant [dominant?];",Familial calcium pyrophosphate deposition;Craniometaphyseal dysplasia,Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) (gain of function) in,Response to fenofibrate (total cholesterol levels)[27002377];Glaucoma[30054594;30054594];Glaucoma (primary open-angle)[29891935];Blood metabolite levels[24816252];Urate levels (BMI interaction)[25811787];Homeostasis model assessment of insulin resistance (dietary factor interaction)[24204828];Intraocular pressure[30054594;29785010];,0.08736196319018405,0.4814337287261475,0.7692508483424694,0.7685696746470227
186,979,ANKLE2,616062,616681;,"[MIM:616681]Microcephaly 16, primary, autosomal recessive [recessive?];",Autosomal recessive primary microcephaly,Disease-causing germline mutation(s) in,Immune response to smallpox vaccine (IL-6)[22542470];,0.931042944785276,0.3947911294481692,0.07752545027407988,0.1505524861878453
187,983,ANKRD1,609599,106700;,[MIM:106700]Total anomalous pulmonary venous return;,Familial isolated dilated cardiomyopathy,Disease-causing germline mutation(s) in,Intraocular pressure[29617998];,0.32380368098159507,0.10959257349149046,0.7287914382667711,0.13812154696132597
188,990,ANKRD11,611192,148050;,[MIM:148050]KBG syndrome;,KBG syndrome;16q24.3 microdeletion syndrome,Disease-causing germline mutation(s) in;Role in the phenotype of,Lymphocyte counts[27863252];,0.5997546012269939,0.8019597730789066,0.245105716523101,0.9622467771639043
189,1028,ANKRD26,610855,188000;,[MIM:188000]Thrombocytopenia 2;,Hereditary thrombocytopenia with normal platelets-hematological cancer predisposition syndrome,Disease-causing germline mutation(s) in,,0.7820858895705521,0.3427024239298608,0.13338553902375358,0.015500306936771025
190,1072,ANKRD55,615189,,,Oligoarticular juvenile idiopathic arthritis;Rheumatoid factor-negative juvenile idiopathic arthritis,Major susceptibility factor in;Major susceptibility factor in,"Type 2 diabetes[26818947;22885922;22885922;29358691;28869590;28869590;27189021];Multiple sclerosis[24076602;27386562];Waist-to-hip ratio adjusted for BMI in active individuals[28448500];Chronic inflammatory diseases (ankylosing spondylitis, Crohn's disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy)[26974007];Sero-negative rheumatoid arthritis[28706201];Waist-to-hip ratio adjusted for BMI[26426971];Alzheimer's disease (cognitive decline)[23535033];Rheumatoid arthritis (ACPA-positive)[23143596;24532676];Post-traumatic stress disorder[27167565];Lung function (FEV1)[30061609];Waist-to-hip ratio adjusted for body mass index[28448500;25673412;25673412;25673412;25673412];Waist-to-hip ratio adjusted for BMI x sex x age interaction (4df test)[26426971];Celiac disease or Rheumatoid arthritis[21383967];IgG glycosylation[23382691;23382691;23382691;23382691;23382691;23382691;23382691;23382691;23382691;23382691;23382691];Urate levels[23263486];Waist-to-hip ratio adjusted for BMI (adjusted for smoking behaviour)[28443625;28443625];Waist-to-hip ratio adjusted for BMI (joint analysis for main effect and physical activity interaction)[28448500];Waist-to-hip ratio adjusted for BMI in non-smokers[28443625];Triglycerides[20686565];Crohn's disease[28067908];Rheumatoid arthritis (ACPA-negative)[23143596];Pediatric autoimmune diseases[26301688];Waist-to-hip ratio adjusted for BMI (age <50)[26426971];Waist-to-hip ratio adjusted for BMI (joint analysis main effects and smoking interaction)[28443625];Juvenile idiopathic arthritis (oligoarticular or rheumatoid factor-negative polyarticular)[23603761];Rheumatoid arthritis[24390342;24390342;20453842;23143596];Monocyte count[27863252];",0.27361963190184047,0.3223310985043837,0.575306708431219,0.12676488643339473
191,1084,ANKS3,617310,,,Situs inversus totalis,Disease-causing germline mutation(s) in,,0.3449079754601227,0.5420319752449716,0.4006786739754633,0.2694904849600982
192,1086,ANKS6,615370,615382;,[MIM:615382]Nephronophthisis 16;,Infantile nephronophthisis;Juvenile nephronophthisis,Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in,Body mass index[28892062];,0.6635582822085889,0.22099020113460546,0.4925606891151135,0.23204419889502761
193,1089,ANLN,616027,616032;,[MIM:616032]Focal segmental glomerulosclerosis 8;,Familial idiopathic steroid-resistant nephrotic syndrome with focal segmental hyalinosis,Disease-causing germline mutation(s) in,Systolic blood pressure[26969751;26969751];,0.6716564417177914,0.8548220732336256,0.04202558078830593,0.1821669736034377
194,1093,ANO3,610110,615034;,,Cranio-cervical dystonia with laryngeal and upper-limb involvement,Disease-causing germline mutation(s) in,Febrile seizures (MMR vaccine-unrelated)[25344690];Febrile seizures[25344690];Exhaled nitric oxide levels[28109725];Exhaled nitric oxide output[28109725];Diisocyanate-induced asthma[25918132];Gait variability[26219847];Thrombin-activatable fibrinolysis inhibitor activation peptide[29378355];Inflammatory skin disease[25574825];Febrile seizures (MMR vaccine-related)[25344690];Photic sneeze reflex[27182965];,0.5885889570552147,0.04744713769984528,0.7465413730096581,0.09806629834254144
195,1095,ANO5,608662,166260;611307;613319;,[MIM:611307]Limb-girdle muscular dystrophy 2L [recessive?];[MIM:613319]Miyoshi muscular dystrophy 3;,Autosomal recessive limb-girdle muscular dystrophy type 2L;Distal anoctaminopathy;Gnathodiaphyseal dysplasia,Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in,"Autism spectrum disorder, attention deficit-hyperactivity disorder, bipolar disorder, major depressive disorder, and schizophrenia (combined)[23453885];Creatine kinase levels[29403010];Plasma thyroid-stimulating hormone levels[24722205];",0.514478527607362,0.0221763795771016,0.42599843382928737,0.028698588090853284
196,1096,ANO6,608663,262890;,,Scott syndrome,Disease-causing germline mutation(s) in,Insomnia[29520036];Ankylosing spondylitis[22138694];Urate levels in obese individuals[25811787];,0.9190184049079755,0.010056730273336771,0.33907595927956147,0.005371393492940454
197,1101,ANO10,613726,613728;,,Adult-onset autosomal recessive cerebellar ataxia,Disease-causing germline mutation(s) in,Obesity-related traits[23251661];,0.6923926380368098,0.2297576070139247,0.27721221613155833,0.10205647636586863
198,1103,ANOS1,300836,308700;,[MIM:308700]Hypogonadotropic hypogonadism 1 with or without anosmia;,Kallmann syndrome;Normosmic congenital hypogonadotropic hypogonadism,Disease-causing germline mutation(s) (loss of function) in;Disease-causing germline mutation(s) in,,0.16220858895705523,0.9370809695719443,0.0,0.0
199,1116,ANTXR1,606410,230740;602089;,"[MIM:602089]Hemangioma, capillary infantile;[MIM:230740]GAPO syndrome;",GAPO syndrome,Disease-causing germline mutation(s) (loss of function) in,Glaucoma[30054594];Height[21998595];Intraocular pressure[29617998;29617998;29235454;30054594;29785010];,0.6884662576687116,0.8960804538421867,0.5202297050378492,0.7051872314303254
200,1117,ANTXR2,608041,228600;,[MIM:228600]Hyaline fibromatosis syndrome [recessive?];,Juvenile hyaline fibromatosis;Infantile systemic hyalinosis,Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in,"Spherical equivalent or myopia (age of diagnosis)[29808027];Lymphocyte percentage of white cells[27863252];Carotid plaque burden[28282560];Neutrophil percentage of white cells[27863252];Lymphocyte counts[27863252];Myopia[27182965];Chronic inflammatory diseases (ankylosing spondylitis, Crohn's disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy)[26974007];Hand grip strength[29691431];Bipolar disorder (inflammation and infection response interaction)[25781172];Ankylosing spondylitis[21743469;20062062];",0.2585276073619632,0.42625064466219703,0.5251892456277735,0.32903621853898096
201,1135,ANXA11,602572,617839;,[MIM:617839]Amyotrophic lateral sclerosis 23 [dominant?];,Amyotrophic lateral sclerosis,Disease-causing germline mutation(s) in,Sarcoidosis[22936702];Sarcoidosis (non-Lofgren's syndrome without extrapulmonary manifestations)[26651848];Chronic obstructive pulmonary disease-related biomarkers[23144326];Diabetic kidney disease[26305897];,0.8446625766871165,0.13022176379577102,0.031323414252153486,0.059085328422345
202,1139,AOC1,104610,,,Amyotrophic lateral sclerosis,Disease-causing germline mutation(s) in,Serum metabolite concentrations in chronic kidney disease[29545352];Blood protein levels[30072576];Eyebrow thickness[26926045];,0.22687116564417178,0.15626611655492523,0.06316888540850953,0.0
203,1155,AP1S1,603531,609313;,"[MIM:609313]Mental retardation, enteropathy, deafness, peripheral neuropathy, ichthyosis, and keratoderma;",MEDNIK syndrome,Disease-causing germline mutation(s) (loss of function) in,,0.567239263803681,0.48066013408973696,0.0,0.27440147329650094
204,1156,AP1S2,300629,304340;,,X-linked intellectual disability-Dandy-Walker malformation-basal ganglia disease-seizures syndrome;X-linked intellectual disability-hypotonia-facial dysmorphism-aggressive behavior syndrome;Fried syndrome,Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in,,0.4894478527607362,0.8476018566271274,0.9966066301226834,0.0
205,1158,AP1S3,615781,616106;,,Acrodermatitis continua of Hallopeau;Pustulosis palmaris et plantaris;Generalized pustular psoriasis,Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in,Sodium levels[29403010];Airway wall thickness[25517131;25517131;25517131];Night sleep phenotypes[27126917];,0.2947239263803681,0.5123775141825684,0.5857478465152701,0.4114487415592388
206,1163,AP2S1,602242,600740;,"[MIM:600740]Hypocalciuric hypercalcemia, familial 3 [dominant?];",Familial hypocalciuric hypercalcemia type 3,Disease-causing germline mutation(s) in,,0.9575460122699386,0.8648788035069623,0.9979117723831897,0.66804788213628
207,1164,AP3B1,603401,203300;608233;,[MIM:608233]Hermansky-Pudlak syndrome 2 [recessive?];,Hermansky-Pudlak syndrome with neutropenia,Disease-causing germline mutation(s) in,Insulin resistance/response[21901158];Lung function (FEV1)[30061609];Triglycerides[26780889];Lung function (FVC)[30061609;30061609;30061609];,0.945276073619632,0.3710675605982465,0.34925606891151134,0.37185389809699204
208,1165,AP3B2,602166,617276;,"[MIM:617276]Epileptic encephalopathy, early infantile, 48 [recessive?];",Undetermined early-onset epileptic encephalopathy,Disease-causing germline mutation(s) in,Lipoprotein-associated phospholipase A2 activity change in response to statin therapy[23118302];Schizophrenia[28991256];,0.3749693251533742,0.7493553378029912,0.49595405899243017,0.0
209,1166,AP3D1,607246,617050;,,Ocular albinism,Candidate gene tested in,Myocardial infarction[24916648];Hematocrit[27863252];Red blood cell count[27863252];Hemoglobin concentration[27863252];,0.900122699386503,0.77720474471377,0.41268598277212215,0.61817065684469
210,1171,AP4B1,607245,614066;,,Severe intellectual disability and progressive spastic paraplegia,Disease-causing germline mutation(s) in,Crohn's disease[28067908];Breast cancer[23535729];Obesity-related traits[23251661];Alopecia areata[25608926];,0.7273619631901841,0.6933986591026302,0.05716523101018011,0.05386740331491713
211,1173,AP4E1,607244,184450;613744;,"[MIM:184450]Stuttering, familial persistent 1 [dominant?];",Severe intellectual disability and progressive spastic paraplegia,Disease-causing germline mutation(s) in,Creatinine levels[29403010];Chloride levels[29403010];Potassium levels[29403010];Response to fenofibrate (HDL cholesterol levels)[27002377];Glomerular filtration rate[29403010];,0.8276073619631902,0.39092315626611657,0.07909162098668755,0.22314303253529774
212,1174,AP4M1,602296,612936;,,Severe intellectual disability and progressive spastic paraplegia,Disease-causing germline mutation(s) in,,0.5153374233128835,0.149045899948427,0.4646306447402767,0.16313689379987723
213,1175,AP4S1,607243,614067;,,Severe intellectual disability and progressive spastic paraplegia,Disease-causing germline mutation(s) in,,0.8525153374233129,0.14492006188757092,0.868963717045158,0.4576427255985267
214,1179,AP5Z1,613653,613647;,"[MIM:613647]Spastic paraplegia 48, autosomal recessive [recessive?];",Autosomal recessive spastic paraplegia type 48,Disease-causing germline mutation(s) (loss of function) in,Parental extreme longevity (95 years and older)[27015805];,0.4894478527607362,0.019855595667870037,0.24980422866092403,0.0
215,1188,APC,611731,114550;135290;155255;175100;613659;,[MIM:175100]Familial adenomatous polyposis;[MIM:135290]Hereditary desmoid disease;[MIM:155255]Medulloblastoma;[MIM:613659]Gastric cancer;[MIM:114550]Hepatocellular carcinoma;,APC-related attenuated familial adenomatous polyposis;Familial adenomatous polyposis due to 5q22.2 microdeletion;Cenani-Lenz syndrome;Gastric adenocarcinoma and proximal polyposis of the stomach;Desmoid tumor;Gardner syndrome;Turcot syndrome with polyposis,Disease-causing germline mutation(s) in;Role in the phenotype of;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing somatic mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in,Total body bone mineral density[29304378];Reaction time[29844566;29844566;29844566];Angiotensin-converting enzyme inhibitor intolerance[28030426;28030426];,0.8871165644171779,0.9614492006188757,0.40798747063429913,0.9864947820748926
216,1189,APC2,612034,617169;,[MIM:617169]Sotos syndrome 3 [recessive?];,Sotos syndrome,Disease-causing germline mutation(s) (loss of function) in,,0.5301840490797546,0.7392986075296545,0.1297311406943357,0.0
217,1190,APCDD1,607479,605389;,[MIM:605389]Hypotrichosis 1;,Hypotrichosis simplex,Disease-causing germline mutation(s) in,Non-small cell lung cancer[21866343];Metabolite levels (Pyroglutamine)[23934736];Serum protein levels (sST2)[23999434];,0.19190184049079756,0.4510056730273337,0.3356825894022448,0.31675874769797424
218,1210,APOA1,107680,105200;205400;604091;,[MIM:604091]High density lipoprotein deficiency 2 [dominant?];[MIM:205400]High density lipoprotein deficiency 1;[MIM:105200]Amyloidosis 8;,Apolipoprotein A-I deficiency;AApoAI amyloidosis,Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in,"Delirium[29631748];Hearing function[25060954];Very low density lipoprotein cholesterol levels[28548082];Triglyceride levels[26763881;28371326;28548082;28334899;28334899;28334899];Triglycerides[21909109;20686565;20864672;18193046;18193044;18193043;19060911;19060906;19074352;20139978;24097068;26582766];Blood protein levels[29875488;30072576;30072576;30072576];Coronary heart disease[21378990];Infantile hypertrophic pyloric stenosis[23989729];Coronary artery disease[24262325];HDL cholesterol[20686565;20864672;19060906;24097068;26582766];HDL cholesterol levels[28334899;28334899;28334899];Lipid metabolism phenotypes[22286219];Total cholesterol levels[28334899;28334899];Hypertriglyceridemia[27599772;27599772;23505323];Allergic rhinitis[30013184];Lipid traits[24386095];Metabolite levels[22916037];LDL cholesterol levels[28334899];Cholesterol, total[20686565;19060911;24097068];LDL cholesterol[20686565;20864672;18179892;19060911;24097068];Hematological and biochemical traits[20139978];Coronary artery disease (myocardial infarction, percutaneous transluminal coronary angioplasty, coronary artery bypass grafting, angina or chromic ischemic heart disease)[28714975];",0.7246625766871165,0.4045899948427024,0.7856956408248499,0.44505831798649476
219,1212,APOA2,107670,,,AApoAII amyloidosis,Disease-causing germline mutation(s) in,,0.6370552147239263,0.5629190304280557,0.9939963456016706,0.48066298342541436
220,1215,APOB,107730,144010;615558;,"[MIM:615558]Hypobetalipoproteinemia, familial, 1;[MIM:144010]Familial ligand-defective apolipoprotein B-100;",Homozygous familial hypercholesterolemia,Disease-causing germline mutation(s) in,"Binge eating behaviour and bipolar disorder[24882193];Triglyceride levels[29403010];Response to statin therapy[20339536];Triglycerides[20686565;20864672;18193044;19060911;19060906;25961943];Blood protein levels[28240269;29875488;30072576;30072576;30072576;30072576];Metabolite levels (lipoprotein measures)[27005778];Metabolic syndrome[22399527;22399527];Erectile dysfunction and prostate cancer treatment[20932654];HDL cholesterol[20686565;20864672;19060911;25961943];Lipoprotein-associated phospholipase A2 activity and mass[23118302];Lipid metabolism phenotypes[19936222;19936222;19936222;19936222;19936222;19936222;19936222;19936222;19936222;19936222;19936222;19936222];Total cholesterol levels[28334899;28334899;28334899];Hypertriglyceridemia[20657596];Metabolite levels[22916037];LDL cholesterol levels[17463246;28334899;28334899;28334899];Cardiovascular disease risk factors[21943158];Cholesterol, total[20686565;19060911;24097068;25961943;26582766];LDL cholesterol[20686565;20864672;21059979;21059979;18262040;18193043;19060911;19060910;23726366;21347282;19060906;24097068;26780889;18193044;25961943;26582766];Metabolic traits[19060910];Coronary artery disease (myocardial infarction, percutaneous transluminal coronary angioplasty, coronary artery bypass grafting, angina or chromic ischemic heart disease)[28714975];",0.6635582822085889,0.6134605466735431,0.006264682850430697,0.1976672805402087
221,1232,APOC2,608083,207750;,[MIM:207750]Hyperlipoproteinemia 1B;,Familial apolipoprotein C-II deficiency,Disease-causing germline mutation(s) (loss of function) in,"Low density lipoprotein cholesterol[28548082];Triglyceride levels[28334899];Triglycerides[20686565];Blood protein levels[28240269];Quantitative traits[19197348;19197348;19197348];HDL cholesterol[20686565];Very long-chain saturated fatty acid levels (fatty acid 20:0)[25378659];HDL cholesterol levels[28334899;28334899;28334899];Lipid metabolism phenotypes[22286219];Total cholesterol levels[28548082;28334899;28334899;28334899];LDL cholesterol levels[28334899;28334899;28334899];Cholesterol, total[20686565];LDL cholesterol[20686565;20864672;18802019;19060906;18193044];",0.5614723926380368,0.5293965961835998,0.0,0.39149785144260285
222,1233,APOC3,107720,614028;,[MIM:614028]Hyperalphalipoproteinemia 2;,Cholesterol-ester transfer protein deficiency,Disease-causing germline mutation(s) (loss of function) in,"Delirium[29631748];Triglyceride levels[26763881;28371326;28548082;28334899;28334899;28334899];Plateletcrit[27863252];Triglycerides[21909109;20686565;20864672;18193044;18193043;19060911;19060906;19074352;20139978;26582766];Blood protein levels[30072576;30072576;30072576;30072576;30072576];Coronary heart disease[21378990];Lipoprotein (a) - cholesterol levels[25575512];HDL cholesterol[20686565;20864672;19060906;26582766;28270201];HDL cholesterol levels[28334899;28334899;28334899];Lipid metabolism phenotypes[22286219];Total cholesterol levels[28334899;28334899];Hypertriglyceridemia[23505323];Lipid traits[24386095];Metabolite levels[22916037];LDL cholesterol levels[28334899];Cholesterol, total[20686565;19060911];LDL cholesterol[20686565;20864672;18179892;19060911];High density lipoprotein cholesterol levels[28548082];Hematological and biochemical traits[20139978];Platelet count[27863252];",0.6357055214723927,0.5572460030943786,0.8673975463325503,0.2776243093922652
223,1237,APOE,107741,104310;143890;269600;611771;617347;,[MIM:617347]Hyperlipoproteinemia 3;[MIM:104310]Alzheimer disease 2;[MIM:269600]Sea-blue histiocyte disease;[MIM:611771]Lipoprotein glomerulopathy;[MIM:143890]Familial hypercholesterolemia [dominant?];,Sea-blue histiocytosis;Dysbetalipoproteinemia;Lipoprotein glomerulopathy,Disease-causing germline mutation(s) in;Major susceptibility factor in;Disease-causing germline mutation(s) in,"Lipoprotein-associated phospholipase A2 activity change in response to darapladib treatment in cardiovascular disease[28753643];Type 2 diabetes[28869590;28869590;27189021];C-reactive protein[18439548;18439552;23844046;19567438];Psychosis and Alzheimer's disease[22005930];Advanced age-related macular degeneration[26691988;26691988];Alzheimer disease and age of onset[26830138];Neuritic plaques or cerebral amyloid angiopathy (pleiotropy)[29458411];Cerebrospinal AB1-42 levels in Alzheimer's disease dementia[25027320];Triglyceride levels[28334899;29403010];High light scatter reticulocyte count[27863252];Total cholesterol levels in LDL[29084231];Immature fraction of reticulocytes[27863252];Body fat percentage[26833246;26833246;26833246;26833246];Cerebrospinal P-tau181p levels[28247064];Cerebral amyloid deposition (PET imaging)[26252872];Body mass index[26426971];Total cholesterol levels[28548082;29403010;28334899;28334899;28334899];Reticulocyte fraction of red cells[27863252];Lipoprotein phospholipase A2 activity in cardiovascular disease[28753643];Cardiovascular risk factors[20838585];Cingulate cortical amyloid beta load[26421299];Cholesterol, total[20686565;19060911;24097068;25961943;28270201];Alzheimer's disease[17998437;17975299;18823527;22245343;22245343;19125160;19734902;20061627;19734903;21627779;22832961;20460622;24770881;24755620];Coronary artery disease (myocardial infarction, percutaneous transluminal coronary angioplasty, coronary artery bypass grafting, angina or chromic ischemic heart disease)[28714975];Lipoprotein(a) levels adjusted for apolipoprotein(a) isoforms[28512139];Brain imaging[20100581;20100581];High light scatter reticulocyte percentage of red cells[27863252];Lipoprotein (a) levels[28512139];Reticulocyte count[27863252];Low density lipoprotein cholesterol[28548082;29403010];Mortality[27029810];Cerebrospinal T-tau levels[28247064];Posterior cortical atrophy and Alzheimer's disease[26993346];Alzheimer's disease progression score[29860282];Longevity (90 years and older)[24688116];Longevity[21418511];Metabolite levels (lipoprotein measures)[27005778];Blood protein levels[29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;30072576;30072576;30072576;30072576;30072576;30072576;30072576;30072576;30072576;30072576;30072576;30072576;30072576;30072576;30072576;30072576;30072576;30072576;30072576;30072576;30072576;30072576;30072576;30072576;30072576;30072576;30072576;30072576;30072576;30072576;30072576;30072576;30072576;30072576];Very long-chain saturated fatty acid levels (fatty acid 20:0)[25378659];Free cholesterol levels in large LDL[29084231];Longevity (85 years and older)[24688116];Blood metabolite ratios[24816252];Body mass index x age interaction[26426971];HDL cholesterol levels[28334899;28334899;28334899];Verbal declarative memory[25648963;25648963;25648963;25648963];Body mass index x sex x age interaction (4df test)[26426971];Metabolite levels[22916037];LDL cholesterol levels[28371326;26763881;17463246;28334899;28334899;28334899];Cognitive decline (age-related)[24468470;28078323];High density lipoprotein cholesterol levels[29403010];Cerebrospinal fluid AB1-42 levels[28247064;28247064;28641921];Sphingolipid levels[26068415];Vigorous physical activity[29899525];Apolipoprotein Levels[23031429];Metabolic syndrome[22399527];Red cell distribution width[27863252;27863252];Cerebral amyloid deposition positivity (PET imaging)[26252872];Cerebrospinal fluid t-tau:AB1-42 ratio[28641921];Moderate to vigorous physical activity levels[29899525];Lipoprotein-associated phospholipase A2 activity and mass[23118302];Cognitive decline[22054870];Neuritic plaques or neurofibrillary tangles (pleiotropy)[29458411];Lipid traits[24023260;24023260];Body mass index (age>50)[26426971];Gut microbiota (functional units)[27694959;27694959];Platelet count[27863252];Parental lifespan[29030599];Alzheimer's disease (late onset)[20885792;17474819;23565137;26339675;28714976];Lewy body disease[25188341;25188341;25188341];C-reactive protein levels[29403010];Alzheimer's disease biomarkers[21123754;23419831;23562540;23562540];Triglycerides[20686565;19060911;25961943;26582766];Neurofibrillary tangles or cerebral amyloid angiopathy (pleiotropy)[29458411];Alzheimer's disease (age of onset)[22005931];Quantitative traits[19197348;19197348;19197348];Coronary artery disease[26343387;29212778;29212778;29212778];Cerebrospinal fluid t-tau levels[28641921];HDL cholesterol[21909109;20686565;19060911;24097068;25961943;28270201];Hippocampal atrophy[22745009;22745009];Verbal memory performance (immediate recall change)[28800603];Lipid metabolism phenotypes[22286219];Resting heart rate[27798624];Response to statins (LDL cholesterol change)[22331829;25350695];Serum total cholesterol levels[29084231];Age-related macular degeneration[23326517;23326517;23326517;23455636];Ideal cardiovascular health (clinical)[27179730];LDL cholesterol[20686565;20864672;18193043;18802019;19060911;23726366;19060906;24097068;23067351;18193044;25961943];Verbal memory performance (residualized delayed recall level)[28800603];Dementia with Lewy bodies[29263008];",0.791042944785276,0.4571944301186178,0.20751761942051683,0.0
224,1240,APOL1,603743,612551;,[MIM:612551]Focal segmental glomerulosclerosis 4;,Sporadic idiopathic steroid-resistant nephrotic syndrome with focal segmental hyalinosis,Major susceptibility factor in,Glomerulosclerosis[20668430];Blood protein levels[29875488;29875488;30072576;30072576];Diabetic kidney disease[26305897;26305897];,0.4190184049079755,0.18617844249613202,0.34534064212999216,0.025475751995089013
225,1256,APOPT1,616003,,,Non-progressive predominantly posterior cavitating leukoencephalopathy with peripheral neuropathy,Disease-causing germline mutation(s) in,Body mass index[26426971];Autism spectrum disorder or schizophrenia[28540026;28540026;28540026];Schizophrenia[25056061];Depression[29700475];,0.08736196319018405,0.3935018050541516,0.27851735839206476,0.0
226,1257,APP,104760,104300;605714;,"[MIM:104300]Alzheimer disease 1;[MIM:605714]Cerebral amyloid angiopathy, APP-related;","Early-onset autosomal dominant Alzheimer disease;ABetaA21G amyloidosis;ABeta amyloidosis, Italian type;ABeta amyloidosis, Arctic type;ABeta amyloidosis, Iowa type;ABetaL34V amyloidosis;ABeta amyloidosis, Dutch type",Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in,Cerebrospinal fluid α-synuclein levels[29959729];Longitudinal change in brain amyloid plaque burden[26268530];,0.9874846625766871,0.9043321299638989,0.6512659879926912,0.9849600982197667
227,1259,APPL1,604299,616511;,[MIM:616511]Maturity-onset diabetes of the young 14 [dominant?];,MODY,Disease-causing germline mutation(s) (loss of function) in,,0.9160736196319018,0.5969571944301186,0.32576350822239625,0.12476979742173112
228,1261,APRT,102600,614723;,[MIM:614723]Adenine phosphoribosyltransferase deficiency;,Adenine phosphoribosyltransferase deficiency,Disease-causing germline mutation(s) (loss of function) in,Hair color[26926045];,0.8213496932515337,0.11939143888602373,0.754894283476899,0.569060773480663
229,1263,APTX,606350,208920;,[MIM:208920]Ataxia-oculomotor apraxia syndrome [recessive?];,Ataxia-oculomotor apraxia type 1,Disease-causing germline mutation(s) in,Menopause (age at onset)[26414677];,0.6683435582822086,0.25863847343991747,0.6721482641607935,0.5612338858195212
230,1265,AQP2,107777,125800;,"[MIM:125800]Diabetes insipidus, nephrogenic, autosomal [dominant?];",Nephrogenic diabetes insipidus,Disease-causing germline mutation(s) in,"Allergic disease (asthma, hay fever or eczema)[29083406];Allergic rhinitis[30013184];Obsessive-compulsive disorder[22889921];",0.12711656441717792,0.1665807117070655,0.9355259723309841,0.6527010435850215
231,1269,AQP5,600442,600231;,"[MIM:600231]Keratoderma, palmoplantar, Bothnian type;",Non-epidermolytic palmoplantar keratoderma,Disease-causing germline mutation(s) (gain of function) in,Allergic rhinitis[30013184];,0.17791411042944785,0.5273336771531717,0.759592795614722,0.6527010435850215
232,1284,AR,313700,300068;312300;313200;,"[MIM:300068]Androgen insensitivity syndrome;[MIM:313200]Spinal and bulbar muscular atrophy X-linked 1;[MIM:312300]Androgen insensitivity, partial;",Kennedy disease;Familial hypospadias;Partial androgen insensitivity syndrome;Complete androgen insensitivity syndrome,Disease-causing germline mutation(s) in;Candidate gene tested in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in,Male-pattern baldness[18849991;22032556;22693459;27182965;29146897];Excessive daytime sleepiness[27992416];Balding[26926045];LDL cholesterol[19060910];Prostate cancer[21743467];,0.7312883435582822,0.8710675605982465,0.19785956669276952,0.9636279926335175
233,1298,ARF1,103180,,,Periventricular nodular heterotopia,Disease-causing germline mutation(s) in,,0.9022085889570552,0.8553378029912326,0.9966066301226834,0.0
234,1317,ARFGEF2,605371,608097;,[MIM:608097]Periventricular nodular heterotopia 2 [recessive?];,Periventricular nodular heterotopia,Disease-causing germline mutation(s) in,Anger[24489884];Intelligence (MTAG)[29326435;29326435;29326435;29326435;29326435;29326435;29326435];Waist circumference adjusted for BMI in non-smokers[28443625];Waist circumference adjusted for BMI (joint analysis main effects and smoking interaction)[28443625];Waist circumference adjusted for BMI (adjusted for smoking behaviour)[28443625];General cognitive ability[29844566;29844566];,0.7125153374233129,0.9802733367715317,0.5674758548681806,0.44613259668508287
235,1322,ARG1,608313,207800;,[MIM:207800]Argininemia [recessive?];,Argininemia,Disease-causing germline mutation(s) in,Obesity[21552555];C-reactive protein levels[24763700];Creatinine levels[29403010];Change in glucose in response to thiazide diuretic treatment in hypertension[29523524];Blood protein levels[30072576];Glomerular filtration rate[29403010];,0.6900613496932515,0.3040226921093347,0.8488645262333594,0.5197974217311234
236,1351,ARHGAP24,610586,,,Familial idiopathic steroid-resistant nephrotic syndrome with focal segmental hyalinosis,Disease-causing germline mutation(s) (loss of function) in,Systolic blood pressure[26390057;27618452;28739976];QT interval[29213071];Peanut allergy[29030101];Diisocyanate-induced asthma[25918132;25918132];Heel bone mineral density[28869591;28869591];PR interval[20062060;23139255;29127183];Pulse pressure[28739976];Height[28270201];Electrocardiographic traits[20062063];Obesity-related traits[23251661];PR segment[24850809];Systolic blood pressure (cigarette smoking interaction)[29455858];,0.16220858895705523,0.24729241877256317,0.4883842338814931,0.1663597298956415
237,1361,ARHGAP29,610496,,,Cleft lip/palate,Major susceptibility factor in,Cleft lip with or without cleft palate[28054174;28054174];D-dimer levels[21502573];Orofacial clefts[28054174;28054174];,0.6131288343558282,0.9247034553893759,0.6092404072043853,0.3740024554941682
238,1363,ARHGAP31,610911,100300;,[MIM:100300]Adams-Oliver syndrome 1;,Adams-Oliver syndrome,Disease-causing germline mutation(s) (gain of function) in,Celiac disease[22057235];Schizophrenia[23894747];,0.5276073619631901,0.7398143372872614,0.5014356564865571,0.6042050337630448
239,1379,ARHGDIA,601925,615244;,[MIM:615244]Nephrotic syndrome 8;,Familial idiopathic steroid-resistant nephrotic syndrome with diffuse mesangial sclerosis,Disease-causing germline mutation(s) (loss of function) in,,0.8790184049079754,0.3408973697782362,0.7488906290785695,0.6223143032535298
240,1388,ARHGEF6,300267,300436;,,X-linked non-syndromic intellectual disability,Disease-causing germline mutation(s) in,Breast cancer[29059683];,0.6370552147239263,0.9748581743166581,0.6528321587052989,0.6022099447513812
241,1389,ARHGEF7,605477,,,X-linked non-syndromic intellectual disability,Disease-causing germline mutation(s) (loss of function) in,Menopause (age at onset)[19448619];Menarche (age at onset)[21102462];Bilirubin levels[19414484];Fasting insulin (dietary factor interaction)[24204828];Homeostasis model assessment of insulin resistance (dietary factor interaction)[24204828];,0.6923926380368098,0.5340381640020629,0.6575306708431219,0.4062308164518109
242,1393,ARHGEF9,300429,300607;,,Hyperekplexia-epilepsy syndrome,Disease-causing germline mutation(s) (loss of function) in,,0.19190184049079756,0.9490716864363073,0.9263899765074393,0.8549723756906077
243,1395,ARHGEF10,608136,608236;,[MIM:608236]Slowed nerve conduction velocity [dominant?];,Autosomal dominant slowed nerve conduction velocity,Disease-causing germline mutation(s) in,Toenail selenium levels[25343990];Multiple sclerosis[23412934];Delta-6 desaturase activity response to n3-polyunsaturated fat supplement[29246731];,0.7900613496932515,0.016761217122227952,0.3179326546593579,0.15484960098219766
244,1402,ARHGEF18,616432,617433;,,Retinitis pigmentosa,Disease-causing germline mutation(s) in,,0.3706748466257669,0.43553378029912326,0.39049856434351343,0.43569674647022716
245,1417,ARID1A,603024,614607;,,Coffin-Siris syndrome,Disease-causing germline mutation(s) in,Rosacea symptom severity[29771307];Granulocyte percentage of myeloid white cells[27863252];Heel bone mineral density[28869591;28869591];Monocyte percentage of white cells[27863252];White matter hyperintensities in ischemic stroke[26674333];,0.7842944785276074,0.9586126869520372,0.40172278778386844,0.9404542664211173
246,1418,ARID1B,614556,135900;,[MIM:135900]Coffin-Siris syndrome 1 [dominant?] [recessive?];,Coffin-Siris syndrome;6q25 microdeletion syndrome,Disease-causing germline mutation(s) in;Role in the phenotype of,"Calcium levels[24068962];Vein graft stenosis in coronary artery bypass grafting[25881214];Type 2 diabetes[29621232];Psychosis proneness (perceptual aberration scale and revised physical anhedonia scale)[28525603];Allergic disease (asthma, hay fever or eczema)[29083406];Lipoprotein (a) levels[26377243];Western dietary pattern[28644415];Pancreatic cancer[22158540];Multiple system atrophy (pathologically confirmed)[27629089];Sensory disturbances after bilateral sagittal split ramus osteotomy[23834954;23834954];Alzheimer's disease biomarkers[23419831];Diastolic blood pressure x smoking status (current vs non-current) interaction (2df test)[29455858];",0.792883435582822,1.0,0.33803184547115633,0.4972375690607735
247,1419,ARID2,609539,617808;,[MIM:617808]Coffin-Siris syndrome 6 [dominant?] [recessive?];,Coffin-Siris syndrome,Disease-causing germline mutation(s) (loss of function) in,Intelligence (MTAG)[29326435];Spherical equivalent or myopia (age of diagnosis)[29808027];Hippocampal atrophy[19668339];,0.7403680981595092,0.9592573491490459,0.44322631166797183,0.5813382443216697
248,1434,ARL2BP,615407,615434;,,Retinitis pigmentosa,Disease-causing germline mutation(s) in,Mean corpuscular hemoglobin concentration[29403010];,0.46883435582822086,0.334192882929345,0.0,0.2104051565377532
249,1445,ARL3,604695,,,Retinitis pigmentosa;Joubert syndrome,Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in,Waist-to-hip ratio adjusted for BMI (age >50)[26426971];Mean arterial pressure (long-term average)[28348047];Autism spectrum disorder or schizophrenia[28540026;28540026];Systolic blood pressure (long-term average)[28348047];Schizophrenia[27922604;25056061;28991256];Blood protein levels[30072576];Prostate cancer[23535732];Waist-to-hip ratio adjusted for BMI[26426971];Waist-to-hip ratio adjusted for BMI x sex x age interaction (4df test)[26426971];,0.4936196319018405,0.3597215059308922,0.9318715740015662,0.48281154082259053
250,1461,ARL6,608845,600151;613575;,[MIM:600151]Bardet-Biedl syndrome 3 [recessive?];[MIM:613575]Retinitis pigmentosa 55;,Retinitis pigmentosa;Bardet-Biedl syndrome,Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in,Male infertility[19478329];,0.33975460122699386,0.6549767921609077,0.854085095275385,0.5285451197053407
251,1462,ARL6IP1,607669,615685;,"[MIM:615685]Spastic paraplegia 61, autosomal recessive [recessive?];",Autosomal recessive spastic paraplegia type 61,Disease-causing germline mutation(s) in,,0.46883435582822086,0.5556988138215575,0.0,0.2576734192756292
252,1468,ARL6IP6,616495,,,Cutis marmorata telangiectatica congenita,Candidate gene tested in,Lung cancer[28604730];Pancreatic cancer[29422604];,0.3168098159509202,0.4739556472408458,0.6992952231793266,0.4743707796193984
253,1473,ARL11,609351,151400;,,B-cell chronic lymphocytic leukemia,Major susceptibility factor in,Multiple sclerosis[23412934];,0.17791411042944785,0.40897369778236203,0.46959018533020097,0.38459177409453654
254,1475,ARL13B,608922,612291;,[MIM:612291]Joubert syndrome 8;,Joubert syndrome,Disease-causing germline mutation(s) in,,0.8414723926380369,0.3555956678700361,0.3576089793787523,0.058011049723756904
255,1488,ARMC4,615408,615451;,,Primary ciliary dyskinesia,Disease-causing germline mutation(s) (loss of function) in,Diisocyanate-induced asthma[25918132];Prostate-specific antigen levels (conditioned on lead SNPs)[28139693];Obesity-related traits[23251661];,0.038773006134969326,0.059824651882413614,0.1918559122944401,0.4594843462246777
256,1490,ARMC5,615549,615954;,[MIM:615954]ACTH-independent macronodular adrenal hyperplasia 2;,Cushing syndrome due to macronodular adrenal hyperplasia,Disease-causing germline mutation(s) in,,0.6694478527607362,0.9151624548736462,0.32158705298877577,0.3997851442602824
257,1495,ARMC9,617612,617622;,[MIM:617622]Joubert syndrome 30 [recessive?];,Joubert syndrome,Disease-causing germline mutation(s) in,Food antigen IgG levels[24962563];,0.21484662576687116,0.3078906652913873,0.4492299660663012,0.0620012277470841
258,1515,ARNT2,606036,615926;,[MIM:615926]Webb-Dattani syndrome;,Septo-optic dysplasia spectrum,Disease-causing germline mutation(s) (loss of function) in,Body mass index[26426971];Attention deficit hyperactivity disorder[29325848];Atrial fibrillation[30061737;29892015;29892015;30061737];Post bronchodilator FEV1/FVC ratio[26634245];Post bronchodilator FEV1[26634245];,0.47337423312883437,0.9280556988138216,0.27825632993996346,0.5650705954573357
259,1546,ARSA,607574,250100;272200;,[MIM:250100]Metachromatic leukodystrophy [recessive?];[MIM:272200]Multiple sulfatase deficiency;,"Metachromatic leukodystrophy, adult form;Metachromatic leukodystrophy, late infantile form;Metachromatic leukodystrophy, juvenile form",Disease-causing germline mutation(s) (loss of function) in;Disease-causing germline mutation(s) (loss of function) in;Disease-causing germline mutation(s) (loss of function) in,Blood metabolite levels[24816252;24816252];Fibrinogen[23969696];Fibrinogen levels[28107422];QT interval (ambient particulate matter interaction)[28749367];,0.7786503067484662,0.08793192367199587,0.08405116157661185,0.9809699201964396
260,1547,ARSB,611542,253200;272200;,[MIM:253200]Mucopolysaccharidosis 6 [recessive?];[MIM:272200]Multiple sulfatase deficiency;,"Mucopolysaccharidosis type 6, slowly progressing;Mucopolysaccharidosis type 6, rapidly progressing",Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in,Toenail selenium levels[25343990;25343990];Iron status biomarkers[19084217];Attention deficit hyperactivity disorder[23728934];Blood and toenail selenium levels[25343990;25343990;25343990;25343990;25343990];Blood protein levels[28240269;28240269;29875488];Hippocampal atrophy[19668339];,0.4538650306748466,0.23001547189272822,0.056382145653876274,0.7978821362799263
261,1552,ARSE,300180,302950;,"[MIM:302950]Chondrodysplasia punctata 1, X-linked recessive;",Brachytelephalangic chondrodysplasia punctata,Disease-causing germline mutation(s) in,Height[21998595;22021425];,0.12711656441717792,0.7150593089221248,0.7823022709475332,0.7539901780233272
262,1558,ARSI,610009,,,Autosomal recessive spastic paraplegia type 66,Disease-causing germline mutation(s) in,Epstein-Barr virus copy number in lymphoblastoid cell lines[28654678];,0.12711656441717792,0.07426508509541001,0.5609501435656487,0.7346531614487416
263,1567,ARTN,603886,,,Familial prostate cancer;Nijmegen breakage syndrome;Hereditary breast and ovarian cancer syndrome,Major susceptibility factor in;Disease-causing germline mutation(s) in;Candidate gene tested in,Autism spectrum disorder or schizophrenia[28540026];,0.038773006134969326,0.6712222795255286,0.9725920125293657,0.0
264,1568,ARV1,611647,617020;,,Undetermined early-onset epileptic encephalopathy,Candidate gene tested in,,0.33226993865030674,0.21634863331614235,0.0,0.17357274401473297
265,1569,ARVCF,602269,,,22q11.2 deletion syndrome,Role in the phenotype of,Central corneal thickness[29760442];White blood cell count[27863252];Lymphocyte counts[27863252];Pulse pressure[28739976;28739976;28135244];Monocyte count[27863252];Systolic blood pressure x alcohol consumption interaction (2df test)[29912962];Platelet count[22139419;27863252];,0.2947239263803681,0.09541000515729757,0.1482641607935265,0.21255371393492942
266,1572,ARX,300382,300004;300215;300419;308350;309510;,"[MIM:308350]Epileptic encephalopathy, early infantile, 1;[MIM:309510]Partington syndrome;[MIM:300419]Mental retardation, X-linked, ARX-related;[MIM:300004]Agenesis of the corpus callosum, with abnormal genitalia;",Early infantile epileptic encephalopathy;West syndrome;Corpus callosum agenesis-abnormal genitalia syndrome;X-linked spasticity-intellectual disability-epilepsy syndrome;X-linked non-syndromic intellectual disability;X-linked lissencephaly with abnormal genitalia;Infantile epileptic-dyskinetic encephalopathy;Partington syndrome,Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) (loss of function) in;Disease-causing germline mutation(s) (loss of function) in;Disease-causing germline mutation(s) in,,0.38061349693251534,0.8677153171738009,0.961628817541112,0.0
267,1574,ASAH1,613468,159950;228000;,[MIM:159950]Spinal muscular atrophy with progressive myoclonic epilepsy [recessive?];,Farber disease;Spinal muscular atrophy-progressive myoclonic epilepsy syndrome,Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in,Obesity[21552555;21552555;21552555];Atrial fibrillation[28416818;30061737;29892015;29892015];Night sleep phenotypes[27126917];,0.4750920245398773,0.06756059824651882,0.3855390237535891,0.42464702271332105
268,1602,ASCC1,614215,614266;616867;,[MIM:616867]Spinal muscular atrophy with congenital bone fractures 2 [recessive?];,Prenatal-onset spinal muscular atrophy with congenital bone fractures,Disease-causing germline mutation(s) in,Body mass index[30045251];,0.6120245398773007,0.05698813821557504,0.23884103367267032,0.0
269,1605,ASCL1,100790,,,Haddad syndrome,Disease-causing germline mutation(s) in,Menopause (age at onset)[26414677];C-reactive protein levels[21300955];,0.2498159509202454,0.7890665291387313,0.7541111981205951,0.0
270,1629,ASL,608310,207900;,[MIM:207900]Argininosuccinic aciduria [recessive?];,Argininosuccinic aciduria,Disease-causing germline mutation(s) (loss of function) in,,0.3669938650306748,0.12815884476534295,0.8459932132602453,0.8838244321669736
271,1635,ASNS,108370,615574;,[MIM:615574]Asparagine synthetase deficiency;,Congenital microcephaly-severe encephalopathy-progressive cerebral atrophy syndrome,Disease-causing germline mutation(s) (loss of function) in,,0.8912883435582822,0.2563176895306859,0.6397807361002349,0.06276856967464703
272,1643,ASPA,608034,271900;,,Mild Canavan disease;Severe Canavan disease,Disease-causing germline mutation(s) (loss of function) in;Disease-causing germline mutation(s) (loss of function) in,Myopia (pathological)[23049088];,0.16220858895705523,0.7163486333161423,0.7225267554163404,0.7220687538367097
273,1646,ASPH,600582,601552;,,Facial dysmorphism-lens dislocation-anterior segment abnormalities-spontaneous filtering blebs syndrome,Disease-causing germline mutation(s) in,Resting heart rate[28270201];Urate levels in overweight individuals[25811787];Blood protein levels[29875488;30072576];,0.8250306748466257,0.04486848891181021,0.5319759853824066,0.012430939226519336
274,1649,ASPM,605481,608716;,"[MIM:608716]Microcephaly 5, primary, autosomal recessive [recessive?];",Autosomal recessive primary microcephaly,Disease-causing germline mutation(s) in,Age-related macular degeneration[23536807];Matrix metalloproteinase-8 levels[29212897];Blood protein levels[28240269;28240269];Lupus nephritis in systemic lupus erythematosus[24925725];,0.7246625766871165,0.0033522434244455906,0.05090054815974941,0.0167280540208717
275,1652,ASPSCR1,606236,,,Alveolar soft tissue sarcoma;MiT family translocation renal cell carcinoma,Part of a fusion gene in;Part of a fusion gene in,,0.4538650306748466,0.2447137699845281,0.11015400678673976,0.1821669736034377
276,1654,ASS1,603470,215700;,[MIM:215700]Citrullinemia 1 [recessive?];,Acute neonatal citrullinemia type I;Adult-onset citrullinemia type I,Disease-causing germline mutation(s) (loss of function) in;Disease-causing germline mutation(s) (loss of function) in,,0.7460122699386503,0.35456420835482205,0.5768728791438267,0.7911295273173726
277,1674,ASXL1,612990,605039;614286;,[MIM:605039]Bohring-Opitz syndrome;[MIM:614286]Myelodysplastic syndrome;,Bohring-Opitz syndrome,Disease-causing germline mutation(s) in,Inflammatory bowel disease[28067908];,0.6169325153374233,0.7184115523465704,0.29339598016183766,0.04251074278698588
278,1676,ASXL3,615115,615485;,,Severe feeding difficulties-failure to thrive-microcephaly due to ASXL3 deficiency syndrome,Disease-causing germline mutation(s) (loss of function) in,Pulmonary function[23932459];Diisocyanate-induced asthma[25918132;25918132];Multiple system atrophy (pathologically confirmed)[27629089];,0.08736196319018405,0.720216606498195,0.3351605324980423,0.6223143032535298
279,1678,ATAD1,614452,618011;,[MIM:618011]Hyperekplexia 4 [recessive?];,Hereditary hyperekplexia,Disease-causing germline mutation(s) in,Heel bone mineral density[28869591;28869591];,0.6671165644171779,0.3553378029912326,0.9316105455494649,0.5857888275015347
280,1681,ATAD3A,612316,617183;,[MIM:617183]Harel-Yoon syndrome [dominant?] [recessive?];,Optic atrophy-peripheral neuropathy-developmental delay syndrome,Disease-causing germline mutation(s) in,Body mass index[26426971];,0.98,0.167354306343476,0.2103889323936309,0.7989564149785144
281,1686,ATCAY,608179,601238;,"[MIM:601238]Cerebellar ataxia, cayman type;","Cerebellar ataxia, Cayman type",Disease-causing germline mutation(s) in,Aging (time to event)[21782286];,0.14576687116564419,0.6578133058277462,0.8694857739493604,0.43784530386740333
282,1690,ATF1,123803,612160;,[MIM:612160]Angiomatoid fibrous histiocytoma;,Melanoma of soft tissue,Part of a fusion gene in,Sudden cardiac arrest[21658281];Male-pattern baldness[27182965];Colorectal cancer[20972440;24737748;25990418];Mean arterial pressure[27618448];,0.4298159509202454,0.5538937596699329,0.6622291829809449,0.38812154696132595
283,1700,ATF6,605537,616517;,[MIM:616517]Achromatopsia 7;,Cone rod dystrophy;Achromatopsia,Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) (loss of function) in,Chronic bronchitis in chronic obstructive pulmonary disease[25241909];Systemic sclerosis[30247649];Parkinson's disease (age of onset)[19772629];,0.5749693251533742,0.17895822588963384,0.08117984860349778,0.1741866175567833
284,1730,ATIC,601731,608688;,[MIM:608688]AICAR transformylase/IMP cyclohydrolase deficiency;,AICA-ribosiduria,Disease-causing germline mutation(s) in,Airway imaging phenotypes[26030696];,0.7592638036809816,0.03274883960804539,0.08796658835813104,0.2714855739717618
285,1731,ATL1,606439,182600;613708;,"[MIM:613708]Neuropathy, hereditary sensory, 1D;",Hereditary sensory and autonomic neuropathy type 1;Autosomal dominant spastic paraplegia type 3,Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in,Cognitive performance[20125193];Dupuytren's disease[28886342];Periodontal disease-related phenotypes[24347629];,0.20368098159509201,0.7596699329551315,0.9190811798486035,0.6539287906691221
286,1733,ATL3,609369,615632;,,Hereditary sensory and autonomic neuropathy type 1,Disease-causing germline mutation(s) in,,0.5948466257668712,0.13228468282619907,0.31897676846776296,0.2945058317986495
287,1734,ATM,607585,208900;,[MIM:208900]Ataxia telangiectasia;,Ataxia-telangiectasia;Ataxia-telangiectasia variant;B-cell chronic lymphocytic leukemia;Mantle cell lymphoma,Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) (loss of function) in;Disease-causing somatic mutation(s) in;Disease-causing somatic mutation(s) in,Alzheimer's disease (late onset)[28714976];Melanoma[21983787;28212542];Response to metformin in type 2 diabetes (glycemic)[21186350];Eosinophil counts[27863252];Red blood cell count[29403010];Sum eosinophil basophil counts[27863252];Uterine fibroids[30194396;30194396;30194396];Renal cell carcinoma[28598434];Rheumatoid arthritis[24390342;24390342];Gastric adenocarcinoma (histologically verified)[26098866;26098866];Gastric cancer[26098866;26098866];Prostate cancer[29892016];Eosinophil percentage of white cells[27863252];,0.7386503067484662,0.23182052604435277,0.0373270686504829,0.167280540208717
288,1736,ATN1,607462,125370;,[MIM:125370]Dentatorubral-pallidoluysian atrophy;,Dentatorubral pallidoluysian atrophy,Disease-causing germline mutation(s) in,,0.625398773006135,0.9761474987106756,0.30801357347950925,0.3083179864947821
289,1738,ATOH7,609875,221900;,"[MIM:221900]Persistent hyperplastic primary vitreous, autosomal recessive [recessive?];",Congenital cataract microcornea with corneal opacity;Persistent hyperplastic primary vitreous,Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in,Optic nerve measurement (cup area)[20395239];Optic disc parameters[20548946];Optic cup area[25631615;25631615;28073927;28073927];Optic nerve measurement (cup-to-disc ratio)[28061514];Eating disorders (purging via substances)[23568457];Optic disc area[21307088;28073927;28073927;25631615;25631615];Vertical cup-disc ratio[25241763;20548946;28073927;28073927];Optic nerve measurement (disc area)[20395239];,0.038773006134969326,0.5229499742135121,0.8191072826938136,0.521792510742787
290,1741,ATP1A1,182310,,,Autosomal dominant Charcot-Marie-Tooth disease type 2DD,Disease-causing germline mutation(s) in,Coffee consumption[29367735];,0.9955828220858896,1.0,0.7937875228399895,0.9760589318600368
291,1743,ATP1A2,182340,104290;602481;,"[MIM:602481]Migraine, familial hemiplegic, 2;[MIM:104290]Alternating hemiplegia of childhood 1;",Alternating hemiplegia of childhood;Familial or sporadic hemiplegic migraine,Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in,Response to antipsychotic treatment[23241943];,0.5561963190184049,0.34347601856627125,0.7632471939441399,0.7837630448127686
292,1744,ATP1A3,182350,128235;601338;614820;,"[MIM:128235]Dystonia 12 [dominant?];[MIM:614820]Alternating hemiplegia of childhood 2;[MIM:601338]Cerebellar ataxia, areflexia, pes cavus, optic atrophy, and sensorineural hearing loss [dominant?];",Alternating hemiplegia of childhood;Cerebellar ataxia-areflexia-pes cavus-optic atrophy-sensorineural hearing loss syndrome;Rapid-onset dystonia-parkinsonism,Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) (gain of function) in;Disease-causing germline mutation(s) in,,0.43754601226993867,1.0,0.9150352388410337,0.9898710865561694
293,1753,ATP2A1,108730,601003;,[MIM:601003]Brody myopathy;,Brody myopathy,Disease-causing germline mutation(s) (loss of function) in,Inflammatory bowel disease[28067908];BMI in non-smokers[28443625;28443625;28443625];Body mass index[19079260;25673413;25673413;25673413;25673413;28892062];Intelligence (MTAG)[29326435];Cannabis use[30150663];Intelligence[28530673;28530673];Hip circumference[25673412;25673412;25673412];Body mass index (joint analysis main effects and smoking interaction)[28443625;28443625;28443625];Crohn's disease[28067908];Weight[19079260];BMI (adjusted for smoking behaviour)[28443625;28443625;28443625];,0.8422085889570552,0.369778236204229,0.5494648916731923,0.8265807243707797
294,1755,ATP2A2,108740,101900;124200;,[MIM:101900]Acrokeratosis verruciformis [dominant?];[MIM:124200]Darier disease;,Darier disease;Acrokeratosis verruciformis of Hopf,Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) (loss of function) in,Glucose homeostasis traits[25524916];QT interval[24952745];Schizophrenia[25056061;28991256];Protein quantitative trait loci[18464913];,0.9968098159509202,0.7331098504383703,0.8655703471678413,0.9389195825659914
295,1759,ATP2B2,108733,,,Autosomal recessive non-syndromic sensorineural deafness type DFNB,Modifying germline mutation in,Manganese levels[26025379];Autism spectrum disorder or schizophrenia[28540026];Cognitive decline rate in late mild cognitive impairment[26252872];Amyotrophic lateral sclerosis (sporadic)[24529757];Metabolite levels[19043545];,0.5658895705521473,1.0,0.6536152440616028,0.9861878453038674
296,1762,ATP2B3,300014,302500;,,X-linked non progressive cerebellar ataxia,Disease-causing germline mutation(s) in,,0.4226993865030675,0.9782104177411036,0.6382145653876272,0.9969306322897483
297,1763,ATP2B4,108732,,,Autosomal recessive non-syndromic sensorineural deafness type DFNB,Modifying germline mutation in,Mean corpuscular hemoglobin concentration[23263863;28453575;27863252];Obstructive sleep apnea (average oxygen saturation during sleep)[26977737];Mean corpuscular volume[27863252];Malaria[22895189];Lymphocyte counts[27863252];Breast size[22747683];Red cell distribution width[27863252];Hemoglobin concentration[27863252];,0.7110429447852761,0.8231046931407943,0.5228399895588619,0.9211172498465316
298,1764,ATP2C1,604384,169600;,,Familial benign chronic pemphigus,Disease-causing germline mutation(s) in,Restless legs syndrome[29029846];,0.8401226993865031,0.9802733367715317,0.3424693291568781,0.9714548802946593
299,1767,ATP4A,137216,,,Familial gastric type 1 neuroendocrine tumor,Disease-causing germline mutation(s) in,Platelet count[29403010];,0.5128834355828221,0.0964414646725116,0.6285565126598799,0.7558317986494782
300,1769,ATP5F1A,164360,615228;616045;,"[MIM:616045]Combined oxidative phosphorylation deficiency 22;[MIM:615228]Mitochondrial complex V deficiency, nuclear 4;",Isolated ATP synthase deficiency,Disease-causing germline mutation(s) in,Bone mineral density (hip)[30172743];,0.9887116564417178,0.9525528623001547,0.0,0.0
301,1781,ATP5F1D,603150,,,Isolated ATP synthase deficiency,Disease-causing germline mutation(s) in,,0.7842944785276074,0.5477050025786487,0.0,0.0
302,1782,ATP5F1E,606153,614053;,,Isolated ATP synthase deficiency,Disease-causing germline mutation(s) in,,0.674723926380368,0.43604951005673026,0.0,0.0
303,1841,ATP6AP2,300556,300423;300911;,"[MIM:300423]Mental retardation, X-linked, with epilepsy;[MIM:300911]Parkinsonism with spasticity, X-linked;","X-linked parkinsonism-spasticity syndrome;X-linked intellectual disability, Hedera type",Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in,,0.967239263803681,0.7913873130479628,0.8245888801879405,0.6548496009821977
304,1842,ATP6V1A,607027,617403;,,"Autosomal recessive cutis laxa type 2, classic type;Undetermined early-onset epileptic encephalopathy",Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in,Prostate cancer[23535732];,0.9300613496932515,0.8202681794739557,0.8611328634821196,0.6238489871086557
305,1843,ATP6V1B1,192132,267300;,"[MIM:267300]Renal tubular acidosis, distal, with progressive nerve deafness [recessive?];",Autosomal recessive distal renal tubular acidosis,Disease-causing germline mutation(s) in,Acne (severe)[24927181];,0.8615950920245399,0.15781330582774625,0.06003654398329418,0.5767341927562922
306,1845,ATP6V1B2,606939,124480;616455;,"[MIM:616455]Zimmermann-Laband syndrome 2;[MIM:124480]Deafness, congenital, with onychodystrophy, autosomal dominant [dominant?];",Zimmermann-Laband syndrome;Autosomal dominant deafness-onychodystrophy syndrome,Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in,Erythrocyte cadmium concentration in never smokers[27005419];Susceptibility to persistent hepatitis B virus infection[27244555];Circulating myeloperoxidase levels (serum)[23620142];Major depressive disorder (broad)[20038947];,0.8986503067484662,0.6013408973697782,0.6053249804228661,0.7183855125844076
307,1849,ATP6V1E1,108746,617402;,,"Autosomal recessive cutis laxa type 2, classic type",Disease-causing germline mutation(s) in,,0.8907975460122699,0.6972666322846828,0.8115374575828765,0.874462860650706
308,1869,ATP6V0A2,611716,219200;278250;,"[MIM:219200]Cutis laxa, autosomal recessive, 2A [recessive?];[MIM:278250]Wrinkly skin syndrome [recessive?];","Wrinkly skin syndrome;Autosomal recessive cutis laxa type 2, classic type",Disease-causing germline mutation(s) (loss of function) in;Disease-causing germline mutation(s) (loss of function) in,Waist-to-hip ratio adjusted for BMI (age >50)[26426971];Adiponectin levels[22479202];Waist-to-hip ratio adjusted for BMI[26426971];Waist-to-hip ratio adjusted for BMI x sex x age interaction (4df test)[26426971];,0.7001226993865031,0.35714285714285715,0.35604280866614463,0.6981276856967464
309,1870,ATP6V0A4,605239,602722;,,Autosomal recessive distal renal tubular acidosis,Disease-causing germline mutation(s) in,F-cell distribution[21326311];,0.39631901840490796,0.03429602888086643,0.217958757504568,0.9157458563535912
310,1886,ATP7A,300011,300489;304150;309400;,"[MIM:309400]Menkes disease;[MIM:304150]Occipital horn syndrome;[MIM:300489]Distal spinal muscular atrophy, X-linked, 3;",Menkes disease;X-linked distal spinal muscular atrophy type 3;Occipital horn syndrome,Disease-causing germline mutation(s) (loss of function) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in,,0.867239263803681,0.796544610624033,0.10858783607413208,0.9459791282995703
311,1887,ATP7B,606882,277900;,[MIM:277900]Wilson disease [recessive?];,Wilson disease,Disease-causing germline mutation(s) (loss of function) in,Clostridium difficile infection in multiple myeloma[29594489];,0.7749693251533742,0.11964930376482723,0.1370399373531715,0.9145181092694905
312,1890,ATP8A2,605870,615268;,,Dysequilibrium syndrome,Disease-causing germline mutation(s) in,Docetaxel-induced peripheral neuropathy in metastatic castrate-resistant prostate cancer[27143689];Breast milk fatty acid composition (maternal genotype effect)[29514873];Breast milk fatty acid composition (infant genotype effect)[29514873];Eating disorders[23568457];Common carotid intima-media thickness[29206233];,0.10711656441717791,0.08612686952037132,0.624902114330462,0.46608348680171885
313,1894,ATP8B1,602397,147480;211600;243300;,"[MIM:243300]Cholestasis, benign recurrent intrahepatic, 1;[MIM:147480]Cholestasis of pregnancy, intrahepatic 1;",Intrahepatic cholestasis of pregnancy;Progressive familial intrahepatic cholestasis type 1;Benign recurrent intrahepatic cholestasis type 1,Major susceptibility factor in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in,Liver enzyme levels (gamma-glutamyl transferase)[22001757];Manganese levels[26025379];Vitiligo[19890347];Attention deficit hyperactivity disorder and conduct disorder[18951430];Very long-chain saturated fatty acid levels (fatty acid 20:0)[25378659];,0.08736196319018405,0.6598762248581743,0.3025319759853824,0.5240945365254758
314,1901,ATP10A,605855,105830;,,Angelman syndrome due to imprinting defect in 15q11-q13,Role in the phenotype of,Insulin resistance/response[21901158;21901158];Immune reponse to smallpox (secreted IFN-alpha)[22610502];,0.038773006134969326,0.41464672511603917,0.020360219263899765,0.7251381215469613
315,1904,ATP11A,605868,,,Idiopathic pulmonary fibrosis,Major susceptibility factor in,Reticulocyte fraction of red cells[27863252];Mean corpuscular volume[27863252];Glycated hemoglobin levels[20858683;28898252];Interstitial lung disease[23583980];Red cell distribution width[27863252;27863252];,0.10711656441717791,0.27720474471377,0.4685460715217959,0.7346531614487416
316,1911,ATP13A2,610513,606693;617225;,"[MIM:606693]Kufor-Rakeb syndrome [recessive?];[MIM:617225]Spastic paraplegia 78, autosomal recessive [recessive?];",ATP13A2-related juvenile neuronal ceroid lipofuscinosis;Kufor-Rakeb syndrome;Autosomal recessive spastic paraplegia type 78,Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) (loss of function) in;Disease-causing germline mutation(s) in,Waist circumference adjusted for BMI (joint analysis main effects and physical activity interaction)[28448500];Hip circumference adjusted for BMI[25673412;25673412;25673412];Height[20189936;25429064];Waist circumference adjusted for BMI in active individuals[28448500];Intraocular pressure[29617998];,0.5519018404907975,0.45435791645177925,0.5231010180109632,0.925414364640884
317,1918,ATPAF1,608917,,,Isolated ATP synthase deficiency,Candidate gene tested in,,0.9040490797546012,0.4515214027849407,0.6630122683372488,0.0
318,1919,ATPAF2,608918,604273;,,Isolated ATP synthase deficiency,Disease-causing germline mutation(s) in,Schizophrenia[25056061;28991256];,0.8279754601226994,0.41645177926766375,0.6687548942834769,0.3218232044198895
319,1920,ATR,601215,210600;614564;,"[MIM:210600]Seckel syndrome 1 [recessive?];[MIM:614564]Cutaneous telangiectasia and cancer syndrome, familial;",Seckel syndrome;Familial cutaneous telangiectasia and oropharyngeal cancer predisposition syndrome,Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in,Reticulocyte fraction of red cells[27863252];Mean corpuscular volume[29403010];Mean corpuscular hemoglobin[29403010];Reticulocyte count[27863252];Red blood cell count[29403010;27863252];,0.674723926380368,0.6896596183599794,0.2926128948055338,0.20549416820135052
320,1922,ATRIP,606605,,,Seckel syndrome,Disease-causing germline mutation(s) in,Inflammatory bowel disease[28067908];Crohn's disease[28067908];Ulcerative colitis[28067908];,0.8053987730061349,0.35817431665807115,0.3531714956930305,0.15899324739103746
321,1925,ATRX,300032,300448;301040;309580;,"[MIM:301040]Alpha-thalassemia mental retardation syndrome, X-linked;[MIM:309580]Mental retardation, X-linked, syndromic, with hypotonic facies 1;[MIM:300448]Alpha-thalassemia myelodysplasia syndrome;",Alpha-thalassemia-X-linked intellectual disability syndrome;Alpha-thalassemia-myelodysplastic syndrome;Smith-Fineman-Myers syndrome;Chudley-Lowry-Hoar syndrome;Holmes-Gang syndrome;Carpenter-Waziri syndrome;Juberg-Marsidi syndrome;Neuroendocrine tumor of stomach,Disease-causing germline mutation(s) in;Disease-causing somatic mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Candidate gene tested in,,0.7487116564417178,0.7929345023207839,0.6340381101540068,0.9825046040515654
322,1926,ATXN1,601556,164400;,[MIM:164400]Spinocerebellar ataxia 1 [dominant?];,Spinocerebellar ataxia type 1,Disease-causing germline mutation(s) in,Cortical amyloid beta load[29860282];Subcutaneous adipose tissue attenuation (Hounsfield unit scale)[27918534;27918534];Gambling[22780124];Coronary artery calcified atherosclerotic plaque (90 or 130 HU threshold) in type 2 diabetes[29221444];High light scatter reticulocyte percentage of red cells[27863252];Reticulocyte count[27863252];Myeloid white cell count[27863252];Atrial fibrillation[30061737;29892015;29892015];Amyotrophic lateral sclerosis[19451621];Sum basophil neutrophil counts[27863252];High light scatter reticulocyte count[27863252];Sum neutrophil eosinophil counts[27863252];Breast cancer[29059683];Granulocyte count[27863252];Neutrophil count[29403010;27863252];General cognitive ability[29844566];Major depressive disorder[23377640];Total body bone mineral density[30172743];Systemic lupus erythematosus[27399966;27399966;28714469];Reticulocyte fraction of red cells[27863252];White blood cell count[29403010;27863252];Visceral adipose tissue attenuation (Hounslow unit scale)[27918534];,0.6776687116564417,0.9185146982980918,0.447141738449491,0.7992633517495396
323,1928,ATXN2,601517,183090;,[MIM:183090]Spinocerebellar ataxia 2 [dominant?];[MIM:183090]Amyotrophic lateral sclerosis 13;,Amyotrophic lateral sclerosis;Spinocerebellar ataxia type 2,Major susceptibility factor in;Disease-causing germline mutation(s) in,"Primary biliary cirrhosis[22961000];Thyroid peroxidase antibody positivity[24586183];Hematocrit[19862010];Plateletcrit[27863252];High light scatter reticulocyte count[27863252];Eosinophil counts[27863252];Diastolic blood pressure x alcohol consumption interaction (2df test)[29912962];Mean arterial pressure[27618448];Left ventricle diastolic internal dimension[28394258];Immature fraction of reticulocytes[27863252];Blood osmolality (transformed sodium)[28360221];Glaucoma (primary open-angle)[26752265];Beta-2 microglubulin plasma levels[23417110];Body mass index[26426971];Systemic lupus erythematosus[26502338;28714469];Reticulocyte fraction of red cells[27863252];Systolic blood pressure x smoking status (ever vs never) interaction (2df test)[29455858;29455858];Blood pressure[21909110];Mean arterial pressure x alcohol consumption interaction (2df test)[29912962];High light scatter reticulocyte percentage of red cells[27863252];Glycated hemoglobin levels[28898252];Diastolic blood pressure[19430483;26390057;26390057];Platelet distribution width[27863252];Hypothyroidism[22493691;27182965];Systolic blood pressure x smoking status (current vs non-current) interaction (2df test)[29455858;29455858];Systolic blood pressure (cigarette smoking interaction)[29455858];Diastolic blood pressure x alcohol consumption (light vs heavy) interaction (2df test)[29912962];Inflammatory bowel disease[28067908;26192919];Celiac disease[18311140;22057235];Sum eosinophil basophil counts[27863252];Serum total protein level[29403010];Sjögren's syndrome[24097067];Juvenile idiopathic arthritis (oligoarticular or rheumatoid factor-negative polyarticular)[23603761];Thyroid peroxidase antibody levels[24586183];Diastolic blood pressure x smoking status (current vs non-current) interaction (2df test)[29455858;29455858];Reaction time[29844566;29844566;29844566];Monocyte count[27863252];Glomerular filtration rate (cystatin C)[28452372];Diastolic blood pressure (cigarette smoking interaction)[29455858];Mean corpuscular volume[27863252];Peripheral artery disease[25009551];Vitiligo[27723757];Allergic disease (asthma, hay fever or eczema)[29083406];Red blood cell traits[23222517];Allergic rhinitis[30013184];Systolic blood pressure x alcohol consumption interaction (2df test)[29912962];Platelet count[24026423;27863252;29403010];Eosinophil percentage of white cells[27863252];Retinal vascular caliber[21060863];Urate levels[23263486];Sarcoidosis[26051272];Chronic kidney disease[20383146];Crohn's disease[26192919;28067908];Diastolic blood pressure x smoking status (ever vs never) interaction (2df test)[29455858;29455858];Coronary artery disease[29212778;29212778;29212778];Alopecia areata[25608926];Eosinophil percentage of granulocytes[27863252];Primary biliary cholangitis[26394269];Neutrophil percentage of granulocytes[27863252];Intraocular pressure[30054594];",0.8868711656441718,0.926250644662197,0.042286609240407204,0.46608348680171885
324,1931,ATXN3,607047,109150;,[MIM:109150]Spinocerebellar ataxia 3 [dominant?];,Machado-Joseph disease type 1;Machado-Joseph disease type 3;Machado-Joseph disease type 2,Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in,Coronary artery calcification[23870195];Amyotrophic lateral sclerosis[29566793];Height[18391950;18391951];Orofacial clefts[22419666];,0.5460122699386503,0.6820526044352759,0.06369094231271208,0.0836402701043585
325,1933,ATXN7,607640,164500;,[MIM:164500]Spinocerebellar ataxia 7 [dominant?];,Spinocerebellar ataxia type 7,Disease-causing germline mutation(s) in,Schizophrenia[25056061;28991256];,0.6225766871165644,0.9355337802991233,0.07021665361524407,0.4585635359116022
326,1938,ATXN8,613289,608768;,[MIM:608768]Spinocerebellar ataxia 8 [dominant?];,Spinocerebellar ataxia type 8,Disease-causing germline mutation(s) in,,0.038773006134969326,0.0,0.0,0.0
327,1939,ATXN8OS,603680,,,Spinocerebellar ataxia type 8,Disease-causing germline mutation(s) in,Language performance in older adults (adjusted for episodic memory)[28577822];,0.038773006134969326,0.0,0.0,0.0
328,1940,ATXN10,611150,603516;,,Spinocerebellar ataxia type 10,Disease-causing germline mutation(s) in,Hematocrit[29403010];Hemoglobin[29403010];,0.9101840490797546,0.6980402269210934,0.7872618115374576,0.5943830570902394
329,1941,AUH,600529,250950;,[MIM:250950]3-methylglutaconic aciduria 1 [recessive?];,3-methylglutaconic aciduria type 1,Disease-causing germline mutation(s) (loss of function) in,Inflammatory bowel disease[28067908];Response to Homoharringtonine (cytotoxicity)[25628645];Sum eosinophil basophil counts[27863252];Eosinophil percentage of granulocytes[27863252];Total bilirubin levels[29403010];Eosinophil counts[27863252];Type 2 diabetes nephropathy[21150874];Bipolar disorder (inflammation and infection response interaction)[25781172];,0.16220858895705523,0.30092831356369265,0.7658574784651527,0.15316144874155924
330,1946,AURKAIP1,609183,,,Acromegaly;Prolactinoma;Familial isolated pituitary adenoma;Silent pituitary adenoma;Null pituitary adenoma,Major susceptibility factor in;Major susceptibility factor in;Disease-causing germline mutation(s) in;Major susceptibility factor in;Major susceptibility factor in,Inflammatory bowel disease[28067908];Ulcerative colitis[28067908];Intraocular pressure[29617998;29617998];,0.7469938650306749,0.27565755544094894,0.5030018271991648,0.16313689379987723
331,1951,AURKC,603495,243060;,[MIM:243060]Spermatogenic failure 5;,Male infertility due to large-headed multiflagellar polyploid spermatozoa,Disease-causing germline mutation(s) (loss of function) in,,0.3889570552147239,0.5428055698813822,0.8666144609762464,0.07565991405770411
332,1953,AUTS2,607270,615834;,"[MIM:615834]Mental retardation, autosomal dominant 26 [dominant?];",Autism spectrum disorder due to AUTS2 deficiency;Precursor B-cell acute lymphoblastic leukemia,Disease-causing germline mutation(s) in;Part of a fusion gene in,QT interval[29213071];Response to serotonin reuptake inhibitors in non-psychotic unipolar depression[26348319];Amyotrophic lateral sclerosis (sporadic)[24529757];Hand grip strength[29691431;29691431];Bipolar disorder[22925353];General cognitive ability[29844566;29844566];Photic sneeze reflex[27182965];Alcohol consumption[21471458];Childhood ear infection[27182965;28928442];Body mass index[25673413;28892062;28892062];Immune reponse to smallpox (secreted IL-2)[22610502];Male-pattern baldness[22693459;27182965;29146897;29146897];Mosquito bite size[28199695];Monobrow[27182965];Motion sickness[25628336;25628336];Obesity-related traits[23251661];Cognitive decline (age-related)[28078323];,0.703558282208589,0.8171738009283136,0.44296528321587053,0.5240945365254758
333,1957,AVP,192340,125700;,"[MIM:125700]Diabetes insipidus, neurohypophyseal;",Hereditary central diabetes insipidus,Disease-causing germline mutation(s) (loss of function) in,Oral cavity and pharyngeal cancer[21437268];,0.3492024539877301,0.5430634347601857,0.7799530148786218,0.0
334,1961,AVPR2,300538,300539;304800;,"[MIM:304800]Diabetes insipidus, nephrogenic, X-linked;",Nephrogenic diabetes insipidus;Nephrogenic syndrome of inappropriate antidiuresis,Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) (gain of function) in,,0.2947239263803681,0.6975244971634863,0.4899504045941008,0.7848373235113567
335,1966,AXIN1,603816,114550;607864;,[MIM:114550]Hepatocellular carcinoma;[MIM:607864]Caudal duplication anomaly;,Adult hepatocellular carcinoma,Disease-causing somatic mutation(s) in,Body mass index[25673413;25673413;25673413];Mean corpuscular hemoglobin concentration[27863252;27863252];Bone mineral density (spine)[26733130;26733130];Mean corpuscular hemoglobin[27863252;27863252];Mean corpuscular volume[27863252;27863252];Heel bone mineral density[28869591;28869591;28869591];Bone mineral density[22504420];Red blood cell count[27863252];Femoral neck bone mineral density[29499414];Red cell distribution width[27863252];Lumbar spine bone mineral density[29499414];,0.765521472392638,0.5670448684889118,0.474288697468024,0.6895334561080417
336,1967,AXIN2,604025,114500;608615;,[MIM:114500]Colorectal cancer;[MIM:608615]Oligodontia-colorectal cancer syndrome;,Oligodontia-cancer predisposition syndrome;AXIN2-related attenuated familial adenomatous polyposis;Oligodontia,Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in,Heel bone mineral density[28869591;28869591;28869591];,0.5822085889570552,0.8478597215059309,0.1816758026624902,0.6190914671577655
337,1979,B2M,109700,105200;241600;,[MIM:241600]Immunodeficiency 43;[MIM:105200]Amyloidosis 8;,Variant ABeta2M amyloidosis;Immunodeficiency by defective expression of HLA class 1,Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) (loss of function) in,,0.7152147239263804,0.6815368746776689,0.0,0.0
338,1983,B3GALNT2,610194,615181;,[MIM:615181]Muscular dystrophy-dystroglycanopathy congenital with brain and eye anomalies A11 [recessive?];,Muscle-eye-brain disease;Walker-Warburg syndrome;Autosomal recessive non-syndromic intellectual disability,Disease-causing germline mutation(s) (loss of function) in;Disease-causing germline mutation(s) (loss of function) in;Disease-causing germline mutation(s) in,Body mass index[28892062];,0.23865030674846627,0.17483238782877772,0.5954058992430175,0.11678944137507673
339,1990,B3GALT6,615291,271640;615349;,"[MIM:271640]Spondyloepimetaphyseal dysplasia with joint laxity, 1, with or without fractures;","Ehlers-Danlos syndrome, progeroid type;Spondyloepimetaphyseal dysplasia with joint laxity",Disease-causing germline mutation(s) (loss of function) in;Disease-causing germline mutation(s) (loss of function) in,Blood protein levels[30072576];,0.16220858895705523,0.4791129448169159,0.3155833985904464,0.0
340,1993,B3GAT3,606374,245600;,"[MIM:245600]Multiple joint dislocations, short stature, and craniofacial dysmorphism with or without congenital heart defects [recessive?];","Larsen-like syndrome, B3GAT3 type",Disease-causing germline mutation(s) in,Blood protein levels[29875488;30072576;30072576];Waist-to-hip ratio adjusted for BMI[26426971;26426971];Waist-to-hip ratio adjusted for BMI x sex x age interaction (4df test)[26426971;26426971];,0.32380368098159507,0.2929345023207839,0.7042547637692509,0.2826887661141805
341,1995,B3GLCT,610308,261540;,,Peters plus syndrome,Disease-causing germline mutation(s) in,Advanced age-related macular degeneration[26691988];Age-related macular degeneration[23455636];Blood protein levels[30072576];,0.623680981595092,0.040226921093347086,0.0,0.0
342,2009,B4GALNT1,601873,609195;,"[MIM:609195]Spastic paraplegia 26, autosomal recessive [recessive?];",Autosomal recessive spastic paraplegia type 26,Disease-causing germline mutation(s) in,,0.14576687116564419,0.34657039711191334,0.24588880187940484,0.3683241252302026
343,2014,B4GALT1,137060,607091;,[MIM:607091]Congenital disorder of glycosylation 2D;,B4GALT1-CDG,Disease-causing germline mutation(s) in,Mild influenza (H1N1) infection[26379185];IgG glycosylation[23382691;23382691;23382691;23382691;23382691;23382691];Urate levels[23263486];IgG galactosylation phenotypes (multivariate analysis)[28878392];Severe influenza A (H1N1) infection[26379185];IgG fucosylation phenotypes (multivariate analysis)[28878392];IgG N-glycosylation phenotypes (multivariate analysis)[28878392];Aspartate aminotransferase levels[29403010];Blood protein levels[29875488;30072576];Influenza A (H1N1) infection[26379185];,0.5930061349693252,0.5417741103661682,0.7582876533542157,0.648096992019644
344,2022,B4GALT7,604327,130070;,,"Reunion Island Larsen-like syndrome;Ehlers-Danlos syndrome, progeroid type",Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in,Methadone dose in opioid dependence[28115739];Waist-to-hip ratio adjusted for BMI (age <50)[26426971];Blood protein levels[30072576];Waist-to-hip ratio adjusted for BMI[26426971];Waist-to-hip ratio adjusted for BMI x sex x age interaction (4df test)[26426971];,0.6500613496932516,0.7124806601340897,0.7546332550247977,0.43155310006138736
345,2023,B4GAT1,605517,615287;,,Walker-Warburg syndrome,Disease-causing germline mutation(s) (loss of function) in,Bipolar disorder[21926972];,0.4298159509202454,0.1405363589479113,0.0,0.0
346,2024,B9D1,614144,614209;617120;,[MIM:614209]Meckel syndrome 9;[MIM:617120]Joubert syndrome 27 [recessive?];,Meckel syndrome;Joubert syndrome,Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in,,0.7685889570552147,0.4700876740587932,0.12685982772122162,0.31952117863720075
347,2025,B9D2,611951,614175;,[MIM:614175]Meckel syndrome 10;[MIM:614175]Joubert syndrome 34 [recessive?];,Meckel syndrome,Disease-causing germline mutation(s) in,Colorectal cancer[24836286];Coronary artery disease[29212778;29212778;29212778];Preterm birth (maternal effect)[28877031];,0.689079754601227,0.26482723053120166,0.8966327329678935,0.3021792510742787
348,2029,BAAT,602938,607748;,,Familial hypercholanemia,Disease-causing germline mutation(s) in,,0.33226993865030674,0.16554925219185146,0.7729052466718872,0.11955187231430325
349,2045,BAG3,603883,612954;613881;,"[MIM:612954]Myopathy, myofibrillar, 6;[MIM:613881]Cardiomyopathy, dilated 1HH;","Familial isolated dilated cardiomyopathy;Muscular dystrophy, Selcen type",Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in,Parkinson's disease[27182965;28892059];Idiopathic dilated cardiomyopathy[21459883];,0.8192638036809816,0.6521402784940691,0.12764291307752546,0.748158379373849
350,2066,BANF1,603811,614008;,[MIM:614008]Nestor-Guillermo progeria syndrome;,Nestor-Guillermo progeria syndrome,Disease-causing germline mutation(s) in,Acne (severe)[24927181];,0.7916564417177914,0.755801959773079,0.9973897154789872,0.3687845303867403
351,2073,BANK1,610292,152700;,[MIM:152700]Systemic lupus erythematosus;,Systemic lupus erythematosus,Major susceptibility factor in,"Autism spectrum disorder or schizophrenia[28540026];Chronic inflammatory diseases (ankylosing spondylitis, Crohn's disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy)[26974007];Hand grip strength[29691431];Crohn's disease[28067908];Gut microbiota (beta diversity)[27723756];Blood protein levels[28240269];General cognitive ability[29844566;29844566];Inflammatory bowel disease[28067908];Mean platelet volume[27863252];Chronic lymphocytic leukemia[26956414;28165464];Intelligence (MTAG)[29326435;29326435];Systemic lupus erythematosus[18204447;23273568;27399966;26502338;26502338;28714469;28714469;28714469];Autism spectrum disorder, attention deficit-hyperactivity disorder, bipolar disorder, major depressive disorder, and schizophrenia (combined)[23453885];Blood pressure[22763476];",0.4463803680981595,0.11707065497679216,0.1046724092926129,0.003376304481276857
352,2075,BAP1,603089,156240;614327;,"[MIM:156240]Mesothelioma, malignant;[MIM:614327]Tumor predisposition syndrome;",Familial melanoma;BAP1-related tumor predisposition syndrome;Uveal melanoma;Uveal melanoma,Major susceptibility factor in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing somatic mutation(s) in,Parkinson's disease[28892059];Autism spectrum disorder or schizophrenia[28540026;28540026];Schizophrenia[23974872];Bipolar disorder[21926972];,0.685644171779141,0.813821557503868,0.5139650221874185,0.4752915899324739
353,2076,BARD1,601593,,,Hereditary breast and ovarian cancer syndrome,Candidate gene tested in,Neuroblastoma (high-risk)[19412175];Sporadic neuroblastoma[28545128];Neuroblastoma[21124317;22941191];Neuroblastoma (MYCN amplification)[28924153];,0.7125153374233129,0.06034038164002063,0.05194466196815453,0.1111111111111111
354,2090,BAZ1B,605681,,,Williams syndrome,Role in the phenotype of,Urate levels[23263486];Protein C levels[20802025];C-reactive protein levels or HDL-cholesterol levels (pleiotropy)[27286809];Hypertriglyceridemia[23505323];Migraine[27182965];Waist-to-hip ratio adjusted for BMI (joint analysis for main effect and physical activity interaction)[28448500];Pursuit maintenance gain[29064472];Triglycerides[20864672];Waist-to-hip ratio adjusted for body mass index[28448500];,0.8265030674846626,1.0,0.6666666666666666,0.5972989564149785
355,2094,BBIP1,613605,615995;,[MIM:615995]Bardet-Biedl syndrome 18 [recessive?];,Bardet-Biedl syndrome,Disease-causing germline mutation(s) in,,0.4190184049079755,0.43295513151108816,0.9848603497781259,0.0
356,2099,BBS1,209901,209900;,[MIM:209900]Bardet-Biedl syndrome 1 [recessive?];,Bardet-Biedl syndrome,Disease-causing germline mutation(s) in,Bipolar disorder[21926972];,0.6103067484662577,0.33548220732336254,0.9856434351344296,0.6921424186617556
357,2100,BBS2,606151,615981;616562;,[MIM:616562]Retinitis pigmentosa 74;,Retinitis pigmentosa;Bardet-Biedl syndrome,Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in,,0.623680981595092,0.0,0.357347950926651,0.6106507059545734
358,2101,BBS4,600374,615982;,,Bardet-Biedl syndrome,Disease-causing germline mutation(s) in,Body mass index[28448500];Body mass index in physically active individuals[28448500];Theory of mind score in adolescence (Emotional Triangles Task)[29472613];Waist-to-hip ratio adjusted for BMI[26426971];Body mass index (joint analysis main effects and physical activity interaction)[28448500];Waist-to-hip ratio adjusted for BMI x sex x age interaction (4df test)[26426971];,0.6646625766871166,0.07529654461062403,0.14643696162881753,0.30448127685696746
359,2102,BBS5,603650,615983;,[MIM:615983]Bardet-Biedl syndrome 5 [recessive?];,Bardet-Biedl syndrome,Disease-causing germline mutation(s) in,,0.5585276073619632,0.19752449716348633,0.0,0.28698588090853283
360,2103,BBS7,607590,615984;,[MIM:615984]Bardet-Biedl syndrome 7 [recessive?];,Bardet-Biedl syndrome,Disease-causing germline mutation(s) in,,0.6500613496932516,0.44146467251160393,0.6878099712868703,0.4547268262737876
361,2104,BBS9,607968,615986;,[MIM:615986]Bardet-Biedl syndrome 9 [recessive?];,Bardet-Biedl syndrome,Disease-causing germline mutation(s) in,Acute kidney injury in coronary artery bypass surgery (creatinine rise)[26083657];Smooth-surface caries[24556642];Leprosy[27976721];Disease progression in age-related macular degeneration[29346644];Sagittal craniosynostosis[23160099];Asthma[29273806];Intraocular pressure[29785010];,0.6414723926380368,0.37493553378029915,0.18245888801879404,0.7038060159607121
362,2105,BBS10,610148,615987;,[MIM:615987]Bardet-Biedl syndrome 10 [recessive?];,Bardet-Biedl syndrome,Disease-causing germline mutation(s) in,,0.47337423312883437,0.07993811242908716,0.6831114591490473,0.5931553100061387
363,2106,BBS12,610683,615989;,[MIM:615989]Bardet-Biedl syndrome 12 [recessive?];,Bardet-Biedl syndrome,Disease-causing germline mutation(s) in,Itch intensity from mosquito bite adjusted by bite size[28199695;28199695;28199695;28199695];Mosquito bite size[28199695];Itch intensity from mosquito bite[28199695];Night sleep phenotypes[27126917];,0.4538650306748466,0.17276946879834967,0.33829287392325763,0.09806629834254144
364,2111,BCAP31,300398,300475;,"[MIM:300475]Deafness, dystonia, and cerebral hypomyelination;",CADDS;Severe motor and intellectual disabilities-sensorineural deafness-dystonia syndrome,Role in the phenotype of;Disease-causing germline mutation(s) (loss of function) in,,0.9769325153374233,0.6926250644662197,0.9086400417645524,0.0
365,2131,BCHE,177400,617936;,[MIM:617936]Butyrylcholinesterase deficiency [recessive?];,Butyrylcholinesterase deficiency;Curariform drugs toxicity,Disease-causing germline mutation(s) in;Biomarker tested in,Heart failure[20445134];Fast beta electroencephalogram[28070124];Butyrylcholinesterase levels[21862451];Alzheimer's disease biomarkers[23419831];Aspirin hydrolysis (plasma)[23508960];Cardiovascular disease risk factors[21943158];Blood protein levels[29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;30072576;30072576;30072576;30072576;30072576;30072576;30072576;30072576;30072576;30072576;30072576;30072576;30072576;30072576;30072576;30072576;30072576;30072576;30072576;30072576;30072576;30072576;30072576;30072576;30072576;30072576;30072576;30072576];Paclitaxel disposition in epithelial ovarian cancer[29367611;29367611];,0.3492024539877301,0.5397111913357401,0.19316105455494648,0.42955801104972374
366,2132,BCKDHA,608348,248600;,[MIM:248600]Maple syrup urine disease 1A;,Intermediate maple syrup urine disease;Classic maple syrup urine disease;Thiamine-responsive maple syrup urine disease;Intermittent maple syrup urine disease,Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in,Height[25282103];,0.8441717791411043,0.14259927797833935,0.0,0.6468692449355433
367,2133,BCKDHB,248611,248600;,[MIM:248600]Maple syrup urine disease 1B;,Intermediate maple syrup urine disease;Classic maple syrup urine disease;Thiamine-responsive maple syrup urine disease;Intermittent maple syrup urine disease,Disease-causing germline mutation(s) (loss of function) in;Disease-causing germline mutation(s) (loss of function) in;Disease-causing germline mutation(s) (loss of function) in;Disease-causing germline mutation(s) (loss of function) in,Waist circumference adjusted for BMI (joint analysis main effects and physical activity interaction)[28448500];Joint mobility (Beighton score)[27182965];Sitting height ratio[25865494];Prudent dietary pattern[28644415];Height[23563607;25282103];Waist circumference adjusted for body mass index[28448500;28448500];Thiazide-induced adverse metabolic effects in hypertensive patients[23400010];Waist circumference adjusted for BMI in active individuals[28448500];,0.854478527607362,0.37235688499226405,0.8029235186635343,0.6127992633517495
368,2134,BCKDK,614901,614923;,[MIM:614923]Branched-chain ketoacid dehydrogenase kinase deficiency;,Autism-epilepsy syndrome due to branched chain ketoacid dehydrogenase kinase deficiency,Disease-causing germline mutation(s) (loss of function) in,Parkinson's disease[25064009];,0.6661349693251534,0.6364105208870552,0.8136256851996868,0.2392572130141191
369,2135,BCL2,151430,,,Follicular lymphoma;High grade B-cell lymphoma with MYC and/ or BCL2 and/or BCL6 rearrangement;Intravascular large B-cell lymphoma,Part of a fusion gene in;Part of a fusion gene in;Biomarker tested in,Type 2 diabetes[28869590];Pyoderma gangrenosum in inflammatory bowel disease[24487271];Mean corpuscular hemoglobin[27863252];Mean corpuscular volume[27863252];Lymphocyte counts[27863252];Plateletcrit[27863252];Basophil percentage of white cells[27863252];High light scatter reticulocyte count[27863252];Eosinophil counts[27863252];Basophil percentage of granulocytes[27863252];Mean platelet volume[27863252];Body mass index[25673413;28892062];Modified Stumvoll Insulin Sensitivity Index (model adjusted for BMI)[27416945];Cardiac Troponin-T levels[23247143];Waist-to-hip ratio adjusted for body mass index[25673412;25673412];Platelet count[27863252];Eosinophil percentage of white cells[27863252];Waist-to-hip ratio adjusted for BMI (adjusted for smoking behaviour)[28443625];White blood cell count (basophil)[27863252];Reticulocyte count[27863252];Monocyte percentage of white cells[27863252];Red blood cell count[27863252];Albumin-globulin ratio[29403010];Sum eosinophil basophil counts[27863252];Chronic lymphocytic leukemia[23770605;23770605;26956414;28165464];Eosinophil percentage of granulocytes[27863252];Serum total protein level[29403010];Modified Stumvoll Insulin Sensitivity Index (BMI interaction)[27416945];Excessive hairiness[29895819];Follicular lymphoma[25279986];Monocyte count[27863252];Neutrophil percentage of granulocytes[27863252];Non-albumin protein levels[29403010];Prostate cancer[29892016];,0.6131288343558282,0.6431150077359463,0.38423388149308274,0.6057397176181707
370,2149,BCL6,109565,,,Follicular lymphoma;High grade B-cell lymphoma with MYC and/ or BCL2 and/or BCL6 rearrangement;Primary mediastinal large B-cell lymphoma;Intravascular large B-cell lymphoma,Part of a fusion gene in;Part of a fusion gene in;Disease-causing somatic mutation(s) in;Disease-causing somatic mutation(s) in,"Type 2 diabetes[25760438];Glucose homeostasis traits[25524916];Granulocyte percentage of myeloid white cells[27863252];B cell non-Hodgkin lymphoma[23749188];Pulmonary function (smoking interaction)[23284291];PR interval[23534349];Basophil percentage of white cells[27863252];Selective IgA deficiency[27723758];Blood urea nitrogen levels[29403010];Basophil percentage of granulocytes[27863252];Renal function-related traits (BUN)[22797727];Allergic disease (asthma, hay fever or eczema)[29083406;29083406];Self-reported allergy[23817569];Allergic sensitization[23817571];",0.6467484662576687,0.8620422898401238,0.23727486296006264,0.7067219152854513
371,2158,BCL10,603517,137245;616098;,"[MIM:616098]Immunodeficiency 37 [recessive?];[MIM:137245]Lymphoma, mucosa-associated lymphoid type;",MALT lymphoma,Part of a fusion gene in,Multiple sclerosis[24076602];,0.6147239263803681,0.6696750902527075,0.3074915165753067,0.5506445672191529
372,2159,BCL11A,606557,142335;617101;,[MIM:617101]Intellectual developmental disorder with persistence of fetal hemoglobin [dominant?];,Hereditary persistence of fetal hemoglobin-sickle cell disease syndrome,Candidate gene tested in,Fetal hemoglobin levels[18245381;20018918;20018918];Type 2 diabetes[20581827;24509480;22885922;22885922;29358691;28869590;28869590];Mean corpuscular volume[19862010;28017375;27863252];Mean corpuscular hemoglobin[27863252];Endometrial cancer[30093612;30093612];Hemoglobin A2 levels in sickle cell anemia[25042611];Cognitive ability[29186694];High light scatter reticulocyte count[27863252];Menarche (age at onset)[25231870];Red cell distribution width[27863252];Immature fraction of reticulocytes[27863252];Intelligence (MTAG)[29326435;29326435;29326435];Methadone dose in opioid dependence[28115739];Heart rate response to exercise[29769521];Red blood cell traits[23222517];Cognitive ability (MTAG)[29186694];Beta thalassemia/hemoglobin E disease[20183929];Hypersomnia (HLA-DQB1*06:02 negative)[23646285];Endometrial cancer ((endometrioid histology)[30093612;30093612];High light scatter reticulocyte percentage of red cells[27863252];Attention deficit hyperactivity disorder[22012869];Prostate-specific antigen levels[28139693];High fetal hemoglobin in sickle cell disease[27022141];Red blood cell count[27863252];General cognitive ability[29844566];Resting heart rate[27798624];Acne (severe)[24927181];Hemoglobin levels[26366553];F-cell distribution[17767159;21326311;21326311];Sickle cell anemia (haemolysis)[23406172];Heart rate response to recovery post exercise[29769521;29769521];Monocyte early outgrowth colony forming units[21493818];Fetal hemoglobin levels in sickle cell anemia[25372704];,0.7056441717791411,0.9480402269210934,0.860610806577917,0.9464395334561081
373,2165,BCO1,605748,115300;,"[MIM:115300]Hypercarotenemia and vitamin A deficiency, autosomal dominant [dominant?];",Hereditary hypercarotenemia and vitamin A deficiency,Disease-causing germline mutation(s) (loss of function) in,Carotenoid and tocopherol levels[19185284];Waist-to-hip ratio adjusted for BMI (age >50)[26426971];Waist-to-hip ratio adjusted for BMI x sex x age interaction (4df test)[26426971];,0.08736196319018405,0.20268179473955647,0.0,0.0
374,2167,BCOR,300485,300166;,,"Microphthalmia, Lenz type;Oculofaciocardiodental syndrome;Clear cell sarcoma of kidney",Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing somatic mutation(s) in,Pit-and-Fissure caries[23470693];Platelet count[29403010];,0.8300613496932515,0.8406395048994327,0.6217697729052467,0.8606507059545734
375,2170,BCR,151410,608232;,"[MIM:608232]Leukemia, chronic myeloid;",Distal 22q11.2 microdeletion syndrome;Chronic myeloid leukemia;Precursor B-cell acute lymphoblastic leukemia;Precursor T-cell acute lymphoblastic leukemia,Role in the phenotype of;Part of a fusion gene in;Part of a fusion gene in;Part of a fusion gene in,Immune response to smallpox vaccine (IL-6)[22542470];Height[18391951];Coenzyme Q10 levels[27149984];Asthma[27611488];,0.8812269938650307,0.8133058277462609,0.3372487601148525,0.7220687538367097
376,2180,BCS1L,603647,124000;262000;603358;,"[MIM:124000]Mitochondrial complex III deficiency, nuclear 1;[MIM:262000]Bjoernstad syndrome [recessive?];",Renal tubulopathy-encephalopathy-liver failure syndrome;Isolated complex III deficiency;Bj�rnstad syndrome;GRACILE syndrome,Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in,,0.8522699386503068,0.13563692625064466,0.34716784129470113,0.6883057090239411
377,2190,BDNF,113505,209880;,[MIM:209880]Congenital central hypoventilation syndrome;,WAGR syndrome;Ondine syndrome,Modifying germline mutation in;Candidate gene tested in,Obesity[23563607;21708048;23563607;23563607];Body mass index (joint analysis main effects and smoking interaction)[28443625;28443625;28443625];Diastolic blood pressure[28135244];Hand grip strength[29691431];Coffee consumption (cups per day)[25288136];BMI in smokers[28443625;28443625;28443625];Menarche (age at onset)[27182965];Blood protein levels[30072576;30072576];Coronary artery disease[29212778];Weight[19079260;19079260;19079260];Body mass index (joint analysis main effects and physical activity interaction)[28448500;28448500;28448500;28448500;28448500;28448500];Body mass index in physically inactive individuals[28448500;28448500;28448500;28448500];BMI in non-smokers[28443625;28443625;28443625];Diverticular disease[30177863];Body mass index[20935630;23563607;24861553;19079260;19079260;19079260;28448500;28448500;28448500;28448500;28448500;28448500;25673413;25673413;25673413;25673413;28892062;28892062];Waist circumference[25673412;25673412;25673412];Body mass index in physically active individuals[28448500;28448500;28448500;28448500;28448500];Hip circumference[25673412;25673412;25673412];Body mass index (adult)[28430825];Smoking behavior[20418890];Chloride levels[29403010];Childhood body mass index[26604143];BMI (adjusted for smoking behaviour)[28443625;28443625;28443625];Body mass index (SNP x SNP interaction)[22344221];,0.4226993865030675,0.8218153687467767,0.1519185591229444,0.635512584407612
378,2192,BDP1,607012,,,Autosomal recessive non-syndromic sensorineural deafness type DFNB,Disease-causing germline mutation(s) in,Coronary artery calcified atherosclerotic plaque score in type 2 diabetes[29221444];Obesity-related traits[23251661];,0.6208588957055214,0.31356369262506445,0.09501435656486557,0.07750153468385512
379,2194,BEAN1,612051,117210;,[MIM:117210]Spinocerebellar ataxia 31 [dominant?];,Spinocerebellar ataxia type 31,Disease-causing germline mutation(s) in,,0.038773006134969326,0.5691077875193399,0.6820673453406422,0.0
380,2210,BEST1,607854,153700;193220;611809;613194;,"[MIM:153700]Macular dystrophy, vitelliform, 2 [dominant?];[MIM:613194]Retinitis pigmentosa 50;[MIM:611809]Bestrophinopathy, autosomal recessive [recessive?];[MIM:193220]Vitreoretinochoroidopathy, autosomal dominant [dominant?];",Retinitis pigmentosa;Autosomal recessive bestrophinopathy;MRCS syndrome;Autosomal dominant vitreoretinochoroidopathy;Best vitelliform macular dystrophy;Adult-onset foveomacular vitelliform dystrophy,Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in,Plasma omega-3 polyunsaturated fatty acid levels (docosapentaenoic acid)[21829377];Plasma omega-6 polyunsaturated fatty acid levels (arachidonic acid)[24823311;24823311];Plasma omega-6 polyunsaturated fatty acid levels (linoleic acid)[24823311;24823311];Plasma omega-6 polyunsaturated fatty acid levels (gamma-linolenic acid)[24823311];Plasma omega-6 polyunsaturated fatty acid levels (adrenic acid)[24823311];Red blood cell fatty acid levels[25500335];Plasma omega-6 polyunsaturated fatty acid levels (dihomo-gamma-linolenic acid)[24823311];Estradiol levels[22675492];Plasma omega-3 polyunsaturated fatty acid level (eicosapentaenoic acid)[21829377];,0.08736196319018405,0.48246518824136153,0.29470112242234403,0.9683855125844076
381,2223,BFSP1,603307,611391;,,Early-onset nuclear cataract,Disease-causing germline mutation(s) in,,0.2585276073619632,0.19571944301186178,0.38266771078047507,0.4685389809699202
382,2224,BFSP2,603212,611597;,,Early-onset lamellar cataract;Pulverulent cataract;Early-onset sutural cataract,Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in,,0.4493251533742331,0.1740587931923672,0.46489167319237795,0.6284530386740331
383,2228,BGN,301870,300106;300989;,"[MIM:300989]Meester-Loeys syndrome;[MIM:300106]Spondyloepimetaphyseal dysplasia, X-linked;",X-linked spondyloepimetaphyseal dysplasia,Disease-causing germline mutation(s) in,,0.39631901840490796,0.5703971119133574,0.7136517880448969,0.8589625537139349
384,2229,BHLHA9,615416,607539;609432;612576;,"[MIM:612576]Split-hand/foot malformation with long bone deficiency 3;[MIM:609432]Syndactyly, mesoaxial synostotic, with phalangeal reduction [recessive?];[MIM:607539]Camptosynpolydactyly, complex [recessive?];",Mesoaxial synostotic syndactyly with phalangeal reduction;Tibial aplasia-ectrodactyly syndrome,Disease-causing germline mutation(s) in;Major susceptibility factor in,,0.038773006134969326,0.6446621970087674,0.9130775254502741,0.0
385,2241,BICC1,614295,601331;,"[MIM:601331]Renal dysplasia, cystic;",Autosomal dominant polycystic kidney disease,Candidate gene tested in,Glaucoma[30054594];Spherical equivalent or myopia (age of diagnosis)[29808027];Myopia[27182965];LDL cholesterol change in response to fenofibrate in statin-treated type 2 diabetes[28736931];Night sleep phenotypes[27126917];Spherical equivalent (joint analysis main effects and education interaction)[27020472;27020472];Blood urea nitrogen levels[29403010];Total cholesterol change in response to fenofibrate in statin-treated type 2 diabetes[28736931];Midgestational circulating levels of PCBs[28235828];Glaucoma (primary open-angle)[29891935];Manganese levels[26025379];Serum uric acid levels[29403010];Refractive error[23396134];Pursuit maintenance gain[29064472];Hemoglobin[29403010];Obesity-related traits[23251661];,0.4226993865030675,0.8354822073233625,0.4025058731401723,0.39610190300798037
386,2244,BICD2,609797,615290;,"[MIM:615290]Spinal muscular atrophy, lower extremity-predominant 2, autosomal dominant [dominant?];",BICD2-related autosomal dominant childhood-onset proximal spinal muscular atrophy,Disease-causing germline mutation(s) in,Visceral adipose tissue/subcutaneous adipose tissue ratio[22589738];,0.7647852760736197,0.8014440433212996,0.7073871051944662,0.3867403314917127
387,2252,BIN1,601248,255200;,"[MIM:255200]Myopathy, centronuclear, 2;",Autosomal recessive centronuclear myopathy;Autosomal dominant centronuclear myopathy,Disease-causing germline mutation(s) (loss of function) in;Disease-causing germline mutation(s) (loss of function) in,Pelvic organ prolapse (moderate/severe)[26545240;26545240];Neurofibrillary tangles[25188341];Alzheimer's disease in APOE e4+ carriers[25778476];Neuritic plaques or neurofibrillary tangles (pleiotropy)[29458411];Alzheimer's disease (late onset)[21390209;21390209;21460841;24162737;28714976];Systemic lupus erythematosus[24871463];Alzheimer's disease in APOE e4- carriers[25778476];Psychosis and Alzheimer's disease[22005930];Creatine kinase levels[29403010];Dementia and core Alzheimer's disease neuropathologic changes[25188341];Blood protein levels[30072576];Alzheimer's disease[21460840;21627779;22832961];,0.7847852760736196,0.9473955647240846,0.45366744975202294,0.3000306936771025
388,2259,BIRC3,601721,,,MALT lymphoma,Part of a fusion gene in,Whole-brain volume (Alzheimer's disease interaction)[21116278];Prostate cancer[23535732];,0.6528834355828221,0.5332645693656524,0.6956408248499086,0.35082872928176795
389,2273,BLK,191305,613375;,[MIM:613375]Maturity-onset diabetes of the young 11 [dominant?];,Systemic lupus erythematosus;MODY,Major susceptibility factor in;Disease-causing germline mutation(s) in,Systolic blood pressure[28135244;27618452;28739976];Diastolic blood pressure (cigarette smoking interaction)[29455858;29455858];Diastolic blood pressure[27618452];Systemic lupus erythematosus or rheumatoid arthritis[27193031];Albumin-globulin ratio[29403010];Systolic blood pressure x smoking status (current vs non-current) interaction (2df test)[29455858;29455858];Systolic blood pressure (cigarette smoking interaction)[29455858;29455858];Immune response to smallpox vaccine (IL-6)[22610502];Rheumatoid arthritis (ACPA-positive)[24532676];Polymyositis[26362759];Systemic lupus erythematosus[18204098;19165918;21408207;19838193;23053960;23273568;27399966;27399966;26502338;26316170;26502338;28714469;28714469;28714469;28714469;19838195;26663301];Kawasaki disease[22446962;22446961];Barrett's esophagus  or Esophageal adenocarcinoma[27527254];Sjögren's syndrome[24097067];Rheumatoid arthritis[19503088;24390342;24390342;24390342;21452313;23143596];Systemic sclerosis[29293537];Barrett's esophagus[27527254];Systolic blood pressure x smoking status (ever vs never) interaction (2df test)[29455858;29455858];Systemic lupus erythematosus and Systemic sclerosis[23740937];Periodontitis (CDC/AAP)[24024966;24024966];Non-albumin protein levels[29403010];,0.5284662576687117,0.07194430118617844,0.5437222657269642,0.440914671577655
390,2274,BLM,604610,210900;,[MIM:210900]Bloom syndrome [recessive?];,Bloom syndrome,Disease-causing germline mutation(s) in,Daytime sleep phenotypes[27126917];,0.8184049079754602,0.07555440948942754,0.2743409031584443,0.039287906691221605
391,2275,BLMH,602403,,,Resistance to bleomycine in the treatment of testicular cancer,Biomarker tested in,,0.7998773006134969,0.6645177926766375,0.17906551814147742,0.202731737262124
392,2276,BLNK,604515,613502;,"[MIM:613502]Agammaglobulinemia 4, autosomal recessive [recessive?];",Autosomal agammaglobulinemia,Disease-causing germline mutation(s) in,,0.4710429447852761,0.7823620422898401,0.6742364917776038,0.8710865561694291
393,2280,BLOC1S3,609762,614077;,[MIM:614077]Hermansky-Pudlak syndrome 8 [recessive?];,Hermansky-Pudlak syndrome type 8,Disease-causing germline mutation(s) in,Body mass index x age interaction[26426971];Body mass index[26426971];Body mass index x sex x age interaction (4df test)[26426971];Body mass index (age>50)[26426971];Quantitative traits[19197348;19197348];,0.4795092024539877,0.6531717380092832,0.7011224223440355,0.0
394,2284,BLOC1S6,604310,614171;,[MIM:614171]Hermansky-Pudlak syndrome 9 [recessive?];,Hermansky-Pudlak syndrome type 9,Disease-causing germline mutation(s) in,,0.52920245398773,0.23491490458999484,0.97755155311929,0.0
395,2285,BLVRA,109750,614156;,,Hyperbiliverdinemia,Disease-causing germline mutation(s) in,,0.7874846625766871,0.4922640536358948,0.6692769511876795,0.2589011663597299
396,2298,BMP1,112264,614856;,[MIM:614856]Osteogenesis imperfecta 13 [recessive?];,Osteogenesis imperfecta type 3;High bone mass osteogenesis imperfecta,Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in,Hypertriglyceridemia[23505323];Coronary artery disease[29212778;29212778;29212778];,0.45153374233128835,0.18256833419288293,0.31688854085095275,0.22682627378759976
397,2299,BMP2,112261,112600;617877;,"[MIM:617877]Short stature, facial dysmorphism, and skeletal anomalies with or without cardiac anomalies [dominant?];",20p12.3 microdeletion syndrome;Brachydactyly type A2,Role in the phenotype of;Disease-causing germline mutation(s) in,Waist circumference adjusted for BMI (joint analysis main effects and physical activity interaction)[28448500;28448500;28448500];Spherical equivalent or myopia (age of diagnosis)[29808027];QRS complex (Cornell)[27659466];Colorectal cancer[24737748;23266556;26151821;29471430;25990418;25990418];Waist circumference adjusted for BMI (adjusted for smoking behaviour)[28443625;28443625];Lung function (FVC)[28166213];Childhood ear infection[27182965];Body mass index[19079261;23669352;25673413;25673413;28892062];Hip circumference adjusted for BMI[25673412];Copper levels[26025379];Waist circumference adjusted for BMI (joint analysis main effects and smoking interaction)[28443625;28443625];Refractive error[23396134];Height[23563607;20881960;18391951;25429064;25282103;25282103];Obesity-related traits[23251661];Waist circumference adjusted for BMI in active individuals[28448500;28448500;28448500];Waist-to-hip ratio adjusted for body mass index[28448500;28448500;25673412;25673412;25673412;25673412;25673412;25673412];Sagittal craniosynostosis[23160099];Optic cup area[25631615;25631615;28073927;28073927];Waist-to-hip ratio adjusted for BMI (adjusted for smoking behaviour)[28443625];Waist circumference adjusted for BMI in non-smokers[28443625];Atrial fibrillation[29892015;29892015];Waist-to-hip ratio adjusted for BMI (joint analysis for main effect and physical activity interaction)[28448500;28448500];Heel bone mineral density[28869591;28869591];Vertical cup-disc ratio[25241763;28073927;28073927];Waist circumference adjusted for body mass index[28448500;28448500;28448500;25673412;25673412;25673412];Major depressive disorder (stressful life events interaction)[26845276];Axial length[24144296];Nose morphology (partial least square model)[30174134];,0.4117791411042945,0.9275399690562145,0.6925084834246933,0.0
398,2303,BMP4,112262,600625;607932;,[MIM:600625]Non-syndromic orofacial cleft 11;,"Cleft lip/palate;Microphthalmia with brain and digit anomalies;Renal agenesis, unilateral",Major susceptibility factor in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in,Monobrow thickness[26926045];Immune reponse to smallpox (secreted IFN-alpha)[22610502];Spherical equivalent or myopia (age of diagnosis)[29808027];Parkinson's disease[19915575];Optic cup area[25631615;25631615];Colorectal cancer[19011631;25990418;26151821];Myopia[27182965];Heel bone mineral density[28869591;28869591;28869591;28869591;28869591;28869591];Primary tooth development (time to first tooth eruption)[23704328];Dental caries[23259602;23259602];Chin dimples[27182965];Waist-to-hip ratio adjusted for body mass index[27195708];Glomerular filtration rate (creatinine)[26831199];,0.3706748466257669,0.0,0.09788566953797964,0.6069674647022714
399,2305,BMP6,112266,,,Hemochromatosis type 5,Disease-causing germline mutation(s) in,Small cell lung carcinoma[28604730];Lung function (forced vital capacity)[24929828];Hip circumference adjusted for BMI[25673412;25673412];Myopia (pathological)[23049088];Height[23563607;20881960;18391951;25429064;25282103];Blood protein levels[30072576];Orofacial clefts[22419666];,0.26588957055214724,0.814853017019082,0.15974941268598278,0.8428483732351135
400,2312,BMP15,300247,300510;,[MIM:300510]Ovarian dysgenesis 2;[MIM:300510]Premature ovarian failure 4;,"46,XX gonadal dysgenesis",Disease-causing germline mutation(s) in,,0.17791411042944785,0.2849406910778752,0.206734534064213,0.63182934315531
401,2313,BMPER,608699,608022;,,Diaphanospondylodysostosis;Ischiovertebral syndrome,Disease-causing germline mutation(s) (loss of function) in;Disease-causing germline mutation(s) in,CSF tryptophan concentration in tuberculous meningitis[29395996];Estrone/androstenedione ratio in resected early stage-receptor positive breast cancer[28429243];Corneal astigmatism[29422769];Alzheimer's disease[24770881];Post bronchodilator FEV1[26634245];Asthma[29273806];,0.10711656441717791,0.5479628674574523,0.4286087183503002,0.2705647636586863
402,2314,BMPR1A,601299,174900;610069;612242;,"[MIM:610069]Polyposis syndrome, mixed hereditary 2;",Hereditary mixed polyposis syndrome;Generalized juvenile polyposis/juvenile polyposis coli;Familial colorectal cancer Type X;Juvenile polyposis of infancy,Disease-causing germline mutation(s) (loss of function) in;Disease-causing germline mutation(s) in;Candidate gene tested in;Role in the phenotype of,,0.5180368098159509,0.8393501805054152,0.08457321848081441,0.6995089011663598
403,2317,BMPR1B,603248,112600;609441;616849;,"[MIM:609441]Acromesomelic dysplasia, Demirhan type [recessive?];[MIM:112600]Brachydactyly A2;[MIM:616849]Brachydactyly A1, D [dominant?];","Acromesomelic dysplasia, Grebe type;Fibular aplasia-complex brachydactyly syndrome;Brachydactyly type A1;Brachydactyly type C;Brachydactyly type A2",Disease-causing germline mutation(s) (loss of function) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) (loss of function) in;Candidate gene tested in;Disease-causing germline mutation(s) in,Diverticular disease[30177863];Hen's egg allergy[29051540];Attention deficit hyperactivity disorder[20732626];Amyotrophic lateral sclerosis (sporadic)[24529757];Coronary artery disease[29212778];,0.5160736196319018,0.9667354306343476,0.6557034716784129,0.7886740331491713
404,2319,BMPR2,600799,178600;265450;,"[MIM:265450]Pulmonary venoocclusive disease 1, autosomal dominant [dominant?];",Heritable pulmonary arterial hypertension;Drug- or toxin-induced pulmonary arterial hypertension;Pulmonary venoocclusive disease,Disease-causing germline mutation(s) (loss of function) in;Major susceptibility factor in;Candidate gene tested in,Intelligence (MTAG)[29326435];Urate levels[23263486];,0.5244171779141105,0.9802733367715317,0.6118506917253981,0.8812154696132597
405,2320,BMS1,611448,107600;,"[MIM:107600]Aplasia cutis congenita, non-syndromic;",Aplasia cutis congenita,Disease-causing germline mutation(s) in,Progressive supranuclear palsy[21685912];,0.8260122699386503,0.3372872614749871,0.15426781519185592,0.2513812154696133
406,2408,BOLA3,613183,614299;,,Multiple mitochondrial dysfunctions syndrome type 2,Disease-causing germline mutation(s) in,Gestational age at birth (maternal effect)[28877031];,0.3168098159509202,0.5938628158844765,0.8827982250065257,0.5713627992633518
407,2424,BPGM,613896,222800;,[MIM:222800]Bisphosphoglycerate mutase deficiency;,Hemolytic anemia due to diphosphoglycerate mutase deficiency,Disease-causing germline mutation(s) in,Blood protein levels[30072576];,0.3168098159509202,0.7315626611655492,0.8243278517358392,0.3000306936771025
408,2446,BRAF,164757,114500;115150;211980;605027;613706;613707;,[MIM:114500]Colorectal cancer;[MIM:211980]Lung cancer;[MIM:605027]Familial non-Hodgkin lymphoma;[MIM:115150]Cardiofaciocutaneous syndrome 1;[MIM:613706]Noonan syndrome 7;[MIM:613707]LEOPARD syndrome 3;,Noonan syndrome;Differentiated thyroid carcinoma;Noonan syndrome with multiple lentigines;Cardiofaciocutaneous syndrome;Pilomyxoid astrocytoma;Pilomyxoid astrocytoma;Selection of therapeutic option in non-small cell lung carcinoma;Selection of therapeutic option in colorectal cancer;Classic hairy cell leukemia;Craniopharyngioma;Hashimoto-Pritzker syndrome,Disease-causing germline mutation(s) in;Disease-causing somatic mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) (gain of function) in;Disease-causing somatic mutation(s) in;Part of a fusion gene in;Biomarker tested in;Biomarker tested in;Disease-causing somatic mutation(s) in;Disease-causing somatic mutation(s) in;Disease-causing somatic mutation(s) in,Mild influenza (H1N1) infection[26379185];Type 2 diabetes[28869590;28869590];Cerebrospinal T-tau levels[26252872];Cerebrospinal fluid t-tau:AB1-42 ratio[26252872];Response to Vitamin E supplementation[22437554];,0.5160736196319018,0.9339865910263022,0.7233098407726443,0.9412216083486802
409,2449,BRAT1,614506,614498;,"[MIM:614498]Rigidity and multifocal seizure syndrome, lethal neonatal;",Lethal neonatal spasticity-epileptic encephalopathy syndrome,Disease-causing germline mutation(s) in,Obesity-related traits[23251661];,0.49828220858895705,0.09205776173285199,0.17749934742886975,0.0
410,2450,BRCA1,113705,114480;167000;604370;614320;617883;,"[MIM:114480]Breast cancer;[MIM:604370]Breast-ovarian cancer, familial, 1;[MIM:167000]Ovarian cancer;[MIM:614320]Pancreatic cancer 4;[MIM:617883]Fanconi anemia, complementation group S;",Primary peritoneal carcinoma;Fanconi anemia;Familial prostate cancer;Hereditary site-specific ovarian cancer syndrome;Hereditary breast and ovarian cancer syndrome;Hereditary breast cancer;Familial pancreatic carcinoma,Major susceptibility factor in;Disease-causing germline mutation(s) (loss of function) in;Major susceptibility factor in;Major susceptibility factor in;Disease-causing germline mutation(s) (loss of function) in;Major susceptibility factor in;Major susceptibility factor in,Menopause (age at onset)[26414677;29773799];,0.947239263803681,0.39762764311500776,0.07439310884886452,0.9929404542664211
411,2452,BRCA2,600185,114480;605724;612555;613029;613347;,"[MIM:114480]Breast cancer;[MIM:613347]Pancreatic cancer 2;[MIM:612555]Breast-ovarian cancer, familial, 2;[MIM:605724]Fanconi anemia complementation group D1;[MIM:613029]Glioma 3;",Fanconi anemia;Nephroblastoma;Familial prostate cancer;Hereditary site-specific ovarian cancer syndrome;Hereditary breast and ovarian cancer syndrome;Hereditary breast cancer;Familial pancreatic carcinoma;Inherited cancer-predisposing syndrome due to biallelic BRCA2 mutations,Disease-causing germline mutation(s) in;Candidate gene tested in;Major susceptibility factor in;Major susceptibility factor in;Disease-causing germline mutation(s) (loss of function) in;Major susceptibility factor in;Major susceptibility factor in;Disease-causing germline mutation(s) in,Small cell lung carcinoma[28604730];Lung cancer in ever smokers[28604730];Lung cancer[24880342;24880342;28604730];Squamous cell lung carcinoma[28604730];Cancer (pleiotropy)[27197191];Breast cancer[23535733;23535729;29059683];LDL cholesterol levels[28334899;28334899;28334899];LDL cholesterol[24097068];Cancer[27197191];,0.8112883435582822,0.018308406395048993,0.30174889062907856,0.8104665438919583
412,2454,BRCC3,300617,,,Moyamoya angiopathy-short stature-facial dysmorphism-hypergonadotropic hypogonadism syndrome,Role in the phenotype of,,0.6419631901840491,0.4595152140278494,0.9423127120856173,0.34085328422344996
413,2460,BRD4,608749,,,NUT midline carcinoma,Part of a fusion gene in,,0.5631901840490797,0.7962867457452295,0.5345862699034195,0.4766728054020872
414,2475,BRF1,604902,616202;,[MIM:616202]Cerebellofaciodental syndrome [recessive?];,Cerebellar-facial-dental syndrome,Disease-causing germline mutation(s) (loss of function) in,Mean platelet volume[22139419;27863252];Platelet distribution width[27863252];Platelet count[27863252;29403010];Huntington's disease progression[28642124];,0.554601226993865,0.6738009283135636,0.7261811537457583,0.8964088397790055
415,2487,BRIP1,605882,114480;609054;,[MIM:114480]Breast cancer;[MIM:609054]Fanconi anemia complementation group J;,Fanconi anemia;Hereditary breast and ovarian cancer syndrome,Disease-causing germline mutation(s) in;Candidate gene tested in,Ovarian cancer[21964575];,0.6180368098159509,0.8428313563692625,0.5614722004698512,0.2539901780233272
416,2508,BSCL2,606158,269700;270685;600794;615924;,"[MIM:270685]Spastic paraplegia 17, autosomal dominant [dominant?];[MIM:600794]Neuronopathy, distal hereditary motor, 5A;[MIM:615924]Encephalopathy, progressive, with or without lipodystrophy;",Berardinelli-Seip congenital lipodystrophy;Distal hereditary motor neuropathy type 5;Severe neurodegenerative syndrome with lipodystrophy;Autosomal dominant spastic paraplegia type 17,Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in,Response to anti-retroviral therapy (ddI/d4T) in HIV-1 infection (Grade 3 peripheral neuropathy)[24554482];Waist-to-hip ratio adjusted for BMI[26426971;26426971];Waist-to-hip ratio adjusted for BMI x sex x age interaction (4df test)[26426971;26426971];,0.40773006134969325,0.5489943269726664,0.6212477160010441,0.8422344996930632
417,2514,BSND,606412,602522;,"[MIM:602522]Bartter syndrome 4A, neonatal, with sensorineural deafness [recessive?];",Infantile Bartter syndrome with sensorineural deafness;Autosomal recessive non-syndromic sensorineural deafness type DFNB,Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in,Allergic rhinitis[25085501];,0.17791411042944785,0.10159876224858175,0.7974419211694075,0.5174953959484346
418,2545,BTD,609019,253260;,[MIM:253260]Biotinidase deficiency [recessive?];,Biotinidase deficiency,Disease-causing germline mutation(s) in,Diverticular disease[30177863];Blood protein levels[30072576];Moderate or severe diarrhoea in darapladib-treated cardiovascular disease (time to event)[28753643];Inflammatory skin disease[25574825];,0.514478527607362,0.16632284682826198,0.46019316105455493,0.7498465316144874
419,2562,BTF3P11,602543,239000;,"[MIM:239000]Paget disease of bone 5, juvenile-onset [recessive?];",Juvenile Paget disease,Disease-causing germline mutation(s) in,Tourette's syndrome or obsessive-compulsive disorder[25158072];,0.038773006134969326,0.6169417225373904,0.0,0.0
420,2576,BTK,300300,300755;307200;,[MIM:300755]X-linked agammaglobulinemia;[MIM:307200]X-linked hypogammaglobulinemia and isolated growth hormone deficiency;,X-linked agammaglobulinemia;Short stature due to isolated growth hormone deficiency with X-linked hypogammaglobulinemia,Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in,,0.6120245398773007,0.9659618359979371,0.9282171756721482,0.0
421,2586,BTNL2,606000,612387;,[MIM:612387]Sarcoidosis 2;,Sarcoidosis,Major susceptibility factor in,Adult asthma[27611488];Knee osteoarthritis[20305777];Waist-to-hip ratio adjusted for BMI in active individuals[28448500;28448500;28448500;28448500;28448500;28448500;28448500];Lung cancer[28604730];EGFR mutation-positive lung adenocarcinoma[27501781];Marginal zone lymphoma[25569183];HIV-1 viral setpoint[26039976];Lung adenocarcinoma[22797724];Idiopathic membranous nephropathy[21323541];Childhood steroid-sensitive nephrotic syndrome[29903748];Vitiligo[21326295;20410501];Anti-cyclic Citrullinated Peptide Antibody[19287509];Sarcoidosis (non-Lofgren's syndrome without extrapulmonary manifestations)[26651848];Hepatitis C induced liver cirrhosis[23321320];Hemoglobin[29403010];Waist-to-hip ratio adjusted for body mass index[28448500;28448500;28448500;25673412;25673412;25673412;25673412;25673412;25673412];HIV-1 control[20041166];Waist-to-hip ratio adjusted for BMI (adjusted for smoking behaviour)[28443625;28443625];Response to hepatitis B vaccine[29534301];Sarcoidosis[22936702];Autism spectrum disorder or schizophrenia[28540026;28540026;28540026;28540026;28540026;28540026;28540026;28540026;28540026;28540026;28540026;28540026;28540026;28540026;28540026;28540026;28540026];Lung cancer in ever smokers[28604730];Food antigen IgG levels[24962563];Waist-to-hip ratio adjusted for BMI (joint analysis for main effect and physical activity interaction)[28448500;28448500];Serum alkaline phosphatase levels[29403010];Waist-to-hip ratio adjusted for BMI in non-smokers[28443625];Hand grip strength[29691431];Crohn's disease[23850713;23850713];Blood protein levels[28240269];Waist-hip ratio[20935629];Coronary heart disease[22751097];Asthma[21804548;23028483;27611488;27611488;29273806];Type 1 diabetes and autoimmune thyroid diseases[25936594];Inflammatory bowel disease[28067908];Rosacea symptom severity[29771307];Tuberculosis[29036319];Multiple sclerosis (OCB status)[23472185;23472185];Sjögren's syndrome[24097066];Waist-to-hip ratio adjusted for BMI (joint analysis main effects and smoking interaction)[28443625];Primary biliary cholangitis[19458352;19458352];Fibrinogen levels[28107422];Takayasu arteritis[25604533;25604533];Frontotemporal dementia[24943344];Prostate cancer[23535732];Loneliness (multivariate analysis)[27629369];Ulcerative colitis[18836448;19122664;21297633;19915573;20228799;28067908];Hepatitis B vaccine response[24282030];,0.038773006134969326,0.6358947911294481,0.006786739754633255,0.0
422,2591,BTRC,603482,,,Isolated split hand-split foot malformation,Candidate gene tested in,Red blood cell count[29403010];,0.8346012269938651,0.48298091799896853,0.4941268598277212,0.3218232044198895
423,2594,BUB1,602452,,,Mosaic variegated aneuploidy syndrome,Disease-causing germline mutation(s) in,,0.7020858895705522,0.1518824136152656,0.7180892717306187,0.13182934315531
424,2595,BUB1B,602860,176430;257300;,[MIM:176430]Premature chromatid separation trait [dominant?];[MIM:257300]Mosaic variegated aneuploidy syndrome 1;,Mosaic variegated aneuploidy syndrome,Disease-causing germline mutation(s) in,Chronic lymphocytic leukemia[24292274;28165464];,0.747239263803681,0.12300154718927282,0.2850430696945967,0.10604665438919583
425,2598,BUB3,603719,,,Mosaic variegated aneuploidy syndrome,Disease-causing germline mutation(s) in,Body mass index[28892062;28892062];Menopause (age at onset)[24045676];Right lateral prefrontal cortical growth[29682794];,0.9261349693251534,0.7300154718927282,0.9543200208822762,0.5701350521792511
426,2606,BVES,604577,616812;,,Autosomal recessive limb-girdle muscular dystrophy type 2X,Disease-causing germline mutation(s) in,QT interval[29213071];Creatine kinase levels[29403010];Height[18391951];Menarche (age at onset)[19448622];,0.10711656441717791,0.22795255286230015,0.49360480292351866,0.04251074278698588
427,2614,C1D,606997,,,Keratosis follicularis spinulosa decalvans;Atrophoderma vermiculata,Disease-causing germline mutation(s) (loss of function) in;Disease-causing germline mutation(s) (loss of function) in,Restless legs syndrome[29029846];Obstetric antiphospholipid syndrome[28424481];Male-pattern baldness[27182965];Systolic blood pressure response to hydrochlorothiazide in hypertension[27802415];Familial lung adenocarcinoma[29924316];,0.554601226993865,0.5012893243940175,0.3004437483685722,0.043738489871086556
428,2672,C1QA,120550,613652;,[MIM:613652]Complement component C1q deficiency;,Immunodeficiency due to a classical component pathway complement deficiency;Autosomal systemic lupus erythematosus,Disease-causing germline mutation(s) in;Major susceptibility factor in,,0.5519018404907975,0.4597730789066529,0.9483163664839468,0.4562615101289134
429,2673,C1QB,120570,613652;,[MIM:613652]Complement component C1q deficiency;,Immunodeficiency due to a classical component pathway complement deficiency,Disease-causing germline mutation(s) in,,0.427239263803681,0.6181021144920061,0.8619159488384234,0.6368937998772253
430,2678,C1QC,120575,613652;,[MIM:613652]Complement component C1q deficiency;,Immunodeficiency due to a classical component pathway complement deficiency,Disease-causing germline mutation(s) in,Blood protein levels[29875488;30072576];,0.5948466257668712,0.6152656008251676,0.8433829287392326,0.6127992633517495
431,2690,C1QTNF5,608752,605670;,[MIM:605670]Late-onset retinal degeneration;,Late-onset retinal degeneration,Disease-causing germline mutation(s) in,Blood protein levels[29875488;30072576];Lifespan[25918517];,0.038773006134969326,0.8357400722021661,0.8880187940485513,0.0
432,2698,C1R,613785,130080;216950;,"[MIM:130080]Ehlers-Danlos syndrome, periodontal type, 1 [dominant?];","Immunodeficiency due to a classical component pathway complement deficiency;Ehlers-Danlos syndrome, periodontitis type;Pediatric systemic lupus erythematosus",Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) (gain of function) in;Disease-causing germline mutation(s) (loss of function) in,Blood protein levels[30072576;30072576;30072576;30072576;30072576;30072576;30072576;30072576];,0.30319018404907977,0.6523981433728726,0.19133385539023753,0.0
433,2701,C1S,120580,613783;617174;,"[MIM:613783]Complement component C1s deficiency;[MIM:617174]Ehlers-Danlos syndrome, periodontal type, 2 [dominant?];","Immunodeficiency due to a classical component pathway complement deficiency;Ehlers-Danlos syndrome, periodontitis type",Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) (gain of function) in,Activated partial thromboplastin time[29403010];Lung cancer in never smokers[28604730];Red blood cell fatty acid levels[25500335;25500335];Blood protein levels[28240269;28240269;29875488;29875488;29875488;29875488;29875488;29875488];Red cell distribution width[27863252];Coronary artery disease[29212778;29212778];,0.30319018404907977,0.42367199587416193,0.23962411902897415,0.6642111724984653
434,2702,C2,613927,217000;603075;,[MIM:217000]Complement component 2 deficiency;,Immunodeficiency due to a classical component pathway complement deficiency,Disease-causing germline mutation(s) in,"Advanced age-related macular degeneration[26691988;26691988;26691988;26691988];Sulfasalazine-induced agranulocytosis[28762467];Autism spectrum disorder or schizophrenia[28540026;28540026;28540026;28540026;28540026;28540026;28540026;28540026;28540026;28540026;28540026;28540026;28540026;28540026;28540026;28540026;28540026];Hepatocellular carcinoma[21105107];Endometriosis[28881265];Blood protein levels[28240269;28240269;28240269;28240269;28240269;29875488;30072576;30072576;30072576;30072576;30072576;30072576;30072576];Age-related macular degeneration (geographic atrophy)[22705344];Disease progression in age-related macular degeneration[29346644];Coronary artery disease[29212778;29212778;29212778];Inflammatory bowel disease[28067908];Systemic lupus erythematosus[24871463];Itch intensity from mosquito bite adjusted by bite size[28199695;28199695];Age-related macular degeneration[21665990;20385826;20385819;20385819;23455636];Mosquito bite size[28199695];Circulating myeloperoxidase levels (serum)[23620142];Prostate cancer[23535732];Age-related macular degeneration (choroidal neovascularisation)[22705344];Coronary artery disease (myocardial infarction, percutaneous transluminal coronary angioplasty, coronary artery bypass grafting, angina or chromic ischemic heart disease)[28714975];Ulcerative colitis[28067908];",0.22687116564417178,0.07735946364105209,0.5217958757504568,0.580877839165132
435,2706,C2CD3,615944,615948;,[MIM:615948]Orofaciodigital syndrome 14;,Orofaciodigital syndrome type 14,Disease-causing germline mutation(s) in,,0.8755828220858896,0.29886539453326455,0.01905507700339337,0.3580417434008594
436,2746,C3,120700,611378;612925;613779;,"[MIM:613779]Complement component 3 deficiency;[MIM:611378]Macular degeneration, age-related, 9;[MIM:612925]Hemolytic uremic syndrome atypical 5;",Complement component 3 deficiency;Atypical hemolytic-uremic syndrome with C3 anomaly,Disease-causing germline mutation(s) (loss of function) in;Disease-causing germline mutation(s) in,Advanced age-related macular degeneration[26691988;26691988;26691988];Age-related macular degeneration[20861866;21665990;20385826;20385819;23455636];Triglycerides[24097068];Monocyte count[27863252];Blood protein levels[29875488;30072576;30072576;30072576];Age-related macular degeneration (geographic atrophy)[22705344];Disease progression in age-related macular degeneration[29346644];Age-related macular degeneration (choroidal neovascularisation)[22705344];Complement C3 and C4 levels[23028341];,0.5460122699386503,0.8140794223826715,0.3858000522056904,0.5059852670349908
437,2771,C4A,120810,120790;152700;614374;614380;,[MIM:614380]Complement component 4A deficiency;[MIM:152700]Systemic lupus erythematosus;,Systemic lupus erythematosus;Immunodeficiency due to a classical component pathway complement deficiency;Beh�et disease;Autosomal systemic lupus erythematosus,Major susceptibility factor in;Disease-causing germline mutation(s) in;Major susceptibility factor in;Major susceptibility factor in,Inflammatory bowel disease[28067908];Autism spectrum disorder or schizophrenia[28540026;28540026;28540026;28540026;28540026;28540026;28540026;28540026;28540026;28540026;28540026;28540026;28540026;28540026;28540026];Neuromyelitis optica[29769526;29769526];Blood protein levels[28240269;28240269;28240269;28240269;29875488;29875488;29875488];Prostate cancer[23535732];Ulcerative colitis[28067908];,0.3492024539877301,0.13512119649303764,0.7695118767945706,0.0
438,2773,C4B,120820,152700;614374;614379;,[MIM:152700]Systemic lupus erythematosus;[MIM:614379]Complement component 4B deficiency;,Systemic lupus erythematosus;Immunodeficiency due to a classical component pathway complement deficiency,Major susceptibility factor in;Disease-causing germline mutation(s) in,Inflammatory bowel disease[28067908];Autism spectrum disorder or schizophrenia[28540026;28540026;28540026;28540026;28540026;28540026;28540026;28540026;28540026;28540026;28540026;28540026;28540026;28540026;28540026];Neuromyelitis optica[29769526;29769526];Blood protein levels[28240269;28240269;28240269;29875488];Prostate cancer[23535732];Ulcerative colitis[28067908];,0.30319018404907977,0.8041516245487365,0.8593056643174106,0.0
439,2793,C5,120900,609536;615749;,[MIM:609536]Complement component 5 deficiency;,Immunodeficiency due to a late component of complement deficiency,Disease-causing germline mutation(s) in,Hip circumference adjusted for BMI[25673412];Rheumatoid arthritis[19503088;24390342;24390342;20453842];Blood protein levels[30072576];Coronary artery disease[29212778];,0.427239263803681,0.018566271273852502,0.038893239363090575,0.061694290976058934
440,2819,C6,217050,612446;,[MIM:612446]Complement component 6 deficiency;,Immunodeficiency due to a late component of complement deficiency,Disease-causing germline mutation(s) in,Response to fenofibrate (adiponectin levels)[23149075];Blood protein levels[28240269];,0.4190184049079755,0.6415678184631253,0.29078569564082485,0.5664518109269491
441,2841,C7,217070,610102;,[MIM:610102]Complement component 7 deficiency;,Immunodeficiency due to a late component of complement deficiency,Disease-causing germline mutation(s) in,Clozapine-induced cytotoxicity[25656473];Blood protein levels[28240269;28240269;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;30072576;30072576;30072576;30072576;30072576;30072576;30072576;30072576;30072576;30072576;30072576;30072576;30072576;30072576;30072576;30072576;30072576;30072576;30072576;30072576;30072576;30072576;30072576;30072576];Post bronchodilator FEV1/FVC ratio in COPD[26634245];,0.3856441717791411,0.05673027333677153,0.07334899504045941,0.2846838551258441
442,2856,C8A,120950,613790;,"[MIM:613790]Complement component 8 deficiency, 1;",Immunodeficiency due to a late component of complement deficiency,Disease-causing germline mutation(s) in,Blood protein levels[28240269;28240269];,0.3706748466257669,0.05440948942753997,0.11041503523884104,0.5639963167587477
443,2857,C8B,120960,613789;,"[MIM:613789]Complement component 8 deficiency, 2;",Immunodeficiency due to a late component of complement deficiency,Disease-causing germline mutation(s) in,Blood protein levels[28240269;28240269;28240269;28240269;28240269;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488];,0.3749693251533742,0.04306343476018566,0.346123727486296,0.4165131982811541
444,2858,C8G,120930,,,Immunodeficiency due to a late component of complement deficiency,Disease-causing germline mutation(s) in,Blood protein levels[29875488;30072576;30072576;30072576;30072576;30072576];,0.3856441717791411,0.10546673543063435,0.2980944922996607,0.1359729895641498
445,2881,C9,120940,613825;615591;,"[MIM:613825]Complement component 9 deficiency;[MIM:615591]Macular degeneration, age-related, 15;",Immunodeficiency due to a late component of complement deficiency,Disease-causing germline mutation(s) in,Systemic lupus erythematosus[19838195];Advanced age-related macular degeneration[26691988];Chronic kidney disease[20383146];Blood protein levels[29875488;29875488;30072576;30072576];,0.36171779141104293,0.016503352243424446,0.4505351083268076,0.4685389809699202
446,3103,CA2,611492,259730;,"[MIM:259730]Osteopetrosis, autosomal recessive 3 [dominant?] [recessive?];",Osteopetrosis with renal tubular acidosis,Disease-causing germline mutation(s) in,Blood trace element (Zn levels)[23720494];,0.843680981595092,0.20087674058793192,0.5541634038110154,0.38919582565991406
447,3106,CA4,114760,600852;,,Retinitis pigmentosa,Disease-causing germline mutation(s) in,,0.47705521472392637,0.0,0.6460454189506656,0.3354818907305095
448,3107,CA5A,114761,615751;,[MIM:615751]Hyperammonemia due to carbonic anhydrase VA deficiency [recessive?];,Hyperammonemic encephalopathy due to carbonic anhydrase VA deficiency,Disease-causing germline mutation(s) in,White blood cell count (basophil)[27863252];Basophil percentage of white cells[27863252];Basophil percentage of granulocytes[27863252];,0.12711656441717792,0.2748839608045384,0.7264421821978596,0.3729281767955801
449,3113,CA8,114815,613227;,"[MIM:613227]Cerebellar ataxia, mental retardation, and dysequilibrium syndrome 3;",Dysequilibrium syndrome,Disease-causing germline mutation(s) in,Spherical equivalent or myopia (age of diagnosis)[29808027;29808027];Parkinson's disease[27182965];Myopia[27182965];Cardiac hypertrophy[21348951];Schizophrenia[25056061;28991256];Response to amphetamines[22952603];Obesity-related traits[23251661;23251661];Blood protein levels[30072576];,0.3889570552147239,0.515214027849407,0.6862438005742626,0.34714548802946593
450,3132,CABP2,607314,614899;,,Autosomal recessive non-syndromic sensorineural deafness type DFNB,Disease-causing germline mutation(s) in,,0.20368098159509201,0.40226921093347084,0.06525711302531977,0.4145181092694905
451,3133,CABP4,608965,610427;,"[MIM:610427]Cone-rod synaptic disorder, congenital non-progressive;",Congenital stationary night blindness,Disease-causing germline mutation(s) in,Mean corpuscular volume[27863252;27863252];,0.14576687116564419,0.20500257864878804,0.7468024014617594,0.08317986494782074
452,3142,CACNA1A,601011,108500;141500;183086;617106;,"[MIM:183086]Spinocerebellar ataxia 6 [dominant?];[MIM:141500]Migraine, familial hemiplegic, 1;[MIM:108500]Episodic ataxia 2 [dominant?];[MIM:617106]Epileptic encephalopathy, early infantile, 42 [dominant?];",Familial paroxysmal ataxia;Alternating hemiplegia of childhood;Familial or sporadic hemiplegic migraine;Undetermined early-onset epileptic encephalopathy;Benign paroxysmal torticollis of infancy;Spinocerebellar ataxia type 6,Disease-causing germline mutation(s) (loss of function) in;Candidate gene tested in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in,Exfoliation syndrome[25706626;25706626];Proteinuria and chronic kidney disease[26420894];,0.754478527607362,1.0,0.05690420255807883,0.0
453,3144,CACNA1C,114205,601005;611875;,[MIM:601005]Timothy syndrome;[MIM:611875]Brugada syndrome 3;,Brugada syndrome;Timothy syndrome,Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) (gain of function) in,"Acoustic startle blink response[25387708];Bipolar disorder or major depressive disorder[20351715];Autism spectrum disorder or schizophrenia[28540026;28540026];Schizophrenia or bipolar disorder[24280982;24280982;24280982];Hematocrit[27863252];Heel bone mineral density[28869591;28869591;28869591];Psychosis proneness (hypomanic personality scale and revised physical anhedonia scale)[28525603];Schizophrenia[21926974;23974872;22688191;25056061;28991256;28991256];Bipolar disorder[18711365;28072414];Red blood cell count[29403010;27863252];Fractional exhaled nitric oxide (childhood)[24315451];Response to olanzapine in schizophrenia[29503163];Aortic root size[28394258];Hemoglobin concentration[27863252];Sleep quality[23728906];Resting heart rate[27798624;29769521];Warfarin maintenance dose[18535201];Red blood cell traits[23222517];Exploratory eye movement dysfunction in schizophrenia (cognitive search score)[26242244];Autism spectrum disorder, attention deficit-hyperactivity disorder, bipolar disorder, major depressive disorder, and schizophrenia (combined)[23453885];Post bronchodilator FEV1/FVC ratio[26634245];Psychosis proneness (hypomanic personality scale)[28525603];",0.4538650306748466,0.425219185146983,0.47768206734534063,0.9978514426028238
454,3152,CACNA1D,114206,614896;615474;,"[MIM:614896]Sinoatrial node dysfunction and deafness;[MIM:615474]Primary aldosteronism, seizures, and neurologic abnormalities;",Sinoatrial node dysfunction and deafness;Primary hyperaldosteronism-seizures-neurological abnormalities syndrome,Disease-causing germline mutation(s) (loss of function) in;Disease-causing germline mutation(s) (gain of function) in,Systolic blood pressure[25249183;29403010];Hypertension[25249183];Spherical equivalent or myopia (age of diagnosis)[29808027];Diastolic blood pressure[25249183;29403010];Electrocardiographic traits[25055868];Blood protein levels[28240269];Mean arterial pressure[29403010];Insulin resistance/response[21901158;21901158];Body mass index[25673413;25673413];Resting heart rate[27798624];Insomnia[29520036];Refractive error[23396134];Visceral adipose tissue/subcutaneous adipose tissue ratio[26480920];Pursuit maintenance gain[29064472];Axial length[24144296];,0.22687116564417178,0.7068076328004126,0.31427825632993994,0.9852670349907919
455,3154,CACNA1F,300110,300071;300476;300600;,"[MIM:300071]Night blindness, congenital stationary, 2A;[MIM:300476]Cone-rod dystrophy, X-linked 3;[MIM:300600]Aaland island eye disease;",�land Islands eye disease;Congenital stationary night blindness;Cone rod dystrophy,Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in,,0.08736196319018405,0.6954615781330583,0.16940746541373009,0.8703192142418662
456,3155,CACNA1G,604065,616795;,[MIM:616795]Spinocerebellar ataxia 42 [dominant?];,Spinocerebellar ataxia type 42,Disease-causing germline mutation(s) in,Alzheimer's disease (cognitive decline)[23535033];,0.08736196319018405,0.8630737493553378,0.45627773427303575,0.9975445058317987
457,3157,CACNA1H,607904,611942;617027;,"[MIM:611942]Epilepsy, idiopathic generalized 6;[MIM:611942]Epilepsy, childhood absence 6;[MIM:617027]Hyperaldosteronism, familial, 4;",Childhood absence epilepsy,Disease-causing germline mutation(s) in,Blood protein levels[28240269];,0.28662576687116564,0.21273852501289325,0.08535630383711824,0.9828115408225906
458,3159,CACNA1S,114208,170400;188580;601887;,[MIM:170400]Periodic paralysis hypokalemic 1 [dominant?];[MIM:601887]Malignant hyperthermia 5;[MIM:188580]Thyrotoxic periodic paralysis 1;,Hypokalemic periodic paralysis;Malignant hyperthermia of anesthesia;Periodic paralysis with transient compartment-like syndrome;Thyrotoxic periodic paralysis,Disease-causing germline mutation(s) in;Major susceptibility factor in;Disease-causing germline mutation(s) in;Candidate gene tested in,Inflammatory bowel disease[28067908];Tooth agenesis[29364747];Glomerular filtration rate in non diabetics (creatinine)[26831199];Permanent tooth development[21931568];Crohn's disease[28067908];Ulcerative colitis[28067908;20228799];Glomerular filtration rate (creatinine)[28452372];,0.4667484662576687,0.07942238267148015,0.028191072826938137,0.9232658072437078
459,3160,CACNA2D1,114204,,,Brugada syndrome;Familial short QT syndrome,Major susceptibility factor in;Disease-causing germline mutation(s) (loss of function) in,Coronary artery calcified atherosclerotic plaque (90 or 130 HU threshold) in type 2 diabetes[29221444];Gestational age at birth (maternal effect)[28598419];Non-alcoholic fatty liver disease histology (lobular)[20708005];Metabolite levels (Dihydroxy docosatrienoic acid)[23934736];Major depressive disorder[29317602];Spontaneous preterm birth (maternal effect)[28598419];Glaucoma (primary open-angle)[29891935];Response to taxane treatment (docetaxel)[23006423];Major depressive disorder (stressful life events interaction)[26845276];Crohn's disease (need for surgery)[23665963];Obesity-related traits[23251661];Survival in head and neck cancer[27173062];Energy expenditure (24h)[28476931];Ulcerative colitis[20848476];,0.6246625766871166,0.7924187725631769,0.5920125293657008,0.5821055862492327
460,3164,CACNA2D4,608171,610478;,[MIM:610478]Retinal cone dystrophy 4;,Congenital stationary night blindness;Cone rod dystrophy,Candidate gene tested in;Disease-causing germline mutation(s) in,Urate levels in lean individuals[25811787];Blood pressure (smoking interaction)[25189868];,0.08736196319018405,0.008251676121712223,0.3223701383450796,0.202731737262124
461,3166,CACNB2,600003,611876;,[MIM:611876]Brugada syndrome 4;,Brugada syndrome,Disease-causing germline mutation(s) in,"Diastolic blood pressure (cigarette smoking interaction)[29455858];Metabolite levels (HVA/MHPG ratio)[23319000];Schizophrenia[23974872;25056061;28991256];Primary tooth development (time to first tooth eruption)[23704328];Diastolic blood pressure x alcohol consumption interaction (2df test)[29912962;29912962];Mean arterial pressure[27618448];Body mass index[28892062;28892062];Blood pressure[21909110];Systolic blood pressure x alcohol consumption interaction (2df test)[29912962;29912962];Obesity-related traits[23251661];Primary tooth development (number of teeth)[23704328];Protein quantitative trait loci[18464913];Mean arterial pressure x alcohol consumption interaction (2df test)[29912962];Systolic blood pressure[21909115;19430479;28135244;27618452;28739976];Hypertension[21909115;19430479];Cadmium levels[26025379];Autism spectrum disorder or schizophrenia[28540026];Diastolic blood pressure[21909115;19430479;27618452;28739976];Quantitative traits[19197348];Systolic blood pressure x alcohol consumption (light vs heavy) interaction (2df test)[29912962];Systolic blood pressure (cigarette smoking interaction)[29455858];Diverticular disease[30177863];Pulse pressure x alcohol consumption interaction (2df test)[29912962];Small vessel stroke[26732560];Autism spectrum disorder, attention deficit-hyperactivity disorder, bipolar disorder, major depressive disorder, and schizophrenia (combined)[23453885];Brain volume in infants (grey matter)[28763065];",0.20368098159509201,0.49896854048478595,0.30357608979378753,0.9628606507059546
462,3168,CACNB4,601949,607682;613855;,[MIM:607682]Juvenile myoclonic epilepsy 6;[MIM:613855]Episodic ataxia 5;,Juvenile myoclonic epilepsy;Episodic ataxia type 5,Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in,Response to cognitive-behavioural therapy in anxiety disorder[26989097];Adverse response to chemotherapy in breast cancer (alopecia)[24025145];Idiopathic dilated cardiomyopathy[29495422];,0.26588957055214724,0.5458999484270243,0.862438005742626,0.5497237569060773
463,3170,CACNG2,602911,614256;,"[MIM:614256]Mental retardation, autosomal dominant 10 [dominant?];",Autosomal dominant non-syndromic intellectual disability,Disease-causing germline mutation(s) in,Airway responsiveness in chronic obstructive pulmonary disease[25514360];,0.3889570552147239,0.8811242908715833,0.8509527538501697,0.0
464,3184,CAD,114010,616457;,"[MIM:616457]Epileptic encephalopathy, early infantile, 50 [recessive?];",CAD-CDG,Disease-causing germline mutation(s) in,,0.9916564417177914,0.7902269210933471,0.5129209083790133,0.0
465,3212,CALM1,114180,614916;616247;,"[MIM:614916]Ventricular tachycardia, catecholaminergic polymorphic, 4 [dominant?];[MIM:616247]Long QT syndrome 14;",Catecholaminergic polymorphic ventricular tachycardia;Romano-Ward syndrome,Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in,Response to platinum-based neoadjuvant chemotherapy in cervical cancer[28120872];,0.4226993865030675,0.8068592057761733,0.0,0.0
466,3215,CALM2,114182,616249;,[MIM:616249]Long QT syndrome 15;,Catecholaminergic polymorphic ventricular tachycardia;Brugada syndrome;Romano-Ward syndrome,Candidate gene tested in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in,Dialysis-related mortality[21546767];,0.038773006134969326,0.9014956162970603,0.9475332811276429,0.7539901780233272
467,3220,CALM3,114183,,,Catecholaminergic polymorphic ventricular tachycardia,Candidate gene tested in,Crohn's disease[28067908];Ulcerative colitis[23128233];,0.9570552147239264,0.8287777204744714,0.0,0.38152240638428486
468,3227,CALR,109091,,,Essential thrombocythemia;Primary myelofibrosis,Disease-causing somatic mutation(s) in;Disease-causing somatic mutation(s) in,Red blood cell traits[23222517];Clozapine-induced agranulocytosis[25187353];,0.9725153374233129,0.8664259927797834,0.6865048290263639,0.8789134438305709
469,3235,CAMK2A,114078,617798;,"[MIM:617798]Mental retardation, autosomal dominant 53 [dominant?];",Autosomal dominant non-syndromic intellectual disability,Disease-causing germline mutation(s) in,Inflammatory bowel disease[28067908];Obesity-related traits[23251661];Ulcerative colitis[28067908];,0.7026993865030675,0.6890149561629706,0.993474288697468,0.6932166973603437
470,3236,CAMK2B,607707,617799;,"[MIM:617799]Mental retardation, autosomal dominant 54 [dominant?];",Autosomal dominant non-syndromic intellectual disability,Disease-causing germline mutation(s) in,Osteoarthritis (hip)[23989986];Intracranial aneurysm[29531279];Metabolic syndrome[22399527];,0.5858895705521472,0.9164517792676637,0.2289219524928217,0.3011049723756906
471,3244,CAMKMT,609559,,,2p21 microdeletion syndrome;Atypical hypotonia-cystinuria syndrome;2p21 microdeletion syndrome without cystinuria,Role in the phenotype of;Role in the phenotype of;Role in the phenotype of,Immune reponse to smallpox (secreted TNF-alpha)[22610502];antipsychotic drug dosage in schizophrenia or schizoaffective disorder[26821981];Spherical equivalent or myopia (age of diagnosis)[29808027];Myopia[27182965];Anxiety disorder (factor score)[26754954];,0.33226993865030674,0.21067560598246518,0.8548681806316889,0.0
472,3251,CAMTA1,611501,614756;,"[MIM:614756]Cerebellar ataxia, non-progressive, with mental retardation;",Epithelioid hemangioendothelioma;Non-progressive cerebellar ataxia with intellectual disability,Part of a fusion gene in;Disease-causing germline mutation(s) (loss of function) in,Puberty onset (breast development)[24770850];Survival in sporadic amyotrophic lateral sclerosis[27244217];Platelet distribution width[27863252];Alcohol dependence[26365420];Periodontal microbiota[22699663];Crohn's disease[28067908];Photic sneeze reflex[27182965];Inflammatory bowel disease[28067908];Mean platelet volume[27863252];Rosacea symptom severity[29771307];Stearic acid (18:0) levels[23362303];Puberty onset[24770850];Tourette's syndrome or obsessive-compulsive disorder[25158072];Ulcerative colitis[28067908];Post bronchodilator FEV1[26634245];,0.554601226993865,0.6565239814337287,0.2524145131819368,0.9843462246777164
473,3258,CANT1,613165,251450;617719;,"[MIM:251450]Desbuquois dysplasia 1;[MIM:617719]Epiphyseal dysplasia, multiple, 7 [recessive?];",Desbuquois syndrome,Disease-causing germline mutation(s) (loss of function) in,,0.6559509202453988,0.6601340897369778,0.6431741059775515,0.852670349907919
474,3266,CAPN1,114220,616907;,"[MIM:616907]Spastic paraplegia 76, autosomal recessive [recessive?];",Autosomal recessive spastic paraplegia type 76,Disease-causing germline mutation(s) (loss of function) in,,0.6985276073619632,0.29448169159360493,0.33672670321064996,0.3580417434008594
475,3268,CAPN3,114240,253600;,,Autosomal recessive limb-girdle muscular dystrophy type 2A,Disease-causing germline mutation(s) in,Granulocyte percentage of myeloid white cells[27863252];Triglycerides[20686565;24097068;25961943];Fibrinogen levels[26561523;28107422];Monocyte count[27863252];Monocyte percentage of white cells[27863252];,0.32380368098159507,0.13254254770500257,0.11302531975985382,0.9455187231430325
476,3269,CAPN5,602537,193235;,"[MIM:193235]Vitreoretinopathy, neovascular inflammatory;",Autosomal dominant neovascular inflammatory vitreoretinopathy,Disease-causing germline mutation(s) in,Cognitive performance[19734545];,0.49828220858895705,0.4894275399690562,0.4009397024275646,0.6332105586249233
477,3297,CARD9,607212,212050;,"[MIM:212050]Candidiasis, familial, 2;",Predisposition to invasive fungal disease due to CARD9 deficiency,Disease-causing germline mutation(s) in,"Inflammatory bowel disease[28067908;23128233];Acute insulin response[28490609];Pediatric autoimmune diseases[26301688];IgA nephropathy[25305756;25305756];Monocyte chemoattractant protein-1 levels[23017229];Chronic inflammatory diseases (ankylosing spondylitis, Crohn's disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy)[26974007;26974007];Crohn's disease[21102463;22936669;28067908];Obesity-related traits[23251661];Ankylosing spondylitis[21743469;23749187;23749187];Ulcerative colitis[21297633;19915572;28067908;20228799];",0.5900613496932515,0.09154203197524498,0.21064996084573218,0.1338244321669736
478,3299,CARD11,607210,615206;616452;617638;,[MIM:616452]B-cell expansion with NFKB and T-cell anergy [dominant?];[MIM:615206]Immunodeficiency 11 A [recessive?];[MIM:617638]Immunodeficiency 11B with atopic dermatitis [dominant?];,Severe combined immunodeficiency due to CARD11 deficiency;Persistent polyclonal B-cell lymphocytosis;BENTA disease,Disease-causing germline mutation(s) (loss of function) in;Major susceptibility factor in;Disease-causing germline mutation(s) (gain of function) in,Cadmium levels[26025379];Response to fenofibrate (total cholesterol levels)[27002377];Multiple sclerosis[24076602];Dupuytren's disease[28886342];Atopic dermatitis[23042114];Intracranial aneurysm[29531279];White matter integrity[23218918];Daytime sleep phenotypes[27126917];Ulcerative colitis[23128233];,0.4710429447852761,0.9791129448169159,0.546332550247977,0.5914671577655003
479,3300,CARD14,607211,173200;602723;,[MIM:602723]Psoriasis 2;[MIM:173200]Pityriasis rubra pilaris [dominant?];,Pityriasis rubra pilaris,Disease-causing germline mutation(s) in,Moyamoya disease[29273593];Psoriasis[23143594];,0.26588957055214724,0.6567818463125322,0.1318193683111459,0.1289134438305709
480,3315,CARS,123859,,,Inflammatory myofibroblastic tumor,Part of a fusion gene in,Calcium levels[24068962];Longevity[20834067];,0.43153374233128833,0.46596183599793706,0.21404333072304882,0.1576120319214242
481,3317,CARS2,612800,616672;,[MIM:616672]Combined oxidative phosphorylation deficiency 27 [recessive?];,Combined oxidative phosphorylation defect type 27,Disease-causing germline mutation(s) in,Diastolic blood pressure[26969751];,0.8564417177914111,0.33522434244455906,0.24432263116679717,0.20687538367096378
482,3341,CASK,300172,300422;300749;,[MIM:300749]Mental retardation and microcephaly with pontine and cerebellar hypoplasia;[MIM:300422]FG syndrome 4;,"X-linked intellectual disability, Najm type;Early infantile epileptic encephalopathy",Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) (loss of function) in,,0.9568098159509203,1.0,0.9156878099712868,0.8698588090853284
483,3357,CASP8,601763,211980;607271;,[MIM:607271]Caspase-8 deficiency;,Autoimmune lymphoproliferative syndrome with recurrent viral infections;Adult hepatocellular carcinoma,Disease-causing germline mutation(s) in;Disease-causing somatic mutation(s) in,Chronic lymphocytic leukemia[23770605;26956414;28165464];Basal cell carcinoma[28177523;25855136];Rheumatoid arthritis[24390342;24390342];Lymphocyte counts[27863252];Melanoma[21983787;28212542];Esophageal squamous cell carcinoma[25129146];Breast cancer[29059683];Prostate cancer[29892016];,0.7273619631901841,0.5146982980917999,0.6549203863221091,0.5650705954573357
484,3360,CASP10,601762,603909;605027;613659;,[MIM:603909]Autoimmune lymphoproliferative syndrome 2A;[MIM:605027]Familial non-Hodgkin lymphoma;[MIM:613659]Gastric cancer;,Autoimmune lymphoproliferative syndrome,Disease-causing germline mutation(s) in,Chronic lymphocytic leukemia[23770605;28165464];Basal cell carcinoma[25855136];,0.5792638036809816,0.06214543579164518,0.339598016183764,0.3997851442602824
485,3365,CASQ1,114250,160565;616231;,"[MIM:616231]Myopathy, vacuolar, with CASQ1 aggregates [dominant?];[MIM:160565]Myopathy, tubular aggregate, 1;",Tubular aggregate myopathy;Vacuolar myopathy with sarcoplasmic reticulum protein aggregates,Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in,,0.20368098159509201,0.19520371325425476,0.4137300965805273,0.19659300184162062
486,3366,CASQ2,114251,611938;,"[MIM:611938]Ventricular tachycardia, catecholaminergic polymorphic, 2 [recessive?];",Catecholaminergic polymorphic ventricular tachycardia,Disease-causing germline mutation(s) in,Atrial fibrillation[30061737;29892015;29892015];QRS duration[27577874;27577874;27659466];,0.4298159509202454,0.0853532748839608,0.3484729835552075,0.17587476979742173
487,3367,CASR,601199,145980;239200;601198;612899;,"[MIM:145980]Hypocalciuric hypercalcemia, familial 1 [dominant?];[MIM:239200]Hyperparathyroidism, neonatal severe;[MIM:601198]Hypocalcemia, autosomal dominant 1 [dominant?];[MIM:612899]Epilepsy, idiopathic generalized 8;",Neonatal severe primary hyperparathyroidism;Hereditary chronic pancreatitis;Bartter syndrome with hypocalcemia;Autosomal dominant hypocalcemia;Familial hypocalciuric hypercalcemia type 1,Disease-causing germline mutation(s) (loss of function) in;Candidate gene tested in;Disease-causing germline mutation(s) (gain of function) in;Disease-causing germline mutation(s) (gain of function) in;Disease-causing germline mutation(s) (loss of function) in,Calcium levels[20705733;20661308;24068962;25886283;25972035;29403010];Phosphorus levels[20558539];Clinical laboratory measurements[27897004];Serum parathyroid hormone levels[27927781];Cardiac Troponin-T levels[23247143];Kidney stones[26272126];,0.22687116564417178,0.5327488396080454,0.12868702688593056,0.981890730509515
488,3369,CAST,114090,616295;,"[MIM:616295]Peeling skin with leukonychia, acral punctate keratoses, cheilitis, and knuckle pads [recessive?];",Peeling skin-leukonychia-acral punctate keratoses-cheilitis-knuckle pads syndrome,Disease-causing germline mutation(s) (loss of function) in,Body mass index[26426971];Alanine aminotransferase (ALT) levels after remission induction therapy in actute lymphoblastic leukemia (ALL)[28090653];Alcohol dependence[19581569];Blood protein levels[28240269;28240269;28240269];,0.6960736196319018,0.14878803506962351,0.2975724353954581,0.035451197053407
489,3374,CAT,115500,614097;,[MIM:614097]Acatalasemia [recessive?];,Acatalasemia,Disease-causing germline mutation(s) in,Blood protein levels[28240269;29875488;30072576];,0.6830674846625767,0.10675605982465189,0.694074654137301,0.6238489871086557
490,3379,CATSPER1,606389,612997;,[MIM:612997]Spermatogenic failure 7;,Non-syndromic male infertility due to sperm motility disorder,Disease-causing germline mutation(s) in,Acne (severe)[24927181];,0.5261349693251534,0.0959257349149046,0.42156095014356565,0.7701043585021485
491,3380,CATSPER2,607249,611102;,,Deafness-infertility syndrome,Role in the phenotype of,Lung cancer[28604730];Squamous cell lung carcinoma[28604730];,0.038773006134969326,0.5232078390923156,0.25841816758026626,0.6947513812154696
492,3389,CAV1,601047,606721;612526;615343;,"[MIM:612526]Congenital generalized lipodystrophy 3 [recessive?];[MIM:615343]Pulmonary hypertension, primary, 3;[MIM:606721]Partial lipodystrophy, congenital cataracts, and neurodegeneration syndrome;",Berardinelli-Seip congenital lipodystrophy;Heritable pulmonary arterial hypertension;Limited cutaneous systemic sclerosis;Diffuse cutaneous systemic sclerosis,Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Major susceptibility factor in;Major susceptibility factor in,Glaucoma[30054594];QT interval[24952745];High light scatter reticulocyte percentage of red cells[27863252];Reticulocyte count[27863252];Atrial fibrillation[22544366;28416822;30061737;29892015;29892015;29892015];Heart rate response to recovery post exercise (30 sec)[29497042];PR interval[20062060;23139255;25035420;29127183];Heart rate response to recovery post exercise (10 sec)[29497042];High light scatter reticulocyte count[27863252];Electrocardiographic traits[20062063;25055868];Heart rate response to recovery post exercise (20 sec)[29497042];Immature fraction of reticulocytes[27863252];Glaucoma (primary open-angle)[20835238;25173105;29891935];Reticulocyte fraction of red cells[27863252];P wave duration[28794112;28794112];Ischemic stroke (cardioembolic)[29531354];Heart rate response to recovery post exercise (50 sec)[29497042];Heart rate increase in response to exercise[29497042];Heart rate response to recovery post exercise (40 sec)[29497042];PR segment[24850809];Intraocular pressure[28073927;28073927;25173106;29617998;29235454;29235454];,0.9214723926380368,0.6632284682826199,0.9276951187679457,0.8515960712093309
493,3391,CAV3,601253,123320;192600;272120;606072;607801;611818;614321;,"[MIM:607801]Limb-girdle muscular dystrophy 1C [dominant?];[MIM:123320]HyperCKmia;[MIM:606072]Rippling muscle disease 2 [dominant?] [recessive?];[MIM:192600]Cardiomyopathy, familial hypertrophic;[MIM:611818]Long QT syndrome 9;[MIM:272120]Sudden infant death syndrome;[MIM:614321]Myopathy, distal, Tateyama type;","Isolated asymptomatic elevation of creatine phosphokinase;Autosomal dominant limb-girdle muscular dystrophy type 1C;Distal myopathy, Tateyama type;Rippling muscle disease;Romano-Ward syndrome",Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) (gain of function) in,Caudate activity during reward[28927378];,0.5153374233128835,0.4228984012377514,0.42625946228138867,0.8891958256599141
494,3392,CAVIN1,603198,613327;,[MIM:613327]Congenital generalized lipodystrophy 4;,Berardinelli-Seip congenital lipodystrophy,Disease-causing germline mutation(s) in,Inflammatory bowel disease[28067908];Psoriasis[25903422;23143594];Crohn's disease[28067908];Ulcerative colitis[28067908];,0.8771779141104294,0.4105208870551831,0.0,0.0
495,3398,CBFA2T3,603870,,,Acute megakaryoblastic leukemia without Down syndrome,Part of a fusion gene in,Mean platelet volume[27863252];Social autistic-like traits[24133439];Vitiligo[27723757];Mean corpuscular hemoglobin[27863252];Hair color[26926045];,0.5598773006134969,0.0,0.4309579744192117,0.5584714548802947
496,3399,CBFB,121360,,,Acute myeloid leukemia with abnormal bone marrow eosinophils inv(16)(p13q22) or t(16;16)(p13;q22),Part of a fusion gene in,Mean corpuscular hemoglobin[27863252];,0.6423312883435582,0.7880350696235173,0.9250848342469329,0.7022713321055862
497,3400,CBL,165360,613563;,[MIM:613563]Noonan syndrome-like disorder with or without juvenile myelomonocytic leukemia;,Noonan syndrome-like disorder with juvenile myelomonocytic leukemia;Juvenile myelomonocytic leukemia,Disease-causing germline mutation(s) in;Major susceptibility factor in,High light scatter reticulocyte percentage of red cells[27863252];Reticulocyte fraction of red cells[27863252];Reticulocyte count[27863252];Plateletcrit[27863252;27863252];High light scatter reticulocyte count[27863252];Platelet count[22139419;27863252;27863252;29403010];,0.8642944785276073,0.3989169675090253,0.5016966849386583,0.5379066912216084
498,3403,CBLIF,609342,261000;,,Congenital intrinsic factor deficiency,Disease-causing germline mutation(s) in,,0.038773006134969326,0.34631253223310987,0.0,0.0
499,3414,CBS,613381,236200;,,Classic homocystinuria,Disease-causing germline mutation(s) in,Plasma homocysteine levels (post-methionine load test)[24651765];Blood metabolite levels[24816252];Blood and toenail selenium levels[25343990;25343990;25343990];Obesity-related traits[23251661];Homocysteine levels[23824729;23824729;20031578];Blood trace element (Se levels)[23720494];,0.6761963190184049,0.2519339865910263,0.5374575828765336,0.9226519337016574
500,3428,CBX2,602770,613080;,"[MIM:613080]46,XY sex reversal 5;","46,XY complete gonadal dysgenesis",Disease-causing germline mutation(s) (loss of function) in,,0.6878527607361963,0.9352759154203197,0.4095536413469068,0.8529772866789441
501,3447,CC2D1A,610055,608443;,"[MIM:608443]Mental retardation, autosomal recessive 3 [recessive?];",Autosomal recessive non-syndromic intellectual disability,Disease-causing germline mutation(s) in,,0.9700613496932515,0.34682826199071687,0.15844427042547637,0.20395948434622468
502,3449,CC2D2A,612013,216360;612284;612285;,[MIM:612284]Meckel syndrome 6;[MIM:612285]Joubert syndrome 9;[MIM:216360]COACH syndrome;,Meckel syndrome;Joubert syndrome with oculorenal defect;Joubert syndrome with hepatic defect,Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in,Joint mobility (Beighton score)[27182965];Mean corpuscular volume[27863252;29403010];Mean corpuscular hemoglobin[27863252];Initial pursuit acceleration[29064472;29064472];Obesity-related traits[23251661];Red blood cell count[27863252];Blood protein levels[28240269;28240269;28240269];,0.6009815950920245,0.3811242908715833,0.28008352910467244,0.32351135666052794
503,3457,CCBE1,612753,235510;,,Hennekam syndrome,Disease-causing germline mutation(s) in,Age-related hearing impairment[24939585];Major depressive disorder[23857890];,0.21484662576687116,0.6080453842186694,0.5586008874967372,0.5871700429711479
504,3459,CCDC6,601985,,,Differentiated thyroid carcinoma,Part of a fusion gene in,Alopecia areata[25608926];,0.4667484662576687,0.7258896338318721,0.05377186113286348,0.677255985267035
505,3461,CCDC8,614145,614205;,[MIM:614205]3M syndrome 3;,3M syndrome,Disease-causing germline mutation(s) in,Crohn's disease[28067908];Night sleep phenotypes[27126917];,0.7861349693251534,0.6279009798865395,0.1380840511615766,0.23511356660527932
506,3473,CCDC22,300859,300963;,,3C syndrome,Disease-causing germline mutation(s) (loss of function) in,Vitiligo[27723757];,0.8554601226993865,0.972279525528623,0.6724092926128948,0.0
507,3488,CCDC39,613798,613807;,,Primary ciliary dyskinesia,Disease-causing germline mutation(s) in,BMI in non-smokers[28443625];Body mass index (joint analysis main effects and smoking interaction)[28443625];Schizophrenia[25056061];BMI in smokers[28443625];BMI (adjusted for smoking behaviour)[28443625];,0.038773006134969326,0.4298607529654461,0.2894805533803185,0.34499693063228976
508,3490,CCDC40,613799,613808;,"[MIM:613808]Ciliary dyskinesia, primary, 15;",Primary ciliary dyskinesia,Disease-causing germline mutation(s) in,,0.40773006134969325,0.554925219185147,0.21117201774993474,0.12154696132596685
509,3494,CCDC50,611051,607453;,"[MIM:607453]Deafness, autosomal dominant, 44 [dominant?];",Autosomal dominant non-syndromic sensorineural deafness type DFNA,Disease-causing germline mutation(s) in,Lung cancer in never smokers[28604730];Alzheimer's disease biomarkers[23562540];,0.27361963190184047,0.18308406395048996,0.46932915687809973,0.05555555555555555
510,3509,CCDC65,611088,615504;,,Primary ciliary dyskinesia,Disease-causing germline mutation(s) in,,0.038773006134969326,0.12248581743166581,0.06760636909423128,0.040208717004297116
511,3522,CCDC78,614666,614807;,,Congenital myopathy with internal nuclei and atypical cores,Disease-causing germline mutation(s) in,,0.038773006134969326,0.40562145435791647,0.6309057687287914,0.03806015960712093
512,3533,CCDC88A,609736,617507;,[MIM:617507]PEHO-like syndrome [recessive?];,PEHO-like syndrome,Disease-causing germline mutation(s) (loss of function) in,Height[21998595];,0.7131288343558282,0.9802733367715317,0.48499086400417646,0.36955187231430325
513,3535,CCDC88C,611204,236600;616053;,"[MIM:236600]Hydrocephalus, congenital, 1 [recessive?];[MIM:616053]Spinocerebellar ataxia 40 [dominant?];",Congenital non-communicating hydrocephalus;Spinocerebellar ataxia type 40,Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) (gain of function) in,Breast cancer[23535729;29059683];Daytime sleep phenotypes[27126917];Waist-to-hip ratio adjusted for BMI[26426971];Waist-to-hip ratio adjusted for BMI x sex x age interaction (4df test)[26426971];,0.3856441717791411,0.4706034038164002,0.27773427303576087,0.3543585021485574
514,3546,CCDC103,614677,614679;,"[MIM:614679]Ciliary dyskinesia, primary, 17;",Primary ciliary dyskinesia,Disease-causing germline mutation(s) in,Craniofacial microsomia[26853712];,0.36171779141104293,0.3991748323878288,0.9548420777864787,0.3118477593615715
515,3553,CCDC114,615038,615067;,"[MIM:615067]Ciliary dyskinesia, primary, 20;",Primary ciliary dyskinesia,Disease-causing germline mutation(s) (loss of function) in,,0.19190184049079756,0.13537906137184116,0.13782302270947533,0.2213014119091467
516,3554,CCDC115,613734,616828;,,CCDC115-CDG,Disease-causing germline mutation(s) (loss of function) in,,0.9353374233128834,0.277720474471377,0.8867136517880448,0.41267648864333945
517,3571,CCDC141,616031,,,Kallmann syndrome;Kallmann syndrome,Disease-causing germline mutation(s) in;Major susceptibility factor in,Heart rate[23583979];Blood pressure measurement (cold pressor test)[24165912];QT interval[24952745];Resting heart rate[27798624;29769521];Heart rate response to exercise[29769521];Diastolic blood pressure[28135244];Psychosis proneness (hypomanic personality scale and revised physical anhedonia scale)[28525603];Heart rate response to recovery post exercise (10 sec)[29497042;29497042];Psychosis proneness (revised physical anhedonia scale)[28525603];Objective response to lithium treatment[26503763];Heart rate response to recovery post exercise (20 sec)[29497042];Mucinous adenocarcinoma in colorectal cancer[29942513;29942513];,0.12711656441717792,0.06807632800412584,0.13155833985904464,0.0
518,3584,CCDC151,615956,616037;,"[MIM:616037]Ciliary dyskinesia, primary, 30;",Primary ciliary dyskinesia,Disease-causing germline mutation(s) (loss of function) in,Presence of antiphospholipid antibodies[27098658;27098658;27098658];,0.3889570552147239,0.07142857142857142,0.4664578439049856,0.43247391037446287
519,3604,CCDC174,616735,616816;,,Severe hypotonia-psychomotor developmental delay-strabismus-cardiac septal defect syndrome,Disease-causing germline mutation(s) in,Sjögren's syndrome[28076899];,0.5980368098159509,0.1588447653429603,0.46776298616549206,0.0
520,3650,CCL13,601391,,,Acute infantile liver failure-cerebellar ataxia-peripheral sensory motor neuropathy syndrome,Disease-causing germline mutation(s) in,Inflammatory bowel disease[23128233];Crohn's disease[22412388];Blood protein levels[29875488];,0.21484662576687116,0.6939143888602373,0.892456277734273,0.31952117863720075
521,3667,CCM2,607929,603284;,[MIM:603284]Cerebral cavernous malformations 2;,Familial cerebral cavernous malformation,Disease-causing germline mutation(s) (loss of function) in,Coronary artery disease[29212778;29212778];,0.3706748466257669,0.5118617844249613,0.2391020621247716,0.5477286678944138
522,3670,CCN2,121009,,,Limited cutaneous systemic sclerosis;Diffuse cutaneous systemic sclerosis,Major susceptibility factor in;Major susceptibility factor in,Mitral valve prolapse[26301497];Blood protein levels[30072576];,0.038773006134969326,0.37957710159876223,0.0,0.0
523,3674,CCN6,603400,208230;,,Progressive pseudorheumatoid arthropathy of childhood,Disease-causing germline mutation(s) in,,0.038773006134969326,0.3076328004125838,0.0,0.0
524,3687,CCND1,168461,254500;,[MIM:254500]Multiple myeloma;,Multiple myeloma;B-cell chronic lymphocytic leukemia;Mantle cell lymphoma,Major susceptibility factor in;Part of a fusion gene in;Disease-causing somatic mutation(s) in,Breast cancer (early onset)[24493630;24493630];Total body bone mineral density[29304378;29304378];Immunoglobulin light chain (AL) amyloidosis[28025584];Hip circumference[25673412;25673412];Cutaneous malignant melanoma[26237428;26237428];Craniofacial microsomia[26853712];Breast size[22747683;27182965];Melanoma[28212542];Breast cancer[20453838;29059683;29059683];Height[25429064];Multiple myeloma (IgH translocation)[23502783;23502783];Idiopathic dilated cardiomyopathy[29495422];,0.6646625766871166,0.7560598246518824,0.9279561472200469,0.6642111724984653
525,3688,CCND2,123833,615938;,[MIM:615938]Megalencephaly-polymicrogyria-polydactyly-hydrocephalus syndrome 3;,Megalencephaly-polymicrogyria-postaxial polydactyly-hydrocephalus syndrome,Disease-causing germline mutation(s) (gain of function) in,Type 2 diabetes[22885922;22885922;29358691;28869590;28869590];QT interval (drug interaction)[23459443];Mean corpuscular volume[28017375];Mean corpuscular hemoglobin[28017375];Red blood cell traits[23222517];Colorectal cancer[24836286;23266556;23266556;23263487;23263487;26151821];Glucocorticoid-induced osteonecrosis[26265699];Height[28270201];Red blood cell count[20139978;28017375;28017375];Obesity-related traits[23251661];Major depressive disorder[19107115;23377640];,0.8009815950920245,0.8009283135636927,0.9060297572435395,0.7813075506445673
526,3697,CCNF,600227,,,Amyotrophic lateral sclerosis,Disease-causing germline mutation(s) in,,0.39631901840490796,0.5520887055183084,0.593056643174106,0.3687845303867403
527,3714,CCNO,607752,615872;,"[MIM:615872]Ciliary dyskinesia, primary, 29;",Primary ciliary dyskinesia,Disease-causing germline mutation(s) (loss of function) in,,0.19190184049079756,0.3953068592057762,0.6515270164447925,0.2786985880908533
528,3715,CCNQ,300708,300707;,"[MIM:300707]Toe syndactyly, telecanthus, and anogenital and renal malformations;",Syndactyly-telecanthus-anogenital and renal malformations syndrome,Disease-causing germline mutation(s) in,Type 2 diabetes[22961080];Body mass index[28892062];,0.48736196319018404,0.7908715832903559,0.0,0.0
529,3729,CCR1,601159,,,Beh�et disease,Major susceptibility factor in,Inflammatory bowel disease[26192919];Celiac disease[18311140;20190752;22057235];Juvenile idiopathic arthritis (oligoarticular or rheumatoid factor-negative polyarticular)[23603761];Behcet's disease[23291587];Narcolepsy with cataplexy[25986216];Ulcerative colitis[28067908;26192919;26192919];,0.4,0.665807117070655,0.7575045679979118,0.7539901780233272
530,3733,CCR5,601373,609423;610379;612522;,"[MIM:612522]Diabetes mellitus, insulin-dependent, 22;",Susceptibility/resistance to HIV infection,Biomarker tested in,Inflammatory bowel disease[26192919];Celiac disease[20190752];Granulocyte percentage of myeloid white cells[27863252];Type 1 diabetes[25751624];Cerebrospinal fluid levels of Alzheimer's disease-related proteins[25340798];Blood protein levels[28240269];Ulcerative colitis[28067908;26192919;26192919];,0.5479754601226994,0.11242908715832904,0.4098146697990081,0.14901780233271947
531,3734,CCR6,601835,,,Limited cutaneous systemic sclerosis;Diffuse cutaneous systemic sclerosis,Major susceptibility factor in;Major susceptibility factor in,Graves' disease[22922229];Lung cancer[28604730];Autoimmune thyroid diseases (Graves disease or Hashimoto's thyroiditis)[22922229];Crohn's disease[18587394;23850713;20570966;21102463;28067908];Triglycerides[24886709];Response to zileuton treatment in asthma (FEV1 change interaction)[26031901];Albumin-globulin ratio[29403010];Inflammatory bowel disease[27569725;28067908;23128233];Social autistic-like traits[24133439];Vitiligo[20526339;27723757];Rheumatoid arthritis (ACPA-positive)[23143596;24532676;23143596];Rheumatoid arthritis[24390342;24390342;24390342;24782177;20453841;20453842;24782177;24782177;23143596;23143596];Primary biliary cholangitis[28425483];,0.12711656441717792,0.41387313047962865,0.9141216392586792,0.3758440761203192
532,3753,CCT5,610150,256840;,"[MIM:256840]Neuropathy, hereditary sensory, with spastic paraplegia, autosomal recessive [recessive?];",Mutilating hereditary sensory neuropathy with spastic paraplegia,Disease-causing germline mutation(s) in,Pain[22956598];,0.9980368098159509,0.9708612686952037,0.5184025058731402,0.8354818907305095
533,3779,CD2AP,604241,607832;,[MIM:607832]Focal segmental glomerulosclerosis 3;,Sporadic idiopathic steroid-resistant nephrotic syndrome with focal segmental hyalinosis;Familial idiopathic steroid-resistant nephrotic syndrome with focal segmental hyalinosis,Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in,Alzheimer's disease (late onset)[21460841;24162737];High light scatter reticulocyte percentage of red cells[27863252];Reticulocyte fraction of red cells[27863252];Reticulocyte count[27863252];Plasma homocysteine levels[26519441];Amyotrophic lateral sclerosis (sporadic)[24529757];High light scatter reticulocyte count[27863252];Red cell distribution width[27863252];Immature fraction of reticulocytes[27863252];,0.8295705521472393,0.6395048994326973,0.4729835552075176,0.21899938612645795
534,3781,CD3D,186790,615617;,[MIM:615617]Immunodeficiency 19 [recessive?];,T-B+ severe combined immunodeficiency due to CD3delta/CD3epsilon/CD3zeta,Disease-causing germline mutation(s) in,,0.2947239263803681,0.22563176895306858,0.8935003915426781,0.044812768569674644
535,3782,CD3E,186830,615615;,[MIM:615615]Immunodeficiency 18 [recessive?];,T-B+ severe combined immunodeficiency due to CD3delta/CD3epsilon/CD3zeta,Disease-causing germline mutation(s) in,Lung cancer in ever smokers[28604730];,0.427239263803681,0.406910778751934,0.7812581571391282,0.2213014119091467
536,3783,CD3EAP,107325,,,Peeling skin-leukonychia-acral punctate keratoses-cheilitis-knuckle pads syndrome,Disease-causing germline mutation(s) (loss of function) in,Body mass index[26426971];Alanine aminotransferase (ALT) levels after remission induction therapy in actute lymphoblastic leukemia (ALL)[28090653];Alcohol dependence[19581569];Blood protein levels[28240269;28240269;28240269];,0.7116564417177914,0.0,0.09553641346906813,0.1714241866175568
537,3784,CD3G,186740,615607;,[MIM:615607]Immunodeficiency 17 [recessive?];,Combined immunodeficiency due to CD3gamma deficiency,Disease-causing germline mutation(s) in,,0.19190184049079756,0.2444559051057246,0.09684155572957452,0.1359729895641498
538,3790,CD8A,186910,608957;,"[MIM:608957]CD8 deficiency, familial;",Susceptibility to respiratory infections associated with CD8alpha chain mutation,Disease-causing germline mutation(s) in,Blood protein levels[30072576];,0.3706748466257669,0.25244971634863334,0.4719394413991125,0.41006752608962554
539,3795,CD19,107265,613493;,"[MIM:613493]Immunodeficiency, common variable, 3;",Common variable immunodeficiency,Disease-causing germline mutation(s) in,Inflammatory bowel disease[28067908];Intelligence (MTAG)[29326435];Crohn's disease[21102463;28067908];,0.49828220858895705,0.8457968024755028,0.5810493343774471,0.43370165745856354
540,3802,CD27,186711,615122;,[MIM:615122]Lymphoproliferative syndrome 2 [recessive?];,Autosomal recessive lymphoproliferative disease,Disease-causing germline mutation(s) in,Crohn's disease[26192919];,0.3749693251533742,0.4288292934502321,0.2505873140172279,0.478207489257213
541,3804,CD28,186760,,,Classic mycosis fungoides;S�zary syndrome,Part of a fusion gene in;Part of a fusion gene in,"Multiple sclerosis[24076602];Graves' disease[21841780];Chronic inflammatory diseases (ankylosing spondylitis, Crohn's disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy)[26974007];Primary sclerosing cholangitis[27992413];Alopecia areata[25608926];Inflammatory bowel disease[26192919];Celiac disease[20190752;22057235];Rheumatoid arthritis (ACPA-positive)[23143596;24532676;23143596];Systemic lupus erythematosus[28714469];Rheumatoid arthritis[24390342;24390342;23143596;23143596];Primary biliary cholangitis[28425483];Subcutaneous adipose tissue[29178545];Heschl's gyrus morphology[25130324];Ulcerative colitis[26192919];",0.32380368098159507,0.39453326456936566,0.9214304359175151,0.5871700429711479
542,3810,CD40,109535,606843;,,Hyper-IgM syndrome type 3,Disease-causing germline mutation(s) in,"Inflammatory bowel disease[28067908;23128233];Chronic hepatitis B infection[25802187];Multiple sclerosis[22190364;19525955;21833088;24076602];Rheumatoid arthritis (ACPA-positive)[23143596;24532676;23143596];Kawasaki disease[22446962;22446961];Systemic lupus erythematosus[28714469;28714469];Tonsillectomy[27182965;28928442];Rheumatoid arthritis[18794853;24390342;24390342;20453842;23143596];Chronic inflammatory diseases (ankylosing spondylitis, Crohn's disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy)[26974007];Crohn's disease[28067908];",0.5370552147239264,0.8434760185662713,0.8196293395980162,0.7154696132596685
543,3811,CD40LG,300386,308230;,"[MIM:308230]Immunodeficiency with hyper-IgM, type 1;",X-linked hyper-IgM syndrome,Disease-causing germline mutation(s) in,Pediatric autoimmune diseases[26301688];,0.39631901840490796,0.7988653945332646,0.7655964500130514,0.0
544,3814,CD46,120920,612922;,[MIM:612922]Hemolytic uremic syndrome atypical 2;,HELLP syndrome;Atypical hemolytic-uremic syndrome with MCP/CD46 anomaly,Candidate gene tested in;Disease-causing germline mutation(s) in,Heart rate[23583979];Febrile seizures[25344690];Resting heart rate[27798624;29769521];Age-related macular degeneration[23326517;23326517];Schizophrenia[25056061];Immune response to measles vaccine (measles-specific neutralising antibody titre)[28289848;28289848];Obesity-related traits[23251661];Febrile seizures (MMR vaccine-related)[25344690];Biomedical quantitative traits[19396169];Chronic central serous retinopathy[30073298];,0.33226993865030674,0.22073233625580196,0.7423649177760376,0.01780233271945979
545,3822,CD59,107271,612300;,"[MIM:612300]Hemolytic anemia, CD59-mediated, with or without polyneuropathy [recessive?];",Primary CD59 deficiency,Disease-causing germline mutation(s) in,Blood protein levels[29875488;30072576];,0.8041717791411043,0.5977307890665291,0.9986948577394936,0.41267648864333945
546,3829,CD79A,112205,613501;,"[MIM:613501]Agammaglobulinemia 3, autosomal recessive [recessive?];",Autosomal agammaglobulinemia,Disease-causing germline mutation(s) in,,0.4645398773006135,0.8078906652913873,0.7716001044113808,0.5821055862492327
547,3830,CD79B,147245,612692;,"[MIM:612692]Agammaglobulinemia 6, autosomal recessive [recessive?];",Autosomal agammaglobulinemia,Disease-causing germline mutation(s) in,Height[25282103];,0.5439263803680982,0.8633316142341413,0.943878882798225,0.0
548,3832,CD81,186845,613496;,"[MIM:613496]Immunodeficiency, common variable, 6;",Common variable immunodeficiency,Disease-causing germline mutation(s) in,,0.6694478527607362,0.7434244455905106,0.8723570869224746,0.6270718232044199
549,3840,CD96,606037,211750;,[MIM:211750]C syndrome;,C syndrome,Candidate gene tested in,Current cigarettes per day in chronic obstructive pulmonary disease[21685187];,0.2498159509202454,0.7135121196493037,0.5510310623858,0.020411295273173726
550,3845,CD109,608859,,,Fetal and neonatal alloimmune thrombocytopenia,Candidate gene tested in,Calcium levels[24068962];Cadmium levels[26025379];Heel bone mineral density[28869591;28869591];Obesity-related traits[23251661];Blood protein levels[28240269;29875488;30072576];,0.6403680981595092,0.004899432697266632,0.1033672670321065,0.000767341927562922
551,3846,CD151,602243,179620;609057;,[MIM:609057]Nephropathy with pretibial epidermolysis bullosa and deafness;,Nephrotic syndrome-deafness-pretibial epidermolysis bullosa syndrome,Disease-causing germline mutation(s) in,Mean platelet volume[27863252];,0.31079754601226994,0.6727694687983496,0.7903941529626729,0.5679864947820749
552,3850,CD164,603356,616969;,"[MIM:616969]Deafness, autosomal dominant, 66 [dominant?];",Autosomal dominant non-syndromic sensorineural deafness type DFNA,Disease-causing germline mutation(s) in,Midgestational circulating levels of PCBs[28235828;28235828;28235828;28235828;28235828;28235828;28235828;28235828];Granulocyte percentage of myeloid white cells[27863252];Mean corpuscular volume[19862010;20139978;28017375;28017375;29403010];Mean corpuscular hemoglobin[20139978;28017375;28017375;29403010];Red blood cell traits[23446634];White blood cell count (basophil)[29403010];Lung cancer[28604730];Height[18391951];Red blood cell count[20139978;28017375;28017375;29403010];,0.20368098159509201,0.5507993811242908,0.851213782302271,0.42326580724370777
553,3863,CD247,186780,610163;,[MIM:610163]Immunodeficiency 25;,T-B+ severe combined immunodeficiency due to CD3delta/CD3epsilon/CD3zeta;Oligoarticular juvenile idiopathic arthritis;Rheumatoid factor-negative juvenile idiopathic arthritis,Disease-causing germline mutation(s) in;Major susceptibility factor in;Major susceptibility factor in,"Celiac disease or Rheumatoid arthritis[21383967];Celiac disease[20190752];Allergic disease (asthma, hay fever or eczema)[29083406];Systemic sclerosis[21750679;21779181;20383147;29293537];Rheumatoid arthritis[20453842];Asthma[27182965];",0.58,0.5600825167612171,0.8908901070216654,0.742633517495396
554,3876,CD320,606475,613646;,,Methylmalonic aciduria due to transcobalamin receptor defect,Disease-causing germline mutation(s) in,,0.3492024539877301,0.7243424445590511,0.23936309057687288,0.7516881522406385
555,3879,CDAN1,607465,224120;,,Congenital dyserythropoietic anemia type I,Disease-causing germline mutation(s) in,MGMT methylation in smokers[26183928];Protein quantitative trait loci[18464913];,0.4226993865030675,0.5745229499742135,0.015400678673975463,0.8520564763658687
556,3883,CDC6,602627,613805;,[MIM:613805]Meier-Gorlin syndrome 5;,Ear-patella-short stature syndrome,Disease-causing germline mutation(s) (loss of function) in,,0.723558282208589,0.6204228984012378,0.11902897415818324,0.17357274401473297
557,3885,CDC14A,603504,616958;,"[MIM:616958]Deafness, autosomal recessive, 105 [recessive?];",Autosomal recessive non-syndromic sensorineural deafness type DFNB,Disease-causing germline mutation(s) (loss of function) in,,0.4403680981595092,0.21609076843733885,0.6499608457321848,0.21132596685082872
558,3917,CDC42,116952,616737;,[MIM:616737]Takenouchi-Kosaki syndrome;,Macrothrombocytopenia-lymphedema-developmental delay-facial dysmorphism-camptodactyly syndrome,Disease-causing germline mutation(s) in,Immune response to smallpox vaccine (IL-6)[22610502];Uterine fibroids[30194396];Gestational age at birth (maternal effect)[28877031];Colorectal cancer[25990418];Daytime sleep phenotypes[27126917];,0.9396319018404908,0.6330582774626096,0.9096841555729575,0.557243707796194
559,3936,CDC45,603465,,,Ear-patella-short stature syndrome,Disease-causing germline mutation(s) (loss of function) in,Cognitive decline rate in late mild cognitive impairment[26252872;26252872];,0.6617177914110429,0.7261474987106756,0.6238580005220569,0.0
560,3937,CDC73,607393,145000;145001;608266;,[MIM:145000]Hyperparathyroidism 1 [dominant?];[MIM:145001]Hyperparathyroidism 2 with jaw tumors [dominant?];[MIM:608266]Parathyroid carcinoma;,Parathyroid carcinoma;Familial isolated hyperparathyroidism;Hyperparathyroidism-jaw tumor syndrome,Disease-causing somatic mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) (gain of function) in,White matter hyperintensity burden[25663218];Subcutaneous adipose tissue[22589738];Takayasu arteritis[25604533];Ovarian disease with few adhesions[28333195];Photic sneeze reflex[27182965];,0.9202453987730062,0.9773078906652913,0.9605847037327069,0.7728667894413751
561,3947,CDCA7,609937,616910;,[MIM:616910]Immunodeficiency-centromeric instability-facial anomalies syndrome 3;,ICF syndrome,Disease-causing germline mutation(s) in,Blood pressure measurement (low sodium intervention)[24165912;24165912;24165912];Male-pattern baldness[27182965;29146897];End-stage renal disease in Type 1 diabetics[24029427];Mosquito bite size[28199695];Lung cancer[28604730];Otitis media (chronic/recurrent)[23974705];Breast cancer[23535729;29059683];Lung adenocarcinoma[28604730];Prostate cancer[29892016];Asthma[27611488];Blood pressure measurement (high sodium and potassium intervention)[24165912;24165912;24165912];,0.21484662576687116,0.5869004641567819,0.8214565387627252,0.19551872314303254
562,3952,CDH1,192090,119580;137215;167000;608089;,"[MIM:137215]Hereditary diffuse gastric cancer;[MIM:608089]Endometrial cancer;[MIM:167000]Ovarian cancer;[MIM:137215]Breast cancer, lobular;[MIM:119580]Blepharocheilodontic syndrome 1 [dominant?];",Cleft lip/palate;Blepharo-cheilo-odontic syndrome;Hereditary diffuse gastric cancer,Major susceptibility factor in;Disease-causing germline mutation(s) (loss of function) in;Disease-causing germline mutation(s) in,High light scatter reticulocyte percentage of red cells[27863252];Mean corpuscular hemoglobin[27863252];Reticulocyte fraction of red cells[27863252];Mean corpuscular volume[27863252];Reticulocyte count[27863252];Cutaneous malignant melanoma[26237428];Colorectal cancer[19011631];Late-onset Alzheimer's disease[27770636];High light scatter reticulocyte count[27863252];Ulcerative colitis[19915572];,0.8893251533742331,0.5314595152140279,0.6095014356564865,0.5112031921424187
563,3954,CDH3,114021,225280;601553;,"[MIM:601553]Hypotrichosis congenital with juvenile macular dystrophy;[MIM:225280]Ectodermal dysplasia, ectrodactyly, and macular dystrophy syndrome [recessive?];",Hypotrichosis with juvenile macular degeneration;EEM syndrome,Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in,Multiple sclerosis[24076602];Glycated hemoglobin levels[28898252];Red cell distribution width[27863252];Ulcerative colitis[28067908];,0.40773006134969325,0.11913357400722022,0.1678412947011224,0.1998158379373849
564,3962,CDH11,600023,211380;,[MIM:211380]Elsahy-Waters syndrome [recessive?];,Branchioskeletogenital syndrome,Disease-causing germline mutation(s) (loss of function) in,Glaucoma[30054594];Resting heart rate[27798624];Lung cancer in never smokers[28604730];Cerebrospinal T-tau levels[26252872];Hand grip strength[29691431];Schizophrenia[28991256];Blood protein levels[30072576];Very long-chain saturated fatty acid levels (fatty acid 20:0)[25378659];Venous thromboembolism adjusted for sickle cell variant rs77121243-T[28203683];Intraocular pressure[29617998;29617998;30054594;29785010];,0.21484662576687116,0.8878287777204745,0.04750717828243278,0.0
565,3969,CDH15,114019,612580;,"[MIM:612580]Mental retardation, autosomal dominant 3 [dominant?];",Autosomal dominant non-syndromic intellectual disability,Disease-causing germline mutation(s) in,Multiple sclerosis[24076602];Glycated hemoglobin levels[28898252];Red cell distribution width[27863252];Ulcerative colitis[28067908];,0.23865030674846627,0.0665291387313048,0.19890368050117463,0.240024554941682
566,3977,CDH23,605516,276900;601067;601386;617540;,"[MIM:601067]Usher syndrome 1D;[MIM:601067]Usher syndrome 1D/F;[MIM:601386]Deafness, autosomal recessive, 12 [recessive?];[MIM:617540]Pituitary adenoma 5, multiple types [dominant?];",Prolactinoma;Usher syndrome type 1;Familial isolated pituitary adenoma;Autosomal recessive non-syndromic sensorineural deafness type DFNB;TSH-secreting pituitary adenoma;Cushing disease,Major susceptibility factor in;Disease-causing germline mutation(s) (loss of function) in;Major susceptibility factor in;Disease-causing germline mutation(s) in;Major susceptibility factor in;Major susceptibility factor in,Progranulin levels[29186428];Vitiligo[22951725];Cerebrospinal fluid beta-site APP cleaving enzyme levels[29751835];Kidney function decline traits[25493955];Diisocyanate-induced asthma[25918132];Age at smoking initiation in chronic obstructive pulmonary disease[21685187];Monocyte count[27863252];Selective IgA deficiency[27723758];Blood protein levels[29875488;29875488];Disease progression in age-related macular degeneration[29346644];Diffusing capacity of the lung for carbon monoxide traits[30049742];Bipolar disorder (body mass index interaction)[24322204];,0.32380368098159507,0.5451263537906137,0.0010441138084051162,0.2895948434622468
567,3981,CDHR1,609502,613660;,[MIM:613660]Cone-rod dystrophy 15;,Retinitis pigmentosa;Cone rod dystrophy,Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in,,0.10711656441717791,0.08947911294481692,0.31323414252153486,0.08440761203192143
568,3997,CDK4,123829,609048;,"[MIM:609048]Melanoma, cutaneous malignant 3;",Familial melanoma;Well-differentiated liposarcoma;Dedifferentiated liposarcoma,Major susceptibility factor in;Role in the phenotype of;Role in the phenotype of,Celiac disease or Rheumatoid arthritis[21383967];Rheumatoid arthritis[24390342;24390342];,0.7422085889570552,0.5368746776689015,0.9368311145914905,0.5363720073664825
569,4004,CDK5RAP2,608201,604804;,"[MIM:604804]Microcephaly 3, primary, autosomal recessive [recessive?];",Autosomal recessive primary microcephaly,Disease-causing germline mutation(s) in,Rheumatoid arthritis[24782177;24782177];Response to statin therapy[20339536];Photic sneeze reflex[27182965];Asthma[27611488];,0.8930061349693251,0.5389375966993295,0.28713129731140696,0.0570902394106814
570,4006,CDK6,603368,612223;616080;,"[MIM:616080]Microcephaly 12, primary, autosomal recessive [recessive?];",Autosomal recessive primary microcephaly,Disease-causing germline mutation(s) in,Granulocyte percentage of myeloid white cells[27863252];Mean corpuscular volume[27863252];Lymphocyte percentage of white cells[27863252];Myeloid white cell count[27863252;27863252];Waist circumference adjusted for BMI (adjusted for smoking behaviour)[28443625];Sum basophil neutrophil counts[27863252;27863252];Eosinophil counts[27863252;27863252;29403010];Granulocyte count[27863252;27863252];Ischemic stroke[29531354;29531354];Neutrophil count[25096241;29403010;27863252;27863252];Hip circumference adjusted for BMI[25673412;25673412;25673412];White blood cell types[21738478];Waist circumference adjusted for BMI (joint analysis main effects and smoking interaction)[28443625];Pulse pressure[27618447];Height[19343178;23563607;20881960;18391952;18391950;18391951;25282103];Stroke[29531354;29531354];White blood cell count (basophil)[27863252;27863252];Waist circumference adjusted for BMI in non-smokers[28443625];Atrial fibrillation[30061737;29892015];Sum neutrophil eosinophil counts[27863252;27863252];Monocyte percentage of white cells[27863252];Red blood cell count[29403010];Sum eosinophil basophil counts[27863252;27863252;27863252];White blood cell count[21738479;20139978;25096241;29403010;27863252;27863252];Rheumatoid arthritis[18794853;24390342;24390342];Neutrophil percentage of white cells[27863252];Monocyte count[27863252;29403010];,0.6225766871165644,0.9223826714801444,0.9010702166536152,0.7516881522406385
571,4030,CDKL5,300203,300672;,"[MIM:300672]Epileptic encephalopathy, early infantile, 2;",Early infantile epileptic encephalopathy;West syndrome;Atypical Rett syndrome;CDKL5-related epileptic encephalopathy,Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in,,0.3168098159509202,0.9589994842702424,0.5854868180631689,0.7461632903621854
572,4031,CDKN1A,116899,,,Multiple endocrine neoplasia type 1,Candidate gene tested in,Electrocardiographic conduction measures[23463857];Glaucoma (primary open-angle)[29891935];QRS complex (Cornell)[27659466];Atrial fibrillation[30061737;29892015;29892015];Colorectal cancer[22634755];QRS duration[21076409;27577874;27577874;27659466;25035420];Triglycerides[27036123];Electrocardiographic traits[20062063];Ischemic stroke[29531354];Left ventricular fractional shortening[28394258];Coronary artery disease[29212778;29212778];,0.7531288343558282,0.2924187725631769,0.2793004437483686,0.611878453038674
573,4033,CDKN1B,600778,610755;,[MIM:610755]Multiple endocrine neoplasia 4;,Multiple endocrine neoplasia type 1;Multiple endocrine neoplasia type 4,Candidate gene tested in;Disease-causing germline mutation(s) (loss of function) in,Systemic lupus erythematosus[23273568];Mean arterial pressure[29403010];Prostate cancer[29892016];,0.7288343558282209,0.7542547705002579,0.12920908379013313,0.6345917740945365
574,4034,CDKN1C,600856,130650;614732;,"[MIM:130650]Beckwith-Wiedemann syndrome;[MIM:614732]Intrauterine growth retardation, metaphyseal dysplasia, adrenal hypoplasia congenita, and genital anomalies;",Beckwith-Wiedemann syndrome due to CDKN1C mutation;Silver-Russell syndrome due to a point mutation;Intrauterine growth restriction-short stature-early adult-onset diabetes syndrome;IMAGe syndrome,Disease-causing germline mutation(s) (loss of function) in;Disease-causing germline mutation(s) (gain of function) in;Disease-causing germline mutation(s) (gain of function) in;Disease-causing germline mutation(s) in,Calcium levels[20705733];,0.5911656441717792,0.8303249097472925,0.22004698512137824,0.0
575,4035,CDKN2A,600160,,,Li-Fraumeni syndrome;Melanoma and neural system tumor syndrome;Familial melanoma;Familial pancreatic carcinoma;Familial atypical multiple mole melanoma syndrome;Precursor B-cell acute lymphoblastic leukemia;Precursor T-cell acute lymphoblastic leukemia,Candidate gene tested in;Candidate gene tested in;Major susceptibility factor in;Major susceptibility factor in;Disease-causing germline mutation(s) in;Disease-causing somatic mutation(s) in;Disease-causing somatic mutation(s) in,"Myocardial infarction[17478679;26708285];Type 2 diabetes[18372903;19401414;17463249;17463249;17463246;17463248;21573907;20581827;24509480;23945395;23209189;26818947;29358691;27189021];Basal cell carcinoma[24403052;25855136];Acute lymphoblastic leukemia in childhood (B cell precursor)[29632299;29632299];Endometrial cancer[30093612];Lymphocyte counts[27863252];Glioblastoma[28346443];Multiple myeloma[27363682];Coronary artery calcification[23561647];Plateletcrit[27863252];Coronary heart disease (SNP X SNP interaction)[21626137];Nasopharyngeal carcinoma[26545403;26545403;26545403;26545403];Myocardial infarction (early onset)[19198609];Fasting plasma glucose[25187374];Intracranial aneurysm[18997786;20364137];Platelet count[22139419;27863252];Endometrial cancer ((endometrioid histology)[30093612];Melanoma[21983787;19578364;28212542];Abdominal aortic aneurysm[20622881];Endometriosis[23104006];Breast cancer[20453838;23535729;29059683];Intracranial, abdominal aortic or thoracic aortic aneurysm (pleiotropy)[27418160];Coronary heart disease[21971053;17554300;21378990];Coronary artery disease[21239051;26708285];Non-glioblastoma glioma[28346443];Inflammatory bowel disease[27569725];Glioma[19578367;21531791;28346443];White blood cell count[27863252];Esophageal squamous cell carcinoma[25129146];Monocyte count[27863252];Acute lymphoblastic leukemia (childhood)[29348612];",0.876319018404908,0.6518824136152656,0.8728791438266771,0.7220687538367097
576,4042,CDKN2B,600431,,,Multiple endocrine neoplasia type 1;Familial melanoma,Candidate gene tested in;Candidate gene tested in,"Myocardial infarction[17478679];Type 2 diabetes[18372903;22293688;19056611;19401414;17463249;17463249;17463246;17463248;21573907;22961080;20581827;24509480;23945395;26818947;29358691;27189021];Glaucoma[22792221];Basal cell carcinoma[24403052;27539887;25855136];Psychosis proneness (hypomanic personality scale and perceptual aberration scale)[28525603];Endometrial cancer[30093612];Glioblastoma (age-stratified)[30152087;30152087;30152087];Glioblastoma[28346443];Coronary artery calcification[22144573;23561647];Coronary heart disease (SNP X SNP interaction)[21626137];Glaucoma (primary open-angle)[22419738];Nasopharyngeal carcinoma[20512145;26545403;26545403;26545403];Myocardial infarction (early onset)[19198609];Fasting plasma glucose[25187374];Psychosis proneness (hypomanic personality scale and revised social anhedonia scale)[28525603];Intracranial aneurysm[18997786;20364137];Fasting blood glucose (BMI interaction)[22581228];Psychosis proneness (hypomanic personality scale)[28525603];Non-melanoma skin cancer[29739929];Endometrial cancer ((endometrioid histology)[30093612];Fasting blood glucose[22581228];Ankle-brachial index[22199011];Psychosis proneness (hypomanic personality scale and revised physical anhedonia scale)[28525603];Endometriosis[23104006];Breast cancer[20453838;23535729;29059683];Vertical cup-disc ratio[20548946];Intracranial, abdominal aortic or thoracic aortic aneurysm (pleiotropy)[27418160];Coronary heart disease[21971053;17554300;21378990;29615537];Coronary artery disease[21239051;29263402;29212778;26708285];Non-glioblastoma glioma[28346443];Inflammatory bowel disease[27569725];Chronic lymphocytic leukemia[23770605];Glioma[19578367;21531791;28346443];Carotid plaque burden[28282560];Cancer (pleiotropy)[27197191];Esophageal squamous cell carcinoma[25129146];Cancer[27197191];",0.4667484662576687,0.6931407942238267,0.9514487079091621,0.4562615101289134
577,4044,CDKN2C,603369,,,Multiple endocrine neoplasia type 1,Candidate gene tested in,Ischemic stroke (large artery atherosclerosis)[26732560];Atrial fibrillation[29290336];QRS complex (12-leadsum)[27659466];Ventricular ectopy[29618737];QRS duration[21076409;27577874;27577874;27659466];Ventricular ectopy or supraventricular ectopy (pleiotropy)[29618737];,0.5439263803680982,0.6879834966477566,0.8436439571913339,0.5197974217311234
578,4045,CDKN2D,600927,,,Familial melanoma,Candidate gene tested in,,0.4538650306748466,0.7233109850438371,0.9626729313495171,0.0
579,4051,CDON,608707,614226;,[MIM:614226]Holoprosencephaly 11;,Microform holoprosencephaly;Septopreoptic holoprosencephaly;Semilobar holoprosencephaly;Pituitary stalk interruption syndrome;Midline interhemispheric variant of holoprosencephaly;Lobar holoprosencephaly;Alobar holoprosencephaly,Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in,Alzheimer's disease (late onset)[22881374];Primary tooth development (time to first tooth eruption)[23704328];Lung function (FEV1)[28166213];Blood protein levels[28240269;29875488;30072576];,0.27361963190184047,0.4161939143888602,0.15661707126076743,0.07658072437077962
580,4074,CDSN,602593,146520;270300;,[MIM:146520]Hypotrichosis 2;[MIM:270300]Peeling skin syndrome 1;,Peeling skin syndrome type B;Hypotrichosis simplex of the scalp,Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in,Inflammatory bowel disease[28067908];Hematology traits[23263863];HIV-1 control[20041166];White blood cell count[21738480;20139978];Autism spectrum disorder or schizophrenia[28540026;28540026;28540026;28540026;28540026;28540026;28540026;28540026;28540026;28540026;28540026;28540026;28540026;28540026;28540026;28540026;28540026;28540026;28540026;28540026;28540026];Multiple myeloma[23955597];Schizophrenia[28991256];Blood protein levels[28240269];Takayasu arteritis[25604533];Ulcerative colitis[28067908];,0.7044171779141104,0.7109334708612687,0.04463586530931871,0.2837630448127686
581,4075,CDT1,605525,613804;,[MIM:613804]Meier-Gorlin syndrome 4;,Ear-patella-short stature syndrome,Disease-causing germline mutation(s) (loss of function) in,Mean corpuscular hemoglobin concentration[20139978;28017375;29403010];Mean corpuscular volume[29403010];Glycated hemoglobin levels[28898252;28898252];Hair color[26926045];Hemoglobin A1c levels[29403010];,0.6357055214723927,0.2735946364105209,0.4839467501957713,0.18262737875997545
582,4116,CEACAM16,614591,614614;,"[MIM:614614]Deafness, autosomal dominant, 4B [dominant?];",Autosomal dominant non-syndromic sensorineural deafness type DFNA,Disease-causing germline mutation(s) in,Alzheimer's disease (late onset)[23565137];,0.038773006134969326,0.3140794223826715,0.6964239102062125,0.3601903007980356
583,4133,CEBPA,116897,601626;,"[MIM:601626]Leukemia, acute myelogenous;",Acute myeloid leukemia with CEBPA somatic mutations;Inherited acute myeloid leukemia;Acute myeloid leukemia with t(8;21)(q22;q22) translocation,Disease-causing somatic mutation(s) in;Disease-causing germline mutation(s) in;Biomarker tested in,"Waist-to-hip ratio adjusted for BMI (adjusted for smoking behaviour)[28443625];Allergic disease (asthma, hay fever or eczema)[29083406];White blood cell count (basophil)[28158719;29403010];Waist-to-hip ratio adjusted for BMI in active individuals[28448500;28448500;28448500;28448500;28448500];Allergic rhinitis[30013184];Waist-to-hip ratio adjusted for BMI (joint analysis for main effect and physical activity interaction)[28448500;28448500;28448500;28448500];Red blood cell count[29403010];Waist-to-hip ratio adjusted for body mass index[28448500;28448500;28448500;28448500;25673412;25673412;25673412;25673412;25673412;25673412];",0.780122699386503,0.7444559051057246,0.9441399112503263,0.0
584,4138,CEBPE,600749,245480;,[MIM:245480]Specific granule deficiency 1 [recessive?];,Recurrent infection due to specific granule deficiency,Disease-causing germline mutation(s) (loss of function) in,Granulocyte percentage of myeloid white cells[27863252];White blood cell count (basophil)[28158719;29403010;27863252];Acute lymphoblastic leukemia in childhood (B cell precursor)[29632299];Basophil percentage of white cells[27863252;27863252];Eosinophil counts[27863252];Monocyte percentage of white cells[27863252;27863252];Basophil percentage of granulocytes[27863252;27863252];Sum eosinophil basophil counts[27863252;27863252];Eosinophil percentage of granulocytes[27863252];Neutrophil percentage of white cells[27863252];Monocyte count[27863252;29403010];Acute lymphoblastic leukemia (childhood)[23512250;22076464;22076464;19684604;29348612];Neutrophil percentage of granulocytes[27863252;27863252];Acute lymphoblastic leukemia (B-cell precursor)[23996088];Eosinophil percentage of white cells[27863252;27863252];,0.4538650306748466,0.42418772563176893,0.811015400678674,0.3525168815224064
585,4147,CEL,114840,606391;609812;,,MODY,Disease-causing germline mutation(s) in,Blood protein levels[29875488;30072576];Early-onset Parkinson's disease[28256260];,0.038773006134969326,0.19391438886023724,0.4622813886713652,0.0
586,4178,CENPE,117143,616051;,"[MIM:616051]Microcephaly 13, primary, autosomal recessive [recessive?];",Seckel syndrome,Disease-causing germline mutation(s) in,Schizophrenia[28991256];Chlamydia trachomatis seropositivity[29967566];Testicular germ cell tumor[23666240;25877299;28604732;28604728];,0.6822085889570552,0.854564208354822,0.25110937092143043,0.15316144874155924
587,4179,CENPF,600236,243605;,[MIM:243605]Stromme syndrome [recessive?];,Lethal fetal brain malformation-duodenal atresia-bilateral renal hypoplasia syndrome;Stromme syndrome,Disease-causing germline mutation(s) (loss of function) in;Disease-causing germline mutation(s) in,Response to antineoplastic agents[21659360];Lung function (FVC)[30061609];,0.6930061349693252,0.006704486848891181,0.012268337248760116,0.03130755064456722
588,4183,CENPJ,609279,608393;613676;,"[MIM:608393]Microcephaly 6, primary, autosomal recessive [recessive?];[MIM:613676]Seckel syndrome 4 [recessive?];",Autosomal recessive primary microcephaly;Seckel syndrome,Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in,Stroke[26089329];,0.9339877300613497,0.026817947395564725,0.3270686504829026,0.03192142418661756
589,4203,CEP19,615586,615703;,[MIM:615703]Morbid obesity and spermatogenic failure [recessive?];,Obesity due to CEP19 deficiency,Disease-causing germline mutation(s) (loss of function) in,"Allergic disease (asthma, hay fever or eczema)[29083406];",0.6391411042944786,0.44636410520887054,0.17410597755155313,0.0
590,4204,CEP41,610523,614464;,[MIM:614464]Joubert syndrome 15 [recessive?];,Joubert syndrome;Joubert syndrome with ocular defect,Disease-causing germline mutation(s) (loss of function) in;Disease-causing germline mutation(s) (loss of function) in,Waist-to-hip ratio adjusted for BMI (age >50)[26426971];Antipsychotic drug-induced QTc interval change in schizophrenia[29064910];Waist-to-hip ratio adjusted for BMI x sex x age interaction (4df test)[26426971];,0.8739877300613497,0.2377514182568334,0.6272513703993735,0.0
591,4206,CEP55,610000,236500;,"[MIM:236500]Multinucleated neurons, anhydramnios, renal dysplasia, cerebellar hypoplasia and hydranencephaly [recessive?];",Meckel syndrome;Multinucleated neurons-anhydramnios-renal dysplasia-cerebellar hypoplasia-hydranencephaly syndrome,Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) (loss of function) in,,0.9413496932515337,0.36823104693140796,0.12738188462542416,0.10205647636586863
592,4207,CEP57,607951,614114;,[MIM:614114]Mosaic variegated aneuploidy syndrome 2;,Mosaic variegated aneuploidy syndrome,Disease-causing germline mutation(s) in,Intelligence (MTAG)[29326435];Rheumatoid arthritis[24390342;24390342];Erosive tooth wear (severe vs non-severe)[29898447];Cognitive ability (MTAG)[29186694];,0.8679754601226994,0.47962867457452296,0.19524928217175672,0.24754450583179866
593,4210,CEP63,614724,614728;,[MIM:614728]Seckel syndrome 6 [recessive?];,Autosomal recessive primary microcephaly,Disease-causing germline mutation(s) in,Waist circumference adjusted for BMI (joint analysis main effects and physical activity interaction)[28448500;28448500;28448500];Waist circumference adjusted for BMI in non-smokers[28443625;28443625;28443625];Waist circumference adjusted for BMI (joint analysis main effects and smoking interaction)[28443625;28443625;28443625];Late-onset Alzheimer's disease[27770636];Waist circumference adjusted for BMI (adjusted for smoking behaviour)[28443625;28443625;28443625];Height[18391952];Waist circumference adjusted for body mass index[28448500;28448500;28448500;25673412;25673412;25673412];Waist circumference adjusted for BMI in active individuals[28448500;28448500;28448500];Neurocognitive impairment in HIV-1 infection (dichotomous)[28447399];,0.9306748466257668,0.017276946879834967,0.12137823022709475,0.000767341927562922
594,4215,CEP78,617110,617236;,[MIM:617236]Cone-rod dystrophy and hearing loss [recessive?];,Usher syndrome type 3,Disease-causing germline mutation(s) in,,0.8949693251533742,0.08200103145951522,0.5760897937875228,0.020411295273173726
595,4216,CEP83,615847,615862;,[MIM:615862]Nephronophthisis 18 [recessive?];,Infantile nephronophthisis,Disease-causing germline mutation(s) in,Sodium levels[29403010];Chloride levels[29403010];,0.7452760736196319,0.47524497163486334,0.0,0.0
596,4223,CEP104,616690,616781;,[MIM:616781]Joubert syndrome 25 [recessive?];,Joubert syndrome,Disease-causing germline mutation(s) in,Mean corpuscular volume[27863252];,0.6650306748466258,0.5116039195461578,0.13469068128425998,0.0
597,4225,CEP120,613446,616300;617761;,[MIM:616300]Short-rib thoracic dysplasia 13 with or without polydactyly [recessive?];[MIM:617761]Joubert syndrome 31 [recessive?];,Jeune syndrome;Joubert syndrome;Joubert syndrome with ocular defect,Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in,Waist circumference[26785701;26785701;26785701];Virologic severity in Herpes simplex virus type 2 infection[29535370];Body mass index[28892062;28892062];Height[20881960;25429064];Coronary artery disease[29212778];,0.8844171779141105,0.43914388860237236,0.02453667449752023,0.043738489871086556
598,4226,CEP126,614634,,,Monomelic amyotrophy,Major susceptibility factor in,Systemic sclerosis[29293537];Response to methotrexate in juvenile idiopathic arthritis[24709693];,0.5261349693251534,0.07271789582258896,0.0,0.0
599,4229,CEP135,611423,614673;,"[MIM:614673]Microcephaly 8, primary, autosomal recessive [recessive?];",Autosomal recessive primary microcephaly,Disease-causing germline mutation(s) in,Bone mineral density (hip)[30172743];Daytime sleep phenotypes[27126917];Femoral neck bone mineral density[30172743];Waist-to-hip ratio adjusted for BMI x sex x age interaction (4df test)[26426971];,0.934723926380368,0.2882929345023208,0.4844688070999739,0.006599140577041129
600,4230,CEP152,613529,613823;614852;,"[MIM:614852]Microcephaly 9, primary, autosomal recessive [recessive?];[MIM:613823]Seckel syndrome 5 [recessive?];",Autosomal recessive primary microcephaly;Seckel syndrome,Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in,Insomnia[23728906];Obesity-related traits[23251661];,0.9388957055214724,0.3563692625064466,0.211433046202036,0.0216390423572744
601,4232,CEP164,614848,614845;,[MIM:614845]Nephronophthisis 15 [recessive?];,Senior-Loken syndrome,Disease-causing germline mutation(s) in,Pulse pressure[28135244];,0.9150920245398773,0.3001547189272821,0.09631949882537197,0.09223449969306323
602,4239,CEP290,610142,610188;610189;611134;611755;615991;,[MIM:610188]Joubert syndrome 5;[MIM:610189]Senior-Loken syndrome 6;[MIM:611755]Leber congenital amaurosis 10;[MIM:611134]Meckel syndrome 4;[MIM:615991]Bardet-Biedl syndrome 14 [recessive?];,Meckel syndrome;Joubert syndrome with oculorenal defect;Senior-Loken syndrome;Leber congenital amaurosis;Bardet-Biedl syndrome,Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in,Mild influenza (H1N1) infection[26379185];Clozapine-induced agranulocytosis[25187353];,0.9415950920245398,0.061371841155234655,0.12894805533803186,0.2213014119091467
603,4248,CERKL,608381,608380;,[MIM:608380]Retinitis pigmentosa 26;,Retinitis pigmentosa,Disease-causing germline mutation(s) in,Response to iloperidone treatment (QT prolongation)[18521091];White blood cell count[21738480];Psychosis proneness (perceptual aberration scale and revised social anhedonia scale)[28525603];,0.21484662576687116,0.021144920061887573,0.19237796919864264,0.012430939226519336
604,4252,CERS1,606919,616230;,"[MIM:616230]Epilepsy, progressive myoclonic 8;",Progressive myoclonic epilepsy type 8,Disease-causing germline mutation(s) in,,0.7226993865030675,0.6619391438886024,0.9477943095797442,0.0
605,4254,CERS3,615276,615023;,,Ichthyosis-short stature-brachydactyly-microspherophakia syndrome;Congenital non-bullous ichthyosiform erythroderma,Role in the phenotype of;Disease-causing germline mutation(s) in,Cotinine glucuronidation[25293881];,0.038773006134969326,0.0,0.47872618115374577,0.0
606,4272,CETP,118470,143470;,[MIM:143470]Hyperalphalipoproteinemia 1;,Cholesterol-ester transfer protein deficiency,Disease-causing germline mutation(s) in,"Biochemical measures[19260141];Advanced age-related macular degeneration[26691988;26691988];Blood metabolite levels[24816252;24816252];Triglyceride levels[28334899;29403010];Metabolic syndrome[20694148;22399527;21386085];Lipoprotein-associated phospholipase A2 activity and mass[22003152;23118302];Exudative age-related macular degeneration[25629512;25629512];Total cholesterol levels[29403010;28334899;28334899;28334899];Cardiovascular risk factors[20838585];Lipid traits[24023260;24023261;24386095];HDL Cholesterol in HIV-infection[25884002];Cardiovascular disease risk factors[21943158];Cholesterol, total[20686565;24097068;26582766;24886709];Hematological and biochemical traits[20139978];Coronary artery disease (myocardial infarction, percutaneous transluminal coronary angioplasty, coronary artery bypass grafting, angina or chromic ischemic heart disease)[28714975];Apolipoprotein A1 levels[17463246];Cholesteryl ester transfer protein levels[29728394;29728394;29728394];Triglycerides[20686565;24097068;25961943];Metabolite levels (lipoprotein measures)[27005778];Coronary artery disease[29212778;29212778;29212778];Cholesterol[20066028];HDL cholesterol[21909109;20686565;20864672;18193044;19060911;19060910;23726366;23726366;23505323;21347282;19060906;19359809;20031538;20031564;24097068;26780889;25961943;26582766;24886709;28270201;18193043;18193043;18193043;29404214;29404214;29404214];HDL cholesterol levels[26763881;28334899;17463246;28334899;28334899];Lipid metabolism phenotypes[22286219;19936222;19936222;19936222;19936222;19936222;19936222;19936222;19936222;19936222;19936222;19936222;19936222;19936222];Age-related macular degeneration[21665990;23455636];C-reactive protein levels or HDL-cholesterol levels (pleiotropy)[27286809];C-reactive protein levels or triglyceride levels (pleiotropy)[27286809];Diisocyanate-induced asthma[25918132];Metabolite levels[22916037];LDL cholesterol levels[28334899];Metabolic syndrome (bivariate traits)[21386085;21386085;21386085];LDL cholesterol[20686565;24097068;25961943];High density lipoprotein cholesterol levels[28548082;29403010;30108155];Waist circumference and related phenotypes[18454146];HDL Cholesterol - Triglycerides (HDLC-TG)[21386085];Response to statins (HDL cholesterol change)[27587472];Low high density lipoprotein cholesterol levels[26879886];",0.16220858895705523,0.02320783909231563,0.442443226311668,0.02961939840392879
607,4275,CFAP43,617558,617592;,,Non-syndromic male infertility due to sperm motility disorder,Disease-causing germline mutation(s) (loss of function) in,Attention deficit hyperactivity disorder[18839057];,0.038773006134969326,0.1263537906137184,0.0,0.0
608,4276,CFAP44,617559,617593;,,Non-syndromic male infertility due to sperm motility disorder,Disease-causing germline mutation(s) (loss of function) in,Response to simvastatin treatment (PCSK9 protein level change)[25089948];Colorectal cancer[29228715];Prostate cancer[23535732];,0.5571779141104295,0.5696235172769469,0.0,0.0
609,4281,CFAP52,609804,,,Situs inversus totalis,Disease-causing germline mutation(s) in,,0.2498159509202454,0.4963898916967509,0.0,0.0
610,4282,CFAP53,614759,614779;,,Situs ambiguus;Situs inversus totalis,Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in,,0.28662576687116564,0.037132542547705004,0.0,0.0
611,4289,CFAP69,617949,,,Non-syndromic male infertility due to sperm motility disorder,Disease-causing germline mutation(s) in,,0.038773006134969326,0.15446106240330068,0.0,0.0
612,4304,CFAP298,615494,615500;,"[MIM:615500]Ciliary dyskinesia, primary, 26;",Primary ciliary dyskinesia,Disease-causing germline mutation(s) in,,0.038773006134969326,0.351985559566787,0.0,0.0
613,4306,CFAP300,618058,,,Primary ciliary dyskinesia,Disease-causing germline mutation(s) (loss of function) in,Post bronchodilator FEV1/FVC ratio[26634245];,0.038773006134969326,0.4847859721505931,0.0,0.0
614,4308,CFB,138470,603075;612924;615561;,[MIM:612924]Hemolytic uremic syndrome atypical 4;[MIM:615561]Complement factor B deficiency;,Atypical hemolytic-uremic syndrome with B factor anomaly,Disease-causing germline mutation(s) in,Chronic hepatitis B infection[25802187];Hematology traits[23263863];Advanced age-related macular degeneration[26691988;26691988;26691988;26691988];Autism spectrum disorder or schizophrenia[28540026;28540026;28540026;28540026;28540026;28540026;28540026;28540026;28540026;28540026;28540026;28540026;28540026;28540026;28540026;28540026];Blood protein levels[28240269;28240269;28240269;28240269;29875488;29875488;29875488;29875488;30072576;30072576;30072576;30072576;30072576;30072576;30072576;30072576;30072576];Age-related macular degeneration (geographic atrophy)[22705344];Disease progression in age-related macular degeneration[29346644];Coronary artery disease[29212778];Type 1 diabetes and autoimmune thyroid diseases[25936594];Inflammatory bowel disease[28067908];Rosacea symptom severity[29771307];Age-related macular degeneration (extreme sampling)[23577725];Age-related macular degeneration[22694956;23577725;21665990;20385826;20385819;20385819;23455636];Prostate cancer[23535732];Age-related macular degeneration (choroidal neovascularisation)[22705344];Ulcerative colitis[24837172;28067908];,0.5766871165644172,0.04538421866941723,0.3513442965283216,0.47068753836709637
615,4309,CFC1,605194,605376;,"[MIM:605376]Heterotaxy, visceral, 2, autosomal;",Situs ambiguus;Biliary atresia with splenic malformation syndrome;Isolated congenitally uncorrected transposition of the great arteries;Congenitally uncorrected transposition of the great arteries with cardiac malformation;Congenitally uncorrected transposition of the great arteries with coarctation,Candidate gene tested in;Candidate gene tested in;Candidate gene tested in;Candidate gene tested in;Candidate gene tested in,,0.038773006134969326,0.5603403816400206,0.7922213521273819,0.0
616,4311,CFD,134350,613912;,[MIM:613912]Complement factor D deficiency;,Recurrent Neisseria infections due to factor D deficiency,Disease-causing germline mutation(s) in,,0.5631901840490797,0.32723053120165035,0.490211433046202,0.0
617,4313,CFH,134370,126700;235400;609814;610698;,"[MIM:609814]Complement factor H deficiency;[MIM:235400]Hemolytic uremic syndrome atypical 1;[MIM:610698]Macular degeneration, age-related, 4;",Immunodeficiency with factor H anomaly;HELLP syndrome;De novo thrombotic microangiopathy after kidney transplantation;Immunoglobulin-mediated membranoproliferative glomerulonephritis;Familial drusen;Dense deposit disease;Atypical hemolytic-uremic syndrome with H factor anomaly,Disease-causing germline mutation(s) in;Candidate gene tested in;Biomarker tested in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in,Advanced age-related macular degeneration[26691988;26691988;26691988;26691988;26691988;26691988;26691988;26691988];Disease progression to choroidal neovascularization form in age-related macular degeneration[29346644];Matrix metalloproteinase-8 levels[29212897];Sub-foveal choroidal thickness[29844195];Blood protein levels[28240269;28240269;28240269;28240269;28240269;28240269;28240269;28240269;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;30072576;30072576;30072576;30072576;30072576;30072576;30072576;30072576;30072576;30072576;30072576];Age-related macular degeneration (geographic atrophy)[22705344];Disease progression in age-related macular degeneration[29346644];Chronic central serous retinopathy[30073298];Exudative age-related macular degeneration[25629512];Fuchs's corneal dystrophy[28358029];Nephropathy[21399633];Systemic lupus erythematosus[28714469];Age-related macular degeneration (extreme sampling)[23577725];Age-related macular degeneration[20861866;15761122;23577725;21665990;22694956;20385826;20385826;20385819;20385819;23326517;23326517;23455636;23536807];Serum C3d:C3 ratio (systemic complement activation)[29398083];Neovascular age-related macular degeneration[28703135;28703135];Disease progression to geographic atrophy form in age-related macular degeneration[29346644];Circulating myeloperoxidase levels (serum)[23620142];Post bronchodilator FEV1/FVC ratio in COPD[26634245;26634245;26634245;26634245;26634245;26634245;26634245;26634245;26634245;26634245;26634245;26634245;26634245;26634245;26634245;26634245;26634245;26634245;26634245;26634245;26634245];Age-related macular degeneration (choroidal neovascularisation)[22705344];Complement C3 and C4 levels[23028341];Meningococcal disease[20694013];,0.5964417177914111,0.7826199071686436,0.26677107804750716,0.4817372621240025
618,4314,CFHR1,134371,235400;,[MIM:235400]Hemolytic uremic syndrome atypical 1;,C3 glomerulonephritis;Dense deposit disease;Atypical hemolytic-uremic syndrome with anti-factor H antibodies,Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in,Nephropathy[21399633];IgA nephropathy[25305756];Advanced age-related macular degeneration[26691988];Matrix metalloproteinase-8 levels[29212897];Blood protein levels[30072576;30072576;30072576;30072576;30072576;30072576;30072576;30072576;30072576;30072576;30072576;30072576];Complement C3 and C4 levels[23028341];,0.14576687116564419,0.14620938628158844,0.6953797963978073,0.1329036218538981
619,4316,CFHR3,605336,235400;,,Atypical hemolytic-uremic syndrome with anti-factor H antibodies,Disease-causing germline mutation(s) in,Nephropathy[21399633];IgA nephropathy[25305756;25305756;25305756];Advanced age-related macular degeneration[26691988];Age-related macular degeneration[23536807];Complement C3 and C4 levels[23028341];Meningococcal disease[20694013];,0.12711656441717792,0.13176895306859207,0.40850952753850167,0.3337937384898711
620,4317,CFHR4,605337,,,Atypical hemolytic-uremic syndrome with anti-factor H antibodies,Disease-causing germline mutation(s) in,Phenytoin-induced maculopapular exanthema[29288229];Nephropathy[21399633];Age-related macular degeneration (extreme sampling)[23577725];Age-related macular degeneration[23577725;23536807];Serum C3d:C3 ratio (systemic complement activation)[29398083];Matrix metalloproteinase-8 levels[29212897];Blood protein levels[28240269;28240269;28240269;29875488;29875488;30072576;30072576;30072576;30072576;30072576;30072576;30072576;30072576;30072576;30072576;30072576;30072576;30072576;30072576;30072576;30072576];End-stage coagulation[23381943;23381943;23381943;23381943;23381943];,0.10711656441717791,0.3447653429602888,0.5473766640563822,0.0
621,4318,CFHR5,608593,614809;,[MIM:614809]CFHR5 deficiency;,C3 glomerulonephritis;Atypical hemolytic-uremic syndrome with anti-factor H antibodies,Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in,Nephropathy[21399633];Age-related macular degeneration (extreme sampling)[23577725];Age-related macular degeneration[23577725;23536807];Matrix metalloproteinase-8 levels[29212897];Blood protein levels[28240269;28240269;29875488;29875488;29875488;29875488;30072576;30072576;30072576;30072576;30072576;30072576;30072576;30072576;30072576;30072576;30072576;30072576;30072576;30072576;30072576;30072576;30072576;30072576;30072576;30072576;30072576;30072576;30072576;30072576;30072576;30072576;30072576;30072576;30072576;30072576;30072576;30072576;30072576;30072576;30072576];Lupus nephritis in systemic lupus erythematosus[24925725];Asthma[29273806];,0.17791411042944785,0.009283135636926251,0.3873662229182981,0.2733271945979128
622,4319,CFI,217030,610984;612923;615439;,"[MIM:610984]Complement factor I deficiency;[MIM:615439]Macular degeneration, age-related, 13;",Immunodeficiency with factor I anomaly;HELLP syndrome;De novo thrombotic microangiopathy after kidney transplantation;Familial drusen;Atypical hemolytic-uremic syndrome with I factor anomaly,Disease-causing germline mutation(s) in;Candidate gene tested in;Biomarker tested in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in,Advanced age-related macular degeneration[26691988;26691988];Age-related macular degeneration[21665990;20385826;20385819;23455636];Blood protein levels[28240269;29875488;30072576];Fasting insulin (dietary factor interaction)[24204828];Post bronchodilator FEV1/FVC ratio in COPD[26634245];Age-related macular degeneration (geographic atrophy)[22705344];Homeostasis model assessment of insulin resistance (dietary factor interaction)[24204828];,0.2585276073619632,0.1446621970087674,0.6392586791960324,0.7038060159607121
623,4329,CFL2,601443,610687;,[MIM:610687]Nemaline myopathy 7;,Typical nemaline myopathy,Disease-causing germline mutation(s) in,Atrial fibrillation[30061737;29892015;29892015];,0.7884662576687117,0.4187725631768953,0.9919081179848603,0.3113873542050338
624,4334,CFP,300383,312060;,[MIM:312060]Properdin deficiency;,Properdin deficiency,Disease-causing germline mutation(s) in,,0.4,0.5814853017019082,0.6901592273557818,0.5099754450583179
625,4335,CFTR,602421,219700;277180;,[MIM:219700]Cystic fibrosis [recessive?];[MIM:277180]Congenital bilateral absence of the vas deferens;,Cystic fibrosis;Hereditary chronic pancreatitis;Congenital bilateral absence of vas deferens;Male infertility with azoospermia or oligozoospermia due to single gene mutation;Aquagenic palmoplantar keratoderma;Idiopathic bronchiectasis,Disease-causing germline mutation(s) (loss of function) in;Candidate gene tested in;Disease-causing germline mutation(s) in;Major susceptibility factor in;Candidate gene tested in;Candidate gene tested in,Glaucoma[30054594];Barrett's esophagus  or Esophageal adenocarcinoma[27527254];Gout[22179738];Response to platinum-based chemotherapy in non-small-cell lung cancer[22872573];Response to methotrexate in juvenile idiopathic arthritis[24709693;24709693];Waist-to-hip ratio adjusted for BMI[26426971];Waist-to-hip ratio adjusted for BMI x sex x age interaction (4df test)[26426971];,0.7105521472392639,0.3960804538421867,0.33437744714173845,0.9361571516267649
626,4361,CHAMP1,616327,616579;,"[MIM:616579]Mental retardation, autosomal dominant 40 [dominant?];",Autosomal dominant non-syndromic intellectual disability,Disease-causing germline mutation(s) in,Blood protein levels[28240269;30072576;30072576];,0.7900613496932515,0.5170190820010314,0.5619942573740537,0.0
627,4362,CHAT,118490,254210;,"[MIM:254210]Myasthenic syndrome, congenital, 6, presynaptic [recessive?];",Presynaptic congenital myasthenic syndromes,Disease-causing germline mutation(s) (loss of function) in,Pulse pressure x alcohol consumption interaction (2df test)[29912962];Interleukin-1-receptor antagonist levels[22205395];Glaucoma (primary angle closure)[27064256;27064256];,0.22687116564417178,0.16787003610108303,0.14147742103889324,0.9788213627992634
628,4389,CHCHD10,615903,615048;615911;616209;,"[MIM:615048]Spinal muscular atrophy, Jokela type [dominant?];[MIM:616209]Myopathy, isolated mitochondrial, autosomal dominant [dominant?];",Amyotrophic lateral sclerosis;Frontotemporal dementia with motor neuron disease;Lower motor neuron syndrome with late-adult onset;Autosomal dominant mitochondrial myopathy with exercise intolerance,Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in,,0.4936196319018405,0.47988653945332643,0.38893239363090576,0.0
629,4392,CHD2,602119,615369;,"[MIM:615369]Epileptic encephalopathy, childhood-onset;",Lennox-Gastaut syndrome;Myoclonic-astastic epilepsy,Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in,Amyotrophic lateral sclerosis (sporadic)[24529757];,0.50920245398773,0.8821557503867973,0.5426781519185592,0.8164518109269491
630,4397,CHD7,608892,214800;608765;612370;,[MIM:608765]Idiopathic scoliosis 3;[MIM:612370]Hypogonadotropic hypogonadism 5 with or without anosmia;,CHARGE syndrome;Kallmann syndrome;Normosmic congenital hypogonadotropic hypogonadism;Omenn syndrome,Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in,Granulocyte percentage of myeloid white cells[27863252];Lymphocyte percentage of white cells[27863252];Myeloid white cell count[27863252];Urinary albumin excretion (no hypertensive medication)[30220432];Basophil percentage of white cells[27863252];Sum basophil neutrophil counts[27863252];Eosinophil counts[27863252;27863252;29403010];Sum neutrophil eosinophil counts[27863252];Monocyte percentage of white cells[27863252];Granulocyte count[27863252];Neutrophil count[29403010;27863252];Basophil percentage of granulocytes[27863252];Sum eosinophil basophil counts[27863252;27863252];Eosinophil percentage of granulocytes[27863252];Pulmonary function decline[22424883];Menopause (age at onset)[26414677];White blood cell count[29403010;27863252];Neutrophil percentage of white cells[27863252];Refractive error[23396134];Neutrophil percentage of granulocytes[27863252];Eosinophil percentage of white cells[27863252];,0.5244171779141105,0.6467251160391955,0.35917515009136,0.9266421117249847
631,4402,CHEK2,604373,114480;176807;259500;609265;,[MIM:609265]Li-Fraumeni syndrome 2;[MIM:176807]Prostate cancer;[MIM:259500]Osteogenic sarcoma;[MIM:114480]Breast cancer;,Li-Fraumeni syndrome;Familial prostate cancer;Hereditary breast and ovarian cancer syndrome;Osteosarcoma,Candidate gene tested in;Major susceptibility factor in;Candidate gene tested in;Candidate gene tested in,Esophageal cancer and gastric cancer[20729852];Optic cup area[25631615;25631615;28073927;28073927];Lung cancer[24880342;24880342];Breast size[22747683];Plateletcrit[27863252];Vertical cup-disc ratio[25241763;20548946;28073927;28073927];Breast cancer[23535729;29059683];Glaucoma (primary open-angle)[29891935];Menopause (age at onset)[26414677];Pancreatic cancer[25086665];Esophageal cancer (squamous cell)[22960999];Esophageal squamous cell carcinoma[25129146];Optic disc area[28073927;28073927];Prostate cancer[29117387];,0.6622085889570553,0.1000515729757607,0.5888801879404855,0.4843462246777164
632,4423,CHKB,612395,,,Megaconial congenital muscular dystrophy;Proximal myopathy with focal depletion of mitochondria,Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in,Blood protein levels[30072576];,0.5561963190184049,0.17947395564724083,0.8235447663795353,0.11832412523020258
633,4429,CHM,300390,303100;,[MIM:303100]Choroideremia;,Choroideremia,Disease-causing germline mutation(s) in,Smooth-surface caries[24556642];Pit-and-Fissure caries[24556642];,0.6847852760736196,0.9290871583290355,0.5677368833202819,0.0
634,4431,CHMP1A,164010,614961;,[MIM:614961]Pontocerebellar hypoplasia 8 [recessive?];,Pontocerebellar hypoplasia type 8,Disease-causing germline mutation(s) (loss of function) in,Low tan response[29739929;29739929];,0.7379141104294479,0.2607013924703455,0.38449490994518404,0.6106507059545734
635,4437,CHMP2B,609512,600795;614696;,"[MIM:600795]Frontotemporal dementia, chromosome 3-linked;[MIM:614696]Amyotrophic lateral sclerosis 17;",Amyotrophic lateral sclerosis;Behavioral variant of frontotemporal dementia;Semantic dementia;Progressive non-fluent aphasia,Disease-causing germline mutation(s) in;Major susceptibility factor in;Major susceptibility factor in;Major susceptibility factor in,Tourette's syndrome or obsessive-compulsive disorder[25158072];,0.7358282208588957,0.2181536874677669,0.7206995562516314,0.2895948434622468
636,4440,CHMP4B,610897,605387;,"[MIM:605387]Cataract 31, multiple types;",Early-onset posterior subcapsular cataract;Early-onset posterior polar cataract,Disease-causing germline mutation(s) (gain of function) in;Disease-causing germline mutation(s) in,Stearic acid (18:0) levels[23362303];Loneliness[27629369];,0.8984049079754601,0.9022692109334709,0.9715478987209606,0.0
637,4446,CHN1,118423,604356;,[MIM:604356]Duane retraction syndrome 2;,Duane retraction syndrome,Disease-causing germline mutation(s) in,Post bronchodilator FEV1[26634245];,0.26588957055214724,0.6346054667354306,0.8825371965544244,0.3769183548189073
638,4459,CHRDL1,300350,309300;,"[MIM:309300]Megalocornea 1, X-linked;",Isolated congenital megalocornea,Disease-causing germline mutation(s) in,,0.19190184049079756,0.5497679216090768,0.5617332289219525,0.21731123388581952
639,4466,CHRM3,118494,100100;,[MIM:100100]Prune belly syndrome;,Prune belly syndrome,Disease-causing germline mutation(s) (loss of function) in,Hypertension[17554300];Electroencephalogram traits[25387704];Lung function (FEV1/FVC)[28166213];Sulfasalazine-induced agranulocytosis[28762467];Interleukin-6 (red blood cell fatty acid level interaction)[28820441];Colorectal cancer[29228715;29228715];Depression in smokers[30219690];Thiazide-induced adverse metabolic effects in hypertensive patients[23400010];Platelet count[21507922];Epilepsy (generalized)[22949513];Post bronchodilator FEV1[26634245;26634245;26634245;26634245];,0.45680981595092024,0.741619391438886,0.6496998172800835,0.0
640,4471,CHRNA1,100690,253290;254200;601462;608930;,"[MIM:601462]Myasthenic syndrome, congenital, 1A, slow-channel;[MIM:608930]Myasthenic syndrome, congenital, 1B, fast-channel;",Lethal multiple pterygium syndrome;Postsynaptic congenital myasthenic syndromes;Postsynaptic congenital myasthenic syndromes,Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) (loss of function) in;Disease-causing germline mutation(s) (gain of function) in,Atrial fibrillation[29892015;29892015];,0.12711656441717792,0.13408973697782361,0.4894283476898982,0.6962860650705954
641,4472,CHRNA2,118502,610353;,"[MIM:610353]Epilepsy, nocturnal frontal lobe, 4 [dominant?];[MIM:610353]Seizures, benign familial infantile, 6 [dominant?];",Autosomal dominant nocturnal frontal lobe epilepsy,Disease-causing germline mutation(s) in,Autism spectrum disorder or schizophrenia[28540026];Lung cancer[28604730];Response to zileuton treatment in asthma (FEV1 change interaction)[26031901];,0.10711656441717791,0.46518824136152653,0.7757765596450013,0.488182934315531
642,4474,CHRNA4,118504,600513;,"[MIM:600513]Epilepsy, nocturnal frontal lobe, 1 [dominant?];",Autosomal dominant nocturnal frontal lobe epilepsy,Disease-causing germline mutation(s) in,Emphysema imaging phenotypes[26030696;26030696];Chronic obstructive pulmonary disease[19300482];Nicotine dependence[26440539];,0.30319018404907977,0.2779783393501805,0.7481075437222657,0.7915899324739104
643,4477,CHRNA7,118511,,,15q13.3 microdeletion syndrome,Role in the phenotype of,,0.26588957055214724,0.7906137184115524,0.7731662751239885,0.0
644,4480,CHRNB1,100710,616313;616314;,"[MIM:616313]Myasthenic syndrome, congenital, 2A, slow-channel;[MIM:616314]Myasthenic syndrome, congenital, 2C, associated with acetylcholine receptor deficiency [recessive?];",Postsynaptic congenital myasthenic syndromes;Postsynaptic congenital myasthenic syndromes,Disease-causing germline mutation(s) (loss of function) in;Disease-causing germline mutation(s) (gain of function) in,,0.17791411042944785,0.1781846312532233,0.22265726964239102,0.44843462246777166
645,4481,CHRNB2,118507,605375;,"[MIM:605375]Epilepsy, nocturnal frontal lobe, 3 [dominant?];",Autosomal dominant nocturnal frontal lobe epilepsy,Disease-causing germline mutation(s) in,Nicotine dependence[28440896];,0.26588957055214724,0.33806085611139763,0.8491255546854607,0.8360957642725598
646,4484,CHRND,100720,253290;616321;616322;616323;,"[MIM:253290]Multiple pterygium syndrome, lethal type;[MIM:616321]Myasthenic syndrome, congenital, 3A, slow-channel;[MIM:616322]Myasthenic syndrome, congenital, 3B, fast-channel;[MIM:616323]Myasthenic syndrome, congenital, 3C, associated with acetylcholine receptor deficiency [recessive?];",Lethal multiple pterygium syndrome;Postsynaptic congenital myasthenic syndromes;Postsynaptic congenital myasthenic syndromes,Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) (loss of function) in;Disease-causing germline mutation(s) (gain of function) in,Brain lesion load[19010793];,0.4493251533742331,0.16864363073749356,0.6342991386061081,0.6138735420503376
647,4485,CHRNE,100725,254200;605809;608931;616324;,"[MIM:605809]Myasthenic syndrome, congenital, 4A, slow-channel;[MIM:616324]Myasthenic syndrome, congenital, 4B, fast-channel;[MIM:608931]Myasthenic syndrome, congenital, 4C, associated with acetylcholine receptor deficiency [recessive?];",Postsynaptic congenital myasthenic syndromes;Postsynaptic congenital myasthenic syndromes,Disease-causing germline mutation(s) (loss of function) in;Disease-causing germline mutation(s) (gain of function) in,Platelet count[29403010];,0.08736196319018405,0.1219700876740588,0.5773949360480293,0.6995089011663598
648,4486,CHRNG,100730,253290;265000;,"[MIM:253290]Multiple pterygium syndrome, lethal type;[MIM:265000]Multiple pterygium syndrome, Escobar variant [recessive?];",Autosomal recessive multiple pterygium syndrome;Lethal multiple pterygium syndrome,Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in,Refractive error[23396134];,0.32380368098159507,0.030943785456420837,0.3735317149569303,0.5308471454880295
649,4489,CHST3,603799,143095;,,CHST3-related skeletal dysplasia,Disease-causing germline mutation(s) in,Itch intensity from mosquito bite adjusted by bite size[28199695];Disc degeneration (lumbar)[24216480;24216480];,0.19190184049079756,0.4303764827230531,0.17880448968937615,0.7383364027010436
650,4492,CHST6,605294,217800;,,Macular corneal dystrophy,Disease-causing germline mutation(s) (loss of function) in,Dupuytren's disease[28886342];Pancreatic cancer[25086665];,0.2498159509202454,0.14724084579680247,0.6058470373270687,0.7140883977900553
651,4494,CHST8,610190,616265;,[MIM:616265]Peeling skin syndrome 3;,Peeling skin syndrome type A,Disease-causing germline mutation(s) (loss of function) in,Body mass index[19079260];Response to antipsychotic treatment in schizophrenia (working memory)[21107309];Inflammatory skin disease[25574825];Weight[19079260];Major depressive disorder[23377640];,0.38061349693251534,0.3478597215059309,0.7945706081962934,0.26120319214241866
652,4500,CHST14,608429,601776;,,"Ehlers-Danlos syndrome, musculocontractural type",Disease-causing germline mutation(s) (loss of function) in,,0.14576687116564419,0.41825683341928827,0.8031845471156356,0.3021792510742787
653,4502,CHSY1,608183,605282;,,Temtamy preaxial brachydactyly syndrome,Disease-causing germline mutation(s) (loss of function) in,Relative hand skill in reading disability[24068947];Granulocyte percentage of myeloid white cells[27863252];Central corneal thickness[29760442];Corneal structure[23291589];Neutrophil percentage of white cells[27863252];Myeloid white cell count[27863252];Sum basophil neutrophil counts[27863252];Sum neutrophil eosinophil counts[27863252];Monocyte percentage of white cells[27863252];Granulocyte count[27863252];Neutrophil count[27863252];,0.603680981595092,0.8661681279009799,0.18898459932132602,0.7638121546961326
654,4508,CHUK,600664,613630;,[MIM:613630]Cocoon syndrome;,Fetal encasement syndrome,Disease-causing germline mutation(s) in,Psoriasis[28537254];Liver enzyme levels[18940312];,0.7993865030674847,0.943527591542032,0.5943617854346124,0.4949355432780847
655,4519,CIB2,605564,609439;614869;,[MIM:614869]Usher syndrome 1J;,Usher syndrome type 1;Autosomal recessive non-syndromic sensorineural deafness type DFNB,Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in,Eyebrow thickness[26926045];,0.10711656441717791,0.6178442496132027,0.7361002349256069,0.26534683855125846
656,4522,CIC,612082,617600;,,Autosomal dominant non-syndromic intellectual disability,Disease-causing germline mutation(s) (loss of function) in,,0.5519018404907975,0.8916967509025271,0.5019577133907596,0.9548802946593001
657,4553,CIDEC,612120,615238;,"[MIM:615238]Lipodystrophy, familial partial, 5;",CIDEC-related familial partial lipodystrophy,Disease-causing germline mutation(s) (loss of function) in,,0.2498159509202454,0.47885507993811244,0.5601670582093449,0.30570902394106814
658,4555,CIITA,600005,209920;,[MIM:209920]Bare lymphocyte syndrome 2;,Immunodeficiency by defective expression of HLA class 2,Disease-causing germline mutation(s) in,Nasopharyngeal carcinoma[27436580];Celiac disease[20190752;22057235];Systemic lupus erythematosus[27399966;26502338;26502338];Ulcerative colitis[20228799];Alopecia areata[25608926;25608926];,0.4463803680981595,0.4035585353274884,0.40616027146959016,0.3750767341927563
659,4569,CISD2,611507,604928;,,Wolfram syndrome,Disease-causing germline mutation(s) in,Type 2 diabetes[28869590];Primary biliary cholangitis[26394269];Schizophrenia[28991256];,0.8530061349693252,0.4932955131511088,0.6478726181153746,0.63182934315531
660,4573,CIT,605629,617090;,"[MIM:617090]Microcephaly 17, primary, autosomal recessive [recessive?];",Autosomal recessive primary microcephaly,Disease-causing germline mutation(s) in,Urgency urinary incontinence[25524241];,0.5276073619631901,0.8744198040226921,0.42782563299399634,0.38152240638428486
661,4575,CITED2,602937,614431;614433;,[MIM:614431]Ventricular septal defect 2;[MIM:614433]Atrial septal defect 8;,"Tetralogy of Fallot;Atrial septal defect, sinus venosus type;Atrial septal defect, ostium secundum type;Situs inversus totalis",Major susceptibility factor in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Major susceptibility factor in,Urate levels in lean individuals[25811787];Mean corpuscular hemoglobin[19862010;20139978;23263863;28017375;28453575];Mean corpuscular volume[19862010;20139978;23263863;28017375;28453575];Systolic blood pressure response to hydrochlorothiazide in hypertension[27802415];Glycated hemoglobin levels[28898252];Triglycerides[25961943];Albumin-globulin ratio[29403010];HDL cholesterol[20686565;24097068];HDL cholesterol levels[28334899];Caudate volume in trauma-exposed individuals[29187748];Red blood cell traits[23222517];Obesity-related traits[23251661];Non-albumin protein levels[29403010];Blood trace element (Se levels)[23720494];,0.2947239263803681,0.8029912325941206,0.7217436700600366,0.0
662,4577,CIZ1,611420,,,"Adult-onset cervical dystonia, DYT23 type",Candidate gene tested in,Body mass index[26426971];,0.6080981595092024,0.44687983496647754,0.3972853040981467,0.3000306936771025
663,4579,CKAP2L,616174,272440;,[MIM:272440]Filippi syndrome;,Filippi syndrome,Disease-causing germline mutation(s) (loss of function) in,Mean platelet volume[27863252];,0.7257668711656442,0.5776173285198556,0.10702166536152441,0.17863720073664824
664,4612,CLCA4,616857,,,Cystic fibrosis,Modifying germline mutation in,,0.038773006134969326,0.05054151624548736,0.3228921952492822,0.048496009821976674
665,4615,CLCF1,607672,610313;,,Cold-induced sweating syndrome;Crisponi syndrome,Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in,Metabolite levels (lipid measures)[27005778];,0.14576687116564419,0.8720990201134605,0.5823544766379536,0.4731430325352977
666,4616,CLCN1,118425,160800;255700;,"[MIM:255700]Myotonia congenita, autosomal recessive [dominant?] [recessive?];",Thomsen and Becker disease,Disease-causing germline mutation(s) (loss of function) in,,0.21484662576687116,0.030170190820010316,0.15087444531453928,0.8275015346838551
667,4617,CLCN2,600570,607628;615651;,"[MIM:607628]Epilepsy, idiopathic generalized 11;[MIM:607628]Juvenile absence epilepsy 2;[MIM:607628]Juvenile myoclonic epilepsy 8;[MIM:615651]Leukoencephalopathy with ataxia [recessive?];",Juvenile myoclonic epilepsy;Leukoencephalopathy with mild cerebellar ataxia and white matter edema,Major susceptibility factor in;Disease-causing germline mutation(s) (loss of function) in,General cognitive ability[29844566];,0.403680981595092,0.08844765342960288,0.07804750717828243,0.9666973603437692
668,4620,CLCN4,302910,300114;,,X-linked non-syndromic intellectual disability;CLCN4-related X-linked intellectual disability syndrome,Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in,Mild influenza (H1N1) infection[26379185];,0.038773006134969326,0.8200103145951522,0.9169929522317932,0.0
669,4621,CLCN5,300008,300009;300554;308990;310468;,"[MIM:300554]Hypophosphatemic rickets, X-linked recessive;[MIM:300009]Nephrolithiasis 2;[MIM:310468]Nephrolithiasis 1;[MIM:308990]Low molecular weight proteinuria with hypercalciuria and nephrocalcinosis;",Dent disease type 1,Disease-causing germline mutation(s) (loss of function) in,,0.22687116564417178,0.6977823620422898,0.7000783085356304,0.9614794352363413
670,4623,CLCN7,602727,166600;259710;611490;,"[MIM:166600]Osteopetrosis, autosomal dominant 2 [dominant?] [recessive?];[MIM:259710]Osteopetrosis, autosomal recessive 2 [dominant?] [recessive?];",Albers-Sch�nberg osteopetrosis;Autosomal recessive malignant osteopetrosis;Intermediate osteopetrosis,Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in,,0.9408588957055215,0.6010830324909747,0.26102845210127906,0.8885819521178637
671,4624,CLCNKA,602024,613090;,,Infantile Bartter syndrome with sensorineural deafness,Disease-causing germline mutation(s) (loss of function) in,,0.27361963190184047,0.039195461578133056,0.2351866353432524,0.8502148557397177
672,4625,CLCNKB,602023,607364;613090;,"[MIM:613090]Bartter syndrome 4B, neonatal, with sensorineural deafness [recessive?];",Gitelman syndrome;Infantile Bartter syndrome with sensorineural deafness;Classic Bartter syndrome,Disease-causing germline mutation(s) (loss of function) in;Disease-causing germline mutation(s) (loss of function) in;Disease-causing germline mutation(s) in,Red blood cell count[27863252];,0.038773006134969326,0.30866425992779783,0.25972330984077263,0.7599754450583179
673,4628,CLDN1,603718,607626;,,Neonatal ichthyosis-sclerosing cholangitis syndrome,Disease-causing germline mutation(s) (loss of function) in,Response to antipsychotic treatment in schizophrenia (working memory)[21107309];,0.30319018404907977,0.35224342444559054,0.2988775776559645,0.6384284837323512
674,4637,CLDN10,617579,617671;,[MIM:617671]HELIX syndrome [recessive?];,Hypohidrosis-electrolyte imbalance-lacrimal gland dysfunction-ichthyosis-xerostomia syndrome,Disease-causing germline mutation(s) in,Psychosis proneness (hypomanic personality scale)[28525603];,0.14576687116564419,0.36436307374935534,0.9553641346906813,0.5405156537753223
675,4641,CLDN14,605608,614035;,,Autosomal recessive non-syndromic sensorineural deafness type DFNB,Disease-causing germline mutation(s) in,Urinary electrolytes (magnesium/calcium ratio)[27915449];Hematocrit[27863252];Bone mineral density[24249740;24249740;24249740];Serum parathyroid hormone levels[27927781];Hemoglobin concentration[27863252];Kidney stones[19561606;26272126];Glomerular filtration rate[29403010];,0.038773006134969326,0.27952552862300156,0.4494909945184025,0.8238182934315531
676,4643,CLDN16,603959,248250;,,Familial primary hypomagnesemia with hypercalciuria and nephrocalcinosis without severe ocular involvement,Disease-causing germline mutation(s) (loss of function) in,,0.10711656441717791,0.6356369262506446,0.2654659357870008,0.7200736648250461
677,4646,CLDN19,610036,248190;,"[MIM:248190]Hypomagnesemia 5, renal, with or without ocular involvement;",Familial primary hypomagnesemia with hypercalciuria and nephrocalcinosis with severe ocular involvement,Disease-causing germline mutation(s) in,,0.33226993865030674,0.601985559566787,0.5452884364395719,0.8170656844689994
678,4673,CLEC7A,606264,613108;614079;,"[MIM:613108]Candidiasis, familial, 4;",Chronic mucocutaneous candidiasis,Disease-causing germline mutation(s) in,,0.40773006134969325,0.09386281588447654,0.3265465935787001,0.17295887047268263
679,4693,CLIC2,300138,300886;,"[MIM:300886]Mental retardation, X-linked, syndromic, 32;",X-linked intellectual disability-cardiomegaly-congestive heart failure syndrome,Disease-causing germline mutation(s) in,,0.14576687116564419,0.5288808664259927,0.9135995823544767,0.7271332105586249
680,4699,CLIC5,607293,616042;,"[MIM:616042]Deafness, autosomal recessive, 103 [recessive?];",Autosomal recessive non-syndromic sensorineural deafness type DFNB,Disease-causing germline mutation(s) in,Mosquito bite size[28199695];Periodontal microbiota[22699663];Itch intensity from mosquito bite[28199695];Blood protein levels[29875488;30072576];Intraocular pressure[29785010];,0.26588957055214724,0.22408457968024756,0.5110937092143043,0.7090239410681399
681,4700,CLIC6,615321,,,Autosomal recessive non-syndromic sensorineural deafness type DFNB,Disease-causing germline mutation(s) in,Psoriasis[25903422];,0.12711656441717792,0.22872614749871067,0.08613938919342208,0.0
682,4702,CLIP1,179838,,,Autosomal recessive non-syndromic intellectual disability,Disease-causing germline mutation(s) (loss of function) in,Body mass index[25673413;25673413;25673413];Hip circumference[25673412;25673412];,0.6147239263803681,0.9383702939659618,0.01592273557817802,0.1998158379373849
683,4704,CLIP2,603432,,,Williams syndrome,Role in the phenotype of,,0.5406134969325154,0.41954615781330584,0.3359436178543461,0.748158379373849
684,4718,CLMP,611693,615237;,[MIM:615237]Congenital short bowel syndrome;,Congenital short bowel syndrome,Disease-causing germline mutation(s) (loss of function) in,Perceived unattractiveness to mosquitoes[28199695];Mean corpuscular hemoglobin concentration[29403010];Proteinuria in chronic kidney disease[26420894];Blood protein levels[29875488;30072576];Red cell distribution width[27863252];,0.17791411042944785,0.16838576585869006,0.47637692508483426,0.0
685,4719,CLN3,607042,204200;,"[MIM:204200]Ceroid lipofuscinosis, neuronal, 3;",CLN3 disease,Disease-causing germline mutation(s) in,Inflammatory bowel disease[28067908];Intelligence (MTAG)[29326435];Platelet distribution width[27863252];Inflammatory bowel disease (early onset)[19915574];Crohn's disease[28067908];General cognitive ability[29844566];,0.5571779141104295,0.16168127900979887,0.18846254241712346,0.6127992633517495
686,4720,CLN5,608102,256731;,"[MIM:256731]Ceroid lipofuscinosis, neuronal, 5;",CLN5 disease,Disease-causing germline mutation(s) in,Tourette's syndrome or obsessive-compulsive disorder[25158072];Morning vs. evening chronotype[26835600];Blood protein levels[30072576];,0.4154601226993865,0.16503352243424446,0.1359958235447664,0.552793124616329
687,4721,CLN6,606725,204300;601780;,"[MIM:601780]Ceroid lipofuscinosis, neuronal, 6;[MIM:204300]Ceroid lipofuscinosis, neuronal, 4A;",CLN6 disease;CLN4A disease,Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in,Restless legs syndrome[29029846];Major depressive disorder[23377640];,0.8390184049079754,0.40794223826714804,0.7086922474549726,0.6869244935543278
688,4722,CLN8,607837,600143;610003;,"[MIM:600143]Ceroid lipofuscinosis, neuronal, 8;[MIM:610003]Ceroid lipofuscinosis, neuronal, 8, Northern epilepsy variant;","Progressive epilepsy-intellectual disability syndrome, Finnish type;CLN8 disease",Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in,Gaucher disease severity[22388998];Eye morphology[29921221];Total cholesterol change in response to fenofibrate in statin-treated type 2 diabetes[28736931];,0.36171779141104293,0.3842186694172254,0.6778908901070216,0.7251381215469613
689,4728,CLP1,608757,615803;,[MIM:615803]Pontocerebellar hypoplasia 10;,Pontocerebellar hypoplasia type 10,Disease-causing germline mutation(s) (loss of function) in,Neuroticism[29255261];Autism spectrum disorder or schizophrenia[28540026];Schizophrenia[25056061];,0.4667484662576687,0.5807117070654977,0.8230227094753328,0.5448127685696746
690,4729,CLPB,616254,616271;,,3-methylglutaconic aciduria type 7,Disease-causing germline mutation(s) (loss of function) in,Heart rate response to recovery post exercise (10 sec)[29497042];,0.8797546012269939,0.43527591542031974,0.41529626729313496,0.15131982811540823
691,4730,CLPP,601119,614129;,,Perrault syndrome,Disease-causing germline mutation(s) in,,0.9022085889570552,0.5,0.9809449229966066,0.6306015960712094
692,4738,CLRN1,606397,276902;614180;,[MIM:614180]Retinitis pigmentosa 61;,Retinitis pigmentosa;Usher syndrome type 3,Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in,,0.038773006134969326,0.47163486333161425,0.8775776559645001,0.2532228360957643
693,4749,CLTC,118955,617854;,"[MIM:617854]Mental retardation, autosomal dominant 56 [dominant?];",Autosomal dominant non-syndromic intellectual disability;Inflammatory myofibroblastic tumor;MiT family translocation renal cell carcinoma;Undetermined early-onset epileptic encephalopathy,Disease-causing germline mutation(s) in;Part of a fusion gene in;Part of a fusion gene in;Disease-causing germline mutation(s) in,,0.990920245398773,0.6781846312532233,0.831636648394675,0.6626764886433395
694,4750,CLTCL1,601273,,,Congenital insensitivity to pain with severe intellectual disability,Disease-causing germline mutation(s) in,Cognitive decline rate in late mild cognitive impairment[26252872;26252872];Metabolite levels[22916037];,0.7939877300613497,0.4254770500257865,0.02401461759331767,0.000767341927562922
695,4811,CNBP,116955,602668;,[MIM:602668]Dystrophia myotonica 2;,Proximal myotonic myopathy,Disease-causing germline mutation(s) in,Waist-to-hip ratio adjusted for BMI (age >50)[26426971];Waist-to-hip ratio adjusted for BMI[26426971];Waist-to-hip ratio adjusted for BMI x sex x age interaction (4df test)[26426971];,0.7842944785276074,0.8256833419288293,0.948577394936048,0.8233578882750153
696,4817,CNGA1,123825,613756;,[MIM:613756]Retinitis pigmentosa 49;,Retinitis pigmentosa,Disease-causing germline mutation(s) in,,0.08736196319018405,0.08715832903558535,0.2004698512137823,0.5019950890116636
697,4818,CNGA2,300338,,,Isolated congenital anosmia,Disease-causing germline mutation(s) in,,0.10711656441717791,0.38705518308406395,0.21456538762725136,0.8557397176181707
698,4819,CNGA3,600053,216900;,[MIM:216900]Achromatopsia 2 [recessive?];,Cone rod dystrophy;Achromatopsia,Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in,,0.3449079754601227,0.02810727178958226,0.3064474027669016,0.8821362799263351
699,4821,CNGB1,600724,613767;,[MIM:613767]Retinitis pigmentosa 45;,Retinitis pigmentosa,Disease-causing germline mutation(s) in,Prudent dietary pattern[28644415];,0.17791411042944785,0.4687983496647757,0.15766118506917254,0.7022713321055862
700,4822,CNGB3,605080,248200;262300;,[MIM:262300]Achromatopsia 3 [recessive?];,Stargardt disease;Progressive cone dystrophy;Achromatopsia,Candidate gene tested in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in,Response to simvastatin treatment (PCSK9 protein level change)[25089948];Night sleep phenotypes[27126917];,0.038773006134969326,0.32155750386797316,0.32054293918037063,0.6238489871086557
701,4828,CNKSR2,300724,301008;,"[MIM:301008]Mental retardation, X-linked, syndromic, Houge type;",X-linked non-syndromic intellectual disability;Undetermined early-onset epileptic encephalopathy,Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in,Schizophrenia[25056061];Educational attainment (years of education)[30038396];,0.3856441717791411,0.9626095925734915,0.6131558339859045,0.4713014119091467
702,4847,CNNM2,607803,613882;616418;,"[MIM:616418]Hypomagnesemia, seizures, and mental retardation;",Familial primary hypomagnesemia with normocalciuria and normocalcemia,Disease-causing germline mutation(s) in,"Systolic blood pressure[19430483];Myocardial infarction[26343387];Parkinson's disease[19915575];Mean corpuscular hemoglobin[27863252];Mean corpuscular volume[27863252];Reticulocyte count[27863252];Autism spectrum disorder or schizophrenia[28540026;28540026];Schizophrenia[21926974;23974872;22688191;25056061;23894747;28991256];Creatine kinase levels[29403010];Arsenic metabolism[22383894];Mean arterial pressure[27618448];Coronary heart disease[21378990];Coronary artery disease[26343387;29212778;24262325];Waist-to-hip ratio adjusted for BMI[26426971];Waist-to-hip ratio adjusted for BMI (age >50)[26426971];Autism spectrum disorder, attention deficit-hyperactivity disorder, bipolar disorder, major depressive disorder, and schizophrenia (combined)[23453885];Intracranial aneurysm[20364137];White matter lesion progression[26451028];Blood pressure[21572416;21572416];Coronary artery disease or large artery stroke[24262325];Prostate cancer[23535732];Microalbuminuria[26631737];Coronary artery disease (myocardial infarction, percutaneous transluminal coronary angioplasty, coronary artery bypass grafting, angina or chromic ischemic heart disease)[28714975];",0.767361963190184,0.9530685920577617,0.4708953275907074,0.8284223449969307
703,4850,CNNM4,607805,217080;,,Jalili syndrome,Disease-causing germline mutation(s) (loss of function) in,Bipolar disorder[21926972;28072414];,0.7817177914110429,0.2996389891696751,0.7679457060819629,0.5099754450583179
704,4853,CNOT3,604910,,,Precursor T-cell acute lymphoblastic leukemia,Disease-causing somatic mutation(s) in,,0.7159509202453987,0.7189272821041774,0.6486557034716784,0.43646408839779005
705,4871,CNPY3,610774,617929;,"[MIM:617929]Epileptic encephalopathy, early infantile, 60 [recessive?];",West syndrome,Disease-causing germline mutation(s) in,Blood protein levels[28240269];,0.5261349693251534,0.7282104177411036,0.16523101018010963,0.5059852670349908
706,4883,CNTN1,600016,612540;,,"Congenital lethal myopathy, Compton-North type",Disease-causing germline mutation(s) in,Body mass index[26426971;26426971];Cerebral amyloid deposition in APOEe4 non-carriers (PET imaging)[26252872];Motion sickness[25628336];Dementia and core Alzheimer's disease neuropathologic changes[25188341];Metabolite levels  (X-11787)[23934736];Blood protein levels[30072576];Protein quantitative trait loci[18464913];Pneumoconiosis in silica exposure[24986923];,0.5338650306748466,0.6552346570397112,0.5539023753589141,0.4894106813996317
707,4884,CNTN2,190197,615400;,"[MIM:615400]Epilepsy, familial adult myoclonic, 5;",Benign adult familial myoclonic epilepsy,Disease-causing germline mutation(s) in,Mean platelet volume[24026423];Red blood cell count[27863252];Blood protein levels[28240269;28240269;29875488;30072576];,0.26588957055214724,0.4009798865394533,0.13416862438005742,0.28698588090853283
708,4891,CNTNAP1,602346,616286;,,Hypomyelination neuropathy-arthrogryposis syndrome,Disease-causing germline mutation(s) in,Breast cancer[29059683];Major depressive disorder[27777418];,0.3889570552147239,0.24368231046931407,0.43931088488645265,0.5604665438919583
709,4892,CNTNAP2,604569,610042;612100;,[MIM:610042]Pitt-Hopkins-like syndrome 1;,Cortical dysplasia-focal epilepsy syndrome;Pitt-Hopkins-like syndrome,Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in,QT interval (drug interaction)[23459443];Alzheimer's disease (late onset)[26049409];Common carotid intima-media thickness in HIV negative individuals[29206233];Crohn's disease[26192919];Response to radiotherapy in cancer (late toxicity)[24785509];Blood protein levels[29875488;30072576];Angiotensin-converting enzyme inhibitor intolerance[28030426];Inflammatory bowel disease[26192919];Body mass index[25760438];Lung function (FEV1/FVC)[30061609];Itch intensity from mosquito bite adjusted by bite size[28199695];Body mass index (dietary energy interaction)[23192594];Chronic kidney disease (severe chronic kidney disease vs normal kidney function) in type 1 diabetes[27647854];Visceral adipose tissue/subcutaneous adipose tissue ratio[22589738];Initial pursuit acceleration[29064472];Age-related hearing impairment[24939585];Bone mineral density[17903296];Bipolar disorder and schizophrenia[20889312];Obesity-related traits[23251661];Alzheimer's disease[22159054];Ulcerative colitis[26192919];Diabetic kidney disease[26305897];,0.2498159509202454,0.39556472408457966,0.5301487862176977,0.66804788213628
710,4910,COA3,614775,,,Isolated cytochrome C oxidase deficiency,Disease-causing germline mutation(s) in,,0.5439263803680982,0.5399690562145436,0.9697206995562516,0.0
711,4912,COA5,613920,616500;,"[MIM:616500]Cardioencephalomyopathy, fatal infantile, due to cytochrome c oxidase deficiency 3;",Fatal infantile cytochrome C oxidase deficiency,Disease-causing germline mutation(s) in,,0.12711656441717792,0.5275915420319752,0.9705037849125555,0.0
712,4913,COA6,614772,616501;,"[MIM:616501]Cardioencephalomyopathy, fatal infantile, due to cytochrome c oxidase deficiency 4;",Fatal infantile cytochrome C oxidase deficiency,Disease-causing germline mutation(s) in,,0.7730061349693251,0.44945848375451264,0.8389454450535109,0.0
713,4916,COASY,609855,615643;,,COASY protein-associated neurodegeneration,Disease-causing germline mutation(s) in,,0.36171779141104293,0.5907684373388344,0.6405638214565388,0.3502148557397176
714,4919,COCH,603196,601369;,"[MIM:601369]Deafness, autosomal dominant, 9 [dominant?];",Autosomal dominant non-syndromic sensorineural deafness type DFNA,Disease-causing germline mutation(s) in,Mean platelet volume[27863252];Night sleep phenotypes[27126917];Blood protein levels[29875488;30072576];,0.26588957055214724,0.2475502836513667,0.1182458888018794,0.6057397176181707
715,4921,COG1,606973,611209;,[MIM:611209]Congenital disorder of glycosylation 2G;,COG1-CDG,Disease-causing germline mutation(s) in,,0.6968098159509203,0.6869520371325425,0.3811015400678674,0.3136893799877225
716,4922,COG2,606974,617395;,[MIM:617395]Congenital disorder of glycosylation 2Q [recessive?];,COG2-CDG,Disease-causing germline mutation(s) (loss of function) in,,0.6089570552147239,0.28313563692625066,0.27355781780214045,0.1289134438305709
717,4924,COG4,606976,613489;,[MIM:613489]Congenital disorder of glycosylation 2J;,"COG4-CDG;Microcephalic osteodysplastic dysplasia, Saul-Wilson type",Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in,Menarche (age at onset)[25231870;25231870];,0.5858895705521472,0.7354306343476018,0.613677890890107,0.1338244321669736
718,4925,COG5,606821,613612;,[MIM:613612]Congenital disorder of glycosylation 2I;,COG5-CDG,Disease-causing germline mutation(s) in,Atrial fibrillation[29892015];Osteoarthritis[20112360];Waist-to-hip ratio adjusted for BMI[26426971];Waist-to-hip ratio adjusted for BMI x sex x age interaction (4df test)[26426971];,0.6559509202453988,0.36023723568849925,0.2879143826677108,0.020411295273173726
719,4926,COG6,606977,614576;615328;,[MIM:614576]Congenital disorder of glycosylation 2L;[MIM:615328]Shaheen syndrome [recessive?];,Hypohidrosis-enamel hypoplasia-palmoplantar keratoderma-intellectual disability syndrome;COG6-CGD,Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in,Peripheral arterial disease (traffic-related air pollution interaction)[27082954];Multiple sclerosis[24076602];Psoriasis[18369459;25903422;25903422];Eosinophil counts[27863252];Menarche (age at onset)[25231870];Systemic lupus erythematosus or rheumatoid arthritis[27193031];Sum eosinophil basophil counts[27863252];Eosinophil percentage of granulocytes[27863252];Rheumatoid arthritis (ACPA-positive)[23143596;24532676];Juvenile idiopathic arthritis (oligoarticular or rheumatoid factor-negative polyarticular)[23603761];Rheumatoid arthritis[24390342;24390342];Neutrophil percentage of granulocytes[27863252];Eosinophil percentage of white cells[27863252];,0.6612269938650307,0.05466735430634347,0.014617593317671627,0.03038674033149171
720,4927,COG7,606978,608779;,[MIM:608779]Congenital disorder of glycosylation 2E;,COG7-CDG,Disease-causing germline mutation(s) in,Egg allergy[25710614];,0.45153374233128835,0.7276946879834967,0.33855390237535893,0.1921424186617557
721,4928,COG8,606979,611182;,[MIM:611182]Congenital disorder of glycosylation 2H;,COG8-CDG,Disease-causing germline mutation(s) in,Body mass index[26426971];,0.4350920245398773,0.4520371325425477,0.4706342991386061,0.20227133210558626
722,4932,COL1A1,120150,114000;130000;130060;166200;166210;166220;166710;259420;607907;,"[MIM:114000]Caffey disease;[MIM:130000]Ehlers-Danlos syndrome, classic type, 1 [dominant?];[MIM:130060]Ehlers-Danlos syndrome, arthrochalasia type, 1 [dominant?];[MIM:166200]Osteogenesis imperfecta 1 [dominant?];[MIM:166210]Osteogenesis imperfecta 2 [dominant?];[MIM:259420]Osteogenesis imperfecta 3 [dominant?];[MIM:166220]Osteogenesis imperfecta 4 [dominant?];[MIM:166710]Osteoporosis;","Caffey disease;Osteogenesis imperfecta type 1;Osteogenesis imperfecta type 2;Osteogenesis imperfecta type 3;Osteogenesis imperfecta type 4;Ehlers-Danlos/osteogenesis imperfecta syndrome;Ehlers-Danlos syndrome, vascular-like type;High bone mass osteogenesis imperfecta;Dermatofibrosarcoma protuberans;Ehlers-Danlos syndrome type 2;Ehlers-Danlos syndrome type 1;Ehlers-Danlos syndrome type 7A",Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Part of a fusion gene in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in,Response to taxane treatment (docetaxel)[23006423];Breast cancer[17903305];,0.5731288343558282,0.6428571428571429,0.5914904724614983,0.9858809085328423
723,4933,COL1A2,120160,166200;166210;166220;225320;259420;617821;,"[MIM:617821]Ehlers-Danlos syndrome, arthrochalasia type, 2 [dominant?];[MIM:166200]Osteogenesis imperfecta 1 [dominant?];[MIM:166210]Osteogenesis imperfecta 2 [dominant?];[MIM:225320]Ehlers-Danlos syndrome, cardiac valvular type [recessive?];[MIM:259420]Osteogenesis imperfecta 3 [dominant?];[MIM:166220]Osteogenesis imperfecta 4 [dominant?];","Osteogenesis imperfecta type 1;Osteogenesis imperfecta type 2;Osteogenesis imperfecta type 3;Osteogenesis imperfecta type 4;Ehlers-Danlos/osteogenesis imperfecta syndrome;Ehlers-Danlos syndrome, cardiac valvular type;High bone mass osteogenesis imperfecta;Ehlers-Danlos syndrome type 7B",Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in,Low bone mineral density (hip)[26235824];Intelligence[22449649;22449649];Aging[22773346];Mean forced vital capacity from 2 exams[17903307];Low bone mineral density (spine)[26235824];PR interval in Tripanosoma cruzi seropositivity[24324551];Immune reponse to smallpox (secreted IL-12p40)[22610502];Post bronchodilator FEV1[26634245];,0.6103067484662577,1.0,0.5549464891673193,0.9766728054020871
724,4936,COL2A1,120140,108300;132450;150600;151210;156550;183900;184250;200610;271700;604864;608805;609162;609508;616583;,"[MIM:183900]Spondyloepiphyseal dysplasia congenital type;[MIM:616583]Spondyloepiphyseal dysplasia, Stanescu type [dominant?];[MIM:184250]Spondyloepimetaphyseal dysplasia, Strudwick type;[MIM:200610]Achondrogenesis 2 [dominant?];[MIM:150600]Legg-Calve-Perthes disease;[MIM:156550]Kniest dysplasia;[MIM:608805]Avascular necrosis of femoral head, primary, 1 [dominant?];[MIM:604864]Osteoarthritis with mild chondrodysplasia;[MIM:151210]Platyspondylic lethal skeletal dysplasia Torrance type;[MIM:132450]Multiple epiphyseal dysplasia with myopia and conductive deafness [dominant?];[MIM:271700]Spondyloperipheral dysplasia;[MIM:108300]Stickler syndrome 1 [dominant?];[MIM:609508]Stickler syndrome 1 non-syndromic ocular [dominant?];[MIM:609508]Rhegmatogenous retinal detachment autosomal dominant [dominant?];[MIM:609162]Czech dysplasia;","Multiple epiphyseal dysplasia, Beighton type;Legg-Calv�-Perthes disease;Czech dysplasia, metatarsal type;Kniest dysplasia;Weissenbacher- Zweymuller syndrome;Spondyloperipheral dysplasia-short ulna syndrome;Autosomal dominant rhegmatogenous retinal detachment;Spondyloepiphyseal dysplasia, Stanescu type;Mild spondyloepiphyseal dysplasia due to COL2A1 mutation with early-onset osteoarthritis;Spondyloepimetaphyseal dysplasia congenita, Strudwick type;Achondrogenesis type 2;Hypochondrogenesis;Spondylometaphyseal dysplasia, 'corner fracture' type;Spondylometaphyseal dysplasia, Schmidt type;Stickler syndrome type 1;Dysspondyloenchondromatosis;Familial avascular necrosis of femoral head;Platyspondylic dysplasia, Torrance type;Spondyloepiphyseal dysplasia congenita",Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Candidate gene tested in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Candidate gene tested in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in,,0.47337423312883437,1.0,0.1456538762725137,0.978207489257213
725,4937,COL3A1,120180,130050;,"[MIM:130050]Ehlers-Danlos syndrome, vascular type [dominant?];","Familial abdominal aortic aneurysm;Acrogeria;Familial cerebral saccular aneurysm;Ehlers-Danlos syndrome, vascular type",Major susceptibility factor in;Disease-causing germline mutation(s) in;Candidate gene tested in;Disease-causing germline mutation(s) in,Parkinson disease and lewy body pathology[25663231];,0.30319018404907977,0.85146982980918,0.15244061602714695,0.9426028238182934
726,4938,COL4A1,120130,175780;180000;269160;607595;611773;614519;,[MIM:607595]Brain small vessel disease with or without ocular anomalies [dominant?];[MIM:611773]Hereditary angiopathy with nephropathy aneurysms and muscle cramps;[MIM:175780]Porencephaly 1;[MIM:614519]Intracerebral hemorrhage;[MIM:180000]Tortuosity of retinal arteries;[MIM:269160]Schizencephaly;,Walker-Warburg syndrome;Familial schizencephaly;Pontine autosomal dominant microangiopathy with leukoencephalopathy;Retinal arterial tortuosity;HANAC syndrome;COL4A1-related familial vascular leukoencephalopathy;Familial porencephaly,Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in,"Myocardial infarction[26343387];Stroke[29531354];Arterial stiffness[20031579];Age-related nuclear cataracts[24951543];Monocyte count[27863252];Obesity-related traits[23251661;23251661];Night sleep phenotypes[27126917;27126917;27126917];Coronary heart disease[21378990];Behavioral disturbance or psychiatric symptoms and prion disease[25897833];Coronary artery disease[26343387;29212778;29212778;29212778;29212778;24262325];Coronary artery disease (myocardial infarction, percutaneous transluminal coronary angioplasty, coronary artery bypass grafting, angina or chromic ischemic heart disease)[28714975];Intraocular pressure[29785010];",0.46883435582822086,0.9743424445590511,0.06160271469590185,0.9643953345610804
727,4939,COL4A2,120090,614483;614519;,[MIM:614483]Porencephaly 2;[MIM:614519]Intracerebral hemorrhage;,Familial porencephaly,Disease-causing germline mutation(s) in,"Myocardial infarction[26343387];Coronary artery calcification[22144573];White matter hyperintensity burden[25663218];Night sleep phenotypes[27126917;27126917;27126917];Coronary heart disease[21378990];Coronary artery disease[26343387;29212778;29212778;29212778;29212778;24262325];Ischemic stroke (small-vessel)[29531354];Coronary artery disease (myocardial infarction, percutaneous transluminal coronary angioplasty, coronary artery bypass grafting, angina or chromic ischemic heart disease)[28714975];Glomerular filtration rate[29403010];",0.7834355828220859,0.47215059308922125,0.13991125032628557,0.8075506445672191
728,4942,COL4A3,120070,104200;141200;203780;,"[MIM:203780]Alport syndrome, autosomal recessive [recessive?];[MIM:141200]Hematuria, benign familial [dominant?];[MIM:104200]Alport syndrome, autosomal dominant [dominant?];",Autosomal dominant Alport syndrome;Autosomal recessive Alport syndrome;Familial idiopathic steroid-resistant nephrotic syndrome with focal segmental hyalinosis,Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Modifying germline mutation in,Resting heart rate[27798624];Metabolite levels (5-HIAA/ MHPG Ratio)[23319000];Advanced age-related macular degeneration[26691988];Central corneal thickness[29760442];Corneal structure[23291589];Intraocular pressure[29235454];,0.3925153374233129,0.08586900464156781,0.04019838162359697,0.7911295273173726
729,4944,COL4A4,120131,141200;203780;,"[MIM:203780]Alport syndrome, autosomal recessive [recessive?];[MIM:141200]Hematuria, benign familial [dominant?];",Autosomal dominant Alport syndrome;Autosomal recessive Alport syndrome,Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in,Body mass index[28270201;25673413;25673413];Immune reponse to smallpox (secreted IFN-alpha)[22610502];Urinary albumin excretion[30220432];Urinary albumin excretion (no hypertensive medication)[30220432];Coronary artery disease[29212778];,0.30319018404907977,0.052862300154718926,0.04829026363873662,0.8225905463474524
730,4945,COL4A5,303630,301050;,"[MIM:301050]Alport syndrome, X-linked;",X-linked Alport syndrome-diffuse leiomyomatosis;X-linked Alport syndrome,Role in the phenotype of;Disease-causing germline mutation(s) in,,0.629079754601227,0.6472408457968025,0.3014878621769773,0.9914057704112953
731,4946,COL4A6,303631,300914;,"[MIM:300914]Deafness, X-linked, 6;",X-linked Alport syndrome-diffuse leiomyomatosis;X-linked non-syndromic sensorineural deafness type DFN,Role in the phenotype of;Disease-causing germline mutation(s) in,Electrodermal activity[25387706];,0.32380368098159507,0.8184631253223311,0.4233881493082746,0.9269490484960098
732,4947,COL5A1,120215,130000;,"[MIM:130000]Ehlers-Danlos syndrome, classic type, 1 [dominant?];","Ehlers-Danlos syndrome, vascular type;Ehlers-Danlos syndrome type 2;Ehlers-Danlos syndrome type 1",Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in,Central corneal thickness[20719862;23493294;22814818;28171582;28171582;23493294;29760442;29760442;29760442];Corneal structure[23291589;23291589];Crohn's disease (need for surgery)[23665963];Blood pressure[24954895];Longevity[20834067];Intraocular pressure[29617998;29617998];,0.4431901840490797,0.4997421351211965,0.2876533542156095,0.9666973603437692
733,4949,COL5A2,120190,130010;,"[MIM:130010]Ehlers-Danlos syndrome, classic type, 2 [dominant?];",Ehlers-Danlos syndrome type 2;Ehlers-Danlos syndrome type 1,Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in,Parkinson's disease[26227905];,0.21484662576687116,1.0,0.3275907073871052,0.9834254143646409
734,4951,COL6A1,120220,158810;254090;,[MIM:158810]Bethlem myopathy 1;[MIM:254090]Ullrich congenital muscular dystrophy 1;,"Bethlem myopathy;Congenital muscular dystrophy, Ullrich type",Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in,Diverticular disease[30177863];Bone mineral density (lumbar spine) in inflammatory bowel disease[29603369];Spherical equivalent or myopia (age of diagnosis)[29808027];Myopia[27182965];Waist circumference adjusted for body mass index[25673412;25673412];Blood protein levels[29875488;30072576];Intraocular pressure[29617998;29235454];,0.3856441717791411,0.9868488911810211,0.06055860088749674,0.8928790669122161
735,4952,COL6A2,120240,158810;254090;255600;,[MIM:158810]Bethlem myopathy 1;[MIM:254090]Ullrich congenital muscular dystrophy 1;[MIM:255600]Myosclerosis autosomal recessive [recessive?];,"Bethlem myopathy;Myosclerosis;Congenital muscular dystrophy, Ullrich type",Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in,Central corneal thickness[29760442];Intraocular pressure[29235454];,0.3749693251533742,0.72279525528623,0.037066040198381625,0.9631675874769797
736,4953,COL6A3,120250,158810;254090;616411;,[MIM:158810]Bethlem myopathy 1;[MIM:254090]Ullrich congenital muscular dystrophy 1;[MIM:616411]Dystonia 27 [recessive?];,"Bethlem myopathy;Primary dystonia, DYT27 type;Congenital muscular dystrophy, Ullrich type",Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in,Lung cancer[28604730];Aging (time to event)[21782286];Coronary artery disease[29212778];Intraocular pressure[29617998;29617998;29235454];,0.22687116564417178,0.30634347601856626,0.047246149830331506,0.9868017188459177
737,4958,COL7A1,120120,131705;131750;131850;132000;226600;604129;607523;,"[MIM:131750]Epidermolysis bullosa dystrophica, autosomal dominant [dominant?];[MIM:226600]Epidermolysis bullosa dystrophica, autosomal recessive [recessive?];[MIM:131705]Transient bullous dermolysis of the newborn;[MIM:131850]Epidermolysis bullosa dystrophica, pretibial type [dominant?];[MIM:132000]Epidermolysis bullosa dystrophica, Bart type [dominant?];[MIM:604129]Epidermolysis bullosa pruriginosa [dominant?];[MIM:607523]Nail disorder, non-syndromic congenital, 8;[MIM:131750]Epidermolysis bullosa dystrophica, with subcorneal cleavage;","Dominant dystrophic epidermolysis bullosa, nails only;Acral dystrophic epidermolysis bullosa;Generalized dominant dystrophic epidermolysis bullosa;Dystrophic epidermolysis bullosa pruriginosa;Recessive dystrophic epidermolysis bullosa, generalized intermediate;Centripetalis recessive dystrophic epidermolysis bullosa;Epidermolysis bullosa simplex superficialis;Recessive dystrophic epidermolysis bullosa inversa;Severe generalized recessive dystrophic epidermolysis bullosa;Transient bullous dermolysis of the newborn;Pretibial dystrophic epidermolysis bullosa",Disease-causing germline mutation(s) (loss of function) in;Disease-causing germline mutation(s) (loss of function) in;Disease-causing germline mutation(s) (loss of function) in;Disease-causing germline mutation(s) (loss of function) in;Disease-causing germline mutation(s) (loss of function) in;Disease-causing germline mutation(s) (loss of function) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) (loss of function) in;Disease-causing germline mutation(s) (loss of function) in;Disease-causing germline mutation(s) (loss of function) in;Disease-causing germline mutation(s) (loss of function) in,Inflammatory bowel disease[28067908];Bone fracture in osteoporosis[28580392];Crohn's disease[28067908];Blood protein levels[29875488];Ulcerative colitis[28067908];,0.48576687116564415,0.005415162454873646,0.280605586008875,0.9074585635359116
738,4960,COL8A2,120252,136800;609140;,"[MIM:136800]Corneal dystrophy, Fuchs endothelial, 1;[MIM:609140]Corneal dystrophy, posterior polymorphous, 2;",Posterior polymorphous corneal dystrophy;Fuchs endothelial corneal dystrophy,Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in,Central corneal thickness[29760442];Corneal structure[23291589];Intraocular pressure[29617998;29617998;29785010];,0.31079754601226994,0.6173285198555957,0.3153223701383451,0.0
739,4961,COL9A1,120210,614134;614135;,[MIM:614135]Multiple epiphyseal dysplasia 6;[MIM:614134]Stickler syndrome 4 [recessive?];,Multiple epiphyseal dysplasia due to collagen 9 anomaly;Autosomal recessive Stickler syndrome,Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in,,0.22687116564417178,0.17225373904074265,0.022709475332811275,0.8499079189686924
740,4962,COL9A2,120260,600204;603932;614284;,[MIM:600204]Multiple epiphyseal dysplasia 2;[MIM:603932]Intervertebral disc disease;[MIM:614284]Stickler syndrome 5 [recessive?];,Multiple epiphyseal dysplasia due to collagen 9 anomaly;Autosomal recessive Stickler syndrome,Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) (loss of function) in,,0.23865030674846627,0.32104177411036616,0.06342991386061081,0.795426642111725
741,4963,COL9A3,120270,600969;603932;,[MIM:600969]Multiple epiphyseal dysplasia 3;[MIM:603932]Intervertebral disc disease;,Multiple epiphyseal dysplasia due to collagen 9 anomaly;Autosomal recessive Stickler syndrome,Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) (loss of function) in,,0.14576687116564419,0.314337287261475,0.12659879926912032,0.8060159607120934
742,4964,COL10A1,120110,156500;,[MIM:156500]Schmid type metaphyseal chondrodysplasia;,"Metaphyseal chondrodysplasia, Schmid type",Disease-causing germline mutation(s) in,Spherical equivalent or myopia (age of diagnosis)[29808027];Age-related macular degeneration[21665990;23455636];Myopia[27182965];,0.27361963190184047,0.37184115523465705,0.06264682850430697,0.6947513812154696
743,4965,COL11A1,120280,154780;228520;604841;,[MIM:604841]Stickler syndrome 2 [dominant?];[MIM:154780]Marshall syndrome [dominant?];[MIM:228520]Fibrochondrogenesis 1;,Marshall syndrome;Fibrochondrogenesis;Autosomal recessive Stickler syndrome;Autosomal dominant myopia-midfacial retrusion-sensorineural hearing loss-rhizomelic dysplasia syndrome;Stickler syndrome type 2,Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) (loss of function) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in,Glaucoma (primary open-angle)[29891935];Intelligence (MTAG)[29326435];Glaucoma (primary angle closure)[22922875;27064256;27064256];Systemic juvenile idiopathic arthritis[27927641];Open-angle glaucoma and optic cup area[29449654];Bone mineral density[22504420];Bone mineral density change response to combined chemotherapy in acute lymphoblastic leukemia[29266176];Urate levels (BMI interaction)[25811787];Protein quantitative trait loci[18464913];,0.19190184049079756,1.0,0.02218741842860872,0.9702271332105586
744,4966,COL11A2,120290,184840;215150;601868;609706;614524;,"[MIM:184840]Otospondylomegaepiphyseal dysplasia, autosomal dominant [dominant?];[MIM:215150]Otospondylomegaepiphyseal dysplasia, autosomal recessive [recessive?];[MIM:601868]Deafness, autosomal dominant, 13 [dominant?];[MIM:609706]Deafness, autosomal recessive, 53 [recessive?];[MIM:614524]Fibrochondrogenesis 2;",Stickler syndrome type 3;Otospondylomegaepiphyseal dysplasia;Fibrochondrogenesis;Weissenbacher- Zweymuller syndrome;Autosomal dominant non-syndromic sensorineural deafness type DFNA;Autosomal recessive non-syndromic sensorineural deafness type DFNB,Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) (loss of function) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in,Rosacea symptom severity[29771307];Sjögren's syndrome[24097066];Lung cancer[28604730];Blood protein levels[29875488;30072576;30072576];Antineutrophil cytoplasmic antibody-associated vasculitis[22808956];Wegener's granulomatosis[23740775];,0.33226993865030674,0.3365136668385766,0.05768728791438267,0.9429097605893186
745,4968,COL12A1,120320,616470;616471;,[MIM:616470]Ullrich congenital muscular dystrophy 2;[MIM:616471]Bethlem myopathy 2 [dominant?];,"Bethlem myopathy;Congenital muscular dystrophy, Ullrich type",Disease-causing germline mutation(s) (gain of function) in;Disease-causing germline mutation(s) (loss of function) in,Joint mobility (Beighton score)[27182965];Central corneal thickness[29760442];Systemic juvenile idiopathic arthritis[27927641];,0.5276073619631901,0.6146209386281588,0.21247716001044115,0.8861264579496624
746,4969,COL13A1,120350,616720;,,Presynaptic congenital myasthenic syndromes;Postsynaptic congenital myasthenic syndromes,Disease-causing germline mutation(s) (loss of function) in;Disease-causing germline mutation(s) (loss of function) in,CSF tryptophan concentration in tuberculous meningitis[29395996];Response to fenofibrate (total cholesterol levels)[27002377];Parkinson's disease[23793441];Early childhood aggressive behavior[26087016];Middle childhood and early adolescence aggressive behavior[26087016];Upper eyelid morphology[29921221];Carboplatin disposition in epthelial ovarian cancer[29367611];Non-alcoholic fatty liver disease histology (lobular)[20708005;20708005];Ulcerative colitis[25082827];,0.16220858895705523,0.08561113976276431,0.48238057948316365,0.9119091467157765
747,4970,COL14A1,120324,,,Punctate palmoplantar keratoderma type 1,Disease-causing germline mutation(s) in,Cerebrospinal T-tau levels[28247064];Parasitemia in Tripanosoma cruzi seropositivity[24324551];Gastritis[25317112];,0.4667484662576687,0.3102114492006189,0.24484468807099974,0.6855432780847146
748,4973,COL17A1,113811,122400;226650;,[MIM:226650]Generalized atrophic benign epidermolysis bullosa;[MIM:122400]Epithelial recurrent erosion dystrophy;,"Localized junctional epidermolysis bullosa, non-Herlitz type;Epithelial recurrent erosion dystrophy;Junctional epidermolysis bullosa, generalized intermediate;Late-onset junctional epidermolysis bullosa",Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) (gain of function) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in,Cardiac hypertrophy[21348951];,0.5110429447852761,0.4479112944816916,0.14330462020360218,0.7848373235113567
749,4974,COL18A1,120328,267750;,[MIM:267750]Knobloch syndrome 1;,Knobloch syndrome,Disease-causing germline mutation(s) in,Bone mineral density (total hip)[29883787];Pursuit maintenance gain[29064472];Ankle injury[28957384];Blood protein levels[29875488;29875488;30072576];Hippocampal atrophy[22745009];Early-onset Parkinson's disease[28256260];,0.803803680981595,0.6487880350696236,0.040459410075698254,0.7067219152854513
750,4983,COL25A1,610004,616219;,"[MIM:616219]Fibrosis of extraocular muscles, congenital, 5;",Duane retraction syndrome;Congenital ptosis,Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in,Body mass index[25133637];Systemic lupus erythematosus[21408207];Carotid plaque burden[28282560];Common carotid intima-media thickness in HIV negative individuals[29206233];Late-onset Alzheimer's disease[27770636];Schizophrenia (age at onset)[21688384];,0.12711656441717792,0.6075296544610624,0.5839206473505613,0.6947513812154696
751,4985,COL27A1,608461,615155;,[MIM:615155]Steel syndrome;,Steel syndrome,Disease-causing germline mutation(s) in,Height[18391951];Social communication problems[24564958];Tourette syndrome[22889924];,0.038773006134969326,0.8401237751418257,0.013834507961367789,0.950890116635973
752,4989,COLEC10,607620,248340;,,3MC syndrome,Disease-causing germline mutation(s) in,"Osteoprotegerin levels[25080503;25080503];Blood pressure (smoking interaction)[25189868;25189868];Bone mineral density (paediatric, skull)[24945404;24945404];Asthma[29273806];",0.28662576687116564,0.37931923671995876,0.738971547898721,0.5207182320441989
753,4990,COLEC11,612502,265050;,,3MC syndrome,Disease-causing germline mutation(s) (loss of function) in,Fibrinogen levels[26561523];Blood protein levels[28240269;28240269;28240269;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;30072576;30072576];,0.27975460122699386,0.5848375451263538,0.23335943617854346,0.5188766114180479
754,4994,COLQ,603033,603034;,"[MIM:603034]Myasthenic syndrome, congenital, 5 [recessive?];",Synaptic congenital myasthenic syndromes,Disease-causing germline mutation(s) in,Diverticular disease[30177863];,0.2947239263803681,0.1784424961320268,0.4048551292090838,0.8296500920810314
755,5006,COMP,600310,132400;177170;,[MIM:132400]Multiple epiphyseal dysplasia 1;[MIM:177170]Pseudoachondroplasia;,Pseudoachondroplasia;Multiple epiphyseal dysplasia type 1,Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in,QT interval[29213071];Osteoarthritis (with total hip replacement)[28319091];Osteoarthritis biomarkers[25057126];,0.26588957055214724,0.11294481691593605,0.36805011746280347,0.6803253529772867
756,5007,COMT,116790,103780;181500;,[MIM:181500]Schizophrenia;,22q11.2 deletion syndrome;Cisplatin toxicity;Toxicity or absent response to clozapine,Role in the phenotype of;Biomarker tested in;Biomarker tested in,Serum metabolite levels[23093944;23093944];Blood metabolite levels[24816252;24816252];Systolic blood pressure x alcohol consumption interaction (2df test)[29912962];,0.4226993865030675,0.25322331098504386,0.1620986687548943,0.18861264579496623
757,5010,COPA,601924,616414;,"[MIM:616414]Autoimmune interstitial lung, joint, and kidney disease;",Autoimmune interstitial lung disease-arthritis syndrome,Disease-causing germline mutation(s) in,Breast size[27182965];,0.992638036809816,1.0,0.37823022709475335,0.5268569674647022
758,5012,COPB2,606990,617800;,"[MIM:617800]Microcephaly 19, primary, autosomal recessive [recessive?];",Autosomal recessive primary microcephaly,Disease-causing germline mutation(s) in,Male-pattern baldness[29146897;29146897];Kawasaki disease[22446961];,0.9321472392638037,0.903816400206292,0.7024275646045419,0.8063228974831185
759,5034,COQ2,609825,146500;607426;,[MIM:146500]Multiple system atrophy 1;,"Leigh syndrome with nephrotic syndrome;Multiple system atrophy, cerebellar type;Multiple system atrophy, parkinsonian type",Disease-causing germline mutation(s) in;Major susceptibility factor in;Major susceptibility factor in,QRS interval (sulfonylurea treatment interaction)[27958378];,0.5009815950920246,0.3486333161423414,0.6523101018010963,0.3396255371393493
760,5036,COQ4,612898,616276;,,Neonatal encephalomyopathy-cardiomyopathy-respiratory distress syndrome,Disease-causing germline mutation(s) (loss of function) in,Body mass index[26426971];Obesity-related traits[23251661;23251661];,0.26588957055214724,0.6516245487364621,0.43513442965283217,0.0
761,5038,COQ6,614647,614650;,,Familial steroid-resistant nephrotic syndrome with sensorineural deafness;Neurofibromatosis type 3,Disease-causing germline mutation(s) in;Major susceptibility factor in,Blood protein levels[28240269];,0.4226993865030675,0.28416709644146465,0.05507700339336988,0.11740331491712708
762,5040,COQ8A,606980,612016;,"[MIM:612016]Coenzyme Q10 deficiency, primary, 4 [recessive?];",Autosomal recessive ataxia due to ubiquinone deficiency,Disease-causing germline mutation(s) in,Granulocyte percentage of myeloid white cells[27863252];Lymphocyte percentage of white cells[27863252];Sum basophil neutrophil counts[27863252];Sum neutrophil eosinophil counts[27863252];Granulocyte count[27863252];Neutrophil count[27863252];,0.7361963190184049,0.147498710675606,0.0,0.0
763,5041,COQ8B,615567,615573;,[MIM:615573]Nephrotic syndrome 9;,Familial idiopathic steroid-resistant nephrotic syndrome with focal segmental hyalinosis,Disease-causing germline mutation(s) (loss of function) in,"Caffeine metabolism (plasma 1,7-dimethylxanthine (paraxanthine) to 1,3,7-trimethylxanthine (caffeine) ratio)[27702941;27702941;27702941;27702941;27702941;27702941;27702941;27702941;27702941;27702941;27702941;27702941;27702941;27702941;27702941;27702941;27702941];Caffeine metabolism (plasma 3,7-dimethylxanthine (theobromine) level)[27702941];Caffeine metabolism (plasma 1,7-dimethylxanthine (paraxanthine) level)[27702941];Blood protein levels[28240269];",0.7775460122699387,0.22021660649819494,0.0,0.0
764,5042,COQ9,612837,614654;,"[MIM:614654]Coenzyme Q10 deficiency, primary, 5 [recessive?];",Encephalopathy-hypertrophic cardiomyopathy-renal tubular disease syndrome,Disease-causing germline mutation(s) in,,0.6045398773006135,0.2697266632284683,0.4881232054293918,0.5260896255371393
765,5051,CORIN,605236,614595;,[MIM:614595]Pre-eclampsia/eclampsia 5;,Preeclampsia,Major susceptibility factor in,,0.038773006134969326,0.014956162970603403,0.36935525972330985,0.6513198281154082
766,5052,CORO1A,605000,615401;,[MIM:615401]Immunodeficiency 8;,Severe combined immunodeficiency due to CORO1A deficiency,Disease-causing germline mutation(s) in,Tonsillectomy[27182965;28928442];,0.48208588957055215,0.8268437338834451,0.8582615505090054,0.7286678944137508
767,5067,COX4I2,607976,612714;,,Pancreatic insufficiency-anemia-hyperostosis syndrome,Disease-causing germline mutation(s) in,Oppositional defiant disorder dimensions in attention-deficit hyperactivity disorder[26184070;26184070];,0.14576687116564419,0.28726147498710675,0.4361785434612373,0.14901780233271947
768,5068,COX5A,603773,,,Isolated cytochrome C oxidase deficiency,Disease-causing germline mutation(s) (loss of function) in,Diastolic blood pressure x smoking status (current vs non-current) interaction (2df test)[29455858;29455858];Systolic blood pressure x smoking status (ever vs never) interaction (2df test)[29455858;29455858];Systolic blood pressure x alcohol consumption interaction (2df test)[29912962];Diastolic blood pressure x smoking status (ever vs never) interaction (2df test)[29455858;29455858];Caffeine consumption[21490707];Systolic blood pressure x smoking status (current vs non-current) interaction (2df test)[29455858;29455858];Systolic blood pressure x alcohol consumption (light vs heavy) interaction (2df test)[29912962;29912962];Diastolic blood pressure x alcohol consumption (light vs heavy) interaction (2df test)[29912962];Mean arterial pressure x alcohol consumption interaction (2df test)[29912962];,0.8880981595092025,0.6982980917998969,0.9459671104150352,0.7329650092081031
769,5080,COX6A1,602072,616039;,"[MIM:616039]Charcot-Marie-Tooth disease, recessive, intermediate type, D;",Autosomal recessive intermediate Charcot-Marie-Tooth disease type D,Disease-causing germline mutation(s) (loss of function) in,Reading disability or specific language impairment adjusted for intelligence quotient (pleiotropy)[25065397];Reading disability or specific language impairment (pleiotropy)[25065397];,0.554601226993865,0.3788035069623517,0.9402244844688071,0.4843462246777164
770,5085,COX6B1,124089,220110;,[MIM:220110]Mitochondrial complex IV deficiency;,Isolated cytochrome C oxidase deficiency,Disease-causing germline mutation(s) in,,0.8595092024539878,0.575812274368231,0.9838162359697207,0.415438919582566
771,5118,COX7B,300885,300887;,[MIM:300887]Linear skin defects with multiple congenital anomalies 2;,Microphthalmia with linear skin defects syndrome,Disease-causing germline mutation(s) in,,0.7720245398773006,0.7831356369262507,0.6637953536935526,0.0
772,5124,COX8A,123870,,,Isolated cytochrome C oxidase deficiency,Disease-causing germline mutation(s) (loss of function) in,,0.17791411042944785,0.5639504899432697,0.8817541111981206,0.0
773,5127,COX10,602125,220110;256000;,[MIM:220110]Mitochondrial complex IV deficiency;[MIM:256000]Leigh syndrome;,Isolated cytochrome C oxidase deficiency,Disease-causing germline mutation(s) in,Midgestational circulating levels of PCBs[28235828];Temperament[22832960];,0.038773006134969326,0.5948942753996905,0.03471678412947011,0.7783916513198281
774,5131,COX14,614478,,,Isolated cytochrome C oxidase deficiency,Disease-causing germline mutation(s) in,,0.6269938650306749,0.6756059824651882,0.990602975724354,0.0
775,5132,COX15,603646,256000;615119;,[MIM:256000]Leigh syndrome;,Leigh syndrome with leukodystrophy;Fatal infantile cytochrome C oxidase deficiency,Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in,Colorectal cancer[26151821;26151821];Crohn's disease[22412388];Obesity-related traits[23251661];,0.901840490797546,0.06575554409489427,0.6074132080396764,0.6912216083486802
776,5138,COX20,614698,220110;,[MIM:220110]Mitochondrial complex IV deficiency;,Isolated cytochrome C oxidase deficiency,Disease-causing germline mutation(s) in,,0.6861349693251534,0.4718927282104177,0.8613938919342208,0.0
777,5141,CP,117700,604290;,,Aceruloplasminemia,Disease-causing germline mutation(s) (loss of function) in,Subcutaneous adipose tissue[22589738];,0.5110429447852761,0.21686436307374934,0.36543983294179067,0.8011049723756906
778,5142,CPA1,114850,,,Hereditary chronic pancreatitis,Major susceptibility factor in,Waist-to-hip ratio adjusted for BMI (age >50)[26426971];Waist-to-hip ratio adjusted for BMI x sex x age interaction (4df test)[26426971];,0.038773006134969326,0.2328519855595668,0.7441921169407465,0.13459177409453651
779,5147,CPA6,609562,614417;614418;,"[MIM:614417]Epilepsy, familial temporal lobe, 5;[MIM:614418]Febrile seizures, familial, 11;",Familial mesial temporal lobe epilepsy with febrile seizures;Benign familial mesial temporal lobe epilepsy,Disease-causing germline mutation(s) (loss of function) in;Disease-causing germline mutation(s) (gain of function) in,"Type 2 diabetes[25102180];Hearing function[25060954];Cholesterol, total[27036123];",0.22687116564417178,0.11500773594636411,0.07256590968415558,0.043738489871086556
780,5165,CPLANE1,614571,277170;614615;,[MIM:614615]Joubert syndrome 17;[MIM:277170]Orofaciodigital syndrome 6;,Joubert syndrome;Orofaciodigital syndrome type 6;Monomelic amyotrophy,Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Major susceptibility factor in,Telomere length[24795349];,0.038773006134969326,0.012377514182568335,0.0,0.0
781,5167,CPLX1,605032,617976;,,Familial infantile myoclonic epilepsy,Disease-causing germline mutation(s) in,,0.4538650306748466,0.8091799896854048,0.905507700339337,0.0
782,5185,CPOX,612732,121300;,[MIM:121300]Hereditary coproporphyria;,Hereditary coproporphyria,Disease-causing germline mutation(s) in,Urinary albumin excretion (no hypertensive medication)[30220432];Subcutaneous adipose tissue[22589738];,0.9131288343558283,0.6057246003094379,0.08065779169929523,0.7183855125844076
783,5189,CPS1,608307,237300;615371;,"[MIM:237300]Carbamoyl phosphate synthetase 1 deficiency [recessive?];[MIM:615371]Pulmonary hypertension, neonatal;",Carbamoyl-phosphate synthetase 1 deficiency,Disease-causing germline mutation(s) (loss of function) in,Serum metabolite levels[24625756];Mean corpuscular volume[27863252;29403010];Mean corpuscular hemoglobin[27863252;29403010];Creatinine levels[29403010];Urinary albumin excretion (no hypertensive medication)[30220432];Blood metabolite levels[24816252;24816252;24816252;24816252;24816252;24816252;24816252;24816252];Plateletcrit[27863252];Amino acid levels[26068415;26068415];Homocysteine levels[23824729;20154341];Urate levels in obese individuals[25811787];Mean platelet volume[27863252];Body mass index[25673413;25673413;26426971;26426971];Alzheimer's disease in APOE e4+ carriers[25778476];Urinary metabolites[26352407;26352407];Metabolite levels (small molecules and protein measures)[27005778];Glomerular filtration rate in non diabetics (creatinine)[26831199];Plasma homocysteine levels (post-methionine load test)[24651765];Fibrinogen[20031577;23969696];Body mass index in asthmatics[23517042];Platelet count[27863252];Eosinophil percentage of white cells[27863252];Acylcarnitine levels[26068415];Urinary albumin excretion[30220432];Alanine transaminase levels[29403010];Chronic kidney disease[20383146;26831199];Betaine levels in individuals undergoing cardiac evaluation[26822151];HDL cholesterol[24097068];Glomerular filtration rate[27588450;29403010];Eosinophil percentage of granulocytes[27863252];Non-small cell lung cancer[23144319];Macular telangiectasia type 2[28250457];Metabolite levels[23378610];Fibrinogen levels[26561523;28107422;28107422];Serum metabolite concentrations in chronic kidney disease[29545352];Metabolic traits[21886157];Glomerular filtration rate (creatinine)[26831199;28452372];,0.7688343558282209,0.8563692625064466,0.023492560689115115,0.958256599140577
784,5199,CPT1A,600528,255120;,[MIM:255120]Carnitine palmitoyltransferase 1A deficiency [recessive?];,Carnitine palmitoyl transferase 1A deficiency,Disease-causing germline mutation(s) (loss of function) in,Lipid metabolism phenotypes[22286219];Coronary artery calcified atherosclerotic plaque score in type 2 diabetes[29221444];Obesity-related traits[23251661];,0.7993865030674847,0.5858690046415678,0.44505351083268074,0.9152854511970534
785,5201,CPT1C,608846,616282;,,Autosomal dominant spastic paraplegia type 73,Disease-causing germline mutation(s) in,Lung function (FEV1/FVC)[30061609];,0.038773006134969326,0.8372872614749871,0.6442182197859566,0.8515960712093309
786,5202,CPT2,600650,255110;600649;608836;614212;,"[MIM:255110]Carnitine palmitoyltransferase 2 deficiency, myopathic, stress-induced [recessive?];[MIM:600649]Carnitine palmitoyltransferase 2 deficiency, infantile [recessive?];[MIM:608836]Carnitine palmitoyltransferase 2 deficiency, lethal neonatal [recessive?];[MIM:614212]Encephalopathy, acute, infection-induced, 4;","Acute necrotizing encephalopathy of childhood;Carnitine palmitoyl transferase II deficiency, myopathic form;Carnitine palmitoyl transferase II deficiency, severe infantile form;Carnitine palmitoyl transferase II deficiency, neonatal form",Candidate gene tested in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in,Blood metabolite levels[24816252];,0.7775460122699387,0.11217122227952553,0.14252153484729835,0.7412523020257827
787,5212,CR2,120650,610927;614699;,"[MIM:614699]Immunodeficiency, common variable, 7;",Systemic lupus erythematosus;Common variable immunodeficiency,Major susceptibility factor in;Disease-causing germline mutation(s) in,Type 2 diabetes[21490949];Systemic sclerosis[29293537];,0.33226993865030674,0.047189272821041774,0.04124249543200209,0.04558011049723757
788,5217,CRADD,603454,614499;,"[MIM:614499]Mental retardation, autosomal recessive 34, with variant lissencephaly [recessive?];",Autosomal recessive non-syndromic intellectual disability,Disease-causing germline mutation(s) in,Hip circumference adjusted for BMI[25673412;25673412;25673412];Heel bone mineral density[28869591;28869591];Height[18391951;25282103];Alzheimer's disease (cognitive decline)[23535033];Lung function (FVC)[30061609];,0.45950920245398774,0.6320268179473956,0.7311406943356826,0.63182934315531
789,5220,CRB1,604210,172870;268000;600105;613835;,[MIM:600105]Retinitis pigmentosa 12 [recessive?];[MIM:613835]Leber congenital amaurosis 8;[MIM:172870]Pigmented paravenous chorioretinal atrophy;,Retinitis pigmentosa;Pigmented paravenous retinochoroidal atrophy;Leber congenital amaurosis,Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in,Inflammatory bowel disease[28067908];Pediatric autoimmune diseases[26301688];Body mass index[28892062];Chin dimples[27182965];Crohn's disease[28067908];Blood protein levels[28240269;28240269];Lupus nephritis in systemic lupus erythematosus[24925725];Asthma[20032318;20032318];,0.5867484662576687,0.09283135636926251,0.5899243017488907,0.9008594229588704
790,5221,CRB2,609720,219730;616220;,[MIM:616220]Focal segmental glomerulosclerosis 9;[MIM:219730]Ventriculomegaly with cystic kidney disease [recessive?];,Ventriculomegaly-cystic kidney disease;Familial idiopathic steroid-resistant nephrotic syndrome with focal segmental hyalinosis,Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) (loss of function) in,Body mass index[25673413;25673413];,0.10711656441717791,0.05956678700361011,0.09057687287914383,0.7856046654389196
791,5224,CRBN,609262,607417;,"[MIM:607417]Mental retardation, autosomal recessive 2A [recessive?];",Autosomal recessive non-syndromic intellectual disability,Disease-causing germline mutation(s) in,Immune response to smallpox vaccine (IL-6)[22542470];Restless legs syndrome[29029846];Knee osteoarthritis[27696742];White blood cell count (basophil)[29403010;27863252];Amyotrophic lateral sclerosis (sporadic)[24529757];Basophil percentage of white cells[27863252];White matter integrity[23218918];Basophil percentage of granulocytes[27863252];,0.6186503067484662,0.6237751418256834,0.8290263638736622,0.6270718232044199
792,5227,CREB1,123810,612160;,[MIM:612160]Angiomatoid fibrous histiocytoma;,Melanoma of soft tissue,Part of a fusion gene in,Body mass index[25673413;25673413;25673413;28892062];Food antigen IgG levels[24962563];,0.7382822085889571,0.7225373904074265,0.6160271469590185,0.0
793,5229,CREB3L1,616215,616229;,[MIM:616229]Osteogenesis imperfecta 16 [recessive?];,Osteogenesis imperfecta type 3;Myxofibrosarcoma,Disease-causing germline mutation(s) in;Part of a fusion gene in,Fasting blood glucose[22581228];Autism spectrum disorder or schizophrenia[28540026;28540026];,0.5885889570552147,0.7374935533780299,0.34038110154006784,0.0
794,5230,CREB3L2,608834,,,Myxofibrosarcoma,Part of a fusion gene in,,0.2498159509202454,0.6544610624033007,0.6815452884364396,0.2539901780233272
795,5234,CREBBP,600140,180849;,[MIM:180849]Rubinstein-Taybi syndrome 1;,Acute myeloid leukemia with t(8;16)(p11;p13) translocation;Rubinstein-Taybi syndrome due to CREBBP mutations;Rubinstein-Taybi syndrome due to 16p13.3 microdeletion,Part of a fusion gene in;Disease-causing germline mutation(s) in;Role in the phenotype of,QT interval[24952745];QT interval (drug interaction)[23459443];Nonsyndromic cleft lip with or without cleft palate[25775280];Metabolite levels (HVA/5-HIAA ratio)[23319000];Obesity-related traits[23251661];Nonsyndromic cleft lip with cleft palate[28232668];,0.7906748466257669,0.927797833935018,0.4291307752545027,0.9953959484346224
796,5240,CRELD1,607170,606217;,[MIM:606217]Atrioventricular septal defect 2;,Partial atrioventricular canal;Complete atrioventricular canal-tetralogy of Fallot syndrome;Complete atrioventricular canal-ventricle hypoplasia syndrome;Complete atrioventricular canal-left heart obstruction syndrome,Disease-causing germline mutation(s) (loss of function) in;Major susceptibility factor in;Major susceptibility factor in;Major susceptibility factor in,Blood protein levels[29875488;30072576];,0.3168098159509202,0.14827230531201652,0.480814408770556,0.4224984653161449
797,5243,CRH,122560,,,Autosomal dominant nocturnal frontal lobe epilepsy,Disease-causing germline mutation(s) in,Coronary heart disease event reduction (statin therapy interaction)[22666496];,0.2585276073619632,0.7978339350180506,0.8629600626468285,0.0
798,5247,CRIM1,606189,,,Colobomatous macrophthalmia-microcornea syndrome,Disease-causing germline mutation(s) in,Bone mineral density (total hip)[29883787];Anthropometric traits[19260139];QRS duration[27577874;27577874];Height[25429064;25282103];IgE levels in asthmatics[23967269];,0.12711656441717792,0.7514182568334193,0.33176716262072564,0.5931553100061387
799,5264,CRKL,602007,,,Distal 22q11.2 microdeletion syndrome,Role in the phenotype of,Platelet distribution width[27863252];,0.9298159509202454,0.7080969571944301,0.8569564082484991,0.8643339472068754
800,5265,CRLF1,604237,272430;,[MIM:272430]Crisponi/Cold-induced sweating syndrome 1 [recessive?];,Idiopathic achalasia;Cold-induced sweating syndrome;Crisponi syndrome,Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in,Blood protein levels[30072576];,0.16220858895705523,0.3659102630221764,0.10023492560689115,0.5121240024554942
801,5286,CRTAP,605497,610682;,,Osteogenesis imperfecta type 2;Osteogenesis imperfecta type 3;Osteogenesis imperfecta type 4,Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in,Major depressive disorder[29317602];,0.8065030674846626,0.49432697266632286,0.22396241190289742,0.0
802,5291,CRX,602225,120970;268000;613829;,[MIM:120970]Cone-rod dystrophy 2;[MIM:268000]Retinitis pigmentosa;,Retinitis pigmentosa;Cone rod dystrophy;Leber congenital amaurosis,Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in,,0.538282208588957,0.701392470345539,0.536935525972331,0.7701043585021485
803,5294,CRYAA,123580,604219;,"[MIM:604219]Cataract 9, multiple types;",Cataract-microcornea syndrome;Early-onset lamellar cataract;Early-onset anterior polar cataract;Early-onset nuclear cataract;Total early-onset cataract,Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in,Systolic blood pressure[27618452;28739976];Age-related nuclear cataracts[24951543];Diastolic blood pressure[27618452;28739976;28135244];,0.2947239263803681,0.5515729757607014,0.8731401722787784,0.5857888275015347
804,5296,CRYAB,123590,608810;613763;613869;615184;,"[MIM:608810]Myopathy, myofibrillar, 2;[MIM:613763]Cataract 16, multiple types;[MIM:613869]Myopathy, myofibrillar, fatal infantile hypertonic, alpha-B crystallin-related;[MIM:615184]Cardiomyopathy, dilated 1II;",Familial isolated dilated cardiomyopathy;Fatal infantile hypertonic myofibrillar myopathy;Alpha-B crystallin-related late-onset myopathy;Early-onset lamellar cataract;Early-onset nuclear cataract;Early-onset posterior polar cataract,Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in,,0.6754601226993865,0.7607013924703455,0.8780997128687027,0.4958563535911602
805,5297,CRYBA1,123610,600881;,"[MIM:600881]Cataract 10, multiple types;",Early-onset lamellar cataract;Early-onset sutural cataract;Early-onset nuclear cataract;Early-onset posterior polar cataract,Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in,Depression[29700475];Night sleep phenotypes[27126917];,0.32380368098159507,0.2705002578648788,0.7209605847037327,0.1741866175567833
806,5298,CRYBA2,600836,115900;,[MIM:115900]Cataract 42;,Early-onset anterior polar cataract;Early-onset nuclear cataract,Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in,Height[18391951];,0.31079754601226994,0.49045899948427024,0.7285304098146698,0.3052486187845304
807,5299,CRYBA4,123631,610425;,"[MIM:610425]Cataract 23, multiple types;",Cataract-microcornea syndrome;Early-onset lamellar cataract,Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in,,0.33226993865030674,0.12841670964414648,0.5700861393891934,0.19367710251688153
808,5300,CRYBB1,600929,611544;,"[MIM:611544]Cataract 17, multiple types;",Cataract-microcornea syndrome;Pulverulent cataract;Early-onset nuclear cataract,Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in,,0.21484662576687116,0.3334192882929345,0.7697729052466719,0.20825659914057704
809,5301,CRYBB2,123620,601547;,"[MIM:601547]Cataract 3, multiple types;",Cataract-microcornea syndrome;Early-onset posterior subcapsular cataract;Cerulean cataract;Pulverulent cataract;Early-onset sutural cataract;Early-onset nuclear cataract;Total early-onset cataract,Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in,,0.20368098159509201,0.6526560082516761,0.5160532498042286,0.405463474524248
810,5303,CRYBB3,123630,609741;,"[MIM:609741]Cataract 22, multiple types;",Early-onset anterior polar cataract;Early-onset nuclear cataract,Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in,,0.17791411042944785,0.15291387313047963,0.39963456016705823,0.14809699201964396
811,5308,CRYGB,123670,615188;,"[MIM:615188]Cataract 39, multiple types;",Early-onset lamellar cataract;Early-onset anterior polar cataract;Total early-onset cataract,Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in,,0.038773006134969326,0.15961835997937082,0.695118767945706,0.214548802946593
812,5309,CRYGC,123680,604307;,"[MIM:604307]Cataract 2, multiple types;",Cataract-microcornea syndrome;Early-onset lamellar cataract;Pulverulent cataract;Early-onset nuclear cataract,Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in,Attention deficit hyperactivity disorder[18839057];,0.20368098159509201,0.3298091799896854,0.568780997128687,0.3902701043585021
813,5310,CRYGD,123690,115700;,"[MIM:115700]Cataract 4, multiple types;",Cataract-microcornea syndrome;Early-onset lamellar cataract;Coralliform cataract;Cerulean cataract;Pulverulent cataract;Early-onset nuclear cataract,Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in,,0.10711656441717791,0.3104693140794224,0.712868702688593,0.2937384898710866
814,5315,CRYGS,123730,116100;,"[MIM:116100]Cataract 20, multiple types;",Early-onset lamellar cataract;Early-onset sutural cataract,Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in,Open-angle glaucoma and vertical cup-disc ratio[29449654];Glaucoma (primary open-angle)[29449654];Illicit drug use[23942779];,0.038773006134969326,0.48684889118102115,0.9023753589141217,0.31261510128913444
815,5317,CRYM,123740,616357;,,Autosomal dominant non-syndromic sensorineural deafness type DFNA,Disease-causing germline mutation(s) in,Pelvic organ prolapse[26545240];,0.4917791411042945,0.5353274883960805,0.6444792482380579,0.4538060159607121
816,5336,CSF1R,164770,221820;,"[MIM:221820]Leukoencephalopathy, diffuse hereditary, with spheroids [dominant?];",Hereditary diffuse leukoencephalopathy with axonal spheroids and pigmented glia,Disease-causing germline mutation(s) (loss of function) in,Granulocyte percentage of myeloid white cells[27863252;27863252];Monocyte count[27863252;27863252];Monocyte percentage of white cells[27863252;27863252];Blood protein levels[28240269;30072576];,0.3925153374233129,0.6843733883445074,0.26912033411641867,0.7140883977900553
817,5338,CSF2RA,306250;425000,300770;,[MIM:300770]Pulmonary surfactant metabolism dysfunction 4;,Hereditary pulmonary alveolar proteinosis,Disease-causing germline mutation(s) in,Schizophrenia[17522711];,0.505398773006135,0.23671995874161939,0.29496215087444533,0.9511970534069981
818,5339,CSF2RB,138981,614370;,[MIM:614370]Pulmonary surfactant metabolism dysfunction 5;,Hereditary pulmonary alveolar proteinosis,Disease-causing germline mutation(s) in,Inflammatory bowel disease[27569725];Multiple sclerosis[24076602];Perceived unattractiveness to mosquitoes[28199695];Itch intensity from mosquito bite adjusted by bite size[28199695;28199695;28199695];Mosquito bite size[28199695];Itch intensity from mosquito bite[28199695];Blood protein levels[29875488;30072576];,0.6131288343558282,0.5278494069107788,0.25319759853824064,0.8213627992633518
819,5342,CSF3R,138971,162830;617014;,"[MIM:162830]Hereditary neutrophilia;[MIM:617014]Neutropenia, severe congenital 7, autosomal recessive [recessive?];",Hereditary neutrophilia;Autosomal recessive severe congenital neutropenia due to CSF3R deficiency;Chronic neutrophilic leukemia;Atypical chronic myeloid leukemia,Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) (loss of function) in;Disease-causing somatic mutation(s) in;Disease-causing somatic mutation(s) in,Granulocyte percentage of myeloid white cells[27863252;27863252];Lymphocyte percentage of white cells[27863252;27863252];White blood cell count[29403010;27863252;27863252];Neutrophil percentage of white cells[27863252;27863252];Myeloid white cell count[27863252;27863252];Iron status biomarkers (total iron binding capacity)[28334935];Sum basophil neutrophil counts[27863252;27863252];Sum neutrophil eosinophil counts[27863252;27863252];Monocyte percentage of white cells[27863252];Granulocyte count[27863252;27863252];Neutrophil count[27863252;27863252];,0.3449079754601227,0.0,0.3330723048812321,0.16451810926949048
820,5364,CSNK1D,600864,615224;,"[MIM:615224]Advanced sleep phase syndrome, familial, 2;",Familial advanced sleep-phase syndrome,Disease-causing germline mutation(s) in,,0.9884662576687117,0.87132542547705,0.7603758809710258,0.0
821,5374,CSNK2B,115441,,,Autosomal dominant non-syndromic intellectual disability,Disease-causing germline mutation(s) (loss of function) in,Inflammatory bowel disease[28067908];Systemic lupus erythematosus[26316170];Cutaneous lupus erythematosus[25827949];Autism spectrum disorder or schizophrenia[28540026;28540026;28540026;28540026;28540026;28540026;28540026;28540026;28540026;28540026;28540026;28540026;28540026;28540026;28540026];Blood protein levels[28240269];Ulcerative colitis[28067908];,0.9478527607361963,0.8834450747808148,0.8974158183241974,0.766267648864334
822,5389,CSPP1,611654,615636;,[MIM:615636]Joubert syndrome 21;,Meckel syndrome;Joubert syndrome;Joubert syndrome with Jeune asphyxiating thoracic dystrophy,Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) (loss of function) in;Disease-causing germline mutation(s) (loss of function) in,,0.9536196319018405,0.43243940175348117,0.18872357086922475,0.044812768569674644
823,5396,CSRP3,600824,607482;612124;,"[MIM:607482]Cardiomyopathy, dilated 1M;[MIM:612124]Cardiomyopathy, familial hypertrophic 12;",Familial isolated dilated cardiomyopathy,Disease-causing germline mutation(s) in,Mean corpuscular hemoglobin[27863252];Mean corpuscular volume[27863252];Mosquito bite size[28199695];Red blood cell count[27863252];,0.30319018404907977,0.2900979886539453,0.8486034977812582,0.5029158993247391
824,5400,CST3,604312,105150;611953;,"[MIM:105150]Amyloidosis 6;[MIM:611953]Macular degeneration, age-related, 11;",ACys amyloidosis,Disease-causing germline mutation(s) in,Cystatin C[17903292];Plasma cystastin c levels in acute coronary syndrome[24952865;24952865];Chronic kidney disease[20383146];Blood protein levels[28240269;30072576;30072576;30072576];Glomerular filtration rate (cystatin C)[28452372];,0.5692024539877301,0.39401753481175866,0.27538501696684936,0.22314303253529774
825,5413,CSTA,184600,607936;,,Acral peeling skin syndrome;Exfoliative ichthyosis,Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) (loss of function) in,Calcium levels[20705733;25972035;29403010];,0.6793865030674847,0.702423929860753,0.30566431741059774,0.17664211172498465
826,5414,CSTB,601145,254800;,"[MIM:254800]Epilepsy, progressive myoclonic 1 [recessive?];",Unverricht-Lundborg disease,Disease-causing germline mutation(s) in,Acne (severe)[24927181];Blood protein levels[29875488;29875488;30072576];,0.8482208588957055,0.4210933470861269,0.9331767162620725,0.24125230202578268
827,5482,CTC1,613129,612199;,[MIM:612199]Cerebroretinal microangiopathy with calcifications and cysts 1 [recessive?];,Dyskeratosis congenita;Coats plus syndrome,Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in,Bipolar disorder[28115744];Telomere length[23001564];,0.27361963190184047,0.4020113460546674,0.40015661707126077,0.0
828,5483,CTCF,604167,615502;,"[MIM:615502]Mental retardation, autosomal dominant 21 [dominant?];",Intellectual disability-feeding difficulties-developmental delay-microcephaly syndrome,Disease-causing germline mutation(s) in,Elevated fasting plasma glucose[30004843];HDL cholesterol[19060911];,0.8721472392638037,0.9412068076328004,0.9407465413730096,0.9171270718232044
829,5487,CTDP1,604927,604168;,"[MIM:604168]Congenital cataracts, facial dysmorphism, and neuropathy [recessive?];",Congenital cataracts-facial dysmorphism-neuropathy syndrome,Disease-causing germline mutation(s) (loss of function) in,Cerebrospinal P-tau181p levels[28247064];Schizophrenia[23212062];Monocyte count[27863252];,0.6711656441717792,0.3416709644146467,0.2680762203080136,0.5914671577655003
830,5489,CTDSP2,608711,,,Leukoencephalopathy-dystonia-motor neuropathy syndrome,Disease-causing germline mutation(s) in,,0.4190184049079755,0.4925219185146983,0.9143826677107805,0.39149785144260285
831,5494,CTH,607657,219500;,[MIM:219500]Cystathioninuria;,Cystathioninuria,Disease-causing germline mutation(s) (loss of function) in,Adverse response to chemotherapy in breast cancer (alopecia) (cyclophosphamide+doxorubicin+/-5FU)[24025145];Brain volume in infants (grey matter)[28763065];,0.45680981595092024,0.15368746776689016,0.23466457843904986,0.648096992019644
832,5499,CTLA4,123890,109100;152700;601388;609755;610424;616100;,"[MIM:152700]Systemic lupus erythematosus;[MIM:601388]Diabetes mellitus, insulin-dependent, 12;[MIM:609755]Celiac disease 3;[MIM:616100]Autoimmune lymphoproliferative syndrome 5 [dominant?];",Systemic lupus erythematosus;Granulomatosis with polyangiitis;Classic mycosis fungoides;S�zary syndrome;Adult-onset myasthenia gravis;Autoimmune lymphoproliferative syndrome due to CTLA4 haploinsuffiency,Major susceptibility factor in;Major susceptibility factor in;Part of a fusion gene in;Part of a fusion gene in;Major susceptibility factor in;Disease-causing germline mutation(s) in,Multiple sclerosis[24076602];Graves' disease[21841780];Hypothyroidism[22493691;27182965];Alopecia areata[20596022;25608926];Inflammatory bowel disease[26192919];Celiac disease[20190752;22057235];Rheumatoid arthritis (ACPA-positive)[23143596;24532676;23143596];Vitiligo[27723757];Myasthenia gravis[25643325];Type 1 diabetes[18978792;19430480;21829393;25751624];Rheumatoid arthritis[19503088;24390342;24390342;20453842;23143596;23143596;23143596];Primary biliary cholangitis[28425483];Subcutaneous adipose tissue[29178545];Ulcerative colitis[26192919];,0.35496932515337426,0.8050541516245487,0.9511876794570608,0.6746470227133211
833,5500,CTNNA1,116805,608970;,"[MIM:608970]Macular dystrophy, patterned, 2 [dominant?];",Hereditary diffuse gastric cancer;Butterfly-shaped pigment dystrophy,Candidate gene tested in;Disease-causing germline mutation(s) in,Schizophrenia[25056061];,0.9062576687116565,0.9311500773594636,0.7314017227877838,0.5019950890116636
834,5503,CTNNA3,607667,615616;,,"Familial isolated arrhythmogenic ventricular dysplasia, right dominant form;Familial isolated arrhythmogenic ventricular dysplasia, biventricular form;Familial isolated arrhythmogenic ventricular dysplasia, left dominant form",Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in,Nickel levels[26025379];Docetaxel-induced peripheral neuropathy in metastatic castrate-resistant prostate cancer[27143689];Schizophrenia (cytomegalovirus infection interaction)[23358160];Night sleep phenotypes[27126917];Asthma (toluene diisocyanate-induced)[19187332];Lung function (FVC)[24023788];Psoriatic arthritis[26626624];Dental caries[23064961];Systemic lupus erythematosus[28714469];Epstein-Barr virus copy number in lymphoblastoid cell lines[28654678];Bronchopulmonary dysplasia[23897914];Optic disc area[28073927];Obesity-related traits[23251661];Subcutaneous adipose tissue[29178545;29178545];Metabolite levels (Pyroglutamine)[23934736];Essential tremor[27797806];Nicotine dependence[17158188];,0.4750920245398773,0.24651882413615264,0.10884886452623337,0.10804174340085942
835,5505,CTNNB1,116806,114500;132600;155255;156240;167000;181030;615075;617572;,"[MIM:114500]Colorectal cancer;[MIM:132600]Pilomatrixoma;[MIM:155255]Medulloblastoma;[MIM:167000]Ovarian cancer;[MIM:156240]Mesothelioma, malignant;[MIM:615075]Mental retardation, autosomal dominant 19 [dominant?];[MIM:617572]Vitreoretinopathy, exudative 7;",Adult hepatocellular carcinoma;Familial exudative vitreoretinopathy;Severe intellectual disability-progressive spastic diplegia syndrome;Desmoid tumor;Craniopharyngioma;Pediatric hepatocellular carcinoma;Pilomatrixoma,Candidate gene tested in;Disease-causing germline mutation(s) (loss of function) in;Disease-causing germline mutation(s) in;Disease-causing somatic mutation(s) in;Disease-causing somatic mutation(s) in;Candidate gene tested in;Disease-causing somatic mutation(s) in,Bone mineral density (hip)[19801982;27311723];Bone mineral density (total hip)[29883787];Fractures[30158200];Colorectal cancer[26151821;26151821];Heel bone mineral density[28869591;28869591;28869591];Bone mineral density[22504420];Femoral neck bone mineral density[29499414];Lumbar spine bone mineral density[29499414];,0.9736196319018405,0.9868488911810211,0.9376141999477943,0.6416513198281154
836,5508,CTNND1,601045,617681;,[MIM:617681]Blepharocheilodontic syndrome 2 [dominant?];,Blepharo-cheilo-odontic syndrome,Disease-causing germline mutation(s) (loss of function) in,Neuroticism[29255261];Parkinson's disease[27182965];Autism spectrum disorder or schizophrenia[28540026];Schizophrenia[25056061];,0.996319018404908,0.870809695719443,0.33020099190811797,0.3305709023941068
837,5509,CTNND2,604275,,,Monosomy 5p;Benign adult familial myoclonic epilepsy,Role in the phenotype of;Disease-causing germline mutation(s) in,Common carotid intima-media thickness in HIV infection[29206233];Lewy body disease[25188341];Myopia (pathological)[21095009];Amyotrophic lateral sclerosis (sporadic)[24529757];Facial emotion recognition[28608620];Cannabis dependence symptom count[27028160];Very long-chain saturated fatty acid levels (fatty acid 20:0)[25378659];,0.3492024539877301,0.9020113460546674,0.6507439310884886,0.983732351135666
838,5510,CTNS,606272,219750;219800;219900;,"[MIM:219750]Cystinosis, adult, non-nephropathic type;[MIM:219900]Cystinosis, late-onset juvenile or adolescent nephropathic type;",Nephropathic infantile cystinosis;Ocular cystinosis;Juvenile nephropathic cystinosis,Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in,,0.038773006134969326,0.37983496647756576,0.3362046463064474,0.8585021485573971
839,5512,CTPS1,123860,615897;,[MIM:615897]Immunodeficiency 24;,Severe combined immunodeficiency due to CTPS1 deficiency,Disease-causing germline mutation(s) (loss of function) in,,0.7613496932515338,0.5350696235172769,0.8626990341947273,0.0
840,5517,CTRC,601405,167800;,,Hereditary chronic pancreatitis;Tropical pancreatitis,Candidate gene tested in;Major susceptibility factor in,Alcoholic chronic pancreatitis[28754779;28754779;28754779;28754779;28754779;28754779;28754779;28754779;28754779;28754779];,0.30319018404907977,0.07503867973182053,0.5779169929522318,0.5593922651933702
841,5519,CTSA,613111,256540;,[MIM:256540]Galactosialidosis;,Galactosialidosis,Disease-causing germline mutation(s) in,,0.6009815950920245,0.4938112429087158,0.4395719133385539,0.8456108041743401
842,5520,CTSB,116810,,,Keratolytic winter erythema,Role in the phenotype of,Parkinson's disease[28892059];C-reactive protein levels or triglyceride levels (pleiotropy)[27286809];Leprosy[27976721];Blood protein levels[28240269;29875488;30072576;30072576;30072576;30072576;30072576];,0.7553374233128834,0.27204744713769985,0.10493343774471417,0.8968692449355433
843,5521,CTSC,602365,170650;245000;245010;,"[MIM:245000]Papillon-Lefevre syndrome [recessive?];[MIM:245010]Haim-Munk syndrome [recessive?];[MIM:170650]Periodontititis, aggressive, 1;",Haim-Munk syndrome;Papillon-Lef�vre syndrome,Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) (loss of function) in,Blood protein levels[30072576];,0.5900613496932515,0.20422898401237752,0.3523884103367267,0.6932166973603437
844,5522,CTSD,116840,610127;,"[MIM:610127]Ceroid lipofuscinosis, neuronal, 10;",CLN10 disease,Disease-causing germline mutation(s) in,Blood protein levels[30072576];,0.734601226993865,0.5018050541516246,0.6170712607674237,0.332719459791283
845,5524,CTSF,603539,615362;,,CLN13 disease,Disease-causing germline mutation(s) in,Airway imaging phenotypes[26030696];Bipolar disorder[21926972];Blood protein levels[29875488;29875488;30072576];,0.22687116564417178,0.32026817947395564,0.5559906029757243,0.38919582565991406
846,5526,CTSH,116820,,,Narcolepsy type 1,Major susceptibility factor in,Multiple sclerosis[24076602];Type 1 diabetes[18978792;19430480;25751624];Bipolar disorder[21771265];Narcolepsy[23459209];Blood protein levels[29875488;30072576;30072576];,0.3168098159509202,0.2931923671995874,0.1406943356825894,0.40316144874155924
847,5527,CTSK,601105,265800;,,Pycnodysostosis,Disease-causing germline mutation(s) (loss of function) in,Body mass index[26426971];Melanoma[21983785];Blood protein levels[28240269];Rhegmatogenous retinal detachment[23585552];Congenital left-sided heart lesions[26965164];,0.26588957055214724,0.2993811242908716,0.8979378752283999,0.5379066912216084
848,5551,CUBN,602997,261100;,[MIM:261100]Recessive hereditary megaloblastic anemia 1;,Imerslund-Gr�sbeck syndrome,Disease-causing germline mutation(s) in,"Binge eating behaviour in bipolar disorder[29391396];Urinary albumin excretion[21355061;30220432;30220432;30220432;30220432];Urinary albumin excretion (no hypertensive medication)[30220432;30220432;30220432];Colorectal cancer[25990418];Platelet distribution width[27863252];Urinary albumin-to-creatinine ratio[27650483;26631737];Quantitative traits[19197348];Homocysteine levels[23824729;23824729];Molybdenum levels[26025379];Urinary albumin-to-creatinine ratio in non-diabetics[26631737];Vitamin B levels in ischemic stroke[25147783];Total cholesterol levels[28334899];Whole-brain volume[21116278];Cholesterol, total[24097068];Folate pathway vitamin levels[19744961;19303062];Microalbuminuria[26631737];",0.4622085889570552,0.3824136152656008,0.028974158183241974,0.07136279926335175
849,5560,CUL3,603136,614496;,[MIM:614496]Pseudohypoaldosteronism 2E [dominant?];,Pseudohypoaldosteronism type 2E,Disease-causing germline mutation(s) in,Response to bupropion and depression[27622933];Schizophrenia[25056061;28991256];Acute graft versus host disease in bone marrow transplantation (recipient effect)[27595289];Thrombin-activatable fibrinolysis inhibitor activation peptide[29378355];,0.9026993865030675,0.740587931923672,0.22187418428608718,0.42955801104972374
850,5563,CUL4B,300304,300354;,"[MIM:300354]Mental retardation, X-linked, syndromic, 15;","X-linked intellectual disability, Cabezas type",Disease-causing germline mutation(s) in,,0.8304294478527607,1.0,0.9436178543461238,0.0
851,5565,CUL7,609577,273750;,[MIM:273750]3M syndrome 1 [recessive?];,3M syndrome,Disease-causing germline mutation(s) in,,0.8117791411042945,0.02372356884992264,0.3095797441921169,0.5888581952117864
852,5570,CUX1,116896,,,Autosomal dominant non-syndromic intellectual disability,Disease-causing germline mutation(s) in,Mean platelet volume[27863252;27863252];Intelligence (MTAG)[29326435];Basal cell carcinoma[27539887];Reticulocyte fraction of red cells[27863252];Reticulocyte count[27863252];Attention deficit hyperactivity disorder symptom score[27663945];Platelet distribution width[27863252];Response to antidepressants[22584459];Plateletcrit[27863252];Breast cancer[29059683];,0.8412269938650306,1.0,0.5061341686243801,0.4370779619398404
853,5571,CUX2,610648,,,Lennox-Gastaut syndrome,Disease-causing germline mutation(s) in,Mean corpuscular hemoglobin concentration[29403010];Mean corpuscular volume[29403010];Mean corpuscular hemoglobin[29403010];Gout[27899376;25646370];Renal underexcretion gout[27899376];Creatinine levels[29403010];Colorectal cancer[26151821;26151821];Blood sugar levels[29403010];Mean arterial pressure[29403010];Blood urea nitrogen levels[29403010];Blood osmolality (transformed sodium)[28360221];Body mass index[26426971];Activated partial thromboplastin time[29403010];Renal overload gout[27899376];Pulse pressure[29403010];Systolic blood pressure x alcohol consumption interaction (2df test)[29912962];Aspartate aminotransferase levels[29403010];Coffee consumption[29367735];Mean arterial pressure x alcohol consumption interaction (2df test)[29912962];Systolic blood pressure[29403010];Sodium levels[29403010];Atrial fibrillation[28416822];Diastolic blood pressure[29403010];Low density lipoprotein cholesterol[29403010];Alanine transaminase levels[29403010];Red blood cell count[29403010];Coronary heart disease[23364394];Gamma glutamyl transferase levels[29403010];Glomerular filtration rate[29403010];Serum uric acid levels[29403010];Idiopathic osteonecrosis of the femoral head[29118346];Alcohol consumption (maxi-drinks)[29460428];Type 1 diabetes[22293688];Response to alcohol consumption (flushing response)[29460428];Chloride levels[29403010];High density lipoprotein cholesterol levels[29403010];,0.08736196319018405,0.7220216606498195,0.39284782041242494,0.5593922651933702
854,5578,CWC27,617170,250410;,[MIM:250410]Retinitis pigmentosa with or without skeletal anomalies [recessive?];,Brachydactyly-short stature-retinitis pigmentosa syndrome,Disease-causing germline mutation(s) in,Diverticular disease[30177863];Central corneal thickness[29760442];Glucocorticoid-induced osteonecrosis (age 10 years and older)[26265699];Urinary albumin excretion[30220432];Urinary albumin excretion (no hypertensive medication)[30220432];Obesity-related traits[23251661];Bladder cancer[27206850];,0.6878527607361963,0.30324909747292417,0.7776037588097102,0.12231430325352978
855,5579,CWF19L1,616120,616127;,,Autosomal recessive cerebellar ataxia due to CWF19L1 deficiency,Disease-causing germline mutation(s) in,,0.8689570552147239,0.22769468798349665,0.09397024275646046,0.0798035604665439
856,5597,CXCL10,147310,,,Immunodeficiency due to a late component of complement deficiency,Disease-causing germline mutation(s) in,Interferon gamma-induced protein 10 levels[27989323];Blood protein levels[28240269;28240269;29875488;30072576];,0.16220858895705523,0.6805054151624549,0.8796658835813104,0.0
857,5605,CXCR2,146928,,,Autosomal recessive severe congenital neutropenia due to CXCR2 deficiency,Disease-causing germline mutation(s) in,"Granulocyte percentage of myeloid white cells[27863252];Smooth-surface caries[23470693];Lymphocyte percentage of white cells[27863252];Myeloid white cell count[27863252];Chronic inflammatory diseases (ankylosing spondylitis, Crohn's disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy)[26974007];Sum basophil neutrophil counts[27863252];Sum neutrophil eosinophil counts[27863252];Monocyte percentage of white cells[27863252];Granulocyte count[27863252];Neutrophil count[27863252];Inflammatory bowel disease[28067908;23128233];White blood cell count[27863252];Neutrophil percentage of white cells[27863252];",0.4117791411042945,0.5990201134605466,0.7421038893239363,0.38152240638428486
858,5608,CXCR4,162643,193670;,[MIM:193670]WHIM syndrome;,WHIM syndrome,Disease-causing germline mutation(s) (gain of function) in,Body mass index[26426971];Multiple sclerosis[19525953];Arthritis (juvenile idiopathic)[27005825];Amyotrophic lateral sclerosis (sporadic)[24529757];Colorectal cancer[29228715];Telomere length[20421499];Non-albumin protein levels[29403010];Albumin-globulin ratio[29403010];,0.689079754601227,0.45745229499742135,0.9509266510049595,0.5112031921424187
859,5624,CXXC1,609150,,,Systemic lupus erythematosus;Pediatric systemic lupus erythematosus,Major susceptibility factor in;Major susceptibility factor in,Chronic lymphocytic leukemia[28165464];,0.8122699386503067,0.8942753996905621,0.7321848081440877,0.5541743400859422
860,5630,CYB5A,613218,250790;,[MIM:250790]Methemoglobinemia and ambiguous genitalia [recessive?];,"Hereditary methemoglobinemia;46,XY disorder of sex development due to isolated 17,20-lyase deficiency",Candidate gene tested in;Disease-causing germline mutation(s) in,Blood protein levels[30072576];,0.35496932515337426,0.406395048994327,0.7977029496215088,0.48649478207489255
861,5640,CYB5R3,613213,250800;,[MIM:250800]Methemoglobinemia CYB5R3-related;,Hereditary methemoglobinemia,Disease-causing germline mutation(s) in,Initial pursuit acceleration[29064472];,0.9185276073619631,0.29706034038164003,0.3054032889584965,0.9554941682013505
862,5647,CYBA,608508,233690;,"[MIM:233690]Granulomatous disease, chronic, cytochrome-b-negative, autosomal recessive [recessive?];",Chronic granulomatous disease,Disease-causing germline mutation(s) in,Glycated hemoglobin levels[24647736];Hair color[26926045];,0.4667484662576687,0.35353274883960806,0.41007569825110934,0.0
863,5648,CYBB,300481,300645;306400;,"[MIM:306400]Granulomatous disease, chronic, X-linked;[MIM:300645]Immunodeficiency 34;",Chronic granulomatous disease;X-linked mendelian susceptibility to mycobacterial diseases due to CYBB deficiency,Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in,,0.4463803680981595,0.9517792676637442,0.8016183764030279,0.9680785758133824
864,5651,CYC1,123980,615453;,"[MIM:615453]Mitochondrial complex III deficiency, nuclear 6 [recessive?];",Isolated complex III deficiency,Disease-causing germline mutation(s) in,,0.943558282208589,0.5972150593089222,0.8441660140955364,0.6332105586249233
865,5652,CYCS,123970,612004;,[MIM:612004]Thrombocytopenia 4;,Autosomal thrombocytopenia with normal platelets,Disease-causing germline mutation(s) in,Systemic lupus erythematosus[19838195];Alzheimer's disease (cognitive decline)[23535033];,0.7398773006134969,0.7728210417741104,0.9587575045679979,0.0
866,5700,CYFIP2,606323,618008;,"[MIM:618008]Epileptic encephalopathy, early infantile, 65 [dominant?];",Undetermined early-onset epileptic encephalopathy,Disease-causing germline mutation(s) in,Lung function (FEV1/FVC)[28166213];Daytime sleep phenotypes[27126917];Gamma glutamyl transferase levels[29403010];,0.9011042944785276,1.0,0.7345340642129993,0.0
867,5705,CYLD,605018,132700;601606;605041;,"[MIM:132700]Cylindromatosis, familial;[MIM:601606]Multiple familial trichoepithelioma 1;[MIM:605041]Brooke-Spiegler syndrome [dominant?];",Familial multiple trichoepithelioma;Familial cylindromatosis,Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in,Inflammatory bowel disease[28067908];Body mass index[28892062];Leprosy[22019778;25642632;25642632];Bone mineral density[22504420];Crohn's disease[28067908;22412388];Femoral neck bone mineral density[29499414];Lumbar spine bone mineral density[29499414];,0.9461349693251534,0.8182052604435276,0.8535630383711824,0.8494475138121547
868,5710,CYP1A2,124060,,,Toxicity or absent response to clozapine,Biomarker tested in,Urinary albumin excretion[30220432];Diastolic blood pressure[19430483];Lung cancer[28604730];Coffee consumption (cups per day)[25288136];Red blood cell count[27863252];Caffeine consumption[21490707;21490707;21490707];Mean arterial pressure[27618448];Bladder cancer[25281661];Serum albumin level[29403010];Coffee consumption[21876539;25288136;21357676];,0.16220858895705523,0.1075296544610624,0.5844427042547637,0.31261510128913444
869,5711,CYP1B1,601771,137750;231300;617315;,"[MIM:617315]Anterior segment dysgenesis 6;[MIM:231300]Glaucoma 3, primary congenital, A [recessive?];[MIM:137750]Glaucoma 1, open angle, A;",Peters anomaly;Congenital glaucoma;Juvenile glaucoma,Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Major susceptibility factor in,Parkinson's disease[26227905];Cutaneous malignant melanoma[26237428];Melanoma[28212542];,0.10711656441717791,0.24703455389375967,0.09240407204385279,0.4894106813996317
870,5714,CYP2A6,122720,,,Familial mesial temporal lobe epilepsy with febrile seizures;Benign familial mesial temporal lobe epilepsy,Disease-causing germline mutation(s) (loss of function) in;Disease-causing germline mutation(s) (gain of function) in,"Local histogram emphysema pattern[25006744;25006744];Lung cancer in ever smokers[28604730];nicotine metabolite ratio in current smokers[27488534;27488534;27488534;27488534;27488534;27488534;27488534;27488534;28921760;28921760];Lung cancer[28604730];Alanine transaminase levels[29403010];Caffeine metabolism (plasma 3,7-dimethylxanthine (theobromine) level)[27702941];Caffeine metabolism (plasma 1,7-dimethylxanthine (paraxanthine) level)[27702941];Cerebrospinal fluid p-Tau181p:AB1-42 ratio[26252872];Blood protein levels[28240269];Lung adenocarcinoma[28604730];Cerebrospinal P-tau181p levels[26252872];Caffeine metabolism (plasma 1,7-dimethylxanthine (paraxanthine) to 1,3,7-trimethylxanthine (caffeine) ratio)[27702941;27702941;27702941;27702941;27702941;27702941;27702941;27702941;27702941;27702941;27702941;27702941;27702941;27702941;27702941;27702941;27702941];Smoking behavior[20418888;20418890;23049750];Squamous cell lung carcinoma[28604730];Chronic obstructive pulmonary disease[22080838;28166215];Post bronchodilator FEV1/FVC ratio[26634245;26634245];Aspartate aminotransferase levels[29403010];Post bronchodilator FEV1[26634245;26634245];",0.17791411042944785,0.13357400722021662,0.4184286087183503,0.06952117863720074
871,5721,CYP2B6,123930,614546;,,Efavirenz toxicity,Biomarker tested in,"Midgestational circulating levels of organochlorine pesticides[28235828];Midgestational circulating levels of PBDEs[28235828;28235828;28235828];Nicotine metabolite ratio[26921259];Smoking behavior[20418888];nicotine metabolite ratio in current smokers[27488534];Polychlorinated biphenyl levels[25839716;25839716;25839716];DDT metabolite (p,p'-DDE levels)[27839851;27839851];",0.12711656441717792,0.2516761217122228,0.33933698773166276,0.08916513198281154
872,5724,CYP2C9,601130,,,Vitamin K antagonists toxicity or dose selection;Oral antidiabetic drugs toxicity or dose selection,Biomarker tested in;Biomarker tested in,Immune response to smallpox vaccine (IL-6)[22542470];Response to clopidogrel therapy[19706858;28207573];Serum metabolite levels[23093944;23093944];Warfarin maintenance dose[20833655;18535201;23755828;19300499;19300499;26265036];Response to serotonin reuptake inhibitors in major depressive disorder (plasma drug and metabolite levels)[24528284;24528284];Blood metabolite levels[24816252;24816252;24816252];Dehydroepiandrosterone sulphate levels[21533175];Clopidogrel active metabolite levels[28207573];,0.31079754601226994,0.10624033006704486,0.2701644479248238,0.07826887661141804
873,5726,CYP2C19,124020,609535;,,Voriconazole toxicity;Resistance to clopidogrel;Antidepressant or antipsychotic toxicity or dose selection,Biomarker tested in;Biomarker tested in;Biomarker tested in,Response to clopidogrel therapy[19706858;28207573];Serum metabolite levels[23093944;23093944;23093944];Warfarin maintenance dose[23755828];Acenocoumarol maintenance dosage[19578179];Diastolic blood pressure[27618448];Response to serotonin reuptake inhibitors in major depressive disorder (plasma drug and metabolite levels)[24528284;24528284];Mean arterial pressure[27618448];Thiopurine-induced alopecia in inflammatory bowel disease[29923122];Clopidogrel active metabolite levels[28207573];,0.08736196319018405,0.029138731304796286,0.4160793526494388,0.0649171270718232
874,5736,CYP2D6,124030,608902;,,Codeine toxicity;Resistance to tamoxifene;Antidepressant or antipsychotic toxicity or dose selection,Biomarker tested in;Biomarker tested in;Biomarker tested in,Intelligence[28530673;28530673];Autism spectrum disorder or schizophrenia[28540026;28540026];Response to serotonin reuptake inhibitors in major depressive disorder (plasma drug and metabolite levels)[24528284;24528284];Schizophrenia[25056061];,0.10711656441717791,0.018824136152656008,0.08640041764552336,0.0
875,5745,CYP2R1,608713,600081;,[MIM:600081]Rickets vitamin D-dependent 1B [recessive?];,Hypocalcemic vitamin D-dependent rickets,Disease-causing germline mutation(s) in,Serum 25-Hydroxyvitamin D levels[29325163;29545823];Vitamin D levels (dietary vitamin D intake interaction)[29343764];Vitamin D levels[20418485;25208829;25208829;29343764;28757204];Vitamin D insufficiency[20541252];,0.038773006134969326,0.35327488396080453,0.7517619420516837,0.23756906077348067
876,5749,CYP2U1,610670,615030;,"[MIM:615030]Spastic paraplegia 56, autosomal recessive [recessive?];",Autosomal recessive spastic paraplegia type 56,Disease-causing germline mutation(s) in,,0.038773006134969326,0.5587931923671996,0.7491516575306708,0.5679864947820749
877,5751,CYP3A4,124010,,,Tacrolimus dose selection,Biomarker tested in,Ticagrelor levels in individuals with acute coronary syndromes treated with ticagrelor[25935875];Sex hormone levels[26014426;26014426;26014426];Tacrolimus trough concentration in kidney transplant patients[29160300];Metabolic traits[21886157];,0.28662576687116564,0.36101083032490977,0.6789350039154268,0.06077348066298342
878,5752,CYP3A5,605325,,,Tacrolimus dose selection,Biomarker tested in,Blood metabolite ratios[24816252];Serum metabolite levels[23093944;23093944];Ticagrelor levels in individuals with acute coronary syndromes treated with ticagrelor[25935875];Blood metabolite levels[24816252;24816252;24816252;24816252;24816252];Platelet count[29403010];,0.19190184049079756,0.2441980402269211,0.45914904724614986,0.0738182934315531
879,5768,CYP4F2,604426,122700;,,Vitamin K antagonists toxicity or dose selection,Biomarker tested in,Vitamin E levels[21729881];Warfarin maintenance dose[20833655;19300499];Acenocoumarol maintenance dosage[19578179];Metabolite levels[23281178];Circulating phylloquinone levels[25411281];Response to Vitamin E supplementation[22437554];,0.17791411042944785,0.6542031975244972,0.08144087705559906,0.44014732965009207
880,5775,CYP4F22,611495,604777;,"[MIM:604777]Ichthyosis, congenital, autosomal recessive 5 [recessive?];",Lamellar ichthyosis,Disease-causing germline mutation(s) in,,0.038773006134969326,0.21248066013408973,0.4722004698512138,0.38459177409453654
881,5795,CYP4V2,608614,210370;,,Bietti crystalline dystrophy,Disease-causing germline mutation(s) in,L-arginine levels[27656708];Metabolite levels[22916037];Blood protein levels[28240269];,0.14576687116564419,0.10469314079422383,0.1793265465935787,0.3319521178637201
882,5799,CYP7A1,118455,,,Hypercholesterolemia due to cholesterol 7alpha-hydroxylase deficiency,Disease-causing germline mutation(s) in,"Total cholesterol levels[29403010;28334899];Low density lipoprotein cholesterol[29403010];LDL cholesterol levels[28334899];Cholesterol, total[20686565;24097068;25961943];LDL cholesterol[20686565;24097068;25961943];Gallstone disease[27094239];",0.038773006134969326,0.3035069623517277,0.5507700339336987,0.1987415592387968
883,5800,CYP7B1,603711,270800;613812;,[MIM:613812]Congenital bile acid synthesis defect 3;,Congenital bile acid synthesis defect type 3;Autosomal recessive spastic paraplegia type 5A,Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in,Body mass index[26426971];Verbal declarative memory[25648963];Self-reported risk-taking behaviour[30181555];HIV-1 susceptibility[22174851];Retinopathy in non-diabetics[23393555];Food allergy (maternal genetic effects)[29489655];Thiazide-induced adverse metabolic effects in hypertensive patients[23400010];,0.08736196319018405,0.21402784940691078,0.49621508744453147,0.3750767341927563
884,5802,CYP11A1,118485,613743;,"[MIM:613743]Adrenal insufficiency, congenital, with 46,XY sex reversal;","46,XY disorder of sex development-adrenal insufficiency due to CYP11A1 deficiency;Inherited isolated adrenal insufficiency due to partial CYP11A1 deficiency",Disease-causing germline mutation(s) (loss of function) in;Disease-causing germline mutation(s) (loss of function) in,Craniofacial microsomia[26853712];Diisocyanate-induced asthma[25918132];,0.403680981595092,0.0,0.7449752022970504,0.29066912216083485
885,5803,CYP11B1,610613,103900;202010;,"[MIM:202010]Adrenal hyperplasia 4;[MIM:103900]Hyperaldosteronism, familial, 1;",Familial hyperaldosteronism type I;Congenital adrenal hyperplasia due to 11-beta-hydroxylase deficiency,Part of a fusion gene in;Disease-causing germline mutation(s) in,Systolic blood pressure[29403010];,0.038773006134969326,0.42057761732851984,0.4288697468024015,0.3514426028238183
886,5804,CYP11B2,124080,103900;203400;610600;,"[MIM:203400]Corticosterone methyloxidase 1 deficiency;[MIM:610600]Corticosterone methyloxidase 2 deficiency;[MIM:103900]Hyperaldosteronism, familial, 1;",Familial hyperaldosteronism type I;Familial hyperreninemic hypoaldosteronism type 1,Part of a fusion gene in;Disease-causing germline mutation(s) in,Systolic blood pressure[29403010];Mean arterial pressure[29403010];Plasma androstenedione levels in resected early stage-receptor positive breast cancer[28429243];,0.10711656441717791,0.03481175863847344,0.4547115635604281,0.0689073050951504
887,5805,CYP17A1,609300,202110;,[MIM:202110]Adrenal hyperplasia 5;,"Congenital adrenal hyperplasia due to 17-alpha-hydroxylase deficiency;46,XY disorder of sex development due to isolated 17,20-lyase deficiency",Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in,"Systolic blood pressure[21909115;25249183;19430483;19430479;26390057;26390057;28135244;27618452;28739976;27618447];Hypertension[25249183];Myocardial infarction[26343387];Diastolic blood pressure (cigarette smoking interaction)[29455858];Sodium levels[29403010];Parkinson's disease[19915575];Autism spectrum disorder or schizophrenia[28540026;28540026];Diastolic blood pressure[25249183;27618452;28739976];Colorectal cancer[26965516];Schizophrenia[23974872;25056061];Mean arterial pressure[26390057;27618448];Coronary heart disease[21378990];Coronary artery disease[26343387;24262325];Waist-to-hip ratio adjusted for BMI[26426971];Systolic blood pressure (cigarette smoking interaction)[29455858];Waist-to-hip ratio adjusted for BMI (age >50)[26426971];Waist circumference[25673412];Hip circumference[25673412;25673412];Pulse pressure[28739976];Blood pressure[21909110;21909110;21572416;21572416;24001895];Prostate cancer[23535732];Microalbuminuria[26631737];Coronary artery disease (myocardial infarction, percutaneous transluminal coronary angioplasty, coronary artery bypass grafting, angina or chromic ischemic heart disease)[28714975];Waist-to-hip ratio adjusted for BMI x sex x age interaction (4df test)[26426971];",0.27975460122699386,0.29396596183599794,0.9464891673192378,0.3993247391037446
888,5807,CYP19A1,107910,139300;613546;,[MIM:139300]Aromatase excess syndrome [dominant?];[MIM:613546]Aromatase deficiency;,Aromatase excess syndrome;Aromatase deficiency,Disease-causing germline mutation(s) (gain of function) in;Disease-causing germline mutation(s) (loss of function) in,Endometrial cancer ((endometrioid histology)[30093612];Estrone/androstenedione ratio in resected early stage-receptor positive breast cancer[28429243];Endometrial cancer[27135401;30093612];Heel bone mineral density[28869591;28869591;28869591;28869591;28869591];Endometrial endometrioid carcinoma[27135401];Serum alkaline phosphatase levels[29403010];Menarche (age at onset)[23599027];Hormone measurements[24049095;24049095];Follicule stimulating hormone[24049095];Response to fenofibrate (HDL cholesterol levels)[27002377];Total body bone mineral density[29304378];Airway wall thickness[25517131];Estradiol levels[22675492;29325096];Height[20189936;20881960;23456168;25429064;25282103];Estrone levels[29325096;29325096];Thiazide-induced adverse metabolic effects in hypertensive patients[23400010];Cerebrospinal fluid AB1-42 levels[20932310];,0.403680981595092,0.19262506446621971,0.24197337509788566,0.3623388581952118
889,5810,CYP21A2,613815,201910;,[MIM:201910]Adrenal hyperplasia 3;,"Classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency, simple virilizing form;Classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency, salt wasting form",Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in,Systolic blood pressure[25249183];Hypertension[25249183];Autism spectrum disorder or schizophrenia[28540026;28540026;28540026;28540026;28540026;28540026;28540026;28540026;28540026;28540026;28540026;28540026;28540026;28540026;28540026];Diastolic blood pressure[25249183];Diastolic blood pressure x smoking status (ever vs never) interaction (2df test)[29455858;29455858;29455858;29455858];Postoperative atrial fibrillation in coronary artery bypass grafting surgery[26385043];Blood protein levels[28240269;28240269;28240269];Systolic blood pressure x smoking status (current vs non-current) interaction (2df test)[29455858;29455858];Inflammatory bowel disease[28067908];Diastolic blood pressure x smoking status (current vs non-current) interaction (2df test)[29455858;29455858;29455858];Systolic blood pressure x smoking status (ever vs never) interaction (2df test)[29455858;29455858];Prostate cancer[23535732];Ulcerative colitis[28067908];,0.038773006134969326,0.7349149045899949,0.11876794570608196,0.0
890,5811,CYP24A1,126065,143880;,"[MIM:143880]Hypercalcemia, infantile, 1;",Autosomal recessive infantile hypercalcemia,Disease-causing germline mutation(s) (loss of function) in,Calcium levels[24068962;29403010];Multiple sclerosis[21833088;24076602];Vitamin D levels (dietary vitamin D intake interaction)[29343764];Vitamin D levels[29343764];Atopic dermatitis[23042114];Colorectal cancer (oestrogen-progestogen hormone therapy interaction)[26766742];Serum parathyroid hormone levels[27927781;27927781];Post bronchodilator FEV1[26634245];Circulating fibroblast growth factor 23 levels[30217807];,0.32380368098159507,0.02475502836513667,0.4053771861132863,0.027010435850214856
891,5813,CYP26B1,605207,614416;,[MIM:614416]Radiohumeral fusions with other skeletal and craniofacial anomalies;,Lethal occipital encephalocele-skeletal dysplasia syndrome,Disease-causing germline mutation(s) (loss of function) in,Schizophrenia[25056061];,0.038773006134969326,0.9239298607529655,0.20725659096841556,0.39333947206875386
892,5814,CYP26C1,608428,614974;,[MIM:614974]Focal facial dermal dysplasia 4;,Focal facial dermal dysplasia type IV,Disease-causing germline mutation(s) (loss of function) in,Glaucoma (primary open-angle)[29449654];Triglyceride levels[29403010];,0.038773006134969326,0.3604951005673027,0.3594361785434612,0.0
893,5815,CYP27A1,606530,213700;,[MIM:213700]Cerebrotendinous xanthomatosis;,Cerebrotendinous xanthomatosis,Disease-causing germline mutation(s) in,Reticulocyte count[27863252];High light scatter reticulocyte count[27863252];,0.16220858895705523,0.12403300670448685,0.4682850430696946,0.21255371393492942
894,5816,CYP27B1,609506,264700;,,Hypocalcemic vitamin D-dependent rickets,Disease-causing germline mutation(s) in,Multiple sclerosis[19525955;21833088];,0.038773006134969326,0.32774626095925735,0.626729313495171,0.3984039287906691
895,5821,CYP51A1,601637,,,Congenital cataract-severe neonatal hepatopathy-global developmental delay syndrome,Disease-causing germline mutation(s) in,Lifespan[25918517];,0.8716564417177914,0.24883960804538421,0.7013834507961367,0.45027624309392267
896,5829,CYSLTR2,605666,,,Uveal melanoma,Disease-causing somatic mutation(s) in,Response to inhaled corticosteroid treatment in asthma (change in FEV1)[24792382];Systemic juvenile idiopathic arthritis[27927641];Post bronchodilator FEV1/FVC ratio[26634245];,0.14576687116564419,0.2813305827746261,0.5236230749151658,0.1505524861878453
897,5841,D2HGDH,609186,600721;,[MIM:600721]D-2-hydroxyglutaric aciduria 1;,D-2-hydroxyglutaric aciduria,Disease-causing germline mutation(s) in,"Allergy[27182965];Sum eosinophil basophil counts[27863252];Eosinophil percentage of granulocytes[27863252];Allergic disease (asthma, hay fever or eczema)[29083406];Eosinophil counts[27863252];Neutrophil percentage of granulocytes[27863252];Asthma[27182965];Eosinophil percentage of white cells[27863252];",0.35496932515337426,0.5324909747292419,0.0921430435917515,0.8087783916513198
898,5844,DAB1,603448,615945;,[MIM:615945]Spinocerebellar ataxia 37 [dominant?];,Spinocerebellar ataxia type 37,Disease-causing germline mutation(s) in,Pubertal anthropometrics[23449627];Kawasaki disease[21221998];Plasma amyloid beta peptide concentrations (ABx-40)[24535457];Immune reponse to smallpox (secreted IL-10)[22610502];Alzheimer's disease progression score[29860282];Bulimia nervosa[23568457];Coronary artery disease[29472232];White matter hyperintensities in ischemic stroke[26674333];,0.5531288343558283,0.7176379577101599,0.535108326807622,0.5725905463474524
899,5851,DACT1,607861,182940;617466;,[MIM:182940]Neural tube defects;[MIM:617466]Townes-Brocks syndrome 2 [dominant?];,Townes-Brocks syndrome;Occipital encephalocele;Craniorachischisis,Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) (loss of function) in,,0.5040490797546012,0.5924445590510572,0.1396502218741843,0.5988336402701043
900,5857,DAG1,128239,613818;616538;,[MIM:613818]Muscular dystrophy-dystroglycanopathy limb-girdle C9 [recessive?];[MIM:616538]Muscular dystrophy-dystroglycanopathy congenital with brain and eye anomalies A9 [recessive?];,Autosomal recessive limb-girdle muscular dystrophy type 2P;Muscle-eye-brain disease with bilateral multicystic leucodystrophy;Walker-Warburg syndrome,Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) (loss of function) in,Inflammatory bowel disease[28067908];Body mass index[26426971];Pediatric autoimmune diseases[26301688];Resting heart rate[27798624];Intelligence (MTAG)[29326435];Gut microbiota (functional units)[27694959];Crohn's disease[28067908];Blood protein levels[28240269;29875488];Ulcerative colitis[28067908];,0.625398773006135,0.9056214543579164,0.5176194205168363,0.994475138121547
901,5866,DAO,124050,181500;,[MIM:181500]Schizophrenia;,Amyotrophic lateral sclerosis,Disease-causing germline mutation(s) in,,0.19190184049079756,0.0443527591542032,0.7744714173844949,0.31215469613259667
902,5879,DARS,603084,615281;,,Hypomyelination with brain stem and spinal cord involvement and leg spasticity,Disease-causing germline mutation(s) in,Body mass index[26426971];Systemic lupus erythematosus[28714469];White blood cell count[29403010];Mosquito bite size[28199695];Monocyte count[29403010];Neutrophil count[29403010];Total cholesterol change in response to fenofibrate in statin-treated type 2 diabetes[28736931];,0.9120245398773006,0.27075812274368233,0.6465674758548682,0.3984039287906691
903,5881,DARS2,610956,611105;,[MIM:611105]Leukoencephalopathy with brainstem and spinal cord involvement and lactate elevation;,Leukoencephalopathy with brain stem and spinal cord involvement-high lactate syndrome,Disease-causing germline mutation(s) in,,0.918282208588957,0.07684373388344508,0.431219002871313,0.43784530386740333
904,5883,DAXX,603186,,,Neuroendocrine tumor of stomach,Candidate gene tested in,Autism spectrum disorder or schizophrenia[28540026;28540026];Lung cancer in ever smokers[28604730];Disrupted circadian rhythm (low relative amplitude of rest-activity cycles)[30120083];Lung cancer[28604730];,0.72,0.6309953584321816,0.6833724876011485,0.8634131368937998
905,5884,DAZ1,400003,415000;,[MIM:415000]Spermatogenic failure Y-linked 2;,Partial chromosome Y deletion,Candidate gene tested in,,0.21484662576687116,0.0,0.0,0.0
906,5885,DAZ2,400026,415000;,[MIM:415000]Spermatogenic failure Y-linked 2;,Partial chromosome Y deletion,Candidate gene tested in,,0.038773006134969326,0.6410520887055183,0.0,0.0
907,5886,DAZ3,400027,415000;,[MIM:415000]Spermatogenic failure Y-linked 2;,Partial chromosome Y deletion,Candidate gene tested in,,0.038773006134969326,0.0,0.0,0.0
908,5887,DAZ4,,415000;,[MIM:415000]Spermatogenic failure Y-linked 2;,Partial chromosome Y deletion,Candidate gene tested in,,0.14576687116564419,0.0,0.0,0.0
909,5898,DBH,609312,223360;,[MIM:223360]Dopamine beta-hydroxylase deficiency;,Dopamine beta-hydroxylase deficiency,Disease-causing germline mutation(s) in,Systolic blood pressure[27618452];Smoking behavior[20418890];Squamous cell lung carcinoma[28604730];Diastolic blood pressure[27618452;28739976];Post bronchodilator FEV1/FVC ratio[26634245;26634245;26634245;26634245;26634245;26634245;26634245];Mean arterial pressure[27618448];Post bronchodilator FEV1[26634245;26634245;26634245];,0.16220858895705523,0.11036616812790098,0.33411641868963715,0.15239410681399632
910,5912,DBT,248610,248600;,[MIM:248600]Maple syrup urine disease 2;,Intermediate maple syrup urine disease;Classic maple syrup urine disease;Thiamine-responsive maple syrup urine disease;Intermittent maple syrup urine disease,Disease-causing germline mutation(s) (loss of function) in;Disease-causing germline mutation(s) (loss of function) in;Disease-causing germline mutation(s) (loss of function) in;Disease-causing germline mutation(s) (loss of function) in,Lung cancer in ever smokers[28604730];,0.927361963190184,0.23800928313563693,0.5455494648916732,0.0
911,5922,DCAF8,615820,610100;,"[MIM:610100]Giant axonal neuropathy 2, autosomal dominant [dominant?];",Autosomal dominant Charcot-Marie-Tooth disease type 2 with giant axons,Disease-causing germline mutation(s) in,Lung function (FEV1/FVC)[30061609;30061609];Squamous cell lung carcinoma[28604730];Breast size[27182965];,0.45680981595092024,0.8367715317173801,0.703471678412947,0.0
912,5936,DCAF17,612515,241080;,,Woodhouse-Sakati syndrome,Disease-causing germline mutation(s) (loss of function) in,,0.43153374233128833,0.26946879834966475,0.4993474288697468,0.12384898710865562
913,5941,DCC,120470,157600;617542;,"[MIM:157600]Mirror movements 1;[MIM:617542]Gaze palsy, familial horizontal, with progressive scoliosis, 2 [recessive?];",Kallmann syndrome;Familial congenital mirror movements,Disease-causing germline mutation(s) (loss of function) in;Disease-causing germline mutation(s) in,Alcoholism (alcohol use disorder factor score)[21529783];Response to fenofibrate (total cholesterol levels)[27002377];Glucose homeostasis traits[25524916];Nickel levels[26025379];Body mass index (ever vs never smoking interaction)[23192594];Putamen volume[29147026];Cognitive ability[29186694];Depression[27089181;29700475];Response to mTOR inhibitor (everolimus)[24009623];Subcortical brain region volumes[25607358];General cognitive ability[29844566;29844566;29844566;29844566;29844566;29844566];Gallbladder cancer[22318345];Response to exercise (triglyceride level interaction)[26491034];Lung function (FVC)[30061609;30061609];Survival in colorectal cancer (distant metastatic)[26586795;26586795];Body mass index[28892062];Intelligence (MTAG)[29326435;29326435;29326435;29326435;29326435;29326435;29326435;29326435;29326435;29326435;29326435;29326435;29326435;29326435;29326435];Smoking behaviour (cigarettes smoked per day)[27393504];Bortezomib-induced peripheral neuropathy in multiple myeloma[28317148];Mosquito bite size[28199695];Cognitive ability (MTAG)[29186694];Obesity-related traits[23251661];Coenzyme Q10 levels[27149984];Mood instability[29187730;29187730];,0.567239263803681,0.7733367715317174,0.04437483685721744,0.5260896255371393
914,5944,DCDC2,605755,600202;610212;616217;617394;,"[MIM:616217]Nephronophthisis 19 [recessive?];[MIM:610212]Deafness, autosomal recessive, 66 [recessive?];[MIM:617394]Sclerosing cholangitis, neonatal [recessive?];",Isolated neonatal sclerosing cholangitis;Autosomal recessive non-syndromic sensorineural deafness type DFNB;Senior-Boichis syndrome,Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in,Uric acid levels[21294900];Information processing speed[21130836];General cognitive ability[29844566];Airflow obstruction[22837378];,0.567239263803681,0.4564208354822073,0.18115374575828766,0.38321055862492326
915,5947,DCHS1,603057,601390;607829;,[MIM:607829]Mitral valve prolapse 2;,Cerebrofacioarticular syndrome;Familial mitral valve prolapse,Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) (loss of function) in,,0.27975460122699386,0.9791129448169159,0.14121639258679197,0.5796500920810314
916,5955,DCLRE1C,605988,602450;603554;,[MIM:602450]Severe combined immunodeficiency autosomal recessive T- cell-negative/B-cell-negative/NK-cell-positive with sensitivity to ionizing radiation [recessive?];[MIM:602450]Severe combined immunodeficiency Athabaskan type [recessive?];[MIM:603554]Omenn syndrome;,Severe combined immunodeficiency due to DCLRE1C deficiency;Omenn syndrome,Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in,,0.541840490797546,0.7681794739556472,0.16288175411119812,0.07458563535911603
917,5957,DCN,125255,610048;,"[MIM:610048]Corneal dystrophy, congenital stromal;",Congenital stromal corneal dystrophy,Disease-causing germline mutation(s) in,Sudden cardiac arrest[21658281];Central corneal thickness[29760442];Blood protein levels[30072576];Intraocular pressure[29617998];,0.5469938650306748,0.6245487364620939,0.5392847820412425,0.20089011663597298
918,5961,DCPS,610534,616459;,[MIM:616459]Al-Raqad syndrome;,Autosomal recessive non-syndromic intellectual disability,Disease-causing germline mutation(s) in,Neutrophil percentage of white cells[27863252];,0.403680981595092,0.17173800928313562,0.5262333594361785,0.5188766114180479
919,5969,DCTN1,601143,105400;168605;607641;,"[MIM:607641]Neuronopathy, distal hereditary motor, 7B;[MIM:105400]Amyotrophic lateral sclerosis;[MIM:168605]Perry syndrome;",Amyotrophic lateral sclerosis;Perry syndrome;Distal hereditary motor neuropathy type 7,Candidate gene tested in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in,Alanine aminotransferase (ALT) levels after remission induction therapy in actute lymphoblastic leukemia (ALL)[28090653];,0.9761963190184049,0.3256833419288293,0.3771861132863482,0.941682013505218
920,5973,DCTN4,614758,,,Cystic fibrosis,Modifying germline mutation in,Inflammatory bowel disease[28067908];Dimensional psychopathology (Arousal)[29496196];Cholangiocarcinoma in primary sclerosing cholangitis[28779025];Crohn's disease[28067908];Lung adenocarcinoma[28604730];,0.6866257668711656,0.46493037648272306,0.1320803967632472,0.33824432166973606
921,5983,DCX,300121,300067;,"[MIM:300067]Lissencephaly, X-linked 1;[MIM:300067]Subcortical band heterotopia X-linked;",Lissencephaly type 1 due to doublecortin gene mutation;Subcortical band heterotopia,Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in,,0.4431901840490797,0.9115523465703971,0.9266510049595406,0.9303253529772867
922,5984,DCXR,608347,260800;,,Pentosuria,Disease-causing germline mutation(s) in,,0.7933742331288344,0.19133574007220217,0.6152440616027147,0.1663597298956415
923,5990,DDB2,600811,278740;,[MIM:278740]Xeroderma pigmentosum complementation group E [recessive?];,Xeroderma pigmentosum,Disease-causing germline mutation(s) in,Neuroticism[29255261];Acne (severe)[24399259];Autism spectrum disorder or schizophrenia[28540026];,0.7044171779141104,0.23207839092315627,0.8144087705559906,0.2213014119091467
924,5991,DDC,107930,608643;,[MIM:608643]Aromatic L-amino-acid decarboxylase deficiency [recessive?];,Aromatic L-amino acid decarboxylase deficiency,Disease-causing germline mutation(s) in,Blood metabolite ratios[24816252];Body mass index[25673413;25673413;26426971];Body mass index (age <50)[26426971];Body mass index x sex x age interaction (4df test)[26426971];Malaria[19465909];Acute lymphoblastic leukemia (childhood)[23512250;22076464;22076464;19684603];Schizophrenia (treatment resistant)[25223841];,0.12711656441717792,0.15678184631253222,0.4119028974158183,0.1576120319214242
925,5993,DDHD1,614603,609340;,,Autosomal recessive spastic paraplegia type 28,Disease-causing germline mutation(s) in,Lung function (FEV1/FVC)[30061609;30061609];Optic cup area[25631615;25631615;28073927;28073927];Chin dimples[27182965];Response to cyclophosphamide in systemic lupus erythematosus with lupus nephritis[26980576;26980576];Prostate cancer[23535732];,0.541840490797546,0.815368746776689,0.30853563038371185,0.9053100061387355
926,5994,DDHD2,615003,615033;,"[MIM:615033]Spastic paraplegia 54, autosomal recessive [recessive?];",Autosomal recessive spastic paraplegia type 54,Disease-causing germline mutation(s) in,Autism spectrum disorder or schizophrenia[28540026];Schizophrenia[28991256];,0.27975460122699386,0.3630737493553378,0.19968676585747847,0.024248004910988337
927,5998,DDIT3,126337,,,Myxoid/round cell liposarcoma,Part of a fusion gene in,,0.5191411042944786,0.7643115007735947,0.6045418950665623,0.3011049723756906
928,6005,DDOST,602202,614507;,[MIM:614507]Congenital disorder of glycosylation 1R;,DDOST-CDG,Disease-causing germline mutation(s) in,,0.9806134969325153,0.33135636926250644,0.6530931871574002,0.45196439533456106
929,6008,DDR2,191311,271665;,[MIM:271665]Spondyloepimetaphyseal dysplasia short limb-hand type;,Spondyloepimetaphyseal dysplasia-short limb-abnormal calcification syndrome,Disease-causing germline mutation(s) in,Dupuytren's disease[28886342];Alanine aminotransferase (ALT) levels after remission induction therapy in actute lymphoblastic leukemia (ALL)[28090653];,0.6120245398773007,0.5054151624548736,0.6282954842077787,0.8953345610804174
930,6009,DDRGK1,616177,602557;,"[MIM:602557]Spondyloepimetaphyseal dysplasia, Shohat type [recessive?];","Spondyloepimetaphyseal dysplasia, Shohat type",Disease-causing germline mutation(s) (loss of function) in,Ribavirin-induced anemia[20637204];Parkinson's disease[25064009;28892059];Response to hepatitis C treatment[21659334;21659334];Night sleep phenotypes[27126917];,0.9764417177914111,0.3006704486848891,0.36491777603758807,0.23204419889502761
931,6018,DDX3X,300160,300958;,"[MIM:300958]Mental retardation, X-linked 102;",Toriello-Carey syndrome;X-linked intellectual disability-hypotonia-movement disorder syndrome;Precursor T-cell acute lymphoblastic leukemia,Disease-causing germline mutation(s) (loss of function) in;Disease-causing germline mutation(s) (loss of function) in;Part of a fusion gene in,,0.9931288343558282,0.5342960288808665,0.9900809188201514,0.8738489871086557
932,6019,DDX3Y,400010,,,Partial chromosome Y deletion,Candidate gene tested in,,0.8314110429447853,0.7625064466219701,0.9501435656486557,0.0
933,6028,DDX11,601150,613398;,[MIM:613398]Warsaw breakage syndrome;,Warsaw breakage syndrome,Disease-causing germline mutation(s) in,Sudden cardiac arrest[21658281];Fasting blood insulin (BMI interaction)[22581228];Response to anti-depressant treatment in major depressive disorder[22041458];Problematic alcohol use in trauma-exposed individuals[29082582];Parkinsonism in frontotemporal lobe dementia[29724592];Adolescent idiopathic scoliosis[21216876];Response to statin therapy[20339536;20339536];Obesity-related traits[23251661;23251661];Blood protein levels[29875488;30072576];,0.5110429447852761,0.030685920577617327,0.1634038110154007,0.1714241866175568
934,6070,DDX41,608170,616871;,"[MIM:616871]Myeloproliferative/lymphoproliferative neoplasms, familial [dominant?];",DDX41-related hematologic malignancy predisposition syndrome,Major susceptibility factor in,Waist-to-hip ratio adjusted for BMI (age <50)[26426971];Waist-to-hip ratio adjusted for BMI[26426971];Coronary artery disease[29212778];Waist-to-hip ratio adjusted for BMI x sex x age interaction (4df test)[26426971];,0.9609815950920245,0.1593604951005673,0.5050900548159749,0.0
935,6089,DDX58,609631,616298;,[MIM:616298]Singleton-Merten syndrome 2 [dominant?];,Singleton-Merten dysplasia,Disease-causing germline mutation(s) in,Psoriasis vulgaris[26626624];Psoriasis[25903422;25574825;23143594];Bone mineral density (spine) and age at menarche[26312577];Hematocrit[27863252];Red blood cell count[27863252];Blood protein levels[30072576];Inflammatory skin disease[25574825];Hemoglobin concentration[27863252];,0.6403680981595092,0.050283651366683856,0.22213521273818845,0.01780233271945979
936,6090,DDX59,615464,174300;,[MIM:174300]Orofaciodigital syndrome 5;,Orofaciodigital syndrome type 5,Disease-causing germline mutation(s) in,Coronary artery disease[29212778;29212778];,0.14576687116564419,0.7158329035585353,0.18271991647089533,0.4003990178023327
937,6093,DEAF1,602635,615828;617171;,"[MIM:615828]Mental retardation, autosomal dominant 24 [dominant?];[MIM:617171]Dyskinesia, seizures, and intellectual developmental disorder [recessive?];",Smith-Magenis syndrome;Autosomal dominant non-syndromic intellectual disability;Intellectual disability-epilepsy-extrapyramidal syndrome,Candidate gene tested in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in,,0.3749693251533742,0.35843218153687467,0.6718872357086922,0.3136893799877225
938,6174,DEK,125264,,,Acute myeloid leukemia with t(6;9)(p23;q34),Part of a fusion gene in,Atrial fibrillation[30061737];,0.819877300613497,0.6268695203713254,0.8632210910989297,0.09561080417434009
939,6196,DEPDC1B,616073,,,Moyamoya angiopathy-short stature-facial dysmorphism-hypergonadotropic hypogonadism syndrome,Role in the phenotype of,Intelligence (MTAG)[29326435];Autism spectrum disorder or schizophrenia[28540026;28540026];,0.910920245398773,0.13666838576585869,0.7726442182197859,0.3758440761203192
940,6200,DEPDC5,614191,604364;,"[MIM:604364]Epilepsy, familial focal, with variable foci 1 [dominant?];",Familial focal epilepsy with variable foci;Autosomal dominant nocturnal frontal lobe epilepsy;Autosomal dominant epilepsy with auditory features,Disease-causing germline mutation(s) (loss of function) in;Disease-causing germline mutation(s) (loss of function) in;Disease-causing germline mutation(s) (loss of function) in,Type 2 diabetes[30130595];Intelligence[22449649];Alanine aminotransferase (ALT) levels after remission induction therapy in actute lymphoblastic leukemia (ALL)[28090653];Age-related hearing impairment[24939585];Chronic hepatitis C infection[21725309];,0.3749693251533742,0.851985559566787,0.27982250065257114,0.3632596685082873
941,6208,DES,125660,181400;601419;604765;615325;,"[MIM:601419]Myopathy, myofibrillar, 1;[MIM:604765]Cardiomyopathy, dilated 1I;[MIM:181400]Neurogenic scapuloperoneal syndrome Kaeser type;[MIM:615325]Limb-girdle muscular dystrophy 2R;","Familial isolated dilated cardiomyopathy;Autosomal recessive limb-girdle muscular dystrophy type 2R;Autosomal dominant limb-girdle muscular dystrophy type 1E;Neurogenic scapuloperoneal syndrome, Kaeser type;Desminopathy",Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in,Resting heart rate[27798624];,0.8780368098159509,0.424703455389376,0.566953797963978,0.8020257826887661
942,6215,DFFB,601883,,,CAD-CDG,Disease-causing germline mutation(s) in,Blood trace element (Cu levels)[23720494];,0.4190184049079755,0.5208870551830841,0.3706604019838162,0.20549416820135052
943,6290,DGAT1,604900,615863;,[MIM:615863]Diarrhea 7;,Congenital chronic diarrhea with protein-losing enteropathy,Disease-causing germline mutation(s) (loss of function) in,Dupuytren's disease[28886342];,0.6671165644171779,0.2178958225889634,0.4544505351083268,0.14487415592387967
944,6291,DGAT2,606983,,,Autosomal dominant Charcot-Marie-Tooth disease type 2 due to DGAT2 mutation,Disease-causing germline mutation(s) in,HDL cholesterol levels[28334899];HDL cholesterol[24097068];,0.10711656441717791,0.30608561113976274,0.4382667710780475,0.11602209944751381
945,6307,DGKE,601440,615008;,[MIM:615008]Hemolytic uremic syndrome atypical 7;,Immunoglobulin-mediated membranoproliferative glomerulonephritis;Atypical hemolytic-uremic syndrome with DGKE deficiency,Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) (loss of function) in,Height[18391951];Crohn's disease[28067908];,0.8003680981595092,0.33935018050541516,0.6259462281388671,0.413597298956415
946,6316,DGUOK,601465,251880;617068;617070;,"[MIM:617068]Portal hypertension, non-cirrhotic [recessive?];[MIM:617070]Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal recessive 4 [recessive?];","Mitochondrial DNA depletion syndrome, hepatocerebral form due to DGUOK deficiency;Adult-onset multiple mitochondrial DNA deletion syndrome due to DGUOK deficiency;Early-onset familial noncirrhotic portal hypertension",Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) (loss of function) in,Systemic lupus erythematosus[23273568;23273568];Dialysis-related mortality[21546767];,0.48576687116564415,0.185146982980918,0.6624902114330462,0.6416513198281154
947,6318,DHCR7,602858,270400;,,Smith-Lemli-Opitz syndrome,Disease-causing germline mutation(s) (loss of function) in,Serum 25-Hydroxyvitamin D levels[29325163];Vitamin D levels (dietary vitamin D intake interaction)[29343764];Vitamin D levels[20418485;29343764];Systemic lupus erythematosus[26502338];Vitamin D insufficiency[20541252];,0.9423312883435583,0.481175863847344,0.6165492038632211,0.9030079803560467
948,6319,DHCR24,606418,602398;,,Desmosterolosis,Disease-causing germline mutation(s) in,,0.6174233128834355,0.521402784940691,0.6601409553641346,0.9186617556783303
949,6321,DHDDS,608172,613861;617836;,[MIM:617836]Developmental delay and seizures with or without movement abnormalities [dominant?];,Retinitis pigmentosa;Undetermined early-onset epileptic encephalopathy,Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in,,0.16220858895705523,0.8073749355337803,0.09658052727747324,0.3867403314917127
950,6323,DHFR,126060,613839;,,Constitutional megaloblastic anemia with severe neurologic disease,Disease-causing germline mutation(s) in,Shingles[25297839;25297839];Glomerular filtration rate (creatinine)[26831199];Huntington's disease progression[28642124];,0.8224539877300614,0.5410005157297576,0.9352649438788828,0.2254450583179865
951,6330,DHH,605423,233420;607080;,"[MIM:607080]Partial gonadal dysgenesis with minifascicular neuropathy 46,XY;[MIM:233420]46,XY sex reversal 7;","46,XY gonadal dysgenesis-motor and sensory neuropathy syndrome;46,XY complete gonadal dysgenesis",Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in,Body mass index[25673413;25673413];Bone mineral density[22504420];,0.2498159509202454,0.6294481691593605,0.838162359697207,0.0
952,6331,DHODH,126064,263750;,[MIM:263750]Postaxial acrofacial dysostosis;,Postaxial acrofacial dysostosis,Disease-causing germline mutation(s) (loss of function) in,Bone mineral density (hip)[30172743];Total cholesterol levels[29403010];Low density lipoprotein cholesterol[29403010];Hand grip strength[29691431];Attention deficit hyperactivity disorder and conduct disorder[18951430];Fibrinogen levels[28107422];,0.2498159509202454,0.5740072202166066,0.35395458104933436,0.677255985267035
953,6349,DHTKD1,614984,204750;615025;,[MIM:615025]Charcot-Marie-Tooth disease 2Q;[MIM:204750]2-aminoadipic 2-oxoadipic aciduria;,Autosomal dominant Charcot-Marie-Tooth disease type 2Q;2-aminoadipic 2-oxoadipic aciduria,Disease-causing germline mutation(s) (loss of function) in;Disease-causing germline mutation(s) in,,0.8306748466257668,0.2225373904074265,0.07700339336987731,0.5007673419275629
954,6363,DHX38,605584,,,Retinitis pigmentosa,Disease-causing germline mutation(s) in,"Metabolite levels[22916037];Depression[29700475];Cholesterol, total[20686565;25961943];Blood protein levels[28240269;28240269;28240269;28240269;28240269;28240269];LDL cholesterol[20686565;25961943];Coronary artery disease[29212778;29212778];",0.7658895705521472,0.3594636410520887,0.5646045418950666,0.24462860650705956
955,6368,DIABLO,605219,614152;,"[MIM:614152]Deafness, autosomal dominant, 64 [dominant?];",Autosomal dominant non-syndromic sensorineural deafness type DFNA,Disease-causing germline mutation(s) in,,0.6269938650306749,0.26508509541000513,0.8256329939963456,0.27992633517495397
956,6370,DIAPH1,602121,124900;616632;,"[MIM:124900]Deafness, autosomal dominant, 1 [dominant?];[MIM:616632]Seizures, cortical blindness, and microcephaly syndrome [recessive?];",DIAPH1-related sensorineural hearing loss-thrombocytopenia syndrome;Progressive microcephaly-seizures-cortical blindness-developmental delay syndrome,Disease-causing germline mutation(s) (gain of function) in;Disease-causing germline mutation(s) (loss of function) in,"Mean platelet volume[27863252];Allergic disease (asthma, hay fever or eczema)[29083406];",0.6939877300613497,0.8223310985043837,0.5860088749673714,0.5701350521792511
957,6373,DIAPH3,614567,609129;,"[MIM:609129]Auditory neuropathy, autosomal dominant, 1 [dominant?];",Autosomal dominant non-syndromic sensorineural deafness type DFNA,Disease-causing germline mutation(s) in,Body mass index[28892062];Breast milk fatty acid composition (maternal genotype effect)[29514873];Breast milk fatty acid composition (infant genotype effect)[29514873];Gut microbiota (functional units)[27694959];,0.7408588957055214,0.06162970603403816,0.26259462281388674,0.6138735420503376
958,6376,DICER1,606241,138800;180295;601200;,"[MIM:601200]Pleuropulmonary blastoma;[MIM:138800]Goiter multinodular 1, with or without Sertoli-Leydig cell tumors;[MIM:180295]Rhabdomyosarcoma, embryonal, 2;",Familial multinodular goiter;Pleuropulmonary blastoma familial tumor susceptibility syndrome;Global developmental delay-lung cysts-overgrowth-Wilms tumor syndrome;Malignant Sertoli-Leydig cell tumor of the ovary;Maligant granulosa cell tumor of the ovary;Gynandroblastoma,Major susceptibility factor in;Disease-causing germline mutation(s) (loss of function) in;Disease-causing somatic mutation(s) in;Major susceptibility factor in;Major susceptibility factor in;Major susceptibility factor in,Body mass index[25760438];Body mass index (dietary energy interaction)[23192594;23192594];Nose size[27182965];Heel bone mineral density[28869591;28869591];Chin dimples[27182965];Response to statin therapy[20339536];Diastolic blood pressure x smoking status (ever vs never) interaction (2df test)[29455858];,0.9418404907975461,0.9595152140278495,0.5693030540328896,0.6106507059545734
959,6401,DIRC3,608262,,,Differentiated thyroid carcinoma;Hereditary clear cell renal cell carcinoma,Major susceptibility factor in;Part of a fusion gene in,Acoustic startle blink response[25387708];Papillary thyroid cancer[28703219];Breast cancer[23535729;29059683];Differentiated thyroid cancer[28703219];Response to bronchodilator in chronic obstructive pulmonary disease (change in FEV1)[26503814;26503814];Mitral valve prolapse[26301497];Thyroid cancer[22267200;23894154];Metabolite levels (MHPG)[23319000];Congenital heart disease (inherited effect)[28468790];Optic disc area[28073927;25631615;25631615;28073927];Post bronchodilator FEV1/FVC ratio[26634245];Carboplatin disposition in epthelial ovarian cancer[29367611];Post bronchodilator FEV1[26634245];,0.038773006134969326,0.17870036101083034,0.2552858261550509,0.0
960,6405,DIS3L2,614184,267000;,[MIM:267000]Perlman syndrome [recessive?];,Nephroblastoma;Perlman syndrome,Major susceptibility factor in;Disease-causing germline mutation(s) in,Waist circumference adjusted for BMI (joint analysis main effects and physical activity interaction)[28448500;28448500;28448500];Waist circumference adjusted for BMI in non-smokers[28443625];Hip circumference adjusted for BMI[25673412;25673412];Waist circumference adjusted for BMI (joint analysis main effects and smoking interaction)[28443625];Waist circumference adjusted for BMI (adjusted for smoking behaviour)[28443625];Height[19570815;23563607;20189936;18391951;25429064;25282103];Waist circumference adjusted for body mass index[28448500;28448500;28448500;28448500;25673412;25673412];Waist circumference adjusted for BMI in active individuals[28448500;28448500];,0.38061349693251534,0.7534811758638473,0.37144348734012006,0.3136893799877225
961,6407,DISC1,605210,604906;,[MIM:604906]Schizophrenia 9;,Microcephaly-polymicrogyria-corpus callosum agenesis syndrome,Candidate gene tested in,Pelvic organ prolapse (moderate/severe)[26545240];Neuranatomic and neurocognitive phenotypes[21483430];Response to antineoplastic agents[21659360];Amyotrophic lateral sclerosis (sporadic)[24529757];Response to statin therapy[20339536];Amyotrophic lateral sclerosis[19451621];Chronic periodontitis (mean interproximal clinical attachment level)[27601451];Alzheimer's disease[19118814];,0.6403680981595092,0.313305827746261,0.0957974419211694,0.1359729895641498
962,6411,DISP1,607502,,,Microform holoprosencephaly;Septopreoptic holoprosencephaly;Semilobar holoprosencephaly;Midline interhemispheric variant of holoprosencephaly;Lobar holoprosencephaly;Alobar holoprosencephaly,Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in,,0.10711656441717791,0.6915936049510056,0.05742625946228139,0.8597298956414978
963,6415,DKC1,300126,305000;,[MIM:305000]Hoyeraal-Hreidarsson syndrome;,Dyskeratosis congenita;Hoyeraal-Hreidarsson syndrome,Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in,,0.9485889570552147,0.9192882929345023,0.7066040198381623,0.0
964,6416,DKK1,605189,,,Arnold-Chiari malformation type I;Idiopathic juvenile osteoporosis,Disease-causing germline mutation(s) in;Major susceptibility factor in,Fractures[30158200];QRS complex (Cornell)[27659466];Monobrow[27182965];QRS complex (12-leadsum)[27659466];Chin dimples[27182965];QRS duration[21076409;27577874;27577874;27659466];Electrocardiographic traits[20062063];Blood protein levels[29875488;30072576;30072576];Bone properties (heel)[24430505;24430505];Periodontitis (Mean PAL)[24024966];,0.3449079754601227,0.6052088705518308,0.7969198642652049,0.44505831798649476
965,6422,DLAT,608770,245348;,[MIM:245348]Pyruvate dehydrogenase E2 deficiency;,Pyruvate dehydrogenase E2 deficiency,Disease-causing germline mutation(s) (loss of function) in,,0.9661349693251534,0.18024755028365136,0.0274079874706343,0.06675874769797421
966,6424,DLD,238331,246900;,[MIM:246900]Dihydrolipoamide dehydrogenase deficiency [recessive?];,Pyruvate dehydrogenase E3 deficiency,Disease-causing germline mutation(s) (loss of function) in,Inflammatory bowel disease[28067908];Waist-to-hip ratio adjusted for BMI[26426971];Ulcerative colitis[19122664;19122664;19122664;23128233;20228799;28067908];Waist-to-hip ratio adjusted for BMI x sex x age interaction (4df test)[26426971];,0.9428220858895705,0.5337802991232594,0.6517880448968938,0.41789441375076736
967,6425,DLEC1,604050,133239;211980;,[MIM:211980]Lung cancer;[MIM:133239]Esophageal cancer;,Squamous cell carcinoma of the esophagus,Candidate gene tested in,Gut microbiota (bacterial taxa)[27723756];Common carotid intima-media thickness in HIV negative individuals[29206233];Carotid intima media thickness[26343869];,0.038773006134969326,0.007735946364105209,0.09919081179848603,0.0570902394106814
968,6433,DLG1,601014,,,Cleft lip/palate,Major susceptibility factor in,Allergic rhinitis[25085501];,0.9450306748466257,0.8837029396596183,0.1819368311145915,0.2668815224063843
969,6437,DLG3,300189,300850;,"[MIM:300850]Mental retardation, X-linked 90;",X-linked non-syndromic intellectual disability,Disease-causing germline mutation(s) in,,0.8003680981595092,0.963383187209902,0.8439049856434351,0.7940454266421118
970,6453,DLGAP5,617859,,,Cleft lip/palate,Major susceptibility factor in,Protein biomarker[23056639];Blood protein levels[28240269];Testicular germ cell tumor[28604728];,0.6225766871165644,0.3292934502320784,0.0597755155311929,0.027624309392265192
971,6455,DLK1,176290,,,Idiopathic central precocious puberty;Temple syndrome due to paternal 14q32.2 microdeletion;Kagami-Ogata syndrome due to maternal 14q32.2 microdeletion;Kagami-Ogata syndrome due to maternal 14q32.2 hypermethylation;Temple syndrome due to paternal 14q32.2 hypomethylation;Temple syndrome due to maternal uniparental disomy of chromosome 14;Kagami-Ogata syndrome due to paternal uniparental disomy of chromosome 14,Role in the phenotype of;Role in the phenotype of;Role in the phenotype of;Role in the phenotype of;Role in the phenotype of;Role in the phenotype of;Role in the phenotype of,Type 1 diabetes[19966805];Menarche (age at onset)[25231870;25231870];Blood protein levels[29875488;29875488;30072576;30072576];Platelet count[22139419;29403010];,0.4936196319018405,0.7478081485301702,0.34273035760897935,0.7575199508901166
972,6457,DLL1,606582,,,Microform holoprosencephaly;Septopreoptic holoprosencephaly;Semilobar holoprosencephaly;Midline interhemispheric variant of holoprosencephaly;Lobar holoprosencephaly;Alobar holoprosencephaly,Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in,Type 1 diabetes[21980299];Interferon alpha levels in systemic lupus erythematosus[25338677];Blood protein levels[29875488];Intraocular pressure[29785010];,0.33226993865030674,0.9868488911810211,0.5635604280866614,0.987415592387968
973,6458,DLL3,602768,277300;,"[MIM:277300]Spondylocostal dysostosis 1, autosomal recessive [recessive?];",Autosomal recessive spondylocostal dysostosis,Disease-causing germline mutation(s) in,,0.038773006134969326,0.5312016503352244,0.20647350561211172,0.0
974,6459,DLL4,605185,616589;,[MIM:616589]Adams-Oliver syndrome 6;,Adams-Oliver syndrome;Aplasia cutis congenita,Disease-causing germline mutation(s) (loss of function) in;Disease-causing germline mutation(s) (loss of function) in,Intelligence (MTAG)[29326435];Visceral adipose tissue/subcutaneous adipose tissue ratio[22589738];General cognitive ability[29844566];,0.14576687116564419,0.9818205260443528,0.782041242495432,0.9241866175567833
975,6465,DLX3,600525,104510;190320;,[MIM:190320]Trichodentoosseous syndrome [dominant?];[MIM:104510]Amelogenesis imperfecta 4 [dominant?];,Tricho-dento-osseous syndrome;Hypomaturation-hypoplastic amelogenesis imperfecta with taurodontism,Disease-causing germline mutation(s) (loss of function) in;Disease-causing germline mutation(s) in,,0.12711656441717792,0.5113460546673543,0.7783868441660141,0.6565377532228361
976,6466,DLX4,601911,616788;,,Cleft lip/palate,Disease-causing germline mutation(s) in,Cognitive decline rate in late mild cognitive impairment[26252872];Serum alkaline phosphatase levels[29403010];Blood urea nitrogen levels[29403010];,0.31079754601226994,0.5041258380608561,0.4922996606630123,0.5488029465930019
977,6467,DLX5,600028,220600;,"[MIM:220600]Split-hand/foot malformation 1 with sensorineural hearing loss, autosomal recessive [recessive?];",Isolated split hand-split foot malformation;Split hand-split foot-deafness syndrome,Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in,Heel bone mineral density[28869591;28869591];Morning vs. evening chronotype[26835600];,0.7110429447852761,0.7382671480144405,0.8668754894283477,0.8339472068753837
978,6468,DLX6,600030,,,Isolated split hand-split foot malformation,Disease-causing germline mutation(s) in,Diverticular disease[30177863];,0.08736196319018405,0.8359979370809696,0.23988514748107545,0.5833333333333334
979,6480,DMD,300377,300376;302045;310200;,"[MIM:310200]Duchenne muscular dystrophy;[MIM:300376]Becker muscular dystrophy;[MIM:302045]Cardiomyopathy, dilated, X-linked 3B;",Familial isolated dilated cardiomyopathy;Symptomatic form of muscular dystrophy of Duchenne and Becker in female carriers;X-linked non-syndromic intellectual disability;Becker muscular dystrophy;Duchenne muscular dystrophy,Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in,Mild influenza (H1N1) infection[26379185];Body mass index[28892062];Response to anti-depressant treatment in major depressive disorder[22041458];Itch intensity from mosquito bite adjusted by bite size[28199695];Temporomandibular joint disorder[28081371];Anxiety in major depressive disorder[24047446];Influenza A (H1N1) infection[26379185];,0.6269938650306749,1.0,0.018794048551292093,0.49923265807243705
980,6482,DMGDH,605849,605850;,[MIM:605850]DMGDH deficiency;,Dimethylglycine dehydrogenase deficiency,Disease-causing germline mutation(s) in,Toenail selenium levels[25343990;25343990];Urinary metabolites[26352407];Blood and toenail selenium levels[25343990;25343990;25343990;25343990;25343990];Betaine levels in individuals undergoing cardiac evaluation[26822151];Blood trace element (Se levels)[23720494;23720494];,0.038773006134969326,0.08096957194430118,0.05403288958496476,0.49386126457949664
981,6484,DMP1,600980,241520;,"[MIM:241520]Hypophosphatemic rickets, autosomal recessive, 1 [recessive?];",Autosomal recessive hypophosphatemic rickets,Disease-causing germline mutation(s) in,Dental caries[23064961];Heel bone mineral density[28869591;28869591;28869591];,0.16220858895705523,0.16915936049510058,0.2093448185852258,0.1576120319214242
982,6485,DMPK,605377,160900;,[MIM:160900]Dystrophia myotonica 1;,Steinert myotonic dystrophy,Disease-causing germline mutation(s) in,,0.3449079754601227,0.6116554925219185,0.20882276168102323,0.2550644567219153
983,6486,DMRT1,602424,154230;273300;,"[MIM:273300]Testicular germ cell tumor;[MIM:154230]46,XY sex reversal 4;","46,XY complete gonadal dysgenesis",Candidate gene tested in,Uterine fibroids[30194396];Dupuytren's disease[28886342];Testicular germ cell cancer[20543847];Obesity-related traits[23251661];Night sleep phenotypes[27126917;27126917];Testicular germ cell tumor[23666239;23666240;28604732;28604732;28604732;28604728];Testicular cancer[21551455;21551455];Major depressive disorder[23377640];,0.038773006134969326,0.66838576585869,0.3221091098929783,0.8601903007980356
984,6488,DMRT3,614754,,,"46,XY partial gonadal dysgenesis",Candidate gene tested in,Response to Homoharringtonine (cytotoxicity)[25628645];Dupuytren's disease[28886342];Night sleep phenotypes[27126917;27126917];Major depressive disorder[23377640];,0.4710429447852761,0.4265085095410005,0.2341425215348473,0.29772866789441377
985,6495,DMTF1,608491,,,Autosomal recessive hypophosphatemic rickets,Disease-causing germline mutation(s) in,Bipolar disorder or major depressive disorder[20351715];Brachial circumference[22479309];Schizophrenia[28991256];,0.17791411042944785,0.5330067044868488,0.4594100756982511,0.18753836709637814
986,6499,DMXL2,612186,616113;617605;,"[MIM:616113]Polyendocrine-polyneuropathy syndrome;[MIM:617605]Deafness, autosomal dominant, 71 [dominant?];",Polyendocrine-polyneuropathy syndrome;Autosomal dominant non-syndromic sensorineural deafness type DFNA,Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in,Body mass index[25673413;25673413;25673413];Intelligence (MTAG)[29326435];Body mass index (joint analysis main effects and smoking interaction)[28443625];BMI (adjusted for smoking behaviour)[28443625];,0.27361963190184047,1.0,0.13103628295484207,0.322744014732965
987,6500,DNA2,601810,615156;615807;,"[MIM:615156]Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal dominant, 6 [dominant?];[MIM:615807]Seckel syndrome 8 [recessive?];",DNA2-related mitochondrial DNA deletion syndrome,Disease-causing germline mutation(s) in,,0.39631901840490796,0.07864878803506963,0.24876011485251892,0.0
988,6501,DNAAF1,613190,613193;,,Primary ciliary dyskinesia,Disease-causing germline mutation(s) in,Systolic blood pressure response to hydrochlorothiazide in hypertension[27802415];Response to platinum-based neoadjuvant chemotherapy in cervical cancer[28120872];Post bronchodilator FEV1/FVC ratio[26634245];,0.4667484662576687,0.222279525528623,0.11981205951448708,0.0
989,6502,DNAAF2,612517,612518;,"[MIM:612518]Ciliary dyskinesia, primary, 10;",Primary ciliary dyskinesia,Disease-causing germline mutation(s) in,Carotid intima media thickness[26343869];,0.5920245398773006,0.14388860237235687,0.04646306447402767,0.0
990,6503,DNAAF3,614566,606763;,"[MIM:606763]Ciliary dyskinesia, primary, 2;",Primary ciliary dyskinesia,Disease-causing germline mutation(s) in,,0.08736196319018405,0.2668901495616297,0.12059514487079091,0.0
991,6504,DNAAF4,608706,127700;615482;,"[MIM:615482]Ciliary dyskinesia, primary, 25;",Primary ciliary dyskinesia,Disease-causing germline mutation(s) (loss of function) in,,0.4795092024539877,0.09798865394533264,0.0,0.0
992,6506,DNAAF5,614864,614874;,"[MIM:614874]Ciliary dyskinesia, primary, 18;",Primary ciliary dyskinesia,Disease-causing germline mutation(s) in,Cerebrospinal P-tau181p levels[28247064];Initial pursuit acceleration[29064472];,0.6208588957055214,0.09824651882413615,0.0,0.0
993,6507,DNAH1,603332,617576;617577;,"[MIM:617576]Spermatogenic failure 18 [recessive?];[MIM:617577]Ciliary dyskinesia, primary, 37 [recessive?];",Primary ciliary dyskinesia;Non-syndromic male infertility due to sperm motility disorder,Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in,Electroencephalogram traits[25387704];Parkinson's disease[28892059];Autism spectrum disorder or schizophrenia[28540026;28540026];Schizophrenia[23974872];Bipolar disorder[21926972];,0.36171779141104293,0.6384734399174833,0.0647350561211172,0.17480049109883364
994,6510,DNAH5,603335,608644;,"[MIM:608644]Ciliary dyskinesia, primary, 3;",Primary ciliary dyskinesia,Disease-causing germline mutation(s) in,"Visceral fat[22589738];Post bronchodilator FEV1 in COPD[26634245];Subclinical atherosclerosis traits (other)[17903303;17903303;17903303];Emphysema imaging phenotypes[26030696];Corneal astigmatism[23322567];Post bronchodilator FEV1/FVC ratio in COPD[26634245;26634245;26634245;26634245;26634245;26634245;26634245;26634245;26634245;26634245];IgE grass sensitization[22036096];Response to radiotherapy in prostate cancer (toxicity, decreased urine stream)[27515689];Coffee consumption[29367735];",0.038773006134969326,0.0012893243940175349,0.0028713129731140694,0.051718845917740945
995,6514,DNAH9,603330,,,Primary ciliary dyskinesia,Disease-causing germline mutation(s) in,Myopia (pathological)[23049088];Immune response to measles-mumps-rubella vaccine[24811271];Spherical equivalent (joint analysis main effects and education interaction)[27020472;27020472];Cerebellum growth[29682794];,0.08736196319018405,0.052346570397111915,0.0075698251109370925,0.034223449969306326
996,6517,DNAH11,603339,611884;,"[MIM:611884]Ciliary dyskinesia, primary, 7;",Primary ciliary dyskinesia,Disease-causing germline mutation(s) in,"Bone mineral density (hip)[30172743];Multiple myeloma[22120009;26007630];Total ventricular volume[21116278];Breast cancer[29059683];Metabolite levels (lipoprotein measures)[27005778];Total cholesterol levels[28334899];Multiple myeloma and monoclonal gammopathy[26007630];Whole-brain volume[21116278];LDL cholesterol levels[28334899];Cholesterol, total[20686565;19060911;24097068;25961943];LDL cholesterol[20686565;19060911;24097068;25961943];Cognitive decline (age-related)[24468470];Multiple cancers (lung cancer, gastric cancer, and squamous cell carcinoma)[23103227;23103227;23103227;23103227];",0.038773006134969326,0.4956162970603404,0.0018271991647089533,0.0
997,6522,DNAI1,604366,244400;,"[MIM:244400]Ciliary dyskinesia, primary, 1;[MIM:244400]Kartagener syndrome [recessive?];",Primary ciliary dyskinesia,Disease-causing germline mutation(s) in,,0.08736196319018405,0.7251160391954615,0.15296267293134952,0.27992633517495397
998,6523,DNAI2,605483,612444;,,Primary ciliary dyskinesia,Disease-causing germline mutation(s) in,Information processing speed[21130836];,0.23865030674846627,0.08277462609592573,0.058209344818585224,0.2678023327194598
999,6534,DNAJB1,604572,,,Fibrolamellar hepatocellular carcinoma,Part of a fusion gene in,,0.9638036809815951,0.5546673543063435,0.8423388149308274,0.6306015960712094
1000,6536,DNAJB2,604139,614881;,"[MIM:614881]Distal spinal muscular atrophy, autosomal recessive, 5 [recessive?];",Young adult-onset distal hereditary motor neuropathy;DNAJB2-related Charcot-Marie-Tooth disease type 2,Disease-causing germline mutation(s) (loss of function) in;Disease-causing germline mutation(s) in,,0.7968098159509203,0.3690046415678185,0.6048029235186635,0.14103744628606507
1001,6542,DNAJB6,611332,603511;,[MIM:603511]Limb-girdle muscular dystrophy 1E [dominant?];,Autosomal dominant limb-girdle muscular dystrophy type 1D,Disease-causing germline mutation(s) in,,0.9007361963190184,0.8486333161423414,0.8392064735056121,0.37814610190300796
1002,6549,DNAJB13,610263,617091;,,Primary ciliary dyskinesia,Disease-causing germline mutation(s) (loss of function) in,Dimensional psychopathology (Cognitive)[29496196];,0.20368098159509201,0.7668901495616297,0.15713912816496997,0.0
1003,6553,DNAJC3,601184,616192;,"[MIM:616192]Ataxia, combined cerebellar and peripheral, with hearing loss and diabetes mellitus;",Juvenile-onset diabetes mellitus-central and peripheral neurodegeneration syndrome,Disease-causing germline mutation(s) (loss of function) in,,0.7390184049079754,0.44326972666322845,0.6648394675019577,0.33732351135666055
1004,6556,DNAJC5,611203,162350;,"[MIM:162350]Ceroid lipofuscinosis, neuronal, 4B;",CLN4B disease,Disease-causing germline mutation(s) in,Prostate cancer[23535732];,0.2498159509202454,0.888602372356885,0.9806838945445053,0.0
1005,6559,DNAJC6,608375,615528;,"[MIM:615528]Parkinson disease 19B, early-onset [recessive?];",Young-onset Parkinson disease;Atypical juvenile parkinsonism,Disease-causing germline mutation(s) (loss of function) in;Disease-causing germline mutation(s) in,Idiopathic osteonecrosis of the femoral head[28000841];Anticoagulant levels[22216198];,0.5505521472392638,0.961835997937081,0.5552075176194206,0.8680171884591774
1006,6567,DNAJC12,606060,617384;,"[MIM:617384]Hyperphenylalaninemia, mild, non-BH4-deficient [recessive?];",Hyperphenylalaninemia due to DNAJC12 deficiency,Disease-causing germline mutation(s) in,,0.27361963190184047,0.2372356884992264,0.5685199686765857,0.08241252302025782
1007,6568,DNAJC13,614334,168600;,[MIM:168600]Parkinson disease;,Hereditary late-onset Parkinson disease,Disease-causing germline mutation(s) (gain of function) in,Body mass index[26426971];Iron status biomarkers (total iron binding capacity)[28334935];Blood protein levels[28240269;29875488];Red cell distribution width[27863252];Coronary artery disease[29212778;29212778];,0.8828220858895706,1.0,0.2897415818324197,0.4685389809699202
1008,6574,DNAJC19,608977,610198;,,Dilated cardiomyopathy with ataxia,Disease-causing germline mutation(s) in,Schizophrenia[25056061;28991256];,0.4298159509202454,0.3329035585353275,0.9209083790133125,0.23680171884591775
1009,6584,DNAJC21,617048,617052;,,Shwachman-Diamond syndrome,Disease-causing germline mutation(s) in,Response to angiotensin II receptor blocker therapy[22566498];,0.6811042944785276,0.16890149561629705,0.6144609762464108,0.040208717004297116
1010,6593,DNAL1,610062,614017;,,Primary ciliary dyskinesia,Disease-causing germline mutation(s) in,,0.10711656441717791,0.500515729757607,0.8519968676585747,0.21639042357274402
1011,6594,DNAL4,610565,616059;,[MIM:616059]Mirror movements 3;,Familial congenital mirror movements,Disease-causing germline mutation(s) in,,0.26588957055214724,0.41206807632800413,0.9540589924301749,0.6565377532228361
1012,6596,DNASE1,125505,152700;,[MIM:152700]Systemic lupus erythematosus;,Systemic lupus erythematosus;Autosomal systemic lupus erythematosus,Major susceptibility factor in;Disease-causing germline mutation(s) in,,0.12711656441717792,0.5887055183084065,0.12607674236491778,0.27532228360957645
1013,6599,DNASE1L3,602244,614420;,[MIM:614420]Systemic lupus erythematosus 16 [recessive?];,Autosomal systemic lupus erythematosus;Hypocomplementemic urticarial vasculitis,Disease-causing germline mutation(s) (loss of function) in;Disease-causing germline mutation(s) (loss of function) in,Rheumatoid arthritis (ACPA-positive)[23143596];Rheumatoid arthritis[24390342;23143596];Systemic sclerosis[28314753;24387989;24387989];Eating disorders (purging via substances)[23568457];Limited cutaneous systemic scleroderma[24387989];,0.3669938650306748,0.4522949974213512,0.45184025058731403,0.32443216697360344
1014,6608,DNM1,602377,616346;,"[MIM:616346]Epileptic encephalopathy, early infantile, 31;",Lennox-Gastaut syndrome;Undetermined early-onset epileptic encephalopathy,Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in,Body mass index[26426971];Attention deficit hyperactivity disorder[18839057];Coenzyme Q10 levels[27149984];,0.5874846625766871,0.9681536874677669,0.5100495954058992,0.8594229588704727
1015,6609,DNM1L,603850,610708;614388;,[MIM:614388]Encephalopathy due to defective mitochondrial and peroxisomal fission 1 [dominant?];[MIM:610708]Optic atrophy 5 [dominant?];,"DNM1L-related encephalopathy due to mitochondrial and peroxisomal fission defect;Autosomal dominant optic atrophy, classic form",Disease-causing germline mutation(s) (gain of function) in;Disease-causing germline mutation(s) in,,0.8473619631901841,0.2890665291387313,0.84286087183503,0.7441682013505218
1016,6642,DNM2,602378,160150;606482;615368;,"[MIM:160150]Myopathy, centronuclear, 1;[MIM:615368]Lethal congenital contracture syndrome 5 [recessive?];[MIM:606482]Charcot-Marie-Tooth disease, dominant, intermediate type, B;[MIM:606482]Charcot-Marie-Tooth disease 2M;",Autosomal dominant centronuclear myopathy;Autosomal dominant Charcot-Marie-Tooth disease type 2M;Fetal akinesia-cerebral and retinal hemorrhage syndrome;Autosomal dominant intermediate Charcot-Marie-Tooth disease type B,Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in,Height[25429064];LDL cholesterol[21347282];,0.8547239263803681,0.49484270242392986,0.7559383972853041,0.7713321055862492
1017,6648,DNMT1,126375,604121;614116;,"[MIM:614116]Neuropathy, hereditary sensory, 1E;[MIM:604121]Cerebellar ataxia, deafness, and narcolepsy, autosomal dominant [dominant?];",Autosomal dominant cerebellar ataxia-deafness-narcolepsy syndrome;Hereditary sensory neuropathy-deafness-dementia syndrome,Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in,Reticulocyte fraction of red cells[27863252];Reticulocyte count[27863252];Narcolepsy[24204295];Immature fraction of reticulocytes[27863252];,0.9207361963190184,0.6593604951005673,0.5003915426781519,0.8882750153468385
1018,6649,DNMT3A,602769,615879;,[MIM:615879]Tatton-Brown-Rahman syndrome;,Tall stature-intellectual disability-facial dysmorphism syndrome,Disease-causing germline mutation(s) in,"Waist circumference adjusted for BMI (joint analysis main effects and physical activity interaction)[28448500;28448500;28448500;28448500];Lymphocyte percentage of white cells[27863252];Waist circumference adjusted for BMI in non-smokers[28443625];Lymphocyte counts[27863252];Chronic inflammatory diseases (ankylosing spondylitis, Crohn's disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy)[26974007];Waist circumference adjusted for BMI (adjusted for smoking behaviour)[28443625;28443625];Crohn's disease[21102463;28067908];Waist circumference adjusted for body mass index[28448500;28448500;28448500;28448500;28448500;25673412;25673412;25673412];Inflammatory bowel disease[28067908];Waist circumference adjusted for BMI in smokers[28443625;28443625];Body mass index (age <50)[26426971];Body mass index[26426971];Body mass index x sex x age interaction (4df test)[26426971];Type 1 diabetes[21980299];Neutrophil percentage of white cells[27863252];Waist circumference adjusted for BMI (joint analysis main effects and smoking interaction)[28443625;28443625];Body mass index (age>50)[26426971];Height[18391951;25429064;25282103];Waist circumference adjusted for BMI in active individuals[28448500;28448500;28448500;28448500];",0.50920245398773,0.8318720990201135,0.7862176977290525,0.7140883977900553
1019,6651,DNMT3B,602900,158901;242860;,[MIM:242860]Immunodeficiency-centromeric instability-facial anomalies syndrome 1;[MIM:158901]Facioscapulohumeral muscular dystrophy 2;,ICF syndrome,Disease-causing germline mutation(s) in,"Inflammatory bowel disease[23128233];Lymphocyte percentage of white cells[27863252];Iron status biomarkers (iron levels)[28334935];Lymphocyte counts[27863252];Chronic inflammatory diseases (ankylosing spondylitis, Crohn's disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy)[26974007];Prostate cancer[29892016];",0.5930061349693252,0.6707065497679217,0.5272774732445836,0.9693063228974831
1020,6662,DOCK2,603122,616433;,[MIM:616433]Immunodeficiency 40;,DOCK2 deficiency,Disease-causing germline mutation(s) (loss of function) in,Acne (severe)[24927181];Pneumococcal bacteremia[27236921];Body mass index and waist-hip ratio (pleiotropy)[29868124];Placental abruption[29884306];Prostate cancer[29892016];Protein quantitative trait loci[18464913];,0.45950920245398774,0.835224342444559,0.4205168363351605,0.5059852670349908
1021,6667,DOCK6,614194,614219;,[MIM:614219]Adams-Oliver syndrome 2;,Adams-Oliver syndrome,Disease-causing germline mutation(s) (loss of function) in,"Cholesterol, total[26780889];Coronary artery disease[29212778];HDL cholesterol[20686565;23505323;21347282];",0.6917791411042945,0.1374419804022692,0.17723831897676848,0.06015960712093309
1022,6668,DOCK7,615730,615859;,"[MIM:615859]Epileptic encephalopathy, early infantile, 23;",Early-onset epileptic encephalopathy-cortical blindness-intellectual disability-facial dysmorphism syndrome,Disease-causing germline mutation(s) (loss of function) in,"Total cholesterol levels[29403010];Lipid traits[24386095;24386095];Pneumococcal bacteremia[27236921];Platelet distribution width[27863252];Triglyceride levels[29615537;29403010];Metabolite levels[22916037];Metabolite levels (lipid measures)[27005778];Triglycerides[20686565;20864672;18193044;19060911;25961943];Crohn's disease[28067908];Cholesterol, total[20686565;19060911;25961943;28270201];LDL cholesterol[20686565;19060911;25961943];Very long-chain saturated fatty acid levels (fatty acid 20:0)[25378659];",0.8601226993865031,0.6957194430118618,0.3878882798225006,0.17019643953345612
1023,6669,DOCK8,611432,243700;614113;,"[MIM:243700]Hyperimmunoglobulin E recurrent infection syndrome, autosomal recessive [recessive?];[MIM:614113]Mental retardation, autosomal dominant 2 [dominant?];",Autosomal dominant non-syndromic intellectual disability;Combined immunodeficiency due to DOCK8 deficiency,Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in,Mean platelet volume[22139419;27863252;27863252;27863252;27863252;27863252];Granulocyte percentage of myeloid white cells[27863252];White blood cell count[27863252];Myeloid white cell count[27863252];Platelet distribution width[27863252];Sum basophil neutrophil counts[27863252];Sum neutrophil eosinophil counts[27863252];Obesity-related traits[23251661];Granulocyte count[27863252];Neutrophil count[27863252];Platelet count[27863252];Post bronchodilator FEV1[26634245;26634245];,0.6566871165644171,0.3831872099020113,0.021665361524406162,0.2607427869858809
1024,6683,DOK7,610285,254300;,"[MIM:254300]Myasthenic syndrome, congenital, 10 [recessive?];",Fetal akinesia deformation sequence;Postsynaptic congenital myasthenic syndromes,Disease-causing germline mutation(s) (loss of function) in;Disease-causing germline mutation(s) in,Calcium levels[29403010];Fibrinogen levels[28107422;28107422];,0.17791411042944785,0.27617328519855594,0.13025319759853823,0.0
1025,6684,DOLK,610746,610768;,,Familial isolated dilated cardiomyopathy;DK1-CDG,Disease-causing germline mutation(s) (loss of function) in;Disease-causing germline mutation(s) in,,0.7749693251533742,0.3476018566271274,0.6823283737927434,0.6539287906691221
1026,6690,DPAGT1,191350,608093;614750;,"[MIM:608093]Congenital disorder of glycosylation 1J;[MIM:614750]Myasthenic syndrome, congenital, 13;",Congenital myasthenic syndromes with glycosylation defect;DPAGT1-CDG,Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) (loss of function) in,GLP-1 levels in response to oral glucose tolerance test (fasting)[29093273];Age at first birth[27798627;27798627];Educational attainment[25201988];,0.20368098159509201,0.6000515729757607,0.37379274340903157,0.4562615101289134
1027,6697,DPF2,601671,,,Coffin-Siris syndrome,Disease-causing germline mutation(s) in,Acne (severe)[24927181];,0.634601226993865,0.8423156266116555,0.9772905246671887,0.0
1028,6699,DPH1,603527,616901;,,Craniofacial dysplasia-short stature-ectodermal anomalies-intellectual disability syndrome,Disease-causing germline mutation(s) in,Diisocyanate-induced asthma[25918132];Itch intensity from mosquito bite[28199695];,0.6131288343558282,0.2258896338318721,0.2573740537718611,0.14103744628606507
1029,6708,DPM1,603503,608799;,[MIM:608799]Congenital disorder of glycosylation 1E;,DPM1-CDG,Disease-causing germline mutation(s) in,,0.9739877300613496,0.22666322846828263,0.0,0.40730509515039903
1030,6709,DPM2,603564,615042;,[MIM:615042]Congenital disorder of glycosylation 1U;,Congenital muscular dystrophy with intellectual disability and severe epilepsy,Disease-causing germline mutation(s) in,Body mass index[26426971];Glaucoma (primary angle closure)[27064256;27064256];,0.26588957055214724,0.759412068076328,0.9070738710519447,0.24631675874769798
1031,6710,DPM3,605951,612937;,[MIM:612937]Congenital disorder of glycosylation 1O;,DPM3-CDG,Disease-causing germline mutation(s) in,Liver enzyme levels (gamma-glutamyl transferase)[22001757];Inflammatory bowel disease[28067908];Crohn's disease[28067908];Prostate cancer[23535732];,0.6379141104294479,0.6219700876740588,0.9770294962150874,0.5161141804788214
1032,6715,DPP6,126141,612956;616311;,"[MIM:612956]Familial paroxysmal ventricular fibrillation 2;[MIM:616311]Mental retardation, autosomal dominant 33 [dominant?];","Autosomal dominant primary microcephaly;Idiopathic ventricular fibrillation, non Brugada type",Disease-causing germline mutation(s) (loss of function) in;Disease-causing germline mutation(s) in,Post bronchodilator FEV1 in COPD[26634245];QT interval[23534349];Spherical equivalent or myopia (age of diagnosis)[29808027];Pancreatic cancer[20686608];Post-traumatic stress disorder[24677629];Amyotrophic lateral sclerosis[18084291;18057069;18987618];Colorectal cancer (diet interaction)[24743840];Pelvic organ prolapse[26545240;26545240];Tardive dyskinesia[21826085];Gestational age at birth in premature rupture of membrane-initiated deliveries (maternal effect)[27490719];Bone mineral accretion in asthma (oral corticosteroid dose interaction)[26025128];Venous thromboembolism adjusted for sickle cell variant rs77121243-T[28203683];,0.16220858895705523,0.591542031975245,0.2592012529365701,0.0
1033,6718,DPP9,608258,,,Idiopathic pulmonary fibrosis,Major susceptibility factor in,Interstitial lung disease[23583980];,0.4936196319018405,0.796028880866426,0.5131819368311146,0.3902701043585021
1034,6752,DPY19L2,613893,613958;,,Male infertility due to globozoospermia,Disease-causing germline mutation(s) in,,0.038773006134969326,0.0,0.06812842599843383,0.10405156537753223
1035,6763,DPYD,612779,274270;,,Dihydropyrimidine dehydrogenase deficiency;5-fluorouracil toxicity;1p21.3 microdeletion syndrome,Disease-causing germline mutation(s) in;Biomarker tested in;Role in the phenotype of,"Body mass index[25673413;25673413];Intelligence (MTAG)[29326435];Methadone dose in opioid dependence[28115739];Autism spectrum disorder, attention deficit-hyperactivity disorder, bipolar disorder, major depressive disorder, and schizophrenia (combined)[23453885];Autism spectrum disorder or schizophrenia[28540026;28540026];Schizophrenia[23974872;22688191;25056061];Menarche (age at onset)[25231870];Coronary artery disease[29212778];Platelet count[21507922];Borderline personality disorder[28632202];",0.20368098159509201,0.240587931923672,0.1720177499347429,0.7763965623081646
1036,6767,DPYS,613326,222748;,[MIM:222748]Dihydropyrimidinase deficiency [recessive?];,Dihydropyrimidinuria,Disease-causing germline mutation(s) (loss of function) in,,0.16220858895705523,0.38396080453842185,0.4372226572696424,0.5738182934315531
1037,6776,DRAM2,613360,616502;,[MIM:616502]Cone-rod dystrophy 21;,Cone rod dystrophy,Disease-causing germline mutation(s) (loss of function) in,,0.038773006134969326,0.27694687983496646,0.7762986165492038,0.2519950890116636
1038,6780,DRC1,615288,615294;,"[MIM:615294]Ciliary dyskinesia, primary, 21;",Primary ciliary dyskinesia,Disease-causing germline mutation(s) (loss of function) in,Metabolite levels (HVA/MHPG ratio)[23319000];Metabolite levels (HVA)[23319000];,0.14576687116564419,0.3096957194430119,0.055338031845471154,0.0
1039,6784,DRD2,126450,103780;,,Myoclonus-dystonia syndrome,Candidate gene tested in,Neuroticism[27089181;29255261];Systolic blood pressure in sickle cell anemia[24058526];Body mass index[26426971];Alcoholic chronic pancreatitis[28754779];Response to antipsychotic treatment in schizophrenia (working memory)[21107309];Autism spectrum disorder or schizophrenia[28540026];Interferon alpha levels in systemic lupus erythematosus[25338677];Schizophrenia[25056061;28991256];Information processing speed[25869804];Select biomarker traits[17903293];Sleep duration[27992416];,0.403680981595092,0.8166580711707065,0.4857739493604803,0.5339165131982812
1040,6797,DSC2,125645,610476;,"[MIM:610476]Arrhythmogenic right ventricular dysplasia, familial, 11;","Familial isolated arrhythmogenic ventricular dysplasia, right dominant form;Familial isolated arrhythmogenic ventricular dysplasia, biventricular form;Familial isolated arrhythmogenic ventricular dysplasia, left dominant form",Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in,Bronchopulmonary dysplasia[23897914];Blood protein levels[29875488;30072576];,0.7984049079754602,0.1591026302217638,0.21299921691464369,0.19337016574585636
1041,6798,DSC3,600271,613102;,[MIM:613102]Hypotrichosis and recurrent skin vesicles;,Hereditary hypotrichosis with recurrent skin vesicles,Disease-causing germline mutation(s) in,Bronchopulmonary dysplasia[23897914];Obesity-related traits[23251661];Protein quantitative trait loci[18464913];Supraventricular ectopy[29618737];,0.7252760736196319,0.14956162970603404,0.1707126076742365,0.034223449969306326
1042,6810,DSE,605942,615539;,,"Ehlers-Danlos syndrome, musculocontractural type",Disease-causing germline mutation(s) (loss of function) in,Fast beta electroencephalogram[28040410];Heschl's gyrus morphology[25130324];,0.21484662576687116,0.2895822588963383,0.16001044113808405,0.17971147943523635
1043,6812,DSG1,125670,148700;615508;,"[MIM:148700]Palmoplantar keratoderma 1, striate, focal, or diffuse;[MIM:615508]Erythroderma, congenital, with palmoplantar keratoderma, hypotrichosis, and hyper IgE;",Severe dermatitis-multiple allergies-metabolic wasting syndrome;Focal palmoplantar keratoderma with joint keratoses;Diffuse palmoplantar keratoderma with painful fissures;Striate palmoplantar keratoderma,Disease-causing germline mutation(s) (loss of function) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in,Yeast infection[28928442];Eosinophilic esophagitis (pediatric)[20208534];,0.5867484662576687,0.5613718411552346,0.08431219002871312,0.478207489257213
1044,6814,DSG2,125671,610193;612877;,"[MIM:610193]Arrhythmogenic right ventricular dysplasia, familial, 10;[MIM:612877]Cardiomyopathy, dilated 1BB;","Familial isolated dilated cardiomyopathy;Familial isolated arrhythmogenic ventricular dysplasia, right dominant form;Familial isolated arrhythmogenic ventricular dysplasia, biventricular form;Familial isolated arrhythmogenic ventricular dysplasia, left dominant form",Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in,Blood protein levels[29875488;30072576];,0.989079754601227,0.18669417225373905,0.1480031323414252,0.1663597298956415
1045,6817,DSG4,607892,607903;,[MIM:607903]Hypotrichosis 6;,Monilethrix;Hypotrichosis simplex,Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in,,0.4,0.073749355337803,0.35186635343252415,0.049263351749539594
1046,6819,DSP,125647,605676;607450;607655;609638;612908;615821;,"[MIM:612908]Keratoderma, palmoplantar, striate 2;[MIM:605676]Cardiomyopathy, dilated, with woolly hair and keratoderma [recessive?];[MIM:607450]Arrhythmogenic right ventricular dysplasia, familial, 8;[MIM:607655]Skin fragility-woolly hair syndrome [recessive?];[MIM:609638]Epidermolysis bullosa, lethal acantholytic;[MIM:615821]Cardiomyopathy, dilated, with woolly hair, keratoderma, and tooth agenesis;","Lethal acantholytic epidermolysis bullosa;Severe dermatitis-multiple allergies-metabolic wasting syndrome;Familial isolated arrhythmogenic ventricular dysplasia, right dominant form;Familial isolated arrhythmogenic ventricular dysplasia, biventricular form;Familial isolated arrhythmogenic ventricular dysplasia, left dominant form;Skin fragility-woolly hair-palmoplantar keratoderma syndrome;Idiopathic pulmonary fibrosis;Erythrokeratodermia-cardiomyopathy syndrome;Carvajal syndrome;Striate palmoplantar keratoderma",Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Major susceptibility factor in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in,Response to fenofibrate (triglyceride levels)[27002377];Resting heart rate[27798624];Idiopathic pulmonary fibrosis[29066090];Chronic obstructive pulmonary disease[28166215];Interstitial lung disease[23583980];,0.9263803680981595,1.0,0.05142260506395197,0.8311847759361571
1047,6820,DSPP,125485,125420;125490;125500;605594;,"[MIM:605594]Deafness, autosomal dominant, 39, with dentinogenesis imperfecta 1 [dominant?];[MIM:125490]Dentinogenesis imperfecta, Shields type 2 [dominant?];[MIM:125500]Dentinogenesis imperfecta, Shields type 3 [dominant?];[MIM:125420]Dentin dysplasia 2;",Dentinogenesis imperfecta type 2;Dentinogenesis imperfecta type 3;Dentin dysplasia type I;Dentin dysplasia type II,Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in,Dental caries[23064961];Idiopathic dilated cardiomyopathy[29495422];,0.12711656441717792,0.1918514698298092,0.00548159749412686,0.8703192142418662
1048,6821,DST,113810,614653;615425;,"[MIM:614653]Neuropathy, hereditary sensory and autonomic, 6 [recessive?];[MIM:615425]Epidermolysis bullosa simplex, autosomal recessive 2 [recessive?];",Hereditary sensory and autonomic neuropathy type 6;Epidermolysis bullosa simplex due to BP230 deficiency,Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in,Small cell lung carcinoma[28604730];Alzheimer disease and age of onset[26830138];Menarche (age at onset)[25231870];Daytime sleep phenotypes[27126917];Attention function in attention deficit hyperactive disorder[26174813];Cerebrospinal fluid clusterin levels[26545630];,0.9280981595092025,0.7833935018050542,0.013051422605063952,0.31752608962553713
1049,6828,DSTYK,612666,270750;610805;,[MIM:270750]Spastic paraplegia 23 [recessive?];,"Renal agenesis, unilateral;Autosomal recessive spastic paraplegia type 23",Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in,Systemic lupus erythematosus[26606652];White blood cell count (basophil)[27863252];Reticulocyte count[27863252];Basophil percentage of white cells[27863252];Obesity-related traits[23251661];Blood protein levels[28240269];Hair color[29662168];Red cell distribution width[27863252];,0.5645398773006135,0.8491490458999484,0.3897154789872096,0.5019950890116636
1050,6829,DTD1,610996,,,Perrault syndrome,Disease-causing germline mutation(s) in,C-reactive protein (red blood cell fatty acid level interaction)[28820441];Night sleep phenotypes[27126917];,0.2498159509202454,0.4174832387828778,0.48264160793526495,0.6642111724984653
1051,6833,DTNA,601239,604169;,[MIM:604169]Left ventricular non-compaction 1 [dominant?];,Left ventricular noncompaction,Candidate gene tested in,Urate levels in overweight individuals[25811787];Coronary artery calcified atherosclerotic plaque (130 HU threshold) in type 2 diabetes[29221444];,0.541840490797546,0.6351211964930377,0.6577916992952232,0.6746470227133211
1052,6835,DTNBP1,607145,614076;,[MIM:614076]Hermansky-Pudlak syndrome 7 [recessive?];,Hermansky-Pudlak syndrome type 7,Disease-causing germline mutation(s) in,Multiple myeloma[27363682];,0.6379141104294479,0.21299638989169675,0.3701383450796137,0.059085328422345
1053,6848,DUOX2,606759,607200;,[MIM:607200]Thyroid dyshormonogenesis 6;,Genetic transient congenital hypothyroidism;Familial thyroid dyshormonogenesis,Disease-causing germline mutation(s) (loss of function) in;Disease-causing germline mutation(s) in,,0.10711656441717791,0.0018050541516245488,0.23858000522056905,0.7360343769183548
1054,6850,DUOXA2,612772,274900;,[MIM:274900]Thyroid dyshormonogenesis 5;,Familial thyroid dyshormonogenesis,Disease-causing germline mutation(s) in,,0.038773006134969326,0.047705002578648785,0.7462803445575568,0.21347452424800492
1055,6864,DUSP6,602748,615269;,[MIM:615269]Hypogonadotropic hypogonadism 19 with or without anosmia;,Kallmann syndrome;Normosmic congenital hypogonadotropic hypogonadism,Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in,Attention deficit hyperactivity disorder[29325848];Night sleep phenotypes[27126917];,0.45950920245398774,0.7640536358947911,0.03915426781519186,0.8480662983425414
1056,6900,DUX4,606009,158900;,[MIM:158900]Facioscapulohumeral muscular dystrophy 1;,Facioscapulohumeral dystrophy,Candidate gene tested in,,0.6202453987730061,0.0,0.0,0.0
1057,6901,DUX4L1,,158900;,[MIM:158900]Facioscapulohumeral muscular dystrophy 1;,Facioscapulohumeral dystrophy,Candidate gene tested in,,0.038773006134969326,0.0,0.0,0.0
1058,6967,DVL1,601365,616331;,"[MIM:616331]Robinow syndrome, autosomal dominant 2 [dominant?];",Autosomal dominant Robinow syndrome,Disease-causing germline mutation(s) in,Inflammatory bowel disease[28067908];Ulcerative colitis[28067908];,0.8839263803680981,0.24265085095410005,0.602453667449752,0.41697360343769185
1059,6970,DVL3,601368,616894;,"[MIM:616894]Robinow syndrome, autosomal dominant 3 [dominant?];",Autosomal dominant Robinow syndrome,Disease-causing germline mutation(s) in,Major depressive disorder[22472876];,0.8910429447852761,0.6603919546157814,0.6296006264682851,0.557243707796194
1060,6975,DYM,607461,223800;607326;,[MIM:223800]Dyggve-Melchior-Clausen syndrome [recessive?];[MIM:607326]Smith-McCort dysplasia 1 [recessive?];,Dyggve-Melchior-Clausen disease;Smith-McCort dysplasia,Disease-causing germline mutation(s) (loss of function) in;Disease-causing germline mutation(s) (loss of function) in,Body fat percentage[28270201];Systolic blood pressure x smoking status (current vs non-current) interaction (1df test)[29455858];Hip circumference adjusted for BMI[25673412;25673412;25673412];Height[21998595;22021425;23563607;20881960;18391952;25429064];Systolic blood pressure x smoking status (current vs non-current) interaction (2df test)[29455858];,0.2947239263803681,0.24239298607529655,0.5820934481858523,0.6617556783302639
1061,6977,DYNC1H1,600112,158600;614228;614563;,"[MIM:614228]Charcot-Marie-Tooth disease 2O;[MIM:614563]Mental retardation, autosomal dominant 13 [dominant?];[MIM:158600]Spinal muscular atrophy, lower extremity-predominant 1, autosomal dominant [dominant?];",Autosomal dominant non-syndromic intellectual disability;DYNC1H1-related autosomal dominant childhood-onset proximal spinal muscular atrophy;Autosomal dominant Charcot-Marie-Tooth disease type 2O,Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in,,0.9975460122699387,0.8898916967509025,0.274079874706343,0.947206875383671
1062,6983,DYNC2H1,603297,613091;,[MIM:613091]Short-rib thoracic dysplasia 3 with or without polydactyly [recessive?];,"Jeune syndrome;Short rib-polydactyly syndrome, Verma-Naumoff type;Short rib-polydactyly syndrome, Majewski type;Short rib-polydactyly syndrome, Saldino-Noonan type",Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in,Toenail selenium levels[25343990];Small-cell lung cancer (survival)[21118971];Tuberculosis[24057671];Spine bone mineral density and alcohol drinking[28012008];Diisocyanate-induced asthma[25918132];Response to lurasidone in schizophrenia[29730043];,0.8520245398773006,0.3635894791129448,0.041764552336204644,0.003376304481276857
1063,6984,DYNC2LI1,617083,617088;,,Jeune syndrome;Ellis Van Creveld syndrome,Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in,Diastolic blood pressure x smoking status (current vs non-current) interaction (2df test)[29455858;29455858];Systolic blood pressure x smoking status (ever vs never) interaction (2df test)[29455858;29455858];Diastolic blood pressure x smoking status (ever vs never) interaction (2df test)[29455858;29455858];Systolic blood pressure x smoking status (current vs non-current) interaction (2df test)[29455858;29455858];Coronary artery disease[29212778];,0.5026993865030674,0.12454873646209386,0.1970764813364657,0.14717618170656846
1064,7000,DYRK1A,600855,614104;,"[MIM:614104]Mental retardation, autosomal dominant 7 [dominant?];",DYRK1A-related intellectual disability syndrome due to 21q22.13q22.2 microdeletion;Intellectual disability syndrome due to a DYRK1A point mutation,Role in the phenotype of;Disease-causing germline mutation(s) (loss of function) in,HIV-1 replication[21364930];Metabolic syndrome[20694148];,0.6678527607361964,0.9498452810727179,0.7734273035760898,0.625537139349294
1065,7007,DYSF,603009,253601;254130;606768;,[MIM:253601]Limb-girdle muscular dystrophy 2B [recessive?];[MIM:254130]Miyoshi muscular dystrophy 1;[MIM:606768]Distal myopathy with anterior tibial onset [recessive?];,"Distal myopathy with anterior tibial onset;Congenital myopathy, Paradas type;Autosomal recessive limb-girdle muscular dystrophy type 2B;Miyoshi myopathy",Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in,Nonalcoholic steatohepatitis-derived hepatocellular carcinoma[29385134];Urate levels in overweight individuals[25811787];General cognitive ability[29844566];Protein quantitative trait loci[18464913];PR interval in Tripanosoma cruzi seropositivity[24324551];,0.5997546012269939,0.007220216606498195,0.1895066562255286,0.9923265807243707
1066,7010,DYT13,607671,,,"Primary dystonia, DYT13 type",Disease-causing germline mutation(s) in,,0.038773006134969326,0.0,0.0,0.0
1067,7011,DYT15,607488,,,Myoclonus-dystonia syndrome,Role in the phenotype of,,0.038773006134969326,0.0,0.0,0.0
1068,7012,DYT17,612406,,,"Primary dystonia, DYT17 type",Disease-causing germline mutation(s) in,,0.038773006134969326,0.0,0.0,0.0
1069,7013,DYT21,614588,,,"Primary dystonia, DYT21 type",Disease-causing germline mutation(s) in,,0.038773006134969326,0.0,0.0,0.0
1070,7027,DZIP1L,617570,617610;,[MIM:617610]Polycystic kidney disease 5 [recessive?];,Autosomal recessive polycystic kidney disease,Disease-causing germline mutation(s) (loss of function) in,,0.21484662576687116,0.0,0.5413730096580527,0.008440761203192142
1071,7029,E2F1,189971,,,Retinitis pigmentosa,Disease-causing germline mutation(s) in,Corneal curvature[24963161];,0.6743558282208589,0.9234141309953584,0.5776559645001305,0.0
1072,7051,EARS2,612799,614924;,[MIM:614924]Combined oxidative phosphorylation deficiency 12 [recessive?];,Leukoencephalopathy-thalamus and brainstem anomalies-high lactate syndrome,Disease-causing germline mutation(s) in,,0.7693251533742331,0.12738525012893243,0.4296528321587053,0.23511356660527932
1073,7064,EBP,300205,300960;302960;,"[MIM:302960]Chondrodysplasia punctata 2, X-linked dominant;[MIM:300960]MEND syndrome;",MEND syndrome;X-linked dominant chondrodysplasia punctata,Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) (loss of function) in,,0.892760736196319,0.8880866425992779,0.9013312451057165,0.0
1074,7072,ECE1,600423,613870;,,Hirschsprung disease,Major susceptibility factor in,Height[25282103];Obesity-related traits[23251661];,0.6045398773006135,0.8037648272305312,0.4489689376141999,0.9401473296500921
1075,7074,ECEL1,605896,615065;,"[MIM:615065]Arthrogryposis, distal, 5D [recessive?];",Distal arthrogryposis type 5D,Disease-causing germline mutation(s) in,,0.21484662576687116,0.1637441980402269,0.3938919342208301,0.6431860036832413
1076,7082,ECHS1,602292,616277;,,Leigh syndrome with leukodystrophy,Disease-causing germline mutation(s) in,Lifespan[25918517];,0.9045398773006135,0.3452810727178958,0.9284782041242495,0.3601903007980356
1077,7085,ECM1,602201,247100;,,Lipoid proteinosis,Disease-causing germline mutation(s) (loss of function) in,Migraine[27322543];Schizophrenia[28991256];Blood protein levels[28240269;28240269;30072576;30072576;30072576;30072576];,0.4622085889570552,0.054925219185146985,0.1631427825632994,0.42004297114794353
1078,7094,EDA,300451,305100;313500;,"[MIM:305100]Ectodermal dysplasia 1, hypohidrotic, X-linked;[MIM:313500]Tooth agenesis, selective, X-linked, 1;",X-linked hypohidrotic ectodermal dysplasia;Oligodontia,Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in,Tooth agenesis (maxillary lateral incisors)[29364747];Monobrow[27182965];Primary tooth development (time to first tooth eruption)[23704328;20195514];Primary tooth development (number of teeth)[23704328;20195514];,0.5040490797546012,0.7576070139247034,0.6982511093709214,0.0
1079,7095,EDA2R,300276,,,X-linked hypohidrotic ectodermal dysplasia,Disease-causing germline mutation(s) in,Male-pattern baldness[22032556;27182965];Balding[26926045];,0.31079754601226994,0.313821557503868,0.8060558600887496,0.4530386740331492
1080,7096,EDAR,604095,129490;224900;612630;,"[MIM:129490]Ectodermal dysplasia 10A, hypohidrotic/hair/nail type, autosomal dominant [dominant?];[MIM:224900]Ectodermal dysplasia 10B, hypohidrotic/hair/tooth type, autosomal recessive [recessive?];",Autosomal recessive hypohidrotic ectodermal dysplasia;Autosomal dominant hypohidrotic ectodermal dysplasia,Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in,Monobrow thickness[26926045];Scalp hair shape[26926045];Thick vs thin eyebrows[29895819];lower facial morphology traits (quantitative measurement)[27193062];Lobe attachment[26105758];Cleft lip with or without cleft palate (maternal periconceptional alcohol intake interaction)[29535761];Blood protein levels[28240269;28240269;29875488;30072576];Beard thickness[26926045];Lung function (FVC)[30061609];Ear morphology[26105758];Male-pattern baldness[27182965];Lobe size[26105758];Monobrow[27182965];Ear protrusion[26105758];Lobe attachment (rater scored)[29198719];Straight vs curly hair[29895819;27487801;27487801];Helix rolling[26105758];,0.27361963190184047,0.22356884992264053,0.1294701122422344,0.7022713321055862
1081,7097,EDARADD,606603,614940;614941;,"[MIM:614941]Ectodermal dysplasia 11B, hypohidrotic/hair/tooth type, autosomal recessive [recessive?];",Autosomal recessive hypohidrotic ectodermal dysplasia;Autosomal dominant hypohidrotic ectodermal dysplasia;Oligodontia,Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in,Urate levels (BMI interaction)[25811787;25811787];,0.45680981595092024,0.5110881897885508,0.6564865570347168,0.447206875383671
1082,7098,EDC3,609842,616460;,"[MIM:616460]Mental retardation, autosomal recessive 50 [recessive?];",Autosomal recessive non-syndromic intellectual disability,Disease-causing germline mutation(s) in,"Caffeine metabolism (plasma 1,7-dimethylxanthine (paraxanthine) to 1,3,7-trimethylxanthine (caffeine) ratio)[27702941;27702941;27702941;27702941;27702941];Craniofacial microsomia[26853712];Caffeine consumption[21490707];Caffeine metabolism (plasma 1,3-dimethylxanthine (theophylline) level)[27702941;27702941;27702941;27702941];Caffeine metabolism (plasma 1,3,7-trimethylxanthine (caffeine) level)[27702941;27702941;27702941;27702941;27702941];",0.8877300613496932,0.774626095925735,0.7768206734534064,0.7306629834254144
1083,7110,EDN1,131240,612798;615706;,[MIM:615706]Auriculocondylar syndrome 3;,Auriculocondylar syndrome,Disease-causing germline mutation(s) in,Circulating vasoactive peptide levels[23381795];Body mass index[26426971];Oppositional defiant disorder dimensions in attention-deficit hyperactivity disorder[27021288];Multiple system atrophy[27629089];Coronary artery disease[29212778];,0.22687116564417178,0.7055183084063951,0.307752545027408,0.6708103130755064
1084,7112,EDN3,131242,209880;613265;613712;,[MIM:209880]Congenital central hypoventilation syndrome;[MIM:613265]Waardenburg syndrome 4B;,Hirschsprung disease;Waardenburg-Shah syndrome;Ondine syndrome,Major susceptibility factor in;Disease-causing germline mutation(s) in;Candidate gene tested in,Hypertension[21909115;19430479];Systolic blood pressure[21909115;27618452;28739976;27618447];Diastolic blood pressure (cigarette smoking interaction)[29455858];Diastolic blood pressure[21909115;27618452;28739976];Blood pressure[21909110;21909110];Response to diuretic therapy in hypertension[23753411];Systolic blood pressure (cigarette smoking interaction)[29455858];,0.14576687116564419,0.37674058793192367,0.7637692508483425,0.8365561694290976
1085,7113,EDNRA,131243,616367;,,Mandibulofacial dysostosis with alopecia,Disease-causing germline mutation(s) (gain of function) in,"Myocardial infarction[26343387];Plasma clusterin levels[26545630];Lead levels[26025379];Peripheral artery disease[26488411];Plateletcrit[27863252];Coronary artery disease[26343387;29212778;29212778;24262325];Dental caries[23064961];Resting heart rate[27798624];Ischemic stroke (large artery atherosclerosis)[29531354;29531354];Intracranial aneurysm[22286173];Pancreatic cancer[29422604];Carotid intima media thickness[21909108;21909108];Obesity-related traits[23251661];Coronary artery disease or large artery stroke[24262325];Coronary artery disease (myocardial infarction, percutaneous transluminal coronary angioplasty, coronary artery bypass grafting, angina or chromic ischemic heart disease)[28714975];",0.3706748466257669,0.9182568334192883,0.9577133907595928,0.7166973603437692
1086,7114,EDNRB,131244,142623;277580;600155;600501;,[MIM:277580]Waardenburg syndrome 4A;[MIM:600155]Hirschsprung disease 2;[MIM:600501]ABCD syndrome [recessive?];,Waardenburg syndrome type 2;Hirschsprung disease;Waardenburg-Shah syndrome,Disease-causing germline mutation(s) (loss of function) in;Major susceptibility factor in;Disease-causing germline mutation(s) in,Total ventricular volume (Alzheimer's disease interaction)[21116278];Craniofacial microsomia[26853712];Hair color[23548203;29662168];,0.38061349693251534,0.7062919030428055,0.6455233620464631,0.47928176795580113
1087,7121,EED,605984,617561;,[MIM:617561]Cohen-Gibson syndrome [dominant?];,Weaver syndrome,Disease-causing germline mutation(s) in,,0.8377914110429447,0.8437338834450748,0.9256068911511355,0.0
1088,7166,EEF1A2,602959,616393;616409;,"[MIM:616409]Epileptic encephalopathy, early infantile, 33;[MIM:616393]Mental retardation, autosomal dominant 38 [dominant?];",Autosomal dominant non-syndromic intellectual disability;Undetermined early-onset epileptic encephalopathy,Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in,Autism spectrum disorder or schizophrenia[28540026];Prostate cancer[23535732];,0.6641717791411043,0.9432697266632285,0.9921691464369616,0.0
1089,7203,EEF2,130610,609306;,[MIM:609306]Spinocerebellar ataxia 26;,Spinocerebellar ataxia type 26,Disease-causing germline mutation(s) in,,0.9869938650306749,0.6591026302217637,0.9373531714956931,0.7874462860650706
1090,7226,EFEMP1,601548,126600;,,Familial drusen,Disease-causing germline mutation(s) in,Pelvic organ prolapse (moderate/severe)[26545240];Chronic venous disease[28374850];Waist circumference adjusted for BMI (joint analysis main effects and physical activity interaction)[28448500;28448500;28448500;28448500;28448500];Spherical equivalent or myopia (age of diagnosis)[29808027];Optic cup area[28073927;28073927;25631615;25631615];Joint mobility (Beighton score)[27182965];Waist circumference adjusted for BMI in non-smokers[28443625;28443625];Amyotrophic lateral sclerosis[19451621];Waist circumference adjusted for BMI (adjusted for smoking behaviour)[28443625;28443625;28443625];Waist circumference adjusted for body mass index[26785701;26785701;26785701;26785701;28448500;28448500;28448500;28448500;28448500;25673412;25673412];Blood protein levels[30072576];Childhood ear infection[27182965;28928442];Waist circumference adjusted for BMI in smokers[28443625];Diverticular disease[30177863];Lung function (forced vital capacity)[24929828;24929828];Hip circumference adjusted for BMI[25673412;25673412;25673412];Waist circumference adjusted for BMI (joint analysis main effects and smoking interaction)[28443625;28443625;28443625];White matter hyperintensity burden[25663218;25663218];Height[19396169;23563607;19893584;20189936;20397748;20881960;20881960;18391952;18391951;25429064;25282103];White matter hyperintensity volume[29752348];Inguinal hernia[26686553];Waist circumference adjusted for BMI in active individuals[28448500;28448500;28448500;28448500;28448500];Intraocular pressure[29617998;29617998;29235454;30054594;29785010];,0.5760736196319018,0.8022176379577102,0.7713390759592795,0.9597912829957029
1091,7227,EFEMP2,604633,614437;,"[MIM:614437]Cutis laxa, autosomal recessive, 1B [recessive?];",Lethal arteriopathy syndrome due to fibulin-4 deficiency;Autosomal recessive cutis laxa type 1,Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in,Acne (severe)[24927181];,0.5692024539877301,0.5172769468798349,0.7924823805794832,0.7516881522406385
1092,7229,EFHC1,608815,254770;607631;,[MIM:607631]Juvenile absence epilepsy 1;,Juvenile myoclonic epilepsy;Juvenile absence epilepsy,Major susceptibility factor in;Major susceptibility factor in,Atopic march[26542096];Mean platelet volume[27863252];Post bronchodilator FEV1/FVC ratio in COPD[26634245];,0.4431901840490797,0.04177411036616813,0.25084834246932913,0.008440761203192142
1093,7233,EFL1,617538,617941;,,Shwachman-Diamond syndrome,Disease-causing germline mutation(s) in,Intelligence (MTAG)[29326435;29326435;29326435;29326435];Cognitive ability[29186694;29186694];Cognitive ability (MTAG)[29186694];Cognitive decline (age-related)[28078323];General cognitive ability[29844566];Left superior temporal gyrus thickness (schizophrenia interaction)[26249676];,0.4298159509202454,0.0,0.0,0.0
1094,7241,EFNB1,300035,304110;,[MIM:304110]Craniofrontonasal syndrome;,Craniofrontonasal dysplasia,Disease-causing germline mutation(s) in,,0.8787730061349693,0.8643630737493554,0.7428869746802401,0.0
1095,7247,EFTUD2,603892,610536;,[MIM:610536]Mandibulofacial dysostosis with microcephaly;,Mandibulofacial dysostosis-microcephaly syndrome,Disease-causing germline mutation(s) in,Craniofacial microsomia[26853712];,0.9705521472392638,0.8579164517792677,0.8757504567997911,0.9395334561080417
1096,7248,EGF,131530,611718;,[MIM:611718]Hypomagnesemia 4;,Adult hepatocellular carcinoma;Familial primary hypomagnesemia with normocalciuria and normocalcemia,Major susceptibility factor in;Disease-causing germline mutation(s) in,Reticulocyte fraction of red cells[27863252];Mean corpuscular volume[29403010];Reticulocyte count[27863252];Plateletcrit[27863252];Blood protein levels[29875488;30072576];Non-albumin protein levels[29403010];Albumin-globulin ratio[29403010];Hair morphology[19896111];Platelet count[27863252;29403010];,0.4894478527607362,0.05518308406395049,0.23492560689115113,0.8845917740945365
1097,7258,EGFR,131550,211980;616069;,"[MIM:211980]Lung cancer;[MIM:616069]Inflammatory skin and bowel disease, neonatal, 2;",Gliosarcoma;Giant cell glioblastoma;Selection of therapeutic option in non-small cell lung carcinoma;Neonatal inflammatory skin and bowel disease,Part of a fusion gene in;Part of a fusion gene in;Biomarker tested in;Disease-causing germline mutation(s) (loss of function) in,Subjective response to lithium treatment[26503763];Glioma[21531791;21531791;28346443;29743610;29743610;29743610];Glioblastoma (age-stratified)[30152087;30152087;30152087;30152087;30152087;30152087;30152087];Glioblastoma[28346443;28346443;29743610;29743610;29743610];Non-glioblastoma glioma[28346443];,0.9357055214723926,0.6214543579164518,0.6123727486296007,0.8902701043585022
1098,7261,EGLN1,606425,609820;,"[MIM:609820]Erythrocytosis, familial, 3 [dominant?];",Autosomal dominant secondary polycythemia,Disease-causing germline mutation(s) (loss of function) in,Hematocrit[27863252;27863252];High altitude adaptation[28373541];Red blood cell count[27863252;27863252];Hemoglobin concentration[27863252];,0.88,0.9143888602372356,0.25998433829287393,0.0
1099,7269,EGR2,129010,145900;605253;607678;,"[MIM:605253]Neuropathy, congenital hypomyelinating or amyelinating [dominant?];[MIM:607678]Charcot-Marie-Tooth disease 1D;[MIM:145900]Dejerine-Sottas syndrome [dominant?] [recessive?];",Dejerine-Sottas syndrome;Charcot-Marie-Tooth disease type 1D;Charcot-Marie-Tooth disease type 4E,Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in,Ewing sarcoma[22327514];Atopic dermatitis[23042114];Vogt-Koyanagi-Harada syndrome[25108386];Selective IgA deficiency[27723758];Temperament[22832960];Alopecia areata[25608926];,0.30319018404907977,0.7408457968024755,0.8089271730618638,0.6106507059545734
1100,7280,EHHADH,607037,615605;,[MIM:615605]Fanconi renotubular syndrome 3;,Bifunctional enzyme deficiency;Primary Fanconi syndrome,Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in,Cognitive performance[19734545];Major depressive disorder[21042317;27519822];,0.3749693251533742,0.1444043321299639,0.10806577916992952,0.5148864333947207
1101,7282,EHMT1,607001,610253;,[MIM:610253]Kleefstra syndrome 1 [dominant?];,Kleefstra syndrome due to a point mutation;Kleefstra syndrome due to 9q34 microdeletion,Disease-causing germline mutation(s) (loss of function) in;Role in the phenotype of,,0.8739877300613497,0.9761474987106756,0.4074654137300966,0.9493554327808471
1102,7297,EIF1AX,300186,,,Differentiated thyroid carcinoma,Disease-causing somatic mutation(s) in,,0.7202453987730061,0.8656523981433729,0.0,0.0
1103,7314,EIF2AK3,604032,226980;,[MIM:226980]Wolcott-Rallison syndrome [recessive?];,Wolcott-Rallison syndrome,Disease-causing germline mutation(s) in,Progressive supranuclear palsy[21685912];Height[20881960;25429064;25282103];,0.8478527607361963,0.31665807117070655,0.11145914904724614,0.2452424800491099
1104,7316,EIF2AK4,609280,234810;,"[MIM:234810]Pulmonary venoocclusive disease 2, autosomal recessive [recessive?];",Pulmonary capillary hemangiomatosis;Heritable pulmonary arterial hypertension;Pulmonary venoocclusive disease,Disease-causing germline mutation(s) (loss of function) in;Disease-causing germline mutation(s) (loss of function) in;Disease-causing germline mutation(s) (loss of function) in,Body mass index[24827717];Ewing sarcoma[22327514];High light scatter reticulocyte percentage of red cells[27863252];Mean corpuscular hemoglobin[27863252];Reticulocyte fraction of red cells[27863252];Response to haloperidol in psychosis[24751813];Corneal curvature[22969067];Red cell distribution width[27863252];,0.5786503067484663,0.05002578648788035,0.11433046202036022,0.10558624923265807
1105,7321,EIF2B1,606686,603896;,[MIM:603896]Leukodystrophy with vanishing white matter;,Late infantile CACH syndrome;Juvenile or adult CACH syndrome;Congenital or early infantile CACH syndrome;Ovarioleukodystrophy;Cree leukoencephalopathy,Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in,Waist-to-hip ratio adjusted for BMI (age >50)[26426971];Waist-to-hip ratio adjusted for BMI[26426971];Waist-to-hip ratio adjusted for BMI x sex x age interaction (4df test)[26426971];,0.9057668711656441,0.21712222795255287,0.8452101279039416,0.4752915899324739
1106,7322,EIF2B2,606454,603896;,[MIM:603896]Leukodystrophy with vanishing white matter;,Late infantile CACH syndrome;Juvenile or adult CACH syndrome;Congenital or early infantile CACH syndrome;Ovarioleukodystrophy;Cree leukoencephalopathy,Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in,Mood instability[29187730;29187730];,0.7131288343558282,0.39865910263022175,0.7723831897676847,0.5240945365254758
1107,7323,EIF2B3,606273,603896;,[MIM:603896]Leukodystrophy with vanishing white matter;,Late infantile CACH syndrome;Juvenile or adult CACH syndrome;Congenital or early infantile CACH syndrome;Ovarioleukodystrophy;Cree leukoencephalopathy,Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in,,0.8588957055214724,0.6787003610108303,0.7682067345340642,0.7575199508901166
1108,7324,EIF2B4,606687,603896;,[MIM:603896]Leukodystrophy with vanishing white matter;,Late infantile CACH syndrome;Juvenile or adult CACH syndrome;Congenital or early infantile CACH syndrome;Ovarioleukodystrophy;Cree leukoencephalopathy,Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in,,0.8993865030674847,0.9002062919030428,0.7347950926651005,0.9206568446899939
1109,7325,EIF2B5,603945,603896;,[MIM:603896]Leukodystrophy with vanishing white matter;,Late infantile CACH syndrome;Juvenile or adult CACH syndrome;Congenital or early infantile CACH syndrome;Ovarioleukodystrophy;Cree leukoencephalopathy,Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in,Plateletcrit[27863252;27863252;27863252];General cognitive ability[29844566];Major depressive disorder[22472876];Platelet count[27863252;27863252;27863252];Immature fraction of reticulocytes[27863252];,0.8450306748466258,0.5804538421866942,0.07178282432785174,0.9386126457949663
1110,7336,EIF2S3,300161,300148;,,MEHMO syndrome,Disease-causing germline mutation(s) in,Prostate-specific antigen levels[28139693];,0.8795092024539878,0.8047962867457452,0.3675280605586009,0.7638121546961326
1111,7387,EIF4A3,608546,268305;,,Richieri Costa-Pereira syndrome,Disease-causing germline mutation(s) (loss of function) in,Myocardial infarction[26708285];High light scatter reticulocyte percentage of red cells[27863252];Reticulocyte fraction of red cells[27863252];Reticulocyte count[27863252];High light scatter reticulocyte count[27863252];Immature fraction of reticulocytes[27863252];,0.9754601226993865,0.8705518308406395,0.9417906551814148,0.0
1112,7419,EIF4G1,600495,614251;,[MIM:614251]Parkinson disease 18 [dominant?];,Hereditary late-onset Parkinson disease,Candidate gene tested in,Menarche (age at onset)[25231870];,0.9312883435582822,0.8695203713254255,0.42391020621247716,0.7360343769183548
1113,7441,ELAC2,605367,176807;614731;615440;,[MIM:615440]Combined oxidative phosphorylation deficiency 17 [recessive?];,Familial prostate cancer;Combined oxidative phosphorylation defect type 17,Major susceptibility factor in;Disease-causing germline mutation(s) in,Squamous cell lung carcinoma[28604730];,0.9158282208588957,0.3739040742650851,0.22474549725920126,0.06123388581952118
1114,7442,ELANE,130130,162800;202700;,"[MIM:202700]Neutropenia, severe congenital 1, autosomal dominant [dominant?];",Autosomal dominant severe congenital neutropenia;Cyclic neutropenia,Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in,Blood protein levels[30072576];,0.4710429447852761,0.3561113976276431,0.7133907595927956,0.9640883977900553
1115,7456,ELF4,300775,,,Short stature due to isolated growth hormone deficiency with X-linked hypogammaglobulinemia,Disease-causing germline mutation(s) in,,0.26588957055214724,0.6039195461578133,0.7653354215609501,0.48066298342541436
1116,7476,ELMO2,606421,606893;,,Primary intraosseous venous malformation;Ramon syndrome,Disease-causing germline mutation(s) (loss of function) in;Disease-causing germline mutation(s) in,,0.2947239263803681,0.2632800412583806,0.5990602975724354,0.2019643953345611
1117,7481,ELMOD3,615427,615429;,,Autosomal recessive non-syndromic sensorineural deafness type DFNB,Disease-causing germline mutation(s) in,,0.12711656441717792,0.20293965961835997,0.31714956930305405,0.0019950890116635974
1118,7483,ELN,130160,123700;185500;,"[MIM:123700]Cutis laxa, autosomal dominant, 1 [dominant?];[MIM:185500]Supravalvular aortic stenosis [dominant?];",Williams syndrome;Supravalvular aortic stenosis;Autosomal dominant cutis laxa;Familial thoracic aortic aneurysm and aortic dissection,Role in the phenotype of;Disease-causing germline mutation(s) (loss of function) in;Disease-causing germline mutation(s) in;Candidate gene tested in,Diverticular disease[30177863];,0.38061349693251534,0.0593089221248066,0.28191072826938135,0.14303253529772866
1119,7536,ELOVL4,605512,133190;600110;614457;,"[MIM:600110]Stargardt disease 3;[MIM:614457]Ichthyosis, spastic quadriplegia, and mental retardation [recessive?];[MIM:133190]Spinocerebellar ataxia 34 [dominant?];",Stargardt disease;Spinocerebellar ataxia type 34;Congenital ichthyosis-intellectual disability-spastic quadriplegia syndrome,Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in,Body mass index[23669352];Partial epilepsies[20522523];Aging[22773346];Chronic obstructive pulmonary disease[28166215];Daytime sleep phenotypes[27126917;27126917];,0.14576687116564419,0.8344507478081485,0.26442182197859565,0.32443216697360344
1120,7537,ELOVL5,611805,615957;,,Spinocerebellar ataxia type 38,Disease-causing germline mutation(s) in,Glaucoma[20363506];Survival in colorectal cancer (distant metastatic)[26586795;26586795];Familial squamous cell lung carcinoma[29924316];Daytime sleep phenotypes[27126917];Cerebrospinal fluid AB1-42 levels[26252872];,0.4463803680981595,0.9319236719958741,0.8478204124249543,0.5931553100061387
1121,7540,ELP1,603722,223900;,"[MIM:223900]Neuropathy, hereditary sensory and autonomic, 3;",Familial dysautonomia,Disease-causing germline mutation(s) in,Tenofovir clearance in HIV infection[26148204];,0.9224539877300614,0.08432181536874678,0.0,0.0
1122,7549,EMC1,616846,616875;,"[MIM:616875]Cerebellar atrophy, visual impairment, and psychomotor retardation [recessive?];",Global developmental delay-visual anomalies-progressive cerebellar atrophy-truncal hypotonia syndrome,Disease-causing germline mutation(s) in,Brain structure[20171287];,0.9860122699386503,0.16451779267663744,0.20229705037849124,0.0
1123,7561,EMD,300384,310300;,"[MIM:310300]Emery-Dreifuss muscular dystrophy 1, X-linked;",X-linked Emery-Dreifuss muscular dystrophy,Disease-causing germline mutation(s) in,,1.0,0.8780299123259412,0.8799269120334117,0.0
1124,7564,EMG1,611531,211180;,[MIM:211180]Bowen-Conradi syndrome [recessive?];,Bowen-Conradi syndrome,Disease-causing germline mutation(s) in,,0.9187730061349694,0.24290871583290355,0.59592795614722,0.0
1125,7566,EMILIN1,130660,,,EMILIN-1-related connective tissue disease,Disease-causing germline mutation(s) in,,0.4710429447852761,0.4695719443011862,0.4748107543722266,0.0
1126,7569,EML1,602033,600348;,[MIM:600348]Band heterotopia;,Subcortical band heterotopia,Disease-causing germline mutation(s) in,Scalp hair shape[26926045];Depression in smokers[30219690];Coronary artery disease[29212778];,0.621717791411043,0.5469314079422383,0.16105455494648915,0.427255985267035
1127,7573,EML4,607442,,,Selection of therapeutic option in non-small cell lung carcinoma,Biomarker tested in,Lung function (FEV1)[30061609;30061609];,0.845398773006135,0.79706034038164,0.13912816496998173,0.17971147943523635
1128,7577,EMP2,602334,615861;,[MIM:615861]Nephrotic syndrome 10;,Familial idiopathic steroid-resistant nephrotic syndrome with minimal changes;Idiopathic steroid-sensitive nephrotic syndrome with minimal change;Idiopathic steroid-sensitive nephrotic syndrome with diffuse mesangial proliferation;Idiopathic steroid-sensitive nephrotic syndrome with focal segmental hyalinosis,Disease-causing germline mutation(s) (loss of function) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in,Metabolite levels (MHPG)[23319000];Attention deficit hyperactivity disorder[20732626];Eating disorders[23568457];,0.7484662576687117,0.17612171222279527,0.9496215087444532,0.5405156537753223
1129,7582,EMX2,600035,269160;,,Acquired schizencephaly,Major susceptibility factor in,Neuroticism[29255261];Double-edged eyelids[29895819;29895819];Low tan response[29739929];Photic sneeze reflex[27182965];Airflow obstruction[22837378];Cardiac repolarization[22683750];Celiac disease[23936387];Serum uric acid levels[29403010];Homeostasis model assessment of beta-cell function (dietary factor interaction)[24204828];Obesity-related traits[23251661];Pulmonary function in asthmatics[23541324];Ovarian disease with few adhesions[28333195];Response to quetiapine in schizophrenia[29503163];,0.16220858895705523,0.8958225889633832,0.9065518141477421,0.0
1130,7587,ENAM,606585,104500;204650;,[MIM:104500]Amelogenesis imperfecta 1B [dominant?];[MIM:204650]Amelogenesis imperfecta 1C [recessive?];,Hypoplastic amelogenesis imperfecta,Disease-causing germline mutation(s) in,,0.10711656441717791,0.08019597730789066,0.22448446880709996,0.16206261510128914
1131,7593,ENG,131195,187300;,"[MIM:187300]Telangiectasia, hereditary hemorrhagic, 1;",Hereditary hemorrhagic telangiectasia;Heritable pulmonary arterial hypertension;Familial cerebral saccular aneurysm;Generalized juvenile polyposis/juvenile polyposis coli,Disease-causing germline mutation(s) in;Candidate gene tested in;Major susceptibility factor in;Candidate gene tested in,Body mass index[26426971];Blood protein levels[30072576];Metabolic syndrome[20694148];,0.58,0.9574522949974213,0.4581049334377447,0.919889502762431
1132,7606,ENO3,131370,612932;,[MIM:612932]Glycogen storage disease 13;,Glycogen storage disease due to muscle beta-enolase deficiency,Disease-causing germline mutation(s) in,,0.45950920245398774,0.1441464672511604,0.09814669799008092,0.38152240638428486
1133,7615,ENPP1,173335,125853;208000;602475;613312;615522;,"[MIM:602475]Ossification of the posterior longitudinal ligament of the spine;[MIM:208000]Arterial calcification of infancy, generalized, 1 [recessive?];[MIM:125853]Diabetes mellitus, non-insulin-dependent;[MIM:613312]Hypophosphatemic rickets, autosomal recessive, 2 [recessive?];[MIM:615522]Cole disease [dominant?];",Pseudoxanthoma elasticum;Hypopigmentation-punctate palmoplantar keratoderma syndrome;Autosomal recessive hypophosphatemic rickets;Generalized arterial calcification of infancy,Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) (loss of function) in,Obesity-related traits[23251661];,0.4917791411042945,0.15085095410005156,0.15896632732967894,0.1663597298956415
1134,7641,ENTPD1,601752,615683;,"[MIM:615683]Spastic paraplegia 64, autosomal recessive [recessive?];",Autosomal recessive spastic paraplegia type 64,Disease-causing germline mutation(s) in,Blood protein levels[29875488;30072576];,0.08736196319018405,0.38653945332645695,0.7160010441138084,0.3064763658686311
1135,7655,EOGT,614789,615297;,[MIM:615297]Adams-Oliver syndrome 4;,Adams-Oliver syndrome,Disease-causing germline mutation(s) in,,0.4463803680981595,0.16606498194945848,0.40381101540067865,0.0
1136,7656,EOMES,604615,,,Microcephaly-polymicrogyria-corpus callosum agenesis syndrome,Disease-causing germline mutation(s) in,"Systolic blood pressure[29403010];Multiple sclerosis[22190364;21833088;24076602];Chronic lymphocytic leukemia[26956414;28165464];Rheumatoid arthritis (ACPA-positive)[24532676];Systemic lupus erythematosus[27399966];Epstein Barr virus nuclear antigen 1 IgG levels or multiple sclerosis[26819262];Rheumatoid arthritis[24390342;24390342];Pulse pressure[29403010];B-cell malignancies (chronic lymphocytic leukemia, Hodgkin lymphoma or multiple myeloma) (pleiotropy)[28112199];Mean arterial pressure[29403010];Ankylosing spondylitis[23749187;23749187];Hodgkin's lymphoma[24149102];",0.12711656441717792,0.9030428055698814,0.5732184808144087,0.0
1137,7657,EP300,602700,613684;,[MIM:613684]Rubinstein-Taybi syndrome 2;,Rubinstein-Taybi syndrome due to EP300 haploinsufficiency,Disease-causing germline mutation(s) (loss of function) in,Neuroticism[29255261];Autism spectrum disorder or schizophrenia[28540026];Schizophrenia[25056061;28991256];Crohn's disease[22936669];,0.8404907975460123,1.0,0.24458365961889847,0.998158379373849
1138,7661,EPAS1,603349,611783;,"[MIM:611783]Erythrocytosis, familial, 4 [dominant?];",Autosomal dominant secondary polycythemia;Sporadic pheochromocytoma;Sporadic secreting paraganglioma;Multiple paragangliomas associated with polycythemia,Disease-causing germline mutation(s) (gain of function) in;Disease-causing somatic mutation(s) in;Disease-causing somatic mutation(s) in;Disease-causing somatic mutation(s) in,Peak velocity of the mitral A-wave[28394258];Cerebral amyloid deposition in APOEe4 non-carriers (PET imaging)[26252872];P wave duration[28794112;28794112];Renal cell carcinoma[21131975;25826619];Craniofacial microsomia[26853712];Diisocyanate-induced asthma[25918132];High altitude adaptation[28373541];Birth weight[27680694];Facial morphology[29921221;29921221];,0.5682208588957055,0.609850438370294,0.3850169668493866,0.8448434622467772
1139,7662,EPB41,130500,611804;,[MIM:611804]Elliptocytosis 1 [dominant?];,Hereditary elliptocytosis,Disease-causing germline mutation(s) in,Amyotrophic lateral sclerosis (sporadic)[24529757];,0.7456441717791411,0.4381124290871583,0.4818585225789611,0.9089932473910375
1140,7663,EPB41L1,602879,614257;,,Autosomal dominant non-syndromic intellectual disability,Disease-causing germline mutation(s) in,Hip circumference[25673412;25673412];Height[23563607];,0.8883435582822086,0.4809179989685405,0.5672148264160793,0.8914978514426029
1141,7671,EPB42,177070,612690;,[MIM:612690]Spherocytosis 5;,Hereditary spherocytosis,Disease-causing germline mutation(s) in,,0.27975460122699386,0.388086642599278,0.5695640824849909,0.5415899324739104
1142,7674,EPCAM,185535,613217;613244;,"[MIM:613217]Diarrhea 5, with tufting enteropathy, congenital;[MIM:613244]Hereditary non-polyposis colorectal cancer 8 [dominant?];",Lynch syndrome;Congenital tufting enteropathy,Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in,,0.7494478527607362,0.35662712738525015,0.11380840511615765,0.20395948434622468
1143,7677,EPG5,615068,242840;,[MIM:242840]Vici syndrome;,Vici syndrome,Disease-causing germline mutation(s) (loss of function) in,,0.038773006134969326,0.2215059308922125,0.0323675280605586,0.0
1144,7681,EPHA2,176946,116600;,"[MIM:116600]Cataract 6, multiple types;",Early-onset posterior subcapsular cataract;Early-onset nuclear cataract;Total early-onset cataract;Early-onset posterior polar cataract,Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in,Liver enzyme levels (gamma-glutamyl transferase)[22001757];Blood protein levels[30072576];Gamma glutamyl transferase levels[29403010];,0.9523926380368098,0.23156266116554924,0.4092926128948055,0.38321055862492326
1145,7683,EPHA4,602188,,,Amyotrophic lateral sclerosis,Candidate gene tested in,Urate levels in lean individuals[25811787];Brain imaging[20100581];Nose size[27182965];Adolescent idiopathic scoliosis[26394188];Diisocyanate-induced asthma[25918132];Immune response to measles-mumps-rubella vaccine[24811271];Paclitaxel-induced neuropathy[23776197];Hair color[29662168];,0.765521472392638,0.8940175348117586,0.7157400156617071,0.7622774708410067
1146,7691,EPHB2,600997,176807;603688;,,Familial prostate cancer,Major susceptibility factor in,Blood protein levels[28240269;29875488;29875488;29875488;30072576;30072576;30072576];,0.4463803680981595,0.9381124290871583,0.5358914121639259,0.7728667894413751
1147,7693,EPHB4,600011,617300;,"[MIM:617300]Hydrops fetalis, non-immune, and/or atrial septal defect [dominant?];",Vein of Galen aneurysmal malformation,Disease-causing germline mutation(s) (loss of function) in,Resting heart rate[27798624];Mean corpuscular volume[27863252];Mean corpuscular hemoglobin[27863252];Plasminogen activator inhibitor type 1 levels (PAI-1)[22990020];,0.7328834355828221,0.41722537390407427,0.5447663795353693,0.5650705954573357
1148,7695,EPHX1,132810,607748;,[MIM:607748]Familial hypercholanemia;,Familial hypercholanemia,Disease-causing germline mutation(s) in,Response to cyclophosphamide in systemic lupus erythematosus with lupus nephritis[26980576];,0.3749693251533742,0.43965961835997935,0.04411380840511616,0.12231430325352978
1149,7699,EPM2A,607566,,,Lafora disease,Disease-causing germline mutation(s) (loss of function) in,Mean platelet volume[27863252];Methadone dose in opioid dependence[28115739];Response to mepolizumab in severe asthma[29229094];Loneliness (multivariate analysis)[27629369];,0.743680981595092,0.36152656008251677,0.6121117201774994,0.0
1150,7706,EPO,133170,612623;617907;617911;,"[MIM:617907]Erythrocytosis, familial, 5 [dominant?];[MIM:617911]Diamond-Blackfan anemia-like [recessive?];",Autosomal dominant secondary polycythemia,Disease-causing germline mutation(s) (gain of function) in,Inflammatory bowel disease[23128233];Other erythrocyte phenotypes[19862010];Hematocrit[27863252;27863252];Red blood cell count[27863252];Blood protein levels[30072576];Pursuit maintenance gain in psychotic disorders[29064472];Hemoglobin concentration[27863252];,0.3168098159509202,0.44894275399690564,0.7911772383189768,0.48649478207489255
1151,7708,EPOR,133171,133100;,"[MIM:133100]Erythrocytosis, familial, 1 [dominant?];",Primary familial polycythemia,Disease-causing germline mutation(s) in,Serum erythropoietin levels[30271932];Coronary artery disease[29212778];,0.4710429447852761,0.32955131511088187,0.4398329417906552,0.6057397176181707
1152,7712,EPRS,138295,617951;,"[MIM:617951]Leukodystrophy, hypomyelinating, 15 [recessive?];",Diffuse cerebral and cerebellar atrophy-intractable seizures-progressive microcephaly syndrome;Microcephaly-short stature-intellectual disability-facial dysmorphism syndrome,Disease-causing germline mutation(s) (loss of function) in;Disease-causing germline mutation(s) in,Waist-to-hip ratio adjusted for BMI (age >50)[26426971];Waist-to-hip ratio adjusted for BMI (age <50)[26426971];High light scatter reticulocyte percentage of red cells[27863252];High light scatter reticulocyte count[27863252];Waist-to-hip ratio adjusted for BMI[26426971];Waist-to-hip ratio adjusted for BMI x sex x age interaction (4df test)[26426971];Immature fraction of reticulocytes[27863252];,0.9808588957055214,0.2080969571944301,0.28478204124249545,0.16958256599140578
1153,7713,EPS8,600206,615974;,"[MIM:615974]Deafness, autosomal recessive, 102 [recessive?];",Autosomal recessive non-syndromic sensorineural deafness type DFNB,Disease-causing germline mutation(s) (loss of function) in,Protein quantitative trait loci[18464913];,0.5519018404907975,0.7173800928313564,0.45888801879404856,0.0
1154,7715,EPS8L2,614988,617637;,,Autosomal recessive non-syndromic sensorineural deafness type DFNB,Disease-causing germline mutation(s) in,,0.7520245398773007,0.7952552862300155,0.4531453928478204,0.28084714548802947
1155,7716,EPS8L3,614989,,,Marie Unna hereditary hypotrichosis,Disease-causing germline mutation(s) in,"Fibrinogen levels (smoking status, alcohol consumption or body mass index interaction)[25551457];",0.16220858895705523,0.06369262506446621,0.021143304620203602,0.048496009821976674
1156,7718,EPS15L1,616826,,,Isolated split hand-split foot malformation,Disease-causing germline mutation(s) (loss of function) in,Multiple sclerosis[22190364;24076602];Eosinophil percentage of granulocytes[27863252];Lymphocyte percentage of white cells[27863252];White blood cell count[21738480;27863252];Lymphocyte counts[29403010;27863252;27863252];Neutrophil percentage of white cells[27863252];Monocyte percentage of white cells[27863252];White matter integrity[23218918];Neutrophil percentage of granulocytes[27863252];,0.8365644171779141,0.6418256833419288,0.6972069955625163,0.5713627992633518
1157,7721,EPX,131399,261500;,[MIM:261500]Eosinophil peroxidase deficiency;,Autosomal dominant secondary polycythemia,Disease-causing germline mutation(s) (gain of function) in,Inflammatory bowel disease[23128233];Other erythrocyte phenotypes[19862010];Hematocrit[27863252;27863252];Red blood cell count[27863252];Blood protein levels[30072576];Pursuit maintenance gain in psychotic disorders[29064472];Hemoglobin concentration[27863252];,0.14576687116564419,0.027333677153171736,0.08352910467240929,0.10972989564149785
1158,7724,ERAL1,607435,617565;,[MIM:617565]Perrault syndrome 6 [recessive?];,Perrault syndrome,Disease-causing germline mutation(s) in,Mean corpuscular hemoglobin[28017375];High light scatter reticulocyte percentage of red cells[27863252];Mean corpuscular volume[29403010];Glycated hemoglobin levels[28898252];High light scatter reticulocyte count[27863252];Immature fraction of reticulocytes[27863252];,0.952638036809816,0.38757091284167094,0.7222657269642391,0.5423572744014733
1159,7725,ERAP1,606832,,,Beh�et disease,Major susceptibility factor in,"Psoriasis[20953190;25574825;23143594;23143594];Colorectal cancer[25990418];Chronic inflammatory diseases (ankylosing spondylitis, Crohn's disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy)[26974007];Birdshot chorioretinopathy[24957906];Alcohol dependence[19581569];Behcet's disease[23291587;23291587];Blood protein levels[28240269;28240269;29875488;30072576];Inflammatory skin disease[25574825];Urate levels (BMI interaction)[25811787];Inflammatory bowel disease[23128233];Body mass index[26426971];Psoriasis vulgaris[26626624];Ankylosing spondylitis[21743469;20062062;23749187;23749187;23749187;23749187];Hodgkin's lymphoma[22286212];",0.33975460122699386,0.18050541516245489,0.028713129731140694,0.0019950890116635974
1160,7729,ERBB3,190151,607598;,[MIM:607598]Lethal congenital contracture syndrome 2 [recessive?];,Lethal congenital contracture syndrome type 2,Disease-causing germline mutation(s) (loss of function) in,Polycystic ovary syndrome[26416764];Vitiligo[22951725];Type 1 diabetes[18198356;17554300;17554260;18978792;19430480;21829393];Anorexia nervosa[28494655];Obesity-related traits[23251661];Hypothyroidism[27182965];Cognitive function[25644384];Alopecia areata[25608926];,0.6750920245398773,0.3715832903558535,0.3197598538240668,0.5285451197053407
1161,7730,ERBB4,600543,615515;,[MIM:615515]Amyotrophic lateral sclerosis 19;,Amyotrophic lateral sclerosis,Disease-causing germline mutation(s) in,Polycystic ovary syndrome[26416764];Body mass index (change over time)[25133637];Body mass index (joint analysis main effects and smoking interaction)[28443625;28443625];Atrial fibrillation[30061737;29892015];Amyotrophic lateral sclerosis (sporadic)[24529757];Coronary artery calcification[23870195];Breast cancer[22452962];Sperm motility[29453196];Glomerular filtration rate[29403010];BMI in non-smokers[28443625;28443625];Body mass index[25673413;25673413;25673413;28892062];Intelligence (MTAG)[29326435];Skin aging (microtopography measurement)[28502801];Personality dimensions[23903073];Asthma (sex interaction)[24824216];QT interval (ambient particulate matter interaction)[28749367];Type 1 diabetes nephropathy[23028342];BMI (adjusted for smoking behaviour)[28443625;28443625];,0.5997546012269939,0.9535843218153688,0.6502218741842861,0.7166973603437692
1162,7732,ERC1,607127,,,Differentiated thyroid carcinoma;Distal monosomy 12p,Part of a fusion gene in;Role in the phenotype of,Body mass index[26426971];Forehead morphology[29921221];Bone mineral density[22504420];Height[29782485];,0.9177914110429448,0.33986591026302215,0.16758026624902114,0.5174953959484346
1163,7733,ERC2,617250,,,Peeling skin-leukonychia-acral punctate keratoses-cheilitis-knuckle pads syndrome,Disease-causing germline mutation(s) (loss of function) in,Sense of smell[26632684];Heel bone mineral density[28869591;28869591;28869591;28869591;28869591;28869591];Hip geometry[17903296];Morning vs. evening chronotype[27494321;26955885];Alcohol dependence[24166409];Bipolar disorder and schizophrenia[21057379];Chronotype[26955885];Post bronchodilator FEV1/FVC ratio[26634245];Daytime sleep phenotypes[27126917];Night sleep phenotypes[27126917];Acute lymphoblastic leukemia (childhood)[22076464];Periodontitis (Mean PAL)[24024966];,0.5997546012269939,0.9468798349664775,0.3268076220308014,0.19659300184162062
1164,7735,ERCC1,126380,610758;,[MIM:610758]Cerebro-oculo-facio-skeletal syndrome 4;,COFS syndrome;Cockayne syndrome type 2,Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in,Body mass index x age interaction[26426971];Body mass index[26426971];Body mass index x sex x age interaction (4df test)[26426971];Body mass index (age>50)[26426971];,0.6357055214723927,0.444559051057246,0.86530931871574,0.10972989564149785
1165,7736,ERCC2,126340,278730;601675;610756;,"[MIM:278730]Xeroderma pigmentosum complementation group D [recessive?];[MIM:601675]Trichothiodystrophy 1, photosensitive [recessive?];[MIM:610756]Cerebro-oculo-facio-skeletal syndrome 2;",COFS syndrome;Xeroderma pigmentosum;Xeroderma pigmentosum-Cockayne syndrome complex;Trichothiodystrophy,Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in,Lung Cancer (DNA repair capacity)[23108145];,0.8369325153374233,0.4082001031459515,0.07648133646567476,0.43646408839779005
1166,7737,ERCC3,133510,610651;616390;,"[MIM:610651]Xeroderma pigmentosum complementation group B [recessive?];[MIM:616390]Trichothiodystrophy 2, photosensitive [recessive?];",Xeroderma pigmentosum;Xeroderma pigmentosum-Cockayne syndrome complex;Trichothiodystrophy,Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in,,0.7626993865030675,0.08638473439917484,0.669799008091882,0.1230816451810927
1167,7738,ERCC4,133520,278760;610965;615272;,[MIM:278760]Xeroderma pigmentosum complementation group F [recessive?];[MIM:610965]XFE progeroid syndrome;[MIM:278760]Xeroderma pigmentosum type F/Cockayne syndrome;[MIM:615272]Fanconi anemia complementation group Q;,Fanconi anemia;Xeroderma pigmentosum;Xeroderma pigmentosum-Cockayne syndrome complex;Cockayne syndrome type 1,Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in,Bone mineral density (total hip)[29883787];Emphysema imaging phenotypes[26030696];Bipolar disorder lithium response (categorical) or schizophrenia[29121268];Schizophrenia[25056061;28991256];Night sleep phenotypes[27126917;27126917];Bilirubin levels[22085899];Metabolic syndrome[20694148];Egg allergy[25710614];Asthma (childhood onset)[27611488];Conduct disorder (symptom count)[20585324];Asthma[27611488];,0.7406134969325153,0.15832903558535327,0.3589141216392587,0.09668508287292818
1168,7739,ERCC5,133530,278780;616570;,[MIM:278780]Xeroderma pigmentosum complementation group G [recessive?];[MIM:616570]Cerebro-oculo-facio-skeletal syndrome 3;,COFS syndrome;Xeroderma pigmentosum;Xeroderma pigmentosum-Cockayne syndrome complex,Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in,,0.607239263803681,0.3367715317173801,0.13677890890107022,0.08241252302025782
1169,7740,ERCC6,609413,133540;214150;278800;600630;613761;,"[MIM:133540]Cockayne syndrome B;[MIM:214150]Cerebro-oculo-facio-skeletal syndrome 1;[MIM:278800]De Sanctis-Cacchione syndrome [recessive?];[MIM:613761]Macular degeneration, age-related, 5;[MIM:600630]UV-sensitive syndrome 1 [recessive?];",UV-sensitive syndrome;COFS syndrome;Cockayne syndrome type 2;Cockayne syndrome type 1;Cockayne syndrome type 3,Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) (loss of function) in;Disease-causing germline mutation(s) (loss of function) in;Disease-causing germline mutation(s) (loss of function) in,Pulse pressure x alcohol consumption interaction (2df test)[29912962];,0.7482208588957056,0.0776173285198556,0.0822239624119029,0.8509821976672806
1170,7742,ERCC6L2,615667,615715;,[MIM:615715]Bone marrow failure syndrome 2 [recessive?];,Pancytopenia-developmental delay syndrome,Disease-causing germline mutation(s) (loss of function) in,Monobrow[27182965];Parkinson's disease (pesticide exposure interaction)[27545685];,0.49828220858895705,0.21376998452810728,0.06995562516314278,0.0
1171,7743,ERCC8,609412,216400;614621;,[MIM:216400]Cockayne syndrome A;[MIM:614621]UV-sensitive syndrome 2 [recessive?];,UV-sensitive syndrome;Cockayne syndrome type 2;Cockayne syndrome type 1;Cockayne syndrome type 3,Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in,Autism spectrum disorder or schizophrenia[28540026;28540026;28540026];,0.5997546012269939,0.0966993295513151,0.22944400939702428,0.2678023327194598
1172,7747,ERF,611888,600775;617180;,[MIM:600775]Craniosynostosis 4;[MIM:617180]Chitayat syndrome [dominant?];,Crouzon disease;Isolated cloverleaf skull syndrome;Familial lambdoid synostosis;Isolated scaphocephaly,Disease-causing germline mutation(s) (loss of function) in;Disease-causing germline mutation(s) (loss of function) in;Disease-causing germline mutation(s) (loss of function) in;Disease-causing germline mutation(s) (loss of function) in,Monocyte count[27863252];,0.6312883435582822,0.7661165549252192,0.7867397546332551,0.9449048496009822
1173,7749,ERG,165080,612219;,[MIM:612219]Ewing sarcoma;,Ewing sarcoma;Extraskeletal Ewing sarcoma,Part of a fusion gene in;Part of a fusion gene in,Multiple sclerosis[27386562];Granulocyte percentage of myeloid white cells[27863252];Mean corpuscular hemoglobin[27863252];Mean corpuscular volume[27863252];Neonatal lupus[20662065];White blood cell count (basophil)[29403010];Amyotrophic lateral sclerosis (sporadic)[24529757];Abdominal aortic aneurysm[27899403];Heel bone mineral density[28869591;28869591;28869591];Plateletcrit[27863252];Response to cognitive-behavioural therapy in anxiety disorder[26989097];Monocyte percentage of white cells[27863252];General cognitive ability[25383866];Non-response to antidepressants and depression[27622933];Sum eosinophil basophil counts[27863252];Iron status biomarkers (iron levels)[28334935];White blood cell types[21738478];Metabolite levels (HVA)[23319000];Platelet count[27863252];,0.5829447852760736,0.8233625580195977,0.8640041764552336,0.8365561694290976
1174,7751,ERGIC1,617946,208100;,"[MIM:208100]Arthrogryposis multiplex congenita, neurogenic type [recessive?];",Neurogenic arthrogryposis multiplex congenita,Disease-causing germline mutation(s) in,Inflammatory bowel disease[28067908];Periodontitis (CDC/AAP)[24024966];Adverse response to chemotherapy (neutropenia/leucopenia) (paclitaxel)[23648065];,0.6208588957055214,0.5154718927282104,0.8585225789611067,0.4909453652547575
1175,7773,ERLIN1,611604,615681;,,Autosomal recessive spastic paraplegia type 62,Disease-causing germline mutation(s) in,Squamous cell lung carcinoma[28604730];Liver enzyme levels[18940312];Response to radiotherapy in cancer (late toxicity)[24785509];Thiazide-induced adverse metabolic effects in hypertensive patients[23400010];General cognitive ability[29844566];,0.9469938650306748,0.6062403300670449,0.20856173322892196,0.3462246777163904
1176,7774,ERLIN2,611605,611225;,,Juvenile primary lateral sclerosis;Recessive intellectual disability-motor dysfunction-multiple joint contractures syndrome;Autosomal recessive spastic paraplegia type 18,Disease-causing germline mutation(s) (loss of function) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in,Axial length[24144296];,0.9825766871165644,0.49355337802991234,0.9323936309057688,0.5888581952117864
1177,7777,ERMARD,615532,615544;,[MIM:615544]Periventricular nodular heterotopia 6;,6q terminal deletion syndrome;Periventricular nodular heterotopia,Role in the phenotype of;Disease-causing germline mutation(s) in,,0.038773006134969326,0.5636926250644663,0.31219002871312973,0.0
1178,7909,ESCO2,609353,268300;269000;,[MIM:268300]Roberts syndrome [recessive?];[MIM:269000]SC phocomelia syndrome;,Roberts syndrome,Disease-causing germline mutation(s) in,,0.6678527607361964,0.5850954100051573,0.36961628817541115,0.28161448741559236
1179,7914,ESPN,606351,609006;,"[MIM:609006]Deafness, autosomal recessive, 36, with or without vestibular involvement [recessive?];",Autosomal recessive non-syndromic sensorineural deafness type DFNB,Disease-causing germline mutation(s) in,Male-pattern baldness[29146897];,0.10711656441717791,0.6493037648272305,0.20595144870790916,0.0
1180,7917,ESR1,133430,615363;,[MIM:615363]Estrogen resistance;,Estrogen resistance syndrome,Disease-causing germline mutation(s) (loss of function) in,"Resistance to Mycobacterium tuberculosis in HIV-positive individuals measured by a negative tuberculin skin test (dichotomous)[28628665];Bone ultrasound measurement (velocity of sound)[28472463;28472463];Breast size[22747683;27182965];Alcohol dependence[19581569];Menarche (age at onset)[25231870];Developmental language disorder[27016271];Bone ultrasound measurement (broadband ultrasound attenuation)[28472463;28472463];Bone properties (heel)[24430505;24430505;24430505;24430505];Bone mineral density (spine)[18445777;18445777;18445777;19079262;19801982;26911590;27424934;27424934;30172743];Western dietary pattern[28644415];Pulse pressure[28135244];Height[23563607;20881960;25282103];Obesity-related traits[23251661];Age at first birth[27798627;27798627];Sudden cardiac arrest[21658281];Bone mineral density (hip)[18445777;18445777;19079262;19801982];Breast Cancer in BRCA1 mutation carriers[29058716];Heel bone mineral density[28869591;28869591;28869591;28869591;28869591;28869591;30048462;30048462];Endometriosis[28537267];Breast cancer[21263130;22383897;23535733;19219042;20453838;27117709;27117709;25327703;23535729;29059683;29059683;29059683];Chronic myeloid leukemia[21540461];Breast cancer (estrogen-receptor negative)[27117709;27117709;29058716;29058716];Smoking status (current vs former)[27393504];Mammographic density (dense area)[25342443];Fractures[30158200];Breast cancer (estrogen-receptor negative, progesterone-receptor negative, and human epidermal growth factor-receptor negative)[24325915];Bone mineral density (Ward's triangle area)[27397699];Bone mineral density[23437003];Birth weight[27680694];",0.8631901840490798,0.9414646725116039,0.5750456799791177,0.988950276243094
1181,7918,ESR2,601663,,,Familial medullary thyroid carcinoma,Disease-causing germline mutation(s) (loss of function) in,Atrial fibrillation[30061737];Hematocrit[27863252];Depression[29700475];Red blood cell count[27863252];Prostate cancer[26443449];Hemoglobin concentration[27863252];,0.7267484662576688,0.18720990201134605,0.6510049595405899,0.8987108655616943
1182,7925,ESRRB,602167,608565;,"[MIM:608565]Deafness, autosomal recessive, 35 [recessive?];",Autosomal recessive non-syndromic sensorineural deafness type DFNB,Disease-causing germline mutation(s) in,Maximal oxygen uptake response[25729143];,0.5191411042944786,0.9045899948427024,0.3249804228660924,0.6594536525475752
1183,7936,ETF1,600285,,,Crouzon disease;Isolated cloverleaf skull syndrome;Familial lambdoid synostosis;Isolated scaphocephaly,Disease-causing germline mutation(s) (loss of function) in;Disease-causing germline mutation(s) (loss of function) in;Disease-causing germline mutation(s) (loss of function) in;Disease-causing germline mutation(s) (loss of function) in,Autism spectrum disorder or schizophrenia[28540026];Schizophrenia[25056061;28991256];,0.8851533742331288,0.8145951521402784,0.9945184025058731,0.0
1184,7940,ETFA,608053,231680;,[MIM:231680]Glutaric aciduria 2A [recessive?];,"Multiple acyl-CoA dehydrogenase deficiency, mild type;Multiple acyl-CoA dehydrogenase deficiency, severe neonatal type",Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in,Diverticular disease[30177863;30177863];Response to tocilizumab in rheumatoid arthritis[22491018];Glioma[28346443];Non-glioblastoma glioma[26424050;28346443];,0.994601226993865,0.6797318205260443,0.4163403811015401,0.5972989564149785
1185,7941,ETFB,130410,231680;,[MIM:231680]Glutaric aciduria 2B [recessive?];,"Multiple acyl-CoA dehydrogenase deficiency, mild type;Multiple acyl-CoA dehydrogenase deficiency, severe neonatal type",Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in,,0.9325153374233128,0.3847343991748324,0.05220569042025581,0.7575199508901166
1186,7943,ETFDH,231675,231680;,[MIM:231680]Glutaric aciduria 2C [recessive?];,"Multiple acyl-CoA dehydrogenase deficiency, mild type;Multiple acyl-CoA dehydrogenase deficiency, severe neonatal type",Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in,Blood metabolite ratios[24816252];Serum metabolite levels[23093944;23093944];Acylcarnitine levels[26068415;26068415];Blood metabolite levels[24816252;24816252;24816252];Metabolite levels[20037589];Blood protein levels[28240269];Metabolic traits[21886157];,0.20368098159509201,0.6936565239814337,0.756721482641608,0.5541743400859422
1187,7945,ETHE1,608451,602473;,,Ethylmalonic encephalopathy,Disease-causing germline mutation(s) in,,0.5682208588957055,0.2078390923156266,0.6071521795875751,0.5112031921424187
1188,7951,ETS1,164720,,,Systemic lupus erythematosus,Major susceptibility factor in,"Glaucoma[30054594];Multiple sclerosis[24076602];Liver fibrosis in pediatric non-alcoholic fatty acid liver disease[28918882];Lymphocyte percentage of white cells[27863252];Lymphocyte counts[27863252];Myeloid white cell count[27863252];Chronic inflammatory diseases (ankylosing spondylitis, Crohn's disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy)[26974007;26974007];Plateletcrit[27863252];Sum basophil neutrophil counts[27863252];Itch intensity from mosquito bite[28199695];Granulocyte count[27863252];Neutrophil count[27863252];Lung function (FVC)[30061609;30061609];Manganese levels[26025379];Rheumatoid arthritis (ACPA-positive)[24532676];Systemic lupus erythematosus[19838193;20169177;23273568;27399966;26502338;26502338;28714469;28714469;28714469;26663301];Psoriasis vulgaris[26626624];Allergic disease (asthma, hay fever or eczema)[29083406];Atopic dermatitis[26482879;26482879];Self-reported allergy[23817569];Obesity-related traits[23251661];Platelet count[27863252];Psoriasis[25903422;25903422;25903422;25903422;25903422;23143594];Depressive episodes in bipolar disorder[26297903];Sum neutrophil eosinophil counts[27863252];Albumin-globulin ratio[29403010];Depressive and manic episodes in bipolar disorder[26297903];Inflammatory bowel disease[28067908];Celiac disease[20190752;22057235];White blood cell count[27863252];Mosquito bite size[28199695];Rheumatoid arthritis[22446963;24390342;24390342;24390342];Follicular lymphoma[25279986];Monocyte count[27863252];Non-albumin protein levels[29403010];Ulcerative colitis[28067908];Intraocular pressure[29617998;29617998;30054594;29785010];",0.5705521472392638,0.5768437338834451,0.867136517880449,0.8198281154082259
1189,7954,ETV1,600541,612219;,[MIM:612219]Ewing sarcoma;,Ewing sarcoma,Part of a fusion gene in,Type 2 diabetes[24509480];Post bronchodilator percent predicted FEV1 in smoking[30068317];Verbal declarative memory[25648963];Lymphocyte counts[27863252];Post bronchodilator FEV1/FVC ratio in smoking[30068317];Coronary artery disease[29212778];,0.40773006134969325,0.5551830840639504,0.12790394152962672,0.0
1190,7958,ETV4,600711,,,Ewing sarcoma,Part of a fusion gene in,,0.35496932515337426,0.14672511603919547,0.5178804489689376,0.10497237569060773
1191,7961,ETV6,600618,131440;601626;616216;,"[MIM:131440]Myeloproliferative disorder chronic with eosinophilia;[MIM:601626]Leukemia, acute myelogenous;[MIM:616216]Thrombocytopenia 5 [dominant?];",Congenital mesoblastic nephroma;Differentiated thyroid carcinoma;Fibrosarcoma;Primary hypereosinophilic syndrome;Hereditary thrombocytopenia with normal platelets-hematological cancer predisposition syndrome;Chronic myelomonocytic leukemia;Precursor B-cell acute lymphoblastic leukemia,Part of a fusion gene in;Part of a fusion gene in;Part of a fusion gene in;Part of a fusion gene in;Disease-causing germline mutation(s) in;Part of a fusion gene in;Part of a fusion gene in,Phosphorus levels[29403010];Colorectal cancer[27145994;27145994];Height[23563607;20881960;18391951;25282103];Night sleep phenotypes[27126917];Asthma[27611488];,0.43754601226993867,0.6830840639504899,0.6919864265204907,0.6784837323511357
1192,7966,EVC,604831,193530;225500;,"[MIM:193530]Acrofacial dysostosis, Weyers type [dominant?];","Ellis Van Creveld syndrome;Acrofacial dysostosis, Weyers type",Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in,,0.16220858895705523,0.05776173285198556,0.06786739754633254,0.1289134438305709
1193,7967,EVC2,607261,193530;225500;,"[MIM:193530]Acrofacial dysostosis, Weyers type [dominant?];","Ellis Van Creveld syndrome;Acrofacial dysostosis, Weyers type",Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in,Body mass index (change over time) in gastrointestinal cancer or chronic obstructive pulmonary disease[28044437];,0.6370552147239263,0.006446621970087674,0.11172017749934743,0.04788213627992634
1194,7980,EWSR1,133450,612160;612219;,[MIM:612219]Ewing sarcoma;[MIM:612160]Angiomatoid fibrous histiocytoma;,Extraskeletal myxoid chondrosarcoma;Ewing sarcoma;Extraskeletal Ewing sarcoma;Desmoplastic small round cell tumor;Melanoma of soft tissue,Part of a fusion gene in;Part of a fusion gene in;Part of a fusion gene in;Part of a fusion gene in;Part of a fusion gene in,Pancreatic cancer[25086665];Breast cancer[23535729];Platelet count[27863252];,0.9283435582822086,0.9502320783909232,0.7919603236752806,0.8462246777163904
1195,8005,EXOSC2,602238,617763;,"[MIM:617763]Short stature, hearing loss, retinitis pigmentosa, and distinctive facies [recessive?];",Retinitis pigmentosa-hearing loss-premature aging-short stature-facial dysmorphism syndrome,Disease-causing germline mutation(s) in,,0.9123926380368098,0.23078906652913872,0.6836335160532498,0.4495089011663597
1196,8006,EXOSC3,606489,614678;,[MIM:614678]Pontocerebellar hypoplasia 1B [recessive?];,Pontocerebellar hypoplasia type 1,Disease-causing germline mutation(s) in,,0.8925153374233129,0.4896854048478597,0.4335682589402245,0.5207182320441989
1197,8013,EXOSC8,606019,616081;,[MIM:616081]Pontocerebellar hypoplasia 1C [recessive?];,Pontocerebellar hypoplasia type 1,Disease-causing germline mutation(s) in,,0.9209815950920245,0.3517276946879835,0.6426520490733489,0.13014119091467158
1198,8014,EXOSC9,606180,,,Pontocerebellar hypoplasia type 1,Disease-causing germline mutation(s) in,Mean corpuscular volume[27863252];Mean corpuscular hemoglobin[27863252];,0.9052760736196319,0.14002062919030428,0.2192638997650744,0.022866789441375077
1199,8017,EXPH5,612878,615028;,,Epidermolysis bullosa simplex due to exophilin 5 deficiency,Disease-causing germline mutation(s) in,Lymphocyte counts[27863252];,0.35496932515337426,0.04899432697266632,0.010441138084051161,0.028698588090853284
1200,8018,EXT1,608177,133700;150230;215300;,[MIM:150230]Tricho-rhino-phalangeal syndrome 2;[MIM:215300]Chondrosarcoma;,Trichorhinophalangeal syndrome type 2;Multiple osteochondromas;Chondrosarcoma,Role in the phenotype of;Disease-causing germline mutation(s) in;Candidate gene tested in,Systolic blood pressure x smoking status (current vs non-current) interaction (1df test)[29455858];Common carotid intima-media thickness in HIV infection[29206233];Endometrial cancer (Non-endometrioid histology)[30093612];White blood cell count (basophil)[29403010];Common carotid intima-media thickness[29206233];Height[19893584];Obesity-related traits[23251661];Systolic blood pressure x smoking status (current vs non-current) interaction (2df test)[29455858];Depression in smokers[30219690];General cognitive ability[29844566];Autism spectrum disorder[28540026];Urate levels in obese individuals[25811787];,0.3168098159509202,0.8179473955647241,0.7841294701122422,0.9751381215469613
1201,8019,EXT2,608210,133701;601224;616682;,"[MIM:601224]Potocki-Shaffer syndrome;[MIM:616682]Seizures, scoliosis, and macrocephaly syndrome [recessive?];",Multiple osteochondromas;Seizures-scoliosis-macrocephaly syndrome;Potocki-Shaffer syndrome,Disease-causing germline mutation(s) (loss of function) in;Disease-causing germline mutation(s) (loss of function) in;Role in the phenotype of,,0.36171779141104293,0.1422124806601341,0.5121378230227095,0.9060773480662984
1202,8020,EXT3,600209,133701;601224;616682;,"[MIM:601224]Potocki-Shaffer syndrome;[MIM:616682]Seizures, scoliosis, and macrocephaly syndrome [recessive?];",Multiple osteochondromas;Seizures-scoliosis-macrocephaly syndrome;Potocki-Shaffer syndrome,Disease-causing germline mutation(s) (loss of function) in;Disease-causing germline mutation(s) (loss of function) in;Role in the phenotype of,,0.038773006134969326,0.1422124806601341,0.0,0.0
1203,8024,EXTL3,605744,617425;,,Skeletal dysplasia-T-cell immunodeficiency-developmental delay syndrome,Disease-causing germline mutation(s) in,Height[25429064];,0.3749693251533742,0.3243940175348118,0.7162620725659097,0.8176795580110497
1204,8026,EYA1,601653,113650;166780;602588;,[MIM:113650]Branchiootorenal syndrome 1;[MIM:166780]Otofaciocervical syndrome 1;[MIM:602588]Branchiootic syndrome 1;[MIM:602588]Anterior segment anomalies with or without cataract;,BOR syndrome;Otofaciocervical syndrome;Branchiootic syndrome,Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in,Longevity (85 years and older)[24688116];Sleep-related phenotypes[17903308];Paneth cell defects in Crohn's disease[28352666];Hypospadias[25108383];Waist-to-hip ratio adjusted for BMI in active individuals[28448500];Waist-to-hip ratio adjusted for BMI (joint analysis for main effect and physical activity interaction)[28448500;28448500];Heel bone mineral density[28869591;28869591;28869591];Chronic obstructive pulmonary disease-related biomarkers[23144326];Chin dimples[27182965];Waist-to-hip ratio adjusted for BMI[26426971];Waist-to-hip ratio adjusted for body mass index[28448500;28448500];Waist-to-hip ratio adjusted for BMI x sex x age interaction (4df test)[26426971];,0.32380368098159507,0.9205776173285198,0.3500391542678152,0.965316144874156
1205,8029,EYA4,603550,601316;605362;,"[MIM:605362]Cardiomyopathy, dilated 1J;",Sensorineural deafness with dilated cardiomyopathy;Autosomal dominant non-syndromic sensorineural deafness type DFNA,Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in,"Visceral fat[22589738];Methadone dose in opioid dependence[28115739];Waist-to-hip ratio adjusted for BMI (adjusted for smoking behaviour)[28443625];Bone mineral density (paediatric, skull)[24945404;24945404];Atrial fibrillation[29892015];Heel bone mineral density[28869591;28869591;28869591;28869591;28869591;28869591];Waist-to-hip ratio adjusted for BMI in non-smokers[28443625];Response to angiotensin II receptor blocker therapy[22566498];Protein quantitative trait loci[18464913];Glomerular filtration rate (creatinine)[28452372];",0.5338650306748466,0.45255286230015473,0.052988775776559645,0.7946593001841621
1206,8031,EYS,612424,602772;,,Retinitis pigmentosa,Disease-causing germline mutation(s) in,Exhaled nitric oxide levels[28109725];Body mass index[28892062];Methadone dose in opioid dependence[28115739];Iris color (a* coordinate)[29109912];Exhaled nitric oxide output[28109725];Melanoma[24980573];Schizophrenia[28991256];Systolic blood pressure x alcohol consumption interaction (2df test)[29912962];Response to paclitaxel in ovarian cancer (Caspase 3/7 EC50)[27047539];,0.08736196319018405,0.005673027333677153,0.012007308796658836,0.877378759975445
1207,8033,EZH2,601573,277590;,[MIM:277590]Weaver syndrome;,Weaver syndrome,Disease-causing germline mutation(s) in,Inflammatory bowel disease[28067908];Colorectal or endometrial cancer[26621817];Waist circumference adjusted for BMI in non-smokers[28443625];Waist circumference adjusted for BMI (joint analysis main effects and smoking interaction)[28443625];Waist circumference adjusted for BMI (adjusted for smoking behaviour)[28443625];Crohn's disease[28067908];Height[25282103];Waist circumference adjusted for body mass index[25673412;25673412];Familial squamous cell lung carcinoma[29924316];,0.794601226993865,1.0,0.312451057165231,0.9610190300798036
1208,8035,EZR,123900,,,Autosomal recessive non-syndromic intellectual disability,Disease-causing germline mutation(s) (loss of function) in,Hair color[29662168];Bladder cancer (smoking interaction)[24662972];,0.9384049079754602,0.558019597730789,0.725920125293657,0.8615715162676488
1209,8037,F2,176930,188050;601367;613679;614390;,"[MIM:613679]Factor II deficiency;[MIM:601367]Ischemic stroke;[MIM:188050]Thrombophilia due to thrombin defect;[MIM:614390]Pregnancy loss, recurrent, 2;",Congenital factor II deficiency;Cerebral sinovenous thrombosis,Disease-causing germline mutation(s) in;Major susceptibility factor in,Prothrombin time[29403010];Autism spectrum disorder or schizophrenia[28540026;28540026];Immunoglobulin A[20694011];Thrombosis[26908601];Venous thromboembolism[28373160;28373160;25772935];Intraocular pressure[29617998];,0.6192638036809816,0.33574007220216606,0.2229182980944923,0.7516881522406385
1210,8042,F3,134390,,,Congenital atransferrinemia,Disease-causing germline mutation(s) in,Type 2 diabetes[22238593];D-dimer levels[21502573];End-stage coagulation[23381943];,0.31079754601226994,0.4930376482723053,0.6191594883842338,0.37093308778391654
1211,8043,F5,612309,188055;227400;600880;601367;614389;,"[MIM:227400]Factor V deficiency;[MIM:188055]Thrombophilia due to activated protein C resistance;[MIM:600880]Budd-Chiari syndrome;[MIM:601367]Ischemic stroke;[MIM:614389]Pregnancy loss, recurrent, 1;",Budd-Chiari syndrome;Congenital factor V deficiency;Cerebral sinovenous thrombosis;East Texas bleeding disorder,Candidate gene tested in;Disease-causing germline mutation(s) in;Major susceptibility factor in;Disease-causing germline mutation(s) (gain of function) in,Uric acid levels[23703922];D-dimer levels[21502573];Stem cell growth factor beta levels[27989323];Vertical cup-disc ratio[28073927;28073927];Ischemic stroke[26732560];Blood protein levels[28240269;28240269;28240269;28240269;28240269;28240269;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;30072576;30072576;30072576];Thrombosis[26908601];Hippocampal atrophy[22745009];Activated partial thromboplastin time[22703881;29403010];Prothrombin time[29403010];Hemostatic factors and hematological phenotypes[22443383];Optic disc area[25631615;25631615];Venous thromboembolism[21980494;22672568;28373160;25772935;25772935;23650146];,0.2947239263803681,0.370809695719443,0.019838162359697206,0.8156844689993862
1212,8044,F7,613878,227500;,[MIM:227500]Factor VII deficiency;,Congenital factor VII deficiency,Disease-causing germline mutation(s) in,Prothrombin time[22703881;29403010];Factor VII levels[20231535];Blood protein levels[30072576];Factor VII[17903294];,0.6617177914110429,0.20139247034553895,0.5291046724092926,0.8538980969920197
1213,8046,F8,300841,134500;306700;,[MIM:306700]Hemophilia A;,Mild hemophilia A;Severe hemophilia A;Moderately severe hemophilia A;Symptomatic form of hemophilia A in female carriers,Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in,Red blood cell traits[23446634;23446634];Antineutrophil cytoplasmic antibody-associated vasculitis[22808956];Thrombosis[26908601];,0.30319018404907977,0.8215575038679732,0.4231271208561733,0.9941682013505218
1214,8050,F9,300746,300807;306900;,"[MIM:306900]Hemophilia B;[MIM:300807]Thrombophilia, X-linked, due to factor IX defect;",Mild hemophilia B;Moderately severe hemophilia B;Severe hemophilia B;Symptomatic form of hemophilia B in female carriers,Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in,,0.4,0.9406910778751933,0.8318976768467763,0.0
1215,8051,F10,613872,227600;,[MIM:227600]Factor X deficiency;,Congenital factor X deficiency,Disease-causing germline mutation(s) in,Blood protein levels[28240269;29875488;29875488;29875488;29875488;30072576];Factor VII[17903294];,0.3492024539877301,0.23955647240845795,0.6418689637170452,0.7813075506445673
1216,8053,F11,264900,612416;,[MIM:612416]Factor XI deficiency;,Congenital factor XI deficiency,Disease-causing germline mutation(s) in,L-arginine levels[27656708];Factor XI[28053049];Activated partial thromboplastin time[22703881;22703881;29403010];Ischemic stroke (cardioembolic)[29531354];Response to statin therapy[20339536];Blood protein levels[28240269;30072576;30072576;30072576];Thrombosis[26908601];Venous thromboembolism[21980494;28373160;25772935;23650146];,0.26588957055214724,0.12532233109850438,0.5275385016966849,0.6431860036832413
1217,8056,F12,610619,234000;610618;,[MIM:234000]Factor XII deficiency;[MIM:610618]Hereditary angioedema 3 [dominant?];,Congenital factor XII deficiency;Hereditary angioedema type 3,Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) (gain of function) in,L-arginine levels[27656708];Chronic kidney disease[20383146];Nephrolithiasis[22396660];Blood protein levels[28240269;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488];Waist-to-hip ratio adjusted for BMI[26426971];Blood metabolite ratios[24816252];Circulating vasoactive peptide levels[23381795;23381795];Activated partial thromboplastin time[22703881;20303064;29403010];Waist-to-hip ratio adjusted for BMI (age <50)[26426971];Metabolite levels (small molecules and protein measures)[27005778];Metabolite levels[22286219;22916037];Platelet function and related traits[21546496];Circulating chromogranin peptide levels[28011710];Waist-to-hip ratio adjusted for BMI x sex x age interaction (4df test)[26426971];,0.3449079754601227,0.1743166580711707,0.5878360741320804,0.5174953959484346
1218,8057,F13A1,134570,613225;,[MIM:613225]Factor XIII subunit A deficiency [recessive?];,Congenital factor XIII deficiency,Disease-causing germline mutation(s) in,Waist-to-hip ratio adjusted for BMI (age >50)[26426971];Waist-to-hip ratio adjusted for BMI (age <50)[26426971];Interleukin-10 levels[22205395];Type 2 diabetes (age of onset)[28060188];GIP levels in response to oral glucose tolerance test (120 minutes)[29093273];Night sleep phenotypes[27126917];Waist-to-hip ratio adjusted for BMI[26426971];End-stage coagulation[23381943;23381943;23381943;23381943;23381943];Entorhinal cortical volume[21116278];Waist-to-hip ratio adjusted for BMI x sex x age interaction (4df test)[26426971];,0.35496932515337426,0.44275399690562145,0.06290785695640824,0.6708103130755064
1219,8058,F13B,134580,613235;,[MIM:613235]Factor XIII subunit B deficiency [recessive?];,Congenital factor XIII deficiency,Disease-causing germline mutation(s) in,Age-related macular degeneration[23536807];Erectile dysfunction in type 1 diabetes[22704111];Blood protein levels[28240269;30072576;30072576;30072576;30072576;30072576;30072576;30072576;30072576;30072576];Lupus nephritis in systemic lupus erythematosus[24925725];,0.08736196319018405,0.129190304280557,0.5993213260245367,0.3514426028238183
1220,8059,FA2H,611026,612319;,"[MIM:612319]Spastic paraplegia 35, autosomal recessive [recessive?];",Autosomal recessive spastic paraplegia type 35;Fatty acid hydroxylase-associated neurodegeneration,Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in,Pancreatic cancer[25086665];White matter lesion progression (adjusted for white matter lesion burden at baseline)[26451028];General cognitive ability[25383866];,0.6661349693251534,0.4375966993295513,0.8217175672148264,0.876304481276857
1221,8094,FADD,602457,613759;,"[MIM:613759]Infections, recurrent, associated with encephalopathy, hepatic dysfunction and cardiovascular malformations;",FADD-related immunodeficiency;Oculootodental syndrome,Disease-causing germline mutation(s) in;Role in the phenotype of,Diverticular disease[30177863;30177863];,0.6896932515337423,0.7346570397111913,0.9689376141999478,0.8627992633517495
1222,8103,FAH,613871,276700;,,Tyrosinemia type 1,Disease-causing germline mutation(s) in,Blood protein levels[29875488;30072576];,0.22687116564417178,0.04332129963898917,0.5721743670060037,0.6042050337630448
1223,8130,FAM13A,613299,,,Idiopathic pulmonary fibrosis,Major susceptibility factor in,Chronic obstructive pulmonary disease (severe)[24621683];Waist-to-hip ratio adjusted for BMI (adjusted for smoking behaviour)[28443625;28443625];Pulmonary function (smoking interaction)[23284291];Waist-to-hip ratio adjusted for BMI in non-smokers[28443625;28443625];Longevity[26912274];Hair greying[26926045];Interstitial lung disease[23583980];Waist-to-hip ratio adjusted for BMI[26426971];HDL cholesterol[24097068];HDL cholesterol levels[28334899];Chronic bronchitis and chronic obstructive pulmonary disease[25241909;25241909];Lung function (FEV1/FVC)[28166213;28166213];Waist-to-hip ratio adjusted for BMI (age <50)[26426971];Chronic obstructive pulmonary disease (moderate to severe)[24621683];Pulmonary function[20010835];Waist-to-hip ratio adjusted for BMI (joint analysis main effects and smoking interaction)[28443625];Chronic obstructive pulmonary disease[22080838;25101718;25241909;20173748;28166215];Pre bronchodilator FEV1/FVC ratio in never-smokers[27612410];Post bronchodilator FEV1/FVC ratio[26634245;26634245;26634245;26634245;26634245;26634245;26634245;26634245;26634245;26634245;26634245;26634245;26634245;26634245;26634245;26634245;26634245;26634245;26634245;26634245;26634245;26634245;26634245;26634245;26634245;26634245;26634245;26634245;26634245;26634245;26634245;26634245;26634245;26634245;26634245;26634245;26634245;26634245;26634245;26634245;26634245;26634245;26634245;26634245;26634245;26634245;26634245;26634245;26634245;26634245;26634245;26634245;26634245;26634245;26634245;26634245;26634245;26634245;26634245;26634245;26634245;26634245];Waist-to-hip ratio adjusted for body mass index[28430825;25673412;25673412;25673412;25673412];Post bronchodilator FEV1[26634245;26634245;26634245;26634245;26634245;26634245;26634245;26634245;26634245;26634245;26634245;26634245;26634245;26634245;26634245;26634245;26634245;26634245;26634245;26634245;26634245;26634245;26634245;26634245;26634245;26634245;26634245;26634245;26634245;26634245;26634245;26634245;26634245;26634245;26634245;26634245;26634245;26634245;26634245;26634245;26634245;26634245;26634245;26634245;26634245;26634245;26634245;26634245;26634245;26634245;26634245;26634245;26634245;26634245;26634245;26634245;26634245;26634245;26634245;26634245;26634245;26634245;26634245;26634245;26634245;26634245;26634245;26634245;26634245;26634245;26634245;26634245;26634245;26634245];Waist-to-hip ratio adjusted for BMI x sex x age interaction (4df test)[26426971];,0.5692024539877301,0.17689530685920576,0.39336987731662754,0.013965623081645182
1224,8139,FAM20A,611062,204690;,[MIM:204690]Amelogenesis imperfecta 1G;,Enamel-renal syndrome,Disease-causing germline mutation(s) in,Blood protein levels[29875488;30072576];,0.19190184049079756,0.1884992264053636,0.08979378752284,0.4607120933087784
1225,8141,FAM20C,611061,259775;,[MIM:259775]Raine syndrome;,Lethal osteosclerotic bone dysplasia,Disease-causing germline mutation(s) (loss of function) in,Alzheimer's disease in APOE e4- carriers[25778476];Allergic rhinitis[25085501];,0.49570552147239266,0.6389891696750902,0.4147742103889324,0.6912216083486802
1226,8227,FAM83H,611927,130900;,,Hypocalcified amelogenesis imperfecta,Disease-causing germline mutation(s) in,,0.8125153374233128,0.8416709644146467,0.20490733489950405,0.0
1227,8283,FAM92A,617273,,,Postaxial polydactyly type A,Disease-causing germline mutation(s) in,Temperament[22832960];,0.14576687116564419,0.5131511088189789,0.0,0.0
1228,8311,FAM111A,615292,127000;602361;,[MIM:127000]Kenny-Caffey syndrome 2;[MIM:602361]Gracile bone dysplasia;,Osteocraniostenosis;Autosomal dominant Kenny-Caffey syndrome,Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in,,0.6166871165644172,0.36874677668901495,0.5186635343252415,0.6042050337630448
1229,8313,FAM111B,615584,615704;,,Hereditary fibrosing poikiloderma-tendon contractures-myopathy-pulmonary fibrosis syndrome,Disease-causing germline mutation(s) in,,0.5009815950920246,0.0,0.4860349778125816,0.32535297728667895
1230,8329,FAM126A,610531,610532;,"[MIM:610532]Leukodystrophy, hypomyelinating, 5;",Hypomyelination-congenital cataract syndrome,Disease-causing germline mutation(s) in,Breastfeeding duration[25475840];Parkinson's disease[27182965];Periodontitis (Mean PAL)[24024966];,0.7516564417177914,0.4850438370293966,0.5690420255807883,0.3525168815224064
1231,8372,FAM161A,613596,606068;,,Retinitis pigmentosa,Disease-causing germline mutation(s) in,Systemic lupus erythematosus[28714469];Atrial fibrillation[29892015];,0.7226993865030675,0.12790097988653945,0.16079352649438788,0.11602209944751381
1232,8538,FAN1,613534,614817;,"[MIM:614817]Interstitial nephritis, karyomegalic;",Lynch syndrome;Karyomegalic interstitial nephritis,Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in,Huntington's disease progression[28642124];,0.5170552147239263,0.06059824651882414,0.4346123727486296,0.0
1233,8539,FANCA,607139,227650;,"[MIM:227650]Fanconi anemia, complementation group A;",Fanconi anemia,Disease-causing germline mutation(s) in,Rosacea symptom severity[29771307];Low tan response[29739929;29739929;29739929;29739929];Homocysteine levels[23824729];Intraocular pressure[29617998;30054594;29785010];,0.6871165644171779,0.0010314595152140279,0.18715740015661708,0.8233578882750153
1234,8540,FANCB,300515,300514;,[MIM:300514]Fanconi anemia complementation group B;,Fanconi anemia;VACTERL with hydrocephalus,Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) (loss of function) in,,0.6045398773006135,0.9373388344507478,0.46149830331506136,0.0
1235,8541,FANCC,613899,227645;,[MIM:227645]Fanconi anemia complementation group C;,Fanconi anemia,Disease-causing germline mutation(s) in,Polycystic ovary syndrome[26284813];,0.64920245398773,0.32052604435275917,0.48760114852518927,0.04619398403928791
1236,8542,FANCD2,613984,227646;,[MIM:227646]Fanconi anemia complementation group D2;,Fanconi anemia,Disease-causing germline mutation(s) in,Alzheimer's disease[24755620];,0.7699386503067485,0.21222279525528623,0.3174105977551553,0.011203192142418661
1237,8546,FANCE,613976,600901;,[MIM:600901]Fanconi anemia complementation group E;,Fanconi anemia,Disease-causing germline mutation(s) in,Pulmonary function (smoking interaction)[23284291];,0.6160736196319019,0.23104693140794225,0.20073087966588357,0.14103744628606507
1238,8547,FANCF,613897,603467;,[MIM:603467]Fanconi anemia complementation group F;,Fanconi anemia,Disease-causing germline mutation(s) in,,0.6269938650306749,0.7070654976792161,0.6241190289741582,0.0
1239,8548,FANCG,602956,614082;,,Fanconi anemia,Disease-causing germline mutation(s) in,,0.6723926380368098,0.18385765858690045,0.31036282954842076,0.10082872928176796
1240,8549,FANCI,611360,609053;,[MIM:609053]Fanconi anemia complementation group I;,Fanconi anemia,Disease-causing germline mutation(s) in,Menopause (age at onset)[26414677];Height[25282103];,0.8807361963190184,0.44997421351211964,0.026102845210127904,0.5756599140577041
1241,8550,FANCL,608111,614083;,[MIM:614083]Fanconi anemia complementation group L;,Fanconi anemia,Disease-causing germline mutation(s) in,Body mass index[20935630];Obesity[23563607;23563607;23563607];Waist circumference[25673412;25673412];Autism spectrum disorder or schizophrenia[28540026;28540026];Hirschsprung disease[27702942];Epilepsy[25087078];Schizophrenia[25056061];Initial pursuit acceleration[29064472];Response to selective serotonin reuptake inhibitors and depression[27622933];Waist-hip ratio[25673412;25673412];,0.6517791411042945,0.13460546673543064,0.5815713912816497,0.015500306936771025
1242,8551,FANCM,609644,,,Fanconi anemia;Male infertility with azoospermia or oligozoospermia due to single gene mutation,Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) (loss of function) in,Severe influenza A (H1N1) infection[26379185];,0.6790184049079755,0.06549767921609077,0.030540328895849646,0.03806015960712093
1243,8555,FAR1,616107,616154;,[MIM:616154]Peroxisomal fatty acyl-CoA reductase 1 disorder [recessive?];,Severe intellectual disability-epilepsy-cataract syndrome due to fatty acyl-CoA reductase 1 deficiency,Disease-causing germline mutation(s) in,Childhood ear infection[27182965];Visceral adipose tissue adjusted for BMI[26480920];Response to TNF inhibitor in rheumatoid arthritis (change in swollen 28-joint count)[30166627];Common carotid intima-media thickness in HIV negative individuals[29206233];Response to TNF inhibitor in rheumatoid arthritis (change in tender 28-joint count)[30166627];Night sleep phenotypes[27126917];,0.7682208588957056,0.869778236204229,0.8762725137039937,0.4949355432780847
1244,8566,FARS2,611592,614946;617046;,"[MIM:614946]Combined oxidative phosphorylation deficiency 14 [recessive?];[MIM:617046]Spastic paraplegia 77, autosomal recessive [recessive?];",Combined oxidative phosphorylation defect type 14;Autosomal recessive spastic paraplegia type 77,Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) (loss of function) in,JT interval (sulfonylurea treatment interaction)[27958378];Copper levels[26025379];Change in glucose in response to thiazide diuretic treatment in hypertension[29523524];Obesity (early onset extreme)[23563609];,0.8107975460122699,0.0,0.6311667971808927,0.19551872314303254
1245,8569,FARSB,609690,,,"Brain calcification, Rajab type",Disease-causing germline mutation(s) in,Schizophrenia (inflammation and infection response interaction)[25781172];Chin dimples[27182965];,0.9344785276073619,0.44404332129963897,0.6844166014095536,0.5598526703499079
1246,8571,FAS,134637,601859;,[MIM:601859]Autoimmune lymphoproliferative syndrome 1A;,Beh�et disease;Autoimmune lymphoproliferative syndrome;Autoimmune lymphoproliferative syndrome;Vogt-Koyanagi-Harada disease,Major susceptibility factor in;Disease-causing germline mutation(s) in;Disease-causing somatic mutation(s) in;Major susceptibility factor in,Chronic lymphocytic leukemia[23770605;24292274;26956414;28165464];Juvenile idiopathic arthritis (oligoarticular or rheumatoid factor-negative polyarticular)[23603761];Mosquito bite size[28199695];Atrioventricular conduction[21041692];Selective IgA deficiency[27723758];Obesity-related traits[23251661;23251661;23251661;23251661];Blood protein levels[29875488;29875488;30072576];Immunoglobulin A[20694011];,0.6338650306748467,0.7942238267148014,0.6199425737405377,0.8601903007980356
1247,8573,FASLG,134638,601859;,[MIM:601859]Autoimmune lymphoproliferative syndrome 1B;,Autoimmune lymphoproliferative syndrome,Disease-causing germline mutation(s) in,"Celiac disease[20190752;24999842;22057235;22057235];Vitiligo[27723757];Allergic disease (asthma, hay fever or eczema)[29083406];Systemic lupus erythematosus[28714469;28714469];Psoriasis[28537254];Crohn's disease[21102463;23128233];Itch intensity from mosquito bite[28199695];Daytime sleep phenotypes[27126917];Allergic sensitization[30013184];",0.5938650306748466,0.60881897885508,0.8337248760114853,0.8414671577655003
1248,8574,FASN,600212,,,Beh�et disease;Autoimmune lymphoproliferative syndrome;Autoimmune lymphoproliferative syndrome;Vogt-Koyanagi-Harada disease,Major susceptibility factor in;Disease-causing germline mutation(s) in;Disease-causing somatic mutation(s) in;Major susceptibility factor in,Blood protein levels[30072576];Major depressive disorder[27777418];,0.9779141104294479,1.0,0.2748629600626468,0.9278698588090853
1249,8577,FASTKD2,612322,,,FASTKD2-related infantile mitochondrial encephalomyopathy,Disease-causing germline mutation(s) (loss of function) in,QT interval (drug interaction)[23459443];Body mass index[26426971];Height[20966902];Episodic memory[25385369];,0.6414723926380368,0.5618875709128417,0.2717306186374315,0.09131368937998773
1250,8584,FAT4,612411,615546;616006;,[MIM:615546]Van Maldergem syndrome 2 [recessive?];[MIM:616006]Hennekam lymphangiectasia-lymphedema syndrome 2;,Hennekam syndrome;Cerebrofacioarticular syndrome,Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in,Cognitive performance[19734545];Bone mineral density (spine)[26911590];Bipolar disorder or major depressive disorder[20351715];Small vessel stroke[29123153];Chin dimples[27182965];Cerebrospinal fluid AB1-42 levels[26252872];Memory dysfunction in frontotemporal lobe dementia[29724592];,0.32380368098159507,1.0,0.006003654398329418,0.5174953959484346
1251,8592,FBF1,616807,,,Congenital analbuminemia,Disease-causing germline mutation(s) in,White matter hyperintensity burden[25663218;25663218];Coronary artery disease[29212778];,0.8196319018404908,0.029396596183599792,0.0,0.009515039901780233
1252,8597,FBLN1,135820,608180;,,Synpolydactyly type 2;FBLN1-related developmental delay-central nervous system anomaly-syndactyly syndrome,Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in,QT interval[29213071];Paneth cell defects in Crohn's disease[28352666];Hematocrit[27863252];Red blood cell count[27863252];Blood protein levels[30072576;30072576];Temperament (bipolar disorder)[22365631];Hemoglobin concentration[27863252];,0.6739877300613497,0.62867457452295,0.557556773688332,0.9436771025168815
1253,8599,FBLN5,604580,219100;608895;614434;,"[MIM:608895]Neuropathy, hereditary, with or without age-related macular degeneration [dominant?];[MIM:614434]Cutis laxa, autosomal dominant, 2 [dominant?];[MIM:219100]Cutis laxa, autosomal recessive, 1A [recessive?];[MIM:608895]Macular degeneration, age-related, 3;",Hereditary sensorimotor neuropathy with hyperelastic skin;Autosomal dominant cutis laxa;Autosomal recessive cutis laxa type 1,Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in,Height[18391951;25429064];,0.3669938650306748,0.9515214027849407,0.8355520751761942,0.9011663597298957
1254,8601,FBN1,134797,102370;129600;154700;184900;604308;608328;614185;616914;,"[MIM:154700]Marfan syndrome;[MIM:129600]Ectopia lentis 1, isolated, autosomal dominant [dominant?];[MIM:608328]Weill-Marchesani syndrome 2;[MIM:604308]Overlap connective tissue disease;[MIM:184900]Stiff skin syndrome;[MIM:614185]Geleophysic dysplasia 2 [dominant?];[MIM:102370]Acromicric dysplasia [dominant?];[MIM:616914]Marfan lipodystrophy syndrome;",Isolated ectopia lentis;Acromicric dysplasia;Glaucoma-ectopia lentis-microspherophakia-stiff joints-short stature syndrome;Shprintzen-Goldberg syndrome;Geleophysic dysplasia;Stiff skin syndrome;Weill-Marchesani syndrome;Marfan syndrome type 1;Neonatal Marfan syndrome;Progeroid and marfanoid aspect-lipodystrophy syndrome;Familial thoracic aortic aneurysm and aortic dissection,Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Candidate gene tested in;Candidate gene tested in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in,"Spherical equivalent or myopia (age of diagnosis)[29808027];Central corneal thickness[29760442];Pulse pressure x alcohol consumption interaction (2df test)[29912962];Thoracic aortic aneurysms and dissections[21909107];Pulse pressure[28739976];Breast cancer[17903305];Systolic blood pressure x alcohol consumption interaction (2df test)[29912962];Intracranial, abdominal aortic or thoracic aortic aneurysm (pleiotropy)[27418160];Hepcidin/ferritin ratio[27846281];Spherical equivalent (joint analysis main effects and education interaction)[27020472;27020472];Intraocular pressure[29617998];",0.4463803680981595,0.6848891181021145,0.27590707387105196,0.9901780233271946
1255,8602,FBN2,612570,121050;616118;,"[MIM:616118]Macular degeneration, early-onset;",Congenital contractural arachnodactyly,Disease-causing germline mutation(s) in,Systolic blood pressure[28135244];Response to fenofibrate (total cholesterol levels)[27002377];Breastfeeding duration[25475840];Obesity (extreme)[19553259];Atrial fibrillation[29892015];Multiple system atrophy[27629089];Height[21998595];Night sleep phenotypes[27126917];Beard thickness[26926045];Temperament[22832960];Heschl's gyrus morphology[25130324];Intraocular pressure[29617998];,0.6671165644171779,0.9868488911810211,0.08744453145392848,0.974524248004911
1256,8604,FBP1,611570,229700;,"[MIM:229700]Fructose-1,6-bisphosphatase deficiency [recessive?];","Fructose-1,6-bisphosphatase deficiency",Disease-causing germline mutation(s) in,Colorectal or endometrial cancer[26621817];Obesity-related traits[23251661];Cerebrospinal fluid t-tau:AB1-42 ratio[28641921;28641921];,0.4331288343558282,0.5456420835482207,0.5828765335421561,0.3953345610804174
1257,8611,FBXL4,605654,615471;,,"Mitochondrial DNA depletion syndrome, encephalomyopathic form with variable craniofacial anomalies",Disease-causing germline mutation(s) (loss of function) in,Depression[29700475];Major depressive disorder[27479909];,0.5705521472392638,0.1330582774626096,0.5867919603236753,0.24125230202578268
1258,8634,FBXO7,605648,260300;,[MIM:260300]Parkinson disease 15;,Parkinsonian-pyramidal syndrome,Disease-causing germline mutation(s) in,Mean corpuscular hemoglobin[27863252;29403010];Mean corpuscular volume[27863252;29403010];Red blood cell traits[23222517];Red blood cell count[27863252];Blood protein levels[29875488];Red cell distribution width[27863252];,0.6754601226993865,0.2710159876224858,0.7173061863743148,0.08440761203192143
1259,8649,FBXO31,609102,615979;,"[MIM:615979]Mental retardation, autosomal recessive 45 [recessive?];",Autosomal recessive non-syndromic intellectual disability,Disease-causing germline mutation(s) (loss of function) in,Neuroticism[29255261];Major depressive disorder[22472876];,0.5692024539877301,0.8537906137184116,0.8538240668232837,0.809085328422345
1260,8656,FBXO38,608533,615575;,"[MIM:615575]Neuronopathy, distal hereditary motor, 2D;",Distal hereditary motor neuropathy type 2,Disease-causing germline mutation(s) in,Zinc levels[26025379];Periodontal microbiota[22699663];,0.6153374233128834,0.9662197008767406,0.10519446619681545,0.3514426028238183
1261,8701,FCGR2B,604590,152700;611162;,[MIM:152700]Systemic lupus erythematosus;,Systemic lupus erythematosus,Major susceptibility factor in,Myeloid white cell count[27863252];Sum basophil neutrophil counts[27863252];Sum neutrophil eosinophil counts[27863252];Monocyte percentage of white cells[27863252];Granulocyte count[27863252];Blood protein levels[28240269;28240269;29875488;30072576];Neutrophil count[27863252];Hemoglobin concentration[27863252];Inflammatory bowel disease[28067908;23128233];Lipid metabolism phenotypes[22286219];Systemic lupus erythematosus[26502338];Serum total protein level[29403010];White blood cell count[27863252];Response to cyclophosphamide in systemic lupus erythematosus with lupus nephritis[26980576];Birth weight[27680694];Ulcerative colitis[21297633;28067908];,0.38061349693251534,0.630221763795771,0.19655442443226312,0.12384898710865562
1262,8702,FCGR2C,612169,,,Immune thrombocytopenic purpura,Candidate gene tested in,Systemic lupus erythematosus[28714469];Systemic sclerosis[29293537];Limited cutaneous systemic scleroderma[29293537];Systemic sclerosis (anti-centromere-positive)[29293537];Ulcerative colitis[20228799];,0.2585276073619632,0.0,0.0,0.0
1263,8703,FCGR3A,146740,615707;,[MIM:615707]Immunodeficiency 20 [recessive?];,Autosomal recessive primary immunodeficiency with defective spontaneous natural killer cell cytotoxicity,Disease-causing germline mutation(s) in,"Inflammatory bowel disease[28067908;23128233];Systemic lupus erythematosus[28714469];Functional impairment in major depressive disorder, bipolar disorder and schizophrenia[24039173];Blood protein levels[28240269;28240269;28240269];Ulcerative colitis[28067908];",0.30319018404907977,0.32516761217122225,0.6489167319237797,0.010589318600368325
1264,8704,FCGR3B,610665,,,Systemic lupus erythematosus;Neonatal alloimmune neutropenia,Major susceptibility factor in;Biomarker tested in,Inflammatory bowel disease[28067908;23128233];Systemic lupus erythematosus[26502338];Basophil percentage of white cells[27863252];Response to cyclophosphamide in systemic lupus erythematosus with lupus nephritis[26980576];Blood protein levels[29875488;30072576];Limited cutaneous systemic scleroderma[29293537];Basophil percentage of granulocytes[27863252];Systemic sclerosis (anti-centromere-positive)[29293537];Ulcerative colitis[28067908];,0.3168098159509202,0.38151108818978857,0.555729574523623,0.4429097605893186
1265,8716,FCN3,604973,613860;,[MIM:613860]Ficolin 3 deficiency;,Immunodeficiency due to ficolin3 deficiency,Disease-causing germline mutation(s) in,Blood protein levels[30072576];,0.10711656441717791,0.43888602372356883,0.5293657008613939,0.2826887661141805
1266,8729,FDPS,134629,616631;,"[MIM:616631]Porokeratosis 9, multiple types;",Disseminated superficial actinic porokeratosis,Disease-causing germline mutation(s) in,Inflammatory bowel disease[28067908];Crohn's disease[28067908];,0.6914110429447853,0.48813821557503867,0.6050639519707648,0.05079803560466544
1267,8752,FECH,612386,177000;,"[MIM:177000]Protoporphyria, erythropoietic, 1 [recessive?];",Autosomal erythropoietic protoporphyria,Disease-causing germline mutation(s) (loss of function) in,Mean corpuscular volume[29403010];Mean corpuscular hemoglobin[29403010];Migraine[27182965];,0.8959509202453988,0.370293965961836,0.375097885669538,0.8241252302025782
1268,8771,FERMT1,607900,173650;,[MIM:173650]Kindler syndrome [recessive?];,Kindler syndrome,Disease-causing germline mutation(s) (loss of function) in,Inflammatory bowel disease[28067908];Smooth-surface caries[24556642];Abdominal aortic aneurysm[27899403];Crohn's disease[28067908];,0.5775460122699386,0.12558019597730788,0.03576089793787523,0.3838244321669736
1269,8773,FERMT3,607901,612840;,[MIM:612840]Leukocyte adhesion deficiency 3;,Leukocyte adhesion deficiency type III,Disease-causing germline mutation(s) (loss of function) in,High light scatter reticulocyte percentage of red cells[27863252];Attention deficit hyperactivity disorder[21784300];High light scatter reticulocyte count[27863252];Crohn's disease[28067908];Immature fraction of reticulocytes[27863252];,0.6444171779141105,0.6263537906137184,0.5972330984077264,0.5339165131982812
1270,8780,FEZF1,613301,616030;,,Kallmann syndrome,Disease-causing germline mutation(s) (loss of function) in,,0.17791411042944785,0.889118102114492,0.8102323153223702,0.44613259668508287
1271,8787,FGA,134820,105200;202400;616004;,"[MIM:202400]Congenital afibrinogenemia [recessive?];[MIM:105200]Amyloidosis 8;[MIM:616004]Dysfibrinogenemia, congenital;",Familial hypodysfibrinogenemia;AFib amyloidosis;Familial dysfibrinogenemia;Familial afibrinogenemia;Familial hypofibrinogenemia,Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in,Stroke[29531354;29531354];D-dimer levels[21502573];Fibrinogen[21757653;20031577];Ischemic stroke[29531354;29531354];Venous thromboembolism[21980494];,0.6954601226993865,0.20397111913357402,0.4113808405116158,0.4843462246777164
1272,8788,FGB,134830,202400;616004;,"[MIM:202400]Congenital afibrinogenemia [recessive?];[MIM:616004]Dysfibrinogenemia, congenital;",Familial hypodysfibrinogenemia;Familial dysfibrinogenemia;Familial afibrinogenemia;Familial hypofibrinogenemia,Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in,Fibrinogen[21757653;20031576;20031577;23969696];Chronic obstructive pulmonary disease-related biomarkers[23144326];Fibrinogen levels[26561523;26561523;26561523;28107422;28107422;29403010];,0.5980368098159509,0.5874161939143888,0.6097624641085878,0.6580724370779619
1273,8789,FGD1,300546,305400;,[MIM:305400]Aarskog-Scott syndrome;,Aarskog-Scott syndrome,Disease-causing germline mutation(s) in,,0.32380368098159507,0.9657039711191335,0.6102845210127904,0.7397176181706568
1274,8792,FGD4,611104,609311;,[MIM:609311]Charcot-Marie-Tooth disease 4H [recessive?];,Charcot-Marie-Tooth disease type 4H,Disease-causing germline mutation(s) (loss of function) in,Mean platelet volume[27863252];,0.35496932515337426,0.6623259412068077,0.05899243017488906,0.22912829957028852
1275,8799,FGF3,164950,610706;,"[MIM:610706]Deafness with labyrinthine aplasia, microtia and microdontia [recessive?];","Otodental syndrome;Deafness with labyrinthine aplasia, microtia, and microdontia;Oculootodental syndrome",Role in the phenotype of;Disease-causing germline mutation(s) in;Role in the phenotype of,Childhood ear infection[27182965;28928442];White blood cell count (basophil)[29403010];Monobrow[27182965];Attention deficit hyperactivity disorder[29325848];Craniofacial microsomia[26853712];Breast cancer[20453838];Urate levels in overweight individuals[25811787];Protein quantitative trait loci[18464913];,0.45950920245398774,0.2753996905621454,0.766118506917254,0.0
1276,8801,FGF5,165190,190330;,[MIM:190330]Trichomegaly;,Familial isolated trichomegaly,Disease-causing germline mutation(s) in,"Diastolic blood pressure (cigarette smoking interaction)[29455858];Creatinine levels[29403010];Diastolic blood pressure x alcohol consumption interaction (2df test)[29912962];Mean arterial pressure[26390057;26390057;26390057;28871152;29403010];Blood urea nitrogen levels[29403010];Male-pattern baldness[27182965;29146897];Pulse pressure[29403010;28739976];Blood pressure[21909110;24954895;24954895];Systolic blood pressure x alcohol consumption interaction (2df test)[29912962;29912962];Potassium levels[29403010];Coronary artery disease (myocardial infarction, percutaneous transluminal coronary angioplasty, coronary artery bypass grafting, angina or chromic ischemic heart disease)[28714975];Mean arterial pressure x alcohol consumption (light vs heavy) interaction (2df test)[29912962;29912962];Mean arterial pressure x alcohol consumption interaction (2df test)[29912962;29912962];Systolic blood pressure[21909115;25249183;26390057;26390057;28135244;29403010;27618452;28871152;28739976];Hypertension[25249183];Urate levels[23263486];Diastolic blood pressure[21909115;25249183;19430483;26390057;26390057;26390057;29403010;27618452;28871152;28739976;28135244;27618447];Atrial fibrillation[30061737;29892015];Red blood cell count[29403010];Coronary artery disease[29212778;29212778;29212778];Systolic blood pressure x alcohol consumption (light vs heavy) interaction (2df test)[29912962;29912962];Systolic blood pressure (cigarette smoking interaction)[29455858];Diastolic blood pressure x alcohol consumption (light vs heavy) interaction (2df test)[29912962;29912962];Glomerular filtration rate[29403010];Serum uric acid levels[29403010];Pulse pressure x alcohol consumption interaction (2df test)[29912962];Monobrow[27182965];",0.16220858895705523,0.24187725631768953,0.47115635604280864,0.24125230202578268
1277,8812,FGF8,600483,612702;,[MIM:612702]Hypogonadotropic hypogonadism 6 with or without anosmia;,Microform holoprosencephaly;Septopreoptic holoprosencephaly;Kallmann syndrome;Semilobar holoprosencephaly;Normosmic congenital hypogonadotropic hypogonadism;Midline interhemispheric variant of holoprosencephaly;Lobar holoprosencephaly;Alobar holoprosencephaly,Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) (loss of function) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) (loss of function) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in,Intelligence (MTAG)[29326435];General cognitive ability[29844566];,0.5261349693251534,0.83161423414131,0.9378752283998956,0.0
1278,8813,FGF9,600921,612961;,[MIM:612961]Multiple synostoses syndrome 3;,Multiple synostoses syndrome,Disease-causing germline mutation(s) in,Central corneal thickness[29760442];Modified Stumvoll Insulin Sensitivity Index (BMI interaction)[27416945];Corneal structure[23291589];Amyotrophic lateral sclerosis (sporadic)[24529757];Chin dimples[27182965];Asthma (childhood onset)[27611488];,0.2498159509202454,0.8945332645693657,0.852257896110676,0.0
1279,8814,FGF10,602115,149730;180920;,[MIM:180920]Aplasia of lacrimal and salivary glands;[MIM:149730]Lacrimo-auriculo-dento-digital syndrome [dominant?];,Lacrimoauriculodentodigital syndrome;Aplasia of lacrimal and salivary glands,Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in,Parkinson's disease[26227905];Alzheimer disease and age of onset[26830138];High altitude adaptation[28373541];Breast cancer[29059683];Nonsyndromic cleft lip with cleft palate[28232668];Prostate cancer[21743467];,0.22687116564417178,0.7178958225889633,0.8864526233359437,0.0
1280,8817,FGF12,601513,617166;,,Undetermined early-onset epileptic encephalopathy,Disease-causing germline mutation(s) (gain of function) in,Sleep quality[23728906];Severe influenza A (H1N1) infection[26379185];Ileal carcinoids[21139019];Metabolite levels[19043545];Serum metabolite concentrations in chronic kidney disease[29545352];Post bronchodilator FEV1/FVC ratio[26634245;26634245;26634245];Major depressive disorder[23377640;23377640];Idiopathic dilated cardiomyopathy[29495422];,0.35496932515337426,0.7692109334708612,0.9227355781780214,0.6398096992019644
1281,8823,FGF14,601515,609307;,,Spinocerebellar ataxia type 27,Disease-causing germline mutation(s) in,Bone mineral density (hip)[30172743];Response to methylphenidate treatment in attention-deficit/hyperactivity disorder (blood pressure)[21130132];Response to protease inhibitor treatment in hepatitis c (bilirubin toxicity)[24503447];Preeclampsia[23551011];LDL cholesterol change in response to fenofibrate in statin-treated type 2 diabetes[28736931];Plasma parathyroid hormone levels[30134803];Total cholesterol change in response to fenofibrate in statin-treated type 2 diabetes[28736931];,0.10711656441717791,0.6273852501289324,0.8564343513442966,0.6080417434008594
1282,8827,FGF16,300827,309630;,[MIM:309630]Metacarpal 4-5 fusion;,Syndactyly type 8,Disease-causing germline mutation(s) in,,0.16220858895705523,0.8081485301701908,0.0,0.0
1283,8828,FGF17,603725,615270;,[MIM:615270]Hypogonadotropic hypogonadism 20 with or without anosmia;,Kallmann syndrome;Normosmic congenital hypogonadotropic hypogonadism,Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in,,0.14576687116564419,0.8950489943269727,0.9665883581310363,0.7969613259668509
1284,8831,FGF20,605558,615721;,,"Renal agenesis, bilateral",Disease-causing germline mutation(s) (loss of function) in,Allergic rhinitis in asthma[25085501];Parkinson's disease[25064009];Attention function in attention deficit hyperactive disorder[26174813];,0.038773006134969326,0.7650850954100051,0.42573740537718613,0.0
1285,8834,FGF23,605380,193100;617993;,"[MIM:193100]Hypophosphatemic rickets, autosomal dominant [dominant?];[MIM:617993]Tumoral calcinosis, hyperphosphatemic, familial, 2 [recessive?];",Familial hyperphosphatemic tumoral calcinosis/Hyperphosphatemic hyperostosis syndrome;Autosomal dominant hypophosphatemic rickets,Disease-causing germline mutation(s) (loss of function) in;Disease-causing germline mutation(s) (gain of function) in,Phosphorus levels[20558539;29403010];Migraine[27182965];Colorectal cancer[23263487;23263487];,0.20368098159509201,0.5038679731820526,0.8574784651527017,0.6803253529772867
1286,8838,FGFR1,136350,101600;123150;147950;166250;190440;613001;615465;,[MIM:101600]Pfeiffer syndrome [dominant?];[MIM:147950]Hypogonadotropic hypogonadism 2 with or without anosmia;[MIM:166250]Osteoglophonic dysplasia [dominant?];[MIM:615465]Hartsfield syndrome;[MIM:190440]Trigonocephaly 1;[MIM:613001]Encephalocraniocutaneous lipomatosis;[MIM:123150]Jackson-Weiss syndrome [dominant?];,Myeloid/lymphoid neoplasm associated with FGFR1 rearrangement;Hartsfield syndrome;Encephalocraniocutaneous lipomatosis;Gliosarcoma;Giant cell glioblastoma;Pilomyxoid astrocytoma;Osteoglosphonic dysplasia;Isolated trigonocephaly;Septo-optic dysplasia spectrum;Microform holoprosencephaly;Kallmann syndrome;Semilobar holoprosencephaly;Primary hypereosinophilic syndrome;Normosmic congenital hypogonadotropic hypogonadism;Pfeiffer syndrome type 1;Lobar holoprosencephaly;Oligodontia,Part of a fusion gene in;Disease-causing germline mutation(s) (loss of function) in;Disease-causing somatic mutation(s) in;Part of a fusion gene in;Part of a fusion gene in;Disease-causing somatic mutation(s) in;Disease-causing germline mutation(s) (gain of function) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Candidate gene tested in;Disease-causing germline mutation(s) (loss of function) in;Disease-causing germline mutation(s) in;Part of a fusion gene in;Disease-causing germline mutation(s) (loss of function) in;Disease-causing germline mutation(s) in;Candidate gene tested in;Disease-causing germline mutation(s) in,Autism spectrum disorder or schizophrenia[28540026];Erosive tooth wear (severe vs non-severe)[29898447;29898447;29898447;29898447;29898447;29898447];Response to cognitive-behavioural therapy in anxiety disorder[26989097];Erosive tooth wear (severe vs none or mild)[29898447;29898447];Nonsyndromic cleft lip with cleft palate[28232668];,0.5741104294478527,0.8298091799896854,0.5951448707909162,0.9821976672805403
1287,8842,FGFR2,176943,101200;101400;101600;123150;123500;123790;149730;207410;609579;614592;,"[MIM:123500]Crouzon syndrome [dominant?];[MIM:123150]Jackson-Weiss syndrome [dominant?];[MIM:101200]Apert syndrome;[MIM:101600]Pfeiffer syndrome [dominant?];[MIM:123790]Beare-Stevenson cutis gyrata syndrome [dominant?];[MIM:609579]Familial scaphocephaly syndrome [dominant?];[MIM:149730]Lacrimo-auriculo-dento-digital syndrome [dominant?];[MIM:207410]Antley-Bixler syndrome, without genital anomalies or disordered steroidogenesis;[MIM:614592]Bent bone dysplasia syndrome;[MIM:101400]Saethre-Chotzen syndrome;","Saethre-Chotzen syndrome;Crouzon disease;Apert syndrome;Familial scaphocephaly syndrome, McGillivray type;Antley-Bixler syndrome;Jackson-Weiss syndrome;Cutis gyrata-acanthosis nigricans-craniosynostosis syndrome;Lacrimoauriculodentodigital syndrome;FGFR2-related bent bone dysplasia;Pfeiffer syndrome type 3;Pfeiffer syndrome type 2;Pfeiffer syndrome type 1",Candidate gene tested in;Disease-causing germline mutation(s) (gain of function) in;Disease-causing germline mutation(s) (gain of function) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) (gain of function) in;Disease-causing germline mutation(s) (gain of function) in;Disease-causing germline mutation(s) (gain of function) in,Breast cancer in BRCA2 mutation carriers[21060860];Breast cancer (early onset)[24493630];Prostate-specific antigen levels (conditioned on lead SNPs)[28139693;28139693];Prostate-specific antigen levels[28139693;28139693;28139693;28139693;28139693];Breast cancer[20872241;21263130;21263130;17529967;17529973;19330030;24143190;22951594;20453838;25956309;23354978;23535729;29059683;29059683;29059683];Magnesium levels[26685716];Estrogen receptor status in HER2 negative breast cancer[27764800];Childhood ear infection[27182965];Body mass index[28892062;28892062];Serum prostate-specific antigen levels[21160077];Adiponectin levels[24105470];Cancer (pleiotropy)[27197191];High density lipoprotein cholesterol levels[29403010];Estrogen receptor status in breast cancer[27764800];,0.5741104294478527,0.9285714285714286,0.3463847559383973,0.9935543278084714
1288,8843,FGFR3,134934,100800;109800;146000;149730;162900;182000;187600;187601;254500;273300;602849;603956;610474;612247;616482;,"[MIM:100800]Achondroplasia [dominant?];[MIM:612247]Crouzon syndrome with acanthosis nigricans [dominant?];[MIM:187600]Thanatophoric dysplasia 1;[MIM:187601]Thanatophoric dysplasia 2;[MIM:146000]Hypochondroplasia;[MIM:109800]Bladder cancer;[MIM:603956]Cervical cancer;[MIM:610474]Camptodactyly, tall stature, and hearing loss syndrome [dominant?];[MIM:254500]Multiple myeloma;[MIM:149730]Lacrimo-auriculo-dento-digital syndrome [dominant?];[MIM:162900]Keratinocytic non-epidermolytic nevus;[MIM:602849]Muenke syndrome;[MIM:182000]Keratosis, seborrheic;[MIM:273300]Testicular germ cell tumor;[MIM:616482]Achondroplasia, severe, with developmental delay and acanthosis nigricans;",Achondroplasia;Hypochondroplasia;Saethre-Chotzen syndrome;Thanatophoric dysplasia type 1;Lacrimoauriculodentodigital syndrome;Gliosarcoma;Giant cell glioblastoma;Isolated brachycephaly;Isolated plagiocephaly;Muenke syndrome;Crouzon syndrome-acanthosis nigricans syndrome;Thanatophoric dysplasia type 2;Camptodactyly-tall stature-scoliosis-hearing loss syndrome;Severe achondroplasia-developmental delay-acanthosis nigricans syndrome,Disease-causing germline mutation(s) (gain of function) in;Disease-causing germline mutation(s) (gain of function) in;Candidate gene tested in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Part of a fusion gene in;Part of a fusion gene in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) (loss of function) in;Disease-causing germline mutation(s) in,Urinary bladder cancer[20348956];Blood protein levels[30072576];Bladder cancer[20972438;24163127];,0.4795092024539877,0.5954100051572976,0.6008874967371444,0.9376918354818907
1289,8852,FGG,134850,202400;616004;,"[MIM:202400]Congenital afibrinogenemia [recessive?];[MIM:616004]Dysfibrinogenemia, congenital;",Familial hypodysfibrinogenemia;Familial dysfibrinogenemia;Familial afibrinogenemia;Familial hypofibrinogenemia,Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in,Activated partial thromboplastin time[29403010];D-dimer levels[21502573];Prothrombin time[29403010];Fibrinogen[21757653;20031577];Fibrinogen levels[26561523;26561523];Blood protein levels[30072576];Thrombosis[26908601];Venous thromboembolism[21980494;28373160;25772935;23650146];,0.4894478527607362,0.777720474471377,0.5403288958496476,0.7498465316144874
1290,8860,FH,136850,150800;606812;,[MIM:150800]Hereditary leiomyomatosis and renal cell cancer;,Fumaric aciduria;Hereditary pheochromocytoma-paraganglioma;Hereditary leiomyomatosis and renal cell cancer,Disease-causing germline mutation(s) (loss of function) in;Disease-causing germline mutation(s) (loss of function) in;Disease-causing germline mutation(s) in,Daytime sleep phenotypes[27126917];Major depressive disorder[27479909];,0.8148466257668712,0.5541516245487365,0.7721221613155834,0.8348680171884592
1291,8863,FHIT,601153,,,Hereditary clear cell renal cell carcinoma,Part of a fusion gene in,Papillary thyroid cancer[28703219];Body mass index (joint analysis main effects and smoking interaction)[28443625;28443625;28443625];Depressive symptom measurement or major depressive disorder[28049566];BMI in smokers[28443625;28443625];Major depressive disorder[20125088];Photic sneeze reflex[27182965];Differentiated thyroid cancer[28703219];Asparaginase-induced acute pancreatitis in acute lymphoblastic leukemia (onset time)[27114598];Body mass index[28448500;28448500;28448500;28448500;28448500;28448500;25673413;25673413;25673413;25673413;28892062];Methadone dose in opioid dependence[28115739];Intracranial aneurysm[29531279];Lung function (maximal voluntary ventilation)[29095316];Blood pressure[24954895];Major coronary event in placebo-treated cardiovascular disease (time to event)[28753643];BMI (adjusted for smoking behaviour)[28443625;28443625;28443625];Urinary metabolite concentrations in chronic kidney disease[29545352];Autism spectrum disorder or schizophrenia[28540026];Attention deficit hyperactivity disorder[18821565];Conotruncal heart defects[24800985];Response to amphetamines[22952603];Blood protein levels[30072576];Aortic root size[21223598];Orofacial clefts[22419666];Body mass index (joint analysis main effects and physical activity interaction)[28448500;28448500;28448500;28448500;28448500;28448500];Adverse response to lamotrigine and phenytoin[22379998];BMI in non-smokers[28443625;28443625];Response to citalopram treatment[22760553];Major coronary event in cardiovascular disease (time to event) (darapladib treatment interaction)[28753643];Body mass index in physically active individuals[28448500;28448500;28448500;28448500;28448500];Myopia (pathological)[23049088];Irritable bowel syndrome[29673008];Bronchopulmonary dysplasia[23897914];Cognitive function[25644384];Asperger disorder[21182207];,0.3492024539877301,0.3579164517792677,0.7608979378752284,0.6803253529772867
1292,8864,FHL1,300163,300280;300695;300696;300717;300718;,"[MIM:300696]Emery-Dreifuss muscular dystrophy 6, X-linked;[MIM:300695]Scapuloperoneal myopathy, X-linked dominant;[MIM:300696]Myopathy, X-linked, with postural muscle atrophy;[MIM:300717]Reducing body myopathy, X-linked 1A, severe, with infantile or early childhood onset;[MIM:300718]Reducing body myopathy, X-linked 1B, with late childhood or adult onset;[MIM:300280]Uruguay faciocardiomusculoskeletal syndrome;",X-linked myopathy with postural muscle atrophy;X-linked scapuloperoneal muscular dystrophy;Reducing body myopathy;X-linked Emery-Dreifuss muscular dystrophy,Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in,,0.8539877300613496,0.8758380608561114,0.9261289480553381,0.0
1293,8865,FHL2,602633,,,Familial isolated dilated cardiomyopathy,Disease-causing germline mutation(s) in,Lung cancer in ever smokers[28604730];,0.7152147239263804,0.6704486848891181,0.5395458104933438,0.8674033149171271
1294,8873,FIBP,608296,617107;,,Tall stature-intellectual disability-renal anomalies syndrome,Disease-causing germline mutation(s) (loss of function) in,"Acne (severe)[24927181];Psoriasis[28537254];Chronic inflammatory diseases (ankylosing spondylitis, Crohn's disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy)[26974007];",0.5370552147239264,0.14853017019082002,0.6040198381623597,0.11955187231430325
1295,8875,FIG4,609390,216340;611228;612577;612691;,"[MIM:611228]Charcot-Marie-Tooth disease 4J [recessive?];[MIM:612577]Amyotrophic lateral sclerosis 11;[MIM:216340]Yunis-Varon syndrome [recessive?];[MIM:612691]Polymicrogyria, bilateral temporooccipital;",Amyotrophic lateral sclerosis;Charcot-Marie-Tooth disease type 4J;Yunis-Varon syndrome;Bilateral parasagittal parieto-occipital polymicrogyria,Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) (loss of function) in;Disease-causing germline mutation(s) (loss of function) in,Iron status biomarkers (iron levels)[28334935];Depression in smokers[30219690];Iron status biomarkers (transferrin saturation)[28334935];,0.22687116564417178,0.11655492521918515,0.13521273818846255,0.024248004910988337
1296,8883,FIP1L1,607686,607685;,,Chronic eosinophilic leukemia;Primary hypereosinophilic syndrome;Acute promyelocytic leukemia,Part of a fusion gene in;Part of a fusion gene in;Part of a fusion gene in,DNA methylation (variation)[23725790];Serum VEGFR2 concentration[25411163];Red blood cell count[28453575];,0.8098159509202454,0.7235688499226406,0.7079091620986687,0.6088090853284224
1297,8913,FKBP10,607063,259450;610968;,[MIM:610968]Osteogenesis imperfecta 11 [recessive?];[MIM:259450]Bruck syndrome 1;,Bruck syndrome;Kuskokwim syndrome;Osteogenesis imperfecta type 3;Osteogenesis imperfecta type 4,Disease-causing germline mutation(s) (loss of function) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in,Immune reponse to smallpox (secreted IL-12p40)[22610502];,0.6723926380368098,0.5085095410005157,0.6423910206212478,0.5044505831798649
1298,8915,FKBP14,614505,614557;,"[MIM:614557]Ehlers-Danlos syndrome, kyphoscoliotic type, 2 [recessive?];","Ehlers-Danlos syndrome, kyphoscoliotic and deafness type",Disease-causing germline mutation(s) in,Estradiol levels[22675492];,0.4190184049079755,0.2292418772563177,0.8034455755677369,0.18615715162676488
1299,8918,FKRP,606596,606612;607155;613153;,[MIM:613153]Muscular dystrophy-dystroglycanopathy congenital with brain and eye anomalies A5 [recessive?];[MIM:606612]Muscular dystrophy-dystroglycanopathy congenital with or without mental retardation B5;[MIM:607155]Muscular dystrophy-dystroglycanopathy limb-girdle C5 [recessive?];,Congenital muscular dystrophy with cerebellar involvement;Congenital muscular dystrophy with intellectual disability;Congenital muscular dystrophy without intellectual disability;Muscle-eye-brain disease;Walker-Warburg syndrome;Autosomal recessive limb-girdle muscular dystrophy type 2I,Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) (loss of function) in;Disease-causing germline mutation(s) in,,0.27975460122699386,0.6513666838576586,0.5873140172278778,0.0
1300,8919,FKTN,607440,253800;611588;611615;613152;,"[MIM:613152]Muscular dystrophy-dystroglycanopathy congenital without mental retardation B4 [recessive?];[MIM:611588]Muscular dystrophy-dystroglycanopathy limb-girdle C4 [recessive?];[MIM:611615]Cardiomyopathy, dilated 1X;","Familial isolated dilated cardiomyopathy;Autosomal recessive limb-girdle muscular dystrophy type 2M;Congenital muscular dystrophy without intellectual disability;Muscle-eye-brain disease;Walker-Warburg syndrome;Congenital muscular dystrophy, Fukuyama type",Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) (loss of function) in;Disease-causing germline mutation(s) in,Menarche (age at onset)[19448620];,0.08736196319018405,0.18824136152656007,0.16496998172800836,0.5188766114180479
1301,8920,FLAD1,610595,255100;,[MIM:255100]Lipid storage myopathy due to flavin adenine dinucleotide synthetase deficiency [recessive?];,"Multiple acyl-CoA dehydrogenase deficiency, mild type;Multiple acyl-CoA dehydrogenase deficiency, severe neonatal type",Disease-causing germline mutation(s) (loss of function) in;Disease-causing germline mutation(s) (loss of function) in,Prostate cancer[23535732];,0.8824539877300613,0.17792676637441981,0.6705820934481859,0.8494475138121547
1302,8921,FLCN,607273,135150;144700;173600;,[MIM:135150]Birt-Hogg-Dube syndrome [dominant?];[MIM:173600]Primary spontaneous pneumothorax [dominant?] [recessive?];[MIM:144700]Renal cell carcinoma;,Familial spontaneous pneumothorax;Hereditary clear cell renal cell carcinoma;Birt-Hogg-Dub� syndrome,Disease-causing germline mutation(s) in;Candidate gene tested in;Disease-causing germline mutation(s) in,,0.5213496932515338,0.6498194945848376,0.8277212216131559,0.8026396562308165
1303,8924,FLG2,616284,,,Peeling skin syndrome type A,Disease-causing germline mutation(s) (loss of function) in,Eating disorders[23568457];,0.6080981595092024,0.4669932955131511,0.02949621508744453,0.0187231430325353
1304,8925,FLI1,193067,612219;617443;,"[MIM:612219]Ewing sarcoma;[MIM:617443]Bleeding disorder, platelet-type 21;",Jacobsen syndrome;Isolated delta-storage pool disease;Paris-Trousseau thrombocytopenia;Ewing sarcoma;Peripheral primitive neuroectodermal tumor;Extraskeletal Ewing sarcoma,Role in the phenotype of;Disease-causing germline mutation(s) in;Role in the phenotype of;Part of a fusion gene in;Part of a fusion gene in;Part of a fusion gene in,Digit length ratio (right hand)[29659830];Amyotrophic lateral sclerosis (sporadic)[24529757];Plateletcrit[27863252];Albumin-globulin ratio[29403010];Rheumatoid arthritis (ACPA-positive)[24532676];Vitiligo[27723757];Systemic lupus erythematosus[27399966;26502338;26502338];Rheumatoid arthritis[22446963];Myopia (pathological)[23049088];Digit length ratio (left hand)[29659830;29659830];Height[20881960];Digit length ratio[29659830];Non-albumin protein levels[29403010];Coronary artery calcified atherosclerotic plaque (130 HU threshold) in type 2 diabetes[29221444];Platelet count[27863252];Left ventricular obstructive tract defect (inherited effect)[28468790];,0.36171779141104293,0.9161939143888602,0.8024014617593318,0.4722222222222222
1305,8927,FLII,600362,,,Smith-Magenis syndrome,Candidate gene tested in,,0.9766871165644172,0.44610624033006707,0.43696162881754114,0.16881522406384286
1306,8928,FLNA,300017,300048;300049;300244;300321;304120;305620;309350;311300;314400;,"[MIM:300049]Periventricular nodular heterotopia 1;[MIM:311300]Otopalatodigital syndrome 1;[MIM:304120]Otopalatodigital syndrome 2;[MIM:305620]Frontometaphyseal dysplasia 1;[MIM:309350]Melnick-Needles syndrome;[MIM:300048]Intestinal pseudoobstruction, neuronal, chronic idiopathic, X-linked;[MIM:300321]FG syndrome 2;[MIM:300244]Terminal osseous dysplasia;[MIM:314400]Cardiac valvular dysplasia X-linked;[MIM:300048]Congenital short bowel syndrome, X-linked;","Congenital short bowel syndrome;Frontometaphyseal dysplasia;Melnick-Needles syndrome;Congenital valvular dysplasia;Ehlers-Danlos syndrome, cardiac valvular type;X-linked keloid scarring-reduced joint mobility-increased optic cup-to-disc ratio syndrome;Terminal osseous dysplasia-pigmentary defects syndrome;Otopalatodigital syndrome type 2;Otopalatodigital syndrome type 1;Ehlers-Danlos syndrome with periventricular heterotopia;Periventricular nodular heterotopia;Neuronal intestinal pseudoobstruction",Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) (gain of function) in;Disease-causing germline mutation(s) (gain of function) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) (loss of function) in;Disease-causing germline mutation(s) (loss of function) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) (gain of function) in;Disease-causing germline mutation(s) (gain of function) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) (loss of function) in;Disease-causing germline mutation(s) in,,0.989079754601227,0.7743682310469314,0.296528321587053,0.996316758747698
1307,8929,FLNB,603381,108720;108721;112310;150250;272460;,[MIM:108720]Atelosteogenesis 1;[MIM:108721]Atelosteogenesis 3;[MIM:112310]Boomerang dysplasia;[MIM:150250]Larsen syndrome;[MIM:272460]Spondylocarpotarsal synostosis syndrome;,Boomerang dysplasia;Atelosteogenesis type I;Spondylocarpotarsal synostosis;Larsen syndrome;Atelosteogenesis type III,Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) (gain of function) in;Disease-causing germline mutation(s) (loss of function) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in,Optic cup area[28073927;28073927;25631615;25631615];High light scatter reticulocyte percentage of red cells[27863252];Reticulocyte fraction of red cells[27863252];Gut microbiota (bacterial taxa)[27723756];Reticulocyte count[27863252];Eating disorders (purging via substances)[23568457];High light scatter reticulocyte count[27863252];Vertical cup-disc ratio[28073927;28073927];Adverse response to chemotherapy (neutropenia/leucopenia) (carboplatin)[23648065];Immature fraction of reticulocytes[27863252];,0.8849079754601227,0.17199587416193915,0.2636387366222918,0.990791896869245
1308,8931,FLNC,102565,609524;614065;617047;,"[MIM:609524]Myopathy, myofibrillar, 5;[MIM:614065]Myopathy, distal, 4;[MIM:617047]Cardiomyopathy, familial hypertrophic 26;[MIM:617047]Cardiomyopathy, familial restrictive 5;",Muscle filaminopathy;Distal myopathy with posterior leg and anterior hand involvement;Familial isolated restrictive cardiomyopathy,Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in,Reading disability or specific language impairment adjusted for intelligence quotient (pleiotropy)[25065397];Reading disability or specific language impairment (pleiotropy)[25065397];,0.900122699386503,0.9689272821041774,0.27329678935003915,0.9779005524861878
1309,8935,FLRT1,604806,,,Spastic paraplegia-optic atrophy-neuropathy syndrome,Disease-causing germline mutation(s) in,Inflammatory bowel disease[23128233];,0.27975460122699386,0.6534296028880866,0.7131297311406943,0.8825966850828729
1310,8937,FLRT3,604808,615271;,[MIM:615271]Hypogonadotropic hypogonadism 21 with or without anosmia;,Kallmann syndrome,Disease-causing germline mutation(s) in,Mood disorder in prion disease[25897833];Blood protein levels[29875488;30072576];,0.22687116564417178,0.61397627643115,0.14878621769772904,0.7183855125844076
1311,8938,FLT1,165070,,,Preeclampsia,Major susceptibility factor in,"Body mass index[26426971];Cognitive performance[19734545];Spherical equivalent or myopia (age of diagnosis)[29808027];Coronary heart disease[23364394];Coronary artery disease[29212778;29212778;29212778];Coronary artery disease (myocardial infarction, percutaneous transluminal coronary angioplasty, coronary artery bypass grafting, angina or chromic ischemic heart disease)[28714975];",0.48208588957055215,0.5781330582774626,0.6113286348211955,0.39241866175567836
1312,8940,FLT3,136351,601626;,"[MIM:601626]Leukemia, acute myelogenous;",Mixed phenotype acute leukemia;Acute myeloblastic leukemia without maturation;Acute myeloblastic leukemia with maturation;Acute myeloid leukemia with minimal differentiation;Acute myeloid leukemia with abnormal bone marrow eosinophils inv(16)(p13q22) or t(16;16)(p13;q22);Acute myeloid leukemia with t(8;21)(q22;q22) translocation;Precursor B-cell acute lymphoblastic leukemia;Precursor T-cell acute lymphoblastic leukemia,Disease-causing somatic mutation(s) in;Disease-causing somatic mutation(s) in;Disease-causing somatic mutation(s) in;Disease-causing somatic mutation(s) in;Biomarker tested in;Biomarker tested in;Disease-causing somatic mutation(s) in;Disease-causing somatic mutation(s) in,Granulocyte percentage of myeloid white cells[27863252;27863252];Lymphocyte percentage of white cells[27863252];White blood cell count (monocyte)[28158719];Myeloid white cell count[27863252;27863252;27863252];Sum basophil neutrophil counts[27863252];Sum neutrophil eosinophil counts[27863252];Monocyte percentage of white cells[27863252;27863252];Granulocyte count[27863252];Neutrophil count[27863252];Body mass index[25673413;25673413];Serum total protein level[29403010];White blood cell count[27863252;27863252];Pancreatic cancer[25086665];Monocyte count[27863252;27863252;27863252;27863252;29403010];Non-albumin protein levels[29403010];,0.33975460122699386,0.8156266116554926,0.0871835030018272,0.6284530386740331
1313,8942,FLT4,136352,153100;602089;,"[MIM:153100]Lymphedema, hereditary, 1A;[MIM:602089]Hemangioma, capillary infantile;",Milroy disease,Disease-causing germline mutation(s) in,Serum folate levels[29953918];Blood protein levels[29875488;30072576];,0.5040490797546012,0.849406910778752,0.29287392325763506,0.9370779619398404
1314,8943,FLVCR1,609144,609033;,[MIM:609033]Posterior column ataxia with retinitis pigmentosa;,Posterior column ataxia-retinitis pigmentosa syndrome,Disease-causing germline mutation(s) in,,0.7638036809815951,0.4834966477565756,0.11354737666405638,0.3902701043585021
1315,8945,FLVCR2,610865,225790;,,Fowler syndrome,Disease-causing germline mutation(s) in,,0.038773006134969326,0.6186178442496132,0.2738188462542417,0.2576734192756292
1316,8951,FMN2,606373,616193;,"[MIM:616193]Mental retardation, autosomal recessive 47 [recessive?];",Autosomal recessive non-syndromic intellectual disability,Disease-causing germline mutation(s) in,Anger[24489884];Heel bone mineral density[28869591;28869591;28869591];Bone mineral density (Ward's triangle area)[27397699];Bone mineral density[23437003];Alzheimer's disease (cognitive decline)[23535033];Urate levels in obese individuals[25811787];,0.2498159509202454,0.8347086126869521,0.07883059253458627,0.2438612645794966
1317,8957,FMO3,136132,602079;,,Severe primary trimethylaminuria,Disease-causing germline mutation(s) (loss of function) in,Blood metabolite levels[24816252];Lentiform nucleus volume[22903471];,0.12711656441717792,0.053893759669932956,0.05116157661185069,0.004450583179864948
1318,8967,FMR1,309550,300623;300624;311360;616034;,[MIM:300624]Fragile X syndrome;[MIM:300623]Fragile X tremor/ataxia syndrome;[MIM:311360]Premature ovarian failure 1;,Fragile X syndrome;Xq27.3q28 duplication syndrome;Symptomatic form of fragile X syndrome in female carrier;Fragile X-associated tremor/ataxia syndrome,Disease-causing germline mutation(s) (loss of function) in;Role in the phenotype of;Disease-causing germline mutation(s) (loss of function) in;Disease-causing germline mutation(s) (gain of function) in,Antineutrophil cytoplasmic antibody-associated vasculitis[22808956];,0.9649079754601227,0.7246003094378546,0.653876272513704,0.32642725598526706
1319,8971,FMR3,,,,FRAXE intellectual disability,Disease-causing germline mutation(s) in,,0.038773006134969326,0.0,0.0,0.0
1320,8972,FN1,135600,184255;601894;,"[MIM:601894]Glomerulopathy with fibronectin deposits 2 [dominant?];[MIM:184255]Spondylometaphyseal dysplasia, corner fracture type [dominant?];","Spondylometaphyseal dysplasia, 'corner fracture' type;Fibronectin glomerulopathy",Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in,"Total cholesterol levels[28334899];Pulse pressure[28135244;28135244];LDL cholesterol levels[28334899];Cholesterol, total[26780889];Blood protein levels[28240269;28240269;28240269;30072576;30072576;30072576;30072576;30072576;30072576;30072576];LDL cholesterol[24097068];Coronary artery disease[29212778;29212778;29212778];Coronary artery disease (myocardial infarction, percutaneous transluminal coronary angioplasty, coronary artery bypass grafting, angina or chromic ischemic heart disease)[28714975];",0.8777914110429448,0.28261990716864366,0.29522317932654657,0.20395948434622468
1321,9002,FOLR1,136430,613068;,[MIM:613068]Neurodegeneration due to cerebral folate transport deficiency;,Neurodegenerative syndrome due to cerebral folate transport deficiency,Disease-causing germline mutation(s) (loss of function) in,,0.7494478527607362,0.5605982465188242,0.8253719655442443,0.13182934315531
1322,9008,FOS,164810,,,Berardinelli-Seip congenital lipodystrophy,Disease-causing germline mutation(s) in,"Inflammatory bowel disease[23128233];Chronic inflammatory diseases (ankylosing spondylitis, Crohn's disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy)[26974007];Periodontal microbiota[22699663];Crohn's disease[28067908];",0.7300613496932515,0.7748839608045385,0.8010963194988254,0.5857888275015347
1323,9018,FOXC1,601090,601631;602482;,[MIM:602482]Axenfeld-Rieger syndrome 3 [dominant?];[MIM:601631]Anterior segment dysgenesis 3 [dominant?];,Isolated aniridia;Peters anomaly;Axenfeld-Rieger syndrome;Rieger anomaly;Axenfeld anomaly,Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in,Glaucoma (primary open-angle)[26752265;26752265;29891935];Glaucoma[30054594];Monobrow thickness[26926045];Non-response to citalopram or escitalopram and depression[27622933];Glaucoma (high intraocular pressure)[26752265];Response to platinum-based agents[22020760];Daytime sleep phenotypes[27126917;27126917];Coronary artery disease[29212778;29212778];Intraocular pressure[30054594;29785010];,0.7904294478527607,0.8953068592057761,0.19472722526755418,0.0
1324,9019,FOXC2,602402,153400;,[MIM:153400]Lymphedema-distichiasis;,Lymphedema-distichiasis syndrome,Disease-causing germline mutation(s) in,Nose size[27182965];Systemic juvenile idiopathic arthritis[27927641];Sepsis in extremely premature infants[28283553];,0.5911656441717792,0.5822588963383187,0.7564604541895067,0.0
1325,9034,FOXE1,602617,241850;616534;,"[MIM:241850]Bamforth-Lazarus syndrome;[MIM:616534]Thyroid cancer, non-medullary, 4;",Differentiated thyroid carcinoma;Bamforth-Lazarus syndrome;Familial papillary or follicular thyroid carcinoma;Athyreosis,Major susceptibility factor in;Disease-causing germline mutation(s) (loss of function) in;Disease-causing germline mutation(s) in;Candidate gene tested in,"Thyroid hormone levels[23408906;23408906;23408906];Papillary thyroid cancer[28703219];Alzheimer disease and age of onset[26830138];Parent of origin effect on language impairment (paternal)[24571439];Serum thyroid-stimulating hormone levels[24852370;25436638];Plasma thyroid-stimulating hormone levels[28333968];Hypothyroidism[21981779;22493691;27182965];Orofacial clefts[28054174];Differentiated thyroid cancer[28703219];Alopecia areata[25608926];Thyroid cancer (Papillary, radiation-related)[20350937];Thyroid cancer[19198613;23894154;25855579;25855579];Obesity-related traits[23251661];",0.5822085889570552,0.8176895306859205,0.6802401461759332,0.0
1326,9035,FOXE3,601094,610256;612968;617349;,"[MIM:610256]Anterior segment dysgenesis 2 [recessive?];[MIM:612968]Cataract 34, multiple types;[MIM:617349]Aortic aneurysm, familial thoracic 11;",Peters anomaly;Anterior segment developmental anomaly;Familial thoracic aortic aneurysm and aortic dissection;Congenital primary aphakia,Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in,,0.038773006134969326,0.7426508509541001,0.6567475854868181,0.0
1327,9036,FOXF1,601089,265380;,[MIM:265380]Alveolar capillary dysplasia with misalignment of pulmonary veins;,Congenital alveolar capillary dysplasia,Disease-causing germline mutation(s) in,Breast cancer (survival)[25526632];Barrett's esophagus  or Esophageal adenocarcinoma[27527254];Barrett's esophagus[22961001];Corneal astigmatism[23322567];Digestive system disease (Barrett's esophagus and esophageal adenocarcinoma combined)[24121790];Esophageal adenocarcinoma[24121790];Obesity (early onset extreme)[23563609];,0.3706748466257669,0.8978855079938113,0.6708431219002872,0.0
1328,9038,FOXG1,164874,613454;,,14q12 microdeletion syndrome;14q11.2 microduplication syndrome;Atypical Rett syndrome,Role in the phenotype of;Role in the phenotype of;Disease-causing germline mutation(s) in,Plasma omega-3 polyunsaturated fatty acid levels (docosapentaenoic acid)[21829377];Manganese levels[26025379];Resting oxygen saturation in chronic osbtructive pulmonary disease (pulse oxymetry)[24825563];Longevity[20834067];Takayasu arteritis[25604533];,0.5786503067484663,0.8909231562661165,0.9026363873662229,0.0
1329,9040,FOXH1,603621,,,Microform holoprosencephaly;Septopreoptic holoprosencephaly;Semilobar holoprosencephaly;Midline interhemispheric variant of holoprosencephaly;Lobar holoprosencephaly;Alobar holoprosencephaly,Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in,General cognitive ability[29844566];Educational attainment[25201988];,0.5585276073619632,0.5190820010314595,0.48655703471678413,0.7329650092081031
1330,9041,FOXI1,601093,,,Pendred syndrome;Autosomal recessive distal renal tubular acidosis,Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in,Adverse response to chemotherapy (neutropenia/leucopenia) (all platinum-based drugs)[23648065];Acne (severe)[24927181];,0.43754601226993867,0.7684373388344508,0.7961367789089011,0.9137507673419276
1331,9050,FOXL2,605597,110100;608996;,"[MIM:110100]Blepharophimosis, ptosis, and epicanthus inversus syndrome;[MIM:608996]Premature ovarian failure 3;",Blepharophimosis-epicanthus inversus-ptosis due to copy number variations;Blepharophimosis-epicanthus inversus-ptosis due to 3q23 rearrangement syndrome;Blepharophimosis-epicanthus inversus-ptosis due to a point mutation syndrome;Maligant granulosa cell tumor of the ovary,Disease-causing germline mutation(s) in;Role in the phenotype of;Disease-causing germline mutation(s) in;Disease-causing somatic mutation(s) in,Ear morphology[26105758];Lobe size[26105758];Keloid[20711176];Lobe attachment (rater scored)[29198719;29198719];Eyebrow thickness[26926045];Lobe attachment (rater-scored or self-reported)[29198719];,0.5479754601226994,0.8525012893243941,0.21769772905246673,0.0
1332,9053,FOXN1,600838,601705;,,Alymphoid cystic thymic dysgenesis,Disease-causing germline mutation(s) in,Tonsillectomy[27182965;28928442];,0.45950920245398774,0.8795771015987622,0.1419994779430958,0.8677102516881522
1333,9060,FOXO1,136533,268220;,[MIM:268220]Rhabdomyosarcoma 2;,Alveolar rhabdomyosarcoma,Part of a fusion gene in,"Granulocyte percentage of myeloid white cells[27863252];Mean corpuscular hemoglobin[27863252;29403010];Mean corpuscular volume[27863252;29403010];Corneal structure[23291589];Eosinophil counts[27863252];Monocyte percentage of white cells[27863252];Red blood cell count[29403010];Sum eosinophil basophil counts[27863252];Uterine fibroids[30194396];Eosinophil percentage of granulocytes[27863252];Allergic disease (asthma, hay fever or eczema)[29083406];Central corneal thickness[20719862;20485516;29760442];Monocyte count[27863252];Eosinophil percentage of white cells[27863252];Intraocular pressure[29617998;29617998;29235454];",0.5312883435582823,0.94559051057246,0.437744714173845,0.0
1334,9066,FOXP1,605515,613670;,[MIM:613670]Mental retardation with language impairment and autistic features;,Intellectual disability-severe speech delay-mild dysmorphism syndrome;MALT lymphoma;Precursor B-cell acute lymphoblastic leukemia,Disease-causing germline mutation(s) in;Part of a fusion gene in;Part of a fusion gene in,Multiple sclerosis[24076602];Basal cell carcinoma[27539887];Mean corpuscular volume[27863252];Mean corpuscular hemoglobin[27863252];Lymphocyte percentage of white cells[27863252;27863252];Lymphocyte counts[27863252];Prudent dietary pattern[28644415];Primary sclerosing cholangitis[27992413;27992413];Selective IgA deficiency[27723758];Intelligence (MTAG)[29326435];Vitiligo[27723757];Barrett's esophagus  or Esophageal adenocarcinoma[27527254];Barrett's esophagus[24121790];Cognitive ability (MTAG)[29186694];Familial lung adenocarcinoma[29924316];Subcutaneous adipose tissue[22589738];Esophageal adenocarcinoma[24121790];Non-melanoma skin cancer[29739929];Squamous cell carcinoma[26829030];Autism spectrum disorder or schizophrenia[28540026];Attention deficit hyperactivity disorder[18821565];Hand grip strength[29691431;29691431];Crohn's disease[28067908];Breast cancer[29059683];Red blood cell count[27863252];LDL cholesterol change in response to fenofibrate in statin-treated type 2 diabetes[28736931];General cognitive ability[29844566;29844566];Inflammatory bowel disease[28067908];Tooth agenesis (maxillary lateral incisors)[29364747];Nose size[27182965];Neutrophil percentage of white cells[27863252];Digestive system disease (Barrett's esophagus and esophageal adenocarcinoma combined)[24121790];Intraocular pressure[24002674;29617998;29617998];,0.4154601226993865,0.9834966477565755,0.73061863743148,0.8646408839779005
1335,9069,FOXP2,605317,602081;,[MIM:602081]Speech-language disorder 1;,7q31 microdeletion syndrome;Childhood apraxia of speech,Role in the phenotype of;Disease-causing germline mutation(s) in,Pelvic organ prolapse (moderate/severe)[26545240];Neuroticism[29255261];Conotruncal heart defects (maternal effects)[28468790];Midgestational circulating levels of PBDEs (fetal genetic effect)[28235828];Blood pressure (smoking interaction)[25189868;25189868];Self-reported risk-taking behaviour[30181555];Serum sulfate level[27412988];Crohn's disease[22936669];Beard thickness[26926045];Sleep duration[27992416];Urate levels in obese individuals[25811787];Congenital heart disease (maternal effect)[28468790];Body mass index[25673413;28892062];Deep ovarian and/or rectovaginal disease with dense adhesions[28333195];Age at first birth[27798627;27798627];,0.5469938650306748,0.7362042289840124,0.5053510832680762,0.7638121546961326
1336,9070,FOXP3,300292,304790;,"[MIM:304790]Immunodeficiency polyendocrinopathy, enteropathy, X- linked syndrome;",Immune dysregulation-polyendocrinopathy-enteropathy-X-linked syndrome,Disease-causing germline mutation(s) in,Vitiligo[27723757];,0.6147239263803681,0.9363073749355337,0.7849125554685461,0.930939226519337
1337,9076,FOXRED1,613622,252010;,[MIM:252010]Mitochondrial complex I deficiency;,Isolated complex I deficiency;Leigh syndrome with leukodystrophy,Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in,,0.8471165644171779,0.04641567818463126,0.10676063690942313,0.5515653775322283
1338,9082,FPR1,136537,,,Susceptibility to localized juvenile periodontitis,Disease-causing germline mutation(s) in,Neutrophil percentage of granulocytes[27863252];Alopecia areata[25608926];,0.2498159509202454,0.0,0.1915948838423388,0.3052486187845304
1339,9197,FRAS1,607830,219000;,[MIM:219000]Fraser syndrome 1 [recessive?];,"Fraser syndrome;Renal agenesis, unilateral",Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in,Left ventricular obstructive tract defect (maternal effect)[28468790];QT interval[29213071];Uric acid levels[23703922];Itch intensity from mosquito bite adjusted by bite size[28199695];Response to carboplatin in ovarian cancer (MTT IC50)[27047539];Hair shape[29220522];Night sleep phenotypes[27126917];Hair morphology[19896111];,0.47705521472392637,0.03197524497163486,0.018010963194988253,0.1496316758747698
1340,9207,FREM1,608944,248450;608980;614485;,"[MIM:608980]Bifid nose, with or without anorectal and renal anomalies;[MIM:248450]Manitoba oculotrichoanal syndrome;[MIM:614485]Trigonocephaly 2;","Oculotrichoanal syndrome;Isolated trigonocephaly;BNAR syndrome;Renal agenesis, unilateral",Disease-causing germline mutation(s) (loss of function) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) (loss of function) in;Disease-causing germline mutation(s) in,"Alcoholic chronic pancreatitis[28754779];Facial morphology (factor 17, height of vermillion upper lip)[28441456];Height[19893584];",0.08736196319018405,0.0030943785456420837,0.04802923518663534,0.006599140577041129
1341,9208,FREM2,608945,617666;,[MIM:617666]Fraser syndrome 2 [recessive?];,"Fraser syndrome;Renal agenesis, unilateral;Complete cryptophthalmia",Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) (loss of function) in,Cytomegalovirus antibody response[21993531];Yu-Zhi constitution type in type 2 diabetes[26169365];,0.33975460122699386,0.09334708612686952,0.008613938919342208,0.21132596685082872
1342,9211,FRG1,601278,158900;,,Facioscapulohumeral dystrophy,Candidate gene tested in,Brain volume in infants (cerebrospinal fluid)[28763065];Urinary albumin excretion[30220432];Urinary albumin excretion (no hypertensive medication)[30220432];Periodontitis (CDC/AAP)[24024966];,0.8666257668711657,0.4711191335740072,0.6726703210649961,0.02608962553713935
1343,9239,FRMD4A,616305,616819;,"[MIM:616819]Agenesis of the corpus callosum, with facial anomalies and cerebellar ataxia [recessive?];",Severe intellectual disability-corpus callosum agenesis-facial dysmorphism-cerebellar ataxia syndrome,Disease-causing germline mutation(s) in,Obstetric antiphospholipid syndrome[28424481];Knee osteoarthritis[27696742];Adiponectin levels[26299439];Alcohol consumption (maxi-drinks)[29460428];RR interval (heart rate)[20031603];Craniofacial microsomia[26853712];Takayasu arteritis[25604533];Red cell distribution width[27863252];Alzheimer's disease[22430674];,0.12711656441717792,0.6823104693140795,0.4032889584964761,0.8414671577655003
1344,9253,FRMPD4,300838,300983;,"[MIM:300983]Mental retardation, X-linked 104;",X-linked non-syndromic intellectual disability,Disease-causing germline mutation(s) in,,0.12711656441717792,1.0,0.7188723570869224,0.9468999386126458
1345,9256,FRRS1L,604574,616981;,,Continuous spikes and waves during sleep;Autosomal recessive non-syndromic intellectual disability,Candidate gene tested in;Disease-causing germline mutation(s) in,Body mass index[28892062];Early-onset Parkinson's disease[28256260];,0.038773006134969326,0.4198040226921093,0.7640302793004438,0.0
1346,9267,FSCN2,607643,607921;,,Retinitis pigmentosa,Disease-causing germline mutation(s) in,,0.10711656441717791,0.0703971119133574,0.5215348472983555,0.0
1347,9272,FSHB,136530,229070;,[MIM:229070]Hypogonadotropic hypogonadism 24 without anosmia;,Isolated follicle stimulating hormone deficiency,Disease-causing germline mutation(s) (loss of function) in,Polycystic ovary syndrome[26416764;26284813];Body mass index[25673413];Spherical equivalent or myopia (age of diagnosis)[29808027];Menopause (age at onset)[26414677];Spontaneous dizygotic twinning[27132594];Sex hormone levels[26014426;26014426];Length of menstrual cycle[26732621];Endometriosis[28537267;28537267];Menarche (age at onset)[25231870;27182965];Luteinizing hormone levels in polycystic ovary syndrome[26284813];,0.20368098159509201,0.666322846828262,0.8773166275123988,0.48756906077348067
1348,9275,FSHR,136435,233300;608115;,[MIM:233300]Ovarian dysgenesis 1 [recessive?];[MIM:608115]Ovarian hyperstimulation syndrome;,"46,XX gonadal dysgenesis;Ovarian hyperstimulation syndrome",Disease-causing germline mutation(s) (loss of function) in;Major susceptibility factor in,Polycystic ovary syndrome[21151128;22885925];Adverse response to chemotherapy (neutropenia/leucopenia) (etoposide)[23648065];Radiation response[20923822];Lung cancer in ever smokers[28604730];Response to anti-retroviral therapy (ddI/d4T) in HIV-1 infection (Grade 3 peripheral neuropathy)[24554482];Erectile dysfunction and prostate cancer treatment[20932654];Laterality in neovascular age-related macular degeneration[28775256];Depressive symptoms (SSRI exposure interaction)[25649181];,0.4190184049079755,0.24136152656008253,0.11850691725398069,0.43370165745856354
1349,9277,FSIP2,615796,,,Non-syndromic male infertility due to sperm motility disorder,Disease-causing germline mutation(s) in,,0.038773006134969326,0.43501805054151627,0.03837118245888802,0.0
1350,9285,FTCD,606806,229100;,[MIM:229100]Glutamate formiminotransferase deficiency;,Formiminoglutamic aciduria,Disease-causing germline mutation(s) in,Blood protein levels[30072576];,0.16220858895705523,0.5219185146982981,0.29678935003915424,0.4743707796193984
1351,9288,FTH1,134770,615517;,,FTH1-related iron overload,Disease-causing germline mutation(s) in,Plasma omega-3 polyunsaturated fatty acid levels (docosapentaenoic acid)[21829377];Plasma omega-6 polyunsaturated fatty acid levels (arachidonic acid)[24823311;24823311];Plasma omega-6 polyunsaturated fatty acid levels (linoleic acid)[24823311;24823311];Plasma omega-6 polyunsaturated fatty acid levels (gamma-linolenic acid)[24823311];Plasma omega-6 polyunsaturated fatty acid levels (dihomo-gamma-linolenic acid)[24823311];Estradiol levels[22675492];Plasma omega-3 polyunsaturated fatty acid level (eicosapentaenoic acid)[21829377];,0.554601226993865,0.610366168127901,0.9467501957713391,0.6895334561080417
1352,9316,FTL,134790,600886;606159;615604;,[MIM:600886]Hyperferritinemia with or without cataract [dominant?];[MIM:606159]Neurodegeneration with brain iron accumulation 3;[MIM:615604]L-ferritin deficiency;,Hereditary hyperferritinemia-cataract syndrome;Neuroferritinopathy;Genetic hyperferritinemia without iron overload;L-ferritin deficiency;L-ferritin deficiency,Disease-causing germline mutation(s) (gain of function) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) (loss of function) in;Disease-causing germline mutation(s) (gain of function) in,,0.5244171779141105,0.12119649303764828,0.9336987731662751,0.1603744628606507
1353,9337,FTO,610966,601665;612460;612938;,"[MIM:612938]Growth retardation, developmental delay, and facial dysmorphism;[MIM:601665]Obesity;","Lethal polymalformative syndrome, Boissel type",Disease-causing germline mutation(s) (loss of function) in,Type 2 diabetes[17554300;18372903;19056611;17463249;17463248;22693455;20581827;24509480;23209189;26818947;22885922;22885922;22885922;28869590;28869590];Body mass index (joint analysis main effects and smoking interaction)[28443625;28443625;28443625];Response to TNF inhibitor in rheumatoid arthritis (change in swollen 28-joint count)[30166627];Breast size[27182965];Triglyceride levels[28334899];Menarche (age at onset)[21102462;25231870;27182965];Biomedical quantitative traits[19396169];Body fat percentage[26833246;26833246;26833246;26833246;26833246;26833246;28270201];Body mass index in physically inactive individuals[28448500;28448500;28448500;28448500;28448500;28448500];Body mass index[20935630;17434869;18454148;19079261;24064335;23669352;23563607;24861553;24348519;22982992;19079260;19079260;28448500;28448500;28448500;28448500;28448500;28448500;28270201;23583978;25673413;25673413;25673413;25673413;26426971;25953783;25953783;28892062;28892062;30045251];Body mass index (age interaction)[25953783];Body mass index (adult)[28430825;28430825;28430825];Lean body mass[28724990];Systolic blood pressure x smoking status (ever vs never) interaction (2df test)[29455858;29455858];BMI (adjusted for smoking behaviour)[28443625;28443625;28443625];Body mass index (SNP x SNP interaction)[22344221];Mean arterial pressure x alcohol consumption interaction (2df test)[29912962;29912962];Obesity[23563607;21544081;21552555;23563607;23563607;23563607;19151714;19151714;19151714];Glycated hemoglobin levels[28898252];Obesity (extreme)[19553259];Melanoma[28212542;23455637];Waist-hip ratio[25673412;25673412;25673412];Systolic blood pressure x smoking status (current vs non-current) interaction (2df test)[29455858;29455858];Weight[19079260;19079260];Body mass index (joint analysis main effects and physical activity interaction)[28448500;28448500;28448500;28448500;28448500;28448500];Sasang constitutional medicine type (So-Eum)[25888059];Waist circumference[19557197;25673412;25673412;25673412];HDL cholesterol levels[28334899];Body mass index x sex x age interaction (4df test)[26426971];Pulse pressure x alcohol consumption interaction (2df test)[29912962;29912962;29912962];Diastolic blood pressure x smoking status (current vs non-current) interaction (2df test)[29455858;29455858];Dietary macronutrient intake[23636237;29988085];Body mass in chronic obstructive pulmonary disease[21037115];Osteoarthritis[22763110];circulating leptin levels[26833098;26833098];Strenuous sports or other exercises[29899525];BMI in smokers[28443625;28443625;28443625];Metabolic syndrome[22399527];Blood urea nitrogen levels[29403010];Body mass index (age <50)[26426971];Adiposity[21706003];Hip circumference[25673412;25673412;25673412];Allergic rhinitis[25085501];Body mass index (age>50)[26426971];Systolic blood pressure x alcohol consumption interaction (2df test)[29912962];Obesity-related traits[17658951;17658951;17658951];Subcutaneous adipose tissue[22589738;22589738;27918534];Eyebrow thickness[26926045];Childhood body mass index[26604143];Sex hormone-binding globulin levels[22675492];Heel bone mineral density[28869591;28869591];Hand grip strength[29691431;29691431];Breast cancer[23535733;27117709;27117709;23535729;23535733;29059683;29059683];Triglycerides[24097068];Diastolic blood pressure x smoking status (ever vs never) interaction (2df test)[29455858;29455858];Breast cancer (estrogen-receptor negative)[27117709;27117709;29058716];Obesity (early onset extreme)[18159244;20421936;23563609];HDL cholesterol[24097068];BMI in non-smokers[28443625;28443625;28443625];Body mass index in physically active individuals[28448500;28448500;28448500;28448500;28448500;28448500];C-reactive protein levels or HDL-cholesterol levels (pleiotropy)[27286809];Height adjusted BMI[25044758];Thiopurine-induced leukopenia in inflammatory bowel disease[27558924];,0.52920245398773,0.16193914388860237,0.6491777603758809,0.44843462246777166
1354,9340,FTSJ1,300499,309549;,,X-linked non-syndromic intellectual disability,Disease-causing germline mutation(s) (loss of function) in,,0.8476073619631902,0.9365652398143373,0.7843904985643435,0.0
1355,9345,FUCA1,612280,230000;,[MIM:230000]Fucosidosis [recessive?];,Fucosidosis,Disease-causing germline mutation(s) in,,0.4431901840490797,0.148014440433213,0.12111720177499348,0.10405156537753223
1356,9357,FUS,137070,608030;612160;614782;,"[MIM:612160]Angiomatoid fibrous histiocytoma;[MIM:608030]Amyotrophic lateral sclerosis 6, with or without frontotemporal dementia;[MIM:614782]Tremor, hereditary essential 4 [dominant?];",Amyotrophic lateral sclerosis;Frontotemporal dementia with motor neuron disease;Juvenile amyotrophic lateral sclerosis;Myxofibrosarcoma;Myxoid/round cell liposarcoma,Disease-causing germline mutation(s) in;Major susceptibility factor in;Disease-causing germline mutation(s) in;Part of a fusion gene in;Part of a fusion gene in,,0.9555828220858895,0.9671222279525529,0.688593056643174,0.9831184775936157
1357,9371,FUZ,610622,,,Arnold-Chiari malformation type II;Caudal regression sequence;Upper thoracic spina bifida cystica;Cervicothoracic spina bifida cystica;Cervical spina bifida cystica;Lumbosacral spina bifida cystica;Thoracolumbosacral spina bifida cystica;Total spina bifida cystica;Upper thoracic spina bifida aperta;Thoracolumbosacral spina bifida aperta;Lumbosacral spina bifida aperta;Cervical spina bifida aperta;Cervicothoracic spina bifida aperta;Total spina bifida aperta,Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in,,0.28662576687116564,0.259412068076328,0.33698773166275126,0.15653775322283608
1358,9372,FXN,606829,229300;,[MIM:229300]Friedreich ataxia;,Friedreich ataxia,Disease-causing germline mutation(s) (loss of function) in,Headache[29397368];Seasonality[25562672];Myopia[27182965];Night sleep phenotypes[27126917];,0.2585276073619632,0.5995358432181537,0.8365961889845993,0.9559545733578882
1359,9378,FXYD2,601814,154020;,,Autosomal dominant primary hypomagnesemia with hypocalciuria,Disease-causing germline mutation(s) in,Myopia[27182965];,0.08736196319018405,0.5853532748839608,0.8645262333594361,0.5584714548802947
1360,9390,FYCO1,607182,610019;,,Early-onset nuclear cataract;Total early-onset cataract,Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in,,0.6338650306748467,0.01598762248581743,0.027669015922735577,0.07136279926335175
1361,9395,FZD2,600667,,,Autosomal dominant Robinow syndrome;Autosomal dominant omodysplasia,Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in,,0.3749693251533742,0.7849406910778752,0.7246149830331506,0.8344076120319214
1362,9397,FZD4,604579,133780;,"[MIM:133780]Vitreoretinopathy, exudative 1;",Familial exudative vitreoretinopathy;Retinopathy of prematurity;Persistent hyperplastic primary vitreous,Disease-causing germline mutation(s) in;Major susceptibility factor in;Disease-causing germline mutation(s) in,Hepatocellular carcinoma in hepatitis B infection[26870257];,0.38061349693251534,0.9391438886023724,0.507961367789089,0.8690914671577655
1363,9398,FZD5,601723,,,Coloboma of choroid and retina;Coloboma of optic disc;Coloboma of macula;Coloboma of eyelid;Coloboma of eye lens;Coloboma of iris,Disease-causing germline mutation(s) (gain of function) in;Disease-causing germline mutation(s) (gain of function) in;Disease-causing germline mutation(s) (gain of function) in;Disease-causing germline mutation(s) (gain of function) in;Disease-causing germline mutation(s) (gain of function) in;Disease-causing germline mutation(s) (gain of function) in,,0.7050306748466257,0.9244455905105725,0.5382406682328373,0.8442295887047269
1364,9399,FZD6,603409,614157;,"[MIM:614157]Nail disorder, non-syndromic congenital, 10;",Autosomal recessive nail dysplasia,Disease-causing germline mutation(s) in,,0.7549693251533742,0.13099535843218155,0.043330723048812324,0.552793124616329
1365,9405,FZR1,603619,,,Cleft lip/palate;Blepharo-cheilo-odontic syndrome;Hereditary diffuse gastric cancer,Major susceptibility factor in;Disease-causing germline mutation(s) (loss of function) in;Disease-causing germline mutation(s) in,High light scatter reticulocyte percentage of red cells[27863252];Mean corpuscular hemoglobin[27863252];Reticulocyte fraction of red cells[27863252];Mean corpuscular volume[27863252];Reticulocyte count[27863252];Cutaneous malignant melanoma[26237428];Colorectal cancer[19011631];Late-onset Alzheimer's disease[27770636];High light scatter reticulocyte count[27863252];Ulcerative colitis[19915572];,0.6968098159509203,0.9716348633316142,0.9360480292351866,0.8947206875383671
1366,9410,G6PC,613742,232200;,[MIM:232200]Glycogen storage disease 1A;,Glycogen storage disease due to glucose-6-phosphatase deficiency type Ia,Disease-causing germline mutation(s) in,,0.12711656441717792,0.4218669417225374,0.881232054293918,0.0
1367,9412,G6PC3,611045,612541;,[MIM:612541]Dursun syndrome;,Autosomal recessive severe congenital neutropenia due to G6PC3 deficiency,Disease-causing germline mutation(s) in,Glycated hemoglobin levels[24244560];,0.038773006134969326,0.2986075296544611,0.5113547376664056,0.20150399017802334
1368,9413,G6PD,305900,300908;,"[MIM:300908]Anemia, non-spherocytic hemolytic, due to G6PD deficiency;",Class I glucose-6-phosphate dehydrogenase deficiency,Disease-causing germline mutation(s) in,Mean corpuscular volume[28453575;28453575];Mean corpuscular hemoglobin[28453575];Red blood cell traits[23696099;23696099;23696099;23446634;23446634;23446634;23446634;23446634];Glycated hemoglobin levels[28898252];Hemoglobin levels[26366553];Red blood cell count[28453575];Bilirubin levels[19419973];Red cell distribution width[28453575];Iron status biomarkers (transferrin saturation)[28334935];,0.8101840490797546,0.8999484270242393,0.37327068650482903,0.9530386740331491
1369,9415,GAA,606800,232300;,[MIM:232300]Glycogen storage disease 2;,"Glycogen storage disease due to acid maltase deficiency, infantile onset;Glycogen storage disease due to acid maltase deficiency, late-onset",Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in,Blood protein levels[30072576];,0.4431901840490797,0.596183599793708,0.18454711563560428,0.9201964395334561
1370,9425,GABBR2,607340,617903;617904;,"[MIM:617903]Neurodevelopmental disorder with poor language and loss of hand skills [dominant?];[MIM:617904]Epileptic encephalopathy, early infantile, 59 [dominant?];",Atypical Rett syndrome,Disease-causing germline mutation(s) in,Response to simvastatin treatment (PCSK9 protein level change)[25089948];Pulse pressure x alcohol consumption interaction (2df test)[29912962];Response to TNF inhibitor in rheumatoid arthritis (change in tender 28-joint count)[30166627];Systolic blood pressure change trajectories[27980656];Post-traumatic stress disorder (asjusted for relatedness)[23726511];,0.23865030674846627,0.9868488911810211,0.2252675541634038,0.7306629834254144
1371,9432,GABRA1,137160,611136;615744;,"[MIM:611136]Epilepsy, childhood absence 4;[MIM:611136]Epilepsy, idiopathic generalized 13;[MIM:611136]Juvenile myoclonic epilepsy 5;[MIM:615744]Epileptic encephalopathy, early infantile, 19;",Juvenile myoclonic epilepsy;Childhood absence epilepsy;Dravet syndrome,Disease-causing germline mutation(s) in;Candidate gene tested in;Disease-causing germline mutation(s) in,Cognitive decline rate in late mild cognitive impairment[26252872];Gait speed in old age[28077804];,0.47705521472392637,0.8045384218669417,0.9047246149830331,0.949048496009822
1372,9434,GABRA3,305660,,,Thyrotoxic periodic paralysis,Major susceptibility factor in,,0.4463803680981595,0.6722537390407427,0.950404594100757,0.5888581952117864
1373,9439,GABRB2,600232,617829;,,Undetermined early-onset epileptic encephalopathy,Disease-causing germline mutation(s) in,Plasma neurofilament light levels[29747637];,0.3669938650306748,0.8674574522949974,0.8995040459410075,0.832719459791283
1374,9440,GABRB3,137192,612269;617113;,"[MIM:612269]Epilepsy, childhood absence 5;[MIM:617113]Epileptic encephalopathy, early infantile, 43 [dominant?];",Lennox-Gastaut syndrome;Childhood absence epilepsy,Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in,Body mass index[28892062];Cognitive performance[19734545];Response to methotrexate in juvenile idiopathic arthritis[24709693];Longevity[20834067];,0.31079754601226994,0.8653945332645694,0.14095536413469067,0.7539901780233272
1375,9441,GABRD,137163,613060;,"[MIM:613060]Generalized epilepsy with febrile seizures plus 5 [dominant?];[MIM:613060]Epilepsy, idiopathic generalized 10;[MIM:613060]Juvenile myoclonic epilepsy 7;",Juvenile myoclonic epilepsy;1p36 deletion syndrome;Generalized epilepsy with febrile seizures-plus,Major susceptibility factor in;Role in the phenotype of;Candidate gene tested in,Body mass index[26426971;26426971];,0.26588957055214724,0.9368231046931408,0.7308796658835813,0.9656230816451811
1376,9444,GABRG2,137164,604233;607681;611277;,"[MIM:607681]Epilepsy, childhood absence 2;[MIM:611277]Febrile seizures, familial, 8;[MIM:611277]Generalized epilepsy with febrile seizures plus 3 [dominant?];",Rolandic epilepsy;Childhood absence epilepsy;Generalized epilepsy with febrile seizures-plus;Dravet syndrome,Disease-causing germline mutation(s) in;Candidate gene tested in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in,Cognitive decline rate in late mild cognitive impairment[26252872];Severe influenza A (H1N1) infection[26379185];Post bronchodilator FEV1/FVC ratio in COPD[26634245];Angiotensin-converting enzyme inhibitor intolerance[28030426];,0.3856441717791411,0.8829293450232079,0.8945445053510833,0.8336402701043585
1377,9455,GAD1,605363,603513;,,Inherited congenital spastic tetraplegia,Disease-causing germline mutation(s) in,Menopause (age at onset)[26414677];,0.28662576687116564,0.7689530685920578,0.3612633777081702,0.37185389809699204
1378,9491,GALC,606890,245200;,"[MIM:245200]Leukodystrophy, globoid cell [recessive?];",Infantile Krabbe disease;Late-infantile/juvenile Krabbe disease;Adult Krabbe disease,Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in,Response to fenofibrate (total cholesterol levels)[27002377];Multiple sclerosis[24076602];Parkinson's disease[28892059];Breast cancer[22923054];Crohn's disease[21102463;28067908];Adverse response to chemotherapy (neutropenia/leucopenia) (docetaxel)[23648065];Staphylococcus aureus nasal carriage (intermittent)[26569114];Inflammatory bowel disease[28067908;23128233];Pulmonary artery enlargement in chronic obstructive pulmonary disease[25101718];Systemic lupus erythematosus[28714469];Epstein-Barr virus copy number in lymphoblastoid cell lines[28654678];Viral capsid antigen IgG seropositivity[29868224];Chromium levels[26025379];,0.5948466257668712,0.06266116554925219,0.03001827199164709,0.5902394106813996
1379,9492,GALE,606953,230350;,[MIM:230350]Epimerase-deficiency galactosemia;,Generalized galactose epimerase deficiency;Erythrocyte galactose epimerase deficiency,Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in,,0.30319018404907977,0.40923156266116556,0.6504829026363874,0.8620319214241866
1380,9493,GALK1,604313,230200;,[MIM:230200]Galactosemia II;,Galactokinase deficiency,Disease-causing germline mutation(s) (loss of function) in,,0.8325153374233129,0.4332129963898917,0.7029496215087444,0.5871700429711479
1381,9496,GALNS,612222,253000;,[MIM:253000]Mucopolysaccharidosis 4A [recessive?];,Mucopolysaccharidosis type 4A,Disease-causing germline mutation(s) in,Hair color[26926045];,0.38061349693251534,0.7145435791645178,0.19446619681545288,0.8201350521792511
1382,9499,GALNT3,601756,211900;,"[MIM:211900]Tumoral calcinosis, hyperphosphatemic, familial, 1 [recessive?];",Familial hyperphosphatemic tumoral calcinosis/Hyperphosphatemic hyperostosis syndrome,Disease-causing germline mutation(s) (loss of function) in,"Bone mineral density (paediatric, lower limb)[24945404];Bone mineral density (paediatric, total body less head)[24945404;24945404];Bone mineral density[21533022;22504420];Bone mineral density (paediatric, upper limb)[24945404;24945404];",0.10711656441717791,0.0,0.5189245627773428,0.23373235113566607
1383,9522,GALT,606999,230400;,[MIM:230400]Galactosemia;,Classic galactosemia,Disease-causing germline mutation(s) in,,0.21484662576687116,0.26817947395564723,0.36648394675019574,0.8993247391037447
1384,9523,GAMT,601240,612736;,,Guanidinoacetate methyltransferase deficiency,Disease-causing germline mutation(s) in,,0.21484662576687116,0.3855079938112429,0.7282693813625685,0.7271332105586249
1385,9526,GAN,605379,256850;,"[MIM:256850]Giant axonal neuropathy 1, autosomal recessive [recessive?];",Giant axonal neuropathy,Disease-causing germline mutation(s) in,Waist-to-hip ratio adjusted for BMI (age >50)[26426971];Age-related cataracts[25352737];Post bronchodilator FEV1[26634245;26634245;26634245];Waist-to-hip ratio adjusted for BMI x sex x age interaction (4df test)[26426971];,0.6435582822085889,0.48375451263537905,0.7577655964500131,0.48756906077348067
1386,9527,GANAB,104160,600666;617874;,,Autosomal dominant polycystic kidney disease,Disease-causing germline mutation(s) in,Waist-to-hip ratio adjusted for BMI[26426971;26426971];Waist-to-hip ratio adjusted for BMI x sex x age interaction (4df test)[26426971;26426971];,0.9231901840490797,0.9265085095410005,0.40198381623596974,0.9220380601596071
1387,9598,GAPVD1,611714,,,Familial idiopathic steroid-resistant nephrotic syndrome with focal segmental hyalinosis,Disease-causing germline mutation(s) in,Body mass index[28892062;28892062];,0.7573006134969326,1.0,0.5421560950143566,0.9103744628606507
1388,9603,GARS,600287,600794;601472;,"[MIM:600794]Neuronopathy, distal hereditary motor, 5A;",Distal hereditary motor neuropathy type 5;Autosomal dominant Charcot-Marie-Tooth disease type 2D,Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in,Response to cognitive-behavioural therapy in anxiety disorder[26989097];Lung function (FEV1)[30061609;30061609];,0.9519018404907975,0.6049510056730273,0.577133907595928,0.5497237569060773
1389,9607,GAS1,139185,,,Microform holoprosencephaly;Septopreoptic holoprosencephaly;Semilobar holoprosencephaly;Midline interhemispheric variant of holoprosencephaly;Lobar holoprosencephaly;Alobar holoprosencephaly,Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in,Insulin resistance/response[21901158];Blood protein levels[30072576];Borderline personality disorder[28632202];,0.14576687116564419,0.8259412068076328,0.9381362568519969,0.0
1390,9621,GAS8,605178,616726;,,Primary ciliary dyskinesia,Disease-causing germline mutation(s) (loss of function) in,,0.038773006134969326,0.27591542031975247,0.3338553902375359,0.16958256599140578
1391,9622,GAS8-AS1,605179,,,Differentiated thyroid carcinoma,Disease-causing somatic mutation(s) in,,0.038773006134969326,0.0,0.0,0.0
1392,9627,GATA1,305371,300367;300835;314050;,"[MIM:300367]X-linked dyserythropoietic anemia and thrombocytopenia;[MIM:314050]Thrombocytopenia with beta-thalassemia, X-linked;[MIM:300835]Anemia without thrombocytopenia, X-linked;",Blackfan-Diamond anemia;Beta-thalassemia-X-linked thrombocytopenia syndrome;X-linked dyserythropoietic anemia with abnormal platelets and neutropenia;Transient myeloproliferative syndrome;Thrombocytopenia with congenital dyserythropoietic anemia;Congenital erythropoietic porphyria;Acute basophilic leukemia;Acute megakaryoblastic leukemia in Down syndrome,Disease-causing germline mutation(s) (loss of function) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing somatic mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Part of a fusion gene in;Disease-causing somatic mutation(s) in,,0.5755828220858896,0.8919546157813306,0.9115113547376664,0.9082259054634745
1393,9628,GATA2,137295,614038;614172;614286;,"[MIM:614038]Lymphedema, primary, with myelodysplasia;[MIM:614286]Myelodysplastic syndrome;",Deafness-lymphedema-leukemia syndrome;Monocytopenia with susceptibility to infections;Inherited acute myeloid leukemia;Myelodysplastic syndrome,Major susceptibility factor in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Major susceptibility factor in,White blood cell count (basophil)[28158719];Lymphocyte percentage of white cells[27863252];White blood cell count[21738480];Neutrophil percentage of white cells[27863252];White blood cell types[21738478;21738478];Pulse pressure[28135244];Eosinophil counts[19198610];White blood cell count (eosinophil)[28158719];Preterm birth (maternal effect)[28877031];,0.4710429447852761,0.0,0.15374575828765336,0.0
1394,9630,GATA3,131320,146255;,"[MIM:146255]Hypoparathyroidism, sensorineural deafness, and renal disease;",Hypoparathyroidism-sensorineural deafness-renal disease syndrome;Precursor B-cell acute lymphoblastic leukemia,Disease-causing germline mutation(s) (loss of function) in;Major susceptibility factor in,"Mild influenza (H1N1) infection[26379185];Allergy[27182965];Basal cell carcinoma[27539887;25855136];Acute lymphoblastic leukemia in childhood (B cell precursor)[29632299];B cell acute lymphoblastic leukaemia in adulthood[29296818];Colorectal cancer[24737748;25990418;28869801];Recalcitrant atopic dermatitis[25935106];Colorectal cancer (diet interaction)[24743840];Eosinophil counts[27863252];Selective IgA deficiency[27723758];B cell acute lymphoblastic leukaemia in young adulthood[29296818];Calcium levels[24068962];Rheumatoid arthritis (ACPA-positive)[23143596;24532676;23143596];Systemic lupus erythematosus[26502338];Allergic disease (asthma, hay fever or eczema)[29083406;29083406;29083406;29083406;29083406;29083406];Intracranial aneurysm[29531279;29531279];Craniofacial microsomia[26853712];Allergic rhinitis[30013184];Self-reported allergy[23817569];Hair shape[29220522];Hodgkin's lymphoma[21037568;24920014;29196614];Obstetric antiphospholipid syndrome[28424481];Stroke[26089329];Scalp hair shape[26926045];Nodular sclerosis Hodgkin lymphoma[29196614];B cell acute lymphoblastic leukaemia (Philadelphia chromosome negative)[29296818];Plasma parathyroid hormone levels[30134803];B cell acute lymphoblastic leukaemia (abnormal cytogenetics)[29296818];Asthma[27182965;29273806;29273806];B cell acute lymphoblastic leukaemia (hyperdiploid negative)[29296818];Acute lymphoblastic leukemia (adolescents and young adults)[25468567];B cell acute lymphoblastic leukaemia (normal cytogenetics)[29296818];Rheumatoid arthritis[24390342;24390342;23143596];Benign prostatic hyperplasia and/or lower urinary tract symptoms[28656603];Takayasu arteritis[25604533];Acute lymphoblastic leukemia (B-cell precursor)[23996088;29296818];Paclitaxel disposition in epithelial ovarian cancer[29367611];",0.6333742331288343,0.8602372356884992,0.8663534325241451,0.9324739103744628
1395,9632,GATA4,600576,187500;607941;614429;614430;615542;,[MIM:607941]Atrial septal defect 2;[MIM:614429]Ventricular septal defect 1;[MIM:187500]Tetralogy of Fallot;[MIM:614430]Atrioventricular septal defect 4;[MIM:615542]Testicular anomalies with or without congenital heart disease;,"Tetralogy of Fallot;8p23.1 microdeletion syndrome;46,XY partial gonadal dysgenesis;Familial atrial fibrillation;Partial atrioventricular canal;Complete atrioventricular canal-tetralogy of Fallot syndrome;Complete atrioventricular canal-ventricle hypoplasia syndrome;Complete atrioventricular canal-left heart obstruction syndrome;Atrial septal defect, ostium secundum type",Disease-causing germline mutation(s) (loss of function) in;Role in the phenotype of;Disease-causing germline mutation(s) (loss of function) in;Disease-causing germline mutation(s) (loss of function) in;Disease-causing germline mutation(s) (loss of function) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in,Systolic blood pressure[28135244;27618452;28739976];Polycystic ovary syndrome[26284813];Diastolic blood pressure (cigarette smoking interaction)[29455858;29455858];Retinal vascular caliber[21060863];Diastolic blood pressure[27618452];Atrial fibrillation[30061737;29892015];Myopia (pathological)[23049088];Systolic blood pressure x alcohol consumption interaction (2df test)[29912962;29912962];Testicular germ cell tumor[28604728];Systolic blood pressure (cigarette smoking interaction)[29455858;29455858];,0.5406134969325154,0.0,0.38919342208300706,0.0
1396,9633,GATA5,611496,617912;,"[MIM:617912]Congenital heart defects, multiple types, 5 [dominant?];",Tetralogy of Fallot;Familial bicuspid aortic valve;Familial atrial fibrillation,Disease-causing germline mutation(s) (loss of function) in;Disease-causing germline mutation(s) (loss of function) in;Disease-causing germline mutation(s) (loss of function) in,Prostate cancer[23535732];Chronic central serous retinopathy[30073298];,0.19190184049079756,0.780814853017019,0.2855651265987993,0.0
1397,9634,GATA6,601656,187500;217095;600001;614474;614475;,[MIM:217095]Conotruncal heart malformations;[MIM:614475]Atrial septal defect 9;[MIM:187500]Tetralogy of Fallot;[MIM:614474]Atrioventricular septal defect 5;[MIM:600001]Pancreatic agenesis and congenital heart defects [dominant?];,"Congenital diaphragmatic hernia;Tetralogy of Fallot;Pancreatic hypoplasia-diabetes-congenital heart disease syndrome;Familial atrial fibrillation;Partial atrioventricular canal;Complete atrioventricular canal-ventricle hypoplasia syndrome;Atrial septal defect, ostium secundum type",Major susceptibility factor in;Major susceptibility factor in;Disease-causing germline mutation(s) (loss of function) in;Disease-causing germline mutation(s) (loss of function) in;Disease-causing germline mutation(s) (loss of function) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in,Endometrial cancer ((endometrioid histology)[30093612];Diverticular disease[30177863];Resting heart rate[27798624];Tuberculosis[20694014];Endometrial cancer[30093612];LDL cholesterol[25961943];Severe progression in rheumatoid arthritis[29065906];,0.632760736196319,0.9437854564208354,0.6275123988514748,0.0
1398,9636,GATAD1,614518,614672;,,Familial isolated dilated cardiomyopathy,Disease-causing germline mutation(s) in,Height[18391951];,0.5964417177914111,0.6944301186178442,0.4330462020360219,0.766267648864334
1399,9638,GATAD2B,614998,615074;,"[MIM:615074]Mental retardation, autosomal dominant 18 [dominant?];",Severe intellectual disability-poor language-strabismus-grimacing face-long fingers syndrome,Disease-causing germline mutation(s) (loss of function) in,Number of children ever born[27798627;27798627];Empathy quotient[29527006];General cognitive ability[29844566];Age at first birth[27798627;27798627;27798627];Lentiform nucleus volume[22903471];,0.8901840490797546,0.9834966477565755,0.7152179587575046,0.8750767341927563
1400,9644,GATM,602360,612718;,[MIM:612718]Cerebral creatine deficiency syndrome 3 [recessive?];,L-Arginine:glycine amidinotransferase deficiency,Disease-causing germline mutation(s) in,Serum metabolite levels[24625756];Metabolite levels (small molecules and protein measures)[27005778];Glomerular filtration rate in non diabetics (creatinine)[26831199];Homoarginine levels[24047826];Renal function and chronic kidney disease[19430482];Chronic kidney disease[20383146;26831199];Glomerular filtration rate[27588450;27588450];Glomerular filtration rate (creatinine)[26831199;28452372];,0.08736196319018405,0.6547189272821041,0.9394413991125032,0.4562615101289134
1401,9646,GBA,606463,168600;230800;230900;231000;231005;608013;,[MIM:230800]Gaucher disease;[MIM:230800]Gaucher disease 1;[MIM:230900]Gaucher disease 2;[MIM:231000]Gaucher disease 3;[MIM:231005]Gaucher disease 3C;[MIM:608013]Gaucher disease perinatal lethal;[MIM:168600]Parkinson disease;,Gaucher disease-ophthalmoplegia-cardiovascular calcification syndrome;Hereditary late-onset Parkinson disease;Gaucher disease type 3;Gaucher disease type 2;Gaucher disease type 1;Fetal Gaucher disease,Disease-causing germline mutation(s) in;Major susceptibility factor in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in,Inflammatory bowel disease[28067908];Parkinson's disease[22451204;21738487;24842889;27182965;25064009;28892059];Renal function-related traits (BUN)[22797727];Crohn's disease[28067908];Dementia with Lewy bodies[29263008];,0.7056441717791411,0.22511603919546158,0.5737405377186113,0.9736034376918354
1402,9647,GBA2,609471,614409;,,Autosomal recessive spastic paraplegia type 46;Autosomal recessive cerebellar ataxia with late-onset spasticity,Disease-causing germline mutation(s) (loss of function) in;Disease-causing germline mutation(s) (loss of function) in,,0.6110429447852761,0.02527075812274368,0.3134951709736361,0.6981276856967464
1403,9652,GBE1,607839,232500;263570;,"[MIM:232500]Glycogen storage disease 4;[MIM:263570]Polyglucosan body neuropathy, adult form;","Adult polyglucosan body disease;Glycogen storage disease due to glycogen branching enzyme deficiency, childhood neuromuscular form;Glycogen storage disease due to glycogen branching enzyme deficiency, adult neuromuscular form;Glycogen storage disease due to glycogen branching enzyme deficiency, congenital neuromuscular form;Glycogen storage disease due to glycogen branching enzyme deficiency, childhood combined hepatic and myopathic form;Glycogen storage disease due to glycogen branching enzyme deficiency, fatal perinatal neuromuscular form;Glycogen storage disease due to glycogen branching enzyme deficiency, non progressive hepatic form;Glycogen storage disease due to glycogen branching enzyme deficiency, progressive hepatic form",Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in,Cadmium levels[26025379];Body mass index[25673413;25673413;25673413];Waist circumference[25673412];Extraversion[27918536];Hand grip strength[29691431];Lead levels in blood[25820613];Iron status biomarkers (transferrin saturation)[28334935];,0.6058895705521472,0.0892212480660134,0.08300704776820673,0.766267648864334
1404,9673,GCDH,608801,231670;,,Glutaryl-CoA dehydrogenase deficiency,Disease-causing germline mutation(s) (loss of function) in,Mean corpuscular hemoglobin concentration[27863252];Mean corpuscular hemoglobin[19862010;27863252;27863252];Reticulocyte fraction of red cells[27863252];Mean corpuscular volume[27863252;27863252];Reticulocyte count[27863252];Clozapine-induced agranulocytosis[25187353];Blood metabolite levels[24816252];Red blood cell count[27863252];,0.8173006134969325,0.3927282104177411,0.7060819629339598,0.808317986494782
1405,9676,GCGR,138033,,,GCGR-related hyperglucagonemia,Disease-causing germline mutation(s) in,,0.17791411042944785,0.5440948942753997,0.6674497520229705,0.0
1406,9677,GCH1,600225,128230;233910;,"[MIM:233910]Hyperphenylalaninemia, BH4-deficient, B;[MIM:128230]Dystonia, dopa-responsive;",GTP cyclohydrolase I deficiency;Autosomal dominant dopa-responsive dystonia,Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in,Parkinson's disease[27182965;25064009;28892059];Rheumatoid arthritis[22446963];Mercury levels[26025379];Obesity-related traits[23251661;23251661];Night sleep phenotypes[27126917];,0.4226993865030675,0.6201650335224342,0.9308274601931611,0.9281767955801105
1407,9679,GCK,138079,125851;125853;602485;606176;606391;,"[MIM:602485]Familial hyperinsulinemic hypoglycemia 3;[MIM:125853]Diabetes mellitus, non-insulin-dependent;[MIM:606176]Diabetes mellitus, permanent neonatal;",MODY;Hyperinsulinism due to glucokinase deficiency;Permanent neonatal diabetes mellitus,Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in,Type 2 diabetes[22885922];Fasting blood glucose[20081858;22581228];Homeostasis model assessment of beta-cell function[20081858];Glycated hemoglobin levels[20858683;19096518;24647736;24244560;28898252;28898252;28898252];Blood sugar levels[29403010];Glycemic traits[23575436;23575436;23575436];Metabolic syndrome[22399527];Hemoglobin A1c levels[29403010];Fasting plasma glucose[19060907;25187374];Metabolite levels (small molecules and protein measures)[27005778];Metabolite levels[21909109];Offspring birth weight[29309628];Birth weight[27680694];Fasting blood glucose (BMI interaction)[22581228];,0.2498159509202454,0.6230015471892728,0.9430957974419212,0.976365868631062
1408,9681,GCLC,606857,230450;,[MIM:230450]Hemolytic anemia due to gamma-glutamylcysteine synthetase deficiency;,Glutamate-cysteine ligase deficiency,Disease-causing germline mutation(s) in,Daytime sleep phenotypes[27126917];,0.20368098159509201,0.6709644146467251,0.6606630122683372,0.3984039287906691
1409,9684,GCM2,603716,146200;617343;,"[MIM:146200]Hypoparathyroidism, familial isolated;[MIM:617343]Hyperparathyroidism 4 [dominant?];",Familial isolated hypoparathyroidism due to agenesis of parathyroid gland;Familial isolated hyperparathyroidism,Disease-causing germline mutation(s) (loss of function) in;Disease-causing germline mutation(s) in,Menarche and menopause (age at onset)[19448621];,0.3669938650306748,0.3414130995358432,0.48864526233359434,0.29066912216083485
1410,9693,GCNT2,600429,110800;116700;,"[MIM:116700]Cataract 13, with adult i phenotype;",Total early-onset cataract,Disease-causing germline mutation(s) in,Monocyte count[27863252];Monocyte percentage of white cells[27863252];,0.20368098159509201,0.24626095925734914,0.6768467762986166,0.024248004910988337
1411,9703,GCSH,238330,605899;,[MIM:605899]Non-ketotic hyperglycinemia;,Atypical glycine encephalopathy;Neonatal glycine encephalopathy;Infantile glycine encephalopathy,Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in,Waist-to-hip ratio adjusted for BMI (age >50)[26426971];Metabolite levels (small molecules and protein measures)[27005778];Waist-to-hip ratio adjusted for BMI x sex x age interaction (4df test)[26426971];,0.22687116564417178,0.611397627643115,0.42417123466457846,0.21132596685082872
1412,9711,GDAP1,606598,214400;607706;607831;608340;,"[MIM:214400]Charcot-Marie-Tooth disease 4A [recessive?];[MIM:607706]Charcot-Marie-Tooth disease, axonal, with vocal cord paresis, autosomal recessive [recessive?];[MIM:607831]Charcot-Marie-Tooth disease 2K [dominant?];[MIM:608340]Charcot-Marie-Tooth disease, recessive, intermediate type, A;",Autosomal recessive intermediate Charcot-Marie-Tooth disease type A;Charcot-Marie-Tooth disease type 2H;Autosomal recessive Charcot-Marie-Tooth disease with hoarseness;Charcot-Marie-Tooth disease type 4A;Autosomal dominant Charcot-Marie-Tooth disease type 2K,Disease-causing germline mutation(s) in;Candidate gene tested in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in,Waist circumference[17903300];Dysmenorrheic pain[27454463];Protein quantitative trait loci[18464913];,0.7743558282208589,0.15059308922124806,0.8499086400417646,0.6345917740945365
1413,9715,GDF1,602880,187500;208530;217095;613854;,"[MIM:613854]Congenital heart defects, multiple types, 6 [dominant?];[MIM:187500]Tetralogy of Fallot;[MIM:208530]Right atrial isomerism;",Tetralogy of Fallot;Congenitally uncorrected transposition of the great arteries;Ivemark syndrome,Major susceptibility factor in;Major susceptibility factor in;Disease-causing germline mutation(s) in,,0.038773006134969326,0.6884992264053635,0.2727747324458366,0.0
1414,9716,GDF2,605120,615506;,"[MIM:615506]Telangiectasia, hereditary hemorrhagic, 5;",Hereditary hemorrhagic telangiectasia,Disease-causing germline mutation(s) in,,0.27361963190184047,0.37622485817431667,0.7355781780214043,0.7713321055862492
1415,9717,GDF3,606522,613702;613703;613704;,"[MIM:613702]Klippel-Feil syndrome 3, autosomal dominant [dominant?];[MIM:613703]Microphthalmia, isolated, with coloboma, 6;[MIM:613704]Microphthalmia, isolated, 7;",Isolated microphthalmia-anophthalmia-coloboma;Isolated Klippel-Feil syndrome;Colobomatous microphthalmia,Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in,Thiazide-induced adverse metabolic effects in hypertensive patients[23400010];,0.10711656441717791,0.26121712222795257,0.2430174889062908,0.4636279926335175
1416,9718,GDF5,601146,112600;113100;200700;201250;228900;610017;612400;615072;615298;,"[MIM:201250]Acromesomelic chondrodysplasia, Hunter-Thompson type [recessive?];[MIM:113100]Brachydactyly C [dominant?];[MIM:228900]Du Pan syndrome [recessive?];[MIM:615298]Symphalangism, proximal 1B;[MIM:610017]Multiple synostoses syndrome 2;[MIM:112600]Brachydactyly A2;[MIM:612400]Osteoarthritis 5;[MIM:615072]Brachydactyly A1, C [dominant?] [recessive?];","Acromesomelic dysplasia, Hunter-Thompson type;Acromesomelic dysplasia, Grebe type;Fibular aplasia-complex brachydactyly syndrome;Multiple synostoses syndrome;Proximal symphalangism;Angel-shaped phalango-epiphyseal dysplasia;Brachydactyly type A1;Brachydactyly type C;Brachydactyly type A2",Disease-causing germline mutation(s) (loss of function) in;Disease-causing germline mutation(s) (loss of function) in;Disease-causing germline mutation(s) (loss of function) in;Disease-causing germline mutation(s) (gain of function) in;Disease-causing germline mutation(s) (gain of function) in;Disease-causing germline mutation(s) (loss of function) in;Disease-causing germline mutation(s) (loss of function) in;Disease-causing germline mutation(s) (loss of function) in;Disease-causing germline mutation(s) in,Waist-to-hip ratio adjusted for BMI (age >50)[26426971];Joint mobility (Beighton score)[27182965];Hip circumference[25673412;25673412];Hip circumference adjusted for BMI[25673412;25673412;25673412];Waist-to-hip ratio adjusted for BMI in active individuals[28448500;28448500;28448500;28448500];Waist-to-hip ratio adjusted for BMI (joint analysis for main effect and physical activity interaction)[28448500;28448500;28448500];Infant length[25281659];Height[23563607;20189936;20881960;18391952;18391950;18391951;25429064;25282103];Blood protein levels[28240269];Waist-to-hip ratio adjusted for BMI[26426971];Waist-to-hip ratio adjusted for body mass index[28448500;25673412;25673412;25673412;25673412];Waist-to-hip ratio adjusted for BMI x sex x age interaction (4df test)[26426971];,0.3749693251533742,0.7839092315626611,0.47794309579744193,0.7022713321055862
1417,9720,GDF6,601147,118100;613094;615360;617898;,"[MIM:118100]Klippel-Feil syndrome 1, autosomal dominant [dominant?];[MIM:613094]Microphthalmia, isolated, 4;[MIM:615360]Leber congenital amaurosis 17;[MIM:617898]Multiple synostoses syndrome 4 [dominant?];",Leber congenital amaurosis;Isolated Klippel-Feil syndrome;Colobomatous microphthalmia,Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Candidate gene tested in,,0.16220858895705523,0.926766374419804,0.7405377186113287,0.0
1418,9726,GDI1,300104,300849;,,X-linked non-syndromic intellectual disability,Disease-causing germline mutation(s) in,,0.8631901840490798,0.9404332129963899,0.9750717828243278,0.0
1419,9730,GDNF,600837,171300;209880;613711;,[MIM:613711]Hirschsprung disease 3;[MIM:209880]Congenital central hypoventilation syndrome;[MIM:171300]Pheochromocytoma;,Hirschsprung disease;Ondine syndrome,Major susceptibility factor in;Candidate gene tested in,Major depressive disorder[20125088];Asthma[29273806];,0.5128834355828221,0.8187209902011346,0.847559383972853,0.9274094536525476
1420,9754,GFAP,137780,203450;,[MIM:203450]Alexander disease;,Alexander disease type II;Alexander disease type I,Disease-causing germline mutation(s) (gain of function) in;Disease-causing germline mutation(s) (gain of function) in,Craniofacial microsomia[26853712];Cognitive function[25644384];,0.6992638036809816,0.0,0.3967632471939441,0.9432166973603437
1421,9755,GFER,600924,613076;,,Congenital cataract-progressive muscular hypotonia-hearing loss-developmental delay syndrome,Disease-causing germline mutation(s) in,,0.8431901840490797,0.5002578648788035,0.5726964239102063,0.0
1422,9756,GFI1,600871,607847;613107;,"[MIM:613107]Neutropenia, severe congenital 2, autosomal dominant [dominant?];[MIM:607847]Dominant nonimmune chronic idiopathic neutropenia of adults;",Autosomal dominant severe congenital neutropenia,Disease-causing germline mutation(s) in,Systemic lupus erythematosus[28714469;28714469];,0.3749693251533742,0.6271273852501289,0.5197076481336466,0.3156844689993861
1423,9757,GFI1B,604383,187900;,"[MIM:187900]Bleeding disorder, platelet-type 17 [dominant?];",Autosomal dominant macrothrombocytopenia;Alpha delta granule deficiency;Gray platelet syndrome,Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in,High light scatter reticulocyte percentage of red cells[27863252];Mean corpuscular volume[27863252];Mean corpuscular hemoglobin[27863252];White blood cell count (basophil)[27863252];Reticulocyte count[27863252;27863252];Myeloid white cell count[27863252];Platelet distribution width[27863252];Plateletcrit[27863252];Basophil percentage of white cells[27863252];High light scatter reticulocyte count[27863252];Eosinophil counts[27863252;27863252];Sum neutrophil eosinophil counts[27863252];Granulocyte count[27863252];Red cell distribution width[27863252];Immature fraction of reticulocytes[27863252;27863252];Mean platelet volume[27863252;27863252];Sum eosinophil basophil counts[27863252;27863252];Eosinophil percentage of granulocytes[27863252;27863252];Reticulocyte fraction of red cells[27863252;27863252];White blood cell count[27863252];Cardiometabolic and hematological traits[27668658];Neutrophil percentage of granulocytes[27863252];Platelet count[27863252;27863252];Eosinophil percentage of white cells[27863252];,0.5009815950920246,0.40175348117586385,0.5194466196815453,0.26243093922651933
1424,9758,GFM1,606639,609060;,[MIM:609060]Combined oxidative phosphorylation deficiency 1;,Hepatoencephalopathy due to combined oxidative phosphorylation defect type 1,Disease-causing germline mutation(s) in,diarrhoeal disease at age 2[27559109];,0.8515337423312883,0.07117070654976793,0.3299399634560167,0.12676488643339473
1425,9763,GFPT1,138292,610542;,,Congenital myasthenic syndromes with glycosylation defect,Disease-causing germline mutation(s) in,,0.9222085889570553,0.925219185146983,0.8352910467240929,0.5078268876611418
1426,9776,GGCX,137167,277450;610842;,[MIM:277450]Combined deficiency of vitamin K-dependent clotting factors 1;[MIM:610842]Pseudoxanthoma elasticum-like disorder with multiple coagulation factor deficiency;,Pseudoxanthoma elasticum-like skin manifestations with retinitis pigmentosa;Body skin hyperlaxity due to vitamin K-dependent coagulation factor deficiency;Hereditary combined deficiency of vitamin K-dependent clotting factors,Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in,"Myocardial infarction[26343387];Prostate cancer[21743467];Coronary artery disease[26343387;29212778];Coronary artery disease (myocardial infarction, percutaneous transluminal coronary angioplasty, coronary artery bypass grafting, angina or chromic ischemic heart disease)[28714975];",0.7857668711656441,0.09876224858174316,0.2542417123466458,0.7965009208103131
1427,9777,GGH,601509,,,Methotrexate toxicity or dose selection,Biomarker tested in,Blood protein levels[29875488;30072576];,0.8603680981595092,0.7452294997421351,0.12424954320020883,0.28882750153468384
1428,9782,GGT1,612346,231950;,[MIM:231950]Glutathionuria [recessive?];,Gamma-glutamyl transpeptidase deficiency,Disease-causing germline mutation(s) in,Liver enzyme levels (gamma-glutamyl transferase)[22001757];Serum metabolite levels[23093944];Acne (severe)[24927181];Blood metabolite levels[24816252];Liver enzyme levels[18940312];Gamma glutamyl transpeptidase[21909109];Hematological and biochemical traits[20139978];Gamma glutamyl transferase levels[29403010];Protein quantitative trait loci[18464913];,0.19190184049079756,0.0,0.6324719394413991,0.1141804788213628
1429,9797,GH1,139250,173100;262400;262650;612781;,"[MIM:262400]Growth hormone deficiency, isolated, 1A [recessive?];[MIM:612781]Growth hormone deficiency, isolated, 1B [recessive?];[MIM:262650]Kowarski syndrome;[MIM:173100]Growth hormone deficiency, isolated, 2 [dominant?];",Isolated growth hormone deficiency type IB;Isolated growth hormone deficiency type II;Isolated growth hormone deficiency type IA;Short stature due to growth hormone qualitative anomaly,Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in,,0.5069938650306749,0.5652398143372873,0.6256851996867658,0.8931860036832413
1430,9802,GHR,600946,143890;262500;604271;,"[MIM:262500]Laron syndrome;[MIM:604271]Growth hormone insensitivity, partial;",Laron syndrome;Short stature due to partial GHR deficiency,Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in,Plasma renin activity levels[29650764];Systemic lupus erythematosus[18204098];Iron status biomarkers[19084217];Response to taxane treatment (docetaxel)[23006423];Height[25429064];Familial squamous cell lung carcinoma[29924316];Menarche (age at onset)[25231870];Blood protein levels[29875488;30072576];,0.45950920245398774,0.5714285714285714,0.050639519707648135,0.6384284837323512
1431,9804,GHRHR,139191,612781;,,Isolated growth hormone deficiency type IB,Disease-causing germline mutation(s) in,,0.10711656441717791,0.3421866941722537,0.34064212999216914,0.13505217925107427
1432,9807,GHSR,601898,615925;,,Short stature due to GHSR deficiency,Disease-causing germline mutation(s) in,Height[23563607;20881960;20881960;25429064;25282103];,0.2498159509202454,0.4860752965446106,0.7102584181675803,0.41789441375076736
1433,9811,GIGYF2,612003,607688;,[MIM:607688]Parkinson disease 11;,Hereditary late-onset Parkinson disease,Candidate gene tested in,"Autism spectrum disorder or schizophrenia[28540026;28540026];Schizophrenia[23974872;25056061];Coronary artery disease[29212778];Coronary artery disease (myocardial infarction, percutaneous transluminal coronary angioplasty, coronary artery bypass grafting, angina or chromic ischemic heart disease)[28714975];",0.8136196319018405,0.7895822588963384,0.2699034194727225,0.4048496009821977
1434,9824,GINGF2,605544,,,Hereditary gingival fibromatosis,Candidate gene tested in,,0.038773006134969326,0.0,0.0,0.0
1435,9828,GINS1,610608,617827;,[MIM:617827]Immunodeficiency 55 [recessive?];,Combined immunodeficiency due to GINS1 deficiency,Disease-causing germline mutation(s) (loss of function) in,Liver enzyme levels (alkaline phosphatase)[22001757];Telomere length[30185882];,0.23865030674846627,0.14285714285714285,0.5998433829287392,0.2846838551258441
1436,9835,GIPC3,608792,601869;,"[MIM:601869]Deafness, autosomal recessive, 15 [recessive?];",Autosomal recessive non-syndromic sensorineural deafness type DFNB,Disease-causing germline mutation(s) in,,0.10711656441717791,0.43837029396596183,0.7663795353693552,0.5285451197053407
1437,9839,GJA1,121014,104100;164200;186100;218400;234100;241550;257850;600309;617525;,"[MIM:164200]Oculodentodigital dysplasia;[MIM:257850]Oculodentodigital dysplasia, autosomal recessive [recessive?];[MIM:186100]Syndactyly 3;[MIM:241550]Hypoplastic left heart syndrome 1;[MIM:234100]Hallermann-Streiff syndrome;[MIM:600309]Atrioventricular septal defect 3;[MIM:218400]Craniometaphyseal dysplasia, autosomal recessive [recessive?];[MIM:617525]Erythrokeratodermia variabilis et progressiva 3;[MIM:104100]Palmoplantar keratoderma and congenital alopecia 1 [dominant?];",Hypoplastic left heart syndrome;Autosomal dominant palmoplantar keratoderma and congenital alopecia;Craniometaphyseal dysplasia;Oculodentodigital dysplasia;Erythrokeratodermia variabilis;Autosomal recessive non-syndromic sensorineural deafness type DFNB;Syndactyly type 3,Major susceptibility factor in;Disease-causing germline mutation(s) (gain of function) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Candidate gene tested in;Disease-causing germline mutation(s) in,Heart rate[23583979;23583979;23583979];Resting heart rate[20639392;20639392;23183192;27798624;29769521];Systolic blood pressure response to hydrochlorothiazide in hypertension[27802415];Migraine[27322543];Atrial fibrillation[28416822;28416818;28416818;29892015;29892015];Pulse pressure[28135244];Peak creatinine levels in vancomycin therapy[26030142];Disease progression in age-related macular degeneration[29346644];Protein quantitative trait loci[18464913];,0.8768098159509202,0.5843218153687467,0.8305925345862699,0.7797728667894414
1438,9841,GJA3,121015,601885;,"[MIM:601885]Cataract 14, multiple types;",Pulverulent cataract;Early-onset nuclear cataract;Early-onset posterior polar cataract,Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in,Facial emotion recognition (happy faces)[28608620];,0.16220858895705523,0.3543063434760186,0.8869746802401461,0.0
1439,9843,GJA5,121013,108770;614049;,"[MIM:108770]Atrial standstill 1;[MIM:614049]Atrial fibrillation, familial, 11;",Tetralogy of Fallot;Familial atrial fibrillation,Major susceptibility factor in;Disease-causing germline mutation(s) in,Cognitive performance[20125193];Atrial fibrillation[30061737;29892015;29892015;30061737];Methotrexate-induced interstitial lung disease in rheumatoid arthritis[28500057];,0.17791411042944785,0.739040742650851,0.9109892978334638,0.6784837323511357
1440,9845,GJA8,600897,116200;,,Cataract-microcornea syndrome;Isolated congenital sclerocornea;Pulverulent cataract;Early-onset sutural cataract;Early-onset nuclear cataract;Total early-onset cataract,Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) (loss of function) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in,,0.08736196319018405,0.4373388344507478,0.8149308274601932,0.7306629834254144
1441,9848,GJB1,304040,145900;302800;,"[MIM:302800]Charcot-Marie-Tooth disease, X-linked dominant, 1;[MIM:145900]Dejerine-Sottas syndrome [dominant?] [recessive?];",X-linked progressive cerebellar ataxia;X-linked Charcot-Marie-Tooth disease type 1,Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in,,0.22687116564417178,0.7181536874677669,0.9112503262855651,0.0
1442,9849,GJB2,121011,124500;148210;148350;149200;220290;601544;602540;,"[MIM:220290]Deafness, autosomal recessive, 1A [recessive?];[MIM:601544]Deafness, autosomal dominant, 3A [dominant?];[MIM:124500]Vohwinkel syndrome [dominant?];[MIM:148350]Keratoderma, palmoplantar, with deafness [dominant?];[MIM:148210]Keratitis-ichthyosis-deafness syndrome [dominant?];[MIM:149200]Bart-Pumphrey syndrome [dominant?];[MIM:602540]Ichthyosis hystrix-like with deafness syndrome [dominant?];",Porokeratotic eccrine ostial and dermal duct nevus;KID syndrome;Keratoderma hereditarium mutilans;Palmoplantar keratoderma-deafness syndrome;Knuckle pads-leukonychia-sensorineural deafness-palmoplantar hyperkeratosis syndrome;Autosomal dominant non-syndromic sensorineural deafness type DFNA;Autosomal recessive non-syndromic sensorineural deafness type DFNB,Disease-causing somatic mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in,Facial emotion recognition (happy faces)[28608620];,0.4117791411042945,0.04693140794223827,0.29939963456016705,0.6962860650705954
1443,9850,GJB3,603324,133200;612644;,"[MIM:133200]Erythrokeratodermia variabilis et progressiva 1;[MIM:612644]Deafness, autosomal dominant, 2B [dominant?];",Neuropathy with hearing impairment;Erythrokeratodermia variabilis;Autosomal dominant non-syndromic sensorineural deafness type DFNA;Autosomal recessive non-syndromic sensorineural deafness type DFNB,Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in,,0.2585276073619632,0.37132542547705005,0.4510571652310102,0.7813075506445673
1444,9851,GJB4,605425,617524;,[MIM:617524]Erythrokeratodermia variabilis et progressiva 2;,Erythrokeratodermia variabilis,Disease-causing germline mutation(s) in,,0.08736196319018405,0.32284682826199074,0.18585225789611068,0.7260589318600368
1445,9853,GJB6,604418,129500;612643;612645;,"[MIM:129500]Ectodermal dysplasia 2, Clouston type [dominant?];[MIM:612645]Deafness, autosomal recessive, 1B [recessive?];[MIM:612643]Deafness, autosomal dominant, 3B [dominant?];",KID syndrome;Hidrotic ectodermal dysplasia;Autosomal dominant non-syndromic sensorineural deafness type DFNA;Autosomal recessive non-syndromic sensorineural deafness type DFNB,Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in,Facial emotion recognition (happy faces)[28608620];,0.21484662576687116,0.1621970087674059,0.7966588358131036,0.8152240638428484
1446,9856,GJC2,608803,608804;613206;613480;,"[MIM:613206]Spastic paraplegia 44, autosomal recessive [recessive?];[MIM:613480]Lymphedema, hereditary, 1C;",Pelizaeus-Merzbacher-like disease due to GJC2 mutation;Autosomal recessive spastic paraplegia type 44;Milroy disease,Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in,,0.5850306748466257,0.4394017534811759,0.8402505873140172,0.0
1447,9862,GK,300474,307030;,,"Glycerol kinase deficiency, adult form;Glycerol kinase deficiency, infantile form;Glycerol kinase deficiency, juvenile form",Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in,Cardiovascular risk factors (age interaction)[20838585];,0.6604907975460123,0.8071170706549768,0.9785956669276952,0.7589011663597299
1448,9874,GLA,300644,301500;,[MIM:301500]Fabry disease;,Fabry disease,Disease-causing germline mutation(s) in,,0.7214723926380369,0.9461062403300671,0.4575828765335422,0.0
1449,9875,GLB1,611458,230500;230600;230650;253010;,[MIM:230600]GM1-gangliosidosis 2 [recessive?];[MIM:230650]GM1-gangliosidosis 3 [recessive?];[MIM:253010]Mucopolysaccharidosis 4B [recessive?];,Mucopolysaccharidosis type 4B;GM1 gangliosidosis type 3;GM1 gangliosidosis type 2;GM1 gangliosidosis type 1,Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in,"Sum eosinophil basophil counts[27863252];Celiac disease[22057235];Eosinophil percentage of granulocytes[27863252];Allergic disease (asthma, hay fever or eczema)[29083406];Atopic dermatitis[23042114];Hepatocellular carcinoma[21105107];Eosinophil counts[27863252;29403010];Neutrophil percentage of granulocytes[27863252];Eosinophil percentage of white cells[27863252];",0.8375460122699386,0.31253223310985045,0.17280083529104673,0.8895027624309392
1450,9896,GLDC,238300,605899;,[MIM:605899]Non-ketotic hyperglycinemia;,Atypical glycine encephalopathy;Neonatal glycine encephalopathy;Infantile glycine encephalopathy,Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in,Overall survival in osteosarcoma[29210060];Metabolite levels (small molecules and protein measures)[27005778];Alanine transaminase levels[29403010];Periodontal microbiota[22699663];,0.938159509202454,0.015729757607013926,0.2526755416340381,0.8007980356046654
1451,9899,GLE1,603371,253310;611890;,[MIM:253310]Lethal congenital contracture syndrome 1 [recessive?];[MIM:611890]Lethal arthrogryposis with anterior horn cell disease;,Amyotrophic lateral sclerosis;Lethal congenital contracture syndrome type 1;Lethal arthrogryposis-anterior horn cell disease syndrome,Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in,Body mass index[26426971];Axial length[24144296];,0.6384049079754601,0.2545126353790614,0.26729313495170975,0.0649171270718232
1452,9901,GLI1,165220,,,Ellis Van Creveld syndrome,Disease-causing germline mutation(s) (loss of function) in,,0.5326380368098159,0.053378029912325944,0.10415035238841033,0.16451810926949048
1453,9902,GLI2,165230,610829;615849;,[MIM:610829]Holoprosencephaly 9;[MIM:615849]Culler-Jones syndrome [dominant?];,"Microform holoprosencephaly;Septopreoptic holoprosencephaly;Semilobar holoprosencephaly;Postaxial polydactyly-anterior pituitary anomalies-facial dysmorphism syndrome;Combined pituitary hormone deficiencies, genetic forms;Midline interhemispheric variant of holoprosencephaly;Lobar holoprosencephaly;Alobar holoprosencephaly",Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) (loss of function) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in,Age-related macular degeneration[23326517;23326517];Breast size[22747683];Diisocyanate-induced asthma[25918132];Height[25429064];Erectile dysfunction and prostate cancer treatment[20932654];Glomerular filtration rate (creatinine)[26831199];,0.6450306748466258,0.9303764827230531,0.3795353693552597,0.4949355432780847
1454,9903,GLI3,165240,146510;174200;174700;175700;,"[MIM:175700]Greig cephalo-poly-syndactyly syndrome;[MIM:146510]Pallister-Hall syndrome [dominant?];[MIM:174200]Polydactyly, postaxial A1;[MIM:174200]Polydactyly, postaxial B;[MIM:174700]Polydactyly preaxial 4;",Acrocallosal syndrome;Greig cephalopolysyndactyly syndrome;Pallister-Hall syndrome;Tibial hemimelia;Postaxial polydactyly type B;Postaxial polydactyly type A;Polysyndactyly,Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) (loss of function) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) (loss of function) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in,Digit length ratio (right hand)[29659830];Age-related macular degeneration[23326517];Allergic rhinitis[22036096];facial morphology traits (multivariate analysis)[27193062];Digit length ratio (left hand)[29659830;29659830];Digit length ratio[29659830];Mean arterial pressure (alcohol consumption interaction)[24376456];Language performance in older adults (adjusted for episodic memory)[28577822];middle facial morphology traits (quantitative measurement)[27193062];Asthma[29273806];,0.6974233128834356,0.8690046415678184,0.11537457582876534,0.9588704726826274
1455,9911,GLIS2,608539,611498;,[MIM:611498]Nephronophthisis 7 [recessive?];,Acute megakaryoblastic leukemia without Down syndrome;Juvenile nephronophthisis,Part of a fusion gene in;Disease-causing germline mutation(s) (loss of function) in,Prostate-specific antigen levels[28139693];,0.45680981595092024,0.8488911810211449,0.3401200730879666,0.7943523634131369
1456,9913,GLIS3,610192,610199;,,Neonatal diabetes-congenital hypothyroidism-congenital glaucoma-hepatic fibrosis-polycystic kidneys syndrome,Disease-causing germline mutation(s) in,Type 2 diabetes[22158537;22961080;24509480;26818947;22885922;22885922;28869590];Osteoarthritis of the hip or knee (with total joint replacement)[29436472];Homeostasis model assessment of beta-cell function[20081858];Osteoarthritis of the hip or knee[29436472];Glaucoma (primary angle closure)[27064256;27064256];Hematocrit[27863252];Blood sugar levels[29403010];Triglyceride change in response to fenofibrate in statin-treated type 2 diabetes[28736931];Response to anti-retroviral therapy (ddI/d4T) in HIV-1 infection (Grade 2 peripheral neuropathy)[24554482];Hemoglobin concentration[27863252];Cerebrospinal P-tau181p levels[28247064];Fasting plasma glucose[25187374];Spontaneous preterm birth (preterm delivery)[25599974];Chin dimples[27182965];Lung function (FEV1)[28166213];Fasting blood glucose (BMI interaction)[22581228];Methotrexate phramacokinetics (acute lymphoblastic leukemia)[19901119];Thyroid hormone levels[23408906;23408906];Fasting blood glucose[20081858;22581228];Cerebrospinal T-tau levels[28247064];Alzheimer's disease biomarkers[23562540;23562540];Red blood cell count[27863252];Central corneal thickness[29760442];Type 1 diabetes[18840781;19430480;25751624];Squamous cell lung carcinoma[28604730];Nicotine dependence[28440896];Low high density lipoprotein cholesterol levels[26879886];Intraocular pressure[29617998;29617998;29235454;30054594;29785010];,0.2498159509202454,0.15033522434244456,0.3087966588358131,0.3337937384898711
1457,9915,GLMN,601749,138000;,[MIM:138000]Glomuvenous malformations;,Glomuvenous malformation,Disease-causing germline mutation(s) in,Granulocyte percentage of myeloid white cells[27863252];Lymphocyte percentage of white cells[27863252];Myeloid white cell count[27863252];Monocyte count[27863252];Monocyte percentage of white cells[27863252];,0.7398773006134969,0.07478081485301702,0.4750717828243278,0.0678330263965623
1458,9922,GLRA1,138491,149400;,[MIM:149400]Hyperekplexia 1;,Hereditary hyperekplexia,Disease-causing germline mutation(s) in,,0.16220858895705523,0.4773078906652914,0.5729574523623074,0.8288827501534684
1459,9926,GLRB,138492,614619;,[MIM:614619]Hyperekplexia 2;,Hereditary hyperekplexia,Disease-causing germline mutation(s) in,Cognitive decline (age-related)[28078323];,0.23865030674846627,0.3457968024755028,0.7896110676063691,0.49923265807243705
1460,9932,GLRX5,609588,616859;616860;,"[MIM:616860]Anemia, sideroblastic, 3, pyridoxine-refractory [recessive?];[MIM:616859]Spasticity, childhood-onset, with hyperglycinemia [recessive?];",Adult-onset autosomal recessive sideroblastic anemia;Childhood-onset spasticity with hyperglycinemia,Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in,Mean corpuscular hemoglobin[27863252];Mean corpuscular volume[27863252];Amyotrophic lateral sclerosis (sporadic)[24529757];Diisocyanate-induced asthma[25918132];Obesity-related traits[23251661];,0.8917791411042945,0.7008767405879319,0.3140172278778387,0.0
1461,9945,GLUD1,138130,606762;,[MIM:606762]Familial hyperinsulinemic hypoglycemia 6;,Hyperinsulinism-hyperammonemia syndrome,Disease-causing germline mutation(s) in,,0.9811042944785276,0.756833419288293,0.6995562516314279,0.611878453038674
1462,9954,GLUL,138290,610015;,[MIM:610015]Congenital systemic glutamine deficiency;,Congenital brain dysgenesis due to glutamine synthetase deficiency,Disease-causing germline mutation(s) (loss of function) in,Cardiovascular heart disease in diabetics[23982368];,0.647361963190184,0.941980402269211,0.9073348995040459,0.0
1463,9971,GLYCTK,610516,220120;,,D-glyceric aciduria,Disease-causing germline mutation(s) in,Autism spectrum disorder or schizophrenia[28540026;28540026];Schizophrenia[23974872;28991256];Bipolar disorder[21926972];,0.45680981595092024,0.25012893243940176,0.44792482380579485,0.1464088397790055
1464,9975,GM2A,613109,272750;,[MIM:272750]GM2-gangliosidosis AB [recessive?];,"GM2 gangliosidosis, AB variant",Disease-causing germline mutation(s) in,Inflammatory bowel disease[28067908];Serum folate levels[29953918];Crohn's disease[28067908];Bulimia nervosa[23568457];,0.5191411042944786,0.5461578133058278,0.43878882798225005,0.4636279926335175
1465,9992,GMNN,602842,616835;,[MIM:616835]Meier-Gorlin syndrome 6;,Ear-patella-short stature syndrome,Disease-causing germline mutation(s) (gain of function) in,,0.6197546012269939,0.6165549252191852,0.18976768467762986,0.31813996316758747
1466,9993,GMPPA,615495,615510;,,Triple A syndrome,Disease-causing germline mutation(s) (loss of function) in,,0.5842944785276074,0.29087158329035584,0.7509788566953798,0.4972375690607735
1467,9994,GMPPB,615320,615350;615351;615352;,[MIM:615350]Muscular dystrophy-dystroglycanopathy congenital with brain and eye anomalies A14 [recessive?];[MIM:615351]Muscular dystrophy-dystroglycanopathy congenital with mental retardation B14;[MIM:615352]Muscular dystrophy-dystroglycanopathy limb-girdle C14 [recessive?];,Congenital muscular dystrophy with cerebellar involvement;Congenital muscular dystrophy with intellectual disability;Autosomal recessive limb-girdle muscular dystrophy type 2T;Congenital myasthenic syndromes with glycosylation defect;Muscle-eye-brain disease,Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in,Resting heart rate[27798624];Blood protein levels[28240269];Ulcerative colitis[21297633];,0.4190184049079755,0.18359979370809695,0.7648133646567475,0.0
1468,9999,GNA11,139313,145981;615361;,"[MIM:145981]Hypocalciuric hypercalcemia, familial 2 [dominant?];[MIM:615361]Hypocalcemia, autosomal dominant 2 [dominant?];",Autosomal dominant hypocalcemia;Uveal melanoma;Phakomatosis cesioflammea;Phakomatosis cesiomarmorata;Familial hypocalciuric hypercalcemia type 2,Disease-causing germline mutation(s) (gain of function) in;Disease-causing somatic mutation(s) in;Disease-causing somatic mutation(s) in;Disease-causing somatic mutation(s) in;Disease-causing germline mutation(s) (loss of function) in,,0.7871165644171779,0.8968540484785972,0.8285043069694596,0.9422958870472683
1469,10002,GNA14,604397,,,Tufted angioma;Kaposiform hemangioendothelioma,Disease-causing somatic mutation(s) in;Disease-causing somatic mutation(s) in,Delirium[29631748];Amyotrophic lateral sclerosis (sporadic)[24529757];,0.23865030674846627,0.04151624548736462,0.6653615244061603,0.4685389809699202
1470,10009,GNAI3,139370,602483;,[MIM:602483]Auriculocondylar syndrome 1 [dominant?];,Auriculocondylar syndrome,Disease-causing germline mutation(s) in,Major depressive disorder[20125088];,0.894478527607362,0.49174832387828776,0.857739493604803,0.4020871700429711
1471,10010,GNAL,139312,615073;,,"Autosomal dominant focal dystonia, DYT25 type",Disease-causing germline mutation(s) in,QT interval (drug interaction)[23459443];Alcohol dependence[26365420];Tandem gait[26219847];Venous thromboembolism adjusted for sickle cell variant rs77121243-T[28203683];,0.4936196319018405,0.8053120165033523,0.5935787000783085,0.9318600368324125
1472,10011,GNAO1,139311,615473;617493;,"[MIM:615473]Epileptic encephalopathy, early infantile, 17;[MIM:617493]Neurodevelopmental disorder with involuntary movements;",Early infantile epileptic encephalopathy,Disease-causing germline mutation(s) in,Dimensional psychopathology (Positive)[29496196];,0.7139877300613497,0.830582774626096,0.9258679196032368,0.0
1473,10012,GNAQ,600998,163000;185300;,"[MIM:163000]Capillary malformations, congenital;[MIM:185300]Sturge-Weber syndrome;",Sturge-Weber syndrome;Familial multiple nevi flammei;Uveal melanoma;Phakomatosis cesioflammea,Disease-causing somatic mutation(s) in;Disease-causing somatic mutation(s) in;Disease-causing somatic mutation(s) in;Disease-causing somatic mutation(s) in,,0.780122699386503,0.8470861268695203,0.9723309840772644,0.7998772252915899
1474,10014,GNAS,139320,219080;603233;,[MIM:219080]ACTH-independent macronodular adrenal hyperplasia 1;[MIM:603233]Pseudohypoparathyroidism 1B;[MIM:139320]GNAS hyperfunction;,McCune-Albright syndrome;Cushing syndrome due to macronodular adrenal hyperplasia;Progressive osseous heteroplasia;Mazabraud syndrome;Polyostotic fibrous dysplasia;Monostotic fibrous dysplasia;Pseudopseudohypoparathyroidism;Pseudohypoparathyroidism type 1C;Pseudohypoparathyroidism type 1A;Pseudohypoparathyroidism type 1B,Disease-causing somatic mutation(s) in;Disease-causing somatic mutation(s) in;Disease-causing germline mutation(s) (loss of function) in;Candidate gene tested in;Disease-causing somatic mutation(s) in;Disease-causing somatic mutation(s) in;Disease-causing germline mutation(s) (loss of function) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) (loss of function) in;Disease-causing germline mutation(s) in,Hypertension[21909115];Systolic blood pressure[21909115;27618452;28739976];DNA methylation (variation)[23725790];Diastolic blood pressure (cigarette smoking interaction)[29455858];Sulfasalazine-induced agranulocytosis[28762467];Diastolic blood pressure[21909115;29403010;27618452;28739976];Platelet distribution width[27863252];Waist circumference adjusted for body mass index[26785701];Mean arterial pressure[29403010];Response to diuretic therapy in hypertension[23753411];Systolic blood pressure (cigarette smoking interaction)[29455858];Renal function-related traits (BUN)[22797727];Blood pressure[21909110;21909110];Post bronchodilator FEV1/FVC ratio[26634245;26634245];,0.8733742331288343,0.9112944816915935,0.4557556773688332,0.9732965009208103
1475,10016,GNAT1,139330,610444;616389;,"[MIM:610444]Night blindness, congenital stationary, autosomal dominant 3 [dominant?];[MIM:616389]Night blindness, congenital stationary, 1G [recessive?];",Congenital stationary night blindness,Disease-causing germline mutation(s) in,Body mass index[26426971];General cognitive ability[29844566];,0.20368098159509201,0.17560598246518824,0.8566953797963978,0.491866175567833
1476,10017,GNAT2,139340,613856;,,Progressive cone dystrophy;Achromatopsia,Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in,BMI in non-smokers[28443625;28443625];Obesity[23563607];Body mass index[28448500;28448500;28448500;28448500;28448500;25673413;25673413;25673413;25673413];Body mass index in physically active individuals[28448500;28448500;28448500];Hip circumference[25673412;25673412];Body mass index (joint analysis main effects and smoking interaction)[28443625;28443625];Hand grip strength[29691431];Major depressive disorder[20125088];Body mass index (joint analysis main effects and physical activity interaction)[28448500;28448500;28448500;28448500];BMI (adjusted for smoking behaviour)[28443625;28443625;28443625];,0.26588957055214724,0.22460030943785456,0.30409814669799007,0.5363720073664825
1477,10020,GNB1,139380,616973;,"[MIM:616973]Mental retardation, autosomal dominant 42 [dominant?];",Global developmental delay-neuro-ophthalmological abnormalities-seizures-intellectual disability syndrome,Disease-causing germline mutation(s) in,Body mass index[25673413;26426971;25673413];,0.9546012269938651,0.907942238267148,0.9997389715478987,0.0
1478,10023,GNB3,139130,617024;,"[MIM:617024]Night blindness, congenital stationary, 1H [recessive?];",Congenital stationary night blindness,Disease-causing germline mutation(s) (loss of function) in,Spherical equivalent or myopia (age of diagnosis)[29808027];Myopia[27182965];Response to Vitamin E supplementation[22437554];,0.5450306748466258,0.11371841155234658,0.5353693552597233,0.20979128299570288
1479,10024,GNB4,610863,615185;,,Autosomal dominant intermediate Charcot-Marie-Tooth disease type F,Disease-causing germline mutation(s) in,Heart rate[23583979];Resting heart rate[27798624;29769521];Atrial fibrillation[30061737;29892015;29892015];,0.623680981595092,0.6095925734914904,0.889584964761159,0.27225291589932477
1480,10026,GNE,603824,269921;600737;605820;,[MIM:269921]Sialuria [dominant?];[MIM:605820]Nonaka myopathy;,Sialuria;GNE myopathy,Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in,Bipolar disorder (inflammation and infection response interaction)[25781172];,0.47337423312883437,0.05724600309437854,0.770817019055077,0.8937998772252916
1481,10054,GNMT,606628,606664;,,Hypermethioninemia due to glycine N-methyltransferase deficiency,Disease-causing germline mutation(s) (loss of function) in,Plasma homocysteine levels (post-methionine load test)[24651765];Blood protein levels[29875488;30072576];,0.33975460122699386,0.4589994842702424,0.7593317671626207,0.4607120933087784
1482,10055,GNPAT,602744,222765;,[MIM:222765]Rhizomelic chondrodysplasia punctata 2;,Rhizomelic chondrodysplasia punctata type 2,Disease-causing germline mutation(s) in,,0.7998773006134969,0.7836513666838577,0.25815713912816496,0.5121240024554942
1483,10057,GNPDA1,601798,,,Hemolytic anemia due to glucophosphate isomerase deficiency,Disease-causing germline mutation(s) in,Squamous cell lung carcinoma[28604730];Erosive tooth wear (severe vs non-severe)[29898447;29898447;29898447];Erosive tooth wear (severe vs none or mild)[29898447];Asthma[29273806];,0.7561963190184049,0.17921609076843734,0.9237796919864265,0.255524861878453
1484,10060,GNPTAB,607840,252500;252600;,[MIM:252500]Mucolipidosis type II [recessive?];[MIM:252600]Mucolipidosis type III complementation group A;,Mucolipidosis type II;Mucolipidosis type III alpha/beta,Disease-causing germline mutation(s) (loss of function) in;Disease-causing germline mutation(s) (loss of function) in,Bone mineral density (total hip)[29883787];Blood protein levels[28240269;28240269;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488];,0.45950920245398774,0.6758638473439917,0.3923257635082224,0.8104665438919583
1485,10061,GNPTG,607838,252605;,[MIM:252605]Mucolipidosis type III complementation group C;,Mucolipidosis type III gamma,Disease-causing germline mutation(s) (loss of function) in,Blood protein levels[30072576];,0.4463803680981595,0.42006188757091284,0.7535891412163925,0.5089011663597299
1486,10062,GNRH1,152760,614841;,[MIM:614841]Hypogonadotropic hypogonadism 12 with or without anosmia;,Normosmic congenital hypogonadotropic hypogonadism,Disease-causing germline mutation(s) in,Menopause (age at onset)[29773799;29773799];,0.20368098159509201,0.6015987622485818,0.39075959279561473,0.2687231430325353
1487,10064,GNRHR,138850,146110;,,Normosmic congenital hypogonadotropic hypogonadism,Disease-causing germline mutation(s) (loss of function) in,,0.10711656441717791,0.5064466219700877,0.8514748107543723,0.3660220994475138
1488,10067,GNS,607664,252940;,[MIM:252940]Mucopolysaccharidosis 3D [recessive?];,Sanfilippo syndrome type D,Disease-causing germline mutation(s) (loss of function) in,,0.5811042944785276,0.4051057246003094,0.4121639258679196,0.578268876611418
1489,10086,GOLGA5,606918,,,Differentiated thyroid carcinoma,Part of a fusion gene in,Body mass index[26426971];,0.9276073619631902,0.7456162970603404,0.21195510310623858,0.34499693063228976
1490,10140,GOPC,606845,,,Male infertility due to globozoospermia,Candidate gene tested in,Atrial fibrillation[29892015];Colorectal cancer[23266556];Facial emotion recognition (fearful faces)[28608620];Night sleep phenotypes[27126917];,0.9585276073619632,0.4290871583290356,0.6985121378230227,0.26611418047882135
1491,10141,GORAB,607983,231070;,[MIM:231070]Geroderma osteodysplasticum [recessive?];,Geroderma osteodysplastica,Disease-causing germline mutation(s) in,Male-pattern baldness[27182965];Waist-to-hip ratio adjusted for BMI (adjusted for smoking behaviour)[28443625;28443625];Waist-to-hip ratio adjusted for BMI (joint analysis main effects and smoking interaction)[28443625;28443625];Waist-to-hip ratio adjusted for BMI in active individuals[28448500;28448500];Atrial fibrillation[29892015];Waist-to-hip ratio adjusted for BMI (joint analysis for main effect and physical activity interaction)[28448500;28448500];Waist-to-hip ratio adjusted for BMI in non-smokers[28443625;28443625];Waist-to-hip ratio adjusted for BMI in inactive individuals[28448500];Waist-hip ratio[25673412;25673412];Waist-to-hip ratio adjusted for BMI[26426971];Waist-to-hip ratio adjusted for body mass index[28448500;28448500;25673412;25673412;25673412;25673412];Waist-to-hip ratio adjusted for BMI x sex x age interaction (4df test)[26426971];,0.8841717791411043,0.2294997421351212,0.7635082223962412,0.09008594229588705
1492,10146,GOSR2,604027,614018;,"[MIM:614018]Epilepsy, progressive myoclonic 6;",Progressive myoclonic epilepsy type 6,Disease-causing germline mutation(s) (loss of function) in,Systolic blood pressure[21909115;28135244;27618452;28739976;27618447];Idiopathic pulmonary fibrosis[29066090];Atrial fibrillation[29892015;29892015];Orofacial clefts[28054174];Mean arterial pressure[27618448];Aortic root size[28394258];Coronary artery disease[29212778;29212778];Blood urea nitrogen levels[29403010];Body mass index[26426971];Cleft lip with or without cleft palate[28054174];Pulse pressure[28739976];Blood pressure[21909110;21909110];QRS duration[21076409;27577874;27577874];Nonsyndromic cleft lip with cleft palate[28232668];,0.8991411042944786,0.18978855079938112,0.10127903941529627,0.12093308778391651
1493,10155,GP1BA,606672,153670;177820;231200;258660;,"[MIM:258660]Non-arteritic anterior ischemic optic neuropathy;[MIM:231200]Bernard-Soulier syndrome;[MIM:153670]Bernard-Soulier syndrome A2, autosomal dominant [dominant?];[MIM:177820]Pseudo-von Willebrand disease;",Bernard-Soulier syndrome;Fetal and neonatal alloimmune thrombocytopenia;Pseudo-von Willebrand disease,Disease-causing germline mutation(s) in;Candidate gene tested in;Disease-causing germline mutation(s) in,Mean platelet volume[27863252];Platelet distribution width[27863252;27863252];Blood protein levels[29875488;30072576];Platelet count[22139419;20139978;27863252;29403010];,0.4154601226993865,0.3780299123259412,0.3487340120073088,0.2607427869858809
1494,10156,GP1BB,138720,231200;,,22q11.2 deletion syndrome;Bernard-Soulier syndrome;Autosomal dominant macrothrombocytopenia;Fetal and neonatal alloimmune thrombocytopenia,Role in the phenotype of;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Candidate gene tested in,Mean platelet volume[27863252];DNA methylation (parent-of-origin)[23725790];Platelet distribution width[27863252];Platelet count[27863252];,0.4298159509202454,0.7269210933470861,0.8183241973375098,0.0
1495,10159,GP6,605546,614201;,"[MIM:614201]Bleeding disorder, platelet-type 11;",Bleeding diathesis due to glycoprotein VI deficiency,Disease-causing germline mutation(s) (loss of function) in,Mean platelet volume[27863252];Reticulocyte fraction of red cells[27863252];Reticulocyte count[27863252];Platelet distribution width[27863252];Breast cancer and/or colorectal cancer[29698419];Platelet aggregation[20526338];Blood protein levels[28240269;30072576];,0.33975460122699386,0.5809695719443012,0.1581832419733751,0.040976058931860036
1496,10160,GP9,173515,231200;,[MIM:231200]Bernard-Soulier syndrome;,Bernard-Soulier syndrome,Disease-causing germline mutation(s) in,,0.3749693251533742,0.7140278494069108,0.4197337509788567,0.0
1497,10183,GPC1,600395,,,Isolated biliary atresia,Major susceptibility factor in,Brain imaging in schizophrenia (dorsolateral prefrontal cortex interaction)[19023125];Blood protein levels[29875488];,0.7555828220858896,0.6338318720990201,0.0,0.4817372621240025
1498,10185,GPC3,300037,312870;,[MIM:312870]Simpson-Golabi-Behmel syndrome 1;,Nephroblastoma;Simpson-Golabi-Behmel syndrome,Biomarker tested in;Disease-causing germline mutation(s) (loss of function) in,Educational attainment (years of education)[30038396];Relative hand skill[24068947];,0.8105521472392638,0.9386281588447654,0.729574523623075,0.0
1499,10187,GPC4,300168,,,Simpson-Golabi-Behmel syndrome,Candidate gene tested in,,0.7641717791411043,0.8496647756575555,0.03393369877316627,0.8038674033149171
1500,10192,GPC6,604404,258315;,[MIM:258315]Omodysplasia 1 [recessive?];,Autosomal recessive omodysplasia,Disease-causing germline mutation(s) (loss of function) in,Visceral fat[22589738];Blood pressure (smoking interaction)[25189868;25189868];Spherical equivalent or myopia (age of diagnosis)[29808027];Attention deficit hyperactivity disorder[18839057];Breast size[22747683];Heel bone mineral density[28869591;28869591;28869591;28869591];Neuroticism (age interaction)[20634892];Disc degeneration (lumbar)[22993228];Pelvic organ prolapse[26545240];Night sleep phenotypes[27126917];Waist-hip ratio[25673412];Response to anti-retroviral therapy (ddI/d4T) in HIV-1 infection (Grade 2 peripheral neuropathy)[24554482];Alzheimer's disease (cognitive decline)[23535033];Renal sinus fat[22044751];Tonometry[17903302];Obesity-related traits[23251661;23251661;23251661];Waist-to-hip ratio adjusted for body mass index[25673412;25673412];,0.23865030674846627,0.589994842702424,0.16731923779691987,0.42863720073664824
1501,10196,GPD1,138420,614480;,"[MIM:614480]Hypertriglyceridemia, transient infantile [recessive?];",Transient infantile hypertriglyceridemia and hepatosteatosis,Disease-causing germline mutation(s) in,,0.21484662576687116,0.4853017019082001,0.5653876272513704,0.22790055248618785
1502,10197,GPD1L,611778,611777;,,Brugada syndrome,Disease-causing germline mutation(s) in,Periodontal disease-related phenotypes[24347629];Schizophrenia[28991256];Alcohol dependence[22004471];,0.35496932515337426,0.5881897885507994,0.8467762986165492,0.3543585021485574
1503,10203,GPHN,603930,615501;,"[MIM:615501]Molybdenum cofactor deficiency, complementation group C [recessive?];",Hereditary hyperekplexia;Sulfite oxidase deficiency due to molybdenum cofactor deficiency type C,Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in,Depression (quantitative trait)[23290196];Tandem gait[26219847];,0.6968098159509203,0.38267148014440433,0.8407726442182197,0.8878146101903008
1504,10204,GPI,172400,613470;,"[MIM:613470]Hemolytic anemia, non-spherocytic, due to glucose phosphate isomerase deficiency;",Hemolytic anemia due to glucophosphate isomerase deficiency,Disease-causing germline mutation(s) in,Non-response to bupropion and depression[27622933];,0.8662576687116564,0.7297576070139247,0.5985382406682328,0.8690914671577655
1505,10205,GPIHBP1,612757,615947;,[MIM:615947]Hyperlipoproteinemia 1D [recessive?];,Familial chylomicronemia syndrome,Disease-causing germline mutation(s) in,,0.038773006134969326,0.594636410520887,0.18010963194988253,0.45196439533456106
1506,10206,GPKOW,301003,,,Lethal intrauterine growth restriction-cortical malformation-congenital contractures syndrome,Disease-causing germline mutation(s) in,,0.6766871165644172,0.9423671995874162,0.8123205429391803,0.9002455494168201
1507,10217,GPNMB,604368,617920;,"[MIM:617920]Amyloidosis, primary localized cutaneous, 3 [recessive?];",Amyloidosis cutis dyschromia,Disease-causing germline mutation(s) (loss of function) in,Parkinson's disease[25064009;28892059];Blood protein levels[28240269;28240269;29875488;29875488;29875488;29875488;30072576;30072576;30072576];Iron status biomarkers (transferrin saturation)[28334935];,0.21484662576687116,0.025786487880350695,0.3920647350561211,0.0167280540208717
1508,10239,GPR35,602646,,,Primary sclerosing cholangitis,Major susceptibility factor in,"Inflammatory bowel disease[28067908;23128233];Pediatric autoimmune diseases[26301688];Granulocyte percentage of myeloid white cells[27863252];Sclerosing cholangitis and ulcerative colitis (combined)[22821403];Chronic inflammatory diseases (ankylosing spondylitis, Crohn's disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy)[26974007;26974007];Monocyte count[27863252];Monocyte percentage of white cells[27863252];Ankylosing spondylitis[23749187;23749187];Ulcerative colitis[21297633;28067908];",0.17791411042944785,0.40871583290355856,0.38162359697206993,0.3201350521792511
1509,10255,GPR68,601404,617217;,,Hypomaturation amelogenesis imperfecta,Disease-causing germline mutation(s) (loss of function) in,Daytime sleep phenotypes[27126917];Waist-to-hip ratio adjusted for BMI[26426971];Waist-to-hip ratio adjusted for BMI x sex x age interaction (4df test)[26426971];,0.038773006134969326,0.31975244971634864,0.7413208039676324,0.3944137507673419
1510,10269,GPR101,300393,300943;,"[MIM:300943]Pituitary adenoma 2, growth hormone-secreting;",Acromegaly;X-linked acrogigantism due to Xq26 microduplication,Major susceptibility factor in;Role in the phenotype of,Body mass index[28892062];,0.08736196319018405,0.7937080969571945,0.08483424693291569,0.7638121546961326
1511,10282,GPR143,300808,300500;300814;,[MIM:300500]Albinism ocular 1;[MIM:300814]Nystagmus congenital X-linked 6;,X-linked recessive ocular albinism,Disease-causing germline mutation(s) in,Prostate cancer[23535732];,0.14576687116564419,0.8798349664775658,0.7616810232315322,0.8186003683241252
1512,10297,GPR161,612250,,,Pituitary stalk interruption syndrome,Disease-causing germline mutation(s) in,Red cell distribution width[27863252];,0.4298159509202454,0.36926250644662195,0.658574784651527,0.2945058317986495
1513,10305,GPR179,614515,614565;,,Congenital stationary night blindness,Disease-causing germline mutation(s) in,Ovarian cancer[23535730];,0.038773006134969326,0.013408973697782363,0.13129731140694337,0.2937384898710866
1514,10311,GPRASP2,300969,,,X-linked external auditory canal atresia-dilated internal auditory canal-facial dysmorphism syndrome,Disease-causing germline mutation(s) in,,0.7170552147239264,0.9231562661165549,0.6825894022448447,0.24631675874769798
1515,10318,GPRIN1,611239,,,Autosomal dominant non-syndromic intellectual disability;Bilateral generalized polymicrogyria,Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in,Post-traumatic stress disorder (asjusted for relatedness)[23726511];,0.7193865030674846,0.9076843733883445,0.14722004698512137,0.36955187231430325
1516,10326,GPSM2,609245,604213;,,Chudley-McCullough syndrome;Autosomal recessive non-syndromic sensorineural deafness type DFNB,Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in,Fat distribution (HIV)[21897333;21897333;21897333];,0.4117791411042945,0.722279525528623,0.27747324458365963,0.5466543891958257
1517,10329,GPT2,138210,616281;,,Postnatal microcephaly-infantile hypotonia-spastic diplegia-dysarthria-intellectual disability syndrome,Disease-causing germline mutation(s) in,,0.5885889570552147,0.5301701908200103,0.7710780475071782,0.600061387354205
1518,10335,GPX4,138322,250220;,,"Spondylometaphyseal dysplasia, Sedaghatian type",Disease-causing germline mutation(s) in,Inflammatory bowel disease[28067908];Sum eosinophil basophil counts[27863252];Eosinophil percentage of granulocytes[27863252];Advanced age-related macular degeneration[26691988];Crohn's disease[21102463;23128233;28067908];Eosinophil counts[27863252];Neutrophil percentage of granulocytes[27863252];Eosinophil percentage of white cells[27863252];,0.9271165644171779,0.2854564208354822,0.0,0.295426642111725
1519,10364,GREB1L,617782,617805;,,"Renal agenesis, bilateral;Renal agenesis, unilateral",Disease-causing germline mutation(s) (loss of function) in;Disease-causing germline mutation(s) (loss of function) in,,0.08736196319018405,0.7279525528623002,0.4463586530931872,0.0
1520,10365,GREM1,603054,601228;,"[MIM:601228]Polyposis syndrome, mixed hereditary 1 [dominant?];",Hereditary mixed polyposis syndrome,Disease-causing germline mutation(s) in,Monobrow[27182965];Hypospadias[25108383];Colorectal cancer[21761138;24737748;23266556;26151821;25990418];Chin dimples[27182965];Orofacial clefts[20023658];,0.17791411042944785,0.6637441980402269,0.9089010702166536,0.0
1521,10368,GRHL2,608576,608641;616029;618031;,"[MIM:608641]Deafness, autosomal dominant, 28 [dominant?];[MIM:616029]Ectodermal dysplasia/short stature syndrome [recessive?];[MIM:618031]Corneal dystrophy, posterior polymorphous, 4 [dominant?];",Nail and teeth abnormalities-marginal palmoplantar keratoderma-oral hyperpigmentation syndrome;Autosomal dominant non-syndromic sensorineural deafness type DFNA;Posterior polymorphous corneal dystrophy,Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in,Rheumatoid arthritis[24390342;24390342];Bronchopulmonary dysplasia[23897914];,0.31079754601226994,0.0,0.41660140955364133,0.6022099447513812
1522,10369,GRHL3,608317,606713;,,Van der Woude syndrome;Submucosal cleft palate;Cleft hard palate;Cleft velum;Bifid uvula,Disease-causing germline mutation(s) in;Major susceptibility factor in;Major susceptibility factor in;Major susceptibility factor in;Major susceptibility factor in,Fasting blood insulin (BMI interaction)[22581228];Cleft palate[28054174;28054174;27018472;27018472;27018472;27018472;27018472];Response to interferon beta in multiple sclerosis[26644207];,0.20368098159509201,0.7821041774110367,0.08953275907073871,0.4011663597298956
1523,10370,GRHPR,604296,260000;,,Primary hyperoxaluria type 2,Disease-causing germline mutation(s) in,,0.3669938650306748,0.1995874161939144,0.519185591229444,0.5078268876611418
1524,10373,GRIA3,305915,300699;,"[MIM:300699]Mental retardation, X-linked 94;",X-linked intellectual disability due to GRIA3 mutations,Disease-causing germline mutation(s) (loss of function) in,Mortality in sepsis[27639821];,0.36171779141104293,0.9693140794223827,0.8833202819107283,0.7813075506445673
1525,10377,GRID2,602368,616204;,"[MIM:616204]Spinocerebellar ataxia, autosomal recessive, 18 [recessive?];",Autosomal recessive congenital cerebellar ataxia due to GRID2 deficiency,Disease-causing germline mutation(s) (loss of function) in,Manganese levels[26025379];Intelligence (MTAG)[29326435];Post bronchodilator FEV1/FVC ratio[26634245;26634245;26634245;26634245];Obesity-related traits[23251661];,0.2498159509202454,0.8158844765342961,0.21821978595666927,0.9074585635359116
1526,10383,GRIK2,138244,611092;,"[MIM:611092]Mental retardation, autosomal recessive 6 [recessive?];",Autosomal recessive non-syndromic intellectual disability,Disease-causing germline mutation(s) (loss of function) in,Biochemical measures[19260141];Emphysema imaging phenotypes[26030696];Palmitic acid (16:0) levels[23362303];Cardiac hypertrophy[21348951];Pursuit maintenance gain[29064472];Obsessive-compulsive disorder[22889921];Longevity (90 years and older)[25199915];Renal function-related traits (eGRFcrea)[22797727];Obesity-related traits[23251661];Heart rate response to recovery post exercise (20 sec)[29497042];,0.33975460122699386,0.8130479628674575,0.6001044113808405,0.8041743400859422
1527,10386,GRIK5,600283,,,Autosomal recessive non-syndromic intellectual disability,Disease-causing germline mutation(s) (loss of function) in,Bipolar disorder[21771265];,0.22687116564417178,0.9602888086642599,0.5927956147220047,0.7220687538367097
1528,10387,GRIN1,138249,614254;617820;,"[MIM:614254]Neurodevelopmental disorder with or without hyperkinetic movements and seizures, autosomal dominant [dominant?];[MIM:617820]Neurodevelopmental disorder with or without hyperkinetic movements and seizures, autosomal recessive [recessive?];",Autosomal dominant non-syndromic intellectual disability;Bilateral generalized polymicrogyria,Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in,Post-traumatic stress disorder (asjusted for relatedness)[23726511];,0.4710429447852761,0.9198040226921094,0.9778125815713913,0.7922038060159607
1529,10388,GRIN2A,138253,245570;,"[MIM:245570]Epilepsy, focal, with speech disorder and with or without mental retardation [dominant?];",Rolandic epilepsy-speech dyspraxia syndrome;Rolandic epilepsy;Early-onset epileptic encephalopathy and intellectual disability due to GRIN2A mutation;Continuous spikes and waves during sleep;Landau-Kleffner syndrome,Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in,"Rosacea symptom severity[29771307];Laryngeal squamous cell carcinoma[25194280];Autism spectrum disorder, attention deficit-hyperactivity disorder, bipolar disorder, major depressive disorder, and schizophrenia (combined)[23453885];Autism spectrum disorder or schizophrenia[28540026];Copper levels[26025379];Schizophrenia[25056061;28991256];Waist circumference adjusted for BMI (smoking interaction)[28443625];Chronic kidney disease[26420894];Tenofovir clearance in HIV infection[26148204];Night sleep phenotypes[27126917];Thiazide-induced adverse metabolic effects in hypertensive patients[23400010];Hepatitis B[22004137];",0.4403680981595092,1.0,0.6128948055338032,0.8179864947820749
1530,10389,GRIN2B,138252,613970;616139;,"[MIM:613970]Mental retardation, autosomal dominant 6, with or without seizures [dominant?];[MIM:616139]Epileptic encephalopathy, early infantile, 27;",Autosomal dominant non-syndromic intellectual disability;West syndrome,Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) (gain of function) in,Immune reponse to smallpox (secreted IL-2)[22610502];Cognitive performance[19734545];Spherical equivalent or myopia (age of diagnosis)[29808027];Brain structure (temporal lobe volume)[20197096];Egg allergy (parent-of-origin effect)[29489655];Total ventricular volume[21116278];Aging (time to event)[21782286];Response to selective serotonin reuptake inhibitors in depression[30034349];Ovarian reserve[22116950];Major depressive disorder[23377640];,0.4710429447852761,1.0,0.7859566692769512,0.6895334561080417
1531,10391,GRIN2D,602717,617162;,"[MIM:617162]Epileptic encephalopathy, early infantile, 46;",Undetermined early-onset epileptic encephalopathy,Disease-causing germline mutation(s) (gain of function) in,,0.3925153374233129,0.9818205260443528,0.6215087444531454,0.0
1532,10395,GRIP1,604597,617667;,[MIM:617667]Fraser syndrome 3 [recessive?];,Fraser syndrome,Disease-causing germline mutation(s) in,Basophil percentage of white cells[27863252];Post bronchodilator FEV1/FVC ratio[26634245;26634245];Basophil percentage of granulocytes[27863252];,0.7332515337423313,0.7666322846828262,0.4755938397285304,0.3083179864947821
1533,10398,GRK1,180381,613411;,"[MIM:613411]Night blindness, congenital stationary, Oguchi type 2;",Congenital stationary night blindness;Oguchi disease,Candidate gene tested in;Disease-causing germline mutation(s) (loss of function) in,,0.21484662576687116,0.2527075812274368,0.48916731923779694,0.0
1534,10407,GRM1,604473,614831;617691;,[MIM:617691]Spinocerebellar ataxia 44 [dominant?];,Autosomal recessive congenital cerebellar ataxia due to MGLUR1 deficiency;Chondromyxoid fibroma,Disease-causing germline mutation(s) in;Part of a fusion gene in,Cerebral amyloid deposition (PET imaging)[26252872;26252872];Waist circumference[29212154];,0.33975460122699386,0.7875193398659103,0.4202558078830593,0.9518109269490485
1535,10413,GRM6,604096,257270;,,Congenital stationary night blindness,Disease-causing germline mutation(s) in,Pubertal anthropometrics[23449627];,0.08736196319018405,0.04409489427539969,0.27094753328112764,0.8624923265807244
1536,10419,GRN,138945,607485;614706;,"[MIM:607485]Ubiquitin-positive frontotemporal dementia [dominant?];[MIM:614706]Ceroid lipofuscinosis, neuronal, 11;",Behavioral variant of frontotemporal dementia;CLN11 disease;Semantic dementia;Progressive non-fluent aphasia,Major susceptibility factor in;Disease-causing germline mutation(s) in;Major susceptibility factor in;Major susceptibility factor in,Progranulin levels[29186428];Intracranial volume[22504418];Subcortical brain region volumes[25607358];Blood protein levels[29875488;29875488;30072576];,0.6462576687116565,0.8375451263537906,0.6147220046985121,0.2856046654389196
1537,10432,GRXCR1,613283,613285;,,Autosomal recessive non-syndromic sensorineural deafness type DFNB,Disease-causing germline mutation(s) in,Response to bronchodilator in chronic obstructive pulmonary disease (change in FEV1)[26503814];Type 2 diabetes (age of onset)[28060188];Interferon alpha levels in systemic lupus erythematosus[25338677];Obesity-related traits[23251661];Takayasu arteritis[25604533];,0.17791411042944785,0.11165549252191852,0.16601409553641347,0.21992019643953345
1538,10433,GRXCR2,615762,615837;,"[MIM:615837]Deafness, autosomal recessive, 101 [recessive?];",Autosomal recessive non-syndromic sensorineural deafness type DFNB,Disease-causing germline mutation(s) (loss of function) in,,0.038773006134969326,0.16090768437338834,0.24380057426259463,0.2826887661141805
1539,10436,GSC,138890,602471;,"[MIM:602471]Short stature, auditory canal atresia, mandibular hypoplasia, skeletal abnormalities [recessive?];",Short stature-auditory canal atresia-mandibular hypoplasia-skeletal anomalies syndrome,Disease-causing germline mutation(s) (loss of function) in,Nose size[27182965];Chin dimples[27182965];Nonsyndromic cleft lip with cleft palate[28232668];,0.22687116564417178,0.6379577101598762,0.5792221352127382,0.0
1540,10443,GSDME,608798,600994;,"[MIM:600994]Deafness, autosomal dominant, 5 [dominant?];",Autosomal dominant non-syndromic sensorineural deafness type DFNA,Disease-causing germline mutation(s) in,Schizophrenia[28991256];Urate levels in obese individuals[25811787];,0.2947239263803681,0.10649819494584838,0.0,0.0
1541,10453,GSN,137350,105120;,[MIM:105120]Amyloidosis 5;,AGel amyloidosis,Disease-causing germline mutation(s) in,Blood protein levels[30072576];,0.9142331288343558,0.1039195461578133,0.16888540850952755,0.08916513198281154
1542,10457,GSR,138300,,,Hemolytic anemia due to glutathione reductase deficiency,Disease-causing germline mutation(s) in,,0.8424539877300613,0.1815368746776689,0.35656486557034717,0.3867403314917127
1543,10458,GSS,601002,231900;266130;,[MIM:266130]Glutathione synthetase deficiency;[MIM:231900]Glutathione synthetase deficiency of erythrocytes;,Glutathione synthetase deficiency with 5-oxoprolinuria;Glutathione synthetase deficiency without 5-oxoprolinuria,Disease-causing germline mutation(s) (loss of function) in;Disease-causing germline mutation(s) in,Waist-to-hip ratio adjusted for BMI (age >50)[26426971];QRS complex (Cornell)[27659466];Hemostatic factors and hematological phenotypes[22443383];Blood protein levels[28240269];Waist-to-hip ratio adjusted for BMI[26426971];Waist-to-hip ratio adjusted for BMI x sex x age interaction (4df test)[26426971];,0.36171779141104293,0.23878287777204746,0.7047768206734534,0.584561080417434
1544,10502,GTF2E2,189964,616943;,"[MIM:616943]Trichothiodystrophy 6, non-photosensitive [recessive?];",Trichothiodystrophy,Disease-causing germline mutation(s) in,Cognitive performance[20125193];Metabolite levels  (X-11787)[23934736];,0.8202453987730062,0.4713769984528107,0.8332028191072827,0.28759975445058317
1545,10514,GTF2H5,608780,616395;,"[MIM:616395]Trichothiodystrophy 3, photosensitive [recessive?];",Trichothiodystrophy,Disease-causing germline mutation(s) in,Lipoprotein (a) levels[26377243];Systemic sclerosis[29293537];,0.6430674846625767,0.5165033522434245,0.9736361263377709,0.34392265193370164
1546,10515,GTF2I,601679,,,Williams syndrome,Role in the phenotype of,Systemic lupus erythematosus[28714469];Sjögren's syndrome[24097066;27503288];Atrial fibrillation[30061737;29892015];Menarche (age at onset)[25231870];,0.950920245398773,0.9027849406910778,0.7039937353171496,0.0
1547,10538,GTF2IRD1,604318,,,Williams syndrome,Role in the phenotype of,Neuroticism[29255261];Systemic lupus erythematosus[28714469;26663301];Aluminium levels[26025379];Sjögren's syndrome[24097066];Severe influenza A (H1N1) infection[26379185];,0.7499386503067484,0.8249097472924187,0.6439571913338554,0.5339165131982812
1548,10559,GTPBP3,608536,580000;616198;,[MIM:616198]Combined oxidative phosphorylation deficiency 23 [recessive?];,Combined oxidative phosphorylation defect type 23,Disease-causing germline mutation(s) in,,0.7425766871165644,0.13873130479628676,0.32602453667449754,0.3218232044198895
1549,10570,GUCA1A,600364,602093;,[MIM:602093]Cone dystrophy 3 [dominant?];,Cone rod dystrophy;Progressive cone dystrophy;Central areolar choroidal dystrophy,Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) (gain of function) in,,0.17791411042944785,0.3184631253223311,0.7580266249021144,0.3207489257213014
1550,10571,GUCA1B,602275,613827;,,Retinitis pigmentosa,Disease-causing germline mutation(s) in,,0.10711656441717791,0.29783393501805056,0.6731923779691986,0.3319521178637201
1551,10576,GUCY1A1,139396,615750;,,Moyamoya disease with early-onset achalasia,Disease-causing germline mutation(s) (loss of function) in,"Systolic blood pressure[21909115;25249183;27618452;28739976];Hypertension[25249183];Myocardial infarction[26343387];Diastolic blood pressure[21909115;25249183;28739976];Diastolic blood pressure x alcohol consumption interaction (2df test)[29912962;29912962];Influenza A (H1N1) severity[26379185];Coronary heart disease[22751097];Coronary artery disease[26343387;29212778;29212778;29212778];Diastolic blood pressure x alcohol consumption (light vs heavy) interaction (2df test)[29912962;29912962];Pulse pressure[28135244];Blood pressure[21909110];Systolic blood pressure x alcohol consumption interaction (2df test)[29912962;29912962;29912962];Coronary artery disease (myocardial infarction, percutaneous transluminal coronary angioplasty, coronary artery bypass grafting, angina or chromic ischemic heart disease)[28714975];Mean arterial pressure x alcohol consumption (light vs heavy) interaction (2df test)[29912962;29912962];Diabetic kidney disease[26305897];Mean arterial pressure x alcohol consumption interaction (2df test)[29912962];",0.2498159509202454,0.1511088189788551,0.0,0.0
1552,10580,GUCY2C,601330,614616;614665;,[MIM:614616]Diarrhea 6;[MIM:614665]Meconium ileus;,Chronic infantile diarrhea due to guanylate cyclase 2C overactivity;Intestinal obstruction in the newborn due to guanylate cyclase 2C deficiency,Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in,Menopause (age at onset)[26414677];Orthostatic hypotension[24124408];,0.14576687116564419,0.0110881897885508,0.6593578700078309,0.46608348680171885
1553,10581,GUCY2D,600179,204000;215500;601777;,"[MIM:601777]Cone-rod dystrophy 6;[MIM:215500]Choroidal dystrophy, central areolar, 1 [recessive?];",Cone rod dystrophy;Leber congenital amaurosis;Central areolar choroidal dystrophy,Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) (loss of function) in;Disease-causing germline mutation(s) in,,0.21484662576687116,0.1258380608561114,0.07543722265726964,0.8044812768569675
1554,10585,GUF1,617064,617065;,"[MIM:617065]Epileptic encephalopathy, early infantile, 40 [recessive?];",West syndrome,Disease-causing germline mutation(s) in,Systolic blood pressure[26969751];,0.8685889570552148,0.0407426508509541,0.09997389715478987,0.058011049723756904
1555,10590,GUSB,611499,253220;,[MIM:253220]Mucopolysaccharidosis 7 [recessive?];,Mucopolysaccharidosis type 7,Disease-causing germline mutation(s) in,,0.8023312883435583,0.2926766374419804,0.8616549203863221,0.8115408225905464
1556,10616,GYG1,603942,613507;616199;,[MIM:613507]Glycogen storage disease 15;[MIM:616199]Polyglucosan body myopathy 2;,Glycogen storage disease with severe cardiomyopathy due to glycogenin deficiency;Polyglucosan body myopathy type 2,Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) (loss of function) in,Diverticular disease[30177863];,0.5920245398773006,0.5526044352759154,0.6473505612111721,0.024248004910988337
1557,10626,GYPC,110750,611162;616089;,,Hereditary elliptocytosis,Disease-causing germline mutation(s) in,Pelvic organ prolapse (moderate/severe)[26545240;26545240];Pyoderma gangrenosum in inflammatory bowel disease[24487271];Intelligence[22449649];Atrial fibrillation[30061737;29892015];Initial pursuit acceleration[29064472];,0.14576687116564419,0.6464672511603919,0.6661446097624641,0.13812154696132597
1558,10628,GYS1,138570,611556;,[MIM:611556]Muscle glycogen storage disease 0;,Glycogen storage disease due to muscle and heart glycogen synthase deficiency,Disease-causing germline mutation(s) in,,0.914601226993865,0.6634863331614235,0.4766379535369355,0.15408225905463474
1559,10629,GYS2,138571,240600;,[MIM:240600]Glycogen storage disease 0;,Glycogen storage disease due to hepatic glycogen synthase deficiency,Disease-causing germline mutation(s) in,Cough in response to angiotensin-converting enzyme inhibitor drugs[28084903];,0.838159509202454,0.02449716348633316,0.3965022187418429,0.09975445058317986
1560,10630,GZF1,613842,617662;,"[MIM:617662]Joint laxity, short stature, and myopia [recessive?];",Severe myopia-generalized joint laxity-short stature syndrome,Disease-causing germline mutation(s) in,,0.6444171779141105,0.7911294481691593,0.5583398590446359,0.3365561694290976
1561,10673,H6PD,138090,604931;,,Hyperandrogenism due to cortisone reductase deficiency,Disease-causing germline mutation(s) (loss of function) in,Height[23563607;25282103];Blood protein levels[29875488;30072576];,0.10711656441717791,0.13821557503867973,0.12633777081701905,0.8141497851442603
1562,10674,H19,103280,,,Nephroblastoma;Isolated hemihyperplasia;Silver-Russell syndrome due to an imprinting defect of 11p15;Silver-Russell syndrome due to 11p15 microduplication;Beckwith-Wiedemann syndrome due to 11p15 microdeletion;Beckwith-Wiedemann syndrome due to imprinting defect of 11p15,Role in the phenotype of;Disease-causing germline mutation(s) in;Role in the phenotype of;Role in the phenotype of;Role in the phenotype of;Role in the phenotype of,Systolic blood pressure[28135244];DNA methylation (variation)[23725790;23725790];Celiac disease[23936387];Diastolic blood pressure (cigarette smoking interaction)[29455858];Squamous cell lung carcinoma[28604730];Creatinine levels[29403010];DNA methylation (parent-of-origin)[23725790];Systolic blood pressure (cigarette smoking interaction)[29455858];Glomerular filtration rate[29403010];,0.038773006134969326,0.0,0.0,0.0
1563,10675,HAAO,604521,617660;,"[MIM:617660]Vertebral, cardiac, renal, and limb defects syndrome 1 [recessive?];",Congenital vertebral-cardiac-renal anomalies syndrome,Disease-causing germline mutation(s) (loss of function) in,Systolic blood pressure[28739976;28739976];Glucose homeostasis traits[25524916];Breastfeeding duration[25475840];Hypospadias[25108383];White matter hyperintensity burden[25663218;25663218];,0.14576687116564419,0.16993295513151108,0.16053249804228661,0.1329036218538981
1564,10676,HABP2,603924,616535;,"[MIM:616535]Thyroid cancer, non-medullary, 5;",Familial papillary or follicular thyroid carcinoma,Disease-causing germline mutation(s) in,Peripheral arterial disease (traffic-related air pollution interaction)[27082954];Central corneal thickness[29760442];Heel bone mineral density[28869591;28869591];Eosinophil counts[27863252];Plasma factor VII activating protease levels[30070759];Ischemic stroke[26732560];Blood protein levels[29875488;29875488;29875488;29875488];Waist-to-hip ratio adjusted for body mass index[28430825];Eosinophil percentage of white cells[27863252];,0.19190184049079756,0.06008251676121712,0.5596450013051423,0.7558317986494782
1565,10678,HACD1,610467,255310;,"[MIM:255310]Myopathy, congenital, with fiber-type disproportion;",Congenital fiber-type disproportion myopathy,Disease-causing germline mutation(s) (loss of function) in,,0.30319018404907977,0.1771531717380093,0.0,0.0
1566,10682,HACE1,610876,616756;,[MIM:616756]Spastic paraplegia and psychomotor retardation with or without seizures [recessive?];,Neuroblastoma;Spastic paraplegia-severe developmental delay-epilepsy syndrome,Major susceptibility factor in;Disease-causing germline mutation(s) (loss of function) in,Waist circumference adjusted for BMI in inactive individuals[28448500];Waist circumference adjusted for BMI (joint analysis main effects and physical activity interaction)[28448500;28448500];Multiple sclerosis[23412934];Age at voice drop[27182965];Schizophrenia[28991256];Thyroid stimulating hormone[17903292];Sporadic neuroblastoma[28545128];Waist circumference adjusted for body mass index[28448500;28448500];Menarche (age at onset)[19448622;27182965];Neuroblastoma[22941191];Epilepsy and lamotrigine-induced maculopapular eruptions[26220383];Major depressive disorder[27479909];Obsessive-compulsive disorder[22889921];Height[18391951];Waist circumference adjusted for BMI in active individuals[28448500];Intraocular pressure[29617998];,0.5867484662576687,0.6206807632800413,0.7736883320281911,0.2303560466543892
1567,10684,HADH,601609,231530;609975;,[MIM:231530]3-alpha-hydroxyacyl-CoA dehydrogenase deficiency [recessive?];[MIM:609975]Familial hyperinsulinemic hypoglycemia 4;,Hyperinsulinism due to short chain 3-hydroxylacyl-CoA dehydrogenase deficiency,Disease-causing germline mutation(s) in,Amyotrophic lateral sclerosis (sporadic)[24529757];,0.8260122699386503,0.27333677153171737,0.21639258679196033,0.5268569674647022
1568,10685,HADHA,600890,609015;609016;,[MIM:609015]Mitochondrial trifunctional protein deficiency;[MIM:609016]Long-chain 3-hydroxyl-CoA dehydrogenase deficiency;[MIM:609016]Maternal acute fatty liver of pregnancy;,Acute fatty liver of pregnancy;Mitochondrial trifunctional protein deficiency;Long chain 3-hydroxyacyl-CoA dehydrogenase deficiency,Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in,,0.9990184049079754,0.5593089221248067,0.4374836857217437,0.4932473910374463
1569,10688,HADHB,143450,609015;,[MIM:609015]Mitochondrial trifunctional protein deficiency;,Mitochondrial trifunctional protein deficiency,Disease-causing germline mutation(s) in,,0.987239263803681,0.09463641052088706,0.6750195771339076,0.5207182320441989
1570,10693,HAL,609457,235800;,[MIM:235800]Histidinemia;,Histidinemia,Disease-causing germline mutation(s) in,Vitamin D levels[28757204];Metabolite levels (small molecules and protein measures)[27005778];,0.5395092024539877,0.0556988138215575,0.57347950926651,0.23680171884591775
1571,10694,HAMP,606464,613313;,[MIM:613313]Hemochromatosis 2B;,Hemochromatosis type 2,Disease-causing germline mutation(s) in,Irritable bowel syndrome[29673008];,0.12711656441717792,0.4283135636926251,0.9613677890890107,0.4114487415592388
1572,10709,HARS,142810,614504;616625;,[MIM:616625]Charcot-Marie-Tooth disease 2W [dominant?];,Usher syndrome type 3;Autosomal dominant Charcot-Marie-Tooth disease type 2W,Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) (loss of function) in,,0.5531288343558283,0.35275915420319753,0.5570347167841295,0.31752608962553713
1573,10710,HARS2,600783,614926;,,Perrault syndrome,Disease-causing germline mutation(s) in,,0.8804907975460122,0.30917998968540483,0.7601148525189245,0.2576734192756292
1574,10737,HAX1,605998,610738;,"[MIM:610738]Neutropenia, severe congenital 3, autosomal recessive [recessive?];",Kostmann syndrome,Disease-causing germline mutation(s) in,Serum total protein level[29403010];Non-albumin protein levels[29403010];Nicotine dependence[28440896];,0.9425766871165644,0.5386797318205261,0.8386844166014096,0.025475751995089013
1575,10738,HBA1,141800,140700;604131;613978;,[MIM:140700]Heinz body anemias;[MIM:604131]Alpha-thalassemia;[MIM:613978]Hemoglobin H disease;,Hb Bart's hydrops fetalis;Hemoglobin M disease;Hemoglobin H disease;Alpha-thalassemia-intellectual disability syndrome linked to chromosome 16,Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Role in the phenotype of,Body mass index[26426971];Mean corpuscular hemoglobin concentration[27863252];Mean corpuscular hemoglobin[20139978;27863252;27863252];Reticulocyte fraction of red cells[27863252];Mean corpuscular volume[27863252];Hemoglobin levels[26366553];Red blood cell count[27863252];,0.6954601226993865,0.5716864363073749,0.9864265204907335,0.0
1576,10739,HBA2,141850,140700;604131;613978;,[MIM:140700]Heinz body anemias;[MIM:604131]Alpha-thalassemia;[MIM:613978]Hemoglobin H disease;,Hb Bart's hydrops fetalis;Hemoglobin M disease;Hemoglobin H disease;Alpha-thalassemia-intellectual disability syndrome linked to chromosome 16,Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Role in the phenotype of,Body mass index[26426971];Mean corpuscular hemoglobin[20139978;28453575];High light scatter reticulocyte percentage of red cells[27863252];Reticulocyte fraction of red cells[27863252];Reticulocyte count[27863252];Hemoglobin levels[26366553];High light scatter reticulocyte count[27863252];Red cell distribution width[27863252];,0.038773006134969326,0.4731820526044353,0.9754633255024797,0.0
1577,10741,HBB,141900,140700;603902;603903;611162;613985;,"[MIM:140700]Heinz body anemias;[MIM:613985]Beta-thalassemia;[MIM:603903]Sickle cell anemia;[MIM:603902]Beta-thalassemia, dominant, inclusion body type [dominant?];",Sickle cell anemia;Hereditary persistence of fetal hemoglobin-sickle cell disease syndrome;Sickle cell-hemoglobin D disease syndrome;Sickle cell-hemoglobin E disease syndrome;Sickle cell-beta-thalassemia disease syndrome;Sickle cell-hemoglobin C disease syndrome;Hemoglobin C disease;Hemoglobin E disease;Hemoglobin E-beta-thalassemia syndrome;Hemoglobin C-beta-thalassemia syndrome;Delta-beta-thalassemia;Dominant beta-thalassemia;Beta-thalassemia intermedia;Beta-thalassemia major;Hemoglobin Lepore-beta-thalassemia syndrome;Hemoglobin M disease;Hereditary persistence of fetal hemoglobin-beta-thalassemia syndrome;Hemoglobin D disease,Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Part of a fusion gene in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in,Fetal hemoglobin levels[18245381];Hematology traits[23263863];Mean corpuscular hemoglobin concentration[23263863;28453575];Mean corpuscular volume[28453575];Malaria[19465909;23717212;22895189];Hemoglobin levels[26366553;26366553];HbA2 levels[23043469];Hematocrit[28453575];F-cell distribution[17767159];Inflammatory biomarkers[22291609];Severe malaria[29381699];Urinary albumin-to-creatinine ratio[27650483;27650483];,0.647361963190184,0.22331098504383703,0.6228138867136518,0.9699201964395334
1578,10743,HBD,142000,,,Delta-beta-thalassemia;Hemoglobin Lepore-beta-thalassemia syndrome,Disease-causing germline mutation(s) in;Part of a fusion gene in,Hematology traits[23263863];Mean corpuscular hemoglobin concentration[23263863];Hemoglobin levels[26366553;26366553];Beta thalassemia/hemoglobin E disease[20183929];,0.5900613496932515,0.40845796802475504,0.874706342991386,0.7306629834254144
1579,10746,HBG1,142200,,,Hereditary persistence of fetal hemoglobin-sickle cell disease syndrome;Delta-beta-thalassemia;Hereditary persistence of fetal hemoglobin-beta-thalassemia syndrome,Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in,Hematology traits[23263863];Mean corpuscular hemoglobin concentration[23263863];Hemoglobin levels[26366553;26366553];Beta thalassemia/hemoglobin E disease[20183929];,0.21484662576687116,0.7343991748323878,0.9741581832419733,0.0
1580,10747,HBG2,142250,613977;,[MIM:613977]Cyanosis transient neonatal;,Hereditary persistence of fetal hemoglobin-sickle cell disease syndrome;Hemoglobinopathy Toms River;Hereditary persistence of fetal hemoglobin-beta-thalassemia syndrome,Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in,Mean corpuscular hemoglobin concentration[28453575];Hemoglobin levels[26366553;26366553];Hemoglobin[28548082];Red cell distribution width[27863252];Beta thalassemia/hemoglobin E disease[20183929];,0.26588957055214724,0.7702423929860753,0.9269120334116419,0.6658993247391037
1581,10758,HCCS,300056,309801;,[MIM:309801]Linear skin defects with multiple congenital anomalies 1;,Microphthalmia with linear skin defects syndrome,Disease-causing germline mutation(s) in,Cognitive performance[19734545];,0.7861349693251534,0.8625580195977308,0.8916731923779692,0.0
1582,10759,HCFC1,300019,309541;,"[MIM:309541]Mental retardation, X-linked 3;","X-linked non-syndromic intellectual disability;Methylmalonic acidemia with homocystinuria, type cblX",Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in,Celiac disease[22057235];Rheumatoid arthritis (ACPA-positive)[23143596];Systemic lupus erythematosus[26502338];Rheumatoid arthritis[23143596];,0.956319018404908,0.9409489427539969,0.7068650482902636,0.9895641497851443
1583,10801,HCN1,602780,615871;,"[MIM:615871]Epileptic encephalopathy, early infantile, 24;",Undetermined early-onset epileptic encephalopathy,Disease-causing germline mutation(s) (gain of function) in,P wave duration[28794112;28794112];Autism spectrum disorder or schizophrenia[28540026];Non-response to bupropion and depression[27622933];Survival in microsatellite instability low/stable colorectal cancer[25866641];Squamous cell lung carcinoma[28604730];Schizophrenia[25056061;28991256];Survival in colon cancer[25866641];Post bronchodilator FEV1/FVC ratio[26634245];Age at first birth[27798627;27798627];,0.12711656441717792,0.9748581743166581,0.5103106238580005,0.7745549416820136
1584,10804,HCN4,605206,163800;613123;,[MIM:163800]Sick sinus syndrome 2;[MIM:613123]Brugada syndrome 8;,Familial sick sinus syndrome;Brugada syndrome,Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in,Heart rate[23583979];Nickel levels[26025379];Resting heart rate[27798624;29769521];Heart rate variability traits (SDNN)[28613276;28613276];Heart rate variability traits (pvRSA/HF)[28613276];Heart rate variability traits (RMSSD)[28613276];Atrial fibrillation[22544366;28416818;30061737;29892015;29892015];Waist-to-hip ratio adjusted for BMI[26426971];Waist-to-hip ratio adjusted for BMI x sex x age interaction (4df test)[26426971];,0.16220858895705523,0.9675090252707581,0.4633255024797703,0.0
1585,10807,HCRT,602358,161400;,[MIM:161400]Narcolepsy 1;,Narcolepsy type 1;Narcolepsy type 2,Major susceptibility factor in;Candidate gene tested in,,0.19190184049079756,0.49767921609076843,0.8660924040720438,0.0
1586,10818,HDAC4,605314,600430;,[MIM:600430]Brachydactyly-mental retardation syndrome;,2q37 microdeletion syndrome,Role in the phenotype of,"Male-pattern baldness[22693459];Perioperative myocardial infarction in coronary artery bypass surgery[25948407];Pulmonary function[21946350;21946350];Alanine aminotransferase (ALT) levels after remission induction therapy in actute lymphoblastic leukemia (ALL)[28090653];Autism spectrum disorder, attention deficit-hyperactivity disorder, bipolar disorder, major depressive disorder, and schizophrenia (combined)[23453885];Pulmonary function (smoking interaction)[23284291];Amyotrophic lateral sclerosis in C9orf72 mutation positive individuals[22959728];Obstructive sleep apnea trait (apnea hypopnea index)[29077507];Mean arterial pressure[29403010];",0.7412269938650307,0.7006188757091284,0.5826155050900548,0.7120933087783916
1587,10821,HDAC6,300272,300863;,"[MIM:300863]Chondrodysplasia with platyspondyly, distinctive brachydactyly, hydrocephaly, and microphthalmia;","X-linked dominant chondrodysplasia, Chassaing-Lacombe type",Disease-causing germline mutation(s) in,,0.8078527607361963,1.0,0.49725920125293654,0.9134438305709024
1588,10823,HDAC8,300269,300882;309585;,[MIM:300882]Cornelia de Lange syndrome 5;[MIM:309585]Wilson-Turner X-linked mental retardation syndrome;,Cornelia de Lange syndrome;Wilson-Turner syndrome,Disease-causing germline mutation(s) (loss of function) in;Disease-causing germline mutation(s) (loss of function) in,Sodium levels[29403010];Chloride levels[29403010];,0.43754601226993867,0.6817947395564724,0.9386583137561995,0.36955187231430325
1589,10865,HELLPAR,614985,,,HELLP syndrome,Major susceptibility factor in,,0.038773006134969326,0.0,0.0,0.0
1590,10866,HELLS,603946,616911;,[MIM:616911]Immunodeficiency-centromeric instability-facial anomalies syndrome 4;,ICF syndrome,Disease-causing germline mutation(s) in,Thiopurine-induced alopecia in inflammatory bowel disease[29923122];,0.8743558282208589,0.6413099535843219,0.7186113286348212,0.6206261510128913
1591,10874,HEPACAM,611642,613925;613926;,"[MIM:613925]Leukoencephalopathy, megalencephalic, with subcortical cysts, 2A;[MIM:613926]Leukoencephalopathy, megalencephalic, with subcortical cysts, 2B;",Macrocephaly-intellectual disability-autism syndrome;Megalencephalic leukoencephalopathy with subcortical cysts,Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in,Breast cancer (survival)[25890600];,0.038773006134969326,0.8282619907168643,0.3959801618376403,0.697206875383671
1592,10879,HERC1,605109,617011;,,Megalencephaly-severe kyphoscoliosis-overgrowth syndrome,Disease-causing germline mutation(s) (loss of function) in,Glucagon levels in response to oral glucose tolerance test (120 minutes)[29093273];Reticulocyte fraction of red cells[27863252];Atrial fibrillation[30061737];Iris characteristics[21835309];Disease progression in age-related macular degeneration[29346644;29346644];,0.5170552147239263,0.5226921093347087,0.0772644218219786,0.24846531614487416
1593,10880,HERC2,605837,227220;615516;,"[MIM:615516]Mental retardation, autosomal recessive 38 [recessive?];",Developmental delay with autism spectrum disorder and gait instability,Disease-causing germline mutation(s) (loss of function) in,Light vs. dark hair color[26184321];Skin sensitivity to sun[25963972];Iris color[18252221];Squamous cell carcinoma[26829030];Eye color[23548203;23548203;23118974];Tanning[23548203];Colorectal cancer[29228715];Uveal melanoma[28781888];Low tan response[29739929];Brown vs. non-brown hair color[26184321];Blond vs non-blond hair color[26184321];Eye color traits[20463881];Rosacea symptom severity[29771307;29771307];Black vs. blond hair color[18483556];Vitiligo[22561518;27723757];Monobrow[27182965];Diisocyanate-induced asthma[25918132];Perceived skin darkness[25963972];Black vs. red hair color[18483556];Hair color[23548203;29662168;26926045];Skin colour saturation[25963972];,0.8792638036809816,0.7715317173800929,0.15948838423388148,0.5320748925721301
1594,10904,HES7,608059,613686;,"[MIM:613686]Spondylocostal dysostosis 4, autosomal recessive [recessive?];",Autosomal recessive spondylocostal dysostosis,Disease-causing germline mutation(s) in,Height[25282103];,0.14576687116564419,0.778236204228984,0.9091620986687549,0.0
1595,10905,HESX1,601802,182230;262600;,"[MIM:182230]Septooptic dysplasia;[MIM:182230]Growth hormone deficiency with pituitary anomalies;[MIM:182230]Pituitary hormone deficiency, combined, 5;","Septo-optic dysplasia spectrum;Kallmann syndrome;Hypothyroidism due to deficient transcription factors involved in pituitary development or function;Pituitary stalk interruption syndrome;Combined pituitary hormone deficiencies, genetic forms",Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in,,0.28662576687116564,0.7864878803506963,0.39754633255024796,0.38459177409453654
1596,10906,HEXA,606869,272800;,[MIM:272800]GM2-gangliosidosis 1 [recessive?];,"Tay-Sachs disease, B variant, juvenile form;Tay-Sachs disease, B variant, infantile form;Tay-Sachs disease, B1 variant;Tay-Sachs disease, B variant, adult form",Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in,,0.7456441717791411,0.09231562661165549,0.5831375619942574,0.6883057090239411
1597,10908,HEXB,606873,268800;,[MIM:268800]GM2-gangliosidosis 2 [recessive?];,"Sandhoff disease, infantile form;Sandhoff disease, adult form;Sandhoff disease, juvenile form",Disease-causing germline mutation(s) (loss of function) in;Disease-causing germline mutation(s) (loss of function) in;Disease-causing germline mutation(s) (loss of function) in,Night sleep phenotypes[27126917];,0.5009815950920246,0.20113460546673542,0.2317932654659358,0.4699201964395335
1598,10916,HFE,613609,176200;235200;612635;614193;,[MIM:235200]Hemochromatosis 1;[MIM:176200]Variegate porphyria;[MIM:612635]Microvascular complications of diabetes 7;,Symptomatic form of hemochromatosis type 1;Sporadic porphyria cutanea tarda;Familial porphyria cutanea tarda,Disease-causing germline mutation(s) in;Major susceptibility factor in;Modifying germline mutation in,"Diastolic blood pressure (cigarette smoking interaction)[29455858];Mean corpuscular hemoglobin concentration[28017375;27863252;27863252;29403010];Mean corpuscular volume[19862010;20139978;28017375];Mean corpuscular hemoglobin[23263863;28017375;28453575;29403010];Hematological parameters[19820697];Hematocrit[19862010;28017375;27863252];High light scatter reticulocyte count[27863252];Mean arterial pressure[27618448];Alcohol consumption (transferrin glycosylation)[21665994];Hemoglobin concentration[27863252];Intelligence (MTAG)[29326435;29326435];Reticulocyte fraction of red cells[27863252;27863252];Red blood cell traits[20927387;20927387;20927387;23222517;23446634];Hemoglobin[19862010;19820698;28453575];Systolic blood pressure x smoking status (ever vs never) interaction (2df test)[29455858;29455858];Hepcidin levels[21785125;21785125;21785125;21785125];Blood pressure[21909110];Cardiovascular disease risk factors[21943158];Cholesterol, total[20686565;24097068];Iron status biomarkers (transferrin saturation)[25352340;28334935];Platelet count[27863252];Hypertension[21909115];Systolic blood pressure[21909115;27618452;28739976];Hematology traits[19853236;23263863];Iron status biomarkers (ferritin levels)[25352340;28334935];Iron status biomarkers[21149283;21149283;21208937;19084217;19084217;19084217;19820699;19820699;21483845;21483845;25224454];High light scatter reticulocyte percentage of red cells[27863252];Reticulocyte count[27863252;27863252];Glycated hemoglobin levels[20858683;28898252;28898252];Autism spectrum disorder or schizophrenia[28540026;28540026;28540026;28540026];Diastolic blood pressure[21909115;27618452;28739976;27618447];Iron status biomarkers (total iron binding capacity)[28334935;28334935];Diastolic blood pressure x smoking status (ever vs never) interaction (2df test)[29455858;29455858];Red blood cell count[27863252];Systolic blood pressure x smoking status (current vs non-current) interaction (2df test)[29455858;29455858];Hepcidin/ferritin ratio[27846281;27846281];Systolic blood pressure (cigarette smoking interaction)[29455858];Iron status biomarkers (transferrin levels)[25352340];Iron status biomarkers (iron levels)[25352340;28334935];Hemoglobin levels[28017375];Diastolic blood pressure x smoking status (current vs non-current) interaction (2df test)[29455858;29455858];LDL cholesterol[20686565;24097068];",0.23865030674846627,0.18695203713254255,0.2986165492038632,0.43784530386740333
1599,10918,HGD,607474,203500;,,Alkaptonuria,Disease-causing germline mutation(s) (loss of function) in,,0.14576687116564419,0.5407426508509541,0.5152701644479248,0.5664518109269491
1600,10919,HGF,142409,608265;,"[MIM:608265]Deafness, autosomal recessive, 39 [recessive?];",Autosomal recessive non-syndromic sensorineural deafness type DFNB,Disease-causing germline mutation(s) in,Rosacea symptom severity[29771307];Tuberculosis[29036319];Gestational age at birth (maternal effect)[28598419];Gout[22179738];Endothelial growth factor levels[25552591];Hepatocyte growth factor levels[27989323];Blood protein levels[29875488;30072576];Spontaneous preterm birth (maternal effect)[28598419];Intraocular pressure[29235454;29785010];,0.5226993865030675,0.9484270242392986,0.5283215870529888,0.7412523020257827
1601,10923,HGSNAT,610453,252930;616544;,[MIM:252930]Mucopolysaccharidosis 3C [recessive?];[MIM:616544]Retinitis pigmentosa 73;,Retinitis pigmentosa;Sanfilippo syndrome type C,Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) (loss of function) in,,0.038773006134969326,0.2627643115007736,0.435917515009136,0.45104358502148556
1602,10924,HHAT,605743,,,Chondrodysplasia-disorder of sex development syndrome,Disease-causing germline mutation(s) (loss of function) in,Cardiovascular disease in hypertension (ACE inhibitor interaction)[26516778];Post bronchodilator percent predicted FEV1 in smoking[30068317];Mosquito bite size[28199695];Body mass index (change over time) in lung cancer or chronic obstructive pulmonary disease[28044437];Body mass index (change over time) in chronic obstructive pulmonary disease[28044437];Heel bone mineral density[28869591;28869591];Schizophrenia[23142968];Post bronchodilator FEV1/FVC ratio in smoking[30068317];Ankylosing spondylitis[23749187;23749187];Alopecia areata[25608926];,0.08736196319018405,0.16812790097988653,0.12372748629600626,0.03683241252302026
1603,10936,HIBCH,610690,250620;,,Neurodegeneration due to 3-hydroxyisobutyryl-CoA hydrolase deficiency,Disease-causing germline mutation(s) in,Urinary metabolites[26352407];Daytime sleep phenotypes[27126917];Blood protein levels[30072576];,0.7533742331288343,0.16425992779783394,0.13651788044896893,0.04251074278698588
1604,10937,HIC1,603825,,,Miller-Dieker syndrome,Candidate gene tested in,Plateletcrit[27863252];Platelet count[27863252];,0.3856441717791411,0.6923671995874162,0.4659357870007831,0.0
1605,10970,HIKESHI,614908,616881;,"[MIM:616881]Leukodystrophy, hypomyelinating, 13 [recessive?];",C11ORF73-related autosomal recessive hypomyelinating leukodystrophy,Disease-causing germline mutation(s) in,Cognitive performance[19734545];,0.23865030674846627,0.6376998452810727,0.0,0.0
1606,10974,HINT1,601314,137200;,,Autosomal recessive axonal neuropathy with neuromyotonia,Disease-causing germline mutation(s) (loss of function) in,Inflammatory bowel disease[28067908];Crohn's disease[28067908];Blood protein levels[29875488];Ulcerative colitis[28067908];,0.7061349693251534,0.6859205776173285,0.9611067606369095,0.3011049723756906
1607,10987,HIRA,600237,,,22q11.2 deletion syndrome,Role in the phenotype of,Cognitive decline rate in late mild cognitive impairment[26252872;26252872];,0.8058895705521473,0.9791129448169159,0.8026624902114331,0.9559545733578882
1608,11081,HIVEP2,143054,616977;,"[MIM:616977]Mental retardation, autosomal dominant 43 [dominant?];",Autosomal dominant non-syndromic intellectual disability,Disease-causing germline mutation(s) (loss of function) in,Adiponectin levels[24105470];Pit-and-Fissure caries[24556642];Daytime sleep phenotypes[27126917];Coronary artery disease[29212778];,0.5026993865030674,1.0,0.3834507961367789,0.9551872314303254
1609,11084,HJV,608374,602390;,[MIM:602390]Hemochromatosis 2A;,Hemochromatosis type 2,Disease-causing germline mutation(s) (loss of function) in,,0.17791411042944785,0.4357916451779268,0.0,0.0
1610,11085,HK1,142600,235700;605285;617460;,"[MIM:235700]Hexokinase deficiency [recessive?];[MIM:605285]Neuropathy, hereditary motor and sensory, Russe type [recessive?];[MIM:617460]Retinitis pigmentosa 79 [dominant?];",Non-spherocytic hemolytic anemia due to hexokinase deficiency;Charcot-Marie-Tooth disease type 4G,Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in,Glycemic traits (pregnancy)[23903356];Mean corpuscular hemoglobin[20139978;27863252];Mean corpuscular volume[20139978;27863252];High light scatter reticulocyte percentage of red cells[27863252];Reticulocyte count[27863252];Glycated hemoglobin levels[20858683;19096518;28898252;28898252];Hematocrit[19862010;27863252];High light scatter reticulocyte count[27863252];Red blood cell count[20139978;27863252];Red cell distribution width[27863252];Hemoglobin A1c levels[29844224];Hemoglobin concentration[27863252];Immature fraction of reticulocytes[27863252];Reticulocyte fraction of red cells[27863252];Red blood cell traits[23222517];Iris color (a* coordinate)[29109912];Ischemic stroke (cardioembolic)[29531354];Hemoglobin levels[28017375];Hemoglobin[19862010];Iris color (b* coordinate)[29109912];,0.8819631901840491,0.7877772047447138,0.4283476898981989,0.8747697974217311
1611,11091,HLA-A,142800,,,Birdshot chorioretinopathy;Phenytoin or carbamazepine toxicity,Major susceptibility factor in;Biomarker tested in,Hematocrit[27863252];Drug-induced liver injury (amoxicillin-clavulanate)[21570397];Plateletcrit[27863252];High light scatter reticulocyte count[27863252];Plantar warts[28928442];Menarche (age at onset)[25231870];Lung adenocarcinoma[28604730];Hemoglobin concentration[27863252];C-peptide levels in type I diabetes[29404672];Nasopharyngeal carcinoma[19664746;20512145];Change in intraocular pressure in response to steroid treatment (triamcinolone acetonide)[25813999];Childhood ear infection[28928442];Beta-2 microglubulin plasma levels[23417110;23417110;23417110;23417110];Vitiligo[20410501;27723757];IgA nephropathy[22197929];Systemic lupus erythematosus[26606652;28714469;28714469];Adverse response to carbamapezine[21149285];Shingles[28928442;28928442;28928442];Mumps[28928442;28928442];Complement C3 and C4 levels[23028341];Cold sores[28928442];Setpoint viral load in HIV-1 infection[26553974];HIV-1 control[20041166];Autism spectrum disorder or schizophrenia[28540026;28540026;28540026;28540026;28540026;28540026;28540026;28540026;28540026;28540026;28540026;28540026;28540026;28540026;28540026;28540026;28540026;28540026];Lung cancer in ever smokers[28604730];Chickenpox[28928442];Heel bone mineral density[28869591;28869591];Hand grip strength[29691431];Crohn's disease[22412388];Red blood cell count[27863252];Blood protein levels[29875488];IgE levels[22075330];Squamous cell lung carcinoma[28604730];Carbamazepine-induced maculopapular exanthema[29288229];Late-onset myasthenia gravis[26562150];,0.9936196319018404,0.4107787519339866,0.0005220569042025581,0.050030693677102514
1612,11092,HLA-B,142830,608579;,,Beh�et disease;Takayasu arteritis;Pulmonary arterial hypertension associated with connective tissue disease;Flucloxacilline toxicity;Abacavir toxicity;Allopurinol toxicity;Phenytoin or carbamazepine toxicity;Stevens-Johnson syndrome,Major susceptibility factor in;Major susceptibility factor in;Major susceptibility factor in;Biomarker tested in;Biomarker tested in;Biomarker tested in;Biomarker tested in;Major susceptibility factor in,"Type 2 diabetes[25102180;25102180];Multiple sclerosis[22190364;19525953];Sarcoidosis (Lofgren's syndrome vs non-Lofgren's syndrome)[26651848];Mean corpuscular hemoglobin[27863252];Graves' disease[21841780];HIV-1 viral setpoint[20205591;26039976];Plateletcrit[27863252];Eosinophil counts[29403010];Nevirapine-induced hypersensitivity in HIV[28062682];Nasopharyngeal carcinoma[20512145];Change in intraocular pressure in response to steroid treatment (triamcinolone acetonide)[25813999];Beta-2 microglubulin plasma levels[23417110;23417110;23417110;23417110;23417110];Psoriasis vulgaris[26626624];Systemic lupus erythematosus[26606652;28714469;28714469;28714469;28714469;28714469];IgA nephropathy[26028593];Atopic dermatitis[25574825];Cardiometabolic and hematological traits[27668658];Epstein-Barr virus immune response (EBNA-1)[23326239];Ankylosing spondylitis[21743469];Systolic blood pressure[25249183];HIV-1 control[21051598;21051598;21051598;20041166;20041166];Lung cancer in ever smokers[28604730];Diastolic blood pressure[25249183];Monocyte percentage of white cells[27863252];Blood protein levels[28240269;28240269;28240269;28240269;28240269;29875488;29875488];Hypothyroidism[22493691];Albumin-globulin ratio[29403010];Rheumatoid arthritis (ACPA-negative)[24532677];Psoriatic arthritis[26626624];Inflammatory bowel disease[28067908];Tuberculosis[28928442];Anti-thyroid drug induced agranulocytosis[27157822];Tonsillectomy[28928442;28928442;28928442];Drug-induced liver injury (flucloxacillin)[19483685];Myositis[26291516;26291516];Monocyte count[29403010];Takayasu arteritis[25604533;25604533;25604533];Non-albumin protein levels[29403010];Cervical cancer[23482656;28806749];Pneumonia[28928442];Basal cell carcinoma[27539887];Sulfasalazine-induced agranulocytosis[28762467];Trichloroethylene-induced hypersensitivity syndrome[26190474;26190474];Marginal zone lymphoma[25569183];Plantar warts[28928442;28928442];Itch intensity from mosquito bite[28199695];Neuromyelitis optica[29769526;29769526];Neutrophil count[29403010];Mean platelet volume[27863252];Vitiligo[20526339];Strep throat[28928442;28928442];CD4:CD8 lymphocyte ratio[20045101;20045101];Allergic disease (asthma, hay fever or eczema)[29083406;29083406];IgG galactosylation phenotypes (multivariate analysis)[28878392];Allergic rhinitis[30013184];Shingles[25297839;25297839;28928442;28928442;28928442;28928442;28928442];Height[19343178;23563607];Platelet count[22139419;27863252];Cold sores[28928442;28928442];Eosinophil percentage of white cells[27863252];Setpoint viral load in HIV-1 infection[26553974;26553974;26553974;26553974;26553974;26553974;26553974;26553974];Small cell lung carcinoma[28604730];Psoriasis[23143594;23143594];White blood cell count (basophil)[27863252];Autism spectrum disorder or schizophrenia[28540026;28540026;28540026;28540026;28540026;28540026;28540026;28540026;28540026;28540026;28540026;28540026;28540026;28540026;28540026;28540026;28540026;28540026;28540026];Visceral adipose tissue adjusted for BMI[22589738];Chickenpox[28928442;28928442];HIV-1 susceptibility[23935489];Crohn's disease[26891255];Serum albumin level[29403010];White blood cell count[21738480;25096241;25096241;25096241;29403010];Clozapine-induced agranulocytosis[25187353];Diffuse large B cell lymphoma[25261932];Giant cell arteritis[28041642];Allergic sensitization[23817571];Ulcerative colitis[28067908];",0.7467484662576687,0.4703455389375967,0.004176455233620465,0.005371393492940454
1613,11093,HLA-C,142840,,,Precursor B-cell acute lymphoblastic leukemia,Major susceptibility factor in,"Granulocyte percentage of myeloid white cells[27863252];Sarcoidosis (Lofgren's syndrome vs non-Lofgren's syndrome)[26651848];Mean corpuscular hemoglobin[29403010];Lung cancer[28604730];Lymphocyte counts[27863252];Myeloid white cell count[27863252];HIV-1 viral setpoint[26039976];Sum basophil neutrophil counts[27863252];Cutaneous psoriasis[26626624];Granulocyte count[27863252];Nasopharyngeal carcinoma[20512145];Childhood ear infection[27182965;28928442];Beta-2 microglubulin plasma levels[23417110;23417110;23417110;23417110];Psoriasis vulgaris[26626624];Systemic lupus erythematosus[28714469;28714469;28714469;28714469;28714469];Itch intensity from mosquito bite adjusted by bite size[28199695;28199695];Atopic dermatitis[23042114;25574825];Severity of facial solar lentigines[27327535];Self-reported allergy[23817569];Cholesterol, total[26582766];Protein quantitative trait loci[18464913];Chronic hepatitis B infection[25802187;25802187];HIV-1 control[21051598;20041166;20041166];Waist-to-hip ratio adjusted for BMI (adjusted for smoking behaviour)[28443625];Response to hepatitis B vaccine[29534301];Reticulocyte count[27863252];Waist-to-hip ratio adjusted for BMI in non-smokers[28443625];Sum neutrophil eosinophil counts[27863252];Blood protein levels[28240269;28240269;28240269;28240269;28240269;28240269;29875488];Hypothyroidism[22493691];Albumin-globulin ratio[29403010];Psoriatic arthritis[20953186;26626624];Asthma[27182965];Stevens-Johnson syndrome and toxic epidermal necrolysis (SJS-TEN)[21912425];Inflammatory bowel disease[28067908];Rosacea symptom severity[29771307];Perceived unattractiveness to mosquitoes[28199695];Tuberculosis[28928442];Tonsillectomy[27182965;28928442;28928442];C-reactive protein levels or triglyceride levels (pleiotropy)[27286809];Cancer (pleiotropy)[27197191];Myositis[26291516];Monocyte count[29403010];Takayasu arteritis[25604533;25604533];Non-albumin protein levels[29403010];Cervical cancer[28806749];Pneumonia[28928442];Mean corpuscular volume[29403010];Plantar warts[28928442];Neuromyelitis optica[29769526;29769526];Neutrophil count[29403010;27863252];Hemoglobin concentration[27863252];Vitiligo[20526339];IgG galactosylation phenotypes (multivariate analysis)[28878392];Allergic rhinitis[30013184];Shingles[28928442;28928442];Height[23563607;25282103];Complement C3 and C4 levels[23028341];Cold sores[28928442];Setpoint viral load in HIV-1 infection[26553974;26553974;26553974;26553974;26553974;26553974;26553974;26553974];Psoriasis[20953188;20953190;18369459;18369459;18364390;19169254;23143594;23143594];Small cell lung carcinoma[28604730];White blood cell count (basophil)[29403010];Autism spectrum disorder or schizophrenia[28540026;28540026;28540026;28540026;28540026;28540026;28540026;28540026;28540026;28540026;28540026;28540026;28540026;28540026;28540026;28540026;28540026;28540026;28540026;28540026;28540026;28540026];White blood cell count (lymphocyte)[28158719];Chickenpox[28928442;28928442];HIV-1 susceptibility[23935489];Crohn's disease[23128233;26891255];IgE levels[24324648];Coronary heart disease[22319020];Serum albumin level[29403010];AIDS progression[19115949];White blood cell count[21738480;28158719;29403010;27863252;27863252];Waist-to-hip ratio adjusted for BMI (joint analysis main effects and smoking interaction)[28443625];Nevirapine-induced hypersensitivity in HIV (Stevens-Johnson syndrome or toxic epidermal necrosis)[28062682];Squamous cell lung carcinoma[28604730];Chronic obstructive pulmonary disease-related biomarkers[23144326];LDL cholesterol[26582766];Allergic sensitization[23817571];Hepatitis B[24162738];Cancer[27197191];Ulcerative colitis[28067908];",0.8154601226993865,0.3037648272305312,0.0015661707126076742,0.043738489871086556
1614,11098,HLA-DPA1,142880,,,Granulomatosis with polyangiitis,Major susceptibility factor in,"Chronic hepatitis B infection[25802187];Response to hepatitis B vaccine[29534301];Autism spectrum disorder or schizophrenia[28540026];Lung cancer in ever smokers[28604730];Lung cancer[28604730];Mortality in sepsis[27639821];Eosinophil percentage of granulocytes[27863252];Nephropathy[21399633];IgA nephropathy[25305756;25305756;25305756];Allergic disease (asthma, hay fever or eczema)[29083406];Sjögren's syndrome[24097066];Systemic sclerosis[21779181];Myositis[26291516;26291516];Takayasu arteritis[25604533];Antineutrophil cytoplasmic antibody-associated vasculitis[28029757];Hepatitis B (viral clearance)[22737229;22737229];Hepatitis B[21750111];Eosinophil percentage of white cells[27863252];",0.5213496932515338,0.27256317689530685,0.01957713390759593,0.07335788827501534
1615,11101,HLA-DPB1,142858,,,Granulomatosis with polyangiitis;Chronic beryllium disease,Major susceptibility factor in;Major susceptibility factor in,Susceptibility to persistent hepatitis B virus infection[27244555];EGFR mutation-positive lung adenocarcinoma[27501781];Plantar warts[28928442;28928442];IgA nephropathy[25305756;25305756;25305756];Sarcoidosis (non-Lofgren's syndrome without extrapulmonary manifestations)[26651848];Acute graft versus host disease in bone marrow transplantation (recipient effect)[27595289];Gait speed in old age[28077804];Aspirin exacerbated respiratory disease in asthmatics[23180272];Antineutrophil cytoplasmic antibody-associated vasculitis[28029757];Hepatitis B (viral clearance)[22737229;22737229];Eosinophil percentage of white cells[27863252];Chronic hepatitis B infection[24940741;25802187;24940741];Response to hepatitis B vaccine[29534301];Autism spectrum disorder or schizophrenia[28540026];Nodular sclerosis Hodgkin lymphoma[29196614];Dermatomyositis[27153935;27153935];Blood protein levels[29875488];Anti-rubella virus IgG levels[30053915];Rosacea symptom severity[29771307];Eosinophil percentage of granulocytes[27863252];Nephropathy[21399633];Sjögren's syndrome[24097066;28076899];Systemic sclerosis[21779181];Primary biliary cholangitis[28425483];Myositis[26291516];Monocyte count[27863252];Wegener's granulomatosis[23740775];Hepatitis B[19349983;21750111];Hepatitis B vaccine response[21764829];,0.40773006134969325,0.518308406395049,0.0033933698773166276,0.026550030693677104
1616,11103,HLA-DQA1,146880,,,Idiopathic achalasia;Adult-onset myasthenia gravis,Major susceptibility factor in;Major susceptibility factor in,"Type 2 diabetes[28566273];Allergy[27182965];Primary biliary cirrhosis[22961000];Granulocyte percentage of myeloid white cells[27863252];Sarcoidosis (Lofgren's syndrome vs non-Lofgren's syndrome)[26651848];Parkinson's disease[27182965;28892059];Cutaneous lupus erythematosus[25827949];Lung cancer[28604730];Lymphocyte counts[29403010];Epstein Barr virus nuclear antigen 1 IgG levels[26819262;26819262;26819262;26819262];Hematocrit[27863252];Immunoglobulin A vasculitis[28698626];Selective IgA deficiency[27723758];Lung adenocarcinoma[28604730];Idiopathic membranous nephropathy[21323541];Autoimmune hepatitis in primary sclerosing cholangitis[28779025];Childhood ear infection[27182965;28928442;28928442];Body mass index[28892062];Systemic lupus erythematosus[18204098;21408207;24871463;26606652;26606652;26606652;26316170];IgA nephropathy[25305756;25305756;25305756;25305756;25305756;25305756;25305756;25305756;25305756;25305756;25305756;26028593;26028593;25305756];Itch intensity from mosquito bite adjusted by bite size[28199695];Atopic dermatitis[26482879];Self-reported allergy[23817569];Response to interferon beta therapy[21502966];Squamous cell carcinoma[26829030];Response to hepatitis B vaccine[29534301];Epstein Barr virus nuclear antigen 1 IgG seropositivity[29868224];Vogt-Koyanagi-Harada syndrome[25108386];Blood protein levels[29875488;29875488;29875488];Hypothyroidism[22493691;27182965];Rheumatoid arthritis (ACPA-negative)[24532677];Asthma[23181788;27182965;29273806;29273806];Glomerular filtration rate[29403010];Inflammatory bowel disease[18758464;28067908;28008999];Rosacea symptom severity[29771307];Celiac disease[17558408;20190752];Nephropathy[21399633];Tuberculosis[28928442;28928442;28928442;28928442];Multiple sclerosis (OCB status)[23472185];Sjögren's syndrome[24097066;28076899;28076899;24097067];Immunoglobulin G index levels in multiple sclerosis[25616667;25616667];Tonsillectomy[28928442];Systemic sclerosis[21779181];Rheumatoid arthritis[18668548;23918589];Neutrophil percentage of white cells[27863252];Myositis[26291516];Immune response to anthrax vaccine[22658931];Takayasu arteritis[25604533];High density lipoprotein cholesterol levels[29403010];Cervical cancer[23482656;28806749;28806749;28806749];Pneumonia[28928442;28928442];Scarlet fever[28928442;28928442];Creatinine levels[29403010];Total bilirubin levels[29403010];Schizophrenia[19571809;23212062];Hepatocellular carcinoma[22807686];Plantar warts[28928442;28928442;28928442;28928442];Neuromyelitis optica[29769526;29769526;29769526;29769526];Chronic hepatitis C infection[24376798];Vitiligo[20410501;27723757];Strep throat[28928442];Myasthenia gravis[25643325];Allergic disease (asthma, hay fever or eczema)[29083406];Sarcoidosis (non-Lofgren's syndrome without extrapulmonary manifestations)[26651848];Allergic rhinitis[30013184];Leishmaniasis (visceral)[23291585];Shingles[28928442;28928442;28928442];Mixed cryoglobulinemia vasculitis in chronic hepatitis C infection[25030430];Antineutrophil cytoplasmic antibody-associated vasculitis[28029757];Parental lifespan[29030599];Small cell lung carcinoma[28604730];Autism spectrum disorder or schizophrenia[28540026;28540026;28540026;28540026;28540026;28540026;28540026;28540026;28540026;28540026;28540026;28540026;28540026;28540026;28540026;28540026;28540026;28540026;28540026];Hand grip strength[29691431];Crohn's disease[23850713;23850713;23266558;26891255];Autoimmune hepatitis type-1[24768677];Epstein-Barr virus immune response (multivariate analysis)[29868224];Red blood cell count[27863252];Lymphoma[23349640;23349640;23349640];Chronic lymphocytic leukemia[21131588];Membranous nephropathy[27333618];Peanut allergy[25710614;25710614];Squamous cell lung carcinoma[28604730];Late-onset myasthenia gravis[26562150;26562150;26562150];Oligoclonal band status in multiple sclerosis[25616667];Giant cell arteritis[28041642;25817017];Neutrophil percentage of granulocytes[27863252];Prostate cancer[23535732];Ulcerative colitis[23511034;19122664;21297633;23128233;28067908;24837172;28008999];Allergic sensitization[23817571];Intraocular pressure[29785010];",0.39631901840490796,0.7730789066529139,0.0036543983294179067,0.26166359729895644
1617,11105,HLA-DQB1,604305,,,Limbic encephalitis with LGI1 antibodies;Idiopathic achalasia;Narcolepsy type 1;Bullous pemphigoid;Pediatric multiple sclerosis;Narcolepsy type 2,Major susceptibility factor in;Major susceptibility factor in;Major susceptibility factor in;Major susceptibility factor in;Biomarker tested in;Major susceptibility factor in,"Allergy[27182965];Primary biliary cirrhosis[22961000;22961000];Multiple sclerosis[20453840];Knee osteoarthritis[20305777];Pulmonary function (smoking interaction)[23284291;23284291];Immunoglobulin A vasculitis[28698626];Autoimmune hepatitis in primary sclerosing cholangitis[28779025;28779025];Serum IgE levels[25488688];Childhood ear infection[28928442];Yeast infection[28928442];Systemic lupus erythematosus[24871463;26502338;26606652;26606652;26606652;26316170];IgA nephropathy[25305756;25305756;25305756;25305756;25305756;25305756;25305756;25305756;25305756;25305756;25305756;26028593;26028593;26028593;25305756];Itch intensity from mosquito bite adjusted by bite size[28199695;28199695];Self-reported allergy[23817569];C-reactive protein levels or LDL-cholesterol levels (pleiotropy)[27286809];Epstein-Barr virus immune response (EBNA-1)[23326239];Iron status biomarkers (transferrin saturation)[28334935];Chronic hepatitis B infection[25802187];Response to hepatitis B vaccine[29534301];Acute-on-chronic liver failure in hepatitis B[28130311];Lung cancer in ever smokers[28604730];Nodular sclerosis Hodgkin lymphoma[22086417;22086417];Diastolic blood pressure[27618447];Oropharynx cancer[27749845];Blood protein levels[29875488;29875488];Hypothyroidism[22493691;27182965];Asthma[21804548];Enteric fever[25383971];Inflammatory bowel disease[28067908];Celiac disease[20190752];Nephropathy[21399633];Tuberculosis[29036319;28928442;28928442;28928442];Pulmonary function[21946350];Multiple sclerosis (OCB status)[23472185];Sjögren's syndrome[28076899;28076899;24097067];Tonsillectomy[28928442];Juvenile idiopathic arthritis (oligoarticular or rheumatoid factor-negative polyarticular)[23603761];Systemic sclerosis[21779181;21779181;20383147];Rheumatoid arthritis[24782177;24782177;24782177;23918589];Asthma and hay fever[24388013];Myositis[26291516;26291516;26291516];Cervical cancer[28806749;28806749];Pneumonia[28928442;28928442];Scarlet fever[28928442;28928442;28928442];Lymphocyte percentage of white cells[27863252];C-reactive protein levels or total cholesterol levels (pleiotropy)[27286809];Plantar warts[28928442;28928442;28928442;28928442;28928442];Sero-negative rheumatoid arthritis[28706201];Neuromyelitis optica[29769526;29769526];Chronic hepatitis C infection[24376798];Moderate to vigorous physical activity levels[29899525];Childhood steroid-sensitive nephrotic syndrome[29903748];Strep throat[28928442];Allergic disease (asthma, hay fever or eczema)[29083406];HPV seropositivity[21896673];Sarcoidosis (non-Lofgren's syndrome without extrapulmonary manifestations)[26651848];Allergic rhinitis[30013184];Shingles[28928442;28928442];Lung function (FEV1)[28166213;28166213];Emphysema imaging phenotypes[26030696];Autism spectrum disorder or schizophrenia[28540026;28540026;28540026;28540026;28540026;28540026;28540026;28540026;28540026;28540026;28540026;28540026;28540026;28540026;28540026;28540026;28540026];High altitude adaptation[28373541];Anti-Epstein-Barr virus nuclear antigen (EBNA) IgG levels[30053915];Crohn's disease[23266558;26891255];Oral cavity and pharyngeal cancer[27749845];Red blood cell count[29403010];IgE levels[23146381];Lymphoma[23349640;23349640];Hepatocellular carcinoma in hepatitis C infection[28921602];Alopecia areata[25608926];Chronic lymphocytic leukemia[26956414];Lung function (FEV1/FVC)[28166213];Eosinophil percentage of granulocytes[27863252];Mosquito bite size[28199695];Peanut allergy[25710614;25710614];Iron status biomarkers (iron levels)[28334935];Follicular lymphoma[20639881;21533074];Primary biliary cholangitis[20639880;19458352;19458352];Late-onset myasthenia gravis[26562150;26562150];Prostate cancer[23535732];Allergic sensitization[23817571];Ulcerative colitis[19122664;23128233;28067908;24837172];Hepatitis B[21750111;28928442];",0.22687116564417178,0.42264053635894794,0.0007830853563038371,0.027624309392265192
1618,11109,HLA-DRA,142860,610424;,,Graham Little-Piccardi-Lassueur syndrome,Major susceptibility factor in,Multiple sclerosis[17660530];Sarcoidosis (Lofgren's syndrome vs non-Lofgren's syndrome)[26651848];Parkinson's disease[20711177];Lung cancer[28604730];Epstein Barr virus nuclear antigen 1 IgG levels[26819262;26819262;26819262;26819262];HIV-1 viral setpoint[26039976];Body mass index[28892062];Itch intensity from mosquito bite adjusted by bite size[28199695];Cardiometabolic and hematological traits[27668658];Non-obstructive azoospermia[22541561];Waist-to-hip ratio adjusted for body mass index[28448500];Hodgkin's lymphoma[21037568;22286212];Obstetric antiphospholipid syndrome[28424481];Response to hepatitis B vaccine[29534301];Acute-on-chronic liver failure in hepatitis B[28130311];Lung cancer in ever smokers[28604730];Nodular sclerosis Hodgkin lymphoma[29196614];Systemic juvenile idiopathic arthritis[27927641];Waist-to-hip ratio adjusted for BMI (joint analysis for main effect and physical activity interaction)[28448500];Endometriosis[28881265];Vogt-Koyanagi-Harada syndrome[25108386];Blood protein levels[28240269;28240269];Asthma[21804548;23028483;29273806];Inflammatory bowel disease[28067908;28008999;28008999];Perceived unattractiveness to mosquitoes[28199695];Tuberculosis[29036319];Multiple sclerosis (OCB status)[23472185;23472185];Sjögren's syndrome[24097066;24097067];Systemic sclerosis[21779181];Staphylococcus aureus infection[26450422];Takayasu arteritis[25604533];Frontotemporal dementia[24943344];Hepatitis B vaccine response[24282030];Antinuclear antibody levels[25186300];Itch intensity from mosquito bite[28199695];Lung disease severity in cystic fibrosis[26417704;26417704;26417704;26417704;26417704];Vitiligo[20410501];Anti-cyclic Citrullinated Peptide Antibody[19287509];Sarcoidosis (non-Lofgren's syndrome without extrapulmonary manifestations)[26651848];Cystic fibrosis severity[21602797];Complement C3 and C4 levels[23028341];Pubertal anthropometrics[23449627];Autism spectrum disorder or schizophrenia[28540026;28540026;28540026;28540026;28540026;28540026;28540026;28540026;28540026;28540026;28540026;28540026;28540026;28540026;28540026;28540026;28540026;28540026];Food antigen IgG levels[24962563];Crohn's disease[23850713;23850713];Lymphoma[23349640];C-reactive protein levels or HDL-cholesterol levels (pleiotropy)[27286809];Primary biliary cholangitis[28425483;28062665];Chloride levels[29403010];Giant cell arteritis[28041642];Fibrinogen levels[28107422];Sarcoidosis (non-Lofgren's syndrome)[26651848];Prostate cancer[23535732];Ulcerative colitis[18836448;19122664;21297633;20228798;23128233;28067908;24837172;28008999;28008999];Hepatitis B[28928442];,0.5775460122699386,0.743166580711707,0.6181153745758288,0.49923265807243705
1619,11110,HLA-DRB1,142857,,,Limbic encephalitis with LGI1 antibodies;Systemic lupus erythematosus;Sarcoidosis;Limited cutaneous systemic sclerosis;Limited systemic sclerosis;Diffuse cutaneous systemic sclerosis;Narcolepsy type 1;Follicular lymphoma;Bullous pemphigoid;Pediatric multiple sclerosis;Systemic-onset juvenile idiopathic arthritis;Narcolepsy type 2,Major susceptibility factor in;Major susceptibility factor in;Major susceptibility factor in;Major susceptibility factor in;Major susceptibility factor in;Major susceptibility factor in;Major susceptibility factor in;Major susceptibility factor in;Candidate gene tested in;Biomarker tested in;Major susceptibility factor in;Major susceptibility factor in,Primary biliary cirrhosis[22961000];Multiple sclerosis[22190364;18941528;19525955;19525953;27386562];Lymphocyte counts[29403010];Epstein Barr virus nuclear antigen 1 IgG levels[26819262;26819262;26819262;26819262];Asparaginase hypersensitivity in acute lymphoblastic leukemia[25987655];Lung adenocarcinoma[28604730];Serum IgE levels[25488688];Rheumatoid arthritis (rheumatoid factor and/or anti-cyclic citrullinated peptide seropositive)[28118524];Childhood onset ulcerative colitis[29562276;29562276];Childhood ear infection[28928442;28928442;28928442];Body mass index[28892062];Yeast infection[28928442];IgA nephropathy[22197929;25305756;25305756;25305756;25305756;25305756;25305756;25305756;25305756;25305756;25305756;25305756;26028593;25305756];Systemic lupus erythematosus[19838193;24871463;23273568;26606652;26606652;19838195;19838195];Atopic dermatitis[26482879];Ulcerative colitis or Crohn's disease[21699788];Epstein-Barr virus immune response (EBNA-1)[23326239];Mixed cellularity Hodgkin lymphoma[29196614];Lumiracoxib-related liver injury[20639878];Response to interferon beta therapy[21502966];Reticulocyte count[27863252];Nodular sclerosis Hodgkin lymphoma[22086417;22086417;29196614];Vogt-Koyanagi-Harada syndrome[25108386];Blood protein levels[29875488];Hypothyroidism[22493691];Rheumatoid arthritis (ACPA-negative)[24532677];Asthma[29273806;29273806];Glomerular filtration rate[29403010];Enteric fever[25383971];Inflammatory bowel disease[28067908];Neurofibrillary tangles[25188341];Arthritis (juvenile idiopathic)[18576341];Nephropathy[21399633];Tuberculosis[29036319;28928442;28928442;28928442;28928442;28928442;28928442;28928442;28928442];Multiple sclerosis (OCB status)[23472185];Sjögren's syndrome[24097066;28076899;28076899];Immunoglobulin G index levels in multiple sclerosis[25616667];Tonsillectomy[28928442;28928442];Systemic sclerosis[21779181;30247649];Rheumatoid arthritis[17554300;17804836;18794853;24390342;24390342;24390342;21452313;20453841;20453842;28118524;25014791];Staphylococcus aureus infection[26450422];Myositis[26291516;26291516;26291516;26291516];Immune response to anthrax vaccine[22658931];Takayasu arteritis[25604533];High density lipoprotein cholesterol levels[29403010];Cervical cancer[23482656;28806749;28806749;28806749;28806749];Hepatitis B vaccine response[24282030];Waist circumference adjusted for BMI (joint analysis main effects and physical activity interaction)[28448500;28448500];Pneumonia[28928442;28928442];Scarlet fever[28928442];Creatinine levels[29403010];Total bilirubin levels[29403010];Schizophrenia[23212062];Hepatocellular carcinoma[22807686];Plantar warts[28928442;28928442;28928442;28928442;28928442;28928442;28928442;28928442];Pemphigus vulgaris[29857070;29857070];Neuromyelitis optica[29769526;29769526];Immunoglobulin A[20694011;20694011];Childhood steroid-sensitive nephrotic syndrome[29903748];Lapatinib-induced hepatotoxicity[25987243;25987243];Strep throat[28928442];Vitiligo[27723757];Myasthenia gravis[25643325];Heart rate response to exercise[29769521];Leishmaniasis (visceral)[23291585];Shingles[28928442;28928442;28928442;28928442;28928442;28928442];Skin and soft tissue Staphylococcus aureus infection[26450422];Mixed cryoglobulinemia vasculitis in chronic hepatitis C infection[25030430];Cold sores[28928442];Parental lifespan[29030599];Alzheimer's disease (late onset)[24162737];Small cell lung carcinoma[28604730];Autism spectrum disorder or schizophrenia[28540026;28540026;28540026;28540026;28540026;28540026;28540026;28540026;28540026;28540026;28540026;28540026;28540026;28540026;28540026;28540026;28540026;28540026;28540026;28540026;28540026;28540026;28540026;28540026;28540026;28540026;28540026;28540026;28540026;28540026;28540026;28540026;28540026;28540026;28540026;28540026;28540026;28540026;28540026;28540026];Hand grip strength[29691431;29691431;29691431;29691431];Crohn's disease[23850713;23850713;23266558;26891255];Waist circumference adjusted for body mass index[28448500;28448500];Lymphoma[23349640];Chronic lymphocytic leukemia[26956414];Type 1 diabetes[17632545];Peanut allergy[25710614];Late-onset myasthenia gravis[26562150;26562150;26562150;26562150];Primary biliary cholangitis[28062665];Oligoclonal band status in multiple sclerosis[25616667;25616667];Giant cell arteritis[28041642;25817017];Prostate cancer[23535732];Ulcerative colitis[23511034;19122664;21297633;23128233;28067908];,0.5571779141104295,0.34605466735430634,0.02662490211433046,0.000767341927562922
1620,11137,HLCS,609018,253270;,,Holocarboxylase synthetase deficiency,Disease-causing germline mutation(s) (loss of function) in,Intracranial aneurysm[29531279];Developmental language disorder (linguistic errors)[27016271;27016271];Night sleep phenotypes[27126917];Developmental language disorder[27016271];,0.4538650306748466,0.6874677668901495,0.5679979117723832,0.8477593615715162
1621,11139,HLF,142385,,,Precursor B-cell acute lymphoblastic leukemia,Part of a fusion gene in,Zinc levels[26025379];Urate levels[23263486];Acute urticaria and angioedema (non-steroidal anti-inflammatory drug-induced)[24236485];Night sleep phenotypes[27126917];Urate levels in obese individuals[25811787];,0.4894478527607362,0.8365136668385765,0.9527538501696685,0.0
1622,11143,HLX,142995,,,Diaphragmatic hernia-short bowel-asplenia syndrome,Disease-causing germline mutation(s) in,Diverticular disease[30177863];Granulocyte percentage of myeloid white cells[27863252];C-reactive protein levels or total cholesterol levels (pleiotropy)[27286809];Waist circumference adjusted for BMI (joint analysis main effects and smoking interaction)[28443625];Waist circumference adjusted for BMI (adjusted for smoking behaviour)[28443625];Waist circumference adjusted for body mass index[25673412;25673412];Monocyte percentage of white cells[27863252];Obesity-related traits[23251661];Cerebrospinal fluid AB1-42 levels[26252872];,0.3168098159509202,0.6455647240845797,0.06708431219002871,0.6223143032535298
1623,11150,HMBS,609806,176000;,,Acute intermittent porphyria,Disease-causing germline mutation(s) in,,0.2498159509202454,0.7637957710159876,0.8543461237274863,0.9329343155310006
1624,11165,HMGA2,600698,150699;611547;,,Pleomorphic salivary gland adenoma;12q14 microdeletion syndrome;Well-differentiated liposarcoma;Dedifferentiated liposarcoma,Part of a fusion gene in;Role in the phenotype of;Role in the phenotype of;Role in the phenotype of,Type 2 diabetes[20581827;24509480;25102180;25102180;22885922;22885922;29358691;28869590;28869590];Polycystic ovary syndrome[22885925];Waist circumference adjusted for BMI in non-smokers[28443625;28443625];Permanent tooth development[21931568];Birth length[25281659];Primary tooth development (time to first tooth eruption)[23704328;20195514];Waist circumference adjusted for BMI (adjusted for smoking behaviour)[28443625;28443625];Infant length[25281659];Waist circumference adjusted for body mass index[25673412;25673412];Aortic root size[19584346];Brain structure[22504417];Head circumference (infant)[22504419];Heart rate response to exercise[29769521];Hip circumference[25673412;25673412];Hip circumference adjusted for BMI[25673412;25673412;25673412];Waist circumference adjusted for BMI (joint analysis main effects and smoking interaction)[28443625;28443625];Chin dimples[27182965];Axial length[24144296];Late-onset Alzheimer's disease[27770636];Height[21998595;22021425;17767157;19343178;23563607;20397748;20881960;18391952;18391950;18391951;25429064;25282103];Birth weight[23202124;27680694];Type 2 diabetes nephropathy[21150874];Primary tooth development (number of teeth)[23704328;20195514];,0.5261349693251534,0.8125322331098505,0.7773427303576089,0.7745549416820136
1625,11254,HMGCL,613898,246450;,,3-hydroxy-3-methylglutaric aciduria,Disease-causing germline mutation(s) in,Reticulocyte fraction of red cells[27863252];High light scatter reticulocyte count[27863252];Immature fraction of reticulocytes[27863252];,0.8044171779141104,0.27875193398659104,0.822239624119029,0.5624616329036218
1626,11258,HMGCS2,600234,605911;,[MIM:605911]3-hydroxy-3-methylglutaryl-CoA synthase-2 deficiency;,3-hydroxy-3-methylglutaryl-CoA synthase deficiency,Disease-causing germline mutation(s) (loss of function) in,Change in glucose in response to thiazide diuretic treatment in hypertension[29523524];,0.3749693251533742,0.0887055183084064,0.7141738449490994,0.6580724370779619
1627,11359,HMX1,142992,612109;,[MIM:612109]Oculoauricular syndrome;,"Oculoauricular syndrome, Schorderet type",Disease-causing germline mutation(s) (loss of function) in,,0.038773006134969326,0.5575038679731821,0.28687026885930567,0.0
1628,11363,HNF1A,142410,142330;600496;606391;612520;,"[MIM:142330]Hepatic adenomas familial;[MIM:600496]Maturity-onset diabetes of the young 3 [dominant?];[MIM:612520]Diabetes mellitus, insulin-dependent, 20;",Hyperinsulinism due to HNF1A deficiency;Chromophobe renal cell carcinoma;Clear cell papillary renal cell carcinoma;MODY,Disease-causing germline mutation(s) in;Biomarker tested in;Biomarker tested in;Disease-causing germline mutation(s) in,"Type 2 diabetes[21573907;20581827;24509480;26818947;22885922;28869590;28869590];C-reactive protein[21196492;18439552;18439548;23844046;19567438;21647738;22939635;22939635];Serum alpha1-antitrypsin levels[26174136];C-reactive protein levels or total cholesterol levels (pleiotropy)[27286809];Blood urea nitrogen levels[29403010];Homocysteine levels[23824729];Liver enzyme levels (gamma-glutamyl transferase)[22001757];Total cholesterol levels[28334899];Cholesterol, total[20686565;24097068;25961943];C-reactive protein levels or LDL-cholesterol levels (pleiotropy)[27286809];Gamma glutamyl transpeptidase[21909109];Urate levels[23263486];Peak insulin response[28490609];C-reactive protein levels[24763700;21300955;29403010];Liver enzyme levels[18940312];Longevity[20834067];Gamma glutamyl transferase levels[22010049;29403010];Coronary heart disease[19198612];Coronary artery disease[29212778;29212778;29212778];Very long-chain saturated fatty acid levels (fatty acid 20:0)[25378659];C-reactive protein and white blood cell count[22788528];Acute insulin response[28490609];Pancreatic cancer[26098869;29422604];Chronic obstructive pulmonary disease-related biomarkers[23144326];Chloride levels[29403010];LDL cholesterol levels[28334899];LDL cholesterol[20686565;19060906;24097068;25961943];N-glycan levels[21203500;21203500;21908519;21908519;21908519;21908519;21908519;21908519];",0.50920245398773,0.8254254770500258,0.04098146697990081,0.8695518723143032
1629,11365,HNF1B,189907,125853;137920;611955;,"[MIM:137920]Renal cysts and diabetes syndrome [dominant?];[MIM:125853]Diabetes mellitus, non-insulin-dependent;[MIM:611955]Prostate cancer, hereditary, 11;",Familial prostate cancer;17q12 microdeletion syndrome;Autosomal dominant primary hypomagnesemia with hypocalciuria;Renal cysts and diabetes syndrome;Unilateral multicystic dysplastic kidney;Bilateral multicystic dysplastic kidney,Major susceptibility factor in;Role in the phenotype of;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in,Type 2 diabetes[22961080;20581827;24509480;23945395;26818947;22885922;22885922;22885922;28869590];Endometrial cancer ((endometrioid histology)[30093612];Endometrial cancer[21499250;27008869;27135401;30093612];Prostate-specific antigen levels[28139693];Endometrial endometrioid carcinoma[27135401];Testicular germ cell tumor[25877299;28604732;28604728];Blood urea nitrogen levels[29403010];Ovarian cancer[23535730];Body mass index[28892062];Serum prostate-specific antigen levels[21160077];Epithelial ovarian cancer[25581431];Pancreatic cancer[29422604];Cancer (pleiotropy)[27197191];Neuritic plaque[25188341];Frontotemporal dementia[26154020];Prostate cancer[20676098;18264097;18264096;27262462;25939597;26443449];Cancer[27197191];,0.33226993865030674,0.9641567818463125,0.6677107804750718,0.9053100061387355
1630,11366,HNF4A,600281,125850;125853;606391;616026;,"[MIM:125850]Maturity-onset diabetes of the young 1 [dominant?];[MIM:125853]Diabetes mellitus, non-insulin-dependent;[MIM:616026]Fanconi renotubular syndrome 4 with maturity-onset diabetes of the young;",Hyperinsulinism due to HNF4A deficiency;MODY;Renal cysts and diabetes syndrome,Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in,"Type 2 diabetes[21874001;22158537;24509480;28869590];C-reactive protein[22939635];C-reactive protein levels[21300955];C-reactive protein levels or total cholesterol levels (pleiotropy)[27286809];Myeloid white cell count[27863252];Hematocrit[27863252];Chronic inflammatory diseases (ankylosing spondylitis, Crohn's disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy)[26974007];Sum basophil neutrophil counts[27863252];Sum neutrophil eosinophil counts[27863252];Granulocyte count[27863252];Neutrophil count[27863252];HDL cholesterol[20686565;19060906;24097068;25961943];C-reactive protein levels or HDL-cholesterol levels (pleiotropy)[27286809];Pancreatic cancer[29422604];Neutrophil percentage of white cells[27863252];Fibrinogen levels[26561523;28107422;28107422];Cholesterol, total[20686565;24097068];C-reactive protein levels or LDL-cholesterol levels (pleiotropy)[27286809];Coenzyme Q10 levels[27149984];Ulcerative colitis[19915572;23128233];",0.5645398773006135,0.8749355337802991,0.4917776037588097,0.9607120933087784
1631,11370,HNMT,605238,616739;,"[MIM:616739]Mental retardation, autosomal recessive 51 [recessive?];",Autosomal recessive non-syndromic intellectual disability,Disease-causing germline mutation(s) in,Daytime sleep phenotypes[27126917];,0.16220858895705523,0.47627643115007734,0.3398590446358653,0.37185389809699204
1632,11372,HNRNPA1,164017,615424;615426;,[MIM:615424]Inclusion body myopathy with early-onset Paget disease with or without frontotemporal dementia 3 [dominant?];[MIM:615426]Amyotrophic lateral sclerosis 20;,Amyotrophic lateral sclerosis;Inclusion body myopathy with Paget disease of bone and frontotemporal dementia,Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in,Waist-to-hip ratio adjusted for BMI x sex x age interaction (4df test)[26426971];,0.9906748466257669,0.8432181536874678,0.7755155311929001,0.625537139349294
1633,11451,HNRNPA2B1,600124,615422;,[MIM:615422]Inclusion body myopathy with early-onset Paget disease with or without frontotemporal dementia 2 [dominant?];,Inclusion body myopathy with Paget disease of bone and frontotemporal dementia,Disease-causing germline mutation(s) in,Waist-to-hip ratio adjusted for BMI (age >50)[26426971];Waist-to-hip ratio adjusted for BMI[26426971];Waist-to-hip ratio adjusted for BMI x sex x age interaction (4df test)[26426971];,0.9938650306748467,0.9428829293450232,0.953275907073871,0.7589011663597299
1634,11486,HNRNPDL,607137,609115;,[MIM:609115]Limb-girdle muscular dystrophy 1G [dominant?];,Autosomal dominant limb-girdle muscular dystrophy type 1G,Disease-causing germline mutation(s) in,,0.9360736196319018,0.8261990716864364,0.5813103628295484,0.0
1635,11496,HNRNPH1,601035,,,Precursor T-cell acute lymphoblastic leukemia,Part of a fusion gene in,Daytime sleep phenotypes[27126917;27126917];,0.9722699386503068,0.9105208870551831,0.8851474810754372,0.8575813382443217
1636,11503,HNRNPK,600712,616580;,[MIM:616580]Au-Kline syndrome;,Neurodevelopmental disorder-craniofacial dysmorphism-cardiac defect-skeletal anomalies syndrome due to 9q21.3 microdeletion;Neurodevelopmental disorder-craniofacial dysmorphism-cardiac defect-skeletal anomalies syndrome due to a point mutation,Role in the phenotype of;Disease-causing germline mutation(s) (loss of function) in,,0.9882208588957055,0.8450232078390923,0.9618898459932133,0.0
1637,11520,HNRNPU,602869,617391;,"[MIM:617391]Epileptic encephalopathy, early infantile, 54;",1q44 microdeletion syndrome,Role in the phenotype of,,0.9965644171779141,1.0,0.7875228399895589,0.6606813996316758
1638,11526,HOGA1,613597,613616;,[MIM:613616]Hyperoxaluria primary 3;,Primary hyperoxaluria type 3,Disease-causing germline mutation(s) in,Metabolite levels (small molecules and protein measures)[27005778];Asparaginase-induced acute pancreatitis in acute lymphoblastic leukemia (onset time)[27114598];,0.23865030674846627,0.11423414130995359,0.7689898198903681,0.0
1639,11528,HOMER2,604799,616707;,"[MIM:616707]Deafness, autosomal dominant, 68 [dominant?];",Autosomal dominant non-syndromic sensorineural deafness type DFNA,Disease-causing germline mutation(s) in,,0.32380368098159507,0.5665291387313048,0.4273035760897938,0.33486801718845915
1640,11534,HOOK1,607820,,,Non-spherocytic hemolytic anemia due to hexokinase deficiency;Charcot-Marie-Tooth disease type 4G,Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in,Alcoholic chronic pancreatitis[28754779];Night sleep phenotypes[27126917];,0.4226993865030675,0.28984012377514184,0.5917515009135996,0.14548802946593
1641,11547,HOXA1,142955,601536;,[MIM:601536]Athabaskan brainstem dysgenesis syndrome;[MIM:601536]Bosley-Salih-Alorainy syndrome;,Bosley-Salih-Alorainy syndrome;Athabaskan brainstem dysgenesis syndrome,Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in,Chronic venous disease[28374850];Small cell lung carcinoma[28604730];Tonsillectomy[27182965;28928442];,0.645521472392638,0.6833419288292935,0.5886191594883843,0.63182934315531
1642,11548,HOXA2,604685,612290;,"[MIM:612290]Microtia, hearing impairment, and cleft palate;[MIM:612290]Microtia with or without hearing impairment;",Bilateral microtia-deafness-cleft palate syndrome;Microtia,Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in,Chronic venous disease[28374850];Tonsillectomy[27182965;28928442];,0.17791411042944785,0.6146209386281588,0.8086661446097625,0.7306629834254144
1643,11557,HOXA11,142958,605432;,[MIM:605432]Radioulnar synostosis with amegakaryocytic thrombocytopenia 1;,Radio-ulnar synostosis-amegakaryocytic thrombocytopenia syndrome,Disease-causing germline mutation(s) in,Waist circumference adjusted for BMI (joint analysis main effects and physical activity interaction)[28448500];Waist-to-hip ratio adjusted for BMI (adjusted for smoking behaviour)[28443625;28443625];Waist circumference adjusted for BMI in non-smokers[28443625];Waist-to-hip ratio adjusted for BMI in active individuals[28448500;28448500;28448500;28448500];Waist circumference adjusted for BMI (joint analysis main effects and smoking interaction)[28443625];Waist-to-hip ratio adjusted for BMI (joint analysis for main effect and physical activity interaction)[28448500;28448500];Heel bone mineral density[28869591;28869591];Waist circumference adjusted for BMI (adjusted for smoking behaviour)[28443625;28443625];Waist circumference adjusted for body mass index[28448500;25673412;25673412;25673412];Waist-hip ratio[25673412];Waist circumference adjusted for BMI in active individuals[28448500];Waist-to-hip ratio adjusted for body mass index[28448500;28448500;28448500;25673412;25673412;25673412;25673412;25673412;25673412];,0.19190184049079756,0.5783909231562662,0.8013573479509266,0.6306015960712094
1644,11559,HOXA13,142959,140000;176305;,[MIM:140000]Hand-foot-genital syndrome;[MIM:176305]Guttmacher syndrome;,Hand-foot-genital syndrome;Guttmacher syndrome,Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in,Hepatitis B surface antigen seroclearance in chronic hepatitis B infection[29975729];,0.6279754601226993,0.8984012377514182,0.608979378752284,0.0
1645,11565,HOXB1,142968,614744;,"[MIM:614744]Facial paresis, hereditary congenital, 3;",Congenital hereditary facial paralysis-variable hearing loss syndrome,Disease-causing germline mutation(s) in,Body mass index[26426971];Colorectal or endometrial cancer[26621817];Primary tooth development (number of teeth)[20195514];,0.26588957055214724,0.5830324909747292,0.2550247977029496,0.7599754450583179
1646,11574,HOXB13,604607,176807;,[MIM:176807]Prostate cancer;,Familial prostate cancer,Major susceptibility factor in,Prostate cancer[23104005;23535732];,0.6426993865030675,0.15471892728210418,0.8225006525711303,0.4752915899324739
1647,11587,HOXC13,142976,614931;,"[MIM:614931]Ectodermal dysplasia 9, hair/nail type;",Pure hair and nail ectodermal dysplasia,Disease-causing germline mutation(s) (loss of function) in,Biliary atresia[20460270];Waist-to-hip ratio adjusted for BMI (adjusted for smoking behaviour)[28443625;28443625];Adverse response to chemotherapy (neutropenia/leucopenia) (all antimetabolite drugs)[23648065];Waist-to-hip ratio adjusted for BMI in active individuals[28448500;28448500;28448500;28448500];Amyotrophic lateral sclerosis (sporadic)[24529757];Waist-to-hip ratio adjusted for BMI (joint analysis for main effect and physical activity interaction)[28448500;28448500;28448500;28448500];Waist-to-hip ratio adjusted for BMI in non-smokers[28443625;28443625];Waist-hip ratio[20935629;25673412;25673412];Waist-to-hip ratio adjusted for BMI[26426971];Toenail selenium levels[25343990];Waist-to-hip ratio adjusted for BMI (age >50)[26426971];Waist-to-hip ratio adjusted for BMI (age <50)[26426971];Waist-to-hip ratio adjusted for BMI (joint analysis main effects and smoking interaction)[28443625;28443625];Hair shape[29220522];Waist-to-hip ratio adjusted for body mass index[28448500;28448500;28448500;25673412;25673412;25673412;25673412;28448500];Waist-to-hip ratio adjusted for BMI x sex x age interaction (4df test)[26426971];,0.7793865030674847,0.89118102114492,0.5170973636126338,0.0
1648,11596,HOXD10,142984,192950;,"[MIM:192950]Vertical talus, congenital;","Congenital vertical talus, unilateral;Congenital vertical talus, bilateral",Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in,Amyotrophic lateral sclerosis (sporadic)[24529757];,0.21484662576687116,0.5286230015471892,0.7747324458365962,0.5070595457335789
1649,11599,HOXD13,142989,113200;113300;186000;186300;192350;610713;,[MIM:186000]Synpolydactyly 1 [dominant?];[MIM:113200]Brachydactyly D;[MIM:186300]Syndactyly 5;[MIM:610713]Brachydactyly-syndactyly syndrome;[MIM:113300]Brachydactyly E1;[MIM:192350]VACTERL association;[MIM:610713]Brachydactyly-syndactyly-oligodactyly syndrome;,"VACTERL/VATER association;Synpolydactyly type 1;Zygodactyly type 3;Syndactyly type 5;Brachydactyly-syndactyly, Zhao type;Brachydactyly type E",Candidate gene tested in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in,,0.7720245398773006,0.5265600825167612,0.6546593578700078,0.6962860650705954
1650,11603,HPCA,142622,224500;,"[MIM:224500]Dystonia 2, torsion, autosomal recessive [recessive?];","Primary dystonia, DYT2 type",Disease-causing germline mutation(s) in,,0.26588957055214724,0.7753996905621454,0.9801618376403028,0.7140883977900553
1651,11607,HPD,609695,140350;276710;,[MIM:276710]Tyrosinemia 3;[MIM:140350]Hawkinsinuria;,Hawkinsinuria;Tyrosinemia type 3,Candidate gene tested in;Disease-causing germline mutation(s) (loss of function) in,Urinary metabolites[21572414;26352407;26352407];Obesity-related traits[23251661];,0.16220858895705523,0.3669417225373904,0.3902375358914122,0.18953345610804173
1652,11612,HPGD,601688,119900;259100;,"[MIM:259100]Hypertrophic osteoarthropathy, primary, autosomal recessive, 1 [recessive?];[MIM:259100]Cranioosteoarthropathy;[MIM:119900]Isolated congenital nail clubbing;",Cranio-osteoarthropathy;Pachydermoperiostosis;Isolated congenital digital clubbing,Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in,Alcohol dependence[26365420];Venous thromboembolism adjusted for sickle cell variant rs77121243-T[28203683];,0.038773006134969326,0.2570912841670964,0.7256590968415557,0.52731737262124
1653,11614,HPLH1,267700,300280;300695;300696;300717;300718;,"[MIM:300696]Emery-Dreifuss muscular dystrophy 6, X-linked;[MIM:300695]Scapuloperoneal myopathy, X-linked dominant;[MIM:300696]Myopathy, X-linked, with postural muscle atrophy;[MIM:300717]Reducing body myopathy, X-linked 1A, severe, with infantile or early childhood onset;[MIM:300718]Reducing body myopathy, X-linked 1B, with late childhood or adult onset;[MIM:300280]Uruguay faciocardiomusculoskeletal syndrome;",X-linked myopathy with postural muscle atrophy;X-linked scapuloperoneal muscular dystrophy;Reducing body myopathy;X-linked Emery-Dreifuss muscular dystrophy,Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in,,0.038773006134969326,0.8758380608561114,0.0,0.0
1654,11619,HPRT1,308000,300322;300323;,[MIM:300322]Lesch-Nyhan syndrome;[MIM:300323]Gout HPRT-related;,Lesch-Nyhan syndrome;Hypoxanthine guanine phosphoribosyltransferase partial deficiency,Disease-causing germline mutation(s) (loss of function) in;Disease-causing germline mutation(s) (loss of function) in,,0.8834355828220859,0.8844765342960289,0.9818585225789611,0.7461632903621854
1655,11623,HPS1,604982,203300;,,Hermansky-Pudlak syndrome with pulmonary fibrosis,Disease-causing germline mutation(s) in,Obesity-related traits[23251661];,0.20368098159509201,0.5299123259412069,0.15400678673975463,0.14441375076734192
1656,11624,HPS3,606118,614072;,,Hermansky-Pudlak syndrome without pulmonary fibrosis,Disease-causing germline mutation(s) in,,0.5829447852760736,0.031201650335224342,0.498564343513443,0.03683241252302026
1657,11625,HPS4,606682,614073;,[MIM:614073]Hermansky-Pudlak syndrome 4 [recessive?];,Hermansky-Pudlak syndrome with pulmonary fibrosis,Disease-causing germline mutation(s) in,Ischemic stroke[26089329];,0.10711656441717791,0.4363073749355338,0.3241973375097886,0.7516881522406385
1658,11626,HPS5,607521,614074;,,Hermansky-Pudlak syndrome without pulmonary fibrosis,Disease-causing germline mutation(s) in,Blood metabolite ratios[24816252];Serum metabolite levels[23093944];Blood metabolite levels[24816252];Blood protein levels[28240269];Amyloid A serum levels[21124955;21124955];Survival in pancreatic cancer[28470677];Metabolic traits[21886157];,0.6202453987730061,0.5394533264569366,0.18037066040198382,0.035451197053407
1659,11627,HPS6,607522,614075;,,Hermansky-Pudlak syndrome without pulmonary fibrosis,Disease-causing germline mutation(s) in,Intelligence (MTAG)[29326435];,0.33226993865030674,0.2973182052604435,0.6851996867658575,0.5007673419275629
1660,11629,HPSE2,613469,236730;,[MIM:236730]Urofacial syndrome 1 [recessive?];,Ochoa syndrome,Disease-causing germline mutation(s) in,Response to anti-retroviral therapy (ddI/d4T) in HIV-1 infection (Grade 1 peripheral neuropathy)[24554482];Migraine[27322543];Obesity-related traits[23251661];Asthma (childhood onset)[23829686];,0.038773006134969326,0.32387828777720473,0.5095275385016966,0.08241252302025782
1661,11636,HR,602302,146550;203655;209500;,[MIM:203655]Alopecia universalis congenita;[MIM:209500]Atrichia with papular lesions [recessive?];[MIM:146550]Hypotrichosis 4 [dominant?];,Alopecia universalis;Marie Unna hereditary hypotrichosis;Atrichia with papular lesions,Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in,Obesity-related traits[23251661];,0.3856441717791411,0.37313047962867457,0.14382667710780475,0.21992019643953345
1662,11637,HRAS,190020,109800;163200;188470;218040;,"[MIM:218040]Costello syndrome;[MIM:218040]Congenital myopathy with excess of muscle spindles;[MIM:188470]Thyroid cancer, non-medullary, 2;[MIM:109800]Bladder cancer;[MIM:163200]Schimmelpenning-Feuerstein-Mims syndrome;",Linear nevus sebaceus syndrome;Costello syndrome;Differentiated thyroid carcinoma;Phakomatosis pigmentokeratotica;Woolly hair nevus,Disease-causing somatic mutation(s) in;Disease-causing germline mutation(s) (gain of function) in;Disease-causing somatic mutation(s) in;Disease-causing somatic mutation(s) in;Disease-causing somatic mutation(s) in,,0.5980368098159509,0.5510572460030944,0.9718089271730619,0.6457949662369552
1663,11644,HRG,142640,613116;,[MIM:613116]Thrombophilia due to histidine-rich glycoprotein deficiency;,Hereditary thrombophilia due to congenital histidine-rich (poly-L) glycoprotein deficiency,Disease-causing germline mutation(s) in,Activated partial thromboplastin time[22703881;20303064];Blood protein levels[28240269;28240269;28240269;28240269;28240269;28240269;28240269;28240269;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;30072576;30072576;30072576;30072576;30072576;30072576;30072576;30072576;30072576;30072576;30072576;30072576;30072576;30072576];,0.2947239263803681,0.06446621970087674,0.03158444270425476,0.04158993247391037
1664,11661,HS6ST1,604846,614880;,[MIM:614880]Hypogonadotropic hypogonadism 15 with or without anosmia;,Kallmann syndrome;Normosmic congenital hypogonadotropic hypogonadism,Disease-causing germline mutation(s) (loss of function) in;Disease-causing germline mutation(s) (loss of function) in,Gut microbiota (bacterial taxa)[27723756;27723756];Palmitic acid (16:0) levels[23362303];Urinary albumin-to-creatinine ratio in diabetes[26631737];Blood protein levels[29875488;30072576];,0.22687116564417178,0.8751933986591026,0.5043069694596711,0.0
1665,11672,HSD3B2,613890,201810;,,Congenital adrenal hyperplasia due to 3-beta-hydroxysteroid dehydrogenase deficiency,Disease-causing germline mutation(s) in,,0.32380368098159507,0.1627127385250129,0.6583137561994258,0.7441682013505218
1666,11673,HSD3B7,607764,607765;,[MIM:607765]Congenital bile acid synthesis defect 1;,Congenital bile acid synthesis defect type 1,Disease-causing germline mutation(s) in,,0.4,0.294997421351212,0.10937092143043592,0.6912216083486802
1667,11679,HSD11B1,600713,614662;,[MIM:614662]Cortisone reductase deficiency 2 [dominant?];,Hyperandrogenism due to cortisone reductase deficiency,Disease-causing germline mutation(s) (loss of function) in,Alopecia areata[25608926];,0.27975460122699386,0.6877256317689531,0.9767684677629862,0.6206261510128913
1668,11682,HSD11B2,614232,218030;,,Apparent mineralocorticoid excess,Disease-causing germline mutation(s) (loss of function) in,Blood protein levels[28240269];Empathy quotient[29527006];Waist-to-hip ratio adjusted for body mass index[28430825];,0.12711656441717792,0.5536358947911294,0.8347689898198903,0.742633517495396
1669,11686,HSD17B3,605573,264300;,,"46,XY disorder of sex development due to 17-beta-hydroxysteroid dehydrogenase 3 deficiency",Disease-causing germline mutation(s) (loss of function) in,Glomerular filtration rate in chronic kidney disease[26420894];Cerebrospinal fluid AB1-42 levels[26252872];,0.5226993865030675,0.19726663228468283,0.4680240146175933,0.6149478207489257
1670,11688,HSD17B4,601860,233400;261515;,[MIM:233400]Perrault syndrome 1;,Perrault syndrome;Bifunctional enzyme deficiency,Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in,QT interval (sulfonylurea treatment interaction)[27958378];Waist-to-hip ratio adjusted for BMI (age >50)[26426971];Pyoderma gangrenosum in inflammatory bowel disease[24487271];Waist-to-hip ratio adjusted for BMI (adjusted for smoking behaviour)[28443625];JT interval (sulfonylurea treatment interaction)[27958378];Waist-hip ratio[25673412];Systolic blood pressure x smoking status (current vs non-current) interaction (2df test)[29455858];Waist-to-hip ratio adjusted for BMI[26426971];Waist-to-hip ratio adjusted for body mass index[25673412;25673412;25673412;25673412];Waist-to-hip ratio adjusted for BMI x sex x age interaction (4df test)[26426971];,0.9353374233128834,0.14027849406910778,0.00809188201513965,0.6106507059545734
1671,11694,HSD17B10,300256,300438;300705;,"[MIM:300705]Mental retardation, X-linked 17;","HSD10 disease, infantile type;HSD10 disease, neonatal type;HSD10 disease, atypical type",Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in,Body mass index[28892062];,0.9784049079754601,0.8615265600825167,0.9694596711041503,0.0
1672,11704,HSF4,602438,116800;,"[MIM:116800]Cataract 5, multiple types;",Early-onset lamellar cataract;Total early-onset cataract,Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in,,0.4645398773006135,0.11835997937080969,0.818585225789611,0.6398096992019644
1673,11766,HSPA9,600548,182170;616854;,"[MIM:182170]Anemia, sideroblastic, 4 [recessive?];[MIM:616854]Even-plus syndrome [recessive?];",Autosomal recessive sideroblastic anemia;EVEN-plus syndrome,Disease-causing germline mutation(s) (loss of function) in;Disease-causing germline mutation(s) in,Autism spectrum disorder or schizophrenia[28540026];Schizophrenia[25056061];,0.9960736196319019,0.7931923671995874,0.8676585747846516,0.42326580724370777
1674,11773,HSPB1,602195,606595;608634;,"[MIM:606595]Charcot-Marie-Tooth disease 2F;[MIM:608634]Neuronopathy, distal hereditary motor, 2B;",Distal hereditary motor neuropathy type 2;Autosomal dominant Charcot-Marie-Tooth disease type 2F,Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in,Blood protein levels[30072576];,0.9516564417177914,0.6402784940691078,0.9031584442704255,0.0
1675,11778,HSPB3,604624,613376;,"[MIM:613376]Neuronopathy, distal hereditary motor, 2C;",Distal hereditary motor neuropathy type 2,Disease-causing germline mutation(s) in,Systolic blood pressure (dietary potassium intake interaction)[29212900];,0.3168098159509202,0.2702423929860753,0.8188462542417123,0.3769183548189073
1676,11781,HSPB8,608014,158590;608673;,"[MIM:158590]Neuronopathy, distal hereditary motor, 2A;[MIM:608673]Charcot-Marie-Tooth disease 2L;",Distal hereditary motor neuropathy type 2;Autosomal dominant distal axonal motor neuropathy-myofibrillar myopathy syndrome;Autosomal dominant Charcot-Marie-Tooth disease type 2L,Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in,PR interval in Tripanosoma cruzi seropositivity[24324551];,0.5792638036809816,0.5492521918514698,0.7781258157139128,0.6149478207489257
1677,11784,HSPBAP1,608263,,,Hereditary clear cell renal cell carcinoma,Part of a fusion gene in,,0.17791411042944785,0.2591542031975245,0.1882015139650222,0.16114180478821363
1678,11786,HSPD1,118190,605280;612233;,"[MIM:605280]Spastic paraplegia 13, autosomal dominant [dominant?];[MIM:612233]Leukodystrophy, hypomyelinating, 4 [recessive?];",Pelizaeus-Merzbacher-like disease due to HSPD1 mutation;Autosomal dominant spastic paraplegia type 13,Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in,Autism spectrum disorder or schizophrenia[28540026;28540026];Schizophrenia[25056061];,0.9992638036809816,0.6588447653429603,0.665100495954059,0.427255985267035
1679,11839,HSPG2,142461,224410;255800;,[MIM:255800]Schwartz-Jampel syndrome [recessive?];[MIM:224410]Dyssegmental dysplasia Silverman-Handmaker type [recessive?];,"Schwartz-Jampel syndrome;Dyssegmental dysplasia, Silverman-Handmaker type",Disease-causing germline mutation(s) (loss of function) in;Disease-causing germline mutation(s) in,Atrial fibrillation[30061737];,0.7288343558282209,0.3775141825683342,0.027930044374836857,0.2918968692449355
1680,11852,HTR1A,109760,614674;,,Menstrual cycle-dependent periodic fever,Candidate gene tested in,Body mass index[20935630];White matter lesion progression[26451028];Bronchopulmonary dysplasia[23897914];Fasting insulin (dietary factor interaction)[24204828];Alcohol and nicotine co-dependence[23216389];White matter lesion progression (adjusted for white matter lesion burden at baseline)[26451028];Homeostasis model assessment of insulin resistance (dietary factor interaction)[24204828];,0.2585276073619632,0.6455647240845797,0.6854607152179587,0.0
1681,11876,HTRA1,602194,600142;610149;616779;,"[MIM:610149]Macular degeneration, age-related, 7;[MIM:600142]Cerebral arteriopathy, autosomal recessive, with subcortical infarcts and leukoencephalopathy [recessive?];[MIM:616779]Cerebral arteriopathy, autosomal dominant, with subcortical infarcts and leukoencephalopathy, 2 [dominant?];",CARASIL;Malignant peripheral nerve sheath tumor;HTRA1-related autosomal dominant cerebral small vessel disease,Disease-causing germline mutation(s) in;Part of a fusion gene in;Disease-causing germline mutation(s) in,Stroke[29531354];Age-related macular degeneration (wet)[17053108];Advanced age-related macular degeneration[26691988];Migraine[27322543];Disease progression to choroidal neovascularization form in age-related macular degeneration[29346644];Age-related macular degeneration (geographic atrophy)[22705344];Disease progression in age-related macular degeneration[29346644];Coronary artery disease[29212778;29212778;29212778];Exudative age-related macular degeneration[25629512];Diverticular disease[30177863];Lung function (FEV1/FVC)[30061609];Age-related macular degeneration (extreme sampling)[23577725];Age-related macular degeneration[20861866;21665990;22694956;20385826;20385819;23326517;23326517;23455636;23536807];Neovascular age-related macular degeneration[28703135];Disease progression to geographic atrophy form in age-related macular degeneration[29346644];Age-related macular degeneration (choroidal neovascularisation)[22705344];Age-related macular degeneration (CNV vs. GA)[22705344];Laterality in neovascular age-related macular degeneration[28775256];,0.7430674846625767,0.33909231562661163,0.402244844688071,0.0
1682,11877,HTRA2,606441,168600;610297;617248;,[MIM:617248]3-methylglutaconic aciduria 8 [recessive?];[MIM:610297]Parkinson disease 13;,Young-onset Parkinson disease;3-methylglutaconic aciduria type 8,Candidate gene tested in;Disease-causing germline mutation(s) in,,0.6733742331288344,0.42934502320783907,0.6679718089271731,0.42955801104972374
1683,11880,HTT,613004,143100;617435;,[MIM:143100]Huntington disease;[MIM:617435]Lopes-Maciel-Rodan syndrome [recessive?];,Huntington disease;Juvenile Huntington disease,Disease-causing germline mutation(s) (gain of function) in;Disease-causing germline mutation(s) in,Tuberculosis[29036319];Itch intensity from mosquito bite adjusted by bite size[28199695];Serum sulfate level[27412988];Monobrow[27182965];,0.7390184049079754,0.7462609592573491,0.009397024275646046,0.47928176795580113
1684,11887,HUWE1,300697,300705;300706;,"[MIM:300706]Mental retardation, X-linked, syndromic, Turner type;[MIM:300705]Mental retardation, X-linked 17;","X-linked intellectual disability, Turner type",Disease-causing germline mutation(s) in,Body mass index[28892062];Educational attainment (years of education)[30038396];,0.939877300613497,0.7779783393501805,0.3876272513703994,0.7346531614487416
1685,11891,HYAL1,607071,601492;,,Hyaluronidase deficiency,Disease-causing germline mutation(s) in,,0.17791411042944785,0.36487880350696233,0.43904985643435135,0.20687538367096378
1686,11892,HYAL2,603551,,,Cleft lip and palate-craniofacial dysmorphism-congenital heart defect-hearing loss syndrome,Disease-causing germline mutation(s) in,Body mass index[26426971];,0.33226993865030674,0.5675605982465188,0.19263899765074394,0.3314917127071823
1687,11897,HYDIN,610812,608647;,"[MIM:608647]Ciliary dyskinesia, primary, 5 [recessive?];",Primary ciliary dyskinesia,Disease-causing germline mutation(s) (loss of function) in,Celiac disease[23936387];Hematocrit[27863252];Chronic obstructive pulmonary disease-related biomarkers[23144326];,0.12711656441717792,0.6477565755544095,0.0052205690420255805,0.0
1688,11902,HYLS1,610693,236680;,[MIM:236680]Hydrolethalus syndrome 1;,Joubert syndrome;Hydrolethalus,Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in,Breast cancer (survival)[25890600];,0.12711656441717792,0.12480660134089737,0.12398851474810754,0.3096992019643953
1689,11903,HYMAI,606546,,,Paternal uniparental disomy of chromosome 6;Transient neonatal diabetes mellitus,Role in the phenotype of;Disease-causing germline mutation(s) in,,0.038773006134969326,0.0,0.0,0.0
1690,11910,IARS2,612801,616007;,"[MIM:616007]Cataracts, growth hormone deficiency, sensory neuropathy, sensorineural hearing loss, and skeletal dysplasia [recessive?];",Cataract-growth hormone deficiency-sensory neuropathy-sensorineural hearing loss-skeletal dysplasia syndrome,Disease-causing germline mutation(s) (loss of function) in,,0.9803680981595092,0.6132026817947396,0.3474288697468024,0.16206261510128914
1691,11913,IBA57,615316,615330;616451;,"[MIM:616451]Spastic paraplegia 74, autosomal recessive [recessive?];",Multiple mitochondrial dysfunctions syndrome type 3;Autosomal recessive spastic paraplegia type 74,Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in,,0.9651533742331289,0.6967509025270758,0.2578961106760637,0.0
1692,11938,ICK,612325,612651;617924;,[MIM:612651]Endocrine-cerebroosteodysplasia;[MIM:617924]Juvenile myoclonic epilepsy 10 [dominant?];,Juvenile myoclonic epilepsy;Endocrine-cerebro-osteodysplasia syndrome,Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in,Staphylococcus aureus nasal carriage (intermittent)[26569114];,0.5561963190184049,0.22717895822588963,0.40041764552336206,0.23848987108655617
1693,11940,ICOS,604558,607594;,"[MIM:607594]Immunodeficiency, common variable, 1;",Common variable immunodeficiency,Disease-causing germline mutation(s) in,Inflammatory bowel disease[26192919];Celiac disease[20190752];Body mass index[28892062];Rheumatoid arthritis (ACPA-positive)[23143596];Aluminium levels[26025379];Rheumatoid arthritis[23143596];Primary biliary cholangitis[28425483];Obesity-related traits[23251661];Hypothyroidism[27182965];Alopecia areata[20596022;25608926];Ulcerative colitis[26192919];Idiopathic dilated cardiomyopathy[29495422];,0.2947239263803681,0.4546157813305828,0.7397546332550248,0.4189686924493554
1694,11967,IDH1,147700,137800;,[MIM:137800]Glioma;,Maffucci syndrome;Ollier disease;Gliosarcoma;Giant cell glioblastoma;Metaphyseal chondromatosis with D-2-hydroxyglutaric aciduria,Disease-causing somatic mutation(s) in;Disease-causing somatic mutation(s) in;Biomarker tested in;Biomarker tested in;Disease-causing somatic mutation(s) in,Glioma[28346443];Non-glioblastoma glioma[28346443];,0.7602453987730061,0.4370809695719443,0.36256851996867656,0.3064763658686311
1695,11969,IDH2,147650,137800;613657;,[MIM:613657]D-2-hydroxyglutaric aciduria 2;[MIM:137800]Glioma;,Maffucci syndrome;Ollier disease;Anaplastic oligodendroglioma;Oligoastrocytoma;Anaplastic oligoastrocytoma;Anaplastic astrocytoma;Protoplasmic astrocytoma;Gemistocytic astrocytoma;Fibrillary astrocytoma;Oligodendroglioma;D-2-hydroxyglutaric aciduria,Disease-causing somatic mutation(s) in;Disease-causing somatic mutation(s) in;Biomarker tested in;Biomarker tested in;Biomarker tested in;Biomarker tested in;Biomarker tested in;Biomarker tested in;Biomarker tested in;Biomarker tested in;Disease-causing germline mutation(s) (gain of function) in,Cerebrospinal fluid clusterin levels[26545630];,0.8828220858895706,0.8192367199587416,0.7901331245105716,0.5320748925721301
1696,11972,IDH3B,604526,612572;,[MIM:612572]Retinitis pigmentosa 46;,Retinitis pigmentosa,Disease-causing germline mutation(s) in,,0.9813496932515338,0.08354822073233625,0.7817802140433308,0.07903621853898098
1697,11980,IDS,300823,309900;,[MIM:309900]Mucopolysaccharidosis 2;,"Mucopolysaccharidosis type 2, attenuated form;Mucopolysaccharidosis type 2, severe form",Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in,Cognitive performance[20125193];,0.4154601226993865,0.8873130479628675,0.564082484990864,0.0
1698,11982,IDUA,252800,607014;607015;607016;,[MIM:607014]Mucopolysaccharidosis 1H;[MIM:607015]Mucopolysaccharidosis 1H/S;[MIM:607016]Mucopolysaccharidosis 1S;,Scheie syndrome;Hurler-Scheie syndrome;Hurler syndrome,Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in,Polymyositis[26362759];Primary biliary cholangitis[26394269];Bone mineral density[22504420];Blood protein levels[29875488;30072576];Limited cutaneous systemic scleroderma[29293537];,0.08736196319018405,0.2686952037132542,0.12294440093970242,0.0
1699,11986,IER3IP1,609382,614231;,,Primary microcephaly-epilepsy-permanent neonatal diabetes syndrome,Disease-causing germline mutation(s) in,,0.2947239263803681,0.4920061887570913,0.8692247454972593,0.34499693063228976
1700,12000,IFIH1,606951,182250;610155;615846;,"[MIM:610155]Diabetes mellitus, insulin-dependent, 19;[MIM:615846]Aicardi-Goutieres syndrome 7;[MIM:182250]Singleton-Merten syndrome 1 [dominant?];",Aicardi-Gouti�res syndrome;Singleton-Merten dysplasia,Disease-causing germline mutation(s) (gain of function) in;Disease-causing germline mutation(s) (gain of function) in,"Inflammatory bowel disease[23128233];Vitiligo[22561518;27723757];Systemic lupus erythematosus[27399966;26502338;26502338;28714469;19838195];Psoriasis vulgaris[26626624];Psoriasis[20953190;25903422;25903422;25903422;25903422;25903422;25574825;23143594;23143594];Type 1 diabetes[17554260;19430480;21829393;25751624;25751624;25751624];Chronic inflammatory diseases (ankylosing spondylitis, Crohn's disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy)[26974007;26974007;26974007];Selective IgA deficiency[27723758];Immunoglobulin A[20694011];Inflammatory skin disease[25574825];",0.4622085889570552,0.4891696750902527,0.058731401722787784,0.009515039901780233
1701,12012,IFITM5,614757,610967;,[MIM:610967]Osteogenesis imperfecta 5 [dominant?];,Osteogenesis imperfecta type 5,Disease-causing germline mutation(s) in,,0.038773006134969326,0.2075812274368231,0.7598538240668233,0.43646408839779005
1702,12034,IFNAR2,602376,610424;616669;,[MIM:616669]Immunodeficiency 45 [recessive?];,Primary immunodeficiency with post-measles-mumps-rubella vaccine viral infection,Major susceptibility factor in,Type 2 diabetes[30130595];Crohn's disease[23128233];,0.4154601226993865,0.17534811758638474,0.3962411902897416,0.07028852056476366
1703,12037,IFNG,147570,609135;,[MIM:609135]Aplastic anemia;,Idiopathic aplastic anemia,Major susceptibility factor in,Inflammatory bowel disease[23128233];Systemic lupus erythematosus[28714469;28714469];Itch intensity from mosquito bite adjusted by bite size[28199695;28199695;28199695];Itch intensity from mosquito bite[28199695];Anti-saccade response[29064472];Ulcerative colitis[19122664;21297633;20228799];Alopecia areata[25608926];,0.3856441717791411,0.7117070654976793,0.991647089532759,0.3483732351135666
1704,12039,IFNGR1,107470,209950;600263;615978;,[MIM:209950]Immunodeficiency 27A;[MIM:615978]Immunodeficiency 27B;,Autosomal dominant mendelian susceptibility to mycobacterial diseases due to partial IFNgammaR1 deficiency;Autosomal recessive mendelian susceptibility to mycobacterial diseases due to partial IFNgammaR1 deficiency;Mendelian susceptibility to mycobacterial diseases due to complete IFNgammaR1 deficiency,Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in,Body mass index[25673413;25673413;25673413];Body mass index (joint analysis main effects and smoking interaction)[28443625];Cognitive decline rate in late mild cognitive impairment[26252872;26252872];BMI (adjusted for smoking behaviour)[28443625];,0.45153374233128835,0.6500773594636411,0.3944139911250326,0.37952731737262124
1705,12040,IFNGR2,147569,614889;,,Mendelian susceptibility to mycobacterial diseases due to complete IFNgammaR2 deficiency;Autosomal dominant mendelian susceptibility to mycobacterial diseases due to partial IFNgammaR2 deficiency;Autosomal recessive mendelian susceptibility to mycobacterial diseases due to partial IFNgammaR2 deficiency,Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in,"Inflammatory bowel disease[28067908];Diverticular disease[30177863];Multiple sclerosis[24076602];Rheumatoid arthritis[24390342;24390342];Chronic inflammatory diseases (ankylosing spondylitis, Crohn's disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy)[26974007];Crohn's disease[22936669;23128233;28067908];Obesity-related traits[23251661];Educational attainment[25201988];",0.31079754601226994,0.7717895822588964,0.429391803706604,0.0
1706,12044,IFNL3,607402,,,Response to antiviral treatment in hepatitis C,Biomarker tested in,Mucinous ovarian carcinoma[26075790;26075790];,0.16220858895705523,0.14569365652398145,0.2714695901853302,0.0
1707,12046,IFNL4,615090,,,Response to antiviral treatment in hepatitis C,Biomarker tested in,Mucinous ovarian carcinoma[26075790;26075790];Hepatitis A[28928442];,0.038773006134969326,0.0,0.0,0.0
1708,12059,IFRD1,603502,,,Spinocerebellar ataxia type 18,Disease-causing germline mutation(s) in,Osteoarthritis (hip)[23989986];Amyotrophic lateral sclerosis (age of onset)[22959728];Mortality in heart failure[20400778];,0.5026993865030674,0.4541000515729758,0.8057948316366484,0.3678637200736648
1709,12063,IFT27,615870,615996;,[MIM:615996]Bardet-Biedl syndrome 19 [recessive?];,Bardet-Biedl syndrome,Disease-causing germline mutation(s) (loss of function) in,,0.7304294478527608,0.2109334708612687,0.5502479770294962,0.0
1710,12064,IFT43,614068,614099;617866;617871;,[MIM:617871]Retinitis pigmentosa 81 [recessive?];[MIM:617866]Short-rib thoracic dysplasia 18 with polydactyly [recessive?];,Cranioectodermal dysplasia,Disease-causing germline mutation(s) in,Acute urticaria and angioedema (non-steroidal anti-inflammatory drug-induced)[24236485;24236485];,0.4894478527607362,0.2723053120165034,0.26337770817019057,0.0
1711,12066,IFT52,617094,617102;,[MIM:617102]Short-rib thoracic dysplasia 16 with or without polydactyly [recessive?];,Cranioectodermal dysplasia,Disease-causing germline mutation(s) in,,0.678282208588957,0.20861268695203714,0.7076481336465674,0.578268876611418
1712,12067,IFT57,606621,617927;,[MIM:617927]Orofaciodigital syndrome 18 [recessive?];,Oral-facial-digital syndrome with short stature and brachymesophalangy,Disease-causing germline mutation(s) in,,0.8139877300613497,0.21583290355853532,0.6784129470112242,0.521792510742787
1713,12070,IFT80,611177,611263;,,"Jeune syndrome;Short rib-polydactyly syndrome, Verma-Naumoff type",Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in,,0.6884662576687116,0.2839092315626612,0.20360219263899765,0.3064763658686311
1714,12072,IFT88,600595,,,Retinitis pigmentosa,Disease-causing germline mutation(s) in,"Dental caries[23064961];Sulfasalazine-induced agranulocytosis[28762467];Coronary artery calcification[23870195];Schizophrenia, bipolar disorder and depression (combined)[20713499];",0.6954601226993865,0.08999484270242393,0.19629339598016185,0.25644567219152853
1715,12073,IFT122,606045,218330;,,"Cranioectodermal dysplasia;Short rib-polydactyly syndrome, Beemer-Langer type",Disease-causing germline mutation(s) in;Candidate gene tested in,Waist-to-hip ratio adjusted for BMI (age >50)[26426971];Diisocyanate-induced asthma[25918132];Systemic sclerosis (anti-topoisomerase-positive)[29293537];Waist-to-hip ratio adjusted for BMI[26426971];Waist-to-hip ratio adjusted for BMI x sex x age interaction (4df test)[26426971];,0.567239263803681,0.13125322331098505,0.46306447402766904,0.049263351749539594
1716,12074,IFT140,614620,266920;617781;,[MIM:266920]Short-rib thoracic dysplasia 9 with or without polydactyly [recessive?];[MIM:617781]Retinitis pigmentosa 80 [recessive?];,Jeune syndrome;Retinitis pigmentosa;Saldino-Mainzer syndrome;Leber congenital amaurosis,Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in,Epilepsy and lamotrigine-induced maculopapular eruptions[26220383];Coronary artery disease[29212778];,0.5203680981595092,0.427282104177411,0.2116940746541373,0.09561080417434009
1717,12075,IFT172,607386,615630;616394;,[MIM:615630]Short-rib thoracic dysplasia 10 with or without polydactyly [recessive?];[MIM:616394]Retinitis pigmentosa 71;,Jeune syndrome;Retinitis pigmentosa;Saldino-Mainzer syndrome;Bardet-Biedl syndrome,Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in,Calcium levels[20705733];Inflammatory bowel disease[28067908];Hypertriglyceridemia[23505323];Chronic kidney disease[20383146];Crohn's disease[28067908];,0.7069938650306749,0.316400206291903,0.42129992169146435,0.03806015960712093
1718,12077,IGBP1,300139,300472;,"[MIM:300472]Mental retardation, X-linked, syndromic, 28;",Corpus callosum agenesis-intellectual disability-coloboma-micrognathia syndrome,Disease-causing germline mutation(s) in,,0.7374233128834355,0.9226405363589479,0.6288175411119812,0.0
1719,12088,IGF1,147440,608747;,[MIM:608747]Insulin-like growth factor I deficiency;,Growth delay due to insulin-like growth factor type 1 deficiency,Disease-causing germline mutation(s) in,Fasting blood insulin (BMI interaction)[22581228];Mammographic density (dense area)[25342443];Fasting blood insulin[20081858;22581228];Homeostasis model assessment of insulin resistance[20081858];Height[19893584;20189936;25429064];Birth weight[27680694];Thiazide-induced adverse metabolic effects in hypertensive patients[23400010];Response to quetiapine in schizophrenia[29503163];Intraocular pressure[29617998;29617998;29785010];,0.47337423312883437,0.4504899432697267,0.6483946750195771,0.7461632903621854
1720,12089,IGF1R,147370,270450;,[MIM:270450]Insulin-like growth factor 1 resistance;,Growth delay due to insulin-like growth factor I resistance,Disease-causing germline mutation(s) in,Urate levels[23263486];Atrial fibrillation[30061737;29892015;29892015];Creatinine levels[29403010];Plateletcrit[27863252];Endometriosis[27506219];Blood urea nitrogen levels[29403010];Glomerular filtration rate[29403010];Rosacea symptom severity[29771307];Serum uric acid levels[29403010];Arthritis (juvenile idiopathic)[22354554];Fasting plasma glucose[25187374];Global electrical heterogeneity phenotypes[29622589];Height[20881960;25429064];Birth weight[27680694];Platelet count[27863252];,0.5969325153374233,0.8104693140794224,0.56121117201775,0.7813075506445673
1721,12090,IGF2,147470,180860;616489;,"[MIM:180860]Silver-Russell syndrome;[MIM:616489]Growth restriction, severe, with distinctive facies;",Isolated hemihyperplasia;Silver-Russell syndrome due to an imprinting defect of 11p15;Silver-Russell syndrome due to 11p15 microduplication;Beckwith-Wiedemann syndrome due to imprinting defect of 11p15;Silver-Russell syndrome due to a point mutation,Disease-causing germline mutation(s) in;Role in the phenotype of;Role in the phenotype of;Role in the phenotype of;Disease-causing germline mutation(s) in,DNA methylation (variation)[23725790];Celiac disease[23936387];Creatinine levels[29403010];Pursuit maintenance gain[29064472];Femoral neck bone geometry and menarche (age at onset)[23593202;23593202];Birth weight[27680694];Prostate cancer[19767753];Glomerular filtration rate[29403010];,0.33226993865030674,0.519339865910263,0.49752022970503784,0.8825966850828729
1722,12097,IGFALS,601489,615961;,,Short stature due to primary acid-labile subunit deficiency,Disease-causing germline mutation(s) in,Insulin-like growth factors[21216879];Blood protein levels[30072576];,0.17791411042944785,0.1738009283135637,0.3769250848342469,0.32734806629834257
1723,12104,IGFBP7,602867,614224;,[MIM:614224]Retinal arterial macroaneurysm with supravalvular pulmonic stenosis [recessive?];,Familial retinal arterial macroaneurysm,Disease-causing germline mutation(s) in,Alcohol consumption (maxi-drinks)[29460428];Hyperemesis gravidarum[29563502];Age-related macular degeneration[21909106];Heel bone mineral density[28869591];Severity of nausea and vomiting of pregnancy[29563502];Brain volume in infants (grey matter)[28763065];Blood protein levels[28240269;29875488;30072576];Congenital heart disease (maternal effect)[28468790];,0.2947239263803681,0.39066529138731304,0.43435134429652833,0.0
1724,12116,IGH,146910;147010;147070,,,Follicular lymphoma;Mantle cell lymphoma;MALT lymphoma;Precursor B-cell acute lymphoblastic leukemia,Part of a fusion gene in;Disease-causing somatic mutation(s) in;Part of a fusion gene in;Disease-causing somatic mutation(s) in,IgG sialylation phenotypes (multivariate analysis)[28878392];IgG monosialylation phenotypes (multivariate analysis)[28878392];Alzheimer's disease (late onset)[24162737];IgG galactosylation phenotypes (multivariate analysis)[28878392];Baseline cortisol levels in response to low dose short synacthen test in corticosteroid treated asthma[29551627];IgG fucosylation phenotypes (multivariate analysis)[28878392];IgG N-glycosylation phenotypes (multivariate analysis)[28878392];IgG bisecting N-acetyl glucosamine phenotypes (multivariate analysis)[28878392];IgG monogalactosylation phenotypes (multivariate analysis)[28878392];,0.038773006134969326,0.0,0.0,0.0
1725,12160,IGHG1,147100,254500;,[MIM:254500]Multiple myeloma;,B-cell chronic lymphocytic leukemia,Part of a fusion gene in,IgG levels[23225573];Blood protein levels[29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488];,0.6733742331288344,0.0,0.0,0.0
1726,12161,IGHG2,147110,,,Recurrent infections associated with rare immunoglobulin isotypes deficiency,Disease-causing germline mutation(s) in,IgG levels[23225573];,0.48208588957055215,0.0,0.0,0.0
1727,12174,IGHM,147020,601495;,"[MIM:601495]Agammaglobulinemia 1, autosomal recessive [recessive?];",Autosomal agammaglobulinemia,Disease-causing germline mutation(s) in,,0.5645398773006135,0.0,0.0,0.0
1728,12175,IGHMBP2,600502,604320;616155;,[MIM:616155]Charcot-Marie-Tooth disease 2S;,Charcot-Marie-Tooth disease type 2S;Spinal muscular atrophy with respiratory distress type 1,Disease-causing germline mutation(s) (loss of function) in;Disease-causing germline mutation(s) in,Heel bone mineral density[28869591;28869591];,0.45680981595092024,0.20061887570912842,0.16653615244061604,0.8299570288520565
1729,12220,IGHV3-21,,,,B-cell chronic lymphocytic leukemia,Biomarker tested in,,0.038773006134969326,0.0,0.0,0.0
1730,12282,IGHV4-34,,,,Hairy cell leukemia variant,Major susceptibility factor in,,0.038773006134969326,0.0,0.0,0.0
1731,12344,IGKC,147200,614102;,[MIM:614102]Immunoglobulin kappa light chain deficiency;,Recurrent infections associated with rare immunoglobulin isotypes deficiency,Disease-causing germline mutation(s) in,,0.7573006134969326,0.0,0.0,0.0
1732,12477,IGLL1,146770,613500;,,Autosomal agammaglobulinemia,Disease-causing germline mutation(s) in,Migraine[21448238];Peripheral artery disease[25009551];Height[18391951];Blood protein levels[29875488;30072576];,0.4117791411042945,0.5345538937596699,0.35552075176194203,0.0
1733,12562,IGSF1,300137,300888;,"[MIM:300888]Hypothyroidism, central, and testicular enlargement;",X-linked central congenital hypothyroidism with late-onset testicular enlargement,Disease-causing germline mutation(s) (loss of function) in,Age at voice drop[27182965];Menarche (age at onset)[27182965];,0.23865030674846627,0.9818205260443528,0.48029235186635344,0.4607120933087784
1734,12563,IGSF3,603491,149700;,,Familial congenital nasolacrimal duct obstruction,Disease-causing germline mutation(s) in,Blood protein levels[30072576];Asthma (childhood onset)[23829686];,0.629079754601227,0.0,0.10728269381362568,0.3562001227747084
1735,12577,IHH,600726,112500;607778;,[MIM:112500]Brachydactyly A1 [dominant?];[MIM:607778]Acrocapitofemoral dysplasia [recessive?];,Acrocapitofemoral dysplasia;Brachydactyly type A1,Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in,Height[20189936;20881960;18391952;18391951];Waist circumference adjusted for body mass index[26785701];,0.19190184049079756,0.6611655492521918,0.5982772122161315,0.8971761817065684
1736,12580,IKBKB,603258,615592;,[MIM:615592]Immunodeficiency 15 [recessive?];,Severe combined immunodeficiency due to IKK2 deficiency,Disease-causing germline mutation(s) (loss of function) in,,0.7450306748466258,0.7289840123775142,0.485512920908379,0.21731123388581952
1737,12582,IKBKG,300248,300291;300301;300584;300636;300640;308300;,"[MIM:300291]Ectodermal dysplasia, anhidrotic, with immunodeficiency X-linked;[MIM:300301]Ectodermal dysplasia, anhidrotic, with immunodeficiency, osteopetrosis and lymphedema;[MIM:300584]Immunodeficiency, NEMO-related, without anhidrotic ectodermal dysplasia;[MIM:300636]Immunodeficiency 33;[MIM:300640]Recurrent isolated invasive pneumococcal disease 2;[MIM:308300]Incontinentia pigmenti;",Incontinentia pigmenti;X-linked mendelian susceptibility to mycobacterial diseases due to IKBKG deficiency;Anhidrotic ectodermal dysplasia-immunodeficiency-osteopetrosis-lymphedema syndrome;Hypohidrotic ectodermal dysplasia with immunodeficiency,Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in,Hemoglobin levels[26366553];,0.8704294478527608,0.7565755544094894,0.9879926912033412,0.0
1738,12584,IKZF1,603023,616873;,"[MIM:616873]Immunodeficiency, common variable, 13 [dominant?];",Pancytopenia due to IKZF1 mutations;Stevens-Johnson syndrome;Precursor B-cell acute lymphoblastic leukemia,Disease-causing germline mutation(s) in;Major susceptibility factor in;Biomarker tested in,"Glucose homeostasis traits[25524916];Granulocyte percentage of myeloid white cells[27863252;27863252;27863252];Multiple sclerosis[24076602];Mean corpuscular hemoglobin[27863252;29403010];Eosinophil counts[27863252];Immature fraction of reticulocytes[27863252];Body mass index[26426971;26426971];Total cholesterol levels[29403010];Systemic lupus erythematosus[19838193;23273568;27399966;26502338;26502338;28714469;28714469;19838195;26663301];Itch intensity from mosquito bite adjusted by bite size[28199695;28199695];Aspartate aminotransferase levels[29403010];IgG monogalactosylation phenotypes (multivariate analysis)[28878392];IgG glycosylation[23382691;23382691;23382691;23382691;23382691;23382691;23382691;23382691];B cell acute lymphoblastic leukaemia (Philadelphia chromosome negative)[29296818];Monocyte percentage of white cells[27863252;27863252;27863252];Albumin-globulin ratio[29403010];Inflammatory bowel disease[23128233];Sum eosinophil basophil counts[27863252];HDL cholesterol levels[28334899];Body mass index x sex x age interaction (4df test)[26426971];B cell acute lymphoblastic leukaemia (normal cytogenetics)[29296818];Serum total protein level[29403010];Tonsillectomy[27182965;28928442];Area under the curve of insulin levels[24699409];IgG disialylation phenotypes (multivariate analysis)[28878392];Hemoglobin levels[28017375];Neutrophil percentage of white cells[27863252];Monocyte count[27863252;27863252;27863252;29403010];Acute lymphoblastic leukemia (childhood)[23512250;22076464;22076464;25310577;19684604;19684603;29348612];High density lipoprotein cholesterol levels[29403010];Non-albumin protein levels[29403010];Mean corpuscular volume[19862010;28017375;27863252;28453575;29403010];Acute lymphoblastic leukemia in childhood (B cell precursor)[29632299;29296818];Itch intensity from mosquito bite[28199695];IgG sialylation phenotypes (multivariate analysis)[28878392];Body mass index (age <50)[26426971];Allergic disease (asthma, hay fever or eczema)[29083406];Red blood cell traits[23222517];IgG galactosylation phenotypes (multivariate analysis)[28878392];IgG bisecting N-acetyl glucosamine phenotypes (multivariate analysis)[28878392];Crohn's disease[21102463];Red blood cell count[29403010;27863252];Cold medicine-related Stevens-Johnson syndrome/toxic epidermal necrolysis (SJS/TEN) with severe mucosal involvement[25672763];Hippocampal atrophy[19668339];HDL cholesterol[24097068];B cell acute lymphoblastic leukaemia (hyperdiploid negative)[29296818];Eosinophil percentage of granulocytes[27863252];IgG digalactosylation phenotypes (multivariate analysis)[28878392];Type 1 diabetes[25751624];Mosquito bite size[28199695];IgG N-glycosylation phenotypes (multivariate analysis)[28878392];Acute lymphoblastic leukemia (B-cell precursor)[23996088;29296818;29296818];",0.7352147239263803,0.9154203197524498,0.871835030018272,0.0
1739,12586,IKZF3,606221,,,B-cell chronic lymphocytic leukemia,Disease-causing somatic mutation(s) in,Atopic march[26542096];Primary biliary cirrhosis[22961000];Multiple sclerosis[24076602];Lymphocyte counts[29403010;27863252];Crohn's disease[21102463;28067908];Eosinophil counts[27863252];Selective IgA deficiency[27723758];Asthma[28461288];Inflammatory bowel disease[28067908;23128233];Pediatric autoimmune diseases[26301688];Eosinophil percentage of granulocytes[27863252];Rheumatoid arthritis (ACPA-positive)[23143596;24532676;23143596];Systemic lupus erythematosus[27399966;26502338;26502338];Bronchial hyperresponsiveness in asthma[27439200];Type 1 diabetes[25751624];Rheumatoid arthritis[24390342;24390342;20453842;23143596;23143596];Primary biliary cholangitis[20639880;23000144;28062665;19458352;26394269];Self-reported allergy[23817569];Asthma and hay fever[24388013];Systemic lupus erythematosus and Systemic sclerosis[23740937];Acute lymphoblastic leukemia (childhood)[29348612];Neutrophil percentage of granulocytes[27863252];Ulcerative colitis[21297633;28067908;20228799];Eosinophil percentage of white cells[27863252;27863252];,0.678282208588957,0.8769984528107272,0.7669015922735578,0.766267648864334
1740,12596,IL1RAPL1,300206,300143;,,X-linked non-syndromic intellectual disability,Disease-causing germline mutation(s) in,Cardiovascular risk factors (age interaction)[20838585];Vitiligo[27723757];Itch intensity from mosquito bite adjusted by bite size[28199695];,0.14576687116564419,0.955002578648788,0.9042025580788305,0.0
1741,12600,IL1RN,147679,612628;612852;,[MIM:612852]Interleukin 1 receptor antagonist deficiency;,Sterile multifocal osteomyelitis with periostitis and pustulosis,Disease-causing germline mutation(s) in,Stroke[26089329];C-reactive protein[22939635];Lymphocyte percentage of white cells[27863252];Myeloid white cell count[27863252];Sum basophil neutrophil counts[27863252];Sum neutrophil eosinophil counts[27863252];Granulocyte count[27863252];Blood protein levels[29875488;30072576];Neutrophil count[27863252];Neutrophil percentage of white cells[27863252];Fibrinogen[23969696];Fibrinogen levels[28107422;28107422];Obesity-related traits[23251661];Dysmenorrheic pain[27454463];Protein quantitative trait loci[18464913];,0.22687116564417178,0.628158844765343,0.8778386844166014,0.4648557397176182
1742,12602,IL2RA,147730,601942;606367;,"[MIM:601942]Diabetes mellitus, insulin-dependent, 10;[MIM:606367]Immunodeficiency 41 with lymphoproliferation and autoimmunity;",Immunodeficiency due to CD25 deficiency;Oligoarticular juvenile idiopathic arthritis;Rheumatoid factor-negative juvenile idiopathic arthritis,Disease-causing germline mutation(s) in;Major susceptibility factor in;Major susceptibility factor in,"Soluble interleukin-2 receptor subunit alpha[26293465;26293465;26293465;26293465];Multiple sclerosis[22190364;17660530;19525955;19525953;21833088;21833088;24076602;24076602;28445677;27386562];Lymphocyte percentage of white cells[27863252];Graves' disease[22922229];Lymphocyte counts[27863252];Chronic inflammatory diseases (ankylosing spondylitis, Crohn's disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy)[26974007;26974007;26974007];Inflammatory biomarkers[22228203;22228203];Emotional dysregulation[27643478];Primary sclerosing cholangitis[27992413];Selective IgA deficiency[27723758];Vitiligo[20410501;27723757];Rheumatoid arthritis (ACPA-positive)[23143596];Allergic disease (asthma, hay fever or eczema)[29083406;29083406];Systemic lupus erythematosus[28714469;28714469;28714469];Epstein Barr virus nuclear antigen 1 IgG levels or multiple sclerosis[26819262];Atopic dermatitis[26482879;26482879];Autoimmune thyroid diseases (Graves disease or Hashimoto's thyroiditis)[22922229];Asthma (bronchodilator response)[23508266];Crohn's disease[21102463;28067908];Response to anti-retroviral therapy (ddI/d4T) in HIV-1 infection (Grade 3 peripheral neuropathy)[24554482];Alopecia areata[20596022;25608926];Plasma t-tau levels[28100725];Inflammatory bowel disease[23128233];Pediatric autoimmune diseases[26301688];Type 1 diabetes[18978792;22293688;19430480;21829393;25751624;25751624;25751624];Juvenile idiopathic arthritis (oligoarticular or rheumatoid factor-negative polyarticular)[23603761;23603761];Rheumatoid arthritis[24390342;24390342;20453842;24449572;23143596];Diisocyanate-induced asthma[25918132];Asthma and hay fever[24388013];Interleukin-2 receptor antagonist levels[27989323];",0.5658895705521473,0.8089221248066013,0.9428347689898199,0.36464088397790057
1743,12603,IL2RB,146710,,,Oligoarticular juvenile idiopathic arthritis;Rheumatoid factor-negative juvenile idiopathic arthritis,Major susceptibility factor in;Major susceptibility factor in,Rheumatoid arthritis (ACPA-positive)[23143596;24532676];Tuberculosis[24057671];Mean corpuscular volume[27863252];Type 1 diabetes[21829393];Juvenile idiopathic arthritis (oligoarticular or rheumatoid factor-negative polyarticular)[23603761];Rheumatoid arthritis[24390342;23143596];Asthma[20860503];,0.6320245398773006,0.42857142857142855,0.5056121117201775,0.7728667894413751
1744,12604,IL2RG,308380,300400;312863;,[MIM:300400]Severe combined immunodeficiency X-linked T-cell- negative/B-cell-positive/NK-cell-negative;[MIM:312863]X-linked combined immunodeficiency;,T-B+ severe combined immunodeficiency due to gamma chain deficiency;Omenn syndrome,Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in,,0.6574233128834356,0.5598246518824136,0.9537979639780736,0.7612031921424187
1745,12612,IL6,147620,148000;604302;,[MIM:604302]Rheumatoid arthritis systemic juvenile;,Systemic-onset juvenile idiopathic arthritis,Major susceptibility factor in,Cerebrospinal fluid clusterin levels in APOEe4- carriers[26545630];C-reactive protein[21196492];Dialysis-related mortality[21546767];Juvenile idiopathic arthritis (oligoarticular or rheumatoid factor-negative polyarticular)[23603761];Fibrinogen[23969696];Longevity[26912274];Takayasu arteritis[25604533;25604533];,0.40773006134969325,0.5825167612171223,0.5961889845993213,0.32811540822590546
1746,12619,IL7R,146661,608971;612595;,[MIM:608971]Severe combined immunodeficiency autosomal recessive T- cell-negative/B-cell-positive/NK-cell-positive [recessive?];[MIM:612595]Multiple sclerosis 3;,T-B+ severe combined immunodeficiency due to IL-7Ralpha deficiency;Omenn syndrome,Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in,"Primary biliary cirrhosis[22961000];Multiple sclerosis[19525953;21244703;21833088;24076602];Lymphocyte percentage of white cells[27863252];Lymphocyte counts[27863252];Blood protein levels[28240269;29875488;30072576];Allergic disease (asthma, hay fever or eczema)[29083406];Type 1 diabetes[17554260;25751624];Atopic dermatitis[26482879;26482879];Neutrophil percentage of white cells[27863252];Allergic rhinitis[30013184];Primary biliary cholangitis[21399635;23000144;28062665;26394269];Ankylosing spondylitis[23749187;23749187];Ulcerative colitis[21297633];",0.3669938650306748,0.47343991748323877,0.5465935787000783,0.3113873542050338
1747,12626,IL10,124092,614395;,,Systemic lupus erythematosus;Beh�et disease;Immune dysregulation-inflammatory bowel disease-arthritis-recurrent infections syndrome,Major susceptibility factor in;Major susceptibility factor in;Disease-causing germline mutation(s) (loss of function) in,"Inflammatory bowel disease[28067908;28008999;23128233];Pediatric autoimmune diseases[26301688];Systemic lupus erythematosus[26502338;26502338;28714469;28714469;19838195];Type 1 diabetes[19430480;21829393;25751624];Mosquito bite size[28199695];Chronic inflammatory diseases (ankylosing spondylitis, Crohn's disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy)[26974007];Behcet's disease[20622878;20622879];Crohn's disease[21102463;28067908];Gut microbiota (functional units)[27694959];Itch intensity from mosquito bite[28199695];Ulcerative colitis[18836448;21297633;19915572;20228798;20228799;28067908];",0.3492024539877301,0.4167096441464673,0.9655442443226312,0.3305709023941068
1748,12627,IL10RA,146933,613148;,,Immune dysregulation-inflammatory bowel disease-arthritis-recurrent infections syndrome,Disease-causing germline mutation(s) (loss of function) in,Obesity-related traits[23251661];,0.33226993865030674,0.7527075812274369,0.3529104672409293,0.7329650092081031
1749,12628,IL10RB,123889,610424;612567;,[MIM:612567]Inflammatory bowel disease 25;,Immune dysregulation-inflammatory bowel disease-arthritis-recurrent infections syndrome,Disease-causing germline mutation(s) (loss of function) in,Narcolepsy[24204295;23459209];Crohn's disease[23128233];Blood protein levels[30072576];,0.43754601226993867,0.21041774110366168,0.10649960845732184,0.3147636586863106
1750,12631,IL11RA,600939,614188;,,Craniosynostosis-dental anomalies,Disease-causing germline mutation(s) (loss of function) in,Blood protein levels[29875488;30072576;30072576;30072576];CTACK levels[27989323];,0.12711656441717792,0.0296544610624033,0.6684938658313756,0.051718845917740945
1751,12632,IL12A,161560,,,Beh�et disease;Primary biliary cholangitis,Major susceptibility factor in;Major susceptibility factor in,Celiac disease[18311140;20190752;22057235;22057235;22057235];Primary biliary cirrhosis[22961000;22961000;22961000;22961000;22961000;22961000;22961000;22961000;22961000];Multiple sclerosis[19525953;21833088;24076602;24076602];Systemic lupus erythematosus[27399966;26502338;26502338;28714469];Sjögren's syndrome[24097067];Systemic sclerosis[24387989;24387989;24387989];Primary biliary cholangitis[20639880;21399635;28425483;28062665;19458352;26394269];Behcet's disease[23291587;25799145];Limited cutaneous systemic scleroderma[24387989];Major depressive disorder[23377640];,0.5226993865030675,0.6771531717380093,0.8198903680501175,0.7102516881522406
1752,12633,IL12A-AS1,,,,Beh�et disease,Major susceptibility factor in,,0.038773006134969326,0.0,0.0,0.0
1753,12634,IL12B,161561,612599;614890;,[MIM:614890]Immunodeficiency 29;[MIM:612599]Psoriasis 11;,Takayasu arteritis;Mendelian susceptibility to mycobacterial diseases due to complete IL12B deficiency,Major susceptibility factor in;Disease-causing germline mutation(s) in,"Multiple sclerosis[22190364;22190364;21833088];Psoriasis[20953188;20953190;19169255;19169254;25903422;25903422;25903422;25903422;25903422;25903422;23143594;23143594];Sarcoidosis[26051272];Serum sulfate level[27412988];Chronic inflammatory diseases (ankylosing spondylitis, Crohn's disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy)[26974007];Leprosy[25642632];Crohn's disease[18587394;17554261;20570966;21102463;28067908];Cutaneous psoriasis[26626624];Blood protein levels[29875488;30072576];Response to taxane treatment (placlitaxel)[23006423];Psoriatic arthritis[20953186;26626624];Inflammatory bowel disease[28067908;23128233];Pediatric autoimmune diseases[26301688];Psoriasis vulgaris[26626624];Primary biliary cholangitis[26394269];Ankylosing spondylitis[21743469;23749187;23749187;23749187];Ulcerative colitis[21297633;28067908];",0.48208588957055215,0.28184631253223313,0.5711302531975986,0.22421731123388583
1754,12635,IL12RB1,601604,614891;,[MIM:614891]Immunodeficiency 30;,Primary biliary cholangitis;Mendelian susceptibility to mycobacterial diseases due to complete IL12RB1 deficiency,Major susceptibility factor in;Disease-causing germline mutation(s) in,Blood protein levels[28240269];Pulmonary function in asthmatics[23541324];,0.5153374233128835,0.05827746260959257,0.4445314539284782,0.4303253529772867
1755,12647,IL17F,606496,613956;,,Chronic mucocutaneous candidiasis,Disease-causing germline mutation(s) in,Response to gemcitabine in pancreatic cancer[22142827];Survival in pancreatic cancer[28470677];,0.22687116564417178,0.5095410005157297,0.3623074915165753,0.29266421117249847
1756,12648,IL17RA,605461,613953;,[MIM:613953]Immunodeficiency 51;,Chronic mucocutaneous candidiasis,Disease-causing germline mutation(s) in,Granulocyte percentage of myeloid white cells[27863252];White blood cell count[27863252];Myeloid white cell count[27863252];Monocyte count[27863252;27863252;27863252];Monocyte percentage of white cells[27863252;27863252];Blood protein levels[28240269;29875488;30072576];Heschl's gyrus morphology[25130324];,0.5128834355828221,0.3225889633831872,0.09344818585225789,0.26442602823818295
1757,12650,IL17RC,610925,616445;,"[MIM:616445]Candidiasis, familial, 9;",Chronic mucocutaneous candidiasis,Disease-causing germline mutation(s) (loss of function) in,,0.4493251533742331,0.06395048994326973,0.2375358914121639,0.06015960712093309
1758,12651,IL17RD,606807,615267;,,Kallmann syndrome,Disease-causing germline mutation(s) in,Blood protein levels[28240269;29875488;30072576];,0.21484662576687116,0.36797318205260443,0.1493082746019316,0.22421731123388583
1759,12663,IL21,605384,615767;,,IL21-related infantile inflammatory bowel disease,Disease-causing germline mutation(s) in,"Allergy[27182965];Alzheimer's disease in APOE e4- carriers[25778476];Chronic inflammatory diseases (ankylosing spondylitis, Crohn's disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy)[26974007];Primary sclerosing cholangitis[27992413];Itch intensity from mosquito bite[28199695];Selective IgA deficiency[27723758];Allergic disease (asthma, hay fever or eczema)[29083406];Systemic lupus erythematosus[28714469];Itch intensity from mosquito bite adjusted by bite size[28199695;28199695;28199695;28199695];Atopic dermatitis[26482879;25574825];Allergic rhinitis[30013184];Crohn's disease[28067908];Night sleep phenotypes[27126917];Alopecia areata[20596022;25608926;25608926];Inflammatory bowel disease[28067908;23128233];Celiac disease[17558408;18311140;20190752;24999842;22057235];Pediatric autoimmune diseases[26301688];Progressive supranuclear palsy[21685912];Type 1 diabetes[25751624];Juvenile idiopathic arthritis (oligoarticular or rheumatoid factor-negative polyarticular)[23603761];Mosquito bite size[28199695];Rheumatoid arthritis[24390342;20453842];Primary biliary cholangitis[28425483;28425483];Vaso-occlusive pain in sickle-cell anemia[28584135];Allergic sensitization[23817571];Ulcerative colitis[21297633];",0.23865030674846627,0.7710159876224858,0.9885147481075437,0.5285451197053407
1760,12665,IL21R,605383,615207;,[MIM:615207]Immunodeficiency 56 [recessive?];,Combined immunodeficiency due to IL21R deficiency,Disease-causing germline mutation(s) (loss of function) in,Mosquito bite size[28199695];Self-reported allergy[23817569];Primary biliary cholangitis[28425483;26394269];Leprosy[27976721];Bone mineral density[19874204];Serum IgE levels[25488688];,0.20368098159509201,0.9476534296028881,0.4320020882276168,0.6904542664211173
1761,12671,IL23R,607562,612261;,[MIM:612261]Inflammatory bowel disease 17;,Beh�et disease,Major susceptibility factor in,"Psoriasis[20953190;19169254;25903422;25903422;23143594];Sarcoidosis[26051272];Chronic inflammatory diseases (ankylosing spondylitis, Crohn's disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy)[26974007;26974007;26974007;26974007];Leprosy[22019778;25642632];Severe malaria[29381699];Behcet's disease[20622878;20622879];Crohn's disease[17804789;17804789;18587394;17447842;17554300;17435756;22293688;23850713;20570966;21102463;22936669;28067908;22412388];Vogt-Koyanagi-Harada syndrome[25108386];Severe malaria (adjusted for sickle cell variant rs334)[29381699];Blood protein levels[28240269;29875488;30072576];Inflammatory skin disease[25574825];Psoriatic arthritis[26626624];Inflammatory bowel disease[18758464;28067908;28008999;28008999;23128233];Pediatric autoimmune diseases[26301688];Plasma omega-6 polyunsaturated fatty acid levels (linoleic acid)[24823311];Psoriasis vulgaris[26626624];Type 2 diabetes (age of onset)[28060188];Gut microbiota (functional units)[27694959];Ankylosing spondylitis[21743469;20062062;23749187;23749187;23749187];Ulcerative colitis[19122664;19122664;21297633;19915572;20228799;28067908];",0.38061349693251534,0.7815884476534296,0.46280344557556774,0.4731430325352977
1762,12678,IL31RA,609510,613955;,"[MIM:613955]Amyloidosis, primary localized cutaneous, 2;",Familial primary localized cutaneous amyloidosis,Disease-causing germline mutation(s) in,Crohn's disease[23128233];,0.3749693251533742,0.06523981433728726,0.15035238841033674,0.0689073050951504
1763,12685,IL36RN,605507,614204;,"[MIM:614204]Psoriasis 14, pustular;",Acrodermatitis continua of Hallopeau;Pustulosis palmaris et plantaris;Generalized pustular psoriasis;DITRA,Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) (loss of function) in;Disease-causing germline mutation(s) (loss of function) in,Stroke[26089329];,0.36171779141104293,0.4992264053635895,0.5578178021404333,0.0
1764,12687,ILDR1,609739,609646;,,Autosomal recessive non-syndromic sensorineural deafness type DFNB,Disease-causing germline mutation(s) in,Multiple sclerosis[22190364];Epstein Barr virus nuclear antigen 1 IgG levels or multiple sclerosis[26819262];Blood urea nitrogen levels[29403010];,0.12711656441717792,0.09489427539969056,0.14748107543722266,0.04619398403928791
1765,12712,IMPAD1,614010,614078;,"[MIM:614078]Chondrodysplasia with joint dislocations, GPAPP type;","Chondrodysplasia with joint dislocations, gPAPP type",Disease-causing germline mutation(s) in,Hand grip strength[27325353];Alcohol dependence[24166409];Milk allergy[25710614];Response to selective serotonin reuptake inhibitors and depression[27622933];Blood protein levels[29875488;30072576];,0.31079754601226994,0.4118102114492006,0.7956147220046985,0.6011356660527931
1766,12713,IMPDH1,146690,180105;613837;,[MIM:180105]Retinitis pigmentosa 10;[MIM:613837]Leber congenital amaurosis 11;,Retinitis pigmentosa;Leber congenital amaurosis,Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in,,0.7422085889570552,0.4301186178442496,0.698773166275124,0.8631062001227747
1767,12726,IMPG1,602870,616151;,"[MIM:616151]Macular dystrophy, vitelliform, 4;",Adult-onset foveomacular vitelliform dystrophy,Disease-causing germline mutation(s) in,Response to fenofibrate (total cholesterol levels)[27002377];QT interval[29213071];Alanine aminotransferase (ALT) levels after remission induction therapy in actute lymphoblastic leukemia (ALL)[28090653];Systolic blood pressure x smoking status (ever vs never) interaction (2df test)[29455858];Menarche (age at onset)[25231870];,0.038773006134969326,0.221763795771016,0.1568780997128687,0.034223449969306326
1768,12727,IMPG2,607056,613581;616152;,"[MIM:613581]Retinitis pigmentosa 56;[MIM:616152]Macular dystrophy, vitelliform, 5;",Retinitis pigmentosa;Adult-onset foveomacular vitelliform dystrophy,Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in,Inflammatory bowel disease[28067908];Crohn's disease[28067908];,0.038773006134969326,0.07323362558019597,0.5163142782563299,0.10696746470227134
1769,12736,INF2,610982,613237;614455;,"[MIM:613237]Focal segmental glomerulosclerosis 5;[MIM:614455]Charcot-Marie-Tooth disease, dominant, intermediate type, E;",Autosomal dominant intermediate Charcot-Marie-Tooth disease type E;Familial idiopathic steroid-resistant nephrotic syndrome with focal segmental hyalinosis,Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in,,0.8586503067484662,0.8102114492006188,0.16157661185069172,0.8974831184775937
1770,12737,ING1,601566,275355;,[MIM:275355]Squamous cell carcinoma of the head and neck;,Squamous cell carcinoma of the hypopharynx;Squamous cell carcinoma of the larynx;Squamous cell carcinoma of the oropharynx;Squamous cell carcinoma of salivary glands;Squamous cell carcinoma of the nasal cavity and paranasal sinuses;Squamous cell carcinoma of the oral cavity;Squamous cell carcinoma of the lip,Disease-causing somatic mutation(s) in;Disease-causing somatic mutation(s) in;Disease-causing somatic mutation(s) in;Disease-causing somatic mutation(s) in;Disease-causing somatic mutation(s) in;Disease-causing somatic mutation(s) in;Disease-causing somatic mutation(s) in,Erosive tooth wear (severe vs non-severe)[29898447;29898447;29898447];Blood protein levels[30072576];,0.6403680981595092,0.8561113976276431,0.5648655703471679,0.4972375690607735
1771,12744,INHBA,147290,,,Adenocarcinoma of ovary,Disease-causing germline mutation(s) in,Cortisol levels (saliva)[28843169];Pit-and-Fissure caries[23470693];Parent of origin effect on language impairment (paternal)[24571439];Menarche (age at onset)[21102462;27182965;25231870];Asthma[29273806];,0.27361963190184047,0.9167096441464673,0.8553902375358914,0.894413750767342
1772,12768,INPP5E,613037,213300;610156;,"[MIM:610156]Mental retardation, truncal obesity, retinal dystrophy, and micropenis [recessive?];",Joubert syndrome;Joubert syndrome with hepatic defect;Joubert syndrome with ocular defect;MORM syndrome,Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in,Inflammatory bowel disease[28067908;23128233];Serum total protein level[29403010];White blood cell count[27863252];Myeloid white cell count[27863252];Sum basophil neutrophil counts[27863252];Crohn's disease[28067908];Sum neutrophil eosinophil counts[27863252];Monocyte percentage of white cells[27863252];Granulocyte count[27863252];Neutrophil count[27863252];Hemoglobin A1c levels[29403010];Ulcerative colitis[21297633;28067908];,0.48208588957055215,0.39375966993295514,0.6348211955103106,0.0
1773,12771,INPP5K,607875,617404;,,Marinesco-Sj�gren syndrome,Disease-causing germline mutation(s) in,Mean platelet volume[27863252];,0.8094478527607362,0.627643115007736,0.6990341947272253,0.8434622467771639
1774,12772,INPPL1,600829,125853;258480;,"[MIM:125853]Diabetes mellitus, non-insulin-dependent;[MIM:258480]Opsismodysplasia;",Opsismodysplasia;Schneckenbecken dysplasia,Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in,Heart rate response to recovery post exercise (10 sec)[29497042];,0.6588957055214724,0.35765858690046415,0.2231793265465936,0.810926949048496
1775,12773,INS,176730,125852;606176;613370;616214;,"[MIM:616214]Hyperproinsulinemia [dominant?];[MIM:125852]Diabetes mellitus, insulin-dependent, 2;[MIM:606176]Diabetes mellitus, permanent neonatal;[MIM:613370]Maturity-onset diabetes of the young 10 [dominant?];",MODY;Permanent neonatal diabetes mellitus,Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in,Celiac disease[23936387];Pediatric autoimmune diseases[26301688];Type 1 diabetes[17554260;17632545;19430480;21829393;25751624;25751624];Type 1 diabetes in high risk HLA genotype individuals (time to event)[29310926];Birth weight[27680694];Prostate cancer (SNP x SNP interaction)[22219177;22219177;22219177;22219177];Prostate cancer[19767753];Type 1 diabetes autoantibodies in high risk HLA genotype individuals (time to event)[29310926;29310926];,0.5009815950920246,0.6539453326456937,0.9866875489428347,0.9040822590546348
1776,12784,INSR,147670,125853;246200;262190;609968;610549;,"[MIM:262190]Rabson-Mendenhall syndrome [recessive?];[MIM:246200]Leprechaunism [recessive?];[MIM:125853]Diabetes mellitus, non-insulin-dependent;[MIM:609968]Familial hyperinsulinemic hypoglycemia 5;[MIM:610549]Insulin-resistant diabetes mellitus with acanthosis nigricans type A;",Leprechaunism;Insulin-resistance syndrome type A;Hyperinsulinism due to INSR deficiency;Rabson-Mendenhall syndrome,Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) (loss of function) in,Systolic blood pressure[27618448;27618452;28739976;28135244];Diabetic retinopathy[21441570];Polycystic ovary syndrome[22885925];Diastolic blood pressure (cigarette smoking interaction)[29455858];Urate levels[23263486];Thyroid hormone levels[23408906;23408906];Diastolic blood pressure[27618452;28739976];Triglyceride levels[28334899];Triglycerides[24097068];Diastolic blood pressure x alcohol consumption interaction (2df test)[29912962];Hypothyroidism[22493691;27182965];Systolic blood pressure (cigarette smoking interaction)[29455858];Diverticular disease[30177863];Perceived unattractiveness to mosquitoes[28199695];Hip circumference adjusted for BMI[25673412;25673412;25673412];Pulse pressure[27618448];Height[20881960;25282103];Systolic blood pressure x alcohol consumption interaction (2df test)[29912962];Asthma (childhood onset)[27142222];Mean arterial pressure x alcohol consumption interaction (2df test)[29912962];,0.8009815950920245,0.7756575554409489,0.584703732706865,0.9066912216083487
1777,12812,INVS,243305,602088;,[MIM:602088]Nephronophthisis 2 [recessive?];,Senior-Loken syndrome;Infantile nephronophthisis,Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in,Preeclampsia[23551011];,0.49717791411042944,0.04357916451779267,0.4943878882798225,0.07228360957642725
1778,12817,IPMK,609851,,,Hereditary neuroendocrine tumor of small intestine,Disease-causing germline mutation(s) in,Inflammatory bowel disease[28067908;23128233];Coronary artery calcification[23870195];Crohn's disease[28067908];Obesity-related traits[23251661];Cerebrospinal fluid clusterin levels[26545630];,0.505398773006135,0.8955647240845797,0.24745497259201252,0.6158686310620012
1779,12839,IQCB1,609237,609254;611755;,[MIM:609254]Senior-Loken syndrome 5;[MIM:611755]Leber congenital amaurosis 10;,Senior-Loken syndrome;Leber congenital amaurosis,Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) (loss of function) in,Multiple sclerosis[24076602];,0.8885889570552147,0.6353790613718412,0.08274601931610545,0.015500306936771025
1780,12843,IQCE,617631,,,Postaxial polydactyly type A,Disease-causing germline mutation(s) in,Urate levels in lean individuals[25811787];Food allergy (parent-of-origin effect)[29489655];,0.4795092024539877,0.006962351727694688,0.07126076742364917,0.005371393492940454
1781,12863,IQSEC2,300522,309530;,,Smith-Magenis syndrome;X-linked non-syndromic intellectual disability;Microduplication Xp11.22p11.23 syndrome;Severe intellectual disability-progressive postnatal microcephaly-midline stereotypic hand movements syndrome,Candidate gene tested in;Disease-causing germline mutation(s) in;Role in the phenotype of;Disease-causing germline mutation(s) (loss of function) in,,0.17791411042944785,0.9834966477565755,0.6961628817541112,0.6158686310620012
1782,12870,IRAK1,300283,,,Systemic lupus erythematosus;Pediatric systemic lupus erythematosus,Major susceptibility factor in;Major susceptibility factor in,Celiac disease[22057235];Rheumatoid arthritis (ACPA-positive)[23143596];Systemic lupus erythematosus[26606652;26502338;19838195;26663301];Rheumatoid arthritis[24390342;24390342;23143596];,0.9101840490797546,0.6828261990716864,0.578961106760637,0.6011356660527931
1783,12874,IRAK4,606883,607676;610799;,[MIM:610799]Recurrent isolated invasive pneumococcal disease 1;[MIM:607676]IRAK4 deficiency;,Immunodeficiency due to interleukin-1 receptor-associated kinase-4 deficiency,Disease-causing germline mutation(s) in,Inflammatory bowel disease[27569725];Immune reponse to smallpox (secreted TNF-alpha)[22610502];,0.6261349693251533,0.1376998452810727,0.3239363090576873,0.5555555555555556
1784,12883,IRF5,607218,180300;612245;612251;,[MIM:612245]Inflammatory bowel disease 14;[MIM:612251]Systemic lupus erythematosus 10;[MIM:180300]Rheumatoid arthritis;,Systemic lupus erythematosus;Primary biliary cholangitis;Limited cutaneous systemic sclerosis;Diffuse cutaneous systemic sclerosis,Major susceptibility factor in;Major susceptibility factor in;Major susceptibility factor in;Major susceptibility factor in,"Diffuse cutaneous systemic sclerosis[29293537;29293537];Primary biliary cirrhosis[22961000;22961000;22961000;22961000];Chronic inflammatory diseases (ankylosing spondylitis, Crohn's disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy)[26974007];Systemic lupus erythematosus or rheumatoid arthritis[27193031];Limited cutaneous systemic scleroderma[29293537;29293537];Systemic sclerosis (anti-centromere-positive)[29293537];Rheumatoid arthritis (ACPA-positive)[24532676;23143596];Systemic lupus erythematosus[18204446;18204098;21408207;21408207;19838193;24871463;23053960;23273568;27399966;26502338;26502338;26606652;26606652;26502338;28714469;28714469;28714469;28714469;19838195;26663301];Sjögren's syndrome[28076899;24097067;24097067;24097067];Rheumatoid arthritis[24390342;24390342;21156761;20453842;23143596];Systemic sclerosis[21750679;21779181;21779181;21779181;21779181;20383147;29293537;29293537;24387989;30247649;30247649];Primary biliary cholangitis[20639880;21399635;26394269];Systemic lupus erythematosus and Systemic sclerosis[23740937];Ulcerative colitis[21297633;23128233;28067908];",0.5775460122699386,0.516245487364621,0.04541895066562255,0.8566605279312461
1785,12885,IRF6,607199,119300;119500;608864;,[MIM:119300]Van der Woude syndrome 1 [dominant?];[MIM:119500]Popliteal pterygium syndrome [dominant?];[MIM:608864]Non-syndromic orofacial cleft 6;,Isolated cleft lip;Cleft lip/palate;Van der Woude syndrome;Autosomal dominant popliteal pterygium syndrome;Cleft lip and alveolus;Oligodontia,Major susceptibility factor in;Major susceptibility factor in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Major susceptibility factor in;Disease-causing germline mutation(s) in,Inflammatory bowel disease[28067908];Cleft lip with or without cleft palate[28054174;28054174];Cleft lip[20436469];Nonsyndromic cleft lip with or without cleft palate[25775280];Crohn's disease[28067908];Alzheimer's disease (APOE e4 interaction)[25778476];Orofacial clefts[19270707;22863734;22863734;28054174;28054174];Nonsyndromic cleft lip with cleft palate[28232668];Drug-induced liver injury in interferon-beta-treated multiple sclerosis[30013178];Alopecia areata[25608926];,0.30319018404907977,0.9486848891181021,0.22735578178021404,0.9165131982811541
1786,12887,IRF8,601565,226990;614893;,[MIM:614893]Immunodeficiency 32A;[MIM:226990]Immunodeficiency 32B [recessive?];,Mendelian susceptibility to mycobacterial diseases due to partial IRF8 deficiency,Disease-causing germline mutation(s) in,"Diabetic retinopathy[21441570];Primary biliary cirrhosis[22961000];Multiple sclerosis[19525953;21833088;24076602];Granulocyte percentage of myeloid white cells[27863252;27863252;27863252;27863252;27863252;27863252];Gestational age at birth (maternal effect)[27490719];Sum basophil neutrophil counts[27863252];Sum neutrophil eosinophil counts[27863252];Monocyte percentage of white cells[27863252;27863252;27863252;27863252;27863252;27863252];Granulocyte count[27863252];Limited cutaneous systemic scleroderma[29293537];Neutrophil count[27863252];Major depressive disorder[23857890];Systemic sclerosis (anti-centromere-positive)[29293537];Inflammatory bowel disease[23128233];Chronic lymphocytic leukemia[21131588;23770605;24292274;26956414;28165464];Rheumatoid arthritis (ACPA-positive)[24532676;23143596];Systemic lupus erythematosus[27399966;26502338;26502338;28714469;28714469;19838195;26663301];Rheumatoid arthritis[22446963;24390342;24390342;23143596];Systemic sclerosis[21779181];Neutrophil percentage of white cells[27863252];Systemic lupus erythematosus and Systemic sclerosis[23740937];B-cell malignancies (chronic lymphocytic leukemia, Hodgkin lymphoma or multiple myeloma) (pleiotropy)[28112199];Monocyte count[28193307;23314186;27863252;27863252;27863252;27863252;27863252;29403010];Ulcerative colitis[23511034];",0.47705521472392637,0.7926766374419804,0.7789089010702167,0.6818600368324125
1787,12898,IRX2,606198,,,Clear cell sarcoma of kidney,Part of a fusion gene in,Toenail selenium levels[25343990];Body mass index (adult)[28430825;28430825];,0.12711656441717792,0.5642083548220732,0.2839989558861916,0.0
1788,12902,IRX5,606195,611174;,[MIM:611174]Hamamy syndrome;,Craniofacial dysplasia-osteopenia syndrome,Disease-causing germline mutation(s) in,Dialysis-related mortality[21546767];Hypospadias[25108383];Heel bone mineral density[28869591;28869591;28869591];Social communication problems[24564958];Thrombin-activatable fibrinolysis inhibitor activation peptide[29378355];,0.038773006134969326,0.5688499226405364,0.19864265204907336,0.0
1789,12911,ISCA2,615317,616370;,[MIM:616370]Multiple mitochondrial dysfunctions syndrome 4;,Multiple mitochondrial dysfunctions syndrome type 4,Disease-causing germline mutation(s) in,Advanced glycation end-product levels[26915486];,0.21484662576687116,0.19494584837545126,0.9240407204385278,0.33486801718845915
1790,12913,ISCU,611911,255125;,,Hereditary myopathy with lactic acidosis due to ISCU deficiency,Disease-causing germline mutation(s) in,Acne (severe)[24927181];Intraocular pressure[29617998];,0.8337423312883435,0.5247550283651367,0.7739493604802924,0.5349907918968693
1791,12915,ISG15,147571,616126;,"[MIM:616126]Immunodeficiency 38, with basal ganglia calcification;",Mendelian susceptibility to mycobacterial diseases due to complete ISG15 deficiency,Disease-causing germline mutation(s) in,Blood protein levels[29875488;30072576];,0.7105521472392639,0.684631253223311,0.22056904202558078,0.35681399631675875
1792,12918,ISL1,600366,,,Bladder exstrophy,Major susceptibility factor in,Childhood ear infection[27182965];Dental caries[23259602];QT interval[29213071];Verbal declarative memory[25648963;25648963];Classic bladder exstrophy[25763902];,0.4840490797546012,0.7488396080453842,0.45679979117723835,0.6760282381829343
1793,12927,ISPD,614631,614643;616052;,[MIM:616052]Muscular dystrophy-dystroglycanopathy limb-girdle C7;,Congenital muscular dystrophy without intellectual disability;Autosomal recessive limb-girdle muscular dystrophy type 2U;Walker-Warburg syndrome,Disease-causing germline mutation(s) (loss of function) in;Disease-causing germline mutation(s) (loss of function) in;Disease-causing germline mutation(s) (loss of function) in,Serum tamsulosin hydrochloride concentration[23151678];Waist-to-hip ratio adjusted for BMI x sex interaction[26426971];Waist-to-hip ratio adjusted for BMI[26426971];,0.038773006134969326,0.34192882929345025,0.23231532237013836,0.0
1794,12935,ITCH,606409,613385;,"[MIM:613385]Autoimmune disease, multisystem, with facial dysmorphism;",Syndromic multisystem autoimmune disease due to Itch deficiency,Disease-causing germline mutation(s) in,Vitiligo[27723757];Heel bone mineral density[28869591;28869591;28869591];,0.7323926380368098,1.0,0.7914382667710781,0.6580724370779619
1795,12943,ITGA2,192974,,,Fetal and neonatal alloimmune thrombocytopenia,Candidate gene tested in,Type 2 diabetes[30130595];Acne (severe)[24927181];,0.7365644171779141,0.0997937080969572,0.229182980944923,0.35681399631675875
1796,12944,ITGA2B,607759,187800;273800;,"[MIM:273800]Glanzmann thrombasthenia;[MIM:187800]Bleeding disorder, platelet-type 16 [dominant?];",Autosomal dominant macrothrombocytopenia;Glanzmann thrombasthenia;Fetal and neonatal alloimmune thrombocytopenia,Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Candidate gene tested in,Mean platelet volume[27863252];Platelet distribution width[27863252];Platelet count[22139419;27863252];,0.4917791411042945,0.6808922124806601,0.07361002349256068,0.3580417434008594
1797,12945,ITGA3,605025,614748;,"[MIM:614748]Interstitial lung disease, nephrotic syndrome, and epidermolysis bullosa, congenital;",Junctional epidermolysis bullosa with respiratory and renal involvement,Disease-causing germline mutation(s) (loss of function) in,,0.6357055214723927,0.518824136152656,0.2156095014356565,0.20825659914057704
1798,12948,ITGA6,147556,226730;,"[MIM:226730]Epidermolysis bullosa letalis, with pyloric atresia [recessive?];",Junctional epidermolysis bullosa-pyloric atresia syndrome,Disease-causing germline mutation(s) in,Food allergy[29030101];Peanut allergy[29030101];Alzheimer's disease biomarkers[23419831];Blood protein levels[28240269];Prostate cancer[19767753];Diabetic kidney disease[26305897];,0.8166871165644172,0.22382671480144403,0.09292612894805534,0.27608962553713934
1799,12950,ITGA7,600536,613204;,[MIM:613204]Muscular dystrophy congenital due to integrin alpha-7 deficiency;,Congenital fiber-type disproportion myopathy;Congenital muscular dystrophy with integrin alpha-7 deficiency,Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in,Post bronchodilator FEV1/FVC ratio[26634245];,0.45153374233128835,0.23826714801444043,0.34690681284259983,0.0570902394106814
1800,12951,ITGA8,604063,191830;,,"Renal agenesis, bilateral",Disease-causing germline mutation(s) in,Parkinson's disease[19915575];Diisocyanate-induced asthma[25918132];Periodontitis (CDC/AAP)[24024966];Quantitative traits[19197348];Cerebrospinal fluid t-tau:AB1-42 ratio[28641921;28641921;28641921];,0.36171779141104293,0.07581227436823104,0.3437744714173845,0.0
1801,12959,ITGAM,120980,609939;,[MIM:609939]Systemic lupus erythematosus 6;,Systemic lupus erythematosus,Major susceptibility factor in,Systemic lupus erythematosus[18204446;18204098;19165918;21408207;24871463;23273568;27399966;26502338;26606652;26502338;28714469;28714469;28714469;28714469;19838195];IgA nephropathy[25305756;25305756;25305756];Graves' disease[22922229];Autoimmune thyroid diseases (Graves disease or Hashimoto's thyroiditis)[22922229];Systemic lupus erythematosus and Systemic sclerosis[23740937];,0.541840490797546,0.7810727178958226,0.20516836335160532,0.32642725598526706
1802,12967,ITGB2,600065,116920;,[MIM:116920]Leukocyte adhesion deficiency 1;,Leukocyte adhesion deficiency type I,Disease-causing germline mutation(s) in,Heel bone mineral density[28869591;28869591];,0.5948466257668712,0.0,0.6220308013573479,0.916206261510129
1803,12969,ITGB3,173470,187800;273800;,"[MIM:273800]Glanzmann thrombasthenia;[MIM:187800]Bleeding disorder, platelet-type 16 [dominant?];",Autosomal dominant macrothrombocytopenia;Glanzmann thrombasthenia;Fetal and neonatal alloimmune thrombocytopenia,Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Major susceptibility factor in,Mean platelet volume[27863252];Body mass index[25673413;25673413];Very long-chain saturated fatty acid levels (fatty acid 20:0)[25378659];,0.6776687116564417,0.4339865910263022,0.5486818063168886,0.748158379373849
1804,12971,ITGB4,147557,131800;226650;226730;,"[MIM:226730]Epidermolysis bullosa letalis, with pyloric atresia [recessive?];[MIM:226650]Generalized atrophic benign epidermolysis bullosa;[MIM:131800]Epidermolysis bullosa simplex, Weber-Cockayne type;","Epidermolysis bullosa simplex with pyloric atresia;Localized junctional epidermolysis bullosa, non-Herlitz type;Junctional epidermolysis bullosa-pyloric atresia syndrome;Junctional epidermolysis bullosa, generalized intermediate",Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in,,0.8094478527607362,0.5304280556988138,0.39545810493343775,0.8156844689993862
1805,12974,ITGB6,147558,616221;,[MIM:616221]Amelogenesis imperfecta 1H;,Alopecia-intellectual disability syndrome;Hypocalcified amelogenesis imperfecta;Hypoplastic amelogenesis imperfecta,Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) (loss of function) in,Type 2 diabetes[20418489];Waist circumference adjusted for body mass index[25673412;25673412];Idiopathic membranous nephropathy[21323541];,0.36171779141104293,0.032490974729241874,0.4821195510310624,0.6206261510128913
1806,12985,ITK,186973,613011;,[MIM:613011]Lymphoproliferative syndrome 1;,Autosomal recessive lymphoproliferative disease,Disease-causing germline mutation(s) in,Daytime sleep phenotypes[27126917];Personality traits in bipolar disorder[21368711];,0.48208588957055215,0.37570912841670967,0.7358392064735056,0.5796500920810314
1807,12989,ITM2B,603904,117300;176500;616079;,"[MIM:176500]Cerebral amyloid angiopathy, ITM2B-related 1;[MIM:117300]Cerebral amyloid angiopathy, ITM2B-related 2;[MIM:616079]Retinal dystrophy with inner retinal dysfunction and ganglion cell abnormalities [dominant?];",Retinal dystrophy with inner retinal dysfunction and ganglion cell anomalies;ADan amyloidosis;ABri amyloidosis,Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in,,0.894478527607362,0.7741103661681279,0.5505090054815975,0.38275015346838553
1808,12992,ITPA,147520,613850;616647;,"[MIM:616647]Epileptic encephalopathy, early infantile, 35;",Susceptibility to adverse reaction due to mercaptopurine;ITPA-related encephalopathy,Biomarker tested in;Disease-causing germline mutation(s) in,Ribavirin-induced anemia[20637204];IFN-related cytopenia[21703177];Response to hepatitis C treatment[21659334;21659334];Chronic hepatitis C infection[20173735;20173735];Night sleep phenotypes[27126917];,0.4298159509202454,0.15987622485817432,0.2832158705298878,0.5349907918968693
1809,13000,ITPR1,147265,117360;206700;606658;,[MIM:606658]Spinocerebellar ataxia 15 [dominant?];[MIM:117360]Spinocerebellar ataxia 29 [dominant?];[MIM:206700]Gillespie syndrome;,Aniridia-cerebellar ataxia-intellectual disability syndrome;Spinocerebellar ataxia type 29;Spinocerebellar ataxia type 15/16,Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in,Systolic blood pressure[26969751];Calcium levels[29403010];Uterine fibroids[30194396];Western dietary pattern[28644415];Lead levels[26025379];Hand grip strength[29691431];Breast cancer[23535729];Obesity-related traits[23251661];Thrombin-activatable fibrinolysis inhibitor activation peptide[29378355];Gamma glutamyl transferase levels[29403010];Airflow obstruction[22837378];Diabetic kidney disease[26305897];,0.6703067484662577,0.9782104177411036,0.4980422866092404,0.960098219766728
1810,13002,ITPR2,600144,106190;,"[MIM:106190]Anhidrosis, isolated, with normal sweat glands [recessive?];",Isolated generalized anhidrosis with normal sweat glands,Disease-causing germline mutation(s) (loss of function) in,Waist circumference adjusted for BMI (joint analysis main effects and physical activity interaction)[28448500;28448500;28448500];Waist-to-hip ratio adjusted for BMI (adjusted for smoking behaviour)[28443625;28443625];Smooth-surface caries[24556642];Waist-to-hip ratio adjusted for BMI in active individuals[28448500;28448500;28448500;28448500];Kashin-Beck disease[25303641];Waist-to-hip ratio adjusted for BMI (joint analysis for main effect and physical activity interaction)[28448500;28448500;28448500;28448500];Waist-to-hip ratio adjusted for BMI in non-smokers[28443625];Amyotrophic lateral sclerosis[17827064];Waist circumference adjusted for body mass index[28448500;28448500];Waist-hip ratio[20935629;25673412;25673412];Waist-to-hip ratio adjusted for BMI[26426971];Major depressive disorder[27479909];Waist-to-hip ratio adjusted for BMI (age >50)[26426971];Male-pattern baldness[27182965];Renal cell carcinoma[22010048];Waist-to-hip ratio adjusted for BMI (joint analysis main effects and smoking interaction)[28443625];Birth weight[27680694];Waist circumference adjusted for BMI in active individuals[28448500;28448500;28448500];Waist-to-hip ratio adjusted for body mass index[28448500;28448500;28448500;25673412;25673412;25673412;25673412;28448500];Waist-to-hip ratio adjusted for BMI x sex x age interaction (4df test)[26426971];,0.5645398773006135,0.014698298091799896,0.3202819107282694,0.7286678944137508
1811,13012,IVD,607036,243500;,[MIM:243500]Isovaleric acidemia;,Isovaleric acidemia,Disease-causing germline mutation(s) in,Blood metabolite ratios[24816252];Intelligence (MTAG)[29326435];Blood metabolite levels[24816252];Cognitive ability[29186694];Cognitive ability (MTAG)[29186694];Metabolic traits[21886157];,0.794601226993865,0.5059308922124807,0.711824588880188,0.7081031307550645
1812,13016,IYD,612025,274800;,,Familial thyroid dyshormonogenesis,Disease-causing germline mutation(s) in,Anger[24489884];,0.08736196319018405,0.3653945332645694,0.3312451057165231,0.552793124616329
1813,13026,JAG1,601920,118450;187500;617992;,"[MIM:118450]Alagille syndrome 1 [dominant?];[MIM:187500]Tetralogy of Fallot;[MIM:617992]Deafness, congenital heart defects, and posterior embryotoxon [dominant?];",Tetralogy of Fallot;Alagille syndrome due to 20p12 microdeletion;Alagille syndrome due to a JAG1 point mutation,Disease-causing germline mutation(s) in;Role in the phenotype of;Disease-causing germline mutation(s) in,Systolic blood pressure[21909115;25249183;28135244;27618452;28739976];Type 2 diabetes[28828242];Diastolic blood pressure (cigarette smoking interaction)[29455858];Diastolic blood pressure[21909115;25249183;26390057;26390057;27618452;28739976;28135244;28135244;27618447];Urinary bladder cancer[24861552];Migraine[27322543];Heel bone mineral density[28869591;28869591;28869591;28869591;28869591;28869591];Cardiac hypertrophy[21348951];Frontotemporal dementia with GRN mutation (age at onset)[29724592];Systolic blood pressure (cigarette smoking interaction)[29455858];Lumbar spine bone mineral density[29499414];Bone mineral density (spine)[30172743];Pulse pressure[28135244];Blood pressure[21909110];Bone mineral density[20096396;22504420];Birth weight[27680694];Frontotemporal dementia (age at onset)[29724592];,0.28662576687116564,1.0,0.36282954842077786,0.9785144260282382
1814,13028,JAGN1,616012,616022;,,Autosomal recessive severe congenital neutropenia due to JAGN1 deficiency,Disease-causing germline mutation(s) in,,0.8192638036809816,0.42805569881382155,0.539806838945445,0.4562615101289134
1815,13030,JAK2,147796,254450;263300;600880;601626;614521;,"[MIM:600880]Budd-Chiari syndrome;[MIM:263300]Polycythemia vera;[MIM:614521]Thrombocythemia 3;[MIM:254450]Myelofibrosis;[MIM:601626]Leukemia, acute myelogenous;",Budd-Chiari syndrome;Essential thrombocythemia;Primary myelofibrosis;Polycythemia vera;Familial thrombocytosis,Candidate gene tested in;Disease-causing somatic mutation(s) in;Disease-causing somatic mutation(s) in;Disease-causing somatic mutation(s) in;Disease-causing germline mutation(s) (gain of function) in,"Myeloproliferative neoplasms[19287384;25849990];Chronic inflammatory diseases (ankylosing spondylitis, Crohn's disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy)[26974007];Plateletcrit[27863252;27863252;27863252];Crohn's disease[18587394;21102463;23266558];Eosinophil counts[27863252];Psoriatic arthritis[26626624];Inflammatory bowel disease[23128233];Sum eosinophil basophil counts[27863252];Pediatric autoimmune diseases[26301688];Systemic lupus erythematosus[27399966;27399966;27399966];Allergic disease (asthma, hay fever or eczema)[29083406];Platelet count[27863252;27863252;27863252];Ulcerative colitis[21297633;19915573;20228799];",0.7273619631901841,0.7735946364105208,0.5155311929000261,0.6642111724984653
1816,13031,JAK3,600173,600802;,[MIM:600802]Severe combined immunodeficiency autosomal recessive T- cell-negative/B-cell-positive/NK-cell-negative [recessive?];,T-B+ severe combined immunodeficiency due to JAK3 deficiency,Disease-causing germline mutation(s) in,,0.6930061349693252,0.2728210417741104,0.45236230749151657,0.700890116635973
1817,13037,JAM3,606871,613730;,[MIM:613730]Hemorrhagic destruction of the brain with subependymal calcification and cataracts;,Porencephaly-microcephaly-bilateral congenital cataract syndrome,Disease-causing germline mutation(s) in,Blood protein levels[30072576];,0.27361963190184047,0.47576070139247034,0.6353432524145132,0.22314303253529774
1818,13041,JAZF1,606246,,,Systemic lupus erythematosus;Endometrial stromal sarcoma,Major susceptibility factor in;Part of a fusion gene in,"Type 2 diabetes[18372903;20581827;24509480;22885922;22885922;22885922;29358691;28869590;28869590;27189021];Waist circumference adjusted for BMI (joint analysis main effects and physical activity interaction)[28448500;28448500;28448500;28448500;28448500;28448500];Multiple sclerosis[24076602];Alcoholic chronic pancreatitis[28754779];Lymphocyte percentage of white cells[27863252];Gout[22179738];Lymphocyte counts[27863252];Chronic inflammatory diseases (ankylosing spondylitis, Crohn's disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy)[26974007];Waist circumference adjusted for BMI (adjusted for smoking behaviour)[28443625;28443625;28443625];Systemic lupus erythematosus[26502338;26606652;26502338;28714469;28714469;19838195];Allergic disease (asthma, hay fever or eczema)[29083406];Hip circumference adjusted for BMI[25673412;25673412;25673412];Allergic rhinitis[30013184];Waist circumference adjusted for BMI (joint analysis main effects and smoking interaction)[28443625;28443625;28443625];Height[18952825;19343178;23563607;20881960;25282103];Thiazide-induced adverse metabolic effects in hypertensive patients[23400010];Waist circumference adjusted for BMI in active individuals[28448500;28448500;28448500;28448500;28448500;28448500];Moyamoya disease[29273593;29273593];Waist circumference adjusted for BMI in non-smokers[28443625;28443625];Alanine transaminase levels[29403010];Prostate-specific antigen levels[28139693];Heel bone mineral density[28869591;28869591;28869591];Crohn's disease[23128233];Waist circumference adjusted for body mass index[28448500;28448500;28448500;28448500;28448500;28448500;25673412;25673412;25673412];Total body bone mineral density[29304378];Free thyroxine concentration[24722205];Juvenile idiopathic arthritis (oligoarticular or rheumatoid factor-negative polyarticular)[23603761];Rheumatoid arthritis[24390342;24390342];Systemic lupus erythematosus and Systemic sclerosis[23740937];Prostate cancer[18264096];",0.49570552147239266,0.7106756059824652,0.9517097363612633,0.4438305709023941
1819,13051,JMJD1C,604503,,,22q11.2 deletion syndrome;Germinoma of the central nervous system,Modifying germline mutation in;Major susceptibility factor in,Type 2 diabetes[28406950];Granulocyte percentage of myeloid white cells[27863252];Vascular endothelial growth factor levels[26910538;27989323];Myeloid white cell count[27863252];Total bilirubin levels[29403010];Cognitive ability[29186694];Schizophrenia[28991256];Triglyceride levels[28334899;29403010];Sum basophil neutrophil counts[27863252];High light scatter reticulocyte count[27863252];Granulocyte count[27863252];Neutrophil count[27863252];Basophil percentage of granulocytes[27863252];Immature fraction of reticulocytes[27863252];Mean platelet volume[22423221;19820697;24026423;22139419;27863252];Plasma omega-6 polyunsaturated fatty acid levels (linoleic acid)[24823311];Intelligence (MTAG)[29326435;29326435;29326435;29326435];Prothrombin time[29403010];Fibrinogen[23969696];Lung function (FEV1)[30061609;30061609];Cognitive ability (MTAG)[29186694];Platelet count[24026423;22139419;23263863;26805783;27863252];Asthma (childhood onset)[27611488];Sex hormone-binding globulin levels[22829776;22829776;22829776];Platelet distribution width[27863252];Serum alkaline phosphatase levels[29403010];Liver enzyme levels (alkaline phosphatase)[22001757];Triglycerides[20686565;24097068;25961943];Liver enzyme levels[18940312];Platelet aggregation[20526338];Sum neutrophil eosinophil counts[27863252];Monocyte percentage of white cells[27863252];Blood protein levels[29875488];General cognitive ability[29844566];Androgen levels[22936694];Educational attainment[25201988];Asthma[27611488];Lung function (FEV1/FVC)[30061609];Arthritis (juvenile idiopathic)[22354554];Plasma omega-6 polyunsaturated fatty acid levels (adrenic acid)[24823311];C-reactive protein levels or HDL-cholesterol levels (pleiotropy)[27286809];White blood cell count[27863252];Neutrophil percentage of white cells[27863252];Fibrinogen levels[26561523;28107422;28107422];,0.6852760736196319,1.0,0.04150352388410337,0.9263351749539595
1820,13064,JPH3,605268,606438;,[MIM:606438]Huntington disease-like 2;,Huntington disease-like 2,Disease-causing germline mutation(s) in,Small vessel stroke[27997041];Migraine[27182965];Systemic juvenile idiopathic arthritis[27927641];Post bronchodilator FEV1/FVC ratio in smoking[30068317];Late-onset Alzheimer's disease[27770636];Dementia and core Alzheimer's disease neuropathologic changes[25188341;25188341];Post bronchodilator FEV1[26634245];Idiopathic dilated cardiomyopathy[29495422];,0.14576687116564419,0.953971119133574,0.496737144348734,0.0
1821,13069,JRK,603210,,,Juvenile myoclonic epilepsy;Childhood absence epilepsy,Candidate gene tested in;Candidate gene tested in,Urinary tract infection frequency[28928442];,0.10711656441717791,0.0,0.0,0.0
1822,13078,JUP,173325,601214;611528;,"[MIM:601214]Naxos disease [recessive?];[MIM:611528]Arrhythmogenic right ventricular dysplasia, familial, 12;","Lethal acantholytic epidermolysis bullosa;Familial isolated arrhythmogenic ventricular dysplasia, right dominant form;Familial isolated arrhythmogenic ventricular dysplasia, biventricular form;Familial isolated arrhythmogenic ventricular dysplasia, left dominant form;Naxos disease",Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in,Heel bone mineral density[28869591;28869591];,0.9619631901840491,0.5453842186694172,0.4072043852779953,0.18523634131368938
1823,13081,KANK1,607704,612900;,,Inherited congenital spastic tetraplegia,Disease-causing germline mutation(s) in,Eye morphology[29921221];Uterine fibroids[30194396];Fasting plasma glucose[25187374];Bone mineral density (femoral neck) in inflammatory bowel disease[29603369];Post bronchodilator FEV1/FVC ratio[26634245];Night sleep phenotypes[27126917];,0.6835582822085889,0.03790613718411552,0.034194727225267556,0.1464088397790055
1824,13083,KANK2,614610,616099;,[MIM:616099]Palmoplantar keratoderma and woolly hair;,Woolly hair-palmoplantar keratoderma syndrome,Disease-causing germline mutation(s) in,"High light scatter reticulocyte percentage of red cells[27863252];Reticulocyte fraction of red cells[27863252];Reticulocyte count[27863252];High light scatter reticulocyte count[27863252];Cholesterol, total[26780889];Red cell distribution width[27863252];Coronary artery disease[29212778];HDL cholesterol[23505323];Immature fraction of reticulocytes[27863252;27863252];",0.8360736196319019,0.5760701392470345,0.40877055599060297,0.48281154082259053
1825,13086,KANSL1,612452,,,Koolen-De Vries syndrome due to a point mutation;17q21.31 microdeletion syndrome,Disease-causing germline mutation(s) (loss of function) in;Role in the phenotype of,Neuroticism[29255261];Alzheimer's disease in APOE e4- carriers[25778476];Parkinson's disease[28892059];Mean corpuscular hemoglobin[27863252;29403010];Mean corpuscular volume[27863252;29403010];Lymphocyte percentage of white cells[27863252];Idiopathic pulmonary fibrosis[24429156];Cognitive ability[29186694];High light scatter reticulocyte count[27863252];Eosinophil counts[27863252];Lung function (FVC)[28166213];Male-pattern baldness[27182965];Reticulocyte fraction of red cells[27863252];Lung function (FEV1)[28166213];Eosinophil percentage of white cells[27863252];High light scatter reticulocyte percentage of red cells[27863252];Reticulocyte count[27863252];Hand grip strength[29313844];Breast cancer[29059683];Red blood cell count[29403010];Sum eosinophil basophil counts[27863252];Eosinophil percentage of granulocytes[27863252];Neutrophil percentage of white cells[27863252];Reaction time[29844566;29844566];Cognitive function[28093568;28093568];Neutrophil percentage of granulocytes[27863252];,0.6797546012269938,0.9582258896338318,0.036543983294179065,0.0
1826,13092,KARS,601421,613641;613916;,"[MIM:613641]Charcot-Marie-Tooth disease, recessive, intermediate type, B;[MIM:613916]Deafness, autosomal recessive, 89 [recessive?];",Autosomal recessive intermediate Charcot-Marie-Tooth disease type B;Autosomal recessive non-syndromic sensorineural deafness type DFNB,Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in,Pancreatic cancer[25086665];,0.981840490797546,0.2003610108303249,0.2453667449752023,0.49923265807243705
1827,13099,KAT6A,601408,616268;,"[MIM:616268]Mental retardation, autosomal dominant 32 [dominant?];",Acute myeloid leukemia with t(8;16)(p11;p13) translocation;Autosomal dominant intellectual disability-craniofacial anomalies-cardiac defects syndrome,Part of a fusion gene in;Disease-causing germline mutation(s) in,,0.7001226993865031,1.0,0.22161315583398591,0.0
1828,13100,KAT6B,605880,603736;606170;,"[MIM:603736]Ohdo syndrome, SBBYS variant;[MIM:606170]Genitopatellar syndrome;","Noonan syndrome;Blepharophimosis-intellectual disability syndrome, SBBYS type;Genitopatellar syndrome",Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in,,0.5128834355828221,1.0,0.4226050639519708,0.0
1829,13107,KATNB1,602703,616212;,"[MIM:616212]Lissencephaly 6, with microcephaly;",Microlissencephaly,Disease-causing germline mutation(s) in,,0.6160736196319019,0.6436307374935534,0.3411641868963717,0.3462246777163904
1830,13127,KBTBD13,613727,609273;,[MIM:609273]Nemaline myopathy 6;,Childhood-onset nemaline myopathy,Disease-causing germline mutation(s) in,,0.038773006134969326,0.10520887055183084,0.6134168624380057,0.0
1831,13129,KCNA1,176260,160120;,[MIM:160120]Episodic ataxia 1 [dominant?];[MIM:160120]Myokymia isolated 1;,"Isolated autosomal dominant hypomagnesemia, Glaudemans type;Early infantile epileptic encephalopathy;Hereditary continuous muscle fiber activity;Episodic ataxia type 1;Paroxysmal kinesigenic dyskinesia",Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in,,0.3492024539877301,0.5585353274883961,0.8791438266771078,0.8281154082259055
1832,13130,KCNA2,176262,616366;,"[MIM:616366]Epileptic encephalopathy, early infantile, 32;",Undetermined early-onset epileptic encephalopathy;Undetermined early-onset epileptic encephalopathy,Disease-causing germline mutation(s) (loss of function) in;Disease-causing germline mutation(s) (gain of function) in,,0.3706748466257669,0.8468282619907168,0.9845993213260246,0.9294045426642111
1833,13132,KCNA4,176266,,,Non-spherocytic hemolytic anemia due to hexokinase deficiency;Charcot-Marie-Tooth disease type 4G,Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in,Polycystic ovary syndrome[26284813];Spherical equivalent or myopia (age of diagnosis)[29808027];Menarche (age at onset)[27182965];Luteinizing hormone levels in polycystic ovary syndrome[26284813];,0.33226993865030674,0.9428829293450232,0.8679196032367528,0.0
1834,13133,KCNA5,176267,612240;,"[MIM:612240]Atrial fibrillation, familial, 7;",Familial atrial fibrillation,Disease-causing germline mutation(s) (loss of function) in,Femoral neck bone geometry[22087292];,0.4645398773006135,0.3512119649303765,0.4834246932915688,0.8015653775322283
1835,13140,KCNAB2,601142,,,1p36 deletion syndrome,Role in the phenotype of,,0.6511656441717791,0.9007220216606499,0.5562516314278256,0.3601903007980356
1836,13142,KCNB1,600397,616056;,"[MIM:616056]Epileptic encephalopathy, early infantile, 26;",Undetermined early-onset epileptic encephalopathy,Disease-causing germline mutation(s) in,Alanine aminotransferase (ALT) levels after remission induction therapy in actute lymphoblastic leukemia (ALL)[28090653];Schizophrenia[25056061];White matter hyperintensity burden[25663218;25663218];Obesity-related traits[23251661];,0.27361963190184047,0.9671222279525529,0.6079352649438788,0.9705340699815838
1837,13144,KCNC1,176258,616187;,"[MIM:616187]Epilepsy, progressive myoclonic 7;",Progressive myoclonic epilepsy type 7,Disease-causing germline mutation(s) (loss of function) in,Body mass index[26426971;26426971];Night sleep phenotypes[27126917];Opioid sensitivity[24143882];,0.22687116564417178,0.9326972666322847,0.9203863221091099,0.9686924493554327
1838,13146,KCNC3,176264,605259;,[MIM:605259]Spinocerebellar ataxia 13 [dominant?];,Spinocerebellar ataxia type 13,Disease-causing germline mutation(s) in,,0.038773006134969326,0.6253223310985044,0.45262333594361787,0.0
1839,13150,KCND3,605411,607346;616399;,[MIM:607346]Spinocerebellar ataxia 19;[MIM:616399]Brugada syndrome 9;,Brugada syndrome;Spinocerebellar ataxia type 19/22,Disease-causing germline mutation(s) (gain of function) in;Disease-causing germline mutation(s) in,Cardiac repolarization[22683750];Immune reponse to smallpox (secreted IFN-alpha)[22610502];P wave duration[24850809];P wave terminal force[28794112;28794112];Visceral adipose tissue adjusted for BMI[22589738];Atrial fibrillation[28416822;30061737;29892015;29892015];Response to radiotherapy in cancer (late toxicity)[24785509];,0.3749693251533742,0.9448169159360496,0.8968937614199948,0.9257213014119091
1840,13153,KCNE1,176261,612347;613695;,[MIM:612347]Jervell and Lange-Nielsen syndrome 2 [recessive?];[MIM:613695]Long QT syndrome 5;,Familial atrial fibrillation;Jervell and Lange-Nielsen syndrome;Romano-Ward syndrome,Candidate gene tested in;Disease-causing germline mutation(s) (loss of function) in;Disease-causing germline mutation(s) (loss of function) in,QT interval[24952745;29213071];Electrocardiographic traits[20062063];,0.19190184049079756,0.3922124806601341,0.8065779169929522,0.9533456108041743
1841,13155,KCNE2,603796,611493;613693;,"[MIM:611493]Atrial fibrillation, familial, 4;",Familial atrial fibrillation;Romano-Ward syndrome,Disease-causing germline mutation(s) (gain of function) in;Disease-causing germline mutation(s) (loss of function) in,"Myocardial infarction[26343387;26708285];Lung function (FEV1/FVC)[28166213];Myocardial infarction (early onset)[19198609];Joint mobility (Beighton score)[27182965];Pulmonary function[21946350];Heel bone mineral density[28869591;28869591;28869591];Height[20881960];Body mass index  (smoking years interaction)[23192594];Coronary artery disease[26343387;24262325];Coronary artery disease (myocardial infarction, percutaneous transluminal coronary angioplasty, coronary artery bypass grafting, angina or chromic ischemic heart disease)[28714975];Cancer[29299148];",0.10711656441717791,0.2790097988653945,0.8107543722265727,0.4766728054020872
1842,13156,KCNE3,604433,613119;,,Hypokalemic periodic paralysis;Brugada syndrome,Candidate gene tested in;Disease-causing germline mutation(s) in,Corneal astigmatism[22144915];,0.22687116564417178,0.7132542547705003,0.8804489689376142,0.6270718232044199
1843,13158,KCNE5,300328,300194;,,Brugada syndrome;Alport syndrome-intellectual disability-midface hypoplasia-elliptocytosis syndrome,Candidate gene tested in;Role in the phenotype of,,0.16220858895705523,0.5755544094894275,0.0,0.0
1844,13164,KCNH1,603305,135500;611816;,[MIM:611816]Temple-Baraitser syndrome;[MIM:135500]Zimmermann-Laband syndrome 1;,Zimmermann-Laband syndrome;Temple-Baraitser syndrome,Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) (gain of function) in,Bone mineral density (total hip)[27424934];Bone mineral density (femoral neck)[27424934];Circulating vasoactive peptide levels[23381795];Bone mineral density (spine) and age at menarche[26312577];Cobalt levels[26025379];Cancer[27197191];,0.21484662576687116,0.7490974729241877,0.8146697990080919,0.9085328422344997
1845,13166,KCNH2,152427,609620;613688;,[MIM:613688]Long QT syndrome 2;[MIM:609620]Short QT syndrome 1;,Familial short QT syndrome;Romano-Ward syndrome,Disease-causing germline mutation(s) (gain of function) in;Disease-causing germline mutation(s) (loss of function) in,Diverticular disease[30177863];QT interval[19305408;19305408;19305409;23166209;24952745;24952745;29213071];Atrial fibrillation[30061737;29892015;29892015];Electrocardiographic traits[20062063;20062061];Eyebrow thickness[26926045];,0.3706748466257669,0.8272305312016504,0.24667188723570868,0.9966236955187231
1846,13179,KCNJ1,600359,241200;,"[MIM:241200]Bartter syndrome 2, antenatal [recessive?];",Antenatal Bartter syndrome,Disease-causing germline mutation(s) (loss of function) in,,0.20368098159509201,0.25116039195461576,0.6290785695640825,0.9174340085942296
1847,13180,KCNJ2,600681,170390;609622;613980;,"[MIM:170390]Long QT syndrome 7;[MIM:609622]Short QT syndrome 3;[MIM:613980]Atrial fibrillation, familial, 9;",Familial atrial fibrillation;Andersen-Tawil syndrome;Familial short QT syndrome,Disease-causing germline mutation(s) (gain of function) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) (gain of function) in,Spherical equivalent or myopia (age of diagnosis)[29808027];Pulmonary function (smoking interaction)[23284291;23284291];Waist-to-hip ratio adjusted for BMI in active individuals[28448500;28448500;28448500];Prudent dietary pattern[28644415];Primary tooth development (time to first tooth eruption)[23704328;20195514];Thyrotoxic hypokalemic periodic paralysis[22399142;22863731];Waist-to-hip ratio adjusted for BMI[26426971];Hip circumference adjusted for BMI[25673412;25673412];Refractive error[23396134];Chin dimples[27182965];Obesity-related traits[23251661;23251661];Primary tooth development (number of teeth)[23704328;20195514];Waist-to-hip ratio adjusted for body mass index[28448500;28448500;28448500;25673412;25673412;25673412;25673412];Waist-to-hip ratio adjusted for BMI x sex x age interaction (4df test)[26426971];QT interval[19305409;24952745;24952745;24952745;24952745];Waist-to-hip ratio adjusted for BMI (adjusted for smoking behaviour)[28443625;28443625];Depressive episodes in bipolar disorder[26297903];Atrial fibrillation[29892015;29892015];Waist-to-hip ratio adjusted for BMI (joint analysis for main effect and physical activity interaction)[28448500;28448500;28448500;28448500;28448500];Spherical equivalent (joint analysis main effects and education interaction)[27020472;27020472];Response to bronchodilator in chronic obstructive pulmonary disease (change in FEV1)[26503814;26503814;26503814;26503814];Cardiac repolarization[22342860];Lung function (forced vital capacity)[24929828];Formal thought disorder in schizophrenia[22648509];Adolescent idiopathic scoliosis (severe)[24023777];,0.27975460122699386,0.6691593604951006,0.9454450535108326,0.9373848987108656
1848,13184,KCNJ5,600734,613485;613677;,"[MIM:613677]Hyperaldosteronism, familial, 3;",Familial hyperaldosteronism type III;Andersen-Tawil syndrome;Romano-Ward syndrome,Disease-causing germline mutation(s) (gain of function) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) (loss of function) in,Resting heart rate[27798624];Spherical equivalent or myopia (age of diagnosis)[29808027];Atrial fibrillation[28416818;30061737;29892015;29892015];,0.2947239263803681,0.3187209902011346,0.6959018533020099,0.7874462860650706
1849,13185,KCNJ6,600877,614098;,,Keppen-Lubinsky syndrome,Disease-causing germline mutation(s) in,Rosacea symptom severity[29771307];Electroencephalographic traits in alcoholism[22554406];,0.3168098159509202,0.8445074780814853,0.9522317932654659,0.9034683855125845
1850,13187,KCNJ8,600935,239850;272120;,[MIM:272120]Sudden infant death syndrome;[MIM:239850]Hypertrichotic osteochondrodysplasia;,"Hypertrichotic osteochondrodysplasia, Cantu type;Brugada syndrome",Disease-causing germline mutation(s) in;Major susceptibility factor in,,0.3168098159509202,0.7310469314079422,0.581832419733751,0.5902394106813996
1851,13189,KCNJ10,602208,612780;,,Pendred syndrome;EAST syndrome,Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in,,0.32380368098159507,0.5706549767921609,0.47585486818063166,0.8210558624923265
1852,13190,KCNJ11,600937,601820;606176;610582;616329;,"[MIM:601820]Familial hyperinsulinemic hypoglycemia 2;[MIM:606176]Diabetes mellitus, permanent neonatal;[MIM:610582]Transient neonatal diabetes mellitus 3;[MIM:616329]Maturity-onset diabetes of the young 13 [dominant?];",Autosomal dominant hyperinsulinism due to Kir6.2 deficiency;Diazoxide-resistant focal hyperinsulinism due to Kir6.2 deficiency;MODY;DEND syndrome;Autosomal recessive hyperinsulinism due to Kir6.2 deficiency;Intermediate DEND syndrome;Permanent neonatal diabetes mellitus;Transient neonatal diabetes mellitus,Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) (gain of function) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) (gain of function) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in,Type 2 diabetes[18372903;17463249;19056611;19056611;17463246;17463248;24509480;22885922;22885922;29358691;28869590;28869590];Systolic blood pressure[27618448];Body mass index[25673413;25673413;26426971;28892062];Pulse pressure[27618448];Systolic blood pressure x alcohol consumption interaction (2df test)[29912962];Social communication problems[24564958];Mean arterial pressure[27618448];,0.2947239263803681,0.5502836513666839,0.5458104933437745,0.9478207489257213
1853,13192,KCNJ13,603208,193230;614186;,[MIM:193230]Snowflake vitreoretinal degeneration;[MIM:614186]Leber congenital amaurosis 16;,Leber congenital amaurosis;Snowflake vitreoretinal degeneration,Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in,"Autism spectrum disorder or schizophrenia[28540026;28540026];Schizophrenia[23974872;25056061];Coronary artery disease[29212778];Coronary artery disease (myocardial infarction, percutaneous transluminal coronary angioplasty, coronary artery bypass grafting, angina or chromic ischemic heart disease)[28714975];",0.038773006134969326,0.4858174316658071,0.22683372487601147,0.8050951503990178
1854,13196,KCNJ18,613236,613239;,[MIM:613239]Thyrotoxic periodic paralysis 2;,Thyrotoxic periodic paralysis,Major susceptibility factor in,Body mass index[26426971];,0.038773006134969326,0.0,0.0,0.0
1855,13199,KCNK3,603220,615344;,,Heritable pulmonary arterial hypertension,Disease-causing germline mutation(s) (loss of function) in,Systolic blood pressure[29403010;27618452;28739976];Diastolic blood pressure (cigarette smoking interaction)[29455858];Stroke[29531354];Diastolic blood pressure[29403010;27618452;28739976];Hand grip strength[29691431];Diastolic blood pressure x alcohol consumption interaction (2df test)[29912962;29912962];Ischemic stroke[29531354];Mean arterial pressure[26390057;29403010];Systolic blood pressure x alcohol consumption (light vs heavy) interaction (2df test)[29912962];Systolic blood pressure (cigarette smoking interaction)[29455858];Diastolic blood pressure x alcohol consumption (light vs heavy) interaction (2df test)[29912962];Diverticular disease[30177863];Body mass index[25673413;25673413;25673413;28892062];Pulse pressure x alcohol consumption interaction (2df test)[29912962];Pulse pressure[29403010;28739976];Corneal astigmatism[29422769];Systolic blood pressure x alcohol consumption interaction (2df test)[29912962];Potassium levels[29403010];Mean arterial pressure x alcohol consumption (light vs heavy) interaction (2df test)[29912962];Mean arterial pressure x alcohol consumption interaction (2df test)[29912962;29912962];,0.38061349693251534,0.8584321815368747,0.9300443748368572,0.0
1856,13204,KCNK9,605874,612292;,,"Intellectual disability, Birk-Barel type",Disease-causing germline mutation(s) in,Adiponectin levels[21700879];Cerebrospinal T-tau levels[26252872];Response to lurasidone in schizophrenia[29730043;29730043];Visceral adipose tissue[26480920];Circulating phylloquinone levels[25411281];Urate levels in overweight individuals[25811787;25811787];Menarche (age at onset)[25231870];Cerebrospinal fluid t-tau:AB1-42 ratio[26252872];,0.20368098159509201,0.8963383187209902,0.9658052727747325,0.8724677716390423
1857,13213,KCNMA1,600150,609446;,"[MIM:609446]Paroxysmal nonkinesigenic dyskinesia, 3, with or without generalized epilepsy [dominant?];",Generalized epilepsy-paroxysmal dyskinesia syndrome,Disease-causing germline mutation(s) in,Obesity[21708048];Spherical equivalent or myopia (age of diagnosis)[29808027];Hypospadias[25108383];Myopia[27182965];Heel bone mineral density[28869591;28869591;28869591];Glucocorticoid-induced osteonecrosis[26265699];Mortality in heart failure[20400778];Educational attainment[25201988];Lumbar spine bone mineral density[29499414];Smoking cessation in chronic obstructive pulmonary disease[29631575];Response to ranibizumab in age-related macular degeneration (exudative)[30054556];Bone mineral density (spine)[26911590];Initial pursuit acceleration[29064472];Bone mineral density[22504420];Blood pressure[24954895;24954895];,0.6009815950920245,0.9868488911810211,0.5643435134429653,0.9340085942295887
1858,13226,KCNN4,602754,616689;,[MIM:616689]Dehydrated hereditary stomatocytosis 2 [dominant?];,Dehydrated hereditary stomatocytosis,Disease-causing germline mutation(s) in,Granulocyte percentage of myeloid white cells[27863252];Mean corpuscular hemoglobin concentration[27863252;29403010];Mean corpuscular volume[27863252;29403010];Breast cancer[23535729];Monocyte count[27863252];Monocyte percentage of white cells[27863252];Hemoglobin concentration[27863252];,0.4,0.6959773078906653,0.7434090315844427,0.7102516881522406
1859,13227,KCNQ1,607542,125853;192500;220400;607554;609621;,"[MIM:192500]Long QT syndrome 1;[MIM:220400]Jervell and Lange-Nielsen syndrome 1 [recessive?];[MIM:607554]Atrial fibrillation, familial, 3 [dominant?];[MIM:609621]Short QT syndrome 2;[MIM:125853]Diabetes mellitus, non-insulin-dependent;",Familial atrial fibrillation;Familial short QT syndrome;Jervell and Lange-Nielsen syndrome;Romano-Ward syndrome,Disease-causing germline mutation(s) (gain of function) in;Disease-causing germline mutation(s) (gain of function) in;Disease-causing germline mutation(s) (loss of function) in;Disease-causing germline mutation(s) (loss of function) in,Type 2 diabetes[21799836;18711367;18711366;19401414;24390345;21573907;24101674;20174558;20581827;24509480;22961080;23945395;26818947;26818947;28254843;28254843;28254843;28254843;25102180;25102180;25102180;22885922;22885922;22885922;28869590;28869590;28869590;28869590;28406950];QT interval[19305408;19305408;19305409;23166209;24952745;24952745;24952745;29213071;29213071];Glucose homeostasis traits[25524916];Waist circumference adjusted for BMI (joint analysis main effects and physical activity interaction)[28448500;28448500];Plasma amyloid beta peptide concentrations (ABx-40)[24535457];Glycated hemoglobin levels[28898252];Gout[25967671];Blood sugar levels[29403010];Platelet aggregation[20526338];Waist circumference adjusted for body mass index[28448500;28448500];Electrocardiographic traits[25055868;20062063];Hemoglobin A1c levels[29403010];Body mass index[24861553;28892062;28892062];Blood pressure measurement (high sodium intervention)[24165912;24165912];Glomerular filtration rate in non diabetics (creatinine)[26831199];Mosquito bite size[28199695];Height[20881960;25429064;25282103];Waist circumference adjusted for BMI in active individuals[28448500;28448500];Protein quantitative trait loci[18464913];Glomerular filtration rate (creatinine)[28452372];,0.403680981595092,0.4190304280556988,0.5987992691203341,0.9880294659300184
1860,13230,KCNQ1OT1,604115,,,Isolated hemihyperplasia;Beckwith-Wiedemann syndrome due to imprinting defect of 11p15,Disease-causing germline mutation(s) in;Role in the phenotype of,Plateletcrit[27863252];,0.038773006134969326,0.0,0.0,0.0
1861,13231,KCNQ2,602235,121200;613720;,"[MIM:121200]Seizures, benign familial neonatal 1;[MIM:613720]Epileptic encephalopathy, early infantile, 7 [dominant?];",Benign familial neonatal epilepsy;Benign familial neonatal-infantile seizures;Benign familial infantile epilepsy;KCNQ2-related epileptic encephalopathy,Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in,,0.16220858895705523,0.9782104177411036,0.5009135995823545,0.9904849600982197
1862,13232,KCNQ3,602232,121201;,"[MIM:121201]Seizures, benign familial neonatal 2;",Juvenile myoclonic epilepsy;Benign familial neonatal epilepsy;Benign familial infantile epilepsy,Major susceptibility factor in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in,QT interval[29213071];LDL peak particle diameter (total fat intake interaction)[26112879];Coronary artery calcification[23870195];,0.10711656441717791,0.8512119649303764,0.3662229182980945,0.8216697360343769
1863,13233,KCNQ4,603537,600101;,"[MIM:600101]Deafness, autosomal dominant, 2A [dominant?];",Autosomal dominant non-syndromic sensorineural deafness type DFNA,Disease-causing germline mutation(s) in,,0.20368098159509201,0.7859721505930892,0.3325502479770295,0.8956414978514426
1864,13234,KCNQ5,607357,617601;,"[MIM:617601]Mental retardation, autosomal dominant 46 [dominant?];",Autosomal dominant non-syndromic intellectual disability,Disease-causing germline mutation(s) in,Plasma proprotein convertase subtilisin/kexin type 9 levels in stable coronary artery disease[29748315];Spherical equivalent or myopia (age of diagnosis)[29808027];Myopia[27182965];HIV-1 viral setpoint[26039976];Spherical equivalent (joint analysis main effects and education interaction)[27020472;27020472];Upper eyelid sagging severity[24869959];Rosacea symptom severity[29771307];Lung function (FEV1/FVC)[28166213];Total body bone mineral density[30172743];Periodontitis[25672891];Western dietary pattern[28644415];Carotid plaque burden[28282560];Refractive error[23396134];,0.19190184049079756,0.629706034038164,0.5254502740798747,0.9648557397176182
1865,13241,KCNT1,608167,614959;615005;,"[MIM:614959]Epileptic encephalopathy, early infantile, 14;[MIM:615005]Epilepsy, nocturnal frontal lobe, 5 [dominant?];",Malignant migrating partial seizures of infancy;Autosomal dominant nocturnal frontal lobe epilepsy,Disease-causing germline mutation(s) (gain of function) in;Disease-causing germline mutation(s) in,,0.038773006134969326,0.2661165549252192,0.610806577916993,0.299109883364027
1866,13245,KCNV2,607604,610356;,[MIM:610356]Cone dystrophy retinal 3B;,Cone dystrophy with supernormal rod response,Disease-causing germline mutation(s) in,Vascular endothelial growth factor levels[21757650;26910538];Alzheimer's disease (age of onset)[22005931];Obesity-related traits[23251661];Blood trace element (Se levels)[23720494];,0.17791411042944785,0.015214027849406911,0.303054032889585,0.795426642111725
1867,13247,KCTD1,613420,181270;,[MIM:181270]Scalp-ear-nipple syndrome;,Scalp-ear-nipple syndrome,Disease-causing germline mutation(s) (loss of function) in,Sudden cardiac arrest[21658281];Itch intensity from mosquito bite adjusted by bite size[28199695];Paclitaxel disposition in epithelial ovarian cancer[29367611];,0.33226993865030674,0.8066013408973698,0.4745497259201253,0.8207489257213014
1868,13253,KCTD7,611725,611726;,"[MIM:611726]Epilepsy, progressive myoclonic 3, with or without intracellular inclusions [recessive?];",Progressive myoclonic epilepsy type 3,Disease-causing germline mutation(s) in,Aortic root size[21223598];Cotinine glucuronidation[25293881];,0.3856441717791411,0.37648272305312014,0.7833463847559384,0.2776243093922652
1869,13264,KCTD11,609848,,,REN-related autosomal dominant tubulointerstitial kidney disease;Renal tubular dysgenesis of genetic origin,Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in,Diastolic blood pressure x smoking status (current vs non-current) interaction (2df test)[29455858;29455858];Systolic blood pressure x smoking status (ever vs never) interaction (2df test)[29455858;29455858];Diastolic blood pressure x smoking status (ever vs never) interaction (2df test)[29455858;29455858];Systolic blood pressure x smoking status (current vs non-current) interaction (2df test)[29455858;29455858];,0.14576687116564419,0.3994326972666323,0.586530931871574,0.5624616329036218
1870,13270,KCTD17,616386,616398;,,Myoclonus-dystonia syndrome,Disease-causing germline mutation(s) in,Iron status biomarkers (ferritin levels)[28334935];Mean corpuscular hemoglobin concentration[28453575];Red blood cell traits[23222517];,0.5519018404907975,0.48427024239298605,0.36074132080396765,0.3953345610804174
1871,13282,KDF1,616758,617337;,"[MIM:617337]Ectodermal dysplasia 12, hypohidrotic/hair/tooth/nail type [dominant?];",Autosomal dominant hypohidrotic ectodermal dysplasia,Disease-causing germline mutation(s) in,C-reactive protein levels or HDL-cholesterol levels (pleiotropy)[27286809];,0.14576687116564419,0.555956678700361,0.0,0.0
1872,13283,KDM1A,609132,616728;,"[MIM:616728]Cleft palate, psychomotor retardation, and distinctive facial features;",Palatal anomalies-widely spaced teeth-facial dysmorphism-developmental delay syndrome,Disease-causing germline mutation(s) in,Global electrical heterogeneity phenotypes[29622589];Gamma glutamyl transferase levels[29403010];,0.9268711656441718,0.9605466735430634,0.8621769772905247,0.5044505831798649
1873,13297,KDM5B,605393,,,Autosomal dominant non-syndromic intellectual disability,Candidate gene tested in,,0.5284662576687117,0.057503867973182056,0.48707909162098667,0.6792510742786986
1874,13298,KDM5C,314690,300534;,"[MIM:300534]Mental retardation, X-linked, syndromic, Claes-Jensen type;",Syndromic X-linked intellectual disability due to JARID1C mutation,Disease-causing germline mutation(s) in,,0.5874846625766871,0.9868488911810211,0.8929783346384756,0.8578882750153468
1875,13302,KDM6A,300128,300867;,[MIM:300867]Kabuki syndrome 2;,Kabuki syndrome,Disease-causing germline mutation(s) in,,0.6604907975460123,0.9868488911810211,0.2892195249282172,0.6669736034376919
1876,13308,KDSR,136440,617526;,[MIM:617526]Erythrokeratodermia variabilis et progressiva 4;,Erythrokeratodermia variabilis;Progressive symmetric erythrokeratodermia,Disease-causing germline mutation(s) (loss of function) in;Disease-causing germline mutation(s) (loss of function) in,Pyoderma gangrenosum in inflammatory bowel disease[24487271];,0.28662576687116564,0.5505415162454874,0.8992430174889063,0.5329957028852057
1877,13309,KEAP1,606016,,,Familial multinodular goiter,Disease-causing germline mutation(s) in,"Inflammatory bowel disease[28067908];Chronic inflammatory diseases (ankylosing spondylitis, Crohn's disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy)[26974007];Crohn's disease[28067908];Body mass index and waist-hip ratio (pleiotropy)[29868124];",0.8316564417177914,0.40484785972150594,0.8368572174367006,0.5363720073664825
1878,13311,KERA,603288,217300;,"[MIM:217300]Cornea plana 2, autosomal recessive [recessive?];",Congenital cornea plana,Disease-causing germline mutation(s) (loss of function) in,Pulmonary function (smoking interaction)[23284291];Systolic blood pressure (alcohol consumption interaction)[24376456;24376456];,0.26588957055214724,0.16967509025270758,0.7870007830853563,0.2846838551258441
1879,13316,KHDC3L,611687,614293;,"[MIM:614293]Hydatidiform mole, recurrent, 2;",Partial hydatidiform mole;Complete hydatidiform mole,Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in,,0.038773006134969326,0.5693656523981434,0.368572174367006,0.0
1880,13322,KHK,614058,229800;,,Essential fructosuria,Disease-causing germline mutation(s) in,Self-reported risk-taking behaviour[30181555];,0.32380368098159507,0.10778751933986591,0.09318715740015662,0.31813996316758747
1881,13331,KIAA0319L,613535,,,Systemic lupus erythematosus;Limited cutaneous systemic sclerosis,Major susceptibility factor in;Major susceptibility factor in,Systemic lupus erythematosus and Systemic sclerosis[23740937];,0.8996319018404908,0.3084063950489943,0.5758287653354216,0.18063228974831186
1882,13336,KIAA0556,616650,616784;,[MIM:616784]Joubert syndrome 26 [recessive?];,Joubert syndrome,Disease-causing germline mutation(s) (loss of function) in,Pursuit maintenance gain[29064472];,0.5009815950920246,0.20216606498194944,0.22500652571130253,0.0678330263965623
1883,13337,KIAA0586,610178,616490;616546;,[MIM:616490]Joubert syndrome 23;[MIM:616546]Short-rib thoracic dysplasia 14 with polydactyly [recessive?];,Joubert syndrome;Joubert syndrome with Jeune asphyxiating thoracic dystrophy,Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) (loss of function) in,,0.5850306748466257,0.07607013924703455,0.3150613416862438,0.022866789441375077
1884,13338,KIAA0753,617112,617127;,[MIM:617127]Orofaciodigital syndrome 15 [recessive?];,Orofaciodigital syndrome type 6,Disease-causing germline mutation(s) in,Pulse pressure[28135244];Familial lung cancer[29924316];,0.9445398773006135,0.12093862815884476,0.020882276168102322,0.29496623695518726
1885,13359,KIAA1549,613344,,,Retinitis pigmentosa;Pilomyxoid astrocytoma,Disease-causing germline mutation(s) in;Part of a fusion gene in,,0.6803680981595092,0.9471376998452811,0.01357347950926651,0.3632596685082873
1886,13373,KIDINS220,615759,617296;,"[MIM:617296]Spastic paraplegia, intellectual disability, nystagmus, and obesity [dominant?];",Spastic paraplegia-intellectual disability-nystagmus-obesity syndrome,Disease-causing germline mutation(s) in,Alcoholic chronic pancreatitis[28754779];Neutrophil count[21507922];,0.9240490797546013,0.9236719958741619,0.14356564865570348,0.26534683855125846
1887,13374,KIF1A,601255,610357;614213;614255;,"[MIM:614213]Neuropathy, hereditary sensory, 2C;[MIM:614255]Mental retardation, autosomal dominant 9 [dominant?];",Autosomal dominant non-syndromic intellectual disability;Hereditary sensory and autonomic neuropathy type 2;PEHO syndrome;Autosomal spastic paraplegia type 30,Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) (loss of function) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in,,0.8485889570552148,1.0,0.6162881754111198,0.4114487415592388
1888,13375,KIF1B,605995,118210;171300;256700;,[MIM:256700]Neuroblastoma 1;[MIM:171300]Pheochromocytoma;,Hereditary pheochromocytoma-paraganglioma;Autosomal dominant Charcot-Marie-Tooth disease type 2A1,Disease-causing germline mutation(s) (loss of function) in;Disease-causing germline mutation(s) (loss of function) in,Mean platelet volume[22139419;27863252];Virologic severity in Herpes simplex virus type 2 infection[29535370];Multiple sclerosis[18997785];Waist circumference adjusted for BMI in non-smokers[28443625];Waist circumference adjusted for BMI (joint analysis main effects and smoking interaction)[28443625];Hematocrit[27863252];Hand grip strength[29691431];Hepatocellular carcinoma[20676096];Waist circumference adjusted for BMI (adjusted for smoking behaviour)[28443625];Hepatitis B virus-related hepatocellular carcinoma[29246937];,0.778282208588957,0.8076328004125838,0.31923779691986426,0.6445672191528545
1889,13376,KIF1BP,609367,609460;,,Goldberg-Shprintzen megacolon syndrome,Disease-causing germline mutation(s) (loss of function) in,,0.8407361963190184,0.55440948942754,0.0,0.0
1890,13377,KIF1C,603060,611302;,"[MIM:611302]Spastic ataxia 2, autosomal recessive [recessive?];",Autosomal spastic paraplegia type 58,Disease-causing germline mutation(s) (loss of function) in,,0.7666257668711657,0.649561629706034,0.4027669015922736,0.6069674647022714
1891,13388,KIF5A,602821,604187;617235;617921;,"[MIM:604187]Spastic paraplegia 10, autosomal dominant [dominant?];[MIM:617235]Myoclonus, intractable, neonatal [dominant?];[MIM:617921]Amyotrophic lateral sclerosis 25 [dominant?];",Autosomal dominant Charcot-Marie-Tooth disease type 2 due to KIF5A mutation;Autosomal dominant spastic paraplegia type 10,Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in,Rheumatoid arthritis[18794853;24449572];Amyotrophic lateral sclerosis[29566793];,0.8584049079754601,0.9761474987106756,0.6914643696162882,0.7969613259668509
1892,13392,KIF7,611254,200990;209900;607131;614120;,[MIM:209900]Bardet-Biedl syndrome [recessive?];[MIM:614120]Hydrolethalus syndrome 2;[MIM:200990]Acrocallosal syndrome [recessive?];[MIM:200990]Joubert syndrome 12;[MIM:607131]Al-Gazali-Bakalinova syndrome [recessive?];,"Multiple epiphyseal dysplasia, Al-Gazali type;Acrocallosal syndrome;Hydrolethalus;Orofaciodigital syndrome type 6",Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in,Cobalt levels[26025379];,0.894478527607362,0.026560082516761216,0.015661707126076743,0.16451810926949048
1893,13395,KIF11,148760,152950;,"[MIM:152950]Microcephaly with or without chorioretinopathy, lymphedema, or mental retardation [dominant?];",Microcephaly-lymphedema-chorioretinopathy syndrome,Disease-causing germline mutation(s) in,Type 2 diabetes[21490949];Inflammatory bowel disease[28067908];Intraocular pressure[30054594;29785010];,0.6992638036809816,1.0,0.6269903419472722,0.9315531000613874
1894,13399,KIF14,611279,616258;617914;,"[MIM:616258]Meckel syndrome 12;[MIM:617914]Microcephaly 20, primary, autosomal recessive [recessive?];",Autosomal recessive primary microcephaly;Lethal fetal cerebrorenogenitourinary agenesis/hypoplasia syndrome,Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) (loss of function) in,Tandem gait[26219847];,0.9376687116564417,0.2833935018050541,0.4466196815452884,0.1652854511970534
1895,13400,KIF15,617569,,,21q22.11q22.12 microdeletion syndrome,Disease-causing germline mutation(s) (loss of function) in,Bone mineral density (hip)[30172743];Acne (severe)[24927181];Severe influenza A (H1N1) infection[26379185];,0.4710429447852761,0.07246003094378546,0.30827460193161055,0.05632289748311848
1896,13407,KIF20A,605664,,,Familial isolated restrictive cardiomyopathy,Disease-causing germline mutation(s) (loss of function) in,Autism spectrum disorder or schizophrenia[28540026];,0.5561963190184049,0.4517792676637442,0.549203863221091,0.08578882750153469
1897,13409,KIF21A,608283,135700;,"[MIM:135700]Fibrosis of extraocular muscles, congenital, 1;",Congenital fibrosis of extraocular muscles,Disease-causing germline mutation(s) in,,0.5980368098159509,0.2145435791645178,0.32967893500391543,0.11295273173726213
1898,13411,KIF22,603213,603546;,"[MIM:603546]Spondyloepimetaphyseal dysplasia with joint laxity, 2;",Spondyloepimetaphyseal dysplasia with multiple dislocations,Disease-causing germline mutation(s) in,Red blood cell traits[23222517];,0.7661349693251533,0.315368746776689,0.49960845732184805,0.15408225905463474
1899,13412,KIF23,605064,,,Congenital dyserythropoietic anemia type III,Disease-causing germline mutation(s) in,Rheumatoid arthritis (ACPA-positive)[24532676];,0.8300613496932515,0.9216090768437338,0.40903158444270427,0.3660220994475138
1900,13447,KIRREL3,607761,,,Autosomal dominant non-syndromic intellectual disability,Disease-causing germline mutation(s) in,Response to antipsychotic treatment[20195266];Breast size[22747683];Hippocampal sclerosis[25188341];Attention deficit hyperactivity disorder and conduct disorder[18951430];Menarche (age at onset)[23667675];Hepcidin/ferritin ratio[27846281];Protein quantitative trait loci[18464913];,0.08736196319018405,0.9417225373904075,0.49543200208822763,0.7120933087783916
1901,13451,KISS1,603286,614842;,[MIM:614842]Hypogonadotropic hypogonadism 13 with or without anosmia;,Normosmic congenital hypogonadotropic hypogonadism,Disease-causing germline mutation(s) (loss of function) in,Psychosis proneness (hypomanic personality scale and perceptual aberration scale)[28525603];Psychosis proneness (hypomanic personality scale and revised social anhedonia scale)[28525603];Psychosis proneness (hypomanic personality scale and revised physical anhedonia scale)[28525603];Psychosis proneness (hypomanic personality scale)[28525603];,0.17791411042944785,0.7230531201650335,0.1145914904724615,0.0
1902,13452,KISS1R,604161,176400;614837;,"[MIM:614837]Hypogonadotropic hypogonadism 8 with or without anosmia;[MIM:176400]Precocious puberty, central 1;",Idiopathic central precocious puberty;Kallmann syndrome;Normosmic congenital hypogonadotropic hypogonadism,Candidate gene tested in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) (loss of function) in,Menopause (age at onset)[26414677];,0.10711656441717791,0.7653429602888087,0.6081962933959801,0.0
1903,13453,KIT,164920,172800;273300;601626;606764;,"[MIM:172800]Piebald trait;[MIM:606764]Gastrointestinal stromal tumor;[MIM:273300]Testicular germ cell tumor;[MIM:601626]Leukemia, acute myelogenous;",Classic mast cell leukemia;Aleukemic mast cell leukemia;Plaque-form urticaria pigmentosa;Typical urticaria pigmentosa;Lymphoadenopathic mastocytosis with eosinophilia;Isolated bone marrow mastocytosis;Smouldering systemic mastocytosis;Nodular urticaria pigmentosa;Piebaldism;Testicular seminomatous germ cell tumor;Bullous diffuse cutaneous mastocytosis;Pseudoxanthomatous diffuse cutaneous mastocytosis;Gastrointestinal stromal tumor;Gastrointestinal stromal tumor;Telangiectasia macularis eruptiva perstans;Cutaneous mastocytoma;Acute myeloblastic leukemia with maturation;Acute myeloid leukemia with abnormal bone marrow eosinophils inv(16)(p13q22) or t(16;16)(p13;q22);Systemic mastocytosis with an associated clonal hematologic non-mast cell lineage disease;Acute myeloid leukemia with t(8;21)(q22;q22) translocation,Disease-causing somatic mutation(s) in;Disease-causing somatic mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing somatic mutation(s) in;Disease-causing somatic mutation(s) in;Disease-causing somatic mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) (loss of function) in;Disease-causing somatic mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing somatic mutation(s) in;Disease-causing germline mutation(s) (gain of function) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing somatic mutation(s) in;Biomarker tested in;Disease-causing somatic mutation(s) in;Biomarker tested in,Cadmium levels[26025379];Breastfeeding duration[25475840];Mean corpuscular volume[19862010;20139978;28453575;28017375;29403010];Mean corpuscular hemoglobin[28017375;28453575;29403010];Hematocrit[28017375;29403010];Schizophrenia[26198764];Bipolar disorder[19416921];Red blood cell count[28453575;28017375;28017375;29403010];Systemic lupus erythematosus[29494758];Serum VEGFR2 concentration[25411163];Red blood cell traits[23222517];Hemoglobin levels[28017375];Hemoglobin[29403010];Anorexia nervosa or obsessive-compulsive disorder[30087453];Platelet count[29403010];,0.5719018404907975,0.9283135636926251,0.5118767945706082,0.9920196439533456
1904,13454,KITLG,184745,145250;611664;616697;,"[MIM:145250]Hyperpigmentation with or without hypopigmentation, familial progressive;[MIM:616697]Deafness, congenital, unilateral or asymmetric [dominant?];",Waardenburg syndrome type 2;Non-seminomatous germ cell tumor of testis;Familial progressive hyper- and hypopigmentation;Familial progressive hyperpigmentation;Autosomal dominant non-syndromic sensorineural deafness type DFNA,Disease-causing germline mutation(s) in;Major susceptibility factor in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) (gain of function) in;Disease-causing germline mutation(s) in,Light vs. dark hair color[26184321];Blond vs. brown hair color[17952075];Red blood cell traits[23222517];Testicular germ cell cancer[20543847];Brown vs. non-brown hair color[26184321];Hair color[23548203;29662168];Testicular germ cell tumor[19483681;19483681;23666239;23666240;28604732;28604728];Testicular cancer[19483682];Blond vs non-blond hair color[26184321];,0.40773006134969325,0.6864363073749356,0.7687287914382668,0.31077348066298344
1905,13455,KIZ,615757,615780;,[MIM:615780]Retinitis pigmentosa 69;,Retinitis pigmentosa,Disease-causing germline mutation(s) (loss of function) in,Height[25282103];Lupus nephritis in systemic lupus erythematosus[24925725];,0.7796319018404908,0.0,0.0,0.0
1906,13457,KL,604824,617994;,"[MIM:617994]Tumoral calcinosis, hyperphosphatemic, familial, 3 [recessive?];",Familial hyperphosphatemic tumoral calcinosis/Hyperphosphatemic hyperostosis syndrome,Disease-causing germline mutation(s) (loss of function) in,Type 2 diabetes[28869590;28869590];Multiple sclerosis[24076602];,0.17791411042944785,0.5649819494584838,0.12503262855651265,0.21731123388581952
1907,13460,KLC2,611729,609541;,"[MIM:609541]Spastic paraplegia, optic atrophy, and neuropathy [recessive?];",Spastic paraplegia-optic atrophy-neuropathy syndrome,Disease-causing germline mutation(s) (gain of function) in,Bipolar disorder[21926972];,0.78920245398773,0.7635379061371841,0.21978595666927694,0.4594843462246777
1908,13463,KLF1,600599,111150;613566;613673;,"[MIM:613673]Anemia, congenital dyserythropoietic, 4;",Hereditary persistence of fetal hemoglobin-sickle cell disease syndrome;Congenital dyserythropoietic anemia type IV;Hereditary persistence of fetal hemoglobin-beta-thalassemia syndrome,Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in,Mean corpuscular hemoglobin concentration[27863252];Mean corpuscular hemoglobin[27863252];Reticulocyte fraction of red cells[27863252];Mean corpuscular volume[27863252;29403010];Reticulocyte count[27863252];Clozapine-induced agranulocytosis[25187353];Red blood cell count[27863252];,0.28662576687116564,0.4326972666322847,0.17045157922213522,0.0
1909,13484,KLF11,603301,606391;610508;,[MIM:610508]Maturity-onset diabetes of the young 7 [dominant?];,MODY,Disease-causing germline mutation(s) in,Prostate cancer[23535732];,0.28662576687116564,0.15729757607013925,0.422866092404072,0.14303253529772866
1910,13501,KLHDC8B,613169,236000;,"[MIM:236000]Lymphoma, Hodgkin, classic;","Classic Hodgkin lymphoma, nodular sclerosis type",Candidate gene tested in,Inflammatory bowel disease[28067908];Resting heart rate[27798624];Crohn's disease[28067908];Menarche (age at onset)[21102462];Blood protein levels[28240269];Ulcerative colitis[28067908];,0.10711656441717791,0.3623001547189273,0.891412163925868,0.37952731737262124
1911,13507,KLHL3,605775,614495;,[MIM:614495]Pseudohypoaldosteronism 2D [dominant?];,Pseudohypoaldosteronism type 2D,Disease-causing germline mutation(s) in,Severe malaria[29381699];Bronchopulmonary dysplasia[23897914];Severe malaria (adjusted for sickle cell variant rs334)[29381699];,0.3449079754601227,0.3720990201134605,0.793265465935787,0.6527010435850215
1912,13512,KLHL7,611119,612943;617055;,[MIM:612943]Retinitis pigmentosa 42;,Retinitis pigmentosa;Cold-induced sweating syndrome;Bohring-Opitz syndrome,Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) (loss of function) in;Disease-causing germline mutation(s) in,Parkinson's disease[27182965;28892059];Chronic obstructive pulmonary disease[25584925];Blood protein levels[28240269];,0.6019631901840491,0.5786487880350696,0.896110676063691,0.25076734192756295
1913,13515,KLHL9,611201,,,KLHL9-related early-onset distal myopathy,Disease-causing germline mutation(s) in,,0.647361963190184,0.7893243940175348,0.6481336465674759,0.4349294045426642
1914,13516,KLHL10,608778,615081;,[MIM:615081]Spermatogenic failure 11;,Male infertility with azoospermia or oligozoospermia due to single gene mutation,Disease-causing germline mutation(s) in,Reticulocyte fraction of red cells[27863252];Reticulocyte count[27863252];,0.3925153374233129,0.7699845281072718,0.6846776298616549,0.5131982811540823
1915,13528,KLHL24,611295,617294;,"[MIM:617294]Epidermolysis bullosa simplex, generalized, with scarring and hair loss [dominant?];","Generalized basal epidermolysis bullosa simplex with skin atrophy, scarring and hair loss",Disease-causing germline mutation(s) in,,0.5326380368098159,0.44223826714801445,0.3116679718089272,0.4495089011663597
1916,13542,KLHL40,615340,615348;,,Severe congenital nemaline myopathy,Disease-causing germline mutation(s) (loss of function) in,Alanine aminotransferase (ALT) levels after remission induction therapy in actute lymphoblastic leukemia (ALL)[28090653];,0.4190184049079755,0.2111913357400722,0.4795092665100496,0.0
1917,13543,KLHL41,607701,615731;,[MIM:615731]Nemaline myopathy 9 [recessive?];,Severe congenital nemaline myopathy;Intermediate nemaline myopathy;Typical nemaline myopathy;Childhood-onset nemaline myopathy,Disease-causing germline mutation(s) (loss of function) in;Disease-causing germline mutation(s) (loss of function) in;Disease-causing germline mutation(s) (loss of function) in;Disease-causing germline mutation(s) (loss of function) in,,0.5811042944785276,0.2802991232594121,0.5651265987992691,0.0
1918,13548,KLK4,603767,204700;,"[MIM:204700]Amelogenesis imperfecta, hypomaturation type, 2A1;",Hypomaturation amelogenesis imperfecta,Disease-causing germline mutation(s) in,Celiac disease[23936387];Obesity-related traits[23251661];,0.14576687116564419,0.30685920577617326,0.4207778647872618,0.5902394106813996
1919,13560,KLKB1,229000,612423;,[MIM:612423]Prekallikrein deficiency;,Congenital prekallikrein deficiency,Disease-causing germline mutation(s) in,L-arginine levels[27656708];Serum metabolite levels[24625756;24625756;23093944];B-type natriuretic peptide levels[25561047];Blood metabolite levels[24816252;24816252];Response to statin therapy[20339536];Blood protein levels[28240269;28240269;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;30072576;30072576;30072576;30072576;30072576;30072576;30072576;30072576;30072576;30072576;30072576;30072576;30072576;30072576];Circulating vasoactive peptide levels[23381795;23381795];Plasma renin activity levels[25477429];Metabolite levels (small molecules and protein measures)[27005778];Metabolite levels[22286219;22916037];Obesity-related traits[23251661];Apolipoprotein A-IV levels[27412012];Metabolic traits[21886157];Circulating chromogranin peptide levels[28011710;28011710];,0.28662576687116564,0.07968024755028365,0.0,0.6981276856967464
1920,13562,KLLN,612105,615107;,[MIM:615107]Cowden syndrome 4;,Cowden syndrome;Hereditary breast cancer,Disease-causing germline mutation(s) in;Major susceptibility factor in,Psoriasis[28537254];,0.038773006134969326,0.4004641567818463,0.6115896632732968,0.0
1921,13568,KLRC4,602893,,,Beh�et disease,Major susceptibility factor in,Psoriasis[28537254];Behcet's disease[23291587];Blood protein levels[28240269];,0.26588957055214724,0.4130995358432182,0.998172800835291,0.17587476979742173
1922,13578,KMT2A,159555,605130;,[MIM:605130]Wiedemann-Steiner syndrome;,Cornelia de Lange syndrome;Wiedemann-Steiner syndrome;Acute myeloid leukemia with t(9;11)(p22;q23);Mixed phenotype acute leukemia;Acute undifferentiated leukemia;Acute myeloid leukemia with 11q23 abnormalities;Precursor B-cell acute lymphoblastic leukemia,Candidate gene tested in;Disease-causing germline mutation(s) in;Part of a fusion gene in;Part of a fusion gene in;Part of a fusion gene in;Role in the phenotype of;Part of a fusion gene in,,0.7866257668711657,1.0,0.39911250326285563,0.0
1923,13580,KMT2C,606833,617768;,[MIM:617768]Kleefstra syndrome 2 [dominant?];,Kleefstra syndrome due to a point mutation,Disease-causing germline mutation(s) (loss of function) in,Kidney function decline traits[25493955];,0.6687116564417178,0.8024755028365137,0.017227877838684416,0.0
1924,13581,KMT2D,602113,147920;,[MIM:147920]Kabuki syndrome 1;,Kabuki syndrome,Disease-causing germline mutation(s) in,Intelligence (MTAG)[29326435];General cognitive ability[29844566];,0.689079754601227,0.8323878287777204,0.23205429391803706,0.0
1925,13589,KNG1,612358,228960;,[MIM:228960]High molecular weight kininogen deficiency;,Congenital high-molecular-weight kininogen deficiency,Disease-causing germline mutation(s) in,Factor XI[28053049];Plasma renin activity levels[25477429];Activated partial thromboplastin time[22703881;20303064;29403010];Adiponectin levels[20876611];Small vessel stroke[29123153];Blood metabolite levels[24816252];Neuropathic pain in head and neck cancer[29884837];Blood protein levels[28240269;28240269;28240269;28240269;28240269;28240269;29875488;29875488;29875488;29875488;30072576;30072576;30072576;30072576;30072576;30072576;30072576;30072576;30072576;30072576;30072576;30072576;30072576;30072576;30072576;30072576;30072576;30072576;30072576;30072576;30072576;30072576;30072576];Thrombosis[26908601];Glomerular filtration rate[29403010];,0.4538650306748466,0.24935533780299124,0.105716523101018,0.06629834254143646
1926,13590,KNL1,609173,604321;,"[MIM:604321]Microcephaly 4, primary, autosomal recessive [recessive?];",Autosomal recessive primary microcephaly,Disease-causing germline mutation(s) in,Prostate cancer[29892016];,0.7884662576687117,0.832645693656524,0.0,0.0
1927,13597,KNSTRN,614718,,,Combined immunodeficiency with faciooculoskeletal anomalies,Disease-causing germline mutation(s) in,Heschl's gyrus morphology[25130324];,0.7760736196319018,0.259927797833935,0.3158444270425476,0.0
1928,13607,KPNA6,610563,,,Partial corpus callosum agenesis-cerebellar vermis hypoplasia with posterior fossa cysts syndrome,Disease-causing germline mutation(s) in,Body mass index[26426971];,0.8348466257668712,0.9637699845281072,0.9052466718872357,0.7067219152854513
1929,13608,KPNA7,614107,,,Partial corpus callosum agenesis-cerebellar vermis hypoplasia with posterior fossa cysts syndrome,Disease-causing germline mutation(s) in,Inflammatory bowel disease[28067908];Facial emotion recognition (sad faces)[28608620];Ulcerative colitis[20228798;28067908];,0.12711656441717792,0.06859205776173286,0.6029757243539546,0.0
1930,13611,KPTN,615620,615637;,"[MIM:615637]Mental retardation, autosomal recessive 41 [recessive?];",Macrocephaly-developmental delay syndrome,Disease-causing germline mutation(s) (loss of function) in,,0.4226993865030675,0.7199587416193914,0.6734534064212999,0.40914671577655004
1931,13612,KRAS,190070,601626;607785;609942;613659;615278;,"[MIM:601626]Leukemia, acute myelogenous;[MIM:607785]Leukemia, juvenile myelomonocytic;[MIM:609942]Noonan syndrome 3;[MIM:613659]Gastric cancer;[MIM:615278]Cardiofaciocutaneous syndrome 2;",Noonan syndrome;Linear nevus sebaceus syndrome;Differentiated thyroid carcinoma;Cardiofaciocutaneous syndrome;Encephalocraniocutaneous lipomatosis;Pilomyxoid astrocytoma;RAS-associated autoimmune leukoproliferative disease;Toriello-Lacassie-Droste syndrome;Lynch syndrome;Familial pancreatic carcinoma;Selection of therapeutic option in non-small cell lung carcinoma;Selection of therapeutic option in colorectal cancer;Juvenile myelomonocytic leukemia,Disease-causing germline mutation(s) in;Disease-causing somatic mutation(s) in;Disease-causing somatic mutation(s) in;Disease-causing germline mutation(s) (gain of function) in;Candidate gene tested in;Disease-causing somatic mutation(s) in;Disease-causing somatic mutation(s) in;Disease-causing somatic mutation(s) in;Biomarker tested in;Major susceptibility factor in;Biomarker tested in;Biomarker tested in;Disease-causing somatic mutation(s) in,Disease progression in age-related macular degeneration[29346644];Dysmenorrheic pain[27454463];,0.607239263803681,0.7968024755028366,0.9830331506134169,0.6626764886433395
1932,13623,KRIT1,604214,116860;,[MIM:116860]Cerebral cavernous malformations 1;,Familial cerebral cavernous malformation,Disease-causing germline mutation(s) (loss of function) in,,0.3669938650306748,0.6083032490974729,0.7374053771861133,0.12093308778391651
1933,13626,KRT1,139350,113800;146590;600962;607602;607654;,"[MIM:113800]Epidermolytic hyperkeratosis [dominant?];[MIM:146590]Ichthyosis hystrix, Curth-Macklin type;[MIM:600962]Keratoderma, palmoplantar, non-epidermolytic;[MIM:607602]Ichthyosis annular epidermolytic;[MIM:607654]Keratoderma, palmoplantar, striate 3;",Autosomal dominant epidermolytic ichthyosis;Epidermolytic palmoplantar keratoderma;Congenital reticular ichthyosiform erythroderma;Annular epidermolytic ichthyosis;Striate palmoplantar keratoderma;Ichthyosis hystrix of Curth-Macklin,Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) (gain of function) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in,,0.8240490797546012,0.7774626095925735,0.06186374314800313,0.8715469613259669
1934,13627,KRT2,600194,146800;,[MIM:146800]Ichthyosis bullosa of Siemens [dominant?];,Superficial epidermolytic ichthyosis,Disease-causing germline mutation(s) in,,0.5395092024539877,0.40536358947911294,0.13286348211955104,0.808317986494782
1935,13628,KRT3,148043,122100;,,Meesmann corneal dystrophy,Disease-causing germline mutation(s) in,,0.5353374233128835,0.13383187209902012,0.025580788305925344,0.6947513812154696
1936,13629,KRT4,123940,193900;,[MIM:193900]White sponge nevus 1;,White sponge nevus,Disease-causing germline mutation(s) in,,0.7294478527607362,0.11397627643115008,0.09449229966066301,0.5796500920810314
1937,13630,KRT5,148040,131760;131800;131900;131960;179850;601001;609352;,"[MIM:601001]Epidermolysis bullosa simplex, autosomal recessive 1 [recessive?];[MIM:131760]Epidermolysis bullosa simplex, Dowling-Meara type;[MIM:609352]Epidermolysis bullosa simplex, with migratory circinate erythema;[MIM:131800]Epidermolysis bullosa simplex, Weber-Cockayne type;[MIM:131900]Epidermolysis bullosa simplex, Koebner type;[MIM:131960]Epidermolysis bullosa simplex, with mottled pigmentation;[MIM:179850]Dowling-Degos disease 1 [dominant?];","Epidermolysis bullosa simplex with circinate migratory erythema;Dowling-Degos disease;Epidermolysis bullosa simplex, generalized severe;Epidermolysis bullosa simplex with mottled pigmentation;Epidermolysis bullosa simplex, generalized intermediate;Localized epidermolysis bullosa simplex",Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) (loss of function) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in,Basal cell carcinoma[24403052;27539887;25855136];Non-melanoma skin cancer[29739929];,0.703558282208589,0.6090768437338835,0.17488906290785697,0.9040822590546348
1938,13631,KRT6A,148041,615726;,,Pachyonychia congenita,Disease-causing germline mutation(s) in,,0.6683435582822086,0.27514182568334195,0.11667971808927173,0.9349294045426643
1939,13632,KRT6B,148042,615728;,,Pachyonychia congenita,Disease-causing germline mutation(s) in,,0.7602453987730061,0.11449200618875709,0.36413469068128423,0.7763965623081646
1940,13633,KRT6C,612315,615735;,,Autosomal dominant focal non-epidermolytic palmoplantar keratoderma with plantar blistering,Disease-causing germline mutation(s) in,,0.5719018404907975,0.022692109334708613,0.014878621769772905,0.5477286678944138
1941,13688,KRT9,607606,144200;149100;,"[MIM:144200]Keratoderma, palmoplantar, epidermolytic;",Epidermolytic palmoplantar keratoderma,Disease-causing germline mutation(s) in,,0.7737423312883436,0.36075296544610624,0.6410858783607413,0.7783916513198281
1942,13689,KRT10,148080,113800;607602;609165;,"[MIM:113800]Epidermolytic hyperkeratosis [dominant?];[MIM:607602]Ichthyosis annular epidermolytic;[MIM:609165]Erythroderma, ichthyosiform, congenital reticular;",Autosomal dominant epidermolytic ichthyosis;Congenital reticular ichthyosiform erythroderma;Annular epidermolytic ichthyosis;Autosomal recessive epidermolytic ichthyosis,Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in,Glucose homeostasis traits[25524916];,0.7412269938650307,0.38215575038679733,0.2464108587836074,0.8167587476979742
1943,13690,KRT12,601687,122100;,,Meesmann corneal dystrophy,Disease-causing germline mutation(s) in,,0.12711656441717792,0.062403300670448685,0.3161054554946489,0.6527010435850215
1944,13691,KRT13,148065,615785;,[MIM:615785]White sponge nevus 2;,White sponge nevus,Disease-causing germline mutation(s) in,,0.6622085889570553,0.39736977823620423,0.5925345862699034,0.8637200736648251
1945,13692,KRT14,148066,125595;131760;131800;131900;161000;601001;,"[MIM:131760]Epidermolysis bullosa simplex, Dowling-Meara type;[MIM:131800]Epidermolysis bullosa simplex, Weber-Cockayne type;[MIM:131900]Epidermolysis bullosa simplex, Koebner type;[MIM:601001]Epidermolysis bullosa simplex, autosomal recessive 1 [recessive?];[MIM:161000]Naegeli-Franceschetti-Jadassohn syndrome [dominant?];[MIM:125595]Dermatopathia pigmentosa reticularis;","Naegeli-Franceschetti-Jadassohn syndrome;Dermatopathia pigmentosa reticularis;Epidermolysis bullosa simplex, autosomal recessive K14;Epidermolysis bullosa simplex, generalized severe;Epidermolysis bullosa simplex with mottled pigmentation;Epidermolysis bullosa simplex, generalized intermediate;Localized epidermolysis bullosa simplex",Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in,,0.7447852760736197,0.29757607013924703,0.13234142521534847,0.879987722529159
1946,13694,KRT16,148067,167200;613000;,"[MIM:167200]Pachyonychia congenita 1 [dominant?];[MIM:613000]Keratoderma, palmoplantar, non-epidermolytic, focal 1;",Epidermolytic palmoplantar keratoderma;Pachyonychia congenita;Isolated focal non-epidermolytic palmoplantar keratoderma,Candidate gene tested in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in,,0.750920245398773,0.24987106756059824,0.41686243800574263,0.7599754450583179
1947,13701,KRT17,148069,167210;184500;,[MIM:167210]Pachyonychia congenita 2 [dominant?];[MIM:184500]Steatocystoma multiplex;,Pachyonychia congenita;Sebocystomatosis,Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in,,0.741717791411043,0.37364620938628157,0.3137561994257374,0.6617556783302639
1948,13788,KRT25,616646,616760;,,Woolly hair,Disease-causing germline mutation(s) in,Cognitive decline rate in late mild cognitive impairment[26252872;26252872];,0.32380368098159507,0.129706034038164,0.1657530670843122,0.5738182934315531
1949,13806,KRT71,608245,615896;,[MIM:615896]Hypotrichosis 13;,Woolly hair,Disease-causing germline mutation(s) in,,0.33975460122699386,0.19082001031459514,0.02427564604541895,0.6431860036832413
1950,13810,KRT74,608248,194300;613981;614929;,"[MIM:613981]Hypotrichosis 3;[MIM:614929]Ectodermal dysplasia 7, hair/nail type;",Woolly hair;Pure hair and nail ectodermal dysplasia;Hypotrichosis simplex of the scalp,Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) (loss of function) in;Disease-causing germline mutation(s) in,,0.27361963190184047,0.05363589479112945,0.04933437744714174,0.7166973603437692
1951,13817,KRT81,602153,158000;,,Monilethrix,Disease-causing germline mutation(s) in,Diisocyanate-induced asthma[25918132];,0.45680981595092024,0.0368746776689015,0.11720177499347428,0.0
1952,13819,KRT83,602765,158000;617756;,[MIM:617756]Erythrokeratodermia variabilis et progressiva 5 [recessive?];,Monilethrix;Progressive symmetric erythrokeratodermia,Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) (loss of function) in,,0.4331288343558282,0.06111397627643115,0.08091882015139651,0.5320748925721301
1953,13821,KRT85,602767,602032;,,Pure hair and nail ectodermal dysplasia,Disease-causing germline mutation(s) in,Acute lymphoblastic leukemia (childhood)[19684603];,0.6547239263803681,0.2821041774110366,0.35630383711824587,0.6565377532228361
1954,13822,KRT86,601928,158000;,,Monilethrix,Disease-causing germline mutation(s) in,Plasma amyloid beta peptide concentrations (ABx-42)[24535457];Diisocyanate-induced asthma[25918132];,0.6089570552147239,0.6211964930376482,0.43643957191333854,0.0
1955,13959,KY,605739,617114;,,Kyphosis-lateral tongue atrophy-myofibrillar myopathy syndrome;Kyphoscoliosis-lateral tongue atrophy-hereditary spastic paraplegia syndrome,Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in,Neurocognitive impairment in HIV-1 infection (dichotomous)[28447399];,0.12711656441717792,0.1111397627643115,0.7838684416601409,0.36464088397790057
1956,13962,KYNU,605197,236800;617661;,"[MIM:236800]Hydroxykynureninuria;[MIM:617661]Vertebral, cardiac, renal, and limb defects syndrome 2 [recessive?];",Hydroxykynureninuria;Congenital vertebral-cardiac-renal anomalies syndrome,Disease-causing germline mutation(s) (loss of function) in;Disease-causing germline mutation(s) (loss of function) in,"Toenail selenium levels[25343990];Glomerular filtration rate in chronic kidney disease[26420894];Allergic disease (asthma, hay fever or eczema)[29083406];Blood protein levels[28240269;29875488;30072576];Empathy quotient[29527006;29527006];",0.4431901840490797,0.33264569365652397,0.7267032106499608,0.3298035604665439
1957,13966,L1CAM,308840,303350;304100;307000;,"[MIM:307000]Hydrocephalus due to stenosis of the aqueduct of Sylvius;[MIM:303350]Mental retardation, aphasia, shuffling gait, and adducted thumbs syndrome;[MIM:304100]Agenesis of the corpus callosum, X-linked, partial;",Hydrocephalus with stenosis of the aqueduct of Sylvius;MASA syndrome;X-linked complicated corpus callosum dysgenesis;X-linked complicated spastic paraplegia type 1,Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in,,0.403680981595092,1.0,0.6580527277473245,0.9499693063228974
1958,13969,L2HGDH,609584,236792;,,L-2-hydroxyglutaric aciduria,Disease-causing germline mutation(s) in,Periodontal disease-related phenotypes[24347629];,0.7825766871165644,0.6162970603403817,0.5625163142782563,0.47928176795580113
1959,13976,LACC1,613409,604302;,[MIM:604302]Rheumatoid arthritis systemic juvenile;,Systemic-onset juvenile idiopathic arthritis,Disease-causing germline mutation(s) in,Inflammatory bowel disease[28067908];Leprosy[25642632;27976721;25642632];Depression[29700475];Crohn's disease[23128233;28067908];,0.4710429447852761,0.23594636410520886,0.14043330723048814,0.0
1960,13984,LAGE3,300060,301006;,,Galloway-Mowat syndrome,Disease-causing germline mutation(s) in,,0.7165644171779141,0.5435791645177926,0.7243539545810493,0.0
1961,13990,LAMA1,150320,615960;,[MIM:615960]Poretti-Boltshauser syndrome [recessive?];,Ataxia-intellectual disability-oculomotor apraxia-cerebellar cysts syndrome,Disease-causing germline mutation(s) (loss of function) in,Type 2 diabetes[22693455];Response to citalopram treatment[22760553;22760553];,0.7170552147239264,0.012119649303764827,0.026363873662229184,0.09806629834254144
1962,13991,LAMA2,156225,607855;,[MIM:607855]Merosin-deficient congenital muscular dystrophy 1A;,Congenital muscular dystrophy type 1A,Disease-causing germline mutation(s) in,Body mass index[20397748];Spherical equivalent or myopia (age of diagnosis)[29808027];Myopia[25233373;27182965];Amyotrophic lateral sclerosis (sporadic)[24529757];Refractive error[23396134];Periodontal disease-related phenotypes[24347629];Axial length[24144296];Night sleep phenotypes[27126917;27126917];Spherical equivalent (joint analysis main effects and education interaction)[27020472;27020472];Hyperopia[25233373];,0.5353374233128835,0.0041258380608561115,0.09005481597494126,0.047268262737875995
1963,13992,LAMA3,600805,226700;245660;,"[MIM:226700]Epidermolysis bullosa, junctional, Herlitz type;[MIM:245660]Laryngoonychocutaneous syndrome;","LOC syndrome;Junctional epidermolysis bullosa, generalized intermediate;Junctional epidermolysis bullosa, generalized severe",Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in,High light scatter reticulocyte percentage of red cells[27863252];Allergic rhinitis[25085501];Amyotrophic lateral sclerosis[22959728];High light scatter reticulocyte count[27863252];,0.5069938650306749,0.6761217122227953,0.15165753067084312,0.047268262737875995
1964,13993,LAMA4,600133,615235;,"[MIM:615235]Cardiomyopathy, dilated 1JJ;",Familial isolated dilated cardiomyopathy,Disease-causing germline mutation(s) in,High light scatter reticulocyte percentage of red cells[27863252];Allergic rhinitis[25085501];Amyotrophic lateral sclerosis[22959728];High light scatter reticulocyte count[27863252];,0.4493251533742331,0.02037132542547705,0.08901070216653616,0.439073050951504
1965,13994,LAMA5,601033,,,LAMA5-related multisystemic syndrome,Disease-causing germline mutation(s) in,Colorectal cancer[20972440;24737748;25990418];Pelvic organ prolapse[26545240];Blood protein levels[29875488];Prostate cancer[23535732];,0.5226993865030675,0.7119649303764827,0.01331245105716523,0.3729281767955801
1966,13996,LAMB1,150240,615191;,[MIM:615191]Lissencephaly 5 [recessive?];,Cobblestone lissencephaly without muscular or ocular involvement,Disease-causing germline mutation(s) in,Inflammatory bowel disease[28067908];IgG glycosylation[23382691;23382691;23382691;23382691];Ulcerative colitis[19122664;19122664;19122664;19915572;20228799;28067908];Pneumoconiosis in silica exposure[24986923];,0.7304294478527608,0.6652913873130479,0.14956930305403288,0.259975445058318
1967,13997,LAMB2,150325,609049;614199;,[MIM:609049]Pierson syndrome;[MIM:614199]Nephrotic syndrome 5 with or without ocular abnormalities;,Pierson syndrome;LAMB2-related infantile-onset nephrotic syndrome;Synaptic congenital myasthenic syndromes,Disease-causing germline mutation(s) (loss of function) in;Disease-causing germline mutation(s) (loss of function) in;Disease-causing germline mutation(s) in,Inflammatory bowel disease[28067908];Resting heart rate[27798624];Crohn's disease[28067908];Blood protein levels[28240269];Ulcerative colitis[28067908];,0.49717791411042944,0.6284167096441464,0.23153223701383452,0.12384898710865562
1968,13999,LAMB3,150310,104530;226650;226700;,"[MIM:226700]Epidermolysis bullosa, junctional, Herlitz type;[MIM:226650]Generalized atrophic benign epidermolysis bullosa;[MIM:104530]Amelogenesis imperfecta 1A;","Junctional epidermolysis bullosa, generalized intermediate;Junctional epidermolysis bullosa, generalized severe;Hypoplastic amelogenesis imperfecta",Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in,Fentanyl consumption in laparoscopic-assisted colectomy (first 24 hours)[26566055];,0.5069938650306749,0.3107271789582259,0.09423127120856173,0.040976058931860036
1969,14001,LAMC1,150290,,,Pierson syndrome;LAMB2-related infantile-onset nephrotic syndrome;Synaptic congenital myasthenic syndromes,Disease-causing germline mutation(s) (loss of function) in;Disease-causing germline mutation(s) (loss of function) in;Disease-causing germline mutation(s) in,Fuchs's corneal dystrophy[28358029];Systemic lupus erythematosus[24871463];Hypertriglyceridemia[27599772;27599772];Clozapine-induced agranulocytosis[25187353];Colorectal cancer[23266556];Blood protein levels[29875488];,0.6694478527607362,0.6570397111913358,0.2960062646828504,0.5141190914671577
1970,14003,LAMC2,150292,226700;,"[MIM:226700]Epidermolysis bullosa, junctional, Herlitz type;","Junctional epidermolysis bullosa, generalized intermediate;Junctional epidermolysis bullosa inversa;Junctional epidermolysis bullosa, generalized severe",Disease-causing germline mutation(s) in;Candidate gene tested in;Disease-causing germline mutation(s) in,Systemic lupus erythematosus[21408207];Clozapine-induced agranulocytosis[25187353];Blood protein levels[29875488;30072576];HDL cholesterol[21347282];,0.3925153374233129,0.08406395048994326,0.17776037588097102,0.1714241866175568
1971,14004,LAMC3,604349,614115;,[MIM:614115]Cortical malformations occipital;,Occipital pachygyria and polymicrogyria,Disease-causing germline mutation(s) in,Alcohol consumption (maxi-drinks)[29460428];Oral cavity cancer[27749845];Endometriosis[28333195];Oral cavity and pharyngeal cancer[27749845];Deep ovarian and/or rectovaginal disease with dense adhesions[28333195];,0.33226993865030674,0.019597730789066528,0.02192638997650744,0.12569060773480664
1972,14007,LAMP2,309060,300257;,[MIM:300257]Danon disease;,Glycogen storage disease due to LAMP-2 deficiency,Disease-causing germline mutation(s) in,,0.7971779141104295,0.6191335740072202,0.8311145914904725,0.0
1973,14012,LAMTOR2,610389,610798;,[MIM:610798]Immunodeficiency due to defect in MAPBP-interacting protein;,Primary immunodeficiency syndrome due to p14 deficiency,Disease-causing germline mutation(s) in,,0.7020858895705522,0.6209386281588448,0.9872096058470373,0.0
1974,14034,LARGE1,603590,608840;613154;,[MIM:613154]Muscular dystrophy-dystroglycanopathy congenital with brain and eye anomalies A6 [recessive?];,Congenital muscular dystrophy with intellectual disability;Muscle-eye-brain disease;Walker-Warburg syndrome,Disease-causing germline mutation(s) in;Candidate gene tested in;Disease-causing germline mutation(s) in,Age at first birth[27798627;27798627];,0.2947239263803681,0.5281072717895823,0.0,0.0
1975,14046,LARP7,612026,615071;,[MIM:615071]Alazami syndrome;,"Microcephalic primordial dwarfism, Alazami type",Disease-causing germline mutation(s) (loss of function) in,Body mass index[26426971];,0.9163190184049079,0.6255801959773079,0.27956147220046984,0.03038674033149171
1976,14051,LARS,151350,615438;,[MIM:615438]Infantile liver failure syndrome 1;,Acute infantile liver failure-multisystemic involvement syndrome,Disease-causing germline mutation(s) in,,0.929079754601227,0.14543579164517792,0.07778647872618115,0.11955187231430325
1977,14052,LARS2,604544,615300;617021;,"[MIM:617021]Hydrops, lactic acidosis, and sideroblastic anemia;",Perrault syndrome;Hydrops-lactic acidosis-sideroblastic anemia-multisystemic failure syndrome,Disease-causing germline mutation(s) in;Candidate gene tested in,Acne (severe)[24927181];Inflammatory skin disease[25574825];,0.8905521472392638,0.21196493037648273,0.42521534847298353,0.3073971761817066
1978,14054,LAS1L,300964,309585;,[MIM:309585]Wilson-Turner X-linked mental retardation syndrome;,Wilson-Turner syndrome;Spinal muscular atrophy with respiratory distress type 2,Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in,,0.9288343558282208,0.6730273336771532,0.9506656225528582,0.9094536525475752
1979,14056,LAT,602354,617514;,[MIM:617514]Immunodeficiency 52 [recessive?];,Severe combined immunodeficiency due to LAT deficiency,Disease-causing germline mutation(s) in,Crohn's disease[21102463];Educational attainment[25201988];,0.6588957055214724,0.5917998968540484,0.6794570608196293,0.7978821362799263
1980,14067,LBR,600024,169400;215140;613471;,[MIM:169400]Pelger-Huet anomaly [dominant?];[MIM:215140]Greenberg dysplasia [recessive?];[MIM:613471]Reynolds syndrome;,Greenberg dysplasia;Regressive spondylometaphyseal dysplasia;Reynolds syndrome,Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Candidate gene tested in,Delirium[29631748];,0.9977914110429448,0.5582774626095925,0.559383972853041,0.937998772252916
1981,14072,LCA5,611408,604537;,[MIM:604537]Leber congenital amaurosis 5;,Leber congenital amaurosis;Severe early-childhood-onset retinal dystrophy,Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in,Glucose homeostasis traits[25524916];Hoarding[21302353];Presence of antiphospholipid antibodies[23509613];,0.7120245398773006,0.296028880866426,0.08013573479509266,0.1987415592387968
1982,14075,LCAT,606967,136120;245900;,[MIM:245900]Lecithin-cholesterol acyltransferase deficiency;[MIM:136120]Fish-eye disease;,Familial LCAT deficiency;Fish-eye disease,Disease-causing germline mutation(s) (loss of function) in;Disease-causing germline mutation(s) (loss of function) in,HDL cholesterol levels[28334899;28334899;28334899];Schizophrenia[25056061];Total cholesterol levels in HDL[29084231];HDL cholesterol[20686565;20864672;21347282;19060910;19060906;24097068;25961943;18193043];,0.16220858895705523,0.721248066013409,0.706342991386061,0.748158379373849
1983,14098,LCK,153390,615758;,[MIM:615758]Immunodeficiency 22;,Severe combined immunodeficiency due to LCK deficiency,Disease-causing germline mutation(s) in,,0.707239263803681,0.9564208354822074,0.49099451840250585,0.7461632903621854
1984,14120,LCT,603202,223000;,[MIM:223000]Congenital lactase deficiency;,Congenital lactase deficiency,Disease-causing germline mutation(s) in,Body mass index[26426971];Plasma omega-3 polyunsaturated fatty acid levels (alphalinolenic acid)[21829377];Blood protein levels[29875488;30072576];,0.10711656441717791,0.5128932439401753,0.07987470634299139,0.30448127685696746
1985,14125,LDB3,605906,601493;609452;,"[MIM:601493]Left ventricular non-compaction 3 [dominant?];[MIM:609452]Myopathy, myofibrillar, 4;","Familial isolated dilated cardiomyopathy;Familial isolated arrhythmogenic ventricular dysplasia, right dominant form;Familial isolated arrhythmogenic ventricular dysplasia, biventricular form;Familial isolated arrhythmogenic ventricular dysplasia, left dominant form;Left ventricular noncompaction;Late-onset distal myopathy, Markesbery-Griggs type",Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Major susceptibility factor in;Disease-causing germline mutation(s) in,Post bronchodilator FEV1/FVC ratio[26634245];Plasma androstenedione levels in resected early stage-receptor positive breast cancer[28429243];Post bronchodilator FEV1[26634245];,0.5658895705521473,0.241103661681279,0.3067084312190029,0.8377839165131983
1986,14126,LDHA,150000,612933;,[MIM:612933]Glycogen storage disease 11;,Glycogen storage disease due to lactate dehydrogenase M-subunit deficiency,Disease-causing germline mutation(s) in,Amyloid A serum levels[21124955;21124955];,0.974601226993865,0.5794223826714802,0.7885669537979639,0.7886740331491713
1987,14139,LDHB,150100,614128;,[MIM:614128]Lactate dehydrogenase B deficiency;,Glycogen storage disease due to lactate dehydrogenase H-subunit deficiency,Disease-causing germline mutation(s) in,,0.9656441717791411,0.28777720474471374,0.7376664056382146,0.5089011663597299
1988,14145,LDLR,606945,143890;,[MIM:143890]Familial hypercholesterolemia [dominant?];,Homozygous familial hypercholesterolemia,Disease-causing germline mutation(s) in,"Myocardial infarction[26343387];Cortisol levels (saliva)[28843169];Stroke[29531354;29531354];Coronary artery disease or ischemic stroke[24262325];Low density lipoprotein cholesterol[29403010];Abdominal aortic aneurysm[24046328;27899403];Metabolite levels (lipoprotein measures)[27005778];Ischemic stroke[29531354;29531354];Coronary heart disease[21378990];Coronary artery disease[26343387;29212778;29212778;29212778;24262325];Lipoprotein-associated phospholipase A2 activity and mass[22003152];Lipid metabolism phenotypes[22286219;19936222;19936222;19936222;19936222];Total cholesterol levels[29403010;28334899;28334899];Myocardial infarction (early onset)[19198609];Lipoprotein phospholipase A2 activity in cardiovascular disease[28753643];Carotid intima media thickness[21909108];Metabolite levels[21909109;22916037];LDL cholesterol levels[28334899;28334899];Cardiovascular disease risk factors[21943158];Cholesterol, total[20686565;19060911;24097068;25961943;26582766];LDL cholesterol[20686565;20864672;18193043;19060911;23726366;21347282;19060910;19060906;24097068;24097068;18193044;25961943;26582766];C-reactive protein levels or LDL-cholesterol levels (pleiotropy)[27286809];Coronary artery disease or large artery stroke[24262325];Coronary artery disease (myocardial infarction, percutaneous transluminal coronary angioplasty, coronary artery bypass grafting, angina or chromic ischemic heart disease)[28714975];",0.427239263803681,0.10443527591542032,0.33046202036021927,0.8370165745856354
1989,14151,LDLRAP1,605747,603813;,"[MIM:603813]Hypercholesterolemia, autosomal recessive [recessive?];",Homozygous familial hypercholesterolemia,Disease-causing germline mutation(s) in,"Mean platelet volume[27863252;27863252];Total cholesterol levels[28334899];LDL cholesterol levels[28334899];Cholesterol, total[20686565;24097068;25961943];LDL cholesterol[20686565;24097068;25961943];Platelet count[27863252];",0.30319018404907977,0.22898401237751417,0.5340642129992169,0.21639042357274402
1990,14158,LEFTY2,601877,,[MIM:601877]Left-right axis malformations;,Situs ambiguus,Major susceptibility factor in,,0.23865030674846627,0.33445074780814854,0.36309057687287916,0.5747391037446286
1991,14163,LEMD2,616312,212500;,,Early-onset posterior subcapsular cataract;Total early-onset cataract,Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in,Body mass index[28448500;25673413;25673413];Phosphorus levels[20558539];Crohn's disease[23850713];Alzheimer's disease (age of onset)[22005931];Obesity-related traits[23251661];Body mass index (joint analysis main effects and physical activity interaction)[28448500;28448500];,0.7923926380368098,0.7841670964414647,0.3774471417384495,0.0
1992,14164,LEMD3,607844,166700;,,Isolated osteopoikilosis;Melorheostosis with osteopoikilosis;Buschke-Ollendorff syndrome;12q14 microdeletion syndrome,Disease-causing germline mutation(s) (loss of function) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) (loss of function) in;Role in the phenotype of,Waist-to-hip ratio adjusted for BMI x sex interaction[26426971];Waist-to-hip ratio adjusted for BMI[26426971];Venous thromboembolism adjusted for sickle cell variant rs77121243-T[28203683];,0.9911656441717791,0.9586126869520372,0.692247454972592,0.41006752608962554
1993,14171,LEP,164160,614962;,[MIM:614962]Leptin deficiency;,Obesity due to congenital leptin deficiency,Disease-causing germline mutation(s) in,Type 2 diabetes[23945395;26818947];circulating leptin levels[26833098;26833098];High density lipoprotein cholesterol levels[29403010];circulating leptin levels adjusted for BMI[26833098;26833098];,0.35496932515337426,0.6802475502836514,0.7864787261811538,0.4671577655003069
1994,14172,LEPR,601007,614963;,[MIM:614963]Leptin receptor deficiency;,Obesity due to leptin receptor gene deficiency,Disease-causing germline mutation(s) (loss of function) in,C-reactive protein[18439548;23844046;19567438;22939635];Mean corpuscular volume[27863252];Mean corpuscular hemoglobin[27863252];Lymphocyte percentage of white cells[27863252];C-reactive protein levels[21300955];Age at voice drop[27182965];Myeloid white cell count[27863252;27863252];Sum basophil neutrophil counts[27863252];Sum neutrophil eosinophil counts[27863252];Menarche (age at onset)[25231870];Granulocyte count[27863252;27863252];Blood protein levels[28240269;28240269;28240269;28240269;29875488;29875488;30072576];Neutrophil count[27863252];Obesity (early onset extreme)[23563609];Molybdenum levels[26025379];Soluble leptin receptor levels[20167575];White blood cell count[27863252];C-reactive protein levels or triglyceride levels (pleiotropy)[27286809];Fibrinogen[23969696];Fasting plasma glucose (childhood)[25223902];Fibrinogen levels[26561523;28107422;28107422];Metabolic traits[19060910];,0.4493251533742331,0.8362558019597731,0.11641868963717045,0.27532228360957645
1995,14175,LETM1,604407,,,Wolf-Hirschhorn syndrome,Role in the phenotype of,,0.9736196319018405,0.19468798349664776,0.3335943617854346,0.8182934315531001
1996,14183,LFNG,602576,609813;,"[MIM:609813]Spondylocostal dysostosis 3, autosomal recessive [recessive?];",Autosomal recessive spondylocostal dysostosis,Disease-causing germline mutation(s) in,Systolic blood pressure[27618452];Diastolic blood pressure[27618452;28739976];Post bronchodilator FEV1/FVC ratio[26634245];Post bronchodilator FEV1[26634245];,0.16220858895705523,0.2186694172253739,0.8525189245627773,0.07565991405770411
1997,14197,LGALS12,606096,,,Fraser syndrome,Disease-causing germline mutation(s) in,Basophil percentage of white cells[27863252];Post bronchodilator FEV1/FVC ratio[26634245;26634245];Basophil percentage of granulocytes[27863252];,0.10711656441717791,0.06678700361010831,0.45210127903941527,0.013965623081645182
1998,14203,LGI1,604619,600512;,"[MIM:600512]Epilepsy, familial temporal lobe, 1;",Autosomal dominant epilepsy with auditory features,Disease-causing germline mutation(s) (loss of function) in,Response to perphenazine in schizophrenia[29503163];,0.14576687116564419,0.9512635379061372,0.9444009397024276,0.0
1999,14206,LGI4,608303,617468;,,Hypomyelination neuropathy-arthrogryposis syndrome,Disease-causing germline mutation(s) (loss of function) in,,0.038773006134969326,0.4234141309953584,0.4836857217436701,0.6069674647022714
2000,14216,LHB,152780,228300;,,Leydig cell hypoplasia due to LHB deficiency,Disease-causing germline mutation(s) in,Blood protein levels[28240269;29875488;29875488;30072576;30072576;30072576];,0.20368098159509201,0.36462093862815886,0.4878621769772905,0.4648557397176182
2001,14217,LHCGR,152790,176410;238320;,[MIM:176410]Familial male precocious puberty;[MIM:238320]Luteinizing hormone resistance [recessive?];,Familial male-limited precocious puberty;Leydig cell hypoplasia due to partial LH resistance;Leydig cell hypoplasia due to complete LH resistance,Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) (loss of function) in;Disease-causing germline mutation(s) (loss of function) in,Polycystic ovary syndrome[21151128;22885925];Body mass index[28892062];Sex hormone-binding globulin levels[22829776];Laterality in neovascular age-related macular degeneration[28775256];,0.26588957055214724,0.3904074265085095,0.22631166797180893,0.5561694290976059
2002,14224,LHFPL5,609427,610265;,"[MIM:610265]Deafness, autosomal recessive, 67 [recessive?];",Autosomal recessive non-syndromic sensorineural deafness type DFNB,Disease-causing germline mutation(s) in,,0.16220858895705523,0.30582774626095927,0.8099712868702689,0.5550951503990178
2003,14227,LHX1,601999,,,17q12 microdeletion syndrome,Role in the phenotype of,Body mass index[26426971];,0.22687116564417178,0.703971119133574,0.5296267293134952,0.8317986494782075
2004,14230,LHX3,600577,221750;,"[MIM:221750]Pituitary hormone deficiency, combined, 3;",Hypothyroidism due to deficient transcription factors involved in pituitary development or function;Non-acquired combined pituitary hormone deficiency-sensorineural hearing loss-spine abnormalities syndrome,Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in,Inflammatory bowel disease[28067908];Thyroid hormone levels[23408906;23408906;23408906];Atrial fibrillation[30061737];Height[20189936];Crohn's disease[28067908];Lung function (FVC)[28166213];Ulcerative colitis[28067908];,0.49828220858895705,0.36565239814337286,0.8373792743409032,0.0
2005,14231,LHX4,602146,262700;,"[MIM:262700]Pituitary hormone deficiency, combined, 4;","Hypothyroidism due to deficient transcription factors involved in pituitary development or function;Short stature-pituitary and cerebellar defects-small sella turcica syndrome;Pituitary stalk interruption syndrome;Combined pituitary hormone deficiencies, genetic forms",Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) (loss of function) in,,0.47705521472392637,0.4708612686952037,0.07830853563038372,0.7067219152854513
2006,14238,LIAS,607031,614462;,"[MIM:614462]Hyperglycinemia, lactic acidosis, and seizures [recessive?];",Lipoic acid synthetase deficiency,Disease-causing germline mutation(s) in,,0.038773006134969326,0.33161423414130997,0.8739232576350823,0.3000306936771025
2007,14241,LIFR,151443,601559;,[MIM:601559]Stueve-Wiedemann syndrome [recessive?];,St�ve-Wiedemann syndrome,Disease-causing germline mutation(s) (loss of function) in,Inflammatory bowel disease[26192919];Pursuit maintenance gain[29064472];Crohn's disease[26192919];Blood protein levels[30072576];Ulcerative colitis[26192919];,0.6506748466257669,0.6423414130995359,0.19028974158183243,0.1576120319214242
2008,14245,LIG4,601837,602450;606593;,[MIM:602450]Severe combined immunodeficiency autosomal recessive T- cell-negative/B-cell-negative/NK-cell-positive with sensitivity to ionizing radiation [recessive?];,Dubowitz syndrome;Omenn syndrome;LIG4 syndrome,Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in,Irritable bowel syndrome[29626450];Attention deficit hyperactivity disorder and conduct disorder[18951430];,0.6435582822085889,0.22537390407426508,0.15609501435656487,0.3337937384898711
2009,14260,LIM2,154045,615277;,,Total early-onset cataract,Disease-causing germline mutation(s) in,,0.08736196319018405,0.3677153171738009,0.8193683111459149,0.6732658072437078
2010,14267,LIMK1,601329,,,Williams syndrome,Role in the phenotype of,,0.5128834355828221,0.9504899432697267,0.5442443226311668,0.8251995089011663
2011,14271,LIMS2,607908,616827;,[MIM:616827]Limb-girdle muscular dystrophy 2W [recessive?];,Autosomal recessive limb-girdle muscular dystrophy type 2W,Disease-causing germline mutation(s) in,Type 2 diabetes[25483131];Alzheimer's disease (cognitive decline)[23535033];,0.4894478527607362,0.18592057761732853,0.7473244583659618,0.8403928790669122
2012,14282,LIN28B,611044,,,Neuroblastoma,Major susceptibility factor in,Waist circumference adjusted for BMI (joint analysis main effects and physical activity interaction)[28448500;28448500;28448500;28448500];Puberty onset (breast development)[24770850];Schizophrenia[28991256];Waist circumference adjusted for BMI (adjusted for smoking behaviour)[28443625;28443625];Menarche (age at onset)[21102462;19448623;19448620;19448622;27182965;25231870;25231870;23667675;29773799];Neuroblastoma[22941191];Major depressive disorder[27479909];Waist circumference adjusted for BMI in smokers[28443625;28443625];Hip circumference adjusted for BMI[25673412;25673412;25673412];Waist circumference adjusted for BMI (joint analysis main effects and smoking interaction)[28443625;28443625];Digit length ratio (left hand)[29659830;29659830];Accelerated cognitive decline after conversion of mild cognitive impairment to Alzheimer's disease (Alzhiemer's diagnosis trajectory interaction)[28560309];Menarche and menopause (age at onset)[19448621];Height[23563607;20881960;18391950;18391951;25429064;25282103];Digit length ratio[20303062;29659830];Waist circumference adjusted for BMI in active individuals[28448500;28448500;28448500;28448500];Digit length ratio (right hand)[29659830];Waist circumference adjusted for BMI in inactive individuals[28448500];Pubertal anthropometrics[23449627;23449627];Age at voice drop[27182965];Waist circumference adjusted for BMI in non-smokers[28443625;28443625];Sporadic neuroblastoma[28545128];Waist circumference adjusted for body mass index[28448500;28448500;28448500;28448500;25673412;25673412;25673412];Puberty onset[24770850];Intraocular pressure[29617998;30054594];,0.8234355828220858,0.739556472408458,0.8963717045157922,0.8483732351135667
2013,16245,LINS1,610350,614340;,,Autosomal recessive non-syndromic intellectual disability,Disease-causing germline mutation(s) in,,0.08736196319018405,0.482207323362558,0.0,0.0
2014,16246,LIPA,613497,278000;,[MIM:278000]Wolman disease;[MIM:278000]Cholesteryl ester storage disease;,Cholesteryl ester storage disease;Wolman disease,Disease-causing germline mutation(s) (loss of function) in;Disease-causing germline mutation(s) (loss of function) in,"Myocardial infarction[26343387];Fibrinogen levels[26561523];Sum neutrophil eosinophil counts[27863252];Neutrophil count[27863252];Coronary heart disease[21378988;21606135];Coronary artery disease[26343387;29212778;29212778;29212778];Coronary artery disease (myocardial infarction, percutaneous transluminal coronary angioplasty, coronary artery bypass grafting, angina or chromic ischemic heart disease)[28714975];",0.038773006134969326,0.18076328004125838,0.11511354737666406,0.058011049723756904
2015,16248,LIPC,151670,125853;612797;614025;,[MIM:614025]Hepatic lipase deficiency;,Hyperlipidemia due to hepatic triacylglycerol lipase deficiency,Disease-causing germline mutation(s) in,"Advanced age-related macular degeneration[26691988;26691988];Gout[22179738];Blood metabolite levels[24816252;24816252;24816252];Schizophrenia[26198764];Triglyceride levels[28334899;28334899;28334899;29403010];Ischemic stroke[26089329;26089329];Metabolic syndrome[22399527];Alzheimer's disease (cognitive decline)[23535033];Cognitive performance[20125193];Total cholesterol levels[29615537;29403010;28334899;28334899;28334899];Red blood cell traits[23222517];Lipid traits[24023260;24386095];Cardiovascular disease risk factors[21943158];Cholesterol, total[20686565;19060911;24097068;25961943;26582766];Obesity-related traits[23251661];Hematological and biochemical traits[20139978];Stroke[26089329;26089329];Low density lipoprotein cholesterol[29403010];Amyotrophic lateral sclerosis[18084291];Triglycerides[20686565;18193043;24097068;25961943;26582766];Metabolite levels (lipoprotein measures)[27005778];HDL cholesterol[20686565;20864672;18193044;19060911;19060910;23505323;21347282;19060906;24097068;26780889;25961943;26582766;18193043;29404214];Phospholipid levels (plasma)[22359512];HDL cholesterol levels[28334899;28334899;28334899];Lipid metabolism phenotypes[22286219;19936222;19936222;19936222];Age-related macular degeneration[21665990;20385826;23455636];C-reactive protein levels or HDL-cholesterol levels (pleiotropy)[27286809];Non-small cell lung cancer[23144319];Metabolite levels[19043545;22916037;23281178];Metabolic syndrome (bivariate traits)[21386085;21386085];High density lipoprotein cholesterol levels[29615537;29615537;29403010];",0.16220858895705523,0.2364620938628159,0.6243800574262595,0.6642111724984653
2016,16250,LIPE,151750,615980;,"[MIM:615980]Lipodystrophy, familial partial, 6;",LIPE-related familial partial lipodystrophy,Disease-causing germline mutation(s) in,,0.2585276073619632,0.4566787003610108,0.28817541111981204,0.070902394106814
2017,16254,LIPH,607365,604379;,[MIM:604379]Woolly hair autosomal recessive 2 [recessive?];,Woolly hair;Hypotrichosis simplex,Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in,,0.4403680981595092,0.6150077359463642,0.6301226833724876,0.49923265807243705
2018,16259,LIPN,613924,613943;,"[MIM:613943]Ichthyosis, congenital, autosomal recessive 8 [recessive?];",Lamellar ichthyosis,Disease-causing germline mutation(s) in,Blood protein levels[29875488;30072576];,0.038773006134969326,0.28803506962351727,0.40642129992169146,0.2274401473296501
2019,16260,LIPT1,610284,616299;,,Leigh syndrome with leukodystrophy;Lipoyl transferase 1 deficiency,Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in,Bipolar disorder[21926972];,0.20368098159509201,0.445074780814853,0.6541373009658052,0.7239103744628607
2020,16262,LIPT2,617659,617668;,"[MIM:617668]Encephalopathy, neonatal severe, with lactic acidosis and brain abnormalities [recessive?];",Lipoyl transferase 2 deficiency,Candidate gene tested in,,0.038773006134969326,0.686178442496132,0.21378230227094752,0.0
2021,16263,LITAF,603795,601098;,[MIM:601098]Charcot-Marie-Tooth disease 1C;,Charcot-Marie-Tooth disease type 1C,Disease-causing germline mutation(s) in,"Inflammatory bowel disease[28067908;23128233];QT interval[19305408;19305409;23166209;24952745;24952745;24952745;29213071];Allergic disease (asthma, hay fever or eczema)[29083406];Colorectal or endometrial cancer[26621817];Crohn's disease[28067908];Response to anti-retroviral therapy (ddI/d4T) in HIV-1 infection (Grade 3 peripheral neuropathy)[24554482];",0.4645398773006135,0.6627127385250129,0.8642652049073349,0.8686310620012277
2022,16277,LMAN1,601567,227300;,[MIM:227300]Factor V and factor VIII combined deficiency 1;,Combined deficiency of factor V and factor VIII,Disease-causing germline mutation(s) (loss of function) in,Morning vs. evening chronotype[27494321];Chronotype[27494321];,0.9894478527607362,0.4014956162970603,0.30462020360219266,0.40730509515039903
2023,16280,LMAN2L,609552,616887;,,Autosomal recessive non-syndromic intellectual disability,Disease-causing germline mutation(s) in,Bipolar disorder[21926972;22182935;28072414];Blood protein levels[29875488;30072576];,0.38061349693251534,0.20577617328519857,0.8658313756199426,0.13904235727440148
2024,16281,LMBR1,605522,135750;174500;186200;188740;200500;,[MIM:200500]Acheiropody;[MIM:186200]Syndactyly 4;[MIM:188740]Hypoplasia or aplasia of tibia with polydactyly [dominant?];[MIM:135750]Laurin-Sandrow syndrome [dominant?];,Acheiropodia;Laurin-Sandrow syndrome;Triphalangeal thumb-polysyndactyly syndrome;Hypoplastic tibiae-postaxial polydactyly syndrome;Radial hemimelia;Polydactyly of a triphalangeal thumb;Syndactyly type 4,Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in,Schizophrenia[26198764];,0.4,0.1552346570397112,0.5037849125554685,0.15561694290976058
2025,16283,LMBRD1,612625,277380;,"[MIM:277380]Methylmalonic aciduria and homocystinuria, cblF type [recessive?];",Methylmalonic acidemia with homocystinuria type cblF,Disease-causing germline mutation(s) in,Response to statin therapy[20339536];Sleep duration[25469926];,0.10711656441717791,0.11010830324909747,0.12346645784390499,0.06675874769797421
2026,16287,LMF1,611761,246650;,[MIM:246650]Combined lipase deficiency;,Familial chylomicronemia syndrome,Disease-causing germline mutation(s) in,Polycystic ovary syndrome[25574032];Glioma[28346443];Red blood cell traits[23446634];Glioblastoma[28346443];Non-glioblastoma glioma[28346443];,0.28662576687116564,0.37725631768953066,0.20830070477682067,0.10604665438919583
2027,16293,LMNA,150330,115200;151660;159001;176670;181350;212112;248370;275210;605588;610140;613205;616516;,"[MIM:181350]Emery-Dreifuss muscular dystrophy 2, autosomal dominant [dominant?];[MIM:616516]Emery-Dreifuss muscular dystrophy 3, autosomal recessive [recessive?];[MIM:115200]Cardiomyopathy, dilated 1A;[MIM:151660]Lipodystrophy, familial partial, 2;[MIM:159001]Limb-girdle muscular dystrophy 1B [dominant?];[MIM:605588]Charcot-Marie-Tooth disease 2B1;[MIM:176670]Hutchinson-Gilford progeria syndrome;[MIM:212112]Cardiomyopathy, dilated, with hypergonadotropic hypogonadism;[MIM:248370]Mandibuloacral dysplasia with type A lipodystrophy;[MIM:275210]Lethal tight skin contracture syndrome [recessive?];[MIM:610140]Heart-hand syndrome Slovenian type;[MIM:613205]Muscular dystrophy congenital LMNA-related;","Heart-hand syndrome, Slovenian type;Restrictive dermopathy;Congenital muscular dystrophy due to LMNA mutation;Familial partial lipodystrophy, Dunnigan type;Dilated cardiomyopathy-hypergonadotropic hypogonadism syndrome;Hutchinson-Gilford progeria syndrome;Autosomal semi-dominant severe lipodystrophic laminopathy;LMNA-related cardiocutaneous progeria syndrome;Familial isolated arrhythmogenic ventricular dysplasia, right dominant form;Familial isolated arrhythmogenic ventricular dysplasia, biventricular form;Familial isolated arrhythmogenic ventricular dysplasia, left dominant form;Familial dilated cardiomyopathy with conduction defect due to LMNA mutation;Autosomal dominant limb-girdle muscular dystrophy type 1B;Familial partial lipodystrophy, K�bberling type;Left ventricular noncompaction;Mandibuloacral dysplasia with type A lipodystrophy;Atypical Werner syndrome;Autosomal dominant Emery-Dreifuss muscular dystrophy;Autosomal recessive Emery-Dreifuss muscular dystrophy;Charcot-Marie-Tooth disease type 2B1",Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Candidate gene tested in;Major susceptibility factor in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in,Lung cancer in ever smokers[28604730];,0.9612269938650306,0.9094894275399691,0.8209344818585226,0.9957028852056476
2028,16294,LMNB1,150340,169500;,"[MIM:169500]Leukodystrophy, demyelinating, autosomal dominant, adult- onset [dominant?];",Adult-onset autosomal dominant leukodystrophy,Disease-causing germline mutation(s) in,Parkinson's disease (motor and cognition)[22658654];Blood protein levels[29875488;30072576];,0.900122699386503,0.7656008251676122,0.6076742364917777,0.6732658072437078
2029,16296,LMNB2,150341,608709;616540;,"[MIM:608709]Partial acquired lipodystrophy;[MIM:616540]Epilepsy, progressive myoclonic 9 [recessive?];",Progressive myoclonic epilepsy type 9;Acquired partial lipodystrophy,Disease-causing germline mutation(s) in;Major susceptibility factor in,,0.7663803680981595,0.9818205260443528,0.4528843643957191,0.0
2030,16299,LMO1,186921,,,Neuroblastoma,Major susceptibility factor in,Alcohol consumption[23743675];Systolic blood pressure[27618447];Body mass index (age <50)[26426971];Body mass index[26426971;28892062];Body mass index x sex x age interaction (4df test)[26426971];Fasting blood glucose[22581228];Diastolic blood pressure[27618447];Sporadic neuroblastoma[28545128];Neuroblastoma[21124317;22941191];Fasting blood glucose (BMI interaction)[22581228];Response to fenofibrate (HDL cholesterol levels)[27002377];,0.5191411042944786,0.7307890665291388,0.9415296267293135,0.0
2031,16307,LMOD1,602715,,,Megacystis-microcolon-intestinal hypoperistalsis syndrome,Disease-causing germline mutation(s) (loss of function) in,Body mass index[28448500;28448500;28448500;28448500;28892062];Body mass index in physically active individuals[28448500;28448500];Breast size[27182965];Coronary artery disease[29212778;29212778];Body mass index (joint analysis main effects and physical activity interaction)[28448500;28448500;28448500];,0.038773006134969326,0.8455389375966993,0.4035499869485774,0.0
2032,16309,LMOD3,616112,616165;,[MIM:616165]Nemaline myopathy 10 [recessive?];,Severe congenital nemaline myopathy;Typical nemaline myopathy,Disease-causing germline mutation(s) (loss of function) in;Disease-causing germline mutation(s) (loss of function) in,,0.038773006134969326,0.17302733367715317,0.2902636387366223,0.0
2033,16313,LMX1B,602575,161200;,,Nail-patella syndrome;Nail-patella-like renal disease;9q33.3q34.11 microdeletion syndrome,Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Role in the phenotype of,Glaucoma[30054594;30054594;30054594];Breast cancer[29059683];Social communication problems[24564958];Glaucoma (primary open-angle)[29449654;29891935];Calcium levels[29403010];Body mass index[20935630;25673413;25673413;25673413;28892062];Monobrow[27182965];Open-angle glaucoma and optic cup area[29449654];Chin dimples[27182965];Multiple system atrophy[27629089];Eyebrow thickness[26926045];Childhood body mass index[26604143];Intraocular pressure[29617998;29617998;30054594;30054594;30054594;29785010;29785010];,0.3449079754601227,0.8831872099020114,0.8572174367006004,0.7925107427869859
2034,16326,LNX1,609732,,,Congenital communicating hydrocephalus,Disease-causing germline mutation(s) in,DNA methylation (variation)[23725790];Uterine fibroids[30194396];Cervical artery dissection[25420145];Beard thickness[26926045];,0.734601226993865,0.5894791129448169,0.6298616549203864,0.1338244321669736
2035,16333,LONP1,605490,600373;,[MIM:600373]CODAS syndrome;,CODAS syndrome,Disease-causing germline mutation(s) in,Rosacea symptom severity[29771307];Acne (severe)[24927181];Mean corpuscular volume[27863252];Mean corpuscular hemoglobin[27863252];,0.9240490797546013,0.9559051057246003,0.33881493082746017,0.7360343769183548
2036,16340,LOR,152445,604117;,[MIM:604117]Vohwinkel syndrome with ichthyosis;,Progressive symmetric erythrokeratodermia;Keratoderma hereditarium mutilans with ichthyosis,Candidate gene tested in;Disease-causing germline mutation(s) in,,0.23865030674846627,0.6585869004641568,0.16418689637170453,0.0
2037,16341,LOX,153455,617168;,"[MIM:617168]Aortic aneurysm, familial thoracic 10;",Familial thoracic aortic aneurysm and aortic dissection,Disease-causing germline mutation(s) (loss of function) in,Thiazide-induced adverse metabolic effects in hypertensive patients[23400010];Intraocular pressure[29617998;29617998];,0.4226993865030675,0.9297318205260443,0.2873923257635082,0.5888581952117864
2038,16342,LOXHD1,613072,613079;,"[MIM:613079]Deafness, autosomal recessive, 77 [recessive?];",Autosomal recessive non-syndromic sensorineural deafness type DFNB,Disease-causing germline mutation(s) in,Midgestational circulating levels of PBDEs (fetal genetic effect)[28235828;28235828;28235828];,0.08736196319018405,0.018050541516245487,0.039937353171495694,0.0
2039,16345,LOXL2,606663,,,Progressive symmetric erythrokeratodermia;Keratoderma hereditarium mutilans with ichthyosis,Candidate gene tested in;Disease-causing germline mutation(s) in,Waist-to-hip ratio adjusted for BMI (age >50)[26426971];Waist-to-hip ratio adjusted for BMI (age <50)[26426971];Central corneal thickness[29760442];Attention deficit hyperactivity disorder[20732625];Waist-to-hip ratio adjusted for BMI[26426971];Waist-to-hip ratio adjusted for BMI x sex x age interaction (4df test)[26426971];,0.3889570552147239,0.5866425992779783,0.4460976246410859,0.17295887047268263
2040,16354,LPAR4,300086,,,Differentiated thyroid carcinoma,Disease-causing somatic mutation(s) in,,0.38061349693251534,0.6572975760701393,0.7898720960584704,0.5639963167587477
2041,16356,LPAR6,609239,278150;,[MIM:278150]Woolly hair autosomal recessive 1 with or without hypotrichosis [recessive?];[MIM:278150]Hypotrichosis 8;,Woolly hair;Hypotrichosis simplex,Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in,,0.4622085889570552,0.33625580195977306,0.7752545027407988,0.05555555555555555
2042,16365,LPIN1,605518,268200;,"[MIM:268200]Myoglobinuria, acute recurrent, autosomal recessive [recessive?];",Genetic recurrent myoglobinuria,Disease-causing germline mutation(s) in,Post bronchodilator percent predicted FEV1 in smoking[30068317];,0.5370552147239264,0.19107787519339867,0.11798486034977812,0.48066298342541436
2043,16366,LPIN2,605519,609628;,[MIM:609628]Majeed syndrome [recessive?];,Majeed syndrome,Disease-causing germline mutation(s) in,Type 2 diabetes[21490949];Urinary albumin-to-creatinine ratio in non-diabetics[26631737];Amyotrophic lateral sclerosis (sporadic)[24529757];Body mass index in asthmatics[23517042];Night sleep phenotypes[27126917];,0.10711656441717791,0.5801959773078906,0.4930827460193161,0.521792510742787
2044,16368,LPL,609708,238600;,[MIM:238600]Lipoprotein lipase deficiency;,Familial lipoprotein lipase deficiency,Disease-causing germline mutation(s) (loss of function) in,"Total triglycerides levels[29084231];Susceptibility to persistent hepatitis B virus infection[27244555];Triglyceride levels[26763881;29615537;29615537;29615537;29615537;28334899;28334899;28334899;29403010];Metabolic syndrome[20694148;22399527;22399527;21386085];Triglyceride to HDL cholesterol ratio[28046027];Triglycerides-Blood Pressure (TG-BP)[21386085];Hyperactive-impulsive symptoms[18821565];Lipoprotein phospholipase A2 activity in cardiovascular disease[28753643];Body mass index (adult)[28430825];Lipid traits[24023261;24386095;24386095];Cardiovascular disease risk factors[21943158;21943158];Hematological and biochemical traits[20139978];Coronary artery disease (myocardial infarction, percutaneous transluminal coronary angioplasty, coronary artery bypass grafting, angina or chromic ischemic heart disease)[28714975];Triglycerides[21909109;20686565;22171074;20864672;18193046;18193044;18193043;19060911;23726366;23726366;19060906;24097068;24886709;20139978;25961943;26582766;17463246];Gut microbiota (beta diversity)[27723756];Metabolite levels (lipoprotein measures)[27005778];Coronary artery disease[29212778;29212778;29212778;24262325];HDL cholesterol[21909109;20686565;20864672;18193044;19060911;23726366;21347282;19060906;20031538;24097068;26780889;25961943;26582766;28270201;18193043];HDL cholesterol levels[26763881;28334899;28334899;28334899];Lipid metabolism phenotypes[22286219;19936222;19936222;19936222;19936222;19936222;19936222];Hypertriglyceridemia[20657596;23505323];C-reactive protein levels or triglyceride levels (pleiotropy)[27286809];Metabolic syndrome (multivariate analysis)[29632305];Metabolite levels[22916037];Metabolic syndrome (bivariate traits)[21386085;21386085;21386085];High density lipoprotein cholesterol levels[28548082;29615537;29615537;29615537;29403010];Waist circumference and related phenotypes[18454146];Metabolic traits[19060910];HDL Cholesterol - Triglycerides (HDLC-TG)[21386085];Triglyceride levels in small VLDL[29084231];",0.6045398773006135,0.22485817431665808,0.29444009397024273,0.6548496009821977
2045,16374,LRAT,604863,613341;,[MIM:613341]Leber congenital amaurosis 14;,Retinitis pigmentosa;Leber congenital amaurosis;Severe early-childhood-onset retinal dystrophy,Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in,Activated partial thromboplastin time[29403010];,0.10711656441717791,0.49071686436307377,0.7629861654920387,0.29772866789441377
2046,16375,LRBA,606453,614700;,"[MIM:614700]Immunodeficiency, common variable, 8, with autoimmunity [recessive?];",Combined immunodeficiency due to LRBA deficiency,Disease-causing germline mutation(s) (loss of function) in,Ear morphology[26105758];Helix rolling[26105758];Drug-induced hepatocellular liver injury[28043905];,0.9553374233128834,0.1072717895822589,0.05168363351605325,0.18753836709637814
2047,16390,LRIG2,608869,615112;,,Ochoa syndrome,Disease-causing germline mutation(s) in,,0.12711656441717792,0.042289840123775145,0.3586530931871574,0.05463474524248005
2048,16394,LRIT3,615004,615058;,"[MIM:615058]Night blindness, congenital stationary, 1F [recessive?];",Congenital stationary night blindness,Disease-causing germline mutation(s) in,,0.038773006134969326,0.09025270758122744,0.01096319498825372,0.0
2049,16395,LRMDA,614537,615179;,"[MIM:615179]Albinism, oculocutaneous, 7;",Oculocutaneous albinism type 7,Disease-causing germline mutation(s) in,Urinary albumin excretion (no hypertensive medication)[30220432];,0.038773006134969326,0.6137184115523465,0.0,0.0
2050,16397,LRP1,107770,604093;,[MIM:604093]Keratosis pilaris atrophicans;,Keratosis follicularis spinulosa decalvans;Atrophoderma vermiculata,Disease-causing germline mutation(s) (loss of function) in;Disease-causing germline mutation(s) (loss of function) in,"Migraine without aura[23793025;27322543];Headache[29397368];Moyamoya disease[29273593];Autism spectrum disorder or schizophrenia[28540026];Migraine[22683712;23793025;21666692;27322543;27322543;27182965];Pulmonary function (smoking interaction)[23284291];Abdominal aortic aneurysm[22055160;27899403];Schizophrenia[25056061];Triglyceride levels[28334899];Triglycerides[20686565;24097068;25961943];Itch intensity from mosquito bite[28199695];Migraine - clinic-based[23793025];Coronary artery disease[29212778;29212778];HDL cholesterol[20686565;24097068];Asthma[27182965;29273806;29273806];HDL cholesterol levels[28334899];Cervical artery dissection[25420145];Pulmonary function[21946350];Coronary artery disease (myocardial infarction, percutaneous transluminal coronary angioplasty, coronary artery bypass grafting, angina or chromic ischemic heart disease)[28714975];",0.8247852760736196,0.8543063434760185,0.36674497520229704,0.9910988336402701
2051,16400,LRP2,600073,222448;,[MIM:222448]Donnai-Barrow syndrome [recessive?];,Donnai-Barrow syndrome,Disease-causing germline mutation(s) in,Relapse in multiple sclerosis[28739605];Blood pressure (smoking interaction)[25189868];Serum uric acid levels[29403010];Urate levels[20139978];Creatinine levels[29403010];Anorexia nervosa[21079607];Estimated glomerular filtration rate[29779033];Serum creatinine levels[29779033];Glomerular filtration rate[27588450;27588450;29403010];Glomerular filtration rate (creatinine)[26831199;28452372];,0.7013496932515337,0.9128416709644146,0.16836335160532498,0.9846531614487416
2052,16403,LRP4,604270,212780;614305;616304;,"[MIM:614305]Sclerosteosis 2;[MIM:616304]Myasthenic syndrome, congenital, 17;",Sclerosteosis;Cenani-Lenz syndrome;Postsynaptic congenital myasthenic syndromes,Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) (loss of function) in;Disease-causing germline mutation(s) in,Bone mineral density (hip)[19079262];HDL cholesterol levels[28334899];D-dimer levels[21502573];Autism spectrum disorder or schizophrenia[28540026;28540026];Heel bone mineral density[28869591;28869591;28869591];Reaction time[29844566];HDL cholesterol[20686565;24097068];Intraocular pressure[29617998];,0.45153374233128835,0.761990716864363,0.010702166536152441,0.9195825659914058
2053,16405,LRP5,603506,133780;144750;166710;259770;601813;601884;607634;607636;617875;,"[MIM:133780]Vitreoretinopathy, exudative 1;[MIM:601813]Vitreoretinopathy, exudative 4;[MIM:166710]Osteoporosis;[MIM:259770]Osteoporosis-pseudoglioma syndrome;[MIM:601884]High bone mass trait;[MIM:144750]Endosteal hyperostosis, Worth type [dominant?];[MIM:607634]Osteopetrosis, autosomal dominant 1 [dominant?] [recessive?];[MIM:607636]Van Buchem disease 2 [dominant?];[MIM:617875]Polycystic liver disease 4 with or without kidney cysts [dominant?];","Osteosclerosis-developmental delay-craniosynostosis syndrome;Osteoporosis-pseudoglioma syndrome;Endosteal hyperostosis, Worth type;Autosomal dominant osteopetrosis type 1;Isolated polycystic liver disease;Hyperostosis corticalis generalisata;Familial exudative vitreoretinopathy;LRP5-related primary osteoporosis;LRP5-related primary osteoporosis;Retinopathy of prematurity",Disease-causing germline mutation(s) (gain of function) in;Disease-causing germline mutation(s) (loss of function) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) (gain of function) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Major susceptibility factor in;Major susceptibility factor in,"Bone mineral density (spine)[19801982];Fractures[30158200];Bone mineral density (paediatric, skull)[24945404;24945404];Monobrow[27182965];Heel bone mineral density[28869591;28869591;28869591;28869591;28869591;28869591;28869591;28869591];Bone mineral density (paediatric, total body less head)[28743860];Bone mineral density[18455228;24249740;22504420];Femoral neck bone mineral density[29499414];Lumbar spine bone mineral density[29499414];",0.8456441717791411,0.8623001547189273,0.13860610806577917,0.9576427255985267
2054,16407,LRP6,603507,610947;616724;,"[MIM:610947]Coronary artery disease, autosomal dominant, 2 [dominant?];[MIM:616724]Tooth agenesis, selective, 7 [dominant?];",Oligodontia,Disease-causing germline mutation(s) (loss of function) in,Coronary artery calcification[23870195];Diastolic blood pressure x smoking status (current vs non-current) interaction (2df test)[29455858];Systolic blood pressure x smoking status (ever vs never) interaction (2df test)[29455858;29455858];Diastolic blood pressure x smoking status (ever vs never) interaction (2df test)[29455858;29455858];Systolic blood pressure x smoking status (current vs non-current) interaction (2df test)[29455858;29455858];Tandem gait[26219847];Cerebrospinal fluid t-tau:AB1-42 ratio[28641921];,0.7298159509202454,0.908973697782362,0.34795092665100497,0.9005524861878453
2055,16412,LRPAP1,104225,615431;,"[MIM:615431]Myopia 23, autosomal recessive [recessive?];",Rare isolated myopia,Disease-causing germline mutation(s) (loss of function) in,"Total cholesterol levels[28334899];Tuberculosis[29036319];Fibrinogen[23969696];Triglyceride levels[28334899];Triglycerides[24097068;25961943];LDL cholesterol levels[28334899];Cholesterol, total[24097068;25961943];Blood protein levels[29875488];LDL cholesterol[24097068];",0.8954601226993865,0.18411552346570398,0.3698773166275124,0.31952117863720075
2056,16413,LRPPRC,607544,220111;,,"Congenital lactic acidosis, Saguenay-Lac-Saint-Jean type",Disease-causing germline mutation(s) in,Hand grip strength[29691431;29313844];,0.9943558282208589,0.3633316142341413,0.3970242756460454,0.15976058931860038
2057,16426,LRRC6,614930,614935;,,Primary ciliary dyskinesia,Disease-causing germline mutation(s) (loss of function) in,,0.22687116564417178,0.36126869520371324,0.20334116418689638,0.05386740331491713
2058,16429,LRRC8A,608360,613506;,"[MIM:613506]Agammaglobulinemia 5, autosomal dominant [dominant?];",Autosomal agammaglobulinemia,Disease-causing germline mutation(s) in,"Allergic disease (asthma, hay fever or eczema)[29083406];",0.5026993865030674,0.8803506962351728,0.7045157922213521,0.8535911602209945
2059,16517,LRRK1,610986,,,Osteosclerotic metaphyseal dysplasia,Disease-causing germline mutation(s) in,Central corneal thickness[28171582;29760442;29760442];Corneal structure[23291589];,0.554601226993865,0.5363589479112945,0.050117462803445575,0.3769183548189073
2060,16518,LRRK2,609007,168600;607060;,[MIM:607060]Parkinson disease 8;,Young-onset Parkinson disease;Hereditary late-onset Parkinson disease,Candidate gene tested in;Disease-causing germline mutation(s) (gain of function) in,"Inflammatory bowel disease[28067908;23128233];Pediatric autoimmune diseases[26301688];Parkinson's disease[21292315;22438815;22438815;21738487;19915576;24842889;28011712;27182965;25064009;28892059];Cerebral amyloid deposition in APOEe4 non-carriers (PET imaging)[26252872];Chronic inflammatory diseases (ankylosing spondylitis, Crohn's disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy)[26974007];Leprosy[25642632];Crohn's disease[18587394;21102463;28067908];Obesity-related traits[23251661];Daytime sleep phenotypes[27126917];",0.7629447852760736,0.3066013408973698,0.08692247454972592,0.10405156537753223
2061,16528,LRSAM1,610933,614436;,[MIM:614436]Charcot-Marie-Tooth disease 2P;,Charcot-Marie-Tooth disease type 2P,Disease-causing germline mutation(s) in,,0.48576687116564415,0.07349149045899948,0.5478987209605847,0.14717618170656846
2062,16531,LRTOMT,612414,611451;,"[MIM:611451]Deafness, autosomal recessive, 63 [recessive?];",Autosomal recessive non-syndromic sensorineural deafness type DFNB,Disease-causing germline mutation(s) in,,0.038773006134969326,0.3999484270242393,0.6739754633255025,0.3750767341927563
2063,16569,LSS,600909,616509;,[MIM:616509]Cataract 44;,Total early-onset cataract,Disease-causing germline mutation(s) in,White blood cell count[27863252];,0.5244171779141105,0.21892728210417742,0.18402505873140174,0.15561694290976058
2064,16577,LTBP2,602091,251750;613086;614819;,"[MIM:613086]Glaucoma 3, primary congenital, D [recessive?];[MIM:251750]Microspherophakia and/or megalocornea, with ectopia lentis and with or without secondary glaucoma;[MIM:614819]Weill-Marchesani syndrome 3;",Weill-Marchesani syndrome;Glaucoma secondary to spherophakia/ectopia lentis and megalocornea;Congenital glaucoma,Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in,Height[20881960;25429064;25282103];Mood instability[29187730;29187730];Intraocular pressure[30054594;29785010];,0.17791411042944785,0.4216090768437339,0.2377969198642652,0.8667894413750767
2065,16578,LTBP3,602090,601216;617809;,[MIM:601216]Dental anomalies and short stature;[MIM:617809]Geleophysic dysplasia 3 [dominant?];,Acromicric dysplasia;Geleophysic dysplasia;Brachyolmia-amelogenesis imperfecta syndrome,Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in,Acne (severe)[24927181];Urate levels[23263486];Non-alcoholic fatty liver disease histology (lobular)[20708005];,0.2585276073619632,0.7403300670448685,0.2764291307752545,0.8729281767955801
2066,16579,LTBP4,604710,310200;613177;,[MIM:613177]Urban-Rifkin-Davis syndrome;[MIM:310200]Duchenne muscular dystrophy;,"Cutis laxa with severe pulmonary, gastrointestinal and urinary anomalies;Cutis laxa with severe pulmonary, gastrointestinal and urinary anomalies;Duchenne muscular dystrophy",Disease-causing germline mutation(s) (loss of function) in;Disease-causing germline mutation(s) (gain of function) in;Modifying germline mutation in,,0.47337423312883437,0.9555183084063951,0.011224223440355,0.0
2067,16654,LYRM4,613311,615595;,,Severe neonatal lactic acidosis due to NFS1-ISD11 complex deficiency,Disease-causing germline mutation(s) in,Height[21998595];,0.8719018404907976,0.6160391954615781,0.08039676324719394,0.0
2068,16656,LYRM7,615831,615838;,"[MIM:615838]Mitochondrial complex III deficiency, nuclear 8;",Isolated complex III deficiency,Disease-causing germline mutation(s) in,Inflammatory bowel disease[28067908];Crohn's disease[28067908];Ulcerative colitis[28067908];,0.8932515337423312,0.4185146982980918,0.8462542417123466,0.2733271945979128
2069,16662,LYST,606897,214500;,,Ch�diak-Higashi syndrome;Attenuated Ch�diak-Higashi syndrome,Disease-causing germline mutation(s) (loss of function) in;Disease-causing germline mutation(s) in,Systemic lupus erythematosus[26502338;26502338;19838195];Post bronchodilator FEV1/FVC ratio[26634245];,0.6566871165644171,0.48736462093862815,0.20308013573479508,0.28161448741559236
2070,16665,LYZ,153450,105200;,[MIM:105200]Amyloidosis 8;,ALys amyloidosis,Disease-causing germline mutation(s) in,Response to diuretic therapy[18591461];Granulocyte percentage of myeloid white cells[27863252];Height[18391951];Monocyte count[27863252];Monocyte percentage of white cells[27863252];Blood protein levels[28240269;28240269;29875488;30072576];,0.6458895705521472,0.1964930376482723,0.6374314800313234,0.2429404542664211
2071,16671,LZTFL1,606568,615994;,[MIM:615994]Bardet-Biedl syndrome 17 [recessive?];,Bardet-Biedl syndrome,Disease-causing germline mutation(s) in,Acne (severe)[24927181];Methadone dose in opioid dependence[28115739];,0.6045398773006135,0.4775657555440949,0.32367528060558604,0.2678023327194598
2072,16672,LZTR1,600574,615670;616564;,[MIM:615670]Schwannomatosis 2;[MIM:616564]Noonan syndrome 10;,Noonan syndrome;Gliosarcoma;Giant cell glioblastoma;Neurofibromatosis type 3,Disease-causing germline mutation(s) in;Disease-causing somatic mutation(s) in;Disease-causing somatic mutation(s) in;Major susceptibility factor in,,0.46883435582822086,0.14156781846312533,0.7486296006264683,0.0187231430325353
2073,16682,MAB21L2,604357,615877;,[MIM:615877]Microphthalmia/coloboma and skeletal dysplasia syndrome;,Colobomatous microphthalmia-rhizomelic dysplasia syndrome,Disease-causing germline mutation(s) in,,0.32380368098159507,0.7011346054667354,0.9357870007830854,0.6238489871086557
2074,16699,MAD2L2,604094,617243;,,Fanconi anemia,Disease-causing germline mutation(s) in,Visceral adipose tissue adjusted for BMI[22589738];,0.6391411042944786,0.4927797833935018,0.9182980944922997,0.44613259668508287
2075,16704,MAF,177075,601088;610202;,"[MIM:610202]Cataract 21, multiple types;[MIM:601088]Ayme-Gripp syndrome;",Cataract-microcornea syndrome;Cerulean cataract;Pulverulent cataract,Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in,Obesity[19151714;19151714;19151714];Multiple sclerosis[21833088;24076602];Spherical equivalent or myopia (age of diagnosis)[29808027];Urate levels[23263486];Thyroid hormone levels[23408906;23408906];Serum alkaline phosphatase levels[29403010];Serum thyroid-stimulating hormone levels[24852370];Response to fenofibrate (HDL cholesterol levels)[27002377];Thyroid function[22494929];Renal function-related traits (urea)[22797727];Height[20668459];Thyroid volume[21565293;21565293];Depressive symptoms (SSRI exposure interaction)[25649181];Paclitaxel disposition in epithelial ovarian cancer[29367611];,0.33975460122699386,0.8017019082001031,0.826938136256852,0.0
2076,16708,MAFB,608968,166300;617041;,[MIM:166300]Multicentric carpotarsal osteolysis syndrome;[MIM:617041]Duane retraction syndrome 3 with or without deafness;,Duane retraction syndrome;Multicentric carpo-tarsal osteolysis with or without nephropathy,Disease-causing germline mutation(s) (loss of function) in;Disease-causing germline mutation(s) in,"Bone mineral density (hip)[30172743];Nonsyndromic cleft lip with or without cleft palate[25775280];Paneth cell defects in Crohn's disease[28352666];Response to TNF antagonist treatment[18615156];Cognitive decline rate in late mild cognitive impairment[26252872;26252872];Metabolite levels (lipoprotein measures)[27005778];Plasma parathyroid hormone levels[30134803];Orofacial clefts[28054174;28054174];Drug-induced Stevens-Johnson syndrome or toxic epidermal necrolysis (SJS/TEN)[21221126];Cleft lip with or without cleft palate[28054174;28054174];Total body bone mineral density[29304378];Dupuytren's disease[21732829;28886342];Serum total protein level[29403010];Height[25282103];QT interval (ambient particulate matter interaction)[28749367];Birth weight[27680694];LDL cholesterol levels[28334899;28334899];Cholesterol, total[20686565;24097068;25961943];Obesity-related traits[23251661];LDL cholesterol[20686565;19060906;24097068;25961943];Nonsyndromic cleft lip with cleft palate[28232668];",0.35496932515337426,0.872356884992264,0.9222135212738188,0.0
2077,16714,MAFIP,,,,Early-onset lamellar cataract;Cerulean cataract;Early-onset sutural cataract;Early-onset nuclear cataract;Total early-onset cataract;Early-onset posterior polar cataract,Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in,Axial length[24144296];,0.10711656441717791,0.4960030943785456,0.0,0.0
2078,16717,MAG,159460,616680;,"[MIM:616680]Spastic paraplegia 75, autosomal recessive [recessive?];",Autosomal recessive spastic paraplegia type 75,Disease-causing germline mutation(s) (loss of function) in,,0.28662576687116564,0.4778236204228984,0.3936309057687288,0.37952731737262124
2079,16750,MAGED2,300470,300971;,,Antenatal Bartter syndrome,Disease-causing germline mutation(s) (loss of function) in,,0.9573006134969325,0.9378545642083548,0.5938397285304098,0.0
2080,16757,MAGEL2,605283,615547;,,Prader-Willi syndrome due to paternal deletion of 15q11q13 type 1;Prader-Willi syndrome due to paternal deletion of 15q11q13 type 2;Prader-Willi syndrome due to imprinting mutation;Prader-Willi syndrome due to a point mutation;Prader-Willi syndrome due to maternal uniparental disomy of chromosome 15,Role in the phenotype of;Role in the phenotype of;Role in the phenotype of;Disease-causing germline mutation(s) (loss of function) in;Role in the phenotype of,Serum metabolite concentrations in chronic kidney disease[29545352];Menarche (age at onset)[25231870];,0.2585276073619632,0.9146467251160392,0.33072304881232056,0.0
2081,16758,MAGI1,602625,,,Familial melanoma;BAP1-related tumor predisposition syndrome;Uveal melanoma;Uveal melanoma,Major susceptibility factor in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing somatic mutation(s) in,Neuroticism[25993607];Coronary artery calcified atherosclerotic plaque score in type 2 diabetes[29221444];Knee osteoarthritis[28916551];Adolescent idiopathic scoliosis[28334814];Crohn's disease-related phenotypes[25557950;25557950];Homeostasis model assessment of beta-cell function (dietary factor interaction)[24204828];PR interval[23534349];Post bronchodilator FEV1/FVC ratio[26634245];Asthma (childhood onset)[27611488];Cobalt levels[26025379];Asthma[27611488];,0.5631901840490797,0.7372356884992264,0.3505612111720178,0.34208103130755063
2082,16771,MAGT1,300715,300853;,"[MIM:300853]Immunodeficiency, X-linked, with magnesium defect, Epstein-Barr virus infection and neoplasia;","X-linked immunodeficiency with magnesium defect, Epstein-Barr virus infection and neoplasia",Disease-causing germline mutation(s) in,,0.972760736196319,0.8246518824136153,0.849386583137562,0.5035297728667895
2083,16774,MAK,154235,614181;,[MIM:614181]Retinitis pigmentosa 62;,Retinitis pigmentosa,Disease-causing germline mutation(s) in,Menopause (age at onset)[26414677;26414677];Recurrent major depressive disorder[29317602];,0.30319018404907977,0.06704486848891181,0.5150091359958235,0.03621853898096992
2084,16784,MALT1,604860,615468;,,Combined immunodeficiency due to MALT1 deficiency;MALT lymphoma,Disease-causing germline mutation(s) in;Part of a fusion gene in,Multiple sclerosis[21833088];,0.5450306748466258,0.687209902011346,0.6387366222918298,0.3660220994475138
2085,16791,MAMLD1,300120,300758;,"[MIM:300758]Hypospadias 2, X-linked;",Familial hypospadias;X-linked myotubular myopathy-abnormal genitalia syndrome,Disease-causing germline mutation(s) in;Role in the phenotype of,Immune reponse to smallpox (secreted IFN-alpha)[22610502];,0.038773006134969326,0.8852501289324394,0.48290263638736625,0.0
2086,16796,MAN1B1,604346,614202;,,MAN1B1-CDG;Autosomal recessive non-syndromic intellectual disability,Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in,,0.4493251533742331,0.4969056214543579,0.0,0.43569674647022716
2087,16801,MAN2B1,609458,248500;,"[MIM:248500]Mannosidosis, alpha B, lysosomal;","Alpha-mannosidosis, infantile form;Alpha-mannosidosis, adult form",Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in,Pulmonary emphysema[24383474];,0.27361963190184047,0.19546157813305828,0.12033411641868964,0.6626764886433395
2088,16804,MANBA,609489,248510;,"[MIM:248510]Mannosidosis, beta A, lysosomal [recessive?];",Beta-mannosidosis,Disease-causing germline mutation(s) in,"Primary biliary cirrhosis[22961000];Multiple sclerosis[21833088;24076602];Allergic disease (asthma, hay fever or eczema)[29083406];Sarcoidosis[26051272];Lymphocyte counts[27863252];Allergic rhinitis[30013184];Primary biliary cholangitis[26394269];Primary sclerosing cholangitis[27992413];Blood protein levels[29875488;30072576];Ulcerative colitis[23128233];",0.28662576687116564,0.041258380608561115,0.2417123466457844,0.34775936157151627
2089,16813,MAOA,309850,300615;,[MIM:300615]Brunner syndrome;,Monoamine oxidase A deficiency,Disease-causing germline mutation(s) in,Smoking behavior[19247474];,0.3925153374233129,0.945074780814853,0.8906290785695641,0.0
2090,16816,MAP1B,157129,,,Periventricular nodular heterotopia,Disease-causing germline mutation(s) (loss of function) in,Coronary artery disease in type 1 diabetes[29695241];Attention deficit hyperactivity disorder[18839057];,0.9293251533742332,0.8388344507478082,0.4578439049856434,0.5888581952117864
2091,16825,MAP2K1,176872,615279;,[MIM:615279]Cardiofaciocutaneous syndrome 3;,Cardiofaciocutaneous syndrome,Disease-causing germline mutation(s) (gain of function) in,Testicular germ cell tumor[28604732;28604728];Prostate cancer[29892016];,0.8620858895705521,0.9177411036616813,0.9720699556251632,0.878146101903008
2092,16827,MAP2K2,601263,615280;,[MIM:615280]Cardiofaciocutaneous syndrome 4;,Neurofibromatosis-Noonan syndrome;Cardiofaciocutaneous syndrome,Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) (gain of function) in,Height[29782485];,0.8188957055214724,0.8122743682310469,0.7890890107021665,0.8815224063842848
2093,16834,MAP3K1,600982,613762;,"[MIM:613762]46,XY sex reversal 6;","46,XY complete gonadal dysgenesis;46,XY partial gonadal dysgenesis",Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in,Type 2 diabetes[23209189];Waist circumference adjusted for BMI (joint analysis main effects and physical activity interaction)[28448500;28448500];Waist-to-hip ratio adjusted for BMI in active individuals[28448500;28448500;28448500];Triglyceride levels[28334899];Waist circumference adjusted for BMI (adjusted for smoking behaviour)[28443625];Waist-to-hip ratio adjusted for BMI[26426971];Urate levels (BMI interaction)[25811787];Waist circumference adjusted for BMI (joint analysis main effects and smoking interaction)[28443625];Lung function (FEV1)[30061609];Waist circumference adjusted for BMI in active individuals[28448500;28448500];Waist-to-hip ratio adjusted for body mass index[28448500;28448500;28448500;25673412;25673412;25673412;25673412;25673412;25673412;25673412;25673412];Homeostasis model assessment of insulin resistance (dietary factor interaction)[24204828];Waist-to-hip ratio adjusted for BMI x sex x age interaction (4df test)[26426971];Breast cancer (early onset)[24493630;24493630;24493630;24493630;24493630;24493630;24493630;24493630;24493630;24493630;24493630;24493630];Waist-to-hip ratio adjusted for BMI (smoking interaction)[28443625;28443625];Waist-to-hip ratio adjusted for BMI (adjusted for smoking behaviour)[28443625;28443625;28443625;28443625];Waist circumference adjusted for BMI in non-smokers[28443625];Alanine transaminase levels[29403010];Waist-to-hip ratio adjusted for BMI (joint analysis for main effect and physical activity interaction)[28448500;28448500];Waist-to-hip ratio adjusted for BMI in non-smokers[28443625;28443625];Triglycerides[20686565;24097068];Breast cancer[17529967;19330030;20453838;23535729;29059683];Waist circumference adjusted for body mass index[28448500;28448500;25673412;25673412];Waist-hip ratio[25673412;25673412;25673412];Coronary artery disease[29212778];Waist circumference[23966867];Waist-to-hip ratio adjusted for BMI (age <50)[26426971];Waist-to-hip ratio adjusted for BMI (joint analysis main effects and smoking interaction)[28443625];Sexual dimorphism in anthropometric traits[23754948];Initial pursuit acceleration[29064472];Fasting insulin (dietary factor interaction)[24204828];,0.7246625766871165,1.0,0.04567997911772383,0.5515653775322283
2094,16839,MAP3K6,604468,,,Hereditary diffuse gastric cancer,Disease-causing germline mutation(s) (loss of function) in,,0.5395092024539877,0.042805569881382156,0.08561733228921953,0.11740331491712708
2095,16840,MAP3K7,602614,157800;617137;,[MIM:617137]Frontometaphyseal dysplasia 2 [dominant?];[MIM:157800]Cardiospondylocarpofacial syndrome [dominant?];,Frontometaphyseal dysplasia;Cardiospondylocarpofacial syndrome,Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in,Celiac disease[20190752];Bone mineral density (hip)[30172743];Graves' disease[21841780];Response to inhaled corticosteroid treatment in asthma (change in FEV1)[24792382];Amyotrophic lateral sclerosis (sporadic)[24529757];Severity of nausea and vomiting of pregnancy[29563502];Response to anti-TNF therapy in rheumatoid arthritis[26776603;26776603];Asthma[29273806;29273806];,0.8234355828220858,0.975373904074265,0.9062907856956408,0.8314917127071824
2096,16848,MAP3K14,604655,,,NIK deficiency,Disease-causing germline mutation(s) (loss of function) in,"Multiple sclerosis[21833088];Allergic disease (asthma, hay fever or eczema)[29083406];Cognitive function[28093568];",0.6306748466257669,0.0,0.0,0.0
2097,16852,MAP3K20,609479,616890;617760;,"[MIM:617760]Myopathy, centronuclear, 6, with fiber-type disproportion [recessive?];",Congenital fiber-type disproportion myopathy;Split-foot malformation-mesoaxial polydactyly syndrome,Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in,Adiponectin levels[26299439];Lung cancer[28604730];,0.7871165644171779,0.8651366683857659,0.0,0.0
2098,16857,MAP4K2,603166,,,MODY;Hyperinsulinism due to glucokinase deficiency;Permanent neonatal diabetes mellitus,Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in,Urate levels[21768215;21768215];,0.26588957055214724,0.1820526044352759,0.4400939702427565,0.19137507673419277
2099,16870,MAPK1,176948,,,Distal 22q11.2 microdeletion syndrome,Role in the phenotype of,Inflammatory bowel disease[23128233];Multiple sclerosis[21833088;24076602];,0.9646625766871165,0.9337287261474987,0.9530148786217698,0.0
2100,16890,MAPK10,602897,,,Lennox-Gastaut syndrome,Candidate gene tested in,Liver enzyme levels (alanine transaminase)[22001757];Diisocyanate-induced asthma[25918132];Peripheral artery disease[25009551];Gait speed in old age[28077804];Cobalt levels[26025379];Response to cytidine analogues (gemcitabine)[24483146];,0.4894478527607362,0.9082001031459516,0.8527799530148786,0.6106507059545734
2101,16898,MAPKAPK3,602130,617111;,"[MIM:617111]Macular dystrophy, patterned, 3 [dominant?];",Martinique crinkled retinal pigment epitheliopathy,Disease-causing germline mutation(s) in,Cholangiocarcinoma in primary sclerosing cholangitis (time to event)[28779025];Blood protein levels[28240269];,0.5203680981595092,0.6392470345538938,0.8984599321326024,0.2826887661141805
2102,16902,MAPKBP1,616786,617271;,[MIM:617271]Nephronophthisis 20 [recessive?];,Juvenile nephronophthisis;Late-onset nephronophthisis,Disease-causing germline mutation(s) (loss of function) in;Disease-causing germline mutation(s) (loss of function) in,Urinary albumin excretion[30220432];,0.48576687116564415,0.6928829293450232,0.12190028713129732,0.34131368937998774
2103,16907,MAPRE2,605789,616734;,"[MIM:616734]Skin creases, congenital symmetric circumferential, 2 [dominant?];",Multiple benign circumferential skin creases on limbs,Disease-causing germline mutation(s) in,Cerebrospinal fluid AB1-42 levels[26252872];Facial morphology[29921221];,0.778282208588957,0.9071686436307375,0.9159488384233881,0.8124616329036218
2104,16909,MAPT,157140,172700;260540;600274;601104;,[MIM:600274]Frontotemporal dementia;[MIM:172700]Pick disease of the brain;[MIM:601104]Progressive supranuclear palsy 1 [dominant?];[MIM:260540]Parkinson-dementia syndrome;,Behavioral variant of frontotemporal dementia;Classic progressive supranuclear palsy syndrome;Progressive supranuclear palsy-progressive non-fluent aphasia syndrome;Progressive supranuclear palsy-corticobasal syndrome;Progressive supranuclear palsy-pure akinesia with gait freezing syndrome;Progressive supranuclear palsy-parkinsonism syndrome;Semantic dementia;Progressive non-fluent aphasia,Major susceptibility factor in;Major susceptibility factor in;Major susceptibility factor in;Major susceptibility factor in;Major susceptibility factor in;Major susceptibility factor in;Major susceptibility factor in;Major susceptibility factor in,Neuroticism[29255261];Headache[29397368];Primary biliary cirrhosis[22961000];Parkinson's disease[20711177;21044948;21292315;22438815;21738487;19915575;20070850;24511991;24511991;24842889;25064009;28892059];Alzheimer's disease in APOE e4- carriers[25778476];Intracranial volume[22504418];Idiopathic pulmonary fibrosis[24429156];Atrial fibrillation[29892015];Cognitive ability[29186694];Subcortical brain region volumes[25607358];Interstitial lung disease[23583980];General cognitive ability[29844566;29844566;29844566;29844566;29844566;29844566];Plasma t-tau levels[28100725];Male-pattern baldness[29146897;29146897;29146897];Head circumference (infant)[22504419];Progressive supranuclear palsy[21685912;21685912;30089514];QRS complex (12-leadsum)[27659466];Multiple system atrophy[27629089];Reaction time[29844566;29844566;29844566;29844566;29844566];Bone mineral density[22504420];Cognitive ability (MTAG)[29186694];Corticobasal degeneration[26077951;26077951];,0.8343558282208589,0.9092315626611656,0.06212477160010441,0.8505217925107428
2105,16957,MARS,156560,615486;616280;,[MIM:615486]Interstitial lung and liver disease [recessive?];[MIM:616280]Charcot-Marie-Tooth disease 2U [dominant?];,Autosomal recessive spastic paraplegia type 70;Autosomal dominant Charcot-Marie-Tooth disease type 2U;Severe early-onset pulmonary alveolar proteinosis due to MARS deficiency,Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) (loss of function) in;Disease-causing germline mutation(s) (loss of function) in,,0.8695705521472392,0.334708612686952,0.6335160532498042,0.035451197053407
2106,16958,MARS2,609728,611390;616430;,"[MIM:611390]Spastic ataxia 3, autosomal recessive [recessive?];[MIM:616430]Combined oxidative phosphorylation deficiency 25;",Autosomal recessive spastic ataxia with leukoencephalopathy;Combined oxidative phosphorylation defect type 25,Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in,Autism spectrum disorder or schizophrenia[28540026;28540026];Schizophrenia[25056061];Crohn's disease[28067908];Idiopathic dilated cardiomyopathy[29495422];,0.7712883435582822,0.26843733883445076,0.6319498825371965,0.18999386126457948
2107,16960,MARVELD2,610572,610153;,"[MIM:610153]Deafness, autosomal recessive, 49 [recessive?];",Autosomal recessive non-syndromic sensorineural deafness type DFNB,Disease-causing germline mutation(s) in,,0.7644171779141105,0.3873130479628675,0.27799530148786217,0.039287906691221605
2108,16965,MASP1,600521,257920;,[MIM:257920]3MC syndrome 1 [recessive?];,3MC syndrome,Disease-causing germline mutation(s) (loss of function) in,Type 2 diabetes[30130595];Amyotrophic lateral sclerosis (sporadic)[24529757];Blood protein levels[30072576];,0.5598773006134969,0.4755028365136668,0.35839206473505614,0.748158379373849
2109,16966,MASP2,605102,613791;,[MIM:613791]MASP2 deficiency;,Immunodeficiency due to MASP-2 deficiency,Disease-causing germline mutation(s) in,Beard thickness[26926045];,0.30319018404907977,0.23414130995358431,0.26207256590968414,0.5664518109269491
2110,16973,MASTL,608221,,,Autosomal thrombocytopenia with normal platelets,Disease-causing germline mutation(s) in,Squamous cell lung carcinoma[28604730];Plateletcrit[27863252];,0.7341104294478528,0.0740072202166065,0.3181936831114591,0.0167280540208717
2111,16974,MAT1A,610550,250850;,[MIM:250850]Methionine adenosyltransferase deficiency;,Brain demyelination due to methionine adenosyltransferase deficiency,Disease-causing germline mutation(s) in,Diabetic kidney disease[26305897];,0.23865030674846627,0.6183599793708097,0.8752283998955886,0.8344076120319214
2112,16975,MAT2A,601468,,,Familial thoracic aortic aneurysm and aortic dissection,Candidate gene tested in,Urinary albumin excretion[30220432];Coronary artery disease[29212778];Dysmenorrheic pain[27454463];,0.698159509202454,0.9306343476018566,0.9744192116940746,0.7239103744628607
2113,16981,MATN3,602109,140600;607078;608728;,[MIM:608728]Spondyloepimetaphyseal dysplasia MATN3-related;[MIM:140600]Osteoarthritis 2;,"Spondyloepimetaphyseal dysplasia, matrilin-3 type;Multiple epiphyseal dysplasia type 5",Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in,,0.20368098159509201,0.22124806601340896,0.4314800313234142,0.0
2114,16983,MATR3,164015,606070;,[MIM:606070]Amyotrophic lateral sclerosis 21;,Amyotrophic lateral sclerosis;Vocal cord and pharyngeal distal myopathy,Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in,Body mass index[26426971];,0.9776687116564418,0.9498452810727179,0.8397285304098147,0.6295273173726212
2115,16986,MAX,154950,171300;,[MIM:171300]Pheochromocytoma;,Hereditary pheochromocytoma-paraganglioma,Disease-causing germline mutation(s) in,Mean platelet volume[27863252];Mean corpuscular hemoglobin concentration[27863252;29403010];Mean corpuscular hemoglobin[27863252];Mean corpuscular volume[27863252];Red blood cell traits[23222517];Anthropometric traits[19260139];Blood trace element (Zn levels)[23720494];Obesity-related traits[23251661];Red blood cell count[27863252];Blood protein levels[30072576];Platelet count[27863252];,0.8428220858895705,0.4675090252707581,0.9566692769511876,0.7051872314303254
2116,16990,MBD1,156535,,,Differentiated thyroid carcinoma,Part of a fusion gene in,Chronic lymphocytic leukemia[28165464];,0.6985276073619632,0.9314079422382672,0.23074915165753068,0.9544198895027625
2117,17000,MBD5,611472,156200;,"[MIM:156200]Mental retardation, autosomal dominant 1 [dominant?];",Autosomal dominant non-syndromic intellectual disability;2q23.1 microdeletion syndrome,Disease-causing germline mutation(s) in;Role in the phenotype of,QT interval[29213071];Atrial fibrillation[29892015];,0.38061349693251534,0.9802733367715317,0.5520751761942052,0.9662369551872314
2118,17004,MBL2,154545,610424;614372;,,Susceptibility to infection in immunocompromised patient,Biomarker tested in,Emphysema imaging phenotypes[26030696];Bone ultrasound measurement (velocity of sound)[28472463];Heel bone mineral density[28869591;28869591;28869591;28869591;28869591;28869591;28869591;28869591;28869591;28869591;28869591;28869591];Blood protein levels[28240269;28240269;29875488;30072576];Femoral neck bone mineral density[29499414];Bone ultrasound measurement (broadband ultrasound attenuation)[28472463];Bone properties (heel)[24430505;24430505];Lumbar spine bone mineral density[29499414];Rosacea symptom severity[29771307];Fractures[30158200];Age-related macular degeneration[23326517;23326517];Monobrow[27182965];Chin dimples[27182965];Bone mineral density[22504420];,0.5040490797546012,0.46106240330067044,0.13495170973636125,0.4215776550030694
2119,17015,MBOAT7,606048,617188;,,Autosomal recessive non-syndromic intellectual disability,Disease-causing germline mutation(s) (loss of function) in,Blood metabolite ratios[24816252];Blood metabolite levels[24816252];Obesity-related traits[23251661];Cirrhosis (alcohol related)[26482880];,0.872638036809816,0.555440948942754,0.6943356825894023,0.22421731123388583
2120,17022,MBTPS2,300294,300918;308205;308800;,"[MIM:300918]Olmsted syndrome, X-linked;[MIM:308800]Keratosis follicularis spinulosa decalvans X-linked;",Keratosis follicularis spinulosa decalvans;Ichthyosis follicularis-alopecia-photophobia syndrome;Mutilating palmoplantar keratoderma with periorificial keratotic plaques;BRESEK syndrome,Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in,,0.14576687116564419,0.9507478081485302,0.894283476898982,0.8121546961325967
2121,17023,MC1R,155555,266300;613098;613099;,"[MIM:613099]Melanoma, cutaneous malignant 5;",Large congenital melanocytic nevus;Familial melanoma;Oculocutaneous albinism type 2,Modifying germline mutation in;Major susceptibility factor in;Modifying germline mutation in,Freckling[20585627];Skin sensitivity to sun[17952075;25963972];Light vs. dark hair color[26184321;26184321];Squamous cell carcinoma[26829030];Basal cell carcinoma[21700618;27539887];Blond vs. brown hair color[17952075];Tanning[23548203;19340012;19340012];Melanoma[21983787;19578364;19578364;24980573;28212542;28212542];Low tan response[29739929];Brown vs. non-brown hair color[26184321;26184321];Black vs. non-black hair color[26184321];Facial pigmentation[25705849];Freckles[17952075];Obsessive-compulsive disorder or autism spectrum disorder[28641744];Vitiligo[22561518;27723757];Red vs non-red hair color[17952075;26184321;26184321];Sunburns[23548203];Cutaneous squamous cell carcinoma[27424798];Skin aging (microtopography measurement)[28502801;28502801];Perceived skin darkness[25963972];Black vs. red hair color[18483556];Hair color[23548203;20585627;20585627;29662168];Skin colour saturation[25963972];Non-melanoma skin cancer[23548203;29739929];,0.2585276073619632,0.07890665291387312,0.21848081440877057,0.0
2122,17024,MC2R,607397,202200;,,Familial glucocorticoid deficiency,Disease-causing germline mutation(s) in,,0.14576687116564419,0.5709128416709645,0.47611589663273296,0.4699201964395335
2123,17026,MC4R,155541,601665;,,Obesity due to melanocortin 4 receptor deficiency,Disease-causing germline mutation(s) in,Type 2 diabetes[24509480;22885922;22885922;22885922;28869590;28869590];Body mass index (joint analysis main effects and smoking interaction)[28443625;28443625;28443625];BMI in smokers[28443625;28443625;28443625];Ulna and radius bone mineral density[30172743];Antipsychotic drug-induced weight gain[22566560];Body fat percentage[26833246;26833246;26833246;26833246];Body mass index in physically inactive individuals[28448500;28448500;28448500;28448500;28448500;28448500];Body mass index[20935630;18454148;19079261;24348519;23669352;24064335;23563607;24861553;19079260;28448500;28448500;28448500;28448500;28448500;28448500;25673413;25673413;25673413;25673413;26426971;25953783;25953783;28892062;28892062];Body mass index (age <50)[26426971];Body mass index (age interaction)[25953783];Hip circumference[25673412;25673412;25673412;25673412;25673412;25673412;25673412;25673412];Body mass index (adult)[28430825;28430825;28430825];Body mass index (age>50)[26426971];Height[20881960;25429064;25282103];Obesity-related traits[22013104];Childhood body mass index[26604143];BMI (adjusted for smoking behaviour)[28443625;28443625;28443625];Body mass index (SNP x SNP interaction)[22344221];Obesity[23563607;23563607;23563607;19151714;19151714;19151714];Urate levels[23263486];Hand grip strength[29691431;29691431;29691431;29691431];Daytime sleep phenotypes[27126917];Fat body mass[24064335];Waist-hip ratio[25673412;25673412];Femoral neck bone mineral density[30172743];Coronary artery disease[26343387];Obesity (early onset extreme)[20421936;23563609];Weight[19079260];Body mass index (joint analysis main effects and physical activity interaction)[28448500;28448500;28448500;28448500;28448500;28448500];Cobalt levels[26025379];HDL cholesterol[20686565;24097068];BMI in non-smokers[28443625;28443625;28443625];Waist circumference[19557197;25673412;25673412;25673412];Body mass index x age interaction[26426971];HDL cholesterol levels[28334899];Body mass index x sex x age interaction (4df test)[26426971];Total body bone mineral density[30172743];Body mass index in physically active individuals[28448500;28448500;28448500;28448500;28448500;28448500];C-reactive protein levels or HDL-cholesterol levels (pleiotropy)[27286809];C-reactive protein levels or triglyceride levels (pleiotropy)[27286809];Waist circumference and related phenotypes[18454146];,0.2585276073619632,0.34244455905105725,0.52858261550509,0.17249846531614488
2124,17031,MCCC1,609010,210200;,[MIM:210200]3-methylcrotonoyl-CoA carboxylase 1 deficiency [recessive?];,3-methylcrotonyl-CoA carboxylase deficiency,Disease-causing germline mutation(s) in,Parkinson's disease[21292315;21738487;28011712;27182965;25064009;28892059];Subjective response to lithium treatment[26503763];Blood metabolite levels[24816252];,0.7619631901840491,0.13202681794739557,0.059253458626990343,0.7220687538367097
2125,17033,MCCC2,609014,210210;,[MIM:210210]3-methylcrotonoyl-CoA carboxylase 2 deficiency [recessive?];,3-methylcrotonyl-CoA carboxylase deficiency,Disease-causing germline mutation(s) in,,0.9165644171779141,0.3751933986591026,0.7105194466196816,0.6445672191528545
2126,17041,MCEE,608419,251120;,[MIM:251120]Methylmalonyl-CoA epimerase deficiency;,Methylmalonic acidemia due to methylmalonyl-CoA epimerase deficiency,Disease-causing germline mutation(s) in,Erythema nodosum in inflammatory bowel disease[24487271];,0.10711656441717791,0.6420835482207323,0.17462803445575567,0.23204419889502761
2127,17047,MCFD2,607788,613625;,[MIM:613625]Factor V and factor VIII combined deficiency 2;,Combined deficiency of factor V and factor VIII,Disease-causing germline mutation(s) in,Response to statin therapy[20339536];,0.425398773006135,0.3857658586900464,0.8911511354737667,0.8394720687538367
2128,17052,MCIDAS,614086,,,Primary ciliary dyskinesia,Disease-causing germline mutation(s) (loss of function) in,,0.4190184049079755,0.520371325425477,0.75306708431219,0.0
2129,17055,MCM2,116945,616968;,"[MIM:616968]Deafness, autosomal dominant, 70 [dominant?];",Autosomal dominant non-syndromic sensorineural deafness type DFNA,Disease-causing germline mutation(s) in,Alanine aminotransferase (ALT) levels after remission induction therapy in actute lymphoblastic leukemia (ALL)[28090653];Diastolic blood pressure x smoking status (ever vs never) interaction (2df test)[29455858];,0.9633128834355829,0.28055698813821556,0.3985904463586531,0.41789441375076736
2130,17059,MCM4,602638,609981;,[MIM:609981]Immunodeficiency 54 [recessive?];,Primary immunodeficiency with natural-killer cell deficiency and adrenal insufficiency,Disease-causing germline mutation(s) in,Mean corpuscular volume[27863252];Red blood cell count[27863252];,0.8822085889570552,0.3782877772047447,0.6369094231271208,0.14441375076734192
2131,17062,MCM7,600592,,,Autosomal dominant non-syndromic sensorineural deafness type DFNA,Disease-causing germline mutation(s) in,Alanine aminotransferase (ALT) levels after remission induction therapy in actute lymphoblastic leukemia (ALL)[28090653];Diastolic blood pressure x smoking status (ever vs never) interaction (2df test)[29455858];,0.9411042944785276,0.2555440948942754,0.2028191072826938,0.020411295273173726
2132,17065,MCM9,610098,616185;,[MIM:616185]Ovarian dysgenesis 4;,"46,XX ovarian dysgenesis-short stature syndrome",Disease-causing germline mutation(s) (loss of function) in,Depression in smokers[30219690];,0.30319018404907977,0.7026817947395565,0.3288958496476116,0.0
2133,17069,MCOLN1,605248,252650;,[MIM:252650]Mucolipidosis 4 [recessive?];,Mucolipidosis type IV,Disease-causing germline mutation(s) (loss of function) in,,0.17791411042944785,0.3439917483238783,0.6277734273035761,0.5701350521792511
2134,17072,MCPH1,607117,251200;,"[MIM:251200]Microcephaly 1, primary, autosomal recessive [recessive?];",Autosomal recessive primary microcephaly,Disease-causing germline mutation(s) in,Epirubicin-induced leukopenia[21799462];Alcoholic chronic pancreatitis[28754779];Venlafaxine response in generalised anxiety disorder (remitters vs non-remitters after 24 weeks)[28437668];Cytomegalovirus antibody response[21993531];Post bronchodilator FEV1/FVC ratio[26634245;26634245;26634245;26634245;26634245;26634245;26634245];Intraocular pressure[29785010];,0.5395092024539877,0.1670964414646725,0.04907334899504046,0.1929097605893186
2135,17081,MCTP2,616297,,,Distal monosomy 15q,Role in the phenotype of,Sudden cardiac arrest[21658281];Hippocampal volume[25625606];Night sleep phenotypes[27126917];Bone ultrasound measurement (broadband ultrasound attenuation)[28472463];Bipolar disorder (body mass index interaction)[24322204];Body mass index[25673413;25673413;25673413];Chronic bronchitis and chronic obstructive pulmonary disease[25241909];Cognitive performance[20125193];Stearic acid (18:0) levels[23362303];Heart rate response to exercise[29769521;29769521];Heart rate response to recovery post exercise (50 sec)[29497042];Drug-induced liver injury (flucloxacillin)[19483685];Copper levels[26025379];Heart rate increase in response to exercise[29497042];Motion sickness[25628336];Heart rate response to recovery post exercise[29769521];Overweight status[25133637];White matter hyperintensity burden[25663218];Response to mTOR inhibitor (rapamycin)[24009623];Type 1 diabetes nephropathy[23028342];,0.038773006134969326,0.03455389375966993,0.21221613155833985,0.0019950890116635974
2136,17098,MDH2,154100,617339;,"[MIM:617339]Epileptic encephalopathy, early infantile, 51 [recessive?];",Hereditary pheochromocytoma-paraganglioma,Disease-causing germline mutation(s) in,,0.9442944785276074,0.4401753481175864,0.5168363351605325,0.4722222222222222
2137,17101,MDM2,164785,614401;,,Li-Fraumeni syndrome;Well-differentiated liposarcoma;Dedifferentiated liposarcoma,Modifying germline mutation in;Role in the phenotype of;Role in the phenotype of,Pneumoconiosis in silica exposure[24986923];,0.7669938650306748,0.6799896854048478,0.898981989036805,0.5240945365254758
2138,17115,MECOM,165215,616738;,[MIM:616738]Radioulnar synostosis with amegakaryocytic thrombocytopenia 2 [dominant?];,Acute myeloid leukemia with inv3(q21;q26.2) or t(3;3)(q21;q26.2);Radio-ulnar synostosis-amegakaryocytic thrombocytopenia syndrome;Myelodysplastic syndrome,Part of a fusion gene in;Disease-causing germline mutation(s) in;Part of a fusion gene in,Glaucoma[30054594];Diastolic blood pressure (cigarette smoking interaction)[29455858];Childhood and early adolescence aggressive behavior[26087016];Mean corpuscular volume[29403010];Mean corpuscular hemoglobin[29403010];Pulmonary function (smoking interaction)[23284291];Hematocrit[27863252];Plateletcrit[27863252;27863252];Diastolic blood pressure x alcohol consumption interaction (2df test)[29912962;29912962];Mean arterial pressure[27618448];Blood urea nitrogen levels[29403010];Nasopharyngeal carcinoma[26545403];Response to fenofibrate (triglyceride levels)[27002377];Osteoporosis[23349225];Renal function-related traits (BUN)[22797727];Blood pressure[21909110];Systolic blood pressure x alcohol consumption interaction (2df test)[29912962;29912962];Platelet count[27863252];Mean arterial pressure x alcohol consumption (light vs heavy) interaction (2df test)[29912962;29912962];Mean arterial pressure x alcohol consumption interaction (2df test)[29912962;29912962];Systolic blood pressure[21909115;27618452;28739976;27618447];Blood pressure (smoking interaction)[25189868];Diastolic blood pressure[21909115;27618452;28739976];Myeloproliferative neoplasms[25849990];Red blood cell count[27863252];Systolic blood pressure x alcohol consumption (light vs heavy) interaction (2df test)[29912962;29912962];Systolic blood pressure (cigarette smoking interaction)[29455858];Diastolic blood pressure x alcohol consumption (light vs heavy) interaction (2df test)[29912962;29912962];Glomerular filtration rate[29403010];Lung function (FEV1/FVC)[28166213];Bone mineral density (lumbar spine) in inflammatory bowel disease[29603369];Pulmonary function[21946350];Late-onset Alzheimer's disease[27770636];Aging (time to event)[21782286];Prostate cancer[29892016];Intraocular pressure[29617998;29617998;30054594;29785010];,0.038773006134969326,0.834192882929345,0.24954320020882276,0.0
2139,17116,MECP2,300005,105830;300055;300260;300496;300673;312750;,"[MIM:105830]Angelman syndrome;[MIM:300055]Mental retardation, X-linked, syndromic, 13;[MIM:312750]Rett syndrome;[MIM:300496]Autism, X-linked 3;[MIM:300673]Encephalopathy, neonatal severe, due to MECP2 mutations;[MIM:300260]Mental retardation, X-linked, syndromic, Lubs type;",Rett syndrome;Systemic lupus erythematosus;Trisomy Xq28;X-linked intellectual disability-psychosis-macroorchidism syndrome;X-linked non-syndromic intellectual disability;Atypical Rett syndrome;Severe neonatal-onset encephalopathy with microcephaly,Disease-causing germline mutation(s) in;Major susceptibility factor in;Role in the phenotype of;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) (loss of function) in,Systemic lupus erythematosus[26502338;19838195;26663301];Red blood cell traits[23446634;23446634;23446634];Schizophrenia[24043878];Non-albumin protein levels[29403010];,0.805644171779141,0.8161423414130995,0.6786739754633255,0.9871086556169429
2140,17117,MECR,608205,617282;,,MEPAN syndrome,Disease-causing germline mutation(s) in,Schizophrenia[26531332];,0.35496932515337426,0.34553893759669935,0.6609240407204385,0.10343769183548189
2141,17125,MED9,609878,,,Congenital cataract-microcephaly-nevus flammeus simplex-severe intellectual disability syndrome;Autosomal recessive non-syndromic intellectual disability;Charcot-Marie-Tooth disease type 2B2,Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in,Blood trace element (Se levels)[23720494];,0.8360736196319019,0.6023723568849922,0.5703471678412947,0.5931553100061387
2142,17128,MED12,300188,300895;305450;309520;,"[MIM:309520]Lujan-Fryns syndrome;[MIM:300895]Ohdo syndrome, X-linked;","X-linked intellectual disability with marfanoid habitus;X-linked non-syndromic intellectual disability;Blepharophimosis-intellectual disability syndrome, MKB type;FG syndrome type 1",Disease-causing germline mutation(s) in;Candidate gene tested in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in,Alcoholic chronic pancreatitis[28754779];Diastolic blood pressure[28270201];Brain volume in infants (grey matter)[28763065];Major depressive disorder[27479909];,0.8920245398773006,0.8793192367199587,0.724092926128948,0.0
2143,17131,MED13L,608771,608808;616789;,[MIM:616789]Mental retardation and distinctive facial features with or without cardiac defects [dominant?];,Congenitally uncorrected transposition of the great arteries;Developmental delay-facial dysmorphism syndrome due to MED13L deficiency;Autosomal recessive non-syndromic intellectual disability,Major susceptibility factor in;Disease-causing germline mutation(s) (loss of function) in;Disease-causing germline mutation(s) in,Systolic blood pressure[25249183;29403010];Hypertension[25249183];Diastolic blood pressure[25249183;29403010];Cognitive decline rate in late mild cognitive impairment[26252872;26252872];Colorectal cancer[21761138];Heart rate response to recovery post exercise (30 sec)[29497042];Heart rate response to recovery post exercise (10 sec)[29497042];Diastolic blood pressure x smoking status (ever vs never) interaction (2df test)[29455858;29455858];Mean arterial pressure[29403010];Systolic blood pressure x smoking status (current vs non-current) interaction (2df test)[29455858;29455858];Nose morphology[29921221];Lung function (FVC)[28166213];Heart rate response to recovery post exercise (20 sec)[29497042];Total body bone mineral density[29304378];Left ventricular QRS voltage[27195777];Heart rate response to recovery post exercise (50 sec)[29497042];Heart rate response to recovery post exercise (40 sec)[29497042];Heart rate response to recovery post exercise[29769521];Diastolic blood pressure x smoking status (current vs non-current) interaction (2df test)[29455858;29455858];Systolic blood pressure x smoking status (ever vs never) interaction (2df test)[29455858];Urate levels in overweight individuals[25811787];Diabetic kidney disease[26305897];,0.8625766871165644,0.8411552346570397,0.5181414774210389,0.9100675260896255
2144,17146,MED17,603810,613668;,,Infantile cerebral and cerebellar atrophy with postnatal progressive microcephaly,Disease-causing germline mutation(s) in,,0.932883435582822,0.49123259412068077,0.6619681545288436,0.10696746470227134
2145,17152,MED23,605042,614249;,"[MIM:614249]Mental retardation, autosomal recessive 18 [recessive?];",Autosomal recessive non-syndromic intellectual disability,Disease-causing germline mutation(s) in,L-arginine levels[25245031];,0.9094478527607361,0.20448684889118102,0.7220046985121378,0.43247391037446287
2146,17154,MED25,610197,605589;616449;,[MIM:616449]Basel-Vanagaite-Smirin-Yosef syndrome [recessive?];,Congenital cataract-microcephaly-nevus flammeus simplex-severe intellectual disability syndrome;Autosomal recessive non-syndromic intellectual disability;Charcot-Marie-Tooth disease type 2B2,Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in,Blood trace element (Se levels)[23720494];,0.8651533742331289,0.44533264569365655,0.6977290524667189,0.415438919582566
2147,17174,MEF2C,600662,613443;,"[MIM:613443]Mental retardation, autosomal dominant 20 [dominant?];",5q14.3 microdeletion syndrome,Role in the phenotype of,Waist circumference adjusted for BMI (joint analysis main effects and physical activity interaction)[28448500;28448500];Mean corpuscular volume[27863252];Mean corpuscular hemoglobin[27863252];Intelligence[28530673;28530673];Vascular endothelial growth factor levels[26910538];Cognitive ability[29186694;29186694];Schizophrenia[25056061];Plateletcrit[27863252];Accelerometer-based physical activity measurement (average acceleration)[29899525];Photic sneeze reflex[27182965];Major depressive disorder[27479909;27479909];Mean platelet volume[22139419;27863252];Body mass index[26426971];Intelligence (MTAG)[29326435;29326435;29326435;29326435];Bipolar disorder lithium response (categorical) or schizophrenia[29121268];Tonometry[17903302];Height[20881960;25429064;25282103];Cognitive ability (MTAG)[29186694];Thiazide-induced adverse metabolic effects in hypertensive patients[23400010];Platelet count[22139419;27863252];Waist circumference adjusted for BMI in active individuals[28448500;28448500;28448500];Glomerular filtration rate in chronic kidney disease[26420894;26420894];Bone mineral density (hip)[19801982];Bone mineral density (total hip)[29883787];Retinal vascular caliber[21060863];Alzheimer's disease (late onset)[24162737];Attention deficit hyperactivity disorder[29325848];Platelet distribution width[27863252];Depression[29700475];Waist circumference adjusted for body mass index[28448500;28448500;28448500;28448500];Red blood cell count[27863252];Femoral neck bone mineral density[29499414];General cognitive ability[29844566];Rosacea symptom severity[29771307];Bone mineral density (Ward's triangle area)[27397699];Retinal arteriolar caliber[23776548];Bone mineral density[24249740;21533022;21533022;22504420;23572186];,0.5370552147239264,0.924187725631769,0.9579744192116941,0.4495089011663597
2148,17178,MEFV,608107,134610;249100;,"[MIM:249100]Familial Mediterranean fever, autosomal recessive [recessive?];[MIM:134610]Familial Mediterranean fever, autosomal dominant [dominant?] [recessive?];",Beh�et disease;Familial Mediterranean fever;Intermittent hydrarthrosis,Major susceptibility factor in;Disease-causing germline mutation(s) in;Candidate gene tested in,,0.33975460122699386,0.048736462093862815,0.21352127381884625,0.07228360957642725
2149,17179,MEG3,605636,,,Temple syndrome due to paternal 14q32.2 microdeletion;Kagami-Ogata syndrome due to maternal 14q32.2 microdeletion;Kagami-Ogata syndrome due to maternal 14q32.2 hypermethylation;Temple syndrome due to paternal 14q32.2 hypomethylation;Temple syndrome due to maternal uniparental disomy of chromosome 14;Kagami-Ogata syndrome due to paternal uniparental disomy of chromosome 14,Role in the phenotype of;Role in the phenotype of;Role in the phenotype of;Role in the phenotype of;Role in the phenotype of;Role in the phenotype of,Type 1 diabetes[19966805];Optic nerve measurement (disc area)[20395239];,0.038773006134969326,0.0,0.0,0.0
2150,17183,MEGF8,604267,614976;,[MIM:614976]Carpenter syndrome 2 [recessive?];,Carpenter syndrome,Disease-causing germline mutation(s) in,,0.23865030674846627,0.7630221763795771,0.37300965805272773,0.21899938612645795
2151,17185,MEGF10,612453,614399;,"[MIM:614399]Myopathy, early-onset, areflexia, respiratory distress, and dysphagia [recessive?];",Early-onset myopathy-areflexia-respiratory distress-dysphagia syndrome,Disease-causing germline mutation(s) in,Initial pursuit acceleration[29064472];Response to antipsychotic treatment in schizophrenia[29503163;29503163];Alzheimer's disease (cognitive decline)[23535033];,0.33975460122699386,0.9360495100567303,0.23570869224745497,0.37952731737262124
2152,17192,MEIOB,617670,617706;,,Male infertility with azoospermia or oligozoospermia due to single gene mutation,Disease-causing germline mutation(s) in,,0.10711656441717791,0.2643115007735946,0.12555468546071522,0.0
2153,17197,MEIS2,601740,600987;,"[MIM:600987]Cleft palate, cardiac defects, and mental retardation [dominant?];",15q14 microdeletion syndrome,Role in the phenotype of,Post bronchodilator FEV1 in COPD[26634245];Restless legs syndrome[29029846];Hyperactive-impulsive symptoms[18821565];Response to antipsychotic treatment[20195266];Major depressive disorder[27479909];Intraocular pressure[24002674];Angiotensin-converting enzyme inhibitor intolerance[28030426];,0.4645398773006135,0.9330840639504899,0.841033672670321,0.807243707796194
2154,17211,MEN1,613733,131100;,,Multiple endocrine neoplasia type 1;Prolactinoma;Silent pituitary adenoma;Null pituitary adenoma;Insulinoma;Familial isolated hyperparathyroidism,Disease-causing germline mutation(s) in;Major susceptibility factor in;Major susceptibility factor in;Major susceptibility factor in;Major susceptibility factor in;Disease-causing germline mutation(s) in,Urate levels[21768215];,0.7558282208588957,0.833161423414131,0.7533281127642913,0.0
2155,17212,MEOX1,600147,214300;,"[MIM:214300]Klippel-Feil syndrome 2, autosomal recessive [recessive?];",Isolated Klippel-Feil syndrome,Disease-causing germline mutation(s) in,Fractures[30158200];,0.5326380368098159,0.2065497679216091,0.2153484729835552,0.7329650092081031
2156,17223,MERTK,604705,613862;,[MIM:613862]Retinitis pigmentosa 38;,Retinitis pigmentosa,Disease-causing germline mutation(s) in,Multiple sclerosis[21833088];Hepatitis C induced liver fibrosis[22841784];Coronary artery disease[29212778];,0.2498159509202454,0.2746260959257349,0.2278778386844166,0.1652854511970534
2157,17226,MESP2,605195,608681;,"[MIM:608681]Spondylocostal dysostosis 2, autosomal recessive [recessive?];",Autosomal recessive spondylocostal dysostosis,Disease-causing germline mutation(s) in,Coronary artery aneurysm in Kawasaki disease[27171184];,0.10711656441717791,0.6026302217637958,0.31271208561733227,0.0
2158,17233,MET,164860,114550;605074;607278;616705;,"[MIM:114550]Hepatocellular carcinoma;[MIM:605074]Renal cell carcinoma papillary;[MIM:616705]Deafness, autosomal recessive, 97 [recessive?];[MIM:607278]Osteofibrous dysplasia;",Papillary renal cell carcinoma;Osteofibrous dysplasia;Pediatric hepatocellular carcinoma;Hereditary papillary renal cell carcinoma;Autosomal recessive non-syndromic sensorineural deafness type DFNB,Disease-causing somatic mutation(s) in;Disease-causing germline mutation(s) (gain of function) in;Disease-causing somatic mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in,HDL cholesterol levels[28334899;28334899];Resting heart rate[27798624;29769521];Multiple sclerosis (severity)[19010793];Hematocrit[28017375];Triglyceride levels[28334899;28334899;28334899];Triglycerides[24097068];Blood protein levels[30072576;30072576];PR segment[24850809];Waist-to-hip ratio adjusted for BMI[26426971];Gamma glutamyl transferase levels[29403010];Waist-to-hip ratio adjusted for BMI x sex x age interaction (4df test)[26426971];,0.6841717791411043,0.8594636410520887,0.3831897676846776,0.4085328422344997
2159,17267,METTL23,615262,615942;,"[MIM:615942]Mental retardation, autosomal recessive 44 [recessive?];",Autosomal recessive non-syndromic intellectual disability,Disease-causing germline mutation(s) in,,0.35496932515337426,0.17637957710159877,0.701644479248238,0.0
2160,17282,MFAP5,601103,616166;,"[MIM:616166]Aortic aneurysm, familial thoracic 9;",Familial thoracic aortic aneurysm and aortic dissection,Disease-causing germline mutation(s) (loss of function) in,,0.12711656441717792,0.4608045384218669,0.9180370660401984,0.3492940454266421
2161,17283,MFF,614785,617086;,,MFF-related encephalopathy due to mitochondrial and peroxisomal fission defect,Disease-causing germline mutation(s) (loss of function) in,Intraocular pressure[29617998];,0.7520245398773007,0.6792160907684374,0.052466718872357085,0.10696746470227134
2162,17287,MFN2,608507,601152;609260;617087;,"[MIM:617087]Charcot-Marie-Tooth disease 2A2B [recessive?];[MIM:609260]Charcot-Marie-Tooth disease 2A2A;[MIM:601152]Neuropathy, hereditary motor and sensory, 6A [dominant?];",Multiple symmetric lipomatosis;Hereditary motor and sensory neuropathy type 5;Severe early-onset axonal neuropathy due to MFN2 deficiency;Hereditary motor and sensory neuropathy type 6;Autosomal dominant Charcot-Marie-Tooth disease type 2A2,Disease-causing germline mutation(s) (loss of function) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in,Tuberculosis[29036319];Inflammatory skin disease[25574825];Platelet count[22139419];,0.785521472392638,0.9270242392986076,0.70817019055077,0.9505831798649478
2163,17289,MFRP,606227,609549;611040;,"[MIM:609549]Nanophthalmos 2 [recessive?];[MIM:611040]Microphthalmia, isolated, 5;",Microphthalmia-retinitis pigmentosa-foveoschisis-optic disc drusen syndrome;Nanophthalmia,Disease-causing germline mutation(s) (loss of function) in;Disease-causing germline mutation(s) in,Intraocular pressure[30054594];,0.038773006134969326,0.051315110881897885,0.2602453667449752,0.24923265807243708
2164,17292,MFSD2A,614397,616486;,"[MIM:616486]Microcephaly 15, primary, autosomal recessive [recessive?];",Autosomal recessive primary microcephaly,Disease-causing germline mutation(s) (loss of function) in,PR interval[23534349];,0.038773006134969326,0.5729757607013924,0.6896371704515792,0.7412523020257827
2165,17302,MFSD8,611124,610951;616170;,[MIM:616170]Macular dystrophy with central cone involvement;,CLN7 disease,Disease-causing germline mutation(s) in,Glucose homeostasis traits[25524916;25524916];,0.3168098159509202,0.29525528623001546,0.31062385800052206,0.38812154696132595
2166,17317,MGAT2,602616,212066;,[MIM:212066]Congenital disorder of glycosylation 2A;,MGAT2-CDG,Disease-causing germline mutation(s) (loss of function) in,Blood protein levels[29875488;30072576];,0.7693251533742331,0.49664775657555443,0.7624641085878361,0.7575199508901166
2167,17330,MGME1,615076,615084;,[MIM:615084]Mitochondrial DNA depletion syndrome 11 [recessive?];,Progressive external ophthalmoplegia-myopathy-emaciation syndrome,Disease-causing germline mutation(s) (loss of function) in,,0.8310429447852761,0.3617844249613203,0.48629600626468283,0.0
2168,17331,MGMT,156569,,,Gliosarcoma;Giant cell glioblastoma;Familial melanoma,Biomarker tested in;Biomarker tested in;Major susceptibility factor in,Alzheimer's disease in APOE e4- carriers[25778476];Response to temozolomide[23047291];Waist-to-hip circumference ratio (ever vs never smoking interaction)[23192594];Lead levels[26025379];Hand grip strength[29691431;29313844];Gut microbiota (functional units)[27694959];Metabolite levels  (X-11787)[23934736];MGMT methylation in smokers[26183928];Inflammatory skin disease[25574825];Intraocular pressure[29617998];,0.49570552147239266,0.1634863331614234,0.2612894805533803,0.1359729895641498
2169,17332,MGP,154870,245150;,[MIM:245150]Keutel syndrome [recessive?];,Keutel syndrome,Disease-causing germline mutation(s) (loss of function) in,Blood protein levels[30072576;30072576];,0.038773006134969326,0.7019082001031459,0.25189245627773427,0.32443216697360344
2170,17349,MIB1,608677,615092;,[MIM:615092]Left ventricular non-compaction 7 [dominant?];,Left ventricular noncompaction,Disease-causing germline mutation(s) (loss of function) in,Severe progression in rheumatoid arthritis[29065906];,0.8500613496932515,0.0005157297576070139,0.7556773688332028,0.09330877839165132
2171,17350,MIB2,611141,,,Left ventricular noncompaction,Major susceptibility factor in,Body mass index[26426971];,0.7283435582822085,0.21325425477050025,0.17097363612633776,0.7090239410681399
2172,17368,MICU1,605084,615673;,[MIM:615673]Myopathy with extrapyramidal signs [recessive?];,Proximal myopathy with extrapyramidal signs,Disease-causing germline mutation(s) (loss of function) in,,0.7580368098159509,0.19417225373904073,0.6812842599843383,0.0
2173,17371,MID1,300552,300000;,[MIM:300000]Opitz GBBB syndrome 1;,X-linked Opitz G/BBB syndrome,Disease-causing germline mutation(s) (loss of function) in,,0.541840490797546,0.9221248066013409,0.7026885930566432,0.40316144874155924
2174,17374,MID2,300204,300928;,"[MIM:300928]Mental retardation, X-linked 101;",X-linked non-syndromic intellectual disability,Disease-causing germline mutation(s) in,,0.6628220858895706,0.6623259412068077,0.5309318715740016,0.0
2175,17382,MIF,153620,604302;,[MIM:604302]Rheumatoid arthritis systemic juvenile;,Systemic-onset juvenile idiopathic arthritis,Major susceptibility factor in,Liver enzyme levels (gamma-glutamyl transferase)[22001757];Blood protein levels[30072576];Macrophage Migration Inhibitory Factor levels[27989323];,0.6030674846625766,0.44713769984528107,0.9339598016183764,0.0
2176,17405,MINPP1,605391,188470;,,Familial papillary or follicular thyroid carcinoma,Candidate gene tested in,Forehead morphology[29921221];Pursuit maintenance gain[29064472];Longevity[20304771];Blood protein levels[30072576];,0.625398773006135,0.40948942753996903,0.8948055338031845,0.4307857581338244
2177,17409,MIP,154050,615274;,"[MIM:615274]Cataract 15, multiple types;",Early-onset lamellar cataract;Cerulean cataract;Early-onset sutural cataract;Early-onset nuclear cataract;Total early-onset cataract;Early-onset posterior polar cataract,Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in,Axial length[24144296];,0.2498159509202454,0.4960030943785456,0.5116157661185069,0.6565377532228361
2178,17410,MIPEP,602241,617228;,[MIM:617228]Combined oxidative phosphorylation deficiency 31 [recessive?];,Lethal left ventricular non-compaction-seizures-hypotonia-cataract-developmental delay syndrome,Disease-causing germline mutation(s) in,Lung cancer[21725308];Visceral adipose tissue adjusted for BMI[22589738];Myopia (pathological)[21640322];,0.8065030674846626,0.5765858690046416,0.35447663795353695,0.03683241252302026
2179,17434,MIR17HG,609415,614326;,,Feingold syndrome type 2,Role in the phenotype of,Type 2 diabetes[28869590;28869590];Cognitive ability[29186694];Cognitive ability (MTAG)[29186694];,0.038773006134969326,0.0,0.0,0.0
2180,17482,MIR96,611606,,,Autosomal dominant non-syndromic sensorineural deafness type DFNA,Disease-causing germline mutation(s) in,,0.038773006134969326,0.0,0.0,0.0
2181,17564,MIR184,613146,,,EDICT syndrome,Disease-causing germline mutation(s) in,,0.038773006134969326,0.0,0.0,0.0
2182,17596,MIR204,610942,,,Familial progressive retinal dystrophy-iris coloboma-congenital cataract syndrome,Disease-causing germline mutation(s) (gain of function) in,,0.038773006134969326,0.0,0.0,0.0
2183,19420,MITF,156845,103470;103500;193510;614456;617306;,"[MIM:193510]Waardenburg syndrome 2A [dominant?];[MIM:103470]Waardenburg syndrome 2, with ocular albinism, autosomal recessive [recessive?];[MIM:103500]Tietz albinism-deafness syndrome [dominant?];[MIM:614456]Melanoma, cutaneous malignant 8;[MIM:617306]Coloboma, osteopetrosis, microphthalmia, macrocephaly, albinism, and deafness [recessive?];",Waardenburg syndrome type 2;Familial melanoma;Papillary renal cell carcinoma;Ocular albinism with congenital sensorineural deafness;MITF-related melanoma and renal cell carcinoma predisposition syndrome;Clear cell papillary renal cell carcinoma;Tietz syndrome,Disease-causing germline mutation(s) in;Major susceptibility factor in;Major susceptibility factor in;Disease-causing germline mutation(s) in;Major susceptibility factor in;Major susceptibility factor in;Disease-causing germline mutation(s) in,Severe influenza A (H1N1) infection[26379185];QRS complex (12-leadsum)[27659466];Hematocrit[27863252];Red blood cell count[27863252];Hemoglobin concentration[27863252];Circulating fibroblast growth factor 23 levels[30217807];,0.43754601226993867,0.9399174832387829,0.7332289219524928,0.648096992019644
2184,19424,MKKS,604896,236700;605231;,[MIM:236700]McKusick-Kaufman syndrome;[MIM:605231]Bardet-Biedl syndrome 6 [recessive?];,McKusick-Kaufman syndrome;Bardet-Biedl syndrome,Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in,,0.5040490797546012,0.12661165549252193,0.1991647089532759,0.5756599140577041
2185,19434,MKRN3,603856,615346;,,Idiopathic central precocious puberty,Disease-causing germline mutation(s) (loss of function) in,Menarche (age at onset)[25231870];,0.583558282208589,0.6196493037648272,0.8420777864787262,0.29066912216083485
2186,19442,MKS1,609883,249000;615990;617121;,[MIM:249000]Meckel syndrome 1;[MIM:615990]Bardet-Biedl syndrome 13 [recessive?];[MIM:617121]Joubert syndrome 28 [recessive?];,Meckel syndrome;Joubert syndrome;Bardet-Biedl syndrome;Joubert syndrome with ocular defect,Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in,Post bronchodilator FEV1 in COPD[26634245;26634245;26634245];Post bronchodilator FEV1/FVC ratio in COPD[26634245;26634245;26634245];,0.8510429447852761,0.2408457968024755,0.6178543461237275,0.026550030693677104
2187,19446,MLC1,605908,604004;,,Megalencephalic leukoencephalopathy with subcortical cysts,Disease-causing germline mutation(s) in,Acne (severe)[24927181];Body mass index (adult)[28430825];,0.22687116564417178,0.1854048478597215,0.21587052988775776,0.8032535297728668
2188,19451,MLH1,120436,114500;158320;276300;608089;609310;,[MIM:276300]Mismatch repair cancer syndrome [recessive?];[MIM:158320]Muir-Torre syndrome [dominant?];[MIM:608089]Endometrial cancer;[MIM:114500]Colorectal cancer;,Muir-Torre syndrome;Constitutional mismatch repair deficiency syndrome;Lynch syndrome,Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in,Subjective response to lithium treatment[26503763];Autism spectrum disorder or schizophrenia[28540026];Schizophrenia[28991256];,0.7262576687116564,0.21918514698298092,0.1939441399112503,0.9938612645794966
2189,19452,MLH3,604395,114500;614385;,[MIM:114500]Colorectal cancer;,Lynch syndrome,Modifying germline mutation in,Inflammatory bowel disease[23128233];Mood instability[29187730;29187730];,0.5180368098159509,0.26456936565239814,0.17149569303054032,0.7166973603437692
2190,19458,MLLT3,159558,,,Acute myeloid leukemia with t(9;11)(p22;q23),Part of a fusion gene in,Response to montelukast in asthma (change in FEV1)[26083242];Atrial fibrillation[29892015];,0.6835582822085889,0.9689272821041774,0.735317149569303,0.8979435236341313
2191,19460,MLLT10,602409,,,Precursor T-cell acute lymphoblastic leukemia,Part of a fusion gene in,Epithelial ovarian cancer[25581431];Hand grip strength[29691431;29691431];Breast cancer[23535729];Subcutaneous adipose tissue[26480920];Meningioma[21804547];Ovarian cancer[23535730;23535730];,0.6312883435582822,0.972279525528623,0.6658835813103628,0.5052179251074279
2192,19466,MLPH,606526,609227;,[MIM:609227]Griscelli syndrome 3 [recessive?];,Griscelli syndrome type 3,Disease-causing germline mutation(s) in,Heel bone mineral density[28869591];Prostate cancer[21743057];Intraocular pressure[29617998;29617998];,0.20368098159509201,0.15317173800928313,0.334899504045941,0.14809699201964396
2193,19468,MLX,602976,,,Takayasu arteritis,Major susceptibility factor in,Crohn's disease[21102463];,0.3889570552147239,0.6034038164002062,0.09892978334638476,0.5497237569060773
2194,19471,MLYCD,606761,248360;,[MIM:248360]Malonyl-CoA decarboxylase deficiency;,Malonic aciduria,Disease-causing germline mutation(s) in,Response to bronchodilator in chronic obstructive pulmonary disease (change in FEV1)[26503814];Lead levels[26025379];,0.7954601226993865,0.32826199071686435,0.5207517619420516,0.0
2195,19472,MMAA,607481,251100;,,Vitamin B12-responsive methylmalonic acidemia type cblA,Disease-causing germline mutation(s) in,Response to cognitive-behavioural therapy in anxiety disorder[26989097];,0.5353374233128835,0.26147498710675604,0.35682589402244846,0.5466543891958257
2196,19473,MMAB,607568,251110;,,Vitamin B12-responsive methylmalonic acidemia type cblB,Disease-causing germline mutation(s) in,Polymyositis[26362759];Age-related nuclear cataracts[24951543];HDL cholesterol[20686565;20864672;19060906;25961943;18193043];,0.9180368098159509,0.39814337287261475,0.1579222135212738,0.569060773480663
2197,19474,MMACHC,609831,277400;,,"Methylmalonic acidemia with homocystinuria, type cblC",Disease-causing germline mutation(s) in,Blood protein levels[28240269];Homocysteine levels[23824729];,0.12711656441717792,0.06730273336771532,0.3761419994779431,0.5228667894413751
2198,19475,MMADHC,611935,277410;,,"Methylcobalamin deficiency type cblDv1;Vitamin B12-responsive methylmalonic acidemia, type cblDv2;Methylmalonic acidemia with homocystinuria, type cblD",Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in,Liver enzyme levels (alanine transaminase)[24124411];Daytime sleep phenotypes[27126917];,0.3749693251533742,0.24600309437854564,0.4487079091620987,0.5260896255371393
2199,19478,MME,120520,617017;617018;,[MIM:617017]Charcot-Marie-Tooth disease 2T;[MIM:617018]Spinocerebellar ataxia 43 [dominant?];,Charcot-Marie-Tooth disease type 2T;MME-related autosomal dominant Charcot Marie Tooth disease type 2;Spinocerebellar ataxia type 43,Disease-causing germline mutation(s) (loss of function) in;Disease-causing germline mutation(s) (loss of function) in;Disease-causing germline mutation(s) in,Primary sclerosing cholangitis[27992413];,0.6370552147239263,0.0,0.5862699034194727,0.9544198895027625
2200,19480,MMEL1,618104,,,Primary biliary cholangitis,Major susceptibility factor in,Inflammatory bowel disease[28067908];Celiac disease[20190752;22057235];Body mass index[26426971];Multiple sclerosis[21833088;24076602;27386562];Rheumatoid arthritis (ACPA-positive)[24532676;23143596];Graves' disease[22922229];Rheumatoid arthritis[18794853;24390342;24390342;24390342;23143596];Autoimmune thyroid diseases (Graves disease or Hashimoto's thyroiditis)[22922229];Primary sclerosing cholangitis[27992413];Non-obstructive azoospermia[22197933];Ulcerative colitis[21297633;23128233;28067908];,0.038773006134969326,0.0590510572460031,0.5241451318193683,0.6190914671577655
2201,19482,MMP1,120353,,,Severe generalized recessive dystrophic epidermolysis bullosa,Modifying germline mutation in,Blood protein levels[28240269;30072576];,0.33975460122699386,0.036101083032490974,0.599582354476638,0.07565991405770411
2202,19483,MMP2,120360,259600;,"[MIM:259600]Multicentric osteolysis, nodulosis, and arthropathy [recessive?];",Torg-Winchester syndrome;Nodulosis-arthropathy-osteolysis syndrome,Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in,,0.5244171779141105,0.7846828261990717,0.5335421560950143,0.6497851442602823
2203,19488,MMP9,120361,603932;613073;,[MIM:603932]Intervertebral disc disease;[MIM:613073]Metaphyseal anadysplasia 2;,Metaphyseal anadysplasia,Disease-causing germline mutation(s) (loss of function) in,Mild influenza (H1N1) infection[26379185];Inflammatory bowel disease[23128233];Advanced age-related macular degeneration[26691988];Systemic sclerosis[29293537];Abdominal aortic aneurysm[27899403];Blood protein levels[29875488;30072576];,0.48736196319018404,0.03635894791129448,0.03680501174628034,0.06276856967464703
2204,19492,MMP13,600108,250400;602111;,"[MIM:602111]Spondyloepimetaphyseal dysplasia Missouri type;[MIM:602111]Metaphyseal anadysplasia 1;[MIM:250400]Metaphyseal dysplasia, Spahr type [recessive?];","Metaphyseal anadysplasia;Metaphyseal anadysplasia;Metaphyseal chondrodysplasia, Spahr type;Spondyloepimetaphyseal dysplasia, Missouri type",Disease-causing germline mutation(s) (loss of function) in;Disease-causing germline mutation(s) (gain of function) in;Disease-causing germline mutation(s) (loss of function) in;Disease-causing germline mutation(s) in,Peanut allergy[29030101];Diisocyanate-induced asthma[25918132];Cerebrospinal fluid levels of Alzheimer's disease-related proteins[25340798];,0.2585276073619632,0.037648272305312015,0.6306447402766902,0.11187845303867404
2205,19493,MMP14,600754,277950;,[MIM:277950]Winchester syndrome;,Torg-Winchester syndrome;Nodulosis-arthropathy-osteolysis syndrome,Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in,Dupuytren's disease[28886342];Heel bone mineral density[28869591;28869591;28869591];Prostate cancer[29892016];,0.4917791411042945,0.6333161423414131,0.22709475332811277,0.8838244321669736
2206,19497,MMP19,601807,611543;,[MIM:611543]Cavitary optic disc anomalies;,Familial cavitary optic disc anomaly,Disease-causing germline mutation(s) in,Advanced age-related macular degeneration[26691988];,0.038773006134969326,0.02707581227436823,0.5554685460715217,0.0
2207,19498,MMP20,604629,612529;,"[MIM:612529]Amelogenesis imperfecta, hypomaturation type, 2A2;",Hypomaturation amelogenesis imperfecta,Disease-causing germline mutation(s) in,Urinary metabolite concentrations in chronic kidney disease[29545352];Response to TNF inhibitor in rheumatoid arthritis (change in patient global heath assessment score)[30166627];Neuroblastoma (11q deletion)[28924153];Adverse response to antithyroid drugs in Graves disease[30067105];Night sleep phenotypes[27126917];Prostate cancer[23535732];,0.038773006134969326,0.06343476018566271,0.17384494909945183,0.20748925721301412
2208,19499,MMP21,608416,616749;,"[MIM:616749]Heterotaxy, visceral, 7, autosomal [recessive?];",Situs ambiguus;Situs inversus totalis,Disease-causing germline mutation(s) (loss of function) in;Disease-causing germline mutation(s) (loss of function) in,,0.038773006134969326,0.13705518308406395,0.4468807099973897,0.10082872928176796
2209,19500,MMP23A,603320,,,Situs ambiguus;Situs inversus totalis,Disease-causing germline mutation(s) (loss of function) in;Disease-causing germline mutation(s) (loss of function) in,Body mass index[26426971];,0.08736196319018405,0.13705518308406395,0.0,0.0
2210,19504,MMP25,608482,,,Hypomaturation amelogenesis imperfecta,Disease-causing germline mutation(s) in,Urinary metabolite concentrations in chronic kidney disease[29545352];Response to TNF inhibitor in rheumatoid arthritis (change in patient global heath assessment score)[30166627];Neuroblastoma (11q deletion)[28924153];Adverse response to antithyroid drugs in Graves disease[30067105];Night sleep phenotypes[27126917];Prostate cancer[23535732];,0.10711656441717791,0.08045384218669417,0.33228921952492824,0.1111111111111111
2211,19513,MMUT,609058,251000;,[MIM:251000]Methylmalonic aciduria type mut;,Vitamin B12-unresponsive methylmalonic acidemia type mut0;Vitamin B12-unresponsive methylmalonic acidemia type mut-,Disease-causing germline mutation(s) (loss of function) in;Disease-causing germline mutation(s) (loss of function) in,Nose morphology[29921221];Folate pathway vitamin levels[19744961];Homocysteine levels[23824729];,0.038773006134969326,0.025012893243940175,0.0,0.0
2212,19516,MN1,156100,607174;,,Familial multiple meningioma,Candidate gene tested in,Resting heart rate[27798624];Mitral valve prolapse[26301497];Blood pressure (smoking interaction)[25189868;25189868];Mean corpuscular hemoglobin[27863252];Mean corpuscular volume[27863252];Plateletcrit[27863252];Lung function (FEV1)[28166213];Age-related cataracts[25352737];Platelet count[27863252];Urate levels in obese individuals[25811787];,0.10711656441717791,0.9868488911810211,0.27120856173322894,0.0
2213,19522,MNX1,142994,176450;,,Currarino syndrome,Disease-causing germline mutation(s) in,Type 2 diabetes[28566273];,0.038773006134969326,0.7751418256833419,0.8822761681023231,0.0
2214,19536,MOCOS,613274,603592;,[MIM:603592]Xanthinuria 2;,Xanthinuria type II,Disease-causing germline mutation(s) in,Post bronchodilator FEV1/FVC ratio[26634245];Post bronchodilator FEV1[26634245];,0.7916564417177914,0.03171738009283136,0.07517619420516837,0.5044505831798649
2215,19537,MOCS1,603707,252150;,,Sulfite oxidase deficiency due to molybdenum cofactor deficiency type A,Disease-causing germline mutation(s) (loss of function) in,,0.21484662576687116,0.17509025270758122,0.23101018010963195,0.7220687538367097
2216,19539,MOCS2,603708,252160;,,Sulfite oxidase deficiency due to molybdenum cofactor deficiency type B,Disease-causing germline mutation(s) (loss of function) in,Acne (severe)[24927181];Systemic juvenile idiopathic arthritis[27927641];Intraocular pressure[29235454];,0.554601226993865,0.3274883960804538,0.44348734012007307,0.11049723756906077
2217,19543,MOG,159465,614250;,,Narcolepsy type 1,Major susceptibility factor in,Autism spectrum disorder or schizophrenia[28540026;28540026;28540026;28540026;28540026;28540026;28540026;28540026;28540026;28540026;28540026];Lung cancer in ever smokers[28604730];Pulmonary function (smoking interaction)[23284291];Lung cancer[28604730];Crohn's disease[22412388];Lung adenocarcinoma[28604730];Blood protein levels[28240269];Platelet count[26805783];,0.038773006134969326,0.6242908715832903,0.2665100495954059,0.012430939226519336
2218,19545,MOGAT2,610270,,,MGAT2-CDG,Disease-causing germline mutation(s) (loss of function) in,Bone fracture in osteoporosis[28580392];HDL cholesterol levels[28334899];Plasma omega-6 polyunsaturated fatty acid levels (dihomo-gamma-linolenic acid)[24823311];High density lipoprotein cholesterol levels[29403010];HDL cholesterol[24097068];,0.08736196319018405,0.41232594120680766,0.29913860610806575,0.4215776550030694
2219,19547,MOGS,601336,606056;,[MIM:606056]Type IIb congenital disorder of glycosylation;,MOGS-CDG,Disease-causing germline mutation(s) (loss of function) in,,0.9170552147239264,0.6340897369778237,0.38658313756199425,0.08732351135666053
2220,19554,MORC2,616661,616688;,,Autosomal dominant Charcot-Marie-Tooth disease type 2Z,Disease-causing germline mutation(s) in,,0.7358282208588957,0.8867973182052604,0.6758026624902115,0.0
2221,19584,MPC1,614738,614741;,[MIM:614741]Mitochondrial pyruvate carrier deficiency [recessive?];,Mitochondrial pyruvate carrier deficiency,Disease-causing germline mutation(s) in,,0.12711656441717792,0.5092831356369263,0.732445836596189,0.0
2222,19587,MPDU1,604041,609180;,[MIM:609180]Congenital disorder of glycosylation 1F;,MPDU1-CDG,Disease-causing germline mutation(s) in,IgA nephropathy[22197929];,0.7703067484662577,0.4951005673027334,0.17984860349778126,0.439073050951504
2223,19588,MPDZ,603785,615219;,"[MIM:615219]Hydrocephalus, congenital, 2, with or without brain or eye anomalies [recessive?];",Congenital communicating hydrocephalus,Disease-causing germline mutation(s) in,Central corneal thickness[29760442];Corneal structure[23291589];Heel bone mineral density[28869591;28869591];,0.7079754601226994,0.00593089221248066,0.20960584703732707,0.003376304481276857
2224,19597,MPI,154550,602579;,,MPI-CDG,Disease-causing germline mutation(s) in,Diastolic blood pressure x smoking status (current vs non-current) interaction (2df test)[29455858;29455858;29455858;29455858];Systolic blood pressure x smoking status (ever vs never) interaction (2df test)[29455858;29455858;29455858;29455858];Diastolic blood pressure x smoking status (ever vs never) interaction (2df test)[29455858;29455858;29455858;29455858];Mean arterial pressure[27618448];Systolic blood pressure x smoking status (current vs non-current) interaction (2df test)[29455858;29455858;29455858;29455858];,0.30319018404907977,0.14646725116039194,0.6413469068128426,0.5756599140577041
2225,19599,MPL,159530,254450;601977;604498;,[MIM:604498]Congenital amegakaryocytic thrombocytopenia;[MIM:601977]Thrombocythemia 2;[MIM:254450]Myelofibrosis with myeloid metaplasia;,Congenital amegakaryocytic thrombocytopenia;Essential thrombocythemia;Hereditary isolated aplastic anemia;Primary myelofibrosis;Polycythemia vera;Familial thrombocytosis,Disease-causing germline mutation(s) (loss of function) in;Disease-causing somatic mutation(s) in;Disease-causing germline mutation(s) (loss of function) in;Disease-causing somatic mutation(s) in;Disease-causing somatic mutation(s) in;Disease-causing germline mutation(s) in,,0.21484662576687116,0.15420319752449715,0.47141738449490994,0.4972375690607735
2226,19600,MPLKIP,609188,234050;,"[MIM:234050]Trichothiodystrophy 4, non-photosensitive [recessive?];",Trichothiodystrophy,Disease-causing germline mutation(s) in,Brain volume in infants (grey matter)[28763065];,0.30319018404907977,0.29345023207839094,0.900809188201514,0.0
2227,19602,MPO,606989,254600;,[MIM:254600]Myeloperoxidase deficiency;,Myeloperoxidase deficiency,Disease-causing germline mutation(s) in,Granulocyte percentage of myeloid white cells[27863252];Myeloid white cell count[27863252];Sum basophil neutrophil counts[27863252];Sum neutrophil eosinophil counts[27863252];Monocyte percentage of white cells[27863252];Granulocyte count[27863252];Blood protein levels[29875488;30072576;30072576;30072576];Neutrophil count[27863252];Circulating myeloperoxidase levels (plasma)[23620142];White blood cell count[27863252];Neutrophil percentage of white cells[27863252];Monocyte count[27863252];Post bronchodilator FEV1/FVC ratio in COPD[26634245];,0.4117791411042945,0.463383187209902,0.2719916470895328,0.10880908532842234
2228,19605,MPP3,601114,,,X-linked non-syndromic intellectual disability,Disease-causing germline mutation(s) in,Triglycerides[24097068];,0.4117791411042945,0.18566271273852503,0.31949882537196556,0.18370165745856354
2229,19620,MPV17,137960,256810;,,Navajo neurohepatopathy,Disease-causing germline mutation(s) in,,0.7813496932515337,0.21351211964930378,0.8744453145392848,0.44152854511970535
2230,19623,MPZ,159440,103100;118200;145900;180800;605253;607677;607736;607791;,"[MIM:118200]Charcot-Marie-Tooth disease 1B;[MIM:607677]Charcot-Marie-Tooth disease 2I;[MIM:607736]Charcot-Marie-Tooth disease 2J;[MIM:103100]Adie pupil;[MIM:607791]Charcot-Marie-Tooth disease, dominant, intermediate type, D;[MIM:145900]Dejerine-Sottas syndrome [dominant?] [recessive?];[MIM:605253]Neuropathy, congenital hypomyelinating or amyelinating [dominant?];[MIM:180800]Roussy-Levy syndrome;",Roussy-L�vy syndrome;Autosomal dominant intermediate Charcot-Marie-Tooth disease with neuropathic pain;Dejerine-Sottas syndrome;Charcot-Marie-Tooth disease type 1B;Autosomal dominant intermediate Charcot-Marie-Tooth disease type D;Autosomal dominant Charcot-Marie-Tooth disease type 2I;Autosomal dominant Charcot-Marie-Tooth disease type 2J,Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in,Visceral adipose tissue adjusted for BMI[22589738];,0.12711656441717792,0.6249355337802991,0.9018533020099191,0.7038060159607121
2231,19625,MPZL2,604873,,,Autosomal recessive non-syndromic sensorineural deafness type DFNB,Disease-causing germline mutation(s) in,Lung cancer in ever smokers[28604730];Lung cancer[28604730];Lung adenocarcinoma[28604730];,0.20368098159509201,0.08380608561113977,0.6188984599321325,0.3156844689993861
2232,19628,MRAP,609196,607398;,,Familial glucocorticoid deficiency,Disease-causing germline mutation(s) in,,0.17791411042944785,0.30453842186694174,0.6149830331506134,0.49263351749539597
2233,19633,MRE11,600814,604391;,[MIM:604391]Ataxia-telangiectasia-like disorder 1;,Ataxia-telangiectasia-like disorder;Hereditary breast and ovarian cancer syndrome;Nijmegen breakage syndrome-like disorder,Disease-causing germline mutation(s) in;Candidate gene tested in;Disease-causing germline mutation(s) (loss of function) in,Obstructive sleep apnea trait (apnea hypopnea index)[26977737];,0.9060122699386504,0.427797833935018,0.0,0.0
2234,19672,MRPL3,607118,614582;,[MIM:614582]Combined oxidative phosphorylation deficiency 9;,Combined oxidative phosphorylation defect type 9,Disease-causing germline mutation(s) in,Body mass index[26426971];,0.9461349693251534,0.34424961320268177,0.597755155311929,0.08839779005524862
2235,19714,MRPL36,611842,,,Fanconi anemia;Hereditary breast and ovarian cancer syndrome,Disease-causing germline mutation(s) in;Candidate gene tested in,Response to TNF inhibitor in rheumatoid arthritis (change in tender 28-joint count)[30166627];,0.5585276073619632,0.0,0.8767945706081963,0.4585635359116022
2236,19731,MRPL44,611849,615395;,[MIM:615395]Combined oxidative phosphorylation deficiency 16 [recessive?];,Infantile hypertrophic cardiomyopathy due to MRPL44 deficiency,Disease-causing germline mutation(s) in,,0.9148466257668711,0.12145435791645177,0.49151657530670845,0.14303253529772866
2237,19773,MRPS7,611974,617872;,[MIM:617872]Combined oxidative phosphorylation deficiency 34 [recessive?];,Syndromic sensorineural deafness due to combined oxidative phosphorylation defect,Disease-causing germline mutation(s) in,,0.9602453987730062,0.42444559051057246,0.4797702949621509,0.2733271945979128
2238,19788,MRPS16,609204,610498;,[MIM:610498]Combined oxidative phosphorylation deficiency 2;,Combined oxidative phosphorylation defect type 2,Disease-causing germline mutation(s) in,,0.889079754601227,0.4481691593604951,0.4458365961889846,0.2254450583179865
2239,19820,MRPS22,605810,611719;,[MIM:611719]Combined oxidative phosphorylation deficiency 5;,"46,XX gonadal dysgenesis;Hypotonia with lactic acidemia and hyperammonemia",Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in,Ear morphology[26105758];Rosacea symptom severity[29771307];Male-pattern baldness[27182965];Lobe size[26105758];Lobe attachment (rater scored)[29198719;29198719];Obesity-related traits[22013104;22013104;23251661;23251661];Lobe attachment (rater-scored or self-reported)[29198719];,0.985521472392638,0.5941206807632801,0.6186374314800314,0.4972375690607735
2240,19877,MRTFA,606078,,,Megakaryoblastic acute myeloid leukemia with t(1;22)(p13;q13),Part of a fusion gene in,Mammographic density (dense area)[25342443];Body mass index[26426971];Uterine fibroids[30194396];Autism spectrum disorder or schizophrenia[28540026];Creatinine levels[29403010];Breast size[22747683;27182965];Creatine kinase levels[29403010];Breast cancer[23535733;23535729;29059683];Height[19570815];Treatment response for severe sepsis[22310353];Coronary artery disease[29212778];Glomerular filtration rate[29403010];,0.038773006134969326,0.7148014440433214,0.0,0.0
2241,19929,MS4A1,112210,613495;,"[MIM:613495]Immunodeficiency, common variable, 5;",Common variable immunodeficiency,Disease-causing germline mutation(s) in,Recurrent major depressive disorder[29317602];,0.35496932515337426,0.25373904074265086,0.8342469329156879,0.2203806015960712
2242,19930,MS4A2,147138,,,Common variable immunodeficiency,Disease-causing germline mutation(s) in,Recurrent major depressive disorder[29317602];,0.4,0.46415678184631254,0.24327851735839207,0.15899324739103746
2243,19957,MSH2,609309,114500;120435;158320;276300;608089;,[MIM:120435]Hereditary non-polyposis colorectal cancer 1 [dominant?];[MIM:158320]Muir-Torre syndrome [dominant?];[MIM:608089]Endometrial cancer;[MIM:276300]Mismatch repair cancer syndrome [recessive?];[MIM:114500]Colorectal cancer;,Muir-Torre syndrome;Constitutional mismatch repair deficiency syndrome;Lynch syndrome,Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in,Electroencephalogram traits[25387704];Post bronchodilator FEV1/FVC ratio[26634245];,0.9606134969325153,0.9350180505415162,0.41764552336204647,0.9696132596685083
2244,19958,MSH3,600887,608089;617100;,[MIM:608089]Endometrial cancer;[MIM:617100]Familial adenomatous polyposis 4 [recessive?];,MSH3-related attenuated familial adenomatous polyposis,Disease-causing germline mutation(s) (loss of function) in,HDL cholesterol change in response to fenofibrate in statin-treated type 2 diabetes[28736931];Huntington's disease progression[28642124;28642124];,0.6903067484662576,0.010830324909747292,0.08326807622030802,0.7638121546961326
2245,19962,MSH6,600678,114500;276300;608089;614350;,[MIM:614350]Hereditary non-polyposis colorectal cancer 5 [dominant?];[MIM:608089]Endometrial cancer;[MIM:276300]Mismatch repair cancer syndrome [recessive?];[MIM:114500]Colorectal cancer;,Muir-Torre syndrome;Constitutional mismatch repair deficiency syndrome;Lynch syndrome,Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in,Menopause (age at onset)[26414677];Takayasu arteritis[25604533];Lifetime average cigarettes per day in chronic obstructive pulmonary disease[21685187];,0.8771779141104294,0.7186694172253739,0.21717567214826416,0.9412216083486802
2246,19975,MSMB,157145,611928;,,Familial prostate cancer,Major susceptibility factor in,Prostate cancer (early onset)[24740154];Serum prostate-specific antigen levels[21160077];Mean corpuscular hemoglobin[20139978];Mean corpuscular volume[20139978];Prostate-specific antigen levels[25434496;23269536;28139693];PCA3 expression level[23555189];Blood protein levels[29875488;30072576];Prostate cancer[20676098;18264097;18264096;24753544;21743057;25939597;26443449];,0.08736196319018405,0.4645435791645178,0.9791177238318977,0.240024554941682
2247,19976,MSMO1,607545,616834;,"[MIM:616834]Microcephaly, congenital cataract, and psoriasiform dermatitis [recessive?];",Microcephaly-congenital cataract-psoriasiform dermatitis syndrome,Disease-causing germline mutation(s) in,Neuroticism[27067015];,0.7720245398773006,0.5876740587931923,0.5515531192900026,0.0
2248,19978,MSN,309845,300988;,[MIM:300988]Immunodeficiency 50;,Combined immunodeficiency due to Moesin deficiency,Disease-causing germline mutation(s) in,,0.8009815950920245,0.7792676637441981,0.9446619681545289,0.0
2249,19980,MSR1,153622,176807;614266;,[MIM:614266]Barrett esophagus;,Familial prostate cancer,Major susceptibility factor in,Alcohol dependence[26365420];,0.23865030674846627,0.2261474987106756,0.11772383189767685,0.7826887661141805
2250,19985,MSRB3,613719,613718;,,Autosomal recessive non-syndromic sensorineural deafness type DFNB,Disease-causing germline mutation(s) in,Papillary thyroid cancer[28703219];Primary tooth development (time to first tooth eruption)[23704328;20195514];Hippocampal volume[22504421;28098162];Lung function (FEV1)[28166213];Post bronchodilator FEV1/FVC ratio[26634245];Type 2 diabetes nephropathy[21150874];Subcortical brain region volumes[25607358;25607358];Temperament[22832960];Primary tooth development (number of teeth)[23704328;20195514];Differentiated thyroid cancer[28703219];,0.4154601226993865,0.46854048478597216,0.8201513965022187,0.2254450583179865
2251,19987,MST1,142408,,,Primary sclerosing cholangitis,Major susceptibility factor in,"Inflammatory bowel disease[28067908;23128233];Body mass index[26426971];Chronic inflammatory diseases (ankylosing spondylitis, Crohn's disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy)[26974007];Primary sclerosing cholangitis[21151127;27992413];Crohn's disease[17554300;17554261;18587394;21102463;28067908];Blood protein levels[28240269;29875488;29875488;29875488;29875488;29875488;30072576;30072576;30072576;30072576;30072576;30072576];Ulcerative colitis[21297633;19915572;20228799;25082827;28067908];",0.33975460122699386,0.45023207839092316,0.1981205951448708,0.7154696132596685
2252,19991,MSTN,601788,614160;,[MIM:614160]Muscle hypertrophy;,Myostatin-related muscle hypertrophy,Disease-causing germline mutation(s) in,Daytime sleep phenotypes[27126917];,0.19190184049079756,0.6995874161939144,0.2766901592273558,0.6080417434008594
2253,19992,MSTO1,617619,617675;,,Mitochondrial myopathy-cerebellar ataxia-pigmentary retinopathy syndrome,Disease-causing germline mutation(s) in,Inflammatory bowel disease[28067908;23128233];Crohn's disease[28067908];,0.27975460122699386,0.49742135121196496,0.13756199425737406,0.0
2254,19994,MSX1,142983,106600;189500;608874;,"[MIM:106600]Tooth agenesis, selective, 1;[MIM:189500]Ectodermal dysplasia 3, Witkop type [dominant?];[MIM:608874]Non-syndromic orofacial cleft 5;",Isolated cleft lip;Cleft lip/palate;Cleft lip and alveolus;Hypodontia-dysplasia of nails syndrome;Oligodontia,Major susceptibility factor in;Major susceptibility factor in;Major susceptibility factor in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in,"Electrocardiographic conduction measures[19389651];Allergic disease (asthma, hay fever or eczema)[29083406];Breast cancer and/or colorectal cancer[29698419];Congenital heart disease[23708191];Nonsyndromic cleft lip with cleft palate[28232668];",0.33226993865030674,0.6005673027333677,0.34768989819890367,0.0
2255,19995,MSX2,123101,168500;168550;604757;,[MIM:168500]Parietal foramina 1;[MIM:168550]Parietal foramina with cleidocranial dysplasia;[MIM:604757]Craniosynostosis 2;,"Parietal foramina with clavicular hypoplasia;Craniosynostosis, Boston type;Enlarged parietal foramina",Disease-causing germline mutation(s) (loss of function) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) (loss of function) in,Stroke[26089329];Alanine aminotransferase (ALT) levels after remission induction therapy in actute lymphoblastic leukemia (ALL)[28090653];Chin dimples[27182965];Night sleep phenotypes[27126917;27126917];Depressive symptoms (SSRI exposure interaction)[25649181];,0.4463803680981595,0.6240330067044868,0.8901070216653615,0.0
2256,19997,MT-ATP6,516060,256000;500003;500006;500010;500011;535000;551500;,"[MIM:551500]Neuropathy, ataxia, and retinitis pigmentosa;[MIM:535000]Leber hereditary optic neuropathy;[MIM:256000]Leigh syndrome;[MIM:500003]Mitochondrial infantile bilateral striatal necrosis;[MIM:516060]Mitochondrial complex V deficiency, mitochondrial 1;[MIM:500011]Myopathy, lactic acidosis, and sideroblastic anemia 3;[MIM:500010]Ataxia and polyneuropathy, adult-onset;[MIM:500006]Cardiomyopathy, infantile hypertrophic;",Leber hereditary optic neuropathy;NARP syndrome;Isolated ATP synthase deficiency;Mitochondrial DNA-associated Leigh syndrome;Familial infantile bilateral striatal necrosis;MT-ATP6-related mitochondrial spastic paraplegia;Periodic paralysis with later-onset distal motor neuropathy,Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in,,0.6067484662576688,0.0,0.0,0.0
2257,19998,MT-ATP8,516070,500006;,"[MIM:516070]Mitochondrial complex V deficiency, mitochondrial 2;[MIM:500006]Cardiomyopathy, infantile hypertrophic;",Kearns-Sayre syndrome;Isolated ATP synthase deficiency;Periodic paralysis with later-onset distal motor neuropathy,Candidate gene tested in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in,,0.5885889570552147,0.0,0.0,0.0
2258,19999,MT-CO1,516030,114500;220110;500008;535000;550500;,"[MIM:535000]Leber hereditary optic neuropathy;[MIM:220110]Mitochondrial complex IV deficiency;[MIM:550500]Recurrent myoglobinuria mitochondrial;[MIM:500008]Deafness, sensorineural, mitochondrial;[MIM:114500]Colorectal cancer;",MELAS;Leber hereditary optic neuropathy;Mitochondrial non-syndromic sensorineural deafness with susceptibility to aminoglycoside exposure;Isolated cytochrome C oxidase deficiency;Mitochondrial non-syndromic sensorineural deafness;Genetic recurrent myoglobinuria,Disease-causing germline mutation(s) in;Candidate gene tested in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in,,0.5822085889570552,0.0,0.0,0.0
2259,20000,MT-CO2,516040,220110;,[MIM:220110]Mitochondrial complex IV deficiency;,MELAS;Isolated cytochrome C oxidase deficiency,Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) (loss of function) in,,0.9321472392638037,0.0,0.0,0.0
2260,20001,MT-CO3,516050,220110;535000;550500;,[MIM:535000]Leber hereditary optic neuropathy;[MIM:220110]Mitochondrial complex IV deficiency;[MIM:550500]Recurrent myoglobinuria mitochondrial;,MELAS;Leber hereditary optic neuropathy;Isolated cytochrome C oxidase deficiency;Genetic recurrent myoglobinuria,Candidate gene tested in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in,,0.5645398773006135,0.0,0.0,0.0
2261,20002,MT-CYB,516020,500000;535000;,"[MIM:500000]Cardiomyopathy, infantile histiocytoid;[MIM:535000]Leber hereditary optic neuropathy;",Leber hereditary optic neuropathy;Histiocytoid cardiomyopathy;Isolated complex III deficiency,Disease-causing germline mutation(s) in;Candidate gene tested in;Disease-causing germline mutation(s) in,,0.4431901840490797,0.0,0.0,0.0
2262,20004,MT-ND1,516000,125853;252010;502500;535000;540000;,"[MIM:535000]Leber hereditary optic neuropathy;[MIM:540000]Mitochondrial encephalomyopathy with lactic acidosis and stroke-like episodes syndrome;[MIM:502500]Alzheimer disease mitochondrial;[MIM:125853]Diabetes mellitus, non-insulin-dependent;[MIM:252010]Mitochondrial complex I deficiency;",MELAS;Leber hereditary optic neuropathy;Isolated complex I deficiency;Mitochondrial DNA-associated Leigh syndrome,Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in,,0.8536196319018405,0.0,0.0,0.0
2263,20005,MT-ND2,516001,502500;535000;,[MIM:535000]Leber hereditary optic neuropathy;[MIM:502500]Alzheimer disease mitochondrial;,Leber hereditary optic neuropathy;Isolated complex I deficiency;Mitochondrial DNA-associated Leigh syndrome,Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in,,0.8230674846625767,0.0,0.0,0.0
2264,20006,MT-ND3,516002,252010;256000;,[MIM:256000]Leigh syndrome;[MIM:252010]Mitochondrial complex I deficiency;,Isolated complex I deficiency;Mitochondrial DNA-associated Leigh syndrome;Leber plus disease,Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in,,0.6110429447852761,0.0,0.0,0.0
2265,20007,MT-ND4,516003,500001;535000;540000;,[MIM:535000]Leber hereditary optic neuropathy;[MIM:500001]Leber hereditary optic neuropathy with dystonia;[MIM:540000]Mitochondrial encephalomyopathy with lactic acidosis and stroke-like episodes syndrome;,MELAS;Leber hereditary optic neuropathy;Mitochondrial non-syndromic sensorineural deafness with susceptibility to aminoglycoside exposure;Mitochondrial DNA-associated Leigh syndrome;Leber plus disease,Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Modifying germline mutation in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in,,0.8353374233128834,0.0,0.0,0.0
2266,20008,MT-ND4L,516004,535000;,[MIM:535000]Leber hereditary optic neuropathy;,Leber hereditary optic neuropathy,Disease-causing germline mutation(s) in,,0.5719018404907975,0.0,0.0,0.0
2267,20009,MT-ND5,516005,252010;256000;535000;540000;,[MIM:535000]Leber hereditary optic neuropathy;[MIM:256000]Leigh syndrome;[MIM:252010]Mitochondrial complex I deficiency;[MIM:540000]Mitochondrial encephalomyopathy with lactic acidosis and stroke-like episodes syndrome;,MELAS;MERRF;Leber hereditary optic neuropathy;Mitochondrial DNA-associated Leigh syndrome,Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in,,0.8439263803680982,0.0,0.0,0.0
2268,20010,MT-ND6,516006,252010;500001;535000;540000;,[MIM:535000]Leber hereditary optic neuropathy;[MIM:500001]Leber hereditary optic neuropathy with dystonia;[MIM:540000]Mitochondrial encephalomyopathy with lactic acidosis and stroke-like episodes syndrome;[MIM:252010]Mitochondrial complex I deficiency;,MELAS;Leber hereditary optic neuropathy;Mitochondrial DNA-associated Leigh syndrome;Leber plus disease,Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in,,0.6495705521472392,0.0,0.0,0.0
2269,20011,MT-RNR1,561000,,,MERRF;Mitochondrial non-syndromic sensorineural deafness with susceptibility to aminoglycoside exposure;Mitochondrial non-syndromic sensorineural deafness,Candidate gene tested in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in,,0.038773006134969326,0.0,0.0,0.0
2270,20016,MT-TE,590025,,,Mitochondrial myopathy with reversible cytochrome C oxidase deficiency;Myopathy and diabetes mellitus;Maternally-inherited diabetes and deafness,Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in,,0.038773006134969326,0.0,0.0,0.0
2271,20017,MT-TF,590070,,,MELAS;MERRF,Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in,,0.038773006134969326,0.0,0.0,0.0
2272,20019,MT-TH,590040,,,MELAS;MERRF;Mitochondrial non-syndromic sensorineural deafness,Candidate gene tested in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in,,0.038773006134969326,0.0,0.0,0.0
2273,20021,MT-TK,590060,,,MERRF;Mitochondrial DNA-related cardiomyopathy and hearing loss;Mitochondrial DNA-associated Leigh syndrome;Maternally-inherited diabetes and deafness,Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in,,0.038773006134969326,0.0,0.0,0.0
2274,20022,MT-TL1,590050,,,MELAS;Kearns-Sayre syndrome;MERRF;Mitochondrial DNA-associated Leigh syndrome;Mitochondrial DNA-related progressive external ophthalmoplegia;Hypertrophic cardiomyopathy and renal tubular disease due to mitochondrial DNA mutation;Maternally-inherited diabetes and deafness,Disease-causing germline mutation(s) in;Candidate gene tested in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Candidate gene tested in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in,,0.038773006134969326,0.0,0.0,0.0
2275,20023,MT-TL2,590055,,,Mitochondrial DNA-related progressive external ophthalmoplegia,Disease-causing germline mutation(s) in,,0.038773006134969326,0.0,0.0,0.0
2276,20025,MT-TN,590010,,,Mitochondrial DNA-related progressive external ophthalmoplegia,Disease-causing germline mutation(s) in,,0.038773006134969326,0.0,0.0,0.0
2277,20026,MT-TP,590075,200100;,[MIM:200100]Abetalipoproteinemia [recessive?];,MERRF,Disease-causing germline mutation(s) in,Celiac disease[23936387];,0.038773006134969326,0.18940175348117586,0.0,0.0
2278,20027,MT-TQ,590030,,,MELAS;MERRF,Candidate gene tested in;Candidate gene tested in,,0.038773006134969326,0.0,0.0,0.0
2279,20029,MT-TS1,590080,,,MELAS;MERRF;Mitochondrial non-syndromic sensorineural deafness with susceptibility to aminoglycoside exposure;Palmoplantar keratoderma-deafness syndrome;Mitochondrial DNA-related progressive external ophthalmoplegia;Mitochondrial non-syndromic sensorineural deafness,Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Candidate gene tested in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in,,0.038773006134969326,0.0,0.0,0.0
2280,20030,MT-TS2,590085,,,MELAS;MERRF;Usher syndrome type 3,Candidate gene tested in;Candidate gene tested in;Disease-causing germline mutation(s) in,,0.038773006134969326,0.0,0.0,0.0
2281,20031,MT-TT,590090,,,Lethal infantile mitochondrial myopathy,Candidate gene tested in,,0.038773006134969326,0.0,0.0,0.0
2282,20032,MT-TV,590105,,,Mitochondrial DNA-associated Leigh syndrome,Disease-causing germline mutation(s) in,,0.038773006134969326,0.0,0.0,0.0
2283,20033,MT-TW,590095,,,MELAS;Mitochondrial DNA-associated Leigh syndrome,Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in,,0.038773006134969326,0.0,0.0,0.0
2284,20054,MT3,139255,,,Congenital intrinsic factor deficiency,Disease-causing germline mutation(s) in,,0.08736196319018405,0.6905621454357916,0.9206473505612112,0.26335174953959484
2285,20060,MTAP,156540,112250;,,Diaphyseal medullary stenosis-bone malignancy syndrome,Disease-causing germline mutation(s) in,Cutaneous nevi[19578365];Lung cancer in never smokers[28604730];Glycated hemoglobin levels[28898252];Lung cancer[28604730;28604730];Diastolic blood pressure[28135244];Melanoma[21983787;28212542;28212542];Pediatric bone mineral content (radius)[26041818];Pulse pressure[28135244];Lung adenocarcinoma[28604730];Coronary heart disease[21606135];Diastolic blood pressure response to hydrochlorothiazide in hypertension[27802415];Coronary artery calcified atherosclerotic plaque (130 HU threshold) in type 2 diabetes[29221444];,0.8898159509202453,0.15136668385765858,0.07204385277995301,0.4636279926335175
2286,20100,MTCH1,610449,,,"Encephalopathy due to prosaposin deficiency;Infantile Krabbe disease;Metachromatic leukodystrophy, adult form;Atypical Gaucher disease due to saposin C deficiency;Metachromatic leukodystrophy, late infantile form;Metachromatic leukodystrophy, juvenile form",Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in,Acne (severe)[24927181];Epstein-Barr virus copy number in lymphoblastoid cell lines[28654678];,0.8287116564417177,0.8679731820526044,0.4724614983033151,0.5228667894413751
2287,20302,MTFMT,611766,256000;614947;,[MIM:614947]Combined oxidative phosphorylation deficiency 15 [recessive?];[MIM:256000]Leigh syndrome;,Leigh syndrome with leukodystrophy;Combined oxidative phosphorylation defect type 15,Disease-causing germline mutation(s) (loss of function) in;Disease-causing germline mutation(s) in,,0.12711656441717792,0.21970087674058794,0.38684416601409555,0.141804788213628
2288,20309,MTHFD1,172460,114500;601634;617780;,"[MIM:601634]Neural tube defects, folate-sensitive;[MIM:114500]Colorectal cancer;[MIM:617780]Combined immunodeficiency and megaloblastic anemia with or without hyperhomocysteinemia [recessive?];",Upper thoracic spina bifida cystica;Cervicothoracic spina bifida cystica;Cervical spina bifida cystica;Lumbosacral spina bifida cystica;Thoracolumbosacral spina bifida cystica;Total spina bifida cystica;Upper thoracic spina bifida aperta;Thoracolumbosacral spina bifida aperta;Lumbosacral spina bifida aperta;Cervical spina bifida aperta;Cervicothoracic spina bifida aperta;Total spina bifida aperta,Major susceptibility factor in;Major susceptibility factor in;Major susceptibility factor in;Major susceptibility factor in;Major susceptibility factor in;Major susceptibility factor in;Major susceptibility factor in;Major susceptibility factor in;Major susceptibility factor in;Major susceptibility factor in;Major susceptibility factor in;Major susceptibility factor in,Cognitive performance[19734545];Lymphocyte counts[27863252];Atrial fibrillation[30061737];,0.9447852760736196,0.5951521402784941,0.11198120595144871,0.16114180478821363
2289,20321,MTHFR,607093,181500;236250;601367;601634;603174;,"[MIM:236250]Methylenetetrahydrofolate reductase deficiency;[MIM:601367]Ischemic stroke;[MIM:601634]Neural tube defects, folate-sensitive;[MIM:181500]Schizophrenia;",Homocystinuria due to methylene tetrahydrofolate reductase deficiency;Upper thoracic spina bifida cystica;Cervicothoracic spina bifida cystica;Cervical spina bifida cystica;Lumbosacral spina bifida cystica;Thoracolumbosacral spina bifida cystica;Total spina bifida cystica;Upper thoracic spina bifida aperta;Thoracolumbosacral spina bifida aperta;Lumbosacral spina bifida aperta;Cervical spina bifida aperta;Cervicothoracic spina bifida aperta;Total spina bifida aperta;Isolated anencephaly/exencephaly;Methotrexate toxicity or dose selection,Disease-causing germline mutation(s) in;Major susceptibility factor in;Major susceptibility factor in;Major susceptibility factor in;Major susceptibility factor in;Major susceptibility factor in;Major susceptibility factor in;Major susceptibility factor in;Major susceptibility factor in;Major susceptibility factor in;Major susceptibility factor in;Major susceptibility factor in;Major susceptibility factor in;Major susceptibility factor in;Biomarker tested in,Systolic blood pressure[19430483;27618452;28739976;27618447];Diastolic blood pressure (cigarette smoking interaction)[29455858;29455858];Moyamoya disease[29273593];Serum folate levels[29953918];Atrial fibrillation[19597492];Diastolic blood pressure[29615537;27618452;28739976];High altitude adaptation[28373541];Diastolic blood pressure x smoking status (ever vs never) interaction (2df test)[29455858;29455858;29455858;29455858];Mean arterial pressure[27618448];Systolic blood pressure x smoking status (current vs non-current) interaction (2df test)[29455858;29455858;29455858;29455858];Midregional pro atrial natriuretic peptide levels[29237677];Coronary artery disease[29212778];Homocysteine levels[23824729;23824729;20031578];Systolic blood pressure (cigarette smoking interaction)[29455858;29455858];Diastolic blood pressure x alcohol consumption (light vs heavy) interaction (2df test)[29912962];Tuberculosis[29036319];Diastolic blood pressure x smoking status (current vs non-current) interaction (2df test)[29455858;29455858;29455858;29455858];Systolic blood pressure x smoking status (ever vs never) interaction (2df test)[29455858;29455858;29455858;29455858];Blood pressure[21909110];Folate pathway vitamin levels[19744961];,0.841717791411043,0.0,0.05664317410597755,0.6384284837323512
2290,20333,MTM1,300415,310400;,"[MIM:310400]Myopathy, centronuclear, X-linked;",X-linked centronuclear myopathy;X-linked myotubular myopathy-abnormal genitalia syndrome,Disease-causing germline mutation(s) (loss of function) in;Role in the phenotype of,,0.45153374233128835,0.9396596183599794,0.8921952492821718,0.8850521792510743
2291,20335,MTMR2,603557,601382;,[MIM:601382]Charcot-Marie-Tooth disease 4B1 [recessive?];,Charcot-Marie-Tooth disease type 4B1,Disease-causing germline mutation(s) in,,0.3706748466257669,0.20165033522434245,0.19733750978856696,0.7874462860650706
2292,20346,MTMR14,611089,160150;,,Autosomal dominant centronuclear myopathy,Candidate gene tested in,Daytime sleep phenotypes[27126917];,0.818036809815951,0.5185662712738525,0.6470895327590708,0.7612031921424187
2293,20608,MTO1,614667,614702;,,Mitochondrial hypertrophic cardiomyopathy with lactic acidosis due to MTO1 deficiency,Disease-causing germline mutation(s) in,,0.7950920245398773,0.5683341928829293,0.6645784390498565,0.8029465930018416
2294,20611,MTOR,601231,607341;616638;,[MIM:616638]Smith-Kingsmore syndrome [dominant?];[MIM:607341]Focal cortical dysplasia 2;,Isolated focal cortical dysplasia type IIb;Isolated focal cortical dysplasia type IIa;Macrocephaly-intellectual disability-neurodevelopmental disorder-small thorax syndrome,Disease-causing somatic mutation(s) in;Disease-causing somatic mutation(s) in;Disease-causing germline mutation(s) (gain of function) in,Body mass index[25673413;25673413];Corneal curvature[24963161];Heel bone mineral density[28869591;28869591];Beard thickness[26926045];,0.8282208588957055,0.5263022176379577,0.6476115896632733,0.5962246777163904
2295,20613,MTPAP,613669,613672;,,Autosomal recessive spastic ataxia-optic atrophy-dysarthria syndrome,Disease-causing germline mutation(s) in,Paclitaxel disposition in epithelial ovarian cancer[29367611];,0.9142331288343558,0.8197524497163486,0.676324719394414,0.40316144874155924
2296,20615,MTR,156570,250940;601634;603174;,"[MIM:250940]Homocystinuria-megaloblastic anemia, cblG complementation type [recessive?];[MIM:601634]Neural tube defects, folate-sensitive;",Methylcobalamin deficiency type cblG,Disease-causing germline mutation(s) in,Homocysteine levels[23824729];,0.7193865030674846,0.10082516761217122,0.11746280344557557,0.3525168815224064
2297,20635,MTRR,602568,236270;601634;,"[MIM:601634]Neural tube defects, folate-sensitive;",Methylcobalamin deficiency type cblE,Disease-causing germline mutation(s) in,Verbal declarative memory[25648963;25648963];Capecitabine sensitivity[22864933;22864933];,0.4403680981595092,0.30247550283651364,0.03210649960845732,0.3502148557397176
2298,20644,MTTP,157147,200100;,[MIM:200100]Abetalipoproteinemia [recessive?];,Abetalipoproteinemia,Disease-causing germline mutation(s) in,Celiac disease[23936387];,0.541840490797546,0.18940175348117586,0.04698512137823023,0.295426642111725
2299,20654,MUC1,158340,174000;,[MIM:174000]Medullary cystic kidney disease 1;,MUC1-related autosomal dominant tubulointerstitial kidney disease,Disease-causing germline mutation(s) in,Inflammatory bowel disease[28067908];Urinary albumin-to-creatinine ratio in non-diabetics[26631737];Non-cardia gastric cancer[26701879];Serum uric acid levels[29403010];Serum magnesium levels[29093028];Magnesium levels[20700443;25886283;25886283;26058915];Crohn's disease[21102463;28067908];Urinary albumin-to-creatinine ratio[26631737];Gastric adenocarcinoma (histologically verified)[26098866];Gastric cancer[26129866;26098866;26098866];,0.45680981595092024,0.4602888086642599,0.6068911511354738,0.0
2300,20660,MUC5B,600770,178500;,"[MIM:178500]Pulmonary fibrosis, idiopathic;",Diffuse panbronchiolitis;Idiopathic pulmonary fibrosis,Major susceptibility factor in;Major susceptibility factor in,Idiopathic pulmonary fibrosis[24429156;24429156;24429156;29066090];Major depressive disorder[27777418];,0.2585276073619632,1.0,0.029235186635343254,0.600061387354205
2301,20677,MUCL3,613928,,,Diffuse panbronchiolitis,Major susceptibility factor in,Rosacea symptom severity[29771307];HIV-1 control[20041166];Gestational age at birth (maternal effect)[28877031];Autism spectrum disorder or schizophrenia[28540026;28540026;28540026;28540026;28540026;28540026;28540026;28540026;28540026;28540026;28540026;28540026;28540026;28540026;28540026;28540026;28540026];Pulmonary function (smoking interaction)[23284291;23284291];Schizophrenia[28991256];Idiopathic membranous nephropathy[21323541];,0.038773006134969326,0.23981433728726148,0.0,0.0
2302,20683,MUSK,601296,208150;616325;,"[MIM:616325]Myasthenic syndrome, congenital, 9, associated with acetylcholine receptor deficiency;[MIM:208150]Fetal akinesia deformation sequence;",Fetal akinesia deformation sequence;Postsynaptic congenital myasthenic syndromes,Disease-causing germline mutation(s) (loss of function) in;Disease-causing germline mutation(s) in,Pulmonary function decline[22424883];Type 2 diabetes (dietary heme iron intake interaction)[23386860];,0.32380368098159507,0.1921093347086127,0.22970503784912555,0.44843462246777166
2303,20685,MUTYH,604933,608456;613659;,[MIM:608456]Familial adenomatous polyposis 2;[MIM:613659]Gastric cancer;,MUTYH-related attenuated familial adenomatous polyposis,Disease-causing germline mutation(s) in,,0.33226993865030674,0.5067044868488911,0.1905507700339337,0.9352363413136894
2304,20688,MVD,603236,614714;,,Disseminated superficial actinic porokeratosis,Disease-causing germline mutation(s) in,Hair color[26926045];,0.5009815950920246,0.14981949458483754,0.6204646306447402,0.0
2305,20689,MVK,251170,175900;260920;610377;,"[MIM:610377]Mevalonic aciduria;[MIM:260920]Hyperimmunoglobulinemia D and periodic fever syndrome;[MIM:175900]Porokeratosis 3, multiple types;",Mevalonic aciduria;Hyperimmunoglobulinemia D with periodic fever;Porokeratosis of Mibelli;Disseminated superficial actinic porokeratosis,Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in,HDL cholesterol levels[28334899];Aspartate aminotransferase levels[29403010];Neutrophil count[29403010];High density lipoprotein cholesterol levels[29403010];HDL cholesterol[20686565;20864672;19060906;24097068;25961943;18193043];,0.23865030674846627,0.6511088189788551,0.4549725920125294,0.8431553100061387
2306,20704,MYB,189990,,,Angiocentric glioma;Acute basophilic leukemia;Precursor T-cell acute lymphoblastic leukemia,Part of a fusion gene in;Part of a fusion gene in;Part of a fusion gene in,Multiple sclerosis[21833088];Mean corpuscular hemoglobin concentration[20139978;23263863;29403010];Mean corpuscular hemoglobin[19862010;20139978;23263863;23263863;28548082;28453575;29403010];Mean corpuscular volume[19862010;20139978;23263863;23263863;28453575;29403010];Hematological parameters[19820697];Hematocrit[19862010;29403010];Basophil percentage of white cells[27863252];Eosinophil counts[29403010];Hemoglobin A1c levels[29403010];Basophil percentage of granulocytes[27863252];Mean platelet volume[22423221];Red blood cell traits[20927387;20927387;20927387;20927387;20927387;20927387;23935956;23935956];White blood cell types[21738478];Hemoglobin[29403010];Aspartate aminotransferase levels[29403010];Obesity-related traits[23251661];Hematological and biochemical traits[20139978];Platelet count[24026423;22139419;20139978;26805783;26805783;29066854;29403010];Beta thalassemia/hemoglobin E disease[20183929];Hodgkin's lymphoma[24149102];Hematology traits[19853236;19853236;19853236;23263863];White blood cell count (basophil)[27863252];Glycated hemoglobin levels[24647736;28898252];HbA2 levels[23043469];Myeloproliferative neoplasms[25849990];Red blood cell count[20139978;28453575;29403010];Other erythrocyte phenotypes[19862010;19862010];White blood cell count[20139978;29403010];Hemoglobin levels[26366553;26366553];Fetal hemoglobin levels in sickle cell anemia[25372704];,0.5585276073619632,0.8924703455389376,0.5173583920647351,0.18477593615715163
2307,20709,MYBPC1,160794,614335;614915;,"[MIM:614335]Arthrogryposis, distal, 1B;[MIM:614915]Lethal congenital contracture syndrome 4 [recessive?];",Digitotalar dysmorphism;Lethal congenital contracture syndrome type 3;MYBPC1-related autosomal recessive non-lethal arthrogryposis multiplex congenita syndrome,Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in,Lung function (FEV1)[24023788];Blood protein levels[28240269];,0.32380368098159507,0.4399174832387829,0.2090837901331245,0.2513812154696133
2308,20711,MYBPC3,600958,115197;615396;,"[MIM:115197]Cardiomyopathy, familial hypertrophic 4;[MIM:615396]Cardiomyopathy, dilated 1MM;[MIM:615396]Left ventricular non-compaction 10 [dominant?];",Familial isolated dilated cardiomyopathy;Left ventricular noncompaction,Disease-causing germline mutation(s) in;Candidate gene tested in,Neuroticism[29255261];Thrombin generation potential phenotypes[24357727];Autism spectrum disorder or schizophrenia[28540026];Intraocular pressure[30054594];,0.31079754601226994,0.1364105208870552,0.2576350822239624,0.3601903007980356
2309,20714,MYC,190080,113970;,[MIM:113970]Burkitt lymphoma;,Burkitt lymphoma;High grade B-cell lymphoma with MYC and/ or BCL2 and/or BCL6 rearrangement;Precursor T-cell acute lymphoblastic leukemia,Part of a fusion gene in;Part of a fusion gene in;Part of a fusion gene in,"Multiple sclerosis[21833088];Endometrial cancer[27135401;27135401;30093612;30093612];Urinary bladder cancer[18794855;20348956;24861552];Colorectal cancer[24737748;23266556;25990418;26151821];Prostate-specific antigen levels (conditioned on lead SNPs)[28139693];Glioblastoma[29743610];Ovarian cancer[20852632;23535730];Prostate cancer (early onset)[24740154];Allergic disease (asthma, hay fever or eczema)[29083406];Renal cell carcinoma[24220699];Allergic rhinitis[30013184];Height[25429064];Endometrial cancer ((endometrioid histology)[30093612];Prostate-specific antigen levels[28139693];Endometrial endometrioid carcinoma[27135401];Breast cancer[23535729;29059683];Bladder cancer[20972438];Non-glioblastoma glioma[29743610;29743610];Chronic lymphocytic leukemia[23770605];Glioma[29743610;29743610];Pancreatic cancer[25086665;29422604;27579533];Diffuse large B cell lymphoma[25261932;25261932];Nonsyndromic cleft lip with cleft palate[28232668];Prostate cancer[24753544];Allergic sensitization[23817571];",0.8260122699386503,0.9293450232078391,0.4983033150613417,0.0
2310,20724,MYCN,164840,164280;,[MIM:164280]Feingold syndrome 1;,Neuroblastoma;Non-hereditary retinoblastoma;Hereditary retinoblastoma;Feingold syndrome type 1;Feingold syndrome type 1,Biomarker tested in;Candidate gene tested in;Candidate gene tested in;Disease-causing germline mutation(s) in;Role in the phenotype of,Spherical equivalent or myopia (age of diagnosis)[29808027];Basal cell carcinoma[25855136];Asthma or chronic obstructive pulmonary disease[24993907];Pulmonary function (smoking interaction)[23284291];Wilms tumor[22544364;22544364];,0.50920245398773,0.8597215059308922,0.845732184808144,0.9358502148557397
2311,20728,MYD88,602170,612260;,[MIM:612260]MYD88 deficiency [recessive?];,Pyogenic bacterial infections due to MyD88 deficiency;Waldenstr�m macroglobulinemia,Disease-causing germline mutation(s) in;Disease-causing somatic mutation(s) in,Mean corpuscular hemoglobin concentration[29403010];Gut microbiota (bacterial taxa)[27723756];,0.6661349693251534,0.6199071686436307,0.8444270425476377,0.5738182934315531
2312,20733,MYF6,159991,614408;,,Autosomal dominant centronuclear myopathy,Candidate gene tested in,,0.27361963190184047,0.3984012377514183,0.8125815713912816,0.38919582565991406
2313,20735,MYH2,160740,605637;,"[MIM:605637]Myopathy, proximal, and ophthalmoplegia [dominant?];",Childhood-onset autosomal recessive myopathy with external ophthalmoplegia;Hereditary inclusion body myopathy-joint contractures-ophthalmoplegia syndrome,Disease-causing germline mutation(s) (loss of function) in;Disease-causing germline mutation(s) in,,0.5692024539877301,0.3470861268695204,0.5058731401722788,0.9106813996316758
2314,20736,MYH3,160720,178110;193700;601680;,"[MIM:193700]Arthrogryposis, distal, 2A;[MIM:601680]Arthrogryposis, distal, 2B;[MIM:178110]Arthrogryposis, distal, 8;",Digitotalar dysmorphism;Sheldon-Hall syndrome;Freeman-Sheldon syndrome;Spondylocarpotarsal synostosis;Autosomal dominant multiple pterygium syndrome,Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in,Relative hand skill in reading disability[24068947];Post bronchodilator percent predicted FEV1 in smoking[30068317];,0.4840490797546012,0.028365136668385766,0.3440354998694858,0.7728667894413751
2315,20738,MYH6,160710,613251;613252;614089;614090;,"[MIM:614089]Atrial septal defect 3;[MIM:613251]Cardiomyopathy, familial hypertrophic 14;[MIM:613252]Cardiomyopathy, dilated 1EE;[MIM:614090]Sick sinus syndrome 3;","Familial sick sinus syndrome;Familial isolated dilated cardiomyopathy;Atrial septal defect, ostium secundum type",Major susceptibility factor in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in,Heart rate[23583979];Systolic blood pressure[27618447];Aortic coarctation[29590334];Resting heart rate[20639392;23183192;27798624;28270201;29769521];P wave duration[28794112;28794112];P wave terminal force[28794112;28794112];Atrial fibrillation[30061737];Pulse pressure[27618448;28135244;27618447];Electrocardiographic traits[20062063];,0.6553374233128835,0.010314595152140279,0.04515792221352127,0.8471454880294659
2316,20739,MYH7,160760,160500;181430;192600;255160;608358;613426;,"[MIM:192600]Cardiomyopathy, familial hypertrophic 1;[MIM:608358]Myopathy, myosin storage, autosomal dominant [dominant?];[MIM:181430]Scapuloperoneal myopathy MYH7-related;[MIM:613426]Cardiomyopathy, dilated 1S;[MIM:160500]Myopathy, distal, 1;[MIM:255160]Myopathy, myosin storage, autosomal recessive [recessive?];[MIM:613426]Left ventricular non-compaction 5 [dominant?];",Ebstein malformation;Familial isolated dilated cardiomyopathy;Classic multiminicore myopathy;MYH7-related late-onset scapuloperoneal muscular dystrophy;Laing early-onset distal myopathy;Left ventricular noncompaction;Hyaline body myopathy,Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in,Resting heart rate[20639392;27798624];Atrial fibrillation[30061737;29892015;29892015];,0.6910429447852761,0.046157813305827744,0.6316888540850952,0.8984039287906691
2317,20740,MYH7B,609928,,,Left ventricular noncompaction,Disease-causing germline mutation(s) in,Waist-to-hip ratio adjusted for BMI (age >50)[26426971];Prothrombin time[22703881];QRS complex (Cornell)[27659466];Melanoma[28212542];Anticoagulant levels[22216198];Blood protein levels[28240269];Waist-to-hip ratio adjusted for BMI[26426971];Congenital left-sided heart lesions[26965164];Waist-to-hip ratio adjusted for BMI x sex x age interaction (4df test)[26426971];,0.6080981595092024,0.45874161939143887,0.15009135995823544,0.7763965623081646
2318,20741,MYH8,160741,158300;608837;,"[MIM:608837]Carney complex variant;[MIM:158300]Arthrogryposis, distal, 7;",Trismus-pseudocamptodactyly syndrome;Carney complex-trismus-pseudocamptodactyly syndrome,Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in,,0.3856441717791411,0.0028365136668385767,0.046724092926128946,0.7286678944137508
2319,20742,MYH9,160775,155100;603622;,"[MIM:155100]Macrothrombocytopenia and granulocyte inclusions with or without nephritis or sensorineural hearing loss [dominant?];[MIM:603622]Deafness, autosomal dominant, 17 [dominant?];",MYH9-related disease;Nodular fasciitis;Autosomal dominant non-syndromic sensorineural deafness type DFNA,Disease-causing germline mutation(s) in;Part of a fusion gene in;Disease-causing germline mutation(s) in,Glomerulosclerosis[20668430];Mean corpuscular hemoglobin[27863252];Mean corpuscular volume[27863252];Optic nerve measurement (rim area)[20395239];End-stage renal disease (non-diabetic)[20532800];Language performance in older adults (adjusted for episodic memory)[28577822];Diabetic kidney disease[26305897;26305897];,0.9857668711656442,0.7436823104693141,0.1892456277734273,0.9794352363413137
2320,20744,MYH11,160745,132900;,"[MIM:132900]Aortic aneurysm, familial thoracic 4;",Megacystis-microcolon-intestinal hypoperistalsis syndrome;Familial aortic dissection;Familial thoracic aortic aneurysm and aortic dissection;Acute myeloid leukemia with abnormal bone marrow eosinophils inv(16)(p13q22) or t(16;16)(p13;q22),Disease-causing germline mutation(s) (loss of function) in;Candidate gene tested in;Disease-causing germline mutation(s) in;Part of a fusion gene in,Pelvic organ prolapse (moderate/severe)[26545240];Plasma omega-6 polyunsaturated fatty acid levels (linoleic acid)[24823311;24823311];Resting heart rate[27798624;29769521];Multiple myeloma (survival)[26198393];Plasma omega-6 polyunsaturated fatty acid levels (gamma-linolenic acid)[24823311];Plasma omega-6 polyunsaturated fatty acid levels (dihomo-gamma-linolenic acid)[24823311;24823311];Serum uric acid levels in response to allopurinol in gout[25676789];Waist-hip ratio[23966867];Cognitive function[25644384];Coronary artery disease[29212778;29212778];,0.8877300613496932,0.9443011861784425,0.1681023231532237,0.9791282995702886
2321,20746,MYH14,608568,600652;614369;,"[MIM:600652]Deafness, autosomal dominant, 4A [dominant?];[MIM:614369]Peripheral neuropathy, myopathy, hoarseness, and hearing loss;",Low anorectal malformation;Peripheral neuropathy-myopathy-hoarseness-hearing loss syndrome;Autosomal dominant non-syndromic sensorineural deafness type DFNA,Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in,Glucose homeostasis traits[25524916];Disc degeneration (lumbar)[22993228];,0.9226993865030675,0.8947911294481692,0.1853302009919081,0.9248004910988337
2322,20751,MYL2,160781,608758;,"[MIM:608758]Cardiomyopathy, familial hypertrophic 10;",Congenital fiber-type disproportion myopathy,Disease-causing germline mutation(s) in,Drinking behavior[23364009];Gout[25646370];Glycemic traits[23575436];Metabolic syndrome[25705158];Neutrophil count[29403010];Coronary heart disease[23364394];HDL cholesterol[21909109];Alcohol consumption[21270382];Body mass index[24861553];HDL cholesterol levels[28334899;28334899];Alcohol consumption (maxi-drinks)[29460428];White blood cell count[29403010];Metabolic syndrome (multivariate analysis)[29632305];Gamma glutamyl transpeptidase[21909109];Alcohol consumption (drinkers vs non-drinkers)[28485404];Coffee consumption[29367735];,0.32380368098159507,0.14182568334192883,0.9712868702688593,0.2776243093922652
2323,20753,MYL4,160770,617280;,"[MIM:617280]Atrial fibrillation, familial, 18;",Familial atrial fibrillation,Disease-causing germline mutation(s) in,Body mass index[26426971];Erythema nodosum in inflammatory bowel disease[24487271];,0.6758282208588957,0.25064466219700876,0.7227877838684417,0.5664518109269491
2324,20773,MYLK,600922,613780;,"[MIM:613780]Aortic aneurysm, familial thoracic 7;",Megacystis-microcolon-intestinal hypoperistalsis syndrome;Familial thoracic aortic aneurysm and aortic dissection,Disease-causing germline mutation(s) (loss of function) in;Disease-causing germline mutation(s) in,General cognitive ability[29844566];,0.8623312883435583,0.7204744713769985,0.028452101279039414,0.19551872314303254
2325,20781,MYMK,615345,254940;,[MIM:254940]Carey-Fineman-Ziter syndrome [recessive?];,Carey-Fineman-Ziter  syndrome,Disease-causing germline mutation(s) in,,0.038773006134969326,0.2913873130479629,0.0,0.0
2326,20786,MYO1A,601478,,,Autosomal dominant non-syndromic sensorineural deafness type DFNA,Candidate gene tested in,Schizophrenia[25056061];,0.678282208588957,0.005157297576070139,0.25580788305925345,0.6669736034376919
2327,20788,MYO1C,606538,,,Autosomal dominant non-syndromic sensorineural deafness type DFNA,Disease-causing germline mutation(s) in,Atrial fibrillation[30061737];,0.9845398773006135,0.3022176379577102,0.30435917515009137,0.9168201350521793
2328,20790,MYO1E,601479,614131;,,Familial idiopathic steroid-resistant nephrotic syndrome with focal segmental hyalinosis,Disease-causing germline mutation(s) in,Coronary artery calcified atherosclerotic plaque (90 or 130 HU threshold) in type 2 diabetes[29221444];Metabolite levels[22916037];Social communication problems[24047820];,0.7926380368098159,0.5879319236719959,0.6222918298094492,0.7958870472682628
2329,20793,MYO1H,614636,,,Ondine syndrome,Disease-causing germline mutation(s) in,Headache[29397368];Bipolar disorder lithium response (categorical) or schizophrenia[29121268];HDL cholesterol[20864672];,0.038773006134969326,0.01444043321299639,0.13547376664056382,0.4722222222222222
2330,20794,MYO3A,606808,607101;,,Autosomal recessive non-syndromic sensorineural deafness type DFNB,Disease-causing germline mutation(s) in,Rosacea symptom severity[29771307];Resting-state electroencephalogram vigilance[29703947];PR interval[23534349];Obesity-related traits[23251661;23251661;23251661];,0.28662576687116564,0.03223310985043837,0.01670582093448186,0.5756599140577041
2331,20797,MYO5A,160777,214450;256710;609227;,[MIM:609227]Griscelli syndrome 3 [recessive?];[MIM:256710]Elejalde syndrome;,Neuroectodermal melanolysosomal disease;Griscelli syndrome type 3;Griscelli syndrome type 1,Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in,Metabolite levels (Pyroglutamine)[23934736];,0.8244171779141104,0.6747034553893759,0.18480814408770557,0.7239103744628607
2332,20798,MYO5B,606540,251850;,"[MIM:251850]Diarrhea 2, with microvillus atrophy;",Microvillus inclusion disease;MYO5B-related progressive familial intrahepatic cholestasis;Progressive familial intrahepatic cholestasis type 1,Disease-causing germline mutation(s) (loss of function) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in,Phospholipid levels in large HDL[29084231;29084231;29084231];Medium HDL particle concentration[29084231;29084231];Systolic blood pressure x smoking status (current vs non-current) interaction (1df test)[29455858];Spherical equivalent or myopia (age of diagnosis)[29808027];Apolipoprotein A1 levels[29084231;29084231;29084231];Phospholipid levels in medium HDL[29084231;29084231;29084231];Myopia[27182965];Systolic blood pressure x smoking status (current vs non-current) interaction (2df test)[29455858];Mean diameter of HDL particles[29084231;29084231;29084231];Large HDL particle concentration[29084231;29084231;29084231];Total cholesterol levels in HDL[29084231;29084231];,0.7252760736196319,0.11320268179473955,0.016966849386583136,0.8161448741559238
2333,20803,MYO6,600970,606346;607821;,"[MIM:606346]Deafness, autosomal dominant, 22 [dominant?];[MIM:607821]Deafness, autosomal recessive, 37 [recessive?];[MIM:606346]Deafness, autosomal dominant 22, with hypertrophic cardiomyopathy [dominant?];",Progressive sensorineural hearing loss-hypertrophic cardiomyopathy syndrome;Autosomal dominant non-syndromic sensorineural deafness type DFNA;Autosomal recessive non-syndromic sensorineural deafness type DFNB,Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in,Systolic blood pressure x smoking status (ever vs never) interaction (2df test)[29455858];Prostate cancer[25217961];,0.9828220858895705,0.46183599793708097,0.3983294179065518,0.6760282381829343
2334,20804,MYO7A,276903,276900;600060;601317;,"[MIM:276900]Usher syndrome 1B;[MIM:600060]Deafness, autosomal recessive, 2 [recessive?];[MIM:601317]Deafness, autosomal dominant, 11 [dominant?];",Usher syndrome type 2;Usher syndrome type 1;Autosomal dominant non-syndromic sensorineural deafness type DFNA;Autosomal recessive non-syndromic sensorineural deafness type DFNB,Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) (loss of function) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in,Lewy body disease[25188341];Post bronchodilator FEV1/FVC ratio[26634245];,0.3492024539877301,0.007993811242908716,0.047768206734534066,0.9312461632903621
2335,20806,MYO9A,604875,,,Presynaptic congenital myasthenic syndromes,Disease-causing germline mutation(s) in,Metabolite levels (HVA/MHPG ratio)[23319000];Triglyceride levels[30108155];Height[20881960];Red blood cell count[27863252];Rate of cognitive decline in mild cognitive impairment (time interaction)[22833209];,0.632760736196319,0.7155750386797318,0.24249543200208823,0.8907305095150398
2336,20809,MYO15A,602666,600316;,,Autosomal recessive non-syndromic sensorineural deafness type DFNB,Disease-causing germline mutation(s) in,Serum folate levels[29953918];Schizophrenia[25056061];Obesity-related traits[23251661];,0.26588957055214724,0.2774626095925735,0.033672670321064996,0.8870472682627378
2337,20815,MYO18B,607295,616549;,"[MIM:616549]Klippel-Feil syndrome 4, autosomal recessive, with nemaline myopathy and facial dysmorphism [recessive?];",Klippel-Feil anomaly-myopathy-facial dysmorphism syndrome,Disease-causing germline mutation(s) (loss of function) in,"Urate levels in lean individuals[25811787;25811787];Mathematical ability in children with dyslexia[23423138];Copper levels[26025379];Atrial fibrillation[30061737;29892015];Amyotrophic lateral sclerosis (sporadic)[24529757];Gut microbiota (functional units)[27694959];Schizophrenia, bipolar disorder and depression (combined)[20713499];",0.16220858895705523,0.26353790613718414,0.04306969459671104,0.8753836709637814
2338,20817,MYOC,601652,137750;231300;,"[MIM:137750]Glaucoma 1, open angle, A;[MIM:231300]Glaucoma 3, primary congenital, A [recessive?];",Congenital glaucoma;Juvenile glaucoma,Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in,Cognitive decline rate in late mild cognitive impairment[26252872;26252872];,0.427239263803681,0.08664259927797834,0.2915687809971287,0.6398096992019644
2339,20820,MYOD1,159970,,,Fetal akinesia deformation sequence,Disease-causing germline mutation(s) (loss of function) in,Body mass index[26426971;26426971];Night sleep phenotypes[27126917];,0.5353374233128835,0.5928313563692625,0.7705559906029757,0.5767341927562922
2340,20829,MYOT,604103,159000;182920;609200;,"[MIM:609200]Myopathy, myofibrillar, 3;[MIM:182920]Spheroid body myopathy;",Spheroid body myopathy;Autosomal dominant limb-girdle muscular dystrophy type 1A;Distal myotilinopathy,Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in,Heart rate[23583979];Atrial fibrillation[30061737];Severe malaria[29381699];Severe malaria (adjusted for sickle cell variant rs334)[29381699];,0.28662576687116564,0.19597730789066528,0.4782041242495432,0.0649171270718232
2341,20850,MYPN,608517,615248;617336;,"[MIM:615248]Cardiomyopathy, dilated 1KK;[MIM:615248]Cardiomyopathy, familial hypertrophic 22;[MIM:615248]Cardiomyopathy, familial restrictive 4;",Childhood-onset nemaline myopathy;Familial isolated dilated cardiomyopathy;Cap myopathy;Familial isolated restrictive cardiomyopathy,Disease-causing germline mutation(s) (loss of function) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in,Atrial fibrillation[30061737];Creatinine levels[29403010];Creatine kinase levels[29403010];Optic nerve measurement (disc area)[20395239];Height[25282103];Lung function (FVC)[28166213];Glomerular filtration rate[29403010];,0.6174233128834355,0.2037132542547705,0.004437483685721744,0.29864947820748927
2342,20856,MYSM1,612176,,,Congenital progressive bone marrow failure-B-cell immunodeficiency-skeletal dysplasia syndrome,Disease-causing germline mutation(s) in,Diabetic retinopathy[21310492];Nickel levels[26025379];Night sleep phenotypes[27126917];,0.7633128834355828,0.5134089736977824,0.0984077264421822,0.18861264579496623
2343,20858,MYT1L,613084,616521;,"[MIM:616521]Mental retardation, autosomal dominant 39 [dominant?];",Autosomal dominant non-syndromic intellectual disability,Candidate gene tested in,Diabetic retinopathy[21441570];Glucose homeostasis traits[25524916];Attention deficit hyperactivity disorder[18839057];Cognitive decline rate in late mild cognitive impairment[26252872;26252872;26252872];Response to selective serotonin reuptake inhibitors and depression[27622933];Systolic blood pressure x smoking status (current vs non-current) interaction (2df test)[29455858];Inflammatory skin disease[25574825];Vitamin B levels in ischemic stroke[25147783];Type 2 diabetes (age of onset)[28060188];Erosive tooth wear (severe vs non-severe)[29898447];Systemic sclerosis[30247649];Erosive tooth wear (severe vs none or mild)[29898447];Gut microbiota (functional units)[27694959];,0.16220858895705523,1.0,0.3677890890107022,0.0
2344,20876,NAA10,300013,300855;309800;,"[MIM:300855]N-terminal acetyltransferase deficiency;[MIM:309800]Microphthalmia, syndromic, 1;","Microphthalmia, Lenz type;Ogden syndrome",Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in,Systemic lupus erythematosus[26502338];,0.7889570552147239,0.8109850438370294,0.0,0.5299263351749539
2345,20897,NAB2,602381,,,Solitary fibrous tumor,Part of a fusion gene in,Schizophrenia[25056061];IgE levels[22075330];Asthma[29273806;29273806];,0.5110429447852761,0.5992779783393501,0.727747324458366,0.0
2346,20898,NABP1,612103,,,Acute promyelocytic leukemia,Part of a fusion gene in,Colorectal cancer[23266556];,0.3749693251533742,0.39143888602372356,0.9107282693813625,0.0
2347,20912,NACC1,610672,617393;,,Severe neurodevelopmental disorder with feeding difficulties-stereotypic hand movement-bilateral cataract,Disease-causing germline mutation(s) in,Obesity-related traits[23251661];,0.7067484662576687,0.7738525012893244,0.8005742625946228,0.9229588704726827
2348,20915,NADK2,615787,616034;,,Progressive encephalopathy with leukodystrophy due to DECR deficiency,Disease-causing germline mutation(s) (loss of function) in,Night sleep phenotypes[27126917;27126917];,0.6500613496932516,0.5513151108818979,0.5137039937353172,0.0
2349,20920,NAGA,104170,609241;609242;,[MIM:609241]Schindler disease [recessive?];[MIM:609242]Kanzaki disease;,Alpha-N-acetylgalactosaminidase deficiency type 1;Alpha-N-acetylgalactosaminidase deficiency type 2;Alpha-N-acetylgalactosaminidase deficiency type 3,Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in,Intelligence[28530673;28530673];Autism spectrum disorder or schizophrenia[28540026;28540026];Breast size[22747683];Schizophrenia[25056061];,0.17791411042944785,0.09102630221763795,0.8039676324719395,0.5833333333333334
2350,20922,NAGLU,609701,252920;616491;,[MIM:616491]Charcot-Marie-Tooth disease 2V [dominant?];,Autosomal dominant Charcot-Marie-Tooth disease type 2V;Sanfilippo syndrome type B,Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) (loss of function) in,Inflammatory bowel disease[28067908];Systolic blood pressure change trajectories[27980656];Crohn's disease[28067908];Ulcerative colitis[28067908];,0.5631901840490797,0.7160907684373389,0.4964761158966327,0.700890116635973
2351,20925,NAGS,608300,237310;,[MIM:237310]N-acetylglutamate synthase deficiency [recessive?];,Hyperammonemia due to N-acetylglutamate synthase deficiency,Disease-causing germline mutation(s) in,,0.038773006134969326,0.1774110366168128,0.5974941268598277,0.6306015960712094
2352,20927,NAIP,600355,,,Proximal spinal muscular atrophy type 1;Proximal spinal muscular atrophy type 3;Proximal spinal muscular atrophy type 2,Modifying germline mutation in;Modifying germline mutation in;Modifying germline mutation in,,0.22687116564417178,0.2844249613202682,0.717567214826416,0.0
2353,20928,NALCN,611549,615419;616266;,"[MIM:615419]Hypotonia, infantile, with psychomotor retardation and characteristic facies 1;[MIM:616266]Congenital contractures of the limbs and face, hypotonia, and developmental delay;",Digitotalar dysmorphism;Sheldon-Hall syndrome;Freeman-Sheldon syndrome;Hypotonia-speech impairment-severe cognitive delay syndrome,Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in,Bipolar disorder and eating disorder[26433762];HIV-associated dementia[22628157];Non-small cell lung cancer[23144319];Prudent dietary pattern[28644415];Psychosis (atypical)[24132900];Bipolar disorder and schizophrenia[20889312];Serum uric acid levels in response to allopurinol in gout[25676789];Recurrent major depressive disorder[29317602];Night sleep phenotypes[27126917];,0.17791411042944785,0.33831872099020116,0.5904463586530931,0.7995702885205648
2354,20952,NANOS1,608226,615413;,[MIM:615413]Spermatogenic failure 12;,Male infertility with teratozoospermia due to single gene mutation;Male infertility with azoospermia or oligozoospermia due to single gene mutation,Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in,Alcoholic chronic pancreatitis[28754779;28754779;28754779;28754779;28754779];,0.16220858895705523,0.7328519855595668,0.5090054815974941,0.0
2355,20956,NANS,605202,610442;,,"Spondyloepimetaphyseal dysplasia, Genevi�ve type",Disease-causing germline mutation(s) (loss of function) in,Alopecia areata[25608926];,0.6045398773006135,0.41335740072202165,0.19368311145914904,0.20549416820135052
2356,20983,NARS2,612803,256000;616239;,[MIM:616239]Combined oxidative phosphorylation deficiency 24 [recessive?];[MIM:256000]Leigh syndrome;,Combined oxidative phosphorylation defect type 24,Disease-causing germline mutation(s) in,Verbal declarative memory[25648963;25648963];Alzheimer's disease (survival time)[25649651];,0.8785276073619632,0.17096441464672513,0.6110676063690942,0.3365561694290976
2357,20989,NAT2,612182,243400;,,Isoniazid toxicity,Biomarker tested in,"Blood metabolite levels[24816252;24816252;24816252];Triglyceride levels[28334899;29403010];Triglycerides[20686565;24097068];Night sleep phenotypes[27126917];Urinary metabolites (H-NMR features)[24586186];Bladder cancer[20972438;24163127];Coronary artery disease[29212778];Blood metabolite ratios[24816252];Insulin resistance/response[25798622];Total cholesterol levels[28334899];Urinary metabolites[21572414;26352407];Iron status biomarkers (transferrin levels)[25352340];Cholesterol, total[20686565;24097068];Paclitaxel-induced neuropathy[23776197];Metabolic traits[21886157];",0.33975460122699386,0.44584837545126355,0.03523884103367267,0.14226519337016574
2358,20990,NAT8,606716,,,Fabry disease,Disease-causing germline mutation(s) in,Urinary metabolite concentrations in chronic kidney disease[29545352];Serum metabolite levels[24625756;23093944;23093944;23093944;23093944];Creatinine levels[20383145];Blood metabolite levels[24816252;24816252;24816252;24816252;24816252];Chronic kidney disease[20383146];Glomerular filtration rate[23535967;23535967;23535967];Blood metabolite ratios[24816252];Urinary metabolites[26352407];Urinary metabolite ratios in chronic kidney disease[29545352;29545352;29545352;29545352];Metabolite levels[21931564];Serum metabolite concentrations in chronic kidney disease[29545352];Metabolite levels  (X-11787)[23934736];Metabolic traits[21886157];Glomerular filtration rate (creatinine)[28452372];,0.10711656441717791,0.0,0.5298877577655965,0.2576734192756292
2359,21010,NBAS,608025,614800;616483;,[MIM:616483]Infantile liver failure syndrome 2;,Fever-associated acute infantile liver failure syndrome;Short stature-optic atrophy-Pelger-Hu�t anomaly syndrome,Disease-causing germline mutation(s) (loss of function) in;Disease-causing germline mutation(s) in,LDL peak particle diameter (total fat intake interaction)[26112879;26112879];Recalcitrant atopic dermatitis[25935106];Familial squamous cell lung carcinoma[29924316];Response to platinum-based chemotherapy (carboplatin)[21844884];,0.8046625766871166,0.04925219185146983,0.12581571391281648,0.050030693677102514
2360,21015,NBEAL2,614169,139090;,,Gray platelet syndrome,Disease-causing germline mutation(s) (loss of function) in,Post bronchodilator FEV1/FVC ratio[26634245;26634245];Huntington's disease progression[28642124];,0.621717791411043,0.7679216090768437,0.039415296267293135,0.17756292203806015
2361,21023,NBN,602667,114480;251260;609135;,[MIM:251260]Nijmegen breakage syndrome;[MIM:114480]Breast cancer;[MIM:609135]Aplastic anemia;,Familial prostate cancer;Nijmegen breakage syndrome;Hereditary breast and ovarian cancer syndrome,Major susceptibility factor in;Disease-causing germline mutation(s) in;Candidate gene tested in,,0.7465030674846626,0.28674574522949975,0.13390759592795615,0.14548802946593
2362,21056,NCAPD3,609276,,,Autosomal recessive primary microcephaly,Disease-causing germline mutation(s) in,Verbal declarative memory[25648963];Cognitive test performance[17903297];,0.8595092024539878,0.13073749355337802,0.3881493082746019,0.19659300184162062
2363,21072,NCF1,608512,233700;,"[MIM:233700]Granulomatous disease, chronic, cytochrome-b-positive 1, autosomal recessive [recessive?];",Chronic granulomatous disease,Disease-causing germline mutation(s) in,,0.48576687116564415,0.7274368231046932,0.7836074132080397,0.0
2364,21075,NCF2,608515,233710;,"[MIM:233710]Granulomatous disease, chronic, cytochrome-b-positive 2, autosomal recessive [recessive?];",Chronic granulomatous disease,Disease-causing germline mutation(s) in,Systemic lupus erythematosus[27399966;26502338;26606652;26502338;28714469;19838195];,0.403680981595092,0.5827746260959258,0.05847037327068651,0.07228360957642725
2365,21076,NCF4,601488,613960;,"[MIM:613960]Granulomatous disease, chronic, cytochrome-b-positive 3, autosomal recessive [recessive?];",Chronic granulomatous disease,Disease-causing germline mutation(s) in,Inflammatory bowel disease[27569725];Sum eosinophil basophil counts[27863252];Eosinophil percentage of granulocytes[27863252];Multiple sclerosis[24076602];Itch intensity from mosquito bite adjusted by bite size[28199695;28199695];Atopic dermatitis[22197932];Eosinophil counts[27863252];Crohn's disease[28067908];Neutrophil percentage of granulocytes[27863252];Eosinophil percentage of white cells[27863252];,0.5226993865030675,0.2957710159876225,0.7504567997911772,0.1141804788213628
2366,21095,NCOA2,601993,,,Fraser syndrome,Disease-causing germline mutation(s) in,QT interval[24952745];HDL cholesterol levels[28334899];Multiple sclerosis[24076602];Intelligence (MTAG)[29326435];Spherical equivalent or myopia (age of diagnosis)[29808027];Non-small cell lung cancer[23144319];Serum alkaline phosphatase levels[29403010];Metabolite levels (HVA-5-HIAA Factor score)[23319000];Subclinical trait of interstitial lung disease (basilar peel-core ratio of high attentuation areas on CT scan)[28521775];Cardiac Troponin-T levels[23247143];,0.8267484662576687,0.0,0.5249282171756722,0.0
2367,21097,NCOA4,601984,,,Differentiated thyroid carcinoma,Part of a fusion gene in,Mean corpuscular hemoglobin[20139978;29403010];Mean corpuscular volume[20139978;29403010];Red blood cell count[29403010];,0.6896932515337423,0.20964414646725116,0.4403549986948577,0.1998158379373849
2368,21121,NDE1,609449,605013;614019;,[MIM:614019]Lissencephaly 4;[MIM:605013]Microhydranencephaly;,Hydranencephaly;Microlissencephaly;NDE1-related microhydranencephaly,Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in,Multiple system atrophy (pathologically confirmed)[27629089];Serum uric acid levels in response to allopurinol in gout[25676789];,0.9749693251533742,0.5415162454873647,0.2589402244844688,0.7360343769183548
2369,21129,NDN,602117,176270;,,Prader-Willi syndrome due to paternal deletion of 15q11q13 type 1;Prader-Willi syndrome due to paternal deletion of 15q11q13 type 2;Prader-Willi syndrome due to imprinting mutation;Prader-Willi syndrome due to maternal uniparental disomy of chromosome 15,Role in the phenotype of;Role in the phenotype of;Role in the phenotype of;Role in the phenotype of,Serum metabolite concentrations in chronic kidney disease[29545352];Depressive symptoms (SSRI exposure interaction)[25649181];,0.4750920245398773,0.7697266632284683,0.716523101018011,0.6138735420503376
2370,21132,NDP,300658,305390;310600;,"[MIM:305390]Vitreoretinopathy, exudative 2;",Norrie disease;Coats disease;Familial exudative vitreoretinopathy;Retinopathy of prematurity;Persistent hyperplastic primary vitreous,Disease-causing germline mutation(s) (loss of function) in;Candidate gene tested in;Disease-causing germline mutation(s) in;Major susceptibility factor in;Disease-causing germline mutation(s) in,Heel bone mineral density[28869591;28869591;28869591];Mean arterial pressure[29403010];,0.23865030674846627,0.778751933986591,0.8707909162098669,0.0
2371,21134,NDRG1,605262,601455;,[MIM:601455]Charcot-Marie-Tooth disease 4D [recessive?];,Charcot-Marie-Tooth disease type 4D,Disease-causing germline mutation(s) in,Nontyphoidal Salmonella bacteraemia[29523850];Post-traumatic stress disorder (asjusted for relatedness)[23726511];,0.8759509202453988,0.610881897885508,0.554685460715218,0.1976672805402087
2372,21138,NDST1,600853,616116;,,Autosomal recessive non-syndromic intellectual disability,Disease-causing germline mutation(s) in,Inflammatory bowel disease[28067908];Cholangiocarcinoma in primary sclerosing cholangitis[28779025];Crohn's disease[28067908];Blood protein levels[30072576];,0.20368098159509201,0.970216606498195,0.7606369094231271,0.8979435236341313
2373,21143,NDUFA1,300078,252010;,,Isolated complex I deficiency,Disease-causing germline mutation(s) in,,0.6080981595092024,0.7423929860752966,0.9859044635865309,0.0
2374,21144,NDUFA2,602137,,,Leigh syndrome with leukodystrophy;Cystic leukoencephalopathy without megalencephaly,Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) (loss of function) in,Schizophrenia[28991256];,0.9577914110429447,0.7818463125322331,0.9305664317410598,0.5308471454880295
2375,21152,NDUFA4,603833,256000;,[MIM:256000]Leigh syndrome;,Leigh syndrome with leukodystrophy,Disease-causing germline mutation(s) (loss of function) in,Lung cancer[28604730];Mercury levels[26025379];Heschl's gyrus morphology[25130324];,0.9258895705521473,0.4845281072717896,0.9558861915948839,0.32642725598526706
2376,21174,NDUFA9,603834,256000;,[MIM:256000]Leigh syndrome;,Leigh syndrome with leukodystrophy,Disease-causing germline mutation(s) in,Gut microbiota (bacterial taxa)[27723756];,0.9921472392638037,0.44094894275399693,0.5606891151135474,0.5253222836095764
2377,21176,NDUFA10,603835,256000;,[MIM:256000]Leigh syndrome;,Leigh syndrome with leukodystrophy,Disease-causing germline mutation(s) in,Odorant perception (isobutyraldehyde)[23910658];,0.925521472392638,0.3744198040226921,0.2539806838945445,0.578268876611418
2378,21177,NDUFA11,612638,252010;,[MIM:252010]Mitochondrial complex I deficiency;,Isolated complex I deficiency,Disease-causing germline mutation(s) in,Heart rate variability traits (SDNN)[28613276;28613276;28613276];Heart rate response to exercise[29769521];Heart rate variability traits (pvRSA/HF)[28613276;28613276];Heart rate response to recovery post exercise (50 sec)[29497042];Heart rate variability traits (RMSSD)[28613276;28613276];Heart rate response to recovery post exercise (30 sec)[29497042];Heart rate response to recovery post exercise (10 sec)[29497042];Heart rate response to recovery post exercise (40 sec)[29497042];Heart rate response to recovery post exercise[29769521];Heart rate response to recovery post exercise (20 sec)[29497042];,0.8482208588957055,0.43166580711707064,0.3184547115635604,0.0
2379,21178,NDUFA12,614530,256000;,[MIM:256000]Leigh syndrome;,Leigh syndrome with leukodystrophy,Disease-causing germline mutation(s) in,Coronary artery disease[29212778];,0.9550920245398773,0.29035585353274884,0.9370921430435918,0.18139963167587478
2380,21180,NDUFA13,609435,607464;,[MIM:607464]Hurthle cell thyroid carcinoma;,Differentiated thyroid carcinoma;Leigh syndrome with leukodystrophy,Disease-causing somatic mutation(s) in;Disease-causing germline mutation(s) in,Schizophrenia[23974872;25056061];Platelet count[27863252];,0.9732515337423313,0.16529138731304796,0.8167580266249022,0.23204419889502761
2381,21183,NDUFAF1,606934,,,Isolated complex I deficiency,Disease-causing germline mutation(s) in,Ulcerative colitis[23128233;28067908];Eosinophil percentage of white cells[27863252];,0.907239263803681,0.4345023207839092,0.18324197337509787,0.21639042357274402
2382,21184,NDUFAF2,609653,252010;256000;,[MIM:252010]Mitochondrial complex I deficiency;[MIM:256000]Leigh syndrome;,Isolated complex I deficiency;Leigh syndrome with leukodystrophy,Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in,Intelligence (MTAG)[29326435];Parkinson's disease[27182965];Autism spectrum disorder or schizophrenia[28540026;28540026;28540026];,0.8244171779141104,0.37055183084063953,0.9201252936570086,0.17863720073664824
2383,21185,NDUFAF3,612911,252010;,[MIM:252010]Mitochondrial complex I deficiency;,Isolated complex I deficiency;Leigh syndrome with cardiomyopathy,Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in,Inflammatory bowel disease[28067908];Crohn's disease[28067908];Blood protein levels[28240269];Ulcerative colitis[28067908];,0.8831901840490798,0.3500515729757607,0.48055338031845474,0.44014732965009207
2384,21186,NDUFAF4,611776,252010;,[MIM:252010]Mitochondrial complex I deficiency;,Isolated complex I deficiency,Disease-causing germline mutation(s) in,,0.9285889570552147,0.7271789582258896,0.9078569564082485,0.6539287906691221
2385,21191,NDUFAF5,612360,252010;256000;,[MIM:252010]Mitochondrial complex I deficiency;[MIM:256000]Leigh syndrome;,Isolated complex I deficiency;Leigh syndrome with leukodystrophy,Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in,,0.8957055214723927,0.10598246518824136,0.7452362307491517,0.0
2386,21192,NDUFAF6,612392,252010;,[MIM:252010]Mitochondrial complex I deficiency;,Leigh syndrome with leukodystrophy,Disease-causing germline mutation(s) in,Serum uric acid levels[29403010];Alzheimer's disease (late onset)[24162737];Central corneal thickness[29760442];Vincristine-induced peripheral neuropathy in acute lymphoblastic leukemia[25710658];Alcohol dependence symptom count[29460428];Hemoglobin concentration[27863252];Intraocular pressure[29617998;29617998];,0.10711656441717791,0.1557503867973182,0.7796919864265205,0.0
2387,21201,NDUFB3,603839,252010;,[MIM:252010]Mitochondrial complex I deficiency;,Isolated complex I deficiency,Disease-causing germline mutation(s) in,Breast cancer[27117709];Breast cancer (estrogen-receptor negative)[27117709];,0.8350920245398773,0.24033006704486848,0.9425737405377186,0.22621240024554942
2388,21225,NDUFB8,602140,,,Leigh syndrome with cardiomyopathy,Disease-causing germline mutation(s) in,Palmitoleic acid (16:1n-7) levels[23362303];,0.8856441717791411,0.29112944816915937,0.7627251370399374,0.5067526089625537
2389,21229,NDUFB9,601445,,,Isolated complex I deficiency,Disease-causing germline mutation(s) in,,0.723558282208589,0.3450232078390923,0.7590707387105194,0.299109883364027
2390,21233,NDUFB10,603843,,,Isolated complex I deficiency,Disease-causing germline mutation(s) in,,0.9089570552147239,0.4577101598762249,0.8720960584703733,0.4713014119091467
2391,21236,NDUFB11,300403,252010;300952;,[MIM:252010]Mitochondrial complex I deficiency;,Isolated complex I deficiency;Microphthalmia with linear skin defects syndrome,Candidate gene tested in;Disease-causing germline mutation(s) (loss of function) in,,0.8802453987730061,0.8189788550799381,0.9707648133646567,0.0
2392,21241,NDUFS1,157655,252010;,[MIM:252010]Mitochondrial complex I deficiency;,Isolated complex I deficiency;Leigh syndrome with leukodystrophy,Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in,Frontotemporal dementia with GRN mutation[29724592];Body mass index[26426971];,0.9919018404907975,0.11629706034038163,0.6617071260767423,0.6416513198281154
2393,21242,NDUFS2,602985,252010;,[MIM:252010]Mitochondrial complex I deficiency;,Leber hereditary optic neuropathy;Isolated complex I deficiency;Leigh syndrome with leukodystrophy;Leigh syndrome with cardiomyopathy,Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in,"Granulocyte percentage of myeloid white cells[27863252];Allergic disease (asthma, hay fever or eczema)[29083406];",0.9928834355828221,0.5309437854564208,0.2678151918559123,0.8789134438305709
2394,21243,NDUFS3,603846,,,Isolated complex I deficiency;Leigh syndrome with leukodystrophy,Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in,Neuroticism[29255261];Body mass index[20935630];,0.9982822085889571,0.4100051572975761,0.839989558861916,0.439073050951504
2395,21244,NDUFS4,602694,252010;256000;,[MIM:252010]Mitochondrial complex I deficiency;[MIM:256000]Leigh syndrome;,Isolated complex I deficiency;Leigh syndrome with leukodystrophy,Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in,Midgestational circulating levels of PCBs[28235828];Waist circumference adjusted for BMI (joint analysis main effects and physical activity interaction)[28448500;28448500];Acne (severe)[24927181];Monobrow[27182965];Waist circumference adjusted for body mass index[28448500;28448500];Night sleep phenotypes[27126917];Waist circumference adjusted for BMI in active individuals[28448500;28448500];,0.9495705521472393,0.3218153687467767,0.8232837379274341,0.2372621240024555
2396,21253,NDUFS6,603848,252010;,[MIM:252010]Mitochondrial complex I deficiency;,Isolated complex I deficiency,Disease-causing germline mutation(s) in,,0.974601226993865,0.6028880866425993,0.8770555990602976,0.259975445058318
2397,21255,NDUFS7,601825,252010;256000;,[MIM:256000]Leigh syndrome;[MIM:252010]Mitochondrial complex I deficiency;,Isolated complex I deficiency;Leigh syndrome with leukodystrophy,Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in,,0.9533742331288344,0.8292934502320783,0.22370138345079613,0.748158379373849
2398,21256,NDUFS8,602141,256000;,[MIM:256000]Leigh syndrome;,Isolated complex I deficiency;Leigh syndrome with leukodystrophy,Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in,,0.9958282208588957,0.7042289840123775,0.9154267815191856,0.6580724370779619
2399,21257,NDUFV1,161015,252010;256000;,[MIM:256000]Leigh syndrome;[MIM:252010]Mitochondrial complex I deficiency;,Isolated complex I deficiency;Leigh syndrome with leukodystrophy,Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in,,0.9774233128834355,0.2810727178958226,0.741842860871835,0.7862185389809699
2400,21258,NDUFV2,600532,,,Isolated complex I deficiency;Leigh syndrome with leukodystrophy,Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in,Cerebral amyloid deposition (PET imaging)[26252872;26252872];Epilepsy and lamotrigine-induced maculopapular eruptions[26220383];Response to fenofibrate (HDL cholesterol levels)[27002377];,0.9933742331288343,0.6642599277978339,0.4267815191855912,0.14379987722529158
2401,21263,NEB,161650,256030;,,Severe congenital nemaline myopathy;Intermediate nemaline myopathy;Typical nemaline myopathy;Childhood-onset nemaline myopathy;Distal nebulin myopathy;Lethal multiple pterygium syndrome,Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in,Squamous cell lung carcinoma[28604730];Response to cognitive-behavioural therapy in anxiety disorder[26989097];Creatine kinase levels[29403010];Asparaginase-induced acute pancreatitis in acute lymphoblastic leukemia (onset time)[27114598];,0.49570552147239266,0.00850954100051573,0.0013051422605063951,0.006599140577041129
2402,21264,NEBL,605491,,,Familial isolated dilated cardiomyopathy,Candidate gene tested in,Liver injury in combined anti-retroviral and anti-tuberculosis drug-treated HIV with tuberculosis[28388302];Urate levels in lean individuals[25811787];Coronary artery aneurysm in Kawasaki disease[27171184];Atrial fibrillation[28416822];Response to TNF inhibitor in rheumatoid arthritis (change in swollen 28-joint count)[30166627];Sporadic pituitary adenoma[26029870];Photic sneeze reflex[27182965];Ovarian cancer[23535730;23535730];,0.780122699386503,0.2712738525012893,0.13260245366744974,0.02961939840392879
2403,21269,NECAP1,611623,615833;,"[MIM:615833]Epileptic encephalopathy, early infantile, 21;",Undetermined early-onset epileptic encephalopathy,Disease-causing germline mutation(s) (loss of function) in,,0.8023312883435583,0.7506446621970088,0.7520229705037849,0.0
2404,21273,NECTIN1,600644,225060;,"[MIM:225060]Ectodermal dysplasia, Margarita Island type [recessive?];[MIM:225060]Non-syndromic orofacial cleft 7;",Isolated cleft lip;Cleft lip/palate;Cleft lip and alveolus;Zlotogora-Ogur syndrome,Major susceptibility factor in;Major susceptibility factor in;Major susceptibility factor in;Disease-causing germline mutation(s) in,Tourette's syndrome or obsessive-compulsive disorder[25158072];,0.28662576687116564,0.30995358432181536,0.0,0.0
2405,21277,NECTIN4,609607,613573;,[MIM:613573]Ectodermal dysplasia-syndactyly syndrome 1;,Ectodermal dysplasia-syndactyly syndrome,Disease-causing germline mutation(s) in,Night sleep phenotypes[27126917;27126917];,0.3449079754601227,0.5634347601856627,0.0,0.0
2406,21280,NEDD4L,606384,617201;,[MIM:617201]Periventricular nodular heterotopia 7 [dominant?];,Periventricular nodular heterotopia,Disease-causing germline mutation(s) in,Liver enzyme levels (gamma-glutamyl transferase)[22001757];Manganese levels[26025379];Insomnia (caffeine-induced)[22754043];Amyotrophic lateral sclerosis (sporadic)[24529757];Diisocyanate-induced asthma[25918132];Response to amphetamines[22952603];Gamma glutamyl transferase levels[29403010];,0.6462576687116565,0.0,0.7854346123727486,0.3083179864947821
2407,21284,NEFH,162230,105400;616924;,[MIM:105400]Amyotrophic lateral sclerosis;[MIM:616924]Charcot-Marie-Tooth disease 2CC;,Amyotrophic lateral sclerosis,Major susceptibility factor in,,0.6019631901840491,0.09953584321815369,0.15113547376664058,0.793585021485574
2408,21286,NEFL,162280,607684;607734;,[MIM:607734]Charcot-Marie-Tooth disease 1F;[MIM:607684]Charcot-Marie-Tooth disease 2E;,Charcot-Marie-Tooth disease type 2B5;Charcot-Marie-Tooth disease type 1F;Autosomal dominant Charcot-Marie-Tooth disease type 2E,Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in,Response to anti-retroviral therapy (ddI/d4T) in HIV-1 infection (Grade 3 peripheral neuropathy)[24554482];Response to anti-retroviral therapy (ddI/d4T) in HIV-1 infection (Grade 2 peripheral neuropathy)[24554482];Fear of minor pain[28701861];,0.5488343558282208,0.0,0.0,0.0
2409,21295,NEK1,604588,263520;617892;,[MIM:617892]Amyotrophic lateral sclerosis 24;,"Amyotrophic lateral sclerosis;Orofaciodigital syndrome type 2;Short rib-polydactyly syndrome, Majewski type",Major susceptibility factor in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in,Autism spectrum disorder or schizophrenia[28540026];Schizophrenia[25056061;28991256];Night sleep phenotypes[27126917];,0.6269938650306749,0.021918514698298093,0.21273818846254242,0.03130755064456722
2410,21296,NEK2,604043,615565;,[MIM:615565]Retinitis pigmentosa 67;,Retinitis pigmentosa,Disease-causing germline mutation(s) (loss of function) in,Red cell distribution width[27863252];,0.8901840490797546,0.2374935533780299,0.22578961106760637,0.27931246163290363
2411,21309,NEK8,609799,613824;615415;,[MIM:615415]Renal-hepatic-pancreatic dysplasia 2;,Renal-hepatic-pancreatic dysplasia;Infantile nephronophthisis,Disease-causing germline mutation(s) (loss of function) in;Disease-causing germline mutation(s) in,Reticulocyte count[27863252];,0.5069938650306749,0.5966993295513151,0.7368833202819107,0.4854205033763045
2412,21310,NEK9,609798,614262;617022;617025;,"[MIM:617022]Lethal congenital contracture syndrome 10 [recessive?];[MIM:617025]Nevus comedonicus;[MIM:614262]Arthrogryposis, Perthes disease, and upward gaze palsy [recessive?];",NEK9-related lethal skeletal dysplasia;Nevus comedonicus syndrome,Disease-causing germline mutation(s) (loss of function) in;Disease-causing somatic mutation(s) in,Coronary artery disease[29212778;29212778];,0.8669938650306749,0.629190304280557,0.39180370660401986,0.4003990178023327
2413,21313,NELFA,606026,,,Wolf-Hirschhorn syndrome,Candidate gene tested in,,0.6511656441717791,0.481691593604951,0.6588358131036283,0.0
2414,21333,NEU1,608272,256550;,[MIM:256550]Sialidosis;,Sialidosis type 1;Juvenile sialidosis type 2;Congenital sialidosis type 2,Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in,Inflammatory bowel disease[28067908];Basal cell carcinoma[27539887];Small cell lung carcinoma[28604730];Autism spectrum disorder or schizophrenia[28540026;28540026;28540026;28540026;28540026;28540026;28540026;28540026;28540026;28540026;28540026;28540026;28540026;28540026;28540026;28540026;28540026];Squamous cell lung carcinoma[28604730];Blood protein levels[28240269;28240269];Ulcerative colitis[28067908];,0.5705521472392638,0.25425477050025785,0.5134429652832159,0.5363720073664825
2415,21343,NEUROD1,601724,125853;606394;,"[MIM:606394]Maturity-onset diabetes of the young 6 [dominant?];[MIM:125853]Diabetes mellitus, non-insulin-dependent;",MODY,Disease-causing germline mutation(s) in,,0.3168098159509202,0.8116297060340382,0.6358653093187158,0.6869244935543278
2416,21349,NEUROG3,604882,610370;,"[MIM:610370]Diarrhea 4, malabsorptive, congenital;",Enteric anendocrinosis,Disease-causing germline mutation(s) (loss of function) in,Type 2 diabetes[29358691];Carotid intima media thickness[26343869];Upper eyelid morphology[29921221];,0.4226993865030675,0.22202166064981949,0.145914904724615,0.4585635359116022
2417,21350,NEXMIF,300524,300912;,,"X-linked intellectual disability, Cantagrel type",Disease-causing germline mutation(s) (loss of function) in,,0.08736196319018405,0.6227436823104693,0.0,0.0
2418,21351,NEXN,613121,613122;613876;,"[MIM:613876]Cardiomyopathy, familial hypertrophic 20;",Familial isolated dilated cardiomyopathy,Disease-causing germline mutation(s) (loss of function) in,Lung cancer in never smokers[28604730];,0.8419631901840491,0.06962351727694688,0.22109109892978335,0.06123388581952118
2419,21353,NF1,613113,114500;162200;162210;193520;601321;607785;,"[MIM:162200]Neurofibromatosis 1;[MIM:607785]Leukemia, juvenile myelomonocytic;[MIM:193520]Watson syndrome;[MIM:162210]Familial spinal neurofibromatosis;[MIM:601321]Neurofibromatosis-Noonan syndrome;[MIM:114500]Colorectal cancer;",Neurofibromatosis-Noonan syndrome;17q11.2 microduplication syndrome;Neurofibromatosis type 1 due to NF1 mutation or intragenic deletion;Juvenile myelomonocytic leukemia;17q11 microdeletion syndrome,Disease-causing germline mutation(s) in;Role in the phenotype of;Disease-causing germline mutation(s) (loss of function) in;Disease-causing somatic mutation(s) in;Role in the phenotype of,Endometrial cancer ((endometrioid histology)[30093612];Hip circumference[25673412];Endometrial cancer[30093612];Familial squamous cell lung carcinoma[29924316;29924316];,0.6553374233128835,0.7078390923156266,0.5264943878882798,0.766267648864334
2420,21366,NF2,607379,101000;156240;162091;,"[MIM:101000]Neurofibromatosis 2 [dominant?];[MIM:162091]Schwannomatosis 1;[MIM:156240]Mesothelioma, malignant;",Neurofibromatosis type 2;Neurofibromatosis type 3,Disease-causing germline mutation(s) in;Candidate gene tested in,Carotid atherosclerosis in HIV infection[20009918];,0.794601226993865,0.8739040742650851,0.8292873923257635,0.9729895641497851
2421,21382,NFIA,600727,613735;,[MIM:613735]Brain malformations with or without urinary tract defects;,1p31p32 microdeletion syndrome,Role in the phenotype of,Electrocardiographic conduction measures[23463857];QT interval (sulfonylurea treatment interaction)[27958378];Celiac disease[20190752];Thyroid hormone levels[23408906;23408906;23408906];JT interval (sulfonylurea treatment interaction)[27958378];Myopia[27182965];Bipolar disorder[21738484];Global electrical heterogeneity phenotypes[29622589;29622589];QRS duration[27577874;27577874;27577874;27659466];Plasma omega-3 polyunsaturated fatty acid level (eicosapentaenoic acid)[21829377];Cobalt levels[26025379];,0.7323926380368098,0.7712738525012893,0.9175150091359958,0.8293431553100061
2422,21388,NFIX,164005,602535;614753;,[MIM:614753]Sotos syndrome 2;[MIM:602535]Marshall-Smith syndrome;,Marshall-Smith syndrome;19p13.3 microduplication syndrome;Malan overgrowth syndrome,Disease-causing germline mutation(s) in;Role in the phenotype of;Disease-causing germline mutation(s) in,Body mass index[25673413];Granulocyte percentage of myeloid white cells[27863252];Intelligence (MTAG)[29326435;29326435];Clozapine-induced agranulocytosis[25187353];Bipolar disorder[28115744];Monocyte count[27863252];Monocyte percentage of white cells[27863252];,0.5959509202453988,0.9631253223310985,0.997128687026886,0.8067833026396563
2423,21389,NFKB1,164011,616576;,"[MIM:616576]Immunodeficiency, common variable, 12;",Common variable immunodeficiency,Disease-causing germline mutation(s) in,"Primary biliary cirrhosis[22961000];Multiple sclerosis[21833088];Lymphocyte percentage of white cells[27863252];Chronic inflammatory diseases (ankylosing spondylitis, Crohn's disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy)[26974007];Primary sclerosing cholangitis[27992413];Eosinophil counts[27863252];Copper levels[26025379];Allergic rhinitis[30013184];Homeostasis model assessment of beta-cell function (dietary factor interaction)[24204828];Eosinophil percentage of white cells[27863252];Crohn's disease[28067908];Monocyte percentage of white cells[27863252];Albumin-globulin ratio[29403010];Inflammatory bowel disease[28067908];Sum eosinophil basophil counts[27863252];Eosinophil percentage of granulocytes[27863252];Serum total protein level[29403010];Tonsillectomy[27182965;28928442];Neutrophil percentage of white cells[27863252];Systemic sclerosis[30247649];Primary biliary cholangitis[21399635;23000144;28425483;28062665;26394269];Schizophrenia (treatment resistant)[22479419];Neutrophil percentage of granulocytes[27863252];Non-albumin protein levels[29403010];Ulcerative colitis[23128233];Glomerular filtration rate (creatinine)[26831199];Allergic sensitization[30013184];",0.7984049079754602,0.9743424445590511,0.6752806055860089,0.5320748925721301
2424,21390,NFKB2,164012,615577;,"[MIM:615577]Immunodeficiency, common variable, 10;",Common variable immunodeficiency;Deficiency in anterior pituitary function-variable immunodeficiency syndrome,Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) (gain of function) in,Waist-to-hip ratio adjusted for BMI (age >50)[26426971];Waist-to-hip ratio adjusted for BMI[26426971];Ulcerative colitis[26192919];Waist-to-hip ratio adjusted for BMI x sex x age interaction (4df test)[26426971];,0.8401226993865031,0.6866941722537391,0.7115635604280867,0.6746470227133211
2425,21391,NFKBIA,164008,612132;,"[MIM:612132]Ectodermal dysplasia, anhidrotic, with T-cell immunodeficiency autosomal dominant [dominant?];",Nasopharyngeal carcinoma;Gliosarcoma;Giant cell glioblastoma;Hypohidrotic ectodermal dysplasia with immunodeficiency,Disease-causing somatic mutation(s) in;Biomarker tested in;Biomarker tested in;Disease-causing germline mutation(s) in,"Systolic blood pressure[28739976;28739976];Psoriasis vulgaris[26626624];Psoriasis[20953189;20953190;25903422;25903422;25903422;25574825;23143594];Hip circumference adjusted for BMI[25673412;25673412];Lymphocyte counts[27863252];Chronic inflammatory diseases (ankylosing spondylitis, Crohn's disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy)[26974007;26974007];Creatine kinase levels[29403010];Inflammatory skin disease[25574825];",0.7294478527607362,0.9048478597215059,0.8376403027930044,0.870779619398404
2426,21398,NFS1,603485,,,Severe neonatal lactic acidosis due to NFS1-ISD11 complex deficiency,Disease-causing germline mutation(s) in,Blood protein levels[28240269];,0.9067484662576687,0.535585353274884,0.8175411119812059,0.7763965623081646
2427,21399,NFU1,608100,605711;,[MIM:605711]Multiple mitochondrial dysfunctions syndrome 1;,Multiple mitochondrial dysfunctions syndrome type 1,Disease-causing germline mutation(s) in,,0.7720245398773006,0.6655492521918515,0.3090576872879144,0.2668815224063843
2428,21412,NGF,162030,608654;,"[MIM:608654]Neuropathy, hereditary sensory and autonomic, 5;",Hereditary sensory and autonomic neuropathy type 5,Disease-causing germline mutation(s) in,Migraine without aura[27322543];Obstetric antiphospholipid syndrome[28424481];Migraine[27322543;27322543;27182965];Pediatric non-alcoholic fatty liver disease activity score[23535911];Dysmenorrheic pain[27454463];,0.5571779141104295,0.8084063950489944,0.15870529887757764,0.8004910988336402
2429,21415,NGLY1,610661,615273;,[MIM:615273]Congenital disorder of deglycosylation;,Alacrimia-choreoathetosis-liver dysfunction syndrome,Disease-causing germline mutation(s) (loss of function) in,,0.3925153374233129,0.058793192367199584,0.6366483946750195,0.2918968692449355
2430,21418,NHEJ1,611290,611291;,[MIM:611291]Severe combined immunodeficiency due to NHEJ1 deficiency;,Cernunnos-XLF deficiency,Disease-causing germline mutation(s) in,Height[25429064;25282103];,0.4493251533742331,0.46905621454357915,0.413469068128426,0.3207489257213014
2431,21421,NHLRC1,608072,254780;,"[MIM:254780]Epilepsy, progressive myoclonic 2 [recessive?];",Lafora disease,Disease-causing germline mutation(s) (loss of function) in,Intrinsic epigenetic age acceleration[29374233;29374233];,0.35496932515337426,0.5438370293965962,0.1555729574523623,0.66804788213628
2432,21425,NHP2,606470,613987;,"[MIM:613987]Dyskeratosis congenita, autosomal recessive, 2 [recessive?];",Dyskeratosis congenita,Disease-causing germline mutation(s) in,Platelet count[29403010];,0.7061349693251534,0.572202166064982,0.8431219002871313,0.1998158379373849
2433,21428,NHS,300457,302200;302350;,[MIM:302200]Cataract 40;,Nance-Horan syndrome;Early-onset nuclear cataract;Total early-onset cataract,Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Candidate gene tested in,,0.7479754601226993,0.9868488911810211,0.31453928478204124,0.0
2434,21451,NIN,608684,614851;,[MIM:614851]Seckel syndrome 7 [recessive?];,"Microcephalic primordial dwarfism, Dauber type",Disease-causing germline mutation(s) in,Mean platelet volume[27863252];Cognitive performance[20125193];Periodontal disease-related phenotypes[24347629];Lupus nephritis in systemic lupus erythematosus[24925725];,0.8115337423312884,0.13847343991748323,0.12163925867919603,0.05079803560466544
2435,21459,NIPA1,608145,600363;,,Autosomal dominant spastic paraplegia type 6,Disease-causing germline mutation(s) in,,0.038773006134969326,0.537648272305312,0.3610023492560689,0.5775015346838551
2436,21469,NIPAL4,609383,612281;,,Lamellar ichthyosis;Congenital non-bullous ichthyosiform erythroderma,Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in,,0.12711656441717792,0.38525012893243943,0.3837118245888802,0.6368937998772253
2437,21470,NIPBL,608667,122470;,[MIM:122470]Cornelia de Lange syndrome 1;,Cornelia de Lange syndrome;5p13 microduplication syndrome,Disease-causing germline mutation(s) in;Role in the phenotype of,Height[25282103];Obesity-related traits[23251661];,0.7240490797546012,0.8522434244455905,0.3051422605063952,1.0
2438,21501,NKX2-1,600635,118700;188550;610978;,"[MIM:118700]Chorea, hereditary benign [dominant?];[MIM:610978]Choreoathetosis and congenital hypothyroidism with or without pulmonary dysfunction [dominant?];[MIM:188550]Thyroid cancer, non-medullary, 1;",Differentiated thyroid carcinoma;Benign hereditary chorea;Brain-lung-thyroid syndrome;Athyreosis,Major susceptibility factor in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Candidate gene tested in,Thyroid cancer[19198613];Papillary thyroid cancer[28703219];Height[18391950];Menarche (age at onset)[23667675;29773799;29773799];Differentiated thyroid cancer[28703219];,0.35496932515337426,0.39504899432697266,0.7786478726181154,0.0
2439,21507,NKX2-5,600584,108900;187500;217095;225250;614432;614435;,"[MIM:108900]Atrial septal defect 7, with or without atrioventricular conduction defects;[MIM:187500]Tetralogy of Fallot;[MIM:217095]Conotruncal heart malformations;[MIM:225250]Hypothyroidism, congenital, non-goitrous, 5;[MIM:614432]Ventricular septal defect 3;[MIM:614435]Hypoplastic left heart syndrome 2;","Hypoplastic left heart syndrome;Tetralogy of Fallot;Familial progressive cardiac conduction defect;Deletion 5q35;Atrial septal defect-atrioventricular conduction defects syndrome;Familial bicuspid aortic valve;Familial atrial fibrillation;Athyreosis;Thyroid ectopia;Atrial septal defect, ostium secundum type;Familial isolated congenital asplenia",Major susceptibility factor in;Candidate gene tested in;Modifying germline mutation in;Role in the phenotype of;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) (loss of function) in;Disease-causing germline mutation(s) (loss of function) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in,Heart rate[23583979];Resting heart rate[27798624];Stroke[26089329];Ischemic stroke (cardioembolic)[29531354;29531354];Atrial fibrillation[30061737;29892015;29892015;30061737];PR interval[20062060];Infantile hypertrophic pyloric stenosis[22306654];,0.6541104294478528,0.6157813305827746,0.6690159227355782,0.9069981583793738
2440,21508,NKX2-6,611770,217095;,[MIM:217095]Conotruncal heart malformations;,Tetralogy of Fallot;Truncus arteriosus;Familial atrial fibrillation,Major susceptibility factor in;Major susceptibility factor in;Major susceptibility factor in,Waist circumference adjusted for BMI (joint analysis main effects and physical activity interaction)[28448500];Waist-to-hip ratio adjusted for BMI (adjusted for smoking behaviour)[28443625];Waist circumference adjusted for BMI in non-smokers[28443625];Waist-to-hip ratio adjusted for BMI in active individuals[28448500;28448500;28448500;28448500];Waist-to-hip ratio adjusted for BMI (joint analysis for main effect and physical activity interaction)[28448500;28448500;28448500;28448500];Multiple system atrophy (pathologically confirmed)[27629089];Waist-to-hip ratio adjusted for BMI in non-smokers[28443625];Waist-to-hip ratio adjusted for BMI x sex interaction[26426971];Waist circumference adjusted for BMI (adjusted for smoking behaviour)[28443625];Waist circumference adjusted for body mass index[28448500;28448500;25673412;25673412];Treatment response for severe sepsis[22310353];Waist-to-hip ratio adjusted for BMI[26426971];Waist-to-hip ratio adjusted for BMI (age >50)[26426971];Waist-to-hip ratio adjusted for BMI (age <50)[26426971];Waist circumference adjusted for BMI (joint analysis main effects and smoking interaction)[28443625];Waist circumference adjusted for BMI in active individuals[28448500];Waist-to-hip ratio adjusted for body mass index[28448500;28448500;28448500;28448500];Waist-to-hip ratio adjusted for BMI x sex x age interaction (4df test)[26426971];,0.038773006134969326,0.4151624548736462,0.5849647611589663,0.0
2441,21511,NKX3-2,602183,613330;,,Spondylo-megaepiphyseal-metaphyseal dysplasia,Disease-causing germline mutation(s) in,Periodontal disease-related phenotypes[24347629;24347629];,0.19190184049079756,0.7645693656523982,0.7167841294701123,0.0
2442,21513,NKX6-2,605955,617560;,,NKX6-2-related autosomal recessive hypomyelinating leukodystrophy,Disease-causing germline mutation(s) in,,0.038773006134969326,0.49793708096957195,0.7139128164969982,0.0
2443,21526,NLRC4,606831,616050;616115;,[MIM:616050]Autoinflammation with infantile enterocolitis [dominant?];[MIM:616115]Familial cold autoinflammatory syndrome 4 [dominant?];,CINCA syndrome;Periodic fever-infantile enterocolitis-autoinflammatory syndrome;Familial cold urticaria,Candidate gene tested in;Disease-causing germline mutation(s) (gain of function) in;Disease-causing germline mutation(s) in,Interleukin-18 levels[27989323];Inflammatory biomarkers[24182552];,0.578159509202454,0.08690046415678185,0.7110415035238841,0.11678944137507673
2444,21528,NLRP1,606636,606579;615225;617388;,"[MIM:606579]Vitiligo-associated multiple autoimmune disease 1;[MIM:615225]Palmoplantar carcinoma, multiple self-healing [dominant?];[MIM:617388]Autoinflammation with arthritis and dyskeratosis [dominant?] [recessive?];",Corneal intraepithelial dyskeratosis-palmoplantar hyperkeratosis-laryngeal dyskeratosis syndrome,Disease-causing germline mutation(s) in,Migraine[27322543];,0.5338650306748466,0.04512635379061372,0.1344296528321587,0.06276856967464703
2445,21531,NLRP3,606416,120100;148200;191900;607115;,[MIM:120100]Familial cold autoinflammatory syndrome 1 [dominant?];[MIM:191900]Muckle-Wells syndrome;[MIM:607115]Chronic infantile neurologic cutaneous and articular syndrome;[MIM:148200]Keratoendothelitis fugax hereditaria [dominant?];,Muckle-Wells syndrome;CINCA syndrome;Familial cold urticaria,Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) (gain of function) in,C-reactive protein levels[21300955];Myeloid white cell count[27863252];Sum basophil neutrophil counts[27863252];Sum neutrophil eosinophil counts[27863252];Waist circumference adjusted for body mass index[25673412];Granulocyte count[27863252];Neutrophil count[27863252];Word reading[23738518];White blood cell count[27863252];Neutrophil percentage of white cells[27863252];Fibrinogen[20031576;23969696];Fibrinogen levels[26561523;28107422;28107422];Platelet count[27863252];,0.5439263803680982,0.333677153171738,0.6898981989036805,0.9877225291589933
2446,21536,NLRP7,609661,231090;,"[MIM:231090]Hydatidiform mole, recurrent, 1;",Partial hydatidiform mole;Complete hydatidiform mole,Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in,Inflammatory bowel disease[23128233];,0.12711656441717792,0.049767921609076844,0.5833985904463587,0.0807243707796194
2447,21542,NLRP12,609648,611762;,[MIM:611762]Familial cold autoinflammatory syndrome 2 [dominant?];,NLRP12-associated hereditary periodic fever syndrome,Disease-causing germline mutation(s) in,Granulocyte percentage of myeloid white cells[27863252];Monocyte count[27863252];Monocyte percentage of white cells[27863252];Blood protein levels[29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488];Testicular germ cell tumor[28604728];,0.33226993865030674,0.014182568334192883,0.09135995823544767,0.5639963167587477
2448,21562,NME7,613465,,,Situs inversus totalis,Disease-causing germline mutation(s) in,D-dimer levels[21502573];Coronary artery disease[29212778;29212778;29212778];Venous thromboembolism[21980494;22672568];,0.9406134969325154,0.4007220216606498,0.6379535369355259,0.16114180478821363
2449,21563,NME8,607421,610852;,"[MIM:610852]Ciliary dyskinesia, primary, 6;",Primary ciliary dyskinesia,Disease-causing germline mutation(s) in,Alzheimer's disease (late onset)[24162737];Periodontitis[25672891];,0.33226993865030674,0.13950489943269725,0.1545288436439572,0.0
2450,21566,NMNAT1,608700,608553;,,Cone rod dystrophy;Leber congenital amaurosis,Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in,Resting heart rate[27798624];,0.6566871165644171,0.7099020113460547,0.813886713651788,0.5405156537753223
2451,21614,NNT,607878,614736;,,Familial glucocorticoid deficiency,Disease-causing germline mutation(s) in,Subcutaneous adipose tissue[29178545];Post bronchodilator FEV1/FVC ratio in COPD[26634245;26634245;26634245;26634245;26634245];,0.796441717791411,0.6776689014956163,0.2941790655181415,0.9487415592387968
2452,21626,NOD2,605956,186580;266600;617321;,[MIM:186580]Blau syndrome [dominant?];[MIM:266600]Inflammatory bowel disease 1;[MIM:617321]Yao syndrome;,Blau syndrome,Disease-causing germline mutation(s) in,"Inflammatory bowel disease[18758464;28067908];Pediatric autoimmune diseases[26301688];Chronic inflammatory diseases (ankylosing spondylitis, Crohn's disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy)[26974007;26974007;26974007];Leprosy[25642632;20018961;27976721;25642632;25642632];Crohn's disease[18587394;17554300;17804789;20570966;21102463;22936669;23128233;28067908;22412388];",0.4750920245398773,0.22279525528623,0.3722265726964239,0.10804174340085942
2453,21627,NODAL,601265,270100;,"[MIM:270100]Heterotaxy, visceral, 5, autosomal;",Situs ambiguus;Microform holoprosencephaly;Septopreoptic holoprosencephaly;Semilobar holoprosencephaly;Midline interhemispheric variant of holoprosencephaly;Lobar holoprosencephaly;Alobar holoprosencephaly;Situs inversus totalis,Candidate gene tested in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in,,0.10711656441717791,0.8290355853532749,0.8154528843643957,0.5679864947820749
2454,21628,NOG,602991,184460;185800;186500;186570;611377;,"[MIM:185800]Symphalangism, proximal 1A;[MIM:186500]Multiple synostoses syndrome 1;[MIM:186570]Tarsal-carpal coalition syndrome;[MIM:184460]Stapes ankylosis with broad thumb and toes [dominant?];[MIM:611377]Brachydactyly B2;",Tarsal-carpal coalition syndrome;Stapes ankylosis with broad thumbs and toes;Brachydactyly type B2;Multiple synostoses syndrome;Proximal symphalangism,Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in,Celiac disease[23936387];Cleft lip with or without cleft palate[28054174];Spherical equivalent or myopia (age of diagnosis)[29808027];Amyotrophic lateral sclerosis (sporadic)[24529757];Height[20881960;20881960;18391951];Blood protein levels[29875488];Orofacial clefts[20023658;20023658];Nonsyndromic cleft lip with cleft palate[28232668];,0.14576687116564419,0.8576585869004641,0.9185591229444009,0.8419275629220381
2455,21629,NOL3,605235,614937;,"[MIM:614937]Myoclonus, familial cortical [dominant?];",Familial cortical myoclonus,Disease-causing germline mutation(s) in,,0.3925153374233129,0.29216090768437336,0.679196032367528,0.34499693063228976
2456,21646,NONO,300084,300967;,"[MIM:300967]Mental retardation, X-linked, syndromic, 34;",MiT family translocation renal cell carcinoma;Macrocephaly-intellectual disability-left ventricular non compaction syndrome,Part of a fusion gene in;Disease-causing germline mutation(s) (loss of function) in,,0.9656441717791411,0.9189014956162971,0.8953275907073871,0.26442602823818295
2457,21651,NOP10,606471,224230;,"[MIM:224230]Dyskeratosis congenita, autosomal recessive, 1 [recessive?];",Dyskeratosis congenita,Disease-causing germline mutation(s) in,,0.8065030674846626,0.738009283135637,0.883059253458627,0.4972375690607735
2458,21657,NOP56,614154,614153;,[MIM:614153]Spinocerebellar ataxia 36;,Spinocerebellar ataxia type 36,Disease-causing germline mutation(s) in,,0.9720245398773006,0.5433212996389891,0.13886713651788044,0.5550951503990178
2459,21663,NOS1,163731,,,Idiopathic achalasia,Disease-causing germline mutation(s) in,Neuroticism[29255261];Colorectal cancer[26151821;26151821];Baseline cortisol levels in response to low dose short synacthen test in corticosteroid treated asthma[29551627];Schizophrenia[28991256];,0.4226993865030675,0.2692109334708613,0.07856956408248499,0.5329957028852057
2460,21664,NOS1AP,605551,610141;,,Romano-Ward syndrome,Modifying germline mutation in,QT interval[16648850;19305408;19305408;19305408;19305409;19305409;19587794;22726844;20031603;23166209;24952745;24952745;24952745;24952745;24952745;24952745;24952745;24952745;24952745;24952745;24952745;29213071;29213071;29213071];Granulocyte percentage of myeloid white cells[27863252];Body mass index (change over time)[25133637];Word reading[23738518];Mosquito bite size[28199695];Monocyte percentage of white cells[27863252];Electrocardiographic traits[20062061;20062063;25055868];Obesity-related traits[23251661];,0.7538650306748467,0.7663744198040227,0.7290524667188724,0.5738182934315531
2461,21673,NOTCH1,190198,109730;616028;,[MIM:109730]Aortic valve disease 1;[MIM:616028]Adams-Oliver syndrome 5;,Adams-Oliver syndrome;Familial bicuspid aortic valve,Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in,"Inflammatory bowel disease[28067908];Chronic inflammatory diseases (ankylosing spondylitis, Crohn's disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy)[26974007];Length of menstrual cycle[26732621];Crohn's disease[28067908];Coronary artery calcified atherosclerotic plaque (130 HU threshold) in type 2 diabetes[29221444];Ulcerative colitis[28067908];",0.8492024539877301,1.0,0.352649438788828,0.9993861264579497
2462,21674,NOTCH2,600275,102500;610205;,[MIM:610205]Alagille syndrome 2 [dominant?];[MIM:102500]Hajdu-Cheney syndrome [dominant?];,Acroosteolysis dominant type;Alagille syndrome due to a NOTCH2 point mutation,Disease-causing germline mutation(s) (gain of function) in;Disease-causing germline mutation(s) in,Type 2 diabetes[18372903];Systemic lupus erythematosus[28714469;28714469];Blood protein levels[30072576];,0.9624539877300613,0.8599793708096957,0.38867136517880446,0.9568753836709638
2463,21680,NOTCH3,600276,125310;130720;615293;,"[MIM:125310]Cerebral arteriopathy, autosomal dominant, with subcortical infarcts and leukoencephalopathy, 1 [dominant?];[MIM:615293]Myofibromatosis, infantile 2;[MIM:130720]Lateral meningocele syndrome;",CADASIL;Lateral meningocele syndrome;Infantile myofibromatosis,Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) (gain of function) in;Disease-causing germline mutation(s) in,,0.7806134969325154,0.9249613202681795,0.173061863743148,0.9112952731737262
2464,21711,NPC1,607623,257220;,[MIM:257220]Niemann-Pick disease C1;,"Niemann-Pick disease type C, severe perinatal form;Niemann-Pick disease type C, late infantile neurologic onset;Niemann-Pick disease type C, severe early infantile neurologic onset;Niemann-Pick disease type C, adult neurologic onset;Niemann-Pick disease type C, juvenile neurologic onset",Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in,Obesity[19151714;19151714];White blood cell count[27863252];Myeloid white cell count[27863252];Sum basophil neutrophil counts[27863252];Sum neutrophil eosinophil counts[27863252];Granulocyte count[27863252];Neutrophil count[27863252];Coronary artery disease[29212778];,0.7791411042944786,0.4742135121196493,0.036021926389976505,0.8437691835481891
2465,21713,NPC2,601015,607625;,[MIM:607625]Niemann-Pick disease C2;,"Niemann-Pick disease type C, severe perinatal form;Niemann-Pick disease type C, late infantile neurologic onset;Niemann-Pick disease type C, severe early infantile neurologic onset;Niemann-Pick disease type C, adult neurologic onset;Niemann-Pick disease type C, juvenile neurologic onset",Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in,Blood protein levels[29875488];Advanced glycation end-product levels[26915486];,0.3449079754601227,0.34115523465703973,0.8843643957191334,0.4238796807857581
2466,21721,NPHP1,607100,256100;266900;609583;,[MIM:256100]Nephronophthisis 1 [recessive?];[MIM:266900]Senior-Loken syndrome 1;[MIM:609583]Joubert syndrome 4;,Senior-Loken syndrome;Bardet-Biedl syndrome;Joubert syndrome with renal defect;Juvenile nephronophthisis,Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) (loss of function) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in,,0.7584049079754601,0.06188757091284167,0.5244061602714696,0.008440761203192142
2467,21722,NPHP3,608002,208540;267010;604387;,[MIM:208540]Renal-hepatic-pancreatic dysplasia 1;[MIM:267010]Meckel syndrome 7;,NPHP3-related Meckel-like syndrome;Senior-Loken syndrome;Renal-hepatic-pancreatic dysplasia;Infantile nephronophthisis;Late-onset nephronophthisis,Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) (loss of function) in;Disease-causing germline mutation(s) (loss of function) in;Disease-causing germline mutation(s) in,Mean corpuscular volume[27863252];Mean corpuscular hemoglobin[27863252];Menarche (age at onset)[21102462;27182965];Blood protein levels[28240269];,0.39631901840490796,0.4744713769984528,0.4210388932393631,0.7090239410681399
2468,21725,NPHP4,607215,606966;606996;,[MIM:606996]Senior-Loken syndrome 4;,Senior-Loken syndrome;Juvenile nephronophthisis,Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in,QT interval[19305408];Dimensional psychopathology (Positive)[29496196];Response to taxane treatment (placlitaxel)[23006423];,0.8208588957055215,0.012893243940175348,0.2500652571130253,0.9419889502762431
2469,21726,NPHS1,602716,256300;,[MIM:256300]Nephrotic syndrome 1;,"Congenital nephrotic syndrome, Finnish type;Familial idiopathic steroid-resistant nephrotic syndrome with diffuse mesangial sclerosis;Familial idiopathic steroid-resistant nephrotic syndrome with minimal changes;Familial idiopathic steroid-resistant nephrotic syndrome with diffuse mesangial proliferation;Familial idiopathic steroid-resistant nephrotic syndrome with focal segmental hyalinosis",Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in,,0.5920245398773006,0.06420835482207324,0.10049595405899243,0.3021792510742787
2470,21727,NPHS2,604766,600995;,[MIM:600995]Nephrotic syndrome 2;,Sporadic idiopathic steroid-resistant nephrotic syndrome with minimal changes;Sporadic idiopathic steroid-resistant nephrotic syndrome with focal segmental hyalinosis;Familial idiopathic steroid-resistant nephrotic syndrome with minimal changes;Familial idiopathic steroid-resistant nephrotic syndrome with focal segmental hyalinosis,Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in,,0.27975460122699386,0.1776689014956163,0.42364917776037586,0.5914671577655003
2471,21753,NPM1,164040,,,Primary cutaneous anaplastic large cell lymphoma;Acute myeloid leukemia with NPM1 somatic mutations;Acute promyelocytic leukemia;Acute myeloblastic leukemia without maturation;Acute myeloblastic leukemia with maturation;Lymphomatoid papulosis,Part of a fusion gene in;Disease-causing somatic mutation(s) in;Part of a fusion gene in;Disease-causing somatic mutation(s) in;Disease-causing somatic mutation(s) in;Part of a fusion gene in,,0.803803680981595,0.7674058793192368,0.9391803706604019,0.3396255371393493
2472,21807,NPPA,108780,612201;615745;,"[MIM:615745]Atrial standstill 2;[MIM:612201]Atrial fibrillation, familial, 6;",Atrial standstill;Familial atrial fibrillation,Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in,Systolic blood pressure[19430483];Tuberculosis[29036319];Atrial fibrillation[19597492];Diastolic blood pressure x smoking status (current vs non-current) interaction (2df test)[29455858;29455858;29455858;29455858;29455858;29455858;29455858;29455858];Systolic blood pressure x smoking status (ever vs never) interaction (2df test)[29455858;29455858;29455858;29455858;29455858;29455858;29455858;29455858];Diastolic blood pressure x smoking status (ever vs never) interaction (2df test)[29455858;29455858;29455858;29455858;29455858;29455858;29455858;29455858];Systolic blood pressure x smoking status (current vs non-current) interaction (2df test)[29455858;29455858;29455858;29455858;29455858;29455858;29455858];Midregional pro atrial natriuretic peptide levels[29237677;29237677];,0.4331288343558282,0.3303249097472924,0.22813886713651788,0.2539901780233272
2473,21812,NPR2,108961,602875;615923;616255;,"[MIM:602875]Acromesomelic dysplasia, Maroteaux type [recessive?];[MIM:615923]Epiphyseal chondrodysplasia, Miura type;[MIM:616255]Short stature with non-specific skeletal abnormalities;","Acromesomelic dysplasia, Maroteaux type;Tall stature-scoliosis-macrodactyly of the great toes syndrome",Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) (gain of function) in,Blood protein levels[28240269];,0.14576687116564419,0.667354306343476,0.7512398851474811,0.6497851442602823
2474,21814,NPRL2,607072,617116;,"[MIM:617116]Epilepsy, familial focal, with variable foci 2 [dominant?];",Familial focal epilepsy with variable foci,Disease-causing germline mutation(s) (loss of function) in,Body mass index[26426971];,0.4154601226993865,0.6529138731304797,0.9245627773427304,0.0
2475,21815,NPRL3,600928,617118;,"[MIM:617118]Epilepsy, familial focal, with variable foci 3 [dominant?];",Familial focal epilepsy with variable foci,Disease-causing germline mutation(s) (loss of function) in,Mean corpuscular hemoglobin concentration[27863252;27863252;29403010];Mean corpuscular volume[28453575;27863252;27863252;29403010];High light scatter reticulocyte percentage of red cells[27863252];Mean corpuscular hemoglobin[27863252;27863252;27863252;28453575;29403010];Reticulocyte fraction of red cells[27863252];Red blood cell traits[23222517;23446634;23446634;23446634;23446634];Hemoglobin levels[26366553];Cardiometabolic and hematological traits[27668658];Sickle cell anemia (haemolysis)[23406172];Red blood cell count[29403010;27863252;27863252];,0.4331288343558282,0.8151108818978855,0.5468546071521796,0.0
2476,21839,NR1H4,603826,617049;,"[MIM:617049]Cholestasis, progressive familial intrahepatic, 5 [recessive?];",Progressive familial intrahepatic cholestasis type 5;Intrahepatic cholestasis of pregnancy,Disease-causing germline mutation(s) (loss of function) in;Candidate gene tested in,Squamous cell carcinoma[23341777];Low density lipoprotein cholesterol[29403010];,0.3925153374233129,0.35379061371841153,0.7094753328112764,0.7498465316144874
2477,21848,NR2E3,604485,268100;611131;,[MIM:268100]Enhanced S cone syndrome;[MIM:611131]Retinitis pigmentosa 37;,Retinitis pigmentosa;Goldmann-Favre syndrome,Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in,Metabolite levels (HVA/MHPG ratio)[23319000];,0.38061349693251534,0.0,0.0,0.0
2478,21849,NR2F1,132890,615722;,[MIM:615722]Bosch-Boonstra-Schaaf optic atrophy syndrome [dominant?];,Optic atrophy-intellectual disability syndrome,Disease-causing germline mutation(s) (loss of function) in,,0.6936196319018405,0.9357916451779268,0.9832941790655182,0.0
2479,21851,NR2F2,107773,615779;,,Partial atrioventricular canal;Complete atrioventricular canal-tetralogy of Fallot syndrome;Complete atrioventricular canal-ventricle hypoplasia syndrome;Complete atrioventricular canal-left heart obstruction syndrome,Major susceptibility factor in;Major susceptibility factor in;Major susceptibility factor in;Major susceptibility factor in,Cannabis use[27023175];Cognitive decline rate in late mild cognitive impairment[26252872;26252872];Response to TNF-alpha inhibitors in rheumatoid arthritis[22569225];Sex hormone-binding globulin levels[22829776;22829776;22829776];Immune response to measles-mumps-rubella vaccine[24811271];Motion sickness[25628336];Optic disc area[25631615];Very long-chain saturated fatty acid levels (fatty acid 22:0)[25378659];Photic sneeze reflex[27182965];,0.7093251533742331,0.7449716348633316,0.9750717828243278,0.0
2480,21854,NR3C1,138040,615962;,"[MIM:615962]Glucocorticoid resistance, generalized [dominant?];",Glucocorticoid resistance,Disease-causing germline mutation(s) in,Atrial fibrillation[30061737;29892015;29892015];Night sleep phenotypes[27126917;27126917;27126917];,0.7979141104294478,0.5567302733367715,0.5946228138867137,0.8532842234499693
2481,21856,NR3C2,600983,177735;605115;,"[MIM:177735]Pseudohypoaldosteronism 1, autosomal dominant [dominant?];[MIM:605115]Early-onset hypertension with severe exacerbation in pregnancy [dominant?];",Renal pseudohypoaldosteronism type 1;Hypertension due to gain-of-function mutations in the mineralocorticoid receptor,Disease-causing germline mutation(s) (loss of function) in;Disease-causing germline mutation(s) (gain of function) in,Biochemical measures[19260141];Thyroid hormone levels[23408906;23408906];Alzheimer disease and age of onset[26830138];Corneal structure[23291589];Urinary albumin excretion[30220432];Urinary albumin excretion (no hypertensive medication)[30220432];Amyotrophic lateral sclerosis (sporadic)[24529757];Plasma thyroid-stimulating hormone levels[28333968;28333968];Hypothyroidism[27182965];Vestibular neuritis[30079052];Central corneal thickness[29760442];Thyroid function[22494929];Subcutaneous adipose tissue[22589738];,0.6483435582822086,0.7973182052604435,0.6016705820934481,0.923572744014733
2482,21859,NR4A3,600542,612219;,[MIM:612219]Ewing sarcoma;,Extraskeletal myxoid chondrosarcoma,Part of a fusion gene in,Dental caries[23064961];Lung cancer[28604730];Depression in smokers[30219690];,0.19190184049079756,0.9017534811758638,0.1754111198120595,0.9140577041129527
2483,21860,NR5A1,184757,612964;612965;613957;617480;,"[MIM:612965]46,XY sex reversal 3;[MIM:617480]46,XX sex reversal 4;[MIM:612964]Adrenal insufficiency, NR5A1-related;[MIM:612964]Premature ovarian failure 7;[MIM:613957]Spermatogenic failure 8;","46,XX gonadal dysgenesis;46,XY complete gonadal dysgenesis;46,XX ovotesticular disorder of sex development;46,XY partial gonadal dysgenesis;46,XX testicular disorder of sex development;Male infertility with azoospermia or oligozoospermia due to single gene mutation",Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) (loss of function) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) (loss of function) in;Disease-causing germline mutation(s) in,Urate levels[21768215];,0.48576687116564415,0.8439917483238782,0.8415557295745236,0.9636279926335175
2484,21866,NRAS,164790,137550;162900;188470;249400;607785;613224;614470;,"[MIM:607785]Leukemia, juvenile myelomonocytic;[MIM:613224]Noonan syndrome 6;[MIM:614470]RAS-associated autoimmune leukoproliferative disorder;[MIM:137550]Melanocytic nevus syndrome, congenital;[MIM:249400]Melanosis, neurocutaneous;[MIM:162900]Keratinocytic non-epidermolytic nevus;[MIM:188470]Thyroid cancer, non-medullary, 2;",Noonan syndrome;Large congenital melanocytic nevus;Linear nevus sebaceus syndrome;Differentiated thyroid carcinoma;RAS-associated autoimmune leukoproliferative disease;Selection of therapeutic option in colorectal cancer;Juvenile myelomonocytic leukemia,Disease-causing germline mutation(s) in;Disease-causing somatic mutation(s) in;Candidate gene tested in;Disease-causing somatic mutation(s) in;Disease-causing somatic mutation(s) in;Biomarker tested in;Disease-causing somatic mutation(s) in,Autism[24189344;24189344;24189344];,0.5009815950920246,0.7305312016503352,0.9812059514487079,0.0
2485,21868,NR0B1,300473,300018;300200;,"[MIM:300200]Adrenal hypoplasia, congenital [recessive?];[MIM:300018]46,XY sex reversal 2;","46,XY complete gonadal dysgenesis;46,XY partial gonadal dysgenesis;46,XX testicular disorder of sex development;Cytomegalic congenital adrenal hypoplasia",Role in the phenotype of;Role in the phenotype of;Role in the phenotype of;Disease-causing germline mutation(s) (loss of function) in,,0.2947239263803681,0.8862815884476535,0.8496476115896633,0.9306322897483118
2486,21884,NRG1,142445,,,Hereditary thrombophilia due to congenital histidine-rich (poly-L) glycoprotein deficiency,Disease-causing germline mutation(s) in,Dialysis-related mortality[21546767];Papillary thyroid cancer[28703219];Lung cancer[28604730];Coronary artery calcification[23870195];Lung adenocarcinoma[28604730];Response to serotonin reuptake inhibitors in major depressive disorder[25897834];Obstructive sleep apnea[25325441];Major depressive disorder[29317602];Differentiated thyroid cancer[28703219];Cerebrospinal P-tau181p levels[28247064];Hirschsprung disease[19196962;27702942;25310821];Chin dimples[27182965];Metabolite levels  (X-11787)[23934736];Cardiac Troponin-T levels[23247143];Bone mineral density (hip)[30172743];Refractive astigmatism[25367360];Emphysema imaging phenotypes[26030696;26030696];Thyroid hormone levels[23408906;23408906];Cerebrospinal T-tau levels[28247064];Serum thyroid-stimulating hormone levels[25436638];Hypothyroidism[27182965];Orofacial clefts[28054174];Cleft lip with or without cleft palate[28054174];Thyroid cancer[22267200];Hip geometry[17903296];Post bronchodilator FEV1/FVC ratio in COPD[26634245;26634245;26634245;26634245;26634245];Cognitive function[25644384];,0.554601226993865,0.8888602372356885,0.023231532237013835,0.5148864333947207
2487,21897,NRL,162080,613750;,[MIM:613750]Retinitis pigmentosa 27;[MIM:613750]Retinal degeneration autosomal recessive clumped pigment type [recessive?];,Retinitis pigmentosa,Disease-causing germline mutation(s) in,Attention deficit hyperactivity disorder symptom score[27663945];Post bronchodilator FEV1/FVC ratio[26634245];,0.14576687116564419,0.5242392986075296,0.880187940485513,0.0
2488,21908,NRTN,602018,,,Hirschsprung disease,Major susceptibility factor in,Advanced age-related macular degeneration[26691988];Blood protein levels[29875488];N-glycan levels[21203500;21203500;21203500;21203500;21908519;21908519;21908519;21908519;21908519;21908519;21908519;21908519;21908519;21908519;21908519;21908519;21908519;21908519];,0.10711656441717791,0.49406910778751933,0.37535891412163924,0.0
2489,21909,NRXN1,600565,,,Pitt-Hopkins-like syndrome,Disease-causing germline mutation(s) in,Metabolite levels (HVA/MHPG ratio)[23319000];Refractive astigmatism[25367360;25367360];Lung cancer in ever smokers[28604730];Isovolumetric relaxation time[28394258];Longevity[20834067];Response to zileuton treatment in asthma (FEV1 change interaction)[26031901];Temperament[22832960];Educational attainment[25201988];Total cholesterol change in response to fenofibrate in statin-treated type 2 diabetes[28736931];Severe gingival inflammation[28459102];Body mass index[28892062];Personality dimensions[20691247];Post bronchodilator FEV1/FVC ratio[26634245;26634245];,0.22687116564417178,0.793965961835998,0.6280344557556774,0.5434315531000614
2490,21913,NSD1,606681,117550;130650;,[MIM:130650]Beckwith-Wiedemann syndrome;,Sotos syndrome;Weaver syndrome;Deletion 5q35;5q35 microduplication syndrome;Beckwith-Wiedemann syndrome due to NSD1 mutation,Disease-causing germline mutation(s) (loss of function) in;Candidate gene tested in;Role in the phenotype of;Role in the phenotype of;Disease-causing germline mutation(s) in,Urate levels in lean individuals[25811787];Waist circumference adjusted for BMI (joint analysis main effects and physical activity interaction)[28448500;28448500;28448500;28448500;28448500];Activated partial thromboplastin time[22703881];Waist-to-hip ratio adjusted for BMI (age <50)[26426971];Waist circumference adjusted for body mass index[28448500;28448500;28448500;28448500;28448500];Height[25282103];Waist-to-hip ratio adjusted for BMI[26426971];Waist circumference adjusted for BMI in active individuals[28448500;28448500;28448500;28448500;28448500];Waist-to-hip ratio adjusted for BMI x sex x age interaction (4df test)[26426971];Circulating fibroblast growth factor 23 levels[30217807];,0.4894478527607362,0.7648272305312016,0.14617593317671626,0.9932473910374463
2491,21914,NSD2,602952,,,Wolf-Hirschhorn syndrome,Role in the phenotype of,,0.632760736196319,0.6366683857658587,0.0,0.0
2492,21916,NSDHL,300275,300831;308050;,[MIM:300831]CK syndrome;,CHILD syndrome;CK syndrome,Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) (loss of function) in,,0.9528834355828221,0.905363589479113,0.873662229182981,0.0
2493,21926,NSMCE2,617246,617253;,[MIM:617253]Seckel syndrome 10 [recessive?];,Microcephalic primordial dwarfism-insulin resistance syndrome,Disease-causing germline mutation(s) (loss of function) in,Amyotrophic lateral sclerosis or frontotemporal dementia[24931836];Pursuit maintenance gain[29064472];Response to statin therapy[20339536];Amyotrophic lateral sclerosis[24931836];,0.7013496932515337,0.4626095925734915,0.8206734534064213,0.27225291589932477
2494,21929,NSMF,608137,614838;,[MIM:614838]Hypogonadotropic hypogonadism 9 with or without anosmia;,Kallmann syndrome;Normosmic congenital hypogonadotropic hypogonadism,Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in,,0.33975460122699386,0.5974729241877257,0.8882798225006525,0.0
2495,21932,NSUN2,610916,611091;,"[MIM:611091]Mental retardation, autosomal recessive 5 [recessive?];",Dubowitz syndrome;Autosomal recessive non-syndromic intellectual disability,Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in,Visceral fat[22589738];,0.9840490797546012,0.2870036101083033,0.3633516053249804,0.10082872928176796
2496,21945,NT5C2,600417,613162;,"[MIM:613162]Spastic paraplegia 45, autosomal recessive [recessive?];",Autosomal recessive spastic paraplegia type 45,Disease-causing germline mutation(s) in,"Myocardial infarction[26343387];Diastolic blood pressure (cigarette smoking interaction)[29455858];Body mass index (joint analysis main effects and smoking interaction)[28443625;28443625];Schizophrenia[21926974;23974872;22688191;25056061;23894747;28991256];Systolic blood pressure (long-term average)[28348047];High light scatter reticulocyte count[27863252];Mean arterial pressure[26390057;27618448;29403010];Red cell distribution width[27863252];Waist-to-hip ratio adjusted for BMI[26426971];Body mass index[24861553;25673413;25673413];Reticulocyte fraction of red cells[27863252];Pulse pressure[29403010;28739976];Blood pressure[21909110;21909110;21572416;21572416;24001895];Coronary artery disease or large artery stroke[24262325];BMI (adjusted for smoking behaviour)[28443625;28443625];Coronary artery disease (myocardial infarction, percutaneous transluminal coronary angioplasty, coronary artery bypass grafting, angina or chromic ischemic heart disease)[28714975];Systolic blood pressure[21909115;19430483;26390057;26390057;28135244;29403010;27618452;28739976;27618447];High light scatter reticulocyte percentage of red cells[27863252];Response to citalopram or escitalopram and depression[27622933];Autism spectrum disorder or schizophrenia[28540026;28540026];Diastolic blood pressure[27618452;28739976];Coronary heart disease[21378990];Coronary artery disease[26343387;24262325];Systolic blood pressure (cigarette smoking interaction)[29455858];BMI in non-smokers[28443625;28443625];Waist-to-hip ratio adjusted for BMI (age >50)[26426971];Autism spectrum disorder, attention deficit-hyperactivity disorder, bipolar disorder, major depressive disorder, and schizophrenia (combined)[23453885];White matter lesion progression[26451028];Birth weight[27680694];",0.625398773006135,0.7418772563176895,0.3435134429652832,0.2452424800491099
2497,21946,NT5C3A,606224,266120;,[MIM:266120]P5N deficiency;,Hemolytic anemia due to pyrimidine 5' nucleotidase deficiency,Disease-causing germline mutation(s) in,Red cell distribution width[27863252];,0.5069938650306749,0.46725116039195463,0.6841555729574523,0.0
2498,21956,NT5E,129190,211800;,[MIM:211800]Calcification of joints and arteries;,Hereditary arterial and articular multiple calcification syndrome,Disease-causing germline mutation(s) (loss of function) in,Blood metabolite levels[24816252];Metabolic traits[21886157];,0.50920245398773,0.2998968540484786,0.3724876011485252,0.3483732351135666
2499,21967,NTHL1,602656,616415;,[MIM:616415]Familial adenomatous polyposis 3;,NTHL1-related attenuated familial adenomatous polyposis,Disease-causing germline mutation(s) (loss of function) in,Longevity[20834067];,0.6596319018404908,0.12377514182568335,0.7149569303054033,0.4671577655003069
2500,21972,NTN1,601614,,,Familial congenital mirror movements,Disease-causing germline mutation(s) in,Cleft lip with or without cleft palate[28054174;28054174;28054174];Nonsyndromic cleft lip with or without cleft palate[25775280];Heel bone mineral density[28869591;28869591];Percentage gas trapping[26030696];Breast cancer (prognosis)[23319801];Blood protein levels[29875488;30072576;30072576];Nonsyndromic cleft lip with cleft palate[28232668];Orofacial clefts[28054174;28054174];,0.46883435582822086,0.9637699845281072,0.8501696684938659,0.6947513812154696
2501,21976,NTNG1,608818,,,Atypical Rett syndrome,Disease-causing germline mutation(s) in,Restless legs syndrome[29029846];Body mass index[28892062];Response to cognitive-behavioural therapy in anxiety disorder[26989097];Anorexia nervosa[21079607];Blood protein levels[29875488;30072576];,0.12711656441717792,0.7944816915936049,0.8533020099190812,0.5725905463474524
2502,21977,NTNG2,,,,Atypical Rett syndrome,Disease-causing germline mutation(s) in,Systemic lupus erythematosus[18204098];Current cigarettes per day in chronic obstructive pulmonary disease[29631575];,0.12711656441717792,0.953971119133574,0.6938136256851997,0.5962246777163904
2503,21979,NTRK1,191315,256800;,[MIM:256800]Congenital insensitivity to pain with anhidrosis [recessive?];,Hereditary sensory and autonomic neuropathy type 4;Differentiated thyroid carcinoma;Hereditary sensory and autonomic neuropathy type 5;Familial medullary thyroid carcinoma,Disease-causing germline mutation(s) (loss of function) in;Part of a fusion gene in;Candidate gene tested in;Disease-causing germline mutation(s) in,,0.9175460122699387,0.22743682310469315,0.30227094753328115,0.9014732965009208
2504,21980,NTRK2,600456,613886;617830;,"[MIM:617830]Epileptic encephalopathy, early infantile, 58 [dominant?];[MIM:613886]Obesity, hyperphagia, and developmental delay;",West syndrome;Pilomyxoid astrocytoma;Undetermined early-onset epileptic encephalopathy,Disease-causing germline mutation(s) in;Part of a fusion gene in;Disease-causing germline mutation(s) in,Body mass index[25760438;28892062;28892062];Waist-to-hip circumference ratio (recreational physical activity interaction)[23192594];Birth weight[24950379];Serum metabolite concentrations in chronic kidney disease[29545352];Menarche (age at onset)[25231870];,0.4645398773006135,0.9708612686952037,0.7381884625424171,0.9449048496009822
2505,21981,NTRK3,191316,,,Congenital mesoblastic nephroma;Differentiated thyroid carcinoma;Fibrosarcoma,Part of a fusion gene in;Part of a fusion gene in;Part of a fusion gene in,"Gaucher disease severity[22388998];Autism spectrum disorder, attention deficit-hyperactivity disorder, bipolar disorder, major depressive disorder, and schizophrenia (combined)[23453885];Amyotrophic lateral sclerosis (sporadic)[24529757];Blood protein levels[30072576];",0.4538650306748466,0.7725631768953068,0.7447141738449491,0.901780233271946
2506,21991,NUBPL,613621,252010;,,Isolated complex I deficiency,Disease-causing germline mutation(s) in,Response to iloperidone treatment (QT prolongation)[18521091];Brain lesion load[19010793];,0.7866257668711657,0.388602372356885,0.7507178282432785,0.21347452424800492
2507,22020,NUDT15,615792,616903;,,Azathioprine or 6-mercatopurine toxicity or dose selection,Biomarker tested in,Thiopurine-induced acute severe leukopenia in inflammatory bowel disease[29923122];Thiopurine-induced severe alopecia in inflammatory bowel disease[29923122];Thiopurine-induced severe leukopenia in inflammatory bowel disease[29923122];Thiopurine-induced alopecia in inflammatory bowel disease[29923122];Thiopurine-induced leukopenia in inflammatory bowel disease[27558924;29923122];,0.16220858895705523,0.36513666838576586,0.3787522839989559,0.18370165745856354
2508,22028,NUDT19,,,,Retinitis pigmentosa,Disease-causing germline mutation(s) in,Red blood cell traits[23222517];Major depressive disorder[23377640];,0.8701840490797546,0.06910778751933987,0.2364917776037588,0.0
2509,22042,NUMA1,164009,,,Acute promyelocytic leukemia,Part of a fusion gene in,Antibody level in response to infection[25758998];Severe influenza A (H1N1) infection[26379185];,0.9026993865030675,0.760443527591542,0.25554685460715215,0.44152854511970535
2510,22048,NUP37,609264,,,Familial idiopathic steroid-resistant nephrotic syndrome with focal segmental hyalinosis,Disease-causing germline mutation(s) in,Height[19893584;25429064];,0.7916564417177914,0.23027333677153172,0.8590446358653093,0.23848987108655617
2511,22058,NUP62,605815,271930;,[MIM:271930]Infantile striatonigral degeneration;,Familial infantile bilateral striatal necrosis,Disease-causing germline mutation(s) in,,0.7186503067484663,0.0,0.3027930044374837,0.0
2512,22060,NUP85,170285,,,Familial idiopathic steroid-resistant nephrotic syndrome with focal segmental hyalinosis,Disease-causing germline mutation(s) in,,0.8076073619631902,0.850954100051573,0.6168102323153224,0.8278084714548803
2513,22062,NUP93,614351,616892;,[MIM:616892]Nephrotic syndrome 12 [recessive?];,Familial idiopathic steroid-resistant nephrotic syndrome with diffuse mesangial sclerosis;Familial idiopathic steroid-resistant nephrotic syndrome with focal segmental hyalinosis,Disease-causing germline mutation(s) (loss of function) in;Disease-causing germline mutation(s) (loss of function) in,HDL cholesterol levels[26763881];Gambling[22780124];Potassium levels[29403010];HDL cholesterol[20031564];,0.9638036809815951,0.797576070139247,0.45392847820412424,0.23204419889502761
2514,22064,NUP107,607617,616730;,,"46,XX gonadal dysgenesis;Galloway-Mowat syndrome;Familial idiopathic steroid-resistant nephrotic syndrome with focal segmental hyalinosis",Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in,White blood cell count[20139978];,0.9007361963190184,0.12042289840123775,0.6329939963456017,0.6784837323511357
2515,22065,NUP133,607613,,,Familial idiopathic steroid-resistant nephrotic syndrome with focal segmental hyalinosis,Disease-causing germline mutation(s) in,,0.8809815950920246,0.2656008251676122,0.11694074654137301,0.20933087783916512
2516,22067,NUP155,606694,615770;,"[MIM:615770]Atrial fibrillation, familial, 15;",Familial atrial fibrillation,Disease-causing germline mutation(s) (loss of function) in,,0.9730061349693252,0.7614749871067561,0.6322109109892978,0.2747084100675261
2517,22068,NUP160,607614,,,Familial idiopathic steroid-resistant nephrotic syndrome with focal segmental hyalinosis,Disease-causing germline mutation(s) in,Neuroticism[29255261];Granulocyte percentage of myeloid white cells[27863252];Plateletcrit[27863252];Global electrical heterogeneity phenotypes[29622589];Intraocular pressure[25173106;29617998;29235454];,0.8695705521472392,0.3378029912325941,0.3069694596711042,0.0678330263965623
2518,22070,NUP205,614352,616893;,[MIM:616893]Nephrotic syndrome 13;,Familial idiopathic steroid-resistant nephrotic syndrome with focal segmental hyalinosis,Disease-causing germline mutation(s) in,Paget's disease[21623375];Post bronchodilator FEV1/FVC ratio[26634245];Post bronchodilator FEV1[26634245];Venous thromboembolism adjusted for sickle cell variant rs77121243-T[28203683];,0.9899386503067484,0.8927282104177411,0.34560167058209346,0.3562001227747084
2519,22076,NUP214,114350,,,Acute myeloid leukemia with t(6;9)(p23;q34);Precursor T-cell acute lymphoblastic leukemia,Part of a fusion gene in;Part of a fusion gene in,,0.7214723926380369,0.5608561113976276,0.4270425476376925,0.5954573357888275
2520,22080,NUS1,610463,617082;617831;,"[MIM:617082]Congenital disorder of glycosylation 1AA [recessive?];[MIM:617831]Mental retardation, autosomal dominant 55, with seizures [dominant?];",Undetermined early-onset epileptic encephalopathy,Disease-causing germline mutation(s) in,Blood protein levels[29875488];,0.8505521472392638,0.9200618875709129,0.8162359697206996,0.0
2521,22094,NUTM1,608963,,,NUT midline carcinoma,Part of a fusion gene in,,0.32380368098159507,0.39427539969056213,0.14408770555990602,0.0
2522,22095,NUTM2A,,,,Endometrial stromal sarcoma,Part of a fusion gene in,,0.038773006134969326,0.17973182052604436,0.22605063951970764,0.0
2523,22097,NUTM2B,,,,Endometrial stromal sarcoma;Clear cell sarcoma of kidney,Part of a fusion gene in;Part of a fusion gene in,,0.038773006134969326,0.5379061371841155,0.39806838945445056,0.0
2524,22100,NUTM2E,,,,Clear cell sarcoma of kidney,Part of a fusion gene in,,0.038773006134969326,0.40252707581227437,0.5909684155572957,0.0
2525,22113,NXN,612895,,,Autosomal recessive Robinow syndrome,Disease-causing germline mutation(s) (loss of function) in,Type 2 diabetes[23300278];Economic and political preferences[22566634];Colorectal cancer[24836286;27145994];Blood pressure[24954895;24954895];Taxane-induced peripheral neuropathy in breast cancer[29278617];Prostate cancer[23535732];,0.403680981595092,0.8904074265085096,0.5366744975202297,0.7961939840392879
2526,22135,NYX,300278,310500;,,Congenital stationary night blindness,Disease-causing germline mutation(s) in,,0.2585276073619632,0.5778751933986591,0.6945967110415036,0.0
2527,22141,OAS1,164350,,,Hereditary pulmonary alveolar proteinosis,Disease-causing germline mutation(s) in,Body mass index[26426971];Response to fenofibrate (adiponectin levels)[23149075];Glycemic traits[23575436];Blood protein levels[29875488;30072576];,0.7505521472392638,0.7075812274368231,0.4051161576611851,0.0216390423572744
2528,22147,OAT,613349,258870;,[MIM:258870]Hyperornithinemia with gyrate atrophy of choroid and retina;,Gyrate atrophy of choroid and retina,Disease-causing germline mutation(s) in,,0.9587730061349693,0.24574522949974215,0.8117984860349778,0.7891344383057091
2529,22156,OBSL1,610991,612921;,,3M syndrome,Disease-causing germline mutation(s) in,,0.8206134969325153,0.24161939143888603,0.055860088749673714,0.10972989564149785
2530,22158,OCA2,611409,203200;227220;,"[MIM:203200]Albinism, oculocutaneous, 2 [recessive?];",Prader-Willi syndrome due to paternal deletion of 15q11q13 type 1;Prader-Willi syndrome due to paternal deletion of 15q11q13 type 2;Oculocutaneous albinism type 2;Angelman syndrome due to maternal 15q11q13 deletion;Prader-Willi syndrome due to maternal uniparental disomy of chromosome 15,Role in the phenotype of;Role in the phenotype of;Disease-causing germline mutation(s) in;Role in the phenotype of;Role in the phenotype of,Basal cell carcinoma[27539887];Blond vs. brown hair color[17952075];Blond vs non-blond hair color[26184321];Black vs. blond hair color[18483556];Vitiligo[22561518;27723757];Light vs. dark hair color[26184321];Squamous cell carcinoma[26829030];Eye color[23548203;20585627;20585627;23118974];Melanoma[28212542];Uveal melanoma[28781888];Low tan response[29739929;29739929];Brown vs. non-brown hair color[26184321];Blue vs. green eyes[17952075];Red vs non-red hair color[26184321];Cutaneous squamous cell carcinoma[27424798];Iris color (a* coordinate)[29109912];Blue vs. brown eyes[17952075];Cutaneous malignant melanoma[26237428];Diisocyanate-induced asthma[25918132];Iris color (L* coordinate)[29109912];Post bronchodilator FEV1/FVC ratio[26634245];Black vs. red hair color[18483556];Hair color[20585627;26926045];Skin colour saturation[25963972];Parkinson's disease (age of onset)[19772629];Iris color (b* coordinate)[29109912];,0.10711656441717791,0.612944816915936,0.12999216914643696,0.8130755064456722
2531,22166,OCLN,602876,251290;,[MIM:251290]Pseudo-TORCH syndrome 1 [recessive?];,Congenital intrauterine infection-like syndrome,Disease-causing germline mutation(s) (loss of function) in,Interleukin-18 levels[27989323];,0.9501840490797546,0.3047962867457452,0.6883320281910729,0.0
2532,22170,OCRL,300535,300555;309000;,[MIM:309000]Lowe oculocerebrorenal syndrome;[MIM:300555]Dent disease 2;,Oculocerebrorenal syndrome of Lowe;Dent disease type 2,Disease-causing germline mutation(s) (loss of function) in;Disease-causing germline mutation(s) (loss of function) in,,0.9742331288343559,0.9868488911810211,0.7387105194466197,0.9757519950890117
2533,22173,ODAPH,614829,614832;,,Hypomaturation amelogenesis imperfecta,Disease-causing germline mutation(s) (loss of function) in,Parkinson's disease (motor and cognition)[22658654];Subjective response to lithium treatment in bipolar disorder[26503763];,0.40773006134969325,0.5157297576070139,0.0,0.0
2534,22191,OFD1,300170,300209;300424;300804;311200;,[MIM:300209]Simpson-Golabi-Behmel syndrome 2;[MIM:300804]Joubert syndrome 10;[MIM:300424]Retinitis pigmentosa 23;,Primary ciliary dyskinesia;Retinitis pigmentosa;Orofaciodigital syndrome type 6;Orofaciodigital syndrome type 1;X-linked recessive intellectual disability-macrocephaly-ciliary dysfunction syndrome,Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) (loss of function) in;Disease-causing germline mutation(s) in,,0.9970552147239263,0.8442496132026818,0.681023231532237,0.7638121546961326
2535,22211,OGDH,613022,,,Oxoglutaric aciduria,Candidate gene tested in,Lung cancer in never smokers[28604730];Systolic blood pressure change trajectories[27980656];,0.9386503067484663,0.8855079938112429,0.43252414513181936,0.7346531614487416
2536,22221,OGG1,601982,144700;,,Hereditary clear cell renal cell carcinoma,Candidate gene tested in,,0.20368098159509201,0.08071170706549768,0.5066562255285826,0.3156844689993861
2537,22262,OPA1,605290,125250;165500;210000;616896;,"[MIM:165500]Optic atrophy 1;[MIM:125250]Dominant optic atrophy plus syndrome;[MIM:210000]Behr syndrome [recessive?];[MIM:616896]Mitochondrial DNA depletion syndrome 14, cardioencephalomyopathic type [recessive?];","Autosomal dominant optic atrophy plus syndrome;Autosomal dominant optic atrophy, classic form",Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in,Alcoholic chronic pancreatitis[28754779];Diastolic blood pressure[28270201];Brain volume in infants (grey matter)[28763065];Major depressive disorder[27479909];,0.8176687116564417,0.6387313047962867,0.05324980422866092,0.97268262737876
2538,22264,OPA2,311050,,,Early-onset X-linked optic atrophy,Disease-causing germline mutation(s) in,,0.038773006134969326,0.0,0.0,0.0
2539,22265,OPA3,606580,165300;258501;,[MIM:165300]Optic atrophy 3;,3-methylglutaconic aciduria type 3;Autosomal dominant optic atrophy and cataract,Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in,Depression and alcohol dependence[22064162];,0.36171779141104293,0.6686436307374936,0.8710519446619681,0.5228667894413751
2540,22275,OPHN1,300127,300486;,,X-linked intellectual disability-cerebellar hypoplasia syndrome,Disease-causing germline mutation(s) in,Excessive daytime sleepiness[27992416];,0.12711656441717792,0.970216606498195,0.5450274079874706,0.0
2541,22276,OPLAH,614243,260005;,[MIM:260005]5-oxoprolinase deficiency;,5-oxoprolinase deficiency,Disease-causing germline mutation(s) in,Serum metabolite levels[23093944];Blood metabolite levels[24816252;24816252];Metabolic traits[21886157];,0.10711656441717791,0.0631768953068592,0.1469590185330201,0.0
2542,22277,OPN1LW,300822,303700;303900;,"[MIM:303900]Colorblindness, partial, protan series;[MIM:303700]Blue cone monochromacy;",Blue cone monochromatism;Cone rod dystrophy,Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in,,0.16220858895705523,0.8169159360495101,0.42652049073348997,0.0
2543,22278,OPN1MW,300821,303700;303800;,"[MIM:303800]Colorblindness, partial, deutan series;[MIM:303700]Blue cone monochromacy;[MIM:303700]Cone dystrophy 5;",Blue cone monochromatism;Cone rod dystrophy,Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in,,0.038773006134969326,0.6794739556472409,0.9668493865831376,0.0
2544,22281,OPN1SW,613522,190900;,[MIM:190900]Tritan color blindness;,Tritanopia,Disease-causing germline mutation(s) in,Atrial fibrillation[30061737;29892015];Primary tooth development (time to first tooth eruption)[23704328];Primary tooth development (number of teeth)[23704328];Reading disability or specific language impairment adjusted for intelligence quotient (pleiotropy)[25065397];Reading disability or specific language impairment (pleiotropy)[25065397];,0.038773006134969326,0.48014440433212996,0.705298877577656,0.17480049109883364
2545,22291,OPTN,602432,137760;606657;613435;,"[MIM:137760]Glaucoma 1, open angle, E;[MIM:606657]Glaucoma, normal pressure;[MIM:613435]Amyotrophic lateral sclerosis 12;",Amyotrophic lateral sclerosis,Disease-causing germline mutation(s) in,Paget's disease[21623375;20436471];,0.6153374233128834,0.27978339350180503,0.43409031584442703,0.8385512584407612
2546,23157,ORAI1,610277,612782;615883;,"[MIM:612782]Immunodeficiency 9;[MIM:615883]Myopathy, tubular aggregate, 2;",Stormorken-Sjaastad-Langslet syndrome;Tubular aggregate myopathy;Combined immunodeficiency due to ORAI1 deficiency,Disease-causing germline mutation(s) (gain of function) in;Disease-causing germline mutation(s) (gain of function) in;Disease-causing germline mutation(s) in,Major depressive disorder[27777418];,0.27975460122699386,0.5943785456420836,0.8227616810232316,0.3701657458563536
2547,23161,ORC1,601902,224690;,[MIM:224690]Meier-Gorlin syndrome 1;,Ear-patella-short stature syndrome,Disease-causing germline mutation(s) (loss of function) in,,0.629079754601227,0.060856111397627644,0.35421560950143566,0.0
2548,23164,ORC4,603056,613800;,[MIM:613800]Meier-Gorlin syndrome 2;,Ear-patella-short stature syndrome,Disease-causing germline mutation(s) (loss of function) in,Urate levels[23263486];Response to statin therapy[20339536];,0.85079754601227,0.24497163486333162,0.10284521012790394,0.0
2549,23166,ORC6,607213,613803;,[MIM:613803]Meier-Gorlin syndrome 3;,Ear-patella-short stature syndrome,Disease-causing germline mutation(s) (loss of function) in,,0.5312883435582823,0.23543063434760186,0.878360741320804,0.0
2550,23176,OSBPL2,606731,616340;,,Autosomal dominant non-syndromic sensorineural deafness type DFNA,Disease-causing germline mutation(s) in,Femoral neck bone mineral density[29499414];Prostate cancer[23535732];Lumbar spine bone mineral density[29499414];,0.6517791411042945,0.5595667870036101,0.8384233881493083,0.27608962553713934
2551,23196,OSGEP,610107,617729;,,Galloway-Mowat syndrome,Disease-causing germline mutation(s) in,Food addiction[27106561];,0.703558282208589,0.5667870036101083,0.8308535630383712,0.18861264579496623
2552,23202,OSMR,601743,105250;,"[MIM:105250]Amyloidosis, primary localized cutaneous, 1;",Familial primary localized cutaneous amyloidosis,Disease-causing germline mutation(s) in,"Inflammatory bowel disease[28067908;26192919];Chronic inflammatory diseases (ankylosing spondylitis, Crohn's disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy)[26974007];Crohn's disease[26192919;28067908];Obesity-related traits[23251661];Daytime sleep phenotypes[27126917];Night sleep phenotypes[27126917;27126917];Blood protein levels[29875488];Response to serotonin reuptake inhibitors in major depressive disorder[25897834];Microalbuminuria[26631737];Ulcerative colitis[28067908;26192919];",0.4154601226993865,0.3733883445074781,0.1733228921952493,0.040208717004297116
2553,23218,OSTM1,607649,259720;,"[MIM:259720]Osteopetrosis, autosomal recessive 5 [dominant?] [recessive?];",Infantile osteopetrosis with neuroaxonal dysplasia,Disease-causing germline mutation(s) in,Major depressive disorder[29187746];,0.50920245398773,0.7256317689530686,0.45131819368311143,0.3660220994475138
2554,23222,OTC,300461,311250;,[MIM:311250]Ornithine carbamoyltransferase deficiency;,Ornithine transcarbamylase deficiency,Disease-causing germline mutation(s) in,,0.2498159509202454,0.8566271273852502,0.2565909684155573,0.0
2555,23223,OTOA,607038,607039;,"[MIM:607039]Deafness, autosomal recessive, 22 [recessive?];",Autosomal recessive non-syndromic sensorineural deafness type DFNB,Disease-causing germline mutation(s) in,Thrombin-activatable fibrinolysis inhibitor activation peptide[29378355];,0.038773006134969326,0.11526560082516761,0.24849908640041765,0.2705647636586863
2556,23225,OTOF,603681,601071;,"[MIM:601071]Deafness, autosomal recessive, 9 [recessive?];[MIM:601071]Auditory neuropathy, autosomal recessive, 1 [recessive?];",Autosomal recessive non-syndromic sensorineural deafness type DFNB,Disease-causing germline mutation(s) in,Metabolite levels (HVA/MHPG ratio)[23319000];Periodontal microbiota[22699663];Metabolite levels (HVA)[23319000];,0.14576687116564419,0.574780814853017,0.020621247716001045,0.5248618784530387
2557,23226,OTOG,604487,614945;,"[MIM:614945]Deafness, autosomal recessive, 18B [recessive?];",Autosomal recessive non-syndromic sensorineural deafness type DFNB,Disease-causing germline mutation(s) in,Post bronchodilator FEV1/FVC ratio[26634245];Night sleep phenotypes[27126917];,0.038773006134969326,0.30273336771531717,0.004959540589924301,0.0
2558,23227,OTOGL,614925,614944;,,Autosomal recessive non-syndromic sensorineural deafness type DFNB,Disease-causing germline mutation(s) in,,0.038773006134969326,0.20551830840639504,0.008874967371443488,0.0
2559,23253,OTUD6B,612021,617452;,"[MIM:617452]Intellectual developmental disorder with dysmorphic facies, seizures, and distal limb anomalies [recessive?];",Early-onset seizures-distal limb anomalies-facial dysmorphism-global developmental delay syndrome,Disease-causing germline mutation(s) (loss of function) in,,0.427239263803681,0.32362042289840126,0.5411119812059515,0.29266421117249847
2560,23257,OTULIN,615712,617099;,"[MIM:617099]Autoinflammation, panniculitis, and dermatosis syndrome [recessive?];",Infantile-onset periodic fever-panniculitis-dermatosis syndrome,Disease-causing germline mutation(s) (loss of function) in,,0.3669938650306748,0.7723053120165033,0.0,0.0
2561,23260,OTX2,600037,610125;613986;,"[MIM:610125]Microphthalmia, syndromic, 5;[MIM:613986]Pituitary hormone deficiency, combined, 6;[MIM:610125]Retinal dystrophy, early-onset, with or without pituitary dysfunction [dominant?];","Syndromic microphthalmia type 5;Agnathia-holoprosencephaly-situs inversus syndrome;Septo-optic dysplasia spectrum;Isolated microphthalmia-anophthalmia-coloboma;Combined pituitary hormone deficiencies, genetic forms;Butterfly-shaped pigment dystrophy",Disease-causing germline mutation(s) in;Modifying germline mutation in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in,,0.4431901840490797,0.8842186694172254,0.9498825371965545,0.8247391037446286
2562,23271,OVOL2,616441,122000;,,Posterior polymorphous corneal dystrophy;Congenital hereditary endothelial dystrophy type I,Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in,,0.12711656441717792,0.7898401237751418,0.572435395458105,0.5914671577655003
2563,23274,OXCT1,601424,245050;,,Succinyl-CoA:3-ketoacid CoA transferase deficiency,Disease-causing germline mutation(s) in,,0.8355828220858895,0.5141825683341928,0.6912033411641869,0.635512584407612
2564,23288,P2RX2,600844,608224;,"[MIM:608224]Deafness, autosomal dominant, 41 [dominant?];",Autosomal dominant non-syndromic sensorineural deafness type DFNA,Disease-causing germline mutation(s) in,Body mass index[26426971];,0.33226993865030674,0.30144404332129965,0.591229444009397,0.012430939226519336
2565,23295,P2RX7,602566,,,B-cell chronic lymphocytic leukemia,Biomarker tested in,Chronic obstructive pulmonary disease-related biomarkers[23144326];,0.32380368098159507,0.09412068076328003,0.009919081179848603,0.03238182934315531
2566,23304,P2RY11,602697,,,Narcolepsy type 1,Major susceptibility factor in,Narcolepsy[24204295];,0.038773006134969326,0.4259927797833935,0.8903680501174628,0.21132596685082872
2567,23305,P2RY12,600515,609821;,"[MIM:609821]Bleeding disorder, platelet-type 8;",Resistance to clopidogrel;Bleeding disorder due to P2Y12 defect,Biomarker tested in;Disease-causing germline mutation(s) in,Diverticular disease[30177863];,0.4622085889570552,0.3664259927797834,0.7499347428869747,0.2826887661141805
2568,23308,P3H1,610339,610915;,[MIM:610915]Osteogenesis imperfecta 8;,Osteogenesis imperfecta type 2;Osteogenesis imperfecta type 3,Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in,,0.8866257668711657,0.26224858174316656,0.0,0.0
2569,23309,P3H2,610341,614292;,,Rare isolated myopia,Disease-causing germline mutation(s) in,Itch intensity from mosquito bite adjusted by bite size[28199695];,0.5469938650306748,0.276689014956163,0.0,0.0
2570,23313,P4HA1,176710,,,"Ehlers-Danlos syndrome, musculocontractural type",Disease-causing germline mutation(s) in,,0.9606134969325153,0.962351727694688,0.74079874706343,0.19060773480662985
2571,23318,P4HB,176790,112240;,[MIM:112240]Cole-Carpenter syndrome 1 [dominant?];,Cole-Carpenter syndrome,Disease-causing germline mutation(s) in,,0.9823312883435583,0.8635894791129448,0.8279822500652572,0.4421424186617557
2572,23352,PABPN1,602279,164300;,[MIM:164300]Oculopharyngeal muscular dystrophy;,Oculopharyngeal muscular dystrophy,Disease-causing germline mutation(s) in,Body mass index[26865924];,0.8699386503067484,0.5912841670964415,0.8859305664317411,0.0
2573,23362,PACS1,607492,615009;,[MIM:615009]Schuurs-Hoeijmakers syndrome;,Intellectual disability-craniofacial dysmorphism-cryptorchidism syndrome,Disease-causing germline mutation(s) (gain of function) in,Electroencephalogram traits[25387704];Acne (severe)[24927181];Bipolar disorder[21926972];Obesity (early onset extreme)[23563609];,0.4667484662576687,0.7266632284682826,0.7674236491777604,0.6760282381829343
2574,23369,PADI3,606755,191480;,,Uncombable hair syndrome,Disease-causing germline mutation(s) (loss of function) in,IgA nephropathy[25305756];Pulmonary function (smoking interaction)[23284291];,0.2947239263803681,0.1181021144920062,0.1756721482641608,0.07458563535911603
2575,23375,PAFAH1B1,601545,247200;607432;,[MIM:607432]Lissencephaly 1;[MIM:607432]Subcortical band heterotopia;[MIM:247200]Miller-Dieker lissencephaly syndrome;,17p13.3 microduplication syndrome;Miller-Dieker syndrome;Lissencephaly due to LIS1 mutation;Subcortical band heterotopia,Role in the phenotype of;Role in the phenotype of;Disease-causing germline mutation(s) in;Disease-causing somatic mutation(s) in,Neuroticism[27089181];Self-reported tiredness[28194004];,0.9204907975460123,0.8610108303249098,0.971025841816758,0.8425414364640884
2576,23389,PAH,612349,261600;,[MIM:261600]Phenylketonuria;[MIM:261600]Non-phenylketonuria hyperphenylalaninemia;[MIM:261600]Hyperphenylalaninemia;,Maternal phenylketonuria;Tetrahydrobiopterin-responsive hyperphenylalaninemia/phenylketonuria;Classic phenylketonuria;Mild phenylketonuria;Mild hyperphenylalaninemia,Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) (loss of function) in;Disease-causing germline mutation(s) (loss of function) in;Disease-causing germline mutation(s) (loss of function) in,Metabolite levels (small molecules and protein measures)[27005778];Blood metabolite levels[24816252];Amino acid levels[26068415];,0.14576687116564419,0.020629190304280558,0.6194205168363351,0.961939840392879
2577,23405,PAK3,300142,300558;,"[MIM:300558]Mental retardation, X-linked 30;",X-linked non-syndromic intellectual disability,Disease-causing germline mutation(s) (loss of function) in,,0.5110429447852761,0.9179989685404848,0.959801618376403,0.6837016574585635
2578,23409,PALB2,610355,114480;610832;613348;,[MIM:114480]Breast cancer;[MIM:610832]Fanconi anemia complementation group N;[MIM:613348]Pancreatic cancer 3;,Fanconi anemia;Hereditary breast and ovarian cancer syndrome;Hereditary breast cancer;Familial pancreatic carcinoma,Disease-causing germline mutation(s) in;Candidate gene tested in;Major susceptibility factor in;Major susceptibility factor in,Bipolar disorder[17554300];,0.6439263803680981,0.6217122227952553,0.45418950665622554,0.03314917127071823
2579,23411,PALLD,608092,606856;,[MIM:606856]Pancreatic cancer 1;,Familial pancreatic carcinoma,Major susceptibility factor in,Vein graft stenosis in coronary artery bypass grafting[25881214];Response to iloperidone treatment (QT prolongation)[18521091];Pulse pressure[28135244];Non-alcoholic fatty liver disease histology (AST)[20708005];Advanced glycation end-product levels[26915486];Coronary artery disease[29212778;29212778;29212778];Bacteremia[27236921];,0.8970552147239264,0.5518308406395049,0.16366483946750196,0.0649171270718232
2580,23418,PAM16,614336,613320;,"[MIM:613320]Spondylometaphyseal dysplasia, Megarbane-Dagher-Melike type [recessive?];","Autosomal recessive spondylometaphyseal dysplasia, M�garban� type",Disease-causing germline mutation(s) in,,0.4226993865030675,0.7318205260443528,0.22996606630122685,0.0
2581,23426,PANK2,606157,234200;607236;,"[MIM:607236]Hypoprebetalipoproteinemia, acanthocytosis, retinitis pigmentosa, and pallidal degeneration;",Classic pantothenate kinase-associated neurodegeneration;Atypical pantothenate kinase-associated neurodegeneration,Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in,,0.4840490797546012,0.19056214543579164,0.3262855651265988,0.7397176181706568
2582,23440,PAPPA-AS1,610689,,,Male infertility with azoospermia or oligozoospermia due to single gene mutation,Disease-causing germline mutation(s) in,Visceral adipose tissue adjusted for BMI[22589738];Rhegmatogenous retinal detachment[23585552];,0.038773006134969326,0.6482723053120165,0.08666144609762465,0.0
2583,23444,PAPSS2,603005,612847;,,"Autosomal recessive brachyolmia;Spondyloepimetaphyseal dysplasia, PAPSS2 type",Disease-causing germline mutation(s) (loss of function) in;Disease-causing germline mutation(s) in,Exercise (leisure time)[19727025];Magnesium levels[26685716];,0.26588957055214724,0.10830324909747292,0.3252414513181937,0.08732351135666053
2584,23464,PARK7,602533,168600;606324;,[MIM:606324]Parkinson disease 7;,Young-onset Parkinson disease;Amyotrophic lateral sclerosis-parkinsonism-dementia complex,Disease-causing germline mutation(s) in;Major susceptibility factor in,"Inflammatory bowel disease[28067908];Celiac disease[20190752];Chronic inflammatory diseases (ankylosing spondylitis, Crohn's disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy)[26974007];Crohn's disease[28067908];Ischemic stroke[24262325];Blood protein levels[30072576];Ulcerative colitis[21297633;28067908];",0.7877300613496933,0.8135636926250644,0.7123466457843906,0.7441682013505218
2585,23471,PARN,604212,616353;616371;,"[MIM:616353]Dyskeratosis congenita, autosomal recessive, 6 [recessive?];[MIM:616371]Pulmonary fibrosis, and/or bone marrow failure, telomere- related, 4;",Dyskeratosis congenita;Hoyeraal-Hreidarsson syndrome;Idiopathic pulmonary fibrosis,Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Major susceptibility factor in,Plasma omega-6 polyunsaturated fatty acid levels (linoleic acid)[24823311;24823311];Male-pattern baldness[27182965];Plasma omega-6 polyunsaturated fatty acid levels (gamma-linolenic acid)[24823311];Age at voice drop[27182965];Plasma omega-6 polyunsaturated fatty acid levels (dihomo-gamma-linolenic acid)[24823311;24823311];Height[25429064];Menarche (age at onset)[27182965];,0.658159509202454,0.31923671995874164,0.7055599060297573,0.0
2586,23505,PATL2,614661,617743;,,Female infertility due to oocyte meiotic arrest,Disease-causing germline mutation(s) (loss of function) in,,0.038773006134969326,0.20474471376998452,0.7021665361524406,0.0
2587,23511,PAX1,167411,615560;,[MIM:615560]Otofaciocervical syndrome 2;,Otofaciocervical syndrome,Disease-causing germline mutation(s) in,Male-pattern baldness[18849994;18849991;22693459;27182965;29146897;29146897;29146897];Sulfasalazine-induced agranulocytosis[28762467];Adolescent idiopathic scoliosis[28334814;25784220];Monobrow[27182965];facial morphology traits (multivariate analysis)[27193062];,0.08736196319018405,0.5698813821557503,0.5006525711302532,0.6720380601596071
2588,23512,PAX2,167409,120330;616002;,[MIM:120330]Papillorenal syndrome [dominant?];[MIM:616002]Focal segmental glomerulosclerosis 7;,"Renal coloboma syndrome;Familial idiopathic steroid-resistant nephrotic syndrome with focal segmental hyalinosis;Renal hypoplasia, bilateral",Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) (loss of function) in;Major susceptibility factor in,Systolic blood pressure[28135244];Body mass index (joint analysis main effects and smoking interaction)[28443625];Heart rate response to recovery post exercise (30 sec)[29497042];Heart rate response to recovery post exercise (10 sec)[29497042];Heart rate response to recovery post exercise (20 sec)[29497042];Body mass index[28892062;28892062];Heart rate response to exercise[29769521];Heart rate response to recovery post exercise (50 sec)[29497042];Heart rate increase in response to exercise[29497042];Heart rate response to recovery post exercise (40 sec)[29497042];Heart rate response to recovery post exercise[29769521];Alzheimer's disease[20061627];BMI (adjusted for smoking behaviour)[28443625];,0.3492024539877301,0.907426508509541,0.8339859044635866,0.8192142418661755
2589,23513,PAX3,606597,122880;148820;193500;268220;,[MIM:193500]Waardenburg syndrome 1 [dominant?];[MIM:148820]Waardenburg syndrome 3 [dominant?];[MIM:122880]Craniofacial-deafness-hand syndrome [dominant?];[MIM:268220]Rhabdomyosarcoma 2;,Waardenburg syndrome type 3;Waardenburg syndrome type 1;Craniofacial-deafness-hand syndrome;Alveolar rhabdomyosarcoma,Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Part of a fusion gene in,Monobrow thickness[26926045];Vitamin D levels[25208829];Nose size[27182965];Monobrow[27182965];Adolescent idiopathic scoliosis[26394188];Amyotrophic lateral sclerosis (sporadic)[24529757];Diisocyanate-induced asthma[25918132;25918132];Information processing speed[25869804];middle facial morphology traits (quantitative measurement)[27193062];Facial morphology[22341974];,0.5488343558282208,0.7573491490458999,0.5165753067084312,0.9711479435236341
2590,23514,PAX4,167413,125853;222100;612225;612227;,"[MIM:125853]Diabetes mellitus, non-insulin-dependent;[MIM:222100]Diabetes mellitus, insulin-dependent;[MIM:612227]Diabetes mellitus, ketosis-prone;[MIM:612225]Maturity-onset diabetes of the young 9 [dominant?];",MODY,Disease-causing germline mutation(s) in,Type 2 diabetes[22158537;26818947;23532257];,0.10711656441717791,0.26714801444043323,0.35160532498042285,0.6818600368324125
2591,23515,PAX5,167414,613065;,"[MIM:613065]Leukemia, acute lymphoblastic, 3;",Precursor B-cell acute lymphoblastic leukemia;Precursor B-cell acute lymphoblastic leukemia,Major susceptibility factor in;Part of a fusion gene in,Coronary artery disease in type 1 diabetes[29695241];Intelligence[22449649];HIV-1 susceptibility[25786224;25786224];Obesity-related traits[22013104;22013104];Major depressive disorder[27479909];Moderate to vigorous physical activity levels[29899525];,0.30319018404907977,0.7800412583806086,0.5745236230749151,0.9284837323511357
2592,23516,PAX6,607108,106210;120200;120430;136520;148190;165550;604229;617141;,"[MIM:106210]Aniridia 1;[MIM:604229]Anterior segment dysgenesis 5;[MIM:136520]Foveal hypoplasia 1;[MIM:148190]Keratitis hereditary;[MIM:120200]Coloboma, ocular, autosomal dominant [dominant?];[MIM:120430]Coloboma of optic nerve;[MIM:165550]Bilateral optic nerve hypoplasia;[MIM:617141]Aniridia 2;",WAGR syndrome;Aniridia-cerebellar ataxia-intellectual disability syndrome;Foveal hypoplasia-presenile cataract syndrome;Autosomal dominant keratitis;Isolated optic nerve hypoplasia/aplasia;Isolated aniridia;Peters anomaly;Morning glory disc anomaly;Coloboma of choroid and retina;Coloboma of optic disc;Coloboma of macula;Coloboma of eyelid;Coloboma of eye lens;Coloboma of iris,Role in the phenotype of;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) (loss of function) in;Disease-causing germline mutation(s) in;Candidate gene tested in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in,Body mass index[22344219;28892062];Optic disc area[28073927;28073927];Depression[29700475];Major depressive disorder[27479909];,0.5930061349693252,0.0,0.975724353954581,0.8990178023327194
2593,23518,PAX7,167410,268220;,[MIM:268220]Rhabdomyosarcoma 2;,Alveolar rhabdomyosarcoma,Part of a fusion gene in,Body mass index[23669352];Urate levels in lean individuals[25811787];Cleft lip with or without cleft palate[28054174;28054174];Knee osteoarthritis[28916551];Percentage gas trapping[26030696];Response to amphetamines[22952603];Orofacial clefts[22863734;28054174;28054174];Nonsyndromic cleft lip with cleft palate[28232668];,0.32380368098159507,0.462867457452295,0.6948577394936049,0.9754450583179864
2594,23519,PAX8,167415,218700;,"[MIM:218700]Hypothyroidism, congenital, non-goitrous, 2;",Differentiated thyroid carcinoma;Athyreosis;Thyroid ectopia;Thyroid hypoplasia,Part of a fusion gene in;Disease-causing germline mutation(s) (loss of function) in;Disease-causing germline mutation(s) (loss of function) in;Disease-causing germline mutation(s) (loss of function) in,Renal function-related traits (BUN)[22797727];Mucinous ovarian carcinoma[26075790;26075790];Lymphocyte counts[27863252];Creatinine levels[29403010];Sleep duration (oversleepers vs undersleepers)[27494321];Sleep traits (multi-trait analysis)[27992416];Sleep duration[25469926;27494321;27992416];Glomerular filtration rate[29403010];,0.35496932515337426,0.8914388860237236,0.7410597755155311,0.9297114794352364
2595,23521,PAX9,167416,604625;,"[MIM:604625]Tooth agenesis, selective, 3;",Oligodontia,Disease-causing germline mutation(s) in,Lobe attachment (rater scored)[29198719];Breast cancer[23535729;29059683];Lobe attachment (rater-scored or self-reported)[29198719];Prostate cancer[29892016];,0.31079754601226994,0.8116297060340382,0.17253980683894546,0.8321055862492327
2596,23535,PBRM1,606083,144700;,,Clear cell papillary renal cell carcinoma,Major susceptibility factor in,Waist circumference adjusted for BMI (joint analysis main effects and physical activity interaction)[28448500;28448500;28448500];Waist-to-hip ratio adjusted for BMI (adjusted for smoking behaviour)[28443625;28443625];Autism spectrum disorder or schizophrenia[28540026;28540026;28540026];Waist-to-hip ratio adjusted for BMI in active individuals[28448500;28448500;28448500;28448500];Waist-to-hip ratio adjusted for BMI (joint analysis for main effect and physical activity interaction)[28448500;28448500;28448500];Schizophrenia[23974872;25056061;28991256];Major mood disorders[20081856];Bipolar disorder[21926972];Bipolar disorder with mood-incongruent psychosis[23092984];Waist circumference adjusted for body mass index[28448500;28448500;28448500];Blood protein levels[29875488];General cognitive ability[29844566];Intelligence (MTAG)[29326435];Waist circumference adjusted for BMI in active individuals[28448500;28448500;28448500];Waist-to-hip ratio adjusted for body mass index[28448500;28448500;28448500;25673412;25673412;25673412;25673412];,0.7850306748466258,0.6503352243424445,0.4771600104411381,0.8351749539594844
2597,23536,PBX1,176310,617641;,,"Renal hypoplasia, bilateral;Precursor B-cell acute lymphoblastic leukemia",Role in the phenotype of;Part of a fusion gene in,Spherical equivalent or myopia (age of diagnosis)[29808027];Cough in response to angiotensin-converting enzyme inhibitor drugs[28084903];Myopia[27182965];Response to methotrexate in juvenile idiopathic arthritis[24709693];Height[20966902];Breast cancer (prognosis)[23319801];Night sleep phenotypes[27126917];Early-onset Parkinson's disease[28256260];Asthma[29273806];,0.6996319018404908,0.9035585353274884,0.17358392064735056,0.6642111724984653
2598,23542,PC,608786,266150;,[MIM:266150]Pyruvate carboxylase deficiency;,"Pyruvate carboxylase deficiency, benign type;Pyruvate carboxylase deficiency, infantile type;Pyruvate carboxylase deficiency, severe neonatal type",Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in,Bipolar disorder[21926972];HIV-1 susceptibility[22174851];Familial squamous cell lung carcinoma[29924316];,0.7624539877300613,0.4667354306343476,0.5894022448446881,0.9717618170656844
2599,23545,PCARE,613425,613428;,,Retinitis pigmentosa,Disease-causing germline mutation(s) in,Lung cancer in never smokers[28604730];Major depressive disorder[20125088];,0.038773006134969326,0.03558535327488396,0.0,0.0
2600,23556,PCBD1,126090,264070;,"[MIM:264070]Hyperphenylalaninemia, BH4-deficient, D [recessive?];",Pterin-4 alpha-carbinolamine dehydratase deficiency,Disease-causing germline mutation(s) in,Obesity-related traits[23251661;23251661;23251661];Blood protein levels[30072576];Microalbuminuria[26631737];Immature fraction of reticulocytes[27863252];,0.5180368098159509,0.314853017019082,0.9248238057948316,0.3021792510742787
2601,23567,PCCA,232000,606054;,[MIM:606054]Propionic acidemia type I;,Propionic acidemia,Disease-causing germline mutation(s) in,Spherical equivalent or myopia (age of diagnosis)[29808027;29808027];Refractive error[23396134];Myopia[27182965];,0.6803680981595092,0.3741619391438886,0.4447924823805795,0.766267648864334
2602,23569,PCCB,232050,606054;,[MIM:606054]Propionic acidemia type II;,Propionic acidemia,Disease-causing germline mutation(s) in,Autism spectrum disorder or schizophrenia[28540026];Alanine transaminase levels[29403010];Total bilirubin levels[29403010];Fibrinogen[20031576;23969696];Schizophrenia[25056061;28991256];Height[20881960];Fibrinogen levels[28107422];,0.6246625766871166,0.5121196493037649,0.58365961889846,0.789901780233272
2603,23583,PCDH15,605514,276900;601067;602083;609533;,"[MIM:602083]Usher syndrome 1F;[MIM:601067]Usher syndrome 1D/F;[MIM:609533]Deafness, autosomal recessive, 23 [recessive?];",Usher syndrome type 1;Autosomal recessive non-syndromic sensorineural deafness type DFNB,Disease-causing germline mutation(s) (loss of function) in;Disease-causing germline mutation(s) in,Bone mineral density (hip) and age at menarche[26312577];Disease-free survival in breast cancer[25867717];Airway responsiveness in chronic obstructive pulmonary disease[25514360];Sporadic pituitary adenoma[26029870];Weight[20966902];Sleep duration[27992416];Rosacea symptom severity[29771307];Immune response to smallpox vaccine (IL-6)[22542470];Extraversion[27918536];Epstein-Barr virus copy number in lymphoblastoid cell lines[28654678];Irritable bowel syndrome[24797007];Bone mineral density (spine) and age at menarche[26312577];Carotid intima media thickness[26343869];Post bronchodilator FEV1/FVC ratio in COPD[26634245];Adverse response to chemotherapy in breast cancer (alopecia)[24025145];Thiazide-induced adverse metabolic effects in hypertensive patients[23400010];,0.12711656441717792,0.31227436823104693,0.010180109631949883,0.006599140577041129
2604,23586,PCDH19,300460,300088;,"[MIM:300088]Epileptic encephalopathy, early infantile, 9;",Dravet syndrome;Female restricted epilepsy with intellectual disability,Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in,,0.17791411042944785,0.964414646725116,0.552858261550509,0.7903621853898097
2605,23667,PCK1,614168,261680;,"[MIM:261680]Phosphoenolpyruvate carboxykinase deficiency, cytosolic [recessive?];",Phosphoenolpyruvate carboxykinase deficiency,Disease-causing germline mutation(s) in,Type 2 diabetes[23300278];Response to fenofibrate (adiponectin levels)[23149075];Emphysema imaging phenotypes[26030696;26030696];Prudent dietary pattern[28644415];,0.5395092024539877,0.20603403816400206,0.3333333333333333,0.20549416820135052
2606,23668,PCK2,614095,261650;,[MIM:261650]Mitochondrial phosphoenolpyruvate carboxykinase deficiency [recessive?];,Phosphoenolpyruvate carboxykinase deficiency,Disease-causing germline mutation(s) in,,0.8608588957055214,0.038679731820526045,0.29548420777864787,0.0019950890116635974
2607,23670,PCLO,604918,608027;,[MIM:608027]Pontocerebellar hypoplasia 3;,Pontocerebellar hypoplasia type 3,Disease-causing germline mutation(s) in,Rosacea symptom severity[29771307];Energy expenditure (24h)[28476931];Major depressive disorder[20351715;21621269;28540843];,0.5585276073619632,0.9544868488911811,0.012529365700861394,0.0
2608,23671,PCM1,600299,,,Differentiated thyroid carcinoma,Part of a fusion gene in,Response to bronchodilator in chronic obstructive pulmonary disease (change in FEV1)[26503814];Atrial fibrillation[28416818];Economic and political preferences[22566634];,0.6706748466257668,0.09927797833935018,0.08822761681023232,0.13996316758747698
2609,23683,PCNA,176740,615919;,[MIM:615919]Ataxia-telangiectasia-like disorder 2;,PCNA-related progressive neurodegenerative photosensitivity syndrome,Disease-causing germline mutation(s) in,,0.9850306748466258,0.9156781846312533,0.9639780736100235,0.0
2610,23695,PCNT,605925,210720;,[MIM:210720]Microcephalic osteodysplastic primordial dwarfism 2;,Seckel syndrome;Microcephalic osteodysplastic primordial dwarfism type II,Candidate gene tested in;Disease-causing germline mutation(s) (loss of function) in,,0.8952147239263804,0.30556988138215574,0.006525711302531976,0.08241252302025782
2611,23709,PCSK1,162150,600955;612362;,[MIM:600955]Proprotein convertase 1 deficiency;,Obesity due to prohormone convertase I deficiency,Disease-causing germline mutation(s) in,Body mass index[22344219;24861553;25673413;25673413;28892062];Waist circumference[23966867];Glycemic traits (pregnancy)[23903356];Fasting blood glucose[22581228];Menarche (age at onset)[25231870];Blood protein levels[29875488;30072576];Fasting blood glucose (BMI interaction)[22581228];Proinsulin levels[21873549];,0.17791411042944785,0.5933470861268695,0.17123466457843906,0.569060773480663
2612,23717,PCSK9,607786,603776;,"[MIM:603776]Hypercholesterolemia, autosomal dominant, 3 [dominant?];",Homozygous familial hypercholesterolemia,Disease-causing germline mutation(s) in,"Myocardial infarction[26343387];Plasma proprotein convertase subtilisin/kexin type 9 levels in stable coronary artery disease[29748315;29748315;29748315;29748315;29748315;29748315;29748315;29748315];Metabolite levels (lipoprotein measures)[27005778];Blood protein levels[30072576];Coronary heart disease[21378990];Coronary artery disease[26343387;29212778;29212778;29212778];Lipid metabolism phenotypes[22286219];Total cholesterol levels[29403010;28334899;28334899;28334899];Response to statins (LDL cholesterol change)[22331829];Myocardial infarction (early onset)[19198609];Metabolite levels[22916037];LDL cholesterol levels[28334899;28334899;28334899];Cholesterol, total[20686565;24097068;25961943;26582766;28270201];LDL cholesterol[20686565;20864672;18193043;23726366;19060906;24097068;18193044;25961943;26582766];Coronary artery disease (myocardial infarction, percutaneous transluminal coronary angioplasty, coronary artery bypass grafting, angina or chromic ischemic heart disease)[28714975];",0.47705521472392637,0.09308922124806601,0.31088488645262335,0.38812154696132595
2613,23721,PCYT1A,123695,608940;,[MIM:608940]Spondylometaphyseal dysplasia with cone-rod dystrophy;,Leber congenital amaurosis;Spondylometaphyseal dysplasia-cone-rod dystrophy syndrome,Disease-causing germline mutation(s) (loss of function) in;Disease-causing germline mutation(s) (loss of function) in,,0.7757055214723927,0.6093347086126869,0.6888540850952753,0.5174953959484346
2614,23731,PDCD1,600244,109100;605218;,[MIM:605218]Systemic lupus erythematosus 2;,Systemic lupus erythematosus,Major susceptibility factor in,Crohn's disease[26192919];,0.4350920245398773,0.6596183599793708,0.28217175672148265,0.3970227133210559
2615,23745,PDCD10,609118,603285;,,Familial cerebral cavernous malformation,Disease-causing germline mutation(s) in,Fast beta electroencephalogram[28070124];,0.7707975460122699,0.9025270758122743,0.8219785956669277,0.0
2616,23761,PDE1C,602987,,,Autosomal dominant non-syndromic sensorineural deafness type DFNA,Disease-causing germline mutation(s) in,Verbal-numerical reasoning[27046643];Body mass index[28892062];Intelligence (MTAG)[29326435;29326435];Intelligence[28530673;28530673];Gout[22179738];Cognitive ability[29186694;29186694];Endometriosis[23472165];Cognitive ability (MTAG)[29186694];Presence of antiphospholipid antibodies[23509613];,0.14576687116564419,0.13151108818978854,0.48525189245627776,0.1869244935543278
2617,23763,PDE3A,123805,112410;,[MIM:112410]Hypertension and brachydactyly syndrome;,Brachydactyly-arterial hypertension syndrome,Disease-causing germline mutation(s) (gain of function) in,Systolic blood pressure[27618452;28739976;28739976;28739976;28135244];QT interval[20031603];Diastolic blood pressure (cigarette smoking interaction)[29455858];Spherical equivalent or myopia (age of diagnosis)[29808027];Stroke[29531354];Diastolic blood pressure[26390057;27618452;28739976;28739976;28135244;28135244];Response to TNF-alpha inhibitors in rheumatoid arthritis[22569225];Lung adenocarcinoma[28604730];Ischemic stroke[29531354];Aortic root size[19584346];Systolic blood pressure (cigarette smoking interaction)[29455858];HDL cholesterol[20686565;24097068];Diverticular disease[30177863];HDL cholesterol levels[28334899];Resting heart rate[27798624;29769521];Adiponectin levels[22479202];Male infertility[19478329];Pulse pressure[28135244];Height[18391951;29782485];Response to platinum-based chemotherapy (carboplatin)[21844884];Systolic blood pressure (alcohol consumption interaction)[24376456];Coronary artery calcified atherosclerotic plaque (130 HU threshold) in type 2 diabetes[29221444];,0.629079754601227,0.4156781846312532,0.18089271730618636,0.4438305709023941
2618,23768,PDE4D,600129,614613;,"[MIM:614613]Acrodysostosis 2, with or without hormone resistance;",Acrodysostosis;Acrodysostosis with multiple hormone resistance;PDE4D haploinsufficiency syndrome,Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) (loss of function) in,Neuroticism[17667963];Sleep-related phenotypes[17903308];Forced expiratory volume in 1 second (occupational environmental exposures interaction)[25979521];Response to antipsychotic treatment[23241943];Breast cancer[23535729;29059683];Plasma parathyroid hormone levels[30134803];General cognitive ability[29844566];Asthma[19426955];Immune response to smallpox vaccine (IL-6)[22610502];Intelligence (MTAG)[29326435];Adverse response to chemotherapy (neutropenia/leucopenia) (gemcitabine)[23648065];Esophageal squamous cell carcinoma[25129146];Post bronchodilator FEV1/FVC ratio[26634245;26634245;26634245;26634245];Obesity-related traits[23251661];Cognitive function[28808816];Esophageal cancer[21642993];,0.47705521472392637,0.97279525528623,0.9005481597494127,0.5131982811540823
2619,23772,PDE6A,180071,613810;,[MIM:613810]Retinitis pigmentosa 43;,Retinitis pigmentosa,Disease-causing germline mutation(s) in,,0.21484662576687116,0.019339865910263022,0.28243278517358394,0.32642725598526706
2620,23773,PDE6B,180072,163500;613801;,"[MIM:613801]Retinitis pigmentosa 40;[MIM:163500]Night blindness, congenital stationary, autosomal dominant 2 [dominant?];",Retinitis pigmentosa;Congenital stationary night blindness,Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in,,0.17791411042944785,0.013666838576585868,0.38005742625946226,0.10497237569060773
2621,23774,PDE6C,600827,613093;,[MIM:613093]Cone dystrophy 4;[MIM:613093]Achromatopsia 5 [recessive?];,Progressive cone dystrophy;Achromatopsia,Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in,,0.08736196319018405,0.0446106240330067,0.0997128687026886,0.14226519337016574
2622,23775,PDE6D,602676,615665;,,Orofaciodigital syndrome type 6,Disease-causing germline mutation(s) (loss of function) in,Eating disorders (purging via substances)[23568457];Height[18391951];,0.49570552147239266,0.41593604951005675,0.8081440877055599,0.3580417434008594
2623,23776,PDE6G,180073,613582;,[MIM:613582]Retinitis pigmentosa 57;,Retinitis pigmentosa,Disease-causing germline mutation(s) in,,0.23865030674846627,0.537132542547705,0.3636126337770817,0.27992633517495397
2624,23777,PDE6H,601190,610024;,"[MIM:610024]Cone dystrophy, retinal 3A;",Achromatopsia,Disease-causing germline mutation(s) in,,0.19190184049079756,0.43192367199587417,0.9271730618637432,0.3298035604665439
2625,23781,PDE8B,603390,609161;614190;,"[MIM:609161]Striatal degeneration, autosomal dominant 1 [dominant?];[MIM:614190]Primary pigmented nodular adrenocortical disease 3;",Primary pigmented nodular adrenocortical disease;Autosomal dominant striatal neurodegeneration,Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in,Thyroid hormone levels[23408906;23408906;23408906];Thyroid function[22494929];Sjögren's syndrome[28076899;28076899];Serum thyroid-stimulating hormone levels[25436638];Thyroid stimulating hormone[18514160];Caudate nucleus volume[21502949];Hypothyroidism[22493691;27182965];,0.038773006134969326,0.8408973697782363,0.5941007569825111,0.6069674647022714
2626,23783,PDE10A,610652,616921;616922;,"[MIM:616921]Dyskinesia, limb and orofacial, infantile-onset [recessive?];[MIM:616922]Striatal degeneration, autosomal dominant 2 [dominant?];",Childhood-onset benign chorea with striatal involvement;Infantile-onset generalized dyskinesia with orofacial involvement,Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in,Cortisol levels (saliva)[28843169];Inhibitory control[29251981];Parkinson's disease[26227905];Thyroid hormone levels[23408906;23408906;23408906];Age-related nuclear cataracts[24951543];Diastolic blood pressure[28135244];Plasma thyroid-stimulating hormone levels[28333968;28333968];Diastolic blood pressure x alcohol consumption interaction (2df test)[29912962];Hypothyroidism[27182965];Spherical equivalent (joint analysis main effects and education interaction)[27020472];Conduct disorder (symptom count)[20585324];,0.12711656441717792,0.9834966477565755,0.7622030801357348,0.46193984039287905
2627,23784,PDE11A,604961,610475;,[MIM:610475]Primary pigmented nodular adrenocortical disease 2;,Primary pigmented nodular adrenocortical disease,Disease-causing germline mutation(s) in,Heart rate[23583979];Spherical equivalent or myopia (age of diagnosis)[29808027];Cough in response to angiotensin-converting enzyme inhibitor drugs[28084903];Diastolic blood pressure[29212154];Myopia[27182965];Height[20881960];,0.038773006134969326,0.31614234141309955,0.2547637692508483,0.3534376918354819
2628,23788,PDGFB,190040,607907;615483;,,Bilateral striopallidodentate calcinosis;Familial multiple meningioma;Dermatofibrosarcoma protuberans,Disease-causing germline mutation(s) (loss of function) in;Candidate gene tested in;Part of a fusion gene in,Primary biliary cirrhosis[22961000];Primary biliary cholangitis[26394269];,0.5585276073619632,0.7529654461062403,0.7460193161054555,0.5477286678944138
2629,23791,PDGFRA,173490,606764;607685;,[MIM:606764]Gastrointestinal stromal tumor;,Myeloid/lymphoid neoplasm associated with PDGFRA rearrangement;Chronic eosinophilic leukemia;Primary hypereosinophilic syndrome;Gastrointestinal stromal tumor;Precursor B-cell acute lymphoblastic leukemia,Part of a fusion gene in;Part of a fusion gene in;Part of a fusion gene in;Disease-causing somatic mutation(s) in;Part of a fusion gene in,Cadmium levels[26025379];Adult asthma[27611488];Mean corpuscular hemoglobin[20139978;29403010];Mean corpuscular volume[20139978;29403010];Hematocrit[29403010];Red blood cell count[20139978;28453575;29403010];Blood protein levels[30072576];Lupus nephritis in systemic lupus erythematosus[24925725];Asthma[27611488];Uterine fibroids[30194396];Serum VEGFR2 concentration[25411163];Corneal curvature[21665993;23401653;24963161];Corneal astigmatism[22144915;29422769];Hemoglobin[29403010];Height[18193045];Post bronchodilator FEV1/FVC ratio[26634245;26634245];Platelet count[29403010];,0.5749693251533742,0.8308406395048994,0.3448185852257896,0.7516881522406385
2630,23792,PDGFRB,173410,131440;228550;601626;601812;607785;615007;616592;,"[MIM:131440]Myeloproliferative disorder chronic with eosinophilia;[MIM:601626]Leukemia, acute myelogenous;[MIM:607785]Leukemia, juvenile myelomonocytic;[MIM:615007]Basal ganglia calcification, idiopathic, 4 [dominant?];[MIM:228550]Myofibromatosis, infantile 1;[MIM:616592]Kosaki overgrowth syndrome;[MIM:601812]Premature aging syndrome, Penttinen type;","Myeloid/lymphoid neoplasm associated with PDGFRB rearrangement;Bilateral striopallidodentate calcinosis;Infantile myofibromatosis;Primary hypereosinophilic syndrome;Acroosteolysis-keloid-like lesions-premature aging syndrome;Skeletal overgrowth-craniofacial dysmorphism-hyperelastic skin-white matter lesions syndrome;Chronic myeloproliferative disease, unclassifiable;Chronic myelomonocytic leukemia",Part of a fusion gene in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Part of a fusion gene in;Disease-causing germline mutation(s) (gain of function) in;Disease-causing germline mutation(s) in;Part of a fusion gene in;Part of a fusion gene in,Granulocyte percentage of myeloid white cells[27863252];Monocyte count[27863252];Monocyte percentage of white cells[27863252];Blood protein levels[28240269;28240269;28240269;29875488;30072576];,0.6131288343558282,0.7215059308922125,0.4058992430174889,0.7558317986494782
2631,23793,PDGFRL,604584,114500;,,Adult hepatocellular carcinoma,Candidate gene tested in,Amyotrophic lateral sclerosis (sporadic)[24529757];Plasma parathyroid hormone levels[30134803];Placental abruption[29884306];,0.33226993865030674,0.056472408457968026,0.49125554685460715,0.08578882750153469
2632,23794,PDHA1,300502,312170;,[MIM:312170]Pyruvate dehydrogenase E1-alpha deficiency;,Leigh syndrome with leukodystrophy;Pyruvate dehydrogenase E1-alpha deficiency,Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in,,0.8660122699386503,0.9510056730273336,0.4145131819368311,0.8766114180478821
2633,23797,PDHB,179060,614111;,[MIM:614111]Pyruvate dehydrogenase E1-beta deficiency;,Pyruvate dehydrogenase E1-beta deficiency,Disease-causing germline mutation(s) in,Systemic lupus erythematosus[26502338;28714469];Type 1 diabetes autoantibodies in high risk HLA genotype individuals (time to event)[29310926];,0.8976687116564417,0.5149561629706034,0.8932393630905768,0.7539901780233272
2634,23798,PDHX,608769,245349;,[MIM:245349]Pyruvate dehydrogenase E3-binding protein deficiency;,Pyruvate dehydrogenase E3-binding protein deficiency,Disease-causing germline mutation(s) in,Bone mineral density (hip)[30172743];Uterine fibroids[30194396];Systemic lupus erythematosus[28714469;28714469];,0.9278527607361963,0.8501805054151624,0.1592273557817802,0.0798035604665439
2635,23811,PDK3,300906,300905;,"[MIM:300905]Charcot-Marie-Tooth disease, X-linked dominant, 6;",X-linked Charcot-Marie-Tooth disease type 6,Disease-causing germline mutation(s) (gain of function) in,,0.9558282208588957,0.6908200103145952,0.7251370399373531,0.4547268262737876
2636,23823,PDP1,605993,608782;,[MIM:608782]Pyruvate dehydrogenase phosphatase deficiency;,Pyruvate dehydrogenase phosphatase deficiency,Disease-causing germline mutation(s) (loss of function) in,,0.7030674846625767,0.5662712738525013,0.855912294440094,0.259975445058318
2637,23833,PDSS1,607429,614651;,"[MIM:614651]Coenzyme Q10 deficiency, primary, 2 [recessive?];",Deafness-encephaloneuropathy-obesity-valvulopathy syndrome,Disease-causing germline mutation(s) in,Overall survival in serous epithelial ovarian cancer treated with paclitaxel and cisplatin[28935272];,0.7754601226993865,0.15342960288808663,0.5199686765857479,0.4538060159607121
2638,23836,PDSS2,610564,614652;,"[MIM:614652]Coenzyme Q10 deficiency, primary, 3 [recessive?];",Leigh syndrome with nephrotic syndrome,Disease-causing germline mutation(s) in,Childhood and early adolescence aggressive behavior[26087016];Coronary artery calcified atherosclerotic plaque (90 or 130 HU threshold) in type 2 diabetes[29221444];Airway responsiveness in chronic obstructive pulmonary disease[25514360;25514360];Microalbuminuria[26631737];Forced expiratory volume in 1 second (environmental tobacco smoke interaction)[28738859];,0.19190184049079756,0.3445074780814853,0.44740276690159225,0.1929097605893186
2639,23837,PDX1,600733,125853;260370;606392;,"[MIM:260370]Pancreatic agenesis 1;[MIM:125853]Diabetes mellitus, non-insulin-dependent;[MIM:606392]Maturity-onset diabetes of the young 4 [dominant?];",Partial pancreatic agenesis;MODY;Permanent neonatal diabetes mellitus,Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in,Acute insulin response[28490609];Body mass index[26426971];Fasting blood glucose[22581228];Peak insulin response[28490609];Fasting plasma glucose[28270201;28270201];Glycated hemoglobin levels[28898252];Pancreatic cancer[26098869;25086665;29422604];Blood sugar levels[29403010];Attention deficit hyperactivity disorder and conduct disorder[18951430];Fasting blood glucose (BMI interaction)[22581228];,0.30319018404907977,0.4749871067560598,0.46880709997389713,0.0
2640,23842,PDYN,131340,610245;,[MIM:610245]Spinocerebellar ataxia 23 [dominant?];,Spinocerebellar ataxia type 23,Disease-causing germline mutation(s) in,Immune response to smallpox vaccine (IL-6)[22542470];Immune response to measles-mumps-rubella vaccine[24811271];Aortic root size[21223598];Platelet count[29403010];,0.21484662576687116,0.28365136668385765,0.7154789872096059,0.6345917740945365
2641,23847,PDZD7,612971,276901;605472;618003;,[MIM:605472]Usher syndrome 2C;[MIM:276901]Usher syndrome 2A;,Usher syndrome type 2,Modifying germline mutation in,,0.12711656441717792,0.32078390923156264,0.6032367528060558,0.2705647636586863
2642,23884,PEPD,613230,170100;,[MIM:170100]Prolidase deficiency;,Prolidase deficiency,Disease-causing germline mutation(s) (loss of function) in,Type 2 diabetes[22158537;28869590];Waist circumference adjusted for BMI (joint analysis main effects and physical activity interaction)[28448500;28448500];Waist-to-hip ratio adjusted for BMI in active individuals[28448500;28448500];Waist-to-hip ratio adjusted for BMI (joint analysis for main effect and physical activity interaction)[28448500;28448500];Schizophrenia[26198764];Triglyceride levels[28334899];Waist circumference adjusted for BMI (adjusted for smoking behaviour)[28443625];Creatine kinase levels[29403010];Triglycerides[24097068];Waist circumference adjusted for body mass index[28448500;28448500;25673412;25673412];Waist-hip ratio[25673412;25673412;25673412];HDL cholesterol[24097068];Fasting blood insulin (BMI interaction)[22581228];HDL cholesterol levels[28334899];Adiponectin levels[22479202;22479202;24105470];Waist circumference adjusted for BMI (joint analysis main effects and smoking interaction)[28443625];Birth weight[27680694];Lead levels in blood[25820613];Waist circumference adjusted for BMI in active individuals[28448500;28448500];Waist-to-hip ratio adjusted for body mass index[28448500;28448500;28448500];,0.4,0.3042805569881382,0.1284259984338293,0.5423572744014733
2643,23887,PER2,603426,604348;,"[MIM:604348]Advanced sleep phase syndrome, familial, 1;",Familial advanced sleep-phase syndrome,Disease-causing germline mutation(s) in,Morning vs. evening chronotype[27494321;26955885;26835600];Chronotype[27494321;26955885;26955885];,0.3669938650306748,0.8473439917483239,0.2889584964761159,0.38152240638428486
2644,23888,PER3,603427,616882;,"[MIM:616882]Advanced sleep phase syndrome, familial, 3;",Familial advanced sleep-phase syndrome,Disease-causing germline mutation(s) in,Inflammatory bowel disease[28067908];Morning vs. evening chronotype[26835600];Crohn's disease[28067908];Ulcerative colitis[28067908];,0.40773006134969325,0.258896338318721,0.31480031323414254,0.022866789441375077
2645,23894,PET100,614770,,,Leigh syndrome with leukodystrophy,Disease-causing germline mutation(s) (loss of function) in,,0.038773006134969326,0.5982465188241362,0.5400678673975463,0.0
2646,23895,PET117,614771,,,Isolated cytochrome C oxidase deficiency,Disease-causing germline mutation(s) in,Anorexia nervosa[21079607];,0.038773006134969326,0.501547189272821,0.8151918559122945,0.0
2647,23896,PEX1,602136,214100;234580;601539;,[MIM:214100]Peroxisome biogenesis disorder complementation group 1;[MIM:214100]Peroxisome biogenesis disorder 1A [recessive?];[MIM:601539]Peroxisome biogenesis disorder 1B;[MIM:234580]Heimler syndrome 1;,Zellweger syndrome;Neonatal adrenoleukodystrophy;Deafness-enamel hypoplasia-nail defects syndrome;Infantile Refsum disease,Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) (loss of function) in;Disease-causing germline mutation(s) in,Height[18391951];,0.4622085889570552,0.4038164002062919,0.46906812842599843,0.8195211786372008
2648,23897,PEX2,170993,614866;614867;,[MIM:614866]Peroxisome biogenesis disorder complementation group 5;[MIM:614866]Peroxisome biogenesis disorder 5A;[MIM:614867]Peroxisome biogenesis disorder 5B;,Zellweger syndrome;Neonatal adrenoleukodystrophy;Infantile Refsum disease,Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in,Systolic blood pressure response to hydrochlorothiazide in hypertension[27802415];Infant length[25281659];Height[20881960];Menarche (age at onset)[27182965;25231870];Nicotine dependence[28440896];,0.3889570552147239,0.3029912325941207,0.5032628556512659,0.697206875383671
2649,23898,PEX3,603164,614882;617370;,[MIM:614882]Peroxisome biogenesis disorder 10A;[MIM:617370]Peroxisome biogenesis disorder 10B [recessive?];,Zellweger syndrome;Neonatal adrenoleukodystrophy;Infantile Refsum disease,Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in,,0.7737423312883436,0.51985559566787,0.4988253719655442,0.28806015960712095
2650,23899,PEX5,600414,202370;214110;616716;,[MIM:214110]Peroxisome biogenesis disorder 2A;[MIM:202370]Peroxisome biogenesis disorder 2B;[MIM:616716]Rhizomelic chondrodysplasia punctata 5;,Zellweger syndrome;Neonatal adrenoleukodystrophy;Infantile Refsum disease;Rhizomelic chondrodysplasia punctata type 5,Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) (loss of function) in,IgG glycosylation[23382691];Night sleep phenotypes[27126917];,0.8085889570552147,0.6583290355853533,0.49569303054032887,0.8560466543891958
2651,23903,PEX6,601498,614862;614863;616617;,[MIM:614862]Peroxisome biogenesis disorder 4A;[MIM:614863]Peroxisome biogenesis disorder 4B;[MIM:616617]Heimler syndrome 2;,Zellweger syndrome;Neonatal adrenoleukodystrophy;Deafness-enamel hypoplasia-nail defects syndrome;Infantile Refsum disease;Autosomal recessive spinocerebellar ataxia-blindness-deafness syndrome,Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) (loss of function) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in,Alzheimer's disease in APOE e4+ carriers[25778476];,0.28662576687116564,0.25477050025786485,0.0971025841816758,0.7701043585021485
2652,23904,PEX7,601757,215100;614879;,[MIM:215100]Rhizomelic chondrodysplasia punctata 1;[MIM:614879]Peroxisome biogenesis disorder 9B;,Refsum disease;Rhizomelic chondrodysplasia punctata type 1,Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in,,0.38061349693251534,0.1147498710675606,0.836335160532498,0.2705647636586863
2653,23905,PEX10,602859,614870;614871;,[MIM:614870]Peroxisome biogenesis disorder complementation group 7;[MIM:614870]Peroxisome biogenesis disorder 6A;[MIM:614871]Peroxisome biogenesis disorder 6B;,Zellweger syndrome;Neonatal adrenoleukodystrophy;Autosomal recessive ataxia due to PEX10 deficiency;Infantile Refsum disease,Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in,Body mass index[26426971;26426971];Non-obstructive azoospermia[22197933];,0.3492024539877301,0.0,0.5802662490211433,0.6094229588704727
2654,23907,PEX11B,603867,614920;,[MIM:614920]Peroxisome biogenesis disorder 14B [recessive?];,Zellweger syndrome;Neonatal adrenoleukodystrophy;Infantile Refsum disease,Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in,,0.23865030674846627,0.2550283651366684,0.8274601931610546,0.09729895641497852
2655,23909,PEX12,601758,266510;614859;,[MIM:614859]Peroxisome biogenesis disorder complementation group 3;[MIM:614859]Peroxisome biogenesis disorder 3A;[MIM:266510]Peroxisome biogenesis disorder 3B;,Zellweger syndrome;Neonatal adrenoleukodystrophy;Infantile Refsum disease,Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in,Red cell distribution width[27863252];,0.27361963190184047,0.14337287261474987,0.5223179326546593,0.3670963781461019
2656,23911,PEX13,601789,614883;614885;,[MIM:614883]Peroxisome biogenesis disorder complementation group 13;[MIM:614883]Peroxisome biogenesis disorder 11A;[MIM:614885]Peroxisome biogenesis disorder 11B;,Zellweger syndrome;Neonatal adrenoleukodystrophy;Infantile Refsum disease,Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in,Crohn's disease[22412388];,0.31079754601226994,0.5654976792160907,0.5875750456799791,0.3492940454266421
2657,23912,PEX14,601791,614887;,[MIM:614887]Peroxisome biogenesis disorder complementation group K;[MIM:614887]Peroxisome biogenesis disorder 13A;,Zellweger syndrome;Neonatal adrenoleukodystrophy;Infantile Refsum disease,Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in,Optic nerve measurement (rim area)[20395239];Breast size[27182965];Self-reported allergy[23817569];Hand grip strength[29313844];Breast cancer[23535733;27117709;23535729;29059683];Breast cancer (estrogen-receptor negative)[27117709];Prostate cancer[25217961];Asthma[27182965];,0.7370552147239264,0.7369778236204229,0.4045941007569825,0.4685389809699202
2658,23913,PEX16,603360,614876;614877;,[MIM:614876]Peroxisome biogenesis disorder complementation group 9;[MIM:614876]Peroxisome biogenesis disorder 8A;[MIM:614877]Peroxisome biogenesis disorder 8B;,Zellweger syndrome;Neonatal adrenoleukodystrophy;Infantile Refsum disease,Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in,Axial length[24144296];,0.2947239263803681,0.443011861784425,0.47898720960584706,0.23204419889502761
2659,23914,PEX19,600279,614886;,[MIM:614886]Peroxisome biogenesis disorder 12A;,Zellweger syndrome;Neonatal adrenoleukodystrophy;Infantile Refsum disease,Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in,,0.6817177914110429,0.5028365136668386,0.9146436961628818,0.4972375690607735
2660,23915,PEX26,608666,614872;614873;,[MIM:614872]Peroxisome biogenesis disorder 7A;[MIM:614873]Peroxisome biogenesis disorder 7B;,Zellweger syndrome;Neonatal adrenoleukodystrophy;Infantile Refsum disease,Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in,,0.23865030674846627,0.8568849922640537,0.714695901853302,0.7837630448127686
2661,23929,PFKM,610681,232800;,[MIM:232800]Glycogen storage disease 7;,Glycogen storage disease due to muscle phosphofructokinase deficiency,Disease-causing germline mutation(s) in,Hematocrit[27863252];Longevity (90 years and older)[25199915];Hemoglobin concentration[27863252];,0.7811042944785276,0.5443527591542032,0.07282693813625685,0.5488029465930019
2662,23932,PFN1,176610,614808;,[MIM:614808]Amyotrophic lateral sclerosis 18;,Amyotrophic lateral sclerosis,Disease-causing germline mutation(s) in,,0.9244171779141104,0.7545126353790613,0.38188462542417123,0.6803253529772867
2663,23964,PGAM2,612931,261670;,,Glycogen storage disease due to phosphoglycerate mutase deficiency,Disease-causing germline mutation(s) in,,0.4226993865030675,0.1704486848891181,0.3790133124510572,0.3867403314917127
2664,23971,PGAP1,611655,615802;,"[MIM:615802]Mental retardation, autosomal recessive 42 [recessive?];",Autosomal recessive spastic paraplegia type 67;Autosomal recessive non-syndromic intellectual disability,Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) (loss of function) in,Interferon alpha levels in systemic lupus erythematosus[25338677];,0.583558282208589,0.719185146982981,0.7366222918298094,0.6270718232044199
2665,23972,PGAP2,615187,614207;,,Hyperphosphatasia-intellectual disability syndrome,Disease-causing germline mutation(s) in,,0.35496932515337426,0.4551315110881898,0.0,0.5131982811540823
2666,23973,PGAP3,611801,615716;,,Hyperphosphatasia-intellectual disability syndrome,Disease-causing germline mutation(s) (loss of function) in,Menopause (age at onset)[26414677];Triglyceride levels[30108155];Asthma[29273806];,0.08736196319018405,0.4981949458483754,0.6880709997389716,0.6784837323511357
2667,24001,PGK1,311800,300653;,,Glycogen storage disease due to phosphoglycerate kinase 1 deficiency,Disease-causing germline mutation(s) in,,0.97079754601227,0.7983496647756576,0.8295484207778648,0.0
2668,24010,PGM1,171900,614921;,[MIM:614921]Congenital disorder of glycosylation 1T;,PGM1-CDG,Disease-causing germline mutation(s) in,Type 1 diabetes[19430480];Blood protein levels[29875488];Alcohol consumption (transferrin glycosylation)[21665994];,0.49570552147239266,0.10366168127900979,0.018533020099190813,0.15178023327194598
2669,24013,PGM3,172100,615816;,,PGM3-CDG,Disease-causing germline mutation(s) in,,0.6019631901840491,0.0,0.17593317671626207,0.1576120319214242
2670,24061,PHC1,602978,615414;,"[MIM:615414]Microcephaly 11, primary, autosomal recessive [recessive?];",Autosomal recessive primary microcephaly,Disease-causing germline mutation(s) in,"Total cholesterol levels[28334899];Small cell lung carcinoma[28604730];Cholesterol, total[24097068];",0.7084662576687116,0.9654461062403301,0.23048812320542938,0.44613259668508287
2671,24067,PHEX,300550,307800;,,X-linked hypophosphatemia,Disease-causing germline mutation(s) (loss of function) in,Anger[24489884];Immune reponse to smallpox (secreted IFN-alpha)[22610502];Phosphorus levels[29403010];F-cell distribution[21326311];Tourette syndrome[22889924];,0.08736196319018405,0.9767921609076844,0.8104933437744715,0.8609576427255985
2672,24081,PHF6,300414,301900;,[MIM:301900]Boerjeson-Forssman-Lehmann syndrome;,Borjeson-Forssman-Lehmann syndrome,Disease-causing germline mutation(s) (loss of function) in,,0.8706748466257669,0.944559051057246,0.9524928217175672,0.7251381215469613
2673,24083,PHF8,300560,300263;,"[MIM:300263]Mental retardation, X-linked, syndromic, Siderius type;","X-linked intellectual disability, Siderius type",Disease-causing germline mutation(s) in,Bipolar disorder and schizophrenia[21057379];,0.6517791411042945,0.6774110366168128,0.8240668232837379,0.488182934315531
2674,24093,PHF21A,608325,,,Potocki-Shaffer syndrome,Role in the phenotype of,Axial length[24144296];Height[29782485];Menarche (age at onset)[21102462;25231870];,0.8089570552147239,0.7998968540484785,0.18611328634821195,0.8804481276856968
2675,24097,PHGDH,606879,256520;601815;,[MIM:601815]Phosphoglycerate dehydrogenase deficiency [recessive?];[MIM:256520]Neu-Laxova syndrome 1 [recessive?];,"Neu-Laxova syndrome;3-phosphoglycerate dehydrogenase deficiency, infantile/juvenile form",Disease-causing germline mutation(s) (loss of function) in;Disease-causing germline mutation(s) in,Severe gingival inflammation[28459102];Multiple sclerosis[24076602];Alanine aminotransferase (ALT) levels after remission induction therapy in actute lymphoblastic leukemia (ALL)[28090653];Blood metabolite levels[24816252];Macular telangiectasia type 2[28250457];Metabolite levels[23378610];Height[25282103];Amino acid levels[26068415];Red blood cell count[27863252];Metabolic traits[21886157];,0.9666257668711656,0.28236204228984013,0.6729313495170973,0.7120933087783916
2676,24099,PHIP,612870,,,Kallmann syndrome;Normosmic congenital hypogonadotropic hypogonadism;Pituitary stalk interruption syndrome,Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Candidate gene tested in,Intelligence (MTAG)[29326435;29326435];Sjögren's syndrome[24097067];Diastolic blood pressure[27618448];Mean arterial pressure[27618448];,0.8328834355828221,1.0,0.1307752545027408,0.4062308164518109
2677,24100,PHKA1,311870,300559;,[MIM:300559]Glycogen storage disease 9D;,Glycogen storage disease due to muscle phosphorylase kinase deficiency,Disease-causing germline mutation(s) in,,0.7975460122699386,0.17586384734399174,0.2816496998172801,0.919122160834868
2678,24103,PHKA2,300798,306000;,[MIM:306000]Glycogen storage disease 9A;,Glycogen storage disease due to liver phosphorylase kinase deficiency,Disease-causing germline mutation(s) in,,0.7013496932515337,0.7313047962867457,0.5280605586008875,0.8796807857581338
2679,24105,PHKB,172490,261750;,[MIM:261750]Glycogen storage disease 9B;,Glycogen storage disease due to liver and muscle phosphorylase kinase deficiency,Disease-causing germline mutation(s) in,,0.5326380368098159,0.6554925219185147,0.29313495170973636,0.8720073664825047
2680,24108,PHKG1,172470,,,Glycogen storage disease due to muscle phosphorylase kinase deficiency,Candidate gene tested in,,0.23865030674846627,0.03996905621454358,0.690420255807883,0.048496009821976674
2681,24113,PHKG2,172471,613027;,[MIM:613027]Glycogen storage disease 9C;,Glycogen storage disease due to liver phosphorylase kinase deficiency,Disease-causing germline mutation(s) in,,0.5731288343558282,0.5108303249097473,0.7794309579744192,0.2104051565377532
2682,24124,PHOX2A,602753,602078;,"[MIM:602078]Fibrosis of extraocular muscles, congenital, 2;",Congenital fibrosis of extraocular muscles,Disease-causing germline mutation(s) in,,0.17791411042944785,0.7031975244971634,0.6027146959018533,0.0
2683,24125,PHOX2B,603851,209880;613013;,[MIM:613013]Neuroblastoma 2;,Neuroblastoma;Ondine syndrome;Hirschsprung disease-ganglioneuroblastoma syndrome;Haddad syndrome,Major susceptibility factor in;Disease-causing germline mutation(s) in;Major susceptibility factor in;Disease-causing germline mutation(s) in,Bone mineral density (femoral neck)[26911590];Hirschsprung disease[27702942];,0.038773006134969326,0.5884476534296029,0.8425998433829287,0.8888888888888888
2684,24130,PHYH,602026,266500;,,Refsum disease,Disease-causing germline mutation(s) in,,0.5069938650306749,0.19804022692109335,0.37770817019055075,0.7612031921424187
2685,24138,PI4KA,600286,616531;,,Bilateral perisylvian polymicrogyria,Disease-causing germline mutation(s) in,,0.8373006134969325,0.08741619391438886,0.5022187418428609,0.22851442602823818
2686,24149,PIBF1,607532,617767;,[MIM:617767]Joubert syndrome 33 [recessive?];,Joubert syndrome,Disease-causing germline mutation(s) in,"Blood pressure measurement (low sodium intervention)[24165912];Allergic disease (asthma, hay fever or eczema)[29083406];Mean corpuscular hemoglobin[27863252];",0.9391411042944785,0.09360495100567302,0.33463847559383975,0.05294659300184162
2687,24150,PICALM,603025,,,Precursor T-cell acute lymphoblastic leukemia,Part of a fusion gene in,"Alzheimer's disease in APOE e4+ carriers[25778476;25778476;25778476];Alzheimer's disease (late onset)[21460841;24162737];Alzheimer's disease in APOE e4- carriers[25778476];IgG response to Plasmodium falciparum antigens (GLURP, MSP2 FC27, MSP2 3D7)[26741287];Tourette syndrome[22889924];Alzheimer's disease[19734902;21627779;22832961];Platelet count[27863252];",0.9065030674846626,0.6665807117070655,0.7940485512920908,0.2687231430325353
2688,24152,PICK1,605926,,,Male infertility due to globozoospermia,Disease-causing germline mutation(s) in,Body fat percentage[26833246;26833246;26833246;26833246];,0.7082208588957055,0.7091284167096441,0.9068128425998434,0.44505831798649476
2689,24156,PIEZO1,611184,194380;616843;,"[MIM:194380]Dehydrated hereditary stomatocytosis 1 with or without pseudohyperkalemia and/or perinatal edema [dominant?];[MIM:616843]Lymphedema, hereditary, 3;",Dehydrated hereditary stomatocytosis,Disease-causing germline mutation(s) (gain of function) in,Mean corpuscular hemoglobin concentration[27863252;27863252;27863252;28453575;29403010];Joint mobility (Beighton score)[27182965];High light scatter reticulocyte percentage of red cells[27863252];Mean corpuscular volume[27863252;27863252;29403010];Reticulocyte count[27863252;27863252];High light scatter reticulocyte count[27863252;27863252];Red blood cell count[27863252];Hemoglobin A1c levels[29403010];Hemoglobin concentration[27863252];Diverticular disease[30177863];Reticulocyte fraction of red cells[27863252];Red blood cell traits[23222517];Hair color[26926045];Platelet count[27863252];,0.7159509202453987,0.6193914388860238,0.011746280344557557,0.0
2690,24159,PIEZO2,613629,108145;114300;248700;617146;,"[MIM:108145]Arthrogryposis, distal, 5;[MIM:114300]Arthrogryposis, distal, 3;[MIM:248700]Marden-Walker syndrome;[MIM:617146]Arthrogryposis, distal, with impaired proprioception and touch [recessive?];",Arthrogryposis-oculomotor limitation-electroretinal anomalies syndrome;Gordon syndrome;Marden-Walker syndrome,Disease-causing germline mutation(s) (gain of function) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in,Post bronchodilator FEV1 in COPD[26634245;26634245];Metabolite levels (5-HIAA/ MHPG Ratio)[23319000];Yu-Zhi constitution type in type 2 diabetes[26169365];,0.038773006134969326,0.8638473439917483,0.012790394152962672,0.0
2691,24162,PIGA,311770,300818;300868;,[MIM:300818]Paroxysmal nocturnal hemoglobinuria 1;[MIM:300868]Multiple congenital anomalies-hypotonia-seizures syndrome 2;,Paroxysmal nocturnal hemoglobinuria;West syndrome;Multiple congenital anomalies-hypotonia-seizures syndrome type 2;Ferro-cerebro-cutaneous syndrome,Disease-causing somatic mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in,,0.4154601226993865,0.8463125322331099,0.6893761419994779,0.0
2692,24166,PIGC,601730,617816;,[MIM:617816]Glycosylphosphatidylinositol biosynthesis defect 16 [recessive?];,Autosomal recessive non-syndromic intellectual disability,Disease-causing germline mutation(s) in,Waist-to-hip ratio adjusted for BMI (adjusted for smoking behaviour)[28443625;28443625];Waist-to-hip ratio adjusted for BMI (joint analysis main effects and smoking interaction)[28443625;28443625];Waist-to-hip ratio adjusted for BMI in active individuals[28448500;28448500;28448500;28448500;28448500];Waist-to-hip ratio adjusted for BMI (joint analysis for main effect and physical activity interaction)[28448500;28448500;28448500;28448500];Daytime sleep phenotypes[27126917];Waist-hip ratio[20935629;25673412;25673412];Waist-to-hip ratio adjusted for body mass index[28448500;28448500;28448500;25673412;25673412;25673412;25673412;25673412;25673412;28448500];,0.2947239263803681,0.41774110366168127,0.06656225528582616,0.0678330263965623
2693,24173,PIGG,616918,616917;,"[MIM:616917]Mental retardation, autosomal recessive 53 [recessive?];",Early-onset epilepsy-intellectual disability-brain anomalies syndrome,Disease-causing germline mutation(s) (loss of function) in,,0.19190184049079756,0.24858174316658072,0.06682328373792744,0.11525475751995089
2694,24177,PIGL,605947,280000;,"[MIM:280000]Coloboma, congenital heart disease, ichthyosiform dermatosis, mental retardation and ear anomalies syndrome [recessive?];",Hyperphosphatasia-intellectual disability syndrome;CHIME syndrome,Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in,Granulocyte percentage of myeloid white cells[27863252];Lymphocyte percentage of white cells[27863252];White blood cell count[27863252];Neutrophil percentage of white cells[27863252];Myeloid white cell count[27863252];Amyotrophic lateral sclerosis[22959728];Sum basophil neutrophil counts[27863252];Sum neutrophil eosinophil counts[27863252];Monocyte percentage of white cells[27863252];Granulocyte count[27863252];Neutrophil count[27863252];,0.038773006134969326,0.18437338834450748,0.7916992952231793,0.3147636586863106
2695,24178,PIGM,610273,610293;,[MIM:610293]Glycosylphosphatidylinositol deficiency;,Hypercoagulability syndrome due to glycosylphosphatidylinositol deficiency,Disease-causing germline mutation(s) in,,0.2498159509202454,0.2630221763795771,0.3163664839467502,0.2343462246777164
2696,24179,PIGN,606097,614080;,[MIM:614080]Multiple congenital anomalies-hypotonia-seizures syndrome 1 [recessive?];,Fryns syndrome;Multiple congenital anomalies-hypotonia-seizures syndrome,Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in,,0.22687116564417178,0.33496647756575554,0.4111198120595145,0.0
2697,24180,PIGO,614730,614749;,[MIM:614749]Hyperphosphatasia with mental retardation syndrome 2 [recessive?];,Hyperphosphatasia-intellectual disability syndrome,Disease-causing germline mutation(s) in,Response to quetiapine in schizophrenia[29503163];,0.27975460122699386,0.09721505930892213,0.6225528582615505,0.24754450583179866
2698,24181,PIGP,605938,617599;,,Early infantile epileptic encephalopathy,Disease-causing germline mutation(s) in,,0.26588957055214724,0.3695203713254255,0.2688593056643174,0.05294659300184162
2699,24186,PIGQ,605754,,,Early infantile epileptic encephalopathy,Disease-causing germline mutation(s) (loss of function) in,Mean corpuscular hemoglobin concentration[27863252;27863252];Reticulocyte fraction of red cells[27863252];Reticulocyte count[27863252];Disc degeneration (lumbar)[22993228];,0.35496932515337426,0.6072717895822589,0.6021926389976507,0.13182934315531
2700,24190,PIGT,610272,615398;615399;,[MIM:615398]Multiple congenital anomalies-hypotonia-seizures syndrome 3 [recessive?];[MIM:615399]Paroxysmal nocturnal hemoglobinuria 2;,Intellectual disability-seizures-hypophosphatasia-ophthalmic-skeletal anomalies syndrome,Disease-causing germline mutation(s) in,,0.8574233128834355,0.3156266116554925,0.38031845471156356,0.05294659300184162
2701,24193,PIGV,610274,239300;,[MIM:239300]Hyperphosphatasia with mental retardation syndrome 1;,Hyperphosphatasia-intellectual disability syndrome,Disease-causing germline mutation(s) in,HDL cholesterol levels[28334899];Alanine aminotransferase (ALT) levels after remission induction therapy in actute lymphoblastic leukemia (ALL)[28090653];Triglyceride levels[28334899];Sum basophil neutrophil counts[27863252];Triglycerides[24097068];LDL cholesterol levels[28334899];LDL cholesterol[24097068;25961943];Neutrophil count[27863252];HDL cholesterol[24097068;25961943];,0.038773006134969326,0.298091799896854,0.7494126859827721,0.5821055862492327
2702,24194,PIGW,610275,616025;,[MIM:616025]Glycosylphosphatidylinositol biosynthesis defect 11 [recessive?];,Hyperphosphatasia-intellectual disability syndrome;Hypercoagulability syndrome due to glycosylphosphatidylinositol deficiency,Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in,Body mass index[26426971];,0.19190184049079756,0.2637957710159876,0.3946750195771339,0.5434315531000614
2703,24196,PIGY,610662,616809;,[MIM:616809]Hyperphosphatasia with mental retardation syndrome 6 [recessive?];,Hyperphosphatasia-intellectual disability syndrome,Disease-causing germline mutation(s) (loss of function) in,Waist-to-hip ratio adjusted for BMI (age <50)[26426971];Bipolar disorder[22925353];Waist-to-hip ratio adjusted for BMI[26426971];Waist-to-hip ratio adjusted for BMI x sex x age interaction (4df test)[26426971];,0.19190184049079756,0.5626611655492522,0.8987209605847037,0.0
2704,24201,PIH1D3,300933,300991;,,Primary ciliary dyskinesia,Disease-causing germline mutation(s) (loss of function) in,Alcoholic chronic pancreatitis[28754779;28754779];,0.27361963190184047,0.8398659102630222,0.9600626468285043,0.0
2705,24207,PIK3CA,171834,114480;114500;114550;167000;182000;602501;612918;615108;,"[MIM:114500]Colorectal cancer;[MIM:114480]Breast cancer;[MIM:167000]Ovarian cancer;[MIM:114550]Hepatocellular carcinoma;[MIM:182000]Keratosis, seborrheic;[MIM:602501]Megalencephaly-capillary malformation-polymicrogyria syndrome;[MIM:612918]Congenital lipomatous overgrowth, vascular malformations, and epidermal nevi;[MIM:615108]Cowden syndrome 5;","Cowden syndrome;CLOVES syndrome;Hemihyperplasia-multiple lipomatosis syndrome;Lynch syndrome;Adult hepatocellular carcinoma;Segmental progressive overgrowth syndrome with fibroadipose hyperplasia;Macrodactyly of fingers, unilateral;Macrodactyly of toes, unilateral;Megalencephaly-capillary malformation-polymicrogyria syndrome;Hemimegalencephaly",Disease-causing germline mutation(s) (gain of function) in;Disease-causing somatic mutation(s) in;Disease-causing somatic mutation(s) in;Biomarker tested in;Disease-causing somatic mutation(s) in;Disease-causing somatic mutation(s) in;Disease-causing somatic mutation(s) in;Disease-causing somatic mutation(s) in;Disease-causing somatic mutation(s) in;Disease-causing somatic mutation(s) in,Mean corpuscular hemoglobin[29403010];,0.7131288343558282,0.6900464156781846,0.4012007308796659,0.5725905463474524
2706,24209,PIK3CD,602839,615513;,[MIM:615513]Activated PI3K-delta syndrome;,Combined immunodeficiency with faciooculoskeletal anomalies;Activated PI3K-delta syndrome,Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) (gain of function) in,Diisocyanate-induced asthma[25918132];Irritable bowel syndrome[29626450];Monocyte count[27863252];Testicular germ cell tumor[28604728];,0.4,0.8268437338834451,0.4656747585486818,0.6708103130755064
2707,24216,PIK3R1,171833,269880;615214;616005;,"[MIM:615214]Agammaglobulinemia 7, autosomal recessive [recessive?];[MIM:269880]SHORT syndrome;[MIM:616005]Immunodeficiency 36;",SHORT syndrome;Activated PI3K-delta syndrome;Autosomal agammaglobulinemia,Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) (gain of function) in;Disease-causing germline mutation(s) in,Hip minimal joint space width[27701424];Rosacea symptom severity[29771307];Bone mineral density (hip)[26911590];Cleft lip with or without cleft palate[28054174];Intelligence (MTAG)[29326435];Mean corpuscular volume[27863252];Mean corpuscular hemoglobin[27863252];Alzheimer's disease biomarkers[23419831];Menarche (age at onset)[23599027];Red cell distribution width[27863252];Glomerular filtration rate (creatinine)[26831199;28452372];,0.9538650306748466,0.9004641567818463,0.16262072565909685,0.5448127685696746
2708,24217,PIK3R2,603157,603387;,[MIM:603387]Megalencephaly-polymicrogyria-polydactyly-hydrocephalus syndrome 1;,Megalencephaly-polymicrogyria-postaxial polydactyly-hydrocephalus syndrome;Megalencephaly-polymicrogyria-postaxial polydactyly-hydrocephalus syndrome,Disease-causing germline mutation(s) in;Disease-causing somatic mutation(s) in,,0.7677300613496932,0.4559051057246003,0.5077003393369878,0.0
2709,24220,PIK3R5,611317,615217;,[MIM:615217]Ataxia-oculomotor apraxia 3 [recessive?];,Spinocerebellar ataxia with axonal neuropathy type 2,Disease-causing germline mutation(s) in,,0.17791411042944785,0.6946879834966477,0.5499869485773949,0.6166359729895642
2710,24222,PIKFYVE,609414,121850;,"[MIM:121850]Corneal dystrophy, fleck;",Fleck corneal dystrophy,Disease-causing germline mutation(s) (loss of function) in,Adult asthma[27611488];Post bronchodilator FEV1[26634245];,0.776441717791411,0.40974729241877256,0.4186896371704516,0.4909453652547575
2711,24234,PINK1,608309,168600;605909;,[MIM:605909]Parkinson disease 6 [recessive?];,Young-onset Parkinson disease,Disease-causing germline mutation(s) in,Itch intensity from mosquito bite adjusted by bite size[28199695];Paclitaxel disposition in epithelial ovarian cancer[29367611];,0.4936196319018405,0.10134089736977824,0.1096319498825372,0.16313689379987723
2712,24239,PIP4K2A,603140,,,Precursor B-cell acute lymphoblastic leukemia,Major susceptibility factor in,Acute lymphoblastic leukemia in childhood (B cell precursor)[29632299];Severe influenza A (H1N1) infection[26379185];Obesity-related traits[23251661];Acute lymphoblastic leukemia (childhood)[29348612];Acute lymphoblastic leukemia (B-cell precursor)[23996088];,0.8613496932515338,0.7601856627127386,0.20099190811798487,0.5391344383057091
2713,24246,PIP5K1C,606102,611369;,[MIM:611369]Lethal congenital contracture syndrome 3 [recessive?];,Lethal congenital contracture syndrome type 3,Disease-causing germline mutation(s) in,,0.36171779141104293,0.9009798865394534,0.3422083007047768,0.5713627992633518
2714,24378,PITPNM3,608921,600977;,,Cone rod dystrophy,Disease-causing germline mutation(s) in,Response to fenofibrate (HDL cholesterol levels)[27002377];,0.5450306748466258,0.7993811242908716,0.2725137039937353,0.8569674647022714
2715,24381,PITX1,602149,119800;186550;,"[MIM:119800]Clubfoot, congenital, with or without deficiency of long bones and/or mirror-image polydactyly;[MIM:186550]Liebenberg syndrome;",Brachydactyly-elbow wrist dysplasia syndrome;Familial clubfoot due to PITX1 point mutation;Familial clubfoot due to 5q31 microdeletion;Mirror-image polydactyly,Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Role in the phenotype of;Role in the phenotype of,Colorectal cancer[24836286;23263487;23263487];Immune response to anthrax vaccine[22658931];Height[23563607;20881960;18391951;25429064];Testicular germ cell tumor[23666240;28604732];Bulimia nervosa[23568457];,0.5009815950920246,0.6382155750386798,0.09945184025058731,0.7837630448127686
2716,24382,PITX2,601542,137600;180500;180550;,[MIM:180500]Axenfeld-Rieger syndrome 1 [dominant?];[MIM:137600]Anterior segment dysgenesis 4 [dominant?];[MIM:180550]Ring dermoid of cornea;,Peters anomaly;Axenfeld-Rieger syndrome;Axenfeld-Rieger syndrome;Familial atrial fibrillation;Ring dermoid of cornea;Rieger anomaly;Axenfeld anomaly,Candidate gene tested in;Disease-causing germline mutation(s) (loss of function) in;Disease-causing germline mutation(s) (gain of function) in;Disease-causing germline mutation(s) (loss of function) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in,Early onset atrial fibrillation[28460022];Stroke[29531354;29531354];Atrial fibrillation/atrial flutter[17603472;17603472];Prevalent atrial fibrillation[28416818];Ischemic stroke (cardioembolic)[26708676;27068588;29531354;29531354];Atrial fibrillation[19597492;22544366;20173747;28416822;28416822;28416822;29290336;28416818;28416818;28416818;28416818;28416818;30061737;29892015;29892015;29892015;29892015;29892015;29892015;29892015;29892015;29892015;29892015;29892015;30061737;30061737;30061737;30061737;30061737;30061737;30061737;30061737;30061737];Cognitive decline rate in late mild cognitive impairment[26252872;26252872];Lung cancer[28604730];Stroke (ischemic)[23041239;23041239];Ischemic stroke[26708676;24262325;29531354;29531354];Incident atrial fibrillation[28416818];Intraocular pressure[29235454];,0.5930061349693252,0.8238782877772047,0.8937614199947794,0.8357888275015347
2717,24383,PITX3,602669,107250;610623;,"[MIM:610623]Cataract 11, multiple types;",Cataract-glaucoma syndrome;Anterior segment developmental anomaly;Early-onset posterior polar cataract,Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in,Waist-to-hip ratio adjusted for BMI (age >50)[26426971];Intelligence (MTAG)[29326435];Atrial fibrillation[29892015];Cognitive ability[29186694];Cognitive ability (MTAG)[29186694];Waist-to-hip ratio adjusted for BMI[26426971];General cognitive ability[29844566];Waist-to-hip ratio adjusted for BMI x sex x age interaction (4df test)[26426971];,0.14576687116564419,0.8385765858690046,0.9150352388410337,0.0
2718,24390,PJVK,610219,610220;,,Autosomal recessive non-syndromic sensorineural deafness type DFNB,Disease-causing germline mutation(s) in,Rapid functional decline in sporadic amyotrophic lateral sclerosis[26746183];,0.038773006134969326,0.19365652398143374,0.0,0.0
2719,24391,PKD1,601313,173900;,[MIM:173900]Polycystic kidney disease 1 with or without polycystic liver disease [dominant?];,Autosomal dominant polycystic kidney disease;Autosomal dominant polycystic kidney disease type 1 with tuberous sclerosis,Disease-causing germline mutation(s) in;Role in the phenotype of,Major depressive disorder[29317602];,0.4431901840490797,0.910005157297576,0.10232315322370138,0.0
2720,24392,PKD1L1,609721,617205;,,Situs ambiguus;Situs inversus totalis,Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in,Hepatitis C induced liver fibrosis[22841784];Obstructive sleep apnea during REM sleep (apnea hypopnea index)[29077507];Anxiety disorder[25390645];Diastolic blood pressure response to hydrochlorothiazide in hypertension[27802415];,0.038773006134969326,0.6699329551315111,0.08927173061863743,0.0659914057704113
2721,24401,PKD2,173910,613095;,[MIM:613095]Polycystic kidney disease 2 with or without polycystic liver disease [dominant?];,Autosomal dominant polycystic kidney disease,Disease-causing germline mutation(s) in,Dental caries[23064961];Hyperuricemia[28776340];Uric acid levels[29558500];Coffee consumption (cups per day)[25288136];Serum uric acid levels in response to allopurinol in gout[25676789;25676789];,0.43153374233128833,0.556988138215575,0.1855912294440094,0.47375690607734805
2722,24407,PKHD1,606702,263200;,,Autosomal recessive polycystic kidney disease;Caroli disease,Disease-causing germline mutation(s) (loss of function) in;Disease-causing germline mutation(s) in,Response to fenofibrate (triglyceride levels)[27002377];Glaucoma[30054594];Glaucoma (primary open-angle)[29891935];Waist circumference[19557197];Diastolic blood pressure[28135244];Post bronchodilator FEV1/FVC ratio[26634245;26634245;26634245];Weight loss (gastric bypass surgery)[23633212;23633212];Prostate cancer[17903305];Intraocular pressure[24002674;29617998;29617998;29235454;30054594;29785010];,0.10711656441717791,0.0036101083032490976,0.07674236491777604,0.9748311847759361
2723,24413,PKLR,609712,102900;266200;,[MIM:102900]Pyruvate kinase hyperactivity;[MIM:266200]Pyruvate kinase deficiency of red cells;,Hemolytic anemia due to red cell pyruvate kinase deficiency,Disease-causing germline mutation(s) in,Liver enzyme levels (gamma-glutamyl transferase)[22001757];Inflammatory bowel disease[28067908];Urate levels[23263486];High light scatter reticulocyte percentage of red cells[27863252;27863252];Reticulocyte fraction of red cells[27863252;27863252];Reticulocyte count[27863252;27863252];High light scatter reticulocyte count[27863252;27863252];Crohn's disease[28067908];Major depressive disorder[29317602];,0.47705521472392637,0.20242392986075297,0.6818063168885409,0.8649478207489257
2724,24428,PKP1,601975,604536;,,Epidermolysis bullosa simplex due to plakophilin deficiency,Disease-causing germline mutation(s) (loss of function) in,Panic disorder[19165232];,0.5261349693251534,0.5090252707581228,0.2746019316105455,0.41006752608962554
2725,24429,PKP2,602861,609040;,,"Familial isolated arrhythmogenic ventricular dysplasia, right dominant form;Familial isolated arrhythmogenic ventricular dysplasia, biventricular form;Familial isolated arrhythmogenic ventricular dysplasia, left dominant form;Brugada syndrome;Left ventricular noncompaction",Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Candidate gene tested in;Disease-causing germline mutation(s) in,Prevalent atrial fibrillation[28416818];Methadone dose in opioid dependence[28115739];Parkinson's disease[27182965];Body mass index (change over time) in lung cancer[28044437];Atrial fibrillation[30061737;29892015;29892015];Periodontal disease-related phenotypes[26962152];Obesity-related traits[23251661;23251661;23251661];Blood protein levels[30072576];,0.8759509202453988,0.05415162454873646,0.2618115374575829,0.4438305709023941
2726,24443,PLA2G4A,600522,,,Cryptogenic multifocal ulcerous stenosing enteritis;Cytosolic phospholipase-A2 alpha deficiency associated bleeding disorder,Disease-causing germline mutation(s) (loss of function) in;Disease-causing germline mutation(s) in,Zinc levels[26025379];Inflammatory bowel disease[26192919];Knee osteoarthritis[18471798];Crohn's disease[26192919];Epilepsy (generalized)[22949513];,0.4431901840490797,0.3151108818978855,0.6849386583137562,0.2527624309392265
2727,24451,PLA2G5,601192,228980;,"[MIM:228980]Fleck retina, familial benign [recessive?];",Familial benign flecked retina,Disease-causing germline mutation(s) in,Blood protein levels[28240269];,0.038773006134969326,0.25786487880350695,0.8483424693291569,0.2918968692449355
2728,24452,PLA2G6,603604,256600;610217;612953;,[MIM:256600]Neurodegeneration with brain iron accumulation 2A;[MIM:612953]Parkinson disease 14;,Adult-onset dystonia-parkinsonism;Infantile neuroaxonal dystrophy,Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in,Body fat percentage[26833246;26833246;26833246;26833246];Mammographic density (dense area)[25342443];Cutaneous nevi[19578365;21478494];C-reactive protein levels or triglyceride levels (pleiotropy)[27286809];Melanoma[21983787;28212542];Percent mammographic density[25342443];Triglyceride levels[28334899;28334899];Triglycerides[20686565;24097068];Breast cancer[29059683];,0.5719018404907975,0.646982980917999,0.5742625946228139,0.12231430325352978
2729,24462,PLAA,603873,617527;,"[MIM:617527]Neurodevelopmental disorder with progressive microcephaly, spasticity, and brain anomalies [recessive?];",PLAA-associated neurodevelopmental disorder,Disease-causing germline mutation(s) (loss of function) in,Schizophrenia[20185149];,0.5911656441717792,0.8481175863847344,0.7431480031323414,0.3867403314917127
2730,24469,PLAG1,603026,181030;,,Pleomorphic salivary gland adenoma,Part of a fusion gene in,Hip circumference adjusted for BMI[25673412;25673412];Height[19343178;19396169;19893584;20189936;18391951;25429064;25282103];,0.5900613496932515,0.9334708612686952,0.350822239624119,0.7862185389809699
2731,24470,PLAGL1,603044,601410;,[MIM:601410]Transient neonatal diabetes mellitus 1;,Paternal uniparental disomy of chromosome 6;Transient neonatal diabetes mellitus,Role in the phenotype of;Disease-causing germline mutation(s) in,Eosinophil percentage of granulocytes[27863252];Granulocyte percentage of myeloid white cells[27863252];Neutrophil percentage of white cells[27863252];Monocyte count[27863252];Post bronchodilator FEV1/FVC ratio[26634245;26634245;26634245];Monocyte percentage of white cells[27863252];Anti-saccade response[29064472];Neutrophil percentage of granulocytes[27863252];Peanut allergy (maternal genetic effects)[29489655];,0.2498159509202454,0.9125838060856112,0.6807622030801357,0.5857888275015347
2732,24472,PLAT,173370,,,Lethal hydranencephaly-diaphragmatic hernia syndrome,Disease-causing germline mutation(s) in,Systemic lupus erythematosus[28714469];Plasma plasminogen activator levels[24578379];Blood protein levels[30072576];,0.4226993865030675,0.4556472408457968,0.5627773427303576,0.7763965623081646
2733,24473,PLAU,191840,601709;,[MIM:601709]Quebec platelet disorder [dominant?];,Quebec platelet disorder,Disease-causing germline mutation(s) in,"Chronic inflammatory diseases (ankylosing spondylitis, Crohn's disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy)[26974007];Crohn's disease[28067908];Blood protein levels[29875488;30072576;30072576];",0.5170552147239263,0.8174316658071171,0.594883842338815,0.5943830570902394
2734,24479,PLCB1,607120,613722;,"[MIM:613722]Epileptic encephalopathy, early infantile, 12;",West syndrome;Malignant migrating partial seizures of infancy,Disease-causing germline mutation(s) (loss of function) in;Disease-causing germline mutation(s) in,Diastolic blood pressure[28135244];Lymphocyte counts[27863252];Response to irinotecan in non-small-cell lung cancer[22664479];Colorectal cancer[23263487;23263487];Platelet distribution width[27863252];Plateletcrit[27863252];Chronic kidney disease[26420894];Social communication problems[24564958];Daytime sleep phenotypes[27126917];Cognitive performance[20125193;19734545];White blood cell count[27863252];Suicide ideation score in major depressive disorder[26079190];Obstructive sleep apnea trait (average respiratory event duration)[26977737];Monocyte count[27863252];Platelet count[27863252];,0.6444171779141105,0.5812274368231047,0.5040459410075698,0.2960405156537753
2735,24484,PLCB4,600810,614669;,,Auriculocondylar syndrome,Disease-causing germline mutation(s) in,Initial pursuit acceleration in psychotic disorders[29064472];Initial pursuit acceleration[29064472];Daytime sleep phenotypes[27126917];Neutrophil count[20172861];,0.31079754601226994,0.6041774110366168,0.0548159749412686,0.23081645181092694
2736,24485,PLCD1,602142,151600;,"[MIM:151600]Nail disorder, non-syndromic congenital, 3;",Leukonychia totalis,Disease-causing germline mutation(s) in,,0.30319018404907977,0.03532748839608046,0.2631166797180893,0.09223449969306323
2737,24488,PLCE1,608414,610725;,[MIM:610725]Nephrotic syndrome 3;,Sporadic idiopathic steroid-resistant nephrotic syndrome with diffuse mesangial sclerosis;Familial idiopathic steroid-resistant nephrotic syndrome with diffuse mesangial sclerosis;Familial idiopathic steroid-resistant nephrotic syndrome with focal segmental hyalinosis,Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in,Systolic blood pressure[21909115;27618452;28739976];Hypertension[21909115];Sudden cardiac arrest[21658281];Esophageal cancer and gastric cancer[20729852;20729852];Glucose homeostasis traits[25524916;25524916];Diastolic blood pressure[21909115;27618452];Migraine[27322543;27322543;27182965];Waist-to-hip ratio adjusted for BMI (joint analysis for main effect and physical activity interaction)[28448500;28448500];Plateletcrit[27863252];Vertical cup-disc ratio[25241763];Coronary artery disease[29212778];Personality traits in bipolar disorder[21368711];Glaucoma (primary open-angle)[29891935];Pulse pressure[28739976];Esophageal squamous cell carcinoma[25129146];Lifetime average cigarettes per day in chronic obstructive pulmonary disease[21685187];Dengue shock syndrome[22001756];Esophageal cancer[21642993];Waist-to-hip ratio adjusted for body mass index[28448500;28448500;28448500];,0.4894478527607362,0.11346054667354306,0.007308796658835813,0.15239410681399632
2738,24494,PLCG2,600220,614468;614878;,"[MIM:614468]Familial cold autoinflammatory syndrome 3 [dominant?];[MIM:614878]Autoinflammation, antibody deficiency, and immune dysregulation PLCG2-associated [dominant?];",Autoinflammation-PLCG2-associated antibody deficiency-immune dysregulation;PLCG2-associated antibody deficiency and immune dysregulation,Disease-causing germline mutation(s) (gain of function) in;Disease-causing germline mutation(s) (gain of function) in,Inflammatory bowel disease[28067908];Waist-to-hip ratio adjusted for BMI (age >50)[26426971];Mean platelet volume[27863252];Alzheimer's disease (late onset)[28714976];Breast cancer (menopausal hormone therapy interaction)[24080446];Platelet distribution width[27863252];Upper eyelid morphology[29921221];Blood protein levels[30072576];Coronary artery disease[29212778;29212778;29212778];Ulcerative colitis[28067908];Waist-to-hip ratio adjusted for BMI x sex x age interaction (4df test)[26426971];,0.5370552147239264,0.7854564208354822,0.32106499608457323,0.6238489871086557
2739,24513,PLEC,601282,131950;226670;612138;613723;616487;,"[MIM:612138]Epidermolysis bullosa simplex with pyloric atresia;[MIM:226670]Epidermolysis bullosa simplex, with muscular dystrophy;[MIM:131950]Epidermolysis bullosa simplex, Ogna type;[MIM:613723]Limb-girdle muscular dystrophy 2Q;[MIM:616487]Epidermolysis bullosa simplex with nail dystrophy;","Epidermolysis bullosa simplex with pyloric atresia;Autosomal recessive limb-girdle muscular dystrophy type 2Q;Epidermolysis bullosa simplex with muscular dystrophy;Epidermolysis bullosa simplex, Ogna type",Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in,Mean platelet volume[27863252];Resting heart rate[27798624];Knee osteoarthritis[28916551];Mosquito bite size[28199695];Platelet distribution width[27863252];Plateletcrit[27863252];Fibrinogen levels[26561523;28107422];Anti-saccade response[29064472];Platelet count[27863252];Post bronchodilator FEV1[26634245;26634245;26634245;26634245;26634245;26634245;26634245;26634245;26634245;26634245;26634245;26634245;26634245];,0.9126380368098159,0.6964930376482723,0.003915426781519186,0.968999386126458
2740,24534,PLEKHG4,609526,,,Spinocerebellar ataxia type 4,Candidate gene tested in,Heel bone mineral density[28869591;28869591;28869591];Blood protein levels[28240269;29875488];,0.5430674846625767,0.315884476534296,0.031062385800052206,0.05632289748311848
2741,24536,PLEKHG5,611101,611067;615376;,"[MIM:615376]Charcot-Marie-Tooth disease, recessive, intermediate type, C;",Autosomal recessive lower motor neuron disease with childhood onset;Autosomal recessive intermediate Charcot-Marie-Tooth disease type C,Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in,QT interval[19305408];Multiple sclerosis[24076602];,0.27361963190184047,0.25683341928829295,0.1195510310623858,0.15178023327194598
2742,24543,PLEKHM1,611466,611497;,"[MIM:611497]Osteopetrosis, autosomal recessive 6 [dominant?] [recessive?];",Intermediate osteopetrosis,Disease-causing germline mutation(s) in,Remission after SSRI treatment in MDD or neuroticism[29559929];Neuroticism[29255261];Male-pattern baldness[29146897;29146897;29146897];Parkinson's disease[20070850];Epithelial ovarian cancer[25581431];Cognitive function[28093568];,0.21484662576687116,0.833677153171738,0.6596188984599322,0.35543278084714547
2743,24545,PLEKHM2,609613,,,Left ventricular noncompaction,Major susceptibility factor in,Alcoholic chronic pancreatitis[28754779;28754779;28754779];,0.19190184049079756,0.24832387828777722,0.1132863482119551,0.4020871700429711
2744,24552,PLG,173350,217090;,[MIM:217090]Plasminogen deficiency;,Hypoplasminogenemia;Ligneous conjunctivitis,Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in,"Myocardial infarction[26343387];Lipoprotein (a) levels[26377243];Cognitive decline rate in late mild cognitive impairment[26252872;26252872];Plasma plasminogen levels[25208887];Blood protein levels[28240269;29875488;29875488;29875488;30072576;30072576];Coronary artery disease[26343387];Childhood ear infection[27182965;28928442];Body mass index[26426971];Body mass index x sex x age interaction (4df test)[26426971];Aging[22773346];Body mass index (age>50)[26426971];Giant cell arteritis[28041642];Lp (a) levels[21900290];Coronary artery disease (myocardial infarction, percutaneous transluminal coronary angioplasty, coronary artery bypass grafting, angina or chromic ischemic heart disease)[28714975];",0.538282208588957,0.2619907168643631,0.4385277995301488,0.6368937998772253
2745,24557,PLIN1,170290,613877;,"[MIM:613877]Lipodystrophy, familial partial, 4;",PLIN1-related familial partial lipodystrophy,Disease-causing germline mutation(s) in,Amyotrophic lateral sclerosis (sporadic)[24529757];,0.14576687116564419,0.16116554925219184,0.42547637692508483,0.11295273173726213
2746,24565,PLK4,605031,616171;,"[MIM:616171]Microcephaly and chorioretinopathy, autosomal recessive, 2 [recessive?];",Seckel syndrome;Autosomal recessive chorioretinopathy-microcephaly syndrome,Disease-causing germline mutation(s) (loss of function) in;Disease-causing germline mutation(s) in,,0.8692024539877301,0.20887055183084063,0.6590968415557296,0.13014119091467158
2747,24568,PLN,172405,609909;613874;,"[MIM:609909]Cardiomyopathy, dilated 1P;[MIM:613874]Cardiomyopathy, familial hypertrophic 18;",Familial isolated dilated cardiomyopathy,Disease-causing germline mutation(s) in,QT interval[19305408;19305409;19305409;19587794;23166209;24952745;24952745;24952745;24952745;24952745];QRS complex (Sokolow-Lyon)[27659466];Resting heart rate[27798624];Atrial fibrillation[28416818;30061737];QRS duration[27577874;27577874;27659466];Cardiac structure and function[19584346];,0.40773006134969325,0.7086126869520372,0.9911250326285566,0.23373235113566607
2748,24569,PLOD1,153454,225400;,"[MIM:225400]Ehlers-Danlos syndrome, kyphoscoliotic type, 1 [recessive?];","Ehlers-Danlos syndrome, kyphoscoliotic type",Disease-causing germline mutation(s) in,Moyamoya disease[29273593];Tuberculosis[29036319];Plateletcrit[27863252];Diastolic blood pressure x alcohol consumption interaction (2df test)[29912962];Platelet count[27863252];,0.7958282208588957,0.47937080969571944,0.0858783607413208,0.46193984039287905
2749,24570,PLOD2,601865,609220;,,Bruck syndrome,Disease-causing germline mutation(s) (loss of function) in,Zinc levels[26025379];Squamous cell lung carcinoma[28604730];Obesity-related traits[23251661];,0.6817177914110429,0.20912841670964413,0.5907073871051944,0.6689686924493554
2750,24571,PLOD3,603066,612394;,[MIM:612394]Lysyl hydroxylase 3 deficiency;,Connective tissue disorder due to lysyl hydroxylase-3 deficiency,Disease-causing germline mutation(s) in,Blood protein levels[30072576];,0.7829447852760736,0.7503867973182052,0.34977812581571394,0.6011356660527931
2751,24572,PLP1,300401,312080;312920;,"[MIM:312080]Leukodystrophy, hypomyelinating, 1;[MIM:312920]Spastic paraplegia 2, X-linked;","Pelizaeus-Merzbacher disease, connatal form;Pelizaeus-Merzbacher disease, classic form;Null syndrome;Pelizaeus-Merzbacher disease, transitional form;Pelizaeus-Merzbacher disease in female carriers;Spastic paraplegia type 2",Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in,,0.538282208588957,0.7720474471376998,0.9678935003915426,0.0
2752,24574,PLPBP,604436,617290;,"[MIM:617290]Epilepsy, early-onset, vitamin B6-dependent [recessive?];",Pyridoxine-dependent epilepsy,Disease-causing germline mutation(s) in,Axial length[24144296];,0.6058895705521472,0.3888602372356885,0.0,0.0
2753,24580,PLPP6,611666,,,Pyruvate dehydrogenase phosphatase deficiency,Disease-causing germline mutation(s) (loss of function) in,,0.2498159509202454,0.3285198555956679,0.0,0.0
2754,24590,PLS3,300131,166710;300910;,[MIM:166710]Osteoporosis;,X-linked osteoporosis with fractures,Disease-causing germline mutation(s) (loss of function) in,Gestational age at birth (maternal effect)[28877031];Preterm birth (maternal effect)[28877031];,0.8961963190184049,0.8826714801444043,0.8898459932132603,0.9126764886433395
2755,24600,PLVAP,607647,,,Congenital chronic diarrhea with protein-losing enteropathy,Disease-causing germline mutation(s) (loss of function) in,,0.20368098159509201,0.3071170706549768,0.7525450274079875,0.0
2756,24611,PLXND1,604282,,,Moebius syndrome;Truncus arteriosus,Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in,Waist-to-hip ratio adjusted for BMI (age >50)[26426971];Waist-to-hip ratio adjusted for BMI (adjusted for smoking behaviour)[28443625];Hip circumference[25673412;25673412];Hip circumference adjusted for BMI[25673412;25673412;25673412];Waist-to-hip ratio adjusted for BMI in active individuals[28448500;28448500;28448500;28448500;28448500];Waist-to-hip ratio adjusted for BMI (joint analysis for main effect and physical activity interaction)[28448500;28448500;28448500;28448500];Waist-to-hip ratio adjusted for BMI x sex interaction[26426971];Waist-hip ratio[25673412;25673412];Waist-to-hip ratio adjusted for BMI[26426971];Waist-to-hip ratio adjusted for body mass index[28448500;28448500;28448500;25673412;25673412;25673412;25673412;28448500;28448500];Waist-to-hip ratio adjusted for BMI x sex x age interaction (4df test)[26426971];,0.23865030674846627,0.7872614749871067,0.12007308796658836,0.6995089011663598
2757,24618,PMEL,155550,,,Congenital sucrase-isomaltase deficiency with starch intolerance;Congenital sucrase-isomaltase deficiency without starch intolerance;Congenital sucrase-isomaltase deficiency with minimal starch tolerance;Congenital sucrase-isomaltase deficiency with starch and lactose intolerance;Congenital sucrase-isomaltase deficiency without sucrose intolerance,Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in,Vitiligo[22951725];Anorexia nervosa[28494655];Blood protein levels[30072576];,0.4431901840490797,0.035069623517276945,0.3534325241451318,0.0
2758,24619,PMEPA1,606564,,,STAG1-related intellectual disability-facial dysmorphism-gastroesophageal reflux syndrome,Disease-causing germline mutation(s) in,Response to fenofibrate (adiponectin levels)[23149075];,0.20368098159509201,0.8728726147498711,0.3727486296006265,0.4421424186617557
2759,24624,PML,102578,,,Acute promyelocytic leukemia,Part of a fusion gene in,Paget's disease[21623375];Accelerometer-based physical activity measurement (fraction of time with accelerations >425 milli-gravities)[29899525];Myopia (pathological)[23049088];Height[20881960;20881960;25282103];,0.7020858895705522,0.8937596699329551,0.700600365439833,0.967157765500307
2760,24626,PMM2,601785,212065;,[MIM:212065]Congenital disorder of glycosylation 1A [recessive?];,PMM2-CDG,Disease-causing germline mutation(s) in,Glaucoma (high intraocular pressure)[25173107];,0.22687116564417178,0.09850438370293967,0.5766118506917254,0.6431860036832413
2761,24629,PMP2,170715,,,PMP2-related Charcot-Marie-Tooth disease type 1,Disease-causing germline mutation(s) in,Night sleep phenotypes[27126917];Ovarian cancer[23535730;23535730];,0.17791411042944785,0.632800412583806,0.5784390498564344,0.2937384898710866
2762,24630,PMP22,601097,118220;118300;139393;145900;162500;,[MIM:118220]Charcot-Marie-Tooth disease 1A;[MIM:145900]Dejerine-Sottas syndrome [dominant?] [recessive?];[MIM:162500]Hereditary neuropathy with liability to pressure palsies;[MIM:118300]Charcot-Marie-Tooth disease 1E [dominant?];[MIM:139393]Inflammatory demyelinating polyneuropathy;,Hereditary neuropathy with liability to pressure palsies;Hereditary neuropathy with liability to pressure palsies;Roussy-L�vy syndrome;Dejerine-Sottas syndrome;Charcot-Marie-Tooth disease type 1E;Acute inflammatory demyelinating polyradiculoneuropathy;Charcot-Marie-Tooth disease type 1A,Disease-causing germline mutation(s) in;Role in the phenotype of;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Major susceptibility factor in;Disease-causing germline mutation(s) in,Resting heart rate[27798624];Corneal structure[23291589];Allergic rhinitis[25085501];Amyotrophic lateral sclerosis[29566793];Night sleep phenotypes[27126917];Preterm birth (maternal effect)[28877031];,0.33226993865030674,0.7142857142857143,0.4507961367789089,0.8324125230202578
2763,24631,PMPCA,613036,213200;,"[MIM:213200]Spinocerebellar ataxia, autosomal recessive, 2 [recessive?];",Autosomal recessive cerebelloparenchymal disorder type 3,Disease-causing germline mutation(s) in,Inflammatory bowel disease[28067908;23128233];Serum total protein level[29403010];White blood cell count[27863252];Myeloid white cell count[27863252];Sum basophil neutrophil counts[27863252];Crohn's disease[28067908];Sum neutrophil eosinophil counts[27863252];Granulocyte count[27863252];Neutrophil count[27863252];Ulcerative colitis[28067908];,0.8498159509202454,0.3176895306859206,0.7204385277995301,0.2223756906077348
2764,24634,PMS1,600258,,,Lynch syndrome,Candidate gene tested in,Iron status biomarkers (ferritin levels)[28334935];Ferritin levels[25162662];Subcutaneous adipose tissue[22589738];Obesity-related traits[23251661];,0.6773006134969325,0.45332645693656526,0.41790655181414776,0.8222836095764272
2765,24635,PMS2,600259,276300;614337;,[MIM:614337]Hereditary non-polyposis colorectal cancer 4 [dominant?];[MIM:276300]Mismatch repair cancer syndrome [recessive?];,Constitutional mismatch repair deficiency syndrome;Lynch syndrome,Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in,,0.7099386503067485,0.02552862300154719,0.3007047768206735,0.4576427255985267
2766,24649,PMVK,607622,175800;,"[MIM:175800]Porokeratosis 1, multiple types;",Porokeratosis of Mibelli,Disease-causing germline mutation(s) in,Inflammatory bowel disease[27569725];HDL cholesterol levels[28334899];Atrial fibrillation[22544366;29892015;29892015];Prostate cancer[23535732];HDL cholesterol[24097068];,0.7768098159509202,0.2490974729241877,0.46045418950665623,0.1721915285451197
2767,24652,PNKD,609023,118800;,[MIM:118800]Dystonia 8;,Paroxysmal non-kinesigenic dyskinesia,Disease-causing germline mutation(s) in,Inflammatory bowel disease[28067908;23128233];High light scatter reticulocyte percentage of red cells[27863252];White blood cell count[27863252];Myeloid white cell count[27863252];Colorectal cancer[28960316];Plateletcrit[27863252];Sum basophil neutrophil counts[27863252];Sum neutrophil eosinophil counts[27863252];Monocyte count[27863252];Granulocyte count[27863252];Neutrophil count[27863252];Red cell distribution width[27863252];,0.8224539877300614,0.25038679731820523,0.5327590707387105,0.7051872314303254
2768,24654,PNKP,605610,613402;616267;,"[MIM:613402]Microcephaly, seizures, and developmental delay;[MIM:616267]Ataxia-oculomotor apraxia 4 [recessive?];",Early infantile epileptic encephalopathy;Ataxia-oculomotor apraxia type 4,Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in,,0.5658895705521473,0.055440948942754,0.45001305142260506,0.21577655003069368
2769,24676,PNP,164050,613179;,,Purine nucleoside phosphorylase deficiency,Disease-causing germline mutation(s) (loss of function) in,Menopause (age at onset)[26414677];Interferon alpha levels in systemic lupus erythematosus[25338677];Blood protein levels[30072576];Angiotensin-converting enzyme inhibitor intolerance[28030426];,0.6930061349693252,0.7323362558019598,0.17958757504568,0.5506445672191529
2770,24677,PNPLA1,612121,615024;,,Congenital non-bullous ichthyosiform erythroderma,Disease-causing germline mutation(s) in,,0.22687116564417178,0.3310985043837029,0.1383450796136779,0.19060773480662985
2771,24678,PNPLA2,609059,610717;,[MIM:610717]Neutral lipid storage disease with myopathy;,Neutral lipid storage myopathy,Disease-causing germline mutation(s) in,,0.45680981595092024,0.39195461578133056,0.5933176716262073,0.3064763658686311
2772,24683,PNPLA6,603197,215470;245800;275400;612020;,"[MIM:612020]Spastic paraplegia 39, autosomal recessive [recessive?];[MIM:215470]Boucher-Neuhauser syndrome [recessive?];[MIM:245800]Laurence-Moon syndrome [recessive?];[MIM:275400]Oliver-McFarlane syndrome [recessive?];",Laurence-Moon syndrome;Ataxia-hypogonadism-choroidal dystrophy syndrome;Cerebellar ataxia-hypogonadism syndrome;Autosomal recessive spastic paraplegia type 39;Trichomegaly-retina pigmentary degeneration-dwarfism syndrome,Disease-causing germline mutation(s) (loss of function) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) (loss of function) in,,0.8049079754601227,0.4027849406910779,0.2265726964239102,0.13720073664825047
2773,24687,PNPO,603287,610090;,[MIM:610090]Pyridoxine-5'-phosphate oxidase deficiency;,Pyridoxal phosphate-responsive seizures,Disease-causing germline mutation(s) (loss of function) in,Body mass index[26426971];Epilepsy (generalized)[22949513];,0.5692024539877301,0.2875193398659103,0.48003132341425214,0.24846531614487416
2774,24688,PNPT1,610316,614932;614934;,"[MIM:614932]Combined oxidative phosphorylation deficiency 13;[MIM:614934]Deafness, autosomal recessive, 70 [recessive?];",Combined oxidative phosphorylation defect type 13;Autosomal recessive non-syndromic sensorineural deafness type DFNB,Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in,Systolic blood pressure[27618452];Glaucoma (primary open-angle)[29891935];Spherical equivalent or myopia (age of diagnosis)[29808027];Optic cup area[28073927;28073927];Diastolic blood pressure[27618452];Pulse pressure[28135244];Height[18391951;25429064];Intraocular pressure[29617998;29617998];,0.9035582822085889,0.34966477565755544,0.0759592795614722,0.42004297114794353
2775,24694,POC1A,614783,614813;,"[MIM:614813]Short stature, onychodysplasia, facial dysmorphism, and hypotrichosis;",Short stature-onychodysplasia-facial dysmorphism-hypotrichosis syndrome,Disease-causing germline mutation(s) in,,0.7376687116564418,0.2184115523465704,0.46515270164447925,0.0
2776,24695,POC1B,614784,615973;,[MIM:615973]Cone-rod dystrophy 20;,Cone rod dystrophy,Disease-causing germline mutation(s) (loss of function) in,Granulocyte percentage of myeloid white cells[27863252];Pulse pressure x alcohol consumption (light vs heavy) interaction (2df test)[29912962];NT-proBNP levels in acute coronary syndrome[26908625];Diastolic blood pressure x alcohol consumption interaction (2df test)[29912962];Diastolic blood pressure x smoking status (ever vs never) interaction (2df test)[29455858;29455858];Blood protein levels[28240269;28240269;29875488;29875488];Night sleep phenotypes[27126917];Systolic blood pressure x smoking status (current vs non-current) interaction (2df test)[29455858;29455858];B-type natriuretic peptide to N-terminal pro B-type natriuretic peptide ratio[29237677;29237677];Diastolic blood pressure x smoking status (current vs non-current) interaction (2df test)[29455858;29455858];Systolic blood pressure x smoking status (ever vs never) interaction (2df test)[29455858;29455858];Blood pressure[24954895;24954895];Monocyte count[27863252];Systolic blood pressure x alcohol consumption interaction (2df test)[29912962];Mean arterial pressure x alcohol consumption interaction (2df test)[29912962;29912962];,0.6301840490797546,0.4747292418772563,0.6930305403288959,0.0
2777,24701,PODXL,602632,,,Young-onset Parkinson disease;Atypical juvenile parkinsonism,Disease-causing germline mutation(s) (loss of function) in;Disease-causing germline mutation(s) in,Hypertension[28273873];Schizophrenia[25056061];Alcohol dependence symptom count[27151647];Idiopathic dilated cardiomyopathy[29495422];,0.6723926380368098,0.3290355853532749,0.4896893761419995,0.29665438919582565
2778,24704,POFUT1,607491,615327;,[MIM:615327]Dowling-Degos disease 2 [dominant?];,Dowling-Degos disease,Disease-causing germline mutation(s) in,Inflammatory bowel disease[28067908];Chronic obstructive pulmonary disease[28166215];Blood protein levels[29875488;30072576];,0.6197546012269939,0.7519339865910263,0.514487079091621,0.40423572744014735
2779,24707,POGLUT1,615618,615696;617232;,[MIM:617232]Limb-girdle muscular dystrophy 2Z [recessive?];,Autosomal recessive limb-girdle muscular dystrophy type 2Z;Dowling-Degos disease,Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in,Primary biliary cirrhosis[22961000];Blood protein levels[29875488;30072576];,0.36171779141104293,0.4785972150593089,0.7334899504045941,0.0
2780,24708,POGZ,614787,616364;,[MIM:616364]White-Sutton syndrome;,Intellectual disability-microcephaly-strabismus-behavioral abnormalities syndrome,Disease-causing germline mutation(s) (loss of function) in,Body mass index[26426971];Blood trace element (Cu levels)[23720494];,0.801963190184049,0.7509025270758123,0.5001305142260506,0.7461632903621854
2781,24709,POLA1,312040,301220;,"[MIM:301220]Pigmentary disorder, reticulate, with systemic manifestations, X-linked;",X-linked reticulate pigmentary disorder,Disease-causing germline mutation(s) (loss of function) in,,0.7430674846625767,1.0,0.7293134951709737,0.789901780233272
2782,24712,POLD1,174761,612591;615381;,"[MIM:612591]Colorectal cancer 10;[MIM:615381]Mandibular hypoplasia, deafness, progeroid features, and lipodystrophy syndrome [dominant?];",Mandibular hypoplasia-deafness-progeroid features-lipodystrophy syndrome;Polymerase proofreading-related adenomatous polyposis,Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in,Obesity-related traits[23251661];,0.870920245398773,0.7356884992264053,0.35813103628295484,0.24631675874769798
2783,24719,POLE,174762,615083;615139;,"[MIM:615083]Colorectal cancer 12;[MIM:615139]Facial dysmorphism, immunodeficiency, livedo, and short stature;",Facial dysmorphism-immunodeficiency-livedo-short stature syndrome;Polymerase proofreading-related adenomatous polyposis,Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in,Body mass index[26426971];Urate levels in overweight individuals[25811787];,0.8026993865030675,0.07813305827746261,0.14487079091620986,0.10696746470227134
2784,24723,POLG,174763,157640;203700;256000;258450;607459;613662;,"[MIM:157640]Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal dominant, 1 [dominant?];[MIM:258450]Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal recessive, 1 [dominant?] [recessive?];[MIM:607459]Sensory ataxic neuropathy dysarthria and ophthalmoparesis;[MIM:203700]Mitochondrial DNA depletion syndrome 4A [recessive?];[MIM:613662]Mitochondrial DNA depletion syndrome 4B [recessive?];[MIM:256000]Leigh syndrome;[MIM:607459]Spinocerebellar ataxia with epilepsy [recessive?];",Alpers-Huttenlocher syndrome;Autosomal recessive progressive external ophthalmoplegia;Spinocerebellar ataxia with epilepsy;Autosomal dominant progressive external ophthalmoplegia;Progressive myoclonic epilepsy type 5;Mitochondrial neurogastrointestinal encephalomyopathy;Sensory ataxic neuropathy-dysarthria-ophthalmoparesis syndrome;Recessive mitochondrial ataxia syndrome,Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Candidate gene tested in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in,Menopause (age at onset)[22267201;26414677];Schizophrenia[28991256];Height[18193045];Venlafaxine response in generalised anxiety disorder (responders vs non-responders after 24 weeks)[28437668];,0.8465030674846625,0.4314079422382672,0.3617854346123727,0.9585635359116023
2785,24724,POLG2,604983,610131;,"[MIM:610131]Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal dominant, 4 [dominant?];",Autosomal dominant progressive external ophthalmoplegia,Disease-causing germline mutation(s) in,,0.4795092024539877,0.28004125838060856,0.10597755155311929,0.4562615101289134
2786,24725,POLH,603968,278750;,[MIM:278750]Xeroderma pigmentosum variant type [recessive?];,Xeroderma pigmentosum variant,Disease-causing germline mutation(s) in,Waist-to-hip ratio adjusted for BMI (age >50)[26426971];Waist-to-hip ratio adjusted for BMI (age <50)[26426971];Waist-to-hip ratio adjusted for BMI[26426971];Waist-to-hip ratio adjusted for BMI x sex x age interaction (4df test)[26426971];,0.6141104294478528,0.12764311500773595,0.2276168102323153,0.12569060773480664
2787,24733,POLQ,604419,114480;,[MIM:114480]Breast cancer;,Xeroderma pigmentosum variant,Disease-causing germline mutation(s) in,Aging (facial)[23223146];,0.10711656441717791,0.0007735946364105209,0.05272774732445837,0.24984653161448742
2788,24734,POLR1A,616404,616462;,"[MIM:616462]Acrofacial dysostosis, Cincinnati type;",Choanal atresia-hearing loss-cardiac defects-craniofacial dysmorphism syndrome,Disease-causing germline mutation(s) in,Facial emotion recognition (sad faces)[28608620];,0.796441717791411,0.9685404847859721,0.195510310623858,0.44014732965009207
2789,24736,POLR1C,610060,248390;616494;,"[MIM:248390]Treacher Collins syndrome 3;[MIM:616494]Leukodystrophy, hypomyelinating, 11 [recessive?];",Treacher-Collins syndrome;Hypomyelination-hypogonadotropic hypogonadism-hypodontia syndrome,Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in,Waist-to-hip ratio adjusted for BMI (age >50)[26426971];GLP-1 levels in response to oral glucose tolerance test (fasting)[29093273];Waist-to-hip ratio adjusted for BMI (age <50)[26426971];Waist-to-hip ratio adjusted for BMI[26426971];Waist-to-hip ratio adjusted for BMI x sex x age interaction (4df test)[26426971];,0.9504294478527607,0.2521918514698298,0.5377186113286349,0.5477286678944138
2790,24737,POLR1D,613715,,,Treacher-Collins syndrome,Disease-causing germline mutation(s) in,Body mass index[26426971];,0.5505521472392638,0.649045899948427,0.9642391020621248,0.5972989564149785
2791,24743,POLR2D,606017,,,Progressive retinal dystrophy due to retinol transport defect;Colobomatous microphthalmia,Disease-causing germline mutation(s) (loss of function) in;Disease-causing germline mutation(s) in,Retinol levels[21878437];Blood protein levels[30072576;30072576];,0.8434355828220859,0.5796802475502837,0.9937353171495693,0.38551258440761205
2792,24759,POLR3A,614258,607694;,,Hypomyelinating leukodystrophy-ataxia-hypodontia-hypomyelination syndrome;Tremor-ataxia-central hypomyelination syndrome;Hypomyelination-cerebellar atrophy-hypoplasia of the corpus callosum syndrome;Odontoleukodystrophy;Hypomyelination-hypogonadotropic hypogonadism-hypodontia syndrome,Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in,,0.6811042944785276,0.019082001031459517,0.4990864004176455,0.17971147943523635
2793,24760,POLR3B,614366,614381;,"[MIM:614381]Leukodystrophy, hypomyelinating, 8, with or without oligodontia and/or hypogonadotropic hypogonadism [recessive?];",Hypomyelination-hypogonadotropic hypogonadism-hypodontia syndrome;Endosteal sclerosis-cerebellar hypoplasia syndrome,Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in,Glioma[26424050];Glioblastoma[26424050];Cognitive test performance[17903297];Response to methotrexate in juvenile idiopathic arthritis[24709693];Night sleep phenotypes[27126917];Tourette syndrome[22889924];,0.7462576687116564,0.3437338834450748,0.44400939702427566,0.04158993247391037
2794,24792,POMC,176830,601665;609734;,"[MIM:601665]Obesity;[MIM:609734]Obesity, early-onset, with adrenal insufficiency and red hair [recessive?];",Obesity due to pro-opiomelanocortin deficiency,Disease-causing germline mutation(s) in,Inflammatory bowel disease[28067908];Body mass index[20935630;23669352;26426971];Obesity[23563607;23563607];Body mass index (age <50)[26426971];Pubertal anthropometrics[23449627];Body mass index x sex x age interaction (4df test)[26426971];Type 1 diabetes[21980299];Body mass index (age>50)[26426971];Height[23563607;23563607;18391951];Crohn's disease[28067908];,0.38061349693251534,0.26766374419804023,0.3009658052727747,0.0
2795,24793,POMGNT1,606822,253280;613151;613157;617123;,[MIM:253280]Muscular dystrophy-dystroglycanopathy congenital with brain and eye anomalies A3 [recessive?];[MIM:613151]Muscular dystrophy-dystroglycanopathy congenital with mental retardation B3 [recessive?];[MIM:613157]Muscular dystrophy-dystroglycanopathy limb-girdle C3;[MIM:617123]Retinitis pigmentosa 76 [recessive?];,Retinitis pigmentosa;Autosomal recessive limb-girdle muscular dystrophy type 2O;Congenital muscular dystrophy with cerebellar involvement;Muscle-eye-brain disease;Walker-Warburg syndrome,Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) (loss of function) in;Disease-causing germline mutation(s) in,Body mass index[26426971];,0.5128834355828221,0.024239298607529654,0.5708692247454973,0.39610190300798037
2796,24794,POMGNT2,614828,614830;,,Walker-Warburg syndrome,Disease-causing germline mutation(s) (loss of function) in,Blood protein levels[29875488;30072576];,0.4350920245398773,0.21995874161939144,0.41320803967632475,0.0
2797,24795,POMK,615247,615249;616094;,[MIM:616094]Muscular dystrophy-dystroglycanopathy limb-girdle C12 [recessive?];,Congenital muscular dystrophy with cerebellar involvement;Limb-girdle muscular dystrophy due to POMK deficiency;Walker-Warburg syndrome,Disease-causing germline mutation(s) (loss of function) in;Disease-causing germline mutation(s) (loss of function) in;Disease-causing germline mutation(s) (loss of function) in,,0.8536196319018405,0.1629706034038164,0.5418950665622553,0.0
2798,24796,POMP,613386,601952;,[MIM:601952]Keratosis linearis with ichthyosis congenita and sclerosing keratoderma;,Keratosis linearis-ichthyosis congenita-sclerosing keratoderma syndrome,Disease-causing germline mutation(s) in,Breast cancer (menopausal hormone therapy interaction)[24080446];Hematocrit[27863252];Hemoglobin concentration[27863252];,0.634601226993865,0.869262506446622,0.9673714434873402,0.0
2799,24797,POMT1,607423,236670;609308;613155;,[MIM:236670]Muscular dystrophy-dystroglycanopathy congenital with brain and eye anomalies A1 [recessive?];[MIM:609308]Muscular dystrophy-dystroglycanopathy limb-girdle C1 [recessive?];,Congenital muscular dystrophy with cerebellar involvement;Congenital muscular dystrophy with intellectual disability;Congenital muscular dystrophy without intellectual disability;Muscle-eye-brain disease;Walker-Warburg syndrome;Autosomal recessive limb-girdle muscular dystrophy type 2K,Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) (loss of function) in;Disease-causing germline mutation(s) in,,0.38061349693251534,0.11268695203713254,0.24092926128948056,0.9522713321055862
2800,24798,POMT2,607439,613150;613156;613158;,[MIM:613150]Muscular dystrophy-dystroglycanopathy congenital with brain and eye anomalies A2 [recessive?];[MIM:613156]Muscular dystrophy-dystroglycanopathy congenital with mental retardation B2 [recessive?];[MIM:613158]Muscular dystrophy-dystroglycanopathy limb-girdle C2 [recessive?];,Autosomal recessive limb-girdle muscular dystrophy type 2N;Congenital muscular dystrophy with cerebellar involvement;Congenital muscular dystrophy with intellectual disability;Muscle-eye-brain disease;Walker-Warburg syndrome,Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) (loss of function) in,,0.3168098159509202,0.685662712738525,0.4969981728008353,0.7102516881522406
2801,24800,PON1,168820,612633;,[MIM:612633]Microvascular complications of diabetes 5;,Amyotrophic lateral sclerosis,Disease-causing germline mutation(s) in,Response to TNF antagonist treatment[18615156];Metabolite levels[23281178];Blood protein levels[28240269;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488];,0.20368098159509201,0.13976276431150078,0.21743670060036543,0.16390423572744015
2802,24801,PON2,602447,,,Amyotrophic lateral sclerosis,Disease-causing germline mutation(s) in,Yu-Zhi constitution type in type 2 diabetes[26169365];,0.8051533742331288,0.26895306859205775,0.060819629339598016,0.1359729895641498
2803,24802,PON3,602720,,,Amyotrophic lateral sclerosis,Disease-causing germline mutation(s) in,,0.08736196319018405,0.15652398143372873,0.5069172539806839,0.19137507673419277
2804,24803,POP1,602486,617396;,[MIM:617396]Anauxetic dysplasia 2 [recessive?];,Anauxetic dysplasia,Disease-causing germline mutation(s) (loss of function) in,,0.9492024539877301,0.2666322846828262,0.2069955625163143,0.03038674033149171
2805,24809,POR,124015,201750;613571;,"[MIM:201750]Antley-Bixler syndrome, with genital anomalies and disordered steroidogenesis;[MIM:613571]Disordered steroidogenesis due to cytochrome P450 oxidoreductase deficiency;",Congenital adrenal hyperplasia due to cytochrome P450 oxidoreductase deficiency,Disease-causing germline mutation(s) in,Coffee consumption (cups per day)[25288136];Coffee consumption[25288136];,0.858159509202454,0.11990716864363074,0.0,0.5112031921424187
2806,24810,PORCN,300651,305600;,,Focal dermal hypoplasia,Disease-causing germline mutation(s) in,,0.16220858895705523,0.9677668901495616,0.8603497781258157,0.0
2807,24812,POT1,606478,615848;616568;,[MIM:616568]Glioma 9;,Anaplastic oligodendroglioma;Oligodendroglioma;Familial melanoma;B-cell chronic lymphocytic leukemia,Major susceptibility factor in;Major susceptibility factor in;Major susceptibility factor in;Disease-causing somatic mutation(s) in,Chronic lymphocytic leukemia[24292274;28165464];Cutaneous malignant melanoma[26237428];Response to selective serotonin reuptake inhibitors and depression[27622933];,0.7179141104294479,0.794997421351212,0.6765857478465153,0.1289134438305709
2808,24829,POU1F1,173110,613038;,"[MIM:613038]Pituitary hormone deficiency, combined, 1;","Hypothyroidism due to deficient transcription factors involved in pituitary development or function;Isolated growth hormone deficiency type II;Combined pituitary hormone deficiencies, genetic forms",Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) (gain of function) in;Disease-causing germline mutation(s) in,Tourette's syndrome or obsessive-compulsive disorder[25158072];Menarche (age at onset)[25231870];,0.3706748466257669,0.36745745229499743,0.7982250065257113,0.6127992633517495
2809,24830,POU2AF1,601206,,,Primary biliary cholangitis,Major susceptibility factor in,Diverticular disease[30177863];Celiac disease[22057235];Corneal structure[23291589];Primary biliary cholangitis[23000144;28062665];,0.45950920245398774,0.5863847343991748,0.7089532759070739,0.82719459791283
2810,24837,POU3F4,300039,304400;,,X-linked mixed deafness with perilymphatic gusher;Xq21 microdeletion syndrome,Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in,Heschl's gyrus morphology[25130324];,0.12711656441717792,0.7429087158329035,0.9287392325763508,0.0
2811,24840,POU4F3,602460,602459;,,Autosomal dominant non-syndromic sensorineural deafness type DFNA,Disease-causing germline mutation(s) in,,0.14576687116564419,0.8767405879319237,0.8734012007308797,0.7745549416820136
2812,24851,POU6F2,609062,601583;,,Nephroblastoma,Major susceptibility factor in,Motion sickness[25628336];Hand grip strength[29691431;29691431;29691431];Intraocular pressure[30054594;29785010];,0.5614723926380368,0.7764311500773594,0.12816496998172802,0.7763965623081646
2813,24862,PPARG,601487,137800;601665;604367;606641;609338;,"[MIM:601665]Obesity;[MIM:604367]Lipodystrophy, familial partial, 3;[MIM:137800]Glioma 1;",Differentiated thyroid carcinoma;Berardinelli-Seip congenital lipodystrophy;Gliosarcoma;Giant cell glioblastoma;PPARG-related familial partial lipodystrophy,Part of a fusion gene in;Disease-causing germline mutation(s) in;Biomarker tested in;Biomarker tested in;Disease-causing germline mutation(s) in,"Type 2 diabetes[17463246;18372903;17463249;17463248;20581827;24509480;22885922;22885922;22885922;29358691;28869590;28869590];Endometrial cancer[30093612];Waist-to-hip ratio adjusted for BMI in active individuals[28448500;28448500;28448500];Hematocrit[27863252];Eosinophil counts[27863252];Plasminogen activator inhibitor type 1 levels (PAI-1)[22990020];Waist-to-hip ratio adjusted for BMI[26426971];Hemoglobin concentration[27863252];Fasting blood insulin (BMI interaction)[22581228];Body mass index[25673413;25673413;28892062];Systemic lupus erythematosus[28714469];Modified Stumvoll Insulin Sensitivity Index (model adjusted for BMI)[27416945];Hip circumference adjusted for BMI[25673412;25673412];Gut microbiota (functional units)[27694959];Cholesterol, total[25961943];Potassium levels[29403010];Waist-to-hip ratio adjusted for body mass index[28448500;25673412;25673412;25673412;25673412;28448500];Platelet count[29403010];Eosinophil percentage of white cells[27863252];Waist-to-hip ratio adjusted for BMI x sex x age interaction (4df test)[26426971];Endometrial cancer ((endometrioid histology)[30093612];Waist-to-hip ratio adjusted for BMI (adjusted for smoking behaviour)[28443625;28443625];Waist-to-hip ratio adjusted for BMI (joint analysis for main effect and physical activity interaction)[28448500;28448500];Waist-to-hip ratio adjusted for BMI in non-smokers[28443625];Waist-hip ratio[25673412;25673412];Waist-to-hip ratio adjusted for BMI (age >50)[26426971];Eosinophil percentage of granulocytes[27863252];Waist-to-hip ratio adjusted for BMI (age <50)[26426971];Waist-to-hip ratio adjusted for BMI (joint analysis main effects and smoking interaction)[28443625];Sexual dimorphism in anthropometric traits[23754948];Drug-induced liver injury[22968431];LDL cholesterol[25961943];High density lipoprotein cholesterol levels[29403010];Neutrophil percentage of granulocytes[27863252];",0.6279754601226993,0.49716348633316143,0.3510832680762203,0.858195211786372
2814,24863,PPARGC1A,604517,,,Amyotrophic lateral sclerosis,Modifying germline mutation in,Rosacea symptom severity[29771307];Resting heart rate[27798624];Cognitive decline rate in late mild cognitive impairment[26252872;26252872];Lead levels[26025379];Corneal astigmatism[29422769];Molar-incisor hypomineralization[23918034];Essential tremor[27797806];Thiazide-induced adverse metabolic effects in hypertensive patients[23400010];,0.5488343558282208,0.7769468798349665,0.08509527538501696,0.8830570902394107
2815,24872,PPCS,609853,,,Familial isolated dilated cardiomyopathy,Disease-causing germline mutation(s) in,,0.10711656441717791,0.3916967509025271,0.8838423388149308,0.5405156537753223
2816,24985,PPIB,123841,259440;,[MIM:259440]Osteogenesis imperfecta 9 [recessive?];,Osteogenesis imperfecta type 2;Osteogenesis imperfecta type 3;Osteogenesis imperfecta type 4,Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in,,0.921963190184049,0.258380608561114,0.8856695379796398,0.23848987108655617
2817,25008,PPM1B,603770,,,2p21 microdeletion syndrome,Role in the phenotype of,Height[23563607];,0.5719018404907975,0.5023207839092315,0.750195771339076,0.4224984653161449
2818,25009,PPM1D,605100,114480;167000;617450;,[MIM:617450]Intellectual developmental disorder with gastrointestinal difficulties and high pain threshold [dominant?];[MIM:114480]Breast cancer;[MIM:167000]Ovarian cancer;,Hereditary breast cancer,Candidate gene tested in,,0.5069938650306749,0.8460546673543063,0.631427825632994,0.12753222836095765
2819,25015,PPM1K,611065,615135;,"[MIM:615135]Maple syrup urine disease, mild variant;",Intermediate maple syrup urine disease,Disease-causing germline mutation(s) in,Branched-chain amino acid levels (Isoleucine)[27898682];Branched-chain amino acid levels (Leucine)[27898682];Metabolite levels (small molecules and protein measures)[27005778];Blood metabolite levels[24816252;24816252;24816252;24816252];Conduct disorder (maternal expressed emotions interaction)[18846501];Metabolite levels[22286219;22916037];Coffee consumption (cups per day)[25288136];Branched-chain amino acid levels (Valine)[27898682];,0.35496932515337426,0.2893243940175348,0.5580788305925346,0.28882750153468384
2820,25020,PPOX,600923,176200;,,Porphyria variegata,Disease-causing germline mutation(s) in,,0.31079754601226994,0.573233625580196,0.46724092926128946,0.8391651319828115
2821,25022,PPP1CB,600590,617506;,[MIM:617506]Noonan syndrome-like disorder with loose anagen hair 2;,Noonan syndrome-like disorder with loose anagen hair,Disease-causing germline mutation(s) in,Excessive sweating[29895819];Body mass index[25673413];Heel bone mineral density[28869591;28869591];,0.9714110429447853,0.8973697782362042,0.9877316627512399,0.6223143032535298
2822,25074,PPP1R15B,613257,616817;,"[MIM:616817]Microcephaly, short stature, and impaired glucose metabolism 2;",Primary microcephaly-mild intellectual disability-young-onset diabetes syndrome,Disease-causing germline mutation(s) (loss of function) in,Prostate cancer[23535732];,0.6095705521472392,0.6111397627643115,0.48734012007308797,0.491866175567833
2823,25096,PPP2R1A,605983,616362;,"[MIM:616362]Mental retardation, autosomal dominant 36 [dominant?];",Microcephaly-corpus callosum hypoplasia-intellectual disability-facial dysmorphism syndrome,Disease-causing germline mutation(s) in,,0.9985276073619632,0.669417225373904,0.9094231271208562,0.43370165745856354
2824,25099,PPP2R2B,604325,604326;,[MIM:604326]Spinocerebellar ataxia 12 [dominant?];,Spinocerebellar ataxia type 12,Disease-causing germline mutation(s) in,"Urate levels in lean individuals[25811787];Autism spectrum disorder, attention deficit-hyperactivity disorder, bipolar disorder, major depressive disorder, and schizophrenia (combined)[23453885];Alcohol dependence[19581569];Night sleep phenotypes[27126917];",0.6588957055214724,0.8035069623517277,0.876533542156095,0.20319214241866176
2825,25111,PPP2R5D,601646,616355;,"[MIM:616355]Mental retardation, autosomal dominant 35 [dominant?];",Intellectual disability-macrocephaly-hypotonia-behavioral abnormalities syndrome,Disease-causing germline mutation(s) in,Amyotrophic lateral sclerosis (sporadic)[24529757];,0.7823312883435583,0.887055183084064,0.91020621247716,0.5131982811540823
2826,25113,PPP3CA,114105,617711;,"[MIM:617711]Epileptic encephalopathy, infantile or early childhood, 1 [dominant?];",Autosomal dominant non-syndromic intellectual disability;Undetermined early-onset epileptic encephalopathy,Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in,Vitiligo[27723757];Corneal structure[21979947];Blood pressure[22763476;22763476];Anorexia nervosa[24514567];,0.7093251533742331,0.868231046931408,0.9590185330200992,0.8256599140577041
2827,25137,PPT1,600722,256730;,"[MIM:256730]Ceroid lipofuscinosis, neuronal, 1;",CLN1 disease,Disease-causing germline mutation(s) in,Blood protein levels[29875488;30072576];,0.8152147239263804,0.6676121712222796,0.32785173583920646,0.6468692449355433
2828,25142,PPY,167780,,,Purine nucleoside phosphorylase deficiency,Disease-causing germline mutation(s) (loss of function) in,Menopause (age at onset)[26414677];Interferon alpha levels in systemic lupus erythematosus[25338677];Blood protein levels[30072576];Angiotensin-converting enzyme inhibitor intolerance[28030426];,0.14576687116564419,0.45306859205776173,0.7126076742364917,0.447206875383671
2829,25144,PQBP1,300463,309500;,[MIM:309500]Renpenning syndrome 1;,"X-linked intellectual disability, Sutherland-Haan type;X-linked intellectual disability, Golabi-Ito-Hall type;Hamel cerebro-palato-cardiac syndrome;X-linked intellectual disability, Porteous type",Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in,,0.7007361963190184,0.6054667354306343,0.8890629078569564,0.6174033149171271
2830,25201,PRCC,179755,,,MiT family translocation renal cell carcinoma,Part of a fusion gene in,Sjögren's syndrome[28076899];,0.6830674846625767,0.9040742650850954,0.23127120856173322,0.766267648864334
2831,25202,PRCD,610598,610599;,[MIM:610599]Retinitis pigmentosa 36;,Retinitis pigmentosa,Disease-causing germline mutation(s) in,,0.038773006134969326,0.46544610624033006,0.8128425998433829,0.19429097605893186
2832,25208,PRDM5,614161,614170;,,Brittle cornea syndrome,Disease-causing germline mutation(s) in,Monobrow thickness[26926045];Fasting plasma glucose[17903298;17903298];F-cell distribution[21326311];Obesity-related traits[23251661];Loneliness (multivariate analysis)[27629369];,0.4331288343558282,0.18127900979886538,0.49986948577394935,0.43370165745856354
2833,25209,PRDM6,616982,617039;,[MIM:617039]Patent ductus arteriosus 3;,Familial patent arterial duct,Disease-causing germline mutation(s) (loss of function) in,Systolic blood pressure[26390057;27618447];Mammographic density (dense area)[25342443];Body mass index[28892062;28892062];Heart rate response to recovery post exercise (50 sec)[29497042;29497042];Diastolic blood pressure[27618447];Heart rate increase in response to exercise[29497042];Percent mammographic density[25342443];Heart rate response to recovery post exercise (40 sec)[29497042];Pulse pressure[27618447];QRS duration[25035420];Coronary artery disease[29212778];,0.36171779141104293,0.8499226405363589,0.07491516575306709,0.0
2834,25211,PRDM8,616639,616640;,,Early-onset Lafora body disease,Disease-causing germline mutation(s) in,"Systolic blood pressure[29403010];Diastolic blood pressure[19430483;29403010];Creatinine levels[29403010];Atrial fibrillation[29892015];Red blood cell count[29403010];Mean arterial pressure[29403010];Blood urea nitrogen levels[29403010];Glomerular filtration rate[29403010];Male-pattern baldness[29146897];Serum uric acid levels[29403010];Exploratory eye movement dysfunction in schizophrenia (cognitive search score)[26242244];Pulse pressure[29403010];Blood pressure[24954895;24954895];Potassium levels[29403010];Coronary artery disease (myocardial infarction, percutaneous transluminal coronary angioplasty, coronary artery bypass grafting, angina or chromic ischemic heart disease)[28714975];",0.08736196319018405,0.6451779267663744,0.6554424432263116,0.0
2835,25219,PRDM16,605557,615373;,"[MIM:615373]Cardiomyopathy, dilated 1LL;",Familial isolated dilated cardiomyopathy;1p36 deletion syndrome;Left ventricular noncompaction,Disease-causing germline mutation(s) in;Role in the phenotype of;Disease-causing germline mutation(s) in,Systolic blood pressure[27618448];Headache[29397368];Mean corpuscular volume[27863252];Mean corpuscular hemoglobin[27863252];Migraine[23793025;21666692;27322543;27322543;27182965];Diastolic blood pressure[27618448];Hematocrit[27863252];Platelet distribution width[27863252];Plateletcrit[27863252];Response to statin therapy[20339536];Red blood cell count[27863252];Mean arterial pressure[27618448];Nose morphology[29921221];Coronary artery disease[29212778;29212778;29212778];Type 1 diabetes autoantibodies in high risk HLA genotype individuals (time to event)[29310926];Mean platelet volume[27863252];Allergic rhinitis[25085501];Motion sickness[25628336];QRS duration[25035420];Cognitive decline (age-related)[28078323];Post bronchodilator FEV1/FVC ratio in COPD[26634245];,0.19190184049079756,1.0,0.23388149308274603,0.7874462860650706
2836,25236,PRDX6,602316,,,Dejerine-Sottas syndrome;Charcot-Marie-Tooth disease type 4F,Disease-causing germline mutation(s) (loss of function) in;Disease-causing germline mutation(s) in,Systemic lupus erythematosus[26663301;26663301];Blood protein levels[30072576];,0.9137423312883436,0.26044352759154205,0.9334377447141738,0.29066912216083485
2837,25260,PREPL,609557,606407;616224;,"[MIM:616224]Myasthenic syndrome, congenital, 22 [recessive?];",2p21 microdeletion syndrome;Hypotonia-cystinuria syndrome;Atypical hypotonia-cystinuria syndrome;2p21 microdeletion syndrome without cystinuria,Role in the phenotype of;Role in the phenotype of;Role in the phenotype of;Role in the phenotype of,antipsychotic drug dosage in schizophrenia or schizoaffective disorder[26821981];,0.8450306748466258,0.1294481691593605,0.46071521795875753,0.8658686310620012
2838,25263,PRF1,170280,603553;,[MIM:603553]Familial hemophagocytic lymphohistiocytosis 2;,Familial hemophagocytic lymphohistiocytosis;Fatal post-viral neurodegenerative disorder;Idiopathic aplastic anemia,Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Major susceptibility factor in,Obesity (extreme)[19553259];Multiple keratinocyte cancers[28081215];,0.19190184049079756,0.21944301186178441,0.47350561211172015,0.9122160834868017
2839,25266,PRG4,604283,208250;,[MIM:208250]Camptodactyly-arthropathy-coxa vara-pericarditis syndrome [recessive?];,Camptodactyly-arthropathy-coxa-vara-pericarditis syndrome,Disease-causing germline mutation(s) in,Clozapine-induced cytotoxicity[25656473;25656473;25656473];,0.038773006134969326,0.42676637441980403,0.09370921430435918,0.07704112952731737
2840,25269,PRICKLE1,608500,182940;612437;,[MIM:182940]Neural tube defects;,Unverricht-Lundborg disease,Disease-causing germline mutation(s) in,Heart failure[20445134];Parkinson's disease[27182965];Endometrial cancer (Non-endometrioid histology)[30093612];Graves' disease[22922229];Autoimmune thyroid diseases (Graves disease or Hashimoto's thyroiditis)[22922229];Visceral adipose tissue/subcutaneous adipose tissue ratio[22589738];Night sleep phenotypes[27126917];,0.43754601226993867,0.9868488911810211,0.3503001827199165,0.830877839165132
2841,25270,PRICKLE2,608501,,,Progressive myoclonic epilepsy type 5,Candidate gene tested in,Waist-to-hip ratio adjusted for BMI (age >50)[26426971];Waist-to-hip ratio adjusted for BMI (age <50)[26426971];Systemic juvenile idiopathic arthritis[27927641];Diisocyanate-induced asthma[25918132];Coronary artery calcification[23870195];Seborrheic dermatitis[29203360];Waist-to-hip ratio adjusted for BMI[26426971];Folate pathway vitamin levels[19303062];Waist-to-hip ratio adjusted for BMI x sex x age interaction (4df test)[26426971];,0.12711656441717792,0.6747034553893759,0.6570086139389193,0.8331798649478207
2842,25285,PRKACA,601639,615830;,[MIM:615830]Primary pigmented nodular adrenocortical disease 4;,Primary pigmented nodular adrenocortical disease;Fibrolamellar hepatocellular carcinoma,Role in the phenotype of;Part of a fusion gene in,,0.967239263803681,0.8465703971119134,0.9574523623074915,0.8067833026396563
2843,25287,PRKACG,176893,616176;,,Severe autosomal recessive macrothrombocytopenia,Disease-causing germline mutation(s) (loss of function) in,Night sleep phenotypes[27126917];,0.505398773006135,0.0,0.23623074915165754,0.24984653161448742
2844,25289,PRKAG2,602743,194200;261740;600858;,"[MIM:194200]Wolff-Parkinson-White syndrome;[MIM:600858]Cardiomyopathy, familial hypertrophic 6;[MIM:261740]Glycogen storage disease of heart lethal congenital;",Fatal congenital hypertrophic cardiomyopathy due to glycogen storage disease,Disease-causing germline mutation(s) in,Systolic blood pressure[27618447];Urate levels[23263486];Hematocrit[19862010;28017375;27863252];Glomerular filtration rate in diabetes[29703844;29703844];Chronic kidney disease[20383146;26831199];Gut microbiota (beta diversity)[27723756];Red blood cell count[27863252;28453575];Hemoglobin concentration[27863252];Glomerular filtration rate[27588450;27588450];Glaucoma (primary open-angle)[29891935];Glomerular filtration rate in type 2 diabetes[29703844;29703844];Red blood cell traits[23222517];Metabolite levels (small molecules and protein measures)[27005778];Glomerular filtration rate in non diabetics (creatinine)[26831199];Hemoglobin levels[28017375];Hemoglobin[19862010];Urea levels[28270201];Bipolar disorder (age of onset and psychotic symptoms)[21305692];Glomerular filtration rate (creatinine)[26831199;28452372];Intraocular pressure[29785010];,0.5850306748466257,0.9649303764827231,0.44139911250326286,0.9614794352363413
2845,25292,PRKAR1A,188830,101800;160980;255960;610489;,"[MIM:160980]Carney complex 1;[MIM:255960]Intracardiac myxoma [recessive?];[MIM:610489]Primary pigmented nodular adrenocortical disease 1;[MIM:101800]Acrodysostosis 1, with or without hormone resistance;",Primary pigmented nodular adrenocortical disease;Acrodysostosis;Carney complex;Acrodysostosis with multiple hormone resistance;Acute promyelocytic leukemia;Familial atrial myxoma,Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) (gain of function) in;Disease-causing germline mutation(s) (loss of function) in;Disease-causing germline mutation(s) (gain of function) in;Part of a fusion gene in;Disease-causing germline mutation(s) in,,0.8341104294478527,0.8666838576585869,0.9634560167058209,0.877378759975445
2846,25294,PRKAR1B,176911,,,PRKAR1B-related neurodegenerative dementia with intermediate filaments,Disease-causing germline mutation(s) in,Hematocrit[27863252];Red blood cell count[27863252];Hemoglobin concentration[27863252];,0.6301840490797546,0.8403816400206292,0.6872879143826677,0.8715469613259669
2847,25301,PRKCD,176977,615559;,[MIM:615559]Autoimmune lymphoproliferative syndrome 3;,Common variable immunodeficiency;Autoimmune lymphoproliferative syndrome;Autosomal systemic lupus erythematosus,Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) (loss of function) in;Disease-causing germline mutation(s) in,Disrupted circadian rhythm (low relative amplitude of rest-activity cycles)[30120083];Bipolar disorder[21926972];Ulcerative colitis[23128233];,0.7512883435582822,0.8274883960804539,0.7992691203341165,0.6513198281154082
2848,25303,PRKCG,176980,605361;,[MIM:605361]Spinocerebellar ataxia 14 [dominant?];,Spinocerebellar ataxia type 14,Disease-causing germline mutation(s) in,,0.48576687116564415,0.8906652913873131,0.6327329678935004,0.742633517495396
2849,25308,PRKCSH,177060,174050;,[MIM:174050]Polycystic liver disease 1 with or without kidney cysts [dominant?];,Isolated polycystic liver disease,Disease-causing germline mutation(s) in,Presence of antiphospholipid antibodies[27098658;27098658;27098658];,0.9482208588957055,0.29473955647240846,0.04594100756982511,0.405463474524248
2850,25311,PRKD1,605435,617364;,[MIM:617364]Congenital heart defects and ectodermal dysplasia [dominant?];,Malignant epithelial tumor of salivary glands,Disease-causing somatic mutation(s) in,Type 2 diabetes[30130595];Cerebral amyloid deposition in APOEe4 non-carriers (PET imaging)[26252872];Body mass index (joint analysis main effects and smoking interaction)[28443625];Schizophrenia[25056061];General cognitive ability[29844566;29844566];Body mass index (joint analysis main effects and physical activity interaction)[28448500;28448500;28448500;28448500];Body mass index[20935630;23669352;28448500;28448500;28448500;28448500;25673413;25673413;25673413;25673413;25673413;25673413];Waist circumference[25673412;25673412];Intelligence (MTAG)[29326435;29326435];Body mass index in physically active individuals[28448500;28448500;28448500];Carotid plaque burden[28282560];Obesity-related traits[23251661];Childhood body mass index[26604143];BMI (adjusted for smoking behaviour)[28443625];,0.8014723926380368,0.7111913357400722,0.3552597233098408,0.5448127685696746
2851,25312,PRKD2,607074,,,Autosomal dominant polycystic kidney disease,Disease-causing germline mutation(s) in,Chronic lymphocytic leukemia[18758461;28165464];Primary sclerosing cholangitis[27992413];Coronary artery disease[29212778];Post bronchodilator FEV1[26634245;26634245;26634245;26634245;26634245;26634245;26634245];,0.5353374233128835,0.962867457452295,0.525711302531976,0.0
2852,25314,PRKDC,600899,615966;,[MIM:615966]Immunodeficiency 26 with or without neurologic abnormalities;,Severe combined immunodeficiency due to DNA-PKcs deficiency,Disease-causing germline mutation(s) in,,0.9923926380368098,0.7516761217122228,0.2406682328373793,0.0
2853,25315,PRKG1,176894,615436;,"[MIM:615436]Aortic aneurysm, familial thoracic 8;",Familial thoracic aortic aneurysm and aortic dissection,Disease-causing germline mutation(s) (gain of function) in,Rosacea symptom severity[29771307];Mammographic density (non-dense area)[25342443];Autism spectrum disorder or schizophrenia[28540026];Interferon alpha levels in systemic lupus erythematosus[25338677];Obesity-related traits[23251661];Chlamydia trachomatis seropositivity[29967566];Gait rhythm[26219847];Coronary artery disease[29212778];Loneliness (multivariate analysis)[27629369];Asthma[21907864];Alcohol misuse (trauma interaction)[28265120];,0.4538650306748466,0.9577101598762249,0.44531453928478204,0.9089932473910375
2854,25318,PRKN,602544,168600;600116;,[MIM:168600]Parkinson disease;[MIM:600116]Parkinson disease 2;,Young-onset Parkinson disease,Disease-causing germline mutation(s) in,"Cleft palate[27018472;27018472;27018472];Squamous cell carcinoma[26908436];Lipoprotein (a) levels[26377243];Body mass index (joint analysis main effects and smoking interaction)[28443625;28443625];Disc degeneration (lumbar)[22993228];Itch intensity from mosquito bite[28199695];Facial morphology (factor 9, facial height related to vertical position of nasion)[28441456];Body mass index (joint analysis main effects and physical activity interaction)[28448500;28448500;28448500;28448500];Mitochondrial DNA levels[25240745;25240745];Plasma t-tau levels[28100725];BMI in non-smokers[28443625;28443625];Body mass index[28448500;28448500;28448500;28448500;25673413;25673413;25673413];Virologic severity in Herpes simplex virus type 2 infection[29535370];Body mass index in physically active individuals[28448500;28448500;28448500;28448500];Mosquito bite size[28199695];Pancreatic cancer[20686608];Fear of pain[28701861];Aging[22773346];Metabolite levels[19043545];Post bronchodilator FEV1/FVC ratio[26634245;26634245;26634245;26634245;26634245;26634245];Primary vesicoureteric reflux[29097723];BMI (adjusted for smoking behaviour)[28443625;28443625];",0.7209815950920245,0.18798349664775657,0.0,0.0
2855,25319,PRKRA,603424,612067;,[MIM:612067]Dystonia 16;,Dystonia 16,Disease-causing germline mutation(s) in,Multiple sclerosis (OCB status)[23472185];Rapid functional decline in sporadic amyotrophic lateral sclerosis[26746183];Inflammatory skin disease[25574825];,0.7440490797546012,0.6701908200103146,0.15531192900026103,0.5441988950276243
2856,25331,PRLR,176761,615554;615555;,[MIM:615554]Multiple fibroadenomas of the breast;[MIM:615555]Hyperprolactinemia;,Familial  hyperprolactinemia,Disease-causing germline mutation(s) (loss of function) in,Advanced age-related macular degeneration[26691988];Paneth cell defects in Crohn's disease[28352666];Response to lurasidone in schizophrenia[29730043];,0.3706748466257669,0.8865394533264569,0.42991386061080655,0.6094229588704727
2857,25343,PRMT7,610087,617157;,"[MIM:617157]Short stature, brachydactyly, intellectual developmental disability, and seizures [recessive?];",Short stature-brachydactyly-obesity-global developmental delay syndrome,Disease-causing germline mutation(s) (loss of function) in,Body mass index[25673413;25673413;28892062];Serum metabolite levels[23093944];Magnesium levels[20700443];,0.5858895705521472,0.4076843733883445,0.7528060558600888,0.240024554941682
2858,25348,PRNP,176640,,,Gerstmann-Straussler-Scheinker syndrome;Fatal familial insomnia;Huntington disease-like 1;Familial Alzheimer-like prion disease;Inherited Creutzfeldt-Jakob disease;Kuru;PrP systemic amyloidosis,Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Major susceptibility factor in;Disease-causing germline mutation(s) in,Creutzfeldt-Jakob disease (sporadic)[25918841];Creutzfeldt-Jakob disease (variant)[22137330;22137330];Creutzfeldt-Jakob disease[19081515];Waist circumference adjusted for BMI (joint analysis main effects and smoking interaction)[28443625];Prion diseases[22210626];Platelet aggregation[20526338];Waist circumference adjusted for BMI (smoking interaction)[28443625];,0.5598773006134969,0.3145951521402785,0.16966849386583138,0.9594843462246777
2859,25351,PROC,612283,176860;612304;,"[MIM:176860]Thrombophilia due to protein C deficiency, autosomal dominant [dominant?];[MIM:612304]Thrombophilia due to protein C deficiency, autosomal recessive [recessive?];",Severe hereditary thrombophilia due to congenital protein C deficiency,Disease-causing germline mutation(s) in,Protein C levels[20802025;25376901;28082259];Blood protein levels[30072576;30072576];,0.3449079754601227,0.25605982465188243,0.683894544505351,0.7949662369551872
2860,25354,PRODH,606810,181500;239500;600850;,[MIM:239500]Hyperprolinemia 1;[MIM:600850]Schizophrenia 4;,Hyperprolinemia type 1,Disease-causing germline mutation(s) in,Blood metabolite ratios[24816252];Blood metabolite levels[24816252];Serum metabolite concentrations in chronic kidney disease[29545352];Amino acid levels[26068415;26068415];Metabolic traits[21886157];,0.17791411042944785,0.39118102114492004,0.13625685199686766,0.21209330877839166
2861,25357,PROK2,607002,610628;,[MIM:610628]Hypogonadotropic hypogonadism 4 with or without anosmia;,Kallmann syndrome;Normosmic congenital hypogonadotropic hypogonadism,Disease-causing germline mutation(s) (loss of function) in;Disease-causing germline mutation(s) (loss of function) in,Monocyte count[27863252];Blood protein levels[30072576];,0.08736196319018405,0.5074780814853017,0.7120856173322893,0.3580417434008594
2862,25359,PROKR2,607123,244200;,,Septo-optic dysplasia spectrum;Kallmann syndrome;Normosmic congenital hypogonadotropic hypogonadism;Pituitary stalk interruption syndrome,Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) (loss of function) in;Disease-causing germline mutation(s) (loss of function) in;Candidate gene tested in,,0.12711656441717792,0.2117070654976792,0.43278517358392066,0.3543585021485574
2863,25360,PROM1,604365,603786;608051;612095;612657;,[MIM:612095]Retinitis pigmentosa 41;[MIM:612657]Cone-rod dystrophy 12;[MIM:603786]Stargardt disease 4;[MIM:608051]Retinal macular dystrophy 2;,Stargardt disease;Retinitis pigmentosa;Cone rod dystrophy;Retinal macular dystrophy type 2,Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in,Glomerular filtration rate in chronic kidney disease[26420894];Dental caries[23064961];Suicide attempts in depression or bipolar disorder[24964207];Intracranial aneurysm[29531279];Self-rated health[20707712];,0.14576687116564419,0.05621454357916452,0.6520490733489951,0.0
2864,25362,PROP1,601538,262600;,,"Hypothyroidism due to deficient transcription factors involved in pituitary development or function;Panhypopituitarism;Combined pituitary hormone deficiencies, genetic forms",Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in,,0.6914110429447853,0.556472408457968,0.9075959279561472,0.5888581952117864
2865,25365,PROS1,176880,612336;614514;,"[MIM:612336]Thrombophilia due to protein S deficiency, autosomal dominant [dominant?];[MIM:614514]Thrombophilia due to protein S deficiency, autosomal recessive [recessive?];",Severe hereditary thrombophilia due to congenital protein S deficiency,Disease-causing germline mutation(s) in,Systemic lupus erythematosus[28714469];,0.28662576687116564,0.6064981949458483,0.5476376925084834,0.5701350521792511
2866,25374,PROZ,176895,,,Cerebral sinovenous thrombosis,Candidate gene tested in,Food allergy (parent-of-origin effect)[29489655];Blood protein levels[28240269;28240269];Factor VII[17903294];,0.3856441717791411,0.05208870551830841,0.5429391803706604,0.5796500920810314
2867,25375,PRPF3,607301,601414;,[MIM:601414]Retinitis pigmentosa 18;,Retinitis pigmentosa,Disease-causing germline mutation(s) in,Plateletcrit[27863252];Morning vs. evening chronotype[27494321];Chronotype[27494321];Blood protein levels[28240269;28240269];Platelet count[27863252];,0.7990184049079755,0.9579680247550284,0.8950665622552858,0.9215776550030693
2868,25376,PRPF4,607795,615922;,[MIM:615922]Retinitis pigmentosa 70;,Retinitis pigmentosa,Disease-causing germline mutation(s) (loss of function) in,White matter growth[29682794];,0.8863803680981595,0.9733109850438371,0.721221613155834,0.8373235113566605
2869,25378,PRPF6,613979,613983;,,Retinitis pigmentosa,Disease-causing germline mutation(s) in,Prostate cancer[23535732];,0.9366871165644172,0.4406910778751934,0.858783607413208,0.3944137507673419
2870,25379,PRPF8,607300,600059;,[MIM:600059]Retinitis pigmentosa 13;,Retinitis pigmentosa,Disease-causing germline mutation(s) in,Calcium levels[20705733];Stroke[29531354];Blood protein levels[28240269];Ischemic stroke[29531354;29531354];,0.9531288343558282,1.0,0.8608718350300183,0.6697360343769183
2871,25383,PRPF31,606419,600138;,[MIM:600138]Retinitis pigmentosa 11;,Retinitis pigmentosa,Disease-causing germline mutation(s) in,Change in HbA1c levels in response to metformin treatment in type 2 diabetes[29650774];,0.9295705521472393,0.8816400206291903,0.9274340903158445,0.6883057090239411
2872,25391,PRPH,170710,,,Amyotrophic lateral sclerosis,Major susceptibility factor in,Prostate cancer[21743467];,0.8714110429447853,0.18334192882929345,0.4419211694074654,0.447206875383671
2873,25392,PRPH2,179605,136880;169150;268000;608133;608161;613105;,"[MIM:136880]Retinitis punctata albescens;[MIM:608161]Macular dystrophy, vitelliform, 3;[MIM:169150]Macular dystrophy, patterned, 1;[MIM:613105]Choroidal dystrophy, central areolar 2;",Stargardt disease;Retinitis pigmentosa;Cone rod dystrophy;Fundus albipunctatus;Central areolar choroidal dystrophy;Retinitis punctata albescens;Butterfly-shaped pigment dystrophy;Adult-onset foveomacular vitelliform dystrophy;Multifocal pattern dystrophy simulating fundus flavimaculatus,Candidate gene tested in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Candidate gene tested in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in,,0.12711656441717792,0.5871583290355854,0.6559645001305142,0.6869244935543278
2874,25393,PRPS1,311850,300661;301835;304500;311070;,"[MIM:300661]Phosphoribosylpyrophosphate synthetase superactivity;[MIM:311070]Charcot-Marie-Tooth disease, X-linked recessive, 5;[MIM:301835]ARTS syndrome;[MIM:304500]Deafness, X-linked, 1;",Lethal ataxia with deafness and optic atrophy;Mild phosphoribosylpyrophosphate synthetase superactivity;Severe phosphoribosylpyrophosphate synthetase superactivity;X-linked intellectual disability-limb spasticity-retinal dystrophy-diabetes insipidus syndrome;X-linked non-syndromic sensorineural deafness type DFN;X-linked Charcot-Marie-Tooth disease type 5,Disease-causing germline mutation(s) (loss of function) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) (gain of function) in;Disease-causing germline mutation(s) (loss of function) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in,,0.8814723926380368,0.8788035069623518,0.0,0.0
2875,25463,PRRT2,614386,128200;602066;605751;,"[MIM:128200]Episodic kinesigenic dyskinesia 1 [dominant?];[MIM:602066]Convulsions, familial infantile, with paroxysmal choreoathetosis;[MIM:605751]Seizures, benign familial infantile, 2 [dominant?];",Familial or sporadic hemiplegic migraine;Benign familial infantile epilepsy;Infantile convulsions and choreoathetosis;Paroxysmal exertion-induced dyskinesia;Paroxysmal non-kinesigenic dyskinesia;Paroxysmal kinesigenic dyskinesia,Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in,,0.21484662576687116,0.723826714801444,0.5071782824327852,0.38152240638428486
2876,25467,PRRX1,167420,202650;,[MIM:202650]Agnathia-otocephaly complex;,Agnathia-holoprosencephaly-situs inversus syndrome,Disease-causing germline mutation(s) (loss of function) in,Early onset atrial fibrillation[28460022];Prevalent atrial fibrillation[28416818];Emphysema imaging phenotypes[26030696;26030696];Atrial fibrillation[22544366;28416822;29290336;28416818;28416818;29892015;29892015;29892015];Heel bone mineral density[28869591;28869591];Blood protein levels[29875488];Waist-to-hip ratio adjusted for BMI[26426971];Total cholesterol change in response to fenofibrate in statin-treated type 2 diabetes[28736931];Male-pattern baldness[29146897];Ischemic stroke (cardioembolic)[29531354];Hip circumference adjusted for BMI[25673412;25673412;25673412];Response to angiotensin II receptor blocker therapy[22566498];Intraocular pressure[29617998;29617998];Waist-to-hip ratio adjusted for BMI x sex x age interaction (4df test)[26426971];,0.17791411042944785,0.5799381124290871,0.580005220569042,0.8453038674033149
2877,25472,PRSS1,276000,167800;,"[MIM:167800]Pancreatitis, hereditary;",Hereditary chronic pancreatitis,Disease-causing germline mutation(s) (gain of function) in,Alcoholic chronic pancreatitis[28754779;28754779;28754779;28754779;28754779;28754779;28754779;28754779;28754779;28754779;28754779;28754779;28754779;28754779;28754779;28754779;28754779;28754779;28754779;28754779;28754779;28754779;28754779;28754779;28754779;28754779;28754779;28754779;28754779;28754779;28754779;28754779;28754779;28754779;28754779;28754779;28754779;28754779;28754779;28754779;28754779;28754779;28754779;28754779;28754779;28754779];Methadone dose in opioid dependence[28115739];Pancreatitis[23143602];Cancer[29299148];,0.6095705521472392,0.22047447137699847,0.8112764291307752,0.7516881522406385
2878,25473,PRSS2,601564,,,Hereditary chronic pancreatitis,Candidate gene tested in,Pancreatitis[23143602];Blood protein levels[29875488];,0.28662576687116564,0.0,0.0,0.0
2879,25480,PRSS12,606709,249500;,,Autosomal recessive non-syndromic intellectual disability,Disease-causing germline mutation(s) in,Congenital heart disease (maternal effect)[28468790];,0.17791411042944785,0.013151108818978855,0.09188201513965022,0.5285451197053407
2880,25509,PRSS56,613858,613517;,"[MIM:613517]Microphthalmia, isolated, 6;",Nanophthalmia,Disease-causing germline mutation(s) in,Spherical equivalent or myopia (age of diagnosis)[29808027];Refractive error[23396134;23396134];Myopia[27182965];,0.4190184049079755,0.3017019082001031,0.4620203602192639,0.0
2881,25514,PRTN3,177020,,,Granulomatosis with polyangiitis,Major susceptibility factor in,White blood cell count (basophil)[27863252];Basophil percentage of white cells[27863252];Monocyte percentage of white cells[27863252];Blood protein levels[29875488;29875488;30072576;30072576];Antineutrophil cytoplasmic antibody-associated vasculitis[28029757];Basophil percentage of granulocytes[27863252];,0.4463803680981595,0.27643115007735947,0.20412424954320021,0.46193984039287905
2882,25518,PRX,605725,145900;614895;,[MIM:145900]Dejerine-Sottas syndrome [dominant?] [recessive?];[MIM:614895]Charcot-Marie-Tooth disease 4F [recessive?];,Dejerine-Sottas syndrome;Charcot-Marie-Tooth disease type 4F,Disease-causing germline mutation(s) (loss of function) in;Disease-causing germline mutation(s) in,Otitis media (chronic)[27632927];Otitis media[27632927];Otitis media (recurrent)[27632927];,0.23865030674846627,0.06601340897369778,0.29052466718872355,0.18753836709637814
2883,25532,PSAP,176801,249900;610539;611721;611722;,"[MIM:611721]Combined saposin deficiency;[MIM:249900]Leukodystrophy metachromatic due to saposin-B deficiency;[MIM:610539]Gaucher disease, atypical, due to saposin C deficiency;[MIM:611722]Krabbe disease, atypical, due to saposin A deficiency;","Encephalopathy due to prosaposin deficiency;Infantile Krabbe disease;Metachromatic leukodystrophy, adult form;Atypical Gaucher disease due to saposin C deficiency;Metachromatic leukodystrophy, late infantile form;Metachromatic leukodystrophy, juvenile form",Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in,Blood protein levels[30072576;30072576];Asthma (childhood onset)[23829686];,0.5203680981595092,0.9324394017534812,0.7019055077003393,0.8078575813382444
2884,25534,PSAT1,610936,610992;616038;,[MIM:616038]Neu-Laxova syndrome 2 [recessive?];,Neu-Laxova syndrome;Phosphoserine aminotransferase deficiency,Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in,Visceral fat[22589738];Obesity-related traits[23251661];,0.5488343558282208,0.1361526560082517,0.8170190550770033,0.5796500920810314
2885,25546,PSEN1,104311,600274;607822;613694;613737;,"[MIM:607822]Alzheimer disease 3;[MIM:600274]Frontotemporal dementia;[MIM:613694]Cardiomyopathy, dilated 1U;[MIM:613737]Acne inversa, familial, 3;",Early-onset autosomal dominant Alzheimer disease;Familial isolated dilated cardiomyopathy;Behavioral variant of frontotemporal dementia;Semantic dementia;Progressive non-fluent aphasia,Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in,,0.6103067484662577,0.7862300154718928,0.7298355520751761,0.992633517495396
2886,25547,PSEN2,600759,606889;613697;,"[MIM:606889]Alzheimer disease 4;[MIM:613697]Cardiomyopathy, dilated 1V;",Early-onset autosomal dominant Alzheimer disease;Familial isolated dilated cardiomyopathy,Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in,,0.52920245398773,0.0,0.5142260506395198,0.93646408839779
2887,25548,PSENEN,607632,613736;,,Dowling-Degos disease,Disease-causing germline mutation(s) in,,0.4463803680981595,0.7359463641052089,0.9177760375880971,0.0
2888,25581,PSMA7,606607,,,Immunodeficiency due to a late component of complement deficiency,Disease-causing germline mutation(s) in,Response to fenofibrate (adiponectin levels)[23149075];Blood protein levels[28240269];,0.9266257668711656,0.8922124806601341,0.9637170451579222,0.0
2889,25594,PSMB8,177046,256040;,[MIM:256040]Proteasome-associated autoinflammatory syndrome 1 [recessive?];,Nakajo-Nishimura syndrome;JMP syndrome;CANDLE syndrome,Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in,Nephropathy[21399633];IgA nephropathy[25305756];Autism spectrum disorder or schizophrenia[28540026;28540026;28540026;28540026;28540026];Blood protein levels[28240269];,0.7052760736196318,0.4002062919030428,0.1929000261028452,0.11295273173726213
2890,25615,PSMC3IP,608665,614324;,[MIM:614324]Ovarian dysgenesis 3;,"46,XX gonadal dysgenesis",Disease-causing germline mutation(s) in,Colorectal or endometrial cancer[26621817];,0.33975460122699386,0.28287777204744713,0.3599582354476638,0.07458563535911603
2891,25678,PSPH,172480,614023;,[MIM:614023]Phosphoserine phosphatase deficiency [recessive?];,3-phosphoserine phosphatase deficiency,Disease-causing germline mutation(s) in,Plasma homocysteine levels (post-methionine load test)[24651765];Blood metabolite levels[24816252];Macular telangiectasia type 2[28250457];Amino acid levels[26068415];,0.30319018404907977,0.0,0.7642913077525451,0.557243707796194
2892,25683,PSTPIP1,606347,604416;,[MIM:604416]PAPA syndrome [dominant?];,Hyperzincemia and hypercalprotectinemia;Pyogenic arthritis-pyoderma gangrenosum-acne syndrome,Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in,,0.5450306748466258,0.4584837545126354,0.5035238841033672,0.1576120319214242
2893,25696,PTCH1,601309,109400;605462;610828;,[MIM:109400]Basal cell nevus syndrome [dominant?];[MIM:605462]Basal cell carcinoma;[MIM:610828]Holoprosencephaly 7;,Gorlin syndrome;Microform holoprosencephaly;Septopreoptic holoprosencephaly;Semilobar holoprosencephaly;Monosomy 9q22.3;Midline interhemispheric variant of holoprosencephaly;Lobar holoprosencephaly;Alobar holoprosencephaly,Disease-causing germline mutation(s) (loss of function) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Role in the phenotype of;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in,Bone mineral density (hip)[26733130];Waist circumference adjusted for BMI (joint analysis main effects and physical activity interaction)[28448500;28448500;28448500;28448500;28448500];Waist circumference adjusted for BMI in non-smokers[28443625];Pulmonary function (smoking interaction)[23284291];Heel bone mineral density[28869591;28869591;28869591];Waist circumference adjusted for BMI (adjusted for smoking behaviour)[28443625;28443625];Infant length[25281659];Waist circumference adjusted for body mass index[28448500;28448500;28448500;28448500;28448500;25673412;25673412;25673412];Bone mineral density (spine)[26733130];Pulmonary function[20010835];Hip circumference adjusted for BMI[25673412;25673412;25673412];Monobrow[27182965];Waist circumference adjusted for BMI (joint analysis main effects and smoking interaction)[28443625];Height[18391952;25429064;25282103;25282103];Birth weight[27680694];Nonsyndromic cleft lip with cleft palate[28232668];Waist circumference adjusted for BMI in active individuals[28448500;28448500;28448500;28448500;28448500];Thiopurine-induced pancreatitis in inflammatory bowel disease[29923122];,0.541840490797546,0.9012377514182568,0.03262855651265988,0.9987722529158993
2894,25697,PTCH2,603673,155255;605462;,[MIM:155255]Medulloblastoma;[MIM:605462]Basal cell carcinoma;,Gorlin syndrome;Tessier number 7 facial cleft,Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in,,0.14576687116564419,0.03739040742650851,0.37588097102584184,0.9251074278698588
2895,25698,PTCHD1,300828,300830;,,X-linked non-syndromic intellectual disability,Candidate gene tested in,Immune reponse to smallpox (secreted IFN-alpha)[22610502];Hair color[26926045];Response to serotonin reuptake inhibitors in major depressive disorder[25897834];,0.038773006134969326,0.3259412068076328,0.884886452623336,0.8001841620626151
2896,25709,PTDSS1,612792,151050;,[MIM:151050]Lenz-Majewski hyperostotic dwarfism;,Lenz-Majewski hyperostotic dwarfism,Disease-causing germline mutation(s) (gain of function) in,Obesity-related traits[23251661];Huntington's disease progression[28642124];,0.8846625766871166,0.49535843218153686,0.578178021404333,0.34499693063228976
2897,25711,PTEN,601728,137800;158350;176807;275355;605309;608089;612242;613028;,[MIM:158350]Cowden syndrome 1 [dominant?];[MIM:158350]Lhermitte-Duclos disease;[MIM:275355]Squamous cell carcinoma of the head and neck;[MIM:608089]Endometrial cancer;[MIM:613028]Glioma 2;[MIM:176807]Prostate cancer;[MIM:605309]Macrocephaly/autism syndrome;,Cowden syndrome;Proteus syndrome;Bannayan-Riley-Ruvalcaba syndrome;Segmental outgrowth-lipomatosis-arteriovenous malformation-epidermal nevus syndrome;Proteus-like syndrome;Macrocephaly-intellectual disability-autism syndrome;Hereditary breast and ovarian cancer syndrome;Activated PI3K-delta syndrome;Squamous cell carcinoma of the hypopharynx;Squamous cell carcinoma of the larynx;Squamous cell carcinoma of the oropharynx;Squamous cell carcinoma of salivary glands;Squamous cell carcinoma of the nasal cavity and paranasal sinuses;Squamous cell carcinoma of the oral cavity;Squamous cell carcinoma of the lip;Lhermitte-Duclos disease;Juvenile polyposis of infancy,Disease-causing germline mutation(s) (loss of function) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Candidate gene tested in;Disease-causing germline mutation(s) (loss of function) in;Disease-causing somatic mutation(s) in;Disease-causing somatic mutation(s) in;Disease-causing somatic mutation(s) in;Disease-causing somatic mutation(s) in;Disease-causing somatic mutation(s) in;Disease-causing somatic mutation(s) in;Disease-causing somatic mutation(s) in;Disease-causing germline mutation(s) (loss of function) in;Role in the phenotype of,Type 2 diabetes[24509480];Sum eosinophil basophil counts[27863252];Eosinophil percentage of granulocytes[27863252];Psoriasis[28537254];White blood cell count (basophil)[29403010];Mercury levels[26025379];Eosinophil counts[27863252];Neutrophil percentage of granulocytes[27863252];Periodontitis (Mean PAL)[24024966];Eosinophil percentage of white cells[27863252];,0.6694478527607362,0.8277462609592573,0.9818585225789611,0.8035604665438919
2898,25715,PTF1A,607194,609069;615935;,[MIM:615935]Pancreatic agenesis 2;,Partial pancreatic agenesis;Permanent neonatal diabetes mellitus-pancreatic and cerebellar agenesis syndrome,Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in,,0.26588957055214724,0.5956678700361011,0.6525711302531976,0.0
2899,25746,PTH,168450,146200;,"[MIM:146200]Hypoparathyroidism, familial isolated;",Familial isolated hypoparathyroidism due to impaired PTH secretion,Disease-causing germline mutation(s) in,Childhood ear infection[27182965];Bone mineral density[19874204];Menarche (age at onset)[25231870];Progression free survival in serous epithelial ovarian cancer treated with carboplatin and paclitaxel[28935272];,0.16220858895705523,0.44662197008767407,0.9882537196554424,0.38152240638428486
2900,25747,PTH1R,168468,125350;156400;166000;215045;600002;,[MIM:156400]Jansen metaphyseal chondrodysplasia [dominant?];[MIM:215045]Chondrodysplasia Blomstrand type;[MIM:166000]Enchondromatosis multiple;[MIM:600002]Eiken skeletal dysplasia;[MIM:125350]Primary failure of tooth eruption;,"Ollier disease;Primary failure of tooth eruption;Eiken syndrome;Metaphyseal chondrodysplasia, Jansen type;Blomstrand lethal chondrodysplasia",Disease-causing germline mutation(s) (loss of function) in;Disease-causing germline mutation(s) (loss of function) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) (gain of function) in;Disease-causing germline mutation(s) in,Birth weight[27680694];Microalbuminuria[26631737];,0.4667484662576687,0.7387828777720474,0.6468285043069695,0.33594229588704727
2901,25750,PTHLH,168470,613382;,[MIM:613382]Brachydactyly E2;,Brachydactyly type E,Disease-causing germline mutation(s) (loss of function) in,"Bone mineral density (paediatric, lower limb)[24945404;24945404];Breast cancer (estrogen-receptor negative, progesterone-receptor negative, and human epidermal growth factor-receptor negative)[24325915];Breast size[22747683;27182965];Ossification of the posterior longitudinal ligament of the spine[25064007];Asthma and hay fever[24388013];Bone mineral density (paediatric, total body less head)[24945404;24945404];Breast cancer[23535733;27117709;27117709;23535729];Blood protein levels[29875488;30072576];Breast cancer (estrogen-receptor negative)[27117709;27117709];",0.35496932515337426,0.8339350180505415,0.9002871312973114,0.6042050337630448
2902,25794,PTPN2,176887,,,Oligoarticular juvenile idiopathic arthritis;Rheumatoid factor-negative juvenile idiopathic arthritis,Major susceptibility factor in;Major susceptibility factor in,"Celiac disease or Rheumatoid arthritis[21383967];Psoriasis[28537254];C-reactive protein levels[21300955];Chronic inflammatory diseases (ankylosing spondylitis, Crohn's disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy)[26974007;26974007];Crohn's disease[17554300;17554261;18587394;21102463;28067908];Selective IgA deficiency[27723758];Alopecia areata[25608926];Inflammatory bowel disease[28067908];Celiac disease[20190752;22057235];Body mass index[25673413;25673413];Rheumatoid arthritis (ACPA-positive)[24532676];Type 1 diabetes[17554260;18978792;19430480;21829393;25751624;25751624];Juvenile idiopathic arthritis (oligoarticular or rheumatoid factor-negative polyarticular)[23603761;23603761];Rheumatoid arthritis[22446963;24390342;24390342;24390342;23143596];Esophageal cancer (squamous cell)[22960999];Lead levels in blood[25820613];",0.818036809815951,0.776173285198556,0.5270164447924823,0.8268876611418048
2903,25797,PTPN3,176877,,,Cholangiocarcinoma,Disease-causing somatic mutation(s) in,HIV-associated neurocognitive disorder (mild neurocognitive disorder or asymptomatic neurocognitive impairment)[28447399];Coronary artery calcified atherosclerotic plaque (90 or 130 HU threshold) in type 2 diabetes[29221444];Staphylococcus aureus nasal carriage (persistent)[26569114];HIV-associated neurocognitive disorder (asymptomatic neurocogntive impairment)[28447399];HIV-associated neurocognitive disorder[28447399];Serum albumin level[29403010];Coronary artery calcified atherosclerotic plaque (130 HU threshold) in type 2 diabetes[29221444];Red blood cell density in sickle cell anemia[28552477];,0.50920245398773,0.1701908200103146,0.08196293395980161,0.5541743400859422
2904,25803,PTPN11,176876,151100;156250;163950;607785;,"[MIM:151100]LEOPARD syndrome 1;[MIM:163950]Noonan syndrome 1;[MIM:607785]Leukemia, juvenile myelomonocytic;[MIM:156250]Metachondromatosis;",Noonan syndrome;Noonan syndrome with multiple lentigines;Metachondromatosis;Juvenile myelomonocytic leukemia,Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) (loss of function) in;Disease-causing somatic mutation(s) in,Systolic blood pressure[26390057];Tetralogy of Fallot[23297363];Retinal vascular caliber[21060863];Urate levels[23263486];Hematological parameters[19820697];Diastolic blood pressure[26390057];Diastolic blood pressure x smoking status (ever vs never) interaction (2df test)[29455858;29455858];Alcohol dependence symptom count[29460428];Hypothyroidism[22493691];Mean arterial pressure[27618448];Systolic blood pressure x smoking status (current vs non-current) interaction (2df test)[29455858;29455858];Body mass index[26426971];Alcohol consumption (maxi-drinks)[29460428];Type 1 diabetes[17554300];Rheumatoid arthritis[24390342];Response to alcohol consumption (flushing response)[29460428];Diastolic blood pressure x smoking status (current vs non-current) interaction (2df test)[29455858;29455858];Reaction time[29844566;29844566];Systolic blood pressure x smoking status (ever vs never) interaction (2df test)[29455858;29455858];Blood pressure[21572416;21572416];Platelet count[22139419];,0.811042944785276,0.7197008767405879,0.8786217697729053,0.8864333947206875
2905,25806,PTPN14,603155,613611;,[MIM:613611]Choanal atresia and lymphedema;,Lymphedema-posterior choanal atresia syndrome,Disease-causing germline mutation(s) (loss of function) in,Bone mineral density (hip)[30172743];Lipid traits[24386095];Plasma thyroid-stimulating hormone levels[24722205];Height[25429064];,0.7749693251533742,0.5244971634863331,0.285304098146698,0.6921424186617556
2906,25807,PTPN18,606587,,,Autosomal recessive non-syndromic sensorineural deafness type DFNB,Disease-causing germline mutation(s) in,Coronary artery calcified atherosclerotic plaque score in type 2 diabetes[29221444];Obesity-related traits[23251661];,0.4350920245398773,0.33883445074780816,0.11250326285565126,0.4307857581338244
2907,25811,PTPN22,600716,152700;180300;193200;222100;,"[MIM:152700]Systemic lupus erythematosus;[MIM:222100]Diabetes mellitus, insulin-dependent;[MIM:180300]Rheumatoid arthritis;[MIM:193200]Vitiligo;",Systemic lupus erythematosus;Granulomatosis with polyangiitis;Giant cell arteritis;Vogt-Koyanagi-Harada disease;Oligoarticular juvenile idiopathic arthritis;Rheumatoid factor-negative juvenile idiopathic arthritis,Major susceptibility factor in;Major susceptibility factor in;Major susceptibility factor in;Major susceptibility factor in;Major susceptibility factor in;Major susceptibility factor in,"Graves' disease[22922229];Lymphocyte counts[27863252];Myeloid white cell count[27863252];Chronic inflammatory diseases (ankylosing spondylitis, Crohn's disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy)[26974007];Sum basophil neutrophil counts[27863252];Granulocyte count[27863252];Neutrophil count[27863252];Type 1 diabetes autoantibodies in high risk HLA genotype individuals (time to event)[29310926;29310926];Vitiligo[20410501;27723757];Rheumatoid arthritis (ACPA-positive)[23143596;24532676];Myasthenia gravis[23055271];Systemic lupus erythematosus[27399966;26502338;26502338;28714469;28714469;19838195];Obesity-related traits[23251661];Antineutrophil cytoplasmic antibody-associated vasculitis[28029757];Autoimmune thyroid diseases (Graves disease or Hashimoto's thyroiditis)[22922229];Idiopathic inflammatory myopathy[26362759];Crohn's disease[18587394;21102463;23128233;28067908];Breast cancer[23535729];Sum neutrophil eosinophil counts[27863252];Systemic lupus erythematosus or rheumatoid arthritis[27193031];Hypothyroidism[22493691;27182965];Type 1 diabetes and autoimmune thyroid diseases[25936594];Alopecia areata[25608926;25608926];Pediatric autoimmune diseases[26301688];Polymyositis[26362759];Gut microbiota (bacterial taxa)[27694959];Type 1 diabetes[17554260;17554300;17632545;17554260;18978792;19430480;21829393;25751624];White blood cell count[27863252];Juvenile idiopathic arthritis (oligoarticular or rheumatoid factor-negative polyarticular)[23603761];Rheumatoid arthritis[17554300;17804836;18794853;19503088;24390342;21156761;20453842;24449572;23143596];Hashimoto thyroiditis[22922229];Thyroid peroxidase antibody levels[24586183];Late-onset myasthenia gravis[26562150];Giant cell arteritis[25817017];",0.48208588957055215,0.05595667870036101,0.46541373009658055,0.2767034990791897
2908,25815,PTPRC,151460,126200;608971;,[MIM:608971]Severe combined immunodeficiency autosomal recessive T- cell-negative/B-cell-positive/NK-cell-positive [recessive?];[MIM:126200]Multiple sclerosis;,T-B+ severe combined immunodeficiency due to CD45 deficiency,Disease-causing germline mutation(s) in,Inflammatory bowel disease[26192919];Sum eosinophil basophil counts[27863252];Rheumatoid arthritis (ACPA-positive)[24532676];Vitiligo[27723757];Mean corpuscular hemoglobin concentration[29403010];Mean corpuscular hemoglobin[20139978;28017375;28017375;29403010];Systemic lupus erythematosus[27399966;27399966];Mean corpuscular volume[29403010];Lymphocyte counts[27863252];Crohn's disease[26192919;28067908];Red blood cell count[29403010];Ulcerative colitis[24837172];,0.5069938650306749,0.6990716864363073,0.7050378491255547,0.0
2909,25821,PTPRF,179590,616001;,[MIM:616001]Aplasia or hypoplasia of the breasts and/or nipples 2;,Isolated congenital breast hypoplasia/aplasia,Disease-causing germline mutation(s) (loss of function) in,Intelligence (MTAG)[29326435;29326435;29326435;29326435];Stroke[29531354];Autism spectrum disorder or schizophrenia[28540026];Schizophrenia[25056061;28991256];Amyotrophic lateral sclerosis (age of onset)[22959728];Cognitive ability (MTAG)[29186694];General cognitive ability[29844566;29844566;29844566];Educational attainment[27046643];,0.6841717791411043,1.0,0.4768989819890368,0.5099754450583179
2910,25831,PTPRO,600579,614196;,[MIM:614196]Nephrotic syndrome 6;,Familial idiopathic steroid-resistant nephrotic syndrome with diffuse mesangial sclerosis;Familial idiopathic steroid-resistant nephrotic syndrome with minimal changes;Familial idiopathic steroid-resistant nephrotic syndrome with diffuse mesangial proliferation;Familial idiopathic steroid-resistant nephrotic syndrome with focal segmental hyalinosis,Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in,Obstetric antiphospholipid syndrome[28424481];Intelligence (MTAG)[29326435];Cognitive function[22126837];General cognitive ability[29844566;29844566];Glomerular filtration rate (creatinine)[26831199];,0.5301840490797546,0.4136152656008252,0.5471156356042809,0.7140883977900553
2911,25832,PTPRQ,603317,613391;617663;,"[MIM:613391]Deafness, autosomal recessive, 84A [recessive?];[MIM:617663]Deafness, autosomal dominant, 73 [dominant?];",Autosomal dominant non-syndromic sensorineural deafness type DFNA;Autosomal recessive non-syndromic sensorineural deafness type DFNB,Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in,,0.19190184049079756,0.4855595667870036,0.0026102845210127902,0.0
2912,25833,PTPRR,602853,,,Autosomal dominant non-syndromic sensorineural deafness type DFNA;Autosomal recessive non-syndromic sensorineural deafness type DFNB,Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in,Mild influenza (H1N1) infection[26379185];Spherical equivalent or myopia (age of diagnosis)[29808027];Monobrow[27182965];Refractive error[23396134];Influenza A (H1N1) infection[26379185];Intraocular pressure[29785010];,0.4154601226993865,0.5046415678184631,0.32341425215348474,0.4189686924493554
2913,25836,PTPRU,602454,,,Familial idiopathic steroid-resistant nephrotic syndrome with diffuse mesangial sclerosis;Familial idiopathic steroid-resistant nephrotic syndrome with minimal changes;Familial idiopathic steroid-resistant nephrotic syndrome with diffuse mesangial proliferation;Familial idiopathic steroid-resistant nephrotic syndrome with focal segmental hyalinosis,Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in,Pediatric non-alcoholic fatty liver disease activity score[23535911];Schizophrenia[28991256];Bipolar disorder and schizophrenia[20889312];Blood protein levels[30072576];Paclitaxel disposition in epithelial ovarian cancer[29367611];,0.39631901840490796,0.8532748839608045,0.14304359175150091,0.47375690607734805
2914,25841,PTRH2,608625,616263;,"[MIM:616263]Neurologic, endocrine, and pancreatic disease, multisystem, infantile-onset;",Infantile multisystem neurologic-endocrine-pancreatic disease,Disease-causing germline mutation(s) in,,0.8148466257668712,0.33754512635379064,0.8697468024014617,0.5767341927562922
2915,25843,PTS,612719,261640;,"[MIM:261640]Hyperphenylalaninemia, BH4-deficient, A [recessive?];",6-pyruvoyl-tetrahydropterin synthase deficiency,Disease-causing germline mutation(s) in,Objective response to lithium treatment[26503763];,0.3168098159509202,0.4368231046931408,0.9647611589663273,0.4085328422344997
2916,25855,PUF60,604819,615583;,[MIM:615583]Verheij syndrome;,8q24.3 deletion syndrome;Intellectual disability-cardiac anomalies-short stature-joint laxity syndrome,Role in the phenotype of;Disease-causing germline mutation(s) (loss of function) in,,0.905521472392638,0.8754512635379061,0.9493604802923519,0.48281154082259053
2917,25859,PURA,600473,616158;,"[MIM:616158]Mental retardation, autosomal dominant 31 [dominant?];",Severe neonatal hypotonia-seizures-encephalopathy syndrome due to 5q31.3 microdeletion;PURA-related severe neonatal hypotonia-seizures-encephalopathy syndrome due to a point mutation,Role in the phenotype of;Disease-causing germline mutation(s) in,Body mass index[26426971];,0.9198773006134969,0.887570912841671,0.9924301748890629,0.0
2918,25863,PUS1,608109,600462;,,Mitochondrial myopathy and sideroblastic anemia,Disease-causing germline mutation(s) in,Body mass index[26426971];,0.8310429447852761,0.6988138215575038,0.4596711041503524,0.22851442602823818
2919,25864,PUS3,616283,617051;,"[MIM:617051]Mental retardation, autosomal recessive 55 [recessive?];",Severe growth deficiency-strabismus-extensive dermal melanocytosis-intellectual disability syndrome,Disease-causing germline mutation(s) in,,0.038773006134969326,0.2362042289840124,0.1667971808927173,0.07903621853898098
2920,25891,PXDN,605158,269400;,[MIM:269400]Anterior segment dysgenesis 7 [recessive?];,Congenital cataract microcornea with corneal opacity,Disease-causing germline mutation(s) (loss of function) in,Type 2 diabetes (age of onset)[28060188];Erosive tooth wear (severe vs non-severe)[29898447];Systemic sclerosis[30247649];Erosive tooth wear (severe vs none or mild)[29898447];Blood protein levels[30072576];Systolic blood pressure x smoking status (current vs non-current) interaction (2df test)[29455858];,0.33975460122699386,0.43063434760185665,0.36465674758548683,0.0
2921,25893,PXK,611450,,,Systemic lupus erythematosus,Major susceptibility factor in,"Rheumatoid arthritis (ACPA-positive)[23143596];Systemic lupus erythematosus[18204446;27399966;26502338;28714469;28714469;28714469];Rheumatoid arthritis[24390342;20453842;23143596];Systemic sclerosis[24387989];Hematocrit[27863252];Systemic lupus erythematosus and Systemic sclerosis[23740937];Cholesterol, total[24097068];Red blood cell count[27863252];Type 1 diabetes autoantibodies in high risk HLA genotype individuals (time to event)[29310926];",0.2947239263803681,0.4033006704486849,0.12529365700861395,0.3136893799877225
2922,25894,PXMP2,617399,,,Hereditary neuropathy with liability to pressure palsies;Hereditary neuropathy with liability to pressure palsies;Roussy-L�vy syndrome;Dejerine-Sottas syndrome;Charcot-Marie-Tooth disease type 1E;Acute inflammatory demyelinating polyradiculoneuropathy;Charcot-Marie-Tooth disease type 1A,Disease-causing germline mutation(s) in;Role in the phenotype of;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Major susceptibility factor in;Disease-causing germline mutation(s) in,Resting heart rate[27798624];Corneal structure[23291589];Allergic rhinitis[25085501];Amyotrophic lateral sclerosis[29566793];Night sleep phenotypes[27126917];Preterm birth (maternal effect)[28877031];,0.427239263803681,0.1962351727694688,0.7569825110937092,0.5131982811540823
2923,25902,PYCR1,179035,612940;614438;,"[MIM:612940]Cutis laxa, autosomal recessive, 2B [recessive?];[MIM:614438]Cutis laxa, autosomal recessive, 3B [recessive?];",Geroderma osteodysplastica;Autosomal recessive cutis laxa type 2B;PYCR1-related De Barsy syndrome,Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) (loss of function) in;Disease-causing germline mutation(s) in,,0.9793865030674846,0.6067560598246519,0.8172800835291046,0.4020871700429711
2924,25903,PYCR2,616406,616420;,,Autosomal recessive primary microcephaly;PYCR2-related microcephaly-progressive leukoencephalopathy,Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) (loss of function) in,,0.9668711656441717,0.19881382155750388,0.9310884886452623,0.5035297728667895
2925,25905,PYDC1,615700,,,Anauxetic dysplasia,Disease-causing germline mutation(s) (loss of function) in,,0.12711656441717792,0.0,0.9608457321848082,0.2438612645794966
2926,25909,PYGL,613741,232700;,[MIM:232700]Glycogen storage disease 6;,Glycogen storage disease due to liver glycogen phosphorylase deficiency,Disease-causing germline mutation(s) in,Psychosis (atypical)[24132900];Blood protein levels[29875488;30072576];Acute lymphoblastic leukemia (childhood)[23007406];,0.7220858895705522,0.0479628674574523,0.24562777342730358,0.8793738489871087
2927,25910,PYGM,608455,232600;,[MIM:232600]Glycogen storage disease 5;,Glycogen storage disease due to muscle glycogen phosphorylase deficiency,Disease-causing germline mutation(s) in,Urate levels[21768215];,0.3925153374233129,0.08329035585353275,0.29182980944923,0.8964088397790055
2928,25923,QARS,603727,615760;,,Diffuse cerebral and cerebellar atrophy-intractable seizures-progressive microcephaly syndrome;Microcephaly-short stature-intellectual disability-facial dysmorphism syndrome,Disease-causing germline mutation(s) (loss of function) in;Disease-causing germline mutation(s) in,Inflammatory bowel disease[28067908];Crohn's disease[28067908];Blood protein levels[28240269];Coronary artery disease[29212778];Ulcerative colitis[28067908];,0.9379141104294478,0.1967509025270758,0.5147481075437222,0.08839779005524862
2929,25924,QDPR,612676,261630;,"[MIM:261630]Hyperphenylalaninemia, BH4-deficient, C [recessive?];",Dihydropteridine reductase deficiency,Disease-causing germline mutation(s) in,Blood protein levels[29875488;30072576];,0.5261349693251534,0.41026302217637955,0.9128164969981728,0.600061387354205
2930,25925,QKI,609590,,,Angiocentric glioma,Part of a fusion gene in,Mean corpuscular volume[29403010];Mean corpuscular hemoglobin[29403010];Response to TNF antagonist treatment[18615156];Diisocyanate-induced asthma[25918132];Red blood cell count[29403010];Incident myocardial infarction[26950853];,0.7226993865030675,0.5905105724600309,0.9569303054032889,0.9335481890730509
2931,25960,RAB3GAP1,602536,600118;,,Cataract-intellectual disability-hypogonadism syndrome;Micro syndrome,Disease-causing germline mutation(s) (loss of function) in;Disease-causing germline mutation(s) (loss of function) in,"Body mass index[25673413;25673413];Corneal structure[21979947];Blood metabolite levels[24816252];Cholesterol, total[20686565;24097068;25961943];",0.6653987730061349,0.16142341413099537,0.14983033150613417,0.05294659300184162
2932,25961,RAB3GAP2,609275,212720;614225;,[MIM:614225]Warburg micro syndrome 2;,Cataract-intellectual disability-hypogonadism syndrome;Micro syndrome;Autosomal recessive spastic paraplegia type 69,Disease-causing germline mutation(s) (loss of function) in;Disease-causing germline mutation(s) (loss of function) in;Disease-causing germline mutation(s) in,Amyotrophic lateral sclerosis (sporadic)[24529757];Breast size[27182965];,0.6739877300613497,0.5069623517276947,0.1717567214826416,0.42602823818293434
2933,25978,RAB7A,602298,600882;,,Autosomal dominant Charcot-Marie-Tooth disease type 2B,Disease-causing germline mutation(s) in,,0.9693251533742331,0.705002578648788,0.9783346384755939,0.0
2934,25991,RAB11A,605570,,,Autosomal dominant non-syndromic intellectual disability,Disease-causing germline mutation(s) in,Mean corpuscular hemoglobin concentration[29403010];Mean corpuscular hemoglobin[27863252;27863252;29403010];Mean corpuscular volume[27863252;27863252;29403010];Red blood cell count[27863252];Hemoglobin concentration[27863252];,0.7288343558282209,0.9254770500257865,0.9947794309579744,0.6837016574585635
2935,26007,RAB18,602207,614222;,,Micro syndrome,Disease-causing germline mutation(s) (loss of function) in,Childhood ear infection[27182965;28928442];Diisocyanate-induced asthma[25918132];Heel bone mineral density[28869591;28869591;28869591];,0.6711656441717792,0.7694687983496648,0.0,0.32811540822590546
2936,26012,RAB23,606144,201000;,[MIM:201000]Carpenter syndrome 1 [recessive?];,Carpenter syndrome,Disease-causing germline mutation(s) (loss of function) in,Systemic lupus erythematosus[28714469];,0.6976687116564417,0.4110366168127901,0.24797702949621508,0.3970227133210559
2937,26016,RAB27A,603868,607624;,,Griscelli syndrome type 2,Disease-causing germline mutation(s) in,Fractional exhaled nitric oxide levels[25431337];,0.403680981595092,0.18102114492006188,0.8000522056904202,0.20395948434622468
2938,26018,RAB28,612994,615374;,,Cone rod dystrophy,Disease-causing germline mutation(s) in,Periodontal disease-related phenotypes[24347629;24347629];Height[25282103];Obesity-related traits[23251661];,0.28662576687116564,0.21015987622485818,0.8159749412685983,0.16206261510128914
2939,26030,RAB33B,605950,615222;,[MIM:615222]Smith-McCort dysplasia 2 [recessive?];,Smith-McCort dysplasia,Disease-causing germline mutation(s) in,,0.8395092024539877,0.7828777720474471,0.8715740015661707,0.8096992019643954
2940,26037,RAB39B,300774,300271;311510;,[MIM:311510]Waisman syndrome;,Early-onset parkinsonism-intellectual disability syndrome;X-linked non-syndromic intellectual disability,Disease-causing germline mutation(s) (loss of function) in;Disease-causing germline mutation(s) (loss of function) in,,0.33226993865030674,0.8321299638989169,0.0,0.0
2941,26064,RAC1,602048,617751;,"[MIM:617751]Mental retardation, autosomal dominant 48 [dominant?];",Microcephaly-corpus callosum and cerebellar vermis hypoplasia-facial dysmorphism-intellectual disability syndrom,Disease-causing germline mutation(s) in,Body mass index[26426971];Red cell distribution width[27863252];Coronary artery disease[29212778];,0.9373006134969325,0.7919030428055699,0.9746802401461759,0.625537139349294
2942,26074,RAC2,602049,608203;,[MIM:608203]Neutrophil immunodeficiency syndrome;,Neutrophil immunodeficiency syndrome,Disease-causing germline mutation(s) in,Graves' disease[23612905];Type 1 diabetes[25751624];Response to methotrexate in juvenile idiopathic arthritis[24709693];Longevity[20834067];,0.43754601226993867,0.8893759669932955,0.9759853824066823,0.6837016574585635
2943,26088,RAD21,606462,614701;,[MIM:614701]Cornelia de Lange syndrome 4;,Cornelia de Lange syndrome,Disease-causing germline mutation(s) in,Menopause (age at onset)[29773799;29773799];,0.8065030674846626,0.8592057761732852,0.696945967110415,0.42955801104972374
2944,26096,RAD50,604040,613078;,[MIM:613078]Nijmegen breakage syndrome-like disorder;,Hereditary breast and ovarian cancer syndrome;Nijmegen breakage syndrome-like disorder,Candidate gene tested in;Disease-causing germline mutation(s) in,"Polycystic ovary syndrome[26416764];Eosinophil counts[27863252;29403010];Itch intensity from mosquito bite[28199695];IgE levels[18846228];Inflammatory skin disease[25574825];Asthma[20159242;27611488;27182965;29273806;29273806];Venous thromboembolism adjusted for sickle cell variant rs77121243-T[28203683];Rosacea symptom severity[29771307];Sum eosinophil basophil counts[27863252];Eosinophil percentage of granulocytes[27863252];Allergic disease (asthma, hay fever or eczema)[29083406];Atopic dermatitis[23886662;26482879;25865352;25574825];Neutrophil percentage of white cells[27863252];Allergic rhinitis[30013184];Asthma (childhood onset)[24241537;29273806];Eosinophil percentage of white cells[27863252];",0.9133742331288344,0.20835482207323364,0.544505351083268,0.013965623081645182
2945,26097,RAD51,179617,114480;614508;617244;,"[MIM:114480]Breast cancer;[MIM:614508]Mirror movements 2;[MIM:617244]Fanconi anemia, complementation group R;",Fanconi anemia;Hereditary breast and ovarian cancer syndrome;Familial congenital mirror movements,Disease-causing germline mutation(s) in;Candidate gene tested in;Disease-causing germline mutation(s) in,,0.7622085889570552,0.5631768953068592,0.8394675019577134,0.7271332105586249
2946,26103,RAD51C,602774,613390;613399;,"[MIM:613390]Fanconi anemia complementation group O;[MIM:613399]Breast-ovarian cancer, familial, 3;",Fanconi anemia;Hereditary breast and ovarian cancer syndrome,Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in,Primary tooth development (time to first tooth eruption)[23704328];Testicular germ cell tumor[23666240;23666239];Cognitive function[25644384];,0.6115337423312883,0.3287777204744714,0.7300965805272774,0.21347452424800492
2947,26104,RAD51D,602954,614291;,,Hereditary breast and ovarian cancer syndrome,Disease-causing germline mutation(s) in,,0.5766871165644172,0.3488911810211449,0.8702688593056643,0.0
2948,26107,RAD54L,603615,,,Hereditary breast cancer,Candidate gene tested in,Body mass index[26426971];Menopause (age at onset)[26414677];,0.6279754601226993,0.19932955131511088,0.5432002088227617,0.6995089011663598
2949,26119,RAF1,164760,611553;611554;615916;,"[MIM:611553]Noonan syndrome 5;[MIM:611554]LEOPARD syndrome 2;[MIM:615916]Cardiomyopathy, dilated 1NN;",Noonan syndrome;Familial isolated dilated cardiomyopathy;Noonan syndrome with multiple lentigines;Pilomyxoid astrocytoma,Disease-causing germline mutation(s) (gain of function) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) (gain of function) in;Part of a fusion gene in,"Waist-to-hip ratio adjusted for BMI (age >50)[26426971];Total cholesterol levels[28334899];Waist-to-hip ratio adjusted for BMI (age <50)[26426971];Cardiac hypertrophy[21348951];Cholesterol, total[20686565;24097068];Waist-to-hip ratio adjusted for BMI[26426971];Waist-to-hip ratio adjusted for BMI x sex x age interaction (4df test)[26426971];",0.8858895705521472,0.6614234141309954,0.6700600365439833,0.6697360343769183
2950,26121,RAG1,179615,233650;601457;603554;609889;,"[MIM:233650]Combined cellular and humoral immune defects with granulomas;[MIM:601457]Severe combined immunodeficiency autosomal recessive T- cell-negative/B-cell-negative/NK-cell-positive [recessive?];[MIM:603554]Omenn syndrome;[MIM:609889]Alpha/beta T-cell lymphopenia, with gamma/delta T-cell expansion, severe cytomegalovirus infection and autoimmunity;",Combined immunodeficiency with granulomatosis;Combined immunodeficiency due to partial RAG1 deficiency;Severe combined immunodeficiency due to complete RAG1/2 deficiency;Omenn syndrome,Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in,Rheumatoid arthritis[24390342;24390342];,0.38061349693251534,0.2509025270758123,0.1532237013834508,0.7051872314303254
2951,26122,RAG2,179616,233650;601457;603554;,[MIM:233650]Combined cellular and humoral immune defects with granulomas;[MIM:601457]Severe combined immunodeficiency autosomal recessive T- cell-negative/B-cell-negative/NK-cell-positive [recessive?];[MIM:603554]Omenn syndrome;,Combined immunodeficiency with granulomatosis;Severe combined immunodeficiency due to complete RAG1/2 deficiency;Omenn syndrome,Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in,Rheumatoid arthritis[24390342;24390342];,0.14576687116564419,0.0,0.4669799008091882,0.6445672191528545
2952,26123,RAI1,607642,182290;,[MIM:182290]Smith-Magenis syndrome;,Smith-Magenis syndrome;Smith-Magenis syndrome;17p11.2 microduplication syndrome;PMP22-RAI1 contiguous gene duplication syndrome,Disease-causing germline mutation(s) in;Role in the phenotype of;Role in the phenotype of;Role in the phenotype of,"Body mass index[28892062];Parkinson's disease[21738487];Coronary artery disease or ischemic stroke[24262325];Hip circumference[25673412;25673412];Lymphocyte counts[27863252];Schizophrenia[25056061;28991256];Coronary artery disease or large artery stroke[24262325];Coronary artery disease[24262325];General cognitive ability[29844566];Coronary artery disease (myocardial infarction, percutaneous transluminal coronary angioplasty, coronary artery bypass grafting, angina or chromic ischemic heart disease)[28714975];",0.6403680981595092,0.7480660134089737,0.5011746280344558,0.6497851442602823
2953,26148,RANBP2,601181,608033;,"[MIM:608033]Encephalopathy, acute, infection-induced, 3;",Inflammatory myofibroblastic tumor;Acute necrotizing encephalopathy of childhood;Familial acute necrotizing encephalopathy,Part of a fusion gene in;Major susceptibility factor in;Major susceptibility factor in,Monobrow thickness[26926045];Scalp hair shape[26926045];Attention deficit hyperactivity disorder[29325848];Beard thickness[26926045];,0.9069938650306748,1.0,0.2641607935264944,0.3740024554941682
2954,26157,RANGRF,607954,,,Brugada syndrome,Candidate gene tested in,,0.30319018404907977,0.38782877772047447,0.9057687287914382,0.3902701043585021
2955,26167,RAP1A,179520,,,Kabuki syndrome,Disease-causing germline mutation(s) (loss of function) in,Osteoporosis-related phenotypes[20548944];High altitude adaptation[28373541];,0.567239263803681,0.760959257349149,0.9896893761419995,0.0
2956,26169,RAP1B,179530,,,Kabuki syndrome,Disease-causing germline mutation(s) in,White blood cell count[20139978];,0.6979141104294478,0.8236204228984012,0.995301487862177,0.36464088397790057
2957,26190,RAPSN,601592,208150;616326;,"[MIM:616326]Myasthenic syndrome, congenital, 11, associated with acetylcholine receptor deficiency [recessive?];[MIM:208150]Fetal akinesia deformation sequence;",Fetal akinesia deformation sequence;Lethal multiple pterygium syndrome;Postsynaptic congenital myasthenic syndromes,Disease-causing germline mutation(s) (loss of function) in;Candidate gene tested in;Disease-causing germline mutation(s) in,Systolic blood pressure[27618452;28739976];Neuroticism[29255261];Mean corpuscular hemoglobin[27863252];White blood cell count[29403010];Diastolic blood pressure[27618452;28739976];Global electrical heterogeneity phenotypes[29622589];Intraocular pressure[25173106;29617998;29235454];,0.30319018404907977,0.4141309953584322,0.28452101279039416,0.584561080417434
2958,26191,RARA,180240,612376;,,Acute promyelocytic leukemia,Part of a fusion gene in,,0.6793865030674847,0.5856111397627644,0.829809449229966,0.8399324739103745
2959,26193,RARB,180220,615524;,"[MIM:615524]Microphthalmia, syndromic, 12;",Matthew-Wood syndrome,Disease-causing germline mutation(s) in,Body mass index (joint analysis main effects and smoking interaction)[28443625];Pulmonary function (smoking interaction)[23284291];Airway responsiveness in chronic obstructive pulmonary disease[25514360];Gout[22179738];BMI in smokers[28443625];Airflow obstruction[22837378];Calcium levels[25972035];Body mass index in physically inactive individuals[28448500;28448500];Glaucoma (primary open-angle)[29891935];Body mass index[28448500;28448500;28448500;28448500;25673413;25673413;25673413;28892062];Chronic obstructive pulmonary disease[28166215];BMI (adjusted for smoking behaviour)[28443625];Obesity (extreme)[19553259];Heel bone mineral density[28869591;28869591];Body mass index (joint analysis main effects and physical activity interaction)[28448500;28448500;28448500;28448500];Molybdenum levels[26025379];Asthma[29273806];Oppositional defiant disorder dimensions in attention-deficit hyperactivity disorder[26184070];Pulmonary function[21946350];Body mass index in physically active individuals[28448500;28448500;28448500;28448500];Pursuit maintenance gain[29064472];Optic disc area[28073927;25631615;25631615;28073927];Dietary macronutrient intake[29988085];Post bronchodilator FEV1/FVC ratio[26634245];Intraocular pressure[29785010];,0.6547239263803681,0.9494584837545126,0.8846254241712347,0.9568753836709638
2960,26210,RARS,107820,616140;,"[MIM:616140]Leukodystrophy, hypomyelinating, 9 [recessive?];",RARS-related autosomal recessive hypomyelinating leukodystrophy,Disease-causing germline mutation(s) in,Response to platinum-based chemotherapy (carboplatin)[21844884];,0.9192638036809816,0.1933986591026302,0.5497259201252936,0.10205647636586863
2961,26211,RARS2,611524,611523;,[MIM:611523]Pontocerebellar hypoplasia 6;,Pontocerebellar hypoplasia type 6;Pontocerebellar hypoplasia type 1,Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in,Coronary atherosclerosis (increased number of diseased vessels) (traffic exposure interaction)[28355232];Obesity-related traits[23251661;23251661];,0.5755828220858896,0.2991232594120681,0.24353954581049334,0.09561080417434009
2962,26213,RASA1,139150,608354;608355;,[MIM:608354]Capillary malformation-arteriovenous malformation;[MIM:608355]Parkes Weber syndrome;,Capillary malformation-arteriovenous malformation;Parkes Weber syndrome,Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in,Openness[21173776];Prostate cancer aggressiveness[25939597];Major depressive disorder[23377640];,0.5811042944785276,1.0,0.5807883059253459,0.7372621240024555
2963,26214,RASA2,601589,,,Noonan syndrome,Disease-causing germline mutation(s) (loss of function) in,"Granulocyte percentage of myeloid white cells[27863252];Mean corpuscular volume[27863252;27863252];Mean corpuscular hemoglobin[27863252;27863252];Body mass index (joint analysis main effects and smoking interaction)[28443625;28443625;28443625];Myeloid white cell count[27863252];Sum basophil neutrophil counts[27863252];Sum neutrophil eosinophil counts[27863252];Monocyte percentage of white cells[27863252];Granulocyte count[27863252];Body mass index (joint analysis main effects and physical activity interaction)[28448500;28448500;28448500;28448500];BMI in non-smokers[28443625;28443625];Body mass index[28448500;28448500;28448500;28448500;28448500;25673413;25673413;25673413;28892062];Allergic disease (asthma, hay fever or eczema)[29083406];Red blood cell traits[23222517];Body mass index in physically active individuals[28448500;28448500;28448500];White blood cell count[27863252];Prion diseases[22210626];Monocyte count[27863252];BMI (adjusted for smoking behaviour)[28443625;28443625;28443625];",0.08736196319018405,0.01186178442496132,0.419994779430958,0.0
2964,26235,RASGRP1,603962,152700;,[MIM:152700]Systemic lupus erythematosus;,Autoimmune lymphoproliferative syndrome,Disease-causing germline mutation(s) in,Type 2 diabetes[22961080;28254843];Rheumatoid arthritis (ACPA-positive)[24532676;23143596];Multiple sclerosis[24076602];Systemic lupus erythematosus[28714469];Type 1 diabetes[18840781;21829393;25751624];Rheumatoid arthritis[24390342;24390342;24390342;23143596];Bipolar disorder[18711365];Psychosis (atypical)[24132900];Crohn's disease[23128233;28067908];Carboplatin disposition in epthelial ovarian cancer[29367611];,0.20368098159509201,0.9401753481175864,0.20386322109109892,0.17065684468999387
2965,26236,RASGRP2,605577,615888;,"[MIM:615888]Bleeding disorder, platelet-type 18;",Bleeding disorder due to CalDAG-GEFI deficiency,Disease-causing germline mutation(s) in,Urate levels[21768215];,0.17791411042944785,0.8746776689014956,0.7269642391020621,0.5007673419275629
2966,26259,RAX,601881,611038;,,Isolated microphthalmia-anophthalmia-coloboma,Disease-causing germline mutation(s) in,Morning vs. evening chronotype[27494321];Chronotype[27494321];,0.16220858895705523,0.5484785972150593,0.1767162620725659,0.0
2967,26260,RAX2,610362,610381;613757;,"[MIM:613757]Macular degeneration, age-related, 6;[MIM:610381]Cone-rod dystrophy 11;",Cone rod dystrophy,Disease-causing germline mutation(s) in,,0.038773006134969326,0.4334708612686952,0.7235708692247454,0.0
2968,26261,RB1,614041,109800;180200;259500;,[MIM:180200]Childhood cancer retinoblastoma [dominant?];[MIM:109800]Bladder cancer;[MIM:259500]Osteogenic sarcoma;,Monosomy 13q14;Osteosarcoma;Non-hereditary retinoblastoma;Hereditary retinoblastoma;Small cell lung cancer,Role in the phenotype of;Candidate gene tested in;Disease-causing somatic mutation(s) in;Disease-causing germline mutation(s) (loss of function) in;Disease-causing somatic mutation(s) in,Chronic kidney disease[26420894];Birth weight[27680694];Post bronchodilator FEV1/FVC ratio[26634245;26634245];,0.8550920245398773,1.0,0.5371965544244323,0.9742173112338858
2969,26278,RBBP8,604124,251255;606744;,[MIM:606744]Seckel syndrome 2 [recessive?];[MIM:251255]Jawad syndrome;,Seckel syndrome;Jawad syndrome,Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in,"Tuberculosis[20694014];Scalp hair shape[26926045];Intracranial aneurysm[20364137];Late-onset myasthenia gravis[26562150];Lung function (FEV1)[30061609;30061609];Height[18391951;25429064];Intracranial, abdominal aortic or thoracic aortic aneurysm (pleiotropy)[27418160];Eosinophil percentage of white cells[27863252];",0.6180368098159509,0.0,0.7144348734012007,0.0216390423572744
2970,26283,RBCK1,610924,615895;,[MIM:615895]Polyglucosan body myopathy 1 with or without immunodeficiency;,Autoinflammatory syndrome with pyogenic bacterial infection and amylopectinosis;Polyglucosan body myopathy type 1,Disease-causing germline mutation(s) (loss of function) in;Disease-causing germline mutation(s) (loss of function) in,Night sleep phenotypes[27126917];,0.6131288343558282,0.6580711707065497,0.8885408509527538,0.33824432166973606
2971,26299,RBM8A,605313,,,Thrombocytopenia-absent radius syndrome,Disease-causing germline mutation(s) in,,0.8638036809815951,0.8571428571428571,0.9891673192377969,0.0
2972,26301,RBM10,300080,311900;,[MIM:311900]TARP syndrome;,TARP syndrome,Disease-causing germline mutation(s) in,,0.8542331288343559,1.0,0.6932915687809972,0.0
2973,26309,RBM15,606077,,,Megakaryoblastic acute myeloid leukemia with t(1;22)(p13;q13),Part of a fusion gene in,,0.7633128834355828,0.9544868488911811,0.5460715217958757,0.7383364027010436
2974,26319,RBM20,613171,613172;,,Familial isolated dilated cardiomyopathy,Disease-causing germline mutation(s) in,Atrial fibrillation[30061737;29892015];,0.6536196319018405,0.9297318205260443,0.32184808144087707,0.0
2975,26337,RBM28,612074,612079;,,ANE syndrome,Disease-causing germline mutation(s) (loss of function) in,,0.9953374233128834,0.389118102114492,0.32132602453667447,0.03314917127071823
2976,26374,RBMY1A1,400006,,,Partial chromosome Y deletion,Candidate gene tested in,,0.3492024539877301,0.0,0.0,0.0
2977,26409,RBP3,180290,615233;,[MIM:615233]Retinitis pigmentosa 66;,Retinitis pigmentosa,Disease-causing germline mutation(s) in,Corneal curvature[24963161];,0.2498159509202454,0.27385250128932437,0.4732445836596189,0.3769183548189073
2978,26410,RBP4,180250,615147;616428;,"[MIM:615147]Retinal dystrophy, iris coloboma, and comedogenic acne syndrome;[MIM:616428]Microphthalmia, isolated, with coloboma, 10;",Progressive retinal dystrophy due to retinol transport defect;Colobomatous microphthalmia,Disease-causing germline mutation(s) (loss of function) in;Disease-causing germline mutation(s) in,Retinol levels[21878437];Blood protein levels[30072576;30072576];,0.2947239263803681,0.7333677153171738,0.9290002610284521,0.700890116635973
2979,26413,RBPJ,147183,614814;,[MIM:614814]Adams-Oliver syndrome 3 [dominant?];,Adams-Oliver syndrome,Disease-causing germline mutation(s) in,Rheumatoid arthritis (ACPA-positive)[24532676;23143596];Rheumatoid arthritis[20453842;24449572;23143596;23143596];,0.7382822085889571,0.906395048994327,0.82041242495432,0.8244321669736034
2980,26427,RBSN,609511,,,Congenital neutropenia-myelofibrosis-nephromegaly syndrome,Disease-causing germline mutation(s) (loss of function) in,Alcohol and nicotine co-dependence[22488850];,0.807361963190184,0.6557503867973182,0.0,0.0
2981,26437,RCBTB1,607867,617175;,,Reticular dystrophy of the retinal pigment epithelium,Disease-causing germline mutation(s) in,Breastfeeding duration[25475840];Spherical equivalent or myopia (age of diagnosis)[29808027];Myeloid white cell count[27863252];Sum basophil neutrophil counts[27863252];Sum neutrophil eosinophil counts[27863252];Monocyte count[27863252];Granulocyte count[27863252];Neutrophil count[27863252];,0.3168098159509202,0.3370293965961836,0.8008352910467241,0.39333947206875386
2982,26466,RD3,180040,610612;,,Leber congenital amaurosis,Disease-causing germline mutation(s) in,Intelligence (MTAG)[29326435];Retinopathy in non-diabetics[23393555];,0.23865030674846627,0.24522949974213512,0.4573218480814409,0.4011663597298956
2983,26468,RDH5,601617,136880;,,Fundus albipunctatus;Retinitis punctata albescens,Disease-causing germline mutation(s) in;Candidate gene tested in,Spherical equivalent or myopia (age of diagnosis)[29808027];Advanced age-related macular degeneration[26691988];Refractive error[23396134];Myopia[27182965];Spherical equivalent (joint analysis main effects and education interaction)[27020472;27020472];,0.19190184049079756,0.5820010314595152,0.5666927695118767,0.5339165131982812
2984,26472,RDH11,607849,616108;,"[MIM:616108]Retinal dystrophy, juvenile cataracts, and short stature syndrome;",Retinitis pigmentosa-juvenile cataract-short stature-intellectual disability syndrome,Disease-causing germline mutation(s) (loss of function) in,,0.7768098159509202,0.3963383187209902,0.604280866614461,0.6416513198281154
2985,26473,RDH12,608830,612712;,[MIM:612712]Retinitis pigmentosa 53;,Retinitis pigmentosa;Leber congenital amaurosis,Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) (loss of function) in,,0.33975460122699386,0.12506446621970088,0.32550247977029495,0.5506445672191529
2986,26483,RDX,179410,611022;,"[MIM:611022]Deafness, autosomal recessive, 24 [recessive?];",Autosomal recessive non-syndromic sensorineural deafness type DFNB,Disease-causing germline mutation(s) in,Cognitive function[24684796];,0.8576687116564418,0.8762248581743166,0.7238318976768467,0.648096992019644
2987,26490,RECQL4,603780,218600;266280;268400;,[MIM:268400]Rothmund-Thomson syndrome;[MIM:266280]RAPADILINO syndrome;[MIM:218600]Baller-Gerold syndrome [recessive?];,Baller-Gerold syndrome;RAPADILINO syndrome;Rothmund-Thomson syndrome type 2,Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in,General cognitive ability[29844566];Age at first birth[27798627;27798627];Educational attainment[25201988];,0.36171779141104293,0.03300670448684889,0.017488906290785696,0.0
2988,26493,REEP1,609139,610250;614751;,"[MIM:614751]Neuronopathy, distal hereditary motor, 5B;",Distal hereditary motor neuropathy type 5;Autosomal dominant spastic paraplegia type 31,Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in,Facial emotion recognition (sad faces)[28608620];Atrial fibrillation[30061737;29892015;29892015];Night sleep phenotypes[27126917];,0.5128834355828221,0.7857142857142857,0.9216914643696162,0.7813075506445673
2989,26494,REEP2,609347,615625;,,Autosomal spastic paraplegia type 72,Disease-causing germline mutation(s) (loss of function) in,Autism spectrum disorder or schizophrenia[28540026;28540026];Amyotrophic lateral sclerosis (C9orf72 mutation interaction)[22959728];Schizophrenia[25056061];,0.7279754601226994,0.601985559566787,0.8807099973897154,0.7441682013505218
2990,26498,REEP6,609346,617304;,,Retinitis pigmentosa,Disease-causing germline mutation(s) (loss of function) in,,0.48208588957055215,0.18463125322331098,0.6063690942312712,0.39333947206875386
2991,26506,RELA,164014,,,Ependymoma,Part of a fusion gene in,Inflammatory bowel disease[23128233];Diastolic blood pressure (cigarette smoking interaction)[29455858];Acne (severe)[24927181];Systolic blood pressure (cigarette smoking interaction)[29455858];,0.887361963190184,0.8535327488396081,0.8178021404333072,0.5943830570902394
2992,26511,RELN,600514,257320;616436;,"[MIM:257320]Lissencephaly 2;[MIM:616436]Epilepsy, familial temporal lobe, 7;","Lissencephaly syndrome, Norman-Roberts type;Autosomal dominant epilepsy with auditory features",Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in,Multiple sclerosis (age of onset)[19010793];Sjögren's syndrome[28076899;28076899];Schizophrenia[18282107];Night sleep phenotypes[27126917];Metabolite levels (Pyroglutamine)[23934736];Alzheimer's disease[20452100];Otosclerosis[19230858];Venous thromboembolism adjusted for sickle cell variant rs77121243-T[28203683];Intraocular pressure[29785010];,0.4403680981595092,0.6260959257349149,0.13051422605063953,0.6803253529772867
2993,26515,REN,179820,267430;613092;,[MIM:267430]Renal tubular dysgenesis;[MIM:613092]Familial juvenile hyperuricemic nephropathy 2;,REN-related autosomal dominant tubulointerstitial kidney disease;Renal tubular dysgenesis of genetic origin,Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in,Blood protein levels[29875488];,0.22687116564417178,0.16580711707065499,0.7846515270164448,0.20089011663597298
2994,26523,RERE,605226,616975;,"[MIM:616975]Neurodevelopmental disorder with or without anomalies of the brain, eye, or heart [dominant?];",1p36 deletion syndrome;RERE-related neurodevelopmental syndrome,Role in the phenotype of;Disease-causing germline mutation(s) (loss of function) in,"Allergy[27182965];Optic cup area[28073927;28073927;25631615;25631615];Autism spectrum disorder or schizophrenia[28540026];Lymphocyte counts[27863252];Heel bone mineral density[28869591;28869591;28869591];Schizophrenia[28991256];Depression[29700475];Vertical cup-disc ratio[25241763;20548946];Eosinophil counts[27863252];Upper eyelid morphology[29921221;29921221];Major depressive disorder[27479909];Sum eosinophil basophil counts[27863252];Vitiligo[20410501;27723757];Eosinophil percentage of granulocytes[27863252];Total body bone mineral density[29304378];Allergic disease (asthma, hay fever or eczema)[29083406];Tonsillectomy[27182965;28928442];Autism spectrum disorder, attention deficit-hyperactivity disorder, bipolar disorder, major depressive disorder, and schizophrenia (combined)[23453885];White blood cell count[27863252];Allergic rhinitis[30013184];Bone mineral density[22504420];Neutrophil percentage of granulocytes[27863252];Eosinophil percentage of white cells[27863252];",0.6946012269938651,0.8378029912325942,0.341425215348473,0.848987108655617
2995,26533,REST,600571,616806;617626;,"[MIM:617626]Fibromatosis, gingival, 5 [dominant?];",Nephroblastoma;Hereditary gingival fibromatosis,Major susceptibility factor in;Disease-causing germline mutation(s) in,"Mean platelet volume[27863252];Age-related macular degeneration[21909106];Migraine[27322543];Height[25429064];Coronary artery disease[26343387];Response to bleomycin (chromatid breaks)[21106707];Coronary artery disease (myocardial infarction, percutaneous transluminal coronary angioplasty, coronary artery bypass grafting, angina or chromic ischemic heart disease)[28714975];Platelet count[29403010];",0.49717791411042944,0.9375966993295514,0.32941790655181413,0.37185389809699204
2996,26534,RET,164761,114500;142623;155240;162300;171300;171400;209880;,[MIM:114500]Colorectal cancer;[MIM:142623]Hirschsprung disease 1;[MIM:155240]Medullary thyroid carcinoma [dominant?];[MIM:162300]Multiple neoplasia 2B;[MIM:171300]Pheochromocytoma;[MIM:171400]Multiple neoplasia 2A;[MIM:209880]Congenital central hypoventilation syndrome;,"Hirschsprung disease;Differentiated thyroid carcinoma;Multiple endocrine neoplasia type 2B;Multiple endocrine neoplasia type 2A;Renal agenesis, bilateral;Sporadic pheochromocytoma;Hereditary pheochromocytoma-paraganglioma;Renal agenesis, unilateral;Familial medullary thyroid carcinoma;Haddad syndrome",Major susceptibility factor in;Part of a fusion gene in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) (loss of function) in;Major susceptibility factor in;Candidate gene tested in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in,Hirschsprung disease[19196962;27702942;27702942;27702942;25310821;29379196;29379196;29379196;29379196;30031151];Cannabis dependence symptom count[27028160];Blood protein levels[28240269;29875488;30072576];,0.7489570552147239,0.8849922640536358,0.24614983033150614,0.9886433394720687
2997,26537,RETREG1,613114,613115;,"[MIM:613115]Neuropathy, hereditary sensory and autonomic, 2B [recessive?];",Hereditary sensory and autonomic neuropathy type 2,Disease-causing germline mutation(s) (loss of function) in,Urate levels[28270201];,0.7139877300613497,0.31717380092831354,0.0,0.0
2998,26542,REV3L,602776,,,Moebius syndrome,Disease-causing germline mutation(s) in,Inflammatory bowel disease[28067908;23128233];Menopause (age at onset)[26414677];Psoriasis[25574825];Inflammatory skin disease[25574825];Ulcerative colitis[28067908];,0.4493251533742331,1.0,0.19498825371965545,0.6284530386740331
2999,26561,RFC2,600404,194050;,,Williams syndrome,Role in the phenotype of,Triglycerides[24097068];,0.9595092024539877,0.2808148530170191,0.8350300182719916,0.3502148557397176
3000,26591,RFT1,611908,612015;,[MIM:612015]Congenital disorder of glycosylation 1N;,RFT1-CDG,Disease-causing germline mutation(s) in,Immune reponse to smallpox (secreted IL-2)[22610502];Serum uric acid levels[29403010];Hip circumference adjusted for BMI[25673412;25673412;25673412];Autism spectrum disorder or schizophrenia[28540026;28540026];Schizophrenia[23974872];Bipolar disorder[21926972];Height[23563607];Crohn's disease[28067908];,0.8130061349693252,0.10263022176379577,0.3419472722526755,0.6166359729895642
3001,26596,RFWD3,614151,617784;,"[MIM:617784]Fanconi anemia, complementation group W;",Fanconi anemia,Disease-causing germline mutation(s) in,Multiple myeloma[27363682];Testicular germ cell tumor[23666239;28604732;28604728];,0.5395092024539877,0.0,0.15635604280866613,0.18370165745856354
3002,26602,RFX5,601863,209920;,[MIM:209920]Bare lymphocyte syndrome 2;,Immunodeficiency by defective expression of HLA class 2,Disease-causing germline mutation(s) in,Body mass index[26426971];,0.6847852760736196,0.4419804022692109,0.37796919864265205,0.3534376918354819
3003,26603,RFX6,612659,615710;,,Hypoplastic pancreas-intestinal atresia-hypoplastic gallbladder syndrome,Disease-causing germline mutation(s) in,Inflammatory bowel disease[27569725];Serum total protein level[29403010];Lung cancer[28604730];Creatine kinase levels[29403010];Neutrophil percentage of granulocytes[27863252];Prostate cancer[20676098;26443449];,0.40773006134969325,0.3267148014440433,0.40433307230488125,0.32351135666052794
3004,26606,RFXANK,603200,209920;,[MIM:209920]Bare lymphocyte syndrome 2;,Immunodeficiency by defective expression of HLA class 2,Disease-causing germline mutation(s) in,,0.4,0.4296028880866426,0.39519707648133645,0.12093308778391651
3005,26607,RFXAP,601861,209920;,[MIM:209920]Bare lymphocyte syndrome 2;,Immunodeficiency by defective expression of HLA class 2,Disease-causing germline mutation(s) in,Perioperative myocardial infarction in coronary artery bypass surgery[25948407];,0.623680981595092,0.5657555440948943,0.8261550509005482,0.0
3006,26626,RGR,600342,613769;,[MIM:613769]Retinitis pigmentosa 44;,Retinitis pigmentosa,Disease-causing germline mutation(s) in,Myopia[27182965];,0.08736196319018405,0.1928829293450232,0.41947272252675544,0.3083179864947821
3007,26636,RGS9,604067,608415;,[MIM:608415]Prolonged electroretinal response suppression;,Bradyopsia,Disease-causing germline mutation(s) in,Heel bone mineral density[28869591;28869591];Adverse response to antithyroid drugs in Graves disease[30067105];,0.2585276073619632,0.07658586900464157,0.5024797702949622,0.047268262737875995
3008,26637,RGS9BP,607814,608415;,[MIM:608415]Prolonged electroretinal response suppression;,Bradyopsia,Disease-causing germline mutation(s) in,Major depressive disorder[23377640];,0.14576687116564419,0.3769984528107272,0.08770555990602975,0.0
3009,26652,RHAG,180297,185000;268150;,[MIM:268150]Regulator type Rh-null hemolytic anemia;[MIM:185000]Overhydrated hereditary stomatocytosis [dominant?];,Overhydrated hereditary stomatocytosis;Rh deficiency syndrome,Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in,Alcohol dependence[26365420];,0.17791411042944785,0.4592573491490459,0.3101018010963195,0.4122160834868017
3010,26658,RHBDF2,614404,148500;,,Palmoplantar keratoderma-esophageal carcinoma syndrome,Disease-causing germline mutation(s) (gain of function) in,,0.20368098159509201,0.45358432181536873,0.34090315844427044,0.18293431553100062
3011,26663,RHCE,111700,,,Rh deficiency syndrome,Disease-causing germline mutation(s) in,Mean corpuscular hemoglobin concentration[27863252];Reticulocyte fraction of red cells[27863252];Reticulocyte count[27863252];Platelet distribution width[27863252];Blood protein levels[29875488;29875488];Red cell distribution width[27863252];Platelet count[27863252];,0.038773006134969326,0.3800928313563693,0.15740015661707127,0.26442602823818295
3012,26665,RHD,111680,,,Rh deficiency syndrome,Disease-causing germline mutation(s) in,,0.038773006134969326,0.24213512119649303,0.2166536152440616,0.05463474524248005
3013,26673,RHO,180380,610445;613731;,"[MIM:613731]Retinitis pigmentosa 4;[MIM:610445]Night blindness, congenital stationary, autosomal dominant 1 [dominant?];",Retinitis pigmentosa;Congenital stationary night blindness;Retinitis punctata albescens,Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Candidate gene tested in,Waist-to-hip ratio adjusted for BMI (age >50)[26426971];Diisocyanate-induced asthma[25918132];Waist-to-hip ratio adjusted for BMI[26426971];Waist-to-hip ratio adjusted for BMI x sex x age interaction (4df test)[26426971];,0.27975460122699386,0.2857142857142857,0.709997389715479,0.45104358502148556
3014,26684,RHOH,602037,,,T-cell immunodeficiency with epidermodysplasia verruciformis,Disease-causing germline mutation(s) (loss of function) in,Graves' disease[21841780];,0.23865030674846627,0.0,0.8760114852518924,0.48281154082259053
3015,26730,RIMS1,606629,603649;,[MIM:603649]Cone-rod dystrophy 7;,Cone rod dystrophy,Disease-causing germline mutation(s) in,Rosacea symptom severity[29771307];Cognitive performance[20125193];Lung cancer in never smokers[28604730];Autism spectrum disorder or schizophrenia[28540026];Acute urticaria and angioedema (non-steroidal anti-inflammatory drug-induced)[24236485];Lung cancer[28604730];Squamous cell lung carcinoma[28604730];Schizophrenia[25056061];Response to mTOR inhibitor (rapamycin)[24009623];,0.38061349693251534,0.6735430634347602,0.39128164969981727,0.13996316758747698
3016,26735,RIN2,610222,613075;,,RIN2 syndrome,Disease-causing germline mutation(s) (loss of function) in,Bone mineral density (total hip)[29883787];Verbal declarative memory[25648963];Platelet distribution width[27863252];Bipolar disorder and schizophrenia[20889312];Obesity-related traits[23251661];,0.40773006134969325,0.46776689014956163,0.2056904202558079,0.28084714548802947
3017,26749,RIPK4,605706,263650;,"[MIM:263650]Popliteal pterygium syndrome, lethal type [recessive?];",Bartsocas-Papas syndrome,Disease-causing germline mutation(s) (loss of function) in,Venous thromboembolism adjusted for sickle cell variant rs77121243-T[28203683];,0.7179141104294479,0.42573491490459,0.22866092404072044,0.4576427255985267
3018,26751,RIPOR2,611410,616515;,"[MIM:616515]Deafness, autosomal recessive, 104 [recessive?];",Autosomal recessive non-syndromic sensorineural deafness type DFNB,Disease-causing germline mutation(s) in,Lymphocyte percentage of white cells[27863252];Neutrophil percentage of white cells[27863252];Lymphocyte counts[27863252];Liver injury in anti-tuberculosis drug treatment[27671213];Post bronchodilator FEV1/FVC ratio[26634245];Electroencephalographic traits in alcoholism[22554406];,0.22687116564417178,0.41696750902527074,0.0,0.0
3019,26754,RIPPLY2,609891,616566;,"[MIM:616566]Spondylocostal dysostosis 6, autosomal recessive [recessive?];",Autosomal recessive spondylocostal dysostosis,Disease-causing germline mutation(s) in,,0.27975460122699386,0.5159876224858174,0.964500130514226,0.427255985267035
3020,26757,RIT1,609591,615355;,,Noonan syndrome,Disease-causing germline mutation(s) (gain of function) in,Inflammatory bowel disease[28067908;23128233];Body mass index[28892062];Conduct disorder (maternal expressed emotions interaction)[18846501];Crohn's disease[28067908];,0.36171779141104293,0.7137699845281072,0.9929522317932654,0.4894106813996317
3021,26760,RLBP1,180090,136880;607475;607476;,[MIM:607476]Rod-cone dystrophy Newfoundland;[MIM:136880]Retinitis punctata albescens;,Retinitis pigmentosa;Fundus albipunctatus;Retinitis punctata albescens;Bothnia retinal dystrophy,Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) (loss of function) in,Advanced age-related macular degeneration[28813576];Schizophrenia[28991256];Age-related macular degeneration (SNP x mitochondrial G12771A interaction)[28813576];,0.12711656441717792,0.4548736462093863,0.7274862960062647,0.5078268876611418
3022,26763,RLIM,300379,300978;,,Non-specific syndromic intellectual disability,Disease-causing germline mutation(s) in,,0.49938650306748467,0.9388860237235689,0.8955886191594884,0.8833640270104358
3023,26777,RMI2,612426,,,Congenital multiple caf�-au-lait macules-increased sister chromatid exchange syndrome,Disease-causing germline mutation(s) in,"Inflammatory bowel disease[28067908;23128233];Vein graft stenosis in coronary artery bypass grafting[25881214];Multiple sclerosis[24076602];Allergic disease (asthma, hay fever or eczema)[29083406;29083406];Juvenile idiopathic arthritis (oligoarticular or rheumatoid factor-negative polyarticular)[23603761];Allergic rhinitis[30013184];Crohn's disease[28067908];HDL cholesterol[25961943];",0.4154601226993865,0.43862815884476536,0.9232576350822239,0.0
3024,26778,RMND1,614917,614922;,[MIM:614922]Combined oxidative phosphorylation deficiency 11 [recessive?];,Combined oxidative phosphorylation defect type 11,Disease-causing germline mutation(s) (loss of function) in,Chronic myeloid leukemia[21540461];,0.7771779141104295,0.3115007735946364,0.24014617593317672,0.10082872928176796
3025,26781,RMRP,157660,,,Cartilage-hair hypoplasia;Omenn syndrome;Anauxetic dysplasia,Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in,,0.038773006134969326,0.6348633316142341,0.0,0.0
3026,28345,RNASE1,180440,,,Microcephaly-corpus callosum and cerebellar vermis hypoplasia-facial dysmorphism-intellectual disability syndrom,Disease-causing germline mutation(s) in,Obesity-related traits[23251661];Blood protein levels[29875488;30072576];,0.19190184049079756,0.46054667354306345,0.7671626207256591,0.4752915899324739
3027,28347,RNASE3,131398,,,Noonan syndrome;Familial isolated dilated cardiomyopathy;Noonan syndrome with multiple lentigines;Pilomyxoid astrocytoma,Disease-causing germline mutation(s) (gain of function) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) (gain of function) in;Part of a fusion gene in,Blood protein levels[30072576];,0.2498159509202454,0.0,0.9243017488906291,0.23603437691835483
3028,28355,RNASE12,,,,Smith-Magenis syndrome;Smith-Magenis syndrome;17p11.2 microduplication syndrome;PMP22-RAI1 contiguous gene duplication syndrome,Disease-causing germline mutation(s) in;Role in the phenotype of;Role in the phenotype of;Role in the phenotype of,"Body mass index[28892062];Parkinson's disease[21738487];Coronary artery disease or ischemic stroke[24262325];Hip circumference[25673412;25673412];Lymphocyte counts[27863252];Schizophrenia[25056061;28991256];Coronary artery disease or large artery stroke[24262325];Coronary artery disease[24262325];General cognitive ability[29844566];Coronary artery disease (myocardial infarction, percutaneous transluminal coronary angioplasty, coronary artery bypass grafting, angina or chromic ischemic heart disease)[28714975];",0.038773006134969326,0.4321815368746777,0.9462281388671365,0.0
3029,28357,RNASEH1,604123,616479;,,Adult-onset chronic progressive external ophthalmoplegia with mitochondrial myopathy,Disease-causing germline mutation(s) (loss of function) in,,0.36171779141104293,0.44365652398143374,0.9162098668754894,0.4145181092694905
3030,28359,RNASEH1P1,,616479;,,Adult-onset chronic progressive external ophthalmoplegia with mitochondrial myopathy,Disease-causing germline mutation(s) (loss of function) in,Body mass index[25673413;25673413;25673413];,0.038773006134969326,0.44365652398143374,0.0,0.0
3031,28362,RNASEH2A,606034,610333;,[MIM:610333]Aicardi-Goutieres syndrome 4;,Aicardi-Gouti�res syndrome,Disease-causing germline mutation(s) in,Response to bronchodilator in chronic obstructive pulmonary disease (change in FEV1)[26503814;26503814];,0.6671165644171779,0.39014956162970604,0.49334377447141736,0.5871700429711479
3032,28363,RNASEH2B,610326,610181;,,Aicardi-Gouti�res syndrome,Disease-causing germline mutation(s) in,Rheumatoid arthritis (ACPA-negative)[24532677];,0.6661349693251534,0.10933470861268695,0.4813364656747586,0.6594536525475752
3033,28365,RNASEH2C,610330,610329;,,Aicardi-Gouti�res syndrome,Disease-causing germline mutation(s) in,Spherical equivalent or myopia (age of diagnosis)[29808027];Acne (severe)[24927181];Systemic lupus erythematosus[27399966;27399966;28714469];Creatinine levels[29403010];Diastolic blood pressure x smoking status (current vs non-current) interaction (2df test)[29455858;29455858];Systolic blood pressure x smoking status (ever vs never) interaction (2df test)[29455858;29455858];Chronic kidney disease[20383146];Diastolic blood pressure x smoking status (ever vs never) interaction (2df test)[29455858;29455858];Albumin-globulin ratio[29403010];Systolic blood pressure x smoking status (current vs non-current) interaction (2df test)[29455858];Glomerular filtration rate (creatinine)[28452372];,0.4795092024539877,0.34914904589994844,0.5512920908379013,0.5612338858195212
3034,28369,RNASEL,180435,176807;601518;,"[MIM:601518]Prostate cancer, hereditary, 1;",Familial prostate cancer,Major susceptibility factor in,Multiple sclerosis[23412934];Morning vs. evening chronotype[26835600];,0.6080981595092024,0.110881897885508,0.15217958757504568,0.22790055248618785
3035,28370,RNASET2,612944,612951;,,Cystic leukoencephalopathy without megalencephaly,Disease-causing germline mutation(s) in,"Inflammatory bowel disease[28067908;23128233];Vitiligo[20526339;27723757];Allergic disease (asthma, hay fever or eczema)[29083406];Endometrial cancer[24096698];Smooth-surface caries[24556642];Spontaneous preterm birth (preterm birth)[25599974];Graves' disease[21841780];Type 1 diabetes in high risk HLA genotype individuals (time to event)[29310926];Lung cancer[28604730];Crohn's disease[23850713;28067908];Lung adenocarcinoma[28604730];Huntington's disease progression[28642124];",0.22687116564417178,0.29422382671480146,0.5225789611067606,0.32351135666052794
3036,28374,RNF2,608985,,,Familial melanoma;BAP1-related tumor predisposition syndrome;Uveal melanoma;Uveal melanoma,Major susceptibility factor in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing somatic mutation(s) in,Itch intensity from mosquito bite adjusted by bite size[28199695];Obesity-related traits[23251661];Clopidogrel active metabolite levels[28207573;28207573];,0.9560736196319018,0.9120680763280041,0.9138606108065779,0.6206261510128913
3037,28379,RNF6,604242,133239;,[MIM:133239]Esophageal cancer;,Squamous cell carcinoma of the esophagus,Candidate gene tested in,Type 2 diabetes[24509480;28869590;28869590];Sporadic pituitary adenoma[26029870];Urate levels (BMI interaction)[25811787];,0.22687116564417178,0.5616297060340382,0.682850430696946,0.1752608962553714
3038,28381,RNF7,603863,,,Retinitis pigmentosa;Congenital stationary night blindness;Oguchi disease,Disease-causing germline mutation(s) in;Candidate gene tested in;Disease-causing germline mutation(s) (loss of function) in,Pelvic organ prolapse (moderate/severe)[26545240];Hepatitis C induced liver fibrosis[22841784];,0.5614723926380368,0.5464156781846312,0.0,0.26611418047882135
3039,28400,RNF31,612487,,,Autoinflammatory syndrome with pyogenic bacterial infection and amylopectinosis,Disease-causing germline mutation(s) in,Suicide behavior[26079190];,0.6160736196319019,0.6725116039195461,0.4223440354998695,0.42004297114794353
3040,28407,RNF43,612482,617108;,[MIM:617108]Sessile serrated polyposis cancer syndrome;,Hyperplastic polyposis syndrome,Disease-causing germline mutation(s) in,Circulating myeloperoxidase levels (plasma)[23620142];Stroke[29531354];Vitamin D levels[25208829];Mean corpuscular hemoglobin[27863252];Mean corpuscular volume[27863252];Pancreatic cancer[20686608];Cognitive function[25644384];Prostate cancer[29892016];,0.33226993865030674,0.7465188241361527,0.014356564865570347,0.2589011663597299
3041,28413,RNF113A,300951,300953;,,Trichothiodystrophy,Disease-causing germline mutation(s) in,,0.6571779141104295,0.8612686952037133,0.8506917253980684,0.0
3042,28426,RNF135,611358,614192;,,Overgrowth-macrocephaly-facial dysmorphism syndrome,Disease-causing germline mutation(s) in,Height[18391951];,0.4493251533742331,0.3746776689014956,0.17828243278517358,0.0
3043,28430,RNF139,603046,144700;,[MIM:144700]Renal cell carcinoma;,Hereditary clear cell renal cell carcinoma,Part of a fusion gene in,,0.30319018404907977,0.5772305312016504,0.7588097102584181,0.39241866175567836
3044,28449,RNF168,612688,611943;,[MIM:611943]Riddle syndrome;,RIDDLE syndrome,Disease-causing germline mutation(s) in,Fat distribution (HIV)[21897333];,0.5731288343558282,0.06833419288292934,0.20777864787261813,0.17019643953345612
3045,28465,RNF213,613768,607151;,[MIM:607151]Moyamoya disease 2;,Moyamoya disease,Major susceptibility factor in,Moyamoya disease[21048783;29273593;29273593;29273593;29273593;29273593];Alanine aminotransferase (ALT) levels after remission induction therapy in actute lymphoblastic leukemia (ALL)[28090653];Migraine[27322543;27182965];Lipoprotein-associated phospholipase A2 activity change in response to statin therapy[23118302];,0.6058895705521472,0.0025786487880350697,0.06943356825894022,0.6416513198281154
3046,28468,RNF216,609948,212840;,[MIM:212840]Gordon Holmes syndrome;,Cerebellar ataxia-hypogonadism syndrome,Disease-causing germline mutation(s) (loss of function) in,,0.4154601226993865,0.23852501289324393,0.5980161837640303,0.28621853898096994
3047,28494,RNPC3,618016,,,Isolated growth hormone deficiency type IA,Disease-causing germline mutation(s) in,,0.038773006134969326,0.3726147498710676,0.7997911772383189,0.21807857581338244
3048,28791,RNU4ATAC,601428,,,Lowry-Wood syndrome;Microcephalic osteodysplastic primordial dwarfism types I and III;Roifman syndrome,Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in,Cholesterol ester levels in large LDL[29084231;29084231];Total cholesterol levels in LDL[29084231];Total cholesterol levels in small LDL[29084231;29084231;29084231];Total cholesterol levels in large LDL[29084231;29084231];Small LDL particle concentration[29084231;29084231;29084231];Large LDL particle concentration[29084231;29084231];Free cholesterol levels in large LDL[29084231;29084231];Free cholesterol levels[29084231;29084231];Serum total cholesterol levels[29084231];Cholesterol ester levels in medium LDL[29084231;29084231];Total cholesterol levels in medium LDL[29084231;29084231];Medium LDL particle concentration[29084231;29084231];Esterified cholesterol levels[29084231;29084231];,0.038773006134969326,0.0,0.0,0.0
3049,30341,RNU12,,,,Congenital cerebellar ataxia due to RNU12 mutation,Disease-causing germline mutation(s) in,,0.038773006134969326,0.0,0.0,0.0
3050,30342,RNU12-2P,,,,Congenital cerebellar ataxia due to RNU12 mutation,Disease-causing germline mutation(s) in,,0.038773006134969326,0.0,0.0,0.0
3051,30438,ROBO1,602430,,,Pituitary stalk interruption syndrome,Disease-causing germline mutation(s) (loss of function) in,Glomerular filtration rate in chronic kidney disease[26420894];Facial emotion recognition[28608620];Brain imaging in schizophrenia (dorsolateral prefrontal cortex interaction)[19023125];Excessive daytime sleepiness[27992416];Facial emotion recognition (fearful faces)[28608620];Visceral adipose tissue[26480920];Staphylococcus aureus nasal carriage (intermittent)[26569114];Diverticular disease[30177863];Carotid plaque burden[28282560];Nose size[27182965];Craniofacial microsomia[26853712];Liver enzyme levels (aspartate transaminase)[24124411];Takayasu arteritis[25604533];Protein quantitative trait loci[18464913];,0.5353374233128835,0.5678184631253224,0.379796397807361,0.22682627378759976
3052,30439,ROBO2,602431,610878;,[MIM:610878]Vesicoureteral reflux 2;,Familial vesicoureteral reflux,Disease-causing germline mutation(s) in,Expressive vocabulary in infants[25226531];Metabolite levels (5-HIAA/ MHPG Ratio)[23319000];Brain imaging in schizophrenia (dorsolateral prefrontal cortex interaction)[19023125];Hand grip strength[29691431];Post bronchodilator FEV1/FVC ratio[26634245;26634245];Familial lung adenocarcinoma[29924316];Periodontitis (PAL4Q3)[24024966];Post bronchodilator FEV1[26634245];,0.6612269938650307,1.0,0.44166014095536416,0.5161141804788214
3053,30441,ROBO3,608630,607313;,"[MIM:607313]Gaze palsy, familial horizontal, with progressive scoliosis, 1 [recessive?];",Horizontal gaze palsy with progressive scoliosis,Disease-causing germline mutation(s) in,,0.5128834355828221,0.4645435791645178,0.025058731401722788,0.30356046654389196
3054,30447,ROGDI,614574,226750;,,Amelocerebrohypohidrotic syndrome,Disease-causing germline mutation(s) (loss of function) in,Night sleep phenotypes[27126917];,0.2498159509202454,0.48194945848375453,0.6207256590968415,0.19429097605893186
3055,30448,ROM1,180721,608133;,,Retinitis pigmentosa,Disease-causing germline mutation(s) in,Waist-to-hip ratio adjusted for BMI[26426971;26426971];Waist-to-hip ratio adjusted for BMI x sex x age interaction (4df test)[26426971;26426971];,0.16220858895705523,0.5446106240330068,0.5967110415035238,0.25475751995089013
3056,30454,ROR1,602336,617654;,"[MIM:617654]Deafness, autosomal recessive, 108 [recessive?];",Autosomal recessive non-syndromic sensorineural deafness type DFNB,Disease-causing germline mutation(s) in,Pancreatic cancer[26098869];Blood protein levels[29875488;30072576;30072576;30072576];,0.7074846625766871,0.9138731304796287,0.1245105716523101,0.6642111724984653
3057,30456,ROR2,602337,113000;268310;,[MIM:113000]Brachydactyly B1;[MIM:268310]Robinow syndrome autosomal recessive [recessive?];,Autosomal recessive Robinow syndrome;Brachydactyly type B,Disease-causing germline mutation(s) (loss of function) in;Disease-causing germline mutation(s) (gain of function) in,Type 2 diabetes[25483131];Bone mineral density (hip)[26911590];Nose size[27182965];Bipolar disorder and schizophrenia[22688191];Bipolar disorder (inflammation and infection response interaction)[25781172];,0.8089570552147239,0.21531717380092832,0.34951709736361264,0.8612645794966237
3058,30457,RORA,600825,,,Autosomal recessive non-syndromic sensorineural deafness type DFNB,Disease-causing germline mutation(s) in,"Nickel levels[26025379];Cerebrospinal fluid beta-site APP cleaving enzyme levels[29751835];C-reactive protein levels[21300955];C-reactive protein levels or total cholesterol levels (pleiotropy)[27286809];Depression (quantitative trait)[20800221];Schizophrenia[23212062];Neuropathic pain in head and neck cancer[29884837];Menarche (age at onset)[21102462;23599027;25231870;23599027];Blood protein levels[28240269];Gamma glutamyl transferase levels[22010049];Blood urea nitrogen levels[29403010];Asthma[20860503;27182965;29273806;29273806];Chronic central serous retinopathy[30073298];Liver enzyme levels (gamma-glutamyl transferase)[22001757];Total ventricular volume (Alzheimer's disease interaction)[21116278];Body mass index[28892062];Pulmonary function decline[22424883];Response to citalopram treatment[19846067];Allergic disease (asthma, hay fever or eczema)[29083406];Allergic rhinitis[30013184];Subcutaneous adipose tissue[22589738];C-reactive protein levels or LDL-cholesterol levels (pleiotropy)[27286809];Intraocular pressure[29617998;29617998];Allergic sensitization[30013184];",0.4403680981595092,0.6405363589479113,0.87548942834769,0.952731737262124
3059,30462,RORC,602943,616622;,[MIM:616622]Immunodeficiency 42 [recessive?];,Autosomal recessive mendelian susceptibility to mycobacterial diseases due to complete RORgamma receptor deficiency,Disease-causing germline mutation(s) in,"Inflammatory bowel disease[28067908;23128233];Allergic disease (asthma, hay fever or eczema)[29083406];Chronic inflammatory diseases (ankylosing spondylitis, Crohn's disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy)[26974007];Crohn's disease[28067908];Ulcerative colitis[28067908];Depressive symptoms (SSRI exposure interaction)[25649181];",0.8444171779141104,0.9818205260443528,0.3745758287653354,0.9604051565377533
3060,30464,RP1,603937,145750;180100;,[MIM:180100]Retinitis pigmentosa 1;,Retinitis pigmentosa,Disease-causing germline mutation(s) in,Lung cancer in ever smokers[28604730;28604730];Lung cancer[28604730];,0.14576687116564419,0.07297576070139247,0.02375358914121639,0.3612645794966237
3061,30465,RP1L1,608581,613587;,[MIM:613587]Occult macular dystrophy;,Occult macular dystrophy,Disease-causing germline mutation(s) in,Heart rate response to exercise[29769521];Amyotrophic lateral sclerosis (sporadic)[24529757];Systolic blood pressure x alcohol consumption interaction (2df test)[29912962];Obesity-related traits[23251661];Systolic blood pressure x alcohol consumption (light vs heavy) interaction (2df test)[29912962];Mean arterial pressure x alcohol consumption (light vs heavy) interaction (2df test)[29912962];Mean arterial pressure x alcohol consumption interaction (2df test)[29912962];,0.12711656441717792,0.10108303249097472,0.0020882276168102325,0.3396255371393493
3062,30466,RP2,300757,312600;,[MIM:312600]Retinitis pigmentosa 2;,Retinitis pigmentosa,Disease-causing germline mutation(s) in,,0.7577914110429448,0.899045899948427,0.7170451579222136,0.7575199508901166
3063,30468,RP9,607331,180104;,,Retinitis pigmentosa,Disease-causing germline mutation(s) in,,0.50920245398773,0.4221248066013409,0.19577133907595928,0.26442602823818295
3064,30492,RPE65,180069,204100;613794;,[MIM:204100]Leber congenital amaurosis 2;[MIM:613794]Retinitis pigmentosa 20;,Retinitis pigmentosa;Leber congenital amaurosis;Severe early-childhood-onset retinal dystrophy,Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in,Mortality in sepsis[27639821];Vertical cup-disc ratio[28073927;28073927];,0.17791411042944785,0.06472408457968025,0.43017488906290785,0.7701043585021485
3065,30504,RPGR,312610,300029;300455;300834;304020;,"[MIM:300029]Retinitis pigmentosa 3;[MIM:300455]Retinitis pigmentosa and sinorespiratory infections with or without deafness;[MIM:304020]Cone-rod dystrophy, X-linked 1;[MIM:300834]Macular degeneration, X-linked, atrophic;",Primary ciliary dyskinesia;Retinitis pigmentosa;Cone rod dystrophy;Primary ciliary dyskinesia-retinitis pigmentosa syndrome;Achromatopsia,Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Candidate gene tested in,,0.5980368098159509,0.6717380092831357,0.14774210388932393,0.7874462860650706
3066,30505,RPGRIP1,605446,608194;613826;,[MIM:613826]Leber congenital amaurosis 6;[MIM:608194]Cone-rod dystrophy 13;,Meckel syndrome;Cone rod dystrophy;Leber congenital amaurosis,Candidate gene tested in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) (loss of function) in,Body mass index[26426971];Body mass index x sex x age interaction (4df test)[26426971];Body mass index (age>50)[26426971];,0.5353374233128835,0.02630221763795771,0.10754372226572696,0.3592694904849601
3067,30506,RPGRIP1L,610937,216360;611560;611561;,[MIM:611560]Joubert syndrome 7;[MIM:611561]Meckel syndrome 5;[MIM:216360]COACH syndrome;,Meckel syndrome;Joubert syndrome with hepatic defect;Joubert syndrome with renal defect,Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in,Diastolic blood pressure x smoking status (current vs non-current) interaction (2df test)[29455858;29455858];Bipolar disorder[21254220];Triglyceride change in response to fenofibrate in statin-treated type 2 diabetes[28736931];Systolic blood pressure x smoking status (ever vs never) interaction (2df test)[29455858;29455858];Diastolic blood pressure x smoking status (ever vs never) interaction (2df test)[29455858;29455858];Eyebrow thickness[26926045];Systolic blood pressure x smoking status (current vs non-current) interaction (2df test)[29455858;29455858];,0.8748466257668711,0.7336255801959773,0.12268337248760115,0.7200736648250461
3068,30509,RPIA,180430,608611;,[MIM:608611]Ribose 5-phosphate isomerase deficiency;,Ribose-5-P isomerase deficiency,Disease-causing germline mutation(s) in,Blood protein levels[30072576];,0.7779141104294478,0.3269726663228468,0.8131036282954842,0.37047268262737876
3069,30533,RPL5,603634,612561;,[MIM:612561]Diamond-Blackfan anemia 6;,Blackfan-Diamond anemia,Disease-causing germline mutation(s) in,Multiple sclerosis[17660530;19525955];Height[20881960];,0.9865030674846625,0.9347601856627127,0.8600887496737144,0.0
3070,30784,RPL10,312173,300847;300998;,"[MIM:300847]Autism, X-linked 5;[MIM:300998]Mental retardation, X-linked, syndromic, 35;",X-linked intellectual disability-cerebellar hypoplasia-spondylo-epiphyseal dysplasia syndrome;X-linked microcephaly-growth retardation-prognathism-cryptorchidism syndrome,Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) (loss of function) in,Diverticular disease[30177863];Pulse pressure x alcohol consumption interaction (2df test)[29912962];Pulse pressure[28739976];Pulse pressure x alcohol consumption (light vs heavy) interaction (2df test)[29912962;29912962];Blood pressure[21909110];Systolic blood pressure x alcohol consumption interaction (2df test)[29912962];Blood protein levels[29875488;30072576];,0.961717791411043,0.8285198555956679,0.9913860610806577,0.0
3071,30819,RPL11,604175,612562;,[MIM:612562]Diamond-Blackfan anemia 7;,Blackfan-Diamond anemia,Disease-causing germline mutation(s) in,,0.9683435582822086,0.8423156266116555,0.9676324719394414,0.0
3072,30922,RPL15,604174,615550;,[MIM:615550]Diamond-Blackfan anemia 12;,Blackfan-Diamond anemia,Disease-causing germline mutation(s) in,Intelligence (MTAG)[29326435;29326435];Acne (severe)[24927181];,0.9495705521472393,0.6892728210417741,0.88775776559645,0.0
3073,30996,RPL18,604179,,,Blackfan-Diamond anemia,Disease-causing germline mutation(s) in,Bipolar disorder[21926972];Elevated serum carcinoembryonic antigen levels[24941225];,0.983558282208589,0.868746776689015,0.0,0.0
3074,31049,RPL21,603636,615885;,[MIM:615885]Hypotrichosis 12;,Hypotrichosis simplex,Disease-causing germline mutation(s) in,Electrocardiographic traits[17903306];,0.9629447852760736,0.8726147498710676,0.9966066301226834,0.0
3075,31325,RPL26,603704,614900;,[MIM:614900]Diamond-Blackfan anemia 11;,Blackfan-Diamond anemia,Disease-causing germline mutation(s) in,,0.9676073619631902,0.7377514182568334,0.9624119028974158,0.0
3076,31363,RPL27,607526,617408;,[MIM:617408]Diamond-Blackfan anemia 16;,Blackfan-Diamond anemia,Candidate gene tested in,,0.9595092024539877,0.8006704486848891,0.0,0.0
3077,31578,RPL35,,,,Blackfan-Diamond anemia,Disease-causing germline mutation(s) in,,0.9499386503067485,0.7302733367715317,0.9329156878099713,0.0
3078,31579,RPL35A,180468,612528;,,Blackfan-Diamond anemia,Disease-causing germline mutation(s) in,,0.9401226993865031,0.8659102630221763,0.8919342208300705,0.0
3079,31825,RPN1,180470,,,Acute myeloid leukemia with inv3(q21;q26.2) or t(3;3)(q21;q26.2),Part of a fusion gene in,Sum eosinophil basophil counts[27863252];White blood cell count (basophil)[29403010];White blood cell count[21738480;21738480];Eosinophil counts[27863252;29403010];Monocyte count[23314186;27863252;29403010];Monocyte percentage of white cells[27863252];Blood protein levels[29875488;30072576];,0.9950920245398773,0.8986591026302218,0.5311929000261029,0.7874462860650706
3080,32002,RPS6KA3,300075,300844;303600;,"[MIM:303600]Coffin-Lowry syndrome;[MIM:300844]Mental retardation, X-linked 19;",Coffin-Lowry syndrome;Symptomatic form of Coffin-Lowry syndrome in female carriers;X-linked non-syndromic intellectual disability,Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in,,0.5585276073619632,0.9868488911810211,0.7645523362046464,0.0
3081,32036,RPS7,603658,612563;,[MIM:612563]Diamond-Blackfan anemia 8;,Blackfan-Diamond anemia,Disease-causing germline mutation(s) in,,0.9485889570552147,0.870293965961836,0.8264160793526495,0.0
3082,32067,RPS10,603632,613308;,[MIM:613308]Diamond-Blackfan anemia 9;,Blackfan-Diamond anemia,Disease-causing germline mutation(s) in,,0.9514110429447853,0.8935018050541517,0.9584964761158966,0.0
3083,32149,RPS14,130620,,,Myelodysplastic syndrome associated with isolated del(5q) chromosome abnormality,Role in the phenotype of,Inflammatory bowel disease[28067908];Visceral adipose tissue/subcutaneous adipose tissue ratio[22589738];Crohn's disease[28067908];,0.9877300613496932,0.8700361010830325,0.0,0.0
3084,32160,RPS15,180535,,,B-cell chronic lymphocytic leukemia,Disease-causing somatic mutation(s) in,,0.9229447852760736,0.8428313563692625,0.9984338292873923,0.0
3085,32222,RPS17,180472,612527;,[MIM:612527]Diamond-Blackfan anemia 4;,Blackfan-Diamond anemia,Disease-causing germline mutation(s) in,Copper levels[26025379];,0.9455214723926381,0.6606498194945848,0.0,0.0
3086,32254,RPS19,603474,105650;,,Blackfan-Diamond anemia,Disease-causing germline mutation(s) in,,0.9369325153374233,0.7539969056214544,0.9956930305403289,0.0
3087,32263,RPS20,603682,,,Familial colorectal cancer Type X,Disease-causing germline mutation(s) in,Systemic lupus erythematosus[28714469];Height[18391951];,0.9457668711656442,0.5221763795771016,0.833463847559384,0.0
3088,32319,RPS24,602412,610629;,,Blackfan-Diamond anemia,Disease-causing germline mutation(s) in,Diverticular disease[30177863];,0.9688343558282209,0.7885507993811243,0.9660663012268337,0.0
3089,32350,RPS26,603701,613309;,[MIM:613309]Diamond-Blackfan anemia 10;,Blackfan-Diamond anemia,Disease-causing germline mutation(s) in,Vitiligo[22951725];Psoriasis[20953189;25574825];Anorexia nervosa[28494655];Nonsyndromic cleft lip with cleft palate[28232668];Hypothyroidism[27182965];Cognitive function[25644384];Inflammatory skin disease[25574825];,0.9521472392638037,0.8334192882929345,0.9956930305403289,0.0
3090,32409,RPS27,603702,617409;,,Blackfan-Diamond anemia,Candidate gene tested in,,0.8915337423312883,0.6808922124806601,0.9960845732184808,0.0
3091,32460,RPS28,603685,606164;,"[MIM:606164]Diamond-Blackfan anemia 15, with mandibulofacial dysostosis;",Blackfan-Diamond anemia,Disease-causing germline mutation(s) (loss of function) in,,0.9077300613496933,0.7882929345023207,0.9989558861915949,0.0
3092,32470,RPS29,603633,615909;,[MIM:615909]Diamond-Blackfan anemia 13;,Blackfan-Diamond anemia,Disease-causing germline mutation(s) (loss of function) in,Visceral fat[22589738];Rosacea symptom severity[29771307];Visceral adipose tissue/subcutaneous adipose tissue ratio[22589738];Post-traumatic stress disorder (asjusted for relatedness)[23726511;23726511];,0.912883435582822,0.64853017019082,0.9942573740537719,0.0
3093,32504,RPSA,150370,271400;,"[MIM:271400]Asplenia, isolated congenital;",Familial isolated congenital asplenia,Disease-causing germline mutation(s) in,,0.9431901840490797,0.8329035585353275,0.9788566953797964,0.0
3094,32593,RRAS,165090,,,Noonan syndrome;Juvenile myelomonocytic leukemia,Candidate gene tested in;Candidate gene tested in,Systolic blood pressure[27618447];Schizophrenia[25056061];Pulse pressure[27618447];,0.4622085889570552,0.3996905621454358,0.7611589663273297,0.413597298956415
3095,32596,RREB1,602209,,,22q11.2 deletion syndrome,Modifying germline mutation in,Type 2 diabetes[24509480];Multiple sclerosis[21833088];Ewing sarcoma[30093639];Lymphocyte counts[27863252];Myeloid white cell count[27863252];Hematocrit[27863252];Sum basophil neutrophil counts[27863252];High light scatter reticulocyte count[27863252];Neutrophil count[27863252];Waist-to-hip ratio adjusted for BMI[26426971];Hemoglobin concentration[27863252];Reticulocyte fraction of red cells[27863252];Fasting blood glucose (BMI interaction)[22581228];Waist-to-hip ratio adjusted for BMI x sex x age interaction (4df test)[26426971];Urate levels[20884846;23263486];Fasting blood glucose[22581228];Reticulocyte count[27863252];Visceral adipose tissue adjusted for BMI[22589738;22589738;27918534;27918534;27918534];Heel bone mineral density[28869591;28869591;28869591;28869591;28869591;28869591];Vertical cup-disc ratio[28073927;28073927];Red blood cell count[27863252];Waist-hip ratio[23966867];Waist-to-hip ratio adjusted for BMI (age >50)[26426971];Waist-to-hip ratio adjusted for BMI (age <50)[26426971];Age-related macular degeneration[20385826];White blood cell count[27863252];Multiple system atrophy[27629089];Monocyte count[27863252;27863252];,0.7743558282208589,0.6952037132542548,0.02975724353954581,0.9950890116635973
3096,32601,RRM2B,604712,612075;613077;,"[MIM:612075]Mitochondrial DNA depletion syndrome 8A;[MIM:612075]Mitochondrial DNA depletion syndrome 8B;[MIM:613077]Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal dominant, 5 [dominant?];","Kearns-Sayre syndrome;Autosomal dominant progressive external ophthalmoplegia;Mitochondrial DNA depletion syndrome, encephalomyopathic form with renal tubulopathy;Adult-onset chronic progressive external ophthalmoplegia with mitochondrial myopathy;Mitochondrial neurogastrointestinal encephalomyopathy",Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in,Mean corpuscular volume[29403010];Mean corpuscular hemoglobin[29403010];Chronic obstructive pulmonary disease[28166215];Blood protein levels[29875488;30072576];,0.35496932515337426,0.2552862300154719,0.0,0.7166973603437692
3097,32621,RS1,300839,312700;,[MIM:312700]Retinoschisis juvenile X-linked 1;,X-linked retinoschisis,Disease-causing germline mutation(s) in,,0.17791411042944785,0.8971119133574007,0.6173322892195249,0.0
3098,32626,RSC1A1,601966,,,X-linked retinoschisis,Disease-causing germline mutation(s) in,Alcoholic chronic pancreatitis[28754779;28754779];,0.22687116564417178,0.07065497679216091,0.19081179848603497,0.07028852056476366
3099,32644,RSPH1,609314,615481;,,Primary ciliary dyskinesia,Disease-causing germline mutation(s) (loss of function) in,,0.038773006134969326,0.2784940691077875,0.4171234664578439,0.16313689379987723
3100,32645,RSPH3,615876,616481;,"[MIM:616481]Ciliary dyskinesia, primary, 32;",Primary ciliary dyskinesia,Disease-causing germline mutation(s) in,Systemic lupus erythematosus[28714469];Lipoprotein (a) levels[26377243];Bladder cancer (smoking interaction)[24662972];,0.21484662576687116,0.27153171738009285,0.03445575567736883,0.14809699201964396
3101,32646,RSPH4A,612647,612649;,,Primary ciliary dyskinesia,Disease-causing germline mutation(s) in,,0.038773006134969326,0.10856111397627644,0.0947533281127643,0.010589318600368325
3102,32648,RSPH9,612648,612650;,"[MIM:612650]Ciliary dyskinesia, primary, 12;",Primary ciliary dyskinesia,Disease-causing germline mutation(s) in,Waist-to-hip ratio adjusted for BMI (age >50)[26426971];Waist-to-hip ratio adjusted for BMI (age <50)[26426971];Intracranial aneurysm[29531279];Waist-to-hip ratio adjusted for BMI[26426971];Waist-to-hip ratio adjusted for BMI x sex x age interaction (4df test)[26426971];,0.2585276073619632,0.12351727694687983,0.23257635082223962,0.6042050337630448
3103,32652,RSPO1,609595,610644;,"[MIM:610644]Keratoderma, palmoplantar, with squamous cell carcinoma of skin and sex reversal;",Palmoplantar keratoderma-XX sex reversal-predisposition to squamous cell carcinoma syndrome,Disease-causing germline mutation(s) in,Epithelial ovarian cancer[25581431;25581431];Axial length[24144296];Eyebrow thickness[26926045];Intraocular pressure[30054594;29785010];,0.28662576687116564,0.2815884476534296,0.37170451579222136,0.42326580724370777
3104,32653,RSPO2,610575,,,Tetraamelia-multiple malformations syndrome,Disease-causing germline mutation(s) in,Male-pattern baldness[29146897;29146897;29146897];Dupuytren's disease[21732829;28886342];Ossification of the posterior longitudinal ligament of the spine[25064007];Blood protein levels[30072576];Acute lymphoblastic leukemia (childhood)[22076464];,0.26588957055214724,0.463898916967509,0.0485512920908379,0.42602823818293434
3105,32655,RSPO4,610573,206800;,"[MIM:206800]Nail disorder, non-syndromic congenital, 4;",Anonychia congenita totalis,Disease-causing germline mutation(s) in,Blood protein levels[30072576];,0.2498159509202454,0.3494069107787519,0.4667188723570869,0.5434315531000614
3106,32656,RSPRY1,616585,616723;,"[MIM:616723]Spondyloepimetaphyseal dysplasia, Faden-Alkuraya type [recessive?];",Progressive spondyloepimetaphyseal dysplasia-short stature-short fourth metatarsals-intellectual disability syndrome,Disease-causing germline mutation(s) (loss of function) in,Angiotensin-converting enzyme inhibitor intolerance[28030426];,0.7573006134969326,0.7021660649819494,0.7718611328634821,0.7154696132596685
3107,32669,RTEL1,608833,615190;616373;,"[MIM:615190]Dyskeratosis congenita, autosomal recessive, 5 [recessive?];[MIM:615190]Dyskeratosis congenita, autosomal dominant, 4 [dominant?];[MIM:616373]Pulmonary fibrosis, and/or bone marrow failure, telomere- related, 3;",Dyskeratosis congenita;Hoyeraal-Hreidarsson syndrome;Idiopathic pulmonary fibrosis,Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Major susceptibility factor in,"Glioblastoma (age-stratified)[30152087;30152087;30152087];Glioblastoma[28346443;29743610;29743610];Plateletcrit[27863252];Crohn's disease[21102463;28067908];Telomere length[29151059];Non-glioblastoma glioma[28346443;29743610];Inflammatory bowel disease[28067908];Dental caries[23259602];Allergic disease (asthma, hay fever or eczema)[29083406];Glioma[19578367;21531791;22886559;28346443;29743610;29743610];Atopic dermatitis[26482879];Cutaneous malignant melanoma[26237428];Glioma (high-grade)[19578366;19578366;24908248];Prostate cancer[23535732];Ulcerative colitis[21297633;28067908];",0.7257668711656442,0.14311500773594638,0.22839989558861917,0.8804481276856968
3108,32676,RTL1,611896,,,Temple syndrome due to paternal 14q32.2 microdeletion;Kagami-Ogata syndrome due to maternal 14q32.2 microdeletion;Kagami-Ogata syndrome due to maternal 14q32.2 hypermethylation;Temple syndrome due to paternal 14q32.2 hypomethylation;Temple syndrome due to maternal uniparental disomy of chromosome 14;Kagami-Ogata syndrome due to paternal uniparental disomy of chromosome 14,Role in the phenotype of;Role in the phenotype of;Role in the phenotype of;Role in the phenotype of;Role in the phenotype of;Role in the phenotype of,Pelvic organ prolapse (moderate/severe)[26545240];Type 1 diabetes[19966805];,0.08736196319018405,0.3849922640536359,0.09266510049595406,0.29665438919582565
3109,32687,RTN2,603183,604805;,,Autosomal dominant spastic paraplegia type 12,Disease-causing germline mutation(s) in,Cognitive decline rate in late mild cognitive impairment[26252872;26252872];,0.3168098159509202,0.7957710159876225,0.6614460976246411,0.2678023327194598
3110,32691,RTN4IP1,610502,616732;,,Autosomal recessive isolated optic atrophy,Disease-causing germline mutation(s) in,Daytime sleep phenotypes[27126917];,0.8397546012269939,0.29834966477565755,0.7804750717828244,0.14548802946593
3111,32701,RTTN,610436,614833;,"[MIM:614833]Microcephaly, short stature, and polymicrogyria with or without seizures;",Microcephalic primordial dwarfism due to RTTN deficiency,Disease-causing germline mutation(s) in,Mean platelet volume[27863252];Platelet distribution width[27863252];Night sleep phenotypes[27126917];,0.5731288343558282,0.19907168643630738,0.2939180370660402,0.06015960712093309
3112,32702,RUBCN,613516,615705;,"[MIM:615705]Spinocerebellar ataxia, autosomal recessive, 15 [recessive?];",Autosomal recessive cerebellar ataxia-epilepsy-intellectual disability syndrome due to RUBCN deficiency,Disease-causing germline mutation(s) in,,0.5969325153374233,0.2581227436823105,0.0,0.0
3113,32712,RUNX1,151385,601399;,[MIM:601399]Familial platelet disorder with associated myeloid malignancy;,Isolated delta-storage pool disease;Chronic myeloid leukemia;Hereditary thrombocytopenia with normal platelets-hematological cancer predisposition syndrome;Acute myeloid leukemia with t(8;21)(q22;q22) translocation;Precursor B-cell acute lymphoblastic leukemia,Disease-causing germline mutation(s) in;Biomarker tested in;Disease-causing germline mutation(s) in;Part of a fusion gene in;Part of a fusion gene in,"Psoriasis[25903422;25903422];White blood cell count (basophil)[27863252];Plateletcrit[27863252];Basophil percentage of white cells[27863252];Eosinophil counts[27863252;27863252;27863252;27863252];Plasma omega-3 polyunsaturated fatty acid level (eicosapentaenoic acid)[21829377];Basophil percentage of granulocytes[27863252];Immune response to smallpox vaccine (IL-6)[22542470];Sum eosinophil basophil counts[27863252;27863252;27863252;27863252];Male-pattern baldness[27182965;29146897];Eosinophil percentage of granulocytes[27863252;27863252;27863252;27863252];Rheumatoid arthritis (ACPA-positive)[24532676;23143596];Allergic disease (asthma, hay fever or eczema)[29083406];Juvenile idiopathic arthritis (oligoarticular or rheumatoid factor-negative polyarticular)[23603761];Rheumatoid arthritis[24390342;24390342;23143596];Preeclampsia[23551011];Esophageal squamous cell carcinoma[25129146];Neutrophil percentage of granulocytes[27863252;27863252];Esophageal cancer[21642993];Platelet count[27863252];Eosinophil percentage of white cells[27863252;27863252;27863252;27863252];",0.7565644171779141,0.8517276946879835,0.6737144348734012,0.7183855125844076
3114,32714,RUNX1T1,133435,,,Acute myeloid leukemia with t(8;21)(q22;q22) translocation,Part of a fusion gene in,Intelligence (MTAG)[29326435];Oppositional defiant disorder dimensions in attention-deficit hyperactivity disorder[26184070];,0.52920245398773,0.9599020113460547,0.8133646567475855,0.5285451197053407
3115,32715,RUNX2,600211,119600;156510;,[MIM:119600]Cleidocranial dysplasia;[MIM:156510]Metaphyseal dysplasia with maxillary hypoplasia with or without brachydactyly [dominant?];,Cleidocranial dysplasia;Metaphyseal dysplasia-maxillary hypoplasia-brachydacty syndrome,Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) (gain of function) in,Hip minimal joint space width[27701424;27701424];Central corneal thickness[29760442];Mosquito bite size[28199695];Progressive supranuclear palsy[30089514];facial morphology traits (multivariate analysis)[27193062];Periodontal microbiota[22699663];Height[18391951;25429064];Itch intensity from mosquito bite[28199695];Survival in pancreatic cancer[28470677];Intraocular pressure[30054594;29785010];,0.49938650306748467,0.8741619391438886,0.6695379796397808,0.8914978514426029
3116,32740,RXYLT1,605862,615041;,[MIM:615041]Muscular dystrophy-dystroglycanopathy congenital with brain and eye anomalies A10 [recessive?];,Walker-Warburg syndrome,Disease-causing germline mutation(s) (loss of function) in,,0.038773006134969326,0.5335224342444559,0.0,0.0
3117,32745,RYR1,180901,117000;145600;255320;,[MIM:145600]Malignant hyperthermia 1;[MIM:117000]Central core disease of muscle [recessive?];[MIM:255320]Multiminicore disease with external ophthalmoplegia;,Central core disease;Autosomal recessive centronuclear myopathy;Autosomal dominant centronuclear myopathy;Malignant hyperthermia of anesthesia;Moderate multiminicore disease with hand involvement;Benign Samaritan congenital myopathy;Exercise-induced malignant hyperthermia;Congenital myopathy with myasthenic-like onset;Lethal multiple pterygium syndrome;King-Denborough syndrome;Congenital multicore myopathy with external ophthalmoplegia,Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Candidate gene tested in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Major susceptibility factor in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in,Peanut allergy (parent-of-origin effect)[29489655];White blood cell count (basophil)[27863252];Diisocyanate-induced asthma[25918132];Basophil percentage of white cells[27863252];Basophil percentage of granulocytes[27863252];,0.43754601226993867,0.3898916967509025,0.16235969720699556,0.9917127071823204
3118,32746,RYR2,180902,600996;604772;,"[MIM:600996]Arrhythmogenic right ventricular dysplasia, familial, 2;[MIM:604772]Ventricular tachycardia, catecholaminergic polymorphic, 1, with or without atrial dysfunction and/or dilated cardiomyopathy [dominant?];","Catecholaminergic polymorphic ventricular tachycardia;Familial isolated arrhythmogenic ventricular dysplasia, right dominant form;Familial isolated arrhythmogenic ventricular dysplasia, biventricular form;Familial isolated arrhythmogenic ventricular dysplasia, left dominant form",Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in,Hypertension[17554300];Bipolar disorder and eating disorder[26433762];Response to taxane treatment (docetaxel)[23006423];Exercise treadmill test traits[17903301];Lipid traits[24386095];Cerivastatin-induced rhabdomyolysis[21386754];Lung function (FEV1)[30061609];Obesity-related traits[23251661;23251661];Acute lymphoblastic leukemia (childhood)[19684603];Lung function (FVC)[30061609;30061609];,0.6019631901840491,1.0,0.21952492821717567,0.8858195211786372
3119,32749,S1PR2,605111,610419;,"[MIM:610419]Deafness, autosomal recessive, 68 [recessive?];",Autosomal recessive non-syndromic sensorineural deafness type DFNB,Disease-causing germline mutation(s) (loss of function) in,High light scatter reticulocyte percentage of red cells[27863252];Reticulocyte fraction of red cells[27863252];Reticulocyte count[27863252];Alanine transaminase levels[29403010];High light scatter reticulocyte count[27863252];Immature fraction of reticulocytes[27863252];,0.35496932515337426,0.46802475502836516,0.7522839989558862,0.7329650092081031
3120,32768,S100A9,123886,,,Systemic-onset juvenile idiopathic arthritis,Major susceptibility factor in,Matrix metalloproteinase-8 levels[29212897];,0.7231901840490798,0.7088705518308407,0.93265465935787,0.0
3121,32786,SAA1,104750,,,AA amyloidosis,Major susceptibility factor in,Rosacea symptom severity[29771307];Blood protein levels[28240269;29875488;30072576];Amyloid A serum levels[21124955];,0.19190184049079756,0.46003094378545645,0.4570608196293396,0.015500306936771025
3122,32794,SACS,604490,270550;,[MIM:270550]Spastic ataxia Charlevoix-Saguenay type;,Autosomal recessive spastic ataxia of Charlevoix-Saguenay,Disease-causing germline mutation(s) in,Type 2 diabetes[23300278];Blood pressure (smoking interaction)[25189868];Hypothyroidism[22493691];Protein quantitative trait loci[18464913];,0.6312883435582822,0.46235172769468796,0.04881232054293918,0.9536525475751995
3123,32799,SAG,181031,258100;613758;,"[MIM:258100]Night blindness, congenital stationary, Oguchi type 1 [recessive?];[MIM:613758]Retinitis pigmentosa 47;",Retinitis pigmentosa;Congenital stationary night blindness;Oguchi disease,Disease-causing germline mutation(s) in;Candidate gene tested in;Disease-causing germline mutation(s) (loss of function) in,Calcium levels[20705733];Crohn's disease[22412388];,0.17791411042944785,0.15394533264569366,0.2704254763769251,0.09330877839165132
3124,32805,SALL1,602218,107480;,[MIM:107480]Townes-Brocks syndrome 1 [dominant?];,Townes-Brocks syndrome,Disease-causing germline mutation(s) (loss of function) in,Optic disc parameters[20548946];Digit length ratio (right hand)[29659830];Optic cup area[25631615;25631615;28073927;28073927];C-reactive protein levels[21300955];Diabetes mellitus[29615537];Creatinine levels[29403010];Vertical cup-disc ratio[25241763];Left superior temporal gyrus thickness (schizophrenia interaction)[26249676];Glomerular filtration rate[29403010];Uterine fibroids[30194396];Digit length ratio (left hand)[29659830;29659830];Optic disc area[28073927;25631615;25631615;28073927];Bone mineral density[22504420];Digit length ratio[29659830];Weight loss (gastric bypass surgery)[23643386];Blood pressure measurement (high sodium and potassium intervention)[24165912;24165912];,0.7206134969325153,0.9695719443011862,0.5233620464630645,0.8867403314917127
3125,32807,SALL2,602219,216820;,"[MIM:216820]Coloboma, ocular, autosomal recessive [recessive?];",Coloboma of choroid and retina;Coloboma of optic disc;Coloboma of macula;Coloboma of eyelid;Coloboma of eye lens;Coloboma of iris;Precursor T-cell acute lymphoblastic leukemia,Disease-causing germline mutation(s) (loss of function) in;Disease-causing germline mutation(s) (loss of function) in;Disease-causing germline mutation(s) (loss of function) in;Disease-causing germline mutation(s) (loss of function) in;Disease-causing germline mutation(s) (loss of function) in;Disease-causing germline mutation(s) (loss of function) in;Part of a fusion gene in,Response to Homoharringtonine (cytotoxicity)[25628645];,0.40773006134969325,0.24316658071170708,0.12242234403549987,0.2438612645794966
3126,32809,SALL4,607343,147750;607323;,[MIM:607323]Duane-radial ray syndrome;[MIM:147750]Oculootoradial syndrome;,Acro-renal-ocular syndrome;IVIC syndrome;Okihiro syndrome due to 20q13 microdeletion;Okihiro syndrome due to a point mutation,Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Role in the phenotype of;Disease-causing germline mutation(s) in,Male infertility[19478329];Tourette's syndrome or obsessive-compulsive disorder[25158072];,0.38061349693251534,0.8736462093862816,0.08848864526233359,0.7906691221608348
3127,32827,SAMD9,610456,610455;617053;,"[MIM:610455]Tumoral calcinosis, normophosphatemic, familial;[MIM:617053]MIRAGE syndrome;",Familial normophosphatemic tumoral calcinosis;MIRAGE syndrome,Disease-causing germline mutation(s) (loss of function) in;Disease-causing germline mutation(s) in,Mean corpuscular volume[29403010];Mean corpuscular hemoglobin[29403010];Central corneal thickness[29760442];,0.2947239263803681,0.011346054667354307,0.22239624119028975,0.010128913443830571
3128,32828,SAMD9L,611170,159550;,,Ataxia-pancytopenia syndrome,Disease-causing germline mutation(s) in,Systemic lupus erythematosus and Systemic sclerosis[23740937];,0.3925153374233129,0.6949458483754513,0.3273296789350039,0.0
3129,32832,SAMD12,618073,,,Benign adult familial myoclonic epilepsy,Disease-causing germline mutation(s) in,Eye morphology[29921221];Multiple sclerosis[23412934];Asthma[29273806];,0.038773006134969326,0.21738009283135637,0.7893500391542678,0.47928176795580113
3130,32837,SAMHD1,606754,612952;614415;,[MIM:612952]Aicardi-Goutieres syndrome 5;[MIM:614415]Chilblain lupus 2;,Aicardi-Gouti�res syndrome;Familial Chilblain lupus,Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) (loss of function) in,,0.8651533742331289,0.34296028880866425,0.8981989036805011,0.5954573357888275
3131,32865,SAR1B,607690,246700;,,Chylomicron retention disease,Disease-causing germline mutation(s) in,,0.28662576687116564,0.3073749355337803,0.9292612894805534,0.3970227133210559
3132,32867,SARDH,604455,268900;,[MIM:268900]Sarcosinemia;,Sarcosinemia,Disease-causing germline mutation(s) in,Post bronchodilator FEV1/FVC ratio[26634245];Asthma[27611488];,0.08736196319018405,0.05260443527591542,0.09527538501696685,0.7685696746470227
3133,32870,SARS,607529,617709;,"[MIM:617709]Neurodevelopmental disorder with microcephaly, ataxia, and seizures [recessive?];",Autosomal recessive non-syndromic intellectual disability,Disease-causing germline mutation(s) in,,0.8922699386503068,0.9649303764827231,0.7316627512398851,0.7200736648250461
3134,32871,SARS2,612804,613845;,"[MIM:613845]Hyperuricemia, pulmonary hypertension, renal failure, and alkalosis syndrome;",Hyperuricemia-pulmonary hypertension-renal failure-alkalosis syndrome,Disease-causing germline mutation(s) (loss of function) in,,0.9678527607361963,0.12429087158329036,0.35578178021404333,0.22974217311233885
3135,32874,SASH1,607955,,,Familial generalized lentiginosis;Pigmentation defects-palmoplantar keratoderma-skin carcinoma syndrome,Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in,Thyroid hormone levels[23408906;23408906];Resting-state electroencephalogram vigilance[29703947];Gait speed in old age[28077804];Rotator cuff tears[26350878];Type 2 diabetes nephropathy[21150874];Night sleep phenotypes[27126917];Hypothyroidism[27182965];Alzheimer's disease[20061627];Protein quantitative trait loci[18464913];Idiopathic dilated cardiomyopathy[29495422];,0.27361963190184047,0.7083548220732336,0.0696945967110415,0.34085328422344996
3136,32876,SASS6,609321,616402;,"[MIM:616402]Microcephaly 14, primary, autosomal recessive [recessive?];",Autosomal recessive primary microcephaly,Disease-causing germline mutation(s) in,,0.6905521472392638,0.23904074265085096,0.10362829548420778,0.2343462246777164
3137,32877,SAT1,313020,308800;,[MIM:308800]Keratosis follicularis spinulosa decalvans X-linked;,Keratosis follicularis spinulosa decalvans,Candidate gene tested in,,0.5244171779141105,0.8452810727178959,0.9519707648133646,0.0
3138,32881,SATB2,608148,119540;,[MIM:119540]Cleft palate isolated;,2q32q33 microdeletion syndrome;2q33.1 microdeletion syndrome,Role in the phenotype of;Role in the phenotype of,Type 2 diabetes[25760438];Waist circumference[23966867];Barrett's esophagus  or Esophageal adenocarcinoma[27527254];Insomnia[23728906];Autism spectrum disorder or schizophrenia[28540026];Chin dimples[27182965];Schizophrenia[25056061;28991256];Menarche (age at onset)[27182965;25231870;25231870;25231870;29773799];Brain cytoarchitecture[20308991];Loneliness (multivariate analysis)[27629369];Ulcerative colitis[20228799];,0.8606134969325153,0.9868488911810211,0.8814930827460193,0.9145181092694905
3139,32889,SBDS,607444,260400;,,Shwachman-Diamond syndrome;Idiopathic aplastic anemia,Disease-causing germline mutation(s) in;Major susceptibility factor in,Body mass index[26426971];Low high density lipoprotein cholesterol levels[26879886];,0.4667484662576687,0.30943785456420836,0.5424171234664579,0.4648557397176182
3140,32891,SBF1,603560,615284;,[MIM:615284]Charcot-Marie-Tooth disease 4B3 [recessive?];,Charcot-Marie-Tooth disease type 4B3,Disease-causing germline mutation(s) in,,0.6576687116564417,0.6536874677668901,0.31662751239885145,0.8554327808471455
3141,32893,SBF2,607697,604563;,,Charcot-Marie-Tooth disease type 4B2,Disease-causing germline mutation(s) in,Neuroticism[27089181];Serum uric acid levels[29403010];Moyamoya disease[29273593];Urinary albumin excretion[30220432];Pancreatic cancer[23180869];Hematocrit[27863252;27863252];Red blood cell count[27863252];Lung adenocarcinoma[28604730];Survival in pancreatic cancer[28470677];Hemoglobin concentration[27863252;27863252];,0.7077300613496933,0.7498710675605983,0.26964239102062126,0.7894413750767342
3142,32903,SC5D,602286,607330;,[MIM:607330]Lathosterolosis;,Lathosterolosis,Disease-causing germline mutation(s) in,QT interval[29213071];Response to taxane treatment (placlitaxel)[23006423];,0.23865030674846627,0.30892212480660136,0.9039415296267294,0.0
3143,32906,SCA20,,,,Spinocerebellar ataxia type 20,Disease-causing germline mutation(s) in,,0.038773006134969326,0.0,0.0,0.0
3144,32907,SCA25,608703,,,Spinocerebellar ataxia type 25,Disease-causing germline mutation(s) in,,0.038773006134969326,0.0,0.0,0.0
3145,32909,SCA30,613371,,,Spinocerebellar ataxia type 30,Disease-causing germline mutation(s) in,,0.038773006134969326,0.0,0.0,0.0
3146,32910,SCA32,613909,,,Spinocerebellar ataxia type 32,Disease-causing germline mutation(s) in,,0.038773006134969326,0.0,0.0,0.0
3147,32911,SCA37,,,,Spinocerebellar ataxia type 37,Disease-causing germline mutation(s) in,,0.038773006134969326,0.0,0.0,0.0
3148,32928,SCAPER,611611,,,Retinitis pigmentosa,Disease-causing germline mutation(s) in,Blood metabolite levels[24816252];Late-onset Alzheimer's disease[27770636;27770636];Recalcitrant atopic dermatitis[25935106];,0.4622085889570552,0.5020629190304281,0.037588097102584185,0.0167280540208717
3149,32935,SCARB2,602257,254900;,"[MIM:254900]Epilepsy, progressive myoclonic 4, with or without renal failure [recessive?];",Action myoclonus-renal failure syndrome;Unverricht-Lundborg disease;Gaucher disease type 1,Disease-causing germline mutation(s) (loss of function) in;Disease-causing germline mutation(s) in;Modifying germline mutation in,Body mass index[25673413;25673413;25673413];Parkinson's disease[21738487;25064009];Body mass index (joint analysis main effects and smoking interaction)[28443625];BMI (adjusted for smoking behaviour)[28443625];,0.5326380368098159,0.2480660134089737,0.6350822239624119,0.32903621853898096
3150,32937,SCARF2,613619,600920;,,Van den Ende-Gupta syndrome,Disease-causing germline mutation(s) in,Blood protein levels[29875488];,0.22687116564417178,0.9698298091799897,0.06891151135473766,0.0
3151,32992,SCGB1D1,615060,,,Cholesteryl ester storage disease;Wolman disease,Disease-causing germline mutation(s) (loss of function) in;Disease-causing germline mutation(s) (loss of function) in,Plasma omega-6 polyunsaturated fatty acid levels (arachidonic acid)[24823311;24823311];Plasma omega-6 polyunsaturated fatty acid levels (linoleic acid)[24823311;24823311];Waist-to-hip ratio adjusted for BMI[26426971;26426971];Waist-to-hip ratio adjusted for BMI x sex x age interaction (4df test)[26426971;26426971];,0.49570552147239266,0.166838576585869,0.9480553380318455,0.1921424186617557
3152,33017,SCN1A,182389,604403;607208;609634;,"[MIM:604403]Generalized epilepsy with febrile seizures plus 2 [dominant?];[MIM:607208]Epileptic encephalopathy, early infantile, 6;[MIM:607208]Intractable childhood epilepsy with generalized tonic- clonic seizures;[MIM:609634]Migraine, familial hemiplegic, 3;[MIM:604403]Febrile seizures, familial, 3A;",Lennox-Gastaut syndrome;Familial or sporadic hemiplegic migraine;Malignant migrating partial seizures of infancy;Generalized epilepsy with febrile seizures-plus;Dravet syndrome,Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in,Febrile seizures (MMR vaccine-unrelated)[25344690];Febrile seizures[25344690];Epilepsy[25087078;25087078];Mesial temporal lobe epilepsy with hippocampal sclerosis[24014518;24014518];Febrile seizures (MMR vaccine-related)[25344690];Epilepsy (generalized)[22949513];,0.4894478527607362,1.0,0.5755677368833203,0.9996930632289748
3153,33019,SCN1B,600235,604233;612838;615377;617350;,"[MIM:612838]Brugada syndrome 5;[MIM:615377]Atrial fibrillation, familial, 13;[MIM:617350]Epileptic encephalopathy, early infantile, 52 [recessive?];",Familial progressive cardiac conduction defect;Brugada syndrome;Familial atrial fibrillation;Generalized epilepsy with febrile seizures-plus;Dravet syndrome,Disease-causing germline mutation(s) (loss of function) in;Disease-causing germline mutation(s) in;Candidate gene tested in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) (loss of function) in,Serum albumin level[23022100;23022100;23022100];,0.12711656441717792,0.5673027333677153,0.24693291568780998,0.85451197053407
3154,33020,SCN2A,182390,607745;613721;,"[MIM:607745]Seizures, benign familial infantile, 3 [dominant?];[MIM:613721]Epileptic encephalopathy, early infantile, 11 [dominant?];",Early infantile epileptic encephalopathy;West syndrome;Benign familial neonatal-infantile seizures;Benign familial infantile epilepsy;Generalized epilepsy with febrile seizures-plus;Dravet syndrome,Disease-causing germline mutation(s) (gain of function) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Candidate gene tested in;Disease-causing germline mutation(s) in,Febrile seizures (MMR vaccine-unrelated)[25344690];Febrile seizures[25344690];Periodontitis (DPAL)[24024966];Febrile seizures (MMR vaccine-related)[25344690];,0.22687116564417178,0.8550799381124291,0.32080396763247193,0.9947820748925721
3155,33021,SCN2B,601327,615378;,,Brugada syndrome;Familial atrial fibrillation,Candidate gene tested in;Disease-causing germline mutation(s) (loss of function) in,Preeclampsia[23551011];,0.514478527607362,0.36384734399174834,0.9313495170973636,0.5725905463474524
3156,33022,SCN3A,182391,617935;617938;,"[MIM:617935]Epilepsy, familial focal, with variable foci 4 [dominant?];[MIM:617938]Epileptic encephalopathy, early infantile, 62;",Undetermined early-onset epileptic encephalopathy,Disease-causing germline mutation(s) in,Waist-to-hip ratio adjusted for BMI (age >50)[26426971];Body mass index[26426971];Body mass index x sex x age interaction (4df test)[26426971];Waist-to-hip ratio adjusted for BMI (age <50)[26426971];Parkinson's disease[28892059];Obstructive sleep apnea trait (apnea hypopnea index)[29077507;29077507];Body mass index (age>50)[26426971];Waist-to-hip ratio adjusted for BMI x sex x age interaction (4df test)[26426971];,0.5312883435582823,0.9066529138731305,0.35787000783085354,0.9797421731123389
3157,33023,SCN3B,608214,613120;,"[MIM:613120]Atrial fibrillation, familial, 16;",Brugada syndrome;Familial atrial fibrillation,Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) (loss of function) in,Chronic lymphocytic leukemia[23770605;24292274;28165464];Response to citalopram or escitalopram in depression[27622933];,0.4795092024539877,0.5250128932439402,0.9211694074654138,0.6720380601596071
3158,33024,SCN4A,603967,168300;170500;608390;613345;614198;,"[MIM:168300]Paramyotonia congenita of von Eulenburg [dominant?];[MIM:613345]Periodic paralysis hypokalemic 2 [dominant?];[MIM:170500]Periodic paralysis hyperkalemic [dominant?];[MIM:170500]Periodic paralysis normokalemic;[MIM:608390]Myotonia SCN4A-related;[MIM:614198]Myasthenic syndrome, congenital, 16;",Paramyotonia congenita of Von Eulenburg;Hyperkalemic periodic paralysis;Hypokalemic periodic paralysis;Myotonia fluctuans;Myotonia permanens;Acetazolamide-responsive myotonia;Postsynaptic congenital myasthenic syndromes,Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) (gain of function) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in,,0.5301840490797546,0.7676637441980402,0.3847559383972853,0.9803560466543892
3159,33025,SCN4B,608256,611819;,"[MIM:611819]Long QT syndrome 10;[MIM:611819]Atrial fibrillation, familial, 17;",Familial atrial fibrillation;Romano-Ward syndrome,Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) (gain of function) in,,0.038773006134969326,0.4154203197524497,0.8874967371443487,0.4766728054020872
3160,33026,SCN5A,600163,108770;113900;272120;601144;601154;603829;603830;608567;614022;,"[MIM:113900]Progressive familial heart block 1A;[MIM:603830]Long QT syndrome 3;[MIM:601144]Brugada syndrome 1;[MIM:608567]Sick sinus syndrome 1;[MIM:603829]Familial paroxysmal ventricular fibrillation 1;[MIM:272120]Sudden infant death syndrome;[MIM:108770]Atrial standstill 1;[MIM:601154]Cardiomyopathy, dilated 1E;[MIM:614022]Atrial fibrillation, familial, 10;","Familial sick sinus syndrome;Familial isolated dilated cardiomyopathy;Atrial standstill;Familial progressive cardiac conduction defect;Idiopathic ventricular fibrillation, non Brugada type;Brugada syndrome;Familial atrial fibrillation;Romano-Ward syndrome",Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) (gain of function) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) (loss of function) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) (gain of function) in;Disease-causing germline mutation(s) (gain of function) in,Electrocardiographic conduction measures[19389651;19389651;23463857];QT interval[19305408;19305409;24952745;24952745;24952745;24952745;24952745;29213071;29213071];Resting heart rate[27798624];P wave duration[24850809;28794112;28794112;28794112];Brugada syndrome[23872634];Atrial fibrillation[30061737;29892015;29892015;30061737;30061737];PR interval[21347284;21347284;20062060;23139255;23139255;25035420;29127183;29127183;29127183];Global electrical heterogeneity phenotypes[29622589];QRS duration[21076409;21076409;21076409;27577874;27577874;27577874;25035420];Electrocardiographic traits[20062063;20062063];PR segment[24850809];Supraventricular ectopy[29618737];,0.5920245398773006,0.8225889633831872,0.2503262855651266,0.9984653161448741
3161,33028,SCN8A,600702,614306;614558;617080;,"[MIM:614306]Cognitive impairment with or without cerebellar ataxia;[MIM:614558]Epileptic encephalopathy, early infantile, 13;[MIM:617080]Seizures, benign familial infantile, 5 [dominant?];",Benign familial infantile epilepsy;Undetermined early-onset epileptic encephalopathy;Infantile convulsions and choreoathetosis,Disease-causing germline mutation(s) (gain of function) in;Disease-causing germline mutation(s) (gain of function) in;Disease-causing germline mutation(s) (gain of function) in,Response to antidepressants and depression[27622933];Clozapine-induced agranulocytosis/granulocytopenia in treatment-resistant schizophrenia[27400856];,0.16220858895705523,0.9522949974213513,0.6452623335943618,0.956414978514426
3162,33029,SCN9A,603415,133020;167400;243000;613863;,"[MIM:133020]Primary erythermalgia;[MIM:243000]Indifference to pain, congenital, autosomal recessive [recessive?];[MIM:167400]Paroxysmal extreme pain disorder;[MIM:613863]Generalized epilepsy with febrile seizures plus 7 [dominant?];[MIM:613863]Febrile seizures, familial, 3B;",Hereditary sensory and autonomic neuropathy type 2;Sodium channelopathy-related small fiber neuropathy;Generalized epilepsy with febrile seizures-plus;Dravet syndrome;Paroxysmal extreme pain disorder;Primary erythromelalgia;Channelopathy-associated congenital insensitivity to pain,Disease-causing germline mutation(s) (loss of function) in;Disease-causing germline mutation(s) (gain of function) in;Candidate gene tested in;Candidate gene tested in;Disease-causing germline mutation(s) (gain of function) in;Disease-causing germline mutation(s) (gain of function) in;Disease-causing germline mutation(s) (loss of function) in,Dental caries[23259602];Cannabis dependence symptom count[27028160];,0.5191411042944786,0.17148014440433212,0.10989297833463847,0.9648557397176182
3163,33030,SCN10A,604427,615551;,"[MIM:615551]Episodic pain syndrome, familial, 2 [dominant?];",Sodium channelopathy-related small fiber neuropathy;Brugada syndrome;Paroxysmal extreme pain disorder;Primary erythromelalgia;Channelopathy-associated congenital insensitivity to pain;Romano-Ward syndrome,Disease-causing germline mutation(s) (gain of function) in;Major susceptibility factor in;Candidate gene tested in;Candidate gene tested in;Candidate gene tested in;Disease-causing germline mutation(s) (loss of function) in,Electrocardiographic conduction measures[23463857];QT interval[24952745;24952745;24952745;24952745;24952745];Brugada syndrome[23872634];Atrial fibrillation[30061737;29892015;29892015;29892015;30061737;30061737];PR interval[21347284;20062060;23139255;25035420;29127183];Atrioventricular conduction[21041692];Electrocardiographic traits[20062061;20062063;20062063;25055868];P wave duration[24850809;28794112];Systemic lupus erythematosus[23273568];Heart rate response to exercise[29769521];Heart rate response to recovery post exercise[29769521];QRS duration[21076409;21076409;27577874;27577874;27659466;25035420];PR segment[24850809];,0.08736196319018405,0.006188757091284167,0.19603236752806055,0.9048496009821977
3164,33031,SCN11A,604385,615548;615552;,"[MIM:615548]Neuropathy, hereditary sensory and autonomic, 7;[MIM:615552]Episodic pain syndrome, familial, 3 [dominant?];",Sodium channelopathy-related small fiber neuropathy;Familial episodic pain syndrome with predominantly lower limb involvement;Hereditary sensory and autonomic neuropathy type 7;Paroxysmal extreme pain disorder;Primary erythromelalgia;Channelopathy-associated congenital insensitivity to pain,Disease-causing germline mutation(s) (gain of function) in;Disease-causing germline mutation(s) (gain of function) in;Disease-causing germline mutation(s) (gain of function) in;Candidate gene tested in;Candidate gene tested in;Candidate gene tested in,Social communication problems[24564958];,0.2947239263803681,0.021660649819494584,0.39780736100234926,0.8302639656230817
3165,33033,SCNN1A,600228,264350;613021;,"[MIM:264350]Pseudohypoaldosteronism 1, autosomal recessive [recessive?];[MIM:613021]Bronchiectasis with or without elevated sweat chloride 2;",Generalized pseudohypoaldosteronism type 1;Liddle syndrome;Idiopathic bronchiectasis,Disease-causing germline mutation(s) (loss of function) in;Disease-causing germline mutation(s) (gain of function) in;Disease-causing germline mutation(s) in,Primary biliary cirrhosis[22961000;22961000;22961000;22961000];Itch intensity from mosquito bite adjusted by bite size[28199695];Obesity (early onset extreme)[23563609];Alopecia areata[25608926];,0.3449079754601227,0.0850954100051573,0.16470895327590707,0.04558011049723757
3166,33034,SCNN1B,600760,177200;211400;264350;,"[MIM:264350]Pseudohypoaldosteronism 1, autosomal recessive [recessive?];[MIM:177200]Liddle syndrome [dominant?];[MIM:211400]Bronchiectasis with or without elevated sweat chloride 1;",Generalized pseudohypoaldosteronism type 1;Liddle syndrome;Idiopathic bronchiectasis,Disease-causing germline mutation(s) (loss of function) in;Disease-causing germline mutation(s) (gain of function) in;Disease-causing germline mutation(s) in,,0.3449079754601227,0.17122227952552863,0.5210127903941529,0.3187538367096378
3167,33036,SCNN1G,600761,177200;613071;,[MIM:177200]Liddle syndrome [dominant?];[MIM:613071]Bronchiectasis with or without elevated sweat chloride 3;,Generalized pseudohypoaldosteronism type 1;Liddle syndrome;Idiopathic bronchiectasis,Disease-causing germline mutation(s) (loss of function) in;Disease-causing germline mutation(s) (gain of function) in;Disease-causing germline mutation(s) in,,0.31079754601226994,0.6640020629190304,0.32445836596188987,0.3096992019643953
3168,33037,SCO1,603644,220110;,,Fatal infantile cytochrome C oxidase deficiency,Disease-causing germline mutation(s) in,Relative hand skill in reading disability[24068947];Malaria[19465909];,0.8160736196319018,0.333161423414131,0.4928217175672148,0.6416513198281154
3169,33038,SCO2,604272,256000;604377;608908;,[MIM:608908]Myopia 6;[MIM:256000]Leigh syndrome;,Fatal infantile cytochrome C oxidase deficiency;Leigh syndrome with cardiomyopathy;Autosomal recessive axonal Charcot-Marie-Tooth disease due to copper metabolism defect;Rare isolated myopia,Disease-causing germline mutation(s) in;Candidate gene tested in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in,Multiple sclerosis[21833088];Chronic lymphocytic leukemia[28165464];Granulocyte percentage of myeloid white cells[27863252];Mean corpuscular hemoglobin[20139978];Red blood cell traits[23222517];,0.8979141104294478,0.18643630737493552,0.745497259201253,0.8670963781461019
3170,33042,SCP2,184755,613724;,[MIM:613724]Leukoencephalopathy with dystonia and motor neuropathy;,Leukoencephalopathy-dystonia-motor neuropathy syndrome,Disease-causing germline mutation(s) in,,0.5519018404907975,0.3432181536874678,0.9049856434351344,0.6746470227133211
3171,33068,SCYL1,607982,616719;,"[MIM:616719]Spinocerebellar ataxia, autosomal recessive, 21 [recessive?];",Acute infantile liver failure-cerebellar ataxia-peripheral sensory motor neuropathy syndrome,Disease-causing germline mutation(s) in,Acne (severe)[24927181];Vertical cup-disc ratio[20548946];Bone mineral density[22504420];,0.716319018404908,0.10030943785456421,0.5314539284782042,0.23204419889502761
3172,33099,SDCCAG8,613524,613615;615993;,[MIM:615993]Bardet-Biedl syndrome 16 [recessive?];,Senior-Loken syndrome;Bardet-Biedl syndrome,Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) (loss of function) in,"Toenail selenium levels[25343990];Schizophrenia, schizoaffective disorder or bipolar disorder[24166486];Diastolic blood pressure[28135244];Schizophrenia[23974872;25056061];Diastolic blood pressure x smoking status (current vs non-current) interaction (2df test)[29455858;29455858];Cognitive ability (MTAG)[29186694];Diastolic blood pressure x alcohol consumption interaction (2df test)[29912962];Diastolic blood pressure x smoking status (ever vs never) interaction (2df test)[29455858;29455858];Obesity (early onset extreme)[20421936];Educational attainment[25201988];Glomerular filtration rate (creatinine)[26831199];",0.8753374233128834,0.21557503867973182,0.17697729052466718,0.09561080417434009
3173,33104,SDHA,600857,252011;256000;613642;614165;,"[MIM:252011]Mitochondrial complex II deficiency;[MIM:256000]Leigh syndrome;[MIM:613642]Cardiomyopathy, dilated 1GG;[MIM:614165]Paragangliomas 5;",Familial isolated dilated cardiomyopathy;Leigh syndrome with leukodystrophy;Isolated succinate-CoQ reductase deficiency;Hereditary pheochromocytoma-paraganglioma;Gastrointestinal stromal tumor,Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) (loss of function) in,,0.9714110429447853,0.33857658586900463,0.23440354998694857,0.4162062615101289
3174,33105,SDHAF1,612848,252011;,,Isolated succinate-CoQ reductase deficiency,Disease-causing germline mutation(s) in,,0.7737423312883436,0.5531201650335225,0.9164708953275907,0.0
3175,33106,SDHAF2,613019,601650;,[MIM:601650]Paragangliomas 2;,Hereditary pheochromocytoma-paraganglioma,Disease-causing germline mutation(s) in,,0.4154601226993865,0.2937080969571944,0.9814669799008092,0.0
3176,33112,SDHB,185470,115310;171300;606864;,[MIM:171300]Pheochromocytoma;[MIM:115310]Paragangliomas 4;[MIM:606864]Paraganglioma and gastric stromal sarcoma [dominant?];,Cowden syndrome;Sporadic pheochromocytoma;Isolated succinate-CoQ reductase deficiency;Hereditary pheochromocytoma-paraganglioma;Gastrointestinal stromal tumor;Carney-Stratakis syndrome,Disease-causing germline mutation(s) in;Major susceptibility factor in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Candidate gene tested in;Disease-causing germline mutation(s) (loss of function) in,Height[20189936];,0.96,0.30814853017019084,0.570608196293396,0.7271332105586249
3177,33113,SDHC,602413,605373;606864;,[MIM:605373]Paragangliomas 3;[MIM:606864]Paraganglioma and gastric stromal sarcoma [dominant?];,Cowden syndrome;Hereditary pheochromocytoma-paraganglioma;Gastrointestinal stromal tumor;Carney-Stratakis syndrome,Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Candidate gene tested in;Disease-causing germline mutation(s) (loss of function) in,Visceral adipose tissue adjusted for BMI[22589738];Paclitaxel disposition in epithelial ovarian cancer[29367611];,0.7099386503067485,0.31743166580711707,0.968154528843644,0.5059852670349908
3178,33118,SDHD,602690,168000;171300;252011;606864;,[MIM:168000]Paragangliomas 1 [dominant?];[MIM:171300]Pheochromocytoma;[MIM:606864]Paraganglioma and gastric stromal sarcoma [dominant?];[MIM:252011]Mitochondrial complex II deficiency;,Cowden syndrome;Sporadic pheochromocytoma;Isolated succinate-CoQ reductase deficiency;Hereditary pheochromocytoma-paraganglioma;Carney-Stratakis syndrome;Carcinoid syndrome,Disease-causing germline mutation(s) in;Major susceptibility factor in;Disease-causing germline mutation(s) (loss of function) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) (loss of function) in;Candidate gene tested in,,0.16220858895705523,0.6121712222795255,0.7196554424432263,0.7412523020257827
3179,33129,SDR9C7,609769,617574;,,Lamellar ichthyosis,Disease-causing germline mutation(s) in,Migraine without aura[27322543];Headache[29397368];Migraine[27322543;27322543];Familial lung cancer[29924316];Alzheimer's disease (survival time)[25649651];,0.23865030674846627,0.4424961320268179,0.4946489167319238,0.5379066912216084
3180,33152,SEC14L2,607558,,,Immunodeficiency by defective expression of HLA class 1,Disease-causing germline mutation(s) in,Breast size[22747683];Plateletcrit[27863252];,0.14576687116564419,0.2968024755028365,0.08170190550770035,0.3187538367096378
3181,33153,SEC14L3,612824,,,Immunodeficiency by defective expression of HLA class 1,Disease-causing germline mutation(s) in,Urate levels in lean individuals[25811787];Pubertal anthropometrics[23449627];Nephropathy[21399633];IgA nephropathy[25305756];Response to hepatitis B vaccine[29534301];Sarcoidosis (non-Lofgren's syndrome without extrapulmonary manifestations)[26651848];Autism spectrum disorder or schizophrenia[28540026;28540026;28540026;28540026;28540026];Blood protein levels[28240269];Lymphoma[23349640];Type 1 diabetes and autoimmune thyroid diseases[25936594];,0.08736196319018405,0.05312016503352243,0.018271991647089533,0.17863720073664824
3182,33165,SEC23A,610511,607812;,[MIM:607812]Craniolenticulosutural dysplasia;,Craniolenticulosutural dysplasia,Disease-causing germline mutation(s) (loss of function) in,Vitamin D levels[29343764];,0.9838036809815951,0.42315626611655494,0.7880448968937614,0.3580417434008594
3183,33167,SEC23B,610512,224100;616858;,"[MIM:224100]Anemia, congenital dyserythropoietic, 2 [recessive?];",Cowden syndrome;Congenital dyserythropoietic anemia type II,Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) (loss of function) in,,0.9622085889570552,0.10211449200618876,0.16627512398851474,0.7599754450583179
3184,33173,SEC24C,607185,,,22q11.2 deletion syndrome,Modifying germline mutation in,Crohn's disease[28067908];,0.932883435582822,0.9195461578133058,0.5092665100495954,0.7022713321055862
3185,33174,SEC24D,607186,616294;,,Cole-Carpenter syndrome,Disease-causing germline mutation(s) in,Perioperative myocardial infarction in coronary artery bypass surgery[25948407;25948407;25948407];Cannabis dependence symptom count[27028160;27028160];,0.427239263803681,0.40665291387313046,0.41895066562255284,0.40730509515039903
3186,33183,SEC63,608648,617004;,,Isolated polycystic liver disease,Disease-causing germline mutation(s) in,,0.9614723926380369,0.40613718411552346,0.5027407987470635,0.19828115408225905
3187,33186,SECISBP2,607693,609698;,,Short stature-delayed bone age due to thyroid hormone metabolism deficiency,Disease-causing germline mutation(s) in,,0.730920245398773,0.03842186694172254,0.4442704254763769,0.09668508287292818
3188,33197,SELENOI,607915,,,Autosomal recessive complex spastic paraplegia due to Kennedy pathway dysfunction,Disease-causing germline mutation(s) (loss of function) in,Coronary artery disease[29212778];,0.6641717791411043,0.890149561629706,0.0,0.0
3189,33203,SELENON,606210,255310;602771;,"[MIM:602771]Rigid spine muscular dystrophy 1;[MIM:255310]Myopathy, congenital, with fiber-type disproportion;",Congenital fiber-type disproportion myopathy;Classic multiminicore myopathy;Desmin-related myopathy with Mallory body-like inclusions;Rigid spine syndrome,Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in,,0.33975460122699386,0.11191335740072202,0.0,0.0
3190,33217,SEM1,601285,,,Isolated split hand-split foot malformation,Candidate gene tested in,Diverticular disease[30177863];Nicotine glucouronidation[25293881];Fractures[30158200];Attention deficit hyperactivity disorder[20732625];Bone mineral density (Ward's triangle area)[27397699];Chin dimples[27182965];Morning vs. evening chronotype[26835600];Immunoglobulin A[20694011];Frontotemporal dementia with GRN mutation (age at onset)[29724592];,0.730920245398773,0.553378029912326,0.0,0.0
3191,33219,SEMA3A,603961,614897;,[MIM:614897]Hypogonadotropic hypogonadism 16 with or without anosmia;,Kallmann syndrome,Disease-causing germline mutation(s) (loss of function) in,"Major depression and alcohol dependence[29071344];Autism spectrum disorder, attention deficit-hyperactivity disorder, bipolar disorder, major depressive disorder, and schizophrenia (combined)[23453885];Attention deficit hyperactivity disorder[21784300];Prion diseases[22210626];Iris characteristics[21835309;21835309];Obesity-related traits[23251661];Nose morphology[29921221];",0.14576687116564419,0.7003610108303249,0.49778125815713914,0.37814610190300796
3192,33222,SEMA3C,602645,,,Hirschsprung disease,Major susceptibility factor in,CSF tryptophan concentration in tuberculous meningitis[29395996];Glaucoma[30054594];Rosacea symptom severity[29771307];Glaucoma (primary open-angle)[29891935];Glucocorticoid-induced osteonecrosis (age 10 years and older)[26265699];Posterior cortical atrophy and Alzheimer's disease[26993346];Blood protein levels[29875488;30072576];Bilirubin levels[19414484];High density lipoprotein cholesterol levels[29403010];HDL cholesterol[27036123];Intraocular pressure[29617998;29617998;29235454;30054594];,0.16220858895705523,0.3481175863847344,0.3286348211955103,0.24754450583179866
3193,33223,SEMA3D,609907,,,Hirschsprung disease,Major susceptibility factor in,Spherical equivalent or myopia (age of diagnosis)[29808027];Venous thromboembolism adjusted for sickle cell variant rs77121243-T[28203683];,0.038773006134969326,0.5402269210933471,0.14278256329939965,0.20549416820135052
3194,33224,SEMA3E,608166,,,CHARGE syndrome,Candidate gene tested in,Rosacea symptom severity[29771307];Epithelial ovarian cancer[25134534];Heel bone mineral density[28869591;28869591];Blood protein levels[28240269;28240269;29875488;30072576;30072576];Nose morphology[29921221];Asthma (childhood onset)[27142222];,0.14576687116564419,0.7591542031975245,0.26050639519707647,0.20549416820135052
3195,33228,SEMA4A,607292,610282;610283;,[MIM:610282]Retinitis pigmentosa 35;[MIM:610283]Cone-rod dystrophy 10;,Retinitis pigmentosa;Cone rod dystrophy;Familial colorectal cancer Type X,Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in,Stroke[29531354;29531354];Ischemic stroke[29531354;29531354];Ischemic stroke (small-vessel)[29531354];,0.16220858895705523,0.4528107271789582,0.37196554424432265,0.0836402701043585
3196,33234,SEMA5A,609297,,,Monosomy 5p,Candidate gene tested in,Rosacea symptom severity[29771307];Autism[19812673];Verbal declarative memory[25648963;25648963];Parkinson's disease[16252231];Uric acid levels[22229870];Late-onset myasthenia gravis[26562150];Gut microbiota (functional units)[27694959];Obesity-related traits[23251661;23251661];Blood protein levels[29875488;30072576];Thrombin-activatable fibrinolysis inhibitor levels[29378355];Coronary artery disease[29212778;29212778];,0.038773006134969326,0.4143888602372357,0.5343252414513182,0.2589011663597299
3197,33269,SEPSECS,613009,613811;,,Progressive cerebello-cerebral atrophy;Pontocerebellar hypoplasia type 2,Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in,Tonsillectomy[27182965;28928442];,0.3669938650306748,0.4631253223310985,0.2657269642391021,0.43247391037446287
3198,33291,SEPT9,604061,162100;,[MIM:162100]Hereditary neuralgic amyotrophy;,Neuralgic amyotrophy,Major susceptibility factor in,Systolic blood pressure[28739976;28739976];Body mass index[20966902];Illicit drug use[23942779];Heel bone mineral density[28869591;28869591;28869591];Airflow obstruction[22837378];Intraocular pressure[29617998;29617998];,0.6522699386503068,0.8212996389891697,0.41555729574523625,0.18139963167587478
3199,33295,SEPT12,611562,614822;,[MIM:614822]Spermatogenic failure 10;,Non-syndromic male infertility due to sperm motility disorder,Disease-causing germline mutation(s) in,Night sleep phenotypes[27126917];,0.3706748466257669,0.48994326972666324,0.5361524406160272,0.1505524861878453
3200,33296,SEPT14,612140,,,Gliosarcoma;Giant cell glioblastoma,Part of a fusion gene in;Part of a fusion gene in,Alanine transaminase levels[29403010];,0.2498159509202454,0.2539969056214544,0.47376664056382145,0.0
3201,33320,SERAC1,614725,614739;,,MEGDEL syndrome,Disease-causing germline mutation(s) in,Lipoprotein (a) levels[26377243];Systemic sclerosis[29293537];Lipoprotein (a) - cholesterol levels[25575512];,0.7838036809815951,0.6449200618875709,0.4617593317671626,0.41006752608962554
3202,33342,SERPINA1,107400,613490;,[MIM:613490]Alpha-1-antitrypsin deficiency;,Alpha-1-antitrypsin deficiency;Hemorrhagic disease due to alpha-1-antitrypsin Pittsburgh mutation,Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in,Glucagon levels in response to oral glucose tolerance test (fasting)[29093273];Alanine transaminase levels[28887542];Breast size[27182965];Post bronchodilator FEV1/FVC ratio in smoking[30068317];Blood protein levels[28240269;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;30072576;30072576];Coronary artery disease[29212778;29212778];Manganese levels[26025379];Post bronchodilator percent predicted FEV1 in smoking[30068317];Metabolite levels (small molecules and protein measures)[27005778];Metabolite levels[22916037];Post bronchodilator FEV1/FVC ratio[26634245];Height[29782485];Antineutrophil cytoplasmic antibody-associated vasculitis[22808956;28029757];Platelet count[27863252];Post bronchodilator FEV1[26634245];,0.621717791411043,0.5772305312016504,0.47011224223440357,0.9840392879066913
3203,33343,SERPINA2,107410,,,Seckel syndrome;Familial cutaneous telangiectasia and oropharyngeal cancer predisposition syndrome,Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in,Blood protein levels[28240269];Coronary artery disease[29212778;29212778];,0.038773006134969326,0.6896596183599794,0.0,0.0
3204,33347,SERPINA6,122500,611489;,[MIM:611489]Corticosteroid-binding globulin deficiency;,Corticosteroid-binding globulin deficiency,Disease-causing germline mutation(s) in,Manganese levels[26025379];Breast size[22747683];Blood protein levels[28240269];,0.20368098159509201,0.4662197008767406,0.748368572174367,0.6837016574585635
3205,33361,SERPINB6,173321,613453;,,Autosomal recessive non-syndromic sensorineural deafness type DFNB,Disease-causing germline mutation(s) in,Chronic lymphocytic leukemia[26956414];,0.32380368098159507,0.2674058793192367,0.5330200991908118,0.66804788213628
3206,33362,SERPINB7,603357,615598;,,"Palmoplantar keratoderma, Nagashima type",Disease-causing germline mutation(s) (loss of function) in,Systolic blood pressure[29208002];Hen's egg allergy[29051540];Food allergy[29051540];,0.21484662576687116,0.13486333161423414,0.21326024536674498,0.5624616329036218
3207,33363,SERPINB8,601697,617115;,[MIM:617115]Peeling skin syndrome 5 [recessive?];,Exfoliative ichthyosis,Disease-causing germline mutation(s) (loss of function) in,Airflow obstruction[22837378];,0.33975460122699386,0.24342444559051057,0.20438527799530148,0.8133824432166974
3208,33371,SERPINC1,107300,613118;,[MIM:613118]Antithrombin III deficiency;,Hereditary thrombophilia due to congenital antithrombin deficiency,Disease-causing germline mutation(s) in,,0.33975460122699386,0.9569365652398143,0.7475854868180631,0.0
3209,33373,SERPINE1,173360,613329;,[MIM:613329]Plasminogen activator inhibitor-1 deficiency;,Congenital plasminogen activator inhibitor type 1 deficiency,Disease-causing germline mutation(s) in,Plasma plasminogen activator levels[24578379];Blood protein levels[30072576];Plasminogen activator inhibitor type 1 levels (PAI-1)[22990020];,0.427239263803681,0.3862815884476534,0.3808405116157661,0.6883057090239411
3210,33377,SERPINF1,172860,613982;,[MIM:613982]Osteogenesis imperfecta 6 [recessive?];,Osteogenesis imperfecta type 3;Osteogenesis imperfecta type 4,Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in,Calcium levels[20705733];Blood protein levels[29875488;29875488;30072576];,0.5160736196319018,0.353017019082001,0.5259723309840773,0.5561694290976059
3211,33378,SERPINF2,613168,262850;,[MIM:262850]Alpha-2-plasmin inhibitor deficiency [recessive?];,Congenital alpha2-antiplasmin deficiency,Disease-causing germline mutation(s) in,Calcium levels[20705733;24068962];Blood protein levels[29875488];Serum albumin level[23022100;23022100;29403010];,0.2947239263803681,0.5562145435791646,0.06734534064212999,0.9206568446899939
3212,33379,SERPING1,606860,106100;,[MIM:106100]Hereditary angioedema [dominant?];,C1 inhibitor deficiency;Hereditary angioedema type 2;Hereditary angioedema type 1,Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in,Neuroticism[29255261];Autism spectrum disorder or schizophrenia[28540026];Schizophrenia[25056061];Obesity-related traits[23251661];Blood protein levels[28240269;29875488;30072576;30072576;30072576;30072576;30072576;30072576;30072576;30072576];,0.5948466257668712,0.7129963898916968,0.20621247716001045,0.9806629834254144
3213,33380,SERPINH1,600943,610504;613848;,[MIM:613848]Osteogenesis imperfecta 10 [recessive?];,Osteogenesis imperfecta type 3,Disease-causing germline mutation(s) in,Waist circumference adjusted for BMI (joint analysis main effects and physical activity interaction)[28448500;28448500];Hip circumference adjusted for BMI[25673412];Height[22021425;20881960;28270201;25429064;25282103];Waist circumference adjusted for body mass index[28448500;28448500];Coronary artery disease[29212778;29212778;29212778];Waist circumference adjusted for BMI in active individuals[28448500;28448500];,0.9791411042944785,0.5030943785456421,0.7478465152701644,0.7599754450583179
3214,33382,SERPINI1,602445,604218;,,Familial encephalopathy with neuroserpin inclusion bodies,Disease-causing germline mutation(s) in,Heart rate[23534349];Fast beta electroencephalogram[28070124];Height[18391951];,0.12711656441717792,0.5474471376998453,0.2983555207517619,0.8640270104358502
3215,33395,SET,600960,,,Autosomal dominant non-syndromic intellectual disability;Precursor T-cell acute lymphoblastic leukemia,Disease-causing germline mutation(s) in;Part of a fusion gene in,Body mass index[26426971];Eating disorders (purging via substances)[23568457];Axial length[24144296];,0.9077300613496933,0.0,0.870007830853563,0.413597298956415
3216,33396,SETBP1,611060,269150;601626;607785;608232;614286;616078;,"[MIM:614286]Myelodysplastic syndrome;[MIM:616078]Mental retardation, autosomal dominant 29 [dominant?];[MIM:601626]Leukemia, acute myelogenous;[MIM:608232]Leukemia, chronic myeloid, atypical;[MIM:607785]Leukemia, juvenile myelomonocytic;",Schinzel-Giedion syndrome;Intellectual disability-expressive aphasia-facial dysmorphism syndrome,Disease-causing germline mutation(s) (gain of function) in;Disease-causing germline mutation(s) in,Systolic blood pressure[27618452;28739976];Restless legs syndrome[29029846];Male-pattern baldness[22693459;29146897];Coronary artery aneurysm in Kawasaki disease[27171184];QRS interval (sulfonylurea treatment interaction)[27958378];Diastolic blood pressure[27618452];Bone ultrasound measurement (velocity of sound)[28472463];QRS duration[27577874;27577874;27659466;25035420];Breast cancer[29059683;25751625];Hair color[26926045];Platelet thrombus formation[22550155];,0.23865030674846627,0.7547705002578649,0.08874967371443487,0.9238796807857581
3217,33399,SETD2,612778,144700;601626;613065;616831;,"[MIM:144700]Renal cell carcinoma;[MIM:616831]Luscan-Lumish syndrome [dominant?];[MIM:613065]Leukemia, acute lymphoblastic;[MIM:601626]Leukemia, acute myelogenous;",Sotos syndrome,Disease-causing germline mutation(s) (loss of function) in,HDL cholesterol levels[28334899];Granulocyte percentage of myeloid white cells[27863252];White blood cell count (basophil)[27863252];Lymphocyte percentage of white cells[27863252];White blood cell count[27863252];Lymphocyte counts[27863252];Platelet distribution width[27863252];Monocyte count[27863252];Post bronchodilator FEV1/FVC ratio[26634245];Monocyte percentage of white cells[27863252];HDL cholesterol[24097068];Huntington's disease progression[28642124];,0.5496932515337424,0.9649303764827231,0.042808666144609764,0.9244935543278084
3218,33402,SETD5,615743,615761;,"[MIM:615761]Mental retardation, autosomal dominant 23 [dominant?];",Cornelia de Lange syndrome;Intellectual disability-facial dysmorphism syndrome due to SETD5 haploinsufficiency,Disease-causing germline mutation(s) (loss of function) in;Disease-causing germline mutation(s) (loss of function) in,Glucose homeostasis traits[25524916];Cerebrospinal fluid clusterin levels[26545630];,0.35496932515337426,0.7888086642599278,0.3748368572174367,0.9515039901780233
3219,33431,SETX,608465,602433;606002;,"[MIM:606002]Spinocerebellar ataxia, autosomal recessive, 1 [recessive?];[MIM:602433]Amyotrophic lateral sclerosis 4;",Amyotrophic lateral sclerosis type 4;Spinocerebellar ataxia with axonal neuropathy type 2,Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) (loss of function) in,Current cigarettes per day in chronic obstructive pulmonary disease[29631575];,0.7328834355828221,0.5750386797318205,0.2015139650221874,0.9344689993861265
3220,33441,SF3B1,605590,,,Acquired idiopathic sideroblastic anemia;Uveal melanoma,Disease-causing somatic mutation(s) in;Biomarker tested in,Autism spectrum disorder or schizophrenia[28540026;28540026];Schizophrenia[25056061];Major depressive disorder[27479909];,0.9759509202453988,0.7851985559566786,0.9344818585225789,0.0
3221,33444,SF3B4,605593,154400;,"[MIM:154400]Acrofacial dysostosis 1, Nager type;","Nager syndrome;Acrofacial dysostosis, Rodr�guez type",Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) (loss of function) in,Waist circumference adjusted for BMI in non-smokers[28443625;28443625;28443625];Birth length[25281659];Waist circumference adjusted for BMI (joint analysis main effects and smoking interaction)[28443625;28443625;28443625];Waist circumference adjusted for BMI (adjusted for smoking behaviour)[28443625;28443625;28443625];Infant length[25281659];Height[20881960;18391951];Waist circumference adjusted for body mass index[25673412;25673412;25673412];,0.8861349693251533,0.8310985043837029,0.9896893761419995,0.0
3222,33452,SFPQ,605199,,,MiT family translocation renal cell carcinoma,Part of a fusion gene in,"Allergic disease (asthma, hay fever or eczema)[29083406];Endometrial cancer[21499250];",0.9590184049079754,0.9773078906652913,0.7585486818063168,0.0
3223,33459,SFRP4,606570,265900;,[MIM:265900]Pyle disease;,Pyle disease,Disease-causing germline mutation(s) (loss of function) in,Dupuytren's disease[21732829;28886342;28886342];Heel bone mineral density[28869591;28869591;28869591];Blood protein levels[30072576];,0.4,0.3777720474471377,0.3375097885669538,0.2527624309392265
3224,33468,SFTPA1,178630,178500;267450;,"[MIM:178500]Pulmonary fibrosis, idiopathic;[MIM:267450]Respiratory distress syndrome in premature infants;",Idiopathic pulmonary fibrosis,Major susceptibility factor in,,0.2585276073619632,0.3924703455389376,0.2936570086139389,0.6457949662369552
3225,33469,SFTPA2,178642,178500;,"[MIM:178500]Pulmonary fibrosis, idiopathic;",Idiopathic pulmonary fibrosis,Major susceptibility factor in,,0.16220858895705523,0.7320783909231563,0.5891412163925868,0.3396255371393493
3226,33471,SFTPB,178640,265120;267450;,[MIM:265120]Pulmonary surfactant metabolism dysfunction 1;[MIM:267450]Respiratory distress syndrome in premature infants;,Neonatal acute respiratory distress due to SP-B deficiency;Infant acute respiratory distress syndrome,Disease-causing germline mutation(s) (loss of function) in;Major susceptibility factor in,Blood protein levels[30072576];,0.12711656441717792,0.29164517792676636,0.5246671887235709,0.584561080417434
3227,33472,SFTPC,178620,267450;610913;,[MIM:610913]Pulmonary surfactant metabolism dysfunction 2;[MIM:267450]Respiratory distress syndrome in premature infants;,Chronic respiratory distress with surfactant metabolism deficiency;Idiopathic pulmonary fibrosis;Interstitial lung disease due to SP-C deficiency;Infant acute respiratory distress syndrome,Disease-causing germline mutation(s) in;Major susceptibility factor in;Disease-causing germline mutation(s) in;Major susceptibility factor in,Hypertriglyceridemia[23505323];Coronary artery disease[29212778];,0.3889570552147239,0.3568849922640536,0.07073871051944662,0.7575199508901166
3228,33478,SFXN4,615564,615578;,[MIM:615578]Combined oxidative phosphorylation deficiency 18 [recessive?];,Growth and developmental delay-hypotonia-vision impairment-lactic acidosis syndrome,Disease-causing germline mutation(s) (loss of function) in,Alcoholic chronic pancreatitis[28754779];,0.8579141104294479,0.45616297060340383,0.9449229966066302,0.0
3229,33480,SGCA,600119,608099;,,Autosomal recessive limb-girdle muscular dystrophy type 2D,Disease-causing germline mutation(s) in,Temporomandibular joint disorder[28081371];,0.3749693251533742,0.4179989685404848,0.66327329678935,0.8784530386740331
3230,33481,SGCB,600900,604286;,[MIM:604286]Limb-girdle muscular dystrophy 2E [recessive?];,Autosomal recessive limb-girdle muscular dystrophy type 2E,Disease-causing germline mutation(s) in,,0.4,0.2333677153171738,0.6611850691725398,0.6658993247391037
3231,33482,SGCD,601411,601287;606685;,"[MIM:601287]Limb-girdle muscular dystrophy 2F [recessive?];[MIM:606685]Cardiomyopathy, dilated 1L;",Familial isolated dilated cardiomyopathy;Autosomal recessive limb-girdle muscular dystrophy type 2F,Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in,Response to bronchodilator in chronic obstructive pulmonary disease (change in FEV1)[26503814];Multiple sclerosis (age of onset)[19010793];Resting-state electroencephalogram vigilance[29703947];Anthropometric traits[19260139;19260139];Airway responsiveness in chronic obstructive pulmonary disease[25514360;25514360;25514360];HIV-1 viral setpoint[26039976];Obesity-related traits[23251661];Daytime sleep phenotypes[27126917];Egg allergy[25710614];,0.32380368098159507,0.3818978855079938,0.49517097363612633,0.5624616329036218
3232,33483,SGCE,604149,159900;,"[MIM:159900]Dystonia 11, myoclonic [dominant?];",Myoclonus-dystonia syndrome,Disease-causing germline mutation(s) in,,0.2498159509202454,0.4223826714801444,0.7253980683894544,0.8047882136279927
3233,33484,SGCG,608896,253700;,,Autosomal recessive limb-girdle muscular dystrophy type 2C,Disease-causing germline mutation(s) in,Type 2 diabetes[23300278];Central corneal thickness[29760442];Corneal structure[23291589];Atrial fibrillation[30061737];Bipolar disorder[21738484];Asthma[27611488];,0.3749693251533742,0.2625064466219701,0.4810754372226573,0.5253222836095764
3234,33494,SGO1,609168,616201;,[MIM:616201]Chronic atrial and intestinal dysrhythmia;,Chronic atrial and intestinal dysrhythmia syndrome,Disease-causing germline mutation(s) in,Acne (severe)[24927181];Temperament (bipolar disorder)[22365631];Staphylococcus aureus nasal carriage (intermittent)[26569114];,0.7152147239263804,0.11603919546157813,0.0,0.0
3235,33499,SGPL1,603729,617575;,,Familial steroid-resistant nephrotic syndrome with adrenal insufficiency,Disease-causing germline mutation(s) in,Microalbuminuria[26631737];,0.9349693251533743,0.6743166580711707,0.40407204385277995,0.28806015960712095
3236,33502,SGSH,605270,252900;,[MIM:252900]Mucopolysaccharidosis 3A [recessive?];,Sanfilippo syndrome type A,Disease-causing germline mutation(s) (loss of function) in,,0.22687116564417178,0.5373904074265085,0.23805794831636648,0.7329650092081031
3237,33508,SH2B1,608937,,,Distal 16p11.2 microdeletion syndrome;Proximal 16p11.2 microdeletion syndrome;Severe early-onset obesity-insulin resistance syndrome due to SH2B1 deficiency,Role in the phenotype of;Role in the phenotype of;Disease-causing germline mutation(s) (loss of function) in,Obesity[23563607;23563607;23563607];QT interval[29213071];Mean corpuscular volume[27863252];Intelligence[28530673;28530673];Cognitive ability[29186694];Hand grip strength[29691431];Crohn's disease[21102463;28067908];Red blood cell count[27863252];General cognitive ability[29844566;29844566];Weight[19079260];Body mass index (joint analysis main effects and physical activity interaction)[28448500;28448500;28448500;28448500];Educational attainment[25201988];Angiotensin-converting enzyme inhibitor intolerance[28030426];Body fat percentage[26833246;26833246;26833246;26833246];Inflammatory bowel disease[28067908];Body mass index[20935630;19079261;19079260;28448500;28448500;28448500];Waist circumference[25673412;25673412;25673412];Body mass index in physically active individuals[28448500;28448500;28448500;28448500];,0.3925153374233129,0.49097472924187724,0.2054293918037066,0.23787599754450584
3238,33510,SH2B3,605093,222100;612011;,"[MIM:612011]Celiac disease 13;[MIM:222100]Diabetes mellitus, insulin-dependent;",Essential thrombocythemia;Growth retardation-mild developmental delay-chronic hepatitis syndrome,Disease-causing somatic mutation(s) in;Disease-causing germline mutation(s) in,"Myocardial infarction[26343387];Primary biliary cirrhosis[22961000];Thyroid peroxidase antibody positivity[24586183];Mean corpuscular hemoglobin[28017375;27863252];Lymphocyte counts[27863252];Myeloid white cell count[27863252];Hematocrit[19862010;28017375;27863252];Chronic inflammatory diseases (ankylosing spondylitis, Crohn's disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy)[26974007];Plateletcrit[27863252;27863252];Primary sclerosing cholangitis[27992413];Sum basophil neutrophil counts[27863252];Eosinophil counts[19198610];Diastolic blood pressure x alcohol consumption interaction (2df test)[29912962];Granulocyte count[27863252];Ischemic stroke[24262325;29531354;29531354];Mean arterial pressure[27618448];Beta-2 microglubulin plasma levels[23417110];Body mass index[26426971];Systemic lupus erythematosus[27399966;26502338;26502338];Ischemic stroke (large artery atherosclerosis)[29531354];Colorectal or endometrial cancer[26621817];Systolic blood pressure x smoking status (ever vs never) interaction (2df test)[29455858;29455858];Coronary artery disease or large artery stroke[24262325];Ischemic stroke (small-vessel)[29531354];Ankylosing spondylitis[23749187;23749187];Coronary artery disease (myocardial infarction, percutaneous transluminal coronary angioplasty, coronary artery bypass grafting, angina or chromic ischemic heart disease)[28714975];Mean arterial pressure x alcohol consumption (light vs heavy) interaction (2df test)[29912962];Mean arterial pressure x alcohol consumption interaction (2df test)[29912962;29912962];Systolic blood pressure[19430479;27618452;28739976];Celiac disease or Rheumatoid arthritis[21383967];Endometrial cancer ((endometrioid histology)[30093612];Reticulocyte count[27863252];Diastolic blood pressure[21909115;19430483;19430479;26390057;27618452;28739976;27618447];Sum neutrophil eosinophil counts[27863252];Monocyte percentage of white cells[27863252];Blood protein levels[29875488];Hypothyroidism[22493691];Systolic blood pressure x smoking status (current vs non-current) interaction (2df test)[29455858;29455858];Systolic blood pressure x alcohol consumption (light vs heavy) interaction (2df test)[29912962];Systolic blood pressure (cigarette smoking interaction)[29455858];Inflammatory bowel disease[28067908;26192919];Celiac disease[18311140;20190752;22057235];Tonsillectomy[27182965;28928442];Juvenile idiopathic arthritis (oligoarticular or rheumatoid factor-negative polyarticular)[23603761];Rheumatoid arthritis[24390342;20453842];Hemoglobin levels[28017375];Cancer (pleiotropy)[27197191];Thyroid peroxidase antibody levels[24586183];Diastolic blood pressure x smoking status (current vs non-current) interaction (2df test)[29455858;29455858];Monocyte count[27863252];Information processing speed[27046643];Diastolic blood pressure (cigarette smoking interaction)[29455858];Mean corpuscular hemoglobin concentration[28017375];Coronary artery disease or ischemic stroke[24262325];Mean corpuscular volume[28017375];Endometrial cancer[30093612];Blood metabolite levels[24816252];Colorectal cancer[26151821;26151821];Peripheral artery disease[25009551];Neutrophil count[27863252];Hemoglobin concentration[27863252];Type 1 diabetes autoantibodies in high risk HLA genotype individuals (time to event)[29310926];Vitiligo[22561518;27723757];Red blood cell traits[23222517];Allergic rhinitis[30013184];Systolic blood pressure x alcohol consumption interaction (2df test)[29912962];Platelet count[24026423;22139419;20139978;25705162;27863252;27863252];Retinal vascular caliber[21060863];Stroke[29531354;29531354];Sarcoidosis[26051272];Autoimmune hepatitis type-1[24768677];Crohn's disease[26192919;28067908];Diastolic blood pressure x smoking status (ever vs never) interaction (2df test)[29455858;29455858];Red blood cell count[27863252];Coronary heart disease[21378990];Coronary artery disease[26343387;29212778;24262325];Alopecia areata[25608926];Type 1 diabetes[17554300;19430480;21829393;25751624];White blood cell count[27863252];Primary biliary cholangitis[26394269];Fibrinogen levels[26561523;28107422];Cancer[27197191];",0.27361963190184047,0.7264053635894792,0.25371965544244324,0.0
3239,33511,SH2D1A,300490,308240;,,X-linked lymphoproliferative disease,Disease-causing germline mutation(s) in,,0.48736196319018404,0.7153171738009283,0.9950404594100757,0.43155310006138736
3240,33526,SH3BP2,602104,118400;,[MIM:118400]Cherubism [dominant?];,Cherubism,Disease-causing germline mutation(s) in,Multiple sclerosis[24076602];Huntington's disease progression[28642124];,0.4622085889570552,0.35043837029396596,0.6363873662229182,0.9063842848373235
3241,33531,SH3D19,608674,,,MEND syndrome;X-linked dominant chondrodysplasia punctata,Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) (loss of function) in,,0.4936196319018405,0.24007220216606498,0.29104672409292615,0.1976672805402087
3242,33542,SH3PXD2A,,,,Malignant peripheral nerve sheath tumor,Part of a fusion gene in,Manganese levels[26025379];Stroke[29531354;29531354];Cutaneous malignant melanoma[26237428];Atrial fibrillation[28416822;29290336;28416818;28416818;29892015];Diisocyanate-induced asthma[25918132;25918132];White matter hyperintensity burden[25663218;25663218;25663218;25663218];Ischemic stroke[29531354];Ischemic stroke (small-vessel)[29531354];Intraocular pressure[29617998];,0.6596319018404908,0.9490716864363073,0.301226833724876,0.4530386740331492
3243,33544,SH3PXD2B,613293,249420;,[MIM:249420]Frank-Ter Haar syndrome;,Frank-Ter Haar syndrome,Disease-causing germline mutation(s) (loss of function) in,Menopause (age at onset)[26414677];Body mass index (change over time)[25133637;25133637];,0.5705521472392638,0.5495100567302733,0.41059775515531194,0.26166359729895644
3244,33550,SH3TC2,608206,601596;613353;,[MIM:613353]Mononeuropathy of the median nerve mild;,Charcot-Marie-Tooth disease type 4C,Disease-causing germline mutation(s) in,Diastolic blood pressure[26390057;28739976];,0.038773006134969326,0.10495100567302733,0.283476898981989,0.37814610190300796
3245,33558,SHANK3,606230,606232;613950;,[MIM:606232]Phelan-McDermid syndrome;[MIM:613950]Schizophrenia 15;,Monosomy 22q13,Role in the phenotype of,Intelligence (MTAG)[29326435];Fibrinogen[23969696];Fibrinogen levels[26561523;28107422;28107422];Blood protein levels[30072576];Memory dysfunction in frontotemporal lobe dementia[29724592];,0.40773006134969325,1.0,0.10441138084051162,0.0
3246,33575,SHH,600725,135750;142945;147250;174500;188740;611638;,"[MIM:611638]Microphthalmia, isolated, with coloboma, 5;[MIM:142945]Holoprosencephaly 3 [dominant?];[MIM:147250]Solitary median maxillary central incisor;[MIM:174500]Triphalangeal thumb-polysyndactyly syndrome;[MIM:174500]Preaxial polydactyly 2;[MIM:188740]Hypoplasia or aplasia of tibia with polydactyly [dominant?];[MIM:135750]Laurin-Sandrow syndrome [dominant?];",Triphalangeal thumb-polysyndactyly syndrome;Hypoplastic tibiae-postaxial polydactyly syndrome;Microform holoprosencephaly;Septopreoptic holoprosencephaly;Semilobar holoprosencephaly;Acquired schizencephaly;Autosomal dominant preaxial polydactyly-upperback hypertrichosis syndrome;Radial hemimelia;Polydactyly of a triphalangeal thumb;Syndactyly type 4;Midline interhemispheric variant of holoprosencephaly;Lobar holoprosencephaly;Alobar holoprosencephaly;Colobomatous microphthalmia,Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Major susceptibility factor in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in,Creatinine levels[29403010];Corneal astigmatism[23322567];Platelet aggregation[20526338];,0.2947239263803681,0.6740587931923672,0.8749673714434874,0.0
3247,33598,SHOC2,602775,607721;,[MIM:607721]Noonan syndrome-like disorder with loose anagen hair 1;,Noonan syndrome-like disorder with loose anagen hair,Disease-causing germline mutation(s) in,,0.6095705521472392,0.9423671995874162,0.8271991647089533,0.8756906077348067
3248,33599,SHOX,312865;400020,127300;249700;300582;,"[MIM:127300]Leri-Weill dyschondrosteosis;[MIM:249700]Langer mesomelic dysplasia;[MIM:300582]Short stature, idiopathic, X-linked;",L�ri-Weill dyschondrosteosis;Langer mesomelic dysplasia;SHOX-related short stature,Disease-causing germline mutation(s) (loss of function) in;Disease-causing germline mutation(s) (loss of function) in;Disease-causing germline mutation(s) in,,0.16220858895705523,0.779783393501805,0.9188201513965022,0.0
3249,33601,SHPK,605060,617213;,[MIM:617213]Sedoheptulokinase deficiency [recessive?];,Isolated sedoheptulokinase deficiency,Disease-causing germline mutation(s) in,,0.23865030674846627,0.043837029396596186,0.06395197076481336,0.0
3250,33609,SHROOM4,300579,300434;,,"X-linked intellectual disability, Stocco Dos Santos type",Disease-causing germline mutation(s) in,,0.038773006134969326,0.9761474987106756,0.3176716262072566,0.6760282381829343
3251,33611,SI,609845,222900;,[MIM:222900]Congenital sucrase-isomaltase deficiency;,Congenital sucrase-isomaltase deficiency with starch intolerance;Congenital sucrase-isomaltase deficiency without starch intolerance;Congenital sucrase-isomaltase deficiency with minimal starch tolerance;Congenital sucrase-isomaltase deficiency with starch and lactose intolerance;Congenital sucrase-isomaltase deficiency without sucrose intolerance,Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in,"1,5-anhydroglucitol levels[28588231];",0.038773006134969326,0.0015471892728210418,0.11929000261028452,0.8100061387354205
3252,33648,SIGMAR1,601978,605726;614373;,"[MIM:614373]Amyotrophic lateral sclerosis 16, juvenile;[MIM:605726]Distal spinal muscular atrophy, autosomal recessive, 2 [recessive?];","Distal hereditary motor neuropathy, Jerash type;Juvenile amyotrophic lateral sclerosis",Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in,,0.8211042944785276,0.7867457452294997,0.15478987209605846,0.34392265193370164
3253,33649,SIK1,605705,616341;,"[MIM:616341]Epileptic encephalopathy, early infantile, 30;",Early infantile epileptic encephalopathy;Early myoclonic encephalopathy;West syndrome,Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in,"Systolic blood pressure[27618452;28739976];Allergic disease (asthma, hay fever or eczema)[29083406];Alzheimer disease and age of onset[26830138];Diastolic blood pressure[27618452;28739976;28135244];",0.4750920245398773,0.9208354822073234,0.23022709475332812,0.5148864333947207
3254,33655,SIL1,608005,248800;,[MIM:248800]Marinesco-Sjoegren syndrome;,Marinesco-Sj�gren syndrome,Disease-causing germline mutation(s) (loss of function) in,,0.5775460122699386,0.7122227952552862,0.4249543200208823,0.18953345610804173
3255,33656,SIM1,603128,,,6q16 deletion syndrome;Obesity due to SIM1 deficiency;Prader-Willi-like syndrome due to a point mutation,Role in the phenotype of;Disease-causing germline mutation(s) (loss of function) in;Disease-causing germline mutation(s) (loss of function) in,Neuroticism[29255261];Creatinine levels[29403010];Waist-to-hip ratio adjusted for BMI x sex interaction[26426971];Gait speed in old age[28077804];Menarche (age at onset)[25231870;25231870;25231870;25231870];Major depressive disorder[27479909];Glomerular filtration rate[29403010];,0.08736196319018405,0.9528107271789582,0.11615766118506918,0.5405156537753223
3256,33659,SIN3A,607776,,,SIN3A-related intellectual disability syndrome due to a point mutation;15q24 microdeletion syndrome,Disease-causing germline mutation(s) in;Role in the phenotype of,Sudden cardiac arrest[21658281];Height[20189936];,0.9013496932515337,0.7947395564724085,0.6671887235708692,0.0
3257,33668,SIPA1L3,616655,616851;,[MIM:616851]Cataract 45;,Total early-onset cataract,Disease-causing germline mutation(s) in,Gut microbiota (bacterial taxa)[27723756];Glomerular filtration rate (creatinine)[26831199;28452372];,0.9077300613496933,0.7470345538937597,0.19107282693813626,0.7397176181706568
3258,33688,SIX1,601205,605192;608389;,"[MIM:605192]Deafness, autosomal dominant, 23 [dominant?];[MIM:608389]Branchiootic syndrome 3;",BOR syndrome;Branchiootic syndrome;Autosomal dominant non-syndromic sensorineural deafness type DFNA,Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in,Glaucoma (primary open-angle)[22419738;22570617;29891935;29891935;29891935];Gut microbiota (bacterial taxa)[27723756];Exhaled carbon monoxide levels in smokers with chronic obstructive pulmonary disease[29631575];Optic nerve measurement (rim area)[20395239];Vertical cup-disc ratio[25241763;20548946];Prostate cancer[25217961];,0.5469938650306748,0.5482207323362558,0.9545810493343775,0.0
3259,33689,SIX2,604994,,,SIX2-related frontonasal dysplasia,Role in the phenotype of,Fasting blood glucose[29621232];Fasting plasma glucose[25187374];Glycated hemoglobin levels[29170429];Lung cancer[28604730];Blood sugar levels[29403010];Metabolite levels[21909109];Hemoglobin A1c levels[29403010];,0.31079754601226994,0.8808664259927798,0.804489689376142,0.9079189686924494
3260,33690,SIX3,603714,157170;269160;,[MIM:157170]Holoprosencephaly 2;[MIM:269160]Schizencephaly;,Microform holoprosencephaly;Septopreoptic holoprosencephaly;Semilobar holoprosencephaly;Acquired schizencephaly;Midline interhemispheric variant of holoprosencephaly;Lobar holoprosencephaly;Alobar holoprosencephaly,Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Major susceptibility factor in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in,Spherical equivalent or myopia (age of diagnosis)[29808027];Fasting blood glucose[29621232];Fasting plasma glucose[25187374];Glycated hemoglobin levels[29170429];Lung cancer[28604730];Myopia[27182965];Blood sugar levels[29403010];Metabolite levels[21909109];Alcohol and nicotine co-dependence[22488850];Hemoglobin A1c levels[29403010];Intraocular pressure[30054594;29785010];,0.2498159509202454,0.8932439401753481,0.7953536935525972,0.8251995089011663
3261,33693,SIX5,600963,610896;,[MIM:610896]Branchiootorenal syndrome 2;,BOR syndrome,Disease-causing germline mutation(s) in,,0.6357055214723927,0.7550283651366684,0.1534847298355521,0.0
3262,33694,SIX6,606326,212550;,,Isolated microphthalmia-anophthalmia-coloboma;Colobomatous optic disc-macular atrophy-chorioretinopathy syndrome,Candidate gene tested in;Disease-causing germline mutation(s) in,Glaucoma (primary open-angle)[22419738;22570617;25173105;29452408;29891935;29891935;29891935];Glaucoma[30054594];Optic cup area[25631615;25631615;28073927;28073927];Gut microbiota (bacterial taxa)[27723756];Exhaled carbon monoxide levels in smokers with chronic obstructive pulmonary disease[29631575];Refractive error[23396134];Optic disc area[25631615;28073927];Vertical cup-disc ratio[25241763;28073927;28073927];Height[20881960;25429064];Menarche (age at onset)[25231870];Spherical equivalent (joint analysis main effects and education interaction)[27020472;27020472];,0.10711656441717791,0.7413615265600825,0.0908379013312451,0.6206261510128913
3263,33702,SKI,164780,182212;,[MIM:182212]Shprintzen-Goldberg craniosynostosis syndrome;,1p36 deletion syndrome;Shprintzen-Goldberg syndrome,Role in the phenotype of;Disease-causing germline mutation(s) in,Body mass index[26426971;26426971];Platelet distribution width[27863252];Coronary artery disease[29212778;29212778];,0.6733742331288344,0.9561629706034038,0.4356564865570347,0.0
3264,33706,SKIV2L,600478,614602;,[MIM:614602]Trichohepatoenteric syndrome 2;,Syndromic diarrhea,Disease-causing germline mutation(s) in,Inflammatory bowel disease[28067908];Advanced age-related macular degeneration[26691988;26691988;26691988;26691988];Age-related macular degeneration[20861866;23577725];Autism spectrum disorder or schizophrenia[28540026;28540026;28540026;28540026;28540026;28540026;28540026;28540026;28540026;28540026;28540026;28540026;28540026;28540026;28540026;28540026];Blood metabolite levels[24816252];Blood protein levels[28240269;28240269;28240269;28240269;28240269;29875488];Prostate cancer[23535732];Disease progression in age-related macular degeneration[29346644];Coronary artery disease[29212778];Ulcerative colitis[28067908];,0.7651533742331288,0.03145951521402785,0.10623858000522057,0.03314917127071823
3265,33725,SLC1A1,133550,222730;615232;,[MIM:222730]Dicarboxylic aminoaciduria [recessive?];[MIM:615232]Schizophrenia 18;,Hot water reflex epilepsy;Dicarboxylic aminoaciduria,Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) (loss of function) in,Pancreatic cancer[22158540];Squamous cell lung carcinoma[28604730];Response to risperidone in schizophrenia[29503163];Coronary artery calcification[23870195];Response to antipsychotic treatment in schizophrenia[29503163];,0.3889570552147239,0.2846828261990717,0.5387627251370399,0.31675874769797424
3266,33726,SLC1A2,600300,617105;,"[MIM:617105]Epileptic encephalopathy, early infantile, 41 [dominant?];",Undetermined early-onset epileptic encephalopathy,Disease-causing germline mutation(s) in,Relative hand skill in reading disability[24068947];Psychosis proneness (revised physical anhedonia scale and revised social anhedonia scale)[28525603];Vitiligo[27723757];Plasma omega-6 polyunsaturated fatty acid levels (adrenic acid)[24823311];Staphylococcus aureus nasal carriage (persistent)[26569114];Essential tremor[22764253];,0.21484662576687116,0.7171222279525529,0.825110937092143,0.7200736648250461
3267,33727,SLC1A3,600111,612656;,[MIM:612656]Episodic ataxia 6;,Alternating hemiplegia of childhood;Episodic ataxia type 6,Candidate gene tested in;Disease-causing germline mutation(s) in,Heel bone mineral density[28869591;28869591;28869591];Depression in smokers[30219690];Intraocular pressure[29617998;29617998];,0.8157055214723926,0.7980917998968541,0.533281127642913,0.4215776550030694
3268,33728,SLC1A4,600229,616657;,,Spastic tetraplegia-thin corpus callosum-progressive postnatal microcephaly syndrome,Disease-causing germline mutation(s) in,Fractional shortening[29403010];Metabolite levels (small molecules and protein measures)[27005778];Atrial fibrillation[28416822];Blood metabolite levels[24816252];Left ventricular internal dimension in systole[29403010];Metabolite levels[22286219;22916037];Systolic blood pressure x smoking status (ever vs never) interaction (2df test)[29455858];Ejection fraction[29403010];,0.7597546012269939,0.42496132026817945,0.3072304881232054,0.34208103130755063
3269,33732,SLC2A1,138140,601042;606777;608885;612126;614847;,"[MIM:612126]GLUT1 deficiency syndrome 2;[MIM:614847]Epilepsy, idiopathic generalized 12;[MIM:601042]Dystonia 9 [dominant?];[MIM:608885]Stomatin-deficient cryohydrocytosis with neurologic defects;",Hereditary cryohydrocytosis with reduced stomatin;Encephalopathy due to GLUT1 deficiency;Childhood absence epilepsy;Paroxysmal dystonic choreathetosis with episodic ataxia and spasticity;Paroxysmal exertion-induced dyskinesia,Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) (loss of function) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in,Cardiac hypertrophy[21348951];Monocyte count[27863252];,0.9234355828220859,0.8506962351727695,0.8997650743931088,0.8093922651933702
3270,33734,SLC2A2,138160,227810;,[MIM:227810]Fanconi-Bickel syndrome [recessive?];,Glycogen storage disease due to GLUT2 deficiency,Disease-causing germline mutation(s) in,Liver enzyme levels (gamma-glutamyl transferase)[22001757];Response to metformin in type 2 diabetes (HbA1c reduction)[27500523];Fasting blood glucose[20081858;22581228];Fasting plasma glucose[28270201;28270201];Homeostasis model assessment of beta-cell function[20081858];Glycated hemoglobin levels[28898252];Blood sugar levels[29403010];Night sleep phenotypes[27126917];Fasting blood glucose (BMI interaction)[22581228];Hemoglobin A1c levels[29403010];,0.17791411042944785,0.4736977823620423,0.17515009135995824,0.3838244321669736
3271,33735,SLC2A3,138170,,,Huntington disease,Modifying germline mutation in,Waist-to-hip ratio adjusted for BMI x sex interaction[26426971];,0.7494478527607362,0.592057761732852,0.7439310884886453,0.4949355432780847
3272,33745,SLC2A9,606142,612076;,[MIM:612076]Hypouricemia renal 2;,Hereditary renal hypouricemia,Disease-causing germline mutation(s) (loss of function) in,Gout in chronic kidney disease[30181573];Urate levels in lean individuals[25811787;25811787;25811787];Serum metabolite levels[23093944;23093944];Urate levels[20884846;20884846;18327256;18327257;18179892;18834626;20139978;23263486;28270201];Uric acid levels[22229870;23703922;23703922;21294900;19503597;19503597;23703922;29558500;29558500];Biochemical measures[19260141];Mean corpuscular volume[27863252];Psychosis and Alzheimer's disease[22005930];Gout[21983786;27899376;23263486;25646370;29453348];Renal underexcretion gout[27899376];Blood metabolite levels[24816252;24816252];Urate levels in obese individuals[25811787;25811787;25811787];Blood metabolite ratios[24816252];Serum uric acid levels[24513273;21983786;24379826;26902266;26902266;29408531;29403010];Gut microbiota (bacterial taxa)[27723756];Renal overload gout[27899376];Cardiometabolic and hematological traits[27668658];Renal function-related traits (urea)[22797727];Urate levels in overweight individuals[25811787;25811787;25811787];Serum urate levels in chronic kidney disease[30181573];Cleft plate (environmental tobacco smoke interaction)[24516586];Metabolic traits[21886157];,0.038773006134969326,0.3396080453842187,0.0435917515009136,0.415438919582566
3273,33746,SLC2A10,606145,208050;,,Arterial tortuosity syndrome,Disease-causing germline mutation(s) (loss of function) in,Waist-to-hip ratio adjusted for BMI (age >50)[26426971];Waist-to-hip ratio adjusted for BMI (age <50)[26426971];Dimensional psychopathology (Arousal)[29496196];Baseline cortisol levels in response to low dose short synacthen test in corticosteroid treated asthma[29551627];Waist-to-hip ratio adjusted for BMI[26426971];Waist-to-hip ratio adjusted for BMI x sex x age interaction (4df test)[26426971];,0.038773006134969326,0.14698298091799897,0.2638997650743931,0.6295273173726212
3274,33753,SLC3A1,104614,220100;606407;,[MIM:606407]Hypotonia-cystinuria syndrome;,2p21 microdeletion syndrome;Hypotonia-cystinuria syndrome;Atypical hypotonia-cystinuria syndrome;Cystinuria type A,Role in the phenotype of;Role in the phenotype of;Role in the phenotype of;Disease-causing germline mutation(s) in,antipsychotic drug dosage in schizophrenia or schizoaffective disorder[26821981];,0.10711656441717791,0.21763795771015987,0.278778386844166,0.7441682013505218
3275,33755,SLC4A1,109270,110500;112010;112050;130600;166900;179800;185020;601550;601551;611162;611590;612653;,"[MIM:166900]Ovalocytosis, Southeast Asian;[MIM:612653]Spherocytosis 4;[MIM:179800]Renal tubular acidosis, distal, autosomal dominant [dominant?];[MIM:611590]Renal tubular acidosis, distal, with hemolytic anemia;[MIM:611590]Renal tubular acidosis, distal, with normal red cell morphology;[MIM:185020]Cryohydrocytosis [dominant?];",Hereditary spherocytosis;Dehydrated hereditary stomatocytosis;Hereditary cryohydrocytosis with normal stomatin;Distal renal tubular acidosis with anemia;Autosomal dominant distal renal tubular acidosis;Southeast Asian ovalocytosis,Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in,Mean corpuscular hemoglobin concentration[27863252;29403010];Mean corpuscular hemoglobin[27863252];Reticulocyte fraction of red cells[27863252];Reticulocyte count[27863252];Obesity-related traits[23251661];Red cell distribution width[27863252];Hemoglobin concentration[27863252];Immature fraction of reticulocytes[27863252];,0.36171779141104293,0.8207839092315626,0.3200208822761681,0.6995089011663598
3276,33761,SLC4A4,603345,604278;,"[MIM:604278]Renal tubular acidosis, proximal, with ocular abnormalities and mental retardation [recessive?];",Autosomal recessive proximal renal tubular acidosis,Disease-causing germline mutation(s) in,QT interval[24952745];Mosquito bite size[28199695];Age-related nuclear cataracts[24951543];Heel bone mineral density[28869591];Fractional exhaled nitric oxide (childhood)[24315451;24315451];,0.16220858895705523,0.8032490974729242,0.18741842860871835,0.9455187231430325
3277,33767,SLC4A11,610206,217400;217700;613268;,"[MIM:217400]Corneal dystrophy and perceptive deafness;[MIM:217700]Corneal endothelial dystrophy;[MIM:613268]Corneal dystrophy, Fuchs endothelial, 4;",Corneal dystrophy-perceptive deafness syndrome;Congenital hereditary endothelial dystrophy type II;Fuchs endothelial corneal dystrophy,Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in,Night sleep phenotypes[27126917];Asthma[29273806];,0.038773006134969326,0.07220216606498195,0.3683111459149047,0.7120933087783916
3278,33768,SLC5A1,182380,606824;,[MIM:606824]Congenital glucose/galactose malabsorption [recessive?];,Glucose-galactose malabsorption,Disease-causing germline mutation(s) (loss of function) in,"1,5-anhydroglucitol levels[28588231];GLP-1 levels in response to oral glucose tolerance test (120 minutes)[29093273];GIP levels in response to oral glucose tolerance test (120 minutes)[29093273];",0.08736196319018405,0.24677668901495617,0.39937353171495693,0.8305709023941068
3279,33769,SLC5A2,182381,233100;,[MIM:233100]Renal glucosuria;,Familial renal glucosuria,Disease-causing germline mutation(s) in,,0.038773006134969326,0.4878803506962352,0.6773688332028192,0.7271332105586249
3280,33774,SLC5A5,601843,274400;,,Familial thyroid dyshormonogenesis,Disease-causing germline mutation(s) in,Diastolic blood pressure[29208002];,0.22687116564417178,0.38151108818978857,0.6711041503523885,0.7783916513198281
3281,33776,SLC5A7,608761,158580;617143;,"[MIM:158580]Neuronopathy, distal hereditary motor, 7A;[MIM:617143]Myasthenic syndrome, congenital, 20, presynaptic [recessive?];",Distal hereditary motor neuropathy type 7;Presynaptic congenital myasthenic syndromes,Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) (gain of function) in,,0.08736196319018405,0.4365652398143373,0.40668232837379276,0.0
3282,33782,SLC6A1,137165,616421;,[MIM:616421]Myoclonic-atonic epilepsy;,Myoclonic-astastic epilepsy,Disease-causing germline mutation(s) (loss of function) in,Loneliness (linear analysis)[27629369];Longitudinal alcohol consumption[26081443];Conduct disorder (maternal expressed emotions interaction)[18846501];Response to Vitamin E supplementation[22437554];,0.4667484662576687,0.9480402269210934,0.71835030018272,0.0
3283,33784,SLC6A2,163970,604715;,[MIM:604715]Orthostatic intolerance;,Postural orthostatic tachycardia syndrome due to NET deficiency,Disease-causing germline mutation(s) (loss of function) in,Post bronchodilator FEV1[26634245];,0.19190184049079756,0.6142341413099536,0.530409814669799,0.3305709023941068
3284,33785,SLC6A3,126455,613135;,,Infantile dystonia-parkinsonism,Disease-causing germline mutation(s) in,Pancreatic cancer[25086665];,0.30319018404907977,0.9228984012377515,0.8371182458888019,0.6398096992019644
3285,33786,SLC6A4,182138,103780;164230;,,Huntington disease;Juvenile Huntington disease,Disease-causing germline mutation(s) (gain of function) in;Disease-causing germline mutation(s) in,Tuberculosis[29036319];Itch intensity from mosquito bite adjusted by bite size[28199695];Serum sulfate level[27412988];Monobrow[27182965];,0.2498159509202454,0.6315110881897885,0.6196815452884364,0.33594229588704727
3286,33787,SLC6A5,604159,614618;,,Hereditary hyperekplexia,Disease-causing germline mutation(s) in,Epstein-Barr virus copy number in lymphoblastoid cell lines[28654678];Obesity-related traits[23251661];,0.23865030674846627,0.05853532748839608,0.060297572435395456,0.2223756906077348
3287,33791,SLC6A8,300036,300352;,,X-linked creatine transporter deficiency,Disease-causing germline mutation(s) in,,0.9083435582822086,0.6008251676121712,0.8971547898720961,0.6022099447513812
3288,33792,SLC6A9,601019,617301;,,Atypical glycine encephalopathy;Infantile glycine encephalopathy,Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in,Mean corpuscular volume[29403010];Autism spectrum disorder or schizophrenia[28540026];,0.7960736196319018,0.5647240845796803,0.6627512398851475,0.3073971761817066
3289,33800,SLC6A17,610299,616269;,"[MIM:616269]Mental retardation, autosomal recessive 48 [recessive?];",Progressive essential tremor-speech impairment-facial dysmorphism-intellectual disability-abnormal behavior syndrome,Disease-causing germline mutation(s) in,Visceral adipose tissue/subcutaneous adipose tissue ratio[22589738];,0.038773006134969326,0.6921093347086127,0.21012790394152964,0.5988336402701043
3290,33801,SLC6A18,610300,,,Iminoglycinuria,Candidate gene tested in,Pancreatic cancer[25086665];,0.038773006134969326,0.022434244455905104,0.3315061341686244,0.11832412523020258
3291,33802,SLC6A19,608893,138500;234500;242600;,[MIM:138500]Hyperglycinuria;[MIM:242600]Iminoglycinuria;,Hartnup disease;Iminoglycinuria,Disease-causing germline mutation(s) in;Candidate gene tested in,Urinary metabolites[26352407];Pancreatic cancer[25086665];,0.038773006134969326,0.020113460546673543,0.24771600104411381,0.22682627378759976
3292,33803,SLC6A20,605616,138500;242600;,[MIM:242600]Iminoglycinuria;,Iminoglycinuria,Candidate gene tested in,Blood metabolite ratios[24816252];Immune reponse to smallpox (secreted TNF-alpha)[22610502];Urinary metabolites[21572414;26352407;26352407];Acne (severe)[24927181];Hirschsprung disease[25310821];Blood metabolite levels[24816252;24816252];,0.20368098159509201,0.03945332645693656,0.28425998433829286,0.07658072437077962
3293,33814,SLC7A7,603593,222700;,[MIM:222700]Lysinuric protein intolerance;,Lysinuric protein intolerance,Disease-causing germline mutation(s) in,Resting-state electroencephalogram vigilance[29703947];,0.08736196319018405,0.7207323362558019,0.7327068650482903,0.7701043585021485
3294,33816,SLC7A9,604144,220100;,,Cystinuria type B,Disease-causing germline mutation(s) in,Urinary metabolite concentrations in chronic kidney disease[29545352];Urinary metabolites[21572414];Fractional excretion of metabolites in chronic kidney disease[29545352];Glomerular filtration rate in non diabetics (creatinine)[26831199];Creatinine levels[20383145;29403010];Urinary metabolite ratios in chronic kidney disease[29545352;29545352;29545352;29545352;29545352;29545352;29545352;29545352;29545352];Blood metabolite levels[24816252];Chronic kidney disease[20383146];Urinary metabolites (H-NMR features)[24586186;24586186;24586186];Glomerular filtration rate (creatinine)[26831199;28452372];,0.16220858895705523,0.11732851985559567,0.12216131558339859,0.6580724370779619
3295,33821,SLC7A14,615720,615725;,,Retinitis pigmentosa,Disease-causing germline mutation(s) in,,0.08736196319018405,0.4657039711191336,0.41503523884103366,0.8769183548189073
3296,33828,SLC9A1,107310,616291;,[MIM:616291]Lichtenstein-Knorr syndrome [recessive?];,Progressive autosomal recessive ataxia-deafness syndrome,Disease-causing germline mutation(s) (loss of function) in,,0.825276073619632,0.683599793708097,0.7538501696684938,0.45196439533456106
3297,33830,SLC9A3,182307,616868;,"[MIM:616868]Diarrhea 8, secretory sodium, congenital;",Congenital sodium diarrhea,Disease-causing germline mutation(s) (loss of function) in,Ulcerative colitis[23128233;28067908];Lung disease severity in cystic fibrosis[26417704;26417704;26417704;26417704;26417704;26417704];,0.2498159509202454,0.9107787519339866,0.5082223962411903,0.6895334561080417
3298,33835,SLC9A3R1,604990,612287;,"[MIM:612287]Nephrolithiasis/osteoporosis, hypophosphatemic, 2;",Dominant hypophosphatemia with nephrolithiasis or osteoporosis,Disease-causing germline mutation(s) in,Fibrinogen[20031577];Monocyte count[27863252];Monocyte percentage of white cells[27863252];,0.7336196319018405,0.2478081485301702,0.6003654398329418,0.12569060773480664
3299,33839,SLC9A6,300231,300243;,,Christianson syndrome,Disease-causing germline mutation(s) in,,0.3669938650306748,0.9463641052088706,0.9295223179326546,0.0
3300,33863,SLC11A1,600266,607948;610446;,,Tuberculosis,Major susceptibility factor in,Inflammatory bowel disease[23128233];Ulcerative colitis[21297633];,0.038773006134969326,0.10701392470345539,0.4116418689637171,0.07305095150399017
3301,33864,SLC11A2,600523,206100;,"[MIM:206100]Anemia, hypochromic microcytic, with iron overload 1;",Microcytic anemia with liver iron overload,Disease-causing germline mutation(s) in,,0.6694478527607362,0.4883960804538422,0.5896632732967894,0.21807857581338244
3302,33865,SLC12A1,600839,601678;,,Antenatal Bartter syndrome,Disease-causing germline mutation(s) (loss of function) in,Systemic lupus erythematosus[26606652];Metabolite levels (Pyroglutamine)[23934736];,0.10711656441717791,0.3860237235688499,0.37405377186113287,0.8589625537139349
3303,33867,SLC12A3,600968,263800;,[MIM:263800]Gitelman syndrome [recessive?];,Gitelman syndrome,Disease-causing germline mutation(s) (loss of function) in,HDL cholesterol levels[26763881];HDL cholesterol[23505323;20031564];,0.21484662576687116,0.010572460030943786,0.24145131819368312,0.9367710251688153
3304,33869,SLC12A5,606726,616645;616685;,"[MIM:616685]Epilepsy, idiopathic generalized 14 [dominant?];",Malignant migrating partial seizures of infancy,Disease-causing germline mutation(s) (loss of function) in,Inflammatory bowel disease[28067908];Systemic sclerosis[29293537];Crohn's disease[28067908];,0.08736196319018405,0.6562661165549252,0.5356303837118246,0.9723756906077348
3305,33871,SLC12A6,604878,218000;,"[MIM:218000]Agenesis of the corpus callosum, with peripheral neuropathy;",Corpus callosum agenesis-neuronopathy syndrome,Disease-causing germline mutation(s) in,Barrett's esophagus x pack-years of smoking exposure interaction[29551738];,0.8120245398773006,0.538164002062919,0.6966849386583137,0.9321669736034377
3306,33880,SLC13A5,608305,615905;,,Pyridoxine-dependent epilepsy;Amelocerebrohypohidrotic syndrome;Undetermined early-onset epileptic encephalopathy,Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in,Economic and political preferences (time)[22566634];Metabolite levels (small molecules and protein measures)[27005778];Blood metabolite levels[24816252;24816252];,0.26588957055214724,0.6681279009798865,0.7963978073610023,0.2733271945979128
3307,33889,SLC16A1,600682,245340;610021;616095;,[MIM:610021]Familial hyperinsulinemic hypoglycemia 7;[MIM:616095]Monocarboxylate transporter 1 deficiency;,Exercise-induced hyperinsulinism;Metabolic myopathy due to lactate transporter defect;Ketoacidosis due to monocarboxylate transporter-1 deficiency,Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) (loss of function) in,,0.8934969325153375,0.32645693656523983,0.8465152701644479,0.6837016574585635
3308,33892,SLC16A2,300095,300523;,,Allan-Herndon-Dudley syndrome,Disease-causing germline mutation(s) in,,0.16220858895705523,0.8295513151108819,0.7319237796919864,0.0
3309,33903,SLC16A12,611910,612018;,,Juvenile cataract-microcornea-renal glucosuria syndrome,Disease-causing germline mutation(s) in,,0.038773006134969326,0.0,0.5405899243017489,0.20150399017802334
3310,33912,SLC17A5,604322,269920;604369;,[MIM:269920]Infantile sialic acid storage disorder;,"Free sialic acid storage disease, infantile form;Intermediate severe Salla disease;Salla disease",Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in,,0.10711656441717791,0.45693656523981435,0.04072043852779953,0.09330877839165132
3311,33915,SLC17A8,607557,605583;,,Autosomal dominant non-syndromic sensorineural deafness type DFNA,Disease-causing germline mutation(s) in,Squamous cell carcinoma[23341777];,0.038773006134969326,0.4486848891181021,0.6799791177238319,0.1141804788213628
3312,33916,SLC17A9,612107,616063;,,Disseminated superficial actinic porokeratosis,Disease-causing germline mutation(s) in,,0.038773006134969326,0.1624548736462094,0.3291568780997129,0.12676488643339473
3313,33918,SLC18A2,193001,,,Brain dopamine-serotonin vesicular transport disease,Disease-causing germline mutation(s) (loss of function) in,Body mass index[26426971];,0.21484662576687116,0.5412583806085611,0.7984860349778126,0.48649478207489255
3314,33919,SLC18A3,600336,617239;,,Presynaptic congenital myasthenic syndromes,Disease-causing germline mutation(s) in,,0.10711656441717791,0.706034038164002,0.7199164708953276,0.3396255371393493
3315,33921,SLC19A1,600424,,,Methotrexate toxicity or dose selection,Biomarker tested in,Ankle injury[28957384];,0.8360736196319019,0.22692109334708613,0.24719394413991125,0.6669736034376919
3316,33922,SLC19A2,603941,249270;,,Thiamine-responsive megaloblastic anemia syndrome,Disease-causing germline mutation(s) in,Venous thromboembolism[21980494];,0.36171779141104293,0.5577617328519856,0.543461237274863,0.5821055862492327
3317,33923,SLC19A3,606152,607483;,,Thiamine-responsive encephalopathy;Leigh syndrome with leukodystrophy;Infantile spasms-psychomotor retardation-progressive brain atrophy-basal ganglia disease syndrome;Biotin-thiamine-responsive basal ganglia disease,Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in,Obesity-related traits[23251661];,0.14576687116564419,0.39685404847859723,0.4599321326024537,0.6606813996316758
3318,33928,SLC20A2,158378,213600;,"[MIM:213600]Basal ganglia calcification, idiopathic, 1 [dominant?];",Bilateral striopallidodentate calcinosis,Disease-causing germline mutation(s) in,Mean corpuscular hemoglobin concentration[29403010];Mean corpuscular volume[27863252;29403010];Glycated hemoglobin levels[28898252];Pulse pressure[28135244];,0.8974233128834356,0.6678700361010831,0.46097624641085877,0.8910374462860651
3319,33933,SLC22A5,603377,212140;,,Systemic primary carnitine deficiency,Disease-causing germline mutation(s) in,Inflammatory bowel disease[28067908;23128233];Plasma omega-6 polyunsaturated fatty acid levels (arachidonic acid)[24823311];Serum metabolite levels[23093944;23093944];Acylcarnitine levels[26068415;26068415;26068415];Mosquito bite size[28199695];Fibrinogen[20031577;20031577];Crohn's disease[21102463;28067908];Height[20881960];Asthma[20860503;29273806];Ulcerative colitis[28067908];,0.21484662576687116,0.03584321815368747,0.3711824588880188,0.440914671577655
3320,33940,SLC22A12,607096,220150;,,Hereditary renal hypouricemia,Disease-causing germline mutation(s) (loss of function) in,Urate levels in lean individuals[25811787];Serum uric acid levels[26902266];Uric acid levels[19503597];Urate levels[21768215;20139978;23263486];Systemic lupus erythematosus[26606652];Gout[27899376];Renal underexcretion gout[27899376];Renal overload gout[27899376];Renal function-related traits (urea)[22797727];Urate levels in overweight individuals[25811787;25811787];Urate levels in obese individuals[25811787];,0.3669938650306748,0.1848891181021145,0.6494387888279822,0.6921424186617556
3321,33946,SLC22A18,602631,114480;211980;268210;,"[MIM:268210]Rhabdomyosarcoma, embryonal, 1;",Hereditary breast cancer;Embryonal rhabdomyosarcoma,Candidate gene tested in;Candidate gene tested in,Calcium levels[20705733];Total bilirubin levels[29403010];Bilirubin levels[19414484];,0.3492024539877301,0.631253223310985,0.18663534325241452,0.3740024554941682
3322,33957,SLC24A1,603617,613830;,"[MIM:613830]Night blindness, congenital stationary, 1D [recessive?];",Congenital stationary night blindness,Disease-causing germline mutation(s) in,Mean corpuscular hemoglobin[20139978];,0.19190184049079756,0.31175863847343993,0.18141477421038893,0.09898710865561694
3323,33960,SLC24A4,609840,210750;615887;,"[MIM:615887]Amelogenesis imperfecta, hypomaturation type, 2A5;",Hypocalcified amelogenesis imperfecta;Hypomaturation amelogenesis imperfecta,Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in,Light vs. dark hair color[26184321];Eye color[20585627;23548203;23548203;20585627];Alzheimer's disease (late onset)[24162737];Alzheimer's disease in APOE e4- carriers[25778476];Blond vs. brown hair color[17952075];Dialysis-related mortality[21546767;21546767];B cell acute lymphoblastic leukaemia (Philadelphia chromosome negative)[29296818];Brown vs. non-brown hair color[26184321];Blond vs non-blond hair color[26184321];B cell acute lymphoblastic leukaemia (hyperdiploid negative)[29296818];Rosacea symptom severity[29771307];Black vs. blond hair color[18483556];Blue vs. green eyes[17952075];B cell acute lymphoblastic leukaemia (normal cytogenetics)[29296818];Monobrow[27182965];Hair color[23548203;20585627;29662168];,0.038773006134969326,0.759927797833935,0.29966066301226835,0.10297728667894414
3324,33961,SLC24A5,609802,113750;,"[MIM:113750]Albinism, oculocutaneous, 6;",Oculocutaneous albinism type 6,Disease-causing germline mutation(s) in,Body mass index[25133637;25133637];Skin pigmentation[17999355;29195075;29195075;28300201];Hair color[26926045];,0.12711656441717792,0.35146982980918,0.7037327068650483,0.0738182934315531
3325,33962,SLC25A1,190315,615182;,[MIM:615182]Combined D-2- and L-2-hydroxyglutaric aciduria [recessive?];,"D,L-2-hydroxyglutaric aciduria;Presynaptic congenital myasthenic syndromes",Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in,Metabolite levels (small molecules and protein measures)[27005778];Metabolite levels[22286219;22916037];,0.9685889570552147,0.44971634863331617,0.9117723831897677,0.5099754450583179
3326,33969,SLC25A3,600370,610773;,[MIM:610773]Mitochondrial phosphate carrier deficiency;,Cardiomyopathy-hypotonia-lactic acidosis syndrome,Disease-causing germline mutation(s) in,,0.978159509202454,0.798607529654461,0.8726181153745758,0.48066298342541436
3327,33973,SLC25A4,103220,609283;615418;617184;,"[MIM:609283]Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal dominant, 2 [dominant?];[MIM:615418]Mitochondrial DNA depletion syndrome 12B, cardiomyopathic type [recessive?];[MIM:617184]Mitochondrial DNA depletion syndrome 12A, cardiomyopathic type [dominant?];",Congenital cataract-hypertrophic cardiomyopathy-mitochondrial myopathy syndrome;Autosomal dominant progressive external ophthalmoplegia,Disease-causing germline mutation(s) (loss of function) in;Disease-causing germline mutation(s) in,,0.9214723926380368,0.7194430118617844,0.9404855129209084,0.6855432780847146
3328,33994,SLC25A12,603667,612949;,"[MIM:612949]Epileptic encephalopathy, early infantile, 39 [recessive?];",Epileptic encephalopathy with global cerebral demyelination,Disease-causing germline mutation(s) in,Amyotrophic lateral sclerosis (sporadic)[24529757];,0.969079754601227,0.6188757091284167,0.5108326807622031,0.6368937998772253
3329,33995,SLC25A13,603859,603471;605814;,"[MIM:603471]Citrullinemia 2 [recessive?];[MIM:605814]Cholestasis, neonatal intrahepatic, caused by citrin deficiency;",Citrullinemia type II;Neonatal intrahepatic cholestasis due to citrin deficiency,Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in,Bone mineral density[22504420];,0.9867484662576688,0.04564208354822073,0.6703210649960846,0.255524861878453
3330,33998,SLC25A15,603861,238970;,,Hyperornithinemia-hyperammonemia-homocitrullinuria syndrome,Disease-causing germline mutation(s) (loss of function) in,Crohn's disease[23266558];,0.32380368098159507,0.5724600309437855,0.3860610806577917,0.3632596685082873
3331,34008,SLC25A19,606521,607196;613710;,"[MIM:613710]Thiamine metabolism dysfunction syndrome 4, bilateral striatal degeneration and progressive polyneuropathy type;",Progressive polyneuropathy with bilateral striatal necrosis;Amish lethal microcephaly,Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in,,0.8611042944785277,0.6560082516761218,0.1994257374053772,0.7461632903621854
3332,34009,SLC25A20,613698,212138;,[MIM:212138]Carnitine-acylcarnitine translocase deficiency;,Carnitine-acylcarnitine translocase deficiency,Disease-causing germline mutation(s) in,Inflammatory bowel disease[28067908];Crohn's disease[28067908];Blood protein levels[28240269];Ulcerative colitis[28067908];,0.658159509202454,0.19829809179989685,0.7329678935003915,0.19659300184162062
3333,34013,SLC25A22,609302,609304;,,Early infantile epileptic encephalopathy;Early myoclonic encephalopathy;Malignant migrating partial seizures of infancy,Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in,Fuchs's corneal dystrophy[28358029];Intraocular pressure[29617998];,0.8320245398773006,0.6119133574007221,0.5045679979117724,0.48649478207489255
3334,34014,SLC25A23,608746,,,Sotos syndrome,Disease-causing germline mutation(s) (loss of function) in,,0.5191411042944786,0.38963383187209905,0.5956669276951188,0.5833333333333334
3335,34015,SLC25A24,608744,612289;,[MIM:612289]Fontaine progeroid syndrome [dominant?];,"Gorlin-Chaudhry-Moss syndrome;Progeroid syndrome, Petty type",Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in,Granulocyte percentage of myeloid white cells[27863252];White blood cell count[27863252];Eosinophilic esophagitis[25017104];Myeloid white cell count[27863252];Sum basophil neutrophil counts[27863252];Sum neutrophil eosinophil counts[27863252];Monocyte percentage of white cells[27863252];Granulocyte count[27863252];Neutrophil count[27863252];,0.49828220858895705,0.6985559566787004,0.7935264943878882,0.09806629834254144
3336,34020,SLC25A26,611037,616794;,,Neonatal severe cardiopulmonary failure due to mitochondrial methylation defect,Disease-causing germline mutation(s) (loss of function) in,Binge eating behaviour and bipolar disorder[29391396];Atrial fibrillation[30061737;29892015];Colorectal cancer[26151821;26151821];QRS duration[21076409;27659466];,0.10711656441717791,0.4620938628158845,0.1208561733228922,0.2213014119091467
3337,34027,SLC25A32,610815,616839;,,"Multiple acyl-CoA dehydrogenase deficiency, mild type",Disease-causing germline mutation(s) in,,0.28662576687116564,0.23439917483238784,0.4244322631166797,0.34315531000613875
3338,34035,SLC25A38,610819,205950;,,Autosomal recessive sideroblastic anemia,Disease-causing germline mutation(s) in,,0.16220858895705523,0.2331098504383703,0.6254241712346645,0.24754450583179866
3339,34046,SLC25A46,610826,616505;,"[MIM:616505]Neuropathy, hereditary motor and sensory, 6B [recessive?];",Hereditary motor and sensory neuropathy type 6,Disease-causing germline mutation(s) (loss of function) in,"Allergic disease (asthma, hay fever or eczema)[29083406;29083406;29083406];Asthma and hay fever[24388013];Thrombin-activatable fibrinolysis inhibitor levels[29378355];Allergic sensitization[23817571];Cardiac structure and function[19584346];Asthma[27182965;29273806;29273806;29273806];",0.5496932515337424,0.30531201650335227,0.5084834246932916,0.4671577655003069
3340,34057,SLC26A2,606718,222600;226900;256050;600972;,[MIM:600972]Achondrogenesis 1B [recessive?];[MIM:256050]Atelosteogenesis 2;[MIM:226900]Multiple epiphyseal dysplasia 4;,Diastrophic dwarfism;Atelosteogenesis type II;Achondrogenesis type 1B;Multiple epiphyseal dysplasia type 4,Disease-causing germline mutation(s) (loss of function) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in,,0.23865030674846627,0.5322331098504384,0.25632993996345604,0.6497851442602823
3341,34058,SLC26A3,126650,214700;,"[MIM:214700]Diarrhea 1, secretory chloride, congenital;",Congenital chloride diarrhea,Disease-causing germline mutation(s) (loss of function) in,"Inflammatory bowel disease[28067908];Chronic inflammatory diseases (ankylosing spondylitis, Crohn's disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy)[26974007];Behavioural changes in frontotemporal lobe dementia[29724592];Waist-to-hip ratio adjusted for BMI[26426971];Ulcerative colitis[19122664;19122664;19122664;19915573;28067908];Waist-to-hip ratio adjusted for BMI x sex x age interaction (4df test)[26426971];",0.08736196319018405,0.5624033006704486,0.363873662229183,0.7038060159607121
3342,34059,SLC26A4,605646,274600;600791;,"[MIM:600791]Deafness, autosomal recessive, 4 [recessive?];",Pendred syndrome;Autosomal recessive non-syndromic sensorineural deafness type DFNB;Athyreosis;Thyroid hypoplasia,Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) (loss of function) in;Disease-causing germline mutation(s) (loss of function) in,Alcohol consumption[23743675];Serum alkaline phosphatase levels[29403010];Waist-to-hip ratio adjusted for BMI[26426971];Waist-to-hip ratio adjusted for BMI x sex x age interaction (4df test)[26426971];,0.038773006134969326,0.08896338318720991,0.2659879926912033,0.8112338858195212
3343,34061,SLC26A5,604943,613865;,"[MIM:613865]Deafness, autosomal recessive, 61 [recessive?];",Autosomal recessive non-syndromic sensorineural deafness type DFNB,Disease-causing germline mutation(s) in,,0.038773006134969326,0.15265600825167613,0.7084312190028713,0.8996316758747698
3344,34064,SLC26A8,608480,606766;,[MIM:606766]Spermatogenic failure 3;,Non-syndromic male infertility due to sperm motility disorder,Disease-causing germline mutation(s) in,,0.10711656441717791,0.08251676121712223,0.16862438005742625,0.8950276243093923
3345,34072,SLC27A4,604194,608649;,,Ichthyosis-prematurity syndrome,Disease-causing germline mutation(s) in,Body mass index[26426971];,0.8269938650306748,0.3189788550799381,0.5097885669537979,0.2559852670349908
3346,34073,SLC27A5,603314,,,Bile acid CoA ligase deficiency and defective amidation,Candidate gene tested in,,0.10711656441717791,0.06936565239814338,0.41921169407465414,0.11602209944751381
3347,34080,SLC29A3,612373,602782;,,H syndrome;Dysosteosclerosis,Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in,Vitiligo[22951725];Systemic lupus erythematosus[23273568];Diisocyanate-induced asthma[25918132];Obesity-related traits[23251661;23251661];Disease progression in age-related macular degeneration[29346644];,0.038773006134969326,0.17251160391954615,0.020099190811798485,0.28698588090853283
3348,34092,SLC30A9,604604,617595;,,Psychomotor regression-oculomotor apraxia-movement disorder-nephropathy syndrome,Disease-causing germline mutation(s) (loss of function) in,Helping behaviour (self reported)[29324852;29324852];Depression[29700475];,0.2498159509202454,0.23465703971119134,0.7201774993474289,0.15561694290976058
3349,34093,SLC30A10,611146,613280;,[MIM:613280]Hypermanganesemia with dystonia 1 [recessive?];,Cirrhosis-dystonia-polycythemia-hypermanganesemia syndrome,Disease-causing germline mutation(s) in,Urinary electrolytes (magnesium/calcium ratio)[27915449];Waist-to-hip ratio adjusted for BMI (age >50)[26426971];Total body bone mineral density[29304378];Waist-to-hip ratio adjusted for BMI (age <50)[26426971];Reticulocyte fraction of red cells[27863252];Reticulocyte count[27863252];Nose size[27182965];Sexual dimorphism in anthropometric traits[23754948];Waist-to-hip ratio adjusted for BMI[26426971];Waist-to-hip ratio adjusted for BMI x sex x age interaction (4df test)[26426971];,0.19190184049079756,0.8094378545642084,0.8018794048551292,0.8459177409453652
3350,34098,SLC33A1,603690,612539;614482;,"[MIM:614482]Congenital cataracts, hearing loss, and neurodegeneration [recessive?];",Autosomal dominant spastic paraplegia type 42;Congenital cataract-hearing loss-severe developmental delay syndrome,Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in,,0.9548466257668712,0.3628158844765343,0.2440616027146959,0.24125230202578268
3351,34099,SLC34A1,182309,612286;613388;616963;,"[MIM:613388]Fanconi renotubular syndrome 2;[MIM:616963]Hypercalcemia, infantile, 2 [recessive?];",Dominant hypophosphatemia with nephrolithiasis or osteoporosis;Primary Fanconi syndrome;Autosomal recessive infantile hypercalcemia,Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) (loss of function) in;Disease-causing germline mutation(s) (loss of function) in,Phosphorus levels[29403010];Creatinine levels[28270201;29403010];Hematocrit[29403010];Chronic kidney disease[20383146;26831199];Nephrolithiasis[22396660];Red blood cell count[29403010];Waist-to-hip ratio adjusted for BMI[26426971];Glomerular filtration rate[27588450;27588450;27588450;29403010];Urinary electrolytes (magnesium/calcium ratio)[27915449];Calcium levels[24068962];Inflammatory bowel disease[28067908];Activated partial thromboplastin time[22703881];Waist-to-hip ratio adjusted for BMI (age <50)[26426971];Glomerular filtration rate in non diabetics (creatinine)[26831199];Serum parathyroid hormone levels[27927781];Ulcerative colitis[28067908];Glomerular filtration rate (creatinine)[26831199;28452372];Kidney stones[26272126];Waist-to-hip ratio adjusted for BMI x sex x age interaction (4df test)[26426971];,0.2498159509202454,0.04847859721505931,0.4534064212999217,0.4766728054020872
3352,34100,SLC34A2,604217,265100;,[MIM:265100]Pulmonary alveolar microlithiasis;,Pulmonary alveolar microlithiasis,Disease-causing germline mutation(s) (loss of function) in,,0.4117791411042945,0.43424445590510574,0.45653876272513705,0.5415899324739104
3353,34101,SLC34A3,609826,241530;,[MIM:241530]Hereditary hypophosphatemic rickets with hypercalciuria;,Hereditary hypophosphatemic rickets with hypercalciuria,Disease-causing germline mutation(s) (loss of function) in,,0.038773006134969326,0.0629190304280557,0.424693291568781,0.6042050337630448
3354,34102,SLC35A1,605634,603585;,[MIM:603585]Congenital disorder of glycosylation 2F;,SLC35A1-CDG,Disease-causing germline mutation(s) in,Bone mineral density (hip)[30172743];Obesity-related traits[23251661;23251661];,0.20368098159509201,0.8380608561113976,0.5518141477421039,0.4775936157151627
3355,34103,SLC35A2,314375,300896;,[MIM:300896]Congenital disorder of glycosylation 2M;,Isolated focal cortical dysplasia type Ia;SLC35A2-CDG,Disease-causing somatic mutation(s) in;Disease-causing germline mutation(s) in,Total bilirubin levels in HIV-1 infection[25884002];,0.19190184049079756,0.6407942238267148,0.8329417906551814,0.6029772866789441
3356,34104,SLC35A3,605632,615553;,"[MIM:615553]Arthrogryposis, mental retardation, and seizures;",Autism spectrum disorder-epilepsy-arthrogryposis syndrome,Disease-causing germline mutation(s) in,,0.17791411042944785,0.5048994326972667,0.4317410597755155,0.2303560466543892
3357,34111,SLC35C1,605881,266265;,[MIM:266265]Congenital disorder of glycosylation 2C;,Leukocyte adhesion deficiency type II,Disease-causing germline mutation(s) in,Visceral fat[22589738];Diastolic blood pressure[26969751];Axial length[24144296];,0.038773006134969326,0.7532233109850438,0.30200991908117986,0.5299263351749539
3358,34113,SLC35D1,610804,269250;,,Schneckenbecken dysplasia,Disease-causing germline mutation(s) (loss of function) in,Inflammatory bowel disease[28067908];Diverticular disease[30177863];Neutrophil percentage of white cells[27863252];Lymphocyte counts[27863252];Allergic rhinitis[30013184];Crohn's disease[28067908;22412388];Ulcerative colitis[28067908];,0.038773006134969326,0.36255801959773076,0.26703210649960846,0.21347452424800492
3359,34135,SLC36A2,608331,138500;242600;,[MIM:242600]Iminoglycinuria;,Iminoglycinuria,Disease-causing germline mutation(s) in,Inflammatory bowel disease[28067908];Skin aging (microtopography measurement)[28502801];Crohn's disease[28067908];,0.038773006134969326,0.6036616812790098,0.3445575567736883,0.07228360957642725
3360,34141,SLC37A4,602671,232220;232240;,[MIM:232240]Glycogen storage disease 1C;[MIM:232240]Glycogen storage disease 1D;,Glycogen storage disease due to glucose-6-phosphatase deficiency type Ib,Disease-causing germline mutation(s) in,,0.6635582822085889,0.2601856627127385,0.6105455494648917,0.0
3361,34142,SLC38A1,608490,,,Isoniazid toxicity,Biomarker tested in,"Blood metabolite levels[24816252;24816252;24816252];Triglyceride levels[28334899;29403010];Triglycerides[20686565;24097068];Night sleep phenotypes[27126917];Urinary metabolites (H-NMR features)[24586186];Bladder cancer[20972438;24163127];Coronary artery disease[29212778];Blood metabolite ratios[24816252];Insulin resistance/response[25798622];Total cholesterol levels[28334899];Urinary metabolites[21572414;26352407];Iron status biomarkers (transferrin levels)[25352340];Cholesterol, total[20686565;24097068];Paclitaxel-induced neuropathy[23776197];Metabolic traits[21886157];",0.9173006134969325,0.8684889118102115,0.9235186635343252,0.6803253529772867
3362,34149,SLC38A8,615585,609218;,,Foveal hypoplasia-optic nerve decussation defect-anterior segment dysgenesis syndrome,Disease-causing germline mutation(s) (loss of function) in,Response to platinum-based neoadjuvant chemotherapy in cervical cancer[28120872];,0.038773006134969326,0.31304796286745745,0.27068650482902634,0.09131368937998773
3363,34156,SLC39A4,607059,201100;,,Acrodermatitis enteropathica,Disease-causing germline mutation(s) (loss of function) in,,0.5276073619631901,0.5835482207323363,0.025319759853824068,0.33486801718845915
3364,34160,SLC39A8,608732,616721;,[MIM:616721]Congenital disorder of glycosylation 2N [recessive?];,SLC39A8-CDG,Disease-causing germline mutation(s) in,Body mass index (joint analysis main effects and smoking interaction)[28443625;28443625];Hematocrit[27863252];Schizophrenia[25056061];NT-proBNP levels in acute coronary syndrome[26908625];Diastolic blood pressure x alcohol consumption interaction (2df test)[29912962;29912962];Mean arterial pressure[27618448];Hemoglobin concentration[27863252];Body mass index[20935630;28448500;28448500;28448500;28448500;25673413;25673413;25673413;25673413];Manganese levels[26025379];Intelligence (MTAG)[29326435;29326435;29326435;29326435;29326435;29326435];Copper levels[26025379];Blood pressure[21909110];Systolic blood pressure x alcohol consumption interaction (2df test)[29912962];Childhood body mass index[26604143];BMI (adjusted for smoking behaviour)[28443625;28443625];Mean arterial pressure x alcohol consumption interaction (2df test)[29912962;29912962];Systolic blood pressure[21909115;27618452;28739976;27618447];Hypertension[21909115];Erythrocyte cadmium concentration in never smokers[27005419];Autism spectrum disorder or schizophrenia[28540026];Diastolic blood pressure[21909115;27618452;28739976];Platelet distribution width[27863252];Hand grip strength[29691431;29691431];Crohn's disease[28067908];General cognitive ability[29844566;29844566;29844566;29844566;29844566;29844566;29844566];Body mass index (joint analysis main effects and physical activity interaction)[28448500;28448500;28448500;28448500];HDL cholesterol[20686565;24097068;25961943];Inflammatory bowel disease[28067908];BMI in non-smokers[28443625;28443625];Body mass index in physically active individuals[28448500;28448500;28448500;28448500];Serum total protein level[29403010];Initial pursuit acceleration[29064472];,0.3449079754601227,0.4889118102114492,0.44270425476376923,0.4843462246777164
3365,34166,SLC39A13,608735,612350;,"[MIM:612350]Ehlers-Danlos syndrome, spondylodysplastic type, 3 [recessive?];","Ehlers-Danlos syndrome, spondylocheirodysplastic type",Disease-causing germline mutation(s) in,Systolic blood pressure[27618452;28739976];Neuroticism[29255261];Waist circumference[25673412;25673412];Hip circumference[25673412;25673412;25673412];Diastolic blood pressure[27618452;28739976];Global electrical heterogeneity phenotypes[29622589];,0.12711656441717792,0.4404332129963899,0.3871051944661968,0.24631675874769798
3366,34167,SLC39A14,608736,144755;617013;,[MIM:144755]Hyperostosis cranialis interna [dominant?];,Dystonia-parkinsonism-hypermanganesemia syndrome,Disease-causing germline mutation(s) in,Verbal declarative memory[25648963;25648963];B-type natriuretic peptide to N-terminal pro B-type natriuretic peptide ratio[29237677];,0.8937423312883436,0.5763280041258381,0.09109892978334638,0.32535297728667895
3367,34168,SLC40A1,604653,606069;,,Hemochromatosis type 4;Hemochromatosis type 4,Disease-causing germline mutation(s) (loss of function) in;Disease-causing germline mutation(s) (gain of function) in,Bone fracture in osteoporosis[28580392];Iron status biomarkers (ferritin levels)[25352340];Mean corpuscular hemoglobin concentration[27863252];Mean corpuscular hemoglobin[27863252];Iron status biomarkers (transferrin levels)[25352340];Iron status biomarkers (total iron binding capacity)[28334935];Red blood cell count[27863252];,0.12711656441717792,0.6343476018566271,0.5682589402244844,0.8118477593615715
3368,34179,SLC44A4,606107,617606;,"[MIM:617606]Deafness, autosomal dominant, 72 [dominant?];",Autosomal dominant non-syndromic sensorineural deafness type DFNA,Disease-causing germline mutation(s) in,C-reactive protein levels or total cholesterol levels (pleiotropy)[27286809];Autism spectrum disorder or schizophrenia[28540026;28540026;28540026;28540026;28540026;28540026;28540026;28540026;28540026;28540026;28540026;28540026;28540026;28540026;28540026;28540026;28540026];Lung cancer in ever smokers[28604730];Lung cancer[28604730];Iron status biomarkers (total iron binding capacity)[28334935];Itch intensity from mosquito bite[28199695];Diastolic blood pressure x smoking status (ever vs never) interaction (2df test)[29455858;29455858;29455858;29455858];Telomere length[20421499];Blood protein levels[28240269;28240269;28240269];Systolic blood pressure x smoking status (current vs non-current) interaction (2df test)[29455858;29455858];Inflammatory bowel disease[28067908];Exudative age-related macular degeneration[25629512];Perceived unattractiveness to mosquitoes[28199695];Systemic lupus erythematosus[26502338];Itch intensity from mosquito bite adjusted by bite size[28199695];Diastolic blood pressure x smoking status (current vs non-current) interaction (2df test)[29455858;29455858;29455858];Systolic blood pressure x smoking status (ever vs never) interaction (2df test)[29455858;29455858];Ulcerative colitis[24837172;28067908];,0.038773006134969326,0.06498194945848375,0.34325241451318195,0.009515039901780233
3369,34181,SLC45A1,605763,617532;,,Autosomal recessive non-syndromic intellectual disability,Disease-causing germline mutation(s) in,"Psoriasis[25903422;23143594];Autism spectrum disorder or schizophrenia[28540026];Schizophrenia[28991256];Depression[29700475];Breast cancer[23468962];Inflammatory skin disease[25574825];Subclinical trait of interstitial lung disease (basilar peel-core ratio of high attentuation areas on CT scan)[28521775];Strep throat[28928442];Plasma omega-6 polyunsaturated fatty acid levels (gamma-linolenic acid)[24823311];Autism spectrum disorder, attention deficit-hyperactivity disorder, bipolar disorder, major depressive disorder, and schizophrenia (combined)[23453885];Allergic rhinitis[30013184];Hair shape[29220522];Hair color[29662168];",0.038773006134969326,0.3261990716864363,0.6909423127120856,0.6697360343769183
3370,34182,SLC45A2,606202,227240;606574;,"[MIM:606574]Albinism, oculocutaneous, 4;",Oculocutaneous albinism type 4,Disease-causing germline mutation(s) in,Skin sensitivity to sun[25963972];Squamous cell carcinoma[26829030];Skin pigmentation[17999355;28300201];Eye color[20585627];Basal cell carcinoma[27539887];Melanoma[21983787;28212542;28212542];Low tan response[29739929];Black vs. non-black hair color[26184321];Rosacea symptom severity[29771307];Cutaneous squamous cell carcinoma[27424798];Skin aging (microtopography measurement)[28502801];Monobrow[27182965];Perceived skin darkness[25963972];Hair color[20585627;29662168;26926045];Skin colour saturation[25963972];,0.2498159509202454,0.3109850438370294,0.061341686243800576,0.7986494782074892
3371,34185,SLC46A1,611672,229050;,,Hereditary folate malabsorption,Disease-causing germline mutation(s) in,Osteoprotegerin levels[25080503];Blood protein levels[28240269;28240269;28240269;28240269;28240269;28240269];,0.08736196319018405,0.7511603919546158,0.7340120073087967,0.0
3372,34194,SLC49A4,602773,,,Hereditary clear cell renal cell carcinoma,Candidate gene tested in,,0.038773006134969326,0.13924703455389376,0.0,0.0
3373,34198,SLC52A1,607883,615026;,,Maternal riboflavin deficiency,Disease-causing germline mutation(s) in,Lung adenocarcinoma[28604730];,0.08736196319018405,0.2031975244971635,0.09605847037327069,0.0
3374,34199,SLC52A2,607882,614707;,,Riboflavin transporter deficiency;Autosomal recessive spinocerebellar ataxia-blindness-deafness syndrome,Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in,,0.12711656441717792,0.6732851985559567,0.7815191855912295,0.0
3375,34200,SLC52A3,613350,211500;211530;,[MIM:211500]Fazio-Londe disease;,Riboflavin transporter deficiency,Disease-causing germline mutation(s) in,Helping behaviour (self reported)[29324852];,0.038773006134969326,0.5845796802475502,0.14904724614983034,0.0
3376,34202,SLCO1B1,604843,237450;,,Rotor syndrome;Statin toxicity,Disease-causing germline mutation(s) in;Biomarker tested in,Methotrexate phramacokinetics (acute lymphoblastic leukemia)[19901119;19901119;19901119];Serum metabolite levels[23093944;23093944;23093944;23093944;23093944;23093944];Sex hormone-binding globulin levels[22829776];Blood metabolite levels[24816252;24816252;24816252;24816252;24816252;24816252;24816252;24816252;24816252;24816252;24816252;24816252;24816252];Plasma estrone conjugates levels in resected early stage estrogen-receptor positive breast cancer[28429243;28429243];Clinical laboratory measurements[27897004];Response to statin therapy[18650507];Diastolic blood pressure x smoking status (ever vs never) interaction (2df test)[29455858;29455858];Systolic blood pressure x smoking status (current vs non-current) interaction (2df test)[29455858;29455858];AR-C124910XX levels in individuals with acute coronary syndromes treated with ticagrelor[25935875];Blood metabolite ratios[24816252];Chagas cardiomyopathy in Tripanosoma cruzi seropositivity[24324551];Ischemic stroke (large artery atherosclerosis)[26732560];Diisocyanate-induced asthma[25918132];Diastolic blood pressure x smoking status (current vs non-current) interaction (2df test)[29455858;29455858];Metabolite levels[23281178];Systolic blood pressure x smoking status (ever vs never) interaction (2df test)[29455858;29455858];Methotrexate clearance (acute lymphoblastic leukemia)[23233662];Bilirubin levels[19414484;21646302];Estrone conjugates/estrone ratio in resected early stage estrogen-receptor positive breast cancer[28429243];Metabolic traits[21886157];,0.19190184049079756,0.02398143372872615,0.3187157400156617,0.007519950890116636
3377,34203,SLCO1B3,605495,237450;,"[MIM:237450]Hyperbilirubinemia, Rotor type [recessive?];",Rotor syndrome,Disease-causing germline mutation(s) in,Clozapine-induced agranulocytosis/granulocytopenia in treatment-resistant schizophrenia[27400856];Total bilirubin levels[29403010];Diastolic blood pressure x smoking status (current vs non-current) interaction (2df test)[29455858;29455858];Systolic blood pressure x smoking status (ever vs never) interaction (2df test)[29455858;29455858];Height[18391951];Diastolic blood pressure x smoking status (ever vs never) interaction (2df test)[29455858;29455858];Bilirubin levels[20639394;19419973;23371916;23371916;23371916];Systolic blood pressure x smoking status (current vs non-current) interaction (2df test)[29455858;29455858];,0.038773006134969326,0.015471892728210418,0.0,0.15899324739103746
3378,34206,SLCO2A1,601460,614441;,,Pachydermoperiostosis;Chronic enteropathy associated with SLCO2A1 gene,Disease-causing germline mutation(s) (loss of function) in;Disease-causing germline mutation(s) (loss of function) in,Amyotrophic lateral sclerosis (sporadic)[24529757];,0.10711656441717791,0.0961835997937081,0.17645523362046464,0.08732351135666053
3379,34226,SLFN14,614958,616913;,,Autosomal dominant thrombocytopenia with platelet secretion defect,Disease-causing germline mutation(s) in,Mean platelet volume[27863252];Platelet distribution width[27863252;27863252;27863252];Plateletcrit[27863252];Response to radiotherapy in cancer (late toxicity)[24785509];Platelet count[27863252;27863252;29403010];Immature fraction of reticulocytes[27863252];,0.038773006134969326,0.12712738525012893,0.0498564343513443,0.0
3380,34240,SLITRK6,609681,221200;,,High myopia-sensorineural deafness syndrome;Autosomal recessive non-syndromic sensorineural deafness type DFNB,Disease-causing germline mutation(s) (loss of function) in;Disease-causing germline mutation(s) (loss of function) in,Bipolar disorder (mania)[23326512];Male sexual orientation[29217827];,0.038773006134969326,0.07710159876224858,0.6087183503001827,0.13904235727440148
3381,34242,SLMAP,602701,,,Brugada syndrome,Disease-causing germline mutation(s) in,Late-onset Alzheimer's disease[27770636];Obesity-related traits[23251661];,0.821717791411043,0.908457968024755,0.7906551814147742,0.34315531000613875
3382,34247,SLURP1,606119,248300;,[MIM:248300]Mal de Meleda [recessive?];,"Mal de Meleda;Hereditary palmoplantar keratoderma, Gamborg-Nielsen type",Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in,,0.22687116564417178,0.6371841155234657,0.9825110937092143,0.5466543891958257
3383,34253,SLX4,613278,613951;,[MIM:613951]Fanconi anemia complementation group P;,Fanconi anemia,Disease-causing germline mutation(s) in,,0.7365644171779141,0.02784940691077875,0.10180109631949882,0.0
3384,34259,SMAD3,603109,114500;613795;,[MIM:114500]Colorectal cancer;[MIM:613795]Loeys-Dietz syndrome 3;,Aneurysm-osteoarthritis syndrome;Familial thoracic aortic aneurysm and aortic dissection,Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in,"Myocardial infarction[26343387];Allergy[27182965];Chronic inflammatory diseases (ankylosing spondylitis, Crohn's disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy)[26974007;26974007];Waist circumference adjusted for BMI (adjusted for smoking behaviour)[28443625;28443625];Eosinophil counts[27863252];Lung function (FVC)[30061609;30061609];Allergic disease (asthma, hay fever or eczema)[29083406];Allergic rhinitis[30013184];Waist circumference adjusted for BMI (joint analysis main effects and smoking interaction)[28443625;28443625];Self-reported allergy[23817569];Coronary artery disease (myocardial infarction, percutaneous transluminal coronary angioplasty, coronary artery bypass grafting, angina or chromic ischemic heart disease)[28714975];Eosinophil percentage of white cells[27863252];Corneal structure[23291589];Waist circumference adjusted for BMI in non-smokers[28443625;28443625];Heel bone mineral density[28869591;28869591];Crohn's disease[21102463;28067908];Waist circumference adjusted for body mass index[25673412;25673412];Femoral neck bone mineral density[29499414];Coronary heart disease[17634449];Coronary artery disease[26343387;29212778;29212778;29212778];Asthma[20860503;27182965;29273806;29273806];Lumbar spine bone mineral density[29499414];Inflammatory bowel disease[28067908;23128233];Diverticular disease[30177863];Sum eosinophil basophil counts[27863252];Restless legs syndrome[29029846];Pediatric autoimmune diseases[26301688];Eosinophil percentage of granulocytes[27863252];Thyroid cancer[28195142;28195142];Central corneal thickness[29760442];Spontaneous dizygotic twinning[27132594];Lung cancer (smoking interaction)[24658283];Asthma and hay fever[24388013];Pursuit maintenance gain[29064472];Ulcerative colitis[28067908];Intraocular pressure[29617998;29617998;29235454];",0.7699386503067485,0.8813821557503868,0.588358131036283,0.8468385512584408
3385,34260,SMAD4,600993,114500;139210;174900;175050;260350;,[MIM:260350]Pancreatic cancer;[MIM:174900]Juvenile polyposis syndrome;[MIM:175050]Juvenile polyposis/hereditary hemorrhagic telangiectasia syndrome [dominant?];[MIM:114500]Colorectal cancer;[MIM:139210]Myhre syndrome;,Hereditary hemorrhagic telangiectasia;Myhre syndrome;Familial pancreatic carcinoma;Generalized juvenile polyposis/juvenile polyposis coli,Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Major susceptibility factor in;Disease-causing germline mutation(s) in,Oligoclonal band status in multiple sclerosis[25616667];Immune response to anthrax vaccine[22658931];,0.7707975460122699,0.6508509541000516,0.9034194727225268,0.766267648864334
3386,34263,SMAD6,602931,614823;617439;,[MIM:614823]Aortic valve disease 2;[MIM:617439]Craniosynostosis 7;,Familial bicuspid aortic valve,Disease-causing germline mutation(s) in,Waist-to-hip ratio adjusted for BMI (adjusted for smoking behaviour)[28443625];Lung cancer (smoking interaction)[24658283];Subcutaneous adipose tissue[22589738];Waist-hip ratio[25673412];Waist-to-hip ratio adjusted for body mass index[25673412;25673412;25673412;25673412;25673412];Asthma[29273806;29273806];,0.4622085889570552,0.1560082516761217,0.5661707126076743,0.0
3387,34265,SMAD9,603295,615342;,"[MIM:615342]Pulmonary hypertension, primary, 2;",Heritable pulmonary arterial hypertension,Disease-causing germline mutation(s) in,Perioperative myocardial infarction in coronary artery bypass surgery[25948407];Total body bone mineral density[29304378];Spontaneous preterm birth (preterm birth)[25599974];Heel bone mineral density[28869591;28869591];Coronary artery disease[29212778];,0.658159509202454,0.26405363589479114,0.7444531453928478,0.7120933087783916
3388,34272,SMARCA2,600014,181500;601358;,[MIM:601358]Nicolaides-Baraitser syndrome;[MIM:181500]Schizophrenia;,Intellectual disability-sparse hair-brachydactyly syndrome,Disease-causing germline mutation(s) in,"Systolic blood pressure[26969751];Parkinson's disease[26227905];Adverse response to chemotherapy in breast cancer (alopecia) (cyclophosphamide+doxorubicin+/-5FU)[24025145];Nose size[27182965];Autism spectrum disorder, attention deficit-hyperactivity disorder, bipolar disorder, major depressive disorder, and schizophrenia (combined)[23453885];Monobrow[27182965];Superior frontal gyrus grey matter volume[25335168];Amyotrophic lateral sclerosis (sporadic)[24529757];Lead levels[26025379];Lung function (FEV1)[30061609;30061609];Asthma (childhood onset)[27611488];Lung function (FVC)[30061609;30061609;30061609];",0.8173006134969325,0.648014440433213,0.1654920386322109,0.8015653775322283
3389,34273,SMARCA4,603254,613325;614609;,[MIM:614609]Coffin-Siris syndrome 4 [dominant?] [recessive?];,Coffin-Siris syndrome;Familial rhabdoid tumor;Small cell carcinoma of the ovary;SMARCA4-deficient sarcoma of thorax,Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing somatic mutation(s) in,Stroke[29531354;29531354];Coronary artery disease or ischemic stroke[24262325];Ischemic stroke[29531354;29531354];LDL cholesterol[21347282];Coronary artery disease or large artery stroke[24262325];Inflammatory skin disease[25574825];Coronary artery disease[24262325];,0.898159509202454,0.7784940691077875,0.6332550247977029,0.9972375690607734
3390,34274,SMARCA5,603375,,,Extraskeletal Ewing sarcoma,Part of a fusion gene in,,0.958036809815951,1.0,0.9389193422083008,0.8809085328422345
3391,34276,SMARCAD1,612761,129200;136000;,[MIM:129200]Basan syndrome [dominant?];,Absence of fingerprints-congenital milia syndrome;Isolated congenital adermatoglyphia;Huriez syndrome,Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) (loss of function) in;Disease-causing germline mutation(s) in,QT interval[24952745];Heel bone mineral density[28869591;28869591];Hand grip strength[29691431];Capecitabine sensitivity[22864933];Menarche (age at onset)[25231870];Testicular germ cell tumor[23666239;28604732;28604728];,0.7352147239263803,1.0,0.10388932393630906,0.9625537139349294
3392,34277,SMARCAL1,606622,242900;,[MIM:242900]Schimke immuno-osseous dysplasia [recessive?];,Schimke immuno-osseous dysplasia,Disease-causing germline mutation(s) in,Response to anti-TNF therapy in rheumatoid arthritis[26776603;26776603];,0.5312883435582823,0.6322846828261991,0.262855651265988,0.856353591160221
3393,34278,SMARCB1,601607,162091;609322;614608;,[MIM:609322]Rhabdoid tumor predisposition syndrome 1;[MIM:162091]Schwannomatosis 1;[MIM:614608]Coffin-Siris syndrome 3 [dominant?] [recessive?];,Coffin-Siris syndrome;Familial multiple meningioma;Familial rhabdoid tumor;Neurofibromatosis type 3;Atypical teratoid rhabdoid tumor,Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) (loss of function) in;Disease-causing germline mutation(s) in;Disease-causing somatic mutation(s) in,IgG sialylation phenotypes (multivariate analysis)[28878392];Fractional shortening[29403010];IgG glycosylation[23382691;23382691;23382691;23382691;23382691;23382691;23382691;23382691;23382691;23382691;23382691;23382691;23382691;23382691;23382691;23382691;23382691;23382691;23382691;23382691;23382691;23382691];IgG digalactosylation phenotypes (multivariate analysis)[28878392];IgG disialylation phenotypes (multivariate analysis)[28878392];IgG galactosylation phenotypes (multivariate analysis)[28878392];IgG fucosylation phenotypes (multivariate analysis)[28878392];IgG N-glycosylation phenotypes (multivariate analysis)[28878392];IgG bisecting N-acetyl glucosamine phenotypes (multivariate analysis)[28878392];IgG monogalactosylation phenotypes (multivariate analysis)[28878392];,0.8409815950920245,0.9033006704486849,0.9908640041764553,0.0
3394,34282,SMARCD2,601736,617475;,[MIM:617475]Specific granule deficiency 2 [recessive?];,Recurrent infection due to specific granule deficiency,Disease-causing germline mutation(s) (loss of function) in,,0.7592638036809816,0.6397627643115008,0.6450013051422605,0.0
3395,34284,SMARCE1,603111,607174;616938;,[MIM:607174]Meningioma;[MIM:616938]Coffin-Siris syndrome 5 [dominant?] [recessive?];,Coffin-Siris syndrome;Familial multiple meningioma,Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) (loss of function) in,"Allergic disease (asthma, hay fever or eczema)[29083406;29083406];",0.8101840490797546,0.8120165033522434,0.8258940224484469,0.8572744014732965
3396,34293,SMC1A,300040,300590;,[MIM:300590]Cornelia de Lange syndrome 2;,Cornelia de Lange syndrome;Wiedemann-Steiner syndrome,Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in,,0.98,0.9218669417225374,0.9799008091882015,0.9392265193370166
3397,34297,SMC3,606062,610759;,[MIM:610759]Cornelia de Lange syndrome 3;,Cornelia de Lange syndrome,Disease-causing germline mutation(s) in,,0.9752147239263804,1.0,0.9303054032889585,0.8842848373235114
3398,34303,SMCHD1,614982,158901;603457;,[MIM:158901]Facioscapulohumeral muscular dystrophy 2;[MIM:603457]Bosma arhinia microphthalmia syndrome [dominant?];,Facioscapulohumeral dystrophy;Facioscapulohumeral dystrophy;Hyposmia-nasal and ocular hypoplasia-hypogonadotropic hypogonadism syndrome,Disease-causing germline mutation(s) in;Modifying germline mutation in;Disease-causing germline mutation(s) in,,0.9154601226993865,0.7093862815884476,0.1158966327329679,0.6080417434008594
3399,34338,SMIM6,,,,Williams syndrome;Supravalvular aortic stenosis;Autosomal dominant cutis laxa;Familial thoracic aortic aneurysm and aortic dissection,Role in the phenotype of;Disease-causing germline mutation(s) (loss of function) in;Disease-causing germline mutation(s) in;Candidate gene tested in,Diverticular disease[30177863];,0.038773006134969326,0.0,0.9397024275646045,0.0
3400,34383,SMN1,600354,253300;253400;253550;271150;,[MIM:253300]Spinal muscular atrophy 1;[MIM:253550]Spinal muscular atrophy 2 [recessive?];[MIM:253400]Spinal muscular atrophy 3 [recessive?];[MIM:271150]Spinal muscular atrophy 4 [recessive?];,Proximal spinal muscular atrophy type 1;Proximal spinal muscular atrophy type 3;Proximal spinal muscular atrophy type 4;Proximal spinal muscular atrophy type 2,Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in,,0.9015950920245399,0.5361010830324909,0.9976507439310884,0.0
3401,34384,SMN2,601627,253300;253400;253550;271150;,[MIM:253300]Spinal muscular atrophy 1;[MIM:253550]Spinal muscular atrophy 2 [recessive?];[MIM:253400]Spinal muscular atrophy 3 [recessive?];[MIM:271150]Spinal muscular atrophy 4 [recessive?];,Proximal spinal muscular atrophy type 1;Proximal spinal muscular atrophy type 3;Proximal spinal muscular atrophy type 4;Proximal spinal muscular atrophy type 2,Modifying germline mutation in;Modifying germline mutation in;Modifying germline mutation in;Modifying germline mutation in,,0.038773006134969326,0.6660649819494585,0.9780736100234926,0.0
3402,34386,SMO,601500,601707;,[MIM:601707]Curry-Jones syndrome;,Curry-Jones syndrome,Disease-causing somatic mutation(s) in,,0.2498159509202454,0.1887570912841671,0.2803445575567737,0.6011356660527931
3403,34387,SMOC1,608488,206920;,[MIM:206920]Ophthalmoacromelic syndrome;,Microphthalmia with limb anomalies,Disease-causing germline mutation(s) in,Digit length ratio (right hand)[29659830];Tuberculosis[24057671];Mean corpuscular hemoglobin[27863252];Red blood cell traits[23222517];Digit length ratio (left hand)[29659830;29659830];Triglyceride levels[30108155];Bone mineral density[24249740;24249740;24249740;24249740];Digit length ratio[29659830];Daytime sleep phenotypes[27126917];Blood protein levels[29875488;30072576;30072576];Red cell distribution width[27863252];,0.3449079754601227,0.4553893759669933,0.5591229444009397,0.21531614487415593
3404,34388,SMOC2,607223,125400;,[MIM:125400]Dentin dysplasia 1;,Atypical dentin dysplasia due to SMOC2 deficiency,Disease-causing germline mutation(s) in,Vitiligo[19890347];Copper levels[26025379];Loneliness[27629369];,0.10711656441717791,0.6224858174316658,0.6235969720699557,0.21899938612645795
3405,34389,SMOX,615854,,,Curry-Jones syndrome,Disease-causing somatic mutation(s) in,High light scatter reticulocyte percentage of red cells[27863252;27863252];Mean corpuscular hemoglobin[27863252];Reticulocyte fraction of red cells[27863252;27863252;27863252];Reticulocyte count[27863252;27863252;27863252];Panic disorder[19165232];High light scatter reticulocyte count[27863252;27863252;27863252];Height[20881960;25282103];Dementia and core Alzheimer's disease neuropathologic changes[25188341];Immature fraction of reticulocytes[27863252;27863252;27863252];,0.17791411042944785,0.4492006188757091,0.7802140433307231,0.9287906691221608
3406,34390,SMPD1,607608,257200;607616;,[MIM:257200]Niemann-Pick disease A;[MIM:607616]Niemann-Pick disease B;,Niemann-Pick disease type B;Niemann-Pick disease type A,Disease-causing germline mutation(s) (loss of function) in;Disease-causing germline mutation(s) (loss of function) in,Diisocyanate-induced asthma[25918132];Blood protein levels[30072576];,0.28662576687116564,0.6903042805569881,0.2017749934742887,0.8941068139963168
3407,34399,SMPX,300226,300066;,"[MIM:300066]Deafness, X-linked, 4;",X-linked non-syndromic sensorineural deafness type DFN,Disease-causing germline mutation(s) in,,0.10711656441717791,0.7707581227436823,0.986948577394936,0.42464702271332105
3408,34402,SMS,300105,309583;,[MIM:309583]X-linked syndromic mental retardation Snyder-Robinson type;,"X-linked intellectual disability, Snyder type",Disease-causing germline mutation(s) (loss of function) in,,0.505398773006135,0.8857658586900464,0.9451840250587314,0.8127685696746471
3409,34421,SNAI2,602150,172800;608890;,[MIM:608890]Waardenburg syndrome 2D [dominant?];[MIM:172800]Piebald trait;,Waardenburg syndrome type 2;Piebaldism,Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in,Blood metabolite ratios[24816252];Blood metabolite levels[24816252];,0.33226993865030674,0.8243940175348118,0.9036805011746281,0.0
3410,34426,SNAP25,600322,616330;,"[MIM:616330]Myasthenic syndrome, congenital, 18 [dominant?];",Presynaptic congenital myasthenic syndromes,Disease-causing germline mutation(s) in,Psychosis proneness (hypomanic personality scale and revised social anhedonia scale)[28525603];Cardiac hypertrophy[21348951];,0.5822085889570552,0.8396080453842186,0.9621508744453146,0.0
3411,34428,SNAP29,604202,609528;,,CEDNIK syndrome,Disease-causing germline mutation(s) (loss of function) in,,0.9137423312883436,0.6175863847343992,0.5123988514748108,0.5954573357888275
3412,34467,SNCA,163890,127750;168600;168601;605543;,"[MIM:168601]Parkinson disease 1, autosomal dominant [dominant?];[MIM:605543]Parkinson disease 4, autosomal dominant [dominant?];[MIM:127750]Dementia Lewy body;",Parkinsonian-pyramidal syndrome;Young-onset Parkinson disease;Hereditary late-onset Parkinson disease,Disease-causing germline mutation(s) in;Candidate gene tested in;Disease-causing germline mutation(s) (gain of function) in,Parkinson's disease[20711177;21044948;21084426;21292315;22451204;22438815;22438815;21738487;19915576;19915575;20070850;24511991;24511991;28011712;27182965;25064009;28892059];Response to bupropion in depression[27622933];Blood protein levels[29875488;30072576;30072576];Dementia with Lewy bodies[29263008];,0.6604907975460123,0.8607529654461062,0.9000261028452101,0.7837630448127686
3413,34992,SNORD116@,,,,Prader-Willi syndrome due to paternal deletion of 15q11q13 type 1;Prader-Willi syndrome due to paternal deletion of 15q11q13 type 2;Prader-Willi syndrome due to imprinting mutation,Role in the phenotype of;Role in the phenotype of;Role in the phenotype of,,0.038773006134969326,0.0,0.0,0.0
3414,35059,SNRNP200,601664,610359;,[MIM:610359]Retinitis pigmentosa 33;,Retinitis pigmentosa,Disease-causing germline mutation(s) in,,0.9478527607361963,0.9834966477565755,0.541634038110154,0.7728667894413751
3415,35062,SNRPB,182282,117650;,[MIM:117650]Cerebrocostomandibular syndrome;,Cerebrocostomandibular syndrome,Disease-causing germline mutation(s) in,,0.9582822085889571,0.7996389891696751,0.8893239363090577,0.40730509515039903
3416,35091,SNRPE,128260,615059;,,Hypotrichosis simplex,Disease-causing germline mutation(s) in,,0.8591411042944785,0.8715832903558536,0.0,0.0
3417,35128,SNRPN,182279,,,Prader-Willi syndrome due to paternal deletion of 15q11q13 type 1;Prader-Willi syndrome due to paternal deletion of 15q11q13 type 2;Prader-Willi syndrome due to translocation;Prader-Willi syndrome due to imprinting mutation;Angelman syndrome due to imprinting defect in 15q11-q13;Prader-Willi syndrome due to maternal uniparental disomy of chromosome 15,Role in the phenotype of;Role in the phenotype of;Role in the phenotype of;Role in the phenotype of;Role in the phenotype of;Role in the phenotype of,Periodontitis (DPAL)[24024966];Pulmonary function[17903307];Carotid plaque burden[28282560];Periodontal disease-related phenotypes[26962152];Obesity-related traits[23251661];,0.5948466257668712,0.6369262506446622,0.984077264421822,0.6962860650705954
3418,35129,SNTA1,601017,612955;,[MIM:612955]Long QT syndrome 12;,Romano-Ward syndrome,Disease-causing germline mutation(s) (gain of function) in,,0.5276073619631901,0.4125838060856111,0.3884103367267032,0.4530386740331492
3419,35157,SNX10,614780,615085;,"[MIM:615085]Osteopetrosis, autosomal recessive 8 [dominant?] [recessive?];",Autosomal recessive malignant osteopetrosis,Disease-causing germline mutation(s) in,Waist-to-hip ratio adjusted for BMI (age >50)[26426971];Waist-to-hip ratio adjusted for BMI (adjusted for smoking behaviour)[28443625;28443625];Waist-to-hip ratio adjusted for BMI in active individuals[28448500];Visceral adipose tissue/subcutaneous adipose tissue ratio[22589738];Waist-to-hip ratio adjusted for BMI[26426971];Waist-to-hip ratio adjusted for body mass index[25673412;25673412];Waist-to-hip ratio adjusted for BMI x sex x age interaction (4df test)[26426971];,0.10711656441717791,0.15162454873646208,0.8820151396502218,0.29772866789441377
3420,35161,SNX14,616105,616354;,,Intellectual disability-coarse face-macrocephaly-cerebellar hypotrophy syndrome,Disease-causing germline mutation(s) (loss of function) in,,0.2947239263803681,0.050799381124290874,0.5713912816496998,0.034223449969306326
3421,35230,SOD1,147450,105400;,[MIM:105400]Amyotrophic lateral sclerosis 1;,Amyotrophic lateral sclerosis,Disease-causing germline mutation(s) in,Amyotrophic lateral sclerosis[20801718];,0.6960736196319018,0.593604951005673,0.9861654920386322,0.7498465316144874
3422,35240,SOHLH1,610224,617690;,[MIM:617690]Ovarian dysgenesis 5 [recessive?];,Male infertility with azoospermia or oligozoospermia due to single gene mutation,Major susceptibility factor in,,0.32380368098159507,0.37906137184115524,0.6293395980161838,0.3592694904849601
3423,35242,SON,182465,617140;,[MIM:617140]ZTTK syndrome [dominant?];,Brain malformations-musculoskeletal abnormalities-facial dysmorphism-intellectual disability syndrome,Disease-causing germline mutation(s) (loss of function) in,,0.7829447852760736,1.0,0.2169146436961629,0.6539287906691221
3424,35253,SORL1,602005,104300;,[MIM:104300]Alzheimer disease;,Early-onset autosomal dominant Alzheimer disease,Disease-causing germline mutation(s) in,Cardiovascular risk factors (age interaction)[20838585];Cadmium levels[26025379];Alzheimer's disease (late onset)[24162737;23565137];Alzheimer's disease in APOE e4- carriers[25778476];Spontaneous preterm birth (preterm birth)[25599974];Atrial fibrillation[30061737;29892015];Mood disorder in prion disease[25897833];,0.4710429447852761,0.5007735946364105,0.20464630644740275,0.8136893799877225
3425,35255,SOS1,182530,135300;610733;,"[MIM:135300]Fibromatosis, gingival, 1 [dominant?];[MIM:610733]Noonan syndrome 4;",Noonan syndrome;Hereditary gingival fibromatosis,Disease-causing germline mutation(s) (gain of function) in;Disease-causing germline mutation(s) in,Corticobasal degeneration[26077951;26077951];,0.7523926380368098,0.8540484785972151,0.6356042808666145,0.9335481890730509
3426,35257,SOS2,601247,616559;,[MIM:616559]Noonan syndrome 9;,Noonan syndrome,Disease-causing germline mutation(s) in,Periodontal disease-related phenotypes[24347629];Erythema nodosum in inflammatory bowel disease[24487271];Intraocular pressure[29617998;30054594;29785010];,0.49570552147239266,0.973826714801444,0.46254241712346644,0.6166359729895642
3427,35258,SOST,605740,122860;239100;269500;,[MIM:239100]Van Buchem disease [recessive?];[MIM:122860]Craniodiaphyseal dysplasia autosomal dominant [dominant?];,Craniodiaphyseal dysplasia;Hyperostosis corticalis generalisata;Sclerosteosis,Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) (loss of function) in,Bone mineral density (hip)[19079262;26733130;26733130;26733130;26733130];Sum eosinophil basophil counts[27863252];Bone mineral density (spine)[26733130;26733130];Fractures[30158200];Heel bone mineral density[28869591;28869591;28869591;28869591;28869591;28869591];Bone mineral density[22504420];Triglycerides[25961943];Eosinophil counts[27863252];Femoral neck bone mineral density[29499414];HDL cholesterol[27036123;25961943];Lumbar spine bone mineral density[29499414];,0.3449079754601227,0.850438370293966,0.9347428869746802,0.0
3428,35266,SOX2,184429,206900;,"[MIM:206900]Microphthalmia, syndromic, 3;",Septo-optic dysplasia spectrum;Isolated microphthalmia-anophthalmia-coloboma;Anophthalmia/microphthalmia-esophageal atresia syndrome,Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in,Self-reported risk-taking behaviour[30181555];Monobrow[27182965];Excessive hairiness[29895819];Night sleep phenotypes[27126917];,0.7152147239263804,0.8004125838060856,0.9433568258940225,0.0
3429,35268,SOX3,313430,300123;300833;312000;,"[MIM:312000]Panhypopituitarism X-linked;[MIM:300123]Mental retardation, X-linked, with isolated growth hormone deficiency;[MIM:300833]46,XX sex reversal 3;","Septo-optic dysplasia spectrum;46,XX testicular disorder of sex development;X-linked intellectual disability with isolated growth hormone deficiency;Panhypopituitarism;X-linked congenital generalized hypertrichosis",Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) (gain of function) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) (loss of function) in;Disease-causing germline mutation(s) in,,0.12711656441717792,0.7127385250128933,0.5880971025841817,0.0
3430,35270,SOX5,604975,616803;,[MIM:616803]Lamb-Shaffer syndrome [dominant?];,Developmental and speech delay due to SOX5 deficiency;12p12.1 microdeletion syndrome,Disease-causing germline mutation(s) in;Role in the phenotype of,Pelvic organ prolapse (moderate/severe)[26545240];Juvenile osteochondritis dissecans[26422391];Response to antipsychotic treatment[20195266];Attention deficit hyperactivity disorder[29325848];Creatinine levels[29403010];PR interval[20062060;29127183];AIDS[19754311];Response to statin therapy[20339536];Mortality in sepsis[27639821];Depression[29700475];Glomerular filtration rate[29403010];Inflammatory bowel disease[27569725];Body mass index[25673413];Resting heart rate[27798624;29769521];LDL peak particle diameter (total fat intake interaction)[26112879];Oppositional defiant disorder dimensions in attention-deficit hyperactivity disorder[26184070];Heart rate response to exercise[29769521];Systemic sclerosis[21779181;21779181];Heart rate response to recovery post exercise[29769521];Non-obstructive azoospermia[22197933];,0.4117791411042945,0.9868488911810211,0.8958496476115897,0.88182934315531
3431,35276,SOX9,608160,114290;278850;616425;,"[MIM:114290]Campomelic dysplasia;[MIM:278850]46,XX sex reversal 2;[MIM:616425]46,XY sex reversal 10;","Isolated Pierre Robin syndrome;Campomelic dysplasia;46,XY complete gonadal dysgenesis;46,XX ovotesticular disorder of sex development;46,XY partial gonadal dysgenesis;46,XX testicular disorder of sex development",Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) (loss of function) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in,Thyroid hormone levels[23408906;23408906;23408906];Pulmonary function (smoking interaction)[23284291;23284291];Lung cancer[28604730];Coronary artery calcification[23870195];Lung adenocarcinoma[28604730];Nose morphology[29921221;29921221;29921221;29921221;29921221;29921221;29921221;29921221;29921221;29921221;29921221;29921221;29921221;29921221;29921221;29921221;29921221;29921221;29921221;29921221;29921221;29921221;29921221];Liver enzyme levels (gamma-glutamyl transferase)[22001757];Pulmonary function decline[22424883];Nose size[27182965];Adolescent idiopathic scoliosis (severe)[24023777];Chin dimples[27182965];Bone mineral density[22504420];Prostate cancer[24753544];,0.35496932515337426,0.9533264569365653,0.863482119551031,0.0
3432,35278,SOX10,602229,609136;611584;613266;,"[MIM:613266]Waardenburg syndrome 4C;[MIM:609136]Peripheral demyelinating neuropathy, central dysmyelinating leukodystrophy, Waardenburg syndrome and Hirschsprung disease;",Peripheral demyelinating neuropathy-central dysmyelinating leukodystrophy-Waardenburg syndrome-Hirschsprung disease;Waardenburg syndrome type 2;Waardenburg-Shah syndrome;Kallmann syndrome,Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) (loss of function) in,,0.4,0.8646209386281588,0.8517358392064736,0.0
3433,35279,SOX11,600898,615866;,,Coffin-Siris syndrome,Disease-causing germline mutation(s) in,BMI in non-smokers[28443625];Tuberculosis[24057671];Hip circumference[25673412;25673412];Body mass index (joint analysis main effects and smoking interaction)[28443625];Obesity in adult survivors of childhood cancer exposed to cranial radiation[25963547];Crohn's disease[23266558];Chronic kidney disease[20383146];Proteinuria and chronic kidney disease[26420894];Obesity-related traits[23251661];BMI (adjusted for smoking behaviour)[28443625];Diabetic kidney disease[26305897];Intraocular pressure[29617998];,0.21484662576687116,0.8414130995358432,0.9488384233881493,0.0
3434,35284,SOX17,610928,613674;,,Familial vesicoureteral reflux,Disease-causing germline mutation(s) in,"Total cholesterol levels[28334899];Lung cancer in ever smokers[28604730];Intracranial aneurysm[18997786;18997786;20364137;20364137];Lung cancer[28604730];LDL cholesterol levels[28334899];Cholesterol, total[24097068];LDL cholesterol[24097068];",0.21484662576687116,0.8589479112944817,0.6337770817019055,0.0
3435,35285,SOX18,601618,137940;607823;,[MIM:607823]Hypotrichosis-lymphedema-telangiectasia syndrome;[MIM:137940]Hypotrichosis-lymphedema-telangiectasia-renal defect syndrome;,Hypotrichosis-lymphedema-telangiectasia-renal defect syndrome,Disease-causing germline mutation(s) in,,0.14576687116564419,0.5930892212480661,0.8418167580266249,0.0
3436,35298,SP7,606633,613849;,[MIM:613849]Osteogenesis imperfecta 12 [recessive?];,Osteogenesis imperfecta type 4,Disease-causing germline mutation(s) in,Bone mineral density (spine)[19079262;19801982];Mean corpuscular hemoglobin[29403010];Bone mineral density[22504420];,0.20368098159509201,0.8220732336255802,0.8068389454450535,0.415438919582566
3437,35302,SP110,604457,235550;,[MIM:235550]Hepatic venoocclusive disease with immunodeficiency;,Hepatic veno-occlusive disease-immunodeficiency syndrome,Disease-causing germline mutation(s) in,"Inflammatory bowel disease[28067908];Chronic lymphocytic leukemia[18758461;24292274;28165464];Cholangiocarcinoma in primary sclerosing cholangitis (time to event)[28779025];B-cell malignancies (chronic lymphocytic leukemia, Hodgkin lymphoma or multiple myeloma) (pleiotropy)[28112199];Crohn's disease[28067908];Subcutaneous adipose tissue[26480920];Obesity-related traits[23251661];",0.6430674846625767,0.14930376482723054,0.2143043591751501,0.36187845303867405
3438,35317,SPAG1,603395,615505;,,Primary ciliary dyskinesia,Disease-causing germline mutation(s) in,,0.50920245398773,0.33393501805054154,0.21482641607935266,0.04251074278698588
3439,35328,SPAG17,616554,,,Non-syndromic male infertility due to sperm motility disorder,Disease-causing germline mutation(s) in,Post bronchodilator FEV1 in COPD[26634245];Waist circumference adjusted for BMI in inactive individuals[28448500];Waist circumference adjusted for BMI (joint analysis main effects and physical activity interaction)[28448500;28448500;28448500;28448500;28448500;28448500];Waist-to-hip ratio adjusted for BMI (adjusted for smoking behaviour)[28443625];Waist circumference adjusted for BMI in non-smokers[28443625;28443625;28443625];Breast size[27182965];Congenital heart malformation[23708190];Waist circumference adjusted for BMI (adjusted for smoking behaviour)[28443625;28443625;28443625];Infant length[25281659];Waist circumference adjusted for body mass index[28448500;28448500;28448500;28448500;28448500;28448500;25673412;25673412;25673412];Lung function (FVC)[28166213];Male-pattern baldness[27182965];Waist circumference adjusted for BMI (joint analysis main effects and smoking interaction)[28443625;28443625;28443625];Height[23563607;20881960;18391952;25429064;25282103];Obesity-related traits[23251661];Waist circumference adjusted for BMI in active individuals[28448500;28448500;28448500;28448500;28448500];Waist-to-hip ratio adjusted for body mass index[25673412;25673412];,0.038773006134969326,0.22305312016503354,0.03184547115635604,0.01949048496009822
3440,35341,SPARC,182120,616507;,[MIM:616507]Osteogenesis imperfecta 17 [recessive?];,Osteogenesis imperfecta type 4,Disease-causing germline mutation(s) in,,0.3856441717791411,0.7284682826199071,0.4560167058209345,0.584561080417434
3441,35343,SPART,607111,275900;,"[MIM:275900]Spastic paraplegia 20, autosomal recessive [recessive?];",Autosomal recessive spastic paraplegia type 20,Disease-causing germline mutation(s) in,,0.7007361963190184,0.17998968540484786,0.0,0.0
3442,35345,SPAST,604277,182601;,"[MIM:182601]Spastic paraplegia 4, autosomal dominant [dominant?];",Autosomal dominant spastic paraplegia type 4,Disease-causing germline mutation(s) in,Inflammatory biomarkers[24182552];,0.6403680981595092,0.9599020113460547,0.7987470634299139,0.9157458563535912
3443,35353,SPATA5,613940,616577;,"[MIM:616577]Epilepsy, hearing loss, and mental retardation syndrome [recessive?];",Microcephaly-intellectual disability-sensorineural hearing loss-epilepsy-abnormal muscle tone syndrome,Disease-causing germline mutation(s) in,Waist-to-hip ratio adjusted for BMI (adjusted for smoking behaviour)[28443625];Itch intensity from mosquito bite adjusted by bite size[28199695];Mosquito bite size[28199695;28199695];Pelvic organ prolapse[26545240];Itch intensity from mosquito bite[28199695;28199695];Waist-to-hip ratio adjusted for body mass index[25673412;25673412;25673412;25673412];,0.038773006134969326,0.029912325941206807,0.362046463064474,0.6732658072437078
3444,35357,SPATA7,609868,268000;604232;,[MIM:604232]Leber congenital amaurosis 3;[MIM:268000]Retinitis pigmentosa autosomal recessive [recessive?];,Retinitis pigmentosa;Leber congenital amaurosis;Severe early-childhood-onset retinal dystrophy,Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in,Coronary artery calcification[23870195];Information processing speed[21130836];,0.425398773006135,0.06988138215575039,0.0746541373009658,0.013965623081645182
3445,35364,SPATA16,609856,102530;,,Male infertility due to globozoospermia,Disease-causing germline mutation(s) in,,0.038773006134969326,0.10572460030943785,0.03341164186896372,0.051718845917740945
3446,35440,SPECC1L,614140,145410;600251;,"[MIM:600251]Facial clefting, oblique, 1;[MIM:145410]Opitz GBBB syndrome 2;","Tessier number 4 facial cleft;Tessier number 7 facial cleft;Hypertelorism, Teebi type;Autosomal dominant Opitz G/BBB syndrome",Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in,Acne (severe)[24927181];Severity of nausea and vomiting of pregnancy[29563502];Coronary artery disease[29212778];,0.8736196319018404,0.8096957194430119,0.4552336204646306,0.0
3447,35446,SPEG,615950,615959;,"[MIM:615959]Myopathy, centronuclear, 5;",Autosomal recessive centronuclear myopathy,Disease-causing germline mutation(s) in,Resting heart rate[27798624;29769521];,0.4493251533742331,0.4337287261474987,0.014095536413469069,0.3525168815224064
3448,35455,SPG7,602783,607259;,"[MIM:607259]Spastic paraplegia 7, autosomal recessive [recessive?];",Primary lateral sclerosis;Spastic paraplegia type 7,Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in,,0.6506748466257669,0.09695719443011862,0.16131558339859045,0.7856046654389196
3449,35456,SPG11,610844,602099;604360;616668;,"[MIM:602099]Amyotrophic lateral sclerosis 5, juvenile [recessive?];[MIM:616668]Charcot-Marie-Tooth disease 2X [recessive?];",Autosomal recessive spastic paraplegia type 11;Juvenile amyotrophic lateral sclerosis;Autosomal recessive Charcot-Marie-Tooth disease type 2X,Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in,,0.3492024539877301,0.6059824651882414,0.03967632471939441,0.2714855739717618
3450,35457,SPG14,605229,,,Autosomal recessive spastic paraplegia type 14,Disease-causing germline mutation(s) in,,0.038773006134969326,0.0,0.0,0.0
3451,35458,SPG16,300266,,,X-linked spastic paraplegia type 16,Disease-causing germline mutation(s) in,,0.038773006134969326,0.0,0.0,0.0
3452,35459,SPG19,607152,,,Autosomal dominant spastic paraplegia type 19,Disease-causing germline mutation(s) in,,0.038773006134969326,0.0,0.0,0.0
3453,35460,SPG21,608181,248900;,,Autosomal recessive spastic paraplegia type 21,Disease-causing germline mutation(s) in,,0.5749693251533742,0.7073233625580196,0.8841033672670321,0.3740024554941682
3454,35461,SPG23,,,,Autosomal recessive spastic paraplegia type 23,Disease-causing germline mutation(s) in,,0.038773006134969326,0.0,0.0,0.0
3455,35462,SPG24,607584,,,Autosomal recessive spastic paraplegia type 24,Disease-causing germline mutation(s) in,,0.038773006134969326,0.0,0.0,0.0
3456,35463,SPG25,608220,,,Autosomal recessive spastic paraplegia type 25,Disease-causing germline mutation(s) in,,0.038773006134969326,0.0,0.0,0.0
3457,35464,SPG27,609041,,,Autosomal recessive spastic paraplegia type 27,Disease-causing germline mutation(s) in,,0.038773006134969326,0.0,0.0,0.0
3458,35465,SPG29,609727,,,Autosomal dominant spastic paraplegia type 29,Disease-causing germline mutation(s) in,,0.038773006134969326,0.0,0.0,0.0
3459,35466,SPG32,611252,,,Autosomal recessive spastic paraplegia type 32,Disease-causing germline mutation(s) in,,0.038773006134969326,0.0,0.0,0.0
3460,35467,SPG34,300750,,,X-linked spastic paraplegia type 34,Disease-causing germline mutation(s) in,,0.038773006134969326,0.0,0.0,0.0
3461,35468,SPG36,613096,,,Autosomal dominant spastic paraplegia type 36,Disease-causing germline mutation(s) in,,0.038773006134969326,0.0,0.0,0.0
3462,35469,SPG37,611945,,,Autosomal dominant spastic paraplegia type 37,Disease-causing germline mutation(s) in,,0.038773006134969326,0.0,0.0,0.0
3463,35470,SPG38,612335,,,Autosomal dominant spastic paraplegia type 38,Disease-causing germline mutation(s) in,,0.038773006134969326,0.0,0.0,0.0
3464,35471,SPG41,613364,,,Autosomal dominant spastic paraplegia type 41,Disease-causing germline mutation(s) in,,0.038773006134969326,0.0,0.0,0.0
3465,35479,SPIB,606802,,,Primary biliary cholangitis,Major susceptibility factor in,Primary biliary cholangitis[20639880;21399635;26394269];,0.31079754601226994,0.6784424961320268,0.4220830070477682,0.0
3466,35482,SPIDR,615384,,,"46,XX gonadal dysgenesis",Disease-causing germline mutation(s) (loss of function) in,Visceral adipose tissue adjusted for BMI[22589738];,0.5406134969325154,0.04203197524497163,0.43487340120073087,0.0
3467,35490,SPINK1,167790,167800;608189;,"[MIM:167800]Pancreatitis, hereditary;[MIM:608189]Tropical calcific pancreatitis;",Hereditary chronic pancreatitis;Tropical pancreatitis,Disease-causing germline mutation(s) (loss of function) in;Major susceptibility factor in,Alcoholic chronic pancreatitis[28754779];Obesity-related traits[23251661];Blood protein levels[30072576];,0.14576687116564419,0.740072202166065,0.43226311667971806,0.32734806629834257
3468,35493,SPINK5,605010,256500;,[MIM:256500]Netherton syndrome [recessive?];,Netherton syndrome,Disease-causing germline mutation(s) in,Blood protein levels[30072576];,0.21484662576687116,0.3641052088705518,0.0023492560689115116,0.004450583179864948
3469,35502,SPINT2,605124,270420;,"[MIM:270420]Diarrhea 3, secretory sodium, congenital, with or without other congenital anomalies;",Congenital sodium diarrhea,Disease-causing germline mutation(s) (loss of function) in,Blood protein levels[29875488;30072576];Platelet count[27863252];,0.623680981595092,0.3305827746260959,0.6126337770817019,0.2392572130141191
3470,35509,SPNS1,612583,,,Severe combined immunodeficiency due to LAT deficiency,Disease-causing germline mutation(s) in,Educational attainment[25201988];,0.7730061349693251,0.5528623001547189,0.492038632210911,0.29772866789441377
3471,35523,SPP1,166490,,,Systemic lupus erythematosus;Pediatric systemic lupus erythematosus,Major susceptibility factor in;Major susceptibility factor in,Dental caries[23064961];Blood protein levels[30072576];,0.5505521472392638,0.3120165033522434,0.38397285304098144,0.01949048496009822
3472,35529,SPR,182125,612716;,"[MIM:612716]Dystonia, DOPA-responsive, due to sepiapterin reductase deficiency;",Dopa-responsive dystonia due to sepiapterin reductase deficiency,Disease-causing germline mutation(s) in,,0.4350920245398773,0.5180505415162455,0.9363090576872879,0.0
3473,35530,SPRED1,609291,611431;,[MIM:611431]Neurofibromatosis 1-like syndrome;,Legius syndrome,Disease-causing germline mutation(s) in,Hypersomnia (HLA-DQB1*06:02 negative)[23646285];Erosive tooth wear (severe vs non-severe)[29898447];Erosive tooth wear (severe vs none or mild)[29898447];Crohn's disease[23128233];,0.40773006134969325,0.7411036616812791,0.7684677629861655,0.5923879680785759
3474,35547,SPRTN,616086,616200;,[MIM:616200]Ruijs-Aalfs syndrome;,Progeroid features-hepatocellular carcinoma predisposition syndrome,Disease-causing germline mutation(s) (loss of function) in,,0.5997546012269939,0.8669417225373904,0.6859827721221613,0.0
3475,35551,SPRY4,607984,615266;,[MIM:615266]Hypogonadotropic hypogonadism 17 with or without anosmia;,Kallmann syndrome;Non-seminomatous germ cell tumor of testis;Normosmic congenital hypogonadotropic hypogonadism,Disease-causing germline mutation(s) in;Major susceptibility factor in;Disease-causing germline mutation(s) in,Inflammatory bowel disease[23128233];Gut microbiota (bacterial taxa)[27723756];Erosive tooth wear (severe vs non-severe)[29898447;29898447];Testicular germ cell cancer[20543847];Erosive tooth wear (severe vs none or mild)[29898447];Testicular germ cell tumor[19483681;23666239;23666240;28604732;28604728];Asthma[29273806;29273806];,0.9042944785276074,0.44765342960288806,0.6246410858783608,0.30448127685696746
3476,35562,SPTA1,182860,130600;266140;270970;,[MIM:130600]Elliptocytosis 2 [dominant?];[MIM:266140]Hereditary pyropoikilocytosis;[MIM:270970]Spherocytosis 3 [recessive?];,Hereditary spherocytosis;Hereditary elliptocytosis,Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in,Mean corpuscular hemoglobin concentration[27863252;29403010];High light scatter reticulocyte percentage of red cells[27863252;27863252;27863252];Mean corpuscular volume[27863252;27863252;27863252;29403010];Mean corpuscular hemoglobin[27863252];Reticulocyte count[27863252;27863252;27863252];Glycated hemoglobin levels[20858683;28898252];Lymphocyte counts[27863252];High light scatter reticulocyte count[27863252;27863252;27863252];Night sleep phenotypes[27126917];Red cell distribution width[27863252;27863252];Hemoglobin A1c levels[29844224];Immature fraction of reticulocytes[27863252];Other erythrocyte phenotypes[19862010];Reticulocyte fraction of red cells[27863252;27863252;27863252];Red blood cell traits[23222517];Neutrophil percentage of white cells[27863252];QRS duration[27577874;27577874];,0.5811042944785276,0.6374419804022692,0.017749934742886976,0.1496316758747698
3477,35563,SPTAN1,182810,613477;,"[MIM:613477]Epileptic encephalopathy, early infantile, 5;",West syndrome,Disease-causing germline mutation(s) in,Body mass index[26426971];Axial length[24144296];,0.9842944785276073,1.0,0.6400417645523362,0.766267648864334
3478,35564,SPTB,182870,616649;617948;,[MIM:617948]Elliptocytosis 3 [dominant?] [recessive?];[MIM:616649]Spherocytosis 2 [dominant?];,Hereditary spherocytosis;Hereditary elliptocytosis,Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in,Mean corpuscular hemoglobin concentration[27863252];High light scatter reticulocyte percentage of red cells[27863252];Reticulocyte fraction of red cells[27863252];Reticulocyte count[27863252];High light scatter reticulocyte count[27863252];Obesity-related traits[23251661;23251661];Daytime sleep phenotypes[27126917];Red cell distribution width[27863252;27863252];Pediatric areal bone mineral density (radius)[28181694];,0.427239263803681,1.0,0.01931610545549465,0.7220687538367097
3479,35566,SPTBN2,604985,600224;615386;,"[MIM:615386]Spinocerebellar ataxia, autosomal recessive, 14 [recessive?];",Spectrin-associated autosomal recessive cerebellar ataxia;Spinocerebellar ataxia type 5,Disease-causing germline mutation(s) (loss of function) in;Disease-causing germline mutation(s) in,Bipolar disorder[21926972;28115744];,0.8569325153374233,0.2514182568334193,0.32315322370138344,0.38551258440761205
3480,35569,SPTLC1,605712,162400;,"[MIM:162400]Neuropathy, hereditary sensory and autonomic, 1A [dominant?];",Hereditary sensory and autonomic neuropathy type 1,Disease-causing germline mutation(s) in,Left inferior lateral ventricle volume (Cerebrospinal fluid biomarker status interaction)[25140149];Bipolar disorder and schizophrenia[22688191];,0.9033128834355828,0.2439401753481176,0.5390237535891412,0.5541743400859422
3481,35575,SPTLC2,605713,613640;,,Hereditary sensory and autonomic neuropathy type 1,Disease-causing germline mutation(s) in,,0.7808588957055215,0.9069107787519339,0.7097363612633777,0.7928176795580111
3482,35585,SQSTM1,601530,167250;616437;617145;617158;,"[MIM:167250]Paget disease of bone 3;[MIM:616437]Frontotemporal dementia and/or amyotrophic lateral sclerosis 3;[MIM:617145]Neurodegeneration with ataxia, dystonia, and gaze palsy, childhood-onset [recessive?];[MIM:617158]Myopathy, distal, with rimmed vacuoles [dominant?];",Amyotrophic lateral sclerosis;Frontotemporal dementia with motor neuron disease;Behavioral variant of frontotemporal dementia,Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in,Alzheimer's disease (late onset)[24162737];,0.9595092024539877,0.44559051057246,0.5599060297572436,0.9177409453652547
3483,35590,SRC,190090,616937;,[MIM:616937]Thrombocytopenia 6 [dominant?];,Hereditary thrombocytopenia with early-onset myelofibrosis,Disease-causing germline mutation(s) (gain of function) in,Squamous cell carcinoma[26908436];Retinopathy in non-diabetics[23393555];,0.8765644171779141,0.944043321299639,0.9571913338553902,0.939840392879067
3484,35591,SRCAP,611421,136140;,[MIM:136140]Floating-Harbor syndrome;,Floating-Harbor syndrome,Disease-causing germline mutation(s) in,Immunoglobulin light chain (AL) amyloidosis[28025584];Systemic lupus erythematosus[28714469];,0.6711656441717792,0.7537390407426509,0.39154267815191857,0.980049109883364
3485,35595,SRD5A2,607306,264600;,[MIM:264600]Pseudovaginal perineoscrotal hypospadias;,"46,XY disorder of sex development due to 5-alpha-reductase 2 deficiency;Familial prostate cancer",Disease-causing germline mutation(s) (loss of function) in;Candidate gene tested in,Blood metabolite ratios[24816252];Zinc levels[26025379];Male-pattern baldness[27182965;29146897];Idiopathic pulmonary fibrosis[29066090];Blood metabolite levels[24816252;24816252];Inflammatory biomarkers[24182552];,0.038773006134969326,0.0,0.0,0.0
3486,35596,SRD5A3,611715,612379;612713;,[MIM:612713]Kahrizi syndrome [recessive?];,SRD5A3-CDG,Disease-causing germline mutation(s) in,Waist-to-hip ratio adjusted for BMI x sex x age interaction (4df test)[26426971];,0.08736196319018405,0.4412068076328004,0.6421299921691465,0.2931246163290362
3487,35612,SRGAP3,606525,,,Pilomyxoid astrocytoma,Part of a fusion gene in,Lead levels in blood[25820613];,0.4403680981595092,0.9708612686952037,0.5787000783085356,0.5363720073664825
3488,35637,SRP54,604857,,,Autosomal dominant severe congenital neutropenia;Shwachman-Diamond syndrome,Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in,Immunoglobulin light chain (AL) amyloidosis[28025584];,0.7505521472392638,0.9614492006188757,0.969198642652049,0.7797728667894414
3489,35643,SRP72,602122,614675;,[MIM:614675]Bone marrow failure syndrome 1 [dominant?];,Autosomal dominant aplasia and myelodysplasia,Disease-causing germline mutation(s) in,Airflow obstruction[22837378];,0.9757055214723926,0.3112429087158329,0.4421821978595667,0.3729281767955801
3490,35653,SRPX2,300642,300643;,[MIM:300643]Rolandic epilepsy with speech dyspraxia and mental retardation X-linked;,Rolandic epilepsy-speech dyspraxia syndrome;Rolandic epilepsy;Bilateral perisylvian polymicrogyria,Disease-causing germline mutation(s) in;Candidate gene tested in;Candidate gene tested in,,0.12711656441717792,0.46132026817947397,0.7554163403811015,0.39149785144260285
3491,35684,SRY,480000,400044;400045;,"[MIM:400044]46,XY sex reversal 1;[MIM:400045]46,XX sex reversal 1;","46,XY complete gonadal dysgenesis;45,X/46,XY mixed gonadal dysgenesis;46,XX ovotesticular disorder of sex development;46,XY partial gonadal dysgenesis;46,XX testicular disorder of sex development",Disease-causing germline mutation(s) (loss of function) in;Candidate gene tested in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in,,0.26588957055214724,0.0,0.9994779430957974,0.0
3492,35685,SS18,600192,,,Synovial sarcoma,Part of a fusion gene in,Toenail selenium levels[25343990];QT interval (sulfonylurea treatment interaction)[27958378];Nickel levels[26025379];Systemic juvenile idiopathic arthritis[27927641];Obesity-related traits[23251661;23251661;23251661];Rhegmatogenous retinal detachment[23585552];Periodontitis (Mean PAL)[24024966];,0.6467484662576687,0.6003094378545643,0.5523362046463064,0.0
3493,35691,SSBP1,600439,,,Autosomal dominant non-syndromic sensorineural deafness type DFNA,Major susceptibility factor in,Anorexia nervosa[23568457];,0.9833128834355829,0.3958225889633832,0.8211955103106239,0.4280233271945979
3494,35710,SSR4,300090,300934;,[MIM:300934]Congenital disorder of glycosylation 1Y;,SSR4-CDG,Disease-causing germline mutation(s) in,,0.9420858895705522,0.855595667870036,0.9564082484990865,0.0
3495,35731,SSUH2,617479,,,Dentin dysplasia type I,Disease-causing germline mutation(s) in,,0.12711656441717792,0.10985043837029397,0.43043591751500915,0.0
3496,35732,SSX1,312820,,,Synovial sarcoma,Part of a fusion gene in,,0.17791411042944785,0.0046415678184631255,0.6713651788044896,0.10297728667894414
3497,35733,SSX2,300192,,,Synovial sarcoma,Part of a fusion gene in,,0.38061349693251534,0.0,0.0,0.0
3498,35758,ST3GAL3,606494,611090;615006;,"[MIM:611090]Mental retardation, autosomal recessive 12 [recessive?];[MIM:615006]Epileptic encephalopathy, early infantile, 15;",West syndrome;Autosomal recessive non-syndromic intellectual disability,Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in,Intelligence (MTAG)[29326435;29326435;29326435;29326435];Autism spectrum disorder or schizophrenia[28540026];Attention deficit hyperactivity disorder[29325848];Cognitive ability[29186694];Schizophrenia[28991256];Amyotrophic lateral sclerosis (age of onset)[22959728];Cognitive ability (MTAG)[29186694];Aging (time to event)[21782286];General cognitive ability[29844566;29844566;29844566];Coronary artery calcified atherosclerotic plaque (130 HU threshold) in type 2 diabetes[29221444];,0.16220858895705523,0.48865394533264567,0.8164969981728009,0.29066912216083485
3499,35760,ST3GAL5,604402,609056;,[MIM:609056]Salt and pepper developmental regression syndrome [recessive?];,Amish infantile epilepsy syndrome;Salt-and-pepper syndrome,Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) (loss of function) in,Mean platelet volume[27863252];,0.10711656441717791,0.33212996389891697,0.2568519968676586,0.20825659914057704
3500,35815,ST14,606797,602400;,"[MIM:602400]Ichthyosis, congenital, autosomal recessive 11 [recessive?];",Ichthyosis-hypotrichosis syndrome,Disease-causing germline mutation(s) in,,0.2947239263803681,0.7467766890149562,0.23362046463064473,0.8382443216697361
3501,35824,STAC3,615521,255995;,[MIM:255995]Native American myopathy;,Native American myopathy,Disease-causing germline mutation(s) in,Autism spectrum disorder or schizophrenia[28540026];Schizophrenia[25056061];,0.39631901840490796,0.37287261474987105,0.7572435395458105,0.42602823818293434
3502,35825,STAG1,604358,617635;,"[MIM:617635]Mental retardation, autosomal dominant 47 [dominant?];",STAG1-related intellectual disability-facial dysmorphism-gastroesophageal reflux syndrome,Disease-causing germline mutation(s) in,Body mass index[25673413;25673413;25673413;28892062];Central corneal thickness[29760442];C-reactive protein levels or HDL-cholesterol levels (pleiotropy)[27286809];Autism spectrum disorder or schizophrenia[28540026];Schizophrenia[25056061;28991256];Height[25282103];Coronary artery disease[29212778;29212778];Intraocular pressure[29617998;29617998];,0.7720245398773006,1.0,0.3615244061602715,0.6332105586249233
3503,35826,STAG2,300826,,,Xq25 microduplication syndrome,Role in the phenotype of,,0.7584049079754601,0.6789582258896338,0.9470112242234403,0.0
3504,35837,STAMBP,606247,614261;,[MIM:614261]Microcephaly-capillary malformation syndrome;,Microcephaly-capillary malformation syndrome,Disease-causing germline mutation(s) in,Serum metabolite levels[23093944];Anti-saccade response[29064472;29064472];,0.6861349693251534,0.2962867457452295,0.8120595144870791,0.12569060773480664
3505,35841,STAR,600617,201710;,,Familial glucocorticoid deficiency;Classic congenital lipoid adrenal hyperplasia due to STAR deficency;Non-classic congenital lipoid adrenal hyperplasia due to STAR deficency,Candidate gene tested in;Disease-causing germline mutation(s) (loss of function) in;Disease-causing germline mutation(s) (loss of function) in,Menopause (age at onset)[26414677];Orthostatic hypotension[24124408];,0.22687116564417178,0.15497679216090768,0.7303576089793787,0.4894106813996317
3506,35857,STAT1,600555,613796;614162;614892;,[MIM:613796]Immunodeficiency 31B;[MIM:614892]Immunodeficiency 31A;[MIM:614162]Immunodeficiency 31C [dominant?];,Mendelian susceptibility to mycobacterial diseases due to partial STAT1 deficiency;Autoimmune enteropathy and endocrinopathy-susceptibility to chronic infections syndrome;Susceptibility to viral and mycobacterial infections,Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) (gain of function) in;Disease-causing germline mutation(s) in,Inflammatory bowel disease[23128233];Primary biliary cirrhosis[22961000;22961000;22961000;22961000;22961000];Systemic lupus erythematosus[26316170];JT interval (sulfonylurea treatment interaction)[27958378];Systemic sclerosis[29293537];Primary biliary cholangitis[28425483;26394269];Limited cutaneous systemic scleroderma[29293537;29293537];Neutrophil percentage of granulocytes[27863252];,0.8512883435582822,0.8929860752965446,0.8650482902636387,0.7120933087783916
3507,35858,STAT2,600556,616636;,[MIM:616636]Immunodeficiency 44 [recessive?];,Primary immunodeficiency with post-measles-mumps-rubella vaccine viral infection,Disease-causing germline mutation(s) (loss of function) in,Psoriasis vulgaris[26626624];Psoriasis[19169254;25903422;25903422;25574825;23143594];Axial length[24144296];Height[20881960;23456168;25429064];Inflammatory skin disease[25574825];Psoriatic arthritis[26626624];,0.5980368098159509,0.7294997421351211,0.3416862438005743,0.7081031307550645
3508,35859,STAT3,102582,147060;615952;,"[MIM:147060]Hyperimmunoglobulin E recurrent infection syndrome, autosomal dominant [dominant?];[MIM:615952]Autoimmune disease, multisystem, infantile-onset, 1;",Autosomal dominant hyper-IgE syndrome;STAT3-related early-onset multisystem autoimmune disease;Chronic lymphoproliferative disorder of natural killer cells;T-cell large granular lymphocyte leukemia;Permanent neonatal diabetes mellitus,Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) (gain of function) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) (gain of function) in,"Inflammatory bowel disease[27569725;28067908;23128233];Multiple sclerosis[22190364;20159113;21833088;24076602];Systemic lupus erythematosus[28714469];Mean corpuscular volume[27863252];Psoriasis[25903422;23143594];Itch intensity from mosquito bite adjusted by bite size[28199695];Atopic dermatitis[26482879;26482879];Chronic inflammatory diseases (ankylosing spondylitis, Crohn's disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy)[26974007];Crohn's disease[18587394;21102463;23266558;28067908];Itch intensity from mosquito bite[28199695];Ulcerative colitis[28067908];",0.8645398773006135,1.0,0.7379274340903158,0.910988336402701
3509,35860,STAT4,600558,180300;612253;,[MIM:612253]Systemic lupus erythematosus 11;[MIM:180300]Rheumatoid arthritis;,Systemic lupus erythematosus;Beh�et disease;Oligoarticular juvenile idiopathic arthritis;Rheumatoid factor-negative juvenile idiopathic arthritis;Pediatric systemic lupus erythematosus,Major susceptibility factor in;Major susceptibility factor in;Major susceptibility factor in;Major susceptibility factor in;Major susceptibility factor in,Celiac disease or Rheumatoid arthritis[21383967];Nontyphoidal Salmonella bacteraemia[29523850];Primary biliary cirrhosis[22961000;22961000;22961000;22961000;22961000];Multiple sclerosis[24076602];Hepatocellular carcinoma in hepatitis B infection[23242368];Idiopathic inflammatory myopathy[26362759];Behcet's disease[23001997;23001997;23291587];Limited cutaneous systemic scleroderma[29293537;29293537];Gamma glutamyl transferase levels[29403010];Systemic sclerosis (anti-centromere-positive)[29293537];Liver enzyme levels (gamma-glutamyl transferase)[22001757];Inflammatory bowel disease[23128233];Celiac disease[22057235;22057235];Rheumatoid arthritis (ACPA-positive)[23143596;24532676;23143596];Vitiligo[27723757];Systemic lupus erythematosus[19165918;18204098;21408207;21408207;19838193;24871463;23053960;23273568;27399966;27399966;26502338;26502338;26606652;26316170;26502338;28714469;28714469;28714469;19838195;26663301];Sjögren's syndrome[24097066;28076899;28076899;24097067];Juvenile idiopathic arthritis (oligoarticular or rheumatoid factor-negative polyarticular)[23603761;23603761];Rheumatoid arthritis[24390342;24390342;24390342;20453841;20453842;23143596;23143596];Systemic sclerosis[21750679;21779181;20383147;28314753;28314753;29293537;24387989];Primary biliary cholangitis[21399635;23000144;28425483;26394269];Systemic lupus erythematosus and Systemic sclerosis[23740937];,0.45153374233128835,0.664775657555441,0.8073610023492561,0.5029158993247391
3510,35862,STAT5B,604260,245590;,[MIM:245590]Growth hormone insensitivity with immunodeficiency;,Laron syndrome with immunodeficiency;Acute promyelocytic leukemia,Disease-causing germline mutation(s) in;Part of a fusion gene in,"Inflammatory bowel disease[27569725;28067908;23128233];Allergic disease (asthma, hay fever or eczema)[29083406];Crohn's disease[28067908];Ulcerative colitis[28067908];",0.6703067484662577,0.5051572975760701,0.7702949621508745,0.8057090239410681
3511,35863,STAT6,601512,,,Solitary fibrous tumor,Part of a fusion gene in,"Migraine without aura[27322543];Allergy[27182965];Headache[29397368];Eosinophilic esophagitis[25407941];Migraine[27322543;27322543];Schizophrenia[25056061];Familial lung cancer[29924316];Eosinophil counts[27863252];Itch intensity from mosquito bite[28199695];IgE levels[22075330];Asthma[27182965;29273806;29273806];Sum eosinophil basophil counts[27863252];Eosinophil percentage of granulocytes[27863252];Perceived unattractiveness to mosquitoes[28199695];Allergic disease (asthma, hay fever or eczema)[29083406];Itch intensity from mosquito bite adjusted by bite size[28199695];Mosquito bite size[28199695];Sensory disturbances after bilateral sagittal split ramus osteotomy[23834954];Eosinophilic esophagitis (pediatric)[20208534];Neutrophil percentage of granulocytes[27863252];Allergic sensitization[23817571;30013184];Eosinophil percentage of white cells[27863252];",0.5705521472392638,0.758380608561114,0.6551814147742104,0.9034683855125845
3512,35875,STEAP3,609671,615234;,"[MIM:615234]Anemia, hypochromic microcytic, with iron overload 2;",Severe congenital hypochromic anemia with ringed sideroblasts,Disease-causing germline mutation(s) in,Cocaine dependence[23958962];,0.9342331288343558,0.20938628158844766,0.36726703210649964,0.7120933087783916
3513,35879,STIL,181590,612703;,"[MIM:612703]Microcephaly 7, primary, autosomal recessive [recessive?];",Autosomal recessive primary microcephaly;Precursor T-cell acute lymphoblastic leukemia,Disease-causing germline mutation(s) in;Part of a fusion gene in,Clozapine-induced agranulocytosis[25187353];,0.5885889570552147,0.8300670448684889,0.5805272774732446,0.18446899938612646
3514,35880,STIM1,605921,160565;185070;612783;,"[MIM:612783]Immunodeficiency 10;[MIM:160565]Myopathy, tubular aggregate, 1;[MIM:185070]Stormorken syndrome [dominant?];",Stormorken-Sjaastad-Langslet syndrome;Tubular aggregate myopathy;Combined immunodeficiency due to STIM1 deficiency,Disease-causing germline mutation(s) (gain of function) in;Disease-causing germline mutation(s) (gain of function) in;Disease-causing germline mutation(s) in,Mean platelet volume[27863252];Calcium levels[29403010];Platelet distribution width[27863252];,0.9914110429447853,0.6441464672511604,0.49386583137561996,0.5713627992633518
3515,35888,STK4,604965,614868;,"[MIM:614868]T-cell immunodeficiency, recurrent infections, and autoimmunity with or without cardiac malformations;",Combined immunodeficiency due to STK4 deficiency,Disease-causing germline mutation(s) in,"Inflammatory bowel disease[28067908;23128233];Body mass index[26426971];Chronic inflammatory diseases (ankylosing spondylitis, Crohn's disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy)[26974007];Primary sclerosing cholangitis[21151127;27992413];Crohn's disease[17554300;17554261;18587394;21102463;28067908];Blood protein levels[28240269;29875488;29875488;29875488;29875488;29875488;30072576;30072576;30072576;30072576;30072576;30072576];Ulcerative colitis[21297633;19915572;20228799;25082827;28067908];",0.8461349693251534,0.4804022692109335,0.18506917253980684,0.33732351135666055
3516,35891,STK11,602216,175200;273300;,[MIM:175200]Peutz-Jeghers syndrome [dominant?];[MIM:273300]Testicular germ cell tumor;,Peutz-Jeghers syndrome,Disease-causing germline mutation(s) in,"Inflammatory bowel disease[28067908];Psychosis in Alzheimer's disease[22005930];Lymphocyte counts[27863252];Chronic inflammatory diseases (ankylosing spondylitis, Crohn's disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy)[26974007];Crohn's disease[28067908];",0.645521472392638,0.47833935018050544,0.7561994257374054,0.7728667894413751
3517,35897,STK19,604977,,,Retinitis pigmentosa,Disease-causing germline mutation(s) in,Hematology traits[23263863];Sarcoidosis (Lofgren's syndrome vs non-Lofgren's syndrome)[26651848];Autism spectrum disorder or schizophrenia[28540026;28540026;28540026;28540026;28540026;28540026;28540026;28540026;28540026;28540026;28540026;28540026;28540026;28540026;28540026;28540026;28540026];Diastolic blood pressure x smoking status (ever vs never) interaction (2df test)[29455858;29455858;29455858;29455858];Blood protein levels[28240269;28240269;28240269;28240269;28240269;29875488];Systolic blood pressure x smoking status (current vs non-current) interaction (2df test)[29455858;29455858];Disease progression in age-related macular degeneration[29346644];Inflammatory bowel disease[28067908];Age-related macular degeneration[23577725];Diastolic blood pressure x smoking status (current vs non-current) interaction (2df test)[29455858;29455858;29455858];Systolic blood pressure x smoking status (ever vs never) interaction (2df test)[29455858;29455858];Prostate cancer[23535732];Ulcerative colitis[28067908];,0.20368098159509201,0.5291387313047963,0.2813886713651788,0.08732351135666053
3518,35898,STK19B,,312600;,[MIM:312600]Retinitis pigmentosa 2;,Retinitis pigmentosa,Disease-causing germline mutation(s) in,Blood protein levels[28240269];,0.038773006134969326,0.899045899948427,0.0,0.0
3519,35913,STK36,607652,,,Primary ciliary dyskinesia,Disease-causing germline mutation(s) (loss of function) in,Hematocrit[27863252];Amyotrophic lateral sclerosis[22959728];Hemoglobin concentration[27863252];,0.2585276073619632,0.539195461578133,0.030801357347950926,0.09085328422344997
3520,35927,STN1,613128,617341;,[MIM:617341]Cerebroretinal microangiopathy with calcifications and cysts 2 [recessive?];,Coats plus syndrome;Idiopathic pulmonary fibrosis,Disease-causing germline mutation(s) (loss of function) in;Major susceptibility factor in,Uterine fibroids[30194396];,0.4795092024539877,0.10237235688499226,0.0,0.0
3521,35935,STOX1,609397,609404;,,Preeclampsia,Major susceptibility factor in,Amyotrophic lateral sclerosis (sporadic)[24529757];,0.14576687116564419,0.04667354306343476,0.3570869224745497,0.2513812154696133
3522,35943,STRA6,610745,601186;,"[MIM:601186]Microphthalmia, syndromic, 9;",Matthew-Wood syndrome;Colobomatous microphthalmia,Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in,Inhibitory control[29251981];,0.16220858895705523,0.08818978855079938,0.18767945706081962,0.8486801718845918
3523,35946,STRADA,608626,611087;,,Polyhydramnios-megalencephaly-symptomatic epilepsy syndrome,Disease-causing germline mutation(s) (loss of function) in,Height[18391951];,0.4,0.0,0.7749934742886975,0.15316144874155924
3524,35951,STRC,606440,603720;611102;,"[MIM:603720]Deafness, autosomal recessive, 16 [recessive?];[MIM:611102]Deafness-infertility syndrome;",Autosomal recessive non-syndromic sensorineural deafness type DFNB;Deafness-infertility syndrome,Disease-causing germline mutation(s) in;Role in the phenotype of,Lung cancer in ever smokers[28604730];,0.038773006134969326,0.06884992264053635,0.06447402766901593,0.0
3525,35958,STS,300747,308100;,"[MIM:308100]Ichthyosis, X-linked;",Recessive X-linked ichthyosis;Syndromic recessive X-linked ichthyosis,Disease-causing germline mutation(s) in;Role in the phenotype of,,0.4493251533742331,0.8107271789582259,0.7909162098668755,0.0
3526,35960,STT3A,601134,615596;,[MIM:615596]Congenital disorder of glycosylation 1W;,STT3A-CDG,Disease-causing germline mutation(s) in,"Breast cancer (survival)[25890600];Autism spectrum disorder, attention deficit-hyperactivity disorder, bipolar disorder, major depressive disorder, and schizophrenia (combined)[23453885];Schizophrenia[21926974];",0.9511656441717792,0.5126353790613718,0.9196032367528061,0.5624616329036218
3527,35962,STT3B,608605,615597;,[MIM:615597]Congenital disorder of glycosylation 1X;,STT3B-CDG,Disease-causing germline mutation(s) in,Periodontal disease-related phenotypes[24347629];,0.9847852760736197,0.9571944301186178,0.8094492299660663,0.8377839165131983
3528,35963,STUB1,607207,615768;,"[MIM:615768]Spinocerebellar ataxia, autosomal recessive, 16 [recessive?];",Autosomal recessive cerebellar ataxia due to STUB1 deficiency,Disease-causing germline mutation(s) (loss of function) in,,0.9695705521472393,0.47705002578648786,0.8037066040198382,0.35543278084714547
3529,35965,STX1A,186590,,,Cystic fibrosis,Modifying germline mutation in,,0.6547239263803681,0.9133574007220217,0.9365700861393892,0.5423572744014733
3530,35966,STX1B,601485,616172;,[MIM:616172]Generalized epilepsy with febrile seizures plus 9 [dominant?];,Generalized epilepsy with febrile seizures-plus,Disease-causing germline mutation(s) in,Parkinson's disease[25064009];Psoriasis[25574825];Response to metformin (IC50)[28173075];Dementia with Lewy bodies[29263008];,0.5069938650306749,0.8574007220216606,0.966327329678935,0.8399324739103745
3531,35968,STX3,600876,,,Microvillus inclusion disease,Disease-causing germline mutation(s) (loss of function) in,,0.8390184049079754,0.517792676637442,0.5220569042025581,0.41789441375076736
3532,35976,STX11,605014,603552;,[MIM:603552]Familial hemophagocytic lymphohistiocytosis 4;,Familial hemophagocytic lymphohistiocytosis,Disease-causing germline mutation(s) in,,0.5719018404907975,0.32465188241361526,0.3784912555468546,0.4114487415592388
3533,35978,STX16,603666,603233;,,Pseudohypoparathyroidism type 1B,Disease-causing germline mutation(s) in,Cardiovascular risk factors (age interaction)[20838585];,0.896441717791411,0.6887570912841671,0.440616027146959,0.2589011663597299
3534,35987,STXBP1,602926,612164;,,Autosomal dominant non-syndromic intellectual disability;Early infantile epileptic encephalopathy;West syndrome;Atypical Rett syndrome;Undetermined early-onset epileptic encephalopathy;9q33.3q34.11 microdeletion syndrome;Dravet syndrome,Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Role in the phenotype of;Disease-causing germline mutation(s) in,,0.632760736196319,1.0,0.9172539806838945,0.9126764886433395
3535,35988,STXBP2,601717,613101;,,Familial hemophagocytic lymphohistiocytosis,Disease-causing germline mutation(s) in,,0.5009815950920246,0.3280041258380609,0.45157922213521273,0.2767034990791897
3536,36003,SUCLA2,603921,612073;,,"Mitochondrial DNA depletion syndrome, encephalomyopathic form with methylmalonic aciduria",Disease-causing germline mutation(s) in,Visceral adipose tissue adjusted for BMI[22589738];Thiopurine-induced acute severe leukopenia in inflammatory bowel disease[29923122];Thiopurine-induced severe alopecia in inflammatory bowel disease[29923122];Visceral adipose tissue/subcutaneous adipose tissue ratio[22589738];Colorectal cancer (diet interaction)[24743840];Thiopurine-induced severe leukopenia in inflammatory bowel disease[29923122];Aging (time to event)[21782286];Thiopurine-induced alopecia in inflammatory bowel disease[29923122];Thiopurine-induced leukopenia in inflammatory bowel disease[29923122];,0.9111656441717791,0.6474987106756059,0.391020621247716,0.1921424186617557
3537,36008,SUCLG1,611224,245400;,[MIM:245400]Mitochondrial DNA depletion syndrome 9;,Fatal infantile lactic acidosis with methylmalonic aciduria,Disease-causing germline mutation(s) in,Coronary artery calcification[23870195];Gut microbiota (functional units)[27694959];,0.8988957055214724,0.3254254770500258,0.7958757504567998,0.6088090853284224
3538,36019,SUFU,607035,155255;617757;,[MIM:617757]Joubert syndrome 32 [recessive?];,Gorlin syndrome;Acrocallosal syndrome;Desmoplastic/nodular medulloblastoma;Medulloblastoma with extensive nodularity;Familial multiple meningioma;Microform holoprosencephaly,Disease-causing germline mutation(s) (loss of function) in;Disease-causing germline mutation(s) in;Major susceptibility factor in;Major susceptibility factor in;Major susceptibility factor in;Candidate gene tested in,Allergy[27182965];Nickel levels[26025379];Autism spectrum disorder or schizophrenia[28540026;28540026];Creatinine levels[29403010];Waist circumference adjusted for BMI (adjusted for smoking behaviour)[28443625;28443625];Waist circumference adjusted for body mass index[25673412;25673412];Waist-to-hip ratio adjusted for BMI[26426971];Body mass index (joint analysis main effects and physical activity interaction)[28448500];Glomerular filtration rate[29403010];Waist-to-hip ratio adjusted for BMI (age >50)[26426971];Body mass index[28448500;25673413;25673413];Sum eosinophil basophil counts[27863252];Body mass index in physically active individuals[28448500];White blood cell count[29403010];Waist circumference adjusted for BMI (joint analysis main effects and smoking interaction)[28443625;28443625];Prostate cancer[23535732];Waist-to-hip ratio adjusted for BMI x sex x age interaction (4df test)[26426971];,0.7206134969325153,0.9681536874677669,0.7830853563038371,0.0
3539,36020,SUGCT,609187,231690;,,Glutaric acidemia type 3,Disease-causing germline mutation(s) in,Pancreatic cancer[26098869;29422604];Pulse pressure[29403010;28135244];Prostate cancer[29892016];,0.2585276073619632,0.3867973182052604,0.7008613938919342,0.0
3540,36045,SULT2B1,604125,617571;,,Lamellar ichthyosis,Disease-causing germline mutation(s) (loss of function) in,Resting metabolic rate[28476931];Elevated serum carcinoembryonic antigen levels[24941225];,0.28662576687116564,0.626611655492522,0.5277995301487862,0.8549723756906077
3541,36049,SUMF1,607939,272200;,[MIM:272200]Multiple sulfatase deficiency;,Multiple sulfatase deficiency,Disease-causing germline mutation(s) in,Midgestational circulating levels of PCBs[28235828;28235828;28235828;28235828;28235828];Response to fenofibrate (triglyceride levels)[27002377];Multiple sclerosis--Brain Glutamate Levels[20802204];,0.27975460122699386,0.13589479112944816,0.26076742364917777,0.8741559238796808
3542,36051,SUMO1,601912,613705;,[MIM:613705]Non-syndromic orofacial cleft 10;,Oligodontia,Candidate gene tested in,,0.7669938650306748,0.8194945848375451,1.0,0.0
3543,36083,SUOX,606887,272300;,"[MIM:272300]Sulfite oxidase deficiency, isolated [recessive?];",Isolated sulfite oxidase deficiency,Disease-causing germline mutation(s) in,"Polycystic ovary syndrome[22885925];Pediatric autoimmune diseases[26301688];Vitiligo[22951725];Intelligence (MTAG)[29326435];Allergic disease (asthma, hay fever or eczema)[29083406];Type 1 diabetes[18198356];Anorexia nervosa[28494655];Cognitive function[25644384];",0.4403680981595092,0.4729241877256318,0.6760636909423127,0.8448434622467772
3544,36097,SURF1,185620,256000;616684;,[MIM:256000]Leigh syndrome;[MIM:616684]Charcot-Marie-Tooth disease 4K [recessive?];,Leigh syndrome with leukodystrophy;SURF1-related Charcot-Marie-Tooth disease type 4;Leigh syndrome with cardiomyopathy,Disease-causing germline mutation(s) (loss of function) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) (loss of function) in,Blood protein levels[28240269];,0.538282208588957,0.06781846312532233,0.4408770555990603,0.4547268262737876
3545,36112,SUZ12,606245,,,Weaver syndrome;Endometrial stromal sarcoma,Disease-causing germline mutation(s) (loss of function) in;Part of a fusion gene in,Hip circumference adjusted for BMI[25673412;25673412];,0.8083435582822086,0.9818205260443528,0.8047507178282433,0.4349294045426642
3546,36132,SYCE1,611486,616947;616950;,"[MIM:616947]Premature ovarian failure 12;[MIM:616950]Spermatogenic failure, 15 [recessive?];",Male infertility with azoospermia or oligozoospermia due to single gene mutation,Disease-causing germline mutation(s) in,,0.4840490797546012,0.19443011861784426,0.19002871312973113,0.035451197053407
3547,36138,SYCP2,604105,,,Leukoencephalopathy-dystonia-motor neuropathy syndrome,Disease-causing germline mutation(s) in,Delirium[29631748];,0.35496932515337426,0.9868488911810211,0.38292873923257637,0.3156844689993861
3548,36140,SYCP3,604759,270960;,"[MIM:270960]Spermatogenic failure 4;[MIM:270960]Pregnancy loss, recurrent, 4;",Male infertility with azoospermia or oligozoospermia due to single gene mutation,Candidate gene tested in,,0.4117791411042945,0.278236204228984,0.9671104150352389,0.46608348680171885
3549,36149,SYN1,313440,300491;,"[MIM:300491]Epilepsy X-linked, with variable learning disabilities and behavior disorders;",X-linked epilepsy-learning disabilities-behavior disorders syndrome,Disease-causing germline mutation(s) in,,0.49938650306748467,0.9259927797833934,0.5525972330984077,0.0
3550,36156,SYNE1,608441,610743;612998;,"[MIM:610743]Spinocerebellar ataxia, autosomal recessive, 8 [recessive?];[MIM:612998]Emery-Dreifuss muscular dystrophy 4, autosomal dominant [dominant?];","Autosomal recessive myogenic arthrogryposis multiplex congenita;Autosomal recessive ataxia, Beauce type;Autosomal dominant Emery-Dreifuss muscular dystrophy",Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in,"Body mass index[26426971];Uterine fibroids[30194396;30194396;30194396];Bipolar disorder or major depressive disorder[20351715];Autism spectrum disorder, attention deficit-hyperactivity disorder, bipolar disorder, major depressive disorder, and schizophrenia (combined)[23453885];Heel bone mineral density[28869591;28869591];Bipolar disorder[21926972;21738484;28115744;28072414];Endometriosis[28537267;28537267;28537267;28537267];Tonometry[17903302];Post bronchodilator FEV1[26634245;26634245;26634245;26634245;26634245;26634245;26634245;26634245];",0.3925153374233129,0.7096441464672512,0.009658052727747325,0.09422958870472682
3551,36158,SYNE2,608442,612999;,"[MIM:612999]Emery-Dreifuss muscular dystrophy 5, autosomal dominant [dominant?];",Autosomal dominant Emery-Dreifuss muscular dystrophy,Disease-causing germline mutation(s) in,Pulmonary function decline[22424883];Serum metabolite ratios in chronic kidney disease[29545352];Atrial fibrillation[22544366;28416818;30061737;29892015;29892015];Depression[29700475];Serum metabolite concentrations in chronic kidney disease[29545352;29545352];,0.8888343558282209,0.5987622485817432,0.00835291046724093,0.11525475751995089
3552,36160,SYNE4,615535,615540;,"[MIM:615540]Deafness, autosomal recessive, 76 [recessive?];",Autosomal recessive non-syndromic sensorineural deafness type DFNB,Disease-causing germline mutation(s) in,,0.5244171779141105,0.11681279009798866,0.5204907334899505,0.0
3553,36161,SYNGAP1,603384,612621;,"[MIM:612621]Mental retardation, autosomal dominant 5 [dominant?];",Autosomal dominant non-syndromic intellectual disability;Undetermined early-onset epileptic encephalopathy,Disease-causing germline mutation(s) in;Candidate gene tested in,Body mass index[26426971];Autism spectrum disorder or schizophrenia[28540026;28540026;28540026];Late-onset Alzheimer's disease[27770636];,0.3749693251533742,1.0,0.22083007047768208,0.0
3554,36169,SYNJ1,604297,615530;617389;,"[MIM:615530]Parkinson disease 20, early-onset;[MIM:617389]Epileptic encephalopathy, early infantile, 53 [recessive?];",Atypical juvenile parkinsonism;Undetermined early-onset epileptic encephalopathy,Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in,,0.8080981595092025,0.8847343991748324,0.07152179587575046,0.9329343155310006
3555,36181,SYP,313475,300802;,"[MIM:300802]Mental retardation, X-linked 96;",X-linked non-syndromic intellectual disability,Disease-causing germline mutation(s) in,,0.5370552147239264,0.7686952037132543,0.9535369355259723,0.805402087170043
3556,36189,SYT1,185605,,,Infantile hypotonia-oculomotor anomalies-hyperkinetic movements-developmental delay syndrome,Disease-causing germline mutation(s) in,Sodium levels[29403010];Intelligence (MTAG)[29326435];Systemic lupus erythematosus[28714469];Hand grip strength[29313844];Chloride levels[29403010];Obesity-related traits[23251661];General cognitive ability[29844566];,0.4917791411042945,0.7563176895306859,0.9733750978856696,0.37093308778391654
3557,36190,SYT2,600104,616040;,"[MIM:616040]Myasthenic syndrome, congenital, 7, presynaptic [dominant?];",Presynaptic congenital myasthenic syndromes,Disease-causing germline mutation(s) in,Celiac disease[23936387];Epilepsy and lamotrigine-induced maculopapular eruptions[26220383];,0.4795092024539877,0.9213512119649304,0.8449490994518403,0.61817065684469
3558,36202,SYT14,610949,614229;,,Autosomal recessive cerebellar ataxia-psychomotor delay syndrome,Disease-causing germline mutation(s) in,Monobrow[27182965];Manic episodes in bipolar disorder[26297903];Drug-induced liver injury in interferon-beta-treated multiple sclerosis[30013178];Alopecia areata[25608926];,0.038773006134969326,0.9394017534811758,0.31192900026102843,0.5457335788827502
3559,36214,SZT2,615463,615476;,,Undetermined early-onset epileptic encephalopathy,Disease-causing germline mutation(s) in,,0.30319018404907977,0.0482207323362558,0.16183764030279302,0.0
3560,36226,TAB2,605101,614980;,"[MIM:614980]Congenital heart defects, multiple types, 2;",Polyvalvular heart disease syndrome;Polyvalvular heart disease syndrome,Disease-causing germline mutation(s) in;Role in the phenotype of,Dupuytren's disease[21732829;28886342];Breast cancer[22383897;29059683];,0.6946012269938651,0.6910778751933987,0.8976768467762987,0.7558317986494782
3561,36233,TAC3,162330,614839;,[MIM:614839]Hypogonadotropic hypogonadism 10 with or without anosmia;,Normosmic congenital hypogonadotropic hypogonadism,Disease-causing germline mutation(s) (loss of function) in,Menopause (age at onset)[26414677];Schizophrenia[25056061];,0.2498159509202454,0.45126353790613716,0.9122944400939702,0.4594843462246777
3562,36235,TACC1,605301,,,Gliosarcoma;Giant cell glioblastoma,Part of a fusion gene in;Part of a fusion gene in,Midgestational circulating levels of PBDEs[28235828];,0.8566871165644172,0.6400206291903043,0.6755416340381102,0.18370165745856354
3563,36238,TACC3,605303,,,Gliosarcoma;Giant cell glioblastoma,Part of a fusion gene in;Part of a fusion gene in,Urinary bladder cancer[20348956];Bladder cancer[20972438;24163127];,0.6653987730061349,0.45796802475502835,0.16705820934481858,0.2332719459791283
3564,36239,TACO1,612958,256000;,[MIM:256000]Leigh syndrome;,Leigh syndrome with leukodystrophy,Disease-causing germline mutation(s) in,,0.9332515337423313,0.43115007735946365,0.5572957452362307,0.3096992019643953
3565,36240,TACR1,162323,,,Dopa-responsive dystonia due to sepiapterin reductase deficiency,Disease-causing germline mutation(s) in,Brain connectivity[23471985];Diisocyanate-induced asthma[25918132];Sexual dimorphism in anthropometric traits[23754948];Pursuit maintenance gain[29064472];Seborrheic dermatitis[29203360];,0.43153374233128833,0.30505415162454874,0.8551292090837901,0.1279926335174954
3566,36242,TACR3,162332,614840;,[MIM:614840]Hypogonadotropic hypogonadism 11 with or without anosmia;,Kallmann syndrome;Normosmic congenital hypogonadotropic hypogonadism,Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) (loss of function) in,Rosacea symptom severity[29771307];Menarche (age at onset)[27182965;25231870];,0.14576687116564419,0.04048478597215059,0.5870529887757766,0.1603744628606507
3567,36243,TACSTD2,137290,204870;,"[MIM:204870]Corneal dystrophy, gelatinous drop-like [recessive?];",Gelatinous drop-like corneal dystrophy,Disease-causing germline mutation(s) in,Nickel levels[26025379];,0.5900613496932515,0.4040742650850954,0.1644479248238058,0.2694904849600982
3568,36245,TADA2A,602276,,,Sneddon syndrome;Vasculitis due to ADA2 deficiency,Disease-causing germline mutation(s) (loss of function) in;Disease-causing germline mutation(s) (loss of function) in,Ovarian cancer[23535730];,0.7197546012269939,0.295513151108819,0.6384755938397285,0.09008594229588705
3569,36248,TAF1,313650,300966;314250;,"[MIM:314250]Dystonia 3, torsion, X-linked;[MIM:300966]Mental retardation, X-linked, syndromic, 33;",X-linked intellectual disability-global development delay-facial dysmorphism-sacral caudal remnant syndrome;X-linked dystonia-parkinsonism,Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in,,0.8385276073619632,0.9058793192367199,0.4124249543200209,0.7102516881522406
3570,36249,TAF1A,604903,,,Familial isolated dilated cardiomyopathy,Disease-causing germline mutation(s) in,,0.567239263803681,0.1407942238267148,0.4338292873923258,0.26243093922651933
3571,36255,TAF2,604912,615599;,,Microcephaly-thin corpus callosum-intellectual disability syndrome,Disease-causing germline mutation(s) in,Heart rate response to exercise[29769521];,0.7896932515337424,0.4698298091799897,0.2615505090054816,0.20902394106813996
3572,36258,TAF4B,601689,615841;,[MIM:615841]Spermatogenic failure 13;,Male infertility with azoospermia or oligozoospermia due to single gene mutation,Disease-causing germline mutation(s) in,Visceral adipose tissue adjusted for BMI[22589738];Rhegmatogenous retinal detachment[23585552];,0.6483435582822086,0.6126869520371325,0.30618637431480034,0.40316144874155924
3573,36291,TAF13,600774,617432;,"[MIM:617432]Mental retardation, autosomal recessive 60 [recessive?];",Autosomal recessive primary microcephaly,Disease-causing germline mutation(s) in,,0.6803680981595092,0.4693140794223827,0.9853824066823283,0.27225291589932477
3574,36294,TAF15,601574,,,Amyotrophic lateral sclerosis;Extraskeletal myxoid chondrosarcoma,Candidate gene tested in;Part of a fusion gene in,Reticulocyte fraction of red cells[27863252];Reticulocyte count[27863252];Blood protein levels[28240269];,0.7393865030674847,0.6289324394017535,0.6640563821456539,0.6368937998772253
3575,36301,TAL1,187040,,,Precursor T-cell acute lymphoblastic leukemia,Part of a fusion gene in,Body mass index[25673413;25673413];Mean corpuscular volume[27863252];Clozapine-induced agranulocytosis[25187353];,0.5786503067484663,0.7496132026817948,0.6037588097102584,0.0
3576,36303,TALDO1,602063,606003;,[MIM:606003]Transaldolase deficiency;,Transaldolase deficiency,Disease-causing germline mutation(s) in,Proteinuria and chronic kidney disease[26420894];,0.9168098159509203,0.2663744198040227,0.620203602192639,0.6932166973603437
3577,36308,TANGO2,616830,616878;,"[MIM:616878]Metabolic encephalomyopathic crises, recurrent, with rhabdomyolysis, cardiac arrhythmias, and neurodegeneration [recessive?];",Recurrent metabolic encephalomyopathic crises-rhabdomyolysis-cardiac arrhythmia-intellectual disability syndrome,Disease-causing germline mutation(s) (loss of function) in,Plateletcrit[27863252];Intraocular pressure[29617998];,0.31079754601226994,0.27926766374419804,0.562255285826155,0.0
3578,36314,TAP1,170260,604571;,[MIM:604571]Bare lymphocyte syndrome 1;,Immunodeficiency by defective expression of HLA class 1,Disease-causing germline mutation(s) in,Nephropathy[21399633];IgA nephropathy[25305756];Autism spectrum disorder or schizophrenia[28540026;28540026;28540026;28540026;28540026];Blood protein levels[28240269];,0.7936196319018405,0.23053120165033522,0.053510832680762205,0.8149171270718232
3579,36315,TAP2,170261,604571;,[MIM:604571]Bare lymphocyte syndrome 1;,Immunodeficiency by defective expression of HLA class 1,Disease-causing germline mutation(s) in,Urate levels in lean individuals[25811787];Pubertal anthropometrics[23449627];Nephropathy[21399633];IgA nephropathy[25305756];Response to hepatitis B vaccine[29534301];Sarcoidosis (non-Lofgren's syndrome without extrapulmonary manifestations)[26651848];Autism spectrum disorder or schizophrenia[28540026;28540026;28540026;28540026;28540026];Blood protein levels[28240269];Lymphoma[23349640];Type 1 diabetes and autoimmune thyroid diseases[25936594];,0.7561963190184049,0.10056730273336771,0.11093709214304359,0.8655616942909761
3580,36316,TAPBP,601962,604571;,[MIM:604571]Bare lymphocyte syndrome 1;,Immunodeficiency by defective expression of HLA class 1,Disease-causing germline mutation(s) in,Autism spectrum disorder or schizophrenia[28540026;28540026];Blood protein levels[29875488;30072576];,0.4350920245398773,0.14130995358432183,0.6403027930044375,0.024248004910988337
3581,36318,TAPT1,612758,616897;,"[MIM:616897]Osteochondrodysplasia, complex lethal, Symoens-Barnes- Gistelinck type [recessive?];",Complex lethal osteochondrodysplasia,Disease-causing germline mutation(s) in,Glomerular filtration rate in chronic kidney disease[26420894];Systemic juvenile idiopathic arthritis[27927641];Amyotrophic lateral sclerosis (sporadic)[24529757];,0.7336196319018405,0.5838060856111398,0.48890629078569564,0.0
3582,36324,TARDBP,605078,612069;,[MIM:612069]Amyotrophic lateral sclerosis 10;,Amyotrophic lateral sclerosis;Frontotemporal dementia with motor neuron disease,Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in,Ewing sarcoma[22327514];Male-pattern baldness[22693459];Beard thickness[26926045];,0.9710429447852761,0.7612171222279526,0.9903419472722527,0.0
3583,36330,TARS2,612805,615918;,[MIM:615918]Combined oxidative phosphorylation deficiency 21;,Combined oxidative phosphorylation defect type 21,Disease-causing germline mutation(s) in,Morning vs. evening chronotype[27494321];Chronotype[27494321];Blood protein levels[28240269;28240269];,0.9373006134969325,0.09076843733883445,0.6457843904985644,0.439073050951504
3584,36376,TAT,613018,276600;,[MIM:276600]Tyrosinemia 2;,Tyrosinemia type 2,Disease-causing germline mutation(s) (loss of function) in,Metabolite levels[22286219;22916037];,0.16220858895705523,0.40304280556988137,0.3247193944139911,0.5988336402701043
3585,36387,TAZ,300394,302060;,[MIM:302060]Barth syndrome;,Familial isolated dilated cardiomyopathy;Barth syndrome,Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) (loss of function) in,,0.5312883435582823,0.7658586900464157,0.9193422083007048,0.8141497851442603
3586,36414,TBC1D7,612655,248000;,,Isolated megalencephaly,Disease-causing germline mutation(s) (loss of function) in,Migraine without aura[23793025];Migraine[23793025];,0.5226993865030675,0.1343476018566271,0.46985121378230227,0.022866789441375077
3587,36430,TBC1D20,611663,615663;,[MIM:615663]Warburg micro syndrome 4;,Micro syndrome,Disease-causing germline mutation(s) (loss of function) in,Night sleep phenotypes[27126917;27126917];,0.12711656441717792,0.8800928313563693,0.48681806316888543,0.6190914671577655
3588,36436,TBC1D24,613577,220500;605021;614617;615338;616044;,"[MIM:615338]Epileptic encephalopathy, early infantile, 16 [recessive?];[MIM:616044]Deafness, autosomal dominant, 65 [dominant?];[MIM:220500]Deafness, onychodystrophy, osteodystrophy, mental retardation, and seizures syndrome;[MIM:614617]Deafness, autosomal recessive, 86 [recessive?];",Progressive myoclonic epilepsy with dystonia;Focal epilepsy-intellectual disability-cerebro-cerebellar malformation;Familial infantile myoclonic epilepsy;Malignant migrating partial seizures of infancy;Autosomal dominant non-syndromic sensorineural deafness type DFNA;Autosomal recessive non-syndromic sensorineural deafness type DFNB;DOORS syndrome,Disease-causing germline mutation(s) (loss of function) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) (loss of function) in;Disease-causing germline mutation(s) (loss of function) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in,,0.39631901840490796,0.1328004125838061,0.6771078047507179,0.2740945365254758
3589,36452,TBCD,604649,617193;,"[MIM:617193]Encephalopathy, progressive, early-onset, with brain atrophy and thin corpus callosum [recessive?];",Early-onset progressive diffuse brain atrophy-microcephaly-muscle weakness-optic atrophy syndrome,Disease-causing germline mutation(s) (loss of function) in,Bone mineral accretion in asthma (oral corticosteroid dose interaction)[26025128];,0.4840490797546012,0.5752965446106241,0.33646567475854866,0.15484960098219766
3590,36453,TBCE,604934,241410;244460;617207;,"[MIM:241410]Hypoparathyroidism-retardation-dysmorphism syndrome [recessive?];[MIM:244460]Kenny-Caffey syndrome 1 [recessive?];[MIM:617207]Encephalopathy, progressive, with amyotrophy and optic atrophy [recessive?];",Sanjad-Sakati syndrome;Early-onset progressive encephalopathy-spastic ataxia-distal spinal muscular atrophy syndrome;Autosomal recessive Kenny-Caffey syndrome,Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in,Adiposity[19557161];Blood protein levels[30072576];,0.5741104294478527,0.14363073749355337,0.5048290263638736,0.0798035604665439
3591,36455,TBCK,616899,616900;,"[MIM:616900]Hypotonia, infantile, with psychomotor retardation and characteristic facies 3 [recessive?];",TBCK-related intellectual disability syndrome,Disease-causing germline mutation(s) in,Systolic blood pressure[28739976;28739976];Night sleep phenotypes[27126917];,0.40773006134969325,0.4871067560598247,0.20020882276168103,0.0
3592,36457,TBK1,604834,177700;616439;617900;,"[MIM:177700]Glaucoma 1, open angle, P;[MIM:616439]Frontotemporal dementia and/or amyotrophic lateral sclerosis 4;[MIM:617900]Encephalopathy, acute, infection-induced, herpes- specific, 8;",Amyotrophic lateral sclerosis;Frontotemporal dementia with motor neuron disease;Herpes simplex virus encephalitis,Major susceptibility factor in;Disease-causing germline mutation(s) (loss of function) in;Major susceptibility factor in,Amyotrophic lateral sclerosis[29566793;27455348];Lung adenocarcinoma[28604730];,0.9249079754601227,0.7802991232594121,0.6598799269120335,0.32811540822590546
3593,36460,TBL1XR1,608628,602342;616944;,"[MIM:602342]Pierpont syndrome [dominant?];[MIM:616944]Mental retardation, autosomal dominant 41 [dominant?];",Acute promyelocytic leukemia;Pierpont syndrome,Part of a fusion gene in;Disease-causing germline mutation(s) in,Central corneal thickness[29760442];Corneal structure[23291589];Chin dimples[27182965];Inflammatory skin disease[25574825];Esophageal cancer[21642993];,0.8559509202453988,0.9782104177411036,0.9684155572957452,0.0
3594,36464,TBL2,605842,,,Williams syndrome,Candidate gene tested in,Hypertriglyceridemia[27599772;23505323];Low density lipoprotein cholesterol[29403010];Triglycerides[21909109;20864672;18193044];Coffee consumption (cups per day)[25288136];Obesity-related traits[23251661];Gamma glutamyl transpeptidase[21909109];,0.9440490797546012,0.5817431665807117,0.42182197859566695,0.3096992019643953
3595,36466,TBP,600075,607136;,[MIM:607136]Spinocerebellar ataxia 17 [dominant?];,Spinocerebellar ataxia type 17,Disease-causing germline mutation(s) in,Type 1 diabetes[21980299];,0.874601226993865,0.5997937080969572,0.9582354476637953,0.3029465930018416
3596,36469,TBR1,604616,,,2q24 microdeletion syndrome,Candidate gene tested in,Intelligence (MTAG)[29326435];Response to cognitive-behavioural therapy in anxiety disorder[26989097];Educational attainment[25201988];,0.9087116564417178,0.8313563692625064,0.6604019838162359,0.0
3597,36472,TBX1,602054,188400;192430;217095;,[MIM:188400]DiGeorge syndrome;[MIM:192430]Velocardiofacial syndrome;[MIM:217095]Conotruncal heart malformations;,22q11.2 deletion syndrome;22q11.2 deletion syndrome;22q11.2 microduplication syndrome;Tetralogy of Fallot,Disease-causing germline mutation(s) in;Role in the phenotype of;Role in the phenotype of;Candidate gene tested in,Childhood ear infection[27182965;28928442];Myringotomy[28928442];Interleukin-10 levels[22205395];Tonsillectomy[27182965;28928442];Acute kidney injury in critical illness[27576016];DNA methylation (parent-of-origin)[23725790];Schizophrenia[26198764];Prostate cancer[25217961;25217961];,0.08736196319018405,0.8264569365652398,0.18376403027930044,0.0
3598,36475,TBX3,601621,181450;,,Ulnar-mammary syndrome,Disease-causing germline mutation(s) (loss of function) in,Diastolic blood pressure (cigarette smoking interaction)[29455858];Colorectal cancer[23266556];Diastolic blood pressure x alcohol consumption interaction (2df test)[29912962;29912962];Ischemic stroke[29531354];Mean arterial pressure[29403010];Lung function (FVC)[28166213];Methadone dose in opioid dependence[28115739];Percent mammographic density[22532574];Blood pressure[21909110;21572416;21572416];Systolic blood pressure x alcohol consumption interaction (2df test)[29912962;29912962];Mean arterial pressure x alcohol consumption (light vs heavy) interaction (2df test)[29912962];Idiopathic dilated cardiomyopathy[29495422];Mean arterial pressure x alcohol consumption interaction (2df test)[29912962;29912962];Systolic blood pressure[25249183;29403010;27618452];Stroke[29531354];Diastolic blood pressure[19430479;26390057;29403010;27618452;28135244;28135244];Atrial fibrillation[29892015;29892015;29892015];Prostate-specific antigen levels[28139693];Heel bone mineral density[28869591;28869591];PR interval[20062060;25035420];Breast cancer[29059683];Night sleep phenotypes[27126917];Nose morphology[29921221];Systolic blood pressure x alcohol consumption (light vs heavy) interaction (2df test)[29912962];Systolic blood pressure (cigarette smoking interaction)[29455858];Diastolic blood pressure x alcohol consumption (light vs heavy) interaction (2df test)[29912962];Bone mineral density (lumbar spine) in inflammatory bowel disease[29603369];Serum prostate-specific antigen levels[21160077];Left ventricular QRS voltage[27195777];QRS complex (12-leadsum)[27659466];Global electrical heterogeneity phenotypes[29622589;29622589;29622589];QRS duration[27577874;27577874];Urate levels in overweight individuals[25811787];PR segment[24850809];,0.623680981595092,0.9169675090252708,0.49490994518402504,0.985573971761817
3599,36476,TBX4,601719,147891;,[MIM:147891]Ischiocoxopodopatellar syndrome [dominant?];,Coxopodopatellar syndrome;17q23.1q23.2 microdeletion syndrome;Heritable pulmonary arterial hypertension;Familial clubfoot due to 17q23.1q23.2 microduplication,Disease-causing germline mutation(s) in;Role in the phenotype of;Disease-causing germline mutation(s) in;Role in the phenotype of,Brain volume in infants (cerebrospinal fluid)[28763065];Manganese levels[26025379];Height[19893584;18391951;25429064];Post bronchodilator FEV1/FVC ratio in COPD[26634245];,0.038773006134969326,0.7114492006188757,0.07308796658835813,0.7783916513198281
3600,36477,TBX5,601620,142900;,[MIM:142900]Holt-Oram syndrome;,Holt-Oram syndrome,Disease-causing germline mutation(s) in,Visceral fat[22589738];Systolic blood pressure[27618452];Diastolic blood pressure (cigarette smoking interaction)[29455858];Bone mineral density (total hip)[29883787];Laryngeal squamous cell carcinoma[25194280];Diastolic blood pressure[19430479;27618452;28135244;28135244];Atrial fibrillation[28416822;28416818;28416818;30061737;29892015;29892015];PR interval[21347284;20062060;23139255;25035420];Electrocardiographic traits[20062063;20062063;20062063];Thrombin-activatable fibrinolysis inhibitor levels[29378355];Systolic blood pressure (cigarette smoking interaction)[29455858];Airflow obstruction[22837378];Diverticular disease[30177863];Barrett's esophagus  or Esophageal adenocarcinoma[27527254];P wave duration[28794112;28794112;28794112;28794112];Percent mammographic density[22532574];Blood pressure[21909110];QRS duration[21076409;27577874;27577874;27577874];Obesity-related traits[23251661];Prostate cancer[25939597;23535732];,0.27361963190184047,0.9345023207839093,0.6084573218480814,0.0
3601,36479,TBX6,602427,122600;,[MIM:122600]Spondylocostal dysostosis 5 [dominant?];,Autosomal dominant spondylocostal dysostosis,Disease-causing germline mutation(s) in,Sum eosinophil basophil counts[27863252];Mean corpuscular hemoglobin[27863252];Mean corpuscular volume[27863252];Autism spectrum disorder or schizophrenia[28540026];Schizophrenia[25056061];Eosinophil counts[27863252];Menarche (age at onset)[25231870];Red blood cell count[29403010;27863252];,0.3669938650306748,0.5283651366683858,0.6209866875489428,0.625537139349294
3602,36481,TBX15,604127,260660;,[MIM:260660]Cousin syndrome;,Pelviscapular dysplasia,Disease-causing germline mutation(s) (loss of function) in,Waist circumference adjusted for BMI (joint analysis main effects and physical activity interaction)[28448500;28448500;28448500;28448500;28448500;28448500];Waist-to-hip ratio adjusted for BMI in active individuals[28448500;28448500;28448500;28448500;28448500;28448500;28448500];Breast size[27182965;27182965];Waist circumference adjusted for BMI (adjusted for smoking behaviour)[28443625;28443625;28443625];Lung function (FVC)[28166213];Ear morphology[26105758];Body mass index[25673413;28892062];Male-pattern baldness[27182965];Antitragus size[26105758];Waist circumference adjusted for BMI (joint analysis main effects and smoking interaction)[28443625;28443625;28443625];Chin dimples[27182965];Folding of antihelix[26105758];Waist-to-hip ratio adjusted for body mass index[26785701;28448500;28448500;28448500;28448500;25673412;25673412;25673412;25673412;25673412;25673412;25673412;25673412;25673412;25673412;25673412;25673412;25673412;25673412;25673412;25673412;28448500];Waist circumference adjusted for BMI in active individuals[28448500;28448500;28448500;28448500;28448500;28448500];Waist-to-hip ratio adjusted for BMI (adjusted for smoking behaviour)[28443625;28443625;28443625;28443625;28443625;28443625;28443625];Waist circumference adjusted for BMI in non-smokers[28443625;28443625;28443625];Waist-to-hip ratio adjusted for BMI (joint analysis for main effect and physical activity interaction)[28448500;28448500;28448500;28448500;28448500;28448500];Heel bone mineral density[28869591;28869591;28869591];Waist-to-hip ratio adjusted for BMI in non-smokers[28443625;28443625;28443625];Congenital heart malformation[23708190];Waist circumference adjusted for body mass index[28448500;28448500;28448500;28448500;28448500;28448500;25673412;25673412;25673412];Waist-hip ratio[20935629;25673412;25673412];Waist-to-hip ratio adjusted for BMI (joint analysis main effects and smoking interaction)[28443625;28443625;28443625];Excessive hairiness[29895819];Waist-to-hip ratio adjusted for BMI in inactive individuals[28448500];,0.23865030674846627,0.48633316142341415,0.23675280605586008,0.7239103744628607
3603,36482,TBX18,604613,143400;,[MIM:143400]Congenital anomalies of kidney and urinary tract 2;,Congenital hydronephrosis,Disease-causing germline mutation(s) in,Monobrow[27182965];Diabetic retinopathy in type 2 diabetes[25364816];,0.14576687116564419,0.8483754512635379,0.09762464108587836,0.9573357888275016
3604,36484,TBX19,604614,201400;,"[MIM:201400]ACTH deficiency, isolated [recessive?];",Congenital isolated ACTH deficiency,Disease-causing germline mutation(s) in,,0.23865030674846627,0.23362558019597732,0.7765596450013051,0.5604665438919583
3605,36485,TBX20,606061,611363;,[MIM:611363]Atrial septal defect 4;,"Atrial septal defect, ostium secundum type;Atrial septal defect, ostium secundum type",Disease-causing germline mutation(s) (loss of function) in;Disease-causing germline mutation(s) (gain of function) in,Resting heart rate[27798624];QRS duration[27577874;27577874;27659466];Suicide behavior[26079190];Birth weight[27680694];Suicide[26079190];Coronary artery disease[29212778];,0.21484662576687116,0.9149045899948427,0.912033411641869,0.742633517495396
3606,36487,TBX22,300307,302905;303400;,[MIM:302905]Abruzzo-Erickson syndrome;,Abruzzo-Erickson syndrome;X-linked cleft palate and ankyloglossia,Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in,Nose size[27182965];,0.22687116564417178,0.871841155234657,0.5212738188462542,0.8683241252302025
3607,36490,TBXA2R,188070,614009;,"[MIM:614009]Bleeding disorder, platelet-type 13;",Bleeding diathesis due to thromboxane synthesis deficiency,Major susceptibility factor in,,0.3925153374233129,0.5260443527591542,0.5531192900026103,0.49263351749539597
3608,36491,TBXAS1,274180,231095;,,Ghosal hematodiaphyseal dysplasia,Disease-causing germline mutation(s) in,Gray matter volume (schizophrenia interaction)[24086445];Amyotrophic lateral sclerosis (sporadic)[24529757];Late-onset Alzheimer's disease[27770636];Obesity-related traits[23251661];Acute lymphoblastic leukemia (childhood)[23007406];Coronary artery disease[29212778];Cerebellum growth[29682794];Cervical cancer[28806749];,0.08736196319018405,0.2864878803506962,0.27303576089793785,0.01780233271945979
3609,36492,TBXT,601397,182940;215400;615709;,[MIM:215400]Chordoma;[MIM:615709]Sacral agenesis with vertebral anomalies;,Upper thoracic spina bifida cystica;Cervicothoracic spina bifida cystica;Cervical spina bifida cystica;Lumbosacral spina bifida cystica;Thoracolumbosacral spina bifida cystica;Total spina bifida cystica;Upper thoracic spina bifida aperta;Thoracolumbosacral spina bifida aperta;Lumbosacral spina bifida aperta;Cervical spina bifida aperta;Cervicothoracic spina bifida aperta;Total spina bifida aperta;Chordoma;Sacral agenesis-abnormal ossification of the vertebral bodies-persistent notochordal canal syndrome,Major susceptibility factor in;Major susceptibility factor in;Major susceptibility factor in;Major susceptibility factor in;Major susceptibility factor in;Major susceptibility factor in;Major susceptibility factor in;Major susceptibility factor in;Major susceptibility factor in;Major susceptibility factor in;Major susceptibility factor in;Major susceptibility factor in;Major susceptibility factor in;Disease-causing germline mutation(s) (loss of function) in,Visceral adipose tissue/subcutaneous adipose tissue ratio[22589738];Blood urea nitrogen levels[29403010];Asthma[22538805];,0.038773006134969326,0.5964414646725116,0.0,0.0
3610,36501,TCAP,604488,601954;607487;,[MIM:601954]Limb-girdle muscular dystrophy 2G [recessive?];,Familial isolated dilated cardiomyopathy;Autosomal recessive limb-girdle muscular dystrophy type 2G,Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in,Ulcerative colitis[20228799];,0.4154601226993865,0.5892212480660134,0.6917253980683895,0.5019950890116636
3611,36526,TCF3,147141,616941;,"[MIM:616941]Agammaglobulinemia 8, autosomal dominant [dominant?];",Autosomal agammaglobulinemia;Precursor B-cell acute lymphoblastic leukemia,Disease-causing germline mutation(s) in;Part of a fusion gene in,Objective response to lithium treatment[26503763];Hodgkin's lymphoma[24920014;29196614];,0.7370552147239264,0.5072202166064982,0.26233359436178544,0.3612645794966237
3612,36528,TCF4,602272,610954;613267;,"[MIM:610954]Pitt-Hopkins syndrome;[MIM:613267]Corneal dystrophy, Fuchs endothelial, 3;",Autosomal dominant non-syndromic intellectual disability;Primary sclerosing cholangitis;Pitt-Hopkins syndrome;Fuchs endothelial corneal dystrophy,Disease-causing germline mutation(s) in;Major susceptibility factor in;Disease-causing germline mutation(s) (loss of function) in;Disease-causing germline mutation(s) in,"Diabetic retinopathy[21441570];Autism spectrum disorder or schizophrenia[28540026;28540026;28540026;28540026];Urinary albumin excretion[30220432];Schizophrenia[21926974;19571808;19571811;23974872;22688191;25056061;25056061;23894747;28991256];Hand grip strength[29691431;29691431;29313844];Depression[29700475];Obesity (early onset extreme)[23563609];Fuchs's corneal dystrophy[20825314;28358029];Heart rate response to exercise[29769521];Sclerosing cholangitis and ulcerative colitis (combined)[22821403];Autism spectrum disorder, attention deficit-hyperactivity disorder, bipolar disorder, major depressive disorder, and schizophrenia (combined)[23453885];Chin dimples[27182965];Post bronchodilator FEV1/FVC ratio[26634245];Prostate cancer[29892016];Prostate cancer (advanced)[29892016];Intraocular pressure[29617998;29617998;29235454];",0.7220858895705522,0.7705002578648789,0.8788827982250065,0.5457335788827502
3613,36532,TCF7L1,604652,,,Autosomal agammaglobulinemia;Precursor B-cell acute lymphoblastic leukemia,Disease-causing germline mutation(s) in;Part of a fusion gene in,Total body bone mineral density[29304378];Pulse pressure[28135244];,0.14576687116564419,0.57426508509541,0.09031584442704255,0.7622774708410067
3614,36534,TCF7L2,602228,125853;,"[MIM:125853]Diabetes mellitus, non-insulin-dependent;",Autosomal dominant non-syndromic intellectual disability;Primary sclerosing cholangitis;Pitt-Hopkins syndrome;Fuchs endothelial corneal dystrophy,Disease-causing germline mutation(s) in;Major susceptibility factor in;Disease-causing germline mutation(s) (loss of function) in;Disease-causing germline mutation(s) in,Type 2 diabetes[22101970;17293876;17460697;17554300;17668382;18372903;21347282;25483131;19056611;19056611;19401414;17463248;17463246;17463249;24390345;22693455;22693455;20581827;24509480;23945395;23209189;26818947;28254843;23300278;23300278;23300278;23300278;23300278;25102180;25102180;22885922;22885922;22885922;29358691;28869590;28869590;28869590;27189021];Granulocyte percentage of myeloid white cells[27863252];Spherical equivalent or myopia (age of diagnosis)[29808027];Body mass index (joint analysis main effects and smoking interaction)[28443625;28443625];Fasting blood insulin[22581228;22581228];Colorectal cancer[24836286;29471430];Myopia[27182965];Ischemic stroke[26732560];Metabolic syndrome[20694148];Hemoglobin A1c levels[29403010];Fasting blood insulin (BMI interaction)[22581228];Type 2 diabetes and other traits[19734900];Body mass index[28448500;28448500;25673413;25673413;25673413;26426971;28892062;28892062];Hip circumference[25673412;25673412;25673412];Two-hour glucose challenge[20081857];Body mass index (age>50)[26426971];Fasting blood glucose (BMI interaction)[22581228;22581228];Proinsulin levels[21873549];Waist-to-hip ratio adjusted for body mass index[28430825];BMI (adjusted for smoking behaviour)[28443625;28443625];Breast Cancer in BRCA1 mutation carriers[23544013];Fasting blood glucose[20081858;22581228;22581228];Peak insulin response[28490609];Glycated hemoglobin levels[20849430;28898252];Heel bone mineral density[28869591;28869591];Clinical laboratory measurements[27897004];Breast cancer[27117709;23535729];Monocyte percentage of white cells[27863252];Coronary artery disease[29212778];Body mass index (joint analysis main effects and physical activity interaction)[28448500;28448500];Bipolar disorder (body mass index interaction)[24322204];BMI in non-smokers[28443625;28443625];Waist circumference[25673412;25673412];Body mass index x sex x age interaction (4df test)[26426971];Blood glucose levels[29615537];Body mass index in physically active individuals[28448500];Cognitive decline (age-related)[28078323];Prostate cancer[29892016];Intraocular pressure[29617998;29785010];,0.6414723926380368,0.9453326456936565,0.2571130253197599,0.9300184162062615
3615,36535,TCF12,600480,615314;,[MIM:615314]Craniosynostosis 3;,Extraskeletal myxoid chondrosarcoma;Isolated brachycephaly;Isolated plagiocephaly,Part of a fusion gene in;Disease-causing germline mutation(s) (loss of function) in;Disease-causing germline mutation(s) (loss of function) in,Mean platelet volume[27863252];Glaucoma (primary open-angle)[29891935];Body mass index[28892062];,0.7587730061349693,0.6750902527075813,0.48472983555207516,0.26611418047882135
3616,36548,TCIRG1,604592,259700;,,Autosomal dominant severe congenital neutropenia;Autosomal recessive malignant osteopetrosis;Intermediate osteopetrosis,Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) (loss of function) in;Disease-causing germline mutation(s) in,,0.7315337423312883,0.06627127385250128,0.3792743409031584,0.885512584407612
3617,36549,TCL1A,186960,,,Precursor T-cell acute lymphoblastic leukemia,Part of a fusion gene in,Adverse response to aromatase inhibitors[20876420];Mosaic loss of chromosome Y[27064253];,0.403680981595092,0.35404847859721505,0.6870268859305664,0.24232658072437077
3618,36554,TCN2,613441,275350;,[MIM:275350]Transcobalamin II deficiency;,Transcobalamin deficiency,Disease-causing germline mutation(s) in,Moyamoya disease[29273593];Blood protein levels[29875488;30072576];,0.16220858895705523,0.5979886539453326,0.17802140433307231,0.14809699201964396
3619,36555,TCOF1,606847,154500;,[MIM:154500]Treacher Collins syndrome 1;,Treacher-Collins syndrome,Disease-causing germline mutation(s) in,Inflammatory bowel disease[28067908];Crohn's disease[28067908];,0.8656441717791411,0.9174832387828777,0.09736361263377709,0.3984039287906691
3620,36575,TCTN1,609863,614173;,[MIM:614173]Joubert syndrome 13;,Joubert syndrome,Disease-causing germline mutation(s) in,Body mass index[25673413;25673413];,0.7065030674846626,0.05105724600309438,0.5408509527538502,0.5775015346838551
3621,36576,TCTN2,613846,613885;616654;,[MIM:613885]Meckel syndrome 8;[MIM:616654]Joubert syndrome 24;,Meckel syndrome;Joubert syndrome,Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in,Waist-to-hip ratio adjusted for BMI (age >50)[26426971];Waist-to-hip ratio adjusted for BMI[26426971];Waist-to-hip ratio adjusted for BMI x sex x age interaction (4df test)[26426971];,0.7894478527607361,0.05801959773078907,0.7280083529104673,0.7713321055862492
3622,36577,TCTN3,613847,258860;614815;,[MIM:258860]Orofaciodigital syndrome 4;[MIM:614815]Joubert syndrome 18;,Orofaciodigital syndrome type 6;Orofaciodigital syndrome type 4,Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in,,0.8390184049079754,0.14517792676637442,0.36517880448968937,0.6206261510128913
3623,36579,TDGF1,187395,,,Microform holoprosencephaly;Septopreoptic holoprosencephaly;Semilobar holoprosencephaly;Midline interhemispheric variant of holoprosencephaly;Lobar holoprosencephaly;Alobar holoprosencephaly,Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in,Blood protein levels[28240269;28240269;29875488;30072576;30072576];,0.39631901840490796,0.15007735946364106,0.42756460454189504,0.22421731123388583
3624,36589,TDO2,191070,600627;,[MIM:600627]Hypertryptophanemia [recessive?];,Hypertryptophanemia,Disease-causing germline mutation(s) in,Manganese levels[26025379];Blood metabolite levels[24816252];Speech perception in dyslexia[19786962];,0.3168098159509202,0.1299638989169675,0.6019316105455494,0.45196439533456106
3625,36590,TDP1,607198,607250;,"[MIM:607250]Spinocerebellar ataxia, autosomal recessive, with axonal neuropathy [recessive?];",Spinocerebellar ataxia with axonal neuropathy type 1,Disease-causing germline mutation(s) in,,0.43754601226993867,0.3844765342960289,0.6303837118245889,0.007519950890116636
3626,36591,TDP2,605764,616949;,"[MIM:616949]Spinocerebellar ataxia, autosomal recessive, 23 [recessive?];",Autosomal recessive cerebellar ataxia-epilepsy-intellectual disability syndrome due to TUD deficiency,Disease-causing germline mutation(s) in,Colorectal or endometrial cancer[26621817];,0.8017177914110429,0.14595152140278495,0.14539284782041242,0.0
3627,36597,TDRD9,617963,,,Male infertility with azoospermia or oligozoospermia due to single gene mutation,Disease-causing germline mutation(s) in,Body mass index[26426971];Autism spectrum disorder or schizophrenia[28540026];,0.40773006134969325,0.12171222279525529,0.3709214304359175,0.012430939226519336
3628,36605,TEAD1,189967,108985;,,Helicoid peripapillary chorioretinal degeneration,Disease-causing germline mutation(s) in,Intelligence (MTAG)[29326435;29326435];Diisocyanate-induced asthma[25918132];Height[20881960;25282103];,0.5301840490797546,0.973826714801444,0.8741842860871835,0.0
3629,36611,TECPR2,615000,615031;,,Hereditary sensory and autonomic neuropathy due to TECPR2 mutation,Disease-causing germline mutation(s) in,Body mass index[26426971];Birdshot chorioretinopathy[24957906];Blood protein levels[28240269;28240269];Platelet count[27863252];,0.3669938650306748,0.6650335224342444,0.2913077525450274,0.34315531000613875
3630,36612,TECR,610057,614020;,"[MIM:614020]Mental retardation, autosomal recessive 14 [recessive?];",Autosomal recessive non-syndromic intellectual disability,Disease-causing germline mutation(s) in,,0.9541104294478527,0.4876224858174317,0.9253458626990342,0.2960405156537753
3631,36613,TECRL,617242,614021;,,Catecholaminergic polymorphic ventricular tachycardia,Disease-causing germline mutation(s) in,Triptolide cytotoxicity[26121980;26121980];Itch intensity from mosquito bite adjusted by bite size[28199695];Mercury levels[26025379];Disease progression in age-related macular degeneration[29346644];Post-traumatic stress disorder (asjusted for relatedness)[23726511];,0.038773006134969326,0.5685920577617328,0.41738449490994517,0.10497237569060773
3632,36616,TECTA,602574,601543;603629;,"[MIM:601543]Deafness, autosomal dominant, 12 [dominant?];[MIM:603629]Deafness, autosomal recessive, 21 [recessive?];",Autosomal dominant non-syndromic sensorineural deafness type DFNA;Autosomal recessive non-syndromic sensorineural deafness type DFNB,Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in,Alzheimer's disease (late onset)[28714976];,0.038773006134969326,0.04589994842702424,0.049595405899243016,0.6149478207489257
3633,36624,TEK,600221,600195;617272;,"[MIM:600195]Dominantly inherited venous malformations;[MIM:617272]Glaucoma 3, primary congenital, E [dominant?];",Blue rubber bleb nevus;Mucocutaneous venous malformations;Congenital glaucoma,Disease-causing somatic mutation(s) in;Disease-causing germline mutation(s) (gain of function) in;Disease-causing germline mutation(s) (loss of function) in,Adult asthma[27611488;27611488];Blood protein levels[28240269;29875488;30072576];Cognitive decline (age-related)[28078323];Coronary artery disease[29212778];Asthma[27611488;27611488];,0.46883435582822086,0.9716348633316142,0.22135212738188462,0.8898096992019644
3634,36634,TELO2,611140,616954;,[MIM:616954]You-Hoover-Fong syndrome [recessive?];,TELO2-related intellectual disability-neurodevelopmental disorder,Disease-causing germline mutation(s) in,,0.7186503067484663,0.47653429602888087,0.21874184286087184,0.6295273173726212
3635,36638,TENM1,300588,,,Isolated congenital anosmia,Disease-causing germline mutation(s) in,Systolic blood pressure in sickle cell anemia[24058526];Diisocyanate-induced asthma[25918132];Response to amphetamines[22952603];Incident myocardial infarction[26950853];,0.10711656441717791,1.0,0.3309840772644218,0.0
3636,36640,TENM3,610083,615145;,"[MIM:615145]Microphthalmia, isolated, with coloboma, 9;",Colobomatous microphthalmia,Disease-causing germline mutation(s) in,Colorectal cancer (calcium intake interaction)[25192705];Plasma renin activity levels[25477429];Bortezomib-induced peripheral neuropathy in multiple myeloma[28317148];JT interval (sulfonylurea treatment interaction)[27958378];Smoking initiation[24665060];Oropharynx cancer[27749845];Hand grip strength[29691431];,0.7146012269938651,0.5268179473955648,0.39571913338553905,0.0
3637,36655,TERC,602322,,,Dyskeratosis congenita;Idiopathic pulmonary fibrosis;Idiopathic aplastic anemia,Disease-causing germline mutation(s) in;Major susceptibility factor in;Major susceptibility factor in,"Uterine fibroids[30194396];Thyroid cancer[28195142];Mean corpuscular volume[29403010];Mean corpuscular hemoglobin[29403010];Glioma[28346443];Cutaneous malignant melanoma[26237428];Multiple myeloma[23955597];B-cell malignancies (chronic lymphocytic leukemia, Hodgkin lymphoma or multiple myeloma) (pleiotropy)[28112199];Telomere length[23535734;21573004;23900074;20139977;23001564;29151059];Glioma (high-grade)[24908248];Bladder cancer[24163127];",0.038773006134969326,0.0,0.0,0.0
3638,36663,TERF2IP,605061,,,Familial melanoma,Major susceptibility factor in,Diastolic blood pressure x smoking status (current vs non-current) interaction (2df test)[29455858];Systolic blood pressure x smoking status (ever vs never) interaction (2df test)[29455858;29455858];Diastolic blood pressure x smoking status (ever vs never) interaction (2df test)[29455858];Systolic blood pressure x smoking status (current vs non-current) interaction (2df test)[29455858;29455858;29455858];,0.8731288343558282,0.2068076328004126,0.5567736883320282,0.39333947206875386
3639,36665,TERT,187270,178500;609135;613989;614742;615134;,"[MIM:609135]Aplastic anemia;[MIM:613989]Dyskeratosis congenita, autosomal dominant, 2 [dominant?];[MIM:614742]Pulmonary fibrosis, and/or bone marrow failure, telomere- related, 1;[MIM:613989]Dyskeratosis congenita, autosomal recessive, 4 [recessive?];[MIM:178500]Pulmonary fibrosis, idiopathic;[MIM:615134]Melanoma, cutaneous malignant 9;",Dyskeratosis congenita;Hoyeraal-Hreidarsson syndrome;Familial melanoma;Clear cell sarcoma of kidney;Idiopathic pulmonary fibrosis;Idiopathic aplastic anemia,Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Major susceptibility factor in;Part of a fusion gene in;Major susceptibility factor in;Major susceptibility factor in,"Basal cell carcinoma[19151717;24403052;25855136];Mean corpuscular volume[28017375;28017375;27863252;27863252;29403010];Mean corpuscular hemoglobin[28017375;27863252;29403010];Glioblastoma (age-stratified)[30152087;30152087;30152087];Idiopathic pulmonary fibrosis[18835860];Lung cancer[18978790;21725308;23143601;27393504];Myeloid white cell count[27863252];EGFR mutation-positive lung adenocarcinoma[27501781];Glioblastoma[28346443;29743610;29743610];Testicular germ cell cancer[20543847;20543847];Plateletcrit[27863252;27863252];Sum basophil neutrophil counts[27863252];Intrinsic epigenetic age acceleration[29374233];Lung adenocarcinoma[20700438;20871597;22797724;19836008;27393504;28604730];Telomere length[24465473;29151059];Granulocyte count[27863252];Interstitial lung disease[23583980];Neutrophil count[29403010;27863252];Nasopharyngeal carcinoma[27436580;26545403;26545403];Uterine fibroids[30194396];Glioma (high-grade)[24908248];Platelet count[27863252;29403010];Breast Cancer in BRCA1 mutation carriers[29058716];Lung cancer in never smokers[28604730];Melanoma[21983787;28212542];Prostate-specific antigen levels[28139693];Uveal melanoma[28781888];Breast cancer[22037553;23535733;28171663;27117709;27117709;27117709;23535729;29059683;29059683];Sum neutrophil eosinophil counts[27863252];Red blood cell count[20139978;29403010;27863252];Testicular germ cell tumor[23666240;28604732;28604728];Breast cancer (estrogen-receptor negative)[27117709;27117709;27117709;28171663;29058716];Bladder cancer[20972438;24163127];Non-glioblastoma glioma[28346443;29743610;29743610];Chronic lymphocytic leukemia[26956414;28165464];Serum prostate-specific antigen levels[21160077];Thyroid cancer[28195142];Glioma[21827660;19578367;19578367;21531791;22886559;28346443;29743610;29743610];Epithelial ovarian cancer[25581431];White blood cell count[29403010;27863252];Breast cancer (estrogen-receptor negative, progesterone-receptor negative, and human epidermal growth factor-receptor negative)[24325915];Pancreatic cancer[25086665;29422604;29422604;27579533];Neutrophil percentage of white cells[27863252];Cancer (pleiotropy)[27197191];Non-albumin protein levels[29403010];Prostate cancer[21743467;25939597];",0.5531288343558283,0.9566787003610109,0.7402766901592274,0.0
3640,36675,TET2,612839,263300;614286;,[MIM:263300]Polycythemia vera;[MIM:614286]Myelodysplastic syndrome;,Essential thrombocythemia;Primary myelofibrosis;Polycythemia vera;Acquired idiopathic sideroblastic anemia;Refractory anemia with excess blasts;Acute myeloid leukaemia with myelodysplasia-related features;Refractory anemia,Biomarker tested in;Disease-causing somatic mutation(s) in;Disease-causing somatic mutation(s) in;Disease-causing somatic mutation(s) in;Disease-causing somatic mutation(s) in;Disease-causing somatic mutation(s) in;Disease-causing somatic mutation(s) in,Multiple sclerosis[24076602];Lymphocyte percentage of white cells[27863252];Lymphocyte counts[29403010;27863252];Melanoma[24980573];Cognitive ability[29186694];Plateletcrit[27863252];Breast cancer[23535729;29059683];General cognitive ability[29844566;29844566;29844566];Molybdenum levels[26025379];Lung function (FEV1/FVC)[28166213];Intelligence (MTAG)[29326435;29326435;29326435;29326435];Pulmonary function[21946350];Western dietary pattern[28644415];Tonsillectomy[27182965;28928442];Colorectal or endometrial cancer[26621817];Neutrophil percentage of white cells[27863252];Lung function (FEV1)[28166213];Immune response to anthrax vaccine[22658931];Height[20881960;25429064];Chronic obstructive pulmonary disease[28166215];Cognitive ability (MTAG)[29186694];Post bronchodilator FEV1/FVC ratio[26634245];Prostate cancer[19767753;25939597];Post bronchodilator FEV1[26634245];,0.6423312883435582,0.016245487364620937,0.0796136778908901,0.003376304481276857
3641,36681,TEX11,300311,309120;,,Male infertility with azoospermia or oligozoospermia due to single gene mutation,Disease-causing germline mutation(s) (loss of function) in,Mean corpuscular volume[29403010];,0.4917791411042945,1.0,0.2978334638475594,0.0
3642,36688,TEX15,605795,617960;,,Male infertility with azoospermia or oligozoospermia due to single gene mutation,Disease-causing germline mutation(s) in,Daytime sleep phenotypes[27126917];,0.12711656441717792,0.01779267663744198,0.05455494648916732,0.03130755064456722
3643,36722,TF,190000,209300;,[MIM:209300]Atransferrinemia [recessive?];,Congenital atransferrinemia,Disease-causing germline mutation(s) in,Mean corpuscular hemoglobin concentration[27863252;27863252;29403010];Iron status biomarkers[21208937;25224454;19084217;19084217;19084217;19084217;21483845;21483845;25224454];Mean corpuscular volume[27863252;27863252;27863252];Mean corpuscular hemoglobin[27863252;27863252;27863252;29403010];Iron status biomarkers (total iron binding capacity)[28334935;28334935];Blood protein levels[30072576;30072576];Red cell distribution width[27863252];Alcohol consumption (transferrin glycosylation)[21665994;21665994;21665994];Hereditary hemochromatosis-related traits (HFE mutation homozygotes)[25457201;25457201];Iron status biomarkers (transferrin levels)[25352340;25352340];Iron status biomarkers (iron levels)[25352340;28334935];Hepcidin levels[21785125];Iron status biomarkers (transferrin saturation)[25352340;25352340;28334935;28334935];,0.7341104294478528,0.3978855079938112,0.44374836857217437,0.5943830570902394
3644,36726,TFAP2A,107580,113620;,[MIM:113620]Branchiooculofacial syndrome;,Branchio-oculo-facial syndrome,Disease-causing germline mutation(s) in,Zinc levels[26025379];Glucose homeostasis traits[25524916];Iron status biomarkers (ferritin levels)[28334935];Amyotrophic lateral sclerosis (sporadic)[24529757];,0.7677300613496932,0.7341413099535843,0.9099451840250588,0.9539594843462247
3645,36729,TFAP2B,601601,169100;617035;,[MIM:169100]Char syndrome [dominant?];[MIM:617035]Patent ductus arteriosus 2;,Familial patent arterial duct;Char syndrome,Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in,Obesity[23563607;23563607;23563607];Spherical equivalent or myopia (age of diagnosis)[29808027];Body mass index (joint analysis main effects and smoking interaction)[28443625;28443625;28443625];Obesity (extreme)[21935397];Myopia[27182965];Hand grip strength[29691431;29691431];BMI in smokers[28443625;28443625];Waist-hip ratio[25673412;25673412];Blood urea nitrogen levels[29403010];Body mass index (joint analysis main effects and physical activity interaction)[28448500;28448500;28448500;28448500;28448500;28448500];Response to bronchodilator in chronic obstructive pulmonary disease (change in FEV1)[26503814];Body mass index in physically inactive individuals[28448500];BMI in non-smokers[28443625;28443625;28443625];Body mass index[20935630;23563607;24861553;28448500;28448500;28448500;28448500;28448500;28448500;25673413;25673413;25673413;25673413;28892062;28892062];Waist circumference[25673412;25673412;25673412];Renal function-related traits (BUN)[22797727];Adiposity[19557161];Body mass index in physically active individuals[28448500;28448500;28448500;28448500;28448500];Hip circumference[25673412;25673412;25673412];Body mass index (adult)[28430825];Metabolic syndrome (bivariate traits)[21386085];Childhood body mass index[26604143];BMI (adjusted for smoking behaviour)[28443625;28443625;28443625];Intraocular pressure[29617998;29617998];,0.27975460122699386,0.9321815368746776,0.8360741320803967,0.8474524248004911
3646,36734,TFB1M,607033,,,Mitochondrial non-syndromic sensorineural deafness,Modifying germline mutation in,Dimensional psychopathology (Arousal)[29496196];Dimensional psychopathology (Negative)[29496196];,0.8966871165644171,0.11784424961320268,0.6011485251892457,0.07826887661141804
3647,36742,TFE3,314310,,,Alveolar soft tissue sarcoma;Epithelioid hemangioendothelioma;MiT family translocation renal cell carcinoma,Part of a fusion gene in;Part of a fusion gene in;Part of a fusion gene in,,0.5936196319018405,0.9136152656008252,0.7807361002349256,0.6606813996316758
3648,36743,TFEB,600744,,,MiT family translocation renal cell carcinoma,Part of a fusion gene in,Attention deficit hyperactivity disorder[18839057];Creatinine levels[29403010];Colorectal cancer[26965516];Late-onset Alzheimer's disease[27770636];,0.39631901840490796,0.0,0.6139389193422083,0.84085328422345
3649,36748,TFG,602498,604484;615658;,"[MIM:604484]Neuropathy, hereditary motor and sensory, Okinawa type;[MIM:615658]Spastic paraplegia 57, autosomal recessive [recessive?];","Differentiated thyroid carcinoma;Extraskeletal myxoid chondrosarcoma;Autosomal dominant Charcot-Marie-Tooth disease type 2 due to TFG mutation;Autosomal recessive spastic paraplegia type 57;Hereditary motor and sensory neuropathy, Okinawa type",Part of a fusion gene in;Part of a fusion gene in;Disease-causing germline mutation(s) (gain of function) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in,,0.9096932515337424,0.5897369778236204,0.7426259462281388,0.4495089011663597
3650,36754,TFR2,604720,604250;,,Hemochromatosis type 3,Disease-causing germline mutation(s) (loss of function) in,Mean corpuscular hemoglobin concentration[27863252;29403010];Iron status biomarkers[21208937];Mean corpuscular volume[19862010;28017375;28017375;27863252];Mean corpuscular hemoglobin[28017375;27863252;29403010];High light scatter reticulocyte percentage of red cells[27863252];Hematological parameters[19820697];Hematocrit[19862010;28017375;27863252];Plateletcrit[27863252];Red blood cell count[28017375;29403010;27863252;28453575];Red cell distribution width[27863252;27863252;27863252];Hemoglobin concentration[27863252];Immature fraction of reticulocytes[27863252];Reticulocyte fraction of red cells[27863252];Red blood cell traits[23222517];Iron status biomarkers (iron levels)[25352340];Hemoglobin levels[28017375;28017375];Iron status biomarkers (transferrin saturation)[25352340];Platelet count[27863252];,0.2498159509202454,0.26534296028880866,0.39310884886452624,0.20825659914057704
3651,36755,TFRC,190010,616740;,[MIM:616740]Immunodeficiency 46 [recessive?];,Combined immunodeficiency due to TFRC deficiency,Disease-causing germline mutation(s) in,Mean corpuscular hemoglobin concentration[29403010];Mean corpuscular hemoglobin[19862010;20139978;27863252;28453575];Mean corpuscular volume[19862010;20139978;28453575;27863252];High light scatter reticulocyte percentage of red cells[27863252];Reticulocyte fraction of red cells[27863252];Red blood cell traits[23222517];Iron status biomarkers (transferrin levels)[25352340];Pancreatic cancer[22158540];High light scatter reticulocyte count[27863252];Red cell distribution width[27863252;27863252];Iron status biomarkers (transferrin saturation)[25352340];,0.9995092024539878,0.7047447137699845,0.23831897676846775,0.3337937384898711
3652,36756,TG,188450,274700;608175;,[MIM:274700]Thyroid dyshormonogenesis 3;[MIM:608175]Autoimmune thyroid disease 3;,Familial thyroid dyshormonogenesis,Disease-causing germline mutation(s) in,Vitiligo[27723757];Graves' disease[23612905];Bone erosion in rheumatoid arthritis[28512992];Hypothyroidism[27182965];Temperament[22832960];Angiotensin-converting enzyme inhibitor intolerance[28030426];,0.2498159509202454,0.009541000515729758,0.024797702949621508,0.11187845303867404
3653,36758,TGDS,616146,616145;,[MIM:616145]Catel-Manzke syndrome;,Catel-Manzke syndrome,Disease-causing germline mutation(s) in,,0.19190184049079756,0.1410520887055183,0.8084051161576612,0.3678637200736648
3654,36759,TGFA,190170,,,Oligodontia,Disease-causing germline mutation(s) in,Hip minimal joint space width[27701424];Acne (severe)[24927181];Cough in response to angiotensin-converting enzyme inhibitor drugs[28084903];Superior frontal gyrus grey matter volume[25335168];Hand grip strength[29691431;29313844];Longevity[20834067];Pulse pressure in young-onset hypertension[24892410];Obesity-related traits[23251661];Hair shape[29220522];Neutrophil count[21507922];Response to citalopram or escitalopram in depression[27622933];Severe progression in rheumatoid arthritis[29065906];,0.33226993865030674,0.5644662197008767,0.6034977812581571,0.2837630448127686
3655,36761,TGFB1,190180,131300;,[MIM:131300]Camurati-Engelmann disease [dominant?];,Cystic fibrosis;Camurati-Engelmann disease,Modifying germline mutation in;Disease-causing germline mutation(s) in,"Colorectal cancer[24836286;27145994];Blood protein levels[30072576;30072576;30072576;30072576;30072576];Coronary artery disease[29212778;29212778;29212778;29212778];Preterm birth (maternal effect)[28877031];Coronary artery disease (myocardial infarction, percutaneous transluminal coronary angioplasty, coronary artery bypass grafting, angina or chromic ischemic heart disease)[28714975];",0.621717791411043,0.7790097988653946,0.38214565387627253,0.6270718232044199
3656,36763,TGFB2,190220,614816;,[MIM:614816]Loeys-Dietz syndrome 4;,Familial thoracic aortic aneurysm and aortic dissection,Disease-causing germline mutation(s) in,Chronic obstructive pulmonary disease (severe)[24621683];Hip minimal joint space width[27701424];Local histogram emphysema pattern[25006744;25006744;25006744;25006744];Bone mineral density (hip)[30172743];Waist circumference adjusted for BMI (joint analysis main effects and physical activity interaction)[28448500;28448500;28448500;28448500;28448500];Emphysema imaging phenotypes[26030696];Waist circumference adjusted for BMI in non-smokers[28443625;28443625];Waist circumference adjusted for BMI (adjusted for smoking behaviour)[28443625;28443625];Waist circumference adjusted for body mass index[28448500;28448500;28448500;28448500;28448500;25673412;25673412;25673412];Rosacea symptom severity[29771307];Acne (severe)[24927181];Pulmonary function[21946350];Central corneal thickness[29760442];Hip circumference adjusted for BMI[25673412;25673412];Waist circumference adjusted for BMI (joint analysis main effects and smoking interaction)[28443625;28443625];Height[20881960;25429064;25282103;25282103];Chronic obstructive pulmonary disease[28166215];Post bronchodilator FEV1/FVC ratio[26634245;26634245;26634245;26634245;26634245;26634245;26634245;26634245;26634245;26634245;26634245;26634245;26634245;26634245;26634245;26634245;26634245;26634245;26634245;26634245];Waist circumference adjusted for BMI in active individuals[28448500;28448500;28448500;28448500;28448500];Post bronchodilator FEV1[26634245;26634245;26634245;26634245;26634245;26634245;26634245;26634245;26634245;26634245;26634245;26634245;26634245;26634245;26634245;26634245];Intraocular pressure[29617998;29617998];,0.30319018404907977,0.9520371325425477,0.8681806316888541,0.0
3657,36766,TGFB3,190230,107970;615582;,"[MIM:107970]Arrhythmogenic right ventricular dysplasia, familial, 1;[MIM:615582]Loeys-Dietz syndrome 5;","Familial isolated arrhythmogenic ventricular dysplasia, right dominant form;Familial isolated arrhythmogenic ventricular dysplasia, biventricular form;Familial isolated arrhythmogenic ventricular dysplasia, left dominant form;Familial thoracic aortic aneurysm and aortic dissection",Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) (loss of function) in,,0.33226993865030674,0.9118102114492006,0.7770817019055077,0.7622774708410067
3658,36768,TGFBI,601692,121820;121900;122200;602082;607541;608470;608471;,"[MIM:121820]Corneal dystrophy, epithelial basement membrane;[MIM:121900]Corneal dystrophy, Groenouw type 1;[MIM:122200]Corneal dystrophy, lattice type 1;[MIM:602082]Corneal dystrophy, Thiel-Behnke type;[MIM:608470]Corneal dystrophy, Reis-Bucklers type;[MIM:608471]Corneal dystrophy, lattice type 3A [dominant?];[MIM:607541]Corneal dystrophy, Avellino type;",Epithelial basement membrane dystrophy;Lattice corneal dystrophy type I;Granular corneal dystrophy type II;Granular corneal dystrophy type I;Reis-B�cklers corneal dystrophy;Thiel-Behnke corneal dystrophy,Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in,Stroke[26089329];Insomnia[27992416];Blood protein levels[28240269;29875488;30072576];Response to cytidine analogues (gemcitabine)[24483146];,0.33975460122699386,0.5201134605466735,0.47402766901592275,0.7397176181706568
3659,36769,TGFBR1,190181,132800;609192;,[MIM:609192]Loeys-Dietz syndrome 1;[MIM:132800]Multiple self-healing squamous epithelioma;,Multiple self-healing squamous epithelioma;Loeys-Dietz syndrome;Familial thoracic aortic aneurysm and aortic dissection,Disease-causing germline mutation(s) (loss of function) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in,Dental caries[23064961];Callous-unemotional behaviour[23874384];Spherical equivalent or myopia (age of diagnosis)[29808027];Advanced age-related macular degeneration[26691988];Gestational age at birth (maternal effect)[28877031];Epithelial ovarian cancer[25134534];Cough in response to angiotensin-converting enzyme inhibitor drugs[28084903];Age-related macular degeneration[23455636];,0.7638036809815951,0.5448684889118102,0.8940224484468807,0.8759975445058318
3660,36770,TGFBR2,190182,133239;610168;614331;,[MIM:614331]Hereditary non-polyposis colorectal cancer 6 [dominant?];[MIM:133239]Esophageal cancer;[MIM:610168]Loeys-Dietz syndrome 2;,Lynch syndrome;Marfan syndrome type 2;Loeys-Dietz syndrome;Familial thoracic aortic aneurysm and aortic dissection;Squamous cell carcinoma of the esophagus,Candidate gene tested in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Candidate gene tested in,Migraine[22683712;27322543];Cognitive decline rate in late mild cognitive impairment[26252872;26252872];Tonometry[17903302];Breast cancer[23535729;29059683];Migraine - clinic-based[23793025];Night sleep phenotypes[27126917];Response to chemotherapy in breast cancer hypertensive cases (cumulative dose) (bevacizumab)[25117820];,0.6357055214723927,0.591026302217638,0.671626207256591,0.866329036218539
3661,36771,TGFBR3,600742,,,Familial cerebral saccular aneurysm,Candidate gene tested in,Optic disc parameters[20548946];Type 2 diabetes[23209189];Lung function (FEV1/FVC)[28166213;28166213];Gestational age at birth (maternal effect)[28877031];Carotid plaque burden[28282560];Optic nerve measurement (cup-to-disc ratio)[28061514];QT interval (tricyclic/tetracyclic antidepressant use interaction)[28039329];Optic disc area[21307088;28073927;28073927;25631615;25631615];Vertical cup-disc ratio[25241763;28073927;28073927];Bone mineral density[19249006];HDL cholesterol change in response to fenofibrate in statin-treated type 2 diabetes[28736931];,0.40773006134969325,0.3929860752965446,0.20986687548942834,0.5561694290976059
3662,36774,TGIF1,602630,142946;,[MIM:142946]Holoprosencephaly 4;,Microform holoprosencephaly;Septopreoptic holoprosencephaly;Semilobar holoprosencephaly;Midline interhemispheric variant of holoprosencephaly;Lobar holoprosencephaly;Alobar holoprosencephaly,Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in,Periodontitis (DPAL)[24024966];Response to methotrexate in juvenile idiopathic arthritis[24709693];,0.427239263803681,0.7991232594120681,0.10310623858000523,0.5285451197053407
3663,36781,TGM1,190195,242300;,"[MIM:242300]Ichthyosis, congenital, autosomal recessive 1 [recessive?];",Lamellar ichthyosis;Self-improving collodion baby;Acral self-healing collodion baby;Congenital non-bullous ichthyosiform erythroderma;Bathing suit ichthyosis,Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in,,0.4840490797546012,0.0,0.4635865309318716,0.7622774708410067
3664,36783,TGM3,600238,617251;,[MIM:617251]Uncombable hair syndrome 2;,Uncombable hair syndrome,Disease-causing germline mutation(s) (loss of function) in,Basal cell carcinoma[24403052;24403052;27539887;25855136];Inflammatory skin disease[25574825];Non-melanoma skin cancer[29739929];,0.6192638036809816,0.21428571428571427,0.2080396763247194,0.5207182320441989
3665,36785,TGM5,603805,609796;,[MIM:609796]Peeling skin syndrome 2;,Acral peeling skin syndrome,Disease-causing germline mutation(s) in,Lung cancer[19654303];,0.2585276073619632,0.020887055183084063,0.1558339859044636,0.6174033149171271
3666,36786,TGM6,613900,613908;,[MIM:613908]Spinocerebellar ataxia 35;,Spinocerebellar ataxia type 35;Inherited acute myeloid leukemia,Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in,Alzheimer's disease (cognitive decline)[23535033];,0.038773006134969326,0.02888086642599278,0.3038371182458888,0.7329650092081031
3667,36790,TH,191290,605407;,,Autosomal recessive dopa-responsive dystonia,Disease-causing germline mutation(s) in,Type 2 diabetes[25102180];Celiac disease[23936387];Prostate cancer (early onset)[24740154];Type 1 diabetes in high risk HLA genotype individuals (time to event)[29310926];Prostate cancer (SNP x SNP interaction)[22219177;22219177;22219177;22219177];Prostate cancer[19767753];Type 1 diabetes autoantibodies in high risk HLA genotype individuals (time to event)[29310926;29310926];,0.38061349693251534,0.46364105208870554,0.10780475071782825,0.9475138121546961
3668,36794,THAP1,609520,602629;,,"Primary dystonia, DYT6 type",Disease-causing germline mutation(s) in,Pelvic organ prolapse (moderate/severe)[26545240];,0.5226993865030675,0.5832903558535327,0.9731140694335683,0.49263351749539597
3669,36821,THBD,188040,612926;614486;,[MIM:614486]Thrombophilia due to thrombomodulin defect;[MIM:612926]Hemolytic uremic syndrome atypical 6;,Atypical hemolytic-uremic syndrome with thrombomodulin anomaly;Thrombomodulin-related bleeding disorder,Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) (gain of function) in,Venous thromboembolism[26888256;26888256];PR interval in Tripanosoma cruzi seropositivity[24324551];,0.21484662576687116,0.6232594120680763,0.3328112764291308,0.0
3670,36841,THOC2,300395,300957;,,X-linked intellectual disability-short stature-overweight syndrome,Disease-causing germline mutation(s) (loss of function) in,,0.9195092024539877,1.0,0.8003132341425215,0.9496623695518723
3671,36844,THOC6,615403,613680;,[MIM:613680]Beaulieu-Boycott-Innes syndrome [recessive?];,THOC6-related developmental delay-microcephaly-facial dysmorphism syndrome,Disease-causing germline mutation(s) (loss of function) in,,0.8428220858895705,0.29654461062403303,0.7778647872618115,0.07750153468385512
3672,36849,THPO,600044,187950;,[MIM:187950]Thrombocythemia 1;,Thrombocythemia with distal limb defects;Hereditary isolated aplastic anemia;Familial thrombocytosis,Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) (loss of function) in;Disease-causing germline mutation(s) (gain of function) in,Diisocyanate-induced asthma[25918132];Cardiometabolic and hematological traits[27668658];Plateletcrit[27863252;27863252;27863252;27863252];Platelet count[22139419;20139978;27863252;27863252;27863252;27863252;29403010];,0.12711656441717792,0.6258380608561114,0.8248499086400418,0.18861264579496623
3673,36850,THRA,190120,614450;,"[MIM:614450]Hypothyroidism, congenital, non-goitrous, 6;",Peripheral resistance to thyroid hormones,Disease-causing germline mutation(s) in,White blood cell count[21738480;21738480];,0.6058895705521472,0.5422898401237751,0.9410075698251109,0.9344689993861265
3674,36853,THRB,190160,145650;188570;274300;,[MIM:188570]Generalized thyroid hormone resistance;[MIM:274300]Generalized thyroid hormone resistance autosomal recessive [recessive?];[MIM:145650]Selective pituitary thyroid hormone resistance;,Pituitary resistance to thyroid hormone;Generalized resistance to thyroid hormone;Peripheral resistance to thyroid hormones,Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in,Systolic blood pressure in sickle cell anemia[24058526];antipsychotic drug dosage in schizophrenia or schizoaffective disorder[26821981];Mean corpuscular hemoglobin concentration[27863252];Spherical equivalent or myopia (age of diagnosis)[29808027];Mean corpuscular hemoglobin[20139978;28017375;27863252;29403010];Mean corpuscular volume[20139978;28017375;27863252;29403010];High light scatter reticulocyte percentage of red cells[27863252];Reticulocyte count[27863252];Atrial fibrillation[30061737;29892015];Amyotrophic lateral sclerosis (sporadic)[24529757];Myopia[27182965];High light scatter reticulocyte count[27863252];Familial squamous cell lung carcinoma[29924316;29924316];Menarche (age at onset)[25231870];Red blood cell count[29403010;27863252];Red cell distribution width[27863252];Asthma[29273806];Erythrocyte cadmium concentration[27005419];Acne (severe)[24927181];Reticulocyte fraction of red cells[27863252];Red blood cell traits[23222517];Monocyte count[27863252];,0.514478527607362,0.8527591542031975,0.8835813103628295,0.9720687538367097
3675,36858,THSD1,616821,,,Non-immune hydrops fetalis,Disease-causing germline mutation(s) in,Blood protein levels[29875488];,0.038773006134969326,0.24961320268179474,0.3001827199164709,0.09668508287292818
3676,36875,TIA1,603518,604454;,[MIM:604454]Welander distal myopathy [dominant?];,"Distal myopathy, Welander type",Disease-causing germline mutation(s) (gain of function) in,Acne (severe)[24927181];,0.7954601226993865,0.7627643115007736,0.6781519185591229,0.48649478207489255
3677,36880,TICAM1,607601,614850;,"[MIM:614850]Encephalopathy, acute, infection-induced, Herpes- specific, 6;",Herpes simplex virus encephalitis,Major susceptibility factor in,Vitiligo[22561518;27723757];,0.6370552147239263,0.0,0.22344035499869486,0.4909453652547575
3678,36897,TIMM8A,300356,304700;,[MIM:304700]Mohr-Tranebjaerg syndrome;,Mohr-Tranebjaerg syndrome,Disease-causing germline mutation(s) (loss of function) in,,0.8160736196319018,0.757864878803507,0.0,0.0
3679,36918,TIMM50,607381,617698;,[MIM:617698]3-methylglutaconic aciduria 9 [recessive?];,3-methylglutaconic aciduria type 9,Disease-causing germline mutation(s) in,,0.9786503067484662,0.4865910263022176,0.3226311667971809,0.6594536525475752
3680,36919,TIMMDC1,615534,,,Isolated complex I deficiency,Disease-causing germline mutation(s) (loss of function) in,Primary biliary cirrhosis[22961000];Multiple sclerosis[24076602];Systemic lupus erythematosus[28714469;28714469];Juvenile idiopathic arthritis (oligoarticular or rheumatoid factor-negative polyarticular)[23603761];,0.7682208588957056,0.13795771015987623,0.272252675541634,0.0
3681,36920,TIMP1,305370,,,Autosomal dominant secondary polycythemia,Disease-causing germline mutation(s) (gain of function) in,Inflammatory bowel disease[23128233];Other erythrocyte phenotypes[19862010];Hematocrit[27863252;27863252];Red blood cell count[27863252];Blood protein levels[30072576];Pursuit maintenance gain in psychotic disorders[29064472];Hemoglobin concentration[27863252];,0.28662576687116564,0.7524497163486333,0.25606891151135475,0.6468692449355433
3682,36922,TIMP3,188826,136900;,[MIM:136900]Sorsby fundus dystrophy [dominant?];,Sorsby pseudoinflammatory fundus dystrophy,Disease-causing germline mutation(s) in,Pyoderma gangrenosum in inflammatory bowel disease[24487271];Advanced age-related macular degeneration[26691988];Age-related macular degeneration[21665990;20385819;20385826;23455636];Alzheimer's disease progression score[29860282];Blood protein levels[28240269;30072576;30072576;30072576];,0.36171779141104293,0.7759154203197525,0.9219524928217175,0.5584714548802947
3683,36925,TINAGL1,616064,,,Argininemia,Disease-causing germline mutation(s) in,Systolic blood pressure x smoking status (current vs non-current) interaction (1df test)[29455858];Body mass index[26426971];Intelligence (MTAG)[29326435;29326435];Diastolic blood pressure x smoking status (current vs non-current) interaction (2df test)[29455858];Blood protein levels[30072576];Systolic blood pressure x smoking status (current vs non-current) interaction (2df test)[29455858];General cognitive ability[29844566];,0.33226993865030674,0.7001031459515215,0.719394413991125,0.4648557397176182
3684,36927,TINF2,604319,268130;613990;,"[MIM:613990]Dyskeratosis congenita, autosomal dominant, 3 [dominant?];[MIM:268130]Dyskeratosis congenita, autosomal dominant, 5 [dominant?];",Dyskeratosis congenita;Revesz syndrome;Hoyeraal-Hreidarsson syndrome,Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in,Platelet count[29403010];,0.6483435582822086,0.42083548220732336,0.47167841294701124,0.7183855125844076
3685,36936,TJP2,607709,607748;615878;,"[MIM:615878]Cholestasis, progressive familial intrahepatic, 4;",Familial hypercholanemia;Progressive familial intrahepatic cholestasis type 4;Autosomal dominant non-syndromic sensorineural deafness type DFNA,Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in,Spherical equivalent or myopia (age of diagnosis)[29808027];Renal sinus fat[22044751];Refractive error[23396134];Myopia[27182965];Night sleep phenotypes[27126917];Spherical equivalent (joint analysis main effects and education interaction)[27020472;27020472];,0.9101840490797546,0.49845281072717895,0.1743670060036544,0.09008594229588705
3686,36939,TK2,188250,609560;617069;,"[MIM:617069]Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal recessive 3 [recessive?];","Autosomal recessive progressive external ophthalmoplegia;Mitochondrial DNA depletion syndrome, myopathic form",Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in,,0.16220858895705523,0.19855595667870035,0.25867919603236755,0.7286678944137508
3687,36942,TKT,606781,617044;,"[MIM:617044]Short stature, developmental delay, and congenital heart defects [recessive?];",Transketolase deficiency,Disease-causing germline mutation(s) in,Blood metabolite ratios[24816252];Body mass index[26426971];Blood metabolite levels[24816252];QRS duration[27577874;27577874;27659466];,0.9050306748466258,0.4149045899948427,0.5364134690681285,0.6855432780847146
3688,36960,TLL1,606742,613087;,[MIM:613087]Atrial septal defect 6;,"Atrial septal defect, ostium primum type;Atrial septal defect, ostium secundum type",Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in,Glomerular filtration rate in chronic kidney disease[26420894];Hepatocellular carcinoma in post hepatitis C eradication by interferon therapy[28163062];Multiple sclerosis[23412934];Response to hepatitis B vaccine[29534301];Western dietary pattern[28644415];Post-traumatic stress disorder[23726511;23726511];Amyotrophic lateral sclerosis (sporadic)[24529757];Obesity-related traits[23251661];Bone mineral density change response to combined chemotherapy in acute lymphoblastic leukemia[29266176];Post-traumatic stress disorder (asjusted for relatedness)[23726511;23726511];Cerebrospinal fluid clusterin levels[26545630];Intraocular pressure[29785010];,0.10711656441717791,0.5255286230015472,0.4481858522578961,0.3944137507673419
3689,36967,TLR3,603029,613002;,"[MIM:613002]Encephalopathy, acute, infection-induced, Herpes- specific, 2;",Herpes simplex virus encephalitis,Major susceptibility factor in,Breast size[22747683];,0.5040490797546012,0.4417225373904074,0.1271208561733229,0.16789441375076733
3690,36968,TLR4,603030,,,Beh�et disease,Major susceptibility factor in,"Neuroticism[29255261];Body mass index (joint analysis main effects and smoking interaction)[28443625;28443625];Cognitive decline rate in late mild cognitive impairment[26252872;26252872;26252872;26252872];Prostate-specific antigen levels[28139693];Chronic inflammatory diseases (ankylosing spondylitis, Crohn's disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy)[26974007];Plasma omega-6 polyunsaturated fatty acid levels (dihomo-gamma-linolenic acid)[24823311];Osteoarthritis biomarkers[25057126];Blood protein levels[28240269;29875488];Body mass index (joint analysis main effects and physical activity interaction)[28448500;28448500;28448500;28448500];BMI in non-smokers[28443625;28443625];Body mass index[28448500;28448500;28448500;28448500;25673413;25673413;25673413];Body mass index in physically active individuals[28448500;28448500;28448500;28448500];Obesity-related traits[23251661];BMI (adjusted for smoking behaviour)[28443625;28443625];",0.6067484662576688,0.12016503352243424,0.40824849908640043,0.11955187231430325
3691,36977,TLX1,186770,,,Precursor T-cell acute lymphoblastic leukemia,Part of a fusion gene in,,0.28662576687116564,0.703455389375967,0.6429130775254502,0.7306629834254144
3692,36980,TLX3,604640,,,Precursor T-cell acute lymphoblastic leukemia,Part of a fusion gene in,,0.48736196319018404,0.631768953068592,0.7092143043591751,0.9022406384284838
3693,37009,TMC1,606706,600974;606705;,"[MIM:600974]Deafness, autosomal recessive, 7 [recessive?];",Autosomal dominant non-syndromic sensorineural deafness type DFNA;Autosomal recessive non-syndromic sensorineural deafness type DFNB,Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in,,0.19190184049079756,0.038164002062919034,0.10258418167580266,0.13996316758747698
3694,37015,TMC6,605828,226400;,,Epidermodysplasia verruciformis,Disease-causing germline mutation(s) (loss of function) in,High light scatter reticulocyte percentage of red cells[27863252;27863252];Mean corpuscular hemoglobin[27863252;29403010];Mean corpuscular volume[27863252;29403010];Reticulocyte count[27863252];Glycated hemoglobin levels[29170429;28887542];Plateletcrit[27863252];High light scatter reticulocyte count[27863252;27863252];Red blood cell count[29403010;27863252];Red cell distribution width[27863252];Hemoglobin A1c levels[29403010];Immature fraction of reticulocytes[27863252];Serum uric acid levels[29559957];Reticulocyte fraction of red cells[27863252;27863252];,0.12711656441717792,0.630737493553378,0.06630122683372487,0.18615715162676488
3695,37017,TMC8,605829,226400;,,Epidermodysplasia verruciformis,Disease-causing germline mutation(s) (loss of function) in,High light scatter reticulocyte percentage of red cells[27863252];Reticulocyte fraction of red cells[27863252];Glycated hemoglobin levels[29170429];High light scatter reticulocyte count[27863252];,0.08736196319018405,0.41155234657039713,0.34299138606108065,0.08149171270718232
3696,37023,TMCO1,614123,137760;213980;,"[MIM:137760]Glaucoma, primary open angle;",Cerebrofaciothoracic dysplasia,Disease-causing germline mutation(s) (loss of function) in,Glaucoma[21532571;30054594;30054594];Glaucoma (primary open-angle)[25173105;29891935;29891935;29891935];Intraocular pressure[22570627;24002674;28073927;28073927;25173106;29617998;29617998;29235454;29235454;30054594;29785010;29785010];,0.9641717791411043,0.26173285198555957,0.4703732706865048,0.0
3697,37073,TMEM38B,611236,615066;,[MIM:615066]Osteogenesis imperfecta 14 [recessive?];,Osteogenesis imperfecta type 4,Disease-causing germline mutation(s) in,Waist circumference adjusted for BMI (joint analysis main effects and physical activity interaction)[28448500;28448500;28448500;28448500;28448500];Pubertal anthropometrics[23449627];Age at voice drop[27182965];Waist circumference adjusted for BMI in non-smokers[28443625;28443625];Cognitive decline rate in late mild cognitive impairment[26252872;26252872];Melanoma[28212542];Waist circumference adjusted for BMI (adjusted for smoking behaviour)[28443625];Waist circumference adjusted for body mass index[28448500;28448500;28448500;28448500;28448500];Menarche (age at onset)[21102462;25231870;25231870;25231870;19448620;27182965;29773799];Body mass index[28892062];Lung function (FEV1/FVC)[30061609;30061609];Cutaneous malignant melanoma[26237428];Waist circumference adjusted for BMI (joint analysis main effects and smoking interaction)[28443625;28443625];Visceral adipose tissue/subcutaneous adipose tissue ratio[22589738];Waist circumference adjusted for BMI in active individuals[28448500;28448500;28448500;28448500;28448500];Protein quantitative trait loci[18464913];,0.7931288343558283,0.4914904589994843,0.8454711563560429,0.3207489257213014
3698,37080,TMEM43,612048,604400;614302;,"[MIM:614302]Emery-Dreifuss muscular dystrophy 7, autosomal dominant [dominant?];","Familial isolated arrhythmogenic ventricular dysplasia, right dominant form;Familial isolated arrhythmogenic ventricular dysplasia, biventricular form;Familial isolated arrhythmogenic ventricular dysplasia, left dominant form;Autosomal dominant Emery-Dreifuss muscular dystrophy",Disease-causing germline mutation(s) (loss of function) in;Disease-causing germline mutation(s) (loss of function) in;Disease-causing germline mutation(s) (loss of function) in;Disease-causing germline mutation(s) in,,0.9114110429447853,0.07839092315626611,0.02688593056643174,0.11295273173726213
3699,37106,TMEM67,609884,216360;607361;610688;613550;615991;,[MIM:607361]Meckel syndrome 3;[MIM:610688]Joubert syndrome 6;[MIM:615991]Bardet-Biedl syndrome 14 [recessive?];[MIM:216360]COACH syndrome;[MIM:613550]Nephronophthisis 11;,Meckel syndrome;Joubert syndrome;Joubert syndrome with hepatic defect;Senior-Boichis syndrome,Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in,,0.6450306748466258,0.203455389375967,0.6006264682850431,0.8189073050951504
3700,37109,TMEM70,612418,614052;,"[MIM:614052]Mitochondrial complex V deficiency, nuclear 2;",TMEM70-related mitochondrial encephalo-cardio-myopathy,Disease-causing germline mutation(s) in,,0.5614723926380368,0.5711707065497679,0.19994779430957973,0.21899938612645795
3701,37136,TMEM98,615949,615972;,,Nanophthalmia,Disease-causing germline mutation(s) in,Spherical equivalent or myopia (age of diagnosis)[29808027];Myopia[27182965];,0.12711656441717792,0.3182052604435276,0.6974680240146176,0.36464088397790057
3702,37144,TMEM106B,613413,105550;607485;,[MIM:105550]Frontotemporal dementia and/or amyotrophic lateral sclerosis 1 [dominant?];,Behavioral variant of frontotemporal dementia;Semantic dementia;Progressive non-fluent aphasia,Major susceptibility factor in;Major susceptibility factor in;Major susceptibility factor in,Neuroticism[29255261];Response to amphetamines[22952603];Depression[29700475];Alzheimer's disease (APOE e4 interaction)[25778476];Blood protein levels[30072576];Coronary artery disease[29212778;29212778];Response to taxane treatment (placlitaxel)[23006423];Frontotemporal dementia with GRN mutation[29724592];Plasma kynurenine levels in major depressive disorder[29317604];Adverse response to chemotherapy (neutropenia/leucopenia) (all topoisomerase inhibitors)[23648065];Tourette syndrome[22889924];Frontotemporal dementia[29724592];Residual cognition[28441426];Idiopathic dilated cardiomyopathy[29495422];,0.7170552147239264,0.48323878287777206,0.7760375880971025,0.34208103130755063
3703,37146,TMEM107,616183,617562;617563;,[MIM:617562]Meckel syndrome 13;[MIM:617563]Orofaciodigital syndrome 16 [recessive?];,Meckel syndrome,Disease-causing germline mutation(s) (loss of function) in,,0.26588957055214724,0.20629190304280556,0.972853040981467,0.3462246777163904
3704,37162,TMEM126A,612988,612989;,,"Autosomal recessive optic atrophy, OPA7 type",Disease-causing germline mutation(s) in,Height[19570815];,0.6301840490797546,0.38086642599277976,0.7113025319759854,0.1309085328422345
3705,37163,TMEM126B,615533,,,Isolated complex I deficiency,Disease-causing germline mutation(s) (loss of function) in,Height[19570815];,0.7398773006134969,0.32413615265600826,0.7350561211172018,0.0678330263965623
3706,37164,TMEM127,613403,171300;,,Clear cell renal carcinoma;Hereditary pheochromocytoma-paraganglioma,Major susceptibility factor in;Candidate gene tested in,,0.038773006134969326,0.4767921609076844,0.8063168885408509,0.766267648864334
3707,37180,TMEM138,614459,614465;,[MIM:614465]Joubert syndrome 16 [recessive?];,Joubert syndrome with oculorenal defect,Disease-causing germline mutation(s) (loss of function) in,,0.6946012269938651,0.6085611139762764,0.9044635865309318,0.5379066912216084
3708,37206,TMEM165,614726,614727;,,TMEM165-CDG,Disease-causing germline mutation(s) in,Waist-to-hip ratio adjusted for BMI x sex x age interaction (4df test)[26426971];,0.7240490797546012,0.7586384734399175,0.9229966066301227,0.8259668508287292
3709,37215,TMEM173,612374,615934;,"[MIM:615934]STING-associated vasculopathy, infantile-onset;",STING-associated vasculopathy with onset in infancy;Familial Chilblain lupus,Disease-causing germline mutation(s) (gain of function) in;Disease-causing germline mutation(s) (gain of function) in,Body mass index[26426971];Immune reponse to smallpox (secreted IFN-alpha)[22610502];Esophageal squamous cell carcinoma[25129146];,0.5338650306748466,0.4780814853017019,0.06499608457321848,0.2786985880908533
3710,37233,TMEM185A,300031,,,FRAXF syndrome,Disease-causing germline mutation(s) in,,0.45950920245398774,0.6670964414646725,0.9835552075176194,0.0
3711,37248,TMEM199,616815,616829;,[MIM:616829]Congenital disorder of glycosylation 2P [recessive?];,TMEM199-CDG,Disease-causing germline mutation(s) (loss of function) in,Osteoprotegerin levels[25080503];Blood protein levels[29875488];,0.9431901840490797,0.23929860752965446,0.25215348472983556,0.0
3712,37270,TMEM216,613277,603194;608091;,[MIM:608091]Joubert syndrome 2;[MIM:603194]Meckel syndrome 2;,Meckel syndrome;Joubert syndrome with oculorenal defect;Orofaciodigital syndrome type 6,Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in,,0.7788957055214724,0.3666838576585869,0.8326807622030802,0.0
3713,37284,TMEM231,614949,614970;615397;,[MIM:614970]Joubert syndrome 20;[MIM:615397]Meckel syndrome 11;,Meckel syndrome;Joubert syndrome with oculorenal defect,Disease-causing germline mutation(s) (loss of function) in;Disease-causing germline mutation(s) in,Pancreatic cancer[25086665];Diastolic blood pressure x smoking status (current vs non-current) interaction (2df test)[29455858];Systolic blood pressure x smoking status (ever vs never) interaction (2df test)[29455858;29455858];Diarrhoea in darapladib-treated cardiovascular disease (time to event)[28753643];Diastolic blood pressure x smoking status (ever vs never) interaction (2df test)[29455858];Systolic blood pressure x smoking status (current vs non-current) interaction (2df test)[29455858;29455858;29455858];,0.4154601226993865,0.19004641567818464,0.13364656747585488,0.0
3714,37291,TMEM237,614423,614424;,[MIM:614424]Joubert syndrome 14 [recessive?];,Joubert syndrome with oculorenal defect;Joubert syndrome;Joubert syndrome with renal defect,Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in,Lung cancer in ever smokers[28604730];Lung cancer[28604730];,0.8320245398773006,0.07916451779267664,0.37561994257374054,0.0
3715,37295,TMEM240,616101,607454;,[MIM:607454]Spinocerebellar ataxia 21;,Spinocerebellar ataxia type 21,Disease-causing germline mutation(s) in,Body mass index[26426971];,0.038773006134969326,0.6249355337802991,0.7400156617071261,0.0
3716,37337,TMIE,607237,600971;,,Autosomal recessive non-syndromic sensorineural deafness type DFNB,Disease-causing germline mutation(s) in,,0.038773006134969326,0.2730789066529139,0.8303315061341686,0.36464088397790057
3717,37347,TMPO,188380,,,Familial isolated dilated cardiomyopathy,Disease-causing germline mutation(s) in,,0.9997546012269939,0.8390923156266117,0.23596972069955624,0.18063228974831186
3718,37353,TMPRSS3,605511,601072;,"[MIM:601072]Deafness, autosomal recessive, 8 [recessive?];",Autosomal recessive non-syndromic sensorineural deafness type DFNB,Disease-causing germline mutation(s) in,,0.4538650306748466,0.111397627643115,0.06838945445053511,0.7081031307550645
3719,37354,TMPRSS4,606565,,,Autosomal recessive cerebral atrophy,Disease-causing germline mutation(s) in,,0.16220858895705523,0.13898916967509026,0.1331245105716523,0.7286678944137508
3720,37356,TMPRSS6,609862,206200;,[MIM:206200]Iron-refractory iron deficiency anemia;,IRIDA syndrome,Disease-causing germline mutation(s) (loss of function) in,Mean corpuscular hemoglobin concentration[20139978;23263863;28453575;28017375;28017375;27863252;27863252;29403010];Mean corpuscular hemoglobin[19862010;20139978;23263863;23263863;23263863;28017375;27863252;27863252;27863252;27863252;27863252;27863252;28453575;29403010];Mean corpuscular volume[19862010;20139978;23263863;23263863;28453575;28017375;28017375;27863252;27863252;27863252;29403010];Hematological parameters[19820697];Total bilirubin levels[29403010];Hematocrit[19862010;28453575;28017375;28017375;27863252;29403010];Plateletcrit[27863252];Red cell distribution width[27863252;27863252;27863252;27863252];Hemoglobin concentration[27863252;27863252];Immature fraction of reticulocytes[27863252];Reticulocyte fraction of red cells[27863252];Red blood cell traits[20927387;20927387;20927387;23935956;23935956;23222517];Iron levels[19880490];Hemoglobin[19820698;19862010;28453575;29403010];Hepcidin levels[21785125;21785125;21785125];Iron status biomarkers (transferrin saturation)[25352340;28334935];Hematological and biochemical traits[20139978;20139978];Platelet count[27863252];Hematology traits[19853236;19853236;23263863];Iron status biomarkers (ferritin levels)[25352340;28334935;28334935];Iron status biomarkers[21149283;21208937;19084217;19820699;19820699];Hepcidin/transferrin saturation ratio[27846281;27846281];Reticulocyte count[27863252];Glycated hemoglobin levels[20858683;28898252];Clinical laboratory measurements[27897004];Red blood cell count[27863252];Blood protein levels[29875488];Hepcidin/ferritin ratio[27846281;27846281];Iron status biomarkers (transferrin levels)[25352340];Iron status biomarkers (iron levels)[25352340;25352340;28334935];Hemoglobin levels[28017375;28017375];,0.12711656441717792,0.23233625580195977,0.40772644218219783,0.7372621240024555
3721,37369,TMPRSS15,606635,226200;,[MIM:226200]Enterokinase deficiency;,Congenital enteropathy due to enteropeptidase deficiency,Disease-causing germline mutation(s) in,Nucleus accumbens volume in trauma-exposed individuals[29187748];Bulimia nervosa[23568457];Asthma[29273806];,0.32380368098159507,0.5621454357916452,0.0660401983816236,0.0
3722,37388,TMTC3,617218,617255;,[MIM:617255]Lissencephaly 8 [recessive?];,Periventricular nodular heterotopia,Disease-causing germline mutation(s) (loss of function) in,Clozapine-induced agranulocytosis[25187353];,0.8640490797546012,0.7483238782877772,0.2751239885147481,0.16789441375076733
3723,37398,TNC,187380,615629;,"[MIM:615629]Deafness, autosomal dominant, 56 [dominant?];",Autosomal dominant non-syndromic sensorineural deafness type DFNA,Disease-causing germline mutation(s) in,Inflammatory bowel disease[23128233];Mosquito bite size[28199695];Response to bupropion and depression[27622933];Developmental language disorder (syntactic complexity)[27016271;27016271];Blood protein levels[28240269;29875488;29875488;29875488;29875488;29875488;29875488;29875488;30072576;30072576;30072576;30072576;30072576;30072576];,0.3856441717791411,0.6629706034038164,0.0161837640302793,0.26335174953959484
3724,37402,TNFAIP3,191163,616744;,"[MIM:616744]Autoinflammatory syndrome, familial, Behcet-like [dominant?];",Systemic lupus erythematosus;Hereditary pediatric Beh�et-like disease,Major susceptibility factor in;Disease-causing germline mutation(s) (loss of function) in,"Multiple sclerosis[24076602];Psoriasis[20953190;19169254;25903422;25903422;25574825;23143594];Chronic inflammatory diseases (ankylosing spondylitis, Crohn's disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy)[26974007];Cutaneous psoriasis[26626624];Systemic lupus erythematosus or rheumatoid arthritis[27193031];Inflammatory skin disease[25574825;25574825];Inflammatory bowel disease[23128233];Celiac disease[20190752;22057235;22057235];Rheumatoid arthritis (ACPA-positive)[24532676;23143596;24532676];Systemic lupus erythematosus[19165918;19838193;23273568;27399966;27399966;26502338;26502338;28714469;28714469;19838195;19838195;26663301];Psoriasis vulgaris[26626624];Allergic disease (asthma, hay fever or eczema)[29083406];Sjögren's syndrome[24097066;24097067];Tonsillectomy[27182965;28928442];Rheumatoid arthritis[17982456;17982456;24390342;24390342;24390342;20453841;20453842;24449572;23143596];Systemic sclerosis[28314753;28314753];Primary biliary cholangitis[26394269];Systemic lupus erythematosus and Systemic sclerosis[23740937];Cardiac Troponin-T levels[23247143];",0.5614723926380368,0.7622485817431666,0.24223440354998696,0.7260589318600368
3725,37408,TNFRSF1A,191190,142680;614810;,[MIM:142680]Familial hibernian fever;[MIM:614810]Multiple sclerosis 5;,Intermittent hydrarthrosis;Tumor necrosis factor receptor 1 associated periodic syndrome,Candidate gene tested in;Disease-causing germline mutation(s) in,"Primary biliary cirrhosis[22961000;22961000;22961000;22961000];Multiple sclerosis[19525953;19525953;21833088;24076602;27386562];Adverse response to chemotherapy (neutropenia/leucopenia) (all anthracycline-based drugs)[23648065];Adverse response to chemotherapy (neutropenia/leucopenia) (epirubicin)[23648065];Lymphocyte counts[27863252];Colorectal cancer[24836286];Chronic inflammatory diseases (ankylosing spondylitis, Crohn's disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy)[26974007];Plateletcrit[27863252];Crohn's disease[26192919];Alopecia areata[25608926];Primary biliary cholangitis[21399635;28425483;26394269];Monocyte count[27863252];Ankylosing spondylitis[23749187;23749187;23749187];Platelet count[27863252];",0.7613496932515338,0.92573491490459,0.5638214565387627,0.91804788213628
3726,37409,TNFRSF1B,191191,,,Classic mycosis fungoides;S�zary syndrome,Disease-causing somatic mutation(s) in;Disease-causing somatic mutation(s) in,Tuberculosis[29036319];Blood protein levels[29875488;30072576];Urate levels (BMI interaction)[25811787];,0.5959509202453988,0.8086642599277978,0.2203080135734795,0.8262737875997545
3727,37410,TNFRSF4,600315,615593;,[MIM:615593]Immunodeficiency 16 [recessive?];,Combined immunodeficiency due to OX40 deficiency,Disease-causing germline mutation(s) (loss of function) in,Inflammatory bowel disease[23128233];,0.19190184049079756,0.3403816400206292,0.834507961367789,0.0
3728,37416,TNFRSF10B,603612,275355;,[MIM:275355]Squamous cell carcinoma of the head and neck;,Squamous cell carcinoma of the hypopharynx;Squamous cell carcinoma of the larynx;Squamous cell carcinoma of the oropharynx;Squamous cell carcinoma of salivary glands;Squamous cell carcinoma of the nasal cavity and paranasal sinuses;Squamous cell carcinoma of the oral cavity;Squamous cell carcinoma of the lip,Major susceptibility factor in;Major susceptibility factor in;Major susceptibility factor in;Major susceptibility factor in;Major susceptibility factor in;Major susceptibility factor in;Major susceptibility factor in,Renal cell carcinoma[28598434];Blood protein levels[30072576;30072576];,0.7817177914110429,0.22434244455905106,0.36909423127120855,0.655463474524248
3729,37419,TNFRSF11A,603499,174810;602080;612301;,"[MIM:602080]Paget disease of bone 2, early-onset;[MIM:612301]Osteopetrosis, autosomal recessive 7 [dominant?] [recessive?];",Juvenile Paget disease;Osteopetrosis-hypogammaglobulinemia syndrome;Adult-onset myasthenia gravis;Familial expansile osteolysis,Candidate gene tested in;Disease-causing germline mutation(s) in;Major susceptibility factor in;Disease-causing germline mutation(s) in,"Response to antipsychotic treatment[23241943];Bone mineral density (paediatric, skull)[24945404;24945404];Heel bone mineral density[28869591;28869591;28869591];Serum alkaline phosphatase levels[29403010];Blood protein levels[29875488;30072576];Femoral neck bone mineral density[29499414];Serum albumin level[23022100;23022100];Lumbar spine bone mineral density[29499414];Paget's disease[21623375;20436471;20436471];Vitiligo[27723757];Bone mineral density (spine)[19801982];Myasthenia gravis[25643325];Allergic disease (asthma, hay fever or eczema)[29083406];Bone mineral density[22504420];",0.31079754601226994,0.4443011861784425,0.35212738188462545,0.5796500920810314
3730,37420,TNFRSF11B,602643,239000;,"[MIM:239000]Paget disease of bone 5, juvenile-onset [recessive?];",Juvenile Paget disease,Disease-causing germline mutation(s) in,"Bone mineral density (hip)[19801982;27311723];Osteoprotegerin levels[25080503;25080503];Bone mineral density (paediatric, skull)[24945404;24945404];Heel bone mineral density[28869591;28869591];Serum alkaline phosphatase levels[29403010];Eosinophil counts[27863252];Blood protein levels[30072576];Femoral neck bone mineral density[29499414];Lumbar spine bone mineral density[29499414];Asthma[29273806];Sum eosinophil basophil counts[27863252];Bone mineral density (spine)[19801982];Type 1 diabetes[21980299];Osteoporosis-related phenotypes[20548944];Bone mineral density[18455228;24249740;22504420;23437003;23437003];",0.20368098159509201,0.6169417225373904,0.6656225528582616,0.6368937998772253
3731,37422,TNFRSF13B,604907,240500;609529;,[MIM:609529]Immunoglobulin A deficiency 2;,Common variable immunodeficiency,Disease-causing germline mutation(s) in,IgG levels[22673310];Diabetic retinopathy[21441570];Sodium levels[29403010];Hematology traits[23303382];Granulocyte percentage of myeloid white cells[27863252];Immunoglobulin light chain (AL) amyloidosis[28025584];Lymphocyte counts[27863252];Multiple myeloma[23955597;26007630];Plateletcrit[27863252;27863252];Monocyte percentage of white cells[27863252];Albumin-globulin ratio[29403010];Serum albumin level[29403010];Serum total protein level[23022100;23022100;23022100;29403010];Tonsillectomy[27182965;28928442];Multiple myeloma and monoclonal gammopathy[26007630];Monocyte count[27863252;27863252];Immunoglobulin measurement (zinc sulfate turbidity test)[29403010];Non-albumin protein levels[22558069;22558069;29403010];Hematological and biochemical traits[20139978];Platelet count[27863252];,0.4622085889570552,0.08225889633831872,0.32837379274340905,0.6284530386740331
3732,37423,TNFRSF13C,606269,613494;,,Common variable immunodeficiency,Disease-causing germline mutation(s) in,Schizophrenia[25056061];,0.17791411042944785,0.6361526560082517,0.5087444531453928,0.0
3733,37431,TNFSF4,603594,152700;,[MIM:152700]Systemic lupus erythematosus;,Systemic lupus erythematosus;Narcolepsy type 1,Major susceptibility factor in;Major susceptibility factor in,"Vein graft stenosis in coronary artery bypass grafting[25881214];Diabetic retinopathy[21441570];Celiac disease[20190752;24999842];Rheumatoid arthritis (ACPA-positive)[24532676];Systemic lupus erythematosus[19838193;23273568;26663301;27399966;27399966;26502338;26502338;26502338;28714469;28714469;28714469;19838195;26663301];Allergic disease (asthma, hay fever or eczema)[29083406];Systemic lupus erythematosus and Systemic sclerosis[23740937];Crohn's disease[21102463];Asthma[27182965];Alopecia areata[25337690];",0.08736196319018405,0.49458483754512633,0.9125554685460715,0.5664518109269491
3734,37435,TNFSF11,602642,259710;,"[MIM:259710]Osteopetrosis, autosomal recessive 2 [dominant?] [recessive?];",Autosomal recessive malignant osteopetrosis,Disease-causing germline mutation(s) in,"Vitiligo[27723757];Cortical thickness[22792071];C-reactive protein levels[24763700];Allergic rhinitis[30013184];Serum alkaline phosphatase levels[29403010];Bone mineral density (paediatric, total body less head)[24945404;24945404];Bone mineral density[24249740;23437003;23437003];Crohn's disease[21102463];Bone mineral density (paediatric, upper limb)[24945404;24945404;24945404];",0.4226993865030675,0.4448169159360495,0.5544244322631167,0.84085328422345
3735,37436,TNFSF12,602695,,,Common variable immunodeficiency;Common variable immunodeficiency,Disease-causing germline mutation(s) (loss of function) in;Disease-causing germline mutation(s) (gain of function) in,Spherical equivalent or myopia (age of diagnosis)[29808027];Atrial fibrillation[30061737;29892015];Myopia[27182965];Chin dimples[27182965];Diastolic blood pressure x smoking status (current vs non-current) interaction (2df test)[29455858;29455858];Systolic blood pressure x smoking status (ever vs never) interaction (2df test)[29455858;29455858];Diastolic blood pressure x smoking status (ever vs never) interaction (2df test)[29455858;29455858];Blood protein levels[29875488;30072576;30072576;30072576;30072576];Systolic blood pressure x smoking status (current vs non-current) interaction (2df test)[29455858;29455858];,0.3168098159509202,0.8060856111397627,0.0,0.6818600368324125
3736,37441,TNFSF15,604052,,,Primary biliary cholangitis,Major susceptibility factor in,"Inflammatory bowel disease[18758464;27569725;23128233];Pediatric autoimmune diseases[26301688];Chronic inflammatory diseases (ankylosing spondylitis, Crohn's disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy)[26974007];Leprosy[20018961;25642632];Primary biliary cholangitis[23000144;28425483;28062665];Crohn's disease[18587394;21102463;23266558;26891255];Ulcerative colitis or Crohn's disease[21699788];Ulcerative colitis[20848476;21297633];",0.08736196319018405,0.3837029396596184,0.6361263377708171,0.5161141804788214
3737,37443,TNIK,610005,617028;,"[MIM:617028]Mental retardation, autosomal recessive 54 [recessive?];",Autosomal recessive non-syndromic intellectual disability,Disease-causing germline mutation(s) (loss of function) in,Adolescent idiopathic scoliosis[28334814];Lymphocyte counts[27863252];Brain imaging in schizophrenia (dorsolateral prefrontal cortex interaction)[19023125];Response to antipsychotic treatment in schizophrenia[29503163];Night sleep phenotypes[27126917];LDL cholesterol[21347282];Frontotemporal dementia (age at onset)[29724592];,0.821717791411043,1.0,0.47742103889323934,0.38812154696132595
3738,37444,TNIP1,607714,,,Systemic lupus erythematosus,Major susceptibility factor in,"Psoriasis[19169254;25903422;25903422;25574825;23143594];Chronic inflammatory diseases (ankylosing spondylitis, Crohn's disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy)[26974007];Amyotrophic lateral sclerosis[29566793];Eosinophil counts[27863252];Crohn's disease[28067908];Cutaneous psoriasis[26626624];Inflammatory skin disease[25574825];Psoriatic arthritis[26626624];Inflammatory bowel disease[28067908;23128233];Sum eosinophil basophil counts[27863252];Eosinophil percentage of granulocytes[27863252];Rheumatoid arthritis (ACPA-positive)[23143596];Systemic lupus erythematosus[19838193;23273568;27399966;27399966;26502338;26606652;26502338;28714469;28714469;28714469;19838195];Myasthenia gravis[23055271];Psoriasis vulgaris[26626624;29031612];Sjögren's syndrome[24097067];Systemic sclerosis[21750679;29293537];Systemic lupus erythematosus and Systemic sclerosis[23740937];Neutrophil percentage of granulocytes[27863252];Eosinophil percentage of white cells[27863252];",0.8532515337423313,0.8011861784424962,0.28086661446097627,0.3324125230202578
3739,37448,TNK2,606994,,,Infantile-onset mesial temporal lobe epilepsy with severe cognitive regression,Disease-causing germline mutation(s) in,Bronchopulmonary dysplasia[23897914];,0.7536196319018404,0.38035069623517276,0.3048812320542939,0.16881522406384286
3740,37456,TNNC1,191040,611879;613243;,"[MIM:611879]Cardiomyopathy, dilated 1Z;[MIM:613243]Cardiomyopathy, familial hypertrophic 13;",Familial isolated dilated cardiomyopathy,Disease-causing germline mutation(s) in,Autism spectrum disorder or schizophrenia[28540026;28540026];Schizophrenia[23974872];Bipolar disorder[21926972];,0.27361963190184047,0.7805569881382156,0.973897154789872,0.625537139349294
3741,37459,TNNI2,191043,601680;,"[MIM:601680]Arthrogryposis, distal, 2B;",Digitotalar dysmorphism;Sheldon-Hall syndrome,Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in,Inflammatory bowel disease[23128233];Celiac disease[23936387];Diastolic blood pressure x smoking status (current vs non-current) interaction (2df test)[29455858;29455858];Systolic blood pressure x smoking status (ever vs never) interaction (2df test)[29455858;29455858];Diastolic blood pressure x smoking status (ever vs never) interaction (2df test)[29455858;29455858];Systolic blood pressure x smoking status (current vs non-current) interaction (2df test)[29455858;29455858];,0.28662576687116564,0.5791645177926766,0.9765074393108849,0.7461632903621854
3742,37460,TNNI3,191044,115210;611880;613286;613690;,"[MIM:613690]Cardiomyopathy, familial hypertrophic 7;[MIM:115210]Cardiomyopathy, familial restrictive 1;[MIM:611880]Cardiomyopathy, dilated 2A;[MIM:613286]Cardiomyopathy, dilated 1FF;",Familial isolated dilated cardiomyopathy;Familial isolated restrictive cardiomyopathy,Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in,Autism spectrum disorder or schizophrenia[28540026;28540026];Schizophrenia[23974872];Bipolar disorder[21926972];,0.3492024539877301,0.6998452810727179,0.8141477421038893,0.0
3743,37461,TNNI3K,613932,616117;,[MIM:616117]Cardiac conduction disease with or without dilated cardiomyopathy;,Familial atrial tachyarrhythmia-infra-Hisian cardiac conduction disease,Disease-causing germline mutation(s) in,Obesity[23563607;23563607];Pubertal anthropometrics[23449627];Body mass index (joint analysis main effects and smoking interaction)[28443625;28443625];Menarche (age at onset)[27182965;25231870];Body mass index (joint analysis main effects and physical activity interaction)[28448500;28448500;28448500;28448500];Body mass index[20935630;23669352;28448500;28448500;28448500;28448500;26426971;28892062];Body mass index (age <50)[26426971];Body mass index x age interaction[26426971];Body mass index x sex x age interaction (4df test)[26426971];Body mass index in physically active individuals[28448500;28448500;28448500;28448500];Hip circumference[25673412;25673412];Childhood body mass index[26604143];BMI (adjusted for smoking behaviour)[28443625;28443625];,0.21484662576687116,0.08973697782362042,0.0,0.322744014732965
3744,37462,TNNT1,191041,605355;,[MIM:605355]Nemaline myopathy 5;,Amish nemaline myopathy,Disease-causing germline mutation(s) in,,0.48208588957055215,0.09566787003610108,0.4831636648394675,0.7397176181706568
3745,37463,TNNT2,191045,115195;601494;612422;,"[MIM:115195]Cardiomyopathy, familial hypertrophic 2;[MIM:601494]Cardiomyopathy, dilated 1D;[MIM:612422]Cardiomyopathy, familial restrictive 3;",Familial isolated dilated cardiomyopathy;Familial isolated restrictive cardiomyopathy;Left ventricular noncompaction,Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in,Neurofibrillary tangles[25188341];Cardiac Troponin-T levels[23247143];,0.23865030674846627,0.37854564208354824,0.31297311406943357,0.8228974831184775
3746,37464,TNNT3,600692,601680;,,Digitotalar dysmorphism;Sheldon-Hall syndrome,Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in,Systolic blood pressure[27618452];Mammographic density (dense area)[25342443];Celiac disease[23936387];Diastolic blood pressure (cigarette smoking interaction)[29455858];Pulse pressure x alcohol consumption interaction (2df test)[29912962];Diastolic blood pressure[27618452];Diastolic blood pressure x smoking status (current vs non-current) interaction (2df test)[29455858;29455858];Systolic blood pressure x smoking status (ever vs never) interaction (2df test)[29455858;29455858];Diastolic blood pressure x smoking status (ever vs never) interaction (2df test)[29455858;29455858];Mean arterial pressure[27618448];Systolic blood pressure x smoking status (current vs non-current) interaction (2df test)[29455858;29455858];Systolic blood pressure (cigarette smoking interaction)[29455858];,0.22687116564417178,0.3127900979886539,0.9224745497259201,0.6332105586249233
3747,37467,TNPO1,602901,,,Early-onset lamellar cataract;Cerulean cataract;Early-onset sutural cataract;Early-onset nuclear cataract;Total early-onset cataract;Early-onset posterior polar cataract,Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in,Mean platelet volume[27863252];Mean corpuscular hemoglobin concentration[27863252;29403010];Serum albumin level[29403010];Platelet count[27863252];,0.7884662576687117,0.9123259412068077,0.8076220308013573,0.8878146101903008
3748,37472,TNPO3,610032,608423;,,Primary biliary cholangitis;Autosomal dominant limb-girdle muscular dystrophy type 1F,Major susceptibility factor in;Disease-causing germline mutation(s) in,Diffuse cutaneous systemic sclerosis[29293537;29293537];Primary biliary cirrhosis[22961000;22961000];Systemic lupus erythematosus[18204446;18204098;24871463;23053960;26606652;26502338;28714469;28714469;28714469;28714469];Sjögren's syndrome[24097067;24097067;24097067];Systemic sclerosis[21750679;29293537;29293537;30247649];Primary biliary cholangitis[20639880];Systemic lupus erythematosus and Systemic sclerosis[23740937];Systemic sclerosis (anti-topoisomerase-positive)[29293537;29293537];Systemic lupus erythematosus or rheumatoid arthritis[27193031];Limited cutaneous systemic scleroderma[29293537;29293537];Systemic sclerosis (anti-centromere-positive)[29293537];Ulcerative colitis[21297633;23128233];,0.814355828220859,0.20190820010314595,0.7948316366483946,0.5391344383057091
3749,37489,TNXB,600985,606408;615963;,"[MIM:606408]Ehlers-Danlos syndrome, classic-like [recessive?];[MIM:615963]Vesicoureteral reflux 8;","Ehlers-Danlos syndrome due to tenascin-X deficiency;Ehlers-Danlos syndrome, hypermobility type;Familial vesicoureteral reflux",Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in,Mean corpuscular volume[27863252];Lung cancer[28604730];Eosinophil counts[27863252];Systemic lupus erythematosus[21408207;26502338;26316170;28714469];Sarcoidosis (non-Lofgren's syndrome without extrapulmonary manifestations)[26651848];Atopic dermatitis[23886662];Shingles[28928442];Systolic blood pressure x smoking status (ever vs never) interaction (2df test)[29455858;29455858];Plasma omega-3 polyunsaturated fatty acid levels (docosapentaenoic acid)[21829377];Systolic blood pressure[28739976;28739976];HIV-1 control[20041166];Autism spectrum disorder or schizophrenia[28540026;28540026;28540026;28540026;28540026;28540026;28540026;28540026;28540026;28540026;28540026;28540026;28540026;28540026;28540026;28540026];Lung cancer in ever smokers[28604730];Diastolic blood pressure x smoking status (ever vs never) interaction (2df test)[29455858;29455858;29455858;29455858];Blood protein levels[28240269;28240269;28240269;28240269;28240269;29875488;29875488;29875488;30072576;30072576;30072576;30072576;30072576;30072576;30072576];Systolic blood pressure x smoking status (current vs non-current) interaction (2df test)[29455858;29455858];Type 1 diabetes and autoimmune thyroid diseases[25936594];Inflammatory bowel disease[28067908];Sum eosinophil basophil counts[27863252];Age-related macular degeneration[22694956];White blood cell count[27863252];Squamous cell lung carcinoma[28604730];Diastolic blood pressure x smoking status (current vs non-current) interaction (2df test)[29455858;29455858;29455858];Prostate cancer[23535732];Ulcerative colitis[28067908];Intraocular pressure[29617998;30054594];,0.5614723926380368,0.45384218669417226,0.0031323414252153485,0.0
3750,37494,TOE1,613931,614969;,,Pontocerebellar hypoplasia type 7,Disease-causing germline mutation(s) (loss of function) in,,0.69079754601227,0.07632800412583807,0.4753328112764291,0.09975445058317986
3751,37519,TOMM40,608061,,,Early-onset autosomal dominant Alzheimer disease,Biomarker tested in,"Type 2 diabetes[27189021];C-reactive protein[22939635];Body mass index (joint analysis main effects and smoking interaction)[28443625];Metabolic syndrome[22399527];Cerebral amyloid deposition positivity (PET imaging)[26252872];Cerebrospinal fluid t-tau:AB1-42 ratio[28641921;28641921];Cognitive decline[22054870;23207651];Body fat percentage[26833246;26833246;26833246;26833246];Cerebrospinal P-tau181p levels[28247064];Cerebral amyloid deposition (PET imaging)[26252872];Body mass index[25673413;25673413;25673413;26426971];Lipid traits[24386095];Cingulate cortical amyloid beta load[26421299];Body mass index (age>50)[26426971];Cardiovascular disease risk factors[21943158;21943158];Cholesterol, total[19060911];Alzheimer's disease[18823527;19125160;19734902;20061627;22832961;24770881;24755620;29107063];BMI (adjusted for smoking behaviour)[28443625];Alzheimer's disease (late onset)[20885792;23565137;26339675];Brain imaging[20100581];Cerebrospinal T-tau levels[28247064];Sense of smell[26632684];Alzheimer's disease biomarkers[21123754;21123754;23419831;23562540;23562540];Posterior cortical atrophy and Alzheimer's disease[26993346];Triglycerides[19060911];Alzheimer's disease (age of onset)[22005931;29107063];Longevity[21418511];Quantitative traits[19197348;19197348;19197348];Waist-hip ratio[25673412;25673412];Cerebrospinal fluid t-tau levels[28641921;28641921];Coronary artery disease[29212778;29212778;29212778];HDL cholesterol[21909109;19060911];Verbal memory performance (immediate recall change)[28800603];BMI in non-smokers[28443625];Waist circumference[25673412;25673412];Body mass index x age interaction[26426971];Verbal declarative memory[25648963;25648963];Body mass index x sex x age interaction (4df test)[26426971];Age-related macular degeneration[22694956;23326517;23326517;23326517];LDL cholesterol levels[26763881];LDL cholesterol[19060911];Cognitive decline (age-related)[24468470;28078323];Cognitive function[25644384];Verbal memory performance (residualized delayed recall level)[28800603];Cerebrospinal fluid AB1-42 levels[20932310;28247064;28641921;28641921];",0.883680981595092,0.9210933470861269,0.8266771078047507,0.0
3752,37528,TOP2A,126430,,,Neuroblastoma,Biomarker tested in,Hip circumference[25673412;25673412];Hip circumference adjusted for BMI[25673412;25673412];,0.9303067484662577,0.8558535327488396,0.41294701122422345,0.2254450583179865
3753,37530,TOP3A,601243,,,Congenital multiple caf�-au-lait macules-increased sister chromatid exchange syndrome,Disease-causing germline mutation(s) in,,0.7319018404907975,0.09437854564208355,0.2427564604541895,0.11295273173726213
3754,37535,TOPORS,609507,609923;,[MIM:609923]Retinitis pigmentosa 31;,Retinitis pigmentosa,Disease-causing germline mutation(s) in,Immune response to smallpox vaccine (IL-6)[22610502];,0.5110429447852761,0.9664775657555441,0.4661968154528844,0.6837016574585635
3755,37537,TOR1A,605204,128100;,"[MIM:128100]Dystonia 1, torsion, autosomal dominant [dominant?];",Early-onset generalized limb-onset dystonia;Myoclonus-dystonia syndrome,Disease-causing germline mutation(s) in;Candidate gene tested in,Prostate cancer (early onset)[29892016];Prostate cancer[29892016];Prostate cancer (advanced)[29892016];,0.8255214723926381,0.31691593604951007,0.2999216914643696,0.33824432166973606
3756,37538,TOR1AIP1,614512,617072;,,Autosomal recessive limb-girdle muscular dystrophy type 2Y,Disease-causing germline mutation(s) (loss of function) in,,0.9901840490797545,0.11578133058277462,0.5536413469068129,0.15408225905463474
3757,37549,TP53,191170,133239;151623;202300;211980;260500;275355;614740;,[MIM:133239]Esophageal cancer;[MIM:151623]Li-Fraumeni syndrome [dominant?];[MIM:275355]Squamous cell carcinoma of the head and neck;[MIM:211980]Lung cancer;[MIM:260500]Papilloma of choroid plexus;[MIM:202300]Adrenocortical carcinoma;[MIM:614740]Basal cell carcinoma 7;,Li-Fraumeni syndrome;Gliosarcoma;Giant cell glioblastoma;Choroid plexus carcinoma;Papilloma of choroid plexus;Adult hepatocellular carcinoma;Hereditary breast and ovarian cancer syndrome;Osteosarcoma;Osteosarcoma;Adrenocortical carcinoma;Familial pancreatic carcinoma;Essential thrombocythemia;Small cell lung cancer;B-cell chronic lymphocytic leukemia;Precursor B-cell acute lymphoblastic leukemia,Disease-causing germline mutation(s) in;Biomarker tested in;Biomarker tested in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Candidate gene tested in;Candidate gene tested in;Disease-causing somatic mutation(s) in;Disease-causing germline mutation(s) in;Major susceptibility factor in;Major susceptibility factor in;Biomarker tested in;Disease-causing somatic mutation(s) in;Disease-causing somatic mutation(s) in;Major susceptibility factor in,Uterine fibroids[30194396];Basal cell carcinoma[21946351;24403052;27539887;25855136];Mean corpuscular hemoglobin[27863252];Glioma[28346443;29743610;29743610];Glioblastoma (age-stratified)[30152087;30152087;30152087];Sex hormone levels[26014426];Diastolic blood pressure[28135244];Glioblastoma[28346443;29743610;29743610];Pulse pressure[28135244;28135244];Esophageal squamous cell carcinoma[25129146];Sporadic neuroblastoma[28545128];Non-glioblastoma glioma[28346443;29743610;29743610];,0.9941104294478528,0.8241361526560083,0.9021143304620204,0.9960098219766728
3758,37560,TP53RK,608679,617730;,[MIM:617730]Galloway-Mowat syndrome 4;,Galloway-Mowat syndrome,Disease-causing germline mutation(s) in,Waist-to-hip ratio adjusted for BMI (age >50)[26426971];Waist-to-hip ratio adjusted for BMI (age <50)[26426971];Dimensional psychopathology (Arousal)[29496196];Waist-to-hip ratio adjusted for BMI[26426971];Waist-to-hip ratio adjusted for BMI x sex x age interaction (4df test)[26426971];,0.4795092024539877,0.3401237751418257,0.46123727486296007,0.0
3759,37571,TP63,603273,103285;106260;129400;603543;604292;605289;,"[MIM:103285]Acro-dermato-ungual-lacrimal-tooth syndrome [dominant?];[MIM:106260]Ankyloblepharon-ectodermal defects-cleft lip/palate [dominant?];[MIM:604292]Ectrodactyly, ectodermal dysplasia, and cleft lip/palate syndrome 3 [dominant?];[MIM:605289]Split-hand/foot malformation 4;[MIM:603543]Limb-mammary syndrome;[MIM:129400]Ectodermal dysplasia, Rapp-Hodgkin type;[MIM:129400]Non-syndromic orofacial cleft 8;",Isolated cleft lip;Cleft lip/palate;Ankyloblepharon-ectodermal defects-cleft lip/palate syndrome;ADULT syndrome;Cleft lip and alveolus;EEC syndrome;Isolated split hand-split foot malformation;Limb-mammary syndrome;Bladder exstrophy,Major susceptibility factor in;Major susceptibility factor in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Major susceptibility factor in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Major susceptibility factor in,Squamous cell carcinoma[26829030];Brain imaging[20100581];Psoriasis[25903422;25903422];Urinary bladder cancer[18794855;20348956];Lung cancer[21725308;23143601;24880342;28604730];EGFR mutation-positive lung adenocarcinoma[27501781];Lung adenocarcinoma[20871597;22797724;28604730];Orofacial clefts[28054174];Bladder cancer[20972438;24163127];Cleft lip with or without cleft palate[28054174];Psoriasis vulgaris[26626624];Systemic lupus erythematosus[28714469];Pancreatic cancer[26098869;29422604];Acute lymphoblastic leukemia (childhood)[22076464;22076464;22076464];,0.6261349693251533,0.9733109850438371,0.7384494909945184,0.9775936157151627
3760,37572,TP73,601990,,,Small cell lung cancer,Disease-causing somatic mutation(s) in,Visceral fat[22589738;22589738];Visceral adipose tissue adjusted for BMI[22589738];Visceral adipose tissue/subcutaneous adipose tissue ratio[22589738];,0.5858895705521472,0.9301186178442497,0.6251631427825634,0.9502762430939227
3761,37586,TPI1,190450,615512;,[MIM:615512]Triosephosphate isomerase deficiency [recessive?];,Triose phosphate-isomerase deficiency,Disease-causing germline mutation(s) in,Blood protein levels[30072576];,0.7267484662576688,0.6719958741619392,0.7107804750717828,0.7974217311233885
3762,37591,TPK1,606370,614458;,,Childhood encephalopathy due to thiamine pyrophosphokinase deficiency,Disease-causing germline mutation(s) (loss of function) in,,0.08736196319018405,0.6616812790097989,0.8687026885930567,0.5188766114180479
3763,37592,TPM1,191010,115196;611878;,"[MIM:115196]Cardiomyopathy, familial hypertrophic 3;[MIM:611878]Cardiomyopathy, dilated 1Y;[MIM:611878]Left ventricular non-compaction 9 [dominant?];",Familial isolated dilated cardiomyopathy;Left ventricular noncompaction,Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in,"Mean platelet volume[19820697;27863252];Parkinson's disease (familial, age at onset)[27402877];Diverticular disease[30177863];Platelet distribution width[27863252];Orofacial clefts[22863734];Platelet count[22139419;27863252];",0.948957055214724,0.4192882929345023,0.9629339598016183,0.8922651933701657
3764,37594,TPM2,190990,108120;601680;609285;,"[MIM:609285]Nemaline myopathy 4;[MIM:108120]Arthrogryposis, distal, 1A;[MIM:609285]Cap myopathy 2;[MIM:601680]Arthrogryposis, distal, 2B;",Typical nemaline myopathy;Childhood-onset nemaline myopathy;Digitotalar dysmorphism;Sheldon-Hall syndrome;Congenital fiber-type disproportion myopathy;Cap myopathy,Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in,,0.8332515337423313,0.7766890149561629,0.2545027407987471,0.5434315531000614
3765,37595,TPM3,191030,255310;609284;,"[MIM:609284]Nemaline myopathy 1 [dominant?] [recessive?];[MIM:255310]Myopathy, congenital, with fiber-type disproportion;[MIM:609284]Cap myopathy 1;",Intermediate nemaline myopathy;Childhood-onset nemaline myopathy;Congenital fiber-type disproportion myopathy;Inflammatory myofibroblastic tumor;Cap myopathy;Congenital generalized hypercontractile muscle stiffness syndrome,Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Part of a fusion gene in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) (gain of function) in,Mean corpuscular volume[29403010];Mean corpuscular hemoglobin[29403010];Platelet count[27863252];,0.8468711656441718,0.5224342444559051,0.7990080918820152,0.7983425414364641
3766,37605,TPM4,600317,,,Inflammatory myofibroblastic tumor;Autosomal dominant macrothrombocytopenia,Part of a fusion gene in;Disease-causing germline mutation(s) (loss of function) in,Mean platelet volume[22423221;22423221;22139419;27863252;27863252];Platelet distribution width[27863252;27863252];Plateletcrit[27863252];Platelet count[22139419;26805783;27863252;27863252];,0.828957055214724,0.6101083032490975,0.7971808927173062,0.5078268876611418
3767,37607,TPMT,187680,610460;,,Cisplatin toxicity;Azathioprine or 6-mercatopurine toxicity or dose selection,Biomarker tested in;Biomarker tested in,Thiopurine methyltransferase activity in acute lymphoblastic leukemia patients treated with mercaptopurines[27564568];Thiopurine S-methyltransferase activity[27770449];,0.08736196319018405,0.23259412068076327,0.3450796136778909,0.214548802946593
3768,37612,TPO,606765,274500;,[MIM:274500]Thyroid dyshormonogenesis 2A;,Familial thyroid dyshormonogenesis,Disease-causing germline mutation(s) in,Thyroid peroxidase antibody positivity[24586183;24722205];Thyroid peroxidase antibody levels[24586183];Hypothyroidism[27182965];Placebo response in major depressive disorder (% change in symptom score)[28696415];Thrombin-activatable fibrinolysis inhibitor levels[29378355];,0.08736196319018405,0.2743682310469314,0.11485251892456277,0.11479435236341314
3769,37613,TPP1,607998,204500;609270;,"[MIM:204500]Ceroid lipofuscinosis, neuronal, 2;[MIM:609270]Spinocerebellar ataxia, autosomal recessive, 7 [recessive?];",CLN2 disease;Childhood-onset autosomal recessive slowly progressive spinocerebellar ataxia,Disease-causing germline mutation(s) (loss of function) in;Disease-causing germline mutation(s) in,,0.8492024539877301,0.5701392470345539,0.4641085878360741,0.7685696746470227
3770,37614,TPP2,190470,,,Autoimmune hemolytic anemia-autoimmune thrombocytopenia-primary immunodeficiency syndrome,Disease-causing germline mutation(s) (loss of function) in,,0.45680981595092024,0.960804538421867,0.6643174105977552,0.8509821976672806
3771,37618,TPR,189940,,,Differentiated thyroid carcinoma,Part of a fusion gene in,,0.8238036809815951,0.7052604435275915,0.16992952231793265,0.478207489257213
3772,37625,TPRKB,608680,617731;,,Galloway-Mowat syndrome,Disease-causing germline mutation(s) in,Serum metabolite levels[23093944;23093944;23093944;23093944];Creatinine levels[20383145];Metabolite levels[21931564];,0.43754601226993867,0.3586900464156782,0.8927173061863743,0.33732351135666055
3773,37628,TPRN,613354,613307;,,Autosomal recessive non-syndromic sensorineural deafness type DFNB,Disease-causing germline mutation(s) in,Obesity-related traits[23251661];,0.791042944785276,0.42702423929860756,0.26468285043069695,0.0
3774,37670,TRA,,,,Precursor T-cell acute lymphoblastic leukemia,Part of a fusion gene in,Adverse response to chemotherapy (neutropenia/leucopenia) (all platinum-based drugs)[23648065];Periodontal disease-related phenotypes[26962152];Narcolepsy[24204295];,0.038773006134969326,0.0,0.0,0.0
3775,37722,TRAC,186880,615387;,[MIM:615387]Immunodeficiency 7;,TCR-alpha-beta-positive T-cell deficiency,Disease-causing germline mutation(s) in,,0.038773006134969326,0.0,0.0,0.0
3776,37726,TRAF3,601896,614849;,"[MIM:614849]Encephalopathy, acute, infection-induced, Herpes- specific, 5;",Herpes simplex virus encephalitis,Major susceptibility factor in,"Body mass index[25673413;25673413;25673413];Multiple sclerosis[24076602];Allergic disease (asthma, hay fever or eczema)[29083406];Systemic lupus erythematosus[28714469];Lymphocyte percentage of white cells[27863252];Serum total protein level[29403010];Lymphocyte counts[27863252];Brain imaging in schizophrenia (dorsolateral prefrontal cortex interaction)[19023125];Immunoglobulin measurement (zinc sulfate turbidity test)[29403010];Non-albumin protein levels[29403010];Albumin-globulin ratio[29403010];",0.6787730061349693,0.7581227436823105,0.15139650221874185,0.0
3777,37727,TRAF3IP1,607380,616629;,,"Senior-Loken syndrome;Short rib-polydactyly syndrome, Majewski type",Disease-causing germline mutation(s) (loss of function) in;Disease-causing germline mutation(s) in,Lung function (FEV1/FVC)[28166213];Iris characteristics[21835309;21835309];Intraocular pressure[29617998;29617998;30054594;29785010];,0.7445398773006136,0.19700876740587933,0.150613416862438,0.07565991405770411
3778,37728,TRAF3IP2,607043,614070;615527;,"[MIM:615527]Candidiasis, familial, 8;",Chronic mucocutaneous candidiasis,Disease-causing germline mutation(s) in,Inflammatory bowel disease[28067908;23128233];Psoriasis vulgaris[26626624];Psoriasis[20953188;20953190;20953190;25903422;25903422;25903422;25574825;23143594];Inflammatory skin disease[25574825];Psoriatic arthritis[20953186;26626624];Ulcerative colitis[28067908];Intraocular pressure[29617998;29617998];,0.5741104294478527,0.38344507478081485,0.28869746802401464,0.08440761203192143
3779,37733,TRAF6,602355,,,Autosomal dominant hypohidrotic ectodermal dysplasia,Disease-causing germline mutation(s) in,Rheumatoid arthritis[24390342;24390342];Idiopathic inflammatory myopathy[26362759];,0.8220858895705522,0.946621970087674,0.8854085095275385,0.892572130141191
3780,37737,TRAIP,605958,616777;,[MIM:616777]Seckel syndrome 9 [recessive?];,Seckel syndrome,Disease-causing germline mutation(s) (loss of function) in,Intelligence (MTAG)[29326435];Blood protein levels[28240269;29875488];,0.425398773006135,0.23517276946879834,0.7877838684416602,0.5308471454880295
3781,37799,TRAK1,608112,,,Undetermined early-onset epileptic encephalopathy,Disease-causing germline mutation(s) (loss of function) in,Pulse pressure x alcohol consumption interaction (2df test)[29912962;29912962];Visceral adipose tissue/subcutaneous adipose tissue ratio[22589738];Pulse pressure x alcohol consumption (light vs heavy) interaction (2df test)[29912962];,0.6841717791411043,0.5056730273336771,0.47846515270164447,0.22912829957028852
3782,37808,TRAPPC2,300202,313400;,,Spondyloepiphyseal dysplasia tarda,Disease-causing germline mutation(s) in,,0.2498159509202454,0.7292418772563177,0.9926912033411642,0.0
3783,37827,TRAPPC9,611966,613192;,,Intellectual disability-obesity-brain malformations-facial dysmorphism syndrome;Autosomal recessive non-syndromic intellectual disability,Disease-causing germline mutation(s) (loss of function) in;Disease-causing germline mutation(s) (loss of function) in,Emphysema distribution in smoking[27669027];Blood pressure (smoking interaction)[25189868];Pediatric non-alcoholic fatty liver disease activity score[28918882];Pulse pressure[28739976;28739976;28135244];Response to amphetamines[22952603];Obesity-related traits[23251661];Disease progression in age-related macular degeneration[29346644];Major depressive disorder[29317602];,0.7971779141104295,0.1188757091284167,0.37431480031323416,0.9444444444444444
3784,37829,TRAPPC11,614138,615356;,[MIM:615356]Limb-girdle muscular dystrophy 2S;,Triple A syndrome;Autosomal recessive limb-girdle muscular dystrophy type 2S;Intellectual disability-hyperkinetic movement-truncal ataxia syndrome,Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in,Systemic lupus erythematosus[29494758];,0.8677300613496932,0.20526044352759154,0.15505090054815976,0.0
3785,37830,TRAPPC12,614139,617669;,"[MIM:617669]Encephalopathy, progressive, early-onset, with brain atrophy and spasticity [recessive?];",Early-onset progressive encephalopathy-hearing loss-pons hypoplasia-brain atrophy syndrome,Disease-causing germline mutation(s) in,Neuritic plaques or neurofibrillary tangles or cerebral amyloid angiopathy (pleiotropy)[29458411];,0.8228220858895705,0.5270758122743683,0.0386322109109893,0.0
3786,37890,TRB,,,,Precursor T-cell acute lymphoblastic leukemia,Part of a fusion gene in,Narcolepsy[24204295];,0.038773006134969326,0.0,0.0,0.0
3787,38018,TRD,,,,Precursor T-cell acute lymphoblastic leukemia,Part of a fusion gene in,,0.038773006134969326,0.0,0.0,0.0
3788,38037,TRD-GTC9-1,,,,Precursor T-cell acute lymphoblastic leukemia,Part of a fusion gene in,,0.038773006134969326,0.0,0.0,0.0
3789,38048,TRDN,603283,615441;,"[MIM:615441]Ventricular tachycardia, catecholaminergic polymorphic, 5, with or without muscle weakness [recessive?];",Catecholaminergic polymorphic ventricular tachycardia;Romano-Ward syndrome,Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in,Nickel levels[26025379];Cerebral amyloid deposition in APOEe4 non-carriers (PET imaging)[26252872;26252872];Night sleep phenotypes[27126917];Borderline personality disorder[28632202];Post bronchodilator FEV1[26634245];,0.4350920245398773,0.46828261990716863,0.05951448707909162,0.10972989564149785
3790,38096,TREH,275360,612119;,,Trehalase deficiency,Disease-causing germline mutation(s) in,Hip minimal joint space width[27701424];Diffuse cutaneous systemic sclerosis[24387989];Celiac disease[22057235];Vitiligo[22951725];Serum metabolite levels[24625756];Multiple sclerosis[24076602];Systemic sclerosis[24387989];Height[20881960];Non-albumin protein levels[29403010];,0.038773006134969326,0.092573491490459,0.2242234403549987,0.0
3791,38099,TREM2,605086,221770;,,Amyotrophic lateral sclerosis;Early-onset autosomal dominant Alzheimer disease;Nasu-Hakola disease;Behavioral variant of frontotemporal dementia;Semantic dementia;Progressive non-fluent aphasia,Major susceptibility factor in;Candidate gene tested in;Disease-causing germline mutation(s) (loss of function) in;Major susceptibility factor in;Major susceptibility factor in;Major susceptibility factor in,C-reactive protein[22939635];Alzheimer's disease (late onset)[28714976;28714976];Blood protein levels[30072576];Alzheimer's disease[23150908];Supraventricular ectopy[29618737];,0.16220858895705523,0.2001031459515214,0.3899765074393109,0.12476979742173112
3792,38107,TREX1,606609,152700;192315;225750;610448;,"[MIM:225750]Aicardi-Goutieres syndrome 1;[MIM:152700]Systemic lupus erythematosus;[MIM:610448]Chilblain lupus 1;[MIM:192315]Vasculopathy, retinal, with cerebral leukodystrophy;",Systemic lupus erythematosus;Aicardi-Gouti�res syndrome;Retinal vasculopathy with cerebral leukoencephalopathy and systemic manifestations;Familial Chilblain lupus,Major susceptibility factor in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) (loss of function) in,Inflammatory bowel disease[28067908];Crohn's disease[28067908];Obesity-related traits[23251661];Ulcerative colitis[28067908];,0.31079754601226994,0.7168643630737493,0.8313756199425737,0.6818600368324125
3793,38126,TRG,,,,Precursor T-cell acute lymphoblastic leukemia,Candidate gene tested in,,0.038773006134969326,0.0,0.0,0.0
3794,38185,TRH,613879,,,Isolated thyrotropin-releasing hormone deficiency,Candidate gene tested in,Waist-to-hip ratio adjusted for BMI (age >50)[26426971];Waist-to-hip ratio adjusted for BMI[26426971];Waist-to-hip ratio adjusted for BMI x sex x age interaction (4df test)[26426971];,0.14576687116564419,0.38834450747808147,0.21613155833985903,0.30356046654389196
3795,38199,TRHR,188545,,,Resistance to thyrotropin-releasing hormone syndrome,Disease-causing germline mutation(s) (loss of function) in,Daytime sleep phenotypes[27126917];Night sleep phenotypes[27126917];Body mass (lean)[19268274];,0.10711656441717791,0.6438886023723569,0.8556512659879927,0.214548802946593
3796,38232,TRIM2,614141,615490;,[MIM:615490]Charcot-Marie-Tooth disease 2R;,Charcot-Marie-Tooth disease type 2R,Disease-causing germline mutation(s) (loss of function) in,Multiple sclerosis[21654844];,0.5479754601226994,0.6838576585869005,0.8861915948838424,0.5747391037446286
3797,38252,TRIM24,603406,,,Differentiated thyroid carcinoma,Part of a fusion gene in,Quantitative traits[19197348];Disease progression in age-related macular degeneration[29346644];,0.6391411042944786,1.0,0.687548942834769,0.6029772866789441
3798,38256,TRIM27,602165,,,Differentiated thyroid carcinoma,Part of a fusion gene in,Sarcoidosis (Lofgren's syndrome vs non-Lofgren's syndrome)[26651848];Childhood and early adolescence aggressive behavior[26087016];Autism spectrum disorder or schizophrenia[28540026;28540026;28540026;28540026;28540026;28540026;28540026;28540026;28540026];Lung cancer in ever smokers[28604730];Hand grip strength[29691431];Platelet aggregation[20526338];Social communication problems[24047820];Blood protein levels[28240269;28240269];Daytime sleep phenotypes[27126917;27126917];Asthma[29273806;29273806];Alopecia areata[25608926];,0.8465030674846625,0.744198040226921,0.8472983555207517,0.7728667894413751
3799,38257,TRIM28,601742,,,Nephroblastoma;Nephroblastoma,Disease-causing germline mutation(s) in;Disease-causing somatic mutation(s) in,,0.9830674846625767,0.7364620938628159,0.8050117462803446,0.0
3800,38261,TRIM32,602290,254110;615988;,[MIM:254110]Limb-girdle muscular dystrophy 2H [recessive?];[MIM:615988]Bardet-Biedl syndrome 11 [recessive?];,Autosomal recessive limb-girdle muscular dystrophy type 2H;Bardet-Biedl syndrome,Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in,,0.7939877300613497,0.3671995874161939,0.7272252675541634,0.6368937998772253
3801,38262,TRIM33,605769,,,Differentiated thyroid carcinoma,Part of a fusion gene in,Autism[24189344;24189344;24189344;24189344;24189344;24189344;24189344];Mean corpuscular hemoglobin[27863252];,0.8656441717791411,0.9802733367715317,0.4056382145653876,0.9274094536525476
3802,38267,TRIM37,605073,253250;,[MIM:253250]Mulibrey nanism [recessive?];,Mulibrey nanism,Disease-causing germline mutation(s) in,Testicular germ cell tumor[23666239];Cognitive function[25644384];General cognitive ability[29844566];,0.8325153374233129,0.2888086642599278,0.5565126598799269,0.09223449969306323
3803,38277,TRIM44,612298,617142;,,Isolated aniridia,Disease-causing germline mutation(s) (gain of function) in,Response to antipsychotic therapy (extrapyramidal side effects)[19875103];Photic sneeze reflex[27182965];,0.4463803680981595,0.5358432181536875,0.8546071521795876,0.4215776550030694
3804,38351,TRIO,601893,617061;,"[MIM:617061]Mental retardation, autosomal dominant 44 [dominant?];",Micrognathia-recurrent infections-behavioral abnormalities-mild intellectual disability syndrome,Disease-causing germline mutation(s) (loss of function) in,Electroencephalogram traits[25387704];Adverse response to chemotherapy in breast cancer (alopecia) (paclitaxel)[24025145];Paclitaxel-induced neuropathy[23776197];Major depressive disorder[27777418];,0.6030674846625766,1.0,0.3766640563821457,0.5871700429711479
3805,38352,TRIOBP,609761,609823;,"[MIM:609823]Deafness, autosomal recessive, 28 [recessive?];",Autosomal recessive non-syndromic sensorineural deafness type DFNB,Disease-causing germline mutation(s) in,Glaucoma[30054594];Optic cup area[28073927;25631615;25631615];Age-related hearing impairment[27764096];Intraocular pressure[29617998;29617998;30054594;29785010];Total cholesterol change in response to fenofibrate in statin-treated type 2 diabetes[28736931];,0.8970552147239264,0.6918514698298092,0.007830853563038372,0.6869244935543278
3806,38353,TRIP4,604501,616866;617066;,"[MIM:616866]Spinal muscular atrophy with congenital bone fractures 1 [recessive?];[MIM:617066]Muscular dystrophy, congenital, Davignon-Chauveau type [recessive?];",Prenatal-onset spinal muscular atrophy with congenital bone fractures;Congenital muscular dystrophy-respiratory failure-skin abnormalities-joint hyperlaxity syndrome,Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in,Neuroticism[29255261];Alzheimer's disease (late onset)[24162737];,0.6528834355828221,0.3700361010830325,0.6998172800835291,0.6332105586249233
3807,38356,TRIP11,604505,200600;,[MIM:200600]Achondrogenesis 1A;,Achondrogenesis type 1A,Disease-causing germline mutation(s) (loss of function) in,Waist circumference adjusted for BMI (joint analysis main effects and physical activity interaction)[28448500];Waist circumference adjusted for BMI in non-smokers[28443625];Waist circumference adjusted for BMI (joint analysis main effects and smoking interaction)[28443625;28443625];Waist circumference adjusted for BMI (adjusted for smoking behaviour)[28443625;28443625];Height[20881960;18391950;18391951;25429064;25282103];Waist circumference adjusted for body mass index[28448500;25673412;25673412];Waist circumference adjusted for BMI in active individuals[28448500];,0.9083435582822086,0.6763795771015988,0.05612111720177499,0.0807243707796194
3808,38358,TRIP13,604507,617598;,[MIM:617598]Mosaic variegated aneuploidy syndrome 3 [recessive?];,Nephroblastoma;Mosaic variegated aneuploidy syndrome,Disease-causing germline mutation(s) (loss of function) in;Disease-causing germline mutation(s) in,Pancreatic cancer[25086665];,0.8557055214723926,0.8055698813821558,0.8530409814669799,0.7797728667894414
3809,38460,TRMT5,611023,616539;,[MIM:616539]Combined oxidative phosphorylation deficiency 26;,Combined oxidative phosphorylation defect type 26,Disease-causing germline mutation(s) in,,0.8169325153374233,0.40123775141825685,0.5630383711824589,0.15976058931860038
3810,38463,TRMT10A,616013,616033;,,Primary microcephaly-mild intellectual disability-young-onset diabetes syndrome,Disease-causing germline mutation(s) in,Celiac disease[23936387];,0.4226993865030675,0.12068076328004126,0.7825632993996345,0.0
3811,38466,TRMT10C,615423,616974;,[MIM:616974]Combined oxidative phosphorylation deficiency 30 [recessive?];,Combined oxidative phosphorylation defect type 30,Disease-causing germline mutation(s) in,"Allergic disease (asthma, hay fever or eczema)[29083406];",0.9106748466257669,0.25296544610624033,0.27695118767945703,0.0
3812,38481,TRMU,610230,580000;613070;,"[MIM:613070]Liver failure, infantile, transient;",Mitochondrial non-syndromic sensorineural deafness with susceptibility to aminoglycoside exposure;Mitochondrial myopathy with reversible cytochrome C oxidase deficiency;Acute infantile liver failure due to synthesis defect of mtDNA-encoded proteins;Mitochondrial non-syndromic sensorineural deafness,Modifying germline mutation in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Modifying germline mutation in,,0.30319018404907977,0.20990201134605466,0.21508744453145393,0.12753222836095765
3813,38521,TRNT1,612907,616084;616959;,"[MIM:616084]Sideroblastic anemia with B-cell immunodeficiency, periodic fevers, and developmental delay [recessive?];[MIM:616959]Retinitis pigmentosa and erythrocytic microcytosis [recessive?];",Congenital sideroblastic anemia-B-cell immunodeficiency-periodic fever-developmental delay syndrome,Disease-causing germline mutation(s) (loss of function) in,,0.33226993865030674,0.7456162970603404,0.8021404333072305,0.08149171270718232
3814,38552,TRPA1,604775,615040;,"[MIM:615040]Episodic pain syndrome, familial, 1 [dominant?];",Familial episodic pain syndrome with predominantly upper body involvement,Disease-causing germline mutation(s) (gain of function) in,Myocardial infarction[26708285];Adult asthma[27611488];Lung cancer in ever smokers[28604730];Gout[22179738];Waist-to-hip ratio adjusted for BMI[26426971];Coronary artery disease[26708285];Waist-to-hip ratio adjusted for BMI x sex x age interaction (4df test)[26426971];,0.08736196319018405,0.013924703455389376,0.10154006786739754,0.24125230202578268
3815,38555,TRPC3,602345,616410;,,Spinocerebellar ataxia type 41,Disease-causing germline mutation(s) in,Rosacea symptom severity[29771307];Emphysema imaging phenotypes[26030696;26030696];,0.3706748466257669,0.1477565755544095,0.6867658574784652,0.6565377532228361
3816,38560,TRPC6,603652,603965;,[MIM:603965]Focal segmental glomerulosclerosis 2;,Familial idiopathic steroid-resistant nephrotic syndrome with focal segmental hyalinosis,Disease-causing germline mutation(s) (gain of function) in,Severity of nausea and vomiting of pregnancy[29563502];Menarche (age at onset)[25231870];Lung adenocarcinoma[28604730];Change in LVEF in response to paclitaxel and trastuzumab in HER2+ breast cancer[28763429];,0.2947239263803681,0.15807117070654977,0.2863482119551031,0.61817065684469
3817,38565,TRPM1,603576,613216;,"[MIM:613216]Night blindness, congenital stationary, 1C;",Congenital stationary night blindness,Disease-causing germline mutation(s) in,Type 2 diabetes[30130595];Advanced age-related macular degeneration[28813576];Response to antipsychotic treatment[19721433];Hypertriglyceridemia[23505323];Huntington's disease progression[28642124];,0.12711656441717792,0.47266632284682825,0.19838162359697206,0.09223449969306323
3818,38569,TRPM4,606936,604559;,[MIM:604559]Progressive familial heart block 1B;,Familial progressive cardiac conduction defect;Brugada syndrome;Brugada syndrome,Disease-causing germline mutation(s) (gain of function) in;Disease-causing germline mutation(s) in;Major susceptibility factor in,,0.19190184049079756,0.536616812790098,0.45027407987470636,0.18523634131368938
3819,38571,TRPM6,607009,602014;,,Primary hypomagnesemia with secondary hypocalcemia,Disease-causing germline mutation(s) in,Magnesium levels[20700443;26058915];Urinary magnesium-to-creatinine ratio[29093028];,0.12711656441717792,0.12686952037132543,0.1083268076220308,0.2429404542664211
3820,38572,TRPM7,605692,105500;,[MIM:105500]Amyotrophic lateral sclerosis-parkinsonism/dementia complex 1;,Amyotrophic lateral sclerosis-parkinsonism-dementia complex,Major susceptibility factor in,Calcium levels[29403010];QT interval[24952745];,0.8127607361963191,0.5425477050025787,0.2962672931349517,0.15623081645181092
3821,38574,TRPS1,604386,150230;190350;190351;,[MIM:190350]Tricho-rhino-phalangeal syndrome 1;[MIM:150230]Tricho-rhino-phalangeal syndrome 2;[MIM:190351]Tricho-rhino-phalangeal syndrome 3;,Trichorhinophalangeal syndrome type 2;Trichorhinophalangeal syndrome type 1 and 3,Role in the phenotype of;Disease-causing germline mutation(s) in,"Granulocyte percentage of myeloid white cells[27863252];Severe influenza A (H1N1) infection[26379185];Hematocrit[27863252];High light scatter reticulocyte count[27863252];Periodontal microbiota[22699663];Major depressive disorder[22472876];Urate levels (BMI interaction)[25811787];Hemoglobin concentration[27863252];Immature fraction of reticulocytes[27863252];Total cholesterol levels[29403010];Reticulocyte fraction of red cells[27863252];Cholesterol, total[20686565];Platelet count[29403010];Parkinson's disease (familial, age at onset)[27402877];High light scatter reticulocyte percentage of red cells[27863252];Reticulocyte count[27863252];Eating disorders[22911880];Heel bone mineral density[28869591;28869591;28869591];Hand grip strength[29691431];Low tan response[29739929];Monocyte percentage of white cells[27863252];Red blood cell count[27863252];Night sleep phenotypes[27126917];HDL cholesterol[20686565;24097068];Asthma[29273806];Diverticular disease[30177863];HDL cholesterol levels[28334899];Cutaneous squamous cell carcinoma[27424798];Bronchopulmonary dysplasia[23897914];Monocyte count[27863252];Cognitive decline (age-related)[28078323];High density lipoprotein cholesterol levels[29403010];Post-traumatic stress disorder (asjusted for relatedness)[23726511;23726511];",0.7549693251533742,1.0,0.615505090054816,0.9383057090239411
3822,38578,TRPV3,607066,614594;616400;,"[MIM:616400]Palmoplantar keratoderma, non-epidermolytic, focal 2;",Isolated focal non-epidermolytic palmoplantar keratoderma;Mutilating palmoplantar keratoderma with periorificial keratotic plaques,Disease-causing germline mutation(s) (gain of function) in;Disease-causing germline mutation(s) (gain of function) in,,0.038773006134969326,0.021402784940691078,0.09162098668754894,0.6606813996316758
3823,38579,TRPV4,605427,113500;156530;168400;181405;184095;184252;600175;606071;606835;613508;617383;,"[MIM:113500]Brachyolmia 3 [dominant?];[MIM:184252]Spondylometaphyseal dysplasia Kozlowski type;[MIM:156530]Metatropic dysplasia;[MIM:600175]Neuronopathy, distal hereditary motor, 8;[MIM:606071]Charcot-Marie-Tooth disease 2C;[MIM:181405]Scapuloperoneal spinal muscular atrophy;[MIM:184095]Spondyloepiphyseal dysplasia Maroteaux type;[MIM:168400]Parastremmatic dwarfism;[MIM:606835]Digital arthropathy-brachydactyly, familial;[MIM:617383]Avascular necrosis of the femoral head, primary 2;","Metatropic dysplasia;Autosomal dominant congenital benign spinal muscular atrophy;Parastremmatic dwarfism;Spondyloepiphyseal dysplasia, Maroteaux type;Scapuloperoneal spinal muscular atrophy;Autosomal dominant brachyolmia;Spondylometaphyseal dysplasia, Kozlowski type;Familial avascular necrosis of femoral head;Familial digital arthropathy-brachydactyly;Autosomal dominant Charcot-Marie-Tooth disease type 2C",Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) (gain of function) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) (gain of function) in;Disease-causing germline mutation(s) (loss of function) in;Disease-causing germline mutation(s) in,Creatinine levels[29403010];Glomerular filtration rate[29403010];,0.32380368098159507,0.04254770500257865,0.2513703993735317,0.9659300184162063
3824,38581,TRPV6,606680,,,Neonatal severe primary hyperparathyroidism,Disease-causing germline mutation(s) in,Alcoholic chronic pancreatitis[28754779];Cancer[29299148];,0.27361963190184047,0.4840123775141826,0.18219785956669277,0.4894106813996317
3825,38800,TSC1,605284,191100;606690;607341;,[MIM:191100]Tuberous sclerosis 1 [dominant?];[MIM:606690]Lymphangioleiomyomatosis;[MIM:607341]Focal cortical dysplasia 2;,Tuberous sclerosis complex;Isolated focal cortical dysplasia type IIb;Adult hepatocellular carcinoma;Lymphangioleiomyomatosis,Disease-causing germline mutation(s) in;Disease-causing somatic mutation(s) in;Candidate gene tested in;Disease-causing somatic mutation(s) in,Migraine without aura[23793025];Psoriasis[19169254];,0.6320245398773006,1.0,0.30592534586269904,0.9812768569674647
3826,38801,TSC2,191092,606690;607341;613254;,[MIM:613254]Tuberous sclerosis 2 [dominant?];[MIM:606690]Lymphangioleiomyomatosis;[MIM:607341]Focal cortical dysplasia 2;,Tuberous sclerosis complex;Isolated focal cortical dysplasia type IIb;Isolated focal cortical dysplasia type IIa;Adult hepatocellular carcinoma;Lymphangioleiomyomatosis;Autosomal dominant polycystic kidney disease type 1 with tuberous sclerosis,Disease-causing germline mutation(s) in;Disease-causing somatic mutation(s) in;Disease-causing somatic mutation(s) in;Candidate gene tested in;Disease-causing somatic mutation(s) in;Role in the phenotype of,Obesity-related traits[23251661];Major depressive disorder[29317602];,0.7760736196319018,0.9172253739040742,0.38632210910989295,0.9990791896869244
3827,38807,TSEN2,608753,612389;,,Pontocerebellar hypoplasia type 2,Disease-causing germline mutation(s) in,Waist-to-hip ratio adjusted for BMI (age >50)[26426971];Waist-to-hip ratio adjusted for BMI (age <50)[26426971];Systemic lupus erythematosus[28714469];Waist-to-hip ratio adjusted for BMI[26426971];Waist-to-hip ratio adjusted for BMI x sex x age interaction (4df test)[26426971];,0.6536196319018405,0.1222279525528623,0.45862699034194726,0.05463474524248005
3828,38809,TSEN15,608756,617026;,,Pontocerebellar hypoplasia type 2,Disease-causing germline mutation(s) (loss of function) in,Waist circumference adjusted for BMI in inactive individuals[28448500];Waist circumference adjusted for BMI (joint analysis main effects and physical activity interaction)[28448500;28448500;28448500;28448500];Waist circumference adjusted for BMI in non-smokers[28443625;28443625;28443625];Hip circumference adjusted for BMI[25673412;25673412];Waist circumference adjusted for BMI (joint analysis main effects and smoking interaction)[28443625;28443625;28443625];Waist circumference adjusted for BMI (adjusted for smoking behaviour)[28443625;28443625;28443625];Height[20881960];Waist circumference adjusted for body mass index[25673412;25673412;25673412];Waist circumference adjusted for BMI in active individuals[28448500;28448500;28448500];,0.4190184049079755,0.7521918514698298,0.06421299921691465,0.33118477593615714
3829,38813,TSEN34,608754,612390;,[MIM:612390]Pontocerebellar hypoplasia 2C;,Pontocerebellar hypoplasia type 2,Disease-causing germline mutation(s) in,Obesity-related traits[23251661];,0.425398773006135,0.4987106756059825,0.68572174367006,0.41697360343769185
3830,38814,TSEN54,608755,225753;277470;610204;,[MIM:225753]Pontocerebellar hypoplasia 4;[MIM:277470]Pontocerebellar hypoplasia 2A;[MIM:610204]Pontocerebellar hypoplasia 5;,Pontocerebellar hypoplasia type 5;Pontocerebellar hypoplasia type 4;Pontocerebellar hypoplasia type 2;Pontocerebellar hypoplasia type 1,Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in,Lung function (FEV1)[28166213];Sight-threatening diabetic retinopathy in type 2 diabetes[26188370];,0.39631901840490796,0.35894791129448167,0.02244844688071,0.3136893799877225
3831,38815,TSFM,604723,610505;,,Fatal mitochondrial disease due to combined oxidative phosphorylation defect type 3,Disease-causing germline mutation(s) (loss of function) in,Multiple sclerosis[24076602];Alanine aminotransferase (ALT) levels after remission induction therapy in actute lymphoblastic leukemia (ALL)[28090653;28090653];,0.9154601226993865,0.22821041774110365,0.5797441921169407,0.4636279926335175
3832,38820,TSHB,188540,275100;,,Isolated thyroid-stimulating hormone deficiency,Disease-causing germline mutation(s) in,,0.27975460122699386,0.43476018566271274,0.7742103889323936,0.3953345610804174
3833,38821,TSHR,603372,275200;603373;609152;,"[MIM:275200]Hypothyroidism, congenital, non-goitrous, 1;[MIM:603373]Familial gestational hyperthyroidism;[MIM:609152]Hyperthyroidism, non-autoimmune;",Familial hyperthyroidism due to mutations in TSH receptor;Hypothyroidism due to TSH receptor mutations;Athyreosis;Thyroid hypoplasia;Familial gestational hyperthyroidism,Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) (loss of function) in;Disease-causing germline mutation(s) (loss of function) in;Disease-causing germline mutation(s) (loss of function) in;Disease-causing germline mutation(s) in,Visceral fat[22589738];Obstetric antiphospholipid syndrome[28424481];Uric acid levels[21294900];Smooth-surface caries[24556642];Graves' disease[21841780;22922229];Optic nerve measurement (rim area)[20395239];Maximal oxygen uptake response[25729143];Hair morphology[19896111];Male sexual orientation[29217827];,0.4403680981595092,0.24548736462093862,0.290002610284521,0.5679864947820749
3834,38825,TSHZ1,614427,607842;,,External auditory canal aplasia/hypoplasia,Disease-causing germline mutation(s) (loss of function) in,Colorectal or endometrial cancer[26621817];Motion sickness[25628336];Anorexia nervosa[23568457];Prostate cancer[29892016];,0.48736196319018404,0.9555183084063951,0.14852518924562777,0.8331798649478207
3835,38843,TSPAN7,300096,300210;,,X-linked non-syndromic intellectual disability,Disease-causing germline mutation(s) in,,0.23865030674846627,0.7934502320783909,0.9992169146436961,0.0
3836,38849,TSPAN12,613138,613310;,"[MIM:613310]Vitreoretinopathy, exudative 5;",Familial exudative vitreoretinopathy,Disease-causing germline mutation(s) in,,0.17791411042944785,0.814337287261475,0.8324197337509789,0.3984039287906691
3837,38860,TSPEAR,612920,614861;,"[MIM:614861]Deafness, autosomal recessive, 98 [recessive?];",Autosomal recessive non-syndromic sensorineural deafness type DFNB,Disease-causing germline mutation(s) in,Corticobasal degeneration[26077951];,0.038773006134969326,0.0778751933986591,0.5105716523101018,0.0
3838,38867,TSPY1,480100,,,Partial chromosome Y deletion,Modifying germline mutation in,,0.16220858895705523,0.650593089221248,0.0,0.0
3839,38893,TSPYL1,604714,608800;,,Sudden infant death-dysgenesis of the testes syndrome,Disease-causing germline mutation(s) (loss of function) in,,0.5842944785276074,0.18746776689014957,0.07935264943878882,0.37952731737262124
3840,38899,TSR2,300945,300946;,"[MIM:300946]Diamond-Blackfan anemia 14, with mandibulofacial dysostosis;",Blackfan-Diamond anemia,Disease-causing germline mutation(s) (loss of function) in,,0.4894478527607362,0.8228468282619907,0.9457060819629339,0.0
3841,38916,TTBK2,611695,604432;,[MIM:604432]Spinocerebellar ataxia 11 [dominant?];,Spinocerebellar ataxia type 11,Disease-causing germline mutation(s) in,MGMT methylation in smokers[26183928];,0.7040490797546012,0.9330840639504899,0.30331506134168623,0.413597298956415
3842,38925,TTC7A,609332,243150;,,Multiple intestinal atresia;Combined immunodeficiency-enteropathy spectrum,Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) (loss of function) in,Initial pursuit acceleration[29064472];Response to statin therapy[20339536];Erectile dysfunction and prostate cancer treatment[20932654];,0.5430674846625767,0.37545126353790614,0.20255807883059254,0.1289134438305709
3843,38927,TTC8,608132,613464;615985;,[MIM:615985]Bardet-Biedl syndrome 8 [recessive?];,Retinitis pigmentosa;Bardet-Biedl syndrome,Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in,Spherical equivalent or myopia (age of diagnosis)[29808027];Copper levels[26025379];Obesity-related traits[23251661];Limited cutaneous systemic scleroderma[29293537];,0.5496932515337424,0.5103145951521403,0.6262072565909684,0.2489257213014119
3844,38936,TTC19,613814,615157;,"[MIM:615157]Mitochondrial complex III deficiency, nuclear 2;",Isolated complex III deficiency,Disease-causing germline mutation(s) in,,0.8817177914110429,0.6070139247034554,0.344296528321587,0.0
3845,38938,TTC21B,612014,613819;613820;,[MIM:613820]Nephronophthisis 12 [recessive?];[MIM:613819]Short-rib thoracic dysplasia 4 with or without polydactyly [recessive?];[MIM:613820]Joubert syndrome 11;,Jeune syndrome;Infantile nephronophthisis,Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in,Bone mineral density (total hip)[29883787];Diabetic kidney disease[26305897];,0.6338650306748467,0.19778236204228983,0.29574523623074916,0.014732965009208104
3846,38944,TTC25,617095,617092;,,Primary ciliary dyskinesia,Disease-causing germline mutation(s) (loss of function) in,Immature fraction of reticulocytes[27863252];,0.30319018404907977,0.0,0.0,0.0
3847,38957,TTC37,614589,222470;,,Syndromic diarrhea,Disease-causing germline mutation(s) in,Telomere length[30185882];,0.8682208588957055,0.07168643630737494,0.05429391803706604,0.050030693677102514
3848,38970,TTI2,614426,615541;,"[MIM:615541]Mental retardation, autosomal recessive 39 [recessive?];",Severe intellectual disability-short stature-behavioral abnormalities-facial dysmorphism syndrome,Disease-causing germline mutation(s) in,,0.4331288343558282,0.0,0.5338031845471156,0.0
3849,38977,TTLL5,612268,615860;,[MIM:615860]Cone-rod dystrophy 19;,Cone rod dystrophy,Disease-causing germline mutation(s) (loss of function) in,Large artery stroke[24262325];Lead levels[26025379];Height[21998595];,0.7501840490797546,0.023465703971119134,0.03549986948577395,0.039287906691221605
3850,38983,TTLL10,,,,Cone rod dystrophy,Disease-causing germline mutation(s) (loss of function) in,Large artery stroke[24262325];Lead levels[26025379];Height[21998595];,0.27975460122699386,0.09773078906652914,0.11276429130775255,0.04665438919582566
3851,38989,TTN,188840,600334;603689;604145;608807;611705;613765;,"[MIM:603689]Hereditary myopathy with early respiratory failure;[MIM:613765]Cardiomyopathy, familial hypertrophic 9;[MIM:604145]Cardiomyopathy, dilated 1G;[MIM:600334]Tardive tibial muscular dystrophy;[MIM:608807]Limb-girdle muscular dystrophy 2J [recessive?];[MIM:611705]Salih myopathy [recessive?];","Autosomal recessive centronuclear myopathy;Familial isolated dilated cardiomyopathy;Hereditary myopathy with early respiratory failure;Autosomal recessive limb-girdle muscular dystrophy type 2J;Classic multiminicore myopathy;Familial isolated arrhythmogenic ventricular dysplasia, right dominant form;Familial isolated arrhythmogenic ventricular dysplasia, biventricular form;Familial isolated arrhythmogenic ventricular dysplasia, left dominant form;Early-onset myopathy with fatal cardiomyopathy;Childhood-onset progressive contractures-limb-girdle weakness-muscle dystrophy syndrome;Tibial muscular dystrophy",Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) (loss of function) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) (loss of function) in;Disease-causing germline mutation(s) (loss of function) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) (loss of function) in;Disease-causing germline mutation(s) in,QT interval[20031603;24952745;29213071];Bone mineral density (hip)[30172743];Resting heart rate[27798624];Atrial fibrillation[29290336;29290336;30061737;29892015;29892015];Epstein-Barr virus copy number in lymphoblastoid cell lines[28654678];Breast size[22747683];Waist-to-hip ratio adjusted for BMI x sex interaction[26426971];Heart rate response to recovery post exercise (10 sec)[29497042;29497042];Rapid functional decline in sporadic amyotrophic lateral sclerosis[26746183];Heart rate response to recovery post exercise (20 sec)[29497042];,0.8295705521472393,0.0020629190304280558,0.00026102845210127906,0.028698588090853284
3852,38991,TTPA,600415,277460;,[MIM:277460]Ataxia with isolated vitamin E deficiency [recessive?];,Ataxia with vitamin E deficiency,Disease-causing germline mutation(s) in,,0.31079754601226994,0.3599793708096957,0.8405116157661185,0.3769183548189073
3853,38993,TTR,176300,105210;115430;145680;,"[MIM:105210]Amyloidosis, transthyretin-related;[MIM:145680]Hyperthyroxinemia, dystransthyretinemic;[MIM:115430]Carpal tunnel syndrome 1;",ATTRV30M amyloidosis;ATTRV122I amyloidosis,Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in,Retinol levels[21878437];,0.7001226993865031,0.7385250128932439,0.6434351344296528,0.8732351135666053
3854,39043,TUB,601197,616188;,[MIM:616188]Retinal dystrophy and obesity;,Retinitis pigmentosa,Disease-causing germline mutation(s) (loss of function) in,Body mass index[20935630;26426971];Body mass index (age <50)[26426971];Coronary artery disease in type 1 diabetes[29695241];Body mass index x sex x age interaction (4df test)[26426971];Familial lung cancer[29924316];Familial lung adenocarcinoma[29924316];,0.23865030674846627,0.4582258896338319,0.523884103367267,0.8542050337630448
3855,39045,TUBA1A,602529,611603;,[MIM:611603]Lissencephaly 3;,Lissencephaly due to TUBA1A mutation;Tubulinopathy-associated dysgyria,Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in,,0.7114110429447853,0.70293965961836,0.0,0.5604665438919583
3856,39055,TUBA8,605742,613180;,"[MIM:613180]Cortical dysplasia, complex, with other brain malformations 8;",Polymicrogyria with optic nerve hypoplasia,Disease-causing germline mutation(s) in,Atrial fibrillation[30061737;29892015;29892015];Cerebrospinal T-tau levels[28247064];,0.6141104294478528,0.5889633831872099,0.6562255285826155,0.6732658072437078
3857,39061,TUBB,191130,156610;615771;,"[MIM:615771]Cortical dysplasia, complex, with other brain malformations 6;[MIM:156610]Skin creases, congenital symmetric circumferential, 1 [dominant?];",Multiple benign circumferential skin creases on limbs,Disease-causing germline mutation(s) in,Autism spectrum disorder or schizophrenia[28540026;28540026;28540026;28540026;28540026;28540026;28540026;28540026;28540026;28540026;28540026;28540026;28540026;28540026;28540026;28540026;28540026;28540026];Blood protein levels[28240269];,0.9973006134969326,0.8965961835997938,0.0,0.7685696746470227
3858,39062,TUBB1,612901,613112;,"[MIM:613112]Macrothrombocytopenia, autosomal dominant, TUBB1-related [dominant?];",Autosomal dominant macrothrombocytopenia,Disease-causing germline mutation(s) in,Mean platelet volume[22423221;22139419;27863252;27863252];High light scatter reticulocyte percentage of red cells[27863252];Reticulocyte fraction of red cells[27863252];Reticulocyte count[27863252];Platelet distribution width[27863252;27863252;27863252;27863252;27863252];Plateletcrit[27863252];High light scatter reticulocyte count[27863252];Platelet count[27863252;27863252;27863252;29403010];,0.9047852760736196,0.16064981949458484,0.1232054293918037,0.42602823818293434
3859,39065,TUBB2A,615101,615763;,"[MIM:615763]Cortical dysplasia, complex, with other brain malformations 5;",Multiple benign circumferential skin creases on limbs,Disease-causing germline mutation(s) in,Red cell distribution width[27863252];,0.9506748466257668,0.8824136152656008,0.9891673192377969,0.4208103130755064
3860,39066,TUBB2B,612850,208150;610031;,"[MIM:610031]Cortical dysplasia, complex, with other brain malformations 7;[MIM:208150]Fetal akinesia deformation sequence;",Dysequilibrium syndrome;Polymicrogyria due to TUBB2B mutation;Tubulinopathy-associated dysgyria;Congenital fibrosis of extraocular muscles,Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in,,0.90920245398773,0.9272821041774111,0.0,0.0
3861,39068,TUBB3,602661,600638;614039;,"[MIM:600638]Fibrosis of extraocular muscles, congenital, 3A [dominant?];[MIM:614039]Cortical dysplasia, complex, with other brain malformations 1;",Cortical dysgenesis with pontocerebellar hypoplasia due to TUBB3 mutation;Tubulinopathy-associated dysgyria;Congenital fibrosis of extraocular muscles,Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in,Rosacea symptom severity[29771307];Obsessive-compulsive disorder or autism spectrum disorder[28641744];,0.9815950920245399,0.10417741103661682,0.9490994518402506,0.5988336402701043
3862,39071,TUBB4A,602662,128101;612438;,"[MIM:128101]Dystonia 4, torsion, autosomal dominant [dominant?];[MIM:612438]Leukodystrophy, hypomyelinating, 6;","Hypomyelination with atrophy of basal ganglia and cerebellum;Primary dystonia, DYT4 type",Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in,,0.9879754601226994,0.7057761732851986,0.9652832158705299,0.0
3863,39084,TUBB8,616768,616780;,[MIM:616780]Oocyte maturation defect 2 [dominant?];,Female infertility due to oocyte meiotic arrest,Disease-causing germline mutation(s) in,,0.7139877300613497,0.6913357400722022,0.6805011746280345,0.0
3864,39115,TUBGCP4,609610,616335;,,Autosomal recessive chorioretinopathy-microcephaly syndrome,Disease-causing germline mutation(s) in,,0.743680981595092,0.7209902011346054,0.7392325763508223,0.20979128299570288
3865,39117,TUBGCP6,610053,251270;,"[MIM:251270]Microcephaly and chorioretinopathy, autosomal recessive, 1 [recessive?];",Autosomal recessive chorioretinopathy-microcephaly syndrome,Disease-causing germline mutation(s) in,Acne (severe)[24927181];Obesity-related traits[23251661];Major depressive disorder[27479909];,0.827239263803681,0.03403816400206292,0.14226050639519708,0.08578882750153469
3866,39118,TUFM,602389,610678;,[MIM:610678]Combined oxidative phosphorylation deficiency 4;,Combined oxidative phosphorylation defect type 4,Disease-causing germline mutation(s) in,Body fat percentage[26833246;26833246;26833246;26833246];Inflammatory bowel disease[28067908];Body mass index[20935630];Intelligence[28530673;28530673];Hip circumference adjusted for BMI[25673412;25673412];Crohn's disease[28067908];Educational attainment[25201988];,0.9820858895705521,0.3965961835997937,0.79796397807361,0.3492940454266421
3867,39122,TULP1,602280,600132;613843;,[MIM:613843]Leber congenital amaurosis 15;,Retinitis pigmentosa;Leber congenital amaurosis,Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in,Hepatitis C induced liver fibrosis[22841784];,0.19190184049079756,0.39324394017534814,0.3377708170190551,0.7848373235113567
3868,39132,TUSC3,601385,611093;,,Autosomal recessive non-syndromic intellectual disability,Disease-causing germline mutation(s) in,Pulmonary function decline[22424883];Methamphetamine dependence[23594818];Intelligence[22449649];Response to cytadine analogues (cytosine arabinoside)[24483146];Prudent dietary pattern[28644415];Response to SSRI in MDD or openness[29559929];,0.3925153374233129,0.2565755544094894,0.8358131036282955,0.25644567219152853
3869,39150,TWIST1,601622,101400;123100;180750;617746;,[MIM:180750]Robinow-Sorauf syndrome [dominant?];[MIM:123100]Craniosynostosis 1;[MIM:617746]Sweeney-Cox syndrome [dominant?];,Saethre-Chotzen syndrome;Isolated brachycephaly;Isolated plagiocephaly;Isolated scaphocephaly,Disease-causing germline mutation(s) (loss of function) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in,Male-pattern baldness[29146897];Stroke[29531354;29531354];Ischemic stroke (large artery atherosclerosis)[29531354;29531354];Type 2 diabetes (age of onset)[28060188];Diisocyanate-induced asthma[25918132];Pulse pressure[29403010];Obesity-related traits[23251661];Night sleep phenotypes[27126917];Ischemic stroke[29531354;29531354];,0.5766871165644172,0.6714801444043321,0.9104672409292612,0.0
3870,39151,TWIST2,607556,200110;209885;227260;,[MIM:200110]Ablepharon-macrostomia syndrome;[MIM:209885]Barber-Say syndrome;,Ablepharon macrostomia syndrome;Barber-Say syndrome;Focal facial dermal dysplasia type III,Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in,Rosacea symptom severity[29771307];Male-pattern baldness[27182965;29146897];,0.23865030674846627,0.7460030943785456,0.9699817280083529,0.0
3871,39153,TWNK,606075,271245;609286;616138;,[MIM:271245]Mitochondrial DNA depletion syndrome 7;[MIM:616138]Perrault syndrome 5;,"Infantile onset spinocerebellar ataxia;Autosomal dominant progressive external ophthalmoplegia;Perrault syndrome;Mitochondrial DNA depletion syndrome, hepatocerebrorenal form;Sensory ataxic neuropathy-dysarthria-ophthalmoparesis syndrome",Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Candidate gene tested in,,0.6604907975460123,0.32001031459515217,0.0,0.0
3872,39161,TXN2,609063,616811;,,Combined oxidative phosphorylation defect type 29,Disease-causing germline mutation(s) (loss of function) in,,0.5948466257668712,0.5840639504899433,0.9383972853040982,0.2786985880908533
3873,39175,TXNL4A,611595,608572;,[MIM:608572]Burn-McKeown syndrome;,Choanal atresia-hearing loss-cardiac defects-craniofacial dysmorphism syndrome,Disease-causing germline mutation(s) (loss of function) in,,0.7099386503067485,0.5082516761217122,0.9827721221613156,0.40423572744014735
3874,39185,TXNRD2,606448,617825;,,Familial isolated dilated cardiomyopathy;Familial glucocorticoid deficiency,Disease-causing germline mutation(s) (loss of function) in;Disease-causing germline mutation(s) (loss of function) in,Glaucoma (primary open-angle)[26752265;26752265;29891935;29891935];Glaucoma[30054594];Staphylococcus aureus infection[24847357];Glaucoma (primary angle closure)[22922875];Intraocular pressure[30054594;29785010];,0.4750920245398773,0.10185662712738525,0.06238580005220569,0.2856046654389196
3875,39188,TYK2,176941,611521;,[MIM:611521]Immunodeficiency 35;,Susceptibility to infection due to TYK2 deficiency;Primary cutaneous anaplastic large cell lymphoma;Lymphomatoid papulosis,Disease-causing germline mutation(s) (loss of function) in;Part of a fusion gene in;Part of a fusion gene in,"Primary biliary cirrhosis[22961000];Multiple sclerosis[21833088;24076602];Psoriasis[20953190;20953190;23143594;23143594];Sarcoidosis[26051272];Lymphocyte counts[27863252];Chronic inflammatory diseases (ankylosing spondylitis, Crohn's disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy)[26974007;26974007];Crohn's disease[21102463;28067908];Systemic lupus erythematosus or rheumatoid arthritis[27193031];Psoriatic arthritis[26626624];Inflammatory bowel disease[28067908;23128233];Pediatric autoimmune diseases[26301688];Rheumatoid arthritis (ACPA-positive)[23143596;24532676];Systemic lupus erythematosus[27399966;26502338;26502338;28714469;28714469];Psoriasis vulgaris[26626624];Type 1 diabetes[19966805;21829393;25751624;25751624];Juvenile idiopathic arthritis (oligoarticular or rheumatoid factor-negative polyarticular)[23603761];Rheumatoid arthritis[24390342;23143596];Neutrophil percentage of white cells[27863252];Primary biliary cholangitis[26394269];Ankylosing spondylitis[23749187;23749187];Platelet count[27863252];",0.7430674846625767,0.6854048478597216,0.20203602192638997,0.6398096992019644
3876,39189,TYMP,131222,603041;,"[MIM:603041]Mitochondrial DNA depletion syndrome 1, MNGIE type;",Mitochondrial neurogastrointestinal encephalomyopathy,Disease-causing germline mutation(s) (loss of function) in,Chronic lymphocytic leukemia[28165464];Mean corpuscular hemoglobin[20139978;27863252;29403010];Mean corpuscular volume[27863252];Red blood cell traits[23222517];Reticulocyte count[27863252];Blood metabolite levels[24816252];Red blood cell count[27863252];Blood protein levels[30072576];Red cell distribution width[27863252];,0.2947239263803681,0.2919030428055699,0.24119028974158183,0.0
3877,39190,TYMS,188350,,,5-fluorouracil toxicity,Biomarker tested in,Mean corpuscular hemoglobin[27863252];Mean corpuscular volume[27863252];Testicular germ cell tumor[28604728];,0.7047852760736196,0.8063434760185663,0.9603236752806056,0.6837016574585635
3878,39194,TYR,606933,103470;203100;601800;606952;,"[MIM:203100]Albinism, oculocutaneous, 1A [recessive?];[MIM:606952]Albinism, oculocutaneous, 1B [recessive?];",Minimal pigment oculocutaneous albinism type 1;Temperature-sensitive oculocutaneous albinism type 1;Ocular albinism with congenital sensorineural deafness;Oculocutaneous albinism type 1B;Oculocutaneous albinism type 1A,Disease-causing germline mutation(s) (loss of function) in;Disease-causing germline mutation(s) (loss of function) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) (loss of function) in;Disease-causing germline mutation(s) (loss of function) in,Skin sensitivity to sun[17952075];Squamous cell carcinoma[26829030];Eye color[20585627;20585627];Skin pigmentation[17999355];Basal cell carcinoma[27539887];Tanning[23548203;19340012];Melanoma[21983787;19578364;24980573;28212542];Low tan response[29739929];Freckles[17952075];Vitiligo[22561518;20410501;27723757];Blue vs. green eyes[17952075];Sunburns[23548203];Cutaneous squamous cell carcinoma[27424798];Age-related macular degeneration[23326517;23326517];Hair color[29662168;26926045];Intraocular pressure[29617998;29617998];Non-melanoma skin cancer[29739929];,0.12711656441717792,0.009798865394533264,0.14017227877838684,0.8023327194597912
3879,39198,TYROBP,604142,221770;,[MIM:221770]Polycystic lipomembranous osteodysplasia with sclerosing leukoencephalopathy;,Nasu-Hakola disease,Disease-causing germline mutation(s) (loss of function) in,,0.4117791411042945,0.7287261474987107,0.5588619159488384,0.6689686924493554
3880,39199,TYRP1,115501,203290;612271;,"[MIM:203290]Albinism, oculocutaneous, 3 [recessive?];",Oculocutaneous albinism type 3,Disease-causing germline mutation(s) in,Neuroticism[27089181];Blue vs. green eyes[18488028];Eye color[23548203];Skin pigmentation[29195075];Amyotrophic lateral sclerosis (sporadic)[24529757];Low tan response[29739929];Hair color[22556244;29662168];,0.21484662576687116,0.38292934502320786,0.5439832941790655,0.6617556783302639
3881,39215,UBA1,314370,301830;,[MIM:301830]Spinal muscular atrophy X-linked 2;,Infantile-onset X-linked spinal muscular atrophy,Disease-causing germline mutation(s) (loss of function) in,,0.9403680981595092,0.8112429087158329,0.25345862699034194,0.49923265807243705
3882,39216,UBA2,613295,,,Early infantile epileptic encephalopathy;West syndrome;Corpus callosum agenesis-abnormal genitalia syndrome;X-linked spasticity-intellectual disability-epilepsy syndrome;X-linked non-syndromic intellectual disability;X-linked lissencephaly with abnormal genitalia;Infantile epileptic-dyskinetic encephalopathy;Partington syndrome,Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) (loss of function) in;Disease-causing germline mutation(s) (loss of function) in;Disease-causing germline mutation(s) in,,0.6825766871165644,0.8370293965961836,0.5716523101018011,0.8523634131368938
3883,39218,UBA5,610552,617132;617133;,"[MIM:617133]Spinocerebellar ataxia, autosomal recessive, 24 [recessive?];",Undetermined early-onset epileptic encephalopathy,Disease-causing germline mutation(s) (loss of function) in,Blood protein levels[28240269];,0.6770552147239264,0.42031975244971637,0.5306708431219003,0.4280233271945979
3884,39233,UBAC2,,,,Beh�et disease,Major susceptibility factor in,"Inflammatory bowel disease[28067908];Sum eosinophil basophil counts[27863252];Eosinophil percentage of granulocytes[27863252];Basal cell carcinoma[21700618];Psoriasis[28537254];Chronic inflammatory diseases (ankylosing spondylitis, Crohn's disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy)[26974007];Eosinophil counts[27863252];Neutrophil percentage of granulocytes[27863252];Eosinophil percentage of white cells[27863252];",0.8332515337423313,0.6689014956162971,0.7700339336987732,0.4685389809699202
3885,39243,UBB,191339,,,Submucosal cleft palate;Cleft hard palate;Cleft velum;Bifid uvula,Candidate gene tested in;Candidate gene tested in;Candidate gene tested in;Candidate gene tested in,,0.7214723926380369,0.7166064981949458,0.0,0.47068753836709637
3886,39252,UBE2A,312180,300860;,"[MIM:300860]Mental retardation, X-linked, syndromic, Nascimento-type;","X-linked intellectual disability, Nascimento type",Disease-causing germline mutation(s) in,Brain connectivity[23471985];,0.6483435582822086,0.7338834450747808,0.0,0.0
3887,39290,UBE2L3,603721,,,Systemic lupus erythematosus,Major susceptibility factor in,"Mean corpuscular hemoglobin concentration[27863252];Mean corpuscular volume[20139978;28017375;27863252;29403010];Mean corpuscular hemoglobin[27863252];Lymphocyte percentage of white cells[27863252];Lymphocyte counts[27863252];Chronic inflammatory diseases (ankylosing spondylitis, Crohn's disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy)[26974007];High light scatter reticulocyte count[27863252];Red cell distribution width[27863252];Rheumatoid arthritis (ACPA-positive)[24532676];Systemic lupus erythematosus[21408207;19838193;23273568;27399966;27399966;26502338;26502338;28714469;28714469;19838195];Reticulocyte fraction of red cells[27863252];Red blood cell traits[23222517];Ankylosing spondylitis[23749187;23749187];Celiac disease or Rheumatoid arthritis[21383967];High light scatter reticulocyte percentage of red cells[27863252];Psoriasis[23143594];Reticulocyte count[27863252];Crohn's disease[28067908];Systemic lupus erythematosus or rheumatoid arthritis[27193031];HDL cholesterol[20686565;24097068;25961943];Inflammatory bowel disease[28067908;23128233];Celiac disease[20190752;22057235];HDL cholesterol levels[28334899;28334899;28334899];Juvenile idiopathic arthritis (oligoarticular or rheumatoid factor-negative polyarticular)[23603761];Rheumatoid arthritis[24390342;24390342];Neutrophil percentage of white cells[27863252];High density lipoprotein cholesterol levels[29403010];Non-albumin protein levels[29403010];Hepatitis B[24162738];Ulcerative colitis[28067908];Intraocular pressure[29617998;29617998];",0.936441717791411,0.8027333677153172,0.979378752283999,0.0
3888,39321,UBE2T,610538,616435;,[MIM:616435]Fanconi anemia complementation group T;,Fanconi anemia,Disease-causing germline mutation(s) in,Celiac disease[23936387];Breast cancer[23535733];,0.4622085889570552,0.2369778236204229,0.8713129731140694,0.1714241866175568
3889,39347,UBE3A,601623,105830;,[MIM:105830]Angelman syndrome;,15q11q13 microduplication syndrome;Angelman syndrome due to a point mutation;Angelman syndrome due to imprinting defect in 15q11-q13;Angelman syndrome due to paternal uniparental disomy of chromosome 15;Angelman syndrome due to maternal 15q11q13 deletion,Role in the phenotype of;Disease-causing germline mutation(s) (loss of function) in;Role in the phenotype of;Role in the phenotype of;Role in the phenotype of,Cardiac hypertrophy[21348951];Gene methylation in lung tissue[25713168;25713168];Obesity-related traits[23251661];,0.8029447852760736,0.8628158844765343,0.8070999738971548,0.0
3890,39350,UBE3B,608047,244450;,,"Oculocerebrofacial syndrome, Kaufman type",Disease-causing germline mutation(s) (loss of function) in,Polymyositis[26362759];HDL cholesterol[20864672];,0.48208588957055215,0.5216606498194946,0.548159749412686,0.09975445058317986
3891,39357,UBIAD1,611632,121800;,,Schnyder corneal dystrophy,Disease-causing germline mutation(s) in,Beard thickness[26926045];Intraocular pressure[29785010];,0.925521472392638,0.7844249613202682,0.809188201513965,0.6720380601596071
3892,39376,UBQLN2,300264,300857;,"[MIM:300857]Amyotrophic lateral sclerosis 15, with or without frontotemporal dementia;",Amyotrophic lateral sclerosis,Disease-causing germline mutation(s) in,,0.838159509202454,0.8419288292934503,0.9420516836335161,0.7412523020257827
3893,39382,UBR1,605981,243800;,[MIM:243800]Johanson-Blizzard syndrome;,Johanson-Blizzard syndrome,Disease-causing germline mutation(s) (loss of function) in,Triglycerides[25961943];MGMT methylation in smokers[26183928];,0.6936196319018405,0.685146982980918,0.3549986948577395,0.2846838551258441
3894,39391,UBTF,600673,617672;,"[MIM:617672]Neurodegeneration, childhood-onset, with brain atrophy [dominant?];",Childhood-onset motor and cognitive regression syndrome with extrapyramidal movement disorder,Disease-causing germline mutation(s) (gain of function) in,Diverticular disease[30177863];Mean corpuscular hemoglobin concentration[29403010];,0.8136196319018405,1.0,0.9350039154267815,0.9815837937384899
3895,39414,UCHL1,191342,613643;615491;,"[MIM:613643]Parkinson disease 5;[MIM:615491]Spastic paraplegia 79, autosomal recessive [recessive?];",Young-onset Parkinson disease;Early-onset progressive neurodegeneration-blindness-ataxia-spasticity syndrome,Candidate gene tested in;Disease-causing germline mutation(s) (loss of function) in,Cognitive performance[19734545];,0.8164417177914111,0.7555440948942754,0.1357347950926651,0.6238489871086557
3896,39427,UCP2,601693,607447;,,Hyperinsulinism due to UCP2 deficiency,Disease-causing germline mutation(s) (loss of function) in,,0.31079754601226994,0.4112944816915936,0.11119812059514488,0.27532228360957645
3897,39431,UFD1,601754,,,22q11.2 deletion syndrome,Role in the phenotype of,,0.6766871165644172,0.8581743166580712,0.0,0.0
3898,39434,UFM1,610553,617899;,"[MIM:617899]Leukodystrophy, hypomyelinating, 14 [recessive?];",Hypomyelination with atrophy of basal ganglia and cerebellum,Disease-causing germline mutation(s) in,Aggressiveness in attention deficit hyperactivity disorder[27021288];Low vWF levels[26486471];,0.852760736196319,0.6325425477050026,0.9399634560167058,0.2694904849600982
3899,39436,UFSP2,611482,142669;,[MIM:142669]Beukes familial hip dysplasia;,"Hip dysplasia, Beukes type",Disease-causing germline mutation(s) in,,0.814355828220859,0.23388344507478082,0.4792482380579483,0.14103744628606507
3900,39444,UGT1A1,191740,143500;218800;237900;601816;606785;,[MIM:143500]Gilbert syndrome;[MIM:237900]Transient familial neonatal hyperbilirubinemia;[MIM:218800]Crigler-Najjar syndrome 1 [recessive?];[MIM:606785]Crigler-Najjar syndrome 2 [dominant?];,Transient familial neonatal hyperbilirubinemia;Irinotecan toxicity;Raltegravir toxicity;Crigler-Najjar syndrome type 1;Crigler-Najjar syndrome type 2,Candidate gene tested in;Biomarker tested in;Biomarker tested in;Disease-causing germline mutation(s) (loss of function) in;Disease-causing germline mutation(s) (loss of function) in,"Circulating cell-free DNA[22511988];Serum metabolite levels[23093944;23093944;23093944;23093944;23093944;23093944;23093944];Bilirubin levels in extreme obesity[25246029];Total bilirubin levels[29403010];Blood metabolite levels[24816252;24816252;24816252;24816252;24816252;24816252;24816252;24816252];LDL cholesterol levels[28334899];Cholelithiasis-related traits in sickle cell anemia[22558097];Cholesterol, total[24097068];Hair greying[26926045];Bilirubin levels[22085899;20639394;19414484;19419973;20639394;23371916;23371916;23371916;23371916;23371916;23371916;23371916];LDL cholesterol[24097068];Total bilirubin levels in HIV-1 infection[25884002;25884002;25884002;25884002];",0.26588957055214724,0.2148014440433213,0.5348472983555208,0.09422958870472682
3901,39494,UMOD,191845,162000;603860;609886;,[MIM:162000]Familial juvenile hyperuricemic nephropathy 1;[MIM:603860]Medullary cystic kidney disease 2;[MIM:609886]Glomerulocystic kidney disease with hyperuricemia and isosthenuria;,Familial juvenile hyperuricemic nephropathy type 1;UMOD-related autosomal dominant tubulointerstitial kidney disease,Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in,Hypertension[21082022;27618447];Glomerular filtration rate in diabetes[29703844];Renal function and chronic kidney disease[19430482;19430482];Renal function-related traits (sCR)[22797727];Chronic kidney disease[20383146;26831199];Diastolic blood pressure x smoking status (ever vs never) interaction (1df test)[29455858];Diastolic blood pressure x smoking status (ever vs never) interaction (2df test)[29455858];Renal function-related traits (eGRFcrea)[22797727];Glomerular filtration rate in diabetics (creatinine)[26831199];Glomerular filtration rate[27588450;27588450;27588450];Glomerular filtration rate in type 2 diabetes[29703844];Chronic kidney disease and serum creatinine levels[20686651];Glomerular filtration rate in non diabetics (creatinine)[26831199];Kidney function decline traits[25493955;25493955;25493955;25493955];Urinary uromodulin levels[24578125];Femoral neck bone geometry[22087292];Glomerular filtration rate (creatinine)[26831199;28452372];Glomerular filtration rate (cystatin C)[28452372];,0.12711656441717792,0.42135121196493036,0.2923518663534325,0.7763965623081646
3902,39497,UMPS,613891,258900;,[MIM:258900]Orotic aciduria 1;,Hereditary orotic aciduria,Disease-causing germline mutation(s) (loss of function) in,"Coronary artery disease[29212778;29212778;29212778];Coronary artery disease (myocardial infarction, percutaneous transluminal coronary angioplasty, coronary artery bypass grafting, angina or chromic ischemic heart disease)[28714975];",0.9120245398773006,0.36204228984012377,0.3111459149047246,0.29772866789441377
3903,39504,UNC13A,609894,,,Amyotrophic lateral sclerosis,Major susceptibility factor in,Amyotrophic lateral sclerosis (sporadic)[24256812;28931804];Amyotrophic lateral sclerosis in C9orf72 mutation positive individuals[22959728];Amyotrophic lateral sclerosis[19734901;22959728;24931836;29566793;27455348];Obesity-related traits[23251661];Frontotemporal dementia[24931836];,0.14576687116564419,1.0,0.20125293657008614,0.0
3904,39507,UNC13D,608897,608898;,[MIM:608898]Familial hemophagocytic lymphohistiocytosis 3;,Familial hemophagocytic lymphohistiocytosis,Disease-causing germline mutation(s) in,White matter hyperintensity burden[25663218;25663218];Eosinophil counts[27863252];Major depressive disorder[27777418];,0.22687116564417178,0.08457968024755029,0.18689637170451578,0.17756292203806015
3905,39509,UNC45B,611220,616279;,[MIM:616279]Cataract 43;,Early-onset posterior subcapsular cataract;Early-onset nuclear cataract,Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in,Systemic sclerosis[30247649];,0.20368098159509201,0.07013924703455389,0.21091098929783347,0.12384898710865562
3906,39512,UNC80,612636,616801;,"[MIM:616801]Hypotonia, infantile, with psychomotor retardation and characteristic facies 2 [recessive?];",Hypotonia-speech impairment-severe cognitive delay syndrome,Disease-causing germline mutation(s) (loss of function) in,,0.4331288343558282,0.7795255286230015,0.26938136256851997,0.2539901780233272
3907,39514,UNC93B1,608204,610551;,"[MIM:610551]Encephalopathy, acute, infection-induced, Herpes- specific, 1 [recessive?];",Herpes simplex virus encephalitis,Major susceptibility factor in,,0.7352147239263803,0.8058277462609592,0.5719133385539024,0.0
3908,39522,UNC119,604011,615518;,[MIM:615518]Immunodeficiency 13;,Cone rod dystrophy;Idiopathic CD4 lymphocytopenia,Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in,,0.5980368098159509,0.5079938112429088,0.7457582876533542,0.49386126457949664
3909,39525,UNG,191525,608106;,[MIM:608106]Immunodeficiency with hyper-IgM 5;,Hyper-IgM syndrome type 5,Disease-causing germline mutation(s) in,,0.4331288343558282,0.5061887570912842,0.7883059253458627,0.19060773480662985
3910,39532,UPB1,606673,613161;,[MIM:613161]Beta-ureidopropionase deficiency;,Beta-ureidopropionase deficiency,Disease-causing germline mutation(s) in,Acne (severe)[24927181];,0.08736196319018405,0.11062403300670448,0.6345601670582094,0.5584714548802947
3911,39539,UPF3B,300298,300676;,,X-linked intellectual disability with marfanoid habitus;X-linked non-syndromic intellectual disability,Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in,,0.8628220858895705,0.9610624033006705,0.7943095797441921,0.41006752608962554
3912,39544,UPK3A,611559,,,"Renal agenesis, unilateral",Disease-causing germline mutation(s) in,Pulmonary function in asthmatics[23541324];,0.10711656441717791,0.33084063950489945,0.5322370138345079,0.30356046654389196
3913,39554,UQCC2,614461,615824;,,Isolated complex III deficiency,Disease-causing germline mutation(s) in,Gait speed in old age[28077804];,0.6559509202453988,0.47601856627127387,0.5698251109370921,0.0
3914,39555,UQCC3,616097,616111;,"[MIM:616111]Mitochondrial complex III deficiency, nuclear 9;",Isolated complex III deficiency,Disease-causing germline mutation(s) in,Waist-to-hip ratio adjusted for BMI[26426971;26426971];Waist-to-hip ratio adjusted for BMI x sex x age interaction (4df test)[26426971;26426971];,0.17791411042944785,0.502578648788035,0.0,0.0
3915,39558,UQCRB,191330,615158;,"[MIM:615158]Mitochondrial complex III deficiency, nuclear 3;",Isolated complex III deficiency,Disease-causing germline mutation(s) in,Huntington's disease progression[28642124];,0.5450306748466258,0.516761217122228,0.4907334899504046,0.3483732351135666
3916,39563,UQCRC2,191329,615160;,"[MIM:615160]Mitochondrial complex III deficiency, nuclear 5;",Isolated complex III deficiency,Disease-causing germline mutation(s) in,,0.9565644171779141,0.3971119133574007,0.2790394152962673,0.22974217311233885
3917,39575,UQCRQ,612080,615159;,"[MIM:615159]Mitochondrial complex III deficiency, nuclear 4;",Isolated complex III deficiency,Disease-causing germline mutation(s) in,,0.741717791411043,0.5234657039711191,0.9412685982772122,0.4699201964395335
3918,39585,UROC1,613012,276880;,[MIM:276880]Urocanase deficiency;,Urocanic aciduria,Disease-causing germline mutation(s) in,Fast beta electroencephalogram[28040410];Post bronchodilator FEV1[26634245];,0.038773006134969326,0.05157297576070139,0.33202819107282694,0.1464088397790055
3919,39586,UROD,613521,176100;,[MIM:176100]Familial porphyria cutanea tarda [dominant?];[MIM:176100]Hepatoerythropoietic porphyria;,Familial porphyria cutanea tarda;Hepatoerythropoietic porphyria,Disease-causing germline mutation(s) (loss of function) in;Disease-causing germline mutation(s) in,,0.30319018404907977,0.1735430634347602,0.7191333855390237,0.6746470227133211
3920,39587,UROS,606938,263700;,,Congenital erythropoietic porphyria,Disease-causing germline mutation(s) (loss of function) in,Blood protein levels[29875488;30072576];,0.22687116564417178,0.4043321299638989,0.6682328373792743,0.6837016574585635
3921,39588,USB1,613276,604173;,[MIM:604173]Poikiloderma with neutropenia;,Dyskeratosis congenita;Poikiloderma with neutropenia,Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in,,0.35496932515337426,0.5100567302733368,0.41033672670321064,0.0
3922,39594,USH1C,605242,276900;276904;602092;,"[MIM:276904]Usher syndrome 1C;[MIM:602092]Deafness, autosomal recessive, 18A [recessive?];",Usher syndrome type 1;Autosomal recessive non-syndromic sensorineural deafness type DFNB,Disease-causing germline mutation(s) (loss of function) in;Disease-causing germline mutation(s) in,Body mass index[26426971;26426971];Night sleep phenotypes[27126917];,0.4154601226993865,0.1034038164002063,0.06865048290263638,0.06276856967464703
3923,39595,USH1E,602097,,,Usher syndrome type 1,Disease-causing germline mutation(s) in,,0.038773006134969326,0.0,0.0,0.0
3924,39596,USH1G,607696,276900;606943;,,Usher syndrome type 1,Disease-causing germline mutation(s) (loss of function) in,,0.28662576687116564,0.2576070139247035,0.38057948316366486,0.21531614487415593
3925,39597,USH1H,612632,,,Usher syndrome type 1,Disease-causing germline mutation(s) in,,0.038773006134969326,0.0,0.0,0.0
3926,39598,USH1K,614990,,,Usher syndrome type 1,Disease-causing germline mutation(s) in,,0.038773006134969326,0.0,0.0,0.0
3927,39599,USH2A,608400,276901;613809;,[MIM:276901]Usher syndrome 2A;[MIM:613809]Retinitis pigmentosa 39;,Retinitis pigmentosa;Usher syndrome type 2,Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in,Chronic mucus hypersecretion[25234806];,0.58,0.00025786487880350697,0.03027930044374837,0.06414978514426029
3928,39609,USP6,604334,,,Nodular fasciitis,Part of a fusion gene in,,0.23865030674846627,0.007478081485301702,0.03497781258157139,0.005371393492940454
3929,39611,USP7,602519,,,16p13.2 microdeletion syndrome,Role in the phenotype of,Platelet distribution width[27863252];Platelet count[27863252];,0.9788957055214724,0.8617844249613202,0.8794048551292091,0.8652547575199508
3930,39612,USP8,603158,219090;,"[MIM:219090]Pituitary adenoma 4, ACTH-secreting;",Autosomal recessive spastic paraplegia type 59;Cushing disease,Disease-causing germline mutation(s) in;Disease-causing somatic mutation(s) in,,0.8186503067484663,0.7351727694687984,0.29731140694335684,0.4607120933087784
3931,39614,USP9X,300072,300919;,,X-linked non-syndromic intellectual disability;X-linked female restricted facial dysmorphism-short stature-choanal atresia-intellectual disability,Disease-causing germline mutation(s) (loss of function) in;Disease-causing germline mutation(s) (loss of function) in,Migraine[27322543];,0.8034355828220859,1.0,0.8097102584181676,0.0
3932,39615,USP9Y,400005,415000;,[MIM:415000]Spermatogenic failure Y-linked 2;,Partial chromosome Y deletion,Role in the phenotype of,,0.5614723926380368,0.5195977307890666,0.32811276429130776,0.0
3933,39696,USP18,607057,617397;,[MIM:617397]Pseudo-TORCH syndrome 2 [recessive?];,USP18 deficiency,Disease-causing germline mutation(s) (loss of function) in,,0.4117791411042945,0.3550799381124291,0.7178282432785174,0.34208103130755063
3934,39705,USP27X,300975,300984;,"[MIM:300984]Mental retardation, X-linked 105;",X-linked non-syndromic intellectual disability,Disease-causing germline mutation(s) in,,0.38061349693251534,0.8782877772047447,0.9592795614722005,0.0
3935,39744,UTP4,607456,,,Hereditary North American Indian childhood cirrhosis,Disease-causing germline mutation(s) in,Body mass index[26426971];,0.7476073619631902,0.45074780814853016,0.0,0.0
3936,39761,UVSSA,614632,614640;,[MIM:614640]UV-sensitive syndrome 3 [recessive?];,UV-sensitive syndrome,Disease-causing germline mutation(s) in,Systolic blood pressure[26969751];Obesity-related traits[23251661];,0.6160736196319019,0.1186178442496132,0.458365961889846,0.0
3937,39765,VAC14,604632,617054;,"[MIM:617054]Striatonigral degeneration, childhood-onset [recessive?];",Yunis-Varon syndrome;Childhood-onset basal ganglia degeneration syndrome,Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in,Diffuse cutaneous systemic sclerosis[29293537];Docetaxel-induced peripheral neuropathy in metastatic castrate-resistant prostate cancer[27143689];Pulse pressure[28135244];High density lipoprotein cholesterol levels[28548082];,0.8495705521472393,0.6779267663744198,0.6395197076481336,0.6206261510128913
3938,39767,VAMP1,185880,108600;,"[MIM:108600]Spastic ataxia 1, autosomal dominant [dominant?];",Autosomal dominant spastic ataxia type 1;Presynaptic congenital myasthenic syndromes,Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in,Hip geometry[17903296];,0.30319018404907977,0.46157813305827744,0.9762464108587836,0.0
3939,39772,VAMP7,300053,,,"46,XY partial gonadal dysgenesis",Role in the phenotype of,,0.8895705521472392,0.35095410005157296,0.7930044374836858,0.13182934315531
3940,39775,VANGL1,610132,182940;600145;,[MIM:600145]Sacral defect with anterior meningocele [dominant?];,Caudal regression sequence;Upper thoracic spina bifida cystica;Cervicothoracic spina bifida cystica;Cervical spina bifida cystica;Lumbosacral spina bifida cystica;Thoracolumbosacral spina bifida cystica;Total spina bifida cystica;Upper thoracic spina bifida aperta;Thoracolumbosacral spina bifida aperta;Lumbosacral spina bifida aperta;Cervical spina bifida aperta;Cervicothoracic spina bifida aperta;Total spina bifida aperta,Major susceptibility factor in;Major susceptibility factor in;Major susceptibility factor in;Major susceptibility factor in;Major susceptibility factor in;Major susceptibility factor in;Major susceptibility factor in;Major susceptibility factor in;Major susceptibility factor in;Major susceptibility factor in;Major susceptibility factor in;Major susceptibility factor in;Major susceptibility factor in,Gut microbiota (bacterial taxa)[27694959];Itch intensity from mosquito bite adjusted by bite size[28199695];,0.9543558282208588,0.4484270242392986,0.26494387888279824,0.8850521792510743
3941,39776,VANGL2,600533,182940;,[MIM:182940]Neural tube defects;,Upper thoracic spina bifida cystica;Cervicothoracic spina bifida cystica;Cervical spina bifida cystica;Lumbosacral spina bifida cystica;Thoracolumbosacral spina bifida cystica;Total spina bifida cystica;Upper thoracic spina bifida aperta;Thoracolumbosacral spina bifida aperta;Lumbosacral spina bifida aperta;Cervical spina bifida aperta;Cervicothoracic spina bifida aperta;Total spina bifida aperta;Isolated anencephaly/exencephaly,Major susceptibility factor in;Major susceptibility factor in;Major susceptibility factor in;Major susceptibility factor in;Major susceptibility factor in;Major susceptibility factor in;Major susceptibility factor in;Major susceptibility factor in;Major susceptibility factor in;Major susceptibility factor in;Major susceptibility factor in;Major susceptibility factor in;Major susceptibility factor in,Cognitive performance[19734545];Multiple sclerosis[24076602];Systemic lupus erythematosus[28714469];,0.8132515337423313,0.8280041258380608,0.7058209344818586,0.899938612645795
3942,39778,VAPB,605704,182980;608627;,"[MIM:182980]Spinal muscular atrophy, proximal, adult, autosomal dominant [dominant?];",Amyotrophic lateral sclerosis;Autosomal dominant adult-onset proximal spinal muscular atrophy,Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in,,0.9948466257668712,0.7588963383187209,0.8300704776820673,0.557243707796194
3943,39779,VARS,192150,617802;,"[MIM:617802]Neurodevelopmental disorder with microcephaly, seizures, and cortical atrophy [recessive?];",Combined oxidative phosphorylation defect type 20,Disease-causing germline mutation(s) in,Inflammatory bowel disease[28067908];Sarcoidosis (Lofgren's syndrome vs non-Lofgren's syndrome)[26651848];Autism spectrum disorder or schizophrenia[28540026;28540026;28540026;28540026;28540026;28540026;28540026;28540026;28540026;28540026;28540026;28540026;28540026;28540026;28540026;28540026;28540026;28540026];Mosquito bite size[28199695];Monocyte count[27863252;27863252];Blood protein levels[28240269;28240269;28240269;28240269];Ulcerative colitis[28067908];,0.9438036809815951,0.501031459515214,0.03288958496476116,0.26243093922651933
3944,39780,VARS2,612802,615917;,[MIM:615917]Combined oxidative phosphorylation deficiency 20;,Combined oxidative phosphorylation defect type 20,Disease-causing germline mutation(s) in,Conotruncal heart defects (maternal effects)[28468790;28468790];Pubertal anthropometrics[23449627];HIV-1 control[20041166];Gestational age at birth (maternal effect)[28877031];Autism spectrum disorder or schizophrenia[28540026;28540026;28540026;28540026;28540026;28540026;28540026;28540026;28540026;28540026;28540026;28540026;28540026;28540026;28540026;28540026;28540026];Squamous cell lung carcinoma[28604730];Ulcerative colitis[20848476];,0.8202453987730062,0.036616812790097986,0.022970503784912555,0.008440761203192142
3945,39796,VCAN,118661,143200;,[MIM:143200]Wagner vitreoretinopathy;,Wagner disease,Disease-causing germline mutation(s) in,White matter integrity (fractional anisotropy)[29752348;29752348];Joint mobility (Beighton score)[27182965];Laryngeal squamous cell carcinoma[25194280];White matter integrity (mean diffusivity)[29752348;29752348];Diisocyanate-induced asthma[25918132];Lean body mass[28724990];Vertical cup-disc ratio[28073927;28073927];White matter hyperintensity volume[29752348;29752348];Major depressive disorder[20516156];Appendicular lean mass[28724990];,0.3856441717791411,0.9288292934502321,0.05037849125554685,0.9739103744628607
3946,39798,VCL,193065,611407;613255;,"[MIM:611407]Cardiomyopathy, dilated 1W;[MIM:613255]Cardiomyopathy, familial hypertrophic 15;",Familial isolated dilated cardiomyopathy,Disease-causing germline mutation(s) in,Primary tooth development (time to first tooth eruption)[23704328];Left ventricular internal dimension in diastole[29403010];Primary tooth development (number of teeth)[23704328];,0.8550920245398773,0.8041516245487365,0.43670060036543984,0.28084714548802947
3947,39799,VCP,601023,167320;613954;616687;,"[MIM:167320]Inclusion body myopathy with early-onset Paget disease with or without frontotemporal dementia 1 [dominant?];[MIM:613954]Amyotrophic lateral sclerosis 14, with or without frontotemporal dementia;[MIM:616687]Charcot-Marie-Tooth disease 2Y [dominant?];",Amyotrophic lateral sclerosis;Frontotemporal dementia with motor neuron disease;Behavioral variant of frontotemporal dementia;Spastic paraplegia-Paget disease of bone syndrome;Adult-onset distal myopathy due to VCP mutation;Autosomal dominant Charcot-Marie-Tooth disease type 2Y;Inclusion body myopathy with Paget disease of bone and frontotemporal dementia;Progressive non-fluent aphasia,Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Major susceptibility factor in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Major susceptibility factor in,Response to quetiapine in schizophrenia[29503163];,0.9703067484662576,0.8839608045384219,0.9081179848603498,0.0
3948,39830,VDR,601769,277440;607948;,[MIM:277440]Rickets vitamin D-dependent 2A;,Hypocalcemic vitamin D-resistant rickets,Disease-causing germline mutation(s) in,Inflammatory bowel disease[23128233];Gout[22179738];Menarche (age at onset)[25231870];Gut microbiota (beta diversity)[27723756];,0.6186503067484662,0.26792160907684376,0.7415818324197337,0.9215776550030693
3949,39833,VEGFC,601528,615907;,"[MIM:615907]Lymphedema, hereditary, 1D;",Milroy disease,Disease-causing germline mutation(s) in,Serum total protein level[29403010];HIV-1 viral setpoint[22174851];Chin dimples[27182965];Blood protein levels[29875488;30072576];Serum albumin level[29403010];Idiopathic dilated cardiomyopathy[29495422];Intraocular pressure[29785010];,0.27361963190184047,0.725373904074265,0.6543983294179065,0.6149478207489257
3950,39852,VHL,608537,144700;171300;193300;263400;,"[MIM:171300]Pheochromocytoma;[MIM:193300]von Hippel-Lindau disease;[MIM:263400]Erythrocytosis, familial, 2 [recessive?];[MIM:144700]Renal cell carcinoma;",Von Hippel-Lindau disease;Sporadic pheochromocytoma;Chuvash erythrocytosis;Hereditary pheochromocytoma-paraganglioma,Disease-causing germline mutation(s) in;Major susceptibility factor in;Disease-causing germline mutation(s) (loss of function) in;Disease-causing germline mutation(s) in,,0.7541104294478528,0.5734914904589995,0.9133385539023754,0.9097605893186004
3951,39856,VIM,193060,116300;,"[MIM:116300]Cataract 30, multiple types;",Pulverulent cataract,Disease-causing germline mutation(s) in,"Total cholesterol levels[28334899];Cholesterol, total[24097068];",0.9656441717791411,0.816400206291903,0.844688070999739,0.8902701043585022
3952,39860,VIPAS39,613401,613404;,"[MIM:613404]Arthrogryposis, renal dysfunction and cholestasis syndrome 2;",Arthrogryposis-renal dysfunction-cholestasis syndrome,Disease-causing germline mutation(s) in,,0.8031901840490797,0.11758638473439917,0.6416079352649439,0.0
3953,39867,VKORC1,608547,122700;607473;,[MIM:607473]Combined deficiency of vitamin K-dependent clotting factors 2;[MIM:122700]Coumarin resistance;,Vitamin K antagonists toxicity or dose selection;Resistance to vitamin K antagonists;Hereditary combined deficiency of vitamin K-dependent clotting factors,Biomarker tested in;Biomarker tested in;Disease-causing germline mutation(s) in,Warfarin maintenance dose[20833655;18535201;19300499;26265036];,0.8561963190184049,0.3231046931407942,0.9650221874184286,0.0
3954,39871,VLDLR,192977,224050;,"[MIM:224050]Cerebellar ataxia, mental retardation, and dysequilibrium syndrome 1;",Dysequilibrium syndrome,Disease-causing germline mutation(s) in,"Systolic blood pressure[26969751];Gambling[22780124;22780124];Vascular endothelial growth factor levels[21757650;26910538;26910538;27989323];Hematocrit[27863252];LDL cholesterol levels[28334899];Alzheimer's disease (age of onset)[22005931];Cholesterol, total[24097068];LDL cholesterol[24097068];Hemoglobin concentration[27863252];",0.4,0.09128416709644147,0.3688332028191073,0.9022406384284838
3955,39873,VMA21,300913,310440;,"[MIM:310440]Myopathy, X-linked, with excessive autophagy;",X-linked myopathy with excessive autophagy,Disease-causing germline mutation(s) in,,0.9198773006134969,0.5306859205776173,0.3949360480292352,0.0
3956,40014,VPS4B,609983,,,Dentin dysplasia type I,Disease-causing germline mutation(s) (loss of function) in,Pyoderma gangrenosum in inflammatory bowel disease[24487271];,0.5430674846625767,0.5237235688499227,0.8042286609240408,0.6345917740945365
3957,40018,VPS11,608549,616683;,,VPS11-related autosomal recessive hypomyelinating leukodystrophy,Disease-causing germline mutation(s) (loss of function) in,Coronary artery disease[29212778];,0.6528834355828221,0.2741103661681279,0.10910989297833464,0.0
3958,40019,VPS13A,605978,200150;,,Choreoacanthocytosis,Disease-causing germline mutation(s) in,Reticulocyte fraction of red cells[27863252];Reticulocyte count[27863252];Mortality in sepsis[27639821];,0.6878527607361963,0.5144404332129964,0.3093187157400157,0.0807243707796194
3959,40021,VPS13B,607817,216550;,,Cohen syndrome,Disease-causing germline mutation(s) in,Glucose homeostasis traits[25524916];Cough in response to angiotensin-converting enzyme inhibitor drugs[28084903];Nose morphology[29921221];,0.7730061349693251,0.5211449200618876,0.03784912555468546,0.059085328422345
3960,40022,VPS13C,608879,616840;,,Young-onset Parkinson disease,Disease-causing germline mutation(s) (loss of function) in,Glaucoma (primary open-angle)[29891935];Body mass index[28892062;28892062];Parkinson's disease[25064009;28892059];Fasting blood glucose[22581228];Breast size[27182965];Schizophrenia[28991256];Two-hour glucose challenge[20081857];Fasting blood glucose (BMI interaction)[22581228];Proinsulin levels[21873549];Asthma[29273806;29273806];Intraocular pressure[30054594;29785010];,0.6817177914110429,0.004383702939659618,0.07569825110937092,0.028698588090853284
3961,40035,VPS33A,610034,617303;,[MIM:617303]Mucopolysaccharidosis-plus syndrome [recessive?];,Mucopolysaccharidosis-like syndrome with congenital heart defects and hematopoietic disorders,Disease-causing germline mutation(s) in,,0.7693251533742331,0.7248581743166581,0.3596972069955625,0.3096992019643953
3962,40036,VPS33B,608552,208085;,"[MIM:208085]Arthrogryposis, renal dysfunction and cholestasis syndrome 1;",Arthrogryposis-renal dysfunction-cholestasis syndrome,Disease-causing germline mutation(s) in,,0.863558282208589,0.051830840639504897,0.6979900809188202,0.13720073664825047
3963,40038,VPS35,601501,614203;,,Hereditary late-onset Parkinson disease,Disease-causing germline mutation(s) in,,0.8750920245398773,0.9087158329035585,0.7543722265726964,0.43784530386740333
3964,40042,VPS37A,609927,614898;,,Autosomal recessive spastic paraplegia type 53,Disease-causing germline mutation(s) in,Schizophrenia[28991256];Tonometry[17903302];,0.2498159509202454,0.5727178958225889,0.7394936048029235,0.28882750153468384
3965,40048,VPS45,610035,615285;,,Congenital neutropenia-myelofibrosis-nephromegaly syndrome,Disease-causing germline mutation(s) in,Obesity in adult survivors of childhood cancer not exposed to cranial radiation[25963547];Uric acid levels[21294900;21294900];Schizophrenia[25056061];,0.9474846625766871,0.23130479628674575,0.4333072304881232,0.1309085328422345
3966,40052,VPS53,615850,615851;,[MIM:615851]Pontocerebellar hypoplasia 2E;,Progressive cerebello-cerebral atrophy,Disease-causing germline mutation(s) in,Waist circumference adjusted for BMI (joint analysis main effects and physical activity interaction)[28448500;28448500];Waist circumference adjusted for body mass index[28448500;28448500;28448500];Prostate cancer[23535732];Waist circumference adjusted for BMI in active individuals[28448500;28448500];,0.5213496932515338,0.5471892728210418,0.19211694074654137,0.12231430325352978
3967,40055,VRK1,602168,607596;,[MIM:607596]Pontocerebellar hypoplasia 1A;,Pontocerebellar hypoplasia type 1;Microcephaly-complex motor and sensory axonal neuropathy syndrome,Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in,Staphylococcus aureus infection[24847357];Copper levels[26025379];Bone ultrasound measurement (velocity of sound)[28472463];Night sleep phenotypes[27126917];Neutrophil count[21507922];Cognitive function[24684796];Carboplatin disposition in epthelial ovarian cancer[29367611];,0.43754601226993867,0.6044352759154203,0.8480814408770556,0.11786372007366483
3968,40060,VSIG2,606011,,,Cystathioninuria,Disease-causing germline mutation(s) (loss of function) in,Autism spectrum disorder or schizophrenia[28540026];Schizophrenia[25056061];Blood protein levels[28240269];,0.36171779141104293,0.3011861784424961,0.44113808405116156,0.23603437691835483
3969,40075,VSX1,605020,148300;614195;,[MIM:614195]Craniofacial anomalies and anterior segment dysgenesis syndrome;,Posterior polymorphous corneal dystrophy,Disease-causing germline mutation(s) in,,0.22687116564417178,0.5924445590510572,0.43539545810493346,0.0
3970,40076,VSX2,142993,610092;610093;,"[MIM:610092]Microphthalmia with cataracts and iris abnormalities;[MIM:610092]Microphthalmia, isolated, with coloboma, 3;",Isolated microphthalmia-anophthalmia-coloboma;Colobomatous microphthalmia,Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in,Inflammatory bowel disease[28008999];,0.26588957055214724,0.28855079938112427,0.42808666144609764,0.6947513812154696
3971,40110,VWF,613160,193400;277480;613554;,[MIM:193400]von Willebrand disease 1;[MIM:613554]von Willebrand disease 2;[MIM:277480]von Willebrand disease 3;,Von Willebrand disease type 1;Von Willebrand disease type 2A;Von Willebrand disease type 2M;Von Willebrand disease type 2B;Von Willebrand disease type 2N;Von Willebrand disease type 3,Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in,Mean platelet volume[22139419;27863252];vWF levels in ischaemic stroke and hyperhomocysteinaemia[28495826];Coagulation factor levels[23267103;23267103];Blood protein levels[29875488;30072576;30072576];vWF levels[20231535];Platelet count[22139419;26805783];Factor VIII levels[20231535];Low vWF levels[26486471];,0.3492024539877301,0.7552862300154719,0.015139650221874185,0.9223449969306323
3972,40113,WAC,615049,616708;,[MIM:616708]DeSanto-Shinawi syndrome [dominant?];,Facial dysmorphism-developmental delay-behavioral abnormalities syndrome due to 10p11.21p12.31 microdeletion;Facial dysmorphism-developmental delay-behavioral abnormalities syndrome due to WAC point mutation,Role in the phenotype of;Disease-causing germline mutation(s) (loss of function) in,Multiple myeloma[27363682];Intraocular pressure[29617998];,0.64920245398773,0.6993295513151109,0.36021926389976505,0.5148864333947207
3973,40117,WARS2,604733,617710;,,Autosomal recessive non-syndromic intellectual disability,Disease-causing germline mutation(s) in,Waist-to-hip ratio adjusted for BMI (adjusted for smoking behaviour)[28443625;28443625;28443625];Waist circumference adjusted for BMI in non-smokers[28443625;28443625;28443625];Waist-to-hip ratio adjusted for BMI in active individuals[28448500;28448500;28448500;28448500;28448500;28448500;28448500];Waist-to-hip ratio adjusted for BMI (joint analysis for main effect and physical activity interaction)[28448500;28448500;28448500;28448500;28448500;28448500];Waist-to-hip ratio adjusted for BMI in non-smokers[28443625;28443625];Waist circumference adjusted for BMI (adjusted for smoking behaviour)[28443625;28443625;28443625];Waist circumference adjusted for body mass index[25673412;25673412;25673412];Waist-hip ratio[20935629;25673412;25673412];Body mass index[28892062];Male-pattern baldness[29146897;29146897];Waist-to-hip ratio adjusted for BMI (joint analysis main effects and smoking interaction)[28443625;28443625];Monobrow[27182965];Waist circumference adjusted for BMI (joint analysis main effects and smoking interaction)[28443625;28443625;28443625];Waist-to-hip ratio adjusted for BMI in inactive individuals[28448500];Waist-to-hip ratio adjusted for body mass index[28448500;28448500;28448500;28448500;25673412;25673412;25673412;25673412;25673412;25673412;28448500];,0.8728834355828221,0.5296544610624033,0.2761681023231532,0.4843462246777164
3974,40122,WAS,300392,300299;301000;313900;,"[MIM:301000]Wiskott-Aldrich syndrome;[MIM:313900]Thrombocytopenia 1;[MIM:300299]Neutropenia, severe congenital, X-linked;",Wiskott-Aldrich syndrome;X-linked thrombocytopenia with normal platelets;X-linked severe congenital neutropenia,Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in,,0.583558282208589,0.9102630221763796,0.7995301487862176,0.0
3975,40143,WASHC4,615748,615817;,"[MIM:615817]Mental retardation, autosomal recessive 43 [recessive?];",Autosomal recessive non-syndromic intellectual disability,Disease-causing germline mutation(s) in,,0.8517791411042944,0.7367199587416194,0.0,0.0
3976,40144,WASHC5,610657,220210;603563;,[MIM:220210]Ritscher-Schinzel syndrome 1;,3C syndrome;Autosomal dominant spastic paraplegia type 8,Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in,Amyotrophic lateral sclerosis or frontotemporal dementia[24931836];Response to statin therapy[20339536];Amyotrophic lateral sclerosis[24931836];,0.8775460122699387,0.23568849922640536,0.0,0.0
3977,40163,WBP2,606962,617639;,"[MIM:617639]Deafness, autosomal recessive, 107 [recessive?];",Autosomal recessive non-syndromic sensorineural deafness type DFNB,Disease-causing germline mutation(s) in,,0.6541104294478528,0.6459515214027849,0.8052727747324459,0.4909453652547575
3978,40179,WDPCP,613580,217085;615992;,"[MIM:615992]Bardet-Biedl syndrome 15 [recessive?];[MIM:217085]Congenital heart defects, hamartomas of tongue, and polysyndactyly;",Meckel syndrome;Heart defect-tongue hamartoma-polysyndactyly syndrome;Bardet-Biedl syndrome,Candidate gene tested in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in,Childhood ear infection[27182965];Cutaneous malignant melanoma[26237428];Obesity-related traits[23251661];,0.038773006134969326,0.0,0.4643696162881754,0.0
3979,40182,WDR4,605924,,,Galloway-Mowat syndrome,Disease-causing germline mutation(s) in,Fasting plasma glucose[28270201;28270201];Blood and toenail selenium levels[25343990];,0.4750920245398773,0.18231046931407943,0.11563560428086661,0.13904235727440148
3980,40188,WDR11,606417,614858;,[MIM:614858]Hypogonadotropic hypogonadism 14 with or without anosmia;,Kallmann syndrome;Normosmic congenital hypogonadotropic hypogonadism;Pituitary stalk interruption syndrome,Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Candidate gene tested in,Adiponectin levels[24105470];Prostate-specific antigen levels (conditioned on lead SNPs)[28139693;28139693];Prostate-specific antigen levels[28139693;28139693;28139693;28139693];Obesity-related traits[23251661];,0.9317791411042945,0.2859721505930892,0.6533542156095015,0.7745549416820136
3981,40194,WDR19,608151,614376;614377;614378;616307;,[MIM:614378]Cranioectodermal dysplasia 4;[MIM:614376]Short-rib thoracic dysplasia 5 with or without polydactyly [recessive?];[MIM:614377]Nephronophthisis 13 [recessive?];[MIM:616307]Senior-Loken syndrome 8;,Jeune syndrome;Cranioectodermal dysplasia;Senior-Loken syndrome;Juvenile nephronophthisis,Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in,Cognitive function[24684796];,0.5203680981595092,0.6970087674058794,0.28843643957191334,0.3218232044198895
3982,40198,WDR26,617424,617616;,[MIM:617616]Skraban-Deardorff syndrome [dominant?];,Intellectual disability-seizures-abnormal gait-facial dysmorphism syndrome,Disease-causing germline mutation(s) (loss of function) in,White blood cell count[27863252];Major depressive disorder[21042317];,0.754478527607362,0.955002578648788,0.9297833463847559,0.0
3983,40202,WDR34,613363,615633;,,"Jeune syndrome;Short rib-polydactyly syndrome, Verma-Naumoff type",Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in,Body mass index[26426971];Eating disorders (purging via substances)[23568457];Axial length[24144296];,0.6483435582822086,0.3806085611139763,0.6927695118767946,0.16881522406384286
3984,40203,WDR35,613602,613610;614091;,"[MIM:613610]Cranioectodermal dysplasia 2;[MIM:614091]Short-rib thoracic dysplasia 7 with or without polydactyly [recessive?];[MIM:614091]Short-rib thoracic dysplasia 7/20 with polydactyly, digenic;","Cranioectodermal dysplasia;Short rib-polydactyly syndrome type 5;Short rib-polydactyly syndrome, Verma-Naumoff type",Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) (loss of function) in;Disease-causing germline mutation(s) in,Coronary heart disease[22751097];Facial morphology[29921221;29921221];,0.6723926380368098,0.15755544094894275,0.06551814147742104,0.28621853898096994
3985,40210,WDR45,300526,300894;,,Beta-propeller protein-associated neurodegeneration,Disease-causing germline mutation(s) in,,0.6871165644171779,0.9051057246003095,0.7515009135995824,0.4607120933087784
3986,40216,WDR48,612167,,,Autosomal recessive spastic paraplegia type 60,Disease-causing germline mutation(s) in,Social communication problems[24564958];,0.7476073619631902,0.9110366168127901,0.8470373270686505,0.6594536525475752
3987,40222,WDR60,615462,615503;,,"Jeune syndrome;Short rib-polydactyly syndrome, Verma-Naumoff type",Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in,Height[18391950];,0.629079754601227,0.10907684373388345,0.1968154528843644,0.18615715162676488
3988,40224,WDR62,613583,604317;,,Autosomal recessive primary microcephaly,Disease-causing germline mutation(s) in,,0.7852760736196319,0.42392986075296546,0.370399373531715,0.08578882750153469
3989,40227,WDR66,618146,,,Non-syndromic male infertility due to sperm motility disorder,Disease-causing germline mutation(s) in,Mean platelet volume[19110211;19820697;24026423;22139419;27863252];Urinary metabolites[21572414];Blood metabolite levels[24816252];Platelet count[22139419];,0.08736196319018405,0.1260959257349149,0.009135995823544766,0.03238182934315531
3990,40229,WDR72,613214,613211;,"[MIM:613211]Amelogenesis imperfecta, hypomaturation type, 2A3;",Hypomaturation amelogenesis imperfecta,Disease-causing germline mutation(s) in,Sodium levels[29403010];Creatinine levels[29403010];Lead levels[26025379];Renal function-related traits (sCR)[22797727];Chronic kidney disease[20383146];Longevity[20834067];Renal function-related traits (eGRFcrea)[22797727];Blood urea nitrogen levels[29403010];Asthma[27611488];Glomerular filtration rate[27588450;27588450;27588450;29403010];Renal function-related traits (BUN)[22797727];Glomerular filtration rate in non diabetics (creatinine)[26831199];Chloride levels[29403010];Cognitive function[22126837];Potassium levels[29403010];Hematological and biochemical traits[20139978];Glomerular filtration rate (creatinine)[26831199;28452372];,0.038773006134969326,0.03378029912325941,0.01644479248238058,0.0216390423572744
3991,40230,WDR73,616144,251300;,[MIM:251300]Galloway-Mowat syndrome 1 [recessive?];,Galloway-Mowat syndrome;CAMOS syndrome,Disease-causing germline mutation(s) (loss of function) in;Disease-causing germline mutation(s) in,Autism spectrum disorder or schizophrenia[28540026];Periodontitis (CDC/AAP)[24024966];,0.27975460122699386,0.12325941206807632,0.16027146959018532,0.1329036218538981
3992,40236,WDR81,614218,610185;,,Dysequilibrium syndrome,Disease-causing germline mutation(s) in,Calcium levels[20705733;24068962];Serum albumin level[23022100;23022100];,0.5460122699386503,0.6106240330067045,0.0709997389715479,0.3543585021485574
3993,40257,WEE2,614084,,,Female infertility due to oocyte meiotic arrest,Disease-causing germline mutation(s) (loss of function) in,Anorexia nervosa[23568457];,0.038773006134969326,0.6841155234657039,0.6371704515792221,0.17587476979742173
3994,40274,WFS1,606201,116400;222300;600965;614296;,"[MIM:222300]Wolfram syndrome 1;[MIM:600965]Deafness, autosomal dominant, 6 [dominant?];[MIM:614296]Wolfram-like syndrome autosomal dominant [dominant?];[MIM:116400]Cataract 41;",Wolfram syndrome;Wolfram-like syndrome;Autosomal dominant non-syndromic sensorineural deafness type DFNA;Early-onset nuclear cataract,Disease-causing germline mutation(s) (loss of function) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in,Type 2 diabetes[20581827;24509480;22885922;22885922;22885922;29358691;28869590;28869590];Type 2 diabetes and other traits[19734900];Cisplatin-induced ototoxicity[28039263];,0.6861349693251534,0.16761217122227953,0.04385277995301488,0.9772866789441375
3995,40280,WHRN,607928,607084;611383;,"[MIM:607084]Deafness, autosomal recessive, 31 [recessive?];[MIM:611383]Usher syndrome 2D;",Usher syndrome type 2;Autosomal recessive non-syndromic sensorineural deafness type DFNB,Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in,Depressive episodes in bipolar disorder[26297903];Obesity-related traits[23251661];Survival in pancreatic cancer[28470677];Depressive and manic episodes in bipolar disorder[26297903];,0.33975460122699386,0.3323878287777205,0.0,0.0
3996,40283,WIPF1,602357,614493;,[MIM:614493]Wiskott-Aldrich syndrome 2;,Wiskott-Aldrich syndrome,Disease-causing germline mutation(s) in,Resting heart rate[27798624];Atrial fibrillation[30061737;29892015;29892015];Urate levels (BMI interaction)[25811787];,0.5353374233128835,0.666838576585869,0.8282432785173584,0.7200736648250461
3997,40291,WNK1,605232,201300;614492;,"[MIM:614492]Pseudohypoaldosteronism 2C [dominant?];[MIM:201300]Neuropathy, hereditary sensory and autonomic, 2A [recessive?];",Hereditary sensory and autonomic neuropathy type 2;Pseudohypoaldosteronism type 2C,Disease-causing germline mutation(s) (loss of function) in;Disease-causing germline mutation(s) in,Body mass index[25673413;25673413;25673413];Manganese levels[26025379];Stroke[19369658;19369658;19369658;19369658];Lung cancer in ever smokers[28604730];Lung cancer[28604730];Squamous cell lung carcinoma[28604730];Eosinophil counts[27863252];Blood protein levels[29875488];Eosinophil percentage of white cells[27863252];Paclitaxel disposition in epithelial ovarian cancer[29367611];,0.8666257668711657,0.2596699329551315,0.04489689376142,0.32903621853898096
3998,40294,WNK4,601844,614491;,[MIM:614491]Pseudohypoaldosteronism 2B [dominant?];,Pseudohypoaldosteronism type 2B,Disease-causing germline mutation(s) in,,0.6110429447852761,0.5136668385765859,0.17854346123727485,0.08839779005524862
3999,40295,WNT1,164820,166710;615066;615220;615221;,[MIM:166710]Osteoporosis;[MIM:615220]Osteogenesis imperfecta 15 [recessive?];[MIM:615066]Osteogenesis imperfecta 14 [recessive?];,Osteogenesis imperfecta type 3;Osteogenesis imperfecta type 4;Idiopathic juvenile osteoporosis,Disease-causing germline mutation(s) (loss of function) in;Disease-causing germline mutation(s) (loss of function) in;Major susceptibility factor in,Heel bone mineral density[28869591;28869591;28869591];,0.32380368098159507,0.6299638989169675,0.723048812320543,0.5044505831798649
4000,40298,WNT3,165330,273395;,[MIM:273395]Tetraamelia syndrome 1 [recessive?];,Tetraamelia-multiple malformations syndrome,Disease-causing germline mutation(s) (loss of function) in,Parkinson's disease[21812969;22451204];Alzheimer's disease in APOE e4- carriers[25778476];Atrial fibrillation[30061737];Hematocrit[27863252];Red blood cell count[27863252];General cognitive ability[29844566];Hemoglobin concentration[27863252];Lung function (FVC)[30061609;30061609];Body mass index[26426971];Male-pattern baldness[29146897;29146897;29146897];Intelligence (MTAG)[29326435];Itch intensity from mosquito bite adjusted by bite size[28199695];Multiple system atrophy[27629089];Reaction time[29844566];Lung function (FEV1)[30061609;30061609;30061609];Cognitive function[28093568];Post bronchodilator FEV1[26634245];Intraocular pressure[29785010];,0.14576687116564419,0.8586900464156781,0.9686765857478465,0.8388581952117864
4001,40299,WNT3A,606359,,,Idiopathic juvenile osteoporosis,Major susceptibility factor in,Diastolic blood pressure[28135244];,0.4298159509202454,0.853017019082001,0.8809710258418167,0.5624616329036218
4002,40300,WNT4,603490,158330;611812;,"[MIM:611812]46,XX sex reversal with dysgenesis of kidneys, adrenals, and lungs;[MIM:158330]Mullerian aplasia and hyperandrogenism;",SERKAL syndrome;M�llerian aplasia and hyperandrogenism,Disease-causing germline mutation(s) (loss of function) in;Disease-causing germline mutation(s) (loss of function) in,"Bone mineral density (total hip)[29883787];Bone mineral density (paediatric, lower limb)[24945404;24945404];TB-LM or TBLH-BMD (pleiotropy)[28743860];Gestational age at birth (maternal effect)[28877031];Bone mineral density (paediatric, skull)[24945404;24945404];Colorectal cancer[25990418];Heel bone mineral density[28869591;28869591;28869591;28869591;28869591;28869591];Endometriosis[23472165;23472165;23472165;20601957;23104006;28537267;28537267;28333195;23472165;28537267];Daytime sleep phenotypes[27126917];Uterine fibroids[30194396];Dupuytren's disease[21732829;28886342];Hip circumference adjusted for BMI[25673412;25673412];Epithelial ovarian cancer[25581431;25581431];Bone mineral density (paediatric, total body less head)[24945404;24945404;28743860];Bone mineral density[22504420];Deep ovarian and/or rectovaginal disease with dense adhesions[28333195];Birth weight[27680694];Obesity-related traits[23251661];Bone mineral density (paediatric, upper limb)[24945404;24945404];",0.36171779141104293,0.6235172769468799,0.8238057948316366,0.4429097605893186
4003,40301,WNT5A,164975,180700;,"[MIM:180700]Robinow syndrome, autosomal dominant 1 [dominant?];",Autosomal dominant Robinow syndrome,Disease-causing germline mutation(s) in,Type 2 diabetes[30130595];Lung function (FEV1/FVC)[28166213];Carboplatin disposition in epthelial ovarian cancer[29367611];,0.4298159509202454,0.9189014956162971,0.8379013312451057,0.0
4004,40305,WNT7A,601570,228930;276820;,[MIM:276820]Limb pelvis hypoplasia aplasia syndrome;[MIM:228930]Fuhrmann syndrome;,"Phocomelia, Schinzel type;Fuhrmann syndrome",Disease-causing germline mutation(s) (loss of function) in;Disease-causing germline mutation(s) (loss of function) in,Body mass index[26426971];Chronic obstructive pulmonary disease-related biomarkers[23144326];Response to cognitive-behavioural therapy in anxiety disorder[26989097];Glomerular filtration rate (creatinine)[26831199];,0.38061349693251534,0.5036101083032491,0.8598277212216131,0.5515653775322283
4005,40311,WNT10A,606268,150400;224750;257980;,"[MIM:257980]Odonto-onycho-dermal dysplasia [recessive?];[MIM:224750]Schopf-Schulz-Passarge syndrome;[MIM:150400]Tooth agenesis, selective, 4 [dominant?] [recessive?];",Odonto-onycho-dermal dysplasia;Autosomal recessive hypohidrotic ectodermal dysplasia;Sch�pf-Schulz-Passarge syndrome;Oligodontia,Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in,Common traits (Other)[20585627];Male-pattern baldness[27182965;29146897];Tooth agenesis[29364747];Central corneal thickness[29760442];Hair shape[29220522];Hair morphology[19896111];,0.038773006134969326,0.352501289324394,0.4727225267554163,0.0
4006,40312,WNT10B,601906,225300;617073;,"[MIM:225300]Split-hand/foot malformation 6;[MIM:617073]Tooth agenesis, selective, 8 [dominant?];",Isolated split hand-split foot malformation;Oligodontia,Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in,,0.17791411042944785,0.742135121196493,0.743670060036544,0.17664211172498465
4007,40315,WRAP53,612661,613988;,"[MIM:613988]Dyskeratosis congenita, autosomal recessive, 3 [recessive?];",Dyskeratosis congenita,Disease-causing germline mutation(s) in,Cognitive function[28093568];,0.038773006134969326,0.3004125838060856,0.19342208300704777,0.18139963167587478
4008,40319,WRN,604611,114500;277700;,[MIM:277700]Werner syndrome [recessive?];[MIM:114500]Colorectal cancer;,Werner syndrome,Disease-causing germline mutation(s) in,Intelligence (MTAG)[29326435];Exercise treadmill test traits[17903301];Cough in response to angiotensin-converting enzyme inhibitor drugs[28084903];Daytime sleep phenotypes[27126917];Lifespan[25918517];,0.7026993865030675,0.009025270758122744,0.17227877838684416,0.012430939226519336
4009,40327,WT1,607102,136680;156240;194070;194080;256370;608978;,"[MIM:136680]Frasier syndrome [dominant?];[MIM:194070]Wilms tumor 1;[MIM:194080]Denys-Drash syndrome [dominant?];[MIM:256370]Nephrotic syndrome 4;[MIM:608978]Meacham syndrome;[MIM:156240]Mesothelioma, malignant;","WAGR syndrome;Nephroblastoma;Nephroblastoma;46,XY complete gonadal dysgenesis;46,XY partial gonadal dysgenesis;Meacham syndrome;Denys-Drash syndrome;Frasier syndrome;Sporadic idiopathic steroid-resistant nephrotic syndrome with diffuse mesangial sclerosis;Familial idiopathic steroid-resistant nephrotic syndrome with diffuse mesangial sclerosis;Familial idiopathic steroid-resistant nephrotic syndrome with focal segmental hyalinosis;Desmoplastic small round cell tumor",Role in the phenotype of;Disease-causing somatic mutation(s) in;Major susceptibility factor in;Candidate gene tested in;Candidate gene tested in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Part of a fusion gene in,Endometrial cancer ((endometrioid histology)[30093612];Uterine fibroids[30194396];Tuberculosis[22306650;24057671;24057671];Resting-state electroencephalogram vigilance[29703947];Rubella-specific interleukin-6 secretion[29253144];Endometrial cancer[30093612];Inguinal hernia[26686553];,0.4795092024539877,0.88602372356885,0.8321587052988776,0.0
4010,40339,WWOX,605131,133239;614322;616211;,"[MIM:133239]Esophageal cancer;[MIM:614322]Spinocerebellar ataxia, autosomal recessive, 12 [recessive?];[MIM:616211]Epileptic encephalopathy, early infantile, 28;","46,XY partial gonadal dysgenesis;Autosomal recessive cerebellar ataxia-epilepsy-intellectual disability syndrome due to WWOX deficiency;Undetermined early-onset epileptic encephalopathy;Squamous cell carcinoma of the esophagus",Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) (loss of function) in;Disease-causing germline mutation(s) in;Major susceptibility factor in,Type 2 diabetes[22158537];Peripheral arterial disease (traffic-related air pollution interaction)[27082954];Multiple sclerosis[24076602];Pulmonary function (smoking interaction)[23284291;23284291];Colorectal cancer[29228715;29228715];Clozapine-induced cytotoxicity[25656473];Brain volume in infants (white matter)[28763065];Familial squamous cell lung carcinoma[29924316];Epstein-Barr virus copy number in lymphoblastoid cell lines[28654678];Acute graft versus host disease in bone marrow transplantation (recipient effect)[27595289];Idiopathic dilated cardiomyopathy[29495422];Obesity[21552555];Systemic juvenile idiopathic arthritis[27927641];Serum thyroid-stimulating hormone levels[25436638];Response to amphetamines[22952603];Anorexia nervosa[23568457];Daytime sleep phenotypes[27126917];Bipolar disorder (body mass index interaction)[24322204];Early-onset Parkinson's disease[28256260];Molybdenum levels[26025379];Venous thromboembolism adjusted for sickle cell variant rs77121243-T[28203683];Response to fenofibrate (HDL cholesterol levels)[27002377];Radiation response[20923822];Pulmonary function[21946350];Lung function (forced vital capacity)[24929828];Response to antipsychotic treatment in schizophrenia (reasoning)[21107309];Metabolite levels (5-HIAA)[23319000];Post bronchodilator FEV1/FVC ratio[26634245;26634245;26634245;26634245;26634245;26634245];Serum uric acid levels in response to allopurinol in gout[25676789];Cardiac structure and function[19584346];Paclitaxel disposition in epithelial ovarian cancer[29367611];,0.7987730061349694,0.6753481175863847,0.05559906029757244,0.5349907918968693
4011,40344,WWTR1,607392,,,Epithelioid hemangioendothelioma,Part of a fusion gene in,Preeclampsia[23551011];,0.6528834355828221,0.7921609076843734,0.19759853824066823,0.5363720073664825
4012,40364,XDH,607633,278300;,[MIM:278300]Xanthinuria 1;,Xanthinuria type I,Disease-causing germline mutation(s) in,Zinc levels[26025379];Multiple system atrophy[27629089];Obesity-related traits[23251661];,0.4431901840490797,0.02294997421351212,0.2354476637953537,0.06568446899938613
4013,40369,XIAP,300079,300635;,"[MIM:300635]Lymphoproliferative syndrome, X-linked, 2;",X-linked lymphoproliferative disease,Disease-causing germline mutation(s) in,,0.7592638036809816,0.8790613718411552,0.24823805794831635,0.5972989564149785
4014,40379,XK,314850,300842;,[MIM:300842]McLeod syndrome;,McLeod neuroacanthocytosis syndrome,Disease-causing germline mutation(s) in,Red blood cell traits[23696099];Serum selenium levels[23698163];Primary tooth development (time to first tooth eruption)[23704328];Hand grip strength[29691431;29691431;29691431;29691431;29691431;29691431];Response to anti-TNF therapy in rheumatoid arthritis[23555300];Alcohol and nicotine co-dependence[23216389];General cognitive ability[29844566];Primary tooth development (number of teeth)[23704328];,0.20368098159509201,0.8994326972666323,0.9843382928739233,0.0
4015,40397,XPA,611153,278700;,[MIM:278700]Xeroderma pigmentosum complementation group A [recessive?];,Xeroderma pigmentosum,Disease-causing germline mutation(s) in,"Thyroid cancer (Papillary, radiation-related)[20350937];Serum thyroid-stimulating hormone levels[24852370];Obesity-related traits[23251661];Hypothyroidism[27182965];",0.47705521472392637,0.2699845281072718,0.5922735578178021,0.1949048496009822
4016,40398,XPC,613208,278720;,[MIM:278720]Xeroderma pigmentosum complementation group C [recessive?];,Xeroderma pigmentosum,Disease-causing germline mutation(s) in,,0.6920245398773006,0.8210417741103662,0.44766379535369355,0.03806015960712093
4017,40400,XPNPEP2,300145,300909;,[MIM:300909]Angioedema induced by ACE inhibitors;,Renin-angiotensin-aldosterone system-blocker-induced angioedema,Major susceptibility factor in,,0.038773006134969326,0.07091284167096441,0.3547376664056382,0.1663597298956415
4018,40401,XPNPEP3,613553,613159;,,Late-onset nephronophthisis,Disease-causing germline mutation(s) in,Autism spectrum disorder or schizophrenia[28540026;28540026];Schizophrenia[28991256];,0.8488343558282209,0.15703971119133575,0.8412947011224223,0.2504604051565378
4019,40402,XPO1,602559,,,Primary mediastinal large B-cell lymphoma,Candidate gene tested in,Sum eosinophil basophil counts[27863252];Systemic lupus erythematosus[28714469];Atrial fibrillation[29892015;29892015];Eosinophil counts[27863252];,0.9698159509202454,0.8099535843218154,0.9342208300704777,0.0
4020,40409,XPR1,605237,616413;,"[MIM:616413]Basal ganglia calcification, idiopathic, 6 [dominant?];",Bilateral striopallidodentate calcinosis,Disease-causing germline mutation(s) in,Asthma (childhood onset)[23829686];,0.7608588957055215,0.9834966477565755,0.8504306969459671,0.7220687538367097
4021,40411,XRCC2,600375,617247;,"[MIM:617247]Fanconi anemia, complementation group U;",Fanconi anemia;Hereditary breast cancer;Male infertility with azoospermia or oligozoospermia due to single gene mutation,Disease-causing germline mutation(s) in;Major susceptibility factor in;Disease-causing germline mutation(s) in,Mean platelet volume[27863252];Palmitic acid (16:0) levels[23362303];Diabetic kidney disease[26305897];,0.6391411042944786,0.1817947395564724,0.4108587836074132,0.10880908532842234
4022,40413,XRCC4,194363,616541;,"[MIM:616541]Short stature, microcephaly, and endocrine dysfunction;",Microcephalic primordial dwarfism-insulin resistance syndrome;LIG4 syndrome,Disease-causing germline mutation(s) in;Candidate gene tested in,Type 2 diabetes[25760438];White matter integrity (fractional anisotropy)[29752348];Squamous cell lung carcinoma[28604730;28604730];White matter integrity (mean diffusivity)[29752348];Clozapine-induced agranulocytosis[25187353];Diisocyanate-induced asthma[25918132];Osteoarthritis biomarkers[25057126];,0.5811042944785276,0.1890149561629706,0.13730096580527276,0.027624309392265192
4023,40431,XYLT1,608124,264800;615777;,[MIM:615777]Desbuquois dysplasia 2;[MIM:264800]Pseudoxanthoma elasticum;,Desbuquois syndrome;XYLT1-CDG,Disease-causing germline mutation(s) (loss of function) in;Disease-causing germline mutation(s) (loss of function) in,Pathological gambling[27315593];Mosquito bite size[28199695];Corneal astigmatism[23322567];,0.4645398773006135,0.8772563176895307,0.16914643696162882,0.6497851442602823
4024,40432,XYLT2,608125,264800;605822;,[MIM:605822]Spondyloocular syndrome;[MIM:264800]Pseudoxanthoma elasticum;,Spondylo-ocular syndrome,Disease-causing germline mutation(s) (loss of function) in,,0.35496932515337426,0.5523465703971119,0.1417384494909945,0.3623388581952118
4025,40436,YAP1,606608,120433;,"[MIM:120433]Coloboma, ocular, with or without hearing impairment, cleft lip/palate, and/or mental retardation [dominant?];",Uveal coloboma-cleft lip and palate-intellectual disability;Epithelioid hemangioendothelioma,Disease-causing germline mutation(s) (loss of function) in;Part of a fusion gene in,Polycystic ovary syndrome[22885925;26416764];Pubertal anthropometrics[23449627];Cleft palate[27018472;27018472;27018472;27018472];Whole-brain volume (Alzheimer's disease interaction)[21116278];Migraine[27322543];Prostate cancer[23535732];,0.8571779141104294,0.9342444559051057,0.7496737144348734,0.9407612031921424
4026,40440,YARS,603623,608323;,"[MIM:608323]Charcot-Marie-Tooth disease, dominant, intermediate type, C;",Autosomal dominant intermediate Charcot-Marie-Tooth disease type C,Disease-causing germline mutation(s) in,,0.7442944785276073,0.3359979370809696,0.6935525972330984,0.23511356660527932
4027,40441,YARS2,610957,613561;,[MIM:613561]Myopathy with lactic acidosis and sideroblastic anemia 2;,Mitochondrial myopathy and sideroblastic anemia,Disease-causing germline mutation(s) in,Diverticular disease[30177863];,0.9680981595092024,0.09747292418772563,0.2328373792743409,0.11955187231430325
4028,40503,YWHAE,605066,,,Distal 17p13.3 microdeletion syndrome;Endometrial stromal sarcoma;17p13.3 microduplication syndrome;Miller-Dieker syndrome;Clear cell sarcoma of kidney,Role in the phenotype of;Part of a fusion gene in;Role in the phenotype of;Role in the phenotype of;Part of a fusion gene in,Atrial fibrillation[30061737];Schizophrenia[28991256];Reaction time[29844566];,0.9987730061349693,0.8447653429602888,0.9874706342991386,0.7763965623081646
4029,40511,YWHAG,605356,617665;,"[MIM:617665]Epileptic encephalopathy, early infantile, 56 [dominant?];",Undetermined early-onset epileptic encephalopathy,Disease-causing germline mutation(s) in,Multiple sclerosis[21654844;21654844];,0.9796319018404908,0.9061371841155235,0.980422866092404,0.0
4030,40533,YY1,600013,617557;,[MIM:617557]Gabriele-de Vries syndrome [dominant?];,Gabriele-de Vries syndrome,Disease-causing germline mutation(s) (loss of function) in,,0.8284662576687116,0.8775141825683342,0.5964500130514226,0.0
4031,40534,YY1AP1,607860,602531;,,Grange syndrome,Disease-causing germline mutation(s) in,Inflammatory bowel disease[28067908];Crohn's disease[28067908];,0.3889570552147239,0.16013408973697782,0.3354215609501436,0.051718845917740945
4032,40542,ZAP70,176947,269840;617006;,"[MIM:269840]Immunodeficiency 48;[MIM:617006]Autoimmune disease, multisystem, infantile-onset, 2 [recessive?];",Combined immunodeficiency due to ZAP70 deficiency,Disease-causing germline mutation(s) in,,0.5519018404907975,0.7617328519855595,0.7470634299138607,0.8778391651319828
4033,40580,ZBTB16,176797,612447;,"[MIM:612447]Skeletal defects, genital hypoplasia, and mental retardation;",Acute promyelocytic leukemia;Precursor T-cell acute lymphoblastic leukemia,Part of a fusion gene in;Part of a fusion gene in,Polycystic ovary syndrome[26284813];Granulocyte percentage of myeloid white cells[27863252];Paneth cell defects in Crohn's disease[28352666];Myeloid white cell count[27863252;27863252];Conduct disorder (maternal expressed emotions interaction)[18846501];Plateletcrit[27863252];Sum basophil neutrophil counts[27863252;27863252];Sum neutrophil eosinophil counts[27863252;27863252];Monocyte percentage of white cells[27863252;27863252];Granulocyte count[27863252;27863252];Neutrophil count[27863252;27863252];Non-glioblastoma glioma[26424050;28346443];Mean platelet volume[27863252;27863252];White blood cell count[27863252;27863252];Diisocyanate-induced asthma[25918132];Corneal astigmatism[29422769];Platelet count[27863252;27863252];,0.5900613496932515,0.7447137699845281,0.8595666927695119,0.7685696746470227
4034,40582,ZBTB18,608433,612337;,,Distal monosomy 1q,Role in the phenotype of,Mercury levels[26025379];,0.28662576687116564,0.9458483754512635,0.8561733228921953,0.0
4035,40583,ZBTB20,606025,259050;,[MIM:259050]Primrose syndrome;,Intellectual disability-cataracts-calcified pinnae-myopathy syndrome,Disease-causing germline mutation(s) in,Mitochondrial DNA levels[25240745];Type 2 diabetes[26818947];HIV-1 viral setpoint[26039976];Gastric cancer[22037551];Urate levels in obese individuals[25811787];Mucinous adenocarcinoma in colorectal cancer[29942513;29942513];,0.7088343558282209,0.6768953068592057,0.60610806577917,0.0
4036,40591,ZBTB24,614064,614069;,[MIM:614069]Immunodeficiency-centromeric instability-facial anomalies syndrome 2;,ICF syndrome,Disease-causing germline mutation(s) in,Height[20881960;18391951];Depression in smokers[30219690];,0.5040490797546012,0.30195977307890665,0.4139911250326286,0.33302639656230815
4037,40631,ZC3H14,613279,617125;,,Autosomal recessive non-syndromic intellectual disability,Disease-causing germline mutation(s) in,,0.7602453987730061,0.4308922124806601,0.7337509788566954,0.9260282381829343
4038,40638,ZC4H2,300897,314580;,,Intellectual disability-developmental delay-contractures syndrome,Disease-causing germline mutation(s) in,Erectile dysfunction and prostate cancer treatment[20932654];,0.3168098159509202,0.8604951005673027,0.9631949882537196,0.8146101903007981
4039,40667,ZDHHC9,300646,300799;,"[MIM:300799]Mental retardation, X-linked, syndromic, ZDHHC9-related;",X-linked intellectual disability with marfanoid habitus,Disease-causing germline mutation(s) in,,0.31079754601226994,0.7570912841670965,0.985121378230227,0.462707182320442
4040,40688,ZEB1,189909,609141;613270;,"[MIM:613270]Corneal dystrophy, Fuchs endothelial, 6;",Posterior polymorphous corneal dystrophy;Fuchs endothelial corneal dystrophy,Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) (loss of function) in,Pulse pressure[28135244];Waist-hip ratio[20935629];Waist-to-hip ratio adjusted for BMI[26426971];Waist-to-hip ratio adjusted for BMI x sex x age interaction (4df test)[26426971];,0.5997546012269939,0.9203197524497163,0.418167580266249,0.405463474524248
4041,40690,ZEB2,605802,235730;,[MIM:235730]Mowat-Wilson syndrome;,Mowat-Wilson syndrome due to monosomy 2q22;Mowat-Wilson syndrome due to a ZEB2 point mutation,Role in the phenotype of;Disease-causing germline mutation(s) in,"Myocardial infarction[26343387];Mean corpuscular hemoglobin concentration[29403010];Spherical equivalent or myopia (age of diagnosis)[29808027];Mean corpuscular volume[29403010];Mean corpuscular hemoglobin[29403010];Schizophrenia[23974872];Hand grip strength[29691431];Red blood cell count[29403010];Coronary artery disease[26343387;29212778;29212778];Photic sneeze reflex[27182965];Epilepsy (generalized)[22949513];Renal cell carcinoma[23184150;25826619];Chin dimples[27182965];Obesity-related traits[23251661];Coronary artery disease (myocardial infarction, percutaneous transluminal coronary angioplasty, coronary artery bypass grafting, angina or chromic ischemic heart disease)[28714975];",0.5885889570552147,1.0,0.5969720699556251,0.9484346224677717
4042,40709,ZFHX4,606940,,,Congenital ptosis,Candidate gene tested in,Basal cell carcinoma[27539887;25855136];Monobrow[27182965];Height[18391951];Menarche (age at onset)[23667675;29773799];Non-melanoma skin cancer[29739929];,0.6946012269938651,0.5959257349149046,0.11224223440354998,0.42464702271332105
4043,40718,ZFP36L1,601064,,,Cerebellar-facial-dental syndrome,Disease-causing germline mutation(s) (loss of function) in,Inflammatory bowel disease[23128233];Celiac disease[20190752;22057235];Multiple sclerosis[21833088;24076602];Juvenile idiopathic arthritis (oligoarticular or rheumatoid factor-negative polyarticular)[23603761];Urinary albumin excretion[30220432];Crohn's disease[21102463];Fibrinogen levels[26561523;28107422;28107422];Prostate cancer[23535732];,0.30319018404907977,0.6155234657039711,0.8872357086922474,0.42863720073664824
4044,40723,ZFP57,612192,601410;,[MIM:601410]Transient neonatal diabetes mellitus 1;,Transient neonatal diabetes mellitus,Disease-causing germline mutation(s) in,Autism spectrum disorder or schizophrenia[28540026;28540026;28540026;28540026;28540026;28540026;28540026;28540026;28540026;28540026;28540026;28540026];Blood protein levels[28240269];Albumin-globulin ratio[29403010];,0.22687116564417178,0.3220732336255802,0.5379796397807362,0.20687538367096378
4045,40736,ZFPM2,603693,187500;217095;610187;616067;,"[MIM:187500]Tetralogy of Fallot;[MIM:610187]Diaphragmatic hernia 3;[MIM:616067]46,XY sex reversal 9;[MIM:217095]Conotruncal heart malformations;","Congenital diaphragmatic hernia;Tetralogy of Fallot;46,XY partial gonadal dysgenesis",Major susceptibility factor in;Major susceptibility factor in;Disease-causing germline mutation(s) in,"Sudden cardiac arrest[21658281];Systolic blood pressure[28739976;28739976];White blood cell count (basophil)[27863252];Vascular endothelial growth factor levels[21757650;26910538];Platelet distribution width[27863252];Coronary artery calcification[23870195];Plateletcrit[27863252];Blood protein levels[28240269;28240269;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488];Coronary artery disease[29212778;29212778];Glaucoma (primary open-angle)[22570617];Mean platelet volume[27863252];Tuberculosis[24057671];Autism spectrum disorder, attention deficit-hyperactivity disorder, bipolar disorder, major depressive disorder, and schizophrenia (combined)[23453885];Takayasu arteritis[25604533];Platelet count[22139419;26805783;27863252;29403010];Venous thromboembolism[28373160;25772935];",0.634601226993865,0.97279525528623,0.1806316888540851,0.6658993247391037
4046,40738,ZFR,615635,,,Autosomal recessive spastic paraplegia type 71,Disease-causing germline mutation(s) in,,0.9334969325153374,1.0,0.14669799008091883,0.7931246163290362
4047,40752,ZFYVE26,612012,270700;,"[MIM:270700]Spastic paraplegia 15, autosomal recessive [recessive?];",Autosomal recessive spastic paraplegia type 15,Disease-causing germline mutation(s) in,Amyotrophic lateral sclerosis (sporadic)[24529757];,0.4,0.5175348117586385,0.11406943356825894,0.08578882750153469
4048,40764,ZIC1,600470,616602;,[MIM:616602]Craniosynostosis 6;,Isolated Dandy-Walker malformation without hydrocephalus;Isolated Dandy-Walker malformation with hydrocephalus;Isolated oxycephaly;Isolated brachycephaly;Isolated plagiocephaly,Role in the phenotype of;Role in the phenotype of;Disease-causing germline mutation(s) (gain of function) in;Disease-causing germline mutation(s) (gain of function) in;Disease-causing germline mutation(s) (gain of function) in,Multiple sclerosis[19010793];Monobrow[27182965];Chin dimples[27182965];Daytime sleep phenotypes[27126917;27126917];,0.5213496932515338,0.8205260443527591,0.95510310623858,0.919122160834868
4049,40765,ZIC2,603073,609637;,[MIM:609637]Holoprosencephaly 5;,Microform holoprosencephaly;Septopreoptic holoprosencephaly;Semilobar holoprosencephaly;Midline interhemispheric variant of holoprosencephaly;Lobar holoprosencephaly;Alobar holoprosencephaly,Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in,Spherical equivalent or myopia (age of diagnosis)[29808027];Refractive error[23396134];Myopia[27182965];Hyperopia[25233373];,0.48576687116564415,0.9141309953584322,0.4142521534847298,0.0
4050,40766,ZIC3,300265,306955;314390;,"[MIM:306955]Heterotaxy, visceral, 1, X-linked;[MIM:314390]VACTERL association X-linked with or without hydrocephalus;[MIM:306955]Congenital heart defects, multiple types, 1, X-linked;",Situs ambiguus;Isolated congenitally uncorrected transposition of the great arteries,Major susceptibility factor in;Major susceptibility factor in,,0.21484662576687116,0.8777720474471377,0.7363612633777081,0.0
4051,40767,ZIC4,608948,,,Isolated Dandy-Walker malformation without hydrocephalus;Isolated Dandy-Walker malformation with hydrocephalus,Role in the phenotype of;Role in the phenotype of,Adult asthma[27611488];,0.33226993865030674,0.3212996389891697,0.6066301226833725,0.4894106813996317
4052,40793,ZMPSTE24,606480,275210;608612;,[MIM:608612]Mandibuloacral dysplasia with type B lipodystrophy;[MIM:275210]Lethal tight skin contracture syndrome [recessive?];,Restrictive dermopathy;Hutchinson-Gilford progeria syndrome;Mandibuloacral dysplasia with type B lipodystrophy,Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in,,0.8276073619631902,0.04951005673027334,0.828765335421561,0.31077348066298344
4053,40802,ZMYND10,607070,615444;,"[MIM:615444]Ciliary dyskinesia, primary, 22;",Primary ciliary dyskinesia,Disease-causing germline mutation(s) (loss of function) in,,0.45680981595092024,0.35585353274883963,0.6264682850430697,0.40730509515039903
4054,40804,ZMYND11,608668,616083;,"[MIM:616083]Mental retardation, autosomal dominant 30 [dominant?];",Autosomal dominant non-syndromic intellectual disability,Disease-causing germline mutation(s) in,,0.6968098159509203,0.9868488911810211,0.9472722526755416,0.7575199508901166
4055,40806,ZMYND15,614312,615842;,[MIM:615842]Spermatogenic failure 14;,Male infertility with azoospermia or oligozoospermia due to single gene mutation,Disease-causing germline mutation(s) in,,0.038773006134969326,0.10288808664259928,0.4554946489167319,0.06368937998772253
4056,40843,ZNF41,314995,,,X-linked non-syndromic intellectual disability,Candidate gene tested in,,0.19190184049079756,0.5789066529138731,0.4638475593839729,0.13014119091467158
4057,40866,ZNF81,314998,,,X-linked non-syndromic intellectual disability,Disease-causing germline mutation(s) in,,0.038773006134969326,0.7485817431665807,0.44975202297050376,0.49386126457949664
4058,40905,ZNF141,194648,615226;,,Postaxial polydactyly type A,Disease-causing germline mutation(s) in,,0.038773006134969326,0.407426508509541,0.5604280866614461,0.0
4059,40913,ZNF160,600398,,,Congenital factor XI deficiency,Disease-causing germline mutation(s) in,Urate levels[28270201];,0.12711656441717792,0.5319752449716348,0.6664056382145653,0.10804174340085942
4060,41023,ZNF335,610827.0,615095;,"[MIM:615095]Microcephaly 10, primary, autosomal recessive [recessive?];",Microcephalic primordial dwarfism due to ZNF335 deficiency,Disease-causing germline mutation(s) in,Intelligence (MTAG)[29326435];C-reactive protein levels or triglyceride levels (pleiotropy)[27286809];Abdominal aortic aneurysm[27899403];Coronary artery disease[29212778;29212778];General cognitive ability[29844566];,0.31079754601226994,0.15858690046415677,0.3764030279300444,0.26335174953959484
4061,41041,ZNF365,607818.0,605990;,[MIM:605990]Uric acid nephrolithiasis;,Narcolepsy type 1;Narcolepsy type 2,Major susceptibility factor in;Major susceptibility factor in,"Ewing sarcoma[22327514];Basal cell carcinoma[28177523];Intelligence[22449649];Breast size[22747683;27182965];Chronic inflammatory diseases (ankylosing spondylitis, Crohn's disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy)[26974007;26974007;26974007];Eosinophil counts[27863252;27863252;29403010];Allergic disease (asthma, hay fever or eczema)[29083406];Systemic lupus erythematosus[28714469];Atopic dermatitis[23042114;26482879];Percent mammographic density[21278746;25342443];Narcolepsy[24204295;23459209];Eosinophil percentage of white cells[27863252;27863252];Mammographic density (non-dense area)[25342443];Psoriasis[28537254];Breast cancer[21908515;23535733;20453838;27117709;23535729;29059683];Crohn's disease[18587394;21102463;22936669;28067908;22412388];Vogt-Koyanagi-Harada syndrome[25108386];Breast cancer (estrogen-receptor negative)[27117709];Hypothyroidism[27182965];Alopecia areata[25608926];Inflammatory bowel disease[28067908];Mammographic density (dense area)[25342443];Sum eosinophil basophil counts[27863252;27863252];Pediatric autoimmune diseases[26301688];Eosinophil percentage of granulocytes[27863252;27863252];Autism spectrum disorder-related traits[25534755];Neutrophil percentage of granulocytes[27863252;27863252];Ulcerative colitis[28067908];",0.10711656441717791,0.7104177411036616,0.5385016966849386,0.39149785144260285
4062,41062,ZNF408,616454.0,616468;616469;,[MIM:616469]Retinitis pigmentosa 72;,Retinitis pigmentosa;Familial exudative vitreoretinopathy,Disease-causing germline mutation(s) (loss of function) in;Disease-causing germline mutation(s) in,Autism spectrum disorder or schizophrenia[28540026;28540026];Femoral neck bone mineral density[29499414];,0.5598773006134969,0.1998452810727179,0.14434873401200732,0.1998158379373849
4063,41072,ZNF423,604557.0,614844;,[MIM:614844]Nephronophthisis 14 [recessive?];[MIM:614844]Joubert syndrome 19;,Joubert syndrome with oculorenal defect;Infantile nephronophthisis,Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in,Cold medicine-related Stevens-Johnson syndrome/toxic epidermal necrolysis (SJS/TEN) with severe ocular complications[28100913;28100913];Waist circumference adjusted for BMI in non-smokers[28443625];Mosquito bite size[28199695];Waist circumference adjusted for BMI (joint analysis main effects and smoking interaction)[28443625];Inattentive symptoms[18821565];Waist circumference adjusted for BMI (adjusted for smoking behaviour)[28443625];Waist circumference adjusted for body mass index[25673412;25673412];Waist-to-hip ratio adjusted for body mass index[25673412;25673412];,0.32380368098159507,0.9868488911810211,0.4484468807099974,0.9131368937998773
4064,41102,ZNF462,617371.0,,,Metopic ridging-ptosis-facial dysmorphism syndrome,Disease-causing germline mutation(s) in,Adverse response to chemotherapy in breast cancer (alopecia) (anti-microtubule)[24025145];Waist circumference adjusted for BMI (joint analysis main effects and physical activity interaction)[28448500];Lung function (FEV1/FVC)[30061609;30061609];Emphysema imaging phenotypes[26030696];Age at voice drop[27182965];Cutaneous malignant melanoma[26237428];Cognitive decline rate in late mild cognitive impairment[26252872;26252872];Atrial fibrillation[29892015];Height[20881960;18391951];Waist circumference adjusted for body mass index[28448500];Menarche (age at onset)[19448620;27182965];,0.6871165644171779,0.9097472924187726,0.14513181936831115,0.43155310006138736
4065,41105,ZNF469,612078.0,229200;,,Brittle cornea syndrome,Disease-causing germline mutation(s) in,Central corneal thickness[20719862;22814818;20485516;28171582;28171582;29760442;29760442];White blood cell count (basophil)[29403010];Corneal structure[23291589];Pursuit maintenance gain[29064472];Axial length[24144296];Hair color[26926045];Intraocular pressure[29617998;29617998;29235454];,0.6628220858895706,0.5487364620938628,0.0723048812320543,0.0
4066,41137,ZNF513,613598.0,613617;,,Retinitis pigmentosa,Disease-causing germline mutation(s) in,Inflammatory bowel disease[28067908];Crohn's disease[28067908];,0.10711656441717791,0.7671480144404332,0.5656486557034717,0.6468692449355433
4067,41215,ZNF592,613624.0,,,CAMOS syndrome,Candidate gene tested in,Autism spectrum disorder or schizophrenia[28540026];Alzheimer's disease (age of onset)[22005931;22005931];,0.6852760736196319,0.9868488911810211,0.06108065779169929,0.970841006752609
4068,41324,ZNF711,314990.0,300803;,,X-linked non-syndromic intellectual disability,Disease-causing germline mutation(s) in,,0.6988957055214724,0.9316658071170707,0.8684416601409554,0.0
4069,41367,ZNF750,610226.0,610227;,[MIM:610227]Seborrhea-like dermatitis with psoriasiform elements;,Seborrhea-like dermatitis with psoriasiform elements,Disease-causing germline mutation(s) in,,0.038773006134969326,0.7813305827746261,0.2490211433046202,0.4722222222222222
4070,41470,ZNHIT3,604500.0,260565;,[MIM:260565]PEHO syndrome [recessive?];,PEHO syndrome,Disease-causing germline mutation(s) (loss of function) in,Body mass index[26426971];Red cell distribution width[27863252];,0.5842944785276074,0.33187209902011344,0.8647872618115374,0.35543278084714547
4071,41483,ZP1,195000.0,615774;,[MIM:615774]Oocyte maturation defect 1;,Female infertility due to zona pellucida defect,Disease-causing germline mutation(s) in,Response to ziprazidone in schizophrenia[29503163];,0.2498159509202454,0.030428055698813822,0.601409553641347,0.4085328422344997
4072,41484,ZP2,182888.0,,,Female infertility due to zona pellucida defect,Disease-causing germline mutation(s) in,Pelvic organ prolapse[26545240];,0.28662576687116564,0.17328519855595667,0.2190028713129731,0.43370165745856354
4073,41485,ZP3,182889.0,617712;,[MIM:617712]Oocyte maturation defect 3 [dominant?];,Female infertility due to zona pellucida defect,Disease-causing germline mutation(s) (loss of function) in,Parkinson disease and lewy body pathology[25663231];,0.33226993865030674,0.4664775657555441,0.28660924040720437,0.6057397176181707
4074,41531,ZSWIM6,615951.0,603671;617865;,"[MIM:603671]Acromelic frontonasal dysostosis;[MIM:617865]Neurodevelopmental disorder with movement abnormalities, abnormal gait, and autistic features [dominant?];",Acromelic frontonasal dysplasia,Disease-causing germline mutation(s) in,Body mass index[28892062];Number of pregnancies[25742292];Intelligence (MTAG)[29326435;29326435;29326435];Number of children[25742292];Autism spectrum disorder or schizophrenia[28540026;28540026];Schizophrenia[23974872;25056061];General cognitive ability[29844566;29844566];Platelet count[29403010];,0.5469938650306748,1.0,0.03628295484207779,0.0
